PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Narita, K; Sakaguchi, H; Hamada, M; Kataoka, S; Yoshida, N; Kato, K				Narita, K.; Sakaguchi, H.; Hamada, M.; Kataoka, S.; Yoshida, N.; Kato, K.			Salvage therapy for primary graft failure after hematopoietic stem cell transplantation; a single center cohort study	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Narita, K.; Sakaguchi, H.; Hamada, M.; Kataoka, S.; Yoshida, N.; Kato, K.] Japanese Red Cross Nagoya First Hosp, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P598	S419	S420				2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902211		
J	Nishimoto, M; Koh, H; Tokuwame, A; Makuuchi, Y; Kuno, M; Takakuwa, T; Okamura, H; Koh, S; Yoshimura, T; Nanno, S; Hayashi, Y; Nakamae, M; Hirose, A; Nakashima, Y; Nakane, T; Hino, M; Nakamae, H				Nishimoto, M.; Koh, H.; Tokuwame, A.; Makuuchi, Y.; Kuno, M.; Takakuwa, T.; Okamura, H.; Koh, S.; Yoshimura, T.; Nanno, S.; Hayashi, Y.; Nakamae, M.; Hirose, A.; Nakashima, Y.; Nakane, T.; Hino, M.; Nakamae, H.			Drug interaction and safety profiles of concomitant use of caspofungin and tacrolimus in allogeneic hematopoietic stem cell transplant recipients	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Nishimoto, M.; Koh, H.; Makuuchi, Y.; Kuno, M.; Takakuwa, T.; Okamura, H.; Koh, S.; Yoshimura, T.; Nanno, S.; Hayashi, Y.; Nakamae, M.; Hirose, A.; Nakashima, Y.; Nakane, T.; Hino, M.; Nakamae, H.] Osaka City Univ, Grad Sch Med, Hematol, Osaka 558, Japan; [Tokuwame, A.] Osaka City Univ Hosp, Dept Pharm, Osaka, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P575	S408	S408				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902189		
J	Ozawa, Y; Miyamura, K; Ozeki, K; Kohno, A; Morishita, Y				Ozawa, Y.; Miyamura, K.; Ozeki, K.; Kohno, A.; Morishita, Y.			A plasma marker panel predictive for transplant-related complications and survival	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Ozawa, Y.; Miyamura, K.] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Ozeki, K.; Kohno, A.; Morishita, Y.] JA Aichi Konan Kosei Hosp, Dept Hematol, Konan, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P628	S434	S435				2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902241		
J	Sakaguchi, H; Matsumoto, K; Narita, K; Hamada, M; Kataoka, S; Yoshida, N; Ito, M; Kato, K				Sakaguchi, H.; Matsumoto, K.; Narita, K.; Hamada, M.; Kataoka, S.; Yoshida, N.; Ito, M.; Kato, K.			Successful treatment with dexamethasone palmitate for patients with post-transplant cytokine storm syndrome	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Sakaguchi, H.; Narita, K.; Hamada, M.; Kataoka, S.; Yoshida, N.; Kato, K.] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Matsumoto, K.] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan; [Ito, M.] Japanese Red Cross Nagoya First Hosp, Dept Pathol, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P199	S217	S217				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632901195		
J	Sakaguchi, H; Narita, A; Narita, K; Kataoka, S; Hamada, M; Murakami, N; Sekiya, Y; Suzuki, K; Kawashima, N; Okuno, Y; Doisaki, S; Muramatsu, H; Yoshida, N; Nishio, N; Hama, A; Takahashi, Y; Kojima, S; Kato, K				Sakaguchi, H.; Narita, A.; Narita, K.; Kataoka, S.; Hamada, M.; Murakami, N.; Sekiya, Y.; Suzuki, K.; Kawashima, N.; Okuno, Y.; Doisaki, S.; Muramatsu, H.; Yoshida, N.; Nishio, N.; Hama, A.; Takahashi, Y.; Kojima, S.; Kato, K.			Allogeneic hematopoietic stem cell transplantation for pediatric T lineage acute lymphoblastic leukemia	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Sakaguchi, H.; Narita, K.; Kataoka, S.; Hamada, M.; Yoshida, N.; Kato, K.] Nagoya Univ, Grad Sch Med, Japanese Red Cross Nagoya First Hosp, Dept Hematol & Oncol,Childrens Med Ctr, Nagoya, Aichi 4648601, Japan; [Narita, A.; Murakami, N.; Sekiya, Y.; Suzuki, K.; Kawashima, N.; Okuno, Y.; Doisaki, S.; Muramatsu, H.; Nishio, N.; Hama, A.; Takahashi, Y.; Kojima, S.] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P269	S251	S251				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632901264		
J	Sakemura, R; Imahashi, N; Ohashi, H; Terakura, S; Miyao, K; Kato, T; Sawa, M; Yokohata, E; Kurahashi, S; Ozawa, Y; Nishida, T; Kiyoi, H; Watamoto, K; Kohno, A; Kasai, M; Kato, C; Iida, H; Naoe, T; Miyamura, K; Murata, M				Sakemura, R.; Imahashi, N.; Ohashi, H.; Terakura, S.; Miyao, K.; Kato, T.; Sawa, M.; Yokohata, E.; Kurahashi, S.; Ozawa, Y.; Nishida, T.; Kiyoi, H.; Watamoto, K.; Kohno, A.; Kasai, M.; Kato, C.; Iida, H.; Naoe, T.; Miyamura, K.; Murata, M.			Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Sakemura, R.; Miyao, K.; Kato, T.; Sawa, M.] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan; [Sakemura, R.; Imahashi, N.; Terakura, S.; Miyao, K.; Nishida, T.; Kiyoi, H.; Murata, M.] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Ohashi, H.] Toyota Mem Hosp, Div Hematol, Toyota, Japan; [Ohashi, H.; Iida, H.; Naoe, T.] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Yokohata, E.; Kurahashi, S.; Ozawa, Y.; Miyamura, K.] Japanese Red Cross Nagoya Daiichi Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Watamoto, K.; Kohno, A.] JA Aichi Konan Kosei Hosp, Dept Hematol & Oncol, Konan, Japan; [Kasai, M.; Kato, C.] Nagoya Daini Red Cross Hosp, Dept Hematol, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P666	S453	S453				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902279		
J	Sugiyama, M; Terashita, Y; Ohshima, J; Cho, Y; Iguchi, A				Sugiyama, M.; Terashita, Y.; Ohshima, J.; Cho, Y.; Iguchi, A.			The efficacy of tandem stem cell transplantation in patients with high-risk neuroblastoma	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Sugiyama, M.; Terashita, Y.; Ohshima, J.; Cho, Y.; Iguchi, A.] Hokkaido Univ, Grad Sch Med, Pediat, Sapporo, Hokkaido, Japan; [Cho, Y.] Hokkaido Canc Ctr, Pediat, Sapporo, Hokkaido, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P376	S309	S310				2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632901369		
J	Takahashi, Y; Narita, A; Kawashima, N; Sekiya, Y; Suzuki, K; Murakami, N; Kojima, D; Dosisaki, S; Kamei, M; Irie, M; Okuno, Y; Muramatsu, H; Nishio, N; Hama, A; Horibe, K; Kato, K; Kojima, S				Takahashi, Y.; Narita, A.; Kawashima, N.; Sekiya, Y.; Suzuki, K.; Murakami, N.; Kojima, D.; Dosisaki, S.; Kamei, M.; Irie, M.; Okuno, Y.; Muramatsu, H.; Nishio, N.; Hama, A.; Horibe, K.; Kato, K.; Kojima, S.			KIR-ligand incompatibility in the graft-versus-host direction improves progression-free survival in patients with primary high risk neuroblastoma after umbilical cord blood transplantation with nonmyeloablative conditioning	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Takahashi, Y.; Narita, A.; Kawashima, N.; Sekiya, Y.; Suzuki, K.; Murakami, N.; Kojima, D.; Dosisaki, S.; Kamei, M.; Irie, M.; Okuno, Y.; Muramatsu, H.; Nishio, N.; Hama, A.; Kojima, S.] Nagoya Univ Grad Sch Med, Pediat, Nagoya, Aichi, Japan; [Horibe, K.] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Kato, K.] Japanese Red Cross Nagoya First Hosp, Dept Hematol & Oncol, Childrens Med Ctr, Nagoya, Aichi, Japan			Kamei, Michi/Q-1460-2015	Kamei, Michi/0000-0002-3353-7045				0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		O092	S53	S54				2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632900093		
J	Tsuji, M; Araoka, H; Asano-Mori, Y; Uchida, N; Yuasa, M; Koji, D; Kageyama, K; Wada, S; Nishida, A; Ishiwata, K; Takagi, S; Yamamoto, H; Yamamoto, G; Izutsu, K; Wake, A; Makino, S; Yoneyama, A; Taniguchi, S				Tsuji, M.; Araoka, H.; Asano-Mori, Y.; Uchida, N.; Yuasa, M.; Koji, D.; Kageyama, K.; Wada, S.; Nishida, A.; Ishiwata, K.; Takagi, S.; Yamamoto, H.; Yamamoto, G.; Izutsu, K.; Wake, A.; Makino, S.; Yoneyama, A.; Taniguchi, S.			Risk factors associated with Pneumocysctis jirovecii pneumonia after allogeneic stem cell transplantation; when can PCP prophylaxis be discontinued?	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Tsuji, M.; Asano-Mori, Y.; Uchida, N.; Yuasa, M.; Koji, D.; Kageyama, K.; Wada, S.; Ishiwata, K.; Takagi, S.; Yamamoto, H.; Yamamoto, G.; Izutsu, K.; Taniguchi, S.] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Tsuji, M.; Nishida, A.; Wake, A.] Toranomon Hosp Kajigaya, Dept Hematol, Kawasaki, Kanagawa, Japan; [Araoka, H.; Yoneyama, A.] Toranomon Gen Hosp, Dept Clin Infect Dis, Tokyo, Japan; [Ishiwata, K.; Makino, S.] Toranomon Gen Hosp, Dept Transfus Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P571	S406	S406				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902185		
J	Wada, S; Asano-Mori, Y; Yamamoto, H; Yuasa, M; Kageyama, K; Kaji, D; Nishida, A; Ishiwata, K; Tsuji, M; Takagi, S; Yamamoto, G; Uchida, N; Izutsu, K; Makino, S; Wake, A; Taniguchi, S				Wada, S.; Asano-Mori, Y.; Yamamoto, H.; Yuasa, M.; Kageyama, K.; Kaji, D.; Nishida, A.; Ishiwata, K.; Tsuji, M.; Takagi, S.; Yamamoto, G.; Uchida, N.; Izutsu, K.; Makino, S.; Wake, A.; Taniguchi, S.			No post-transplant PRCA development in 106 major ABO incompatible cord blood transplantation: A single center analysis	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Wada, S.; Asano-Mori, Y.; Yamamoto, H.; Yuasa, M.; Kageyama, K.; Kaji, D.; Ishiwata, K.; Takagi, S.; Yamamoto, G.; Uchida, N.; Izutsu, K.; Taniguchi, S.] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Nishida, A.; Tsuji, M.; Wake, A.] Toranomon Hosp Kajigaya, Dept Hematol, Kawasaki, Kanagawa, Japan; [Makino, S.] Toranomon Gen Hosp, Dept Transfus Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		O062	S37	S37				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632900063		
J	Yamashita, T; Uchida, N; Fukuda, T; Iwato, K; Ohashi, K; Etoh, T; Ogawa, H; Nagamura-Inoue, T; Morishima, Y; Ichinohe, T; Atsuta, Y; Takami, A				Yamashita, T.; Uchida, N.; Fukuda, T.; Iwato, K.; Ohashi, K.; Etoh, T.; Ogawa, H.; Nagamura-Inoue, T.; Morishima, Y.; Ichinohe, T.; Atsuta, Y.; Takami, A.		Adult AML Working Grp; Japan Soc Hematopoietic Cell	Cytogenetic risk stratification system for adult patients with AML undergoing allogeneic hematopoietic cell transplantation: A nationwide retrospective study from the adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Yamashita, T.; Fukuda, T.] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan; [Uchida, N.] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Hematol, Tokyo, Japan; [Iwato, K.] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan; [Iwato, K.] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Ohashi, K.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Etoh, T.] Federat Natl Publ Serv Personnel Mutual Aid Assoc, Dept Hematol, Fukuoka, Japan; [Ogawa, H.] Hyogo Coll Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan; [Nagamura-Inoue, T.] Univ Tokyo, Inst Med Sci, Dept Cell Proc & Transfus, Res Hosp, Tokyo, Japan; [Nagamura-Inoue, T.] Japan Cord Blood Bank Network, Tokyo, Japan; [Morishima, Y.] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Morishima, Y.] Japan Marrow Donor Program, Tokyo, Japan; [Ichinohe, T.] Hiroshima Univ Hosp, Dept Hematol & Oncol, Hiroshima, Japan; [Ichinohe, T.] Japan Soc Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Y.] Nagoya Univ Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi, Japan; [Atsuta, Y.] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Takami, A.] Aichi Med Univ Hosp, Dept Hematol, Nagoya, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		O097	S57	S57				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632900098		
J	Yamazaki, F; Kiyotani, C; Shioda, Y; Osumi, T; Terashima, K; Tomizawa, D; Matsumoto, K				Yamazaki, F.; Kiyotani, C.; Shioda, Y.; Osumi, T.; Terashima, K.; Tomizawa, D.; Matsumoto, K.			Mega-dose double conditioning chemotherapy of thiotepa and melphalan is feasible about renal function for the treatment of pediatric solid tumor	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Yamazaki, F.; Kiyotani, C.; Shioda, Y.; Osumi, T.; Terashima, K.; Tomizawa, D.; Matsumoto, K.] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan							Hara J, 1998, BONE MARROW TRANSPL, V22, P7, DOI 10.1038/sj.bmt.1701283	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P195	S215	S215				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632901191		
J	Yanagiaswa, R; Ishii, E; Motoki, N; Yamazaki, S; Morita, D; Sakashita, K; Shiohara, M; Tanaka, M; Hidaka, Y; Kubota, N; Hidaka, E; Ogiso, Y; Nakamura, T; Yasukochi, S				Yanagiaswa, R.; Ishii, E.; Motoki, N.; Yamazaki, S.; Morita, D.; Sakashita, K.; Shiohara, M.; Tanaka, M.; Hidaka, Y.; Kubota, N.; Hidaka, E.; Ogiso, Y.; Nakamura, T.; Yasukochi, S.			Pretransplant corrected QT dispersion as a predictor of pericardial effusion associated with thrombotic microangiopathy after pediatric hematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Yanagiaswa, R.; Sakashita, K.; Nakamura, T.] Nagano Childrens Hosp, Div Hematol Oncol, Azumino, Japan; [Yanagiaswa, R.; Motoki, N.; Yamazaki, S.; Morita, D.; Sakashita, K.; Tanaka, M.; Hidaka, Y.] Shinshu Univ Sch Med, Dept Pediat, Matsumoto, Nagano, Japan; [Ishii, E.] Nagano Prefectural Suzaka Hosp, Dept Pediat, Suzaka, Japan; [Shiohara, M.] Matsumoto Dent Univ Sch Dent, Dept Pediat, Shiojiri, Japan; [Kubota, N.; Hidaka, E.] Nagano Childrens Hosp, Dept Lab Med, Azumino, Japan; [Kubota, N.; Hidaka, E.; Nakamura, T.] Nagano Childrens Hosp, Life Sci Res Ctr, Azumino, Japan; [Ogiso, Y.] Nagano Childrens Hosp, Div Clin Pathol, Azumino, Japan; [Yasukochi, S.] Nagano Childrens Hosp, Div Pediat Cardiol, Azumino, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		P616	S428	S429				2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632902229		
J	Yoshimi, A; Baldomero, H; Passweg, J; Nollke, P; Aljurf, M; Pasquini, M; Atsuta, Y; Iida, M; Bouzas, LF; Szer, J; Lipton, J; Dufour, C; Gratwohl, M; Horowitz, M; Niederwieser, D; Gratwohl, A; Kodera, Y				Yoshimi, A.; Baldomero, H.; Passweg, J.; Noellke, P.; Aljurf, M.; Pasquini, M.; Atsuta, Y.; Iida, M.; Bouzas, L. F.; Szer, J.; Lipton, J.; Dufour, C.; Gratwohl, M.; Horowitz, M.; Niederwieser, D.; Gratwohl, A.; Kodera, Y.		Worldwide Network Blood Marrow	Hematopoietic Stem Cell Transplantation for Bone Marrow Failure and Use of Stem Cell Source: Time for Concerted Actions	BONE MARROW TRANSPLANTATION			English	Meeting Abstract	41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation	MAR 22-25, 2015	Istanbul, TURKEY	European Soc Blood & Marrow Transplantat					[Yoshimi, A.; Noellke, P.] Univ Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Yoshimi, A.; Atsuta, Y.] Nagoya Univ, Asia Pacific Blood & Marrow Transplant Grp Data C, Nagoya, Aichi 4648601, Japan; [Baldomero, H.; Passweg, J.; Gratwohl, A.] Univ Basel Hosp, European Grp Blood & Marrow Transplantat Transpla, CH-4031 Basel, Switzerland; [Aljurf, M.] King Faisal Specialist Hosp & Res Ctr, Eastern Mediterranean Blood & Marrow Transplant G, Riyadh 11211, Saudi Arabia; [Pasquini, M.] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Iida, M.; Kodera, Y.] Aichi Med Univ, Sch Med, Asia Pacific Blood & Marrow Transplant Grp Data C, Negakute, Japan; [Bouzas, L. F.] Inst Nacl Canc, Soc Brasileira Transplante Medula Ossea, Rio De Janeiro, Brazil; [Szer, J.] Royal Melbourne Hosp, Australasian BM Transplant Recipient Registry, Melbourne, Vic, Australia; [Lipton, J.] Princess Margaret Hosp, Canadian Blood & Marrow Transplant Grp, Toronto, ON M4X 1K9, Canada; [Dufour, C.] G Gaslini Childrens Hosp, Clin & Expt Hematol Unit, European Grp Blood & Marrow Transplantat Severe A, Genoa, Italy; [Gratwohl, M.] Univ St Gallen, Inst Operat Res & Computat Finances, St Gallen, Switzerland; [Niederwieser, D.] Univ Hosp, Hematol Oncol Dept, Leipzig, Germany								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	MAR	2015	50			1		O146	S85	S85				1	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	CE2GN	WOS:000351632900147		
J	Abe, Y; Shien, T; Watanabe, S; Nogami, T; Iwamoto, T; Motoki, T; Taira, N; Matsuoka, J; Kimata, Y; Doihara, H				Abe, Y.; Shien, T.; Watanabe, S.; Nogami, T.; Iwamoto, T.; Motoki, T.; Taira, N.; Matsuoka, J.; Kimata, Y.; Doihara, H.			The evaluation of safety of postmastectomy radiation therapy after immediate breast reconstruction	BREAST			English	Meeting Abstract									[Abe, Y.; Shien, T.; Watanabe, S.; Nogami, T.; Iwamoto, T.; Motoki, T.; Taira, N.; Matsuoka, J.; Kimata, Y.; Doihara, H.] Okayama Univ Hosp, Breast Canc Treatment & Reconstruct, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P289	S126	S126				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000318		
J	Adachi, Y; Yoshimura, A; Ichikawa, M; Ishiguro, J; Kotani, H; Hisada, T; Hattori, M; Kondou, N; Sawaki, M; Iwata, H				Adachi, Y.; Yoshimura, A.; Ichikawa, M.; Ishiguro, J.; Kotani, H.; Hisada, T.; Hattori, M.; Kondou, N.; Sawaki, M.; Iwata, H.			Prognostic value of troponin I for chemotherapy-induced cardiac dysfunction in breast cancer patients	BREAST			English	Meeting Abstract									[Adachi, Y.; Yoshimura, A.; Ichikawa, M.; Ishiguro, J.; Kotani, H.; Hisada, T.; Hattori, M.; Kondou, N.; Sawaki, M.; Iwata, H.] Aichi Canc Ctr Hosp, Breast Oncol, Nagoya, Aichi 464, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P139	S72	S73				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000178		
J	Akiyoshi, S; Oikawa, M; Koi, Y; Koga, C; Nishimura, S; Nakamura, Y; Ishida, M; Ohno, S				Akiyoshi, S.; Oikawa, M.; Koi, Y.; Koga, C.; Nishimura, S.; Nakamura, Y.; Ishida, M.; Ohno, S.			Prognosis of hormone receptor positive recurrent breast cancer during endocrine therapy	BREAST			English	Meeting Abstract									[Akiyoshi, S.; Oikawa, M.; Koi, Y.; Koga, C.; Nishimura, S.; Nakamura, Y.; Ishida, M.; Ohno, S.] Kyushu Natl Canc Ctr, Breast Oncol, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P172	S84	S84				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000210		
J	Aogi, K; Hida, A; Oshiro, Y; Inoue, H; Kawaguchi, H; Yamashita, N; Moriya, T				Aogi, K.; Hida, A.; Oshiro, Y.; Inoue, H.; Kawaguchi, H.; Yamashita, N.; Moriya, T.			Ki67 assessment using a 5-grade scale revealed high reproducibility for luminal type breast cancer	BREAST			English	Meeting Abstract									[Aogi, K.] NHO Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan; [Hida, A.; Oshiro, Y.] Matsuyama Red Cross Hosp, Dept Pathol, Matsuyama, Ehime, Japan; [Inoue, H.; Kawaguchi, H.] Matsuyama Red Cross Hosp, Dept Breast Surg, Matsuyama, Ehime, Japan; [Yamashita, N.] NHO Shikoku Canc Ctr, Dept Clin Res, Matsuyama, Ehime, Japan; [Moriya, T.] Kawasaki Med Univ, Kurashiki, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P037	S39	S39				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000084		
J	Fakhrejahani, E; Torii, M; Yamaga, I; Asao, Y; Kitai, T; Kataoka, M; Kanao, S; Takada, M; Shiina, T; Toi, M				Fakhrejahani, E.; Torii, M.; Yamaga, I.; Asao, Y.; Kitai, T.; Kataoka, M.; Kanao, S.; Takada, M.; Shiina, T.; Toi, M.			Photoacoustic imaging of breast cancer and histological markers of angiogenesis	BREAST			English	Meeting Abstract									[Fakhrejahani, E.; Torii, M.; Yamaga, I.; Asao, Y.; Takada, M.; Toi, M.] Kyoto Univ, Dept Breast Surg, Kyoto, Japan; [Kitai, T.] Kishiwada City Hosp, Dept Surg, Osaka, Japan; [Kataoka, M.; Kanao, S.] Kyoto Univ, Dept Diagnost Radiol, Kyoto, Japan; [Shiina, T.] Kyoto Univ, Dept Human Heath Sci, Kyoto, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P051	S44	S44				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000098		
J	Hara, F; Torigoe, E; Kiyoto, S; Takahashi, M; Takashima, S; Aogi, K; Ohsumi, S				Hara, F.; Torigoe, E.; Kiyoto, S.; Takahashi, M.; Takashima, S.; Aogi, K.; Ohsumi, S.			Four cycles of TC regimen might not be suitable for triple negative early stage breast cancer	BREAST			English	Meeting Abstract									[Hara, F.; Torigoe, E.; Kiyoto, S.; Takahashi, M.; Takashima, S.; Aogi, K.; Ohsumi, S.] Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P094	S57	S57				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000135		
J	Hato, Y				Hato, Y.			Prognostic impact of SNPs in or near the ZNF423 and CTSO genes in early breast cancer patients	BREAST			English	Meeting Abstract									[Hato, Y.] Nagoya City Univ, Grad Sch Med Sci, Oncol Immunol & Surg, Nagoya, Aichi, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P224	S102	S102				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000253		
J	Hattori, A; Hirano, A; Ogura, K; Inoue, H; Okubo, F; Miyamoto, R; Jibiki, N; Fujibayashi, M; Shimizu, T				Hattori, A.; Hirano, A.; Ogura, K.; Inoue, H.; Okubo, F.; Miyamoto, R.; Jibiki, N.; Fujibayashi, M.; Shimizu, T.			Phase II study of neoadjuvant weekly albumin-bound paclitaxel for node-positive breast cancer	BREAST			English	Meeting Abstract									[Hattori, A.; Hirano, A.; Ogura, K.; Inoue, H.; Okubo, F.; Fujibayashi, M.; Shimizu, T.] Tokyo Womens Med Univ, Med Ctr East, Breast Surg, Tokyo, Japan; [Miyamoto, R.; Jibiki, N.] Tokyo Womens Med Univ, Yachiyo Med Ctr, Breast Surg, Chiba, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P197	S92	S92				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000228		
J	Hattori, M; Fujita, T; Sawaki, M; Kondou, N; Yoshimura, A; Ichikawa, M; Ishiguro, J; Iwata, H				Hattori, M.; Fujita, T.; Sawaki, M.; Kondou, N.; Yoshimura, A.; Ichikawa, M.; Ishiguro, J.; Iwata, H.			Patterns of recurrence and survival in HER2+patients relapsing after receiving adjuvant trastuzumab	BREAST			English	Meeting Abstract									[Hattori, M.; Fujita, T.; Sawaki, M.; Kondou, N.; Yoshimura, A.; Ichikawa, M.; Ishiguro, J.; Iwata, H.] Aichi Canc Ctr, Dept Breast Oncol, Nagoya, Aichi 464, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P104	S61	S61				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000145		
J	Hayama, S; Sakakibara, M; Takishima, H; Nagashima, T; Sangai, T; Fujimoto, K; Miyazaki, M				Hayama, S.; Sakakibara, M.; Takishima, H.; Nagashima, T.; Sangai, T.; Fujimoto, K.; Miyazaki, M.			Targeted ultrasonography for MRI-detected lesions of preoperative breast cancer patients	BREAST			English	Meeting Abstract									[Hayama, S.; Sakakibara, M.; Nagashima, T.; Sangai, T.; Fujimoto, K.; Miyazaki, M.] Chiba Univ, Grad Sch Med, Gen Surg, Chuuou Ku, Chiba, Japan; [Takishima, H.] Chiba Univ, Grad Sch Med, Radiol, Chuuou Ku, Chiba, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P131	S70	S70				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000170		
J	Higaki, K; Fujihara, M; Yoshimura, Y; Kajiwara, Y; Kochi, M; Ito, M; Otani, S				Higaki, K.; Fujihara, M.; Yoshimura, Y.; Kajiwara, Y.; Kochi, M.; Ito, M.; Otani, S.			Pathological response to NAC for locally advanced breast cancer using MRI and PET/CT	BREAST			English	Meeting Abstract									[Higaki, K.; Fujihara, M.; Yoshimura, Y.; Kajiwara, Y.; Kochi, M.; Ito, M.; Otani, S.] Hiroshima City Hosp, Breast Surg, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P194	S91	S91				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000225		
J	Higuchi, T; Endo, M; Hanamura, T; Gohno, T; Niwa, T; Yamaguchi, Y; Horiguchi, J; Takeyoshi, I; Hayashi, S				Higuchi, T.; Endo, M.; Hanamura, T.; Gohno, T.; Niwa, T.; Yamaguchi, Y.; Horiguchi, J.; Takeyoshi, I.; Hayashi, S.			Contribution of estrone sulfate to cell proliferation in aromatase-inhibitor resistant breast cancer	BREAST			English	Meeting Abstract									[Higuchi, T.; Horiguchi, J.; Takeyoshi, I.] Gunma Univ, Grad Sch Med, Dept Visceral & Thorac Organ Surg, Maebashi, Gumma 371, Japan; [Endo, M.; Gohno, T.; Niwa, T.; Hayashi, S.] Tohoku Univ, Grad Sch Med, Dept Mol & Funct Dynam, Sendai, Miyagi 980, Japan; [Hanamura, T.] Shinshu Univ, Sch Med, Dept Surg, Matsumoto, Nagano 390, Japan; [Yamaguchi, Y.] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P050	S43	S44				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000097		
J	Hironaka, A; Tsuda, H; Yoshida, M; Shimizus, C; Tamuras, K; Fujiwara, Y; Hojo, T; Kinoshita, T; Maeshima, A; Hiraoka, N				Hironaka, A.; Tsuda, H.; Yoshida, M.; Shimizus, C.; Tamuras, K.; Fujiwara, Y.; Hojo, T.; Kinoshita, T.; Maeshima, A.; Hiraoka, N.			Histopathological features of operable breast cancer detected in women younger than 35 years	BREAST			English	Meeting Abstract									[Hironaka, A.; Yoshida, M.; Maeshima, A.; Hiraoka, N.] Natl Canc Ctr, Pathol, Tokyo, Japan; [Tsuda, H.] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan; [Shimizus, C.; Tamuras, K.; Fujiwara, Y.; Hojo, T.; Kinoshita, T.] Natl Canc Ctr, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P019	S32	S32				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000066		
J	Hisada, T; Nakada, J; Okumura, S; Kondou, N; Sawaki, M; Yoshimura, A; Adachi, Y; Ishiguro, J; Kotani, H; Iwata, H				Hisada, T.; Nakada, J.; Okumura, S.; Kondou, N.; Sawaki, M.; Yoshimura, A.; Adachi, Y.; Ishiguro, J.; Kotani, H.; Iwata, H.			Analgesia with thoracic wall nerve block for breast reconstruction with expander or implant	BREAST			English	Meeting Abstract									[Hisada, T.; Nakada, J.; Okumura, S.; Kondou, N.; Sawaki, M.; Yoshimura, A.; Adachi, Y.; Ishiguro, J.; Kotani, H.; Iwata, H.] Aichi Canc Ctr Hosp, Breast Oncol, Nagoya, Aichi 464, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P321	S137	S137				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000348		
J	Horiguchi, J; Takata, D; Nagaoka, R; Sato, A; Tokiniwa, H; Higuchi, T; Uchida, S; Tsuboi, M; Kikuchi, M; Takeyoshi, I				Horiguchi, J.; Takata, D.; Nagaoka, R.; Sato, A.; Tokiniwa, H.; Higuchi, T.; Uchida, S.; Tsuboi, M.; Kikuchi, M.; Takeyoshi, I.			Circulating tumor cells before neoadjuvant chemotherapy in operable breast cancer	BREAST			English	Meeting Abstract									[Horiguchi, J.; Takata, D.; Nagaoka, R.; Sato, A.; Tokiniwa, H.; Higuchi, T.; Uchida, S.; Tsuboi, M.; Kikuchi, M.; Takeyoshi, I.] Gunma Univ Hosp, Breast & Endocrine Surg, Maebashi, Gumma, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P254	S113	S114				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000283		
J	Inoue, H; Hirano, A; Hattori, A; Jibiki, N; Ogura, K; Miyamoto, R; Okubo, F; Naritaka, Y; Fujibayashi, M; Shimizu, T				Inoue, H.; Hirano, A.; Hattori, A.; Jibiki, N.; Ogura, K.; Miyamoto, R.; Okubo, F.; Naritaka, Y.; Fujibayashi, M.; Shimizu, T.			The relationship between dose intensity and pathological effect of nab-paclitaxel as neoadjuvant	BREAST			English	Meeting Abstract									[Inoue, H.; Hirano, A.; Hattori, A.; Ogura, K.; Okubo, F.; Shimizu, T.] Tokyo Womens Med Univ, Med Ctr East, Breast Surg, Tokyo, Japan; [Jibiki, N.; Miyamoto, R.] Tokyo Womens Med Univ, Yachiyo Med Ctr, Breast Surg, Tokyo, Japan; [Naritaka, Y.] Tokyo Womens Med Univ, Med Ctr East, Surg, Tokyo, Japan; [Fujibayashi, M.] Tokyo Womens Med Univ, Med Ctr East, Surg Pathol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P205	S96	S96				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000236		
J	Ishida, M; Saruwatari, A; Koi, Y; Akiyoshi, S; Oikawa, M; Nishimura, S; Koga, C; Nakamura, Y; Ohno, S				Ishida, M.; Saruwatari, A.; Koi, Y.; Akiyoshi, S.; Oikawa, M.; Nishimura, S.; Koga, C.; Nakamura, Y.; Ohno, S.			Indication of PMRT associated with risk of locoregional and distant recurrence in patients with N1-3 axillary nodal metastasis	BREAST			English	Meeting Abstract									[Ishida, M.; Koi, Y.; Akiyoshi, S.; Oikawa, M.; Nishimura, S.; Koga, C.; Nakamura, Y.] Natl Hosp Org, Breast Oncol, Kyushu Canc Ctr, Fukuoka, Japan; [Saruwatari, A.] St Marys Hosp, Surg, Fukuoka, Japan; [Ohno, S.] Natl Hosp Org, Clin Res Inst, Kyushu Canc Ctr, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P287	S125	S126				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000316		
J	Ishiguro, J; Sawaki, M; Hattori, M; Kondou, N; Yoshimura, A; Kotani, H; Adachi, Y; Hisada, T; Okumura, S; Iwata, H				Ishiguro, J.; Sawaki, M.; Hattori, M.; Kondou, N.; Yoshimura, A.; Kotani, H.; Adachi, Y.; Hisada, T.; Okumura, S.; Iwata, H.			Comparison of complication, cosmetic outcome with or without irradiation after breast reconstruction	BREAST			English	Meeting Abstract									[Ishiguro, J.; Sawaki, M.; Hattori, M.; Kondou, N.; Yoshimura, A.; Kotani, H.; Adachi, Y.; Hisada, T.; Iwata, H.] Aichi Canc Ctr, Dept Breast Oncol, Nagoya, Aichi 464, Japan; [Okumura, S.] Aichi Canc Ctr, Dept Plast & Reconstruct Surg, Nagoya, Aichi 464, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P295	S128	S129				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000324		
J	Ito, M; Ito, M; Duan, X; Hirakawa, H; Amari, M; Fukamachi, K; Ishida, T; Ohuchi, N				Ito, Masahiro; Ito, Masatoshi; Duan, X.; Hirakawa, H.; Amari, M.; Fukamachi, K.; Ishida, T.; Ohuchi, N.			Diagnostic accuracy of axillary lymph node metastasis using FDG PET/CT in stage I/II breast cancer	BREAST			English	Meeting Abstract									[Ito, Masahiro; Hirakawa, H.; Amari, M.; Fukamachi, K.] Tohoku Kosai Hosp, Breast Surg, Sendai, Miyagi, Japan; [Ito, Masatoshi; Duan, X.] Sendai Med Imaging Ctr, Sendai, Miyagi, Japan; [Ishida, T.; Ohuchi, N.] Tohoku Univ Sch Med, Surg Oncol, Sendai, Miyagi, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P152	S77	S77				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000191		
J	Iwamoto, M; Tanaka, S; Kimura, K; Matsunami, N; Morishima, H; Yoshidome, K; Nomura, T; Morimoto, T; Yamamoto, D; Tsubota, Y				Iwamoto, M.; Tanaka, S.; Kimura, K.; Matsunami, N.; Morishima, H.; Yoshidome, K.; Nomura, T.; Morimoto, T.; Yamamoto, D.; Tsubota, Y.			Phase 2 study of neoadjuvant anthracycline followed by nab-paclitaxel and trastuzumab	BREAST			English	Meeting Abstract									[Iwamoto, M.] Osaka Med Coll, Breast Surg, Osaka, Japan; [Tanaka, S.; Kimura, K.] Osaka Med Coll, Osaka, Japan; [Matsunami, N.; Morishima, H.] Osaka Rosai Hosp, Osaka, Japan; [Yoshidome, K.] Osaka Police Hosp, Osaka, Japan; [Nomura, T.; Morimoto, T.] Yao Municipal Hosp, Osaka, Japan; [Yamamoto, D.; Tsubota, Y.] Kansai Med Univ, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P202	S94	S94				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000233		
J	Iwase, T; Sangai, T; Ishigami, E; Sakakibara, J; Fujisaki, K; Shiina, N; Fujimoto, H; Sakakibara, M; Nagashima, T; Miyazaki, M				Iwase, T.; Sangai, T.; Ishigami, E.; Sakakibara, J.; Fujisaki, K.; Shiina, N.; Fujimoto, H.; Sakakibara, M.; Nagashima, T.; Miyazaki, M.			The impact of body composition change on neo-adjuvant chemotherapy for breast cancer patients	BREAST			English	Meeting Abstract									[Iwase, T.; Sangai, T.; Ishigami, E.; Sakakibara, J.; Fujisaki, K.; Shiina, N.; Fujimoto, H.; Sakakibara, M.; Nagashima, T.; Miyazaki, M.] Chiba Univ Hosp, Gen Surg, Chiba, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P237	S106	S107				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000266		
J	Iwata, H; Yamamoto, N; Masuda, N; Bando, H; Kuroi, K; Ohno, S; Kasai, H; Morita, S; Sakurai, T; Toi, M				Iwata, H.; Yamamoto, N.; Masuda, N.; Bando, H.; Kuroi, K.; Ohno, S.; Kasai, H.; Morita, S.; Sakurai, T.; Toi, M.		JBCRG-16 Neo-LaTH Study Grp	Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer	BREAST			English	Meeting Abstract									[Iwata, H.] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi, Japan; [Yamamoto, N.] Chiba Canc Ctr, Div Breast Surg, Chiba 2608717, Japan; [Masuda, N.] Natl Hosp Org, Osaka Natl Hosp, Breast Oncol, Dept Surg, Osaka, Japan; [Bando, H.] Univ Tsukuba, Fac Med, Breast & Endocrine Surg, Ibaraki, Japan; [Kuroi, K.] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Dept Breast Surg, Tokyo, Japan; [Ohno, S.] Natl Hosp Org, Kyushu Canc Ctr, Clin Res Inst, Fukuoka, Japan; [Kasai, H.] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept Expt Therapeut, Kyoto 606, Japan; [Morita, S.] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Sakurai, T.] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Toi, M.] Kyoto Univ, Grad Sch Med, Dept Surg Breast Surg, Kyoto, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P203	S95	S95				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000234		
J	Jinno, H; Murata, T; Sunamura, M; Sugimoto, M; Kitagawa, Y				Jinno, H.; Murata, T.; Sunamura, M.; Sugimoto, M.; Kitagawa, Y.			Breast cancer-specific signatures in saliva metabolites for early diagnosis	BREAST			English	Meeting Abstract									[Jinno, H.; Kitagawa, Y.] Keio Univ, Sch Med, Dept Surg, Tokyo, Japan; [Murata, T.] Saitama Municipal Hosp, Saitama, Japan; [Sunamura, M.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Sugimoto, M.] Keio Univ, Inst Adv Biosci, Yamagata, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P057	S46	S46				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000104		
J	Kashiwaba, M; Komatsu, H; Ishida, K; Kawagishi, R; Matsui, Y; Otsuki, H; Kawasaki, T; Uesugi, N; Sugai, T; Wakabayashi, G				Kashiwaba, M.; Komatsu, H.; Ishida, K.; Kawagishi, R.; Matsui, Y.; Otsuki, H.; Kawasaki, T.; Uesugi, N.; Sugai, T.; Wakabayashi, G.			The effectiveness of low-dose olanzapine against CINV caused by anthracycline-containing regimen	BREAST			English	Meeting Abstract									[Kashiwaba, M.; Komatsu, H.; Ishida, K.; Kawagishi, R.; Matsui, Y.; Otsuki, H.; Wakabayashi, G.] Iwate Med Univ, Surg, Morioka, Iwate 020, Japan; [Kawasaki, T.; Uesugi, N.; Sugai, T.] Iwate Med Univ, Mol Diagnost Pathol, Morioka, Iwate 020, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P111	S63	S63				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000152		
J	Kikuyama, M; Kunimata, H; Oka, T; Tachibana, A				Kikuyama, M.; Kunimata, H.; Oka, T.; Tachibana, A.			Clinicopathological analysis of the p53 expression status in breast cancer	BREAST			English	Meeting Abstract									[Kikuyama, M.; Tachibana, A.] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Dept Breast Surg, Tokyo, Japan; [Kunimata, H.] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Diagnost Imaging Ctr, Tokyo, Japan; [Oka, T.] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Dept Pathol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P250	S111	S112				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000279		
J	Kinoshita, T; Tamura, K; Hashimoto, A; Ogura, T; Hironaka, A; Arai, S; Asanabe, M				Kinoshita, T.; Tamura, K.; Hashimoto, A.; Ogura, T.; Hironaka, A.; Arai, S.; Asanabe, M.			Scalp cooling system to prevent hair loss in breast cancer patients receiving chemotherapy	BREAST			English	Meeting Abstract									[Kinoshita, T.; Ogura, T.] Natl Canc Ctr, Div Breast Surg, Tokyo, Japan; [Tamura, K.; Hashimoto, A.; Hironaka, A.; Arai, S.; Asanabe, M.] Natl Canc Ctr, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P098	S59	S59				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000139		
J	Kobayashi, N; Ushimado, K; Hikichi, M; Utsumi, T				Kobayashi, N.; Ushimado, K.; Hikichi, M.; Utsumi, T.			Outcome of elderly women with breast cancer	BREAST			English	Meeting Abstract									[Kobayashi, N.; Ushimado, K.; Hikichi, M.; Utsumi, T.] Fujita Hlth Univ, Breast Surg, Toyoake, Aichi, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P259	S115	S115				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000288		
J	Koi, Y; Akiyoshi, S; Oikawa, M; Koga, C; Nishimura, S; Nakamura, Y; Ishida, M; Ohno, S				Koi, Y.; Akiyoshi, S.; Oikawa, M.; Koga, C.; Nishimura, S.; Nakamura, Y.; Ishida, M.; Ohno, S.			Differentiation between luminal-HER2 and HER2-enriched breast cancer in clinical course	BREAST			English	Meeting Abstract									[Koi, Y.; Akiyoshi, S.; Oikawa, M.; Koga, C.; Nishimura, S.; Nakamura, Y.; Ishida, M.] Kyushu Natl Canc Ctr, Breast Oncol, Fukuoka, Japan; [Ohno, S.] Natl Hosp Org, Clin Res Inst, Kyushu Canc Ctr, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P280	S123	S123				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000309		
J	Kotani, H; Kondou, N; Ishiguro, J; Hisada, T; Adachi, Y; Ichikawa, M; Yoshimura, A; Hattori, M; Sawaki, M; Iwata, H				Kotani, H.; Kondou, N.; Ishiguro, J.; Hisada, T.; Adachi, Y.; Ichikawa, M.; Yoshimura, A.; Hattori, M.; Sawaki, M.; Iwata, H.			Investigation by questionnaire of the employment of Japanese breast cancer patients	BREAST			English	Meeting Abstract									[Kotani, H.; Kondou, N.; Ishiguro, J.; Hisada, T.; Adachi, Y.; Ichikawa, M.; Yoshimura, A.; Hattori, M.; Sawaki, M.; Iwata, H.] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P130	S69	S69				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000169		
J	Kurebayashi, J; Kanomata, N; Yamashita, T; Shimo, T; Moriya, T				Kurebayashi, J.; Kanomata, N.; Yamashita, T.; Shimo, T.; Moriya, T.			Anti-tumor and anti-cancer stem cell activities of eribulin and anti-estrogens in breast cancer cells	BREAST			English	Meeting Abstract									[Kurebayashi, J.; Yamashita, T.; Shimo, T.] Kawasaki Med Univ, Breast & Thyroid Surg, Kurashiki, Okayama, Japan; [Kanomata, N.; Moriya, T.] Kawasaki Med Univ, Pathol 2, Kurashiki, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P083	S53	S53				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000125		
J	Maeda, S; Saimura, M; Minami, S; Kurashita, K; Nishimura, R; Kai, Y; Yano, H; Tanaka, T; Mitsuyama, S; Tamura, K				Maeda, S.; Saimura, M.; Minami, S.; Kurashita, K.; Nishimura, R.; Kai, Y.; Yano, H.; Tanaka, T.; Mitsuyama, S.; Tamura, K.			Efficacy and safety of eribulin as first- to third-line treatment with HER2(-) MBC (KBC-SG 1105)	BREAST			English	Meeting Abstract									[Maeda, S.] Natl Nagasaki Med Ctr, Surg, Omura, Japan; [Saimura, M.; Mitsuyama, S.] Kitakyushu Municipal Med Ctr, Kitakyushu, Fukuoka, Japan; [Minami, S.; Yano, H.] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Kurashita, K.] Urasoe Gen Hosp, Urasoe, Okinawa, Japan; [Nishimura, R.] Kumamoto City Hosp, Breast & Endocrine Surg, Kumamoto, Japan; [Kai, Y.] Ueo Breast Canc Hosp, Oita, Japan; [Tanaka, T.; Tamura, K.] Fukuoka Univ, Div Med Oncol Hematol & Infect Dis, Fukuoka 81401, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P171	S83	S84				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000209		
J	Mashino, K; Mitsuyama, S; Masuda, N; Kawasoe, T; Yamaguchi, M; Wakamatsu, S; Taketani, K; Yamamoto, Y; Tanaka, M; Tamura, K				Mashino, K.; Mitsuyama, S.; Masuda, N.; Kawasoe, T.; Yamaguchi, M.; Wakamatsu, S.; Taketani, K.; Yamamoto, Y.; Tanaka, M.; Tamura, K.			Neoadjuvant chemotherapy of TCH: a phase II trial of Kyushu Breast Cancer Study Group	BREAST			English	Meeting Abstract									[Mashino, K.] Oita Prefectural Hosp, Surg, Oita, Japan; [Mitsuyama, S.] Kitakyushu Municipal Med Ctr, Surg, Kitakyushu, Fukuoka, Japan; [Masuda, N.] Natl Hosp Org Osaka Natl Hosp, Breast Oncol, Dept Surg, Osaka, Japan; [Kawasoe, T.] Japanese Red Cross Kumamoto Hosp, Breast Surg, Kumamoto, Japan; [Yamaguchi, M.; Tanaka, M.] Kurume Gen Hosp, Breast Surg, Kurume, Fukuoka, Japan; [Wakamatsu, S.] Kitakyushu Municipal Med Ctr, Med Oncol, Kitakyushu, Fukuoka, Japan; [Taketani, K.] IIzuka Hosp, Iizuka, Fukuoka, Japan; [Yamamoto, Y.] Kumamoto Univ, Grad Sch Med Sci, Mol Targeting Therapy Breast Canc, Kumamoto, Japan; [Tamura, K.] Fukuoka Univ, Div Med Oncol Hematol & Infect Dis, Fukuoka 81401, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P216	S100	S100				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000247		
J	Matsumoto, A; Jinno, H; Ando, T; Fujii, T; Nakamura, T; Saito, J; Takahashi, M; Hayashida, T; Kitagawa, Y				Matsumoto, A.; Jinno, H.; Ando, T.; Fujii, T.; Nakamura, T.; Saito, J.; Takahashi, M.; Hayashida, T.; Kitagawa, Y.			Prognostic significance of biomarker discordance after neoadjuvant chemotherapy in breast cancer	BREAST			English	Meeting Abstract									[Matsumoto, A.; Ando, T.; Fujii, T.; Nakamura, T.; Saito, J.] Inagi Municipal Hosp, Dept Surg, Tokyo, Japan; [Jinno, H.; Takahashi, M.; Hayashida, T.; Kitagawa, Y.] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P207	S96	S97				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000238		
J	Miyoshi, Y; Shien, T; Omori, M; Abe, Y; Watanabe, A; Hara, A; Mizoo, T; Nogami, T; Taira, N; Doihara, H				Miyoshi, Y.; Shien, T.; Omori, M.; Abe, Y.; Watanabe, A.; Hara, A.; Mizoo, T.; Nogami, T.; Taira, N.; Doihara, H.			Significance of tumor-infiltrating lymphocytes in breast cancer with neoadjuvant chemotherapy	BREAST			English	Meeting Abstract									[Miyoshi, Y.; Shien, T.; Abe, Y.; Watanabe, A.; Hara, A.; Mizoo, T.; Nogami, T.; Taira, N.; Doihara, H.] Okayama Univ Hosp, Breast & Endocrinol Surg, Okayama, Japan; [Omori, M.] Okayama Univ Hosp, Dept Pathol, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P282	S124	S124				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000311		
J	Nagaoka, R; Horiguchi, J; Takata, D; Sato, A; Tokiniwa, H; Higuchi, T; Uchida, S; Tsuboi, M; Kikuchi, M; Takeyoshi, I				Nagaoka, R.; Horiguchi, J.; Takata, D.; Sato, A.; Tokiniwa, H.; Higuchi, T.; Uchida, S.; Tsuboi, M.; Kikuchi, M.; Takeyoshi, I.			Recurrence risk in small, node-negative, early breast cancer	BREAST			English	Meeting Abstract									[Nagaoka, R.; Takeyoshi, I.] Gunma Univ, Grad Sch Med, Thorac & Visceral Organ Surg, Gunma, Japan; [Horiguchi, J.; Takata, D.; Sato, A.; Tokiniwa, H.; Higuchi, T.; Uchida, S.; Tsuboi, M.; Kikuchi, M.] Gunma Univ Hosp, Breast & Endocrine Surg, Maebashi, Gumma, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P268	S118	S119				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000297		
J	Nagasawa, S; Tsugawa, K				Nagasawa, S.; Tsugawa, K.			LSD1 is associated with poor prognosis in basal-like breast cancer	BREAST			English	Meeting Abstract									[Nagasawa, S.; Tsugawa, K.] St Marianna Univ, Sch Med, Breast Surg, Kawasaki, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P226	S102	S103				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000255		
J	Nakagawa, M; Morimoto, M; Takechi, H; Tadokoro, Y; Tangoku, A				Nakagawa, M.; Morimoto, M.; Takechi, H.; Tadokoro, Y.; Tangoku, A.			Preoperative diagnosis for metastasis of sentinel lymph node (SLN) using 3D Cr lymphography (CTLG)	BREAST			English	Meeting Abstract									[Nakagawa, M.; Morimoto, M.; Takechi, H.; Tadokoro, Y.; Tangoku, A.] Univ Tokushima, Thorac Endocrine Surg & Oncol, Tokushima 770, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P306	S132	S132				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000333		
J	Nakagawa, S; Toh, U; Iwakuma, N; Mishima, M; Takahashi, R; Furukawa, M; Yamaguchi, M; Tanaka, M; Ogo, E; Akagi, Y				Nakagawa, S.; Toh, U.; Iwakuma, N.; Mishima, M.; Takahashi, R.; Furukawa, M.; Yamaguchi, M.; Tanaka, M.; Ogo, E.; Akagi, Y.			Study of neoadjuvant therapy with FEC followed by weekly nab-paclitaxel for breast cancer	BREAST			English	Meeting Abstract									[Nakagawa, S.; Takahashi, R.] Kyushu Med Ctr, Natl Hosp Org, Breast Surg, Clin Res Inst, Fukuoka, Japan; [Toh, U.; Iwakuma, N.; Mishima, M.; Furukawa, M.; Akagi, Y.] Kurume Univ, Sch Med, Surg, Kurume, Fukuoka 830, Japan; [Yamaguchi, M.; Tanaka, M.] Kurume Gen Hosp, Breast Surg, Kurume, Fukuoka, Japan; [Tanaka, M.] Kurume Univ, Sch Med, Radiol, Kurume, Fukuoka 830, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P192	S90	S90				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000223		
J	Nakamura, R; Yamamoto, N; Oukubo, Y; Miyaki, T; Itami, M				Nakamura, R.; Yamamoto, N.; Oukubo, Y.; Miyaki, T.; Itami, M.			Sentinel lymph node biopsy can be safely performed in patients with suspicious lymph node	BREAST			English	Meeting Abstract									[Nakamura, R.] Chiba Canc Ctr, Breast Surg, Chiba 2608717, Japan; [Yamamoto, N.; Oukubo, Y.; Miyaki, T.; Itami, M.] Chiba Canc Ctr, Chiba 2608717, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P340	S144	S144				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000367		
J	Nakano, M; Fujisue, M; Tashima, R; Okumura, Y; Nishiyama, Y; Ohsako, T; Toyozumi, Y; Arima, N; Nishimura, R				Nakano, M.; Fujisue, M.; Tashima, R.; Okumura, Y.; Nishiyama, Y.; Ohsako, T.; Toyozumi, Y.; Arima, N.; Nishimura, R.			Clinical and prognostic significance of menopausal status in triple negative breast cancer	BREAST			English	Meeting Abstract									[Nakano, M.; Fujisue, M.; Okumura, Y.; Nishiyama, Y.; Ohsako, T.; Nishimura, R.] Kumamoto City Hosp, Breast & Endocrine Surg, Kumamoto, Japan; [Tashima, R.] Kumamoto City Hosp, Surg, Kumamoto, Japan; [Toyozumi, Y.; Arima, N.] Kumamoto City Hosp, Pathol, Kumamoto, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P244	S109	S109				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000273		
J	Nishimura, S; Akiyoshi, S; Koga, C; Oikawa, M; Nskamura, Y; Ishida, M; Ohno, S				Nishimura, S.; Akiyoshi, S.; Koga, C.; Oikawa, M.; Nskamura, Y.; Ishida, M.; Ohno, S.			Time-to-failure in 1st-line endocrine therapy with ER+/HER2-metastatic breast cancer	BREAST			English	Meeting Abstract									[Nishimura, S.; Akiyoshi, S.; Koga, C.; Oikawa, M.; Nskamura, Y.; Ishida, M.; Ohno, S.] Kyushu Natl Canc Ctr, Breast Oncol, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P168	S82	S83				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000206		
J	Nogami, T; Taira, N; Watanabe, S; Abe, Y; Mizoo, T; Iwamoto, T; Motoki, T; Shien, T; Kimata, Y; Doihara, H				Nogami, T.; Taira, N.; Watanabe, S.; Abe, Y.; Mizoo, T.; Iwamoto, T.; Motoki, T.; Shien, T.; Kimata, Y.; Doihara, H.			Influence of immediate breast reconstruction (IBR) on adjuvant therapy for breast cancer patients	BREAST			English	Meeting Abstract									[Nogami, T.; Taira, N.; Abe, Y.; Mizoo, T.; Iwamoto, T.; Motoki, T.; Shien, T.; Doihara, H.] Okayama Univ Hosp, Breast & Endocrine Surg, Okayama, Japan; [Watanabe, S.; Kimata, Y.] Okayama Univ Hosp, Plast & Reconstruct Surg, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P312	S134	S134				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000339		
J	Ogasawara, Y; Hatono, M; Kawasaki, K				Ogasawara, Y.; Hatono, M.; Kawasaki, K.			Evaluation of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies	BREAST			English	Meeting Abstract									[Ogasawara, Y.; Hatono, M.; Kawasaki, K.] Kagawa Prefectural Cent Hosp, Breast & Endocrine Surg, Takamatsu, Kagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P320	S136	S137				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000347		
J	Ogiya, A; Kitagawa, D; Sakai, T; Miyagi, Y; Iijima, K; Morizono, H; Makita, M; Horii, R; Akiyama, F; Iwase, T				Ogiya, A.; Kitagawa, D.; Sakai, T.; Miyagi, Y.; Iijima, K.; Morizono, H.; Makita, M.; Horii, R.; Akiyama, F.; Iwase, T.			Lymphedema incidence over time with sentinel lymph node dissection alone of Japanese women	BREAST			English	Meeting Abstract									[Ogiya, A.; Kitagawa, D.; Sakai, T.; Miyagi, Y.; Iijima, K.; Morizono, H.; Makita, M.; Iwase, T.] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Surg Oncol, Tokyo, Japan; [Horii, R.] Japanese Fdn Canc Res, Canc Inst Hosp, Pathol, Tokyo, Japan; [Akiyama, F.] Japanese Fdn Canc Res, Inst Canc, Pathol, Tokyo 170, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P325	S138	S138				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000352		
J	Ogura, T; Kinoshita, T; Jimbo, K; Asaga, S; Hojo, T				Ogura, T.; Kinoshita, T.; Jimbo, K.; Asaga, S.; Hojo, T.			A new predictive score for axillary lymph node metastases in breast cancer patients	BREAST			English	Meeting Abstract									[Ogura, T.; Kinoshita, T.; Jimbo, K.; Asaga, S.; Hojo, T.] Natl Canc Ctr, Breast Surg Div, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P313	S134	S134				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000340		
J	Ohashi, Y; Shiba, E; Toyama, T; Kurebayashi, J; Noguchi, S; Iwase, H				Ohashi, Y.; Shiba, E.; Toyama, T.; Kurebayashi, J.; Noguchi, S.; Iwase, H.			QOL score changes in breast cancer patients: 2-year vs. 3-or-more-year administration of leuprorelin	BREAST			English	Meeting Abstract									[Ohashi, Y.] Chuo Univ, Dept Integrated Sci & Engn Sustainable Soc, Tokyo 112, Japan; [Shiba, E.] Osaka Breast Clin, Osaka, Japan; [Toyama, T.] Nagoya City Univ Hosp, Aichi, Japan; [Kurebayashi, J.] Kawasaki Med Univ, Kurashiki, Okayama, Japan; [Noguchi, S.] Osaka Univ, Grad Sch Med, Osaka, Japan; [Iwase, H.] Kumamoto Univ, Kumamoto, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P092	S56	S57				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000134		
J	Oikawa, M; Igawa, A; Ishida, M; Nakamura, Y; Nishimura, S; Koga, C; Akiyoshi, S; Koi, Y; Taguchi, K; Ohno, S				Oikawa, M.; Igawa, A.; Ishida, M.; Nakamura, Y.; Nishimura, S.; Koga, C.; Akiyoshi, S.; Koi, Y.; Taguchi, K.; Ohno, S.			The analysis of cytogenetic intra-tumoral heterogeneity in squamous cell carcinoma of the breast	BREAST			English	Meeting Abstract									[Oikawa, M.; Ishida, M.; Nakamura, Y.; Nishimura, S.; Koga, C.; Akiyoshi, S.; Koi, Y.; Ohno, S.] Kyushu Natl Canc Ctr, Breast Oncol, Fukuoka, Japan; [Igawa, A.; Taguchi, K.] Kyushu Natl Canc Ctr, Pathol, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P027	S35	S35				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000074		
J	Sato, K; Mizuno, Y; Fuchikami, H; Takeda, N; Shimo, T; Kubota, J; Kato, M				Sato, K.; Mizuno, Y.; Fuchikami, H.; Takeda, N.; Shimo, T.; Kubota, J.; Kato, M.			Partial-breast irradiation using multicatheter brachytherapy: a 6-year experience with 252 cases	BREAST			English	Meeting Abstract									[Sato, K.; Mizuno, Y.; Fuchikami, H.; Takeda, N.] Tokyo West Tokushukai Hosp, Dept Breast Oncol, Tokyo, Japan; [Shimo, T.; Kubota, J.; Kato, M.] Tokyo West Tokushukai Hosp, Dept Radiat Oncol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P292	S127	S127				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000321		
J	Seki, H; Jinno, H; Hayashida, T; Takahashi, M; Asanuma, F; Osaku, M; Kitagawa, Y				Seki, H.; Jinno, H.; Hayashida, T.; Takahashi, M.; Asanuma, F.; Osaku, M.; Kitagawa, Y.			Thymidylate synthase is a significant predictive factor of S-1 in metastatic breast cancer patients	BREAST			English	Meeting Abstract									[Seki, H.; Asanuma, F.; Osaku, M.] Kitasato Univ, Kitasato Inst Hosp, Breast Ctr, Tokyo, Japan; [Jinno, H.; Hayashida, T.; Takahashi, M.] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P166	S82	S82				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000204		
J	Shien, T; Abe, Y; Watanabe, A; Miyoshi, Y; Nogami, T; Mizoo, T; Watanabe, S; Taira, N; Doihara, H				Shien, T.; Abe, Y.; Watanabe, A.; Miyoshi, Y.; Nogami, T.; Mizoo, T.; Watanabe, S.; Taira, N.; Doihara, H.			The evaluation of safety of SSM and NSM with reconstruction after NAC for locally advanced BC	BREAST			English	Meeting Abstract									[Shien, T.; Abe, Y.; Watanabe, A.; Miyoshi, Y.; Nogami, T.; Mizoo, T.; Taira, N.; Doihara, H.] Okayama Univ Hosp, Breast & Endocrine Surg, Okayama, Japan; [Watanabe, S.] Okayama Univ Hosp, Breast Canc Treatment & Reconstruct, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P337	S143	S143				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000364		
J	Shigekawa, T; Osaki, A; Ueda, S; Takeuchi, H; Hirokawa, E; Sugitani, I; Sugiyama, M; Shimada, H; Takahashi, T; Saeki, T				Shigekawa, T.; Osaki, A.; Ueda, S.; Takeuchi, H.; Hirokawa, E.; Sugitani, I.; Sugiyama, M.; Shimada, H.; Takahashi, T.; Saeki, T.			Local recurrence rates are low in Japanese breast cancer patients after neoadjuvant chemotherapy	BREAST			English	Meeting Abstract									[Shigekawa, T.; Osaki, A.; Ueda, S.; Takeuchi, H.; Hirokawa, E.; Sugitani, I.; Sugiyama, M.; Shimada, H.; Takahashi, T.; Saeki, T.] Saitama Med Univ, Int Med Ctr, Breast Oncol, Hidaka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P310	S133	S133				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000337		
J	Suzuki, M				Suzuki, M.			Breast cancer screening by evaluating amino acid levels in the blood	BREAST			English	Meeting Abstract									[Suzuki, M.] Kitamurayama Hosp, Breast Ctr, Higashine, Yamagata, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P129	S69	S69				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000168		
J	Tadokoro, Y; Morimoto, M; Nakagawa, M; Takechi, H; Tangoku, A				Tadokoro, Y.; Morimoto, M.; Nakagawa, M.; Takechi, H.; Tangoku, A.			Phase II study with S-1+low dose docetaxel (N-1 study) for operable breast cancer patients	BREAST			English	Meeting Abstract									[Tadokoro, Y.; Morimoto, M.; Nakagawa, M.; Takechi, H.; Tangoku, A.] Univ Tokushima, Grad Sch, Dept Thorac Endocrine Surg & Oncol, Tokushima, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P215	S99	S100				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000246		
J	Taira, F				Taira, F.			Copy number alteration and genomic instability in breast cancer	BREAST			English	Meeting Abstract									[Taira, F.] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P038	S39	S39				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000085		
J	Takabatake, D; Ohisi, K; Kiyoto, S; Takahashi, M; Takashima, S; Aogi, K; Ohsumi, S; Taira, N; Takashima, S				Takabatake, D.; Ohisi, K.; Kiyoto, S.; Takahashi, M.; Takashima, Seiki; Aogi, K.; Ohsumi, S.; Taira, N.; Takashima, Shigemitsu			Clinicopathological assessment of metachronous bilateral breast cancer	BREAST			English	Meeting Abstract									[Takabatake, D.; Ohisi, K.] Kochi Hlth Sci Ctr, Breast Oncol, Kochi, Japan; [Kiyoto, S.; Takahashi, M.; Takashima, Seiki; Aogi, K.; Ohsumi, S.; Takashima, Shigemitsu] Shikoku Canc Ctr, Breast Surg, Matsuyama, Ehime, Japan; [Taira, N.] Okayama Univ, Grad Sch Med, Breast Surg, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P142	S74	S74				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000181		
J	Takayama, S; Matsui, J				Takayama, S.; Matsui, J.			Sentinel lymph node biopsy after primary systemic therapy for locally advanced breast cancer	BREAST			English	Meeting Abstract									[Takayama, S.; Matsui, J.] Ichikawa Gen Hosp, Tokyo Dent Coll, Surg, Chiba, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P329	S140	S140				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000356		
J	Takebe, K; Arai, T				Takebe, K.; Arai, T.			Characteristics of mucocele-like tumors	BREAST			English	Meeting Abstract									[Takebe, K.; Arai, T.] Takebe Breast Canc Care Clin, Breast Surg, Takamatsu, Kagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P028	S35	S36				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000075		
J	Takuwa, H; Yoshimoto, Y; Hagiwara, R; Takahara, S; Yamauchi, A				Takuwa, H.; Yoshimoto, Y.; Hagiwara, R.; Takahara, S.; Yamauchi, A.			Breast cancer treatment and assisted reproductive intervention	BREAST			English	Meeting Abstract									[Takuwa, H.; Yoshimoto, Y.; Hagiwara, R.; Takahara, S.; Yamauchi, A.] Kitano Hosp, Tazuke Kofukai Med Res Inst, Breast Surg, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P099	S59	S59				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000140		
J	Tanabe, Y; Tsuda, H; Yoshida, M; Kinoshita, T; Kodaira, M; Yamamoto, H; Yonemori, K; Shimizu, C; Fujiwara, Y; Tamura, K				Tanabe, Y.; Tsuda, H.; Yoshida, M.; Kinoshita, T.; Kodaira, M.; Yamamoto, H.; Yonemori, K.; Shimizu, C.; Fujiwara, Y.; Tamura, K.			Immunological factors to predict disease progression during neoadjuvant chemotherapy	BREAST			English	Meeting Abstract									[Tanabe, Y.; Kodaira, M.; Yamamoto, H.; Yonemori, K.; Shimizu, C.; Fujiwara, Y.; Tamura, K.] Natl Canc Ctr, Breast & Med Oncol, Tokyo, Japan; [Tsuda, H.] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan; [Yoshida, M.] Natl Canc Ctr, Pathol, Tokyo, Japan; [Kinoshita, T.] Natl Canc Ctr, Breast Surg, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P025	S34	S34				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000072		
J	Tanaka, H; Umeda, S; Murakami, S; Ishikawa, M; Uchiyama, A				Tanaka, H.; Umeda, S.; Murakami, S.; Ishikawa, M.; Uchiyama, A.			Necessity of axillary lymph node dissection - future prospects in sentinel lymph-node positive cases	BREAST			English	Meeting Abstract									[Tanaka, H.; Umeda, S.; Murakami, S.; Ishikawa, M.; Uchiyama, A.] JCHO Kyushu Hosp, Surg, Kitakyushu, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P225	S102	S102				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000254		
J	Tangoku, A				Tangoku, A.			Estimation of sentinel lymph node metastasis with CT lymphography after primary chemotherapy	BREAST			English	Meeting Abstract									[Tangoku, A.] Univ Tokushima, Dept Thorac Endocrine Surg & Oncol, Grad Sch, Tokushima 770, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P331	S140	S141				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000358		
J	Tashima, R; Nishimura, R; Arima, N; Hujisue, M; Nakano, M; Okumura, Y; Osako, T; Toyozumi, Y				Tashima, R.; Nishimura, R.; Arima, N.; Hujisue, M.; Nakano, M.; Okumura, Y.; Osako, T.; Toyozumi, Y.			Evaluation of PgR expression as a prognostic factor in luminal HER2-negative breast cancer	BREAST			English	Meeting Abstract									[Tashima, R.] Kumamoto City Hosp, Surg, Kumamoto, Japan; [Nishimura, R.; Hujisue, M.; Nakano, M.; Okumura, Y.; Osako, T.] Kumamoto City Hosp, Breast & Endocrine Surg, Kumamoto, Japan; [Arima, N.; Okumura, Y.] Kumamoto City Hosp, Pathl, Kumamoto, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P260	S116	S116				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000289		
J	Toh, U; Iwakuma, N; Mishima, M; Furukawa, M; Akagi, Y				Toh, U.; Iwakuma, N.; Mishima, M.; Furukawa, M.; Akagi, Y.			Image-guided sentinel lymph node detection using near-infrared fluorescence in breast cancer	BREAST			English	Meeting Abstract									[Toh, U.; Iwakuma, N.; Mishima, M.; Furukawa, M.; Akagi, Y.] Kurume Univ, Sch Med, Surg, Kurume, Fukuoka 830, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P223	S102	S102				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000252		
J	Toh, U; Iwakuma, N; Mishima, M; Furukawa, M; Fujii, T; Ogo, E; Nakagawa, S; Tanaka, M; Akagi, Y				Toh, U.; Iwakuma, N.; Mishima, M.; Furukawa, M.; Fujii, T.; Ogo, E.; Nakagawa, S.; Tanaka, M.; Akagi, Y.			S-1 in combination with CPT-11 plus trastuzumab for pretreated HER2+metastatic breast cancer	BREAST			English	Meeting Abstract									[Toh, U.; Iwakuma, N.; Mishima, M.; Furukawa, M.; Fujii, T.; Akagi, Y.] Kurume Univ, Sch Med, Surg, Kurume, Fukuoka 830, Japan; [Ogo, E.] Kurume Univ, Sch Med, Radiol, Kurume, Fukuoka 830, Japan; [Nakagawa, S.] Natl Hosp Org, Kyushu Med Ctr, Breast Surg, Fukuoka, Japan; [Tanaka, M.] Kurume Gen Hosp, Breast Surg, Kurume, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P008	S28	S28				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000056		
J	Tsugawa, K; Hayami, R; Uejima, T; Kojima, Y; Nishikawa, T; Kawamoto, H				Tsugawa, K.; Hayami, R.; Uejima, T.; Kojima, Y.; Nishikawa, T.; Kawamoto, H.			Outcome of sentinel node biopsy after neoadjuvant chemotherapy in CN0 breast cancer	BREAST			English	Meeting Abstract									[Tsugawa, K.; Hayami, R.; Uejima, T.; Kojima, Y.; Nishikawa, T.; Kawamoto, H.] St Marianna Univ, Sch Med, Breast & Endocrine Surg, Kawasaki, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P336	S142	S142				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000363		
J	Uehiro, N; Sato, F; Saji, S; Toi, M				Uehiro, N.; Sato, F.; Saji, S.; Toi, M.			Subtype specific DNA methylation in circulating DNA of metastatic breast cancer patients	BREAST			English	Meeting Abstract									[Uehiro, N.; Sato, F.; Toi, M.] Kyoto Univ, Guraduate Sch Med, Dept Breast Surg, Kyoto, Japan; [Saji, S.] Fukushima Med Univ, Dept Med Oncol, Fukushima, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P046	S42	S42				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000093		
J	Watanabe, A; Shien, T; Abe, Y; Nogami, T; Iwamoto, T; Motoki, T; Taira, N; Doihara, H				Watanabe, A.; Shien, T.; Abe, Y.; Nogami, T.; Iwamoto, T.; Motoki, T.; Taira, N.; Doihara, H.			cStage IIIc BC patients diagnosed by PET/CT can get good prognosis with intensive treatment	BREAST			English	Meeting Abstract									[Watanabe, A.; Shien, T.; Abe, Y.; Nogami, T.; Iwamoto, T.; Motoki, T.; Taira, N.; Doihara, H.] Okayama Univ Hosp, Breast & Endocrine Surg Dept, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P165	S81	S82				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000203		
J	Yamamoto, Y; Anan, K; Tanaka, M; Maeda, S; Ueo, H; Sagara, Y; Ohno, S; Iwase, H; Mitsuyama, S; Tamura, K				Yamamoto, Y.; Anan, K.; Tanaka, M.; Maeda, S.; Ueo, H.; Sagara, Y.; Ohno, S.; Iwase, H.; Mitsuyama, S.; Tamura, K.			Neoadjuvant nab-paclitaxel followed by FEC for operable breast cancer: KBC-SG 1103 trial	BREAST			English	Meeting Abstract									[Yamamoto, Y.] Kumamoto Univ Hosp, Mol Targeting Therapy Breast Canc, Kumamoto, Japan; [Anan, K.] Municipal Med Ctr, Dept Surg, Kitakyushu, Fukuoka, Japan; [Tanaka, M.] Kurume Gen Hosp, Breast Surg, Kurume, Fukuoka, Japan; [Maeda, S.] Natl Hosp Org, Nagasaki Med Ctr, Dept Surg, Nagasaki, Japan; [Ueo, H.] Ueo Breast Surg, Dept Breast Surg, Ohita, Japan; [Sagara, Y.] Sagara Hosp, Dept Breast Oncol, Kagoshima, Japan; [Ohno, S.] Natl Hosp Org, Kyushu Canc Ctr, Clin Res Inst, Fukuoka, Japan; [Iwase, H.] Kumamoto Univ, Fac Postgrad Med & Pharmaceut Sci, Dept Breast & Endocrine Surg, Kumamoto, Japan; [Mitsuyama, S.] Kitakyushu Municipal Med Ctr, Kitakyushu, Fukuoka, Japan; [Tamura, K.] Fukuoka Univ, Div Med Oncol Hematol & Infect Dis, Fukuoka 81401, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P213	S99	S99				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000244		
J	Yamashita, K				Yamashita, K.			Endoscopic breast surgery can be navigated by virtual mode of 3D-CT	BREAST			English	Meeting Abstract									[Yamashita, K.] Nippon Med Sch, Breast Surg, Bunkyo Ku, Tokyo 113, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P324	S138	S138				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000351		
J	Yamashita, N; Tokunaga, E; Inoue, Y; Tanaka, K; Nakashima, Y; Ando, K; Ohgaki, K; Saeki, H; Oki, E; Maehara, Y				Yamashita, N.; Tokunaga, E.; Inoue, Y.; Tanaka, K.; Nakashima, Y.; Ando, K.; Ohgaki, K.; Saeki, H.; Oki, E.; Maehara, Y.			Clinical importance of E-cadherin and vimentin expression in invasive breast cancer	BREAST			English	Meeting Abstract									[Yamashita, N.; Inoue, Y.; Tanaka, K.; Nakashima, Y.; Ando, K.; Ohgaki, K.; Saeki, H.; Oki, E.; Maehara, Y.] Kyushu Univ, Surg & Sci, Fukuoka 812, Japan; [Tokunaga, E.] Kyushu Univ, Comprehens Clin Oncol, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P072	S51	S52				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000119		
J	Yoshida, M; Harada, A; Okubo, H; Asari, T; Toshiyasu, T; Kozuka, T; Sumi, M; Oguchi, M				Yoshida, M.; Harada, A.; Okubo, H.; Asari, T.; Toshiyasu, T.; Kozuka, T.; Sumi, M.; Oguchi, M.			Radiation dose for left anterior descending coronary artery in patients treated with BCT	BREAST			English	Meeting Abstract									[Yoshida, M.; Harada, A.; Okubo, H.; Asari, T.; Toshiyasu, T.; Kozuka, T.; Sumi, M.; Oguchi, M.] Canc Inst Hosp JFCR, Radiat Oncol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P304	S131	S131				1	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000332		
J	Yoshimura, Y; Fujihara, M; Kajiwara, Y; Kochi, M; Ito, M; Ohtani, S; Higaki, K				Yoshimura, Y.; Fujihara, M.; Kajiwara, Y.; Kochi, M.; Ito, M.; Ohtani, S.; Higaki, K.			The effectiveness of tamoxifen based on the experience of male breast cancer in our institution	BREAST			English	Meeting Abstract									[Yoshimura, Y.; Fujihara, M.; Kajiwara, Y.; Kochi, M.; Ito, M.; Ohtani, S.; Higaki, K.] Hiroshima City Hiroshima Citizens Hosp, Breast Surg, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0960-9776	1532-3080		BREAST	Breast	MAR	2015	24			1		P112	S63	S64				2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CE4IT	WOS:000351795000153		
J	Sakaki, M				Sakaki, Makoto			On the curvature ellipse of minimal surfaces in N-3(c) x R	BULLETIN OF THE BELGIAN MATHEMATICAL SOCIETY-SIMON STEVIN			English	Article						minimal surface; product space; curvature ellipse	CONSTANT MEAN-CURVATURE; ANGLE SURFACES	We discuss the curvature ellipse of minimal surfaces in the product space N-3(c) x R, where N-3(c) is the 3-dimensional simply connected space form of constant curvature c.	Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan	Sakaki, M (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368561, Japan.	sakaki@hirosaki-u.ac.jp					Abresch U, 2004, ACTA MATH-DJURSHOLM, V193, P141, DOI 10.1007/BF02392562; Dajczer M, 2009, MATH Z, V261, P869, DOI 10.1007/s00209-008-0355-0; GUADALUPE IV, 1983, PAC J MATH, V106, P95; Burstall F., 2002, LECT NOTES MATH, V1772; Chen DG, 2012, B BELG MATH SOC-SIM, V19, P289; Chen Q, 2010, RESULTS MATH, V57, P319, DOI 10.1007/s00025-010-0031-7; Dillen F, 2007, MONATSH MATH, V152, P89, DOI 10.1007/s00605-007-0461-9; Fetcu D., ARXIV13123196V1MATHD; Fetcu D, 2012, MICH MATH J, V61, P715; Hoffman D., 1980, MEM AM MATH SOC, V28; JOHNSON GD, 1991, PAC J MATH, V149, P113; Ruiz-Hernandez G, 2011, ABH MATH SEM HAMBURG, V81, P55, DOI 10.1007/s12188-011-0052-5; Sakaki M, 2014, RESULTS MATH, V66, P343, DOI 10.1007/s00025-014-0380-8; Tribuzy R., 1985, REND SEMIN MAT U PAD, V73, P1	14	0	0	BELGIAN MATHEMATICAL SOC TRIOMPHE	BRUSSELS	CP 218,01 BOULEVARD TRIOMPE, B 1050 BRUSSELS, BELGIUM	1370-1444	2034-1970		B BELG MATH SOC-SIM	Bull. Belg. Math. Soc.-Simon Steven	MAR	2015	22	1					165	172				8	Mathematics	Mathematics	CE5RL	WOS:000351893200014		
J	Adachi, M				Adachi, Masanori			A local expression of the Diederich-Fornaess exponent and the exponent of conformal harmonic measures	BULLETIN OF THE BRAZILIAN MATHEMATICAL SOCIETY			English	Article						Levi-flat; normal bundle; Diederich-Fornaess exponent; conformal harmonic measure	PSEUDOCONVEX DOMAINS; OKAS LEMMA; LEVI; FOLIATIONS; MANIFOLDS; SURFACES; BUNDLES	A local expression of the Diederich-Fornaess exponent of complements of Levi-flat real hypersurfaces is exhibited. This expression describes the correspondence between pseudoconvexity of their complements and positivity of their normal bundles, which was suggested in a work of Brunella, in a quantitative way. As an application, a connection between the Diederich-Fornaess exponent and the exponent of conformal harmonic measures is discussed.	[Adachi, Masanori] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Adachi, M (reprint author), Pohang Univ Sci & Technol, Ctr Geometry & Its Applicat, San 31 Hyoja Dong, Pohang 790784, South Korea.	m08002z@math.nagoya-u.ac.jp					Adachi M, 2014, PUBL RES I MATH SCI, V50, P153, DOI 10.4171/PRIMS/127; Adachi M., NAGOYA MATH IN PRESS; DIEDERICH K, 1977, MATH ANN, V225, P275, DOI 10.1007/BF01425243; Ohsawa T, 1998, NAGOYA MATH J, V149, P1; DIEDERICH K, 1977, INVENT MATH, V39, P129, DOI 10.1007/BF01390105; Barrett D. E., 1988, PUBL MAT, V32, P171; Biard S., 2013, THESIS ECOLE DOCTRAL; Brunella M, 2008, INDIANA U MATH J, V57, P3101; Brunella M, 2007, B BRAZ MATH SOC, V38, P517, DOI 10.1007/s00574-007-0057-y; Deroin B, 2005, ANN SCI ECOLE NORM S, V38, P57, DOI 10.1016/j.ansens.2004.10.004; Deroin B., 2013, LECT NOTES COURSE AV, P3; Diederich K, 2007, PUBL RES I MATH SCI, V43, P171, DOI 10.2977/prims/1199403813; Fornaess JE, 2008, J GEOM ANAL, V18, P400, DOI 10.1007/s12220-008-9018-y; Frankel S., 1995, PREPUBLICATION ECOLE, V1125; Fu S., J GEOM ANAL; Harrington PS, 2007, ASIAN J MATH, V11, P127; Herbig AK, 2012, ILLINOIS J MATH, V56, P195; Ohsawa T, 2007, NAGOYA MATH J, V185, P161	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1678-7544	1678-7714		B BRAZ MATH SOC	Bull. Braz. Math. Soc.	MAR	2015	46	1					65	79		10.1007/s00574-015-0084-z		15	Mathematics	Mathematics	CE9YC	WOS:000352198600003		
J	Tam, NT; Huy, NT; Thoa, LTB; Long, NP; Trang, NTH; Hirayama, K; Karbwang, J				Nguyen Thanh Tam; Nguyen Tien Huy; Le Thi Bich Thoa; Nguyen Phuoc Long; Nguyen Thi Huyen Trang; Hirayama, Kenji; Karbwang, Juntra			Participants' understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis	BULLETIN OF THE WORLD HEALTH ORGANIZATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; PHASE-I TRIALS; DECISION-MAKING; PARENTAL CONSENT; CANCER-PATIENTS; THERAPEUTIC MISCONCEPTION; PATIENTS PERCEPTIONS; CHILDHOOD LEUKEMIA; RANDOM ALLOCATION; ONCOLOGY RESEARCH	Objective To estimate the proportion of participants in clinical trials who understand different components of informed consent. Methods Relevant studies were identified by a systematic review of PubMed, Scopus and Google Scholar and by manually reviewing reference lists for publications up to October 2013. A meta-analysis of study results was performed using a random-effects model to take account of heterogeneity. Findings The analysis included 103 studies evaluating 135 cohorts of participants. The pooled proportion of participants who understood components of informed consent was 75.8% for freedom to withdraw at any time, 74.7% for the nature of study, 74.7% for the voluntary nature of participation, 74.0% for potential benefits, 69.6% for the study's purpose, 67.0% for potential risks and side-effects, 66.2% for confidentiality, 64.1% for the availability of alternative treatment if withdrawn, 62.9% for knowing that treatments were being compared, 53.3% for placebo and 52.1% for randomization. Most participants, 62.4%, had no therapeutic misconceptions and 54.9% could name at least one risk. Subgroup and meta-regression analyses identified covariates, such as age, educational level, critical illness, the study phase and location, that significantly affected understanding and indicated that the proportion of participants who understood informed consent had not increased over 30 years. Conclusion The proportion of participants in clinical trials who understood different components of informed consent varied from 52.1% to 75.8%. Investigators could do more to help participants achieve a complete understanding.	[Nguyen Thanh Tam; Le Thi Bich Thoa; Nguyen Phuoc Long] Ho Chi Minh City Univ Med & Pharm, Ho Chi Minh City, Vietnam; [Nguyen Tien Huy; Karbwang, Juntra] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Clin Product Dev, Nagasaki 8528523, Japan; [Nguyen Thi Huyen Trang] Hue Univ Med & Pharm, Hue City, Vietnam; [Hirayama, Kenji] Inst Trop Med NEKKEN, Dept Immunogenet, Nagasaki, Japan	Huy, NT (reprint author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Clin Product Dev, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	tienhuy@nagasaki-u.ac.jp		Phuoc Long, Nguyen/0000-0002-4678-0546			Annas GJ, 2012, NEW ENGL J MED, V367, P445, DOI 10.1056/NEJMra1108646; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Hill Z, 2008, J MED ETHICS, V34, P48, DOI 10.1136/jme.2006.019059; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; PENMAN DT, 1984, J CLIN ONCOL, V2, P849; Lidz CW, 2004, SOC SCI MED, V58, P1689, DOI 10.1016/S0277-9536(03)00338-1; LYNOE N, 1991, BRIT MED J, V303, P610; Jefford M, 2008, LANCET ONCOL, V9, P485, DOI 10.1016/S1470-2045(08)70128-1; Hereu P, 2010, CONTEMP CLIN TRIALS, V31, P443, DOI 10.1016/j.cct.2010.05.004; Mangset M, 2008, J MED ETHICS, V34, P751, DOI 10.1136/jme.2007.023168; KLUGE EH, 1995, CAN MED ASSOC J, V152, P1495; Leach A, 1999, SOC SCI MED, V48, P139, DOI 10.1016/S0277-9536(98)00317-7; Chappuy H, 2008, PEDIATR BLOOD CANCER, V50, P1043, DOI 10.1002/pbc.21359; de Melo-Martin I, 2008, J MED ETHICS, V34, P202, DOI 10.1136/jme.2006.019406; Mandava A, 2012, J MED ETHICS, V38, P356, DOI 10.1136/medethics-2011-100178; Knifed E, 2008, NEURO-ONCOLOGY, V10, P348, DOI 10.1215/15228517-2008-007; Agrawal M, 2006, J CLIN ONCOL, V24, P4479, DOI 10.1200/JCO.2006.06.0269; Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa; Miller VA, 2013, PEDIATR BLOOD CANCER, V60, P873, DOI 10.1002/pbc.24326; Hietanen P, 2000, EUR J CANCER, V36, P2096, DOI 10.1016/S0959-8049(00)00191-X; Aromataris E, 2014, AM J NURS, V114, P49, DOI 10.1097/01.NAJ.0000446779.99522.f6; Schats R, 2003, J NEUROL NEUROSUR PS, V74, P988, DOI 10.1136/jnnp.74.7.988; Unguru Y, 2010, PEDIATRICS, V125, pE876, DOI 10.1542/peds.2008-3429; Chappuy H, 2010, ARCH DIS CHILD, V95, P800, DOI 10.1136/adc.2009.180695; Russell FM, 2005, J MED ETHICS, V31, P490, DOI 10.1136/jme.2002.002279; Mills N, 2003, CONTROL CLIN TRIALS, V24, P272, DOI 10.1016/S0197-2456(03)00020-5; Joubert G, 2003, AM J PUBLIC HEALTH, V93, P582, DOI 10.2105/AJPH.93.4.582; Baker JN, 2013, CANCER-AM CANCER SOC, V119, P4154, DOI 10.1002/cncr.28335; Lynoe N, 2001, NEW ENGL J MED, V344, P460, DOI 10.1056/NEJM200102083440617; HOWARD JM, 1981, CONTROL CLIN TRIALS, V2, P287, DOI 10.1016/0197-2456(81)90019-2; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; van Stuijvenberg M, 1998, ARCH DIS CHILD, V79, P120; Chappuy H, 2006, ARCH DIS CHILD, V91, P112, DOI 10.1136/adc.2005.076141; del Carmen MG, 2005, ONCOLOGIST, V10, P636, DOI 10.1634/theoncologist.10-8-636; Rivera R, 2007, AM J PUBLIC HEALTH, V97, P25, DOI 10.2105/AJPH.2005.081604; Jenkins V, 2000, BRIT J CANCER, V82, P1783, DOI 10.1054/bjoc.2000.1142; Ellis RD, 2010, AM J TROP MED HYG, V83, P868, DOI 10.4269/ajtmh.2010.10-0062; Criscione LG, 2003, ARTHRIT RHEUM-ARTHR, V49, P361, DOI 10.1002/art.11057; Sreenivasan G, 2003, LANCET, V362, P2016, DOI 10.1016/S0140-6736(03)15025-8; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Bhutta ZA, 2004, B WORLD HEALTH ORGAN, V82, P771; Levi RB, 2000, J PEDIAT HEMATOL ONC, V22, P3, DOI 10.1097/00043426-200001000-00002; Terranova G, 2012, JACC-CARDIOVASC IMAG, V5, P649, DOI 10.1016/j.jcmg.2012.03.007; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; Martenson EK, 2008, J CLIN NURS, V17, P3131, DOI 10.1111/j.1365-2702.2006.01920.x; DAUGHERTY C, 1995, J CLIN ONCOL, V13, P1062; Gammelgaard A, 2004, HEART, V90, P1124, DOI 10.1136/hrt.2003.021931; Featherstone K, 1998, BRIT MED J, V317, P1177; Itoh K, 1997, BRIT J CANCER, V76, P107, DOI 10.1038/bjc.1997.344; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; BERGLER JH, 1980, CLIN PHARMACOL THER, V27, P435; Kodish E, 2004, JAMA-J AM MED ASSOC, V291, P470, DOI 10.1001/jama.291.4.470; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; RODENHUIS S, 1984, EUR J CANCER CLIN ON, V20, P457, DOI 10.1016/0277-5379(84)90229-3; Ekouevi KD, 2004, AIDS, V18, P1486, DOI 10.1097/01.aids.0000131349.22032.63; Ballard Hubert O, 2004, J Perinatol, V24, P409, DOI 10.1038/sj.jp.7211142; Barrett R, 2005, ONCOL NURS FORUM, V32, P751, DOI 10.1188/05.ONF.751-755; Beauchamp TL, 2001, PRINCIPLES BIOMEDICA; Bergenmar M, 2008, EUR J CANCER, V44, P2627, DOI 10.1016/j.ejca.2008.08.013; Bertoli AM, 2007, CONTEMP CLIN TRIALS, V28, P730, DOI 10.1016/j.cct.2007.04.005; Boga M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001089; Burgess E, 2003, ARCH DIS CHILD-FETAL, V88, pF285; Burgess E., 2003, Archives of Disease in Childhood, V88, pF280, DOI 10.1136/fn.88.4.F280; Cargan L, 2007, DOING SOCIAL RES; Chaisson LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022696; Chappuy H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002733; Chenaud C, 2006, CRIT CARE, V10, DOI 10.1186/cc5120; Chu SH, 2012, CONTEMP CLIN TRIALS, V33, P611, DOI 10.1016/j.cct.2012.02.018; Cohen L, 2001, CANCER, V91, P1949, DOI 10.1002/1097-0142(20010515)91:10<1949::AID-CNCR1218>3.0.CO;2-A; Constantinou M, 2012, CAN J OPHTHALMOL, V47, P118, DOI 10.1016/j.jcjo.2012.01.006; Coulibaly-Traore O, 2003, PRESSE MED, V32, P343; Cousino MK, 2012, J CLIN ONCOL, V30, P4367, DOI 10.1200/JCO.2012.42.3004; Cox D. R., 2006, ENCY STAT SCI, V2nd, P1074; Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113; Ducrocq X, 2000, PRESSE MED, V29, P1335; Durand-Zaleski IS, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.023473; Eiser C, 2005, CHILD CARE HLTH DEV, V31, P517, DOI 10.1111/j.1365-2214.2005.00538.x; Estey A, 1994, HLTH LAW REV, V3, P37; Faralli C, 2013, INFORMED CONSENT MED; Fortney JA, 1999, STUD FAMILY PLANN, V30, P339, DOI 10.1111/j.1728-4465.1999.t01-5-.x; Franck LS, 2007, INT J NURS STUD, V44, P525, DOI 10.1016/j.ijnurstu.2006.03.014; GOODMAN NW, 1984, ANAESTHESIA, V39, P911, DOI 10.1111/j.1365-2044.1984.tb06582.x; Griffin JM, 2006, CONTEMP CLIN TRIALS, V27, P441, DOI 10.1016/j.cct.2006.04.006; Grodin MA, 1996, JAMA-J AM MED ASSOC, V276, P1682, DOI 10.1001/jama.276.20.1682; Guarino P, 2006, J CLIN EPIDEMIOL, V59, P608, DOI 10.1016/j.jclinepi.2005.11.009; HARRISON K, 1995, J ACQ IMMUN DEF SYND, V10, P386; HARTH SC, 1995, SOC SCI MED, V40, P1573, DOI 10.1016/0277-9536(94)00412-M; Hazen RA, 2007, CONTEMP CLIN TRIALS, V28, P401, DOI 10.1016/j.cct.2006.10.011; Hofmeijer I, 2007, J NEUROL NEUROSUR PS, V78, P1124; Hutchison C, 1998, Eur J Cancer Care (Engl), V7, P15, DOI 10.1046/j.1365-2354.1998.00062.x; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Hyder AA, 2014, AM J BIOETHICS, V14, P28, DOI 10.1080/15265161.2013.868950; IDANPAANHEIKKILA JE, 1994, ANN MED, V26, P89, DOI 10.3109/07853899409147334; Ioannidis JPA, 2008, BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Isles Alan F, 2013, Front Pediatr, V1, P38, DOI 10.3389/fped.2013.00038; Kaewpoonsri Nantawan, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P996; Kass Nancy E, 2005, IRB, V27, P1, DOI 10.2307/3563534; Kaufert JM, 1998, HEALTH AND CANADIAN; Kenyon S, 2006, QUAL SAF HEALTH CARE, V15, P98; Kiguba R, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-21; Kupst MJ, 2003, J PEDIAT HEMATOL ONC, V25, P787, DOI 10.1097/00043426-200310000-00009; Lad PM, 2014, SCI ENG ETHICS, V20, P469, DOI 10.1007/s11948-013-9461-4; Leroy T, 2011, INVEST NEW DRUG, V29, P700, DOI 10.1007/s10637-009-9315-8; Lynoe N, 2004, SCAND J UROL NEPHROL, V38, P517, DOI 10.1080/00365590410033362; Lynöe N, 2001, Med Law, V20, P515; Lynoe N, 2004, ACTA ONCOL, V43, P769, DOI 10.1080/02841860410002734; Manafa Ogenna, 2007, Indian J Med Ethics, V4, P26; McNally T, 2001, Paediatr Nurs, V13, P11; Meneguin S, 2010, ARQ BRAS CARDIOL, V94, P4, DOI 10.1590/S0066-782X2010000100003; Miller FG, 2013, J MED ETHICS, V39, P761, DOI 10.1136/medethics-2012-100832; Minnies Deon, 2008, BMC Med Ethics, V9, P15, DOI 10.1186/1472-6939-9-15; Montgomery JE, 1998, ANAESTHESIA, V53, P227, DOI 10.1046/j.1365-2044.1998.00309.x; Moodley K, 2005, J MED ETHICS, V31, P727, DOI 10.1136/jme.2004.009910; Moreno J, 1998, JAMA-J AM MED ASSOC, V280, P1951, DOI 10.1001/jama.280.22.1951; NEGRIER S, 1995, EUR J CANCER, V31A, P1650, DOI 10.1016/0959-8049(95)00329-H; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Nurgat LA, 2005, BRIT J CANCER, V92, P1001; OCKENE IS, 1991, CLIN RES, V39, P13; Pace C, 2005, AM J PUBLIC HEALTH, V95, P1184, DOI 10.2105/AJPH.2004.053082; Pace Christine, 2005, IRB, V27, P9, DOI 10.2307/3563866; Paediatric European Network for Treatment of AIDS, 1999, HIV MED, V1, P25; Pentz RD, 2002, J CLIN ONCOL, V20, P3785, DOI 10.1200/JCO.2002.04.084; Petersen I, 2013, PEDIATR BLOOD CANCER, V60, P446, DOI 10.1002/pbc.24330; Pitisuttithum P, 1997, J MED ASS THAI, V80, P47; Pope JE, 2003, J RHEUMATOL, V30, P815; Protection of human subjects, 1995, PROT HUM SUBJ; Queiroz da Fonseca O, 1999, INT J PHARM MED, V13, P253; Richardson Victoria, 2013, J Perioper Pract, V23, P26; Riecken HW, 1982, JAMA-J AM MED ASSOC, V248, P344; Ritsuko A, 2006, FUKUOKA DAIGAKU LGAK, V33, P25; Schutta K M, 2000, Oncol Nurs Forum, V27, P1435; Sedgwick P, 2013, BMJ-BRIT MED J, V2, pf4040; Simon C, 2003, J CLIN ONCOL, V21, P2173, DOI 10.1200/JCO.2003.03.003; Simon CM, 2004, J CLIN ONCOL, V22, P2708, DOI 10.1200/JCO.2004.10.034; Snowdon C, 1997, SOC SCI MED, V45, P1337, DOI 10.1016/S0277-9536(97)00063-4; Stenson BJ, 2004, ARCH DIS CHILD, V89, pF321, DOI 10.1136/adc.2002.021931; Sugarrnan I, 2005, CLIN TRIALS, V2, P34; Takemura Y, 2005, TOHOKU J EXP MED, V206, P151, DOI 10.1620/tjem.206.151; Tamariz L, 2013, J GEN INTERN MED, V28, P121, DOI 10.1007/s11606-012-2133-2; TANKANOW RM, 1992, AM J HOSP PHARM, V49, P633; Vallely A, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-10; Verheggen FWSM, 1996, PATIENT EDUC COUNS, V29, P137, DOI 10.1016/0738-3991(96)00859-2; Weijer C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001346; Wendler D, 2011, JAMA-J AM MED ASSOC, V305, P1587, DOI 10.1001/jama.2011.421; Will JF, 2011, CHEST, V139, P1491, DOI 10.1378/chest.11-0516; World Bank, 2014, COUNTR LEND GROUPS; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Yoong J, 2011, SUPPORT CARE CANCER, V19, P1067, DOI 10.1007/s00520-011-1201-1	152	1	1	WORLD HEALTH ORGANIZATION	GENEVA 27	MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND	0042-9686	1564-0604		B WORLD HEALTH ORGAN	Bull. World Health Organ.	MAR	2015	93	3					186	U159		10.2471/BLT.14.141390		21	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CE0JO	WOS:000351490500011		
J	Michikawa, T; Inoue, M; Sawada, N; Tanaka, Y; Yamaji, T; Iwasaki, M; Shimazu, T; Sasazuki, S; Mizokami, M; Tsugane, S				Michikawa, Takehiro; Inoue, Manami; Sawada, Norie; Tanaka, Yasuhito; Yamaji, Taiki; Iwasaki, Motoki; Shimazu, Taichi; Sasazuki, Shizuka; Mizokami, Masashi; Tsugane, Shoichiro		Japan Public Hth Ctr-Based Prospec	Plasma Isoflavones and Risk of Primary Liver Cancer in Japanese Women and Men with Hepatitis Virus Infection: A Nested Case-Control Study	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							PUBLIC-HEALTH CENTER; MIDDLE-AGED JAPANESE; HEPATOCELLULAR-CARCINOMA; SUBSEQUENT RISK; PROSPECTIVE COHORT; PROSTATE-CANCER; SOYBEAN ISOFLAVONES; BREAST-CANCER; LUNG-CANCER; CONSUMPTION	Background: Evidence suggests that estrogen plays a preventive role in primary liver cancer development, and it might be thought that isoflavones, which are structurally similar to estrogens and bind to estrogen receptors, are associated with the risk of liver cancer. We investigated this suspected association by measuring plasma concentrations of isoflavones in a nested case-control study of a population-based prospective cohort in Japan. Methods: From 18,628 target participants ages 40 to 69 years who returned the baseline questionnaire and provided blood samples, we selected those with either hepatitis B or hepatitis C virus infection at baseline (n = 1,544). Among these, 90 (28 women and 62 men) were newly diagnosed with primary liver cancer from 1993 through 2006; they were matched with 175 controls (54 women and 121 men). Plasma concentrations of isoflavones (genistein, daidzein, glycitein, and equol) were measured using triple quadrupole tandem liquid chromatographymass spectrometry. The ORs of liver cancer development based on plasma concentrations were estimated with a conditional logistic regression model. Results: Basically, distributions of plasma isoflavone concentrations did not differ between the cases and controls. No statistically significant associations of genistein, daidzein, glycitein, and equol with primary liver cancer risk were found in either women or men. Conclusions: In middle-aged Japanese women and men with hepatitis virus infection, plasma isoflavones were unassociated with the occurrence of primary liver cancer. Impact: The role of isoflavones in liver carcinogenesis merits further study using both biomarkers and data on dietary intake of isoflavones. (c) 2014 AACR.	[Michikawa, Takehiro] Ctr Environm Hlth Sci, Natl Inst Environm Studies, 1Environmental Epidemiol Sect, Tsukuba, Ibaraki, Japan; [Michikawa, Takehiro; Inoue, Manami; Sawada, Norie; Yamaji, Taiki; Iwasaki, Motoki; Shimazu, Taichi; Sasazuki, Shizuka; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 104, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Mizuho Ku, Nagoya, Aichi, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Mizuho Ku, Nagoya, Aichi, Japan; [Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan	Inoue, M (reprint author), Univ Tokyo, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mnminoue@m.u-tokyo.ac.jp			National Cancer Center Research and Development Fund; Health and Labour Sciences Research Grant-Research on Hepatitis from the Ministry of Health, Labour, and Welfare, Japan	This study was supported by National Cancer Center Research and Development Fund (to M. Inoue, N. Sawada, T. Yamaji, M. Iwasaki, T. Shimazu, S. Sasazuki, and S. Tsugane), a Grant-in-Aid for Cancer Research (to M. Inoue and S. Tsugane), and by a Health and Labour Sciences Research Grant-Research on Hepatitis from the Ministry of Health, Labour, and Welfare, Japan (to M. Inoue).	Yu MW, 2001, J NATL CANCER I, V93, P1644; Messina M, 2010, J NUTR, V140, p1350S, DOI 10.3945/jn.109.118315; Barnes S, 2010, LYMPHAT RES BIOL, V8, P89, DOI 10.1089/lrb.2009.0030; Tanaka K, 2000, CANCER RES, V60, P5106; GREENLAND S, 1982, AM J EPIDEMIOL, V116, P547; Kurahashi N, 2009, BRIT J CANCER, V100, P181, DOI 10.1038/sj.bjc.6604843; Yamamoto S, 2003, J NATL CANCER I, V95, P906, DOI 10.1093/jnci/95.12.906; Coward L, 1996, CLIN CHIM ACTA, V247, P121, DOI 10.1016/0009-8981(95)06242-4; Watanabe S, 1998, J NUTR, V128, P1710; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191; Iwasaki M, 2008, J CLIN ONCOL, V26, P1677, DOI 10.1200/JCO.2007.13.9964; Michikawa T, 2012, PREV MED, V55, P137, DOI 10.1016/j.ypmed.2012.05.017; XU X, 1995, J NUTR, V125, P2307; Sawada N, 2012, GASTROENTEROLOGY, V142, P1468, DOI 10.1053/j.gastro.2012.02.018; XU X, 1994, J NUTR, V124, P825; Hara A, 2013, J NUTR, V143, P1293, DOI 10.3945/jn.113.175505; Hara A, 2012, AM J CLIN NUTR, V95, P147, DOI 10.3945/ajcn.111.020479; Ishiguro S, 2009, EUR J CANCER PREV, V18, P26, DOI 10.1097/CEJ.0b013e3282fa9edd; Iwasaki M, 2006, EUR J EPIDEMIOL, V21, P253, DOI 10.1007/s10654-006-0004-z; Kurahashi N, 2008, J CLIN ONCOL, V26, P5923, DOI 10.1200/JCO.2008.16.8807; Kurahashi N, 2007, CANCER EPIDEM BIOMAR, V16, P538, DOI 10.1158/1055-9965.EPI-06-0517; Kurahashi N, 2009, INT J CANCER, V124, P1644, DOI 10.1002/ijc.24121; Kurzer MS, 2002, J NUTR, V132, p570S; Lampe JW, 2003, J NUTR, V133, p956S; Magee PJ, 2004, BRIT J NUTR, V91, P513, DOI 10.1079/BJN20031075; Michikawa T, 2013, CANCER EPIDEM BIOMAR, V22, P2250, DOI 10.1158/1055-9965.EPI-13-0363; Shimazu T, 2011, CANCER EPIDEM BIOMAR, V20, P419, DOI 10.1158/1055-9965.EPI-10-1025; Shimazu T, 2010, AM J CLIN NUTR, V91, P722, DOI 10.3945/ajcn.2009.28161; Tsugane S, 2001, J Epidemiol, V11, pS24; Villa Erica, 2008, Womens Health (Lond Engl), V4, P41, DOI 10.2217/17455057.4.1.41; WHO, 2000, INT CLASSIFICATION D; Yamamoto S, 2001, J NUTR, V131, P2741	32	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	MAR	2015	24	3					532	537		10.1158/1055-9965.EPI-14-1118		6	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	CE6NC	WOS:000351953100008		
J	Budhathoki, S; Iwasaki, M; Yamaji, T; Sasazuki, S; Takachi, R; Sakamoto, H; Yoshida, T; Tsugane, S				Budhathoki, Sanjeev; Iwasaki, Motoki; Yamaji, Taiki; Sasazuki, Shizuka; Takachi, Ribeka; Sakamoto, Hiromi; Yoshida, Teruhiko; Tsugane, Shoichiro			Dietary Heterocyclic Amine Intake, NAT2 Genetic Polymorphism, and Colorectal Adenoma Risk: The Colorectal Adenoma Study in Tokyo	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							FOOD FREQUENCY QUESTIONNAIRE; MEAT INTAKE; CANCER RISK; MULTIETHNIC COHORT; MOLECULAR-GENETICS; MUTAGEN EXPOSURE; AROMATIC-AMINES; COOKING METHODS; DISTAL COLON; ASSOCIATION	Background: While several studies have provided support for a positive association between meat intake and colorectal neoplasia, the role of heterocyclic amines (HCA), which is hypothesized to underline this relation, has been less consistent. We evaluated the association of HCA intake with colorectal adenoma risk in a case-control study in a middle-aged Japanese population. Methods: Study subjects were 738 patients with adenoma and 697 controls who underwent total colonoscopy between 2004 and 2005 and responded to self-administered lifestyle and dietary questionnaires. HCA exposure concentration was estimated from meat and fish intake based on an HCA database that was validated against 2-amino-1-methyl-6-phenylimidazo[4,5b] pyridine (PhIP) values measured in human hair. Logistic regression models were used to estimate ORs and 95% confidence interval (CI) for the association between HCA and colorectal adenoma risk after adjusting for potential confounders. Results: High intake of 2-amino-3,4-dimethylimidazo[4, 5-f] quinoline (MeIQ) and total HCA was associated with an increased risk of colorectal adenoma in women but not in men. The multivariate-adjusted OR for the highest versus lowest quartile in women was 2.10 (95% CI, 1.20-3.67; P-trend = 0.01) for MeIQ and 1.73 (95% CI, 0.99-3.01; P-trend = 0.03) for total HCA. No clear association with PhIP or 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) estimates and no effect modification by NAT2 acetylation genotype was observed. Conclusions: This study suggests that high MeIQ and total HCA estimates are positively associated with colorectal adenoma risk. Impact: The findings add to evidence that HCA may play a role in colorectal carcinogenesis in humans. (c) 2015 AACR.	[Budhathoki, Sanjeev; Iwasaki, Motoki; Yamaji, Taiki] Natl Canc Ctr, Div Epidemiol, Tokyo 1040045, Japan; [Sasazuki, Shizuka] Natl Canc Ctr, Div Prevent, Tokyo 1040045, Japan; [Takachi, Ribeka] Niigata Univ, Grad Sch Med & Dent Sci, Div Social & Environm Med, Dept Community Prevent Med, Niigata, Japan; [Sakamoto, Hiromi; Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Tokyo 1040045, Japan	Iwasaki, M (reprint author), Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Div Epidemiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	moiwasak@ncc.go.jp	budhathoki, sanjeev/C-7358-2015	budhathoki, sanjeev/0000-0003-1662-3109	Ministry of Health, Labour, and Welfare of Japan [17-9]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [221S0001]; Japan Society for the Promotion of Science [AA005]; Foundation for Promotion of Cancer Research in Japan [C-24501366, C-24590830]	This study was supported by the Ministry of Health, Labour, and Welfare of Japan [Grant-in-Aid for the 3rd Term Comprehensive 10-Year-Strategy for Cancer Control (S. Tsugane and S. Sasazuki) and Grant-in-Aid for Cancer Research 17-9 (M. Iwasaki and S. Sasazuki)], Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grants-in-Aid for Scientific Research on Innovative Areas: 221S0001(S. Tsugane)], Japan Society for the Promotion of Science [AA005 (A3 Foresight Program)], and Foundation for Promotion of Cancer Research in Japan [Grant-in-Aid for Scientific Research C-24501366 (M. Iwasaki) and C-24590830 (T. Yamaji)].	Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Lijinsky W, 1999, MUTAT RES-GEN TOX EN, V443, P129, DOI 10.1016/S1383-5742(99)00015-0; Gooderham NJ, 2001, DRUG METAB DISPOS, V29, P529; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Nothlings U, 2009, CANCER EPIDEM BIOMAR, V18, P2098, DOI 10.1158/1055-9965.EPI-08-1218; Augustsson K, 1999, LANCET, V353, P703, DOI 10.1016/S0140-6736(98)06099-1; Kono S, 2004, EUR J CANCER PREV, V13, P127; Ramadas A, 2009, ASIAN PAC J CANCER P, V10, P925; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; Voutsinas J, 2013, GUT, V62, P416, DOI 10.1136/gutjnl-2011-300665; Sinha R, 2001, CANCER EPIDEM BIOMAR, V10, P559; Aune D, 2013, CANCER CAUSE CONTROL, V24, P611, DOI 10.1007/s10552-012-0139-z; Kobayashi M, 2002, MUTAT RES-FUND MOL M, V506, P233, DOI 10.1016/S0027-5107(02)00170-7; Kimura Y, 2007, CANCER SCI, V98, P590, DOI 10.1111/j.1349-7006.2007.00425.x; Takachi R, 2011, J EPIDEMIOL, V21, P447, DOI 10.2188/jea.JE20100173; Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29; Suarez-Kurtz G, 2012, PHARMACOGENOMICS, V13, P851, DOI [10.2217/pgs.12.48, 10.2217/PGS.12.48]; Le Marchand L, 2002, MUTAT RES-FUND MOL M, V506, P205, DOI 10.1016/S0027-5107(02)00167-7; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Rohrmann S, 2009, AM J CLIN NUTR, V89, P1418, DOI 10.3945/ajcn.2008.26658; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Gunter MJ, 2005, CARCINOGENESIS, V26, P637, DOI 10.1093/carcin/bgh350; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Shin A, 2008, CANCER EPIDEM BIOMAR, V17, P320, DOI 10.1158/1055-9965.EPI-07-0615; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Sinha R, 2005, CANCER RES, V65, P8034, DOI 10.1158/0008-5472.CAN-04-3429; Parr CL, 2013, INT J CANCER, V133, P1153, DOI 10.1002/ijc.28101; Ollberding NJ, 2012, INT J CANCER, V131, pE1125, DOI 10.1002/ijc.27546; Nagata C, 2001, DIS COLON RECTUM, V44, P105, DOI 10.1007/BF02234831; Barbir A, 2012, CANCER CAUSE CONTROL, V23, P1429, DOI 10.1007/s10552-012-0017-8; Chan DSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020456; Ferrucci LM, 2009, AM J GASTROENTEROL, V104, P1231, DOI 10.1038/ajg.2009.102; Fu ZM, 2011, CANCER PREV RES, V4, P1686, DOI 10.1158/1940-6207.CAPR-11-0191; Gilsing AMJ, 2012, CARCINOGENESIS, V33, P1332, DOI 10.1093/carcin/bgs158; Iwasaki M, 2014, CANCER CAUSE CONTROL, V25, P1015, DOI 10.1007/s10552-014-0401-7; Kobayashi M, 2007, MUTAT RES-GEN TOX EN, V630, P14, DOI 10.1016/jmrgentox.2007.02.003; Kobayashi M, 2009, SCAND J GASTROENTERO, V44, P952, DOI 10.1080/00365520902964721; Liu JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042797; Lubin F, 1997, CANCER EPIDEM BIOMAR, V6, P79; Schut HAJ, 1999, CARCINOGENESIS, V20, P353, DOI 10.1093/carcin/20.3.353; Sinha R, 2002, MUTAT RES-FUND MOL M, V506, P197, DOI 10.1016/S0027-5107(02)00166-5; Sinha R, 1997, MUTAT RES-FUND MOL M, V376, P195, DOI 10.1016/S0027-5107(97)00043-2; Sugimura T, 1997, MUTAT RES-FUND MOL M, V376, P211, DOI 10.1016/S0027-5107(97)00045-6; Wang HS, 2011, CARCINOGENESIS, V32, P203, DOI 10.1093/carcin/bgq237; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu K, 2006, CANCER EPIDEM BIOMAR, V15, P1120, DOI 10.1158/1055-9965.EPI-05-0782; Yamaji T, 2012, AM J EPIDEMIOL, V175, P236, DOI 10.1093/aje/kwr295	47	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	MAR	2015	24	3					613	620		10.1158/1055-9965.EPI-14-1051		8	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	CE6NC	WOS:000351953100018		
J	Shimura, T; Dagher, A; Sachdev, M; Ebi, M; Yamada, T; Yamada, T; Joh, T; Moses, MA				Shimura, Takaya; Dagher, Adelle; Sachdev, Monisha; Ebi, Masahide; Yamada, Tamaki; Yamada, Tomonori; Joh, Takashi; Moses, Marsha A.			Urinary ADAM12 and MMP-9/NGAL Complex Detect the Presence of Gastric Cancer	CANCER PREVENTION RESEARCH			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ENDOSCOPIC SUBMUCOSAL DISSECTION; HUMAN NEUTROPHIL GELATINASE; BREAST-TUMOR GROWTH; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; PRACTICE GUIDELINES; ANGIOGENESIS; PROGRESSION; EXPRESSION	Although the early diagnosis of gastric cancer provides the opportunity for curative endoscopic resection, comprehensive screening endoscopy would be invasive and expensive. To date, there is a complete absence of clinically useful gastric cancer biomarkers. With the goal of discovering noninvasive biomarkers for the early diagnosis of gastric cancer, we have conducted a case-control study using urine samples from individuals with gastric cancer versus healthy control samples. Of the enrolled 106 patients from September, 2012 to April, 2013, a cohort of 70 patients composed of 35 patients with gastric cancer and 35 age-and sex-matched healthy controls was analyzed. The gastric cancer group was composed of stage IA of 62.9% (22/35). The urinary levels of MMP-9/NGAL complex (uMMP-9/NGAL) and ADAM12 (uADAM12) were significantly higher in the gastric cancer group compared with the healthy control group as determined by monospecific ELISAs (uMMP-9/NGAL: median, 85 pg/mL vs. 0 pg/mL; P = 0.020; uADAM12: median, 3.35 ng/mL vs. 1.44 ng/mL; P < 0.001). Multivariate analysis demonstrated that both uMMP-9/NGAL and uADAM12 were significant, independent diagnostic biomarkers for gastric cancer. Moreover, MMP-9/NGAL activity was significantly elevated as determined by gelatin zymography. The combination of uMMP-9/NGAL with uADAM12 distinguished between control samples and gastric cancer samples with an AUC of 0.825 (P < 0.001) in an ROC analysis. Significantly, immunohistochemical analyses demonstrated a high coexpression of MMP-9 and NGAL (P < 0.001) and high expression of ADAM12 (P < 0.001) in gastric cancer tissues compared with adjacent normal tissues (N = 35). In summary, uMMP-9/NGAL and uADAM12 are potential noninvasive biomarkers for gastric cancer, including early-stage disease. (C) 2015 AACR.	[Shimura, Takaya; Dagher, Adelle; Sachdev, Monisha; Moses, Marsha A.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Shimura, Takaya; Moses, Marsha A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Shimura, Takaya; Moses, Marsha A.] Boston Childrens Hosp, Boston, MA 02115 USA; [Ebi, Masahide; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Yamada, Tamaki] Okazaki Publ Hlth Ctr, Okazaki, Aichi, Japan; [Yamada, Tomonori] Japanese Red Cross Nagoya Daini Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan	Moses, MA (reprint author), Boston Childrens Hosp, Karp Family Res Bldg,12-129,300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu			Advanced Medical Research Foundation; Uehara Memorial Foundation, Japan	This study was supported by the Advanced Medical Research Foundation (to M.A. Moses) and the Research Fellowship of the Uehara Memorial Foundation, Japan (to T. Shimura).	Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Shimura T, 2008, CLIN CANCER RES, V14, P3956, DOI 10.1158/1078-0432.CCR-07-4794; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Bergers G, 2000, NAT CELL BIOL, V2, P737; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Strong VE, 2013, J NATL COMPR CANC NE, V11, P60; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Roy R, 2011, J BIOL CHEM, V286, P20758, DOI 10.1074/jbc.M110.216036; Aikou S, 2011, GASTROENTEROLOGY, V141, P837, DOI 10.1053/j.gastro.2011.05.040; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Shimada H, 2014, GASTRIC CANCER, V17, P26, DOI 10.1007/s10120-013-0259-5; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Moses MA, 1997, STEM CELLS, V15, P180; Chu DK, 2011, INT J CANCER, V129, P887, DOI 10.1002/ijc.25734; Nyren-Erickson EK, 2013, BBA-GEN SUBJECTS, V1830, P4445, DOI 10.1016/j.bbagen.2013.05.011; Masunaga R, 2000, CLIN CANCER RES, V6, P4064; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Graham DY, 2001, ALIMENT PHARM THERAP, V15, P699, DOI 10.1046/j.1365-2036.2001.00968.x; Chiu PWY, 2012, SURG ENDOSC, V26, P3584, DOI 10.1007/s00464-012-2371-8; Tashiro A, 2006, WORLD J GASTROENTERO, V12, P4873; McShane LM, 2005, EUR J CANCER, V41, P1690, DOI 10.1016/j.ejca.2005.03.032; Chan LW, 2004, J CLIN ONCOL, V22, P499; Moses MA, 1998, CANCER RES, V58, P1395; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Kubben FJGM, 2007, EUR J CANCER, V43, P1869, DOI 10.1016/j.ejca.2007.05.013; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Wu ZS, 2008, INT J CANCER, V122, P2050, DOI 10.1002/ijc.23337; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Yang J, 2013, FASEB J, V27, P45, DOI 10.1096/fj.12-211730; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Baren JP, 2012, BRIT J CANCER, V107, P143, DOI 10.1038/bjc.2012.239; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Roy R, 2008, CLIN CANCER RES, V14, P6610, DOI 10.1158/1078-0432.CCR-08-1136; Kato M, 2010, GASTROINTEST ENDOSC, V72, P523, DOI 10.1016/j.gie.2010.04.041; Smith ER, 2008, CLIN CANCER RES, V14, P2378, DOI 10.1158/1078-0432.CCR-07-1253; Bollschweiler E, 2014, WORLD J GASTROENTERO, V20, P5672, DOI 10.3748/wjg.v20.i19.5672; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Heissig B, 2003, CURR OPIN HEMATOL, V10, P136, DOI 10.1097/00062752-200303000-00007; Liu Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-270; Shimura T, 2007, J GASTROEN HEPATOL, V22, P821, DOI 10.1111/j.1440-1746.2006.04505.x; Sobin LH, 2009, TNM CLASSIFICATION M, P332; Sturgeon CM, 2010, CLIN CHEM, V56, pE1, DOI 10.1373/clinchem.2009.133124; Sun Y, 2011, CLIN CANCER RES, V17, P4331, DOI 10.1158/1078-0432.CCR-11-0226; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241	53	2	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1940-6207	1940-6215		CANCER PREV RES	Cancer Prev. Res.	MAR	2015	8	3					240	248		10.1158/1940-6207.CAPR-14-0229		9	Oncology	Oncology	CE8FM	WOS:000352077100007		
J	Yamamura, Y; Asai, N; Enomoto, A; Kato, T; Mii, S; Kondo, Y; Ushida, K; Niimi, K; Tsunoda, N; Nagino, M; Ichihara, S; Furukawa, K; Maeda, K; Murohara, T; Takahashi, M				Yamamura, Yumiko; Asai, Naoya; Enomoto, Atsushi; Kato, Takuya; Mii, Shinji; Kondo, Yuji; Ushida, Kaori; Niimi, Kaoru; Tsunoda, Nobuyuki; Nagino, Masato; Ichihara, Shu; Furukawa, Koichi; Maeda, Kengo; Murohara, Toyoaki; Takahashi, Masahide			Akt-Girdin Signaling in Cancer-Associated Fibroblasts Contributes to Tumor Progression	CANCER RESEARCH			English	Article							BINDING PROTEIN GIRDIN; STROMAL FIBROBLASTS; COLORECTAL-CANCER; CELLS; METASTASIS; GROWTH; ROLES; EXPRESSION; INITIATION; MYOFIBROBLASTS	PI3K-Akt signaling is critical for the development, progression, and metastasis of malignant tumors, but its role in the tumor microenvironment has been relatively little studied. Here, we report that the Akt substrate Girdin, an actin-binding protein that regulates cell migration, is expressed and activated by Akt phosphorylation in cancer-associated fibroblasts (CAF) and blood vessels within the tumor microenvironment. Lewis lung tumors grafted into mice defective in Akt-mediated Girdin phosphorylation (SA transgenic mice) exhibited a decrease in both CAF infiltration and tumor growth, compared with wild-type (WT) host control animals. Contrasting with the findings of other studies, we found that Akt-dependent phosphorylation of Girdin was not a rate-limiting step in the growth of endothelial cells. In addition, Lewis lung tumors displayed limited outgrowth when cotransplanted with CAF derived from tumor-bearing SA transgenic mice, compared with CAF derived from tumor-bearing WT mice. Collectively, our results revealed a role for Akt-mediated Girdin phosphorylation in CAF during tumor progression, highlighting the need to inhibit Akt function in both tumor cells and cells that comprise the tumor microenvironment. (C)2015 AACR.	[Yamamura, Yumiko; Asai, Naoya; Enomoto, Atsushi; Kato, Takuya; Mii, Shinji; Ushida, Kaori; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Yamamura, Yumiko; Maeda, Kengo; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Kondo, Yuji; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4668550, Japan; [Niimi, Kaoru] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynaecol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ichihara, Shu] Nagoya Med Ctr, Dept Adv Diag, Div Pathol, Nagoya, Aichi, Japan; [Tsunoda, Nobuyuki; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Showa Ku, Nagoya, Aichi 4668550, Japan	Takahashi, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Pathol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	mtakaha@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; NIIMI, Kaoru/I-7509-2014		Ministry of Education, Culture, Sports, Science, and Technology of Japan [22117005, 23249020, 26221304, 24390095, 20432255]	This work was supported by grant-in-aid for Scientific Research on Innovative Areas (22117005), Scientific Research (A) (23249020) and Scientific Research (S) (26221304; M. Takahashi), grant-in-aid for Scientific Research (C) (24390095; N. Asai), and grant-in-aid for Young Scientists (A) (20432255; A. Enomoto) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Pal I, 2012, ACTA PHARMACOL SIN, V33, P1441, DOI 10.1038/aps.2012.72; Ono S, 2013, CHEST, V143, P963, DOI 10.1378/chest.12-0913; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Tripathi M, 2012, CELL ADHES MIGR, V6, P231, DOI 10.4161/cam.20419; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Herrera M, 2013, CLIN CANCER RES, V19, P5914, DOI 10.1158/1078-0432.CCR-13-0694; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466; Bierie BR, 2011, TUMOR MICROENVIRON, V4, P223, DOI 10.1007/978-94-007-0659-0_12; Busch S, 2015, ONCOGENE, V34, P27, DOI 10.1038/onc.2013.527; Chung LWK, 2011, TUMOR MICROENVIRON, V4, P3, DOI 10.1007/978-94-007-0659-0_1; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Eikesdal HP, 2011, TUMOR MICROENVIRON, V4, P361, DOI 10.1007/978-94-007-0659-0_19; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Hellberg C, 2011, TUMOR MICROENVIRON, V4, P257, DOI 10.1007/978-94-007-0659-0_14; Hinz B, 2011, TUMOR MICROENVIRON, V4, P37, DOI 10.1007/978-94-007-0659-0_3; Ito T, 2013, AM J PATHOL, V182, P586, DOI 10.1016/j.ajpath.2012.10.012; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Miyachi H, 2013, J VASC SURG, V60, P479; Nishimae K, 2013, BREAST CANC; Ohara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036681; Polyak K, 2011, MAMMARY GLAND EXPT M, P163; Rupp C, 2011, TUMOR MICROENVIRON, V4, P383, DOI 10.1007/978-94-007-0659-0_20; Wang Y, 2011, J NEUROSCI, V31, P8109, DOI 10.1523/JNEUROSCI.1130-11.2011; Worthley DL, 2013, EXP CELL RES, V319, P1650, DOI 10.1016/j.yexcr.2013.03.006	50	4	5	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	MAR 1	2015	75	5					813	823		10.1158/0008-5472.CAN-14-1317		11	Oncology	Oncology	CE6GG	WOS:000351934100006		
J	Javidi-Sharifi, N; Traer, E; Martinez, J; Gupta, A; Taguchi, T; Dunlap, J; Heinrich, MC; Corless, CL; Rubin, BP; Druker, BJ; Tyner, JW				Javidi-Sharifi, Nathalie; Traer, Elie; Martinez, Jacqueline; Gupta, Anu; Taguchi, Takehiro; Dunlap, Jennifer; Heinrich, Michael C.; Corless, Christopher L.; Rubin, Brian P.; Druker, Brian J.; Tyner, Jeffrey W.			Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance	CANCER RESEARCH			English	Article							PROSTATE-CANCER; FACTOR RECEPTOR-3; LUNG-CANCER; B-RAF; SURVIVAL; LEUKEMIA; IMATINIB; MUTATION; KINASE; MECHANISMS	Kinase inhibitors such as imatinib have dramatically improved outcomes for patients with gastrointestinal stromal tumor (GIST), but many patients develop resistance to these treatments. Although in some patients this event corresponds with mutations in the GIST driver oncogenic kinase KIT, other patients develop resistance without KIT mutations. In this study, we address this patient subset in reporting a functional dependence of GIST on the FGF receptor FGFR3 and its crosstalk with KIT in GIST cells. Addition of the FGFR3 ligand FGF2 to GIST cells restored KIT phosphorylation during imatinib treatment, allowing sensitive cells to proliferate in the presence of the drug. FGF2 expression was increased in imatinib-resistant GIST cells, the growth of which was blocked by RNAi-mediated silencing of FGFR3. Moreover, combining KIT and FGFR3 inhibitors synergized to block the growth of imatinib-resistant cells. Signaling crosstalk between KIT and FGFR3 activated the MAPK pathway to promote resistance to imatinib. Clinically, an IHC analysis of tumor specimens from imatinib-resistant GIST patients revealed a relative increase in FGF2 levels, with a trend toward increased expression in imatinib-naive samples consistent with possible involvement in drug resistance. Our findings provide a mechanistic rationale to evaluate existing FGFR inhibitors and multikinase inhibitors that target FGFR3 as promising strategies to improve treatment of patients with GIST with de novo or acquired resistance to imatinib. (C)2014 AACR.	[Javidi-Sharifi, Nathalie; Traer, Elie; Martinez, Jacqueline; Dunlap, Jennifer; Heinrich, Michael C.; Corless, Christopher L.; Druker, Brian J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Javidi-Sharifi, Nathalie; Traer, Elie; Heinrich, Michael C.; Druker, Brian J.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA; [Gupta, Anu; Rubin, Brian P.] Lerner Res Inst, Dept Mol Genet, Cleveland, OH USA; [Taguchi, Takehiro] Kochi Univ, Grad Sch Kuroshio Sci, Div Human Hlth & Med Sci, Nankoku, Kochi, Japan; [Dunlap, Jennifer; Corless, Christopher L.] Oregon Hlth & Sci Univ, Depat Anat Pathol, Portland, OR 97239 USA; [Heinrich, Michael C.] Portland VA Med Ctr, Portland, OR USA; [Rubin, Brian P.] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA; [Rubin, Brian P.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Druker, Brian J.] Howard Hughes Med Inst, Portland, OR USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Tyner, JW (reprint author), Oregon Hlth & Sci Univ, Knight Canc Inst, 3181 Southwest Sam Jackson Pk Rd,Mailcode L592, Portland, OR 97239 USA.	tynerj@ohsu.edu			Oregon Clinical and Translational Research Institute (OCTRI); National Center for Advancing Translational Sciences (NCATS) [TL1 RR024159]; NIH; NIH Roadmap for Medical Research; V Foundation for Cancer Research; Leukemia and Lymphoma Society; Gabrielle's Angel Foundation for Cancer Research; National Cancer Institute [5R00CA151457-04, 1R01CA183974-01]; Life Raft Group	N. Javidi-Sharifi was supported by the Oregon Clinical and Translational Research Institute (OCTRI), grant number TL1 RR024159 from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH, and NIH Roadmap for Medical Research. B.J. Druker was an investigator of the Howard Hughes Medical Institute. J.W. Tyner was supported by grants from the V Foundation for Cancer Research, The Leukemia and Lymphoma Society, the Gabrielle's Angel Foundation for Cancer Research, and the National Cancer Institute (5R00CA151457-04; 1R01CA183974-01). B.P. Rubin and A. Gupta were supported by the Life Raft Group.	Karamouzis MV, 2009, LANCET ONCOL, V10, P709, DOI 10.1016/S1470-2045(09)70137-8; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Kwabi-Addo B, 2004, ENDOCR-RELAT CANCER, V11, P709, DOI 10.1677/erc.1.00535; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Greulich H, 2011, TRENDS MOL MED, V17, P283, DOI 10.1016/j.molmed.2011.01.012; Tyner JW, 2008, BLOOD, V111, P2238, DOI 10.1182/blood-2007-06-097253; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Yang F, 2008, ONCOGENE, V27, P450, DOI 10.1038/sj.onc.1210663; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S001-5085(03)01046-1; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Di Martino E, 2012, ADV UROL, V2012, DOI DOI 10.1155/2012/429213; Hirota S, 2001, J PATHOL, V193, P505, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E; Huynh H, 2009, MOL CANCER THER, V8, P152, DOI 10.1158/1535-7163.MCT-08-0553; Johnson MD, 2010, J NEUROSURG, V112, P934, DOI 10.3171/2009.7.JNS09726; Li ZH, 2001, BLOOD, V97, P2413, DOI 10.1182/blood.V97.8.2413; Murphy T, 2010, J PATHOL, V220, P452, DOI 10.1002/path.2657; Onwuazor ON, 2003, BLOOD, V102, P772, DOI 10.1182/blood-2003-04-1204; Salm F, 2013, ONCOGENE, V32, P3944, DOI 10.1038/onc.2012.416; Schlemmer M, 2011, EUR J MED RES, V16, P206; Semrad TJ, 2012, CLIN LUNG CANCER, V13, P90, DOI 10.1016/j.cllc.2011.08.001; Tomlinson DC, 2012, INT J CANCER, V130, P2857, DOI 10.1002/ijc.26304; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102	34	5	5	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	MAR 1	2015	75	5					880	891		10.1158/0008-5472.CAN-14-0573		12	Oncology	Oncology	CE6GG	WOS:000351934100012		
J	Morioka, T; Miyoshi-Imamura, T; Blyth, BJ; Kaminishi, M; Kokubo, T; Nishimura, M; Kito, S; Tokairin, Y; Tani, S; Murakami-Murofushi, K; Yoshimi, N; Shimada, Y; Kakinuma, S				Morioka, Takamitsu; Miyoshi-Imamura, Tomoko; Blyth, Benjamin J.; Kaminishi, Mutsumi; Kokubo, Toshiaki; Nishimura, Mayumi; Kito, Seiji; Tokairin, Yutaka; Tani, Shusuke; Murakami-Murofushi, Kimiko; Yoshimi, Naoki; Shimada, Yoshiya; Kakinuma, Shizuko			Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice	CANCER SCIENCE			English	Article						Colon carcinogenesis; inflammation; Lynch syndrome; Mlh1; radiation	DNA-MISMATCH-REPAIR; HEREDITARY COLORECTAL-CARCINOMA; SODIUM-INDUCED COLITIS; MICROSATELLITE INSTABILITY; BOWEL-DISEASE; ULCERATIVE-COLITIS; SITE MUTATION; LYNCH-SYNDROME; CANCER-RISK; MOUSE MODEL	Genetic, physiological and environmental factors are implicated in colorectal carcinogenesis. Mutations in the mutL homolog 1 (MLH1) gene, one of the DNA mismatch repair genes, are a main cause of hereditary colon cancer syndromes such as Lynch syndrome. Long-term chronic inflammation is also a key risk factor, responsible for colitis-associated colorectal cancer; radiation exposure is also known to increase colorectal cancer risk. Here, we studied the effects of radiation exposure on inflammation-induced colon carcinogenesis in DNA mismatch repair-proficient and repair-deficient mice. Male and female Mlh1(-/-) and Mlh1(+/+) mice were irradiated with 2Gy X-rays when aged 2weeks or 7weeks and/or were treated with 1% dextran sodium sulfate (DSS) in drinking water for 7days at 10weeks old to induce mild inflammatory colitis. No colon tumors developed after X-rays and/or DSS treatment in Mlh1(+/+) mice. Colon tumors developed after DSS treatment alone in Mlh1(-/-) mice, and exposure to radiation prior to DSS treatment increased the number of tumors. Histologically, colon tumors in the mice resembled the subtype of well-to-moderately differentiated adenocarcinomas with tumor-infiltrating lymphocytes of human Lynch syndrome. Immunohistochemistry revealed that expression of both p53 and -catenin and loss of p21 and adenomatosis polyposis coli proteins were observed at the later stages of carcinogenesis, suggesting a course of molecular pathogenesis distinct from typical sporadic or colitis-associated colon cancer in humans. In conclusion, radiation exposure could further increase the risk of colorectal carcinogenesis induced by inflammation under the conditions of Mlh1 deficiency.	[Morioka, Takamitsu; Nishimura, Mayumi; Shimada, Yoshiya; Kakinuma, Shizuko] Natl Inst Radiol Sci, Fukushima Project Headquarters, Radiat Effect Accumulat & Prevent Project, Chiba 2638555, Japan; [Morioka, Takamitsu; Miyoshi-Imamura, Tomoko; Blyth, Benjamin J.; Kaminishi, Mutsumi; Nishimura, Mayumi; Tani, Shusuke; Shimada, Yoshiya; Kakinuma, Shizuko] Natl Inst Radiol Sci, Radiobiol Childrens Hlth Program, Res Ctr Radiat Protect, Chiba 2638555, Japan; [Miyoshi-Imamura, Tomoko; Murakami-Murofushi, Kimiko] Ochanomizu Univ, Grad Sch Humanities & Sci, Genet Counseling Program, Tokyo 112, Japan; [Kokubo, Toshiaki; Kito, Seiji] Natl Inst Radiol Sci, Res Dev & Support Ctr, Chiba 2638555, Japan; [Tokairin, Yutaka] Tokyo Med & Dent Univ, Dept Esophageal & Surg, Tokyo, Japan; [Yoshimi, Naoki] Univ Ryukyus, Dept Pathol & Oncol, Grad Sch Med Sci, Okinawa, Japan	Kakinuma, S (reprint author), Natl Inst Radiol Sci, Radiobiol Childrens Hlth Program, Res Ctr Radiat Protect, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	skakinum@nirs.go.jp		Blyth, Benjamin/0000-0003-4754-6249	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22501009]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (22501009)	Andersen SH, 2008, FAM CANCER, V7, P157, DOI 10.1007/s10689-007-9163-7; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Alexander J, 2001, AM J PATHOL, V158, P527, DOI 10.1016/S0002-9440(10)63994-6; Torlakovic EE, 2008, AM J SURG PATHOL, V32, P21; SUZUKI H, 1994, CANCER RES, V54, P4841; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Berglund M, 2009, CELL IMMUNOL, V259, P27, DOI 10.1016/j.cellimm.2009.05.009; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Hussain SP, 2000, CANCER RES, V60, P3333; Fleisher AS, 2000, CANCER RES, V60, P4864; JOLLY KW, 1994, ONCOGENE, V9, P97; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Young J, 2001, AM J PATHOL, V159, P2107, DOI 10.1016/S0002-9440(10)63062-3; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; PASCAL RR, 1994, HUM PATHOL, V25, P1160, DOI 10.1016/0046-8177(94)90032-9; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DELEON MP, 1989, CANCER RES, V49, P4344; Margel D, 2011, ANN SURG, V254, P947, DOI 10.1097/SLA.0b013e3182382fd5; Greenson JK, 2003, AM J SURG PATHOL, V27, P563, DOI 10.1097/00000478-200305000-00001; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; COOPER HS, 1993, LAB INVEST, V69, P238; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Cooper HS, 2000, CARCINOGENESIS, V21, P757, DOI 10.1093/carcin/21.4.757; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Chen WG, 1996, LAB INVEST, V75, P519; Clarke AR, 2005, BIOCHEM SOC T, V33, P665; Fujiwara I, 2008, DIS COLON RECTUM, V51, P1387, DOI 10.1007/s10350-008-9212-9; Gatalica Z, 2008, FAM CANCER, V7, P15, DOI 10.1007/s10689-007-9146-8; International Commission on Radiological Protection, 1998, ICRP PUBL, V79; Ishizuka S, 1999, CARCINOGENESIS, V20, P1005, DOI 10.1093/carcin/20.6.1005; JASS JR, 1994, MUTAT RES-FUND MOL M, V310, P125, DOI 10.1016/0027-5107(94)90016-7; Jass JR, 2000, ANN NY ACAD SCI, V910, P62; Kohonen-Corish MRJ, 2002, CANCER RES, V62, P2092; Magnusson KP, 2000, GENE, V246, P247, DOI 10.1016/S0378-1119(00)00068-8; Martin LM, 2010, CANCER TREAT REV, V36, P518, DOI 10.1016/j.ctrv.2010.03.008; MECKLIN JP, 1986, DIS COLON RECTUM, V29, P849, DOI 10.1007/BF02555362; MECKLIN JP, 1987, GASTROENTEROLOGY, V93, P1021; Okamoto M, 2005, J RADIAT RES, V46, P83, DOI 10.1269/jrr.46.83; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Rodriguez AM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0943-2; Sakurai N, 2013, PEDIATR INT, V55, P107, DOI 10.1111/j.1442-200X.2012.03641.x; Sehgal R, 2014, GENES-BASEL, V5, P497, DOI 10.3390/genes5030497; Silva Felipe Cavalcanti Carneiro da, 2009, Sao Paulo Med J, V127, P46; TANAKA T, 1993, JPN J CANCER RES, V84, P1031; Taniguchi K, 2006, ONCOLOGY-BASEL, V71, P124, DOI 10.1159/000100522; Tokairin Y, 2006, INT J EXP PATHOL, V87, P89, DOI 10.1111/j.0959-9673.2006.00464.x; United Nations, 2000, UN SAL PUBL; Weil MM, 2001, GENOMICS, V72, P73, DOI 10.1006/geno.2000.6465; Xu XXS, 2001, CANCER RES, V61, P3775; Zhang Y, 2008, DNA REPAIR, V7, P1835, DOI 10.1016/j.dnarep.2008.07.009	62	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					217	226		10.1111/cas.12591		10	Oncology	Oncology	CE3QI	WOS:000351742800001		
J	Aikawa, Y; Yamagata, K; Katsumoto, T; Shima, Y; Shino, M; Stanley, ER; Cleary, ML; Akashi, K; Tenen, DG; Kitabayashi, I				Aikawa, Yukiko; Yamagata, Kazutsune; Katsumoto, Takuo; Shima, Yutaka; Shino, Mika; Stanley, E. Richard; Cleary, Michael L.; Akashi, Koichi; Tenen, Daniel G.; Kitabayashi, Issay			Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells	CANCER SCIENCE			English	Article						Acute myeloid leukemia; CSF-1R; mixed lineage leukemia; Spi-1; stem cells	ACUTE MYELOID-LEUKEMIA; STIMULATING FACTOR-RECEPTOR; PROTO-ONCOPROTEIN MLL; FUSION GENE LEUKEMIA; UP-REGULATION; FACTOR-I; TRANSFORMATION; PROGENITORS; MACROPHAGE; EXPRESSION	Acute myeloid leukemia is a clonal malignant disorder derived from a small number of leukemic stem cells (LSCs). Rearrangements of the mixed lineage leukemia (MLL) gene are found in acute myeloid leukemia associated with poor prognosis. The upregulation of Hox genes is critical for LSC induction and maintenance, but is unlikely to support malignancy and the high LSC frequency observed in MLL leukemias. The present study shows that MLL fusion proteins interact with the transcription factor PU.1 to activate the transcription of CSF-1R, which is critical for LSC activity. Acute myeloid leukemia is cured by either deletion of PU.1 or ablation of cells expressing CSF-1R. Kinase inhibitors specific for CSF-1R prolong survival time. These findings indicate that PU.1-mediated upregulation of CSF-1R is a critical effector of MLL leukemogenesis.	[Aikawa, Yukiko; Yamagata, Kazutsune; Katsumoto, Takuo; Shima, Yutaka; Shino, Mika; Kitabayashi, Issay] Natl Canc Ctr, Div Hematol Malignancy, Res Inst, Tokyo 1040045, Japan; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Cleary, Michael L.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Tenen, Daniel G.] Canc Sci Inst Singapore, Singapore, Singapore; [Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA USA	Kitabayashi, I (reprint author), Natl Canc Ctr, Div Hematol Malignancy, Res Inst, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ikitabay@ncc.go.jp			Ministry of Health, Labor and Welfare, Japan; National Cancer Center Research and Development Fund, Japan; US National Institutes of Health [HL112719, CA32551, 5P30-CA13330]	Ministry of Education, Culture, Sports, Science and Technology, Japan; National Cancer Center Research and Development Fund, Japan; US National Institutes of Health (HL112719, CA32551, and 5P30-CA13330).	Aikawa Y, 2010, NAT MED, V16, P5; Aikawa Y, 2010, NAT MED, V16; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Huang G, 2011, BLOOD, V118, P6544, DOI 10.1182/blood-2010-11-317909; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Aikawa Y, 2010, NAT MED, V16, P580, DOI 10.1038/nm.2122; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; ZHANG DE, 1994, MOL CELL BIOL, V14, P373; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Dou YL, 2008, INT J HEMATOL, V87, P10, DOI 10.1007/s12185-007-0009-8; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-06-0313; GISSELBRECHT S, 1987, NATURE, V329, P259, DOI 10.1038/329259a0; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kumar AR, 2009, BLOOD, V113, P1756, DOI 10.1182/blood-2008-06-163287; Rodriguez-Perales S, 2008, INT J HEMATOL, V87, P3, DOI 10.1007/s12185-007-0001-3; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					227	236		10.1111/cas.12593		10	Oncology	Oncology	CE3QI	WOS:000351742800002		
J	Nakaguro, M; Kiyonari, S; Kishida, S; Cao, DL; Murakami-Tonami, Y; Ichikawa, H; Takeuchi, I; Nakamura, S; Kadomatsu, K				Nakaguro, Masato; Kiyonari, Shinichi; Kishida, Satoshi; Cao, Dongliang; Murakami-Tonami, Yuko; Ichikawa, Hitoshi; Takeuchi, Ichiro; Nakamura, Shigeo; Kadomatsu, Kenji			Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation	CANCER SCIENCE			English	Article						Differentiation; neuroblastoma; nucleolus; PES1; tumorigenesis	DNA-DAMAGE RESPONSE; RETINOIC ACID; CANCER CELLS; EXPRESSION; PESCADILLO; PROLIFERATION; INACTIVATION; CHEMOTHERAPY; DISRUPTION; PATHWAY	Neuroblastoma (NB) is a childhood malignant tumor that arises from precursor cells of the sympathetic nervous system. Spontaneous regression is a phenomenon unique to NBs and is caused by differentiation of tumor cells. PES1 is a multifunctional protein with roles in both neural development and ribosome biogenesis. Various kinds of models have revealed the significance of PES1 in neurodevelopment. However, the roles of PES1 in NB tumorigenesis and differentiation have remained unknown. Here we show that NB cases with MYCN amplification and clinically unfavorable stage (INSS stage 4) express higher levels of PES1. High PES1 expression was associated with worse overall and relapse-free survival. In NB cell lines, PES1 knockdown suppressed tumor cell growth and induced apoptosis. This growth inhibition was associated with the expression of NB differentiation markers. However, when the differentiation of NB cell lines was induced by the use of all-trans retinoic acid, there was a corresponding decrease in PES1 expression. Pes1 expression of tumorspheres originated from MYCN transgenic mice also diminished after the induction of differentiation with growth factors. We also reanalyzed the distribution of PES1 in the nucleolus. PES1 was localized in the dense fibrillar component, but not in the granular component of nucleoli. After treatment with the DNA-damaging agent camptothecin, this distribution was dramatically changed to diffuse nucleoplasmic. These data suggest that PES1 is a marker of NB outcome, that it regulates NB cell proliferation, and is associated with NB differentiation.	[Nakaguro, Masato; Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Lab Med, Nagoya, Aichi, Japan; [Kiyonari, Shinichi; Kishida, Satoshi; Cao, Dongliang; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan; [Murakami-Tonami, Yuko] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan; [Ichikawa, Hitoshi] Natl Canc Inst, Div Genet, Tokyo, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Dept Comp Sci Sci & Engn Simulat, Nagoya, Aichi, Japan	Kadomatsu, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kkadoma@med.nagoya-u.ac.jp	Kiyonari, Shinichi/I-7329-2014; Kadomatsu, Kenji/G-8083-2012		National Cancer Center of Japan; Ministry of Health, Labor and Welfare, Japan	National Cancer Center of Japan; Ministry of Health, Labor and Welfare, Japan.	Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.040163101; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Maris JM, 1999, J CLIN ONCOL, V17, P2264; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; MATSUSHIMA H, 1993, MOL CELL BIOL, V13, P7447; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Oeffinger M, 2002, RNA, V8, P626, DOI 10.1017/S1355838202020022; Li J, 2009, CANCER SCI, V100, P2255, DOI 10.1111/j.1349-7006.2009.01325.x; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Kim B, 2003, CANCER RES, V63, P8248; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Monclair T, 2009, J CLIN ONCOL, V27, P298, DOI 10.1200/JCO.2008.16.6876; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Lutz W, 1996, ONCOGENE, V13, P803; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Murakami-Tonami Y, 2014, CELL CYCLE, V13, P1115, DOI 10.4161/cc.27983; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Buckwalter CA, 1996, CANCER RES, V56, P1674; Cao DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086813; Celay J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062771; Du YC, 2002, CELL, V109, P835; FENAUX P, 1995, LEUKEMIA LYMPHOMA, V16, P431, DOI 10.3109/10428199509054430; Frumm SM, 2013, CHEM BIOL, V20, P713, DOI 10.1016/j.chembiol.2013.03.020; Gessert S, 2007, DEV BIOL, V310, P99, DOI 10.1016/j.ydbio.2007.07.037; Guglielmi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.42; Hill DP, 1997, DEV BRAIN RES, V102, P53, DOI 10.1016/S0165-3806(97)00076-X; Holzel M, 2007, NUCLEIC ACIDS RES, V35, P789, DOI 10.1093/nar/gkl1058; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Kishida S, 2013, CANCER RES, V73, P1318, DOI 10.1158/0008-5472.CAN-12-3070; Kiyonari S, 2015, EXPERT OPIN DRUG DIS, V10, P53, DOI 10.1517/17460441.2015.974544; Kocak H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.84; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Seidman KJN, 1996, J NEUROCHEM, V66, P1011; Simmons T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032317; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Weber A, 2007, HUM PATHOL, V38, P228, DOI 10.1016/j.humpath.2006.07.012; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042253; Xie W, 2013, BIOCHEM BIOPH RES CO, V431, P460, DOI 10.1016/j.bbrc.2012.12.145	47	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					237	243		10.1111/cas.12598		7	Oncology	Oncology	CE3QI	WOS:000351742800003		
J	Nanjo, S; Nakagawa, T; Takeuchi, S; Kita, K; Fukuda, K; Nakada, M; Uehara, H; Nishihara, H; Hara, E; Uramoto, H; Tanaka, F; Yano, S				Nanjo, Shigeki; Nakagawa, Takayuki; Takeuchi, Shinji; Kita, Kenji; Fukuda, Koji; Nakada, Mitsutoshi; Uehara, Hisanori; Nishihara, Hiroshi; Hara, Eiji; Uramoto, Hidetaka; Tanaka, Fumihiro; Yano, Seiji			In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line	CANCER SCIENCE			English	Article						Alectinib; bone metastasis; brain metastasis; crizotinib; pleural effusion	FUSION GENE; ORTHOTOPIC IMPLANTATION; CRIZOTINIB RESISTANCE; GROWTH-FACTOR; MOUSE MODEL; ALK; INHIBITOR; ALECTINIB; VARIANTS; ONCOGENE	EML4-ALK lung cancer accounts for approximately 3-7% of non-small-cell lung cancer cases. To investigate the molecular mechanism underlying tumor progression and targeted drug sensitivity/resistance in EML4-ALK lung cancer, clinically relevant animal models are indispensable. In this study, we found that the lung adenocarcinoma cell line A925L expresses an EML4-ALK gene fusion (variant 5a, E2:A20) and is sensitive to the ALK inhibitors crizotinib and alectinib. We further established highly tumorigenic A925LPE3 cells, which also have the EML4-ALK gene fusion (variant 5a) and are sensitive to ALK inhibitors. By using A925LPE3 cells with luciferase gene transfection, we established in vivo imaging models for pleural carcinomatosis, bone metastasis, and brain metastasis, all of which are significant clinical concerns of advanced EML4-ALK lung cancer. Interestingly, crizotinib caused tumors to shrink in the pleural carcinomatosis model, but not in bone and brain metastasis models, whereas alectinib showed remarkable efficacy in all three models, indicative of the clinical efficacy of these ALK inhibitors. Our in vivo imaging models of multiple organ sites may provide useful resources to analyze further the pathogenesis of EML4-ALK lung cancer and its response and resistance to ALK inhibitors in various organ microenvironments.	[Nanjo, Shigeki; Nakagawa, Takayuki; Takeuchi, Shinji; Kita, Kenji; Fukuda, Koji; Yano, Seiji] Kanazawa Univ, Div Med Oncol, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Nakada, Mitsutoshi] Kanazawa Univ, Dept Neurosurg, Grad Sch Med Sci, Kanazawa, Ishikawa 9200934, Japan; [Uehara, Hisanori] Univ Tokushima, Grad Sch, Dept Mol & Environm Pathol, Inst Hlth Biosci, Tokushima 770, Japan; [Nishihara, Hiroshi] Hokkaido Univ, Grad Sch Med, Lab Translat Pathol, Sapporo, Hokkaido, Japan; [Hara, Eiji] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Tokyo 170, Japan; [Uramoto, Hidetaka] Saitama Canc Ctr, Div Thorac Surg, Saitama, Japan; [Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Kitakyushu, Fukuoka 807, Japan	Yano, S (reprint author), Kanazawa Univ, Div Med Oncol, Canc Res Inst, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.	syano@staff.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390256, 24659403, 22112010A01]	This study was supported by Grants-in-Aid for Cancer Research (S. Yano, 21390256; S. Kita, 24659403), Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" (S. Yano, 22112010A01), and a Grant-in-Aid for a Project for Development of Innovative Research on Cancer Therapeutics from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; FIDLER IJ, 1991, CANCER METAST REV, V10, P229, DOI 10.1007/BF00050794; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Nakataki E, 2006, CANCER SCI, V97, P183, DOI 10.1111/j.1349-7006.2006.00163.x; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Kodama T, 2014, CANCER LETT, V351, P215, DOI 10.1016/j.canlet.2014.05.020; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Uehara H, 2003, J NATL CANCER I, V95, P458; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Wong DWS, 2009, CANCER, V115, P1723, DOI 10.1002/cncr.24181; Soda M, 2012, CLIN CANCER RES, V18, P5682, DOI 10.1158/1078-0432.CCR-11-2947; Conway JRW, 2014, NAT REV CANCER, V14, P314, DOI 10.1038/nrc3724; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Gainor JF, 2013, J THORAC ONCOL, V8, P1570, DOI 10.1097/JTO.0000000000000029; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Heuckmann JM, 2012, CLIN CANCER RES, V18, P4682, DOI 10.1158/1078-0432.CCR-11-3260; Li TH, 2014, J THORAC ONCOL, V9, P18, DOI 10.1097/JTO.0000000000000030; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Sugaya M, 2002, CHEST, V122, P282, DOI 10.1378/chest.122.1.282; GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X; Miyoshi T, 2000, ANTICANCER RES, V20, P161; Muraguchi T, 2011, CANCER RES, V71, P1135, DOI 10.1158/0008-5472.CAN-10-2304; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI 10.1056/NEJMoa1311107; Tanizaki J, 2012, BRIT J CANCER, V106, P763, DOI 10.1038/bjc.2011.586; Yano S, 1996, INT J CANCER, V67, P211, DOI 10.1002/(SICI)1097-0215(19960717)67:2<211::AID-IJC11>3.0.CO;2-E	30	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					244	252		10.1111/cas.12600		9	Oncology	Oncology	CE3QI	WOS:000351742800004		
J	Tsukigawa, K; Liao, L; Nakamura, H; Fang, J; Greish, K; Otagiri, M; Maeda, H				Tsukigawa, Kenji; Liao, Long; Nakamura, Hideaki; Fang, Jun; Greish, Khaled; Otagiri, Masaki; Maeda, Hiroshi			Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin	CANCER SCIENCE			English	Article						Antimetastatic property; antitumor effect; enhanced permeability and retention effect; prolonged plasma half-life; SMA-THP conjugate	LIVER METASTASES; DRUG-DELIVERY; AGENT SMANCS; IN-VITRO; CELLS; NEOCARZINOSTATIN; MICELLES; NANOPARTICLES; DOXORUBICIN; ADRIAMYCIN	Previously, we prepared a pirarubicin (THP)-encapsulated micellar drug using styrene-maleic acid copolymer (SMA) as the drug carrier, in which active THP was non-covalently encapsulated. We have now developed covalently conjugated SMA-THP (SMA-THP conjugate) for further investigation toward clinical development, because covalently linked polymer-drug conjugates are known to be more stable in circulation than drug-encapsulated micelles. The SMA-THP conjugate also formed micelles and showed albumin binding capacity in aqueous solution, which suggested that this conjugate behaved as a macromolecule during blood circulation. Consequently, SMA-THP conjugate showed significantly prolonged circulation time compared to free THP and high tumor-targeting efficiency by the enhanced permeability and retention (EPR) effect. As a result, remarkable antitumor effect was achieved against two types of tumors in mice without apparent adverse effects. Significantly, metastatic lung tumor also showed the EPR effect, and this conjugate reduced metastatic tumor in the lung almost completely at 30mg/kg once i.v. (less than one-fifth of the maximum tolerable dose). Although SMA-THP conjugate per se has little cytotoxicity in vitro (1/100 of free drug THP), tumor-targeted accumulation by the EPR effect ensures sufficient drug concentrations in tumor to produce an antitumor effect, whereas toxicity to normal tissues is much less. These findings suggest the potential of SMA-THP conjugate as a highly favorable candidate for anticancer nanomedicine with good stability and tumor-targeting properties in vivo.	[Tsukigawa, Kenji; Liao, Long; Nakamura, Hideaki; Fang, Jun; Greish, Khaled; Otagiri, Masaki; Maeda, Hiroshi] Sojo Univ, Inst Drug Delivery Sci, Kumamoto 8600082, Japan; [Tsukigawa, Kenji; Nakamura, Hideaki; Fang, Jun; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan	Maeda, H (reprint author), Sojo Univ, Inst Drug Delivery Sci, Nishi Ku, Ikeda 4-22-1, Kumamoto 8600082, Japan.	fangjun@ph.sojo-u.ac.jp; hirmaeda@ph.sojo-u.ac.jp			Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency	Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency.	Maeda H, 2013, CANCER SCI, V104, P779, DOI 10.1111/cas.12152; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Greish K, 2004, J CONTROL RELEASE, V97, P219, DOI 10.1016/j.conrel.2004.03.027; Kaminskas LM, 2012, MOL PHARMACEUT, V9, P355, DOI 10.1021/mp2005966; Stehle G, 1997, CRIT REV ONCOL HEMAT, V26, P77, DOI 10.1016/S1040-8428(97)00015-2; Greish K, 2005, BIOCONJUGATE CHEM, V16, P230, DOI 10.1021/bc040297g; Iyer AK, 2007, BIOMATERIALS, V28, P1871, DOI 10.1016/j.biomaterials.2006.11.051; Daruwalla J, 2009, J VASC RES, V46, P218, DOI 10.1159/000165380; Bertrand N, 2012, J CONTROL RELEASE, V161, P152, DOI 10.1016/j.jconrel.2011.09.098; Nakamura H, 2014, J CONTROL RELEASE, V174, P81, DOI 10.1016/j.jconrel.2013.11.011; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Yeo Y, 2004, ARCH PHARM RES, V27, P1, DOI 10.1007/BF02980037; Lee SJ, 2011, J CONTROL RELEASE, V152, P21, DOI 10.1016/j.jconrel.2011.03.027; Daruwalla J, 2010, CANCER SCI, V101, P1866, DOI 10.1111/j.1349-7006.2010.01619.x; Iigo M, 1997, BRIT J CANCER, V75, P650, DOI 10.1038/bjc.1997.116; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Nakamura H, 2011, J CONTROL RELEASE, V155, P367, DOI 10.1016/j.jconrel.2011.04.025; Koh E, 2002, PEDIATR RES, V51, P256, DOI 10.1203/00006450-200202000-00021; Fang J, 2010, EXP BIOL MED, V235, P487, DOI 10.1258/ebm.2009.009304; Hasan AS, 2007, INT J PHARMACEUT, V344, P53, DOI 10.1016/j.ijpharm.2007.05.066; Hollis CP, 2013, J CONTROL RELEASE, V172, P12, DOI 10.1016/j.jconrel.2013.06.039; Kobayashi A, 1988, J BIOACT COMPAT POL, V3, P319, DOI 10.1177/088391158800300401; KUNIMOTO S, 1984, J ANTIBIOT, V37, P1697; KUNIMOTO S, 1983, J ANTIBIOT, V36, P312; MAEDA H, 1979, GANN, V70, P601; Malugin A, 2007, J CONTROL RELEASE, V124, P6, DOI 10.1016/j.jconrel.2007.08.016; Masuda E, 1996, CANCER RES, V56, P1868; ODA T, 1986, P SOC EXP BIOL MED, V181, P9; OHTSUKA N, 1987, CANCER, V59, P1560, DOI 10.1002/1097-0142(19870501)59:9<1560::AID-CNCR2820590905>3.0.CO;2-J; SUZUKI F, 1988, ANTICANCER RES, V8, P97; SUZUKI F, 1990, CANCER RES, V50, P3897; Suzuki I, 1997, INT J CANCER, V73, P607, DOI 10.1002/(SICI)1097-0215(19971114)73:4<607::AID-IJC24>3.0.CO;2-4; TAKESHITA J, 1982, GANN, V73, P278; UMEZAWA H, 1979, J ANTIBIOT, V32, P1082; Veronese FM, 2005, BIOCONJUGATE CHEM, V16, P775, DOI 10.1021/bc040241m	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					270	278		10.1111/cas.12592		9	Oncology	Oncology	CE3QI	WOS:000351742800007		
J	Wongthai, P; Hagiwara, K; Miyoshi, Y; Wiriyasermkul, P; Wei, L; Ohgaki, R; Kato, I; Hamase, K; Nagamori, S; Kanai, Y				Wongthai, Printip; Hagiwara, Kohei; Miyoshi, Yurika; Wiriyasermkul, Pattama; Wei, Ling; Ohgaki, Ryuichi; Kato, Itsuro; Hamase, Kenji; Nagamori, Shushi; Kanai, Yoshikatsu			Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2	CANCER SCIENCE			English	Article						Amino acid transporter; BNCT; BPA; cancer cell lines; drug delivery	AMINO-ACID TRANSPORTER; GLIOBLASTOMA-MULTIFORME; P-BORONOPHENYLALANINE; BRAIN-TUMORS; DRUG TARGET; CANCER; EXPRESSION; CELLS; SLC6A14; PROTEIN	The efficacy of boron neutron capture therapy relies on the selective delivery of boron carriers to malignant cells. p-Boronophenylalanine (BPA), a boron delivery agent, has been proposed to be localized to cells through transporter-mediated mechanisms. In this study, we screened aromatic amino acid transporters to identify BPA transporters. Human aromatic amino acid transporters were functionally expressed in Xenopus oocytes and examined for BPA uptake and kinetic parameters. The roles of the transporters in BPA uptake were characterized in cancer cell lines. For the quantitative assessment of BPA uptake, HPLC was used throughout the study. Among aromatic amino acid transporters, ATB(0,+), LAT1 and LAT2 were found to transport BPA with Km values of 137.4 +/- 11.7, 20.3 +/- 0.8 and 88.3 +/- 5.6M, respectively. Uptake experiments in cancer cell lines revealed that the LAT1 protein amount was the major determinant of BPA uptake at 100M, whereas the contribution of ATB(0,+) became significant at 1000M, accounting for 20-25% of the total BPA uptake in MCF-7 breast cancer cells. ATB(0,+), LAT1 and LAT2 transport BPA at affinities comparable with their endogenous substrates, suggesting that they could mediate effective BPA uptake in vivo. The high and low affinities of LAT1 and ATB(0,+), respectively, differentiate their roles in BPA uptake. ATB(0,+), as well as LAT1, could contribute significantly to the tumor accumulation of BPA at clinical dose.	[Wongthai, Printip; Hagiwara, Kohei; Wiriyasermkul, Pattama; Wei, Ling; Ohgaki, Ryuichi; Nagamori, Shushi; Kanai, Yoshikatsu] Osaka Univ, Div Biosyst Pharmacol, Dept Pharmacol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Miyoshi, Yurika; Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan; [Kato, Itsuro] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 2, Suita, Osaka 5650871, Japan	Kanai, Y (reprint author), Osaka Univ, Div Biosyst Pharmacol, Dept Pharmacol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ykanai@pharma1.med.osaka-u.ac.jp			Japan Society for the Promotion of Science; Advanced research for medical products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) Regional Innovation Strategy Support Program	Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; Advanced research for medical products Mining Programme of the National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) Regional Innovation Strategy Support Program.	Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Karunakaran S, 2011, J BIOL CHEM, V286, P31830, DOI 10.1074/jbc.M111.229518; Barth RF, 2005, CLIN CANCER RES, V11, P3987, DOI 10.1158/1078-0432.CCR-05-0035; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Karunakaran S, 2008, BIOCHEM J, V414, P343, DOI 10.1042/BJ20080622; Wittig A, 2000, RADIAT RES, V153, P173, DOI 10.1667/0033-7587(2000)153[0173:MOTOPB]2.0.CO;2; Sloan JL, 1999, J BIOL CHEM, V274, P23740, DOI 10.1074/jbc.274.34.23740; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Smith DR, 2001, CANCER RES, V61, P8179; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Detta A, 2009, CANCER RES, V69, P2126, DOI 10.1158/0008-5472.CAN-08-2345; Kato I, 2004, APPL RADIAT ISOTOPES, V61, P1069, DOI 10.1016/j.apradiso.2004.05.059; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Barth R.F., 2012, RADIAT ONCOL, V2012, P146, DOI DOI 10.1186/1748-717X-7-146; Coderre JA, 1997, J NEURO-ONCOL, V33, P141, DOI 10.1023/A:1005741919442; Di Pierro D, 2000, ANAL BIOCHEM, V284, P301, DOI 10.1006/abio.2000.4715; Gupta N, 2005, BBA-MOL BASIS DIS, V1741, P215, DOI 10.1016/j.bbadis.2005.04.002; Haining Zhen, 2012, BMC Clin Pathol, V12, P4, DOI 10.1186/1472-6890-12-4; Henriksson R, 2008, RADIOTHER ONCOL, V88, P183, DOI 10.1016/j.radonc.2006.04.015; Joel DD, 1999, J NEURO-ONCOL, V41, P213, DOI 10.1023/A:1006176901713; Kaira K, 2007, CLIN CANCER RES, V13, P6369, DOI 10.1158/1078-0432.CCR-07-1294; Kanai Y, 2001, CURR DRUG METAB, V2, P229; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Laurent T, 2012, J CELL PHYSIOL, V227, P2898, DOI 10.1002/jcp.23033; Miyoshi Y., 2014, CHROMATOGRAPHY, V35, P49; Muller A, 2014, MOL IMAGING BIOL, V16, P412, DOI 10.1007/s11307-013-0711-2; Nakada N, 2014, HISTOL HISTOPATHOL, V29, P217; Riemann B, 2001, NUCL MED BIOL, V28, P293, DOI 10.1016/S0969-8051(01)00191-3; Sahoo S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00091; Wyss MT, 2007, J NUCL MED, V48, P1047, DOI 10.2967/jnumed.106.038489; Yokoyama K, 2006, J NEURO-ONCOL, V78, P227, DOI 10.1007/s11060-005-9099-4; Yoshida F, 2004, CANCER LETT, V215, P61, DOI 10.1016/j.canlet.2004.06.023; Yoshimoto M, 2013, NUCL MED BIOL, V40, P625, DOI 10.1016/j.nucmedbio.2013.02.010	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					279	286		10.1111/cas.12602		8	Oncology	Oncology	CE3QI	WOS:000351742800008		
J	Hyoda, T; Tsujioka, T; Nakahara, T; Suemori, S; Okamoto, S; Kataoka, M; Tohyama, K				Hyoda, Tomoko; Tsujioka, Takayuki; Nakahara, Takako; Suemori, Shin-ichiro; Okamoto, Shuichiro; Kataoka, Mikio; Tohyama, Kaoru			Rigosertib induces cell death of a myelodysplastic syndrome-derived cell line by DNA damage-induced G2/M arrest	CANCER SCIENCE			English	Article						G2; M arrest; myelodysplastic syndromes; nonsense-mediated mRNA decay; rigosertib; synthetic anticancer agent	CYCLIN D1; PHASE-I; 01910.NA; MDS; INHIBITION; APOPTOSIS; THERAPY; EXPRESSION; AGENT	A multi-kinase inhibitor, rigosertib (ON 01910.Na) has recently been highlighted as a novel type of anti-cancer agent for the treatment of the myelodysplastic syndromes (MDS), but its action mechanisms remain to be clarified. We investigated the invitro effects of rigosertib on an MDS-derived cell line MDS-L and a myeloid leukemia cell line HL-60. Rigosertib suppressed the proliferation of both HL-60 and MDS-L cells and induced apoptosis by inhibition of the PI3 kinase/Akt pathway. As the effects on cell cycle, rigosertib treatment promoted the phosphorylation of histone H2AX and led to the DNA damage-induced G2/M arrest. In addition, an immunofluorescence staining study demonstrated the abnormal localization of aurora A kinase, suggesting that rigosertib causes perturbation of spindle assembly and deregulated mitotic patterns towards cell cycle arrest and apoptosis. We also found that rigosertib exerted growth inhibitory effects on two lymphoid cell lines, Jurkat and Ramos. We further examined the molecular pathways influenced by rigosertib from the gene expression profiling data of MDS-L cells and found a possible involvement of rigosertib treatment in the upregulation of the genes related to microtubule kinetics and the downregulation of the mRNA degradation system. The gene set enrichment analysis showed the suppression of nonsense-mediated mRNA decay (NMD) as the most significantly affected gene set. These data provide a new aspect and a potential utility of rigosertib for the treatment of refractory hematopoietic malignancies.	[Hyoda, Tomoko; Nakahara, Takako; Tohyama, Kaoru] Kawasaki Coll Allied Hlth Profess, Div Med Technol, Okayama, Japan; [Hyoda, Tomoko; Nakahara, Takako; Kataoka, Mikio] Okayama Univ, Grad Sch Hlth Sci, Dept Med Technol, Okayama 7008530, Japan; [Hyoda, Tomoko; Tsujioka, Takayuki; Suemori, Shin-ichiro; Okamoto, Shuichiro; Tohyama, Kaoru] Kawasaki Med Univ, Dept Lab Med, Kurashiki, Okayama 7010192, Japan	Tohyama, K (reprint author), Kawasaki Med Univ, Dept Lab Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	ktohyama@med.kawasaki-m.ac.jp			Japan Society for the Promotion of Science; Japanese Cooperative Study Group for Intractable Bone Marrow Diseases, Ministry of Health, Labor and Welfare of Japan; Kawasaki Medical School Project Grant	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, by the grant of the Japanese Cooperative Study Group for Intractable Bone Marrow Diseases, Ministry of Health, Labor and Welfare of Japan, and by a Kawasaki Medical School Project Grant.	Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Kadia TM, 2011, SEMIN ONCOL, V38, P682, DOI 10.1053/j.seminoncol.2011.04.011; Chapman CM, 2012, CLIN CANCER RES, V18, P1979, DOI 10.1158/1078-0432.CCR-11-2113; Tsujioka T, 2013, EXP HEMATOL, V41, P189, DOI 10.1016/j.exphem.2012.10.006; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Jimeno A, 2008, J CLIN ONCOL, V26, P5504, DOI 10.1200/JCO.2008.17.9788; Oussenko IA, 2011, CANCER RES, V71, P4968, DOI 10.1158/0008-5472.CAN-10-1603; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Olnes MJ, 2012, LEUKEMIA RES, V36, P982, DOI 10.1016/j.leukres.2012.04.002; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; ORMEROD MG, 1992, J IMMUNOL METHODS, V153, P57, DOI 10.1016/0022-1759(92)90305-D; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Matsuoka A, 2010, LEUKEMIA, V24, P748, DOI 10.1038/leu.2009.296; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Komrokji RS, 2013, BRIT J HAEMATOL, V162, P517, DOI 10.1111/bjh.12436; Drexler HG, 2009, LEUKEMIA RES, V33, P1011, DOI 10.1016/j.leukres.2009.03.005; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Seetharam M, 2012, LEUKEMIA RES, V36, P98, DOI 10.1016/j.leukres.2011.08.022; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Wengrod J, 2013, MOL CELL BIOL, V33, P2128, DOI 10.1128/MCB.00174-13; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Prasad A, 2009, ONCOGENE, V28, P1518, DOI 10.1038/onc.2008.502; TOHYAMA K, 1994, BRIT J HAEMATOL, V87, P235, DOI 10.1111/j.1365-2141.1994.tb04904.x; Bachegowda L, 2013, J HEMATOL ONCOL, V10, P6; Brunning RD, 2008, WHO CLASSIFICATION T, P87; Farag SS, 2011, BRIT J HAEMATOL, V155, P561, DOI 10.1111/j.1365-2141.2011.08898.x; Ishigaki Y, 2013, EXP BIOL MED, V238, P889, DOI 10.1177/1535370213494646; List AF, 2012, LEUKEMIA RES, V36, P1470, DOI 10.1016/j.leukres.2012.08.010; Martin L, 2014, CANCER RES, V74, P1; Mundle SD, 2012, LEUKEMIA RES, V36, P964, DOI 10.1016/j.leukres.2012.04.023; Shi YH, 2006, BLOOD, V107, P4554, DOI 10.1182/blood-2005-09-3616; Silverman LR, 2014, HEMATOL ONC IN PRESS	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					287	293		10.1111/cas.12605		7	Oncology	Oncology	CE3QI	WOS:000351742800009		
J	Iizuka, M; Nakanishi, Y; Fuchinoue, F; Maeda, T; Murakami, E; Obana, Y; Enomoto, K; Tani, M; Sakurai, K; Amano, S; Masuda, S				Iizuka, Misato; Nakanishi, Yoko; Fuchinoue, Fumi; Maeda, Tetsuyo; Murakami, Eriko; Obana, Yukari; Enomoto, Katsuhisa; Tani, Mayumi; Sakurai, Kenichi; Amano, Sadao; Masuda, Shinobu			Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes	CANCER SCIENCE			English	Article						Breast cancer; breast cancer subtype; cell polarity; intracellular localization; MUC1	LIPOSOME VACCINE L-BLP25; MESSENGER-RNA; EXPRESSION; TUMOR; CARCINOMA; PROTEINS; ANTIGEN; DOMAIN; CELLS	MUC1 glycoprotein is overexpressed and its intracellular localization altered during breast carcinoma tumorigenesis. The present study aimed to clarify the relationship of cytoplasmic localization of MUC1 with the breast cancer subtype and the correlation of 10 molecules associated with cell polarity in breast cancer subtypes. We immunostained 131 formalin-fixed and paraffin-embedded breast cancer specimens with an anti-MUC1 antibody (MUC1/CORE). For 48 of the 131 tumor specimens, laser-assisted microdissection and real-time quantitative RT-PCR were performed to analyze mRNA levels of MUC1 and 10 molecules, -catenin, E-cadherin, claudin3, claudin4, claudin7, RhoA, cdc42, Rac1, Par3 and Par6. Localization of MUC1 protein varied among breast cancer subtypes, that is, both the apical domain and cytoplasm in luminal A-like tumors (P<0.01) and both the cytoplasm and cell membrane in luminal B-like (growth factor receptor 2 [HER2]+) tumors (P<0.05), and no expression was found in triple negative tumors (P<0.001). Estrogen receptor (ER)+ breast cancers showed higher MUC1 mRNA levels than ER- breast cancers (P<0.01). The incidence of mutual correlations of expression levels between two of the 10 molecules (55 combinations) was 54.5% in normal breast tissue and 38.2% in luminal A-like specimens, 16.4% in luminal B-like (HER2+), 3.6% in HER2 and 18.2% in triple negative specimens. In conclusion, each breast cancer subtype has characteristic cytoplasmic localization patterns of MUC1 and different degrees of disrupted correlation of the expression levels between the 10 examined molecules in comparison with normal breast tissue.	[Iizuka, Misato; Maeda, Tetsuyo; Murakami, Eriko; Enomoto, Katsuhisa; Tani, Mayumi; Sakurai, Kenichi; Amano, Sadao] Nihon Univ, Sch Med, Dept Breast & Endocrine Surg, Tokyo 1738610, Japan; [Nakanishi, Yoko; Fuchinoue, Fumi; Obana, Yukari; Masuda, Shinobu] Nihon Univ, Sch Med, Dept Pathol, Tokyo 1738610, Japan	Masuda, S (reprint author), Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, 30-1 Ohyaguchikami Cho, Tokyo 1738610, Japan.	masuda.shinobu@nihon-u.ac.jp			MEXT	This work was partially supported by a Grant for "Strategic Research Base Development" Program for Private Universities subsidized by MEXT (2010).	Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Mizutani G, 2012, ACTA HISTOCHEM CYTOC, V45, P167, DOI 10.1267/ahc.12006; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Macabeo-Ong M, 2002, MODERN PATHOL, V15, P979, DOI 10.1097/01.MP.0000026054.62220.FC; Weigelt B, 2008, J PATHOL, V216, P141, DOI 10.1002/path.2407; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; Rochlitz C, 2003, J GENE MED, V5, P690, DOI 10.1002/jgm.397; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Yonezawa S, 1997, PATHOL INT, V47, P813, DOI 10.1111/j.1440-1827.1997.tb03713.x; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Ohyanagi F, 2011, JPN J CLIN ONCOL, V41, P718, DOI 10.1093/jjco/hyr021; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Butts C, 2011, J CANCER RES CLIN, V137, P1337, DOI 10.1007/s00432-011-1003-3; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Lakhani SR, 2012, WHO CLASSIFICATION T; Lie KD, 2007, AM J PHYSIOL-RENAL, V293, pF1633; Nakanishi Y, 2006, J CLIN PATHOL, V59, P1108, DOI 10.1136/jcp.2005.026245; Nakanishi Y, 2013, ACTA HISTOCHEM CYTOC, V46, P85, DOI 10.1267/ahc.12024; The Japanese Breast Cancer Society, 2012, GEN RUL CLIN PATH RE; Tobioka H, 2002, J PATHOL, V198, P207, DOI 10.1002/path.1201; Tsukita S, 1998, GENES CELLS, V3, P569, DOI 10.1046/j.1365-2443.1998.00212.x; van der Vegt B, 2007, HISTOPATHOLOGY, V51, P322, DOI 10.1111/j.1365-2559.2007.02757.x; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					307	314		10.1111/cas.12596		8	Oncology	Oncology	CE3QI	WOS:000351742800012		
J	Furuya, M; Hong, SB; Tanaka, R; Kuroda, N; Nagashima, Y; Nagahama, K; Suyama, T; Yao, M; Nakatani, Y				Furuya, Mitsuko; Hong, Seung-Beom; Tanaka, Reiko; Kuroda, Naoto; Nagashima, Yoji; Nagahama, Kiyotaka; Suyama, Takahito; Yao, Masahiro; Nakatani, Yukio			Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dube syndrome	CANCER SCIENCE			English	Article						Birt-Hogg-Dube syndrome (BHD); familial cancer; folliculin (FLCN); glycoprotein non-metastatic B (GPNMB); renal tumor	INDUCED PATHWAY MEMBERS; IMMUNOEXPRESSION STATUS; PROGNOSTIC VALUE; CELL CARCINOMAS; BHD; GENE; MUTATIONS; FAMILIES; KIDNEY; PNEUMOTHORAX	Birt-Hogg-Dube syndrome (BHD) is an inherited disorder associated with a germline mutation of the folliculin gene (FLCN). The affected families have a high risk for developing multiple renal cell carcinomas (RCC). Diagnostic markers that distinguish between FLCN-related RCC and sporadic RCC have not been investigated, and many patients with undiagnosed BHD fail to receive proper medical care. We investigated the histopathology of 27 RCCs obtained from 18 BHD patients who were diagnosed by genetic testing. Possible somatic mutations of RCC lesions were investigated by DNA sequencing. Western blotting and immunohistochemical staining were used to compare the expression levels of FLCN and glycoprotein non-metastatic B (GPNMB) between FLCN-related RCCs and sporadic renal tumors (n=62). The expression of GPNMB was also evaluated by quantitative RT-PCR. Histopathological analysis revealed that the most frequent histological type was chromophobe RCC (n=12), followed by hybrid oncocytic/chromophobe tumor (n=6). Somatic mutation analysis revealed small intragenic mutations in six cases and loss of heterozygosity in two cases. Western blot and immunostaining analyses revealed that FLCN-related RCCs showed overexpression of GPNMB and underexpression of FLCN, whereas sporadic tumors showed inverted patterns. GPNMBmRNA in FLCN-related RCCs was 23-fold more abundant than in sporadic tumors. The distinctive expression patterns of GPNMB and FLCN might identify patients with RCCs who need further work-up for BHD.	[Furuya, Mitsuko] Yokohama City Univ, Dept Mol Pathol, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Hong, Seung-Beom] ISU Abxis, Sungnam, Nepal; [Tanaka, Reiko] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Kuroda, Naoto] Kochi Red Cross Hosp, Dept Pathol, Kochi, Japan; [Nagashima, Yoji] Tokyo Womens Med Univ, Dept Surg Pathol, Tokyo, Japan; [Nagahama, Kiyotaka] Nippon Med Sch, Dept Anat Pathol, Tokyo 113, Japan; [Suyama, Takahito] Chiba Univ, Dept Urol, Grad Sch Med, Chiba, Japan; [Yao, Masahiro] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan; [Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan	Furuya, M (reprint author), Yokohama City Univ, Dept Mol Pathol, Grad Sch Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	mfuruya@yokohama-cu.ac.jp			Japan Society for the Promotion of Science Kakenhi [23590406, 24590408]; Ministry of Health, Labor and Welfare Yokohama Foundation for Advancement of Medical Science Suzuki Hinyoki Igaku Shinko Zaidan Mitsubishi Foundation	Japan Society for the Promotion of Science Kakenhi (23590406). (24590408). Ministry of Health, Labor and Welfare Yokohama Foundation for Advancement of Medical Science Suzuki Hinyoki Igaku Shinko Zaidan Mitsubishi Foundation	Cash TP, 2011, ONCOGENE, V30, P2534, DOI 10.1038/onc.2010.628; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Furuya M, 2012, AM J SURG PATHOL, V36, P589, DOI 10.1097/PAS.0b013e3182475240; Chaux A, 2012, HUM PATHOL, V43, P2129, DOI 10.1016/j.humpath.2012.01.009; Hes O, 2013, HISTOL HISTOPATHOL, V28, P1257; Kuroda N, 2012, HISTOL HISTOPATHOL, V27, P1407; Khoo SK, 2003, CANCER RES, V63, P4583; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Gad S, 2007, BRIT J CANCER, V96, P336, DOI 10.1038/sj.bjc.6603492; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1153/ajpcell.00565.2004; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393; Adley BP, 2006, ARCH PATHOL LAB MED, V130, P1865; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Schultz L, 2011, AM J SURG PATHOL, V35, P1549, DOI 10.1097/PAS.0b013e31822895e5; Petersson F, 2010, VIRCHOWS ARCH, V456, P355, DOI 10.1007/s00428-010-0898-4; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Vocke CD, 2005, J NATL CANCER I, V97, P931, DOI 10.1093/jnci/dji154; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Houweling AC, 2011, BRIT J CANCER, V105, P1912, DOI 10.1038/bjc.2011.463; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; Delongchamps NB, 2009, BJU INT, V103, P1381, DOI 10.1111/j.1464-410X.2008.08263.x; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Kuroda N, 2014, ANN DIAGN PATHOL, V18, P171, DOI 10.1016/j.anndiagpath.2014.03.002; Menko FH, 2012, FAM CANCER, V12, P373; Nagashima Y, 2012, INT J UROL, V19, P468, DOI 10.1111/j.1442-2042.2011.02945.x; Safadi Fayez. F., 2001, Journal of Cellular Biochemistry, V84, P12; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; Pahl MV, 2010, CLIN J AM SOC NEPHRO, V5, P56, DOI 10.2215/CJN.03390509; Zhang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042955	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					315	323		10.1111/cas.12601		9	Oncology	Oncology	CE3QI	WOS:000351742800013		
J	Taniguchi, H; Yamazaki, K; Yoshino, T; Muro, K; Yatabe, Y; Watanabe, T; Ebi, H; Ochiai, A; Baba, E; Tsuchihara, K				Taniguchi, Hiroya; Yamazaki, Kentaro; Yoshino, Takayuki; Muro, Kei; Yatabe, Yasushi; Watanabe, Toshiaki; Ebi, Hiromichi; Ochiai, Atsushi; Baba, Eishi; Tsuchihara, Katsuya			Japanese Society of Medical Oncology Clinical Guidelines: RAS (KRAS/NRAS) mutation testing in colorectal cancer patients	CANCER SCIENCE			English	Article						Anti-EGFR antibodies; colorectal cancer; guideline; K-ras genes; N-ras genes	PANITUMUMAB	The Japanese guidelines for the testing of KRAS mutations in colorectal cancer have been used for the past 5years. However, new findings of RAS (KRAS/NRAS) mutations that can further predict the therapeutic effects of anti-epidermal growth factor receptor (EGFR) antibody therapy necessitated a revision of the guidelines. The revised guidelines included the following five basic requirements for RAS mutation testing to highlight a patient group in which anti-EGFR antibody therapy may be ineffective: First, anti-EGFR antibody therapy may not offer survival benefit and/or tumor shrinkage to patients with expanded RAS mutations. Thus, current methods to detect KRAS exon 2 (codons 12 and 13) mutations are insufficient for selecting appropriate candidates for this therapy. Additional testing of extended KRAS/NRAS mutations is recommended. Second, repeated tests are not required for the detection; tissue materials of either primary or metastatic lesions are applicable for RAS mutation testing. Evaluating RAS mutations prior to anti-EGFR antibody therapy is recommended. Third, direct sequencing with manual dissection or allele-specific PCR-based methods is currently applicable for RAS mutation testing. Fourth, thinly sliced sections of formalin-fixed, paraffin-embedded tissue blocks are applicable for RAS mutation testing. One section stained with H&E should be provided to histologically determine whether the tissue contains sufficient amount of tumor cells for testing. Finally, RAS mutation testing must be performed in laboratories with appropriate testing procedures and specimen management practices.	[Taniguchi, Hiroya; Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan; [Yamazaki, Kentaro] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; [Yoshino, Takayuki] East Hosp, Natl Canc Ctr, Dept Gastrointestinal Oncol, Chiba, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan; [Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Grad Sch Med, Tokyo, Japan; [Watanabe, Toshiaki] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Ebi, Hiromichi] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 9201192, Japan; [Ochiai, Atsushi] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo, Japan; [Baba, Eishi] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 812, Japan; [Tsuchihara, Katsuya] Natl Canc Ctr, Div Translat Res, Exploratory Oncol & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan	Tsuchihara, K (reprint author), Natl Canc Ctr, Div Translat Res, Exploratory Oncol & Clin Trial Ctr, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	ktsuchih@east.ncc.go.jp			Merck Serono; Bristol-Myers K.K.	KY receiving honoraria for lectures from Takeda Pharmaceutical and received research funding from Merck Serono. TY received honoraria for lectures from Takeda Pharmaceutical and Merck Serono, and received research funding from Merck Serono. KM received honoraria for lectures from Takeda Pharmaceutical and Merck Serono, and received research funding from Merck Serono. TW received honoraria for lectures from Takeda Pharmaceutical, Merck Serono and Bristol-Myers K.K., and received research funding from Bristol-Myers K.K.	Baas JM, 2011, ONCOLOGIST, V16, P1239, DOI 10.1634/theoncologist.2011-0024; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Peeters M, 2013, J CLIN ONCOL, V31, P759, DOI 10.1200/JCO.2012.45.1492; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Franklin WA, 2010, J MOL DIAGN, V12, P43, DOI 10.2353/jmoldx.2010.080131; Japanese Society of Medical Oncology, JAP SOC MED ONC CLIN; Karapetis CS, 2008, NEW ENGL J MED, V359, P17; Kudo T, P0195 WCGIC	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	MAR	2015	106	3					324	327		10.1111/cas.12595		4	Oncology	Oncology	CE3QI	WOS:000351742800014		
J	Hattori, T; Tsubone, A; Sawama, Y; Monguchi, Y; Sajiki, H				Hattori, Tomohiro; Tsubone, Aya; Sawama, Yoshinari; Monguchi, Yasunari; Sajiki, Hironao			Palladium on Carbon-Catalyzed Suzuki-Miyaura Coupling Reaction Using an Efficient and Continuous Flow System	CATALYSTS			English	Article							ARYLBORONIC ACIDS; LIGAND-FREE	The continuous flow Suzuki-Miyaura reaction between various haloarenes and arylboronic acids was successfully achieved within only ca. 20 s during the single-pass through a cartridge filled with palladium on carbon (Pd/C). No palladium leaching was observed in the collected reaction solution by atomic absorption spectrometry (detection limit: 1 ppm).	[Hattori, Tomohiro; Tsubone, Aya; Sawama, Yoshinari; Monguchi, Yasunari; Sajiki, Hironao] Gifu Pharmaceut Univ, Dept Organ & Med Chem, Organ Chem Lab, Gifu 5011196, Japan	Monguchi, Y (reprint author), Gifu Pharmaceut Univ, Dept Organ & Med Chem, Organ Chem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	077002@gifu-pu.ac.jp; 095059@gifu-pu.ac.jp; sawama@gifu-pu.ac.jp; monguchi@gifu-pu.ac.jp; sajiki@gifu-pu.ac.jp			Japan Science Society	We sincerely thank Zsolt Lepp, and CEO Richard Jones of ThalesNano Nanotechnology, Inc., and Yuko Kawahashi and Satoshi Ohtsu, Ikeda Scientific Co., Ltd., for their kind assistance and the lending of the H-Cube (R) continuous flow hydrogenator without charge. We highly appreciate the kind gift of 10% Pd/C by the N.E. Chemcat Corporation. Tomohiro Hattori thanks the Sasakawa Scientific Research Grant from the Japan Science Society for the partial financial support of this study.	Cantillo D, 2014, CHEMCATCHEM, V6, P3286, DOI 10.1002/cctc.201402483; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4442, DOI 10.1002/anie.200500368; Shu W, 2011, ANGEW CHEM INT EDIT, V50, P10665, DOI 10.1002/anie.201105223; Noel T, 2011, CHEM SOC REV, V40, P5010, DOI 10.1039/c1cs15075h; Noel T, 2011, ORG LETT, V13, P5180, DOI 10.1021/ol202052q; Kotha S, 2002, TETRAHEDRON, V58, P9633, DOI 10.1016/S0040-4020(02)01188-2; Glasnov TN, 2010, ADV SYNTH CATAL, V352, P3089, DOI 10.1002/adsc.201000646; Maegawa T, 2007, CHEM-EUR J, V13, P5937, DOI 10.1002/chem.200601795; Christakakou M, 2013, SYNLETT, V24, P2411, DOI 10.1055/s-0033-1339870; Baghbanzadeh M, 2011, J ORG CHEM, V76, P1507, DOI 10.1021/jo1024464; Gemoets HPL, 2014, ORG LETT, V16, P5800, DOI 10.1021/ol502910e; Frost CG, 2010, GREEN CHEM, V12, P1687, DOI 10.1039/c0gc00133c; Gauchot V, 2010, CHEM-EUR J, V16, P6748, DOI 10.1002/chem.201000302; Kitamura Y, 2007, TETRAHEDRON, V63, P10596, DOI 10.1016/j.tet.2007.08.017; Hattori T, 2014, TETRAHEDRON, V70, P4790, DOI 10.1016/j.tet.2014.05.038; Li XJ, 2013, J ORG CHEM, V78, P5078, DOI 10.1021/jo4005537; Garcia-Verdugo E, 2010, RSC GREEN CHEM SER, P44; Mateos C, 2014, TETRAHEDRON LETT, V55, P3701, DOI 10.1016/j.tetlet.2014.05.010; Mennecke K, 2009, BEILSTEIN J ORG CHEM, V5, DOI 10.3762/bjoc.5.21; MuCoz J. de M., 2012, ADV SYNTH CATAL, V354, P3456, DOI DOI 10.1002/ADSC.201200678; Subhas MS, 2010, ORG BIOMOL CHEM, V8, P3001, DOI 10.1039/b927367k	22	3	3	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4344			CATALYSTS	Catalysts	MAR	2015	5	1					18	25		10.3390/catal5010018		8	Chemistry, Physical	Chemistry	CE7ZB	WOS:000352059400002		
J	Miyazawa, T; Hanaoka, T; Shimura, K; Hirata, S				Miyazawa, Tomohisa; Hanaoka, Toshiaki; Shimura, Katsuya; Hirata, Satoshi			Ruthenium Modification on Mn and Zr-Modified Co/SiO2 Catalysts for Slurry-Phase Fischer-Tropsch Synthesis	CATALYSTS			English	Article							COBALT CATALYSTS; SUPPORT; SELECTIVITY; PROMOTION; CO; REDUCIBILITY; DISPERSION; DESIGN; RU	The addition of Ru to Mn and Zr-modified Co/SiO2 catalysts, while applying different preparation orders and loading amounts, was investigated as a means of enhancing the Fischer-Tropsch synthesis reaction. The coimpregnation of Zr/SiO2 with Co, Mn and Ru gave the most attractive catalytic properties. This can be attributed to the higher dispersion of Co metal resulting from the coimpregnation of Co and Mn as well as enhanced reducibility due to the presence of Ru. The addition of a moderate amount of Ru together with the appropriate order of addition affected both the Co reducibility and the catalytic activity, primarily because of increased reducibility. The addition of even 0.1 wt.% Ru resulted in an obvious enhancement of Fischer-Tropsch synthesis activity.	[Miyazawa, Tomohisa; Hanaoka, Toshiaki; Shimura, Katsuya; Hirata, Satoshi] Adv Ind Sci & Technol AIST, Biomass Refinery Res Ctr, Higashihiroshima, Hiroshima 7370046, Japan	Miyazawa, T (reprint author), Adv Ind Sci & Technol AIST, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7370046, Japan.	tk-miyazawa@aist.go.jp; t.hanaoka@aist.go.jp; katsuya-shimura@aist.go.jp; satoshi.hirata@aist.go.jp					ALL S, 1995, J CATAL, V157, P35, DOI 10.1006/jcat.1995.1265; Moradi GR, 2003, CATAL COMMUN, V4, P27, DOI 10.1016/S1566-7367(02)00243-1; Pirola C, 2014, FUEL, V132, P62, DOI 10.1016/j.fuel.2014.04.063; Ma WP, 2012, APPL CATAL A-GEN, V437, P1, DOI 10.1016/j.apcata.2012.05.037; Khodakov AY, 2007, CHEM REV, V107, P1692, DOI 10.1021/cr050972v; Kogelbauer A, 1996, J CATAL, V160, P125, DOI 10.1006/jcat.1996.0130; Song SH, 2008, CATAL COMMUN, V9, P2282, DOI 10.1016/j.catcom.2008.05.023; Iglesia E, 1997, APPL CATAL A-GEN, V161, P59, DOI 10.1016/S0926-860X(97)00186-5; Jacobs G, 2002, APPL CATAL A-GEN, V233, P263, DOI 10.1016/S0926-860X(02)00195-3; Xiong HF, 2005, CATAL COMMUN, V6, P512, DOI 10.1016/j.catcom.2005.04.018; Tsubaki N, 2001, J CATAL, V199, P236, DOI 10.1006/jcat.2001.3163; Schulz H, 1999, APPL CATAL A-GEN, V186, P3, DOI 10.1016/S0926-860X(99)00160-X; Miyazawa T, 2013, APPL CATAL A-GEN, V467, P47, DOI 10.1016/j.apcata.2013.07.010; Zhang JL, 2003, FUEL, V82, P581, DOI 10.1016/S0016-2361(02)00331-9; SCHULZ H, 1994, STUD SURF SCI CATAL, V81, P455; Morales F, 2007, J CATAL, V246, P91, DOI 10.1016/j.jcat.2006.11.014; Luque R, 2012, ENERG ENVIRON SCI, V5, P5186, DOI 10.1039/c1ee02238e; Khodakov AY, 2002, J CATAL, V206, P230, DOI 10.1006/jcat.2001.3496; IGLESIA E, 1992, J CATAL, V137, P212, DOI 10.1016/0021-9517(92)90150-G; Bae JW, 2011, CHEMCATCHEM, V3, P1342, DOI 10.1002/cctc.201100102; REUEL RC, 1984, J CATAL, V85, P78, DOI 10.1016/0021-9517(84)90111-8; Hanaoka Toshiaki, 2011, Journal of the Japan Institute of Energy, V90, DOI 10.3775/jie.90.1072; Koizumi N, 2011, CATAL LETT, V141, P931, DOI 10.1007/s10562-011-0633-z; Li JL, 1999, APPL CATAL A-GEN, V181, P201, DOI 10.1016/S0926-860X(98)00434-7; Liu YY, 2009, FUEL PROCESS TECHNOL, V90, P901, DOI 10.1016/j.fuproc.2009.04.004; Souza-Aguiar E. F., 2011, CATAL SCI TECHNOL, V1, p698 713, DOI [10.1039/c1cy00116g, DOI 10.1039/C1CY00116G]; Zhang Y, 2006, ENERG FUEL, V20, P417, DOI 10.1021/ef050218c	27	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4344			CATALYSTS	Catalysts	MAR	2015	5	1					26	37		10.3390/catal5010026		12	Chemistry, Physical	Chemistry	CE7ZB	WOS:000352059400003		
J	Manabe, K				Manabe, Kei			Palladium Catalysts for Cross-Coupling Reaction	CATALYSTS			English	Editorial Material									Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Manabe, K (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	manabe@u-shizuoka-ken.ac.jp					Hikawa H, 2013, CATALYSTS, V3, P486, DOI 10.3390/catal3020486; Obora Y, 2013, CATALYSTS, V3, P794, DOI 10.3390/catal3040794; Brase S., 2014, METAL CATALYZED CROS; Hattori T, 2015, CATALYSTS, V5, P18, DOI 10.3390/catal5010018; Manabe K, 2014, CATALYSTS, V4, DOI 10.3390/catal4030307; Molnar A., 2013, PALLADIUM CATALYZED; Negishi E.-I., 2002, HDB ORGANOPALLADIUM; Ohashi M, 2014, CATALYSTS, V4, P321, DOI 10.3390/catal4030321; Sugita N, 2013, CATALYSTS, V3, P839, DOI 10.3390/catal3040839	9	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4344			CATALYSTS	Catalysts	MAR	2015	5	1					38	39		10.3390/catal5010038		2	Chemistry, Physical	Chemistry	CE7ZB	WOS:000352059400004		
J	Hanaoka, T; Miyazawa, T; Shimura, K; Hirata, S				Hanaoka, Toshiaki; Miyazawa, Tomohisa; Shimura, Katsuya; Hirata, Satoshi			Preparation for Pt-Loaded Zeolite Catalysts Using w/o Microemulsion and Their Hydrocracking Behaviors on Fischer-Tropsch Product	CATALYSTS			English	Article							COLLOIDAL METAL PARTICLES; BETA ZEOLITE; N-DECANE; SIZE; HYDROISOMERIZATION; TRANSFORMATION; PLATINUM; ALUMINA; OIL; GASIFICATION	Pt-loaded beta-type zeolite catalysts with constant Pt content (0.11 wt.%) and similar pore structure were prepared using a water-in-oil (w/o) microemulsion. The effect of Pt particle synthesis conditions using microemulsion (a type of Pt complex-forming agents and the molar ratio of complex-forming agent to Pt4+) on loaded Pt particle size was investigated. The Pt particle size of the Pt catalyst using tetraethylammonium chloride (TEAC) as a complex-forming agent with the molar TEAC/Pt ratio 10 was the minimum value (3.8 nm), and was much smaller than that (6.7 nm) prepared by the impregnation method. The utilization of the complex-forming agent of which hydrophobic groups occupied a small volume and the appropriate complex-forming agent/Pt ratio were favorable for synthesis of small Pt particles. The effect of loaded Pt particle size on the hydrocracking of the Fischer-Tropsch (FT) product was investigated using the Pt-loaded zeolite catalysts at 250 degrees C with an initial H-2 pressure of 0.5 MPa, and reaction time of 1 h. The Pt catalyst with a Pt particle size of 4.2 nm prepared using the microemulsion exhibited the maximum corresponding jet fuel yield (30.0%), which was higher than that of the impregnated catalyst.	[Hanaoka, Toshiaki; Miyazawa, Tomohisa; Shimura, Katsuya; Hirata, Satoshi] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Hiroshima 7390046, Japan	Hanaoka, T (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Kagamiyama 3-11-32, Hiroshima 7390046, Japan.	t.hanaoka@aist.go.jp; tk-miyazawa@aist.go.jp; katsuya-shimura@aist.go.jp; satoshi.hirata@aist.go.jp					ALVAREZ F, 1989, STUD SURF SCI CATAL, V49, P1367; Hoar TP, 1943, NATURE, V152, P102, DOI 10.1038/152102a0; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6; LUISI PL, 1988, BIOCHIM BIOPHYS ACTA, V947, P209, DOI 10.1016/0304-4157(88)90025-1; Trippe F, 2011, FUEL PROCESS TECHNOL, V92, P2169, DOI 10.1016/j.fuproc.2011.06.026; Roussel M, 2005, APPL CATAL A-GEN, V279, P53, DOI 10.1016/j.apcata.2004.10.011; COONRADT HL, 1964, IND ENG CHEM PROC DD, V3, P38, DOI 10.1021/i260009a010; Alvarez F, 1996, J CATAL, V162, P179, DOI 10.1006/jcat.1996.0275; Miyazawa T, 2013, APPL CATAL A-GEN, V467, P47, DOI 10.1016/j.apcata.2013.07.010; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; BOUTONNET M, 1982, COLLOID SURFACE, V5, P209, DOI 10.1016/0166-6622(82)80079-6; ALVAREZ F, 1987, APPL CATAL, V34, P353, DOI 10.1016/S0166-9834(00)82468-9; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BOUTONNET M, 1987, J CATAL, V103, P95, DOI 10.1016/0021-9517(87)90096-0; Camblor MA, 1998, J CATAL, V179, P537, DOI 10.1006/jcat.1998.2249; Chao KJ, 1996, APPL CATAL A-GEN, V143, P223, DOI 10.1016/0926-860X(96)00096-8; Cho KM, 2009, CHEM ENG J, V146, P307, DOI 10.1016/j.cej.2008.10.008; DAUSCHER A, 1987, J CATAL, V105, P233, DOI 10.1016/0021-9517(87)90022-4; Davis H. T., 1987, PHYSICS AMPHIPHILIC, V21, P310; Fujimoto S., 2008, INT ENERGY J, V9, P73; GUISNET M, 1987, CATAL TODAY, V1, P415, DOI 10.1016/0920-5861(87)80007-X; Haan R., 2007, APPL CATAL A-GEN, V327, P247, DOI 10.1016/j.apcata.2007.05.022; Hanaoka T, 2000, APPL CATAL A-GEN, V190, P291, DOI 10.1016/S0926-860X(99)00323-3; Hanaoka Toshiaki, 2011, Journal of the Japan Institute of Energy, V90, DOI 10.3775/jie.90.1072; Hanaoka T, 2012, CATALYSTS, V2, P281, DOI 10.3390/catal2020281; Hardevald R. V., 1969, SURF SCI, V15, P189; Ikeda M, 1999, CATAL LETT, V58, P195, DOI 10.1023/A:1019010908170; Ikeda M., 2001, CATAL COMMUN, V2, P261, DOI 10.1016/S1566-7367(01)00045-0; Kishida M, 1995, KAGAKU KOGAKU RONBUN, V21, P990; Krar M, 2010, BIORESOURCE TECHNOL, V101, P9287, DOI 10.1016/j.biortech.2010.06.107; Krylova A. Yu, 2007, Solid Fuel Chemistry, V41, DOI 10.3103/S0361521907060031; Liu YY, 2009, FUEL PROCESS TECHNOL, V90, P901, DOI 10.1016/j.fuproc.2009.04.004; Maldonado FJ, 2000, J CATAL, V195, P342, DOI 10.1006/jcat.2000.2995; Nagy J.B., 1989, SURFACTANTS SOLUTION, V10, P1; Sunde K, 2011, FOREST POLICY ECON, V13, P591, DOI 10.1016/j.forpol.2011.05.008; Tijmensen MJA, 2002, BIOMASS BIOENERG, V23, P129, DOI 10.1016/S0961-9534(02)00037-5; Vliet O.P.R.V., 2009, ENERGY CONVERSION MA, V50, P855	38	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4344			CATALYSTS	Catalysts	MAR	2015	5	1					88	105		10.3390/catal5010088		18	Chemistry, Physical	Chemistry	CE7ZB	WOS:000352059400008		
J	Ohtaka, A; Okagaki, T; Hamasaka, G; Uozumi, Y; Shinagawa, T; Shimomura, O; Nomura, R				Ohtaka, Atsushi; Okagaki, Toshiyuki; Hamasaka, Go; Uozumi, Yasuhiro; Shinagawa, Tsutomu; Shimomura, Osamu; Nomura, Ryoki			Application of "Boomerang" Linear Polystyrene-Stabilized Pd Nanoparticles to a Series of C-C Coupling Reactions in Water	CATALYSTS			English	Article							SUZUKI-MIYAURA REACTION; SEMI-HETEROGENEOUS CATALYST; PALLADIUM NANOPARTICLES; OLEFIN METATHESIS; HECK REACTION; REVERSIBLE TRANSFER; POLYMERS; SUPPORT; SYSTEMS	The application of a catch-and-release system for soluble Pd species between water (reaction medium) and polystyrene (polymer support) was examined in the Suzuki coupling reaction with 2-bromothiophene and the Heck reaction with styrene or bromobenzene. Although a slight increase in particle size was observed by TEM after re-stabilization of the Pd species on linear polystyrene, no agglomeration was observed.	[Ohtaka, Atsushi; Okagaki, Toshiyuki; Shimomura, Osamu; Nomura, Ryoki] Osaka Inst Technol, Dept Appl Chem, Fac Engn, Asahi Ku, Osaka 5358585, Japan; [Hamasaka, Go; Uozumi, Yasuhiro] IMS, Okazaki, Aichi 4448787, Japan; [Shinagawa, Tsutomu] Osaka Municipal Tech Res Inst, Osaka 5368553, Japan; [Nomura, Ryoki] Osaka Inst Technol, Nanomat & Microdevices Res Ctr, Asahi Ku, Osaka 5358585, Japan	Ohtaka, A (reprint author), Osaka Inst Technol, Dept Appl Chem, Fac Engn, Asahi Ku, 5-16-1 Ohmiya, Osaka 5358585, Japan.	otaka@chem.oit.ac.jp; m1m13504@st.oit.ac.jp; hamasaka@ims.ac.jp; uo@ims.ac.jp; tshina@omtri.or.jp; shimomura@chem.oit.ac.jp; nomura@chem.oit.ac.jp		Hamasaka, Go/0000-0001-9582-0324; Shinagawa, Tsutomu/0000-0001-5671-1512	Nanomaterials and Microdevices Research Center (NMRC) of OIT	The authors are grateful to the Nanomaterials and Microdevices Research Center (NMRC) of OIT for financial and instrumental support.	Ahmed M, 2000, SYNLETT, P1007; Rix D, 2007, CHEM COMMUN, P3771, DOI 10.1039/b705451c; Fang PP, 2011, ANGEW CHEM INT EDIT, V50, P12184, DOI 10.1002/anie.201103465; Kanaoka S, 2007, J AM CHEM SOC, V129, P12060, DOI 10.1021/ja0735599; Schatz A, 2010, CHEM-EUR J, V16, P8950, DOI 10.1002/chem.200903462; Wittmann S, 2010, ANGEW CHEM INT EDIT, V49, P1867, DOI 10.1002/anie.200906166; Ohtaka A, 2011, MOLECULES, V16, P9067, DOI 10.3390/molecules16119067; MacQuarrie S, 2008, ANGEW CHEM INT EDIT, V47, P3279, DOI 10.1002/anie.200800153; Gruttadauria M, 2013, GREEN CHEM, V15, P2608, DOI 10.1039/c3gc41132j; Yu YP, 2011, CHEM COMMUN, V47, P3592, DOI 10.1039/c0cc04498a; Boffi A, 2011, CHEMCATCHEM, V3, P347, DOI 10.1002/cctc.201000260; Dell'Anna MM, 2013, J MOL CATAL A-CHEM, V366, P186, DOI 10.1016/j.molcata.2012.09.022; Gniewek A, 2005, J CATAL, V229, P332, DOI 10.1016/j.jcat.2004.11.003; Hu JF, 2012, CATAL SCI TECHNOL, V2, P2332, DOI 10.1039/c2cy20263h; Zhi J, 2011, CHEM COMMUN, V47, P10707, DOI 10.1039/c1cc14169d; Ohtaka A, 2010, TETRAHEDRON, V66, P5642, DOI 10.1016/j.tet.2010.05.076; Yan N, 2010, COORDIN CHEM REV, V254, P1179, DOI 10.1016/j.ccr.2010.02.015; Gallon BJ, 2007, ANGEW CHEM INT EDIT, V46, P7251, DOI 10.1002/anie.200701389; Astruc D, 2005, ANGEW CHEM INT EDIT, V44, P7852, DOI 10.1002/anie.200500766; Sun W, 2012, CHEM MATER, V24, P3800, DOI 10.1021/cm302464g; Ogasawara S, 2010, J AM CHEM SOC, V132, P4608, DOI 10.1021/ja9062053; Astruc D., 2008, NANOPARTICLES CATALY; Beletskaya IP, 2008, SYNLETT, P1547, DOI 10.1055/s-2008-1078430; Clavier H, 2008, ORGANOMETALLICS, V27, P2287, DOI 10.1021/om8000229; Hamamoto H, 2005, ANGEW CHEM INT EDIT, V44, P4536, DOI 10.1002/anie.200500574; Jafarpour L, 2000, ORG LETT, V2, P4075, DOI 10.1021/ol0067134; Moldal J., 2011, J MOL CATAL A-CHEM, V350, P40, DOI 10.1016/j.molcata.2011.09.002; Ohtaka A., 2011, GREEN SUSTAINABLE CH, V1, P19, DOI 10.4236/gsc.2011.12004; Ohtaka A, 2013, CHEMCATCHEM, V5, P2167, DOI 10.1002/cctc.201300204; Pryjomska-Ray I, 2006, TOP CATAL, V40, P173, DOI 10.1007/s11244-006-0119-1; Varray S, 2003, ORGANOMETALLICS, V22, P2426, DOI 10.1021/om021007n; Zhao FY, 2000, J CATAL, V194, P479, DOI 10.1006/jcat.2000.2934	32	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4344			CATALYSTS	Catalysts	MAR	2015	5	1					106	118		10.3390/catal5010106		13	Chemistry, Physical	Chemistry	CE7ZB	WOS:000352059400009		
J	Saito, S; Tominaga, M				Saito, Shigeru; Tominaga, Makoto			Functional diversity and evolutionary dynamics of thermoTRP channels	CELL CALCIUM			English	Review						ThermoTRP channels; Evolution; Functional diversity; Structural basis	ION-CHANNEL; TRP CHANNEL; INSULIN-SECRETION; MOLECULAR DETERMINANTS; TEMPERATURE SENSATION; SPECIES-DIFFERENCES; CAPSAICIN RECEPTOR; ANKYRIN REPEATS; CATION CHANNEL; HEAT	Animals have evolved sophisticated physiological systems for sensing ambient temperature since changes in environmental temperatures affect various biological processes. Thermosensitive transient receptor potential (thermoTRP) channels serve as thermal sensors in diverse animal species. They are multimodal receptors that are activated by temperature as well as other physical and chemical stimuli. Since thermoTRP channels are calcium permeable non-selective cation channels, their activation leads to an influx of calcium and sodium ions into the cell and triggers downstream signal transduction. ThermoTRP channels have been characterized in diverse animal species over the past several years, illuminating the diversification of thermoTRP channels in the course of evolution. The gene repertoires of thermoTRP channels differ among animal species. Additionally, in some cases, the temperature and chemical sensitivities among orthologous thermoTRP channels vary among species. The evolutionary flexibility of thermoTRP channels enabled them to contribute to unique physiological systems such as infrared sensation in snakes and bats and seasonal adaptation in silk moth. On the other hand, the functional differences of thermoTRP channels among species have been utilized for understanding the molecular basis for their activation (or inhibition) mechanisms, and amino acid residues (or domains) responsible for the respective channel properties have been identified in various thermoTRP channels. Here we summarize the current understanding of the functional diversity and evolutionary dynamics of thermoTRP channels. (C) 2014 Elsevier Ltd. All rights reserved.	[Saito, Shigeru; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Saito, Shigeru; Tominaga, Makoto] Grad Univ Adv Studies, SOKENDAI, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan	Saito, S (reprint author), Okazaki Inst Integrat Biosci, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	sshigeru@nips.ac.jp; tominaga@nips.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [23249012, 20770191]	We thank our collaborators Dr. T. Ohta, Dr. R. Shingai, M. Ohkita, K. Nakatsuka, N. Banzawa, N. Fukuta, and C.T. Saito. We also thank the National Bio-resource Project (NBRP) of the Ministry of Education, Science, Sports and Culture of Japan for providing us with western clawed frogs. This work was supported by the Grant-in-aid from Ministry of Education, Culture, Sports, Science and Technology in Japan (23249012 to MT and 20770191 to SS).	Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Uchida K, 2011, ENDOCR J, V58, P1021; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Strotmann R, 2000, NAT CELL BIOL, V2, P695; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Sato A, 2014, P NATL ACAD SCI USA, V111, pE1249, DOI 10.1073/pnas.1322134111; Lau SY, 2012, J GEN PHYSIOL, V140, P541, DOI 10.1085/jgp.201210810; Ohkita M, 2012, J BIOL CHEM, V287, P2388, DOI 10.1074/jbc.M111.305698; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Saito S, 2014, MOL BIOL EVOL, V31, P708, DOI 10.1093/molbev/msu001; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Caterina MJ, 1997, NATURE, V389, P816; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Gau P, 2013, J NEUROSCI, V33, P5249, DOI 10.1523/JNEUROSCI.5403-12.2013; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Nakatsuka K, 2013, J MOL NEUROSCI, V51, P754, DOI 10.1007/s12031-013-0060-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Saito S, 2012, J BIOL CHEM, V287, P30743, DOI 10.1074/jbc.M112.362194; Banzawa N., 2014, J BIOL CHEM; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3501; Kurganov E, 2014, PFLUG ARCH EUR J PHY, V466, P1873, DOI 10.1007/s00424-013-1420-z; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Tominaga M., 2007, TRP ION CHANNEL FUNC; Uchida K, 2011, ISLETS, V3, P209, DOI 10.4161/isl.3.4.16130; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200	64	5	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0143-4160	1532-1991		CELL CALCIUM	Cell Calcium	MAR	2015	57	3			SI		214	221		10.1016/j.ceca.2014.12.001		8	Cell Biology	Cell Biology	CE4OC	WOS:000351808900011		
J	Heng, JIT; Qu, ZD; Ohtaka-Maruyama, C; Okado, H; Kasai, M; Castro, D; Guillemot, F; Tan, SS				Heng, Julian Ik-Tsen; Qu, Zhengdong; Ohtaka-Maruyama, Chiaki; Okado, Haruo; Kasai, Masataka; Castro, Diogo; Guillemot, Francois; Tan, Seong-Seng			The Zinc Finger Transcription Factor RP58 Negatively Regulates Rnd2 for the Control of Neuronal Migration During Cerebral Cortical Development	CEREBRAL CORTEX			English	Article						cerebral cortex; migration; pattern formation; transcription factor	MOLECULAR-MECHANISMS; PRONEURAL GENES; CELL-MIGRATION; CORTEX; SPECIFICATION; DIFFERENTIATION; TELENCEPHALON; EXPRESSION; NEOCORTEX; REPRESSION	The zinc finger transcription factor RP58 (also known as ZNF238) regulates neurogenesis of the mouse neocortex and cerebellum (Okado et al. 2009; Xiang et al. 2011; Baubet et al. 2012; Ohtaka-Maruyama et al. 2013), but its mechanism of action remains unclear. In this study, we report a cell-autonomous function for RP58 during the differentiation of embryonic cortical projection neurons via its activities as a transcriptional repressor. Disruption of RP58 expression alters the differentiation of immature neurons and impairs their migration and positioning within the mouse cerebral cortex. Loss of RP58 within the embryonic cortex also leads to elevated mRNA for Rnd2, a member of the Rnd family of atypical RhoA-like GTPase proteins important for cortical neuron migration (Heng et al. 2008). Mechanistically, RP58 represses transcription of Rnd2 via binding to a 3'-regulatory enhancer in a sequence-specific fashion. Using reporter assays, we found that RP58 repression of Rnd2 is competed by proneural basic helix-loop-helix transcriptional activators. Finally, our rescue experiments revealed that negative regulation of Rnd2 by RP58 was important for cortical cell migration in vivo. Taken together, these studies demonstrate that RP58 is a key player in the transcriptional control of cell migration in the developing cerebral cortex.	[Heng, Julian Ik-Tsen; Qu, Zhengdong] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Heng, Julian Ik-Tsen; Qu, Zhengdong; Tan, Seong-Seng] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Ohtaka-Maruyama, Chiaki; Okado, Haruo] Tokyo Metropolitan Inst Med Sci, Dept Brain Dev & Neural Regenerat, Setagaya Ku, Tokyo 1568506, Japan; [Kasai, Masataka] Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Minato Ku, Tokyo 1088639, Japan; [Castro, Diogo; Guillemot, Francois] MRC Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	Heng, JIT (reprint author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.	julian.heng@monash.edu			National Health and Medical Research Council (NHMRC); Victorian Government through the Operational Infrastructure Scheme; State Government of Victoria; Australian Government; NHMRC (Australia) [1011505]; Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan;  [20570172]	This work was supported by grants from Project and Program grants from the National Health and Medical Research Council (NHMRC) and the Victorian Government through the Operational Infrastructure Scheme. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. J.I-T.H is a recipient of a Career Development Fellowship (ID: 1011505) from the NHMRC (Australia). This work was supported by research grants in the natural sciences from the Mitsubishi Foundation, grant-in-aid for Scientific Research (C) to C.O-M (#20570172), and grant-in-aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Ohtaka-Maruyama C, 2007, J COMP NEUROL, V502, P1098, DOI 10.1002/cne.21350; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Alfano C, 2011, DEVELOPMENT, V138, P4685, DOI 10.1242/dev.068031; Tabata H, 2003, J NEUROSCI, V23, P9996; Hirai S, 2012, EMBO J, V31, P1190, DOI 10.1038/emboj.2011.486; Baubet V, 2012, DEVELOPMENT, V139, P1903, DOI 10.1242/dev.075606; Dixit R, 2011, CEREB CORTEX, V21, P2599, DOI 10.1093/cercor/bhr046; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Ohtaka-Maruyama C, 2013, CELL REP, V3, P458, DOI 10.1016/j.celrep.2013.01.012; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Okado H, 2009, DEV BIOL, V331, P140, DOI 10.1016/j.ydbio.2009.04.030; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Ohtaka-Maruyama C, 2012, NEUROSCIENCE, V201, P67, DOI 10.1016/j.neuroscience.2011.11.006; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Leventer Richard J, 2008, Dialogues Clin Neurosci, V10, P47; Merot Y, 2009, SEMIN CELL DEV BIOL, V20, P726, DOI 10.1016/j.semcdb.2009.04.003; Perlman SJ, 2013, AM J MED GENET A, V161A, P711, DOI 10.1002/ajmg.a.35779; van Bon BWM, 2008, J MED GENET, V45, P346, DOI 10.1136/jmg.2007.055830; Xiang C, 2011, CELL DEATH DIFFER, V19, P692; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011	39	7	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAR	2015	25	3					806	816		10.1093/cercor/bht277		11	Neurosciences	Neurosciences & Neurology	CE6GW	WOS:000351935800019		
J	Doi, H; Shinohara, K				Doi, Hirokazu; Shinohara, Kazuyuki			Unconscious Presentation of Fearful Face Modulates Electrophysiological Responses to Emotional Prosody	CEREBRAL CORTEX			English	Article						cross-modal integration; facial expression; fear; prosody; unconscious perception	EVENT-RELATED FMRI; CONTINUOUS FLASH SUPPRESSION; FACIAL EXPRESSIONS; MULTISENSORY INTEGRATION; SENSORY CORTICES; AUDIOVISUAL INTEGRATION; CONSCIOUS AWARENESS; AMYGDALA RESPONSES; BODILY EXPRESSIONS; BRAIN POTENTIALS	Cross-modal integration of visual and auditory emotional cues is supposed to be advantageous in the accurate recognition of emotional signals. However, the neural locus of cross-modal integration between affective prosody and unconsciously presented facial expression in the neurologically intact population is still elusive at this point. The present study examined the influences of unconsciously presented facial expressions on the event-related potentials (ERPs) in emotional prosody recognition. In the experiment, fearful, happy, and neutral faces were presented without awareness by continuous flash suppression simultaneously with voices containing laughter and a fearful shout. The conventional peak analysis revealed that the ERPs were modulated interactively by emotional prosody and facial expression at multiple latency ranges, indicating that audio-visual integration of emotional signals takes place automatically without conscious awareness. In addition, the global field power during the late-latency range was larger for shout than for laughter only when a fearful face was presented unconsciously. The neural locus of this effect was localized to the left posterior fusiform gyrus, giving support to the view that the cortical region, traditionally considered to be unisensory region for visual processing, functions as the locus of audiovisual integration of emotional signals.	[Doi, Hirokazu; Shinohara, Kazuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Nagasaki 852, Japan	Shinohara, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Nagasaki 852, Japan.	kazuyuki@nagasaki-u.ac.jp			JSPS KAKENHI [24791218]	This work was supported by JSPS KAKENHI 24791218 to H.D.	Rossignol M, 2005, NEUROSCI LETT, V377, P115, DOI 10.1016/j.neulet.2004.11.091; Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Jessen S, 2011, NEUROIMAGE, V58, P665, DOI 10.1016/j.neuroimage.2011.06.035; Muller VI, 2011, NEUROIMAGE, V54, P2257, DOI 10.1016/j.neuroimage.2010.10.047; Pessoa L, 2006, CEREB CORTEX, V16, P366, DOI 10.1093/cercorbhi115; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Morris JP, 2007, NEUROPSYCHOLOGIA, V45, P3087, DOI 10.1016/j.neuropsychologia.2007.05.020; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Schulz E, 2008, NEUROIMAGE, V41, P153, DOI 10.1016/j.neuroimage.2008.02.012; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; Taylor MJ, 2002, CLIN NEUROPHYSIOL, V113, P1903, DOI 10.1016/S1388-2457(02)00309-7; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Pourtois G, 2006, NEUROIMAGE, V31, P920, DOI 10.1016/j.neuroimage.2005.12.034; Hamann S, 2003, NAT NEUROSCI, V6, P106, DOI 10.1038/nn0203-106; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Carretie L, 2005, NEUROIMAGE, V24, P615, DOI 10.1016/j.neuroimage.2004.09.009; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Snodgrass M, 2006, COGNITION, V101, P43, DOI 10.1016/j.cognition.2005.06.006; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/neuroimage.2004.08.016; Klasen M, 2011, J NEUROSCI, V31, P13635, DOI 10.1523/JNEUROSCI.2833-11.2011; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Oostenveld R, 2011, COMPUT INTEL NEUROSC, DOI 10.1155/2011/156869; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Focker J, 2011, ACTA PSYCHOL, V137, P36, DOI 10.1016/j.actpsy.2011.02.004; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Pegna AJ, 2008, INT J PSYCHOPHYSIOL, V70, P127, DOI 10.1016/j.ijpsycho.2008.08.007; Smith ML, 2012, CEREB CORTEX, V22, P1748, DOI 10.1093/cercor/bhr250; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; Holmes A, 2005, COGNITION EMOTION, V19, P899, DOI 10.1080/02699930441000454; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; Levy I, 2001, NAT NEUROSCI, V4, P533; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Vuilleumier P, 2001, NEUROLOGY, V56, P153; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Smith E, 2013, INT J PSYCHOPHYSIOL, V88, P17, DOI 10.1016/j.ijpsycho.2012.12.004; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Blank H, 2011, J NEUROSCI, V31, P12906, DOI 10.1523/JNEUROSCI.2091-11.2011; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P318, DOI 10.1111/j.1469-8986.2007.00634.x; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; Koenig T, 2011, COMPUT INTEL NEUROSC, DOI 10.1155/2011/938925; Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Puce A, 2007, NEUROPSYCHOLOGIA, V45, P93, DOI 10.1016/j.neuropsychologia.2006.04.017; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Muller VI, 2012, NEUROIMAGE, V60, P553, DOI 10.1016/j.neuroimage.2011.12.007; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; Klasen M, 2012, REV NEUROSCIENCE, V23, P381, DOI 10.1515/revneuro-2012-0040; Cappe C, 2010, J NEUROSCI, V30, P12572, DOI 10.1523/JNEUROSCI.1099-10.2010; Brefczynski-Lewis J, 2009, BRAIN TOPOGR, V21, P193, DOI 10.1007/s10548-009-0093-6; de Gelder B, 2005, Proc Natl Acad Sci U S A, V102, P18682, DOI 10.1073/pnas.0509179102; de Gelder B, 2002, P NATL ACAD SCI USA, V99, P4121, DOI 10.1073/pnas.062018499; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Doehrmann O, 2010, J NEUROSCI, V30, P3370, DOI 10.1523/JNEUROSCI.5074-09.2010; Doi H, 2010, NEUROREPORT, V21, P564, DOI 10.1097/WNR.0b013e328339b61a; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Honey C, 2008, J VISION, V8, DOI 10.1167/8.12.9; Jessen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036070; Joassin F, 2004, NEUROSCI LETT, V369, P132, DOI 10.1016/j.neulet.2004.07.067; Koenig T, 2009, ELECT NEUROIMAGING, P169, DOI 10.1017/CBO9780511596889.009; Kujala T, 1997, PSYCHOPHYSIOLOGY, V34, P213, DOI 10.1111/j.1469-8986.1997.tb02134.x; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Olofsson JK, 2007, BIOL PSYCHOL, V75, P101, DOI 10.1016/j.biopsycho.2006.12.006; Pourtois G, 2002, COGNITIVE BRAIN RES, V14, P99, DOI 10.1016/S0926-6410(02)00064-2; Robins DL, 2009, BRAIN COGNITION, V69, P269, DOI 10.1016/j.bandc.2008.08.007; Shah R, 2003, VIS COGN, V10, P549, DOI 10.1080/13506280244000203; Shimizu H., 1981, JAPANESE J ED PSYCHO, V29, P348; Spielberger CD, 1970, MANUAL STATE TRAIT A; Stienen BMC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025517; Tsuchiya N, 2006, J VISION, V6, P6, DOI DOI 10.1167/6.10.6; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Voss P, 2006, NEUROREPORT, V17, P383, DOI 10.1097/01.wnr.0000204983.21748.2d; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038	108	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAR	2015	25	3					817	832		10.1093/cercor/bht282		16	Neurosciences	Neurosciences & Neurology	CE6GW	WOS:000351935800020		
J	Shimizu, T; Ushiki, I; Ota, M; Sato, Y; Koizumi, N; Inomata, H				Shimizu, Taichi; Ushiki, Ikuo; Ota, Masaki; Sato, Yoshiyuki; Koizumi, Naoto; Inomata, Hiroshi			Preparation of mesoporous silica supported cobalt catalysts using supercritical fluids for Fischer-Tropsch synthesis	CHEMICAL ENGINEERING RESEARCH & DESIGN			English	Article						Carbon dioxide (CO2); Fischer-Tropsch synthesis; Mesoporous silica	CARBON-DIOXIDE; GOLD NANOPARTICLES; PARTICLE-SIZE; HYDROGENATION; IMPREGNATION; SELECTIVITY; DEPOSITION	Cobalt catalysts supported on mesoporous silica for Fischer-Tropsch synthesis were prepared by supercritical CO2 at 333K, 20 MPa with an addition of 10 mol% methanol. Highly dispersed Co particles in mesopores could be observed by TEM for the sample by supercritical CO2 method, while the aggregates of Co particles on external surface of silica were found for the conventional liquid phase impregnation method. Fischer-Tropsch synthesis examined at 503K, 1.1 MPa revealed CO conversion to be 46.7% using the catalyst prepared by supercritical CO2 method, which was about 1.5 times higher than the catalyst prepared by the conventional method. (c) 2015 The Institution of Chemical Engineers. Published by Elsevier BAT. All rights reserved.	[Shimizu, Taichi; Ushiki, Ikuo; Ota, Masaki; Sato, Yoshiyuki; Inomata, Hiroshi] Tohoku Univ, Res Ctr Supercrit Fluid Technol, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Koizumi, Naoto] Tohoku Univ, Dept Appl Chem, Sendai, Miyagi 9808579, Japan	Inomata, H (reprint author), Tohoku Univ, Res Ctr Supercrit Fluid Technol, Aoba Ku, Aramaki Aza Aoba 6-6-11-403, Sendai, Miyagi 9808579, Japan.	inomata@scf.che.tohoku.ac.jp	Ushiki, Ikuo/B-7445-2015	Ushiki, Ikuo/0000-0002-0033-4604			Erkey C, 2009, J SUPERCRIT FLUID, V47, P517, DOI 10.1016/j.supflu.2008.10.019; Bozbag SE, 2012, J MATER SCI, V47, P3469, DOI 10.1007/s10853-011-6064-9; Gupta G, 2005, CHEM MATER, V17, P6728, DOI 10.1021/cm051052w; Martinez A, 2003, J CATAL, V220, P486, DOI 10.1016/S0021-9517(03)00289-6; Alibouri M, 2009, IND ENG CHEM RES, V48, P4283, DOI 10.1021/ie801442c; Lee B, 2009, MICROPOR MESOPOR MAT, V122, P160, DOI 10.1016/j.micromeso.2009.02.029; Yin AY, 2008, APPL CATAL A-GEN, V349, P91, DOI 10.1016/j.apcata.2008.07.020; Komatsu T, 2010, J MOL CATAL A-CHEM, V319, P71, DOI 10.1016/j.molcata.2009.12.002; SCHULZ H, 1994, STUD SURF SCI CATAL, V81, P455; Liu DP, 2009, APPL CATAL A-GEN, V358, P110, DOI 10.1016/j.apcata.2008.12.044; Prashar AK, 2012, CATAL COMMUN, V28, P42, DOI 10.1016/j.catcom.2012.08.017; Park Y, 2004, CATAL TODAY, V97, P195, DOI 10.1016/j.cattod.2004.03.070; Zhang Y, 2005, IND ENG CHEM RES, V44, P4161, DOI 10.1021/ie050345w; Aschenbrenner O, 2008, IND ENG CHEM RES, V47, P3150, DOI 10.1021/ie071221h; REUEL RC, 1984, J CATAL, V85, P78, DOI 10.1016/0021-9517(84)90111-8; Boutros M, 2006, J MOL CATAL A-CHEM, V259, P91, DOI 10.1016/j.molcata.2006.06.007; Chatterjee M, 2006, ADV SYNTH CATAL, V348, P1580, DOI 10.1002/adsc.200606137; Cho YS, 2002, CATAL LETT, V81, P89, DOI 10.1023/A:1016068324731; Du JM, 2008, APPL CATAL B-ENVIRON, V84, P490, DOI 10.1016/j.apcatb.2008.05.004; Hirokado T., 2005, Japan Patent Disclosure, Patent No. [2005-213122, 2005213122]; Li HL, 2006, CATAL LETT, V110, P71, DOI 10.1007/s10562-006-0086-y; Lira E, 2008, J MOL CATAL A-CHEM, V281, P146, DOI 10.1016/j.molcata.2007.11.014; Mochizuki T, 2007, APPL CATAL A-GEN, V317, P97, DOI 10.1016/j.apcata.2006.10.005; Mochizuki T., 2008, J JAPAN I ENERGY, V87, P124, DOI 10.3775/jie.87.124; Ning WS, 2009, ENERG FUEL, V23, P4696, DOI 10.1021/ef9004281; Ohtsuka Y, 2004, CATAL TODAY, V89, P419, DOI 10.1016/j.cattod.2004.01.004; Shimizu T, 2012, J CHEM ENG JPN, V45, P615	27	0	0	INST CHEMICAL ENGINEERS	RUGBY	165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND	0263-8762	1744-3563		CHEM ENG RES DES	Chem. Eng. Res. Des.	MAR	2015	95						64	68		10.1016/j.cherd.2015.01.005		5	Engineering, Chemical	Engineering	CE6RU	WOS:000351966600007		
J	Konno, K; Onoe, K; Takiguchi, Y; Yamaguchi, T				Konno, Katsuya; Onoe, Kaoru; Takiguchi, Yasuyuki; Yamaguchi, Tatsuaki			Conversion of methane by an electric barrier-discharge plasma using an inner electrode with discharge disks set at 5 mm intervals	CHEMICAL ENGINEERING RESEARCH & DESIGN			English	Article						Electric barrier-discharge plasma; Methane; Inner electrode		In this study, we investigated the effect of inner electrode structure on methane conversion (X-CH4) and product selectivity using dielectric barrier-discharge plasma. We used two types of inner electrodes: those with discharge disks set at 5 mm intervals (Type A) and those with discharge disks set at 0 mm intervals (Type B). When electric power (Pw) was increased, the methane conversion (X-CH4) of Type A and TYPe B increased. However, the X-CH4 of Type A reactor was lower than that of Type B reactor, irrespective of Pw. When the total thickness of the discharge disks set at 0 mm intervals was the same as that in Type A, X-CH4 was lower than the X-CH4 for Type A or Type B. This result shows that the presence of discharge disk intervals can result in increased X-CH4. The primary product was ethane when using electrodes with/without intervals under various conditions. When Pw was increased in Type A, the product carbon selectivity (PCS) of propane and C4+ hydrocarbon increased with increased Pw and the PCS of ethylene decreased. When lype B was used, the PCS of acetylene also increased with an increase in Pw. These results show that Type A reactors can promote homologation and Type B reactors can promote dehydration. When the flow rate (F-0) was varied at a Pw of 3 or 32W, X-CH4 decreased with increased F-0. Ethane was again the primary product, and the F-0 value did not dramatically affect the PCS. (c) 2015 Published by Elsevier B.V. on behalf of The Institution of Chemical Engineers.	[Onoe, Kaoru; Takiguchi, Yasuyuki; Yamaguchi, Tatsuaki] Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, Narashino, Chiba 275, Japan	Yamaguchi, T (reprint author), Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, Narashino, Chiba 275, Japan.	tatsuaki.yamaguchi@it-chiba.ac.jp					Li XS, 2004, CATAL TODAY, V98, P617, DOI 10.1016/j.cattod.2004.09.048; Kolb T, 2013, PLASMA CHEM PLASMA P, V33, P631, DOI 10.1007/s11090-013-9448-6; Indarto A, 2008, FUEL PROCESS TECHNOL, V89, P214, DOI 10.1016/j.fuproc.2007.09.006; Kado S, 2004, CATAL TODAY, V89, P47, DOI 10.1016/j.cattod.2003.11.036; Konno K, 2010, J JPN PETROL INST, V53, P144, DOI 10.1627/jpi.53.144; Li X.S., 2008, J PHYS D, V41, P175203; Onoe K, 1997, FUEL, V76, P281, DOI 10.1016/S0016-2361(96)00228-1; Wang Q., 2013, PLASMA CHEM PLASMA P, V29, P217	8	0	0	INST CHEMICAL ENGINEERS	RUGBY	165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND	0263-8762	1744-3563		CHEM ENG RES DES	Chem. Eng. Res. Des.	MAR	2015	95						144	149		10.1016/j.cherd.2015.01.012		6	Engineering, Chemical	Engineering	CE6RU	WOS:000351966600014		
J	Huang, LS; Irie, Y; Liu, YD; Wang, S				Huang Liang-Sheng; Irie, Yoshiro; Liu Yu-Dong; Wang Sheng			Mode error analysis of impedance measurement using twin wires	CHINESE PHYSICS C			English	Article						coupling impedance; accelerator; twin wires; mode error; scattering coefficient		Both longitudinal and transverse coupling impedance for some critical components need to be measured for accelerator design. The twin wires method is widely used to measure longitudinal and transverse impedance on the bench. A mode error is induced when the twin wires method is used with a two-port network analyzer. Here, the mode error is analyzed theoretically and an example analysis is given. Moreover, the mode error in the measurement is a few percent when a hybrid with no less than 25 dB isolation and a splitter with no less than 20 dB magnitude error are used.	[Huang Liang-Sheng; Liu Yu-Dong; Wang Sheng] Chinese Acad Sci, Inst High Energy Phys, Dongguan 523803, Peoples R China; [Huang Liang-Sheng; Liu Yu-Dong; Wang Sheng] Dongguan Inst Neutron Sci, Dongguan 523803, Peoples R China; [Irie, Yoshiro] High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan	Huang, LS (reprint author), Chinese Acad Sci, Inst High Energy Phys, Dongguan Campus, Dongguan 523803, Peoples R China.	wangs@ihep.ac.cn			Natural Science Foundation of China [11175193, 11275221]	Supported by Natural Science Foundation of China (11175193, 11275221)	Arduini G, 2001, P PAC, P2054; Caspers F, 1988, PS8859 CERN; Chao A, 1998, HDB ACCELERATOR PHYS, P576; Gent A.W., 1956, Electrical Communication, V33; Hahn H, 2001, CAA1352, P05; Hahn H, 2004, PHYS REV SPEC TOP-AC, V7, DOI 10.1103/PhysRevSTAB.7.103501; KU H H, 1966, ENG INSTRUMENTATION, V70, P263; NASSIBIAN G, 1979, NUCL INSTRUM METHODS, V159, P21, DOI 10.1016/0029-554X(79)90323-9; Toyama Takeshi, 2013, COUPLING IMPEDANCE B; Toyama Takeshi, 2006, P HB2006, P140; WALLING LS, 1989, NUCL INSTRUM METH A, V281, P433, DOI 10.1016/0168-9002(89)91474-5; Wang JG, 2004, NUCL INSTRUM METH A, V522, P178, DOI 10.1016/j.nima.2003.11.198	12	0	0	CHINESE PHYSICAL SOC	BEIJING	P O BOX 603, BEIJING 100080, PEOPLES R CHINA	1674-1137			CHINESE PHYS C	Chin. Phys. C	MAR	2015	39	3							037003	10.1088/1574-1137/30/3/037003		5	Physics, Nuclear; Physics, Particles & Fields	Physics	CE4NO	WOS:000351807500011		
J	Harada, M; Van Wagoner, DR; Nattel, S				Harada, Masahide; Van Wagoner, David R.; Nattel, Stanley			Role of Inflammation in Atrial Fibrillation Pathophysiology and Management	CIRCULATION JOURNAL			English	Review						Anti-inflammatory drugs; Atrial fibrillation; Inflammatory markers; Thrombogenesis	C-REACTIVE PROTEIN; SUCCESSFUL CATHETER ABLATION; RANDOMIZED CONTROLLED-TRIALS; CORONARY-ARTERY-DISEASE; NF-KAPPA-B; OXIDATIVE STRESS; CARDIAC-SURGERY; HEART-FAILURE; POSTPERICARDIOTOMY-SYNDROME; SUCCESSFUL CARDIOVERSION	Atrial fibrillation (AF) is the most common clinically relevant arrhythmia, but the methods available for treating AF and its complications (of which the most important is thrombogenesis), as well as for assessing AF risk and underlying pathophysiology, are largely limited. Emerging evidence suggests a significant role of inflammation in the pathogenesis of AF. That evidence includes elevated serum levels of inflammatory biomarkers in AF subjects, the expression of inflammatory markers in cardiac tissues of AF patients and animal models of AF, and beneficial effects of anti-inflammatory drugs in experimental AF paradigms. Inflammation is suggested to be linked to various pathological processes, such as oxidative stress, apoptosis, and fibrosis, that promote AF substrate formation. Inflammation has also been associated with endothelial dysfunction, platelet activation, and coagulation cascade activation, leading to thrombogenesis. Thus, inflammation may contribute to both the occurrence/maintenance of AF and its thromboembolic complications. Here, we review the evidence for a role of inflammation and inflammatory biomarkers in the risk management and treatment of AF. We also summarize the current knowledge of inflammation-dependent cellular and molecular mechanisms in AF pathophysiology and their potential as therapeutic targets.	[Harada, Masahide] Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 47011, Japan; [Van Wagoner, David R.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Nattel, Stanley] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Nattel, Stanley] Univ Montreal, Montreal, PQ H1T 1C8, Canada	Nattel, S (reprint author), Montreal Heart Inst, Dept Med, 5000 Belanger St E, Montreal, PQ H1T 1C8, Canada.	stanley.nattel@icm-mhi.org			Canadian Institutes of Health Research [6957, 44365]; Heart and Stroke Foundation of Canada; National Institutes of Health [1R01HL111314]	S.N. is supported by the Canadian Institutes of Health Research (grants 6957 and 44365) and the Heart and Stroke Foundation of Canada. D.R.V.W. is supported by a grant from the National Institutes of Health (1R01HL111314).	Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Baker WL, 2007, HEART RHYTHM, V4, P461, DOI 10.1016/j.hrthm.2006.11.026; Koyama T, 2010, J AM COLL CARDIOL, V56, P1463, DOI 10.1016/j.jacc.2010.04.057; CERMAK J, 1993, BLOOD, V82, P513; Korantzopoulos P, 2005, INT J CARDIOL, V102, P321, DOI 10.1016/j.ijcard.2004.12.041; Suleiman M, 2012, HEART RHYTHM, V9, P172, DOI 10.1016/j.hrthm.2011.09.016; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P376, DOI 10.1111/j.1540-8167.2010.01919.x; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644; Van Wagoner DR, 2008, J CARDIOVASC PHARM, V52, P306, DOI 10.1097/FJC.0b013e31817f9398; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Liao CH, 2010, J CLIN INVEST, V120, P242, DOI 10.1172/JCI39942; Roldan V, 2012, J THROMB HAEMOST, V10, P1500, DOI 10.1111/j.1538-7836.2012.04812.x; Sonmez O, 2014, MED SCI MONITOR, V20, P463, DOI 10.12659/MSM.890635; Tousoulis D, 2009, INT J CARDIOL, V136, P258, DOI 10.1016/j.ijcard.2008.04.087; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Kristensen SL, 2014, EUROPACE, V16, P477, DOI 10.1093/europace/eut312; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Frustaci A, 1997, CIRCULATION, V96, P1180; Won H, 2013, CIRC J, V77, P53, DOI 10.1253/circj.CJ-12-0728; Harling L, 2011, HEART, V97, P1636, DOI 10.1136/heartjnl-2011-300245; Hermida J, 2012, AM J CARDIOL, V109, P95, DOI 10.1016/j.amjcard.2011.08.010; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Conway DSG, 2004, AM HEART J, V148, P462, DOI 10.1016/j.ahj.2004.01.026; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Izumiya Y, 2014, CAN J CARDIOL, V30, P338, DOI 10.1016/j.cjca.2013.12.010; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Yokoyama T, 2000, STROKE, V31, P2287; Leftheriotis DI, 2009, INT J CARDIOL, V135, P361, DOI 10.1016/j.ijcard.2008.04.012; Maesen B, 2012, EUROPACE, V14, P159, DOI 10.1093/europace/eur208; Shang LL, 2008, AM J PHYSIOL-CELL PH, V294, pC372, DOI 10.1152/ajpcell.00186.2007; Watanabe E, 2006, INT J CARDIOL, V108, P346, DOI 10.1016/j.ijcard.2005.05.021; Pinto A, 2009, CLIN SCI, V116, P781, DOI 10.1042/CS20080372; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Mozaffarian D, 2013, J AM COLL CARDIOL, V61, P2194, DOI 10.1016/j.jacc.2013.02.045; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Vilchez JA, 2014, INT J CLIN PRACT, V68, P434, DOI 10.1111/ijcp.12304; Rodrigo R, 2013, J AM COLL CARDIOL, V62, P1457, DOI 10.1016/j.jacc.2013.07.014; Wu N, 2013, INT J CARDIOL, V169, P62, DOI 10.1016/j.ijcard.2013.08.078; Imazio M, 2011, CIRCULATION, V124, P2290, DOI 10.1161/CIRCULATIONAHA.111.026153; Lim HS, 2013, J AM COLL CARDIOL, V61, P852, DOI 10.1016/j.jacc.2012.11.046; Imazio M, 2014, JAMA-J AM MED ASSOC, V312, P1016, DOI 10.1001/jama.2014.11026; Marott SCW, 2010, J AM COLL CARDIOL, V56, P789, DOI 10.1016/j.jacc.2010.02.066; Cao HL, 2011, CIRC J, V75, P2781, DOI 10.1253/circj.CJ-11-0795; Li J, 2010, HEART RHYTHM, V7, P438, DOI 10.1016/j.hrthm.2009.12.009; Sakabe M, 2007, CIRCULATION, V116, P2101, DOI 10.1161/CIRCULATIONAHA.107.704759; Cianfrocca C, 2010, INT J CARDIOL, V142, P22, DOI 10.1016/j.ijcard.2008.12.052; Schiffrin EL, 2013, CAN J CARDIOL, V29, P543, DOI 10.1016/j.cjca.2012.06.009; Bang CN, 2013, INT J CARDIOL, V167, P624, DOI 10.1016/j.ijcard.2012.08.056; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Chen MC, 2008, AM J CARDIOL, V102, P861, DOI 10.1016/j.amjcard.2008.05.038; Conway DSG, 2003, STROKE, V34, P413, DOI 10.1161/01.STR.0000051728.85133.32; Duchatelle V, 2012, CAN J CARDIOL, V28, P678, DOI 10.1016/j.cjca.2012.05.003; Hayashi M, 2011, THROMB RES, V128, pE113, DOI 10.1016/j.thromres.2011.07.013; Hofmann U, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0356-y; Ito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065817; Jacob KA, 2014, EUR J CLIN INVEST, V44, P402, DOI 10.1111/eci.12237; Liew R, 2013, CIRC J, V77, P1171, DOI 10.1253/circj.CJ-12-1155; Lim HS, 2014, HEART RHYTHM, V11, P1912, DOI 10.1016/j.hrthm.2014.07.030; Liuba I, 2008, EUROPACE, V10, P848, DOI 10.1093/europace/eun111; Neumann FJ, 1997, ARTERIOSCL THROM VAS, V17, P3399; Nigam A, 2014, J AM COLL CARDIOL, V64, P1441, DOI 10.1016/j.jacc.2014.07.956; Okumura Y, 2011, J CARDIOVASC ELECTR, V22, P987, DOI 10.1111/j.1540-8167.2011.02059.x; Pena JM, 2012, EUR HEART J, V33, P531, DOI 10.1093/eurheartj/ehr460; Putko BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099495; Qu YC, 2009, SCAND CARDIOVASC J, V43, P292, DOI 10.1080/14017430802651803; Rahimi K, 2011, BMJ-BRIT MED J, V342; Shiroshita-Takeshita A, 2004, CIRCULATION, V110, P2313, DOI 10.1161/01.CIR.0000145163.56529.D1; Shiroshita-Takeshita A, 2006, CARDIOVASC RES, V69, P865, DOI 10.1016/j.cardiores.2005.11.028; Thambidorai SK, 2004, AM J CARDIOL, V94, P805, DOI 10.1016/j.amjcard.2004.06.011; Wallentin L, 2014, CIRCULATION, V130, P1847, DOI 10.1161/CIRCULATIONAHA.114.011204; Wieberdink RG, 2010, STROKE, V41, P2151, DOI 10.1161/STROKEAHA.110.586289	76	6	8	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					495	502		10.1253/circj.CJ-15-0138		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600007		
J	Bando, YK; Murohara, T				Bando, Yasuko K.; Murohara, Toyoaki			UltraSound of Silence Abdominal Aortic Aneurysm - A Milestone Evidence in Japanese Hypertensive Elderly Has Come Out	CIRCULATION JOURNAL			English	Editorial Material							REPAIR; SURVEILLANCE; ENGLAND; WALES		[Bando, Yasuko K.; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan	Bando, YK (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ybando@med.nagoya-u.ac.jp; murohara@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014				Akai A, 2015, J VASC SURG, V61, P287, DOI 10.1016/j.jvs.2014.07.007; Choke E, 2012, CIRCULATION, V125, P1617, DOI 10.1161/CIRCULATIONAHA.111.077503; Kurosawa K, 2013, CIRC J, V77, P2860, DOI 10.1253/circj.CJ-13-1252; Anjum A, 2012, EUR J VASC ENDOVASC, V43, P161, DOI 10.1016/j.ejvs.2011.11.014; Brady AR, 2002, NEW ENGL J MED, V346, P1445; [Anonymous], NHS ABD AORT AN SCRE; Svensjo S, 2011, CIRCULATION, V124, P1118, DOI 10.1161/CIRCULATIONAHA.111.030379; Ouriel K, 2010, J VASC SURG, V51, P1081, DOI 10.1016/j.jvs.2009.10.113; Powell JT, 2003, NEW ENGL J MED, V348, P1895, DOI 10.1056/NEJMcp012641; Cosford PA, 2007, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002945.PUB2; Fukuda S, 2015, CIRC J, V79, P524, DOI 10.1253/circj.CJ-14-0972; Handa N, 2014, CIRC J, V78, P1104, DOI 10.1253/circj.CJ-14-0131; Ishimaru S, 2013, CIRC J, V77, P789, DOI 10.1253/circj.CJ-66-0057; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Rughani G, 2012, COCHRANE DB SYST REV, V9	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					503	504		10.1253/circj.CJ-15-0081		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600008		
J	Higo, T				Higo, Taiki			A Classical But Useful Predictor of Future Left Ventricular Assist Device Explantation - Possible Significant Role of Cardiopulmonary Exercise Testing	CIRCULATION JOURNAL			English	Editorial Material							HEART-FAILURE; CARDIAC TRANSPLANTATION; IMPROVEMENT; REVERSAL		[Higo, Taiki] Kyushu Univ Hosp, Cardiovasc Med, Fukuoka 8128582, Japan	Higo, T (reprint author), Kyushu Univ Hosp, Cardiovasc Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	higo@cardiol.med.kyushu-u.ac.jp					Khan T, 2003, J HEART LUNG TRANSPL, V22, P137, DOI 10.1016/S1053-2498(02)00485-0; Dandel M, 2011, EUR HEART J, V32, P1148, DOI 10.1093/eurheartj/ehq353; MANCINI DM, 1991, CIRCULATION, V83, P778; Kato TS, 2011, CIRC-HEART FAIL, V4, P546, DOI 10.1161/CIRCHEARTFAILURE.111.962142; Chua TP, 1997, J AM COLL CARDIOL, V29, P1585; Maybaum S, 2007, CIRCULATION, V115, P2497, DOI 10.1161/CIRCULATIONAHA.106.633180; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Nakanishi M, 2014, CIRC J, V78, P2268, DOI 10.1253/circj.CJ-14-0047; Buck LA, 1997, J CARDIOPULM REHABIL, V17, P324, DOI 10.1097/00008483-199709000-00006; Humphrey R, 1996, J CARDIOPULM REHABIL, V16, P310, DOI 10.1097/00008483-199609000-00030; Imamura T, 2014, J ARTIF ORGANS, V7, P23; Imamura T, 2015, CIRC J, V79, P560, DOI 10.1253/circj.CJ-14-1058; Peterson LR, 2003, J HEART LUNG TRANSPL, V22, P1141, DOI 10.1016/S1053-2498(02)01225-1	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					505	507		10.1253/circj.CJ-15-0107		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600009		
J	Ohte, N; Little, WC				Ohte, Nobuyuki; Little, William C.			Statins Beneficial for Heart Failure With Preserved Ejection Fraction But Not Heart Failure With Reduced Ejection Fraction?	CIRCULATION JOURNAL			English	Editorial Material							COMORBIDITIES; ROSUVASTATIN; MORTALITY; TRIAL		[Ohte, Nobuyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Cardio Renal Med & Hypertens, Nagoya, Aichi 4678601, Japan; [Little, William C.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	Ohte, N (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Cardio Renal Med & Hypertens, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ohte@med.nagoya-cu.ac.jp					Komajda M, 2014, EUR HEART J, V35, P1022, DOI 10.1093/eurheartj/ehu067; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Little WC, 2012, CIRC-HEART FAIL, V5, P669, DOI 10.1161/CIRCHEARTFAILURE.112.972265; Liu G, 2014, AM J CARDIOL, V113, P1198, DOI 10.1016/j.amjcard.2013.12.023; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Fukuta H, 2005, CIRCULATION, V112, P357, DOI 10.1161/CIRCULATIONAHA.104.519876; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Iwano H, 2013, J CARDIOL, V62, P1, DOI 10.1016/j.jjcc.2013.02.017; Borlaug BA, 2014, CIRC J, V78, P20, DOI 10.1253/circj.CJ-13-1103; Vyas AK, 2006, J AM COLL CARDIOL, V47, P769, DOI 10.1016/j.jacc.2005.09.053; Goto T, 2013, CIRC J, V77, P123, DOI 10.1253/circj.CJ-12-0733; Nochioka K, 2015, CIRC J, V79, P574, DOI 10.1253/circj.CJ-14-0865	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					508	509		10.1253/circj.CJ-15-0016		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600010		
J	Hirooka, Y				Hirooka, Yoshitaka			Importance of Neural Arc for Baroreflex Resetting in Hypertension - Does This Open up the Efficacy of Baroreflex Activation Therapy?	CIRCULATION JOURNAL			English	Editorial Material							NERVOUS-SYSTEM; DISEASE		[Hirooka, Yoshitaka] Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 8128582, Japan	Hirooka, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Adv Cardiovasc Regulat & Therapeut, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hyoshi@cardiol.med.kyushu-u.ac.jp					Mancia G, 2014, CIRC RES, V114, P1804, DOI 10.1161/CIRCRESAHA.114.302524; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; Kawada T, 2011, AM J PHYSIOL-REG I, V300, pR155, DOI 10.1152/ajpregu.00540.2010; Hironaga K, 1998, HYPERTENSION, V31, P27; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Chapleau MW, 1993, CARDIOVASCULAR REFLE, P165; Chapleau M W, 1989, Clin Exp Pharmacol Physiol Suppl, V15, P31; Hirooka Y, 2010, CIRC J, V70, P827; Hirooka Y, 2013, HYPERTENSION, V62, P995, DOI 10.1161/HYPERTENSIONAHA.113.00801; Lohmeier Thomas E, 2013, Handb Clin Neurol, V117, P395, DOI 10.1016/B978-0-444-53491-0.00032-8; Sata Y, 2015, CIRC J, V79, P592, DOI 10.1253/circj.CJ-14-1013; THOREN P, 1987, CLIN EXP HYPERTENS A, V9, P259, DOI 10.3109/10641968709160178; Todoran TM, 2013, CIRC J, V77, P1351, DOI 10.1253/circj.CJ-13-0390; Tomiyama H, 2014, CIRC J, V78, P1414, DOI 10.1253/circj.CJ-14-0064; Zamir M, 2014, J BIOMECH, V47, P237, DOI 10.1016/j.jbiomech.2013.09.031; Zannad F, 2015, HYPERTENSION, V65, P5, DOI 10.1161/HYPERTENSIONAHA.114.04057	16	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					510	512		10.1253/circj.CJ-15-0084		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600011		
J	Sakata, K; Kawashiri, MA; Hayashi, K				Sakata, Kenji; Kawashiri, Masa-aki; Hayashi, Kenshi			Expansion of the Clinical Application of Optical Coherence Tomography to Percutaneous Coronary Intervention and Assessment of the Instability of Coronary Atherosclerosis	CIRCULATION JOURNAL			English	Editorial Material							INTRAVASCULAR ULTRASOUND; INSIGHTS; IMPACT; PLAQUE		[Sakata, Kenji; Kawashiri, Masa-aki; Hayashi, Kenshi] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa 9208640, Japan	Sakata, K (reprint author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	kenjis@yu.incl.ne.jp					Yamagishi M, 2000, J AM COLL CARDIOL, V35, P106, DOI 10.1016/S0735-1097(99)00533-1; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Yonetsu T, 2013, CIRC J, V77, P1933, DOI 10.1253/circj.CJ-13-0643.1; Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327; Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111; Gamou T, 2015, HEART VESSELS, V30, P719, DOI 10.1007/s00380-014-0542-3; Honda Y, 2009, CIRC J, V73, P1371; Kubo T, 2015, CIRC J, V79, P600, DOI 10.1253/circj.CJ-14-1085; Sakata K, 2012, CIRC-CARDIOVASC INTE, V5, P763, DOI 10.1161/CIRCINTERVENTIONS.111.962878	9	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					513	514		10.1253/circj.CJ-15-0103		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600012		
J	Naya, M; Tsutsui, H				Naya, Masanao; Tsutsui, Hiroyuki			Assessment of Coronary Flow Reserve by Dynamic Single-Photon Emission Computed Tomography	CIRCULATION JOURNAL			English	Editorial Material							MYOCARDIAL-PERFUSION; MAGNETIC-RESONANCE; ARTERY-DISEASE; REVASCULARIZATION; TRIAL; PET		[Naya, Masanao; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 0608638, Japan	Naya, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, N-15,W-7, Sapporo, Hokkaido 0608638, Japan.	naya@med.hokudai.ac.jp					Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Murthy VL, 2011, CIRCULATION, V124, P2215, DOI 10.1161/CIRCULATIONAHA.111.050427; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Naya M, 2011, J AM COLL CARDIOL, V58, P1807, DOI 10.1016/j.jacc.2011.06.051; Ben-Haim S, 2013, J NUCL MED, V54, P873, DOI 10.2967/jnumed.112.109652; Naya M, 2013, J AM COLL CARDIOL, V61, P2098, DOI 10.1016/j.jacc.2013.02.029; Ito Y, 2003, EUR J NUCL MED MOL I, V30, P281, DOI 10.1007/s00259-002-1031-y; Naya M, 2014, J NUCL MED, V55, P248, DOI 10.2967/jnumed.113.121442; Gould KL, 2009, JACC-CARDIOVASC IMAG, V2, P1009, DOI 10.1016/j.jcmg.2009.06.004; Kamiya K, 2014, CIRC J, V78, P2468, DOI 10.1253/circj.CJ-13-1454; Shiraishi S, 2015, CIRC J, V79, P623, DOI 10.1253/circj.CJ-14-0932; Taqueti VR, 2015, CIRCULATION, V131, P19, DOI 10.1161/CIRCULATIONAHA.114.011939; Tsukamoto T, 2005, CIRC J, V69, P188, DOI 10.1253/circj.69.188	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					515	516		10.1253/circj.CJ-15-0106		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600013		
J	Ishizu, T; Horigome, H				Ishizu, Tomoko; Horigome, Hitoshi			Assessment and Treatment of Systemic Right Ventricular Dyssynchrony	CIRCULATION JOURNAL			English	Editorial Material							CARDIAC-RESYNCHRONIZATION-THERAPY; CONGENITAL HEART-DISEASE; BUNDLE-BRANCH BLOCK; ECHOCARDIOGRAPHY; ABNORMALITIES; FAILURE		[Ishizu, Tomoko] Univ Tsukuba, Fac Med, Cardiovasc Div, Tsukuba, Ibaraki 3058575, Japan; [Horigome, Hitoshi] Univ Tsukuba, Fac Med, Dept Child Hlth, Tsukuba, Ibaraki 3058575, Japan	Horigome, H (reprint author), Univ Tsukuba, Fac Med, Dept Child Hlth, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hhorigom@md.tsukuba.ac.jp					van der Hulst AE, 2011, EUR HEART J, V32, P2236, DOI 10.1093/eurheartj/ehr093; Cecchin F, 2009, J CARDIOVASC ELECTR, V20, P58, DOI 10.1111/j.1540-8167.2008.01274.x; Tracy CM, 2012, CIRCULATION, V126, P1784, DOI 10.1161/CIR.0b013e3182618569; Janousek J, 2009, HEART, V95, P1165, DOI 10.1136/hrt.2008.160465; Ruschitzka F, 2013, NEW ENGL J MED, V369, P1395, DOI 10.1056/NEJMoa1306687; Dubin AM, 2005, J AM COLL CARDIOL, V46, P2277, DOI 10.1016/j.jacc.2005.05.096; Atsumi A, 2013, CIRC J, V77, P1760, DOI 10.1253/circj.CJ-12-1445; Auricchio A, 2014, CIRC-ARRHYTHMIA ELEC, V7, P532, DOI 10.1161/CIRCEP.113.000628; Doltra A, 2014, JACC-CARDIOVASC IMAG, V7, P969, DOI [10.1016/j.jcmg.2014.03.022, 10.1016/j.jcmg.2014.03.622]; Fantoni C, 2005, J CARDIOVASC ELECTR, V16, P120, DOI DOI 10.1046/J.1540-8167.2005.40777.X; Fantoni C, 2005, J CARDIOVASC ELECTR, V16, P112, DOI 10.1046/j.1540-8167.2005.40777.x; Horigome H, 2014, CIRC J, V78, P1579, DOI 10.1253/circj.CJ-14-0580; Ichikawa K, 2013, J AM SOC ECHOCARDIOG, V26, P483, DOI 10.1016/j.echo.2013.02.010; Sakaguchi H, 2015, CIRC J, V79, P649, DOI 10.1253/circj.CJ-14-0395; Seo Y, 2011, CIRC J, V75, P1156, DOI 10.1253/circj.CJ-10-0861; Silva JNA, 2009, HEART RHYTHM, V6, P1178, DOI 10.1016/j.hrthm.2009.04.017	16	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					519	521		10.1253/circj.CJ-15-0105		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600015		
J	Yoshimura, M				Yoshimura, Michihiro			Developing Improved Clinical Markers to Detect Heart Failure and Chronic Kidney Disease	CIRCULATION JOURNAL			English	Editorial Material							BODY-MASS INDEX; HEMODIALYSIS-PATIENTS; NATRIURETIC PEPTIDE; INFLAMMATION; METAANALYSIS; MORTALITY; OBESITY; PARADOX; IMPACT		[Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 1058461, Japan	Yoshimura, M (reprint author), Jikei Univ, Sch Med, Dept Med, Div Cardiol,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	m.yoshimura@jikei.ac.jp					Ahmadi SF, 2014, AM J NEPHROL, V40, P315, DOI 10.1159/000367812; Kumada Y, 2014, CIRC J, V78, P986, DOI 10.1253/circj.CJ-13-1357; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Komukai K, 2012, CIRC J, V76, P145, DOI 10.1253/circj.CJ-11-0727; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Inoue T, 2010, INTERNAL MED, V49, P2659, DOI 10.2169/internalmedicine.49.4211; Shono M, 2007, CIRC J, V71, P1040, DOI 10.1253/circj.71.1040; Libby P, 2004, AM J MED, V116, P9, DOI 10.1016/j.amjmed.2004.02.006; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Celik T, 2008, INT J CARDIOL, V128, P255, DOI 10.1016/j.ijcard.2007.04.017; Ishii J, 2015, CIRC J, V79, P656, DOI 10.1253/circj.CJ-14-0915; Vashistha T, 2014, AM J KIDNEY DIS, V63, P612, DOI 10.1053/j.ajkd.2013.07.021	12	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					522	523		10.1253/circj.CJ-15-0065		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600016		
J	Fukuda, S; Watanabe, H; Iwakura, K; Daimon, M; Ito, H; Yoshikawa, J				Fukuda, Shota; Watanabe, Hiroyuki; Iwakura, Katsuomi; Daimon, Masao; Ito, Hiroshi; Yoshikawa, Junichi		AAA Japan Study Investigators	Multicenter Investigations of the Prevalence of Abdominal Aortic Aneurysm in Elderly Japanese Patients With Hypertension - The AAA Japan Study	CIRCULATION JOURNAL			English	Article						Aorta; Echocardiography; Hypertension	ENDOVASCULAR REPAIR; PRACTICE GUIDELINES; COST-EFFECTIVENESS; SCREENING-PROGRAM; DEVICE; MANAGEMENT; ECHOCARDIOGRAPHY; VALIDATION; RESIDENTS; COMMUNITY	Background: Physical examination as an initial screening tool to diagnose abdominal aortic aneurysm (AAA) has lost favor over the past 20 years. This multicenter cohort study aimed to determine the prevalence of AAA in elderly Japanese patients with hypertension (HT) and to clarify the diagnostic accuracy of physical examination using a pocket-sized ultrasound imaging device (the "pocket-echo"). Methods and Results: A total of 1,731 patients with HT aged >60 years from 20 collaborating institutions were enrolled in this study. Abdominal palpation was performed on physical examination, and the pocket-echo was used to confirm the diagnosis of AAA. The abdominal aorta was well visualized in 1,692 patients (98%). AAA was discovered in 69 patients (4.1%), with advanced age and male sex identified as independent risk factors. The prevalence of AAA increased according to age regardless of sex, and reached 9.2% and 5.7%, respectively, in males and females >= 80 years. Overall, 33 cases of AAA were missed on abdominal palpation (sensitivity, 52%), whereas for AAAs >40 mm, the sensitivity was 75%. Conclusions: We assessed the utility of the pocket-echo and physical examination for diagnosing AAA in Japanese patients with HT aged over 60 years. Our findings highlight the importance of AAA screening programs in high-risk Japanese populations, and confirm the ability of physical examination to detect large, but not small, AAAs.	[Fukuda, Shota] Osaka Ekisaikai Hosp, Dept Med, Osaka 5500022, Japan; [Watanabe, Hiroyuki] Tokyo Bay Urayasu Ichikawa Med Ctr, Ctr Heart, Urayasu, Japan; [Iwakura, Katsuomi] Sakurabashi Watanabe Hosp, Div Cardiol, Osaka, Japan; [Daimon, Masao] Tokyo Univ Hosp, Clin Lab, Tokyo 113, Japan; [Ito, Hiroshi] Okayama Univ, Grad Sch Med & Dent, Dept Cardiovasc Med, Okayama, Japan; [Yoshikawa, Junichi] Nishinomiya Watanabe Cardiovasc Ctr, Dept Cardiol, Nishinomiya, Hyogo, Japan	Fukuda, S (reprint author), Osaka Ekisaikai Hosp, Dept Med, 2-1-10 Honden, Osaka 5500022, Japan.	h-syouta@mve.biglobe.ne.jp			Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases	This work was supported in part by a research grant from the Osaka Foundation for the Prevention of Cancer and Cardiovascular Diseases.	Aboyans V, 2014, AM J CARDIOL, V114, P1100, DOI 10.1016/j.amjcard.2014.07.024; Adachi K, 2000, SURG TODAY, V30, P594; Kurosawa K, 2013, CIRC J, V77, P2860, DOI 10.1253/circj.CJ-13-1252; Lafitte S, 2011, ULTRASOUND MED BIOL, V37, P798, DOI 10.1016/j.ultrasmedbio.2011.02.010; Pleumeekers HJCM, 1995, AM J EPIDEMIOL, V142, P1291; Fukuda S, 2009, CIRC J, V73, P1092; Scott RAP, 2001, EUR J VASC ENDOVASC, V21, P535, DOI 10.1053/ejvs.2001.1368; Prinz C, 2011, J AM SOC ECHOCARDIOG, V24, P111, DOI 10.1016/j.echo.2010.10.017; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Chaikof EL, 2009, J VASC SURG, V50, P880, DOI 10.1016/j.jvs.2009.07.001; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Bown MJ, 2013, JAMA-J AM MED ASSOC, V309, P806, DOI 10.1001/jama.2013.950; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Fink HA, 2000, ARCH INTERN MED, V160, P833, DOI 10.1001/archinte.160.6.833; Fleming C, 2005, ANN INTERN MED, V142, P203; JOHNSTON KW, 1991, J VASC SURG, V13, P452; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Badgett RG, 1997, JAMA-J AM MED ASSOC, V277, P1712, DOI 10.1001/jama.277.21.1712; BEEDE SD, 1990, ARCH INTERN MED, V150, P549; Bruce CJ, 2000, J AM SOC ECHOCARDIOG, V13, P674, DOI 10.1067/mje.2000.107797; COLLIN J, 1988, LANCET, V2, P613; Dijos M, 2012, ECHOCARDIOGR-J CARD, V29, P285, DOI 10.1111/j.1540-8175.2011.01559.x; FRAME PS, 1993, ANN INTERN MED, V119, P411; Hobbs SD, 2003, EUR J VASC ENDOVASC, V25, P505, DOI 10.1053/ejvs.2002.1884; Hoshina K, 2013, CIRC J, V77, P1996, DOI 10.1253/circj.CJ-13-0204; KATZ DA, 1992, JAMA-J AM MED ASSOC, V268, P2678, DOI 10.1001/jama.268.19.2678; Kitada R, 2013, CLIN CARDIOL, V36, P603, DOI 10.1002/clc.22171; Kono Y, 2011, JACC-CARDIOVASC IMAG, V4, P921, DOI 10.1016/j.jcmg.2011.02.022; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; Lederle FA, 1997, ANN INTERN MED, V126, P441; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; NEVITT MP, 1989, NEW ENGL J MED, V321, P1009, DOI 10.1056/NEJM198910123211504; Salem MK, 2009, EUR J VASC ENDOVASC, V38, P748, DOI 10.1016/j.ejvs.2009.07.012; Spark JI, 2001, BRIT J SURG, V88, P382, DOI 10.1046/j.1365-2168.2001.01709.x; TAKEI H, 1995, SURG TODAY, V25, P608	36	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					524	U99		10.1253/circj.CJ-14-0972		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600017		
J	Nakayama, M; Tanaka, N; Sakoda, K; Hokama, Y; Hoshino, K; Kimura, Y; Ogawa, M; Yamashita, J; Kobori, Y; Uchiyama, T; Aizawa, Y; Yamashina, A				Nakayama, Masafumi; Tanaka, Nobuhiro; Sakoda, Kunihiro; Hokama, Yohei; Hoshino, Kou; Kimura, Yo; Ogawa, Masashi; Yamashita, Jun; Kobori, Yuichi; Uchiyama, Takashi; Aizawa, Yoshifusa; Yamashina, Akira			Papaverine-Induced Polymorphic Ventricular Tachycardia During Coronary Flow Reserve Study of Patients With Moderate Coronary Artery Disease - Analysis of ECG Data	CIRCULATION JOURNAL			English	Article						Coronary factional reserve; Papaverine; QT interval; Ventricular tachyarrhythmia	TORSADES-DE-POINTES; LONG QT SYNDROME; T-U WAVES; INTRACORONARY PAPAVERINE; EARLY AFTERDEPOLARIZATIONS; INTERVAL PROLONGATION; ADENOSINE; INTERVENTION; ARRHYTHMIAS; EPINEPHRINE	Background: Papaverine is useful for evaluating the functional status of a coronary artery, but it may provoke malignant ventricular arrhythmia (VA). The aim of this study was to investigate the incidence, and clinical and ECG characteristics of patients with papaverine-induced VAs. Methods and Results: The 182 consecutive patients underwent fractional flow reserve (FFR) measurement of 277 lesions. FFR was determined after intracoronary papaverine administration by standard procedures. The clinical and ECG characteristics were compared between patients with and without ventricular tachycardia (VT: >= 3 successive premature ventricular beats (PVBs), or ventricular fibrillation (VF)). After papaverine administration, the QTc interval, QTUc interval, and T-peak to U-end interval were prolonged significantly. Single PVBs on the T-wave or U-wave type developed in 29 patients (15.9%). Polymorphic VT (torsade de pointes) occurred in 5 patients (2.8%), and of those, VF developed in 3 patients (1.7%). No clinical and baseline ECG parameters were predictors for VT or VF except for sex and administration of papaverine into the left coronary artery. Excessive prolongation of QT (or QTU), T-peak to U-end intervals and giant T-U waves were found immediately prior to the ventricular tachyarrhythmias (VTAs), which were unpredictable from the baseline data. Conclusions: Intracoronary administration of papaverine induced fatal VTAs, although the incidence is rare. Excessive prolongation of the QT (and QTU) interval appeared prior to VTAs; however, they were unpredictable.	[Nakayama, Masafumi; Tanaka, Nobuhiro; Sakoda, Kunihiro; Hokama, Yohei; Kimura, Yo; Yamashita, Jun; Yamashina, Akira] Tokyo Med Univ, Dept Cardiol, Tokyo 1608402, Japan; [Nakayama, Masafumi; Hoshino, Kou; Kimura, Yo; Kobori, Yuichi; Uchiyama, Takashi] Toda Cent Gen Hosp, Cardiovasc Ctr, Toda, Saitama, Japan; [Ogawa, Masashi] Tokyo Med Univ, Ibaraki Med Ctr, Dept Cardiol, Ibaraki, Japan; [Aizawa, Yoshifusa] Tachikawa Med Ctr, Nagaoka, Niigata, Japan	Nakayama, M (reprint author), Toda Cent Gen Hosp, Cardiovasc Ctr, 1-19-3 Hon Cho, Toda, Saitama 3350023, Japan.	masafumi331@gmail.com					American Diabetes Association, 2012, DIABETES CARE S1, V35, pS64, DOI DOI 10.2337/DC12-S064; De Bruyne B, 2003, CIRCULATION, V107, P1877, DOI 10.1161/01.CIR.0000061950.24940.88; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; HABBAB MA, 1990, AM J MED, V89, P241, DOI 10.1016/0002-9343(90)90307-Y; Kirchhof P, 2009, J AM COLL CARDIOL, V54, P143, DOI 10.1016/j.jacc.2009.03.043; Berger A, 2005, J AM COLL CARDIOL, V46, P438, DOI 10.1016/j.jacc.2005.04.041; Qian JY, 2000, AM HEART J, V140, P502, DOI 10.1067/mhj.2000.109221; Wang JC, 1999, BRIT J PHARMACOL, V128, P1733, DOI 10.1038/sj.bjp.0702959; Pijls NHJ, 2013, CIRC J, V77, P561, DOI 10.1253/circj.CJ-13-0161; Sen S, 2013, J AM COLL CARDIOL, V61, P1409, DOI 10.1016/j.jacc.2013.01.034; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Qaseem A, 2012, ANN INTERN MED, V157, P735, DOI 10.7326/0003-4819-157-10-201211200-00011; Trinkley KE, 2013, CURR MED RES OPIN, V29, P1719, DOI 10.1185/03007995.2013.840568; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Dessertenne F, 1966, Arch Mal Coeur Vaiss, V59, P263; ELSHERIF N, 1988, CIRC RES, V63, P286; Goto M, 2014, INTERNAL MED, V53, P1629, DOI 10.2169/internalmedicine.53.1828; Haverkamp W, 1995, CARDIAC ELECTROPHYSI, P885; INOUE T, 1994, CARDIOLOGY, V84, P9, DOI 10.1159/000176323; JACKMAN WM, 1988, PROG CARDIOVASC DIS, V31, P115, DOI 10.1016/0033-0620(88)90014-X; JAIN A, 1989, CATHETER CARDIO DIAG, V18, P255, DOI 10.1002/ccd.1810180413; Aizawa Y, 2012, CIRC J, V76, P489, DOI 10.1253/circj.CJ-88-0022; KERN MJ, 1990, CATHETER CARDIO DIAG, V19, P229, DOI 10.1002/ccd.1810190402; Kim YJ, 2008, J CARDIOVASC PHARM, V52, P485, DOI 10.1097/FJC.0b013e31818e65c2; Kirchhof P, 2004, HEART RHYTHM, V1, P720, DOI 10.1016/j.hrthm.2004.08.016; Nakayama M, 2009, J CARDIOL, V53, P288, DOI 10.1016/j.jjcc.2008.07.017; Nakayama M, 2012, INTERNAL MED, V51, P351, DOI 10.2169/internalmedicine.51.6567; SHIMIZU W, 1994, J CARDIOVASC ELECTR, V5, P438, DOI 10.1111/j.1540-8167.1994.tb01183.x; TALMAN CL, 1990, J AM COLL CARDIOL, V15, P275; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P733; Urao N, 2004, CIRC J, V68, P587, DOI 10.1253/circj.68.587; VROLIX M, 1991, EUR HEART J, V12, P273; WILSON RF, 1988, AM J CARDIOL, V62, P1301, DOI 10.1016/0002-9149(88)90281-0; Yamashita J, 2013, CIRC J, V77, P1180, DOI 10.1253/circj.CJ-12-1192; Yoshida H, 2001, AM J MED GENET, V98, P348, DOI 10.1002/1096-8628(20010201)98:4<348::AID-AJMG1109>3.0.CO;2-A; Zahid Maliha, 2013, J Cardiovasc Dis Res, V4, P7, DOI 10.1016/j.jcdr.2012.10.001; Zhang Xian, 1993, Chinese Medical Sciences Journal, V8, P248	38	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					530	536		10.1253/circj.CJ-14-1118		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600018		
J	Kainuma, S; Kasegawa, H; Miyagawa, S; Nishi, H; Yaku, H; Takanashi, S; Hashimoto, K; Okada, Y; Nakatani, S; Umezu, M; Daimon, T; Sakaguchi, T; Toda, K; Sawa, Y				Kainuma, Satoshi; Kasegawa, Hitoshi; Miyagawa, Shigeru; Nishi, Hiroyuki; Yaku, Hitoshi; Takanashi, Shuichiro; Hashimoto, Kazuhiro; Okada, Yukikatsu; Nakatani, Satoshi; Umezu, Mitsuo; Daimon, Takashi; Sakaguchi, Taichi; Toda, Koichi; Sawa, Yoshiki		Comm Japanese Soc Stentless Mitral	In Vivo Assessment of Novel Stentless Valve in the Mitral Position	CIRCULATION JOURNAL			English	Article						Animal models; Echocardiography; Mitral valve	REPAIR; REOPERATION; PERICARDIUM; REPLACEMENT; SURGERY; TISSUE	Background: We conducted in vivo examinations of a newly designed stentless mitral valve (SMV), formed by suturing 2 leaflets with the "legs" serving as chorda tendinea, made from bovine pericardium, to a flexible ring. Methods and Results: Seven pigs underwent implantation of the SMV constructed with a 23-mm (n=5) or 25-mm (n=2) Duran ring. Baseline echocardiography examinations were used to evaluate the annular anteroposterior diameter, and distance between the mitral annulus (MA) and papillary muscles (PMs) to determine SMV-leg length. After removing the native valve, the SMV-legs were fixed to the anterior and posterior PMs, followed by fixation of the ring to the native MA. Immediately after surgery, all animals presented none or trivial mitral regurgitation, with mean and peak trans-SMV pressure gradient values of 1.9 +/- 0.8 and 6.0 +/- 3.1 mmHg, respectively. The mean length of the SMV-leg was 19.4 +/- 3.9 mm, which correlated with the distance between anterior and posterior MA-PM (r=0.96 and 0.94, respectively, P<0.01 for both). The discrepancy between the anteroposterior diameter of the ring (outside diameter) and that of the native valve was 1.0 +/- 2.9 mm, which correlated with the trans-SMV pressure gradient (r=0.81, P=0.025). Conclusions: In our preliminary study, the SMV demonstrated excellent diastolic inflow dynamics and closing function in vivo. Preoperative precise assessment of MV configuration may serve as a basis for selection of appropriate ring size and SMV-leg length.	[Kainuma, Satoshi; Miyagawa, Shigeru; Nishi, Hiroyuki; Sakaguchi, Taichi; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Kasegawa, Hitoshi; Takanashi, Shuichiro] Sakakibara Heart Inst, Tokyo, Japan; [Yaku, Hitoshi] Kyoto Prefectural Univ Med, Kyoto, Japan; [Hashimoto, Kazuhiro] Jikei Univ, Tokyo, Japan; [Okada, Yukikatsu] Gen Hosp, Kobe City Med Ctr, Kobe, Hyogo, Japan; [Nakatani, Satoshi] Osaka Univ, Grad Sch Med, Dept Hlth Sci, Div Funct Diagnost, Suita, Osaka 5650871, Japan; [Umezu, Mitsuo] Waseda Univ, Ctr Adv Biomed Sci, Tokyo, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 6638501, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2-E1Yamadaoka, Suita, Osaka 5650871, Japan.	sawa-p@surg1.med.osaka-u.ac.jp			MEXT KAKENHI [23390338]	This study was supported by a MEXT KAKENHI Grant-in Aid for Scientific Research, (B) 23390338.	Acar C, 1996, J THORAC CARDIOV SUR, V111, P367, DOI 10.1016/S0022-5223(96)70446-4; Komeda M, 1997, J THORAC CARDIOV SUR, V113, P292, DOI 10.1016/S0022-5223(97)70326-X; Suri RM, 2006, ANN THORAC SURG, V82, P819, DOI 10.1016/j.athoracsur.2006.03.091; Gammie JS, 2009, ANN THORAC SURG, V87, P1431, DOI 10.1016/j.athoracsur.2009.01.064; Ota T, 2007, ANN THORAC SURG, V83, P1501, DOI 10.1016/j.athoracsur.2006.11.083; Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763; Badhwar V, 2012, ANN THORAC SURG, V94, P1870, DOI 10.1016/j.athoracsur.2012.05.105; Chauvaud S, 1998, J THORAC CARDIOV SUR, V115, P84, DOI 10.1016/S0022-5223(98)99001-8; Dumont E, 2007, ANN THORAC SURG, V84, P444, DOI 10.1016/j.athoracsur.2007.03.078; Grabenwoger M, 1996, ANN THORAC SURG, V62, P772; GUYTON RA, 1984, J THORAC CARDIOV SUR, V87, P619; Kaneko T, 2014, CIRC J, V78, P560, DOI 10.1253/circj.CJ-14-0069; Kasegawa H, 2012, J HEART VALVE DIS, V21, P71; Mirsadraee S, 2007, J SURG RES, V143, P407, DOI 10.1016/j.jss.2007.01.026; Morticelli L, 2013, J HEART VALVE DIS, V22, P340; Murashita T, 2013, CIRC J, V77, P2050, DOI 10.1253/circj.CJ-13-0089; RANGANAT.N, 1970, CIRCULATION, V41, P459	17	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					553	559		10.1253/circj.CJ-14-1113		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600021		
J	Imamura, T; Kinugawa, K; Nitta, D; Fujino, T; Inaba, T; Maki, H; Hatano, M; Kinoshita, O; Nawata, K; Kyo, S; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Nitta, Daisuke; Fujino, Takeo; Inaba, Toshiro; Maki, Hisataka; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Kyo, Shunei; Ono, Minoru			Novel Scoring System Using Postoperative Cardiopulmonary Exercise Testing Predicts Future Explantation of Left Ventricular Assist Device	CIRCULATION JOURNAL			English	Article						Oxygen consumption; Predictor; Reverse remodeling; Ventricular assist device	CHRONIC HEART-FAILURE; CONTINUOUS-FLOW; MYOCARDIAL RECOVERY; POOR-PROGNOSIS; IMPLANTATION; REVERSAL; SUPPORT; AGE; CARDIOMYOPATHY; CAPACITY	Background: Although cardiopulmonary exercise (CPX) testing is an established tool for predicting survival in patients with heart failure (HF), its prognostic impact on explantation of left ventricular assist device (LVAD) was unknown. Methods and Results: We enrolled 33 patients who had undergone implantation of extracorporeal pulsatile flow LVAD and symptom-limited CPX testing at 3 months after operation, and who were followed between 2005 and 2014. Patients who received conversion to continuous flow LVAD were excluded. On Cox regression analysis, E1 (maximum load >= 51W; HR, 27.55), E2 (minute ventilation/carbon dioxide output [(V)over dotE/(V)over dotCO(2)] slope <= 34; HR, 16.86), and E3 (peak oxygen consumption [P(V)over dotO(2)]>= 12.8 ml.kg(-1).min(-1); HR, 18.35) significantly predicted explantation expectancy during 2 years after LVAD implantation (P<0.05 for all). Explantation score, the sum of positive E1-3, significantly stratified 2-year cumulative explantation rate into low (0 points), intermediate (1-2 points), and high (3 points) expectancy groups (0%, 29%, and 86%, respectively, P<0.001). When the scoring system was used for 45 patients with continuous flow LVAD, the 2 patients who had explantation were assigned to the high expectancy group. Conclusions: Explantation score, calculated simply from 3 postoperative symptom-limited CPX testing parameters, is a novel tool to predict explantation expectancy of LVAD and to select good candidates for the weaning test.	[Imamura, Teruhiko; Kinugawa, Koichiro; Kyo, Shunei] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Nitta, Daisuke; Fujino, Takeo; Inaba, Toshiro; Maki, Hisataka; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo 1138655, Japan	Kinugawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kinugawa-tky@umin.ac.jp					Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Zafeiridis A, 1998, CIRCULATION, V98, P656; Imamura T, 2014, CIRC J, V78, P1396, DOI 10.1253/circj.CJ-14-0077; Imamura T, 2014, J ARTIF ORGANS, V17, P23, DOI 10.1007/s10047-013-0748-7; Hatano M, 2011, CIRC J, V75, P1147, DOI 10.1253/circj.CJ-10-1106; Mano A, 2008, J HEART LUNG TRANSPL, V27, P869, DOI 10.1016/j.healun.2008.05.007; Dandel M, 2011, EUR HEART J, V32, P1148, DOI 10.1093/eurheartj/ehq353; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Matsumiya G, 2005, J THORAC CARDIOV SUR, V130, P699, DOI 10.1016/j.jtcvs.2005.05.016; Kato TS, 2011, CIRC-HEART FAIL, V4, P546, DOI 10.1161/CIRCHEARTFAILURE.111.962142; Itoh H, 2013, J CARDIOL, V61, P71, DOI 10.1016/j.jjcc.2012.09.010; Imamura T, 2014, CIRC J, V78, P2259, DOI 10.1253/circj.CJ-14-0368; Mancini DM, 1998, CIRCULATION, V98, P2383; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Imamura T, 2013, CIRC J, V77, P96, DOI 10.1253/circj.CJ-12-0686; Fujimoto N, 2013, CIRCULATION, V127, P55, DOI 10.1161/CIRCULATIONAHA.112.111302; Drakos SG, 2013, J AM COLL CARDIOL, V61, P1985, DOI 10.1016/j.jacc.2013.01.072; Leibner ES, 2013, ASAIO J, V59, P117, DOI 10.1097/MAT.0b013e3182816cb7; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; Yoshioka D, 2012, CIRC J, V76, P372, DOI 10.1253/circj.CJ-11-0833; Goldstein DJ, 1998, NEW ENGL J MED, V339, P1522, DOI 10.1056/NEJM199811193392107; Hori M, 2014, HEART VESSELS, V29, P238, DOI 10.1007/s00380-013-0340-3; Khawaja T, 2014, J CACHEXIA SARCOPENI, V5, P297, DOI 10.1007/s13539-014-0155-9; Saito S, 2014, J HEART LUNG TRANSPL, V33, P599, DOI 10.1016/j.healun.2014.02.015; Simon MA, 2010, J CARD FAIL, V16, P99, DOI 10.1016/j.cardfail.2009.10.018; Simon MA, 2005, CIRCULATION, V112, pI32, DOI 10.1161/CIRCULATIONAHA.104.524124	26	3	3	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					560	566		10.1253/circj.CJ-14-1058		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600022		
J	Akutsu, K; Yoshino, H; Tobaru, T; Hagiya, K; Watanabe, Y; Tanaka, K; Koyama, N; Yamamoto, T; Nagao, K; Takayama, M				Akutsu, Koichi; Yoshino, Hideaki; Tobaru, Tetsuya; Hagiya, Kenichi; Watanabe, Yusuke; Tanaka, Keiji; Koyama, Nobuya; Yamamoto, Takeshi; Nagao, Ken; Takayama, Morimasa			Acute Type B Aortic Dissection With Communicating vs. Non-Communicating False Lumen - Analysis of 502 Patients From the Tokyo CCU-Network Database -	CIRCULATION JOURNAL			English	Article						Classic dissection; Communicating aortic dissection; False lumen; Intramural hematoma; Non-communicating aortic dissection	ACUTE MYOCARDIAL-INFARCTION; ULCER-LIKE PROJECTIONS; LONG-TERM PROGNOSIS; INTRAMURAL HEMATOMA; CLINICAL-OUTCOMES; MEDICAL-TREATMENT; ANEURYSM; MANAGEMENT; DIAGNOSIS; FEATURES	Background: In practice, patients with acute aortic dissection (AAD) are generally divided into 2 groups according to the status of the false lumen: non-communicating or communicating. The similarities and differences between the 2 groups, however, have not been fully determined in a large population. Methods and Results: We studied 502 patients with Stanford type B AAD. Clinical background at symptom onset was compared, and similarities and differences characterized, for patients with non-communicating (NC group, n=288) vs. communicating (C group, n=214) false lumens. Time of day (00.00-06.00 hours, 06.00-12.00 hours, 12.00-18.00 hours, and 18.00-24.00 hours) and extent of physical activity (extreme exertion, slight exertion, at rest, and sleeping) at symptom onset were similar between groups. Patients in the NC group were older (mean age, 71 +/- 11 years vs. 64 +/- 14 years, P<0.01) and had lower prevalence of distally extended aortic dissection (26% vs. 8%, P<0.01) and deaths in hospital (2% vs. 7%, P=0.011) than those in the C group. Conclusions: At symptom onset, clinical circumstances and physical activity were similar between the groups, and old age and a background of DeBakey IIIa aortic dissection may be associated with determination of false lumen status. The outcome in the NC group was better than in the C group.	[Akutsu, Koichi; Yoshino, Hideaki; Tobaru, Tetsuya; Hagiya, Kenichi; Watanabe, Yusuke; Tanaka, Keiji; Koyama, Nobuya; Yamamoto, Takeshi; Nagao, Ken; Takayama, Morimasa] Tokyo CCU Network Sci Comm, Tokyo, Japan; [Akutsu, Koichi] Nippon Med Coll Hosp, Div Cardiovasc Intens Care, Tokyo 1138603, Japan	Akutsu, K (reprint author), Nippon Med Coll Hosp, Div Cardiovasc Intens Care, 1-1-5 Sendagi, Tokyo 1138603, Japan.	koichi-a@nms.ac.jp					Kurosawa K, 2013, CIRC J, V77, P2860, DOI 10.1253/circj.CJ-13-1252; Estrera AL, 2006, CIRCULATION, V114, pI384, DOI 10.1161/CIRCULATIONAHA.105.001479; Quint LE, 2001, RADIOLOGY, V218, P719; Kimura N, 2008, J THORAC CARDIOV SUR, V136, P1160, DOI 10.1016/j.jtcvs.2008.05.052; Nohara R, 2013, CIRC J, V77, P1526, DOI 10.1253/circj.CJ-12-1149; Akutsu K, 2004, EUR J CARDIO-THORAC, V26, P359, DOI 10.1016/j.ejcts.2004.03.026; Miyahara S, 2011, J THORAC CARDIOV SUR, V142, pE25, DOI 10.1016/j.jtcvs.2011.02.015; Takahashi M, 2011, J CARD FAIL, V17, P742, DOI 10.1016/j.cardfail.2011.05.005; Ganaha F, 2002, CIRCULATION, V106, P342, DOI 10.1161/01.CIR.0000022164.26075.5A; Sueyoshi E, 1997, J COMPUT ASSIST TOMO, V21, P931, DOI 10.1097/00004728-199711000-00016; Kozai Y, 2001, JPN CIRC J, V65, P359, DOI 10.1253/jcj.65.359; Uchida K, 2013, EUR J CARDIO-THORAC, V44, P366, DOI 10.1093/ejcts/ezt040; YAMADA T, 1988, RADIOLOGY, V168, P347; Berdat PA, 1999, EUR J CARDIO-THORAC, V15, P108, DOI 10.1016/S1010-7940(98)00259-0; Harris KM, 1997, J THORAC CARDIOV SUR, V114, P619, DOI 10.1016/S0022-5223(97)70052-7; Harris KM, 2012, CIRCULATION, V126, pS91, DOI 10.1161/CIRCULATIONAHA.111.084541; HAYASHI K, 1974, AM J ROENTGENOL, V122, P769; Hsu RB, 2005, ANN THORAC SURG, V79, P794; Hsu RB, 2005, ANN THORAC SURG, V79, P790, DOI 10.1016/j.athorascur.2004.07.061; Ishimaru S, 2013, CIRC J, V77, P789, DOI 10.1253/circj.CJ-66-0057; Kaji S, 2003, CIRCULATION, V108, P307, DOI 10.1161/01.cir.0000087425.86049.74; Kitai T, 2010, CIRCULATION, V122, pS74, DOI [10.1161/CIRCULATIONAHA.109.927517, 10.1161/C1RCULATIONAHA.109.927517]; Makita S, 2006, ANGIOLOGY, V57, P478, DOI 10.1177/0003319706290625; MOHRKAHALY S, 1994, J AM COLL CARDIOL, V23, P658; Murashita T, 2012, CIRC J, V76, P650, DOI 10.1253/circj.CJ-11-0982; Nishigami K, 2000, CIRCULATION, V102, P243; Obayashi T, 2010, CIRC J, V74, P289, DOI 10.1253/circj.CJ-09-0623; Song JK, 2002, AM J MED, V113, P181, DOI 10.1016/S0002-9343(02)01171-3; Sueyoshi E, 2004, ANN THORAC SURG, V78, P2112, DOI 10.1016/j.athoracsur.2004.05.048; Takamoto S, 2006, CIRC J, V70, P1569; Takamoto S, GUIDELINES DIAGNOSIS; TAKANO T, 1987, JPN CIRC J, V51, P338; TAKANO T, 1984, JPN CIRC J, V48, P690; Tamori Y, 2009, CIRC J, V73, P822; Tanaka A, 2014, J VASC SURG, V59, P321, DOI 10.1016/j.jvs.2013.08.031; TISNADO J, 1980, AM J ROENTGENOL, V135, P719; Tolenaar JL, 2013, J VASC SURG, V58, P1498, DOI 10.1016/j.jvs.2013.05.099	37	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					567	573		10.1253/circj.CJ-14-0828		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600023		
J	Nochioka, K; Sakata, Y; Miyata, S; Miura, M; Takada, T; Tadaki, S; Ushigome, R; Yamauchi, T; Takahashi, J; Shimokawa, H				Nochioka, Kotaro; Sakata, Yasuhiko; Miyata, Satoshi; Miura, Masanobu; Takada, Tsuyoshi; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Takahashi, Jun; Shimokawa, Hiroaki		Chart-2 Investigators	Prognostic Impact of Statin Use in Patients With Heart Failure and Preserved Ejection Fraction - A Report From the CHART-2 Study -	CIRCULATION JOURNAL			English	Article						Heart failure; Lipids; Noncardiovascular death; Statins; Sudden death	CLINICAL CHARACTERISTICS; ATORVASTATIN THERAPY; SYSTOLIC FUNCTION; CONTROLLED-TRIAL; ELDERLY-PEOPLE; DOUBLE-BLIND; ROSUVASTATIN; ASSOCIATION; RISK; EPIDEMIOLOGY	Background: The effectiveness of statins remains to be examined in patients with heart failure (HF) with preserved ejection fraction (EF). Methods and Results: Among 4,544 consecutive HF patients registered in the Chronic Heart Failure Registry and Analysis in the Tohoku district-2 (CHART-2) between 2006 and 2010, 3,124 had EF >= 50% (HFpEF; mean age 69 years; male 65%) and 1,420 had EF <50% (HF with reduced EF (HFrEF); mean age 67 years; male 75%). The median follow-up was 3.4 years. The 3-year mortality in HFpEF patients was lower in patients receiving statins [8.7% vs. 14.5%, adjusted hazard ratio (HR) 0.74; 95% confidence interval (CI), 0.58-0.94; P<0.001], which was confirmed in the propensity score-matched cohort (HR, 0.72; 95% CI, 0.49-0.99; P=0.044). The inverse probability of treatment weighted further confirmed that statin use was associated with reduced incidence of all-cause death (HR, 0.71; 95% CI, 0.62-0.82, P<0.001) and noncardiovascular death (HR, 0.53; 95% CI, 0.43-0.66, P<0.001), specifically reduction of sudden death (HR, 0.59; 95% CI, 0.36-0.98, P=0.041) and infection death (HR, 0.53; 95% CI, 0.35-0.77, P=0.001) in HFpEF. In the HFrEF cohort, statin use was not associated with mortality (HR, 0.87; 95% CI, 0.73-1.04, P=0.12), suggesting a lack of statin benefit in HFrEF patients. Conclusions: These results suggest that statin use is associated with improved mortality rates in HFpEF patients, mainly attributable to reductions in sudden death and noncardiovascular death.	[Sakata, Yasuhiko] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; Tohoku Univ, Grad Sch Med, Dept Evidence Based Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Sakata, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	sakatayk@cardio.med.tohoku.ac.jp			Ministry of Health, Labor, and Welfare	We thank all the members of the Tohoku Heart Failure Society and the staff of the Department of Evidence-based Cardiovascular Medicine for their contributions (Appendix S1). This study was supported by Grants-in-Aid from a Research Grant from the Ministry of Health, Labor, and Welfare (H.S.).	Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Paulus WJ, 2010, J AM COLL CARDIOL, V55, P526, DOI 10.1016/j.jacc.2009.06.067; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9; Tanaka S, 2013, ARTERIOSCL THROM VAS, V33, P1591, DOI 10.1161/ATVBAHA.112.300922; Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Lund LH, 2012, JAMA-J AM MED ASSOC, V308, P2108, DOI 10.1001/jama.2012.14785; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.09.046; Kayikcioglu M, 2003, INT J CARDIOL, V90, P63, DOI 10.1016/S0167-5273(02)00516-8; Sakata Y, 2014, CIRC J, V78, P428, DOI 10.1253/circj.CJ-13-1009; Vrtovec B, 2008, J CARD FAIL, V14, P140, DOI 10.1016/j.cardfail.2007.10.013; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Nochioka K, 2013, CIRC J, V77, P2318, DOI 10.1253/circj.CJ-13-0127; Chan MMY, 2013, EUR J HEART FAIL, V15, P604, DOI 10.1093/eurjhf/hft062; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Fukuta H, 2005, CIRCULATION, V112, P357, DOI 10.1161/CIRCULATIONAHA.104.519876; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; WEBER KT, 1991, CIRCULATION, V83, P1849; Takano H, 2013, CIRC J, V77, P917, DOI 10.1253/circj.CJ-12-1062; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Vrtovec B, 2005, J CARD FAIL, V11, P684, DOI 10.1016/j.cardfail.2005.06.439; Steiner S, 2005, CIRCULATION, V111, P1841, DOI 10.1161/01.CIR.0000158665.27783.0C; Novack V, 2009, INTENS CARE MED, V35, P1255, DOI 10.1007/s00134-009-1429-0; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Coleman CI, 2007, CURR MED RES OPIN, V23, P1783, DOI 10.1185/030079907X210570; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Miura M, 2012, EUR J HEART FAIL, V14, P367, DOI 10.1093/eurjhf/hfs001; Deng ZT, 2013, CHINESE J CANCER RES, V25, P679, DOI 10.3978/j.issn.1000-9604.2013.11.02; Gomez-Garre D, 2010, EUR J HEART FAIL, V12, P903, DOI 10.1093/eurjhf/hfq101; Levantesi G, 2007, AM J CARDIOL, V100, P1644, DOI 10.1016/j.amjcard.2007.07.015; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286	41	8	9	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					574	U160		10.1253/circj.CJ-14-0865		15	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600024		
J	Sata, Y; Kawada, T; Shimizu, S; Kamiya, A; Akiyama, T; Sugimachi, M				Sata, Yusuke; Kawada, Toru; Shimizu, Shuji; Kamiya, Atsunori; Akiyama, Tsuyoshi; Sugimachi, Masaru			Predominant Role of Neural Arc in Sympathetic Baroreflex Resetting of Spontaneously Hypertensive Rats - Analysis of an Open-Loop Baroreflex Equilibrium Diagram -	CIRCULATION JOURNAL			English	Article						Equilibrium diagram; Hypertension; Norepinephrine; Phenylephrine; Sympathetic nervous activity	CAROTID BARORECEPTOR STIMULATION; ROSTRAL VENTROLATERAL MEDULLA; BLOOD-PRESSURE; NERVE ACTIVITY; RESISTANT HYPERTENSION; ARTERIAL BAROREFLEX; OXIDATIVE STRESS; NITRIC-OXIDE; REFLEX; SINUS	Background: There is ongoing controversy over whether neural or peripheral factors are the predominant cause of hypertension. The closed-loop negative feedback operation of the arterial baroreflex hampers understanding of how arterial pressure (AP) is determined through the interaction between neural and peripheral factors. Methods and Results: A novel analysis of an isolated open-loop baroreceptor preparation to examine sympathetic nervous activity (SNA) and AP responses to changes in carotid sinus pressure (CSP) in adult spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto rats (WKY) was conducted. In the neural arc (CSP-SNA relationship), the midpoint pressure (128.9 +/- 3.8 vs. 157.9 +/- 8.1 mmHg, P<0.001) and the response range of SNA to CSP (90.5 +/- 3.7 vs. 115.4 +/- 7.6%/mmHg, P=0.011) were higher in SHR. In the peripheral arc (SNA-AP relationship), slope and intercept did not differ. A baroreflex equilibrium diagram was obtained by depicting neural and peripheral arcs in a pressure-SNA plane with rescaled SNA (% in WKY). The operating-point AP (111.3 +/- 4.4 vs. 145.9 +/- 5.2 mmHg, P<0.001) and SNA (90.8 +/- 3.2 vs. 125.1 +/- 6.9% in WKY, P<0.001) were shifted towards a higher level in SHR. Conclusions: The shift of the neural arc towards a higher SNA range indicated a predominant contribution to baroreflex resetting in SHR. Notwithstanding the resetting, the carotid sinus baroreflex in SHR preserved an ability to reduce AP if activated with a high enough pressure.	[Sata, Yusuke; Kawada, Toru; Shimizu, Shuji; Kamiya, Atsunori; Sugimachi, Masaru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Suita, Osaka 5658565, Japan; [Akiyama, Tsuyoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiac Physiol, Suita, Osaka 5658565, Japan; [Sata, Yusuke; Sugimachi, Masaru] Osaka Univ, Grad Sch Med, Dept Artificial Organ Med, Fac Med, Suita, Osaka, Japan	Sata, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	yusukesa@ri.ncvc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23592319, 23.01705, 23700550, 25.5473]; Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center [22-6-27, 24-6-27]	This study was supported by the Grant-in-Aid for Scientific Research (23592319, 23.01705, 23700550, 25.5473) promoted by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by an Intramural Research Fund (22-6-27, 24-6-27) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center.	Mancia G, 2010, HYPERTENSION, V55, P607, DOI 10.1161/HYPERTENSIONAHA.109.147306; DiBona GF, 1997, HYPERTENSION, V30, P1089; ROWELL LB, 1972, J APPL PHYSIOL, V32, P213; CHAPLEAU MW, 1987, CIRC RES, V61, P648; Kishi T, 2013, HYPERTENS RES, V36, P845, DOI 10.1038/hr.2013.73; Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH326; Bakris GL, 2012, J AM SOC HYPERTENS, V6, P152, DOI 10.1016/j.jash.2012.01.003; Kawada T, 2011, AM J PHYSIOL-REG I, V300, pR155, DOI 10.1152/ajpregu.00540.2010; Sattar MA, 1995, EUR J PHARMACOL, V294, P727, DOI 10.1016/0014-2999(95)00637-0; SHOUKAS AA, 1991, AM J PHYSIOL, V260, pH300; Ikeda Y, 1996, AM J PHYSIOL-HEART C, V271, pH882; Lohmeier TE, 2012, J APPL PHYSIOL, V113, P1652, DOI 10.1152/japplphysiol.00552.2012; Kawada T, 2009, J PHYSIOL SCI, V59, P447, DOI 10.1007/s12576-009-0055-5; Shinohara K, 2012, CIRC J, V76, P2814, DOI 10.1253/circj.CJ-12-0399; MILLS E, 1988, HYPERTENSION, V11, P427; TOUW KB, 1980, HYPERTENSION, V2, P408; Lohmeier TE, 2007, HYPERTENSION, V49, P1307, DOI 10.1161/HYPERTENSIONAHA.107.087874; Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH2251; COWLEY AW, 1973, CIRC RES, V32, P564; Sato T, 1998, AM J PHYSIOL-HEART C, V274, pH358; McKeown KP, 1998, AM J PHYSIOL-HEART C, V275, pH322; Gao L, 2005, AM J PHYSIOL-HEART C, V288, pH2271, DOI 10.1152/ajpheart.00949.2004; NOSAKA S, 1972, AM J PHYSIOL, V222, P1079; JUDY WV, 1976, CIRC RES, V38, P21; Kawada T, 2010, J PHYSIOL SCI, V60, P283, DOI 10.1007/s12576-010-0096-9; Kawada T, 2003, AM J PHYSIOL-HEART C, V284, pH404, DOI 10.1152/ajpheart.00319.2002; KENT BB, 1972, CARDIOLOGY, V57, P295, DOI 10.1159/000169528; Lohmeier TE, 2010, AM J PHYSIOL-HEART C, V299, pH402, DOI 10.1152/ajpheart.00372.2010; Bolter CP, 2011, J PHYSIOL SCI, V61, P151, DOI 10.1007/s12576-011-0132-4; COOTE JH, 1977, CIRC RES, V40, P571; FOLKOW B, 1973, CIRC RES, V32, P2; Glantz S., 2002, PRIMER BIOSTATISTICS, P254; GONZALEZ ER, 1983, HYPERTENSION, V5, P346; HARADA S, 1992, AM J PHYSIOL, V263, pR524; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Hirooka Y, 2010, CIRC J, V74, P827, DOI 10.1253/circj.CJ-10-0153; Kawada T, 2014, AUTON NEUROSCI-BASIC, V186, P62, DOI 10.1016/j.autneu.2014.10.016; Kishi T, 2010, CIRC J, V74, P2252; Li B, 2013, CIRC J, V77, P2558, DOI 10.1253/circj.CJ-13-0305; Lundin S, 1983, J Hypertens Suppl, V1, P68; Mohrman DE, 2010, CARDIOVASCULAR PHYSL, P246; OSBORN JW, 1991, HYPERTENSION, V18, P475; Papademetriou V, 2011, INT J HYPERTENS, V2011, DOI DOI 10.4061/2011/964394; RICKSTEN SE, 1981, CLIN SCI, V61, pS169; Sagawa K., 1983, HDB PHYSL 2, VIII, P453; SAPRU HN, 1976, AM J PHYSIOL, V230, P664; THOREN P, 1983, ACTA PHYSIOL SCAND, V117, P91, DOI 10.1111/j.1748-1716.1983.tb07182.x; Tomiyama H, 2014, CIRC J, V78, P1414, DOI 10.1253/circj.CJ-14-0064; YAMAGUCHI I, 1980, AM J PHYSIOL, V238, pH365; Zanchetti A, 1991, HYPERTENSION S3, V18, pIII13, DOI DOI 10.1016/J.NEUROSCIENCE.2009.09.018	50	3	3	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					592	599		10.1253/circj.CJ-14-1013		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600026		
J	Kubo, T; Yamano, T; Liu, Y; Ino, Y; Shiono, Y; Orii, M; Taruya, A; Nishiguchi, T; Shimokado, A; Teraguchi, I; Tanimoto, T; Kitabata, H; Yamaguchi, T; Hirata, K; Tanaka, A; Akasaka, T				Kubo, Takashi; Yamano, Takashi; Liu, Yong; Ino, Yasushi; Shiono, Yasutsugu; Orii, Makoto; Taruya, Akira; Nishiguchi, Tsuyoshi; Shimokado, Aiko; Teraguchi, Ikuko; Tanimoto, Takashi; Kitabata, Hironori; Yamaguchi, Tomoyuki; Hirata, Kumiko; Tanaka, Atsuhi; Akasaka, Takashi			Feasibility of Optical Coronary Tomography in Quantitative Measurement of Coronary Arteries With Lipid-Rich Plaque	CIRCULATION JOURNAL			English	Article						Coronary artery disease; Intravascular ultrasound; Optical coherence tomography	ELEVATION MYOCARDIAL-INFARCTION; COHERENCE TOMOGRAPHY; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROSIS; STENT; INTERVENTION; IMPLANTATION; ACQUISITION; CARDIOLOGY; STANDARDS	Background: The aim of the present study was to evaluate the feasibility of optical coherence tomography (OCT) for measurement of vessel area in coronary arteries with lipid-rich plaque as compared with intravascular ultrasound (IVUS). Methods and Results: We investigated 80 coronary artery segments with lipid-rich plaque on OCT and non-attenuated plaque on IVUS. According to the lipid arc on OCT, the plaques were classified into 4 groups: group 1, lipid arc =90 degrees; group 2, 90 degrees<lipid arc <= 180 degrees; group 3, 180 degrees<lipid arc <= 270 degrees; group 4, lipid arc >270 degrees. Vessel circular arcs that could not be identified due to OCT signal attenuation were interpolated using an approximating algorithm. OCT-measured vessel area was well-correlated with IVUS-measured vessel area (R=0.834, P<0.001). On Bland-Altman plot, there was a good agreement between OCT-measured vessel area and IVUS-measured vessel area, although mean difference and limits of agreement increased with increase of lipid arc (mean difference in groups 1-4: -0.21, -0.31, -1.02, and -2.13 mm(2); lower limit: -1.49, -3.22, -5.24, and -9.25 mm(2); and upper limit: 1.07, 2.60, 3.20, and 4.99 mm(2)). Intra-observer (R=0.97-0.99, P<0.001) and inter-observer (R=0.97-0.99, P<0.001) reproducibility for OCT measurement of vessel area was excellent. Conclusions: Like IVUS, OCT can be used to measure vessel area in coronary arteries with lipid-rich plaque.	[Kubo, Takashi; Yamano, Takashi; Liu, Yong; Ino, Yasushi; Shiono, Yasutsugu; Orii, Makoto; Taruya, Akira; Nishiguchi, Tsuyoshi; Shimokado, Aiko; Teraguchi, Ikuko; Tanimoto, Takashi; Kitabata, Hironori; Yamaguchi, Tomoyuki; Hirata, Kumiko; Tanaka, Atsuhi; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan	Kubo, T (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	takakubo@wakayama-med.ac.jp			St. Jude Medical	Funding Sources: None. Conflict of Interest: Dr Kubo has received lecture fees from St. Jude Medical. Dr Akasaka has received lecture fees from St. Jude Medical. All other authors report that they have no relationships relevant to the contents of this paper to disclose.	Ozaki Y, 2013, CIRC J, V77, P2982, DOI 10.1253/circj.CJ-13-0512; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Di Mario C, 1998, EUR HEART J, V19, P207, DOI 10.1053/euhj.1996.0433; Raffel OC, 2008, EUR HEART J, V29, P1721, DOI 10.1093/eurheartj/ehn286; Fujii K, 2013, CIRC J, V77, P588, DOI 10.1253/circj.CJ-12-1599; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Kubo T, 2013, JACC-CARDIOVASC IMAG, V6, P1095, DOI 10.1016/j.jcmg.2013.04.014; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Kobayashi Y, 2014, CIRC J, V78, P2209, DOI 10.1253/circj.CJ-14-0108; Kubo T, 2012, CIRC J, V76, P2076, DOI 10.1253/circj.CJ-12-0828; Yonetsu T, 2013, CIRC J, V77, P1933, DOI 10.1253/circj.CJ-13-0643.1; Kubo T, 2014, J ATHEROSCLER THROMB, V21, P895; Inoue T, 2014, CIRC J, V78, P92, DOI 10.1253/circj.CJ-13-0374; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Schoenhagen P, 2001, J AM COLL CARDIOL, V38, P297, DOI 10.1016/S0735-1097(01)01374-2; Shiono Y, 2013, JACC-CARDIOVASC INTE, V6, P847, DOI 10.1016/j.jcin.2013.01.142; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Nagoshi R, 2013, CIRC J, V77, P652, DOI 10.1253/circj.CJ-12-0610; Ikenaga H, 2013, J CARDIOL, V62, P71, DOI 10.1016/j.jjcc.2013.03.005; Hiranuma N, 2014, CIRC J, V78, P2665, DOI 10.1253/circj.CJ-14-0315; Konishi A, 2014, CIRC J, V78, P1882, DOI 10.1253/circj.CJ-13-1474; Kubo T, 2014, CIRC J, V78, P2408, DOI 10.1253/circj.CJ-14-0337; Liu Y, 2014, INT J CARDIOVAS IMAG, V30, P271, DOI 10.1007/s10554-013-0330-7; Orii M, 2013, INT HEART J, V54, P64; Zafar H, 2014, J CARDIOL, V64, P19, DOI 10.1016/j.jjcc.2013.11.009	25	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					600	606		10.1253/circj.CJ-14-1085		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600027		
J	Neishi, Y; Okura, H; Kume, T; Fukuhara, K; Yamada, R; Yoshida, K				Neishi, Yoji; Okura, Hiroyuki; Kume, Teruyoshi; Fukuhara, Kenzo; Yamada, Ryotaro; Yoshida, Kiyoshi			Prediction of Chronic Vessel Enlargement by a Novel Intravascular Ultrasound Finding - Peri-Medial High-Echoic Band -	CIRCULATION JOURNAL			English	Article						Intravascular ultrasound; Percutaneous coronary intervention; Stents	OPTICAL COHERENCE TOMOGRAPHY; CHRONIC TOTAL OCCLUSION; ELUTING STENT IMPLANTATION; ENDOTHELIAL DYSFUNCTION; CORONARY-ARTERY; REFERENCE SEGMENTS; DISTAL; RECANALIZATION; ANGIOPLASTY; APPOSITION	Background: Coronary arterial segments distal to the severely stenotic lesion sometimes shrink as a result of decreased coronary flow. Pathological studies have shown that vessel shrinkage is accompanied by folding of the internal elastic membrane (IEM). A peri-medial high-echoic band (PHB) by intravascular ultrasound (IVUS) may represent folding of the IEM and therefore detect chronically shrunken coronary segments that have potential to enlarge subsequently. Methods and Results: IVUS imaging of the distal reference segments was performed in 27 patients after stenting. PHB was defined as a high-echoic band observed at the luminal side of the media. Serial (baseline and 9 months) changes in minimal lumen diameter (LD) were compared between those with (PHB group) and without PHB (non-PHB group). During follow-up, LD increased significantly in PHB group (1.2 +/- 0.3 vs. 1.7 +/- 0.5 mm, P=0.001) but not in the non-PHB group (2.0 +/- 0.7 vs. 2.1 +/- 0.7 mm, P=NS). Late lumen gain (LLG) was observed in 16 of the 27 (59%) lesions. Lesions with LLG showed a trend toward smaller baseline lumen cross-sectional area and significantly higher prevalence of PHB (88% vs. 18%, P=0.007). By multivariable logistic regression analysis, PHB was the only IVUS predictor of LLG. Conclusions: Presence of PHB on IVUS predicts chronic enlargement of the coronary segments distal to the stented lesion.	[Neishi, Yoji; Okura, Hiroyuki; Kume, Teruyoshi; Fukuhara, Kenzo; Yamada, Ryotaro] Kawasaki Med Univ, Div Cardiol, Kurashiki, Okayama 7010192, Japan; [Yoshida, Kiyoshi] Sakakibara Heart Inst Okayama, Dept Cardiol, Okayama, Japan	Okura, H (reprint author), Kawasaki Med Univ, Div Cardiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	hokura@fides.dti.ne.jp					Ahmed JM, 2000, CIRCULATION, V101, P2227; Mintz GS, 1996, CIRCULATION, V94, P35; Okura H, 2013, CIRC J, V77, P1430, DOI 10.1253/circj.CJ-12-0678; Kobayashi Y, 2014, CIRC J, V78, P2209, DOI 10.1253/circj.CJ-14-0108; Mitsutake Y, 2012, JACC-CARDIOVASC INTE, V5, P966, DOI 10.1016/j.jcin.2012.06.010; Kim JW, 2008, JACC-CARDIOVASC INTE, V1, P65, DOI 10.1016/j.jcin.2007.11.002; Terashima M, 2012, JACC-CARDIOVASC INTE, V5, P182, DOI 10.1016/j.jcin.2011.09.022; Yamada R, 2013, J CARDIOL, V61, P149, DOI 10.1016/j.jjcc.2012.10.008; Kume T, 2012, CIRC J, V76, P698, DOI 10.1253/circj.CJ-11-0845; Yamada R, 2010, CIRC-CARDIOVASC INTE, V3, P484, DOI 10.1161/CIRCINTERVENTIONS.109.928911; Galassi AR, 2012, J AM COLL CARDIOL, V59, P711, DOI 10.1016/j.jacc.2011.10.894; Miyamoto Y, 2010, J CARDIOL, V56, P229, DOI 10.1016/j.jjcc.2010.05.007; Mortensen ES, 2007, CARDIOVASC PATHOL, V16, P336, DOI 10.1016/j.carpath.2007.05.006; Nakayama N, 2012, CIRC J, V77, P424; Ogita M, 2011, INT HEART J, V52, P270; Okura H, 2013, EUR HEART J-CARD IMG, V14, P758, DOI 10.1093/ehjci/jes228; Okura H, 2014, CIRC J, V78, P2622, DOI 10.1253/circj.CJ-14-1045; Okura H, 2002, AM HEART J, V144, P323, DOI 10.1067/mhj.2002.122282; Okura H, 2003, AM J CARDIOL, V92, P587, DOI 10.1016/S0002-9149(03)00728-8; Park JJ, 2012, JACC-CARDIOVASC INTE, V5, P827, DOI 10.1016/j.jcin.2012.05.004; Uchida Y, 2011, AM J PHYSIOL-HEART C, V300, pH423, DOI 10.1152/ajpheart.00959.2010; Yamada R, 2014, CIRC J, V78, P502, DOI 10.1253/circj.CJ-13-0708; Yamada R, 2012, J CARDIOL, V61, P201; Yamada R, 2013, J CARDIOL, V61, P201, DOI 10.1016/j.jjcc.2012.10.007	24	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					607	612		10.1253/circj.CJ-14-0917		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600028		
J	Maruo, T; Seo, Y; Yamada, S; Arita, T; Ishizu, T; Shiga, T; Dohi, K; Toide, H; Furugen, A; Inoue, K; Daimon, M; Kawai, H; Tsuruta, H; Nishigami, K; Yuda, S; Ozawa, T; Izumi, C; Fumikura, Y; Wada, Y; Doi, M; Okada, M; Takenaka, K; Aonuma, K				Maruo, Takeshi; Seo, Yoshihiro; Yamada, Satoshi; Arita, Takeshi; Ishizu, Tomoko; Shiga, Tsuyoshi; Dohi, Kaoru; Toide, Hiroyuki; Furugen, Azusa; Inoue, Katsuji; Daimon, Masao; Kawai, Hiroya; Tsuruta, Hikaru; Nishigami, Kazuhiro; Yuda, Satoshi; Ozawa, Tomoya; Izumi, Chisato; Fumikura, Yuko; Wada, Yasuaki; Doi, Mariko; Okada, Masafumi; Takenaka, Katsu; Aonuma, Kazutaka			The Speckle Tracking Imaging for the Assessment of Cardiac Resynchronization Therapy (START) Study	CIRCULATION JOURNAL			English	Article						Cardiac resynchronization therapy; Heart failure; Speckle tracking echocardiography	LEFT-VENTRICULAR DYSSYNCHRONY; BUNDLE-BRANCH BLOCK; HEART-FAILURE; MECHANICAL DYSSYNCHRONY; TISSUE VELOCITY; RADIAL STRAIN; ECHOCARDIOGRAPHY; INDEX; EVENTS; VOLUME	Background: We sought to identify the feasibility of speckle tracking echocardiography (STE) to predict cardiac resynchronization therapy (CRT) responders in a prospective multicenter study. Methods and Results: Patients who were newly implanted with a CRT device were enrolled. Time (T) from QRS to maximum peak radial and circumferential strain (CS) in 6 segments on the left ventricular (LV) short-axis plane, and to the maximum peak of longitudinal strain in 18 segments on 3 apical LV planes was measured (T-max). In segments with multiple peaks on the time-strain curves, time to the first peak (T-first) was also assessed. Difference in T between the earliest and latest segment and standard deviation (SD) of T in each strain component were assessed. CRT responders were defined as having LV end-systolic volume reduction >15% at 6 months after CRT. Clinical outcomes were assessed with a composite endpoint of death from cardiac causes or unplanned hospitalization for heart failure. Among 180 patients, 109 patients were identified as responders. T-first-SD of CS >116 ms was selected as the best independent predictor of CRT responders (P<0.001, hazard ratio=9.83, 95% confidence interval 3.78-25.6). In addition, T-first-SD of CS was associated with the clinical endpoints. Conclusions: This prospective multicenter study revealed the high feasibility of dyssynchrony assessment by STE, which may improve the ability to predict CRT responders.	[Maruo, Takeshi] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan; [Seo, Yoshihiro; Ishizu, Tomoko; Aonuma, Kazutaka] Univ Tsukuba, Cardiovasc Div, Tsukuba, Ibaraki 3058575, Japan; [Yamada, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Arita, Takeshi] Kokura Mem Hosp, Dept Cardiol, Fukuoka, Japan; [Ishizu, Tomoko; Furugen, Azusa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Dohi, Kaoru] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 514, Japan; [Toide, Hiroyuki] Gunma Prefectural Cardiovasc Ctr, Div Cardiol, Maebashi, Gumma, Japan; [Inoue, Katsuji] Ehime Univ, Grad Sch Med, Dept Integrated Med & Informat, Toon, Japan; [Daimon, Masao] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan; [Kawai, Hiroya] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Tsuruta, Hikaru] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Nishigami, Kazuhiro] Saiseikai Kumamoto Hosp, Dept Crit Care & Cardiol, Kumamoto, Japan; [Yuda, Satoshi] Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Sapporo, Hokkaido, Japan; [Ozawa, Tomoya] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 52021, Japan; [Izumi, Chisato] Tenri Hosp, Dept Cardiol, Tenri, Nara 632, Japan; [Fumikura, Yuko] Tsukuba Med Ctr Hosp, Dept Cardiol, Tsukuba, Ibaraki, Japan; [Wada, Yasuaki] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Ube, Yamaguchi 755, Japan; [Doi, Mariko; Okada, Masafumi] Univ Tsukuba, Tsukuba Crit Path Res & Educ Integrated Leading C, Tsukuba, Ibaraki, Japan; [Takenaka, Katsu] Tokyo Univ Hosp, Dept Lab Med, Tokyo 113, Japan	Seo, Y (reprint author), Univ Tsukuba, Cardiovasc Div, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	yo-seo@md.tsukuba.ac.jp		Daimon, Masao/0000-0002-7616-3477	JSPS KAKENHI [22590768]	Financial Support: This work was supported by JSPS KAKENHI Grant Number 22590768. No other disclosures to declare.	Khan FZ, 2012, J AM COLL CARDIOL, V59, P1509, DOI 10.1016/j.jacc.2011.12.030; Hara H, 2012, EUR HEART J, V33, P2680, DOI 10.1093/eurheartj/ehs013; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Knappe D, 2011, CIRC-HEART FAIL, V4, P433, DOI 10.1161/CIRCHEARTFAILURE.111.962902; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Tanaka H, 2010, EUR HEART J, V31, P1690, DOI 10.1093/eurheartj/ehq213; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Risum N, 2013, EUR HEART J, V34, P48, DOI 10.1093/eurheartj/ehs035; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1, DOI 10.1016/j.jacc.2004.02.055; Delgado V, 2008, J AM COLL CARDIOL, V51, P1944, DOI 10.1016/j.jacc.2008.02.040; Duckett SG, 2012, EUROPACE, V14, P99, DOI 10.1093/europace/eur235; Gorcsan J, 2008, J AM SOC ECHOCARDIOG, V21, P191, DOI 10.1016/j.echo.2008.01.003; Suffoletto MS, 2006, CIRCULATION, V113, P960, DOI 10.1161/CIRCULATIONAHA.105.571455; Lim P, 2008, CIRCULATION, V118, P1130, DOI 10.1161/CIRCULATIONAHA.107.750190; Gjesdal O, 2011, CIRC-CARDIOVASC IMAG, V4, P264, DOI 10.1161/CIRCIMAGING.110.961417; Ruschitzka F, 2013, NEW ENGL J MED, V369, P1395, DOI 10.1056/NEJMoa1306687; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Conca C, 2009, AM J CARDIOL, V103, P136, DOI 10.1016/j.amjcard.2008.08.039; Iwano H, 2013, CIRC J, V77, P2757, DOI 10.1253/circj.CJ-13-0483; JCS Joint Working Group, 2013, CIRC J, V77, P249; Miyazaki C, 2008, CIRC-CARDIOVASC IMAG, V1, P14, DOI 10.1161/CIRCIMAGING.108.774513; Miyazaki C, 2008, CIRCULATION, V117, P2617, DOI 10.1161/CIRCULATIONAHA.107.733675; Mochizuki Y, 2014, CIRC J, V78, P2250, DOI 10.1253/circj.CJ-14-0114; Prinzen FW, 1999, J AM COLL CARDIOL, V33, P1735, DOI 10.1016/S0735-1097(99)00068-6; Seo Y, 2011, CIRC J, V75, P1156, DOI 10.1253/circj.CJ-10-0861; Seo Y, 2009, J AM SOC ECHOCARDIOG, V22, P839, DOI 10.1016/j.echo.2009.04.029; Smiseth OA, 2012, EUR HEART J-CARD IMG, V13, P61, DOI [10.1093/ejechocard/jer243, 10.1093/ehjci/jer243]; Tanaka H, 2009, J AM SOC ECHOCARDIOG, V22, P677, DOI 10.1016/j.echo.2009.03.007; Zhang Q, 2008, HEART, V94, P1464, DOI 10.1136/hrt.2007.127498	30	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					613	622		10.1253/circj.CJ-14-0842		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600029		
J	Shiraishi, S; Sakamoto, F; Tsuda, N; Yoshida, M; Tomiguchi, S; Utsunomiya, D; Ogawa, H; Yamashita, Y				Shiraishi, Shinya; Sakamoto, Fumi; Tsuda, Noriko; Yoshida, Morikatsu; Tomiguchi, Seiji; Utsunomiya, Daisuke; Ogawa, Hisao; Yamashita, Yasuyuki			Prediction of Left Main or 3-Vessel Disease Using Myocardial Perfusion Reserve on Dynamic Thallium-201 Single-Photon Emission Computed Tomography With a Semiconductor Gamma Camera	CIRCULATION JOURNAL			English	Article						Balanced ischemia; Myocardial perfusion reserve; Semiconductor gamma camera; Thallium-201; Three-vessel disease	CORONARY-ARTERY-DISEASE; TRANSIENT ISCHEMIC DILATION; FLOW RESERVE; NUCLEAR CARDIOLOGY; WALL-MOTION; GATED SPECT; BLOOD-FLOW; PET; QUANTIFICATION; TRACER	Background: Myocardial perfusion imaging (MPI) may fail to detect balanced ischemia. We evaluated myocardial perfusion reserve (MPR) using Tl dynamic single-photon emission computed tomography (SPECT) and a novel cadmium zinc telluride (CZT) camera for predicting 3-vessel or left main coronary artery disease (CAD). Methods and Results: A total of 55 consecutive patients with suspected CAD underwent SPECT-MPI and coronary angiography. The MPR index was calculated using the standard 2-compartment kinetic model. We analyzed the utility of MPR index, other SPECT findings, and various clinical variables. On multivariate analysis, MPR index and history of previous myocardial infarction (MI) predicted left main and 3-vessel disease. The area under the receiver operating characteristic curve was 0.81 for MPR index, 0.699 for history of previous MI, and 0.86 for MPR index plus history of previous MI. MPR index <= 1.5 yielded the highest diagnostic accuracy. Sensitivity, specificity, and accuracy were 86%, 78%, and 80%, respectively, for MPR index, 64%, 76%, 73% for previous MI, and 57%, 93%, and 84% for MPR index plus history of previous MI. Conclusions: Quantification of MPR using dynamic SPECT and a novel CZT camera may identify balanced ischemia in patients with left main or 3-vessel disease.	[Shiraishi, Shinya; Sakamoto, Fumi; Tsuda, Noriko; Yoshida, Morikatsu; Utsunomiya, Daisuke; Yamashita, Yasuyuki] Kumamoto Univ, Grad Sch Life Sci, Dept Diagnost Radiol, Kumamoto 8608556, Japan; [Tomiguchi, Seiji] Kumamoto Univ, Dept Diagnost Med Imaging, Sch Hlth Fac Life Sci, Kumamoto, Japan; [Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Life Sci, Kumamoto, Japan	Shiraishi, S (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Diagnost Radiol, 1-1-1 Honjyo, Kumamoto 8608556, Japan.	shiraish@kumamoto-u.ac.jp					Ann ICRP, 2008, ANN ICRP, V38, P1, DOI DOI 10.1016/J.ICRP.2008.08.003; WEISS AT, 1987, J AM COLL CARDIOL, V9, P752; Johnson LL, 1997, J AM COLL CARDIOL, V30, P1641, DOI 10.1016/S0735-1097(97)00388-4; Shaw LJ, 2012, J NUCL CARDIOL, V19, P1026, DOI 10.1007/s12350-012-9593-y; Ziadi MC, 2012, J NUCL CARDIOL, V19, P670, DOI 10.1007/s12350-011-9506-5; Naya M, 2011, J AM COLL CARDIOL, V58, P1807, DOI 10.1016/j.jacc.2011.06.051; Maddahi J, 2012, J NUCL CARDIOL, V19, pS30, DOI 10.1007/s12350-011-9491-8; Hajjiri MM, 2009, JACC-CARDIOVASC IMAG, V2, P751, DOI 10.1016/j.jcmg.2009.04.004; Ben-Haim S, 2013, J NUCL MED, V54, P873, DOI 10.2967/jnumed.112.109652; Berman DS, 2007, J NUCL CARDIOL, V14, P521, DOI 10.1016/j.nuclcard.2007.05.008; Ito Y, 2003, EUR J NUCL MED MOL I, V30, P281, DOI 10.1007/s00259-002-1031-y; Parkash R, 2004, J NUCL CARDIOL, V11, P440, DOI 10.1016/j.nuclcard.2004.04.005; Naya M, 2014, J NUCL MED, V55, P248, DOI 10.2967/jnumed.113.121442; Garcia EV, 2011, J NUCL MED, V52, P210, DOI 10.2967/jnumed.110.081323; Hendel RC, 2009, CIRCULATION, V119, pE561, DOI 10.1161/CIRCULATIONAHA.109.192519; Higgins JP, 2007, EUR J NUCL MED MOL I, V34, P584, DOI 10.1007/s00259-006-0293-1; Fiechter M, 2012, J NUCL MED, V53, P1230, DOI 10.2967/jnumed.111.101840; Germano G, 1997, J AM COLL CARDIOL, V30, P1360, DOI 10.1016/S0735-1097(97)00276-3; FALK E, 1995, CIRCULATION, V92, P657; Kajander S, 2010, CIRCULATION, V122, P603, DOI 10.1161/CIRCULATIONAHA.109.915009; Aziz Emad F, 2011, Heart Int, V6, pe22, DOI 10.4081/hi.2011.e22; Heston TF, 2005, J NUCL MED, V46, P1990; Hida S, 2012, CIRC J, V76, P430, DOI 10.1253/circj.CJ-11-0946; Mannting F, 1999, J NUCL MED, V40, P889; Tanaka H, 2013, CIRC J, V77, P2772, DOI 10.1253/circj.CJ-13-0099; Tanaka H, 2014, CIRC J, V78, P2727, DOI 10.1253/circj.CJ-14-0612; Tsukamoto T, 2005, CIRC J, V69, P188, DOI 10.1253/circj.69.188; WEICH HF, 1977, CIRCULATION, V56, P188; Williams KA, 1999, J AM COLL CARDIOL, V34, P420, DOI 10.1016/S0735-1097(99)00193-X	29	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					623	631		10.1253/circj.CJ-14-0932		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600030		
J	Higuma, T; Abe, N; Tateyama, S; Endo, T; Shibutani, S; Yokoyama, H; Hanada, K; Yamada, M; Tomita, H; Hanada, H; Osanai, T; Kume, N; Okumura, K				Higuma, Takumi; Abe, Naoki; Tateyama, Syunta; Endo, Tomohide; Shibutani, Shuji; Yokoyama, Hiroaki; Hanada, Kenji; Yamada, Masahiro; Tomita, Hirofumi; Hanada, Hiroyuki; Osanai, Tomohiro; Kume, Noriaki; Okumura, Ken			Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 as a Novel Prognostic Biomarker in Patients With ST-Segment Elevation Acute Myocardial Infarction	CIRCULATION JOURNAL			English	Article						Acute coronary syndrome; Biomarkers; Soluble lectin-like oxidized low-density lipoprotein receptor-1; (sLOX-1); ST-segment elevation acute myocardial infarction (STEMI)	ACUTE CORONARY SYNDROME; ARTERY ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; LDL RECEPTOR-1; ATHEROSCLEROTIC LESIONS; EXPRESSION; LOX-1; APOPTOSIS; JAPAN; ACTIVATION	Background: Soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) level is a reliable prognostic biomarker in acute coronary syndrome. However, it is unclear whether its plasma level at acute phase is related to the long-term prognosis in patients with ST-segment elevation acute myocardial infarction (STEMI). Methods and Results: We prospectively examined the relation between plasma sLOX-1 level on admission and prognosis in 153 consecutive STEMI patients admitted within 24 h of onset. Primary percutaneous coronary intervention was performed in 144 patients. The patients were divided into 2 groups by the median value (71 pg/ml) of plasma sLOX-1 level on admission [sLOX-1 level <= 71 pg/ml (n=77) and >71 pg/ml (n=76)], and were followed for median of 1,156 days. All-cause mortality and the combined endpoints of major adverse cardiovascular events (MACE) defined as cardiovascular mortality and recurrent MI were both significantly higher in patients with sLOX-1 values above median than in those below median (25.0% vs. 3.9%, P<0.001, and 19.4% vs. 6.5%, P=0.019 by log-rank test, respectively). Even after adjustment for confounders, a level of sLOX-1 above median was an independent predictor for all-cause mortality (hazard ratio (HR): 5.893; 95% confidence interval (CI): 1.665-20.854, P=0.006) and MACE (HR: 3.457; 95% CI: 1.164-10.270, P=0.030). Conclusions: Elevated plasma sLOX-1 level on admission independently predicts long-term all-cause mortality and MACE after STEMI.	[Higuma, Takumi; Abe, Naoki; Tateyama, Syunta; Endo, Tomohide; Shibutani, Shuji; Yokoyama, Hiroaki; Hanada, Kenji; Yamada, Masahiro; Tomita, Hirofumi; Hanada, Hiroyuki; Osanai, Tomohiro; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori 0368562, Japan; [Kume, Noriaki] Kobe Gakuin Univ, Fac Pharmaceut Sci, Div Clin Pharm, Kobe, Hyogo, Japan	Okumura, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Cardiol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	okumura@cc.hirosaki-u.ac.jp					Murase T, 2000, ARTERIOSCL THROM VAS, V20, P715; Kume N, 2010, CIRC J, V74, P1399, DOI 10.1253/circj.CJ-09-0924; Kume N, 1998, CIRC RES, V83, P322; Kojima S, 2013, CIRC J, V77, P2841, DOI 10.1253/circj.CJ-13-1011; Hao K, 2012, CIRC J, V76, P1136, DOI 10.1253/circj.CJ-11-1233; Hofnagel O, 2006, ARTERIOSCL THROM VAS, V26, P604, DOI 10.1161/01.ATV.0000201073.45862.8b; Iwai-Kanai E, 2001, CIRCULATION, V104, P2948, DOI 10.1161/hc4901.100381; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Hayashida K, 2005, CIRCULATION, V112, P812, DOI 10.1161/CIRCULATIONAHA.104.468397; Kataoka K, 2003, BIOCHEM BIOPH RES CO, V300, P656, DOI 10.1016/S0006-291X(02)02905-4; Kataoka H, 1999, CIRCULATION, V99, P3110; Steinberg D, 1997, CIRCULATION, V95, P1062; Nakatani D, 2013, CIRC J, V77, P439, DOI 10.1253/circj.CJ-11-1059; Daida H, 2013, CIRC J, V77, P934, DOI 10.1253/circj.CJ-13-0174; Libby P, 2001, CIRCULATION, V104, P365; Kobayashi N, 2013, INT J CARDIOL, V168, P3217, DOI 10.1016/j.ijcard.2013.04.110; Kume N, 2004, CIRC RES, V94, P269, DOI 10.1161/01.RES.0000119804.92239.97; FALK E, 1995, CIRCULATION, V92, P657; Li DY, 2003, CIRCULATION, V107, P612, DOI 10.1161/01.CIR.0000047276.52039.FB; Draude G, 1999, BIOCHEM PHARMACOL, V57, P383, DOI 10.1016/S0006-2952(98)00313-X; Kataoka H, 2001, ARTERIOSCL THROM VAS, V21, P955; Kobayashi N, 2011, CIRC J, V75, P2862, DOI 10.1253/circj.CJ-11-0724; Li DY, 1999, CIRC RES, V84, P1043; Li L, 2003, DIABETES, V52, P1843, DOI 10.2337/diabetes.52.7.1843; Nakamura M, 2010, J PHARMACEUT BIOMED, V51, P158, DOI 10.1016/j.jpba.2009.06.019; Norata GD, 2002, NUTR METAB CARDIOVAS, V12, P297; Ross R, 1999, NEW ENGL J MED, V340, P115; Takaya T, 2010, CIRC J, V74, P723, DOI 10.1253/circj.CJ-09-0488	28	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					641	648		10.1253/circj.CJ-14-0904		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600032		
J	Sakaguchi, H; Miyazaki, A; Yamada, O; Kagisaki, K; Hoashi, T; Ichikawa, H; Ohuchi, H				Sakaguchi, Heima; Miyazaki, Aya; Yamada, Osamu; Kagisaki, Koji; Hoashi, Takaya; Ichikawa, Hajime; Ohuchi, Hideo			Cardiac Resynchronization Therapy for Various Systemic Ventricular Morphologies in Patients With Congenital Heart Disease	CIRCULATION JOURNAL			English	Article						Cardiac resynchronization therapy; Congenital heart disease; Dyssynchrony; Reverse remodeling; Systemic right ventricle	GREAT-ARTERIES; TRANSPOSITION; FAILURE; DYSSYNCHRONY; DYSFUNCTION; CARVEDILOL; PREDICTION; EXPERIENCE; BLOCKADE; ADULTS	Background: Cardiac resynchronization therapy (CRT) can result in functional improvement and reduced mortality in patients with medically refractory heart failure. Although CRT is reportedly effective in patients with congenital heart disease (CHD), it is still controversial in patients who have systemic right ventricle. Methods and Results: Twenty CHD patients treated with CRT since 2006 were divided into 3 groups based on systemic ventricular (sysV) morphology (7 with left ventricle [sLV], 7 with right ventricle [sRV], and 6 with unbalanced 2 ventricles as a single-ventricular physiology [sBV]). The acute effects of CRT on hemodynamics and sysV function before device implantation was retrospectively evaluated and the chronic (>= 6 months) effects of CRT on late outcomes was assessed. In our CHD populations, sysV volume index was reduced from 139 +/- 41 to 118 +/- 33 ml/m(2) (P=0.04) after CRT, and there was significant improvement in B-type natriuretic peptide levels (from 341 +/- 384 to 160 +/- 152 pg/ml, P=0.01) and New York Heart Association (NYHA) functional class (from 2.1 +/- 0.6 to 1.8 +/- 0.7, P=0.02) on a late outcome. The sRV group did not show a late sysV volume reduction despite significant QRS shortening, and an increase of sysV peak dP/dt in the acute study differed from that of other groups. Conclusions: CRT improves late hemodynamic and functional status in sLV and sBV CHD patients with a dyssynchronized sysV. However, an acute CRT effect cannot guarantee long-term benefit in sRV patients.	[Sakaguchi, Heima; Miyazaki, Aya; Yamada, Osamu; Ohuchi, Hideo] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5658565, Japan; [Kagisaki, Koji; Hoashi, Takaya; Ichikawa, Hajime] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka 5658565, Japan	Sakaguchi, H (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat, 5-7-1 Fujishiro dai, Suita, Osaka 5658565, Japan.	hsakaguc@hsp.ncvc.go.jp			Intramural Research Fund for Cardiovascular Diseases from the National Cerebral and Cardiovascular Center [22-6-6]	The present study was supported by the Intramural Research Fund (22-6-6) for Cardiovascular Diseases from the National Cerebral and Cardiovascular Center.	Babu-Narayan SV, 2005, CIRCULATION, V111, P2091, DOI 10.1161/01.CIR.0000162463.61626.3B; Reuter S, 2000, PACE, V23, P1713; Cecchin F, 2009, J CARDIOVASC ELECTR, V20, P58, DOI 10.1111/j.1540-8167.2008.01274.x; Woo GW, 2005, J INTERV CARD ELECTR, V12, P107, DOI 10.1007/s10840-005-6545-3; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Janousek J, 2009, HEART, V95, P1165, DOI 10.1136/hrt.2008.160465; Sheehan F, 2008, HEART, V94, P1510, DOI 10.1136/hrt.2007.132779; Dubin AM, 2005, J AM COLL CARDIOL, V46, P2277, DOI 10.1016/j.jacc.2005.05.096; Cazeau S, 1996, PACE, V19, P1748, DOI 10.1111/j.1540-8159.1996.tb03218.x; Cua CL, 2012, CIRC J, V76, P22, DOI 10.1253/circj.CJ-11-1267; Doughan ARK, 2007, AM J CARDIOL, V99, P704, DOI 10.1016/j.amjcard.2006.10.025; Fang F, 2013, CIRC J, V77, P1364, DOI 10.1253/circj.CJ-13-0398; Fujimoto S, 2012, CIRC J, V76, P295, DOI 10.1253/circj.CJ-11-1377; Giardini A, 2007, INT J CARDIOL, V114, P241, DOI 10.1016/j.ijcard.2006.01.048; Hechter SJ, 2001, AM J CARDIOL, V87, P660, DOI 10.1016/S0002-9149(00)01452-1; Ishikawa T, 1999, PACE, V22, P1365, DOI 10.1111/j.1540-8159.1999.tb00630.x; Josephson CB, 2006, CAN J CARDIOL, V22, P769; Lester SJ, 2001, AM J CARDIOL, V88, P1314, DOI 10.1016/S0002-9149(01)02098-7; Lindenfeld J, 2003, J HEART LUNG TRANSPL, V22, P198, DOI 10.1016/S1053-2498(02)00656-3; Pérez-Calvo J, 2000, An Med Interna, V17, P527; Robinson B, 2002, PEDIATR CARDIOL, V23, P618, DOI 10.1007/s00246-002-0046-2; Sakaguchi H, 2011, HEART RHYTHM, V8, P1072, DOI 10.1016/j.hrthm.2011.02.004; Sakamaki F, 2012, CIRC J, V76, P689, DOI 10.1253/circj.CJ-11-0774; Suzuki T, 2014, CIRC J, V78, P1710, DOI 10.1253/circj.CJ-13-1379; Therrien J, 2008, INT J CARDIOL, V129, P187, DOI 10.1016/j.ijcard.2008.04.056; Vidal B, 2010, EUR J HEART FAIL, V12, P283, DOI 10.1093/eurjhf/hfq003; Winter MM, 2009, HEART, V95, P960, DOI 10.1136/hrt.2008.156265	27	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					649	655		10.1253/circj.CJ-14-0395		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600033		
J	Ishii, J; Takahashi, H; Kitagawa, F; Kuno, A; Okuyama, R; Kawai, H; Muramatsu, T; Naruse, H; Motoyama, S; Matsui, S; Hasegawa, M; Aoyama, T; Kamoi, D; Kasuga, H; Izawa, H; Ozaki, Y; Yuzawa, Y				Ishii, Junnichi; Takahashi, Hiroshi; Kitagawa, Fumihiko; Kuno, Atsuhiro; Okuyama, Ryuunosuke; Kawai, Hideki; Muramatsu, Takashi; Naruse, Hiroyuki; Motoyama, Sadako; Matsui, Shigeru; Hasegawa, Midori; Aoyama, Toru; Kamoi, Daisuke; Kasuga, Hirotake; Izawa, Hideo; Ozaki, Yukio; Yuzawa, Yukio			Multimarker Approach to Risk Stratification for Long-Term Mortality in Patients on Chronic Hemodialysis	CIRCULATION JOURNAL			English	Article						B-type natriuretic peptide; Cardiac troponin T; Hemodialysis; High-sensitivity C-reactive protein; Mortality	STAGE RENAL-DISEASE; CARDIAC TROPONIN-T; C-REACTIVE PROTEIN; LEFT-VENTRICULAR MASS; PERITONEAL-DIALYSIS PATIENTS; NATRIURETIC-PEPTIDE; CARDIOVASCULAR MORTALITY; PROGNOSTIC VALUE; ALL-CAUSE; MYOCARDIAL-INFARCTION	Background: We prospectively investigated the prognostic value of the combined use of cardiac troponin T (TnT), B-type natriuretic peptide (BNP), and high-sensitivity C-reactive protein (CRP) for long-term mortality in hemodialysis (HD) patients. Methods and Results: Baseline measurements of TnT, BNP, and CRP were performed in 516 patients on chronic HD. Patients were followed up for 10 years. Using the Cox multivariate model with these 3 biomarkers as variables categorized into tertiles for mortality, a simplified score was obtained by underscoring individual biomarkers based on the adjusted hazard ratio (HR). The multimarker score was defined as the sum of these points. TnT, BNP, and CRP levels were individually independent predictors for mortality (P<0.05). Among low-risk (multimarker score <4), intermediate-risk (multimarker score 4-7), and high-risk (multimarker score >= 7) groups, 10-year survival rates were 83.3%, 54.3%, and 27.2% (P<0.0001), respectively. After adjusting for other confounders, the multimarker score had strong predictive power for mortality (HR: 4.26; P<0.0001 for high-risk vs. low-risk group). Furthermore, adding the multimarker score to a baseline model with established risk factors improved the C-index (P<0.01), net reclassification improvement (P<0.0001), and integrated discrimination improvement (P<0.0001) greater than that of any single biomarker or baseline model alone. Conclusions: The multimarker approach (ie, simultaneous assessment of TnT, BNP, and CRP, which individually independently predict prognosis) may improve the prediction of long-term mortality in HD patients.	[Ishii, Junnichi; Kitagawa, Fumihiko; Kuno, Atsuhiro; Naruse, Hiroyuki] Fujita Hlth Univ, Sch Med, Dept Joint Res, Lab Clin Med, Toyoake, Aichi 4701192, Japan; [Takahashi, Hiroshi] Fujita Hlth Univ, Sch Med, Div Stat, Toyoake, Aichi 4701192, Japan; [Okuyama, Ryuunosuke; Kawai, Hideki; Muramatsu, Takashi; Motoyama, Sadako; Matsui, Shigeru; Ozaki, Yukio] Fujita Hlth Univ, Sch Med, Dept Cardiol, Toyoake, Aichi 4701192, Japan; [Hasegawa, Midori; Yuzawa, Yukio] Fujita Hlth Univ, Sch Med, Dept Nephrol, Toyoake, Aichi 4701192, Japan; [Kasuga, Hirotake] Nagoya Kyoritsu Hosp, Dept Nephrol, Nagoya, Aichi, Japan; [Izawa, Hideo] Banbuntane Houtokukai Hosp, Dept Cardiol, Nagoya, Aichi, Japan	Ishii, J (reprint author), Fujita Hlth Univ, Sch Med, Dept Joint Res, Lab Clin Med, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	jishii@fujita-hu.ac.jp					Kumada Y, 2014, CIRC J, V78, P986, DOI 10.1253/circj.CJ-13-1357; Mallamaci F, 2005, KIDNEY INT, V67, P2330, DOI 10.1111/j.1523-1755.2005.00338.x; Bazeley J, 2011, CLIN J AM SOC NEPHRO, V6, P2452, DOI 10.2215/CJN.00710111; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Zoccali C, 2005, SEMIN NEPHROL, V25, P358, DOI 10.1016/j.semnephrol.2005.05.002; Satyan S, 2007, AM J KIDNEY DIS, V50, P1009, DOI 10.1053/j.ajkd.2007.08.017; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; Sekikawa A, 2007, AM J EPIDEMIOL, V165, P617, DOI 10.1093/aje/kwk053; Mueller M, 2013, CIRC J, V77, P1653, DOI 10.1253/circj.CJ-13-0706; Wang AYM, 2007, CLIN CHEM, V53, P882, DOI 10.1373/clinchem.2006.078378; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Wang AYM, 2007, J AM SOC NEPHROL, V18, P321, DOI 10.1681/ASN.2005121299; Ortiz A, 2012, NAT REV NEPHROL, V8, P141, DOI 10.1038/nrneph.2011.170; Arici M, 2001, KIDNEY INT, V59, P407, DOI 10.1046/j.1523-1755.2001.059002407.x; Apple FS, 2004, CLIN CHEM, V50, P2279, DOI 10.1373/clinchem.2004.035741; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; London GM, 2003, SEMIN DIALYSIS, V16, P85, DOI 10.1046/j.1525-139X.2003.16023.x; Winkler K, 2008, EUR HEART J, V29, P2092, DOI 10.1093/eurheartj/ehn278; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; Zoccali C, 2001, J AM SOC NEPHROL, V12, P1508; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hickman PE, 2009, INTERN MED J, V39, P812, DOI 10.1111/j.1445-5994.2009.01846.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Needham DM, 2004, CAN J CARDIOL, V20, P1212; Bargnoux AS, 2013, CLIN CHEM LAB MED, V51, P1865, DOI 10.1515/cclm-2012-0664; Cheng YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079302; Coe CL, 2011, BRAIN BEHAV IMMUN, V25, P494, DOI 10.1016/j.bbi.2010.11.013; Damman Peter, 2011, J Am Coll Cardiol, V57, P29, DOI 10.1016/j.jacc.2010.06.053; Geerse DA, 2013, CLIN CHEM LAB MED, V51, P1321, DOI 10.1515/cclm-2012-0305; Hallen J, 2011, SCAND J UROL NEPHROL, V45, P151, DOI 10.3109/00365599.2010.529819; HELD PJ, 1990, AM J KIDNEY DIS, V15, P451; Ishii J, 2001, CLIN CHIM ACTA, V312, P69, DOI 10.1016/S0009-8981(01)00592-7; KDOQI Workgroup, 2005, AM J KIDNEY DIS S, V45, pS1; Mallamaci F, 2002, AM J KIDNEY DIS, V40, P68, DOI 10.1053/ajkd.2002.33914; McGill D, 2010, CLIN CHIM ACTA, V411, P936, DOI 10.1016/j.cca.2010.03.004; Oldroyd JC, 2009, ATHEROSCLEROSIS, V207, P227, DOI 10.1016/j.atherosclerosis.2009.03.045; Takahashi H, 2013, AM J KIDNEY DIS, V61, P254, DOI 10.1053/j.ajkd.2012.09.007; Wang AYM, 2012, SEMIN DIALYSIS, V25, P388, DOI 10.1111/j.1525-139X.2012.01099.x	40	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					656	663		10.1253/circj.CJ-14-0915		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600034		
J	Onose, T; Nochioka, K; Sakata, Y; Miura, M; Tadaki, S; Ushigome, R; Yamauchi, T; Sato, K; Tsuji, K; Abe, R; Miyata, S; Takahashi, J; Shimokawa, H				Onose, Takeo; Nochioka, Kotaro; Sakata, Yasuhiko; Miura, Masanobu; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Sato, Kenjiro; Tsuji, Kanako; Abe, Ruri; Miyata, Satoshi; Takahashi, Jun; Shimokawa, Hiroaki		Chart-2 Investigators	Predictors and Prognostic Impact of Post-Traumatic Stress Disorder After the Great East Japan Earthquake in Patients With Cardiovascular Disease - Report From the CHART-2 Study -	CIRCULATION JOURNAL			English	Article						Cardiovascular disease; Great East Japan Earthquake; Post-traumatic stress disorder	DISASTER	Background: We examined the prevalence, predictors and prognostic impact of post-traumatic stress disorder (PTSD) after the Great East Japan Earthquake in patients with cardiovascular disease (CVD) in the CHART-2 study. Methods and Results: The prevalence of PTSD was 14.7% at 6 months after the Earthquake. Female sex, experiencing the Tsunami, property loss, poverty, and insomnia medication use were associated with PTSD. The patients with PTSD more frequently experienced a composite of death, acute myocardial infarction, stroke and heart failure (18.5% vs. 15.0%, P=0.035). Conclusions: PTSD was frequent in CVD patients after the Earthquake and had an adverse prognostic impact.	Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; Tohoku Univ, Grad Sch Med, Dept Evidence based Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Sakata, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryo Machi,Aoba Ku, Sendai, Miyagi 9808574, Japan.	sakatayk@cardio.med.tohoku.ac.jp			Ministry of Health, Labour, and Welfare; Banyu Life Science Foundation International	This study was supported in part by Grants-in-Aid from a Research Grant from the Ministry of Health, Labour, and Welfare (H.S. and Y.S.) and by a research grant from Banyu Life Science Foundation International (Y.S.).	Aoki T, 2012, EUR HEART J, V33, P2796, DOI 10.1093/eurheartj/ehs288; Nochioka K, 2013, CIRC J, V77, P2318, DOI 10.1253/circj.CJ-13-0127; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Miura M, 2014, CIRC J, V78, P2276, DOI 10.1253/circj.CJ-14-0387; Nakano M, 2012, CIRC J, V76, P1283, DOI 10.1253/circj.CJ-12-0261; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; Charak R, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25547; Idemudia ES, 2013, J TRAUMA STRESS DISO, V2, P1340, DOI [10.4172/2324-8947.1000110, DOI 10.4172/2324-8947.1000110]; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699	12	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					664	U249		10.1253/circj.CJ-14-1403		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600035		
J	Yamaguchi, T; Miyamoto, T; Yamauchi, Y; Obayashi, T				Yamaguchi, Tetsuo; Miyamoto, Takamichi; Yamauchi, Yasuteru; Obayashi, Tohru			Congenital Left Ventricular Aneurysm - Diagnostic Usefulness of 3-Dimensional Cardiac Magnetic Resonance Imaging and Late Gadolinium Enhancement -	CIRCULATION JOURNAL			English	Editorial Material							CARDIOMYOPATHY; DIVERTICULUM		[Yamaguchi, Tetsuo; Miyamoto, Takamichi; Yamauchi, Yasuteru; Obayashi, Tohru] Musashino Red Cross Hosp, Dept Cardiol, Musashino, Tokyo 1808610, Japan	Yamaguchi, T (reprint author), Musashino Red Cross Hosp, Dept Cardiol, 1-26-1 Kyonanncho, Musashino, Tokyo 1808610, Japan.	tetsuo5672@yahoo.co.jp					TESKE DW, 1993, AM HEART J, V126, P1233, DOI 10.1016/0002-8703(93)90686-4; Moon J, 2013, CIRC J, V77, P1742, DOI 10.1253/circj.CJ-12-1378; Vazquez-Jimenez JF, 1998, ANN THORAC SURG, V65, P1178, DOI 10.1016/S0003-4975(98)00089-7; Nakamori S, 2012, CIRC J, V76, P914, DOI 10.1253/circj.CJ-11-1043; Kido T, 2013, CIRC J, V77, P1235, DOI 10.1253/circj.CJ-12-1106; Papagiannis J, 2001, AM HEART J, V141, P491, DOI 10.1067/mhj.2001.113076; Parthenakis FI, 2005, CHEST, V127, P1452, DOI 10.1378/chest.127.4.1452; Pektok E, 2008, J CARDIAC SURG, V23, P533, DOI 10.1111/j.1540-8191.2008.00574.x	8	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					668	669		10.1253/circj.CJ-14-0719		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600036		
J	Mizuno, A; Kohsaka, S; Shiraishi, Y; Goda, A; Yoshikawa, T				Mizuno, Atsushi; Kohsaka, Shun; Shiraishi, Yasuyuki; Goda, Ayumi; Yoshikawa, Tsutomu			Seasonal Changes in Systemic Volume Overload Are to Be Considered	CIRCULATION JOURNAL			English	Letter							HEART-FAILURE; TASK-FORCE; GUIDELINES		[Mizuno, Atsushi] St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan; [Kohsaka, Shun; Shiraishi, Yasuyuki] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Goda, Ayumi] Kyorin Univ, Sch Med, Div Cardiol, Tokyo, Japan; [Yoshikawa, Tsutomu] Sakakibara Heart Inst, Dept Cardiol, Tokyo, Japan	Mizuno, A (reprint author), St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan.						Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Hirai M, 2015, CIRC J, V79, P129, DOI 10.1253/circj.CJ-14-0710; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C	4	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					670	670				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600037		
J	Hirai, M; Kato, M; Yamamoto, K				Hirai, Masayuki; Kato, Masahiko; Yamamoto, Kazuhiro			Seasonal Changes in Systemic Volume Overload Are to Be Considered - Reply -	CIRCULATION JOURNAL			English	Letter									[Hirai, Masayuki; Kato, Masahiko; Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Div Cardiovasc Med, Dept Mol Med & Therapeut, Yonago, Tottori 683, Japan	Hirai, M (reprint author), Tottori Univ, Fac Med, Div Cardiovasc Med, Dept Mol Med & Therapeut, Yonago, Tottori 683, Japan.						Hirai M, 2015, CIRC J, V79, P129, DOI 10.1253/circj.CJ-14-0710; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C	2	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	MAR	2015	79	3					671	671				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE3PP	WOS:000351740600038		
J	Yokoyama, H; Tomita, H; Nishizaki, F; Hanada, K; Shibutani, S; Yamada, M; Abe, N; Higuma, T; Osanai, T; Okumura, K				Yokoyama, Hiroaki; Tomita, Hirofumi; Nishizaki, Fumie; Hanada, Kenji; Shibutani, Shuji; Yamada, Masahiro; Abe, Naoki; Higuma, Takumi; Osanai, Tomohiro; Okumura, Ken			Deeply Reinverted T Wave at 14 Days After the Onset of First Anterior Acute Myocardial Infarction Predicts Improved Left Ventricular Function at 6 Months	CLINICAL CARDIOLOGY			English	Article							ST-SEGMENT ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; PREDISCHARGE; ANGIOPLASTY; REPERFUSION; VIABILITY; RECOVERY; THERAPY; PATTERN; SIZE	BackgroundChanges in electrocardiogram (ECG), especially in the ST segment and T wave, have been recognized as a noninvasive diagnostic tool for coronary flow or myocardial injury. HypothesisA deeply inverted T wave at 14 days after successful percutaneous coronary intervention (PCI) in patients with ST-segment elevation acute myocardial infarction (STEMI) predicts improved left ventricular (LV) function at 6 months. MethodsWe enrolled 112 consecutive patients (88 men, 6311years) with first anterior STEMI who underwent successful PCI. A 12-lead ECG was recorded everyday from admission through 14 days. After PCI, the first T-wave inversion was observed within 2 days, and the second occurred at 14 days. We measured the maximum depth of the reinverted T wave (Neg-T) and divided the patients into 2 groups based on the median value of Neg-T: the deep group (0.6 mV, n=62) and the nondeep group (<0.6 mV, n=50). ResultsLV ejection fraction (LVEF) at 14 days did not differ between the 2 groups, but it was greater in the deep than in the nondeep group at 6 months (50.0%+/- 8.8% vs 42.5%+/- 9.8 %, P<0.0001). The maximum creatinine phosphokinase-myocardial band (CPK-MB) value was significantly lower in the deep than in the nondeep group. Reappearance of the R wave in precordial leads at 6 months was more frequently observed in the deep than in the nondeep group (68% vs 46%, P=0.02). Multivariate regression analysis showed that the Neg-T and max CPK-MB were independent contributors to LVEF at 6 months. Conclusions<p id="clc22366-para-0005">A deeply reinverted T wave at 14 days after onset of first anterior STEMI can be a useful predictive marker for improved LV function at 6 months.	[Yokoyama, Hiroaki; Tomita, Hirofumi; Nishizaki, Fumie; Hanada, Kenji; Shibutani, Shuji; Yamada, Masahiro; Abe, Naoki; Higuma, Takumi; Osanai, Tomohiro; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori 0368562, Japan	Okumura, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Cardiol, Zaifu Cho 5, Hirosaki, Aomori 0368562, Japan.	okumura@cc.hirosaki-u.ac.jp					Agetsuma H, 1996, HEART, V75, P229, DOI 10.1136/hrt.75.3.229; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; CHRISTIAN TF, 1992, CIRCULATION, V86, P81; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959; Buller CE, 2008, CIRCULATION, V118, P1335, DOI 10.1161/CIRCULATIONAHA.108.767772; Atak R, 2003, INT J CARDIOL, V91, P209, DOI 10.1016/S0167-5273(03)00029-9; Cortadellas J, 2004, EUR HEART J, V25, P224, DOI 10.1016/j.ehj.2003.10.029; Karadede A, 2005, INT HEART J, V46, P961, DOI 10.1536/ihj.46.961; Kosuge M, 2012, CIRC J, V76, P32, DOI 10.1253/circj.CJ-11-1119; Kosuge M, 1999, AM HEART J, V137, P522, DOI 10.1016/S0002-8703(99)70501-6; Matetzky S, 1999, J AM COLL CARDIOL, V34, P1932, DOI 10.1016/S0735-1097(99)00466-0; Nable JV, 2009, AM J EMERG MED, V27, P734, DOI 10.1016/j.ajem.2008.05.025; Nakajima T, 1996, CARDIOLOGY, V87, P91, DOI 10.1159/000177069; Nishizaki F, 2013, HEART VESSELS, V28, P704, DOI 10.1007/s00380-012-0313-y; TIMI Study Group, 1985, NEW ENGL J MED, V312, P932	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-9289	1932-8737		CLIN CARDIOL	Clin. Cardiol.	MAR	2015	38	3					157	163		10.1002/clc.22366		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE2YG	WOS:000351687600005		
J	Isogai, T; Yasunaga, H; Matsui, H; Ueda, T; Tanaka, H; Horiguchi, H; Fushimi, K				Isogai, Toshiaki; Yasunaga, Hideo; Matsui, Hiroki; Ueda, Tetsuro; Tanaka, Hiroyuki; Horiguchi, Hiromasa; Fushimi, Kiyohide			Hospital Volume and Cardiac Complications of Endomyocardial Biopsy: A Retrospective Cohort Study of 9508 Adult Patients Using a Nationwide Inpatient Database in Japan	CLINICAL CARDIOLOGY			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; PROCEDURE-COMBINATION-DATABASE; HEART-TRANSPLANT PATIENTS; DIAGNOSTIC-PROCEDURES; CARDIOMYOPATHY; CATHETER; DISEASE; PERIOD	BackgroundRecent research on complications with endomyocardial biopsy (EMB) has been based on single-center or 2-center studies in high-volume cardiovascular centers. No study has examined the association between hospital volume and the complication rate after EMB. HypothesisHospital volume is inversely associated with cardiac complication rate after EMB. MethodsUsing the Diagnosis Procedure Combination database in Japan, we identified inpatients aged 20years who underwent EMB under fluoroscopic guidance. We assessed cardiac complications requiring the following urgent procedures on the day of EMB or the day after: pericardiocentesis, surgical repair, and temporary pacing. ResultsAmong 9508 eligible patients in 491 hospitals (male, 68%; mean age, 57.0years), dilated cardiomyopathy was the most frequently diagnosed condition (35.4%). Twenty-four patients (0.25%) required pericardiocentesis on the day of EMB. Three patients (0.03%) underwent surgical repair on the day of EMB or the day after. Sixty-three patients (0.70%) required temporary pacing on the day of EMB. Higher hospital volume was associated with lower rates of pericardiocentesis (low volume, 0.4%; medium volume, 0.2%; high volume, 0.1%; P for the trend test, 0.019) and temporary pacing (low volume, 1.0%; medium volume, 0.7%; high volume, 0.2%; P for the trend test, <0.001). In a multivariable logistic regression analysis, high hospital volume was significantly associated with a lower rate of the composite outcome of the procedures (reference, low volume; adjusted odds ratio, 0.22; 95% confidence interval, 0.08-0.62, P=0.004). ConclusionsSerious cardiac complications of EMB were rare, but higher hospital volume was associated with lower complication rate.	[Isogai, Toshiaki; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Isogai, Toshiaki; Tanaka, Hiroyuki] Tokyo Metropolitan Tama Med Ctr, Dept Cardiol, Tokyo, Japan; [Ueda, Tetsuro] Tama Hokubu Med Ctr, Dept Cardiol, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Isogai, T (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	toisogai-circ@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H26-Policy-011]	This work was supported by a grant from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H26-Policy-011).	SAKAKIBARA S, 1962, JPN HEART J, V3, P537; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; BARALDIJUNKINS C, 1993, J HEART LUNG TRANSPL, V12, P63; DECKERS JW, 1992, J AM COLL CARDIOL, V19, P43; Yoshida A, 2013, EUR J HEART FAIL, V15, P166, DOI 10.1093/eurjhf/hfs206; RAGNI T, 1990, J HEART TRANSPLANT, V9, P538; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Chimenti C, 2013, CIRCULATION, V128, P1531, DOI 10.1161/CIRCULATIONAHA.13.001414; From AM, 2011, MAYO CLIN PROC, V86, P1095, DOI 10.4065/mcp.2011.0296; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Saraiva F, 2011, TRANSPL P, V43, P1908, DOI 10.1016/j.transproceed.2011.03.010; Sumitani M, 2011, ANESTHESIOLOGY, V114, P84, DOI 10.1097/ALN.0b013e318200197d; Yilmaz A, 2010, CIRCULATION, V122, P900, DOI 10.1161/CIRCULATIONAHA.109.924167; Deshmukh A, 2013, CIRCULATION, V128, P2104, DOI 10.1161/CIRCULATIONAHA.113.003862; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Holzmann M, 2008, CIRCULATION, V118, P1722, DOI 10.1161/CIRCULATIONAHA.107.743427; Baccouche H, 2009, EUR HEART J, V30, P2869, DOI 10.1093/eurheartj/ehp328; BULLOCH RT, 1965, AM J CARDIOL, V16, P227, DOI 10.1016/0002-9149(65)90477-7; Drury JH, 1997, ECHOCARDIOGR-J CARD, V14, P469, DOI 10.1111/j.1540-8175.1997.tb00754.x; Hiramitsu S, 1998, JPN CIRC J, V62, P909, DOI 10.1253/jcj.62.909; KAWAI C, 1977, AM J CARDIOL, V40, P63, DOI 10.1016/0002-9149(77)90101-1; Kitamura Soichiro, 2012, Gen Thorac Cardiovasc Surg, V60, P639, DOI 10.1007/s11748-012-0110-7; Paul M, 2011, JACC-CARDIOVASC INTE, V4, P1142, DOI 10.1016/j.jcin.2011.06.015; RICHARDS.PJ, 1974, LANCET, V1, P660; Sekiguchi M, 1980, CARDIOMYOPATHY CLIN, P217; STARLING RC, 1991, AM J CARDIOL, V68, P133, DOI 10.1016/0002-9149(91)90729-5; Yasunaga H, 2012, HEPATOL RES, V42, P1073, DOI 10.1111/j.1872-034X.2012.01022.x	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-9289	1932-8737		CLIN CARDIOL	Clin. Cardiol.	MAR	2015	38	3					164	170		10.1002/clc.22368		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE2YG	WOS:000351687600006		
J	Isogai, T; Yasunaga, H; Matsui, H; Tanaka, H; Ueda, T; Horiguchi, H; Fushimi, K				Isogai, Toshiaki; Yasunaga, Hideo; Matsui, Hiroki; Tanaka, Hiroyuki; Ueda, Tetsuro; Horiguchi, Hiromasa; Fushimi, Kiyohide			Serious Cardiac Complications in Coronary Spasm Provocation Tests Using Acetylcholine or Ergonovine: Analysis of 21 512 Patients From the Diagnosis Procedure Combination Database in Japan	CLINICAL CARDIOLOGY			English	Article							LONG-TERM PROGNOSIS; ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; VARIANT ANGINA; ARTERY SPASM; PRACTICE GUIDELINES; VASOSPASTIC ANGINA; AMERICAN-COLLEGE; PREVALENCE; MECHANISMS	BackgroundPrevious studies on complications with coronary spasm provocation tests were based on small sample sizes or were limited to high-volume centers. The risk of provocation tests using acetylcholine (ACH) or ergonovine (ER) remains to be fully examined by a large-scale multicenter study. HypothesisACH provocation tests are associated with a higher rate of serious cardiac complications than ER tests. MethodsUsing the Diagnosis Procedure Combination database in Japan, we identified patients aged 20 years who underwent a pharmacological provocation test during coronary angiography. We assessed the composite outcome of cardiac complications requiring urgent procedures (defibrillation, chest compression, intra-aortic balloon pumping, or extracorporeal membrane oxygenation) or death on the day of the provocation test, and compared the outcome between ACH and ER tests. ResultsOf 21512 eligible patients in 602 hospitals, 10628 (49.4%) underwent an ACH test and 10884 (50.6%) underwent an ER test. The composite outcome occurred in 141 (0.7%) patients. The ACH group was significantly more likely to have the composite outcome than the ER group (0.9% vs 0.4%, P < 0.001). The propensity-score analyses showed consistent results (propensity score-matched, 0.9% vs 0.4%, P = 0.003; inverse probability-weighted, 0.8% vs 0.4%, P < 0.001). In a multivariable logistic regression analysis, ACH tests were significantly associated with a higher rate of the composite outcome than ER tests (odds ratio: 1.75, 95% confidence interval: 1.13-2.69, P = 0.011). ConclusionsThis retrospective cohort study suggested that ACH tests were associated with a higher rate of cardiac complications than ER tests.	[Isogai, Toshiaki; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Isogai, Toshiaki; Tanaka, Hiroyuki] Tokyo Metropolitan Tama Med Ctr, Dept Cardiol, Tokyo, Japan; [Ueda, Tetsuro] Tama Hokubu Med Ctr, Dept Cardiol, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Dept Clin Data Management & Res, Clin Res Ctr, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Isogai, T (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	toisogai-circ@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H26-Policy-011]	This work was supported by a grant from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H26-Policy-011).	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anderson JL, 2013, CIRCULATION, V127, pE663, DOI 10.1161/CIR.0b013e31828478ac; Togashi I, 2013, INT J CARDIOL, V163, P56, DOI 10.1016/j.ijcard.2011.05.055; SHIMOKAWA H, 1988, INT J CARDIOL, V18, P331, DOI 10.1016/0167-5273(88)90052-6; Sueda S, 2004, CORONARY ARTERY DIS, V15, P491, DOI 10.1097/00019501-200412000-00006; Xu S, 2010, VALUE HEALTH, V13, P273, DOI 10.1111/j.1524-4733.2009.00671.x; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; LITOVSKY SH, 1990, CIRC RES, V67, P615; Stern S, 2009, CIRCULATION, V119, P2531, DOI 10.1161/CIRCULATIONAHA.108.843474; Ong P, 2014, CIRCULATION, V129, P1723, DOI 10.1161/CIRCULATIONAHA.113.004096; YASUE H, 1988, CIRCULATION, V78, P1; BERTRAND ME, 1982, CIRCULATION, V65, P1299; Lanza GA, 2011, CIRCULATION, V124, P1774, DOI 10.1161/CIRCULATIONAHA.111.037283; Sueda S, 2000, AM J CARDIOL, V85, P391, DOI 10.1016/S0002-9149(99)00754-7; Sumitani M, 2011, ANESTHESIOLOGY, V114, P84, DOI 10.1097/ALN.0b013e318200197d; Auch-Schwelk W, 2000, J CARDIOVASC PHARM, V36, P631, DOI 10.1097/00005344-200011000-00013; HARDING MB, 1992, J AM COLL CARDIOL, V20, P107; Ogawa H, 2010, CIRC J, V74, P1745, DOI 10.1253/circj.CJ-10-74-0802; Kugiyama K, 1995, INT J CARDIOL, V52, P223, DOI 10.1016/0167-5273(95)02478-6; MACALPIN RN, 1993, AM HEART J, V125, P1011, DOI 10.1016/0002-8703(93)90108-L; Sato K, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000227; Shimokawa H, 2000, JPN CIRC J, V64, P1, DOI 10.1253/jcj.64.1; Suzuki M, 1998, CIRCULATION, V98, P435; Takagi Y, 2013, EUR HEART J, V34, P258, DOI 10.1093/eurheartj/ehs199; WALLING A, 1987, CIRCULATION, V76, P990; WATERS DD, 1983, CIRCULATION, V68, P258; Zaya M, 2014, J AM COLL CARDIOL, V63, P103, DOI 10.1016/j.jacc.2013.10.038	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-9289	1932-8737		CLIN CARDIOL	Clin. Cardiol.	MAR	2015	38	3					171	177		10.1002/clc.22369		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE2YG	WOS:000351687600007		
J	Kondo, T; Mizuno, Y				Kondo, Tomoyoshi; Mizuno, Yoshikuni		Japanese Istradefylline Study Grp	A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease	CLINICAL NEUROPHARMACOLOGY			English	Review						Parkinson disease; istradefylline; adenosine A(2A) antagonist; long term; safety	A(2A) RECEPTOR ANTAGONIST; MOTOR FLUCTUATIONS; BASAL GANGLIA; LEVODOPA; KW-6002; TRIAL; TIME	Objectives: Istradefylline is a selective adenosine A(2A) receptor antagonist. We evaluated the safety and efficacy of istradefylline administered once daily for 52 weeks in Parkinson disease (PD) patients experiencing wearing-off symptoms on levodopa therapy. Methods: This was a phase 3, multicenter, open-label, long-term study in PD patients experiencing wearing-off who had previously completed a double-blind placebo-controlled clinical study of istradefylline in Japan. Istradefylline was administered for 52 weeks at a starting dosage of 20 mg/d, with or without dosage adjustment up to 40 mg/d. Safety was assessed using the incidence of treatment-emergent adverse events, and efficacy was assessed as the change in the daily off time. Results: A total of 308 patients were included in this study. The most frequently reported treatment-emergent adverse events were nasopharyngitis (24.4%) and dyskinesia (21.4%). The mean change in the daily off time from day 1 was -0.65 hour in week 2, fluctuating between -0.71 and -0.04 hour until week 52 in patients who had previously taken placebo in the preceding double-blind study. The off time reduction from baseline of the double-blind study remained at similar levels between weeks 2 and 52 in patients who had previously taken istradefylline 20 and 40 mg/d in the preceding double-blind study. Conclusions: This study showed that istradefylline treatment was well tolerated and produced a sustained reduction in off time in levodopa-treated PD patients over a 52-week period.	[Kondo, Tomoyoshi] Rehabil Hananoie Hosp, Shimotsugagun, Tochigi, Japan; [Mizuno, Yoshikuni] Juntendo Univ, Sch Med, Tokyo 113, Japan	Kondo, T (reprint author), Rehabil Hananoie Hosp, 1196-1 Minamiakatsuka, Shimotsugagun, Tochigi, Japan.	t-kondo@yushikai.jp			Kyowa Hakko Kirin Co, Ltd, Japan	Supported by an unrestricted research grant from Kyowa Hakko Kirin Co, Ltd, Japan.	Gatev P, 2006, MOVEMENT DISORD, V21, P1566, DOI 10.1002/mds.21033; Stacy M, 2008, NEUROLOGY, V70, P2233, DOI 10.1212/01.wnl.0000313834.22171.17; Olanow CW, 2001, NEUROLOGY, V56, pS1; LeWitt PA, 2008, ANN NEUROL, V63, P295, DOI 10.1002/ana.21315; Rajput AH, 2002, MOVEMENT DISORD, V17, P289, DOI 10.1002/mds.10031; Mizuno Y, 2010, MOVEMENT DISORD, V25, P1437, DOI 10.1002/mds.23107; Hauser RA, 2008, MOVEMENT DISORD, V23, P2177, DOI 10.1002/mds.22095; Hauser RA, 2003, NEUROLOGY, V61, P297; Pourcher E, 2012, PARKINSONISM RELAT D, V18, P178, DOI 10.1016/j.parkreldis.2011.09.023; Jenner P, 2005, EXPERT OPIN INV DRUG, V14, P729, DOI 10.1517/13543784.14.6.729; Park A, 2012, EXPERT OPIN PHARMACO, V13, P111, DOI 10.1517/14656566.2012.643869; Hauser RA, 2004, MOVEMENT DISORD, V19, P1409, DOI 10.1002/mds.20248; Factor S, 2010, PARKINSONISM RELAT D, V16, P423, DOI 10.1016/j.parkreldis.2010.02.014; Mizuno Y, 2013, MOVEMENT DISORD, V28, P1138, DOI 10.1002/mds.25418; Obeso JA, 1997, ADV NEUROL, V74, P3; Kase Hiroshi, 2003, Neurology, V61, pS97; Mori Akihisa, 2003, Neurology, V61, pS44; Popoli Patrizia, 2004, Current Medicinal Chemistry - Central Nervous System Agents, V4, P35, DOI 10.2174/1568015043477577	18	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-5664	1537-162X		CLIN NEUROPHARMACOL	Clin. Neuropharmacol.	MAR-APR	2015	38	2					41	46		10.1097/WNF.0000000000000073		6	Clinical Neurology; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CE2VO	WOS:000351678500001		
J	Postnova, IV; Chen, LJ; Shchipunov, YA				Postnova, I. V.; Chen, Li-Jen; Shchipunov, Yu. A.			One-pot synthesis of monolithic macroporous polymethylsilsesquioxane absorbing oil	COLLOID JOURNAL			English	Article							SILICA; FILMS	Single-stage synthesis of monolithic meso/macroporous polymethylsilsesquioxane in a neutral aqueous solution without the use of a catalyst and heating has been described. Calcination at temperatures of no higher than 300A degrees C yields a superhydrophobic material capable of absorbing oil pollutants from water surface.	[Postnova, I. V.] Far East Fed Univ, Vladivostok 690950, Russia; [Postnova, I. V.; Shchipunov, Yu. A.] Russian Acad Sci, Inst Chem, Far East Branch, Vladivostok 690022, Russia; [Chen, Li-Jen] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan; [Shchipunov, Yu. A.] Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan	Postnova, IV (reprint author), Far East Fed Univ, Ul Oktyabrskaya 27, Vladivostok 690950, Russia.	YAS@ich.dvo.ru			Presidium of the Far East Branch, Russian Academy of Sciences; National Science Council of Taiwan [NSC99-2221-E-002-145-MY3]	This work was supported by the Presidium of the Far East Branch, Russian Academy of Sciences (Russian-Taiwan project) and the National Science Council of Taiwan (grant no. NSC99-2221-E-002-145-MY3).	Kanamori K, 2011, CHEM SOC REV, V40, P754, DOI 10.1039/c0cs00068j; Shchipunov YA, 2003, J COLLOID INTERF SCI, V268, P68, DOI 10.1016/S0021-9797(03)00457-0; Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075; Husing N, 2006, J SOL-GEL SCI TECHN, V40, P131, DOI 10.1007/s10971-006-8802-z; Zou H, 2008, CHEM REV, V108, P3893, DOI 10.1021/cr068035q; Postnova IV, 2013, COLLOID J+, V75, P231, DOI 10.1134/S1061933X13020130; Shchipunov YA, 2012, COLLOID J+, V74, P636, DOI 10.1134/S1061933X12050109; Shilova OA, 2013, J SOL-GEL SCI TECHN, V68, P387, DOI 10.1007/s10971-013-3026-5; Slinyakova I.B., 1988, KREMNIIORGANICHESKIE	9	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1061-933X	1608-3067		COLLOID J+	Colloid J.	MAR	2015	77	2					248	250		10.1134/S1061933X15020143		3	Chemistry, Physical	Chemistry	CE5FN	WOS:000351856500018		
J	Alkhatib, H; Faraboschi, P; Frachtenberg, E; Kasahara, H; Lange, D; Laplante, P; Merchant, A; Milojicic, D; Schwan, K				Alkhatib, Hasan; Faraboschi, Paolo; Frachtenberg, Eitan; Kasahara, Hironori; Lange, Danny; Laplante, Phil; Merchant, Arif; Milojicic, Dejan; Schwan, Karsten			What Will 2022 Look Like? The IEEE CS 2022 Report	COMPUTER			English	Article								Over the last two years, nine IEEE Computer Society tech leaders collaborated to identify important industry advances that promise to change the world by 2022. The 23 technologies provide new insights into the emergence of "seamless intelligence."	[Faraboschi, Paolo] HP Labs, Barcelona, Spain; [Frachtenberg, Eitan] Facebook, Cambridge, MA USA; [Kasahara, Hironori] Waseda Univ, Comp Sci, Tokyo, Japan; [Kasahara, Hironori] Waseda Univ, Adv Multicore Res Inst, Tokyo, Japan; [Lange, Danny] Amazon Com, Elast Machine Learning, Bellevue, WA USA; [Laplante, Phil] Penn State Univ, Software Engn, University Pk, PA 16802 USA; [Merchant, Arif] Google, Storage Analyt Grp, Mountain View, CA USA; [Milojicic, Dejan] HP Labs, Palo Alto, CA USA; [Schwan, Karsten] Georgia Tech, Coll Comp, Atlanta, GA USA; [Schwan, Karsten] Georgia Tech, CERCS, Atlanta, GA USA		hsalkhatib@gmail.com; paolo.faraboschi@hp.com; etc_26@yahoo.com; kasahara@waseda.jp; danny@genmagic.com; plaplante@psu.edu; aamerchant@google.com; dejan.milojicic@hp.com; schwan@cc.gatech.edu					CUSUMANO MA, 1992, BUS HIST REV, V66, P51, DOI 10.2307/3117053; Christensen C., 2011, INNOVATORS DILEMMA R; IEEE Communications Society, 2012, 2020 IEEE COMM SOC; Kaplan J.A., 2008, PC MAGAZINE; Milojicic D, 2011, COMPUTER, V44, P84; Sheehan K.B., 2006, J COMPUTER MEDIATED, V6	6	2	2	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9162	1558-0814		COMPUTER	Computer	MAR	2015	48	3					68	76				9	Computer Science, Hardware & Architecture; Computer Science, Software Engineering	Computer Science	CE3UN	WOS:000351755000020		
J	Maezawa, A; Okuno, HG				Maezawa, Akira; Okuno, Hiroshi G.			Bayesian Audio-to-Score Alignment Based on Joint Inference of Timbre, Volume, Tempo, and Note Onset Timings	COMPUTER MUSIC JOURNAL			English	Article							FEATURES	This article presents an offline method for aligning an audio signal to individual instrumental parts constituting a musical score. The proposed method is based on fitting multiple hidden semi-Markov models (HSMMs) to the observed audio signal. The emission probability of each state of the HSMM is described using latent harmonic allocation (LHA), a Bayesian model of a harmonic sound mixture. Each HSMM corresponds to one musical instrument's part, and the state duration probability is conditioned on a linear dynamics system (LDS) tempo model. Variational Bayesian inference is used to jointly infer LHA, HSMM, and the LDS. We evaluate the capability of the method to align musical audio to its score, under reverberation, structural variations, and fluctuations in onset timing among different parts.	[Maezawa, Akira; Okuno, Hiroshi G.] Kyoto Univ, Dept Intelligence Sci & Technol, Grad Sch Informat, Sakyo Ku, Kyoto 6068501, Japan	Maezawa, A (reprint author), Kyoto Univ, Dept Intelligence Sci & Technol, Grad Sch Informat, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	akira.maezawa@music.yamaha.com; okuno@i.kyoto-u.ac.jp			KAKENHI) [24220006]	Akira Maezawa is currently also affiliated with Yamaha Corporation, R&D Division. Hiroshi G. Okuno is currently affiliated with Waseda University. This research was partially supported by Grant-in-Aid for Scientific Research (KAKENHI) 24220006.	Cont A, 2010, IEEE T PATTERN ANAL, V32, P974, DOI 10.1109/TPAMI.2009.106; Montecchio N, 2011, INT CONF ACOUST SPEE, P193; Ewert S, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P129; Otsuka T, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/384651; Yoshii K, 2012, IEEE T AUDIO SPEECH, V20, P717, DOI 10.1109/TASL.2011.2164530; Duan ZY, 2011, INT CONF ACOUST SPEE, P197; Duan ZY, 2011, IEEE J-STSP, V5, P1205, DOI 10.1109/JSTSP.2011.2159701; Arzt A, 2008, FR ART INT, V178, P241, DOI 10.3233/978-1-58603-891-5-241; Bryan N. J., 2013, P INT C MACH LEARN, P208; Cho T., 2010, P SOUND MUS COMP C S, P1; Devaney J., 2009, P INT COMP MUS C, P29; Ewert S, 2009, INT CONF ACOUST SPEE, P1869, DOI 10.1109/ICASSP.2009.4959972; Ewert S., 2011, P INT SOC MUS INF RE, P245; Fremerey C., 2007, P ISMIR VIENN AUSTR, P131; Fremerey C., 2009, P INT C MUS INF RETR, P645; Fujishima T., 1999, P INT COMP MUS C ICM, P464; Goto M., 2004, P 18 INT C AC ICA 20, V1, P553; Han Y., 2007, P INT SOC MUS INF RE, P145; Hu N., 2003, P IEEE WORKSH APPL S, P185; Itoyama K, 2007, INT CONF ACOUST SPEE, P57; Joder C., 2010, P ISMIR UTR HOLL AUG, P39; Macrae R., 2010, P INT SOC MUS INF RE, P423; Maezawa A, 2011, INT CONF ACOUST SPEE, P185; Maezawa A, 2014, IEEE-ACM T AUDIO SPE, V22, P1918, DOI 10.1109/TASLP.2014.2355772; Maezawa A., 2010, P INT C MUS INF RETR, P477; Merimaa J., 2005, CONCERT HALL IMPULSE; Molina-Solana M., 2010, P INT C MUS INF RETR, P225; MULLER M, 2006, P INT C AC SPEECH SI, P9; Muller M., 2008, P 9 INT C MUS INF RE, P389; Muller M, 2010, IEEE T AUDIO SPEECH, V18, P649, DOI 10.1109/TASL.2010.2041394; Niedermayer B., 2010, P INT SOC MUS INF RE, P417; Orio N., 2003, P C NEW INT MUS EXPR, P36; Peeling P., 2007, P ISMIR VIENN AUSTR, P267; Raphael C., 2004, P 5 INT C MUS INF RE, P387; Sapp C. S., 2007, P INT C MUS INF RETR, P2; Walsh E. A., 2013, FREEPATS PROJECT	36	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0148-9267	1531-5169		COMPUT MUSIC J	Comput. Music J.	SPR	2015	39	1					74	87		10.1162/COMJ_a_00286		14	Computer Science, Interdisciplinary Applications; Music	Computer Science; Music	CE2SX	WOS:000351669200005		
J	Moiseev, AV; Baishev, DG; Barkova, ES; Du, A; Yumoto, K				Moiseev, A. V.; Baishev, D. G.; Barkova, E. S.; Du, A.; Yumoto, K.			Specific features of the generation of long-periodic geomagnetic pulsations in the event on June 25, 2008	COSMIC RESEARCH			English	Article							MAGNETOSPHERIC RESPONSE; PRESSURE VARIATIONS; FORESHOCK	The event of the generation of long-periodic geomagnetic Pc5 pulsations occurring on June 25, 2008 under undisturbed geomagnetic conditions is considered using data from ground-based and satellite observations. Two maxima in the frequency bands 1.9-2.2 and 2.9-3.3 mHz are revealed in the spectra of oscillations in the interplanetary medium, magnetosphere, and on the Earth. Pulsations with frequency 1.9-2.2 mHz were detected in all time sectors from low to high latitudes. The maximum amplitude of the oscillations was recorded in the longitude sector coinciding with position of the ion foreshock region. It is assumed that the event under consideration was caused both by variations of the solar wind dynamic pressure (amplified by the foreshock region) and by the direct penetration of ultra-low-frequency waves from solar wind to the magnetosphere.	[Moiseev, A. V.; Baishev, D. G.; Barkova, E. S.] Russian Acad Sci, Shafer Inst Cosmophys Studies & Aeron, Siberian Branch, Yakutsk, Russia; [Du, A.] Chinese Acad Sci, Inst Geol & Geophys, Beijing, Peoples R China; [Yumoto, K.] Kyushu Univ, Int Sci & Educ Ctr Studying Space Weather, Fukuoka 812, Japan	Moiseev, AV (reprint author), Russian Acad Sci, Shafer Inst Cosmophys Studies & Aeron, Siberian Branch, Yakutsk, Russia.	moiseyev@ikfia.ysn.ru		Baishev, Dmitry/0000-0002-0229-5792	Russian Foundation for Basic Research [13-05-00363, 11-05-00908, 12-05-98522]; JSPS	The authors appreciate the possibility to use the data of the projects Themis (thanks to V. Angelopous, U. Auster, K.H. Glassmeier, and V. Baumjohann), Image (E. Tanskanen), and Greenland Coast Chain (C. Stolle), and to use materials of satellite observations through CDAWEB (courtesy of D.J. McComas, R. Lepping, K. Ogilvi, and G. Paschmann (MPE)). The work is supported by the Russian Foundation for Basic Research (grant nos. 13-05-00363, 11-05-00908, and 12-05-98522) and by the "JSPS Core-to-Core Program, B. Asia-Africa Science Platforms."	Kepko L, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009676; HASEGAWA A, 1969, PHYS FLUIDS, V12, P2642, DOI 10.1063/1.1692407; Tsurutani BT, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015913; Hartinger MD, 2013, J GEOPHYS RES-SPACE, V118, P299, DOI 10.1029/2012JA018349; TAKAHASHI K, 1990, J GEOPHYS RES, V95, P3717, DOI 10.1029/JA095iA04p03717; RUSSELL CT, 1978, SPACE SCI REV, V22, P681; Han DS, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011675; Belakhovskii V.B., 2008, GEOMAGN AERON, V48, P188; Du A.M., 2010, PLANET SPACE SCI, V58, P1040; Fairfield D.H., 1979, EUR SPACE AGENCY SPE, V148, P5; GLASSMEIER KH, 1989, J GEOPHYS RES, V94, P2520, DOI 10.1029/JA094iA03p02520; GREENSTADT EW, 1980, J GEOPHYS RES-SPACE, V85, P3473, DOI 10.1029/JA085iA07p03473; KOKUBUN S, 1977, J GEOPHYS RES-SPACE, V82, P2774, DOI 10.1029/JA082i019p02774; Kozyreva O.V., 2007, GEOMAGN AERON, V47, P501; Parkhomov VA, 1998, ANN GEOPHYS-ATM HYDR, V16, P134, DOI 10.1007/s00585-998-0134-6; Potapov A.S., 2012, KOSM ISSLED, V50, p[130, 124]; SIBECK DG, 1990, J GEOPHYS RES, V95, P3755, DOI 10.1029/JA095iA04p03755; SIBECK DG, 1989, J GEOPHYS RES, V94, P2505, DOI 10.1029/JA094iA03p02505; Turner J.M., 1976, TMX71109 NASA	19	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0010-9525	1608-3075		COSMIC RES+	Cosmic Res.	MAR	2015	53	2					111	118		10.1134/S0010952515020057		8	Engineering, Aerospace; Astronomy & Astrophysics	Engineering; Astronomy & Astrophysics	CE5FW	WOS:000351857500003		
J	Suda, Y; Maruyama, K; Iida, T; Takikawa, H; Ue, H; Shimizu, K; Umeda, Y				Suda, Yoshiyuki; Maruyama, Koji; Iida, Tetsuo; Takikawa, Hirofumi; Ue, Hitoshi; Shimizu, Kazuki; Umeda, Yoshito			High-Yield Synthesis of Helical Carbon Nanofibers Using Iron Oxide Fine Powder as a Catalyst	CRYSTALS			English	Article						carbon nanocoil; carbon nanomaterials; chemical vapor deposition; nanodevices; catalyst metals	CHEMICAL-VAPOR-DEPOSITION; FIELD-EMISSION PROPERTIES; GRAPHITIC CARBON; TIN OXIDE; FUEL-CELL; NANOCOILS; GROWTH; NANOTUBES; NANOPARTICLES; MORPHOLOGY	Carbon nanocoil (CNC), which is synthesized by a catalytic chemical vapor deposition (CCVD) method, has a coil diameter of 300-900 nm and a length of several tens of mu m. Although it is very small, CNC is predicted to have a high mechanical strength and hence is expected to have a use in nanodevices such as electromagnetic wave absorbers and field emitters. For nanodevice applications, it is necessary to synthesize CNC in high yield and purity. In this study, we improved the conditions of catalytic layer formation and CCVD. Using optimized CVD conditions, a CNC layer with a thickness of >40 mu m was grown from a SnO2/Fe2O3/SnO2 catalyst on a substrate, and its purity increased to 81% +/- 2%.	[Suda, Yoshiyuki; Maruyama, Koji; Iida, Tetsuo; Takikawa, Hirofumi] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Ue, Hitoshi] Tokai Carbon Co Ltd, Fuji Res Lab, Oyama, Shizuoka 4101431, Japan; [Shimizu, Kazuki] Shonan Plast Mfg Co Ltd, Dept Dev, Hiratsuka, Kanagawa 2540807, Japan; [Umeda, Yoshito] Toho Gas Co Ltd, Corp Res Dept, Nagoya, Aichi 4568511, Japan	Suda, Y (reprint author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan.	suda@ee.tut.ac.jp			EIIRIS Project from Toyohashi University of Technology (TUT); JSPS KAKENHI [24360108, 25630110]	This work was partly supported by the EIIRIS Project from Toyohashi University of Technology (TUT), JSPS KAKENHI Grant Numbers 24360108 and 25630110.	Suda Y, 2013, J PHYS CONF SER, V433, DOI 10.1088/1742-6596/433/1/012008; Wang GZ, 2014, ACS NANO, V8, P5330, DOI 10.1021/nn501709h; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Hosokawa Y, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/20/205418; Yokota M, 2011, J NANOSCI NANOTECHNO, V11, P2344, DOI 10.1166/jnn.2011.3126; Suda Y, 2014, AIP CONF PROC, V1585, P77, DOI 10.1063/1.4866623; Sun LF, 1999, APPL PHYS LETT, V74, P644, DOI 10.1063/1.123027; Hirahara K, 2013, CARBON, V56, P264, DOI 10.1016/j.carbon.2013.01.007; Bajpai V, 2004, J AM CHEM SOC, V126, P5070, DOI 10.1021/ja031738u; Yokota M, 2010, J NANOSCI NANOTECHNO, V10, P3910, DOI 10.1166/jnn.2010.1964; Sugioka Y, 2012, IEEE T PLASMA SCI, V40, P1794, DOI 10.1109/TPS.2012.2199769; Sevilla M, 2009, ELECTROCHIM ACTA, V54, P2234, DOI 10.1016/j.electacta.2008.10.042; Wang W, 2008, ADV MATER, V20, P179, DOI 10.1002/adma.200701143; Fujii M, 2002, J CRYST GROWTH, V237, P1937, DOI 10.1016/S0022-0248(01)02254-0; MOTOJIMA S, 1990, APPL PHYS LETT, V56, P321, DOI 10.1063/1.102816; IHARA S, 1995, CARBON, V33, P931, DOI 10.1016/0008-6223(95)00022-6; Nitze F, 2011, CARBON, V49, P1101, DOI 10.1016/j.carbon.2010.11.015; Eguchi U, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.045102; Feng C, 2011, CARBON, V49, P4688, DOI 10.1016/j.carbon.2011.06.066; Fujiyama Y, 2008, JPN J APPL PHYS, V47, P1991, DOI 10.1143/JJAP.47.1991; Hokushin S, 2007, JPN J APPL PHYS 2, V46, pL565, DOI 10.1143/JJAP.46.L565; Hosokawa Y., 2007, RES LETT MAT SCI, V2007, DOI [10.1155/2007/59167., DOI 10.1155/2007/59167]; KATSUMATA T, 2004, T MAT RES SOC JAPAN, V29, P501; Katsuno T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206701; Lim S.L., 2011, T MAT RES SOC JPN, V36, P469; Lim SL, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NL04; Lu M, 2004, CARBON, V42, P805, DOI 10.1016/j.carbon.2004.01.051; Maruyama K, 2014, AIP CONF PROC, V1585, P89, DOI 10.1063/1.4866624; Mcllroy DN, 2001, APPL PHYS LETT, V79, P1540; Motojima S, 1999, J APPL PHYS, V85, P3919, DOI 10.1063/1.369765; Nishimura K., 2000, J MATER RES, V75, P1303; Pan L, 2005, JPN J APPL PHYS 1, V44, P1652, DOI 10.1143/JJAP.44.1652; Pan LJ, 2002, PHYSICA B, V323, P350, DOI 10.1016/S0921-4526(02)01001-3; Suda Y., 2011, CARBON NANOTUBES BOO, V2, P37; Suda Y, 2014, J MATER RES, V29, P2179, DOI 10.1557/jmr.2014.247; Sugioka Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JF08; Takikawa H, 2000, JPN J APPL PHYS 1, V39, P5177, DOI 10.1143/JJAP.39.5177; Tsou TY, 2012, ACS APPL MATER INTER, V4, P6505, DOI 10.1021/am3015372; Wei JQ, 2007, CARBON, V45, P2152, DOI 10.1016/j.carbon.2007.07.001; Wiliiams K.L., 2006, SENSOR ACTUAT A-PHYS, V130-131, P358; Xu GC, 2005, JPN J APPL PHYS 1, V44, P1569, DOI 10.1143/JJAP.44.1569; Yamamoto K, 2006, ULTRAMICROSCOPY, V106, P314, DOI 10.1016/j.ultramic.2005.10.002; Yang S, 2008, MATER LETT, V62, P1462, DOI 10.1016/j.matlet.2007.08.086; Yonemura T, 2015, CARBON, V83, P183, DOI 10.1016/j.carbon.2014.11.034; Yonemura T, 2012, J APPL PHYS, V112, DOI 10.1063/1.4758921; Zhang M, 2000, JPN J APPL PHYS 2, V39, pL1242, DOI 10.1143/JJAP.39.L1242	47	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4352			CRYSTALS	Crystals	MAR	2015	5	1					47	60		10.3390/cryst5010047		14	Crystallography; Materials Science, Multidisciplinary	Crystallography; Materials Science	CE5LZ	WOS:000351878300005		
J	Fukushima, S; Ariki, K; Yoshinaga, K; Higuchi, H; Kikuchi, H				Fukushima, Seiji; Ariki, Kazuhiro; Yoshinaga, Koki; Higuchi, Hiroki; Kikuchi, Hirotsugu			Infrared Extinction of a Dye-Doped (Polymer/Liquid Crystal) Composite Film	CRYSTALS			English	Article						liquid crystal; variable optical attenuator; dichroic dye; light scattering; composite film	VARIABLE OPTICAL ATTENUATOR; LIQUID-CRYSTAL	Infrared extinction of a dye-doped (polymer/liquid crystal) composite film was investigated. It is found that doping a metal-complex dye into the liquid crystal extended the operation wavelength to an optical fiber communication wavelength of about 1.5 mu m. An aperture placed behind the composite film greatly improves an extinction ratio, which suggests the film functions on the basis of light scattering. Some experimental results agree to Rayleigh scattering. The film exhibits the high extinction ratio of 51 or 17.1 dB and a low polarization dependent loss of 7.6% or 0.32 dB and, then, it could be applied to a telecommunication device such as a variable optical attenuator.	[Fukushima, Seiji; Ariki, Kazuhiro; Yoshinaga, Koki] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Higuchi, Hiroki; Kikuchi, Hirotsugu] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Fukushima, S (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Korimoto 1, Kagoshima 8900065, Japan.	fukushima@eee.kagoshima-u.ac.jp; k5392248@kadai.jp; k1548075@kadai.jp; higuchi@cm.kyushu-u.ac.jp; kikuchi@cm.kyushu-u.ac.jp					Isamoto K, 2004, IEEE J SEL TOP QUANT, V10, P570, DOI 10.1109/JSTQE.2004.828475; Xu S, 2012, OPT EXPRESS, V20, P17059, DOI 10.1364/OE.20.017059; Born M., 1999, PRINCIPLES OPTICS; Cohen S, 2000, LASER FOCUS WORLD, V36, P139; EVE M, 1979, ELECTRON LETT, V15, P146, DOI 10.1049/el:19790104; Fukushima S., 2012, P CD ROM AS COMM PHO; FUKUSHIMA S, 1994, JPN J APPL PHYS 1, V33, P5747, DOI 10.1143/JJAP.33.5747; FUKUSHIMA S, 1993, IEEE J QUANTUM ELECT, V29, P613, DOI 10.1109/3.199316; Fukushima S., 2008, P ANN M IEEE LAS EL, P656; KAJIYAMA T, 1979, CHEM LETT, P679, DOI 10.1246/cl.1979.679; Lu YQ, 2004, OPT EXPRESS, V12, P1221, DOI 10.1364/OPEX.12.001221; Noguchi S., 2009, P KYUSH SEIB BUS GYE; Wu YH, 2004, OPT EXPRESS, V12, P6382, DOI 10.1364/OPEX.12.006382; YAMAZAKI H, 1995, APPL OPTICS, V34, P8137, DOI 10.1364/AO.34.008137; Yokouchi N, 1998, IEEE PHOTONIC TECH L, V10, P863, DOI 10.1109/68.681511	15	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4352			CRYSTALS	Crystals	MAR	2015	5	1					163	171		10.3390/cryst5010163		9	Crystallography; Materials Science, Multidisciplinary	Crystallography; Materials Science	CE5LZ	WOS:000351878300013		
J	Okuda, T; Yonezaki, S; Kiyota, M				Okuda, Takehiro; Yonezaki, Shiroh; Kiyota, Masashi			Spatio-temporal variation in the higher trophic level community structure of the western North Pacific pelagic ecosystem	DEEP-SEA RESEARCH PART II-TOPICAL STUDIES IN OCEANOGRAPHY			English	Article						Community composition; Latitudinal variations; Longitudinal variations; Long-term changes; Pelagic environment; Species diversity	PREDATOR DIVERSITY; SPECIES RICHNESS; CLIMATE-CHANGE; OCEAN; BIODIVERSITY; VARIABILITY; GRADIENTS; COLLAPSE; HOTSPOTS; IMPACT	There are increasing demands for evaluation of the current status of marine ecosystems and impacts of environmental change and anthropogenic activities, but for the open ocean available data are quite limited. The Japanese driftnet survey dataset of Hokkaido University was used to analyze the spatio-temporal variations in the higher trophic level (HTL) community structure in the western North Pacific. The analyses were conducted by using subset of the data that was collected along four regularly surveyed transect lines at 155 degrees E, 170 degrees E, 175 degrees E and 180 degrees E spanning from 36 to 48 degrees N and from 1982 to 1996. Non-size-selective multiple mesh driftnets were used in the survey. Total number of individuals, species richness and Simpson index of species diversity indicated a longitudinal gradient with a lower abundance and diversity in the eastern area. Latitudinal gradient was clear for numerical abundance and species richness, but no trend for Simpson diversity index. Temporal patterns in the HTL community structure were not consistent among the three metrics: numerical abundance showed a significantly decrease and increasing fluctuations in later years, species richness was increased along years, and Simpson index did not show any clear temporal trends. The inconsistency in the temporal patterns of community metrics was considered to arise from the effects of the sampling scheme on community measurements and/or complex structural changes such as the emergence of dominant species related to regime shifts. These results suggest the importance of proper consideration of temporal changes in the sampling scheme when analyzing long-term data. (C) 2014 Elsevier Ltd. All rights reserved.	[Okuda, Takehiro; Yonezaki, Shiroh; Kiyota, Masashi] Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan	Okuda, T (reprint author), Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	okudy@affrc.go.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [4403 2412008]	This study was conducted as a part of NEOPS (New Ocean Paradigm on its Biogeochemistry, Ecosystem and Sustainable Use) supported by a Grant-in-Aid for Scientific Research (No. 4403 2412008) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Angel MV, 1997, MARINE BIODIVERSITY-BOOK, P35, DOI 10.1017/CBO9780511752360.004; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100; Chiba S, 2006, GLOBAL CHANGE BIOL, V12, P907, DOI 10.1111/j.1365-2483.2006.01136.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Qiu B, 2005, J PHYS OCEANOGR, V35, P2090, DOI 10.1175/JPO2807.1; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Nishioka J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004055; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Yatsu A, 2000, FISH OCEANOGR, V9, P163, DOI 10.1046/j.1365-2419.2000.00130.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.292.5517.629; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; McFarlane GA, 2000, PROG OCEANOGR, V47, P147, DOI 10.1016/S0079-6611(00)00034-3; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Yonezaki S, 2008, FISH OCEANOGR, V17, P231, DOI 10.1111/j.1365-2419.2008.00475.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Polovina JJ, 2005, ICES J MAR SCI, V62, P319, DOI 10.1016/j.icesjms.2004.07.031; SUGIMOTO T, 1992, DEEP-SEA RES, V39, pS183; Sugimoto T, 1998, FISH OCEANOGR, V7, P289, DOI 10.1046/j.1365-2419.1998.00070.x; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Cinner J. E., 2008, CONSERV BIOL, V23, P124; COLEMAN BD, 1982, ECOLOGY, V63, P1121, DOI 10.2307/1937249; Dray S., 2006, SPACEMAKER SPATIAL M; Kawai H., 1972, HYDROGRAPHY KUROSHIO, P235; Kawasaki T., 2013, REGIME SHIFT FISH CL; Krebs C. J., 2001, ECOLOGY; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Legendre P., 1998, NUMERICAL ECOLOGY; McKinnell Skip, 1993, International North Pacific Fisheries Commission Bulletin, V53, P91; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Pearcy W. G., 1991, NOAA TECH REP NMFS, V105, P39; Qiu B, 2010, DEEP-SEA RES PT II, V57, P1098, DOI 10.1016/j.dsr2.2008.11.036; R Development Core Team, 2011, R LANG ENV STAT COMP; Ripley BD, 2002, MODERN APPL STAT S; Roden G. I., 1991, NOAA TECH REP NMFS, V105, P1; Rosenzweig M. L., 1995, SPECIES DIVERSITY SP; SHIMAZAKI K, 1984, Bulletin of the Faculty of Fisheries Hokkaido University, V35, P17; Shiomoto A, 1997, MAR ECOL PROG SER, V150, P75, DOI 10.3354/meps150075; Takagi K., 1975, B INT N PACIFIC FISH, V32, P13; Takagi Shogo, 1997, Bulletin of the Faculty of Fisheries Hokkaido University, V48, P13; Williamson M., 1988, P91; Yano A, 2012, NIPPON SUISAN GAKK, V78, P681; Yatsu Akihiko, 1993, International North Pacific Fisheries Commission Bulletin, V53, P111; Yonezaki S, 2015, DEEP-SEA RES PT II, V113, P91, DOI 10.1016/j.dsr2.2014.10.027	53	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0645	1879-0100		DEEP-SEA RES PT II	Deep-Sea Res. Part II-Top. Stud. Oceanogr.	MAR	2015	113				SI		81	90		10.1016/j.dsr2.2014.05.004		10	Oceanography	Oceanography	CE6WK	WOS:000351978700007		
J	Yonezaki, S; Kiyota, M; Okamura, H				Yonezaki, Shiroh; Kiyota, Masashi; Okamura, Hiroshi			Long-term ecosystem change in the western North Pacific inferred from commercial fisheries and top predator diet	DEEP-SEA RESEARCH PART II-TOPICAL STUDIES IN OCEANOGRAPHY			English	Article						Environmental impact; Fishery statistics; Long-term change; Marine mammals; Trophic levels	SEALS CALLORHINUS-URSINUS; MARINE FOOD WEBS; FUR SEALS; FISH COMMUNITIES; DECADAL CHANGES; ISOTOPE RATIOS; STABLE CARBON; OCEAN; ABUNDANCE; NITROGEN	Assessment of the current status of marine ecosystems is necessary for the sustainable utilization of ecosystem services through fisheries and other human activities under changing environmental conditions. Understanding of historical changes in marine ecosystems can help us to assess their current status. In this study, we analyzed Japanese commercial fishery catch data and scientific survey data of the diet of northern fur seal (Callorhinus ursinus, NFS) to investigate potential long-term ecosystem changes in the western North Pacific Ocean off northeastern Japan over the past 60 years. Total commercial catches experienced peaks around 1960 and during the 1980s, decreasing to low levels around 1970 and after 1990. Catches were substantively impacted by the Tohoku earthquake and tsunami in 2011. Species composition of the commercial catch changed over time, resulting in changes in the mean trophic level (MTL) of the catches. Trends in observed commercial catches were affected by many factors, including species population fluctuations potentially related to large-scale environmental shifts, migration and distribution patterns of species related to local oceanography, changes in fishing technology, and the introduction of fishery management frameworks. The composition of NFS diet also changed over time: although overall changes were small, MTL derived from NFS stomach contents declined from the early 1970s to the late 1980s. This fall in the MTL of the diet of NFS is suggestive of a shift in pelagic fish fauna from a "mackerel-dominant regime" to a "sardine-dominant regime". Inconsistencies between changes in species composition and MTLs of the commercial catch and NFS diet resulted from differences in commercial fishing targeting and NFS foraging behavior strategies. Although commercial catch is a valuable source of information for investigating historical changes in fisheries, biological resources, and ecosystems, catch data should be interpreted carefully and other relevant information available should also be considered. (C) 2014 Elsevier Ltd. All rights reserved.	[Yonezaki, Shiroh; Kiyota, Masashi] Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Yokohama, Kanagawa 2368648, Japan; [Okamura, Hiroshi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan	Yonezaki, S (reprint author), Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	yonez@affrc.go.jp; kiyo@affrc.go.jp; okamura@fra.affrc.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [4403 2412008, 21580241]; JST (Japan Science and Technology Agency)	We thank Kazumoto Yoshida, Norihisa Baba, and the numerous researchers and crew members of the research vessels engaged in the collection of the northern fur seal samples ("Miho Collection"). We thank Hiroshi Minami and Yuka Ishihi for their assistance with the stable isotope analysis. Collection, processing and treatment of the northern fur seal samples were performed under a permit issued by the Ministry of Agriculture, Forestry, and Fishery of Government of Japan. We would also like to thank Hideyuki Doi and Kayoko Fukumori for their collection with the commercial fishery data. This study was conducted as a part of NEOPS (New Ocean Paradigm on its Biogeochemistry, Ecosystem and Sustainable Use) supported by a Grant-in-Aid for Scientific Research (No. 4403 2412008), Grant-in-Aid for Scientific Research (C) (No. 21580241) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and CREST supported by JST (Japan Science and Technology Agency).	Ream RR, 2005, DEEP-SEA RES PT II, V52, P823, DOI 10.1016/j.dsr2.2004.12.021; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Okey TA, 2004, ECOL MODEL, V172, P383, DOI 10.1016/j.ecolmodel.2003.09.019; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icejms.2006.05.008; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Mori J, 2001, FISH RES, V52, P91, DOI 10.1016/S0165-7836(01)00233-8; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Garcia SM, 2012, SCIENCE, V335, P1045, DOI 10.1126/science.1214594; Yonezaki S, 2008, FISH OCEANOGR, V17, P231, DOI 10.1111/j.1365-2419.2008.00475.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Kurle CM, 2002, MAR ECOL PROG SER, V236, P289, DOI 10.3354/meps236289; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Ebisawa Y., 1999, REP FISH EXP STN IBA, V37, P29; FAO, 2003, FAO TECHNICAL GUI S2, V4; FAO, 2014, STAT WORLD FISH AQ 2; Favorite F., 1976, B INT N PAC FISH COM, V33; Gentry R.L., 1997, BEHAV ECOLOGY NO FUR; Hilborn R., 2005, P ROY SOC LOND B BIO, V360, P45; Hilborn Ray, 2012, OVERFISHING WHAT EVE; Jefferson TA, 2008, MARINE MAMMALS WORLD; Kajimura H., 1984, NOAA TECH REP NMFS S, V779, P1; Kaneda Y, 2005, FISHERIES FISHING ME; Kawasaki T., 1983, FAO FISH REP, V291, P1065; Kawasaki T., 2013, REGIME SHIFT FISH CL; Kitagawa D., 2008, FIELD GUIDE FISHES N; Kiyota M, 2013, MAMM STUDY, V38, P199; Kodama J, 2004, GEKKAN KAIYO, V36, P11; Makino M., 2011, FISHERIES MANAGEMENT; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mitani Y, 2006, FISHERIES SCI, V72, P69, DOI 10.1111/j.1444-2906.2006.01118.x; Murawski S, 2007, SCIENCE, V316, P1281; Nagashima H., 2000, B MIYAGI PREFECTURE, V16, P3; Nakagami Masayasu, 2011, Aquabiology (Tokyo), V33, P30; Nakashima Sachi, 2007, Kagawa Daigaku Nogakubu Gakujutsu Hokoku, V59, P59; NPFSC, 1984, N PAC FUR SEAL COMM; NPFSC, 1971, N PAC FUR SEAL COMM; NPFSC, 1975, N PAC FUR SEAL COMM; NPFSC, 1969, N PAC FUR SEAL COMM; NPFSC, 1962, N PAC FUR SEAL COMM; NPFSC, 1980, N PAC FUR SEAL COMM; Okamura Hiroshi, 2004, Bulletin of Fisheries Research Agency, V10, P18; Okutani T., 2005, CUTTLEFISHES SQUIDS; Polacheck T, 2006, MAR POLICY, V30, P470, DOI 10.1016/j.marpol.2005.06.016; Sasaki K, 2004, J MOLLUS STUD, V70, P207, DOI 10.1093/mollus/70.3.207; SINCLAIR E, 1994, FISH B-NOAA, V92, P144; SUGISAKI H, 1991, MAR BIOL, V109, P241, DOI 10.1007/BF01319392; Takahashi M, 2001, FISH OCEANOGR, V10, P235, DOI 10.1046/j.1365-2419.2001.00160.x; Taki K., 2002, B FISH RES AGEN, V3, P7; Tian YJ, 2014, ICES J MAR SCI, V71, P19, DOI 10.1093/icesjms/fst169; Wada K., 1971, Bull Tokai reg Fish Res Lab, VNo. 67, P47; Yasue N, 2014, ICES J MAR SCI, V71, P44, DOI 10.1093/icesjms/fst128; Yatsu A, 2003, AM FISH S S, V38, P675; Yatsu A, 2013, ICES J MAR SCI, V70, P922, DOI 10.1093/icesjms/fst084; Yonezaki Shiroh, 2003, Mammal Study, V28, P97, DOI 10.3106/mammalstudy.28.97; Yonezaki S., 2014, B FISH RES AGENCY, V38, P45	64	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0645	1879-0100		DEEP-SEA RES PT II	Deep-Sea Res. Part II-Top. Stud. Oceanogr.	MAR	2015	113				SI		91	101		10.1016/j.dsr2.2014.10.027		11	Oceanography	Oceanography	CE6WK	WOS:000351978700008		
J	Hamazaki, N; Uesaka, M; Nakashima, K; Agata, K; Imamura, T				Hamazaki, Nobuhiko; Uesaka, Masahiro; Nakashima, Kinichi; Agata, Kiyokazu; Imamura, Takuya			Gene activation-associated long noncoding RNAs function in mouse preimplantation development	DEVELOPMENT			English	Article						Long noncoding RNA; DNA demethylation; Early mouse preimplantation development; Zygotic gene activation; Epigenetic regulation; Pluripotency	EMBRYONIC STEM-CELLS; DNA DEMETHYLATION; PATERNAL GENOME; DYNAMIC CPG; METHYLATION; EXPRESSION; TRANSCRIPTION; BLASTOCYST; PROMOTERS; APOPTOSIS	In mice, zygotic activation occurs for a wide variety of genes, mainly at the 2-cell stage. Long noncoding RNAs (lncRNAs) are increasingly being recognized as modulators of gene expression. In this study, directional RNA-seq of MII oocytes and 2-cell embryos identified more than 1000 divergently transcribed lncRNA/mRNA gene pairs. Expression of these bidirectional promoter-associated noncoding RNAs (pancRNAs) was strongly associated with the upregulation of their cognate genes. Conversely, knockdown of three abundant pancRNAs led to reduced mRNA expression, accompanied by sustained DNA methylation even in the presence of enzymes responsible for DNA demethylation. In particular, microinjection of siRNA against the abundant pancRNA partner of interleukin 17d (II17d) mRNA at the 1-cell stage caused embryonic lethality, which was rescued by supplying IL17D protein in vitro at the 4-cell stage. Thus, this novel class of lncRNAs can modulate the transcription machinery in cis to activate zygotic genes and is important for preimplantation development.	[Hamazaki, Nobuhiko; Uesaka, Masahiro; Agata, Kiyokazu; Imamura, Takuya] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Hamazaki, Nobuhiko; Uesaka, Masahiro; Agata, Kiyokazu; Imamura, Takuya] Kyoto Univ, Grad Sch Sci, Global COE Program, Sakyo Ku, Kyoto 6068502, Japan; [Hamazaki, Nobuhiko; Uesaka, Masahiro; Nakashima, Kinichi; Imamura, Takuya] Kyushu Univ, Grad Sch Med Sci, Dept Stem Cell Biol & Med, Div Basic Stem Cell Biol,Higashi Ku, Fukuoka 8128582, Japan	Imamura, T (reprint author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	imamura@scb.med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25660250, 25132706]; Global COE program [A06]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [221S0002]; Asahi Glass Foundation; JSPS Research Fellowship	This work was in part supported by Grants-in-Aid [Nos. 25660250 and 25132706] to T.I. from Japan Society for the Promotion of Science (JSPS), Global COE program A06 (to Kyoto University) and a Grant-in-Aid [No. 221S0002] for Scientific Research on Innovative Areas 'Genome Science' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Asahi Glass Foundation to T.I. N.H. is supported by a JSPS Research Fellowship. Deposited in PMC for immediate release.	Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Teperek-Tkacz M, 2011, REPRODUCTION, V142, P621, DOI 10.1530/REP-11-0148; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Park SJ, 2013, GENE DEV, V27, P2736, DOI 10.1101/gad.227926.113; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Brison DR, 1997, BIOL REPROD, V56, P1088, DOI 10.1095/biolreprod56.5.1088; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Pall GS, 2004, GENOMICS, V84, P1051, DOI 10.1016/j.ygeno.2004.08.017; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Younglai EV, 2001, HUM REPROD, V16, P1950, DOI 10.1093/humrep/16.9.1950; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Tomikawa J, 2011, J BIOL CHEM, V286, P34788, DOI 10.1074/jbc.M111.275750; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Fabian D, 2005, THERIOGENOLOGY, V64, P221, DOI 10.1016/j.theriogenology.2004.11.022; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Imamura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0511; Imamura T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-4; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; LATHAM KE, 1991, DEVELOPMENT, V112, P921; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071349; Mu W, 2010, DEV BIOL, V347, P279, DOI 10.1016/j.ydbio.2010.08.026; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Pages H, 2013, BIOSTRINGS STRING OB; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Uesaka M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-35	49	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	MAR 1	2015	142	5					910	920		10.1242/dev.116996		11	Developmental Biology	Developmental Biology	CE3AW	WOS:000351697400011		
J	Asayama, Y; Nishie, A; Ishigami, K; Ushijima, Y; Takayama, Y; Fujita, N; Kubo, Y; Aishima, S; Shirabe, K; Yoshiura, T; Honda, H				Asayama, Yoshiki; Nishie, Akihiro; Ishigami, Kousei; Ushijima, Yasuhiro; Takayama, Yukihisa; Fujita, Nobuhiro; Kubo, Yuichiro; Aishima, Shinichi; Shirabe, Ken; Yoshiura, Takashi; Honda, Hiroshi			Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI	DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY			English	Article							RADIOLOGIC-PATHOLOGICAL CORRELATION; GD-EOB-DTPA; HEPATIC HEMANGIOMA; CONTRAST AGENT; PATTERNS; LIVER; CT; PSEUDOCAPSULE; IMAGES	PURPOSE We aimed to gain further insight in magnetic resonance imaging characteristics of mass-forming intrahepatic cholangiocarcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiated hepatocellular carcinoma (pHCC). METHODS Fourteen mICC and 22 pHCC nodules were included in this study. Two observers recorded the tumor shape, intratumoral hemorrhage, fat on chemical shift imaging, signal intensity at the center of the tumor on T2-weighted image, fibrous capsule, enhancement pattern on arterial phase of dynamic study, late enhancement three minutes after contrast injection (dynamic late phase), contrast uptake on hepatobiliary phase, apparent diffusion coefficient, vascular invasion, and intrahepatic metastasis. RESULTS Late enhancement was more common in mICC (n=10, 71%) than in pHCC (n=3, 14%) (P < 0.001). A fat component was observed in 11 pHCC cases (50%) versus none of mICC cases (P = 0.002). Fibrous capsule was observed in 13 pHCC cases (59%) versus none of mICC cases (P < 0.001). On T2-weighted images a hypointense area was seen at the center of the tumor in 43% of mICC (6/14) and 9% of pHCC (2/22) cases (P = 0.018). Other parameters were not significantly different between the two types of nodules. CONCLUSION The absence of fat and fibrous capsule, and presence of enhancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC.	[Asayama, Yoshiki; Nishie, Akihiro; Ishigami, Kousei; Ushijima, Yasuhiro; Fujita, Nobuhiro; Yoshiura, Takashi; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Radiol, Fukuoka 812, Japan; [Takayama, Yukihisa] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Fukuoka 812, Japan; [Fujita, Nobuhiro; Kubo, Yuichiro; Aishima, Shinichi] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 812, Japan; [Shirabe, Ken] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Asayama, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Radiol, Fukuoka 812, Japan.	asayama@radiol.med.kyushu-u.ac.jp			JSPS KAKENHI [22591343]	This work was supported by JSPS KAKENHI Grant Number 22591343.	Kitao A, 2011, EUR RADIOL, V21, P2056, DOI 10.1007/s00330-011-2165-8; Maetani Y, 2001, AM J ROENTGENOL, V176, P1499; Ishigami K, 2009, RADIOLOGY, V250, P435, DOI 10.1148/radiol.2501071702; Asayama Y, 2006, RADIOLOGY, V238, P150, DOI 10.1148/radiol.2381041765; Ringe KI, 2010, AM J ROENTGENOL, V195, P13, DOI 10.2214/AJR.10.4392; EGUCHI A, 1992, HEPATOLOGY, V15, P843, DOI 10.1002/hep.1840150516; Asayama Y, 2011, EUR J RADIOL, V80, pE243, DOI 10.1016/j.ejrad.2010.10.032; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Lim JH, 2003, AM J ROENTGENOL, V181, P819; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Lacomis JM, 1997, RADIOLOGY, V203, P98; ITAI Y, 1986, AM J ROENTGENOL, V146, P729; Kang Y, 2012, RADIOLOGY, V264, P751, DOI 10.1148/radiol.12112308; CLEMENT O, 1992, INVEST RADIOL, V27, P612; Kutami R, 2000, J HEPATOL, V33, P282, DOI 10.1016/S0168-8278(00)80369-4; Goshima S, 2010, AM J ROENTGENOL, V195, P941, DOI 10.2214/AJR.09.3730; Doo KW, 2009, AM J ROENTGENOL, V193, pW490, DOI 10.2214/AJR.08.1732; Tanimoto A, 2009, EUR RADIOL, V19, pS975, DOI 10.1007/s00330-009-1624-y; Asayama Y, 2008, AM J ROENTGENOL, V190, pW28, DOI 10.2214/AJR.07.2117; Grazioli L, 1999, EUR RADIOL, V9, P62, DOI 10.1007/s003300050629; Liver Cancer Study Group of Japan, 2008, GEN RUL CLIN PATH ST; Nishie A, 2011, EUR J RADIOL, V80, pE29, DOI 10.1016/j.ejrad.2010.06.019; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59; Tsuda N, 2004, INVEST RADIOL, V39, P80, DOI 10.1097/01.rli.0000105331.11373.c0; Wood R, 2012, CADTH Technol Overv, V2, pe2201	25	0	0	TURKISH SOC RADIOLOGY	ANKARA	HOSDERE CAD, GUZELKENT SOK, CANKAYA EVLERI, F-2, ANKARA, 06540, TURKEY	1305-3825	1305-3612		DIAGN INTERV RADIOL	Diagn. Interv. Radiol.	MAR-APR	2015	21	2					96	104		10.5152/dir.2014.13013		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE3ZQ	WOS:000351769600002		
J	Yabunaka, K; Konishi, H; Nakagami, G; Matsuo, J; Noguchi, A; Sanada, H				Yabunaka, Koichi; Konishi, Hideki; Nakagami, Gojiro; Matsuo, Jyunko; Noguchi, Atsushi; Sanada, Hiromi			Videofluoroscopy-guided balloon dilatation for treatment of severe pharyngeal dysphagia	DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY			English	Article							CRICOPHARYNGEAL DYSFUNCTION; GASTROINTESTINAL-TRACT; STROKE PATIENTS; DILATION; ESOPHAGEAL; CATHETER; ACHALASIA; DIAGNOSIS; STRICTURE	Balloon dilatation is a widely accepted technique in the management of esophageal and other types of gastrointestinal strictures, but it is rarely used for the treatment of pharyngeal dysphagia. Therefore, the aim of our prospective study was to evaluate the use of videofluoroscopy-guided balloon dilatation (VGBD) for the treatment of severe pharyngeal dysphagia. The study included 32 stroke patients who had been diagnosed with oral and/or pharyngeal dysphagia. All patients underwent dilatation of the esophageal inlet using a balloon catheter under videofluoroscopic guidance during one or more sessions. Following esophageal dilatation, manual feeding was provided twice weekly. VGBD was effective in 10 out of 32 patients; however, the remaining 22 patients were unable to attempt oral food consumption because aspiration was not completely resolved on videofluoroscopy. According to this case series, VGBD may provide treatment for patients with severe pharyngeal dysphagia, who have not consumed food orally for a long period of time.	[Yabunaka, Koichi] Katsuragi Hosp, Dept Radiol, Osaka, Japan; [Konishi, Hideki] Katsuragi Hosp, Dept Rehabil Med, Osaka, Japan; [Yabunaka, Koichi; Nakagami, Gojiro; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan; [Matsuo, Jyunko] Osaka Med Coll, Sch Nursing, Osaka, Japan; [Noguchi, Atsushi] Butsuryo Coll Osaka, Sch Hlth Sci, Sakai, Osaka, Japan	Yabunaka, K (reprint author), Katsuragi Hosp, Dept Radiol, Osaka, Japan.						Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Mann G, 1999, STROKE, V30, P744; Kim JH, 2008, KOREAN J RADIOL, V9, P364, DOI 10.3348/kjr.2008.9.4.364; Rofes L, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/818979; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; Blount Kevin J, 2010, Semin Intervent Radiol, V27, P232, DOI 10.1055/s-0030-1253519; Choi GB, 2005, J VASC INTERV RADIOL, V16, P1705, DOI 10.1097/01.RVI.0000179813.93992.9E; Dou ZL, 2012, DYSPHAGIA, V27, P514, DOI 10.1007/s00455-012-9402-4; Finestone HM, 2001, ARCH PHYS MED REHAB, V82, P1744, DOI 10.1053/apmr.2001.27379; Grundy A, 1998, CLIN RADIOL, V39, P229; Linden M, 2007, DYSPHAGIA, V22, P81, DOI 10.1007/s00455-006-9055-2; Oxford LE, 2006, J OTOLARYNGOL, V35, P327, DOI 10.2310/7070.2005.0127; Pohl D, 2007, J GASTROINTEST LIVER, V16, P297; Solt J, 2001, GASTROINTEST ENDOSC, V54, P767, DOI 10.1067/mge.2001.118442; Solt J, 2004, DIS COLON RECTUM, V47, P1499, DOI 10.1007/s10350-004-0619-7; Steele NP, 2007, AM J OTOLARYNG, V28, P98, DOI 10.1016/j.amjoto.2006.07.003; Tatum RP, 2007, J GASTROINTEST SURG, V11, P403; Yi A, 2008, ABDOM IMAGING, V33, P177, DOI 10.1007/s00261-007-9199-z	18	0	0	TURKISH SOC RADIOLOGY	ANKARA	HOSDERE CAD, GUZELKENT SOK, CANKAYA EVLERI, F-2, ANKARA, 06540, TURKEY	1305-3825	1305-3612		DIAGN INTERV RADIOL	Diagn. Interv. Radiol.	MAR-APR	2015	21	2					173	176		10.5152/dir.2014.14146		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE3ZQ	WOS:000351769600014		
J	Takabayashi, S; Yang, M; Eto, T; Hayashi, H; Ogawa, S; Otsuji, T; Takakuwa, Y				Takabayashi, Susumu; Yang, Meng; Eto, Takanori; Hayashi, Hiroyuki; Ogawa, Shuichi; Otsuji, Taiichi; Takakuwa, Yuji			Controlled oxygen-doped diamond-like carbon film synthesized by photoemission-assisted plasma	DIAMOND AND RELATED MATERIALS			English	Article						Diamond-like carbon (DLC); Photoemission-assisted Townsend discharge; Dielectric constant; Breakdown strength	FIELD-EFFECT TRANSISTOR; AMORPHOUS-CARBON; CROSS-SECTIONS; GRAPHENE TRANSISTORS; ELECTRON COLLISIONS; RECENT PROGRESS; THIN-FILMS; MOLECULES; TRIBOLOGY; PROSPECTS	Controlled oxygen doping into a diamond-like carbon (DLC) film was succeeded under a current regulation by the photoemission-assisted Townsend (PAT) discharge plasma with the aid of UV-excited photoelectrons. An oxygen-doped DLC layer was formed on a non-doped DLC underlayer in the methane/argon plasma containing a certain amount of carbon dioxide as an oxygen dopant source. Oxygen-related radicals generated in the doped layer synthesis did not etch and penetrate the underlayer. However, such controlled doping failed in the photoemission-assisted glow (PAG) discharge where high-energy oxygen-related radicals etched the underlayer. A non-doped DLC layer finally capped the doped layer to build an oxygen box-doped DLC film. The dielectric constant of the film was unchanged irrespective of the amount of oxygen incorporated in the doped layer. However, very high breakdown strength was obtained, especially, over 10 MV/cm in negative electrical polarization when the doped layer contained large amount of oxygen. This result suggested that the interfaces between the doped layer and the non-doped side layers exhibited an n-type barrier. The voltage characteristics in the layer syntheses under the same current regulation suggested that the UV photons passed through the doped layer and excited photoelectrons in the non-doped underlayer. The photoelectrons went back through the doped layer and emitted from the surface to cause reactions. (c) 2015 Elsevier B.V. All rights reserved.	[Takabayashi, Susumu; Eto, Takanori; Otsuji, Taiichi] Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Yang, Meng; Hayashi, Hiroyuki; Ogawa, Shuichi; Takakuwa, Yuji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Takabayashi, S (reprint author), Tohoku Univ, Elect Commun Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	stak@riec.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [24760247, 26709017]	This research was partly performed at the Laboratory for Nanoelectronics and Spintronics, Research Institute of Electrical Communication, Tohoku University. The constant current source suitable to the photoemission-assisted discharge was fabricated by Mr. Minaji Furudate and Mr. Tadahiko Goto, Institute of Multidisciplinary Research for Advanced Materials, Tohoku University. The SIMS measurement was supported by Mr. Toshiya Kojima, Micro/Nano-Machining Research and Education Center, Tohoku University. This work was financially supported by the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid (KAKENHI) for Young Scientists (B) and (A), 24760247 and 26709017 (S. T.).	AISENBER.S, 1971, J APPL PHYS, V42, P2953, DOI 10.1063/1.1660654; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Wang XR, 2009, SCIENCE, V324, P768, DOI 10.1126/science.1170335; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Endo M, 2001, CARBON, V39, P1287, DOI 10.1016/S0008-6223(00)00295-5; Yokota K, 2011, NANO LETT, V11, P3669, DOI 10.1021/nl201607t; Bangert U, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245423; Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009; ALLRED AL, 1958, J INORG NUCL CHEM, V5, P264, DOI 10.1016/0022-1902(58)80003-2; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9; Ishihara M, 2006, DIAM RELAT MATER, V15, P1011, DOI 10.1016/j.diamond.2005.12.037; SIGMUND P, 1981, NUCL INSTRUM METHODS, V182, P25, DOI 10.1016/0029-554X(81)90668-6; Donnet C, 1998, SURF COAT TECH, V100, P180, DOI 10.1016/S0257-8972(97)00611-7; Chen W, 2007, J AM CHEM SOC, V129, P10418, DOI 10.1021/ja071658g; Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020; DIMARIA DJ, 1993, J APPL PHYS, V73, P3367, DOI 10.1063/1.352936; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/nnano.2010.89, 10.1038/NNANO.2010.89]; Nagashio K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.070108; Itikawa Y, 2002, J PHYS CHEM REF DATA, V31, P749, DOI 10.1063/1.1481879; Wu YQ, 2011, NATURE, V472, P74, DOI 10.1038/nature09979; Zhao W, 2012, J PHYS CHEM C, V116, P5062, DOI 10.1021/jp209927m; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3; Nagashio K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491804; Ryzhii V, 2011, J APPL PHYS, V110, DOI 10.1063/1.3657853; Erdemir A, 2006, J PHYS D APPL PHYS, V39, pR311, DOI 10.1088/0022-3727/39/18/R01; THOMPSON BA, 1963, J GEOPHYS RES, V68, P6431; Guo BD, 2010, NANO LETT, V10, P4975, DOI 10.1021/nl103079j; Fang T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2776887; Sato Y, 2011, NANO LETT, V11, P3468, DOI 10.1021/nl202002p; Parkinson WH, 2003, CHEM PHYS, V290, P251, DOI 10.1016/S0301-0104(03)00146-0; Aono M, 2014, DIAM RELAT MATER, V41, P20, DOI 10.1016/j.diamond.2013.11.001; Ashcroft N. W., 1976, SOLID STATE PHYS; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Grill A, 1998, J ELECTROCHEM SOC, V145, P1649, DOI 10.1149/1.1838531; Guerino M, 2007, MICROELECTRON J, V38, P915, DOI 10.1016/j.mejo.2007.04.003; HAFF PK, 1977, J APPL PHYS, V48, P3383, DOI 10.1063/1.324179; HUDSON RD, 1971, REV GEOPHYS SPACE GE, V9, P305, DOI 10.1029/RG009i002p00305; Nagashio K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.051304; MCHUGH JA, 1974, RADIAT EFF DEFECT S, V21, P209, DOI 10.1080/00337577408232406; MIMURA T, 1980, JPN J APPL PHYS, V19, pL225, DOI 10.1143/JJAP.19.L225; Morrison RT, 1992, ORGANIC CHEM; Nakatani T, 2007, J PHOTOPOLYM SCI TEC, V20, P221, DOI 10.2494/photopolymer.20.221; Nakatani T, 2006, NEW DIAM FRONT C TEC, V16, P187; Sato Y, 2011, NANO LETT, V11, P4026, DOI 10.1021/nl202643r; Shirai T, 2002, ATOM DATA NUCL DATA, V80, P147, DOI 10.1006/adnd.2001.0878; Sze S. M., 2012, SEMICONDUCTOR DEVICE; Takabayashi S, 2012, DIAM RELAT MATER, V22, P118, DOI 10.1016/j.diamond.2011.12.037; Takabayashi S, 2014, J APPL PHYS, V116, DOI 10.1063/1.4894626; Takami T., 2009, E J SURF SCI NANOTEC, V7, P882; Taur Y., 2009, FUNDAMENTALS MODERN; TAWARA H, 1992, NUCL FUSION, V2, P41; Yang M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.110123	54	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-9635	1879-0062		DIAM RELAT MATER	Diam. Relat. Mat.	MAR	2015	53						11	17		10.1016/j.diamond.2015.01.001		7	Materials Science, Multidisciplinary	Materials Science	CE7UG	WOS:000352046700002		
J	Iritani, R				Iritani, Ryosuke			How parasite-mediated costs drive the evolution of disease state-dependent dispersal	ECOLOGICAL COMPLEXITY			English	Article						Host migration; Dispersal costs; Dispersal evolution; Kin selection	MARGARITIFERA-LAEVIS; GENETICAL EVOLUTION; KIN COMPETITION; LIFE-HISTORY; HOST; MODEL; SELECTION; METAPOPULATION; TRANSMISSION; ENVIRONMENTS	The process of dispersal is central to population biology and evolutionary ecology. Because of negative impacts on host fitness, parasite infection generates potential costs of dispersal. However, theoretical predictions that address this issue are lacking. Here, we develop a mathematical model to demonstrate how the dispersal rate of hosts evolves under the influence of parasites in ecological scenarios incorporating pre-, during-, and post-dispersal infection/recovery events. We show that (1) the dispersal tendency is strongly biased towards either infected individuals or susceptible individuals, (2) the bias is inherently determined by the parasite-mediated relative cost of dispersal, and (3) the dispersal costs are determined by the autocorrelation of disease states (susceptible and infected) between pre- and post-dispersal. Our results suggest that parasite virulence in concert with the timing of infection drive the evolution of disease state-biased dispersal. To understand the evolutionary processes in spatial host-parasite systems, the parasite-induced costs of dispersal need to be taken into account. (C) 2014 Elsevier B.V. All rights reserved.	Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Iritani, R (reprint author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	Lambtani@gmail.com			JSPS KAKENHI [13J00914]	I am grateful to two anonymous reviewers for the fruitful comments and suggestions on the previous versions of the manuscript. I would also like to thank Y. Iwasa for productive discussions. This study is supported by Grant-in-Aid for JSPS Fellows to R.I. with JSPS KAKENHI, Grant number 13J00914.	Akiyama YB, 2009, FUND APPL LIMNOL, V175, P295, DOI 10.1127/1863-9135/2009/0175-0295; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Anderson R.M., 1979, NATURE; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Oli MK, 2006, ECOL MODEL, V198, P183, DOI 10.1016/j.ecolmodel.2006.04.007; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90038-4; Gandon S, 1999, J THEOR BIOL, V199, P275, DOI 10.1006/jtbi.1999.0960; Geritz SAH, 1998, EVOL ECOL, V12, P35; Morales Y, 2006, J N AM BENTHOL SOC, V25, P664, DOI 10.1899/0887-3593(2006)25[664:EOSAHC]2.0.CO;2; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Lion S, 2006, P ROY SOC B-BIOL SCI, V273, P1063, DOI 10.1098/rspb.2005.3412; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; MacColl ADC, 2010, FUNCT ECOL, V24, P847, DOI 10.1111/j.1365-2435.2010.01691.x; Boots M, 2002, AM NAT, V159, P706, DOI 10.1086/339996; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; BROWN CR, 1992, ECOLOGY, V73, P1718, DOI 10.2307/1940023; Chaianunporn T, 2012, J EVOLUTION BIOL, V25, P2511, DOI 10.1111/j.1420-9101.2012.02620.x; CLOBERT J., 2001, DISPERSAL; ESHEL I, 1983, J THEOR BIOL, V103, P99, DOI 10.1016/0022-5193(83)90201-1; Fellous S., 2011, BIOL LETT; Frank S. A., 1998, FDN SOCIAL EVOLUTION; FRANK SA, 1986, J THEOR BIOL, V122, P303, DOI 10.1016/S0022-5193(86)80122-9; Giraud T, 2006, HEREDITY, V97, P316, DOI 10.1038/sj.hdy.6800890; Giraud T, 2006, TRENDS PARASITOL, V22, P151, DOI 10.1016/j.pt.2006.02.001; Goodacre SL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-32; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hamilton W.D., 1977, NATURE; Heeb P, 1999, NATURE, V400, P63, DOI 10.1038/21881; Hughes DP, 2012, HOST MANIPULATION BY PARASITES, P140; Iritani R, 2014, THEOR POPUL BIOL, V92, P1, DOI 10.1016/j.tpb.2013.10.005; Karvonen A., 2012, INT J ECOL, V2012; Knowles S.C., 2013, J ANIM ECOL; Kuhn H. W., 1951, P 2 BERK S MATH STAT; Le Gac M, 2004, TRENDS PARASITOL, V20, P207, DOI 10.1016/j.pt.2004.02.003; Nunn C. L., 2006, INFECT DIS PRIMATES; Rousset F, 2004, GENETIC STRUCTURE SE; Smith J. M., 1993, EVOLUTION THEORY GAM; TAYLOR PD, 1988, J THEOR BIOL, V130, P363, DOI 10.1016/S0022-5193(88)80035-3; Terui A, 2014, FRESHW SCI, V33, P112, DOI 10.1086/674577; Thomas F., 2009, ECOLOGY EVOLUTION PA; Thompson J, 2005, GEOGRAPHIC MOSAIC CO; Vuren DV, 1996, ETHOLOGY, V102, P686, DOI [10.1111/j.1439-0310.1996.tb01159.x, DOI 10.1111/J.1439-0310.1996.TB01159.X)]	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1476-945X	1476-9840		ECOL COMPLEX	Ecol. Complex.	MAR	2015	21				SI		1	13		10.1016/j.ecocom.2014.10.008		13	Ecology	Environmental Sciences & Ecology	CE6SA	WOS:000351967200001		
J	Scotti, T; Mimura, M; Wakano, JY				Scotti, Tommaso; Mimura, Masayasu; Wakano, Joe Yuichiro			Avoiding toxic prey may promote harmful algal blooms	ECOLOGICAL COMPLEXITY			English	Article						Harmful algal blooms; Cyanobacteria; Turing instability; Microcystis; Lotka-Volterra; Reaction-diffusion system	MICROCYSTIS-AERUGINOSA; NONTOXIC PHYTOPLANKTON; FEEDING SELECTIVITY; SWIMMING BEHAVIOR; ZOOPLANKTON; COMPETITION; PREDATOR; DYNAMICS; STRAINS; DAPHNIA	Blooms of freshwater cyanobacteria are a worldwide spread environmental issue. Despite toxin producing planktonic species are generally expected to be poor competitors for resources, dense blooms of toxic cyanobacteria, such as Microcystis, do often occur in nature. Experimental results suggest that the formation of such blooms is promoted by the predatory activity of zooplankton. In fact, such predator grazes on both the nontoxic and toxic species despite the toxicity of the latter actually inhibits its growth. We model this phenomenon through a Lotka-Volterra reaction-diffusion system. Our goal is to investigate the coupled role of toxicity and zooplankton's predation in the persistence of the toxic prey and to study the mechanisms behind the formation of spatially local toxic blooms. It is known that the classical Lotka-Volterra system consisting of one prey and one predator never exhibits pattern formation. In this paper, we show that the introduction of a toxic prey may destabilize the spatially homogeneous coexistence and trigger spatial pattern formation. We also show that local blooms more likely occur when predators avoid the toxic prey and when the strength of the toxicity is of an intermediate level. (C) 2014 Elsevier B.V. All rights reserved.	[Scotti, Tommaso; Mimura, Masayasu; Wakano, Joe Yuichiro] Meiji Univ, Tokyo 101, Japan	Scotti, T (reprint author), Meiji Univ, 164-8525 Nakano 4-21-1, Tokyo 101, Japan.	scotti@meiji.ac.jp					HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; OATEN A, 1975, AM NAT, V109, P299, DOI 10.1086/282999; Wang XD, 2010, J PLANKTON RES, V32, P457, DOI 10.1093/plankt/fbp143; Schatz D, 2005, ENVIRON MICROBIOL, V7, P798, DOI 10.1111/j.1462-2920.2005.00752.x; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; LAMPERT W, 1982, ARCH HYDROBIOL, V95, P207; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; FULTON RS, 1987, J PLANKTON RES, V9, P837, DOI 10.1093/plankt/9.5.837; FUJII K, 1977, J THEOR BIOL, V69, P613, DOI 10.1016/0022-5193(77)90370-8; TAKEUCHI Y, 1983, B MATH BIOL, V45, P877, DOI 10.1007/BF02458820; Briand E, 2008, ENVIRON MICROBIOL, V10, P3337, DOI 10.1111/j.1462-2920.2008.01730.x; WATERBURY JB, 1985, SCIENCE, V230, P74, DOI 10.1126/science.230.4721.74; FREEDMAN HI, 1984, MATH BIOSCI, V68, P213, DOI 10.1016/0025-5564(84)90032-4; DEMOTT WR, 1982, LIMNOL OCEANOGR, V27, P518; Fujimoto N, 1997, LIMNOL OCEANOGR, V42, P250; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; CRAMER NF, 1972, J THEOR BIOL, V34, P289, DOI 10.1016/0022-5193(72)90162-2; Medvinsky AB, 2002, SIAM REV, V44, P311, DOI 10.1137/S0036144502404442; Yamazaki H, 1996, MAR ECOL PROG SER, V144, P299, DOI 10.3354/meps144299; Roy S, 2006, B MATH BIOL, V68, P2303, DOI 10.1007/s11538-006-9109-5; Petrovskii SV, 2001, THEOR POPUL BIOL, V59, P157, DOI 10.1006/tpbi.2000.1509; Flynn KJ, 2008, HARMFUL ALGAE, V8, P129, DOI 10.1016/j.hal.2008.08.007; Chakraborty S, 2012, ECOL COMPLEX, V11, P144, DOI 10.1016/j.ecocom.2012.05.006; Ehlers KM, 1996, P NATL ACAD SCI USA, V93, P8340, DOI 10.1073/pnas.93.16.8340; Falconer Ian R., 1996, Phycologia, V35, P74, DOI 10.2216/i0031-8884-35-6S-74.1; FULTON RS, 1988, B MAR SCI, V43, P500; GILPIN ME, 1979, AM NAT, V113, P306, DOI 10.1086/283389; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; IKEDA T, 1993, J MATH BIOL, V31, P215, DOI 10.1007/BF00166143; Imai H., 2009, INTERDISCIPLINARY ST, P269; Klebanoff A., 1994, MATH BIOSCI, V122, P1221; LAMPERT W, 1974, LIMNOL OCEANOGR, V19, P995; LAMPERT W, 1981, INT REV GES HYDROBIO, V66, P285, DOI 10.1002/iroh.19810660302; Mimura M., 1978, SIAM J APPL MATH, V37, P499; MIMURA M, 1978, J THEOR BIOL, V75, P249, DOI 10.1016/0022-5193(78)90332-6; Mitra A., 2006, BIOL LETT, V2; MURRAY JD, 1975, J THEOR BIOL, V52, P459, DOI 10.1016/0022-5193(75)90012-0; Parrish J.D., 1969, J THEOR BIOL, V1970, P207; Porter K.G., 1980, EVOLUTION ECOLOGY ZO, P268; Reichwaldt E.S., 2013, PLOS ONE, V8; Roy S, 2007, J BIOL PHYS, V33, P1, DOI 10.1007/s10867-007-9038-z; Roy S, 2008, J BIOL PHYS, V34, P459, DOI 10.1007/s10867-008-9100-5; Santos-Medrano GE, 2001, HYDROBIOLOGIA, V446, P35, DOI 10.1023/A:1017512820019; Schaffer W.M., 1985, DIFFERENTIAL SYSTEMS; Seuront L, 2004, ZOOL STUD, V43, P376; Tillmanns AR, 2011, INT REV HYDROBIOL, V96, P20, DOI 10.1002/iroh.201011298; WONG CK, 1986, J PLANKTON RES, V8, P79, DOI 10.1093/plankt/8.1.79	48	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1476-945X	1476-9840		ECOL COMPLEX	Ecol. Complex.	MAR	2015	21				SI		157	165		10.1016/j.ecocom.2014.07.004		9	Ecology	Environmental Sciences & Ecology	CE6SA	WOS:000351967200019		
J	Mimura, M; Tohma, M				Mimura, Masayasu; Tohma, Makoto			Dynamic coexistence in a three-species competition-diffusion system	ECOLOGICAL COMPLEXITY			English	Article						Competitor-mediated coexistence; Reaction-diffusion system; Dynamic pattern; Spiral pattern		From the viewpoint of competitor-mediated coexistence, it is important to study the influence of an exotic species on other native species in terms of exogenous effects, in general, exotic species are weaker than native ones because they have evolved in a different environment. Even if an exotic species is weaker, however, it might cooperate with a native species, after which the competitive relations among native species may have reversed. This motivates us to consider the ecological situation whereby one exotic competing species invades the native system of two strongly competing species. Therefore, we discuss the problem of competitive exclusion or competitor-mediated coexistence using a three-species competition-diffusion system. (C) 2014 Elsevier B.V. All rights reserved.	[Mimura, Masayasu] Meiji Univ, Grad Sch Adv Math Sci, Nakano Ku, Tokyo 1648525, Japan; [Mimura, Masayasu] Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, Tokyo 1648525, Japan; [Tohma, Makoto] Momoyama Gakuin Univ, Dept Econ, Izumi 5941198, Japan	Tohma, M (reprint author), Momoyama Gakuin Univ, Dept Econ, 1-1 Manabino, Izumi 5941198, Japan.	mimura.masayasu@gmail.com; tohma@andrew.ac.jp			Global COE program (G14) "Formation and Development of Mathematical Science based on Modeling and Analysis"	We would like to thank Hideo Ikeda for his suggestion on the stability condition (21). We are grateful for the support of the Global COE program (G14) "Formation and Development of Mathematical Science based on Modeling and Analysis."	Van den Driessche P, 1998, SIAM J APPL MATH, V58, P227; Petrovskii S, 2001, JPN J IND APPL MATH, V18, P459; Chen CC, 2012, DISCRETE CONT DYN-B, V17, P2653, DOI 10.3934/dcdsb.2012.17.2653; Morita Y, 2009, SIAM J MATH ANAL, V40, P2217, DOI 10.1137/080723715; KISHIMOTO K, 1985, J DIFFER EQUATIONS, V58, P15, DOI 10.1016/0022-0396(85)90020-8; Adamson MW, 2012, B MATH BIOL, V74, P2004, DOI 10.1007/s11538-012-9743-z; Ei S.I., 1999, J INTERFACES FREE BO, V1, P57, DOI DOI 10.4171/IFB/4; Hirsch M. W., 1982, DIFFERENTIAL EQUATIO; Ikeda H., 2006, COMMUNICATION; Ikeda H, 1998, JPN J IND APPL MATH, V15, P163; Kan-on Y., 1996, JAPAN J IND APPL MAT, V13, P343; KOKUBU H, 1990, J DIFFER EQUATIONS, V86, P260, DOI 10.1016/0022-0396(90)90033-L; Oldeman B.E., 2010, AUTO 07P CONTINUATIO; Sigmund K., 1998, EVOLUTIONARY GAMES P; Tsujikawa T., 1989, JPN J APPL MATH, V6, P341; Yukio KO, 1997, NONLINEAR ANAL-THEOR, V28, P145, DOI 10.1016/0362-546X(95)00142-I; Zeeman ML, 1993, DYNAMICS STABILITY S, V8, P189, DOI [10.1080/02681119308806158, DOI 10.1080/02681119308806158]	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1476-945X	1476-9840		ECOL COMPLEX	Ecol. Complex.	MAR	2015	21				SI		215	232		10.1016/j.ecocom.2014.05.004		18	Ecology	Environmental Sciences & Ecology	CE6SA	WOS:000351967200024		
J	Young, RC; Kitaysky, AS; Barger, CP; Dorresteijn, I; Ito, M; Watanuki, Y				Young, Rebecca C.; Kitaysky, Alexander S.; Barger, Chris P.; Dorresteijn, Ine; Ito, Motohiro; Watanuki, Yutaka			Telomere length is a strong predictor of foraging behavior in a long-lived seabird	ECOSPHERE			English	Article						Brunnich's Guillemot; data logger; diving behavior; foraging ecology; Pribilof Islands; seabird; telomeres; temperature-depth recorder; Thick-billed Murre; Uria lomvia	THICK-BILLED MURRES; COMMON MURRES; MONOMORPHIC SEABIRD; NORTHWEST ATLANTIC; PRIBILOF-ISLANDS; STABLE-ISOTOPES; PARENTAL EFFORT; URIA-LOMVIA; LIFE-SPAN; AGE	Telomeres are an increasingly studied component of physiological ecology. However, in long-lived birds a large telomere loss with chronological age is not the norm. Telomeres are now regarded less as a chronological aging tool and more as an indicator of individual quality, residual lifespan, or biological age. If telomeres indicate biological aging processes, then they should also be associated with other variables that change with age, especially foraging and reproductive behaviors. This study compared telomere length to a suite of foraging parameters in Thick-billed Murres breeding on three colonies in the Bering Sea. Telomere length, environmental conditions at colonies, and sex played pivotal roles in determining foraging habitat selection. Spatial habitat use, foraging efficiency, and prey selection variables all changed with telomere length. The behavioral evidence indicates that despite losing telomeres, birds with short telomere length retain their ability to use the environment efficiently. This indicates that aging birds remain behaviorally flexible, despite paying physiological costs. Changes in spatial use were largely sex-dependent: females and males differed in their use of the environment as telomere lengths declined. Prey selection was related to telomere length and colony; changes in murre trophic level depended on telomere length, but their direction also depended on habitat quality. We found much support for the continued able functioning of birds with shorter telomeres, indicating that physiological aging does not carry only costs. Murres appear to modify their behavior depending on environmental conditions as their physiological reserves decline.	[Young, Rebecca C.; Kitaysky, Alexander S.; Barger, Chris P.; Dorresteijn, Ine] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Ito, Motohiro] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Watanuki, Yutaka] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Young, RC (reprint author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA.	rcyoung@alaska.edu			JSPS [26304029]; North Pacific Research Board Graduate Student Research Award; BEST-BSIERP program through NPRB [B67, B77]; Institute of Arctic Biology at UAF	The datasets used for these analyses have been deposited with Dryad (DOI: 10.5061/dryad.8104s). This work was designed by A. S. Kitaysky and R. C. Young, field work was performed by A. S. Kitaysky, R. C. Young, C. P. Barger, and I. Dorresteijn. Analyses and TDR data extraction performed by R. C. Young and M. Ito. Financial support provided by Y. Watanuki (via #26304029 JSPS). The manuscript was edited by all authors. Invaluable field work was done by the BEST-BSIERP crews on St. Paul, St. George, and Bogoslof in 2008 and 2009, with special thanks to Sarah Youngren and Thibaut Vergoz. We also thank the crew at the UAF stable isotope facility for their services. Funding was provided by the North Pacific Research Board Graduate Student Research Award 2008 (to R. C. Young), the BEST-BSIERP program through NPRB (B67 and B77 to A. S. Kitaysky), and the Institute of Arctic Biology at UAF. Student support was also provided by the Resilience and Adaptation Program, an NSF IGERT at UAF (to R. C. Young). This work was carried out in the Alaska Maritime National Wildlife Refuge. This work was approved by the University of Alaska Fairbanks IACUC (156937-3 to A. S. Kitaysky), as well as Federal Fish and Wildlife Permit #MB088222, State of Alaska Department of Fish and Game #08-090, and Special Use Permit 06-010A.	Aho T, 1997, BEHAV ECOL SOCIOBIOL, V41, P49, DOI 10.1007/s002650050362; Huettmann F, 2001, ECOL MODEL, V141, P261, DOI 10.1016/S0304-3800(01)00278-2; Stabeno PJ, 1999, UASGCP REP, V99, P193; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Jones IL, 2002, AUK, V119, P1064, DOI 10.1642/0004-8038(2002)119[1064:DPOPED]2.0.CO;2; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Pauli JN, 2011, J MAMMAL, V92, P500, DOI 10.1644/10-MAMM-A-252.1; Dunshea G, 2011, MOL ECOL RESOUR, V11, P225, DOI 10.1111/j.1755-0998.2010.02976.x; Monaghan P, 2014, J EXP BIOL, V217, P57, DOI 10.1242/jeb.090043; Regular PM, 2010, MAR ECOL PROG SER, V415, P295, DOI 10.3354/meps08752; Salomons HM, 2009, P R SOC B, V276, P3157, DOI 10.1098/rspb.2009.0517; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Thaxter CB, 2009, J AVIAN BIOL, V40, P75, DOI 10.1111/j.1600-048X.2008.04507.x; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207; Dias MP, 2012, MAR ECOL PROG SER, V467, P245, DOI 10.3354/meps09966; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Pelletier L, 2014, OECOLOGIA, V176, P399, DOI 10.1007/s00442-014-3018-3; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Foote CG, 2011, BEHAV ECOL, V22, P156, DOI 10.1093/beheco/arq178; Francis N, 2006, FEBS LETT, V580, P4713, DOI 10.1016/j.febslet.2006.07.049; Byrd GV, 2008, DEEP-SEA RES PT II, V55, P1846, DOI 10.1016/j.dsr2.2008.04.004; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Stevenson DE, 2012, DEEP-SEA RES PT II, V65-70, P251, DOI 10.1016/j.dsr2.2012.02.021; Velando A, 2006, P R SOC B, V273, P1443, DOI 10.1098/rspb.2006.3480; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Angelier F, 2013, FUNCT ECOL, V27, P342, DOI 10.1111/1365-2435.12041; DRENT RH, 1980, ARDEA, V68, P225; Monaghan P, 2010, ANN NY ACAD SCI, V1206, P130, DOI 10.1111/j.1749-6632.2010.05705.x; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Williams CT, 2007, OECOLOGIA, V153, P11, DOI 10.1007/s00442-007-0717-z; Holmes D, 2009, AUK, V126, P1, DOI 10.1525/auk.2009.1109; Harding A, 2013, DEEP-SEA RES PT II, V94, P178, DOI 10.1016/j.dsr2.2013.03.013; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Oro D, 2014, ECOLOGY, V95, P446, DOI 10.1890/13-0331.1; Welcker J, 2009, IBIS, V151, P502; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Le Vaillant M, 2013, MAR BIOL, V160, P1147, DOI 10.1007/s00227-013-2167-y; Paredes R, 2008, CAN J ZOOL, V86, P610, DOI 10.1139/Z08-036; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Ito M, 2010, AQUAT BIOL, V8, P279, DOI 10.3354/ab00229; Benoit-Bird KJ, 2011, MAR ECOL PROG SER, V443, P217, DOI 10.3354/meps09408; Codding BF, 2011, P ROY SOC B-BIOL SCI, V278, P2502, DOI 10.1098/rspb.2010.2403; Bauch C., 2012, P ROYAL SOC B, V280, P1; Benetos A, 2001, HYPERTENSION, V37, P381; Buren AD, 2012, MAR ECOL PROG SER, V445, P25, DOI 10.3354/meps09465; Cotter S. C., 2010, FUNCT ECOL, V25, P652, DOI DOI 10.1111/J.1365-2435.2010.01819.X; DESROCHERS A, 1992, ANIM BEHAV, V43, P885, DOI 10.1016/S0003-3472(06)80002-3; Dragoo D. E., 2012, 201201 AMNWR US FISH; Elliott KH, 2015, FUNCT ECOL, V29, P219, DOI 10.1111/1365-2435.12316; Evans TJ, 2013, MAR ECOL PROG SER, V475, P277, DOI 10.3354/meps10125; Friesen V. L., 1992, EVOLUTION, V46, P267; Gaston A. J., 1998, BIRD FAMILIES WORLD; HARRIS MP, 1990, AUK, V107, P603; Haussmann M. F., 2007, MOL ECOLOGY RESOURCE, V8, P264; Haussmann MF, 2002, OECOLOGIA, V130, P325, DOI 10.1007/s00442-001-0827-y; Horn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017199; Ponchon A, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00233.1; R Development Core Team, 2011, R LANG ENV STAT COMP; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P579, DOI 10.1098/rspb.2005.3353; Schultner J, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0889; Smith DL, 2011, J GERONTOL A-BIOL, V66, P1163, DOI 10.1093/gerona/glr136; Takahashi A, 2008, DEEP-SEA RES PT II, V55, P1837, DOI 10.1016/j.dsr2.2008.04.005; WaveMetrics, 2008, IGOR PRO 6 0 3 1; Wiebe KL, 1998, IBIS, V140, P14, DOI 10.1111/j.1474-919X.1998.tb04536.x; Williams CT, 2008, MAR ECOL PROG SER, V363, P287, DOI 10.3354/meps07477; Young RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074931	67	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	2150-8925			ECOSPHERE	Ecosphere	MAR	2015	6	3							39	10.1890/ES14-00345.1		26	Ecology	Environmental Sciences & Ecology	CF0AW	WOS:000352205900012		
J	Islam, MZ; Hoque, MM; Asif-Ul-Alam, SM; Monalisa, K				Islam, M. Z.; Hoque, M. M.; Asif-Ul-Alam, S. M.; Monalisa, K.			Chemical composition, Antioxidant capacities and storage stability of Citrus macroptera and Garcinia pedunculata fruits	EMIRATES JOURNAL OF FOOD AND AGRICULTURE			English	Article						Satkara; Taikor; Chemical composition; Antioxidant capacity; Storage study	PHENOLIC CONTENT; ANTHOCYANINS; TEMPERATURE; CULTIVARS; CHEMISTRY; JUICES; HEALTH	An attempt was made to gain an insight about chemical compositions and antioxidant capacities of selected underutilized fruits Satkara (Citrus macroptera) and Taikor (Garcinia pedunculata) in Sylhet, Bangladesh. The analysis showed beta Carotene and Vitamin C in Satkara 22 +/- 1.50 mg/100g and 210.43 +/- 0.40 mg/100g whereas Taikor contains 45 +/- 1.00 and 142.83 +/- 2.03 mg/100g respectively. The mineral composition of both fruits is appreciable. Total polyphenol content (TPC) and total flavonoids (TF) in Satkara and Taikor were 22.76 +/- 0.52 mg GAE/100g and 18.98 +/- 0.65 mg GAE/100g, 23.38 +/- 1.0 mg RE/g and 18.33 +/- 1.12 mg RE/g respectively. The antioxidant capacities of these fruits were evaluated by DPPH and ABTS method, values expressed as TEAC (Trolox Equivalent Antioxidant Capacity). In case of ABTS showed that the value 19.06 +/- 0.18 TEAC (mu M/g) and 2318.44 +/- 5.60 TEAC (mu M/g); for DPPH showed 16.20 +/- 0.04 TEAC (mu M/g) and 1813.88 +/- 12.62 TEAC (mu M/g) in Satkara and Taikor respectively. The total polyphenol content showed the positive correlation with the antioxidant capacities and ascorbic acid contents of these fruits. Storage studies at two different temperatures at 5 degrees C for 15 days and -18 degrees C for 3 months long storage period antioxidant activity shown to be stable but vitamin C content decreases significantly. The results demonstrate that Citrus macroptera and Garcinia pedunculata fruits contained the considerable levels of nutrients and antioxidant capacity.	[Islam, M. Z.; Hoque, M. M.; Asif-Ul-Alam, S. M.; Monalisa, K.] Shahjalal Univ Sci & Technol, Dept Food Engn & Tea Technol, Sylhet 3114, Bangladesh; [Islam, M. Z.] Univ Tsukuba, Grad Sch Life & Environm Sci, Dept Bioind Sci, Tsukuba, Ibaraki 305, Japan	Islam, MZ (reprint author), Shahjalal Univ Sci & Technol, Dept Food Engn & Tea Technol, Sylhet 3114, Bangladesh.	zohurulislam.engg@gmail.com			Research Center of Shahjajal University of Science and Technology, Sylhet, Bangladesh	The authors would like to thank the Research Center of Shahjajal University of Science and Technology, Sylhet, Bangladesh for providing the financial support to carry out the research successfully.	Akpanyung E. O., 2005, Pakistan Journal of Nutrition, V4, P327; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Du QZ, 2010, FOOD CHEM, V119, P567, DOI 10.1016/j.foodchem.2009.06.059; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; SHAHIDI F, 1992, CRIT REV FOOD SCI, V32, P67; Abu Bakar MF, 2009, FOOD CHEM, V113, P479, DOI 10.1016/j.foodchem.2008.07.081; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Connor AM, 2002, J AGR FOOD CHEM, V50, P893, DOI 10.1021/jf011212y; de Ancos B, 2000, J AGR FOOD CHEM, V48, P873, DOI 10.1021/jf990747c; Piljac-Zegarac J, 2011, FOOD RES INT, V44, P345, DOI 10.1016/j.foodres.2010.09.039; Piljac-Zegarac J, 2009, FOOD CHEM, V113, P394, DOI 10.1016/j.foodchem.2008.07.048; Pinelo M, 2004, J AGR FOOD CHEM, V52, P1177, DOI 10.1021/jf0350515; Kalt W, 1999, J AGR FOOD CHEM, V47, P4638, DOI 10.1021/jf990266t; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Kaur C, 2001, INT J FOOD SCI TECH, V36, P703, DOI 10.1046/j.1365-2621.2001.00513.x; Deepa N, 2006, J FOOD COMPOS ANAL, V19, P572, DOI 10.1016/j.jfca.2005.03.005; Rapisarda P, 1999, J AGR FOOD CHEM, V47, P4718, DOI 10.1021/jf990111l; BRANDWILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; AOAC, 2004, OFF METH AN; Black RE, 2003, J NUTR, V133, p1485S; Coward K. H., 1938, BIOL STANDARDIZATION; Deore A. B., 2011, PHARM GLOBALE INT J, V2, P8; Dioxon B. M., 2004, NIGERIA FOOD CONSUMP; Food and Nutrition Board (FNB): Institute of Medicine, 1997, DIET REF INT CALC PH; Gordon L. R., 1990, J FOOD QUALITY, V13, P361; Holden M. A., 1981, UK B, V22; Hotz C., 2004, FOOD NUTR BULL, V25, pS91; Jagdish Singh, 2007, Journal of Food Composition and Analysis, V20, P106, DOI 10.1016/j.jfca.2006.08.002; Larrauri JA, 1997, J AGR FOOD CHEM, V45, P1390, DOI 10.1021/jf960282f; Lee H. S., 1991, J FOOD SCI, V56, P4; Liu R.H., 2004, J NUTR, V134, P3479; Nizamuddin H., 2014, ASIAN PAC J TROP BIO, V4, P473; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Schreckinger ME, 2010, J MED FOOD, V13, P233, DOI 10.1089/jmf.2009.0233; Trowbridge F., 2002, J NUTR, V85, P875	35	0	0	UNITED ARAB EMIRATES UNIV	AL AIN	P. O. BOX 17551, AL AIN, U ARAB EMIRATES	2079-052X	2079-0538		EMIR J FOOD AGR	Emir. J. Food Agric.	MAR	2015	27	3					275	282		10.9755/ejfa.v27i3.18624		8	Agronomy; Food Science & Technology	Agriculture; Food Science & Technology	CE6UJ	WOS:000351973400006		
J	Fukuoka, H				Fukuoka, Hidenori			Hypophysitis	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA			English	Article						Hypophysitis; Autoimmune; CTLA-4; IgG4; Hypopituitarism; Diabetes insipidus	CLINICAL-PRACTICE GUIDELINE; CENTRAL DIABETES-INSIPIDUS; SINGLE-CENTER EXPERIENCE; OF-THE-LITERATURE; LYMPHOCYTIC HYPOPHYSITIS; AUTOIMMUNE HYPOPHYSITIS; IGG4-RELATED HYPOPHYSITIS; HYPOPITUITARISM; PITUITARY; INFUNDIBULONEUROHYPOPHYSITIS	In this article, an overview is presented of hypophysitis in terms of current clinical and experimental findings, with discussion of the anatomic and histopathologic classification of primary hypophysitis and factors associated with secondary hypophysitis. In addition, discusses the pathophysiology, clinical features, management, and prognosis associated with this disease are discussed.	Kobe Univ Hosp, Div Diabet & Endocrinol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Fukuoka, H (reprint author), Kobe Univ Hosp, Div Diabet & Endocrinol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fukuokah@med.kobe-u.ac.jp					Leporati P, 2011, J CLIN ENDOCR METAB, V96, P1971, DOI 10.1210/jc.2010-2970; Bando H, 2014, EUR J ENDOCRINOL, V170, P161, DOI 10.1530/EJE-13-0642; Corsello SM, 2013, J CLIN ENDOCR METAB, V98, P1361, DOI 10.1210/jc.2012-4075; Caturegli P, 2008, AUTOIMMUN REV, V7, P631, DOI 10.1016/j.autrev.2008.04.016; Caturegli P, 2013, J CLIN ENDOCR METAB, V98, P1865, DOI 10.1210/jc.2013-1912; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hashimoto KI, 2006, ENDOCR J, V53, P593, DOI 10.1507/endocrj.K06-055; Ray DK, 2010, J NEUROSURG, V112, P118, DOI 10.3171/2009.6.JNS081176; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; De Bellis A, 2011, CLIN ENDOCRINOL, V75, P361, DOI 10.1111/j.1365-2265.2011.04056.x; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; IMURA H, 1993, NEW ENGL J MED, V329, P683, DOI 10.1056/NEJM199309023291002; Buxton N, 2001, BRIT J NEUROSURG, V15, P242, DOI 10.1080/02688690120057664; Leung GKK, 2004, J NEUROSURG, V101, P262, DOI 10.3171/jns.2004.101.2.0262; Gonzalez-Cuyar LF, 2009, AM J FOREN MED PATH, V30, P61, DOI [10.1097/PAF.0b013e3181873851, 10.1097/PAF.0b013e318187385l]; Hashimoto K, 1997, ENDOCR J, V44, P1, DOI 10.1507/endocrj.44.1; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Falorni A, 2014, AUTOIMMUN REV, V13, P412, DOI 10.1016/j.autrev.2014.01.021; Caturegli P, 2005, ENDOCR REV, V26, P599, DOI 10.1210/er.2004-0011; Yamamoto M, 2011, J CLIN INVEST, V121, P113, DOI 10.1172/JCI44073; Smith CJA, 2012, EUR J ENDOCRINOL, V166, P391, DOI 10.1530/EJE-11-1015; Abe T, 2008, BRAIN TUMOR PATHOL, V25, P59, DOI 10.1007/s10014-008-0234-8; De Bellis A, 2012, J CLIN ENDOCR METAB, V97, P3684, DOI 10.1210/jc.2012-2269; Shimatsu A, 2009, ENDOCR J, V56, P1033; Aste L, 2010, J ONCOL, V2010; Bellastella G, 2010, J CLIN ENDOCR METAB, V95, P3750, DOI 10.1210/jc.2010-0551; BLISARD KS, 1992, AM J FOREN MED PATH, V13, P207, DOI 10.1097/00000433-199209000-00007; Buxton N, 2001, BRIT J NEUROSURG, V15, P245, DOI DOI 10.1080/02688690120057664); Gal R, 1986, Obstet Gynecol Surv, V41, P619; Hashimoto K, 2002, ENDOCR J, V49, P605, DOI 10.1507/endocrj.49.605; Hunn BH, 2013, PITUITARY, V17, P357; Iwama S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008002; Kanoke Atsushi, 2013, BMC Res Notes, V6, P560, DOI 10.1186/1756-0500-6-560; Khare S, 2013, PITUITARY; Landek-Salgado MA, 2012, J AUTOIMMUN, V38, pJ88, DOI 10.1016/j.jaut.2011.07.001; Mizokami T, 1996, INTERNAL MED, V35, P135, DOI 10.2169/internalmedicine.35.135; Oiso Y, 2013, J CLIN ENDOCR METAB, V98, P3958, DOI 10.1210/jc.2013-2326; Rivera Juan-Andres, 2006, Pituitary, V9, P35, DOI 10.1007/s11102-006-6598-z; Smith CJA, 2014, PITUITARY, V17, P22, DOI 10.1007/s11102-013-0461-9; Suzuki K, 2011, INTERNAL MED, V50, P2025, DOI 10.2169/internalmedicine.50.5386	40	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8529	1558-4410		ENDOCRIN METAB CLIN	Endocrinol. Metabol. Clin. North Amer.	MAR	2015	44	1					143	+		10.1016/j.ecl.2014.10.011		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CE4MN	WOS:000351804800017		
J	Muraoka, M; Susuki, N; Yamaguchi, H; Tsuji, T; Yamamoto, Y				Muraoka, Michihiro; Susuki, Naoko; Yamaguchi, Hiroko; Tsuji, Tomoya; Yamamoto, Yoshitaka			Thermal Properties of a Supercooled Synthetic Sand-Water-Gas-Methane Hydrate Sample	ENERGY & FUELS			English	Article							POROUS-MEDIA; CONDUCTIVITY; DIFFUSIVITY	Understanding the thermal properties of methane hydrate (MH)-bearing sediments is important to develop future energy resources. Thus, in this study, we measured the thermal properties of synthetic hydrate-bearing sediment samples comprising sand, water, methane, and MH using the hot-disk transient plane source technique. The melting heat of MH possibly affects the measurements; thus, the experiments were performed at supercooled conditions during MH formation in the sediment pores. The results show that thermal conductivity and diffusivity of the samples slightly increased as hydrate saturation increased from 0 to 0.3. We also performed thermal conductivity calculations using simple thermophysical models. The distribution model (geometric mean model) shows a relatively good agreement with the experimental data; however, it underestimates the thermal conductivity of the four-component sample. Thus, better prediction models are required to accurately determine the thermal properties of four-component systems.	[Muraoka, Michihiro; Susuki, Naoko; Yamamoto, Yoshitaka] Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, Tsukuba, Ibaraki 3058569, Japan; [Yamaguchi, Hiroko; Tsuji, Tomoya] Nihon Univ, Coll Ind Technol, Narashino, Chiba 2758575, Japan	Yamamoto, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Methane Hydrate Res Ctr, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	mc-yoshitaka@aist.go.jp			MH21 Research Consortium for Methane Hydrate Resources in Japan; National Methane Hydrate Exploitation Program by the Ministry of Economy, Trade, and Industry	This work was financially supported by the MH21 Research Consortium for Methane Hydrate Resources in Japan and the National Methane Hydrate Exploitation Program by the Ministry of Economy, Trade, and Industry. The authors thank T. Maekawa and S. Goto for their assistance with the experiments.	Henninges J, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003734; Muraoka M, 2014, J GEOPHYS RES-SOL EA, V119, P8021, DOI 10.1002/2014JB011324; GUSTAFSSON SE, 1991, REV SCI INSTRUM, V62, P797, DOI 10.1063/1.1142087; Kvenvolden KA, 1999, P NATL ACAD SCI USA, V96, P3420, DOI 10.1073/pnas.96.7.3420; Anderson GK, 2004, J CHEM THERMODYN, V36, P1119, DOI 10.1016/j.jct.2004.07.005; Konno Y, 2010, ENERG FUEL, V24, P1736, DOI 10.1021/ef901115h; Goto S, 2009, EARTH PLANETS SPACE, V61, P863; Uchida T, 2004, RESOUR GEOL, V54, P35, DOI 10.1111/j.1751-3928.2004.tb00185.x; Waite WF, 2007, GEOPHYS J INT, V169, P767, DOI 10.1111/j.1365-246X.2007.03382.x; WOODSIDE W, 1961, J APPL PHYS, V32, P1688, DOI 10.1063/1.1728419; Uchida T, 1999, J CRYST GROWTH, V204, P348, DOI 10.1016/S0022-0248(99)00178-5; Huang DZ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003314; Buffett BA, 2000, MAR GEOL, V164, P69, DOI 10.1016/S0025-3227(99)00127-9; Ohmura R, 2000, J CRYST GROWTH, V218, P372, DOI 10.1016/S0022-0248(00)00564-9; Waite WF, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015988; Muraoka M, 2014, CRYST GROWTH DES, V14, P3813, DOI 10.1021/cg500298u; Cortes DD, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006235; Kumar P, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002763; Kvenvolden KA, 2002, TERRA NOVA, V14, P302, DOI 10.1046/j.1365-3121.2002.00414.x; Kida M, 2009, ENERG FUEL, V23, P5580, DOI 10.1021/ef900612f; Ben Clennell M, 1999, J GEOPHYS RES-SOL EA, V104, P22985, DOI 10.1029/1999JB900175; COOK JG, 1983, GEOPHYS RES LETT, V10, P397, DOI 10.1029/GL010i005p00397; Fujii T., 2009, AAPG MEMOIR, V89, P385; HATZIKIRIAKOS SG, 1993, CHEM ENG SCI, V48, P3963, DOI 10.1016/0009-2509(93)80375-Z; Jung JW, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB000812; Kim YJ, 2013, MAR PETROL GEOL, V47, P77, DOI 10.1016/j.marpetgeo.2013.05.011; Malone R. D., 1985, DOEMETCSP218; Sakamoto Y., 2007, J MMIJ, V123, P386, DOI 10.2473/journalofmmij.123.386; Sloan E.D., 2007, CLATHRATE HYDRATES N; Waite WF, 2009, REV GEOPHYS, V47, DOI 10.1029/2008RG000279; Yamamoto Y, 2004, INT OFFSHORE POLAR E, P36	31	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	MAR	2015	29	3					1345	1351		10.1021/ef502350n		7	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CE2NV	WOS:000351653200008		
J	Wu, SJ; Yang, W; Zhou, J; Wang, H; Xie, ZM				Wu, Sheng-ji; Yang, Wei; Zhou, Jie; Wang, Hui; Xie, Zheng-miao			Effects of Properties of Activated Carbon on Its Activity for Mercury Removal and Mercury Desorption from Used Activated Carbons	ENERGY & FUELS			English	Article							COMBUSTION FLUE-GAS; PROGRAMMED DECOMPOSITION DESORPTION; IRON-BASED SORBENTS; ELEMENTAL MERCURY; FUEL GAS; SULFUR-OXIDES; PHASE MERCURY; CAPTURE; ADSORPTION; CHLORIDE	Activated carbon (AC) is a promising adsorbent for removing mercury from combustion flue gases. Knowing the effects of the physicochemical properties of AC on its mercury removal rate would help select appropriate AC for mercury removal. We thus evaluated the effect of the physicochemical properties of various ACs on their mercury removal capabilities and the thermal stabilities of mercury compounds generated on used ACs in the present study. The Brunauer-Emmett-Teller (BET) surface area and pore structure of AC had no significant effect on its mercury removal rate, although the ACs used in the present study had a BET surface area of 700-1200 m(2)/g, large enough for mercury removal. The AC with a high concentration of Fe showed a high mercury removal rate. The surface functional groups had no relationship to the mercury compounds desorbed from the used ACs. More mercury compound species were generated on used fruit shell and coconut ACs (five species) than those generated on bamboo AC (four species) or coal AC (three species). The mercury compounds generated on used coal AC showed relatively lower thermal stabilities than those generated from other ACs, indicating that coal AC was easier to regenerate and that the mercury compounds generated on used coal AC could be recycled at lower temperatures.	[Wu, Sheng-ji; Zhou, Jie; Wang, Hui; Xie, Zheng-miao] Hangzhou Dianzi Univ, Coll Mat & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China; [Yang, Wei] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan	Wu, SJ (reprint author), Hangzhou Dianzi Univ, Coll Mat & Environm Engn, Xiasha Univ Pk, Hangzhou 310018, Zhejiang, Peoples R China.	wushengji26@hdu.edu.cn			National Natural Science Foundation of China [21406044]; Zhejiang Province Natural Science Foundation of China [LY12E06001]; Science and Technology Planning Project of Zhejiang Province, China [2013C31016]	This work was financially supported by the National Natural Science Foundation of China (Grant 21406044), the Zhejiang Province Natural Science Foundation of China (Grant LY12E06001), and the Science and Technology Planning Project of Zhejiang Province, China (Grant 2013C31016).	Abad-Valle P., 2014, FUEL, V90, P2808; Korpiel JA, 1997, ENVIRON SCI TECHNOL, V31, P2319, DOI 10.1021/es9609260; Li YH, 2003, FUEL, V82, P451, DOI 10.1016/S0016-2361(02)00307-1; Poulston S, 2007, FUEL, V86, P2201, DOI 10.1016/j.fuel.2007.05.015; Lee SF, 2004, ATMOS ENVIRON, V38, P4887, DOI 10.1016/j.atmosenv.2004.05.043; De M, 2013, FUEL, V103, P570, DOI 10.1016/j.fuel.2012.08.011; Presto AA, 2007, ENVIRON SCI TECHNOL, V41, P6579, DOI 10.1021/es0708316; Uddin MA, 2008, ENERG FUEL, V22, P2284, DOI 10.1021/ef800134t; Wilcox J, 2012, INT J COAL GEOL, V90, P4, DOI 10.1016/j.coal.2011.12.003; Wu SJ, 2011, ENERG FUEL, V25, P144, DOI 10.1021/ef1009499; Ochiai R, 2009, ENERG FUEL, V23, P4734, DOI 10.1021/ef900057e; Murakami A, 2010, ENERG FUEL, V24, P4241, DOI 10.1021/ef100288f; Morimoto T, 2005, FUEL, V84, P1968, DOI 10.1016/j.fuel.2005.04.007; Ozaki M, 2008, FUEL, V87, P3610, DOI 10.1016/j.fuel.2008.06.011; Tao SS, 2012, CHEM ENG J, V210, P547, DOI 10.1016/j.cej.2012.09.028; Presto AA, 2007, IND ENG CHEM RES, V46, P8273, DOI 10.1021/ie071045c; Wu SJ, 2008, FUEL, V87, P467, DOI 10.1016/j.fuel.2007.06.016; Hu C. X., 2010, THERM POWER GENER, V39, P1; Hu J., 2009, FUEL PROCESS TECHNOL, V90, P812; Lee SH, 2003, FUEL PROCESS TECHNOL, V84, P197, DOI 10.1016/S0378-3820(03)00055-9; Mclarnon C. R., 2005, PCO PROCESS REMOVAL; Mullett M., 2012, CHEM ENG J, V201, P133; Skodras G, 2007, DESALINATION, V210, P281, DOI 10.1016/j.desal.2005.12.082; Staudt J. E., 2003, EPA600R03110; Tan ZQ, 2011, FUEL, V90, P1471, DOI 10.1016/j.fuel.2010.12.004; U. S. Environmental Protection Agency, 2005, CLEAN AIR MERC RUL; United Nations Environment Programme (UNEP), 2002, 5479001 UNEP; United States Environmental Protection Agency (U.S. EPA), 1990, CLEAN AIR ACT AME 19; United States Environmental Protection Agency (U.S. EPA), 2013, MERC AIR TOX STAND	29	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	MAR	2015	29	3					1946	1950		10.1021/ef502868s		5	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CE2NV	WOS:000351653200069		
J	Li, P; Zheng, TL; Wang, QH; Yang, S; Liu, S; Li, LJ; Huang, PK				Li, Peng; Zheng, Tianlong; Wang, Qunhui; Yang, Shuo; Liu, Shu; Li, Lijie; Huang, Peikun			Treatment of Real High-Concentration Dyeing Wastewater Using a Coagulation-Hydrolysis Acidification-Multilevel Contact Oxidation System	ENVIRONMENTAL PROGRESS & SUSTAINABLE ENERGY			English	Article						dyeing wastewater; coagulation; multilevel contact oxidation; chemical oxygen demand removal; spiral biological carrier	OPERATING PARAMETERS; TEXTILE; NANOFILTRATION; PRETREATMENT; OZONATION; INDUSTRY; REMOVAL; REACTOR; COLOR; REUSE	An integrated system comprising coagulation, hydrolysis acidification, and multilevel contact oxidation was evaluated to make the dyeing effluent meet discharge standards. A new spiral biological carrier was first used in the treatment of dyeing wastewater. The chemical oxygen demand (COD), color, and biodegradability index (i.e., biological oxygen demand (BOD)/COD) of raw dyeing wastewater were 5051 mg/L, 404 times, and 0.29, respectively. During coagulation, 80% COD and 64% color were reduced with 80 mg/L polyaluminum chloride as coagulant. The hydraulic retention time (HRT) of subsequent hydrolysis acidification and multilevel contact oxidation was determined as 23.6 h. After the integrated treatment of coagulation-hydrolysis acidification-multilevel contact oxidation, COD, BOD, color, and ammonia removal efficiencies reached 98%, 99%, 92%, and 99%, respectively. The effluent met Class 1 discharge standards (GB4287-2012). In particular, the new spiral biological carriers used in multilevel contact oxidation led to significant total nitrogen (TN) removal. When the HRT of multilevel contact oxidation process was 16.4 h, the TN removal efficiency was 73.3%. The spiral carriers can provide an anoxic microenvironment in the inner part because of their high strength spiral structure, which facilitates the transformation from nitrate to nitrogen gas through simultaneous nitrification and denitrification. (c) 2014 American Institute of Chemical Engineers Environ Prog, 34: 339-345, 2015	[Li, Peng; Zheng, Tianlong; Wang, Qunhui; Liu, Shu; Li, Lijie; Huang, Peikun] Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Dept Environm Engn, Beijing 100083, Peoples R China; [Li, Peng] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China; [Yang, Shuo] Kyushu Univ, Dept Urban & Environm Engn, Fukuoka 8190395, Japan	Wang, QH (reprint author), Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Dept Environm Engn, Beijing 100083, Peoples R China.	wangqh59@sina.com			Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07201002-6]; B-Tohin Machine (Jiangsu, China) Co., Ltd.; Kikuchi Eco-earth Ltd. (Tokyo, Japan)	Contract grant sponsor: financial support of Major Science and Technology Program for Water Pollution Control and Treatment; contract grant number: 2012ZX07201002-6; Contract grant sponsor: cooperation of B-Tohin Machine (Jiangsu, China) Co., Ltd. and Kikuchi Eco-earth Ltd. (Tokyo, Japan)	Yuksel E, 2013, ENVIRON PROG SUSTAIN, V32, P60, DOI 10.1002/ep.10601; Wu HF, 2012, J HAZARD MATER, V243, P86, DOI 10.1016/j.jhazmat.2012.10.030; You SJ, 2010, J HAZARD MATER, V177, P1112, DOI 10.1016/j.jhazmat.2010.01.036; Ciardelli G, 2001, WATER RES, V35, P567, DOI 10.1016/S0043-1354(00)00286-4; Merzouk B, 2011, DESALINATION, V272, P246, DOI 10.1016/j.desal.2011.01.029; Constapel M, 2009, WATER RES, V43, P733, DOI 10.1016/j.watres.2008.11.006; Isik M, 2008, SEP PURIF TECHNOL, V60, P64, DOI 10.1016/j.seppur.2007.07.043; Sahinkaya E, 2008, J HAZARD MATER, V153, P1142, DOI 10.1016/j.jhazmat.2007.09.072; Liu S, 2010, SEP PURIF TECHNOL, V71, P337, DOI 10.1016/j.seppur.2009.12.021; Garg VK, 2004, DYES PIGMENTS, V63, P243, DOI 10.1016/j.dyepig.2004.03.005; Colindres P, 2010, DESALINATION, V258, P154, DOI 10.1016/j.desal.2010.03.021; Han B, 2005, WATER SCI TECHNOL, V52, P317; Hou W., 2004, IND WATER WASTEWATER, V35, P57; Huang P., 2008, RES DYEING WASTEWATE; Kapdan IK, 2005, J HAZARD MATER, V123, P217, DOI 10.1016/j.jhazmat.2005.04.013; Kong HL, 2008, BIORESOURCE TECHNOL, V99, P7886, DOI 10.1016/j.biortech.2008.02.026; Li X. D., 2007, ENV SCI, V28, P2020; Ministry of Environmental Protection China, 2012, CHIN STAT YB ENV 201; Myung SW, 2005, WATER SCI TECHNOL, V51, P159; Rajagopal R, 2011, BIORESOURCE TECHNOL, V102, P5653, DOI 10.1016/j.biortech.2011.02.068; Wang HY, 2010, WATER SCI TECHNOL, V62, P751, DOI 10.2166/wst.2010.126; Wang Q., 2007, WATER ENVIRON RES, V79, P1; Water and Wastewater Monitoring and Analysis Methods Editorial Board of Chinese Environmental Protection Bureau, 2002, WAT WAST MON AN METH; Xue NT, 2011, WATER SCI TECHNOL, V63, P747, DOI 10.2166/wst.2011.302; Ying F., 2011, DESALINATION, V277, P67; Zuriaga-Agusti E, 2010, CHEM ENG J, V161, P122, DOI 10.1016/j.cej.2010.04.044	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1944-7442	1944-7450		ENVIRON PROG SUSTAIN	Environ. Prog. Sustain. Energy	MAR-APR	2015	34	2					339	345		10.1002/ep.11989		7	Engineering, Environmental; Engineering, Chemical; Engineering, Industrial; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CE2FW	WOS:000351630800004		
J	Wang, G; Tan, L; Sun, ZY; Gou, ZX; Tang, YQ; Kida, K				Wang, Gang; Tan, Li; Sun, Zhao-Yong; Gou, Zi-Xi; Tang, Yue-Qin; Kida, Kenji			Production of Bioethanol from Rice Straw by Simultaneous Saccharification and Fermentation of Whole Pretreated Slurry Using Saccharomyces cerevisiae KF-7	ENVIRONMENTAL PROGRESS & SUSTAINABLE ENERGY			English	Article						dilute sulfuric acid pretreatment; furfural; 5-hydroxymethylfurfural; high solid load	ETHANOL-PRODUCTION; CORN STOVER; ACID HYDROLYSIS; FUEL ETHANOL; BIOMASS; LIGNOCELLULOSE; DETOXIFICATION; PERFORMANCE; INHIBITORS; GLUCOSE	Rice straw is one of the most abundant lignocellulosic waste materials worldwide, and it can serve as feedstock for bioethanol production. In this study, ethanol was produced from rice straw by simultaneous saccharification and fermentation (SSF) of the whole pretreated slurry with high solid load. Pretreatment of rice straw using 0.5% (w/w) H2SO4 was performed to increase the efficiency of enzymatic saccharification. Enzymatic saccharification and SSF of the whole pretreated slurry were subsequently performed to evaluate the inhibitory effect on enzymatic saccharification and the final ethanol yield. The result showed that pretreatment was the key for achieving high ethanol yield of the whole pretreated slurry. Rice straw pretreated at 170 degrees C with a solid load of 15% exhibited efficient enzymatic saccharification. By the result of ethanol yields, no inhibitory effect was found when the whole pretreated slurry was subjected to SSF. The ethanol yield of SSF of the whole pretreated slurry was enhanced to 77.3%, compared with the glucose recovery efficiency of enzymatic saccharification of the washed pretreated rice straw, which was 74.4%. (c) 2014 American Institute of Chemical Engineers Environ Prog, 34: 582-588, 2015	[Wang, Gang; Sun, Zhao-Yong; Gou, Zi-Xi; Tang, Yue-Qin; Kida, Kenji] Sichuan Univ, Coll Architecture & Environm, Kida Environm Biotechnol Res Ctr, Chengdu 610065, Peoples R China; [Tan, Li] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan	Tan, L (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	tanli212002@gmail.com			National Natural Science Foundation of China [31170093]	This work was supported financially by the National Natural Science Foundation of China (31170093).	Adney B., 2008, NRELTP510 LAP, P42628; KIDA K, 1991, J FERMENT BIOENG, V72, P54, DOI 10.1016/0922-338X(91)90146-8; Ishola MM, 2013, BIORESOURCE TECHNOL, V133, P68, DOI 10.1016/j.biortech.2013.01.130; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P1959, DOI 10.1016/j.biortech.2005.01.010; Alvira P, 2013, BIOTECHNOL PROGR, V29, P74, DOI 10.1002/btpr.1666; Ohgren K, 2007, PROCESS BIOCHEM, V42, P834, DOI 10.1016/j.procbio.2007.02.003; Varga E, 2004, BIOTECHNOL BIOENG, V88, P567, DOI 10.1002/bit.20222; Balat M, 2008, PROG ENERG COMBUST, V34, P551, DOI 10.1016/j.pecs.2007.11.001; Qing Q, 2010, BIORESOURCE TECHNOL, V101, P9624, DOI 10.1016/j.biortech.2010.06.137; Tang Y, 2006, PROCESS BIOCHEM, V41, P909, DOI 10.1016/j.procbio.2005.09.008; Cannella D, 2014, BIOTECHNOL BIOENG, V111, P59, DOI 10.1002/bit.25098; Jeong TS, 2012, BIORESOURCE TECHNOL, V116, P435, DOI 10.1016/j.biortech.2012.03.104; Larsson S, 1999, ENZYME MICROB TECH, V24, P151, DOI 10.1016/S0141-0229(98)00101-X; Jung YH, 2014, BIOPROC BIOSYST ENG, V37, P659, DOI 10.1007/s00449-013-1035-y; Lu YF, 2010, APPL BIOCHEM BIOTECH, V160, P360, DOI 10.1007/s12010-008-8306-0; Cantarlla M., 2004, BIOTECHNOL PROGR, V20, P202; Eylen D. V., 2011, BIORESOURCE TECHNOLO, V102, P5995; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Martin C, 2007, BIORESOURCE TECHNOL, V98, P1767, DOI 10.1016/j.biortech.2006.07.021; Miao YL, 2012, APPL BIOCHEM BIOTECH, V167, P358, DOI 10.1007/s12010-012-9689-5; Ohgren K, 2006, BIOMASS BIOENERG, V30, P863, DOI 10.1016/j.biombioe.2006.02.002; Sluiter A., 2008, NRELTP510 LAP, P42622; Sluiter A, 2008, NREL TECHNICAL REPOR, V510, P42618; Sun ZY, 2011, BIORESOURCE TECHNOL, V102, P10929, DOI 10.1016/j.biortech.2011.09.071; Zhang DX, 2013, BIOCHEM ENG J, V72, P77, DOI 10.1016/j.bej.2013.01.003; Zhang XR, 2010, BIORESOURCE TECHNOL, V101, P7093, DOI 10.1016/j.biortech.2010.03.129	26	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1944-7442	1944-7450		ENVIRON PROG SUSTAIN	Environ. Prog. Sustain. Energy	MAR-APR	2015	34	2					582	588		10.1002/ep.11992		7	Engineering, Environmental; Engineering, Chemical; Engineering, Industrial; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CE2FW	WOS:000351630800035		
J	Hirano, K; Ikeda, Y; Sugimura, K; Sakata, Y				Hirano, Ken-ichi; Ikeda, Yoshihiko; Sugimura, Koichiro; Sakata, Yasuhiko			Cardiomyocyte steatosis and defective washout of iodine-123-beta-methyl iodophenyl-pentadecanoic acid in genetic deficiency of adipose triglyceride lipase	EUROPEAN HEART JOURNAL			English	Editorial Material									[Hirano, Ken-ichi] Osaka Univ, Lab Cardiovasc Dis, Novel Noninvas & Nutr Therapeut CNT, Grad Sch Med, Suita, Osaka 5650874, Japan; [Hirano, Ken-ichi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Ikeda, Yoshihiko] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka 5658565, Japan; [Sugimura, Koichiro; Sakata, Yasuhiko] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Hirano, K (reprint author), Osaka Univ, Lab Cardiovasc Dis, Novel Noninvas & Nutr Therapeut CNT, Grad Sch Med, Suita, Osaka 5650874, Japan.	khirano@cnt-osaka.com						0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0195-668X	1522-9645		EUR HEART J	Eur. Heart J.	MAR 1	2015	36	9					580	580		10.1093/eurheartj/ehu417		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE1SI	WOS:000351591800012		
J	Sano, A; Hirano, T; Watanabe, K; Endo, N; Ito, T; Tanabe, N				Sano, Atsuki; Hirano, Toru; Watanabe, Kei; Endo, Naoto; Ito, Takui; Tanabe, Naohito			Body mass index is associated with low back pain in childhood and adolescence: a birth cohort study with a 6-year follow-up in Niigata City, Japan	EUROPEAN SPINE JOURNAL			English	Article						Body mass index; Low back pain; Birth cohort study; Childhood low back pain; Adolescent low back pain	SCHOOL-CHILDREN; SCHOOLCHILDREN; PREVALENCE; SPINE; AGE	To investigate the successive change of low back pain (LBP) prevalence in childhood and adolescence and to examine the associations between LBP and extracurricular sports activities (ECSA) or body mass index (BMI) using a 6-year birth cohort study. LBP reports of a grade (4,597 pupils at the beginning) were tracked over 6 years (between the ages of 9 and 14 years old), and anonymous questionnaires were distributed to them yearly. After grading the severity of the LBP into three levels and noting the transitions of the point and the lifetime prevalence of LBP, associations between point prevalence of LBP and BMI or ECSA were evaluated. The point prevalence of LBP had a tendency to become significantly higher as the pupils got older until they became 13 years old. The lifetime prevalence of LBP significantly increased as they got older yearly. As for the severity of LBP among students with a lifetime prevalence, the rate of more severe LBP (levels 2 and 3) increased as they got older. Significant positive associations were recognized between BMI and point prevalence of LBP in every years old (p < 0.05) and between ECSA and point prevalence of LBP at 11 (p = 0.001) and 14 years old (p < 0.001). The point and lifetime prevalence of LBP and the rate of more severe LBP increased as the pupils got older. BMI may be associated with LBP in childhood and adolescence.	[Sano, Atsuki; Hirano, Toru; Watanabe, Kei; Endo, Naoto] Niigata Univ, Med & Dent Gen Hosp, Dept Orthopaed Surg, Chuo Ku, Niigata 9518510, Japan; [Ito, Takui] Niigata City Gen Hosp, Dept Orthopaed Surg, Niigata, Japan; [Tanabe, Naohito] Univ Niigata Prefecture, Dept Hlth & Nutr, Niigata, Japan	Sano, A (reprint author), Niigata Univ, Med & Dent Gen Hosp, Dept Orthopaed Surg, Chuo Ku, 1-757 Asahimachidori, Niigata 9518510, Japan.	cbe90900@pop06.odn.ne.jp					Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Leboeuf-Yde C, 1998, SPINE, V23, P228, DOI 10.1097/00007632-199801150-00015; Burton AK, 1996, SPINE, V21, P2323, DOI 10.1097/00007632-199610150-00004; BALAGUE F, 1988, SCAND J REHABIL MED, V20, P175; Hestbaek L, 2006, SPINE, V31, P468, DOI 10.1097/01.brs.0000199958.04073.d9; Watson KD, 2002, PAIN, V97, P87, DOI 10.1016/S0304-3959(02)00008-8; WALSH K, 1992, J EPIDEMIOL COMMUN H, V46, P227, DOI 10.1136/jech.46.3.227; Jones GT, 2005, ARCH DIS CHILD, V90, P312, DOI 10.1136/adc.2004.056812; Mikkonen P, 2008, SPINE, V33, P527, DOI 10.1097/BRS.0b013e3181657d3c; Poussa MS, 2005, EUR SPINE J, V14, P595, DOI 10.1007/s00586-004-0872-4; Sato T, 2008, EUR SPINE J, V17, P1441, DOI 10.1007/s00586-008-0788-5; BALAGUE F, 1994, J SPINAL DISORD, V7, P374; Cardon G, 2004, EUR SPINE J, V13, P663, DOI 10.1007/s00586-004-0749-6; Grimmer Karen, 2006, Physiother Res Int, V11, P161, DOI 10.1002/pri.340; HARREBY M, 1995, SPINE, V20, P2298, DOI 10.1097/00007632-199511000-00007; Kelsey JK, 1985, SPINE, V5, P133, DOI DOI 10.1097/00007632-198003000-00007; Kjaer P, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-98; NACHEMSON A L, 1976, Spine, V1, P59, DOI 10.1097/00007632-197603000-00009; SALMINEN JJ, 1995, SPINE, V20, P2101, DOI 10.1097/00007632-199510000-00006; Sato T, 2011, EUR SPINE J, V20, P94, DOI 10.1007/s00586-010-1485-8; Szpalski M, 2002, EUR SPINE J, V11, P459, DOI 10.1007/s00586-002-0385-y; Taimela S, 1997, SPINE, V22, P1132, DOI 10.1097/00007632-199705150-00013; Widhe T, 2001, EUR SPINE J, V10, P118, DOI 10.1007/s005860000230	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	MAR	2015	24	3					474	481		10.1007/s00586-014-3685-0		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CE0SB	WOS:000351514600009		
J	Hiyama, A; Watanabe, M; Katoh, H; Sato, M; Sakai, D; Mochida, J				Hiyama, Akihiko; Watanabe, Masahiko; Katoh, Hiroyuki; Sato, Masato; Sakai, Daisuke; Mochida, Joji			Evaluation of quality of life and neuropathic pain in patients with low back pain using the Japanese Orthopedic Association Back Pain Evaluation Questionnaire	EUROPEAN SPINE JOURNAL			English	Article						PainDETECT (PDQ); Low back pain (LBP); JOA Back Pain Evaluation Questionnaire (JOABPEQ); Neuropathic pain; Quality of life (QOL)	PAINDETECT-QUESTIONNAIRE; CULTURAL-ADAPTATION; GENERAL-POPULATION; LEEDS ASSESSMENT; PREVALENCE; SCALE; EPIDEMIOLOGY; VALIDATION; MECHANISMS; COMPONENTS	To examine the impact that neuropathic or nociceptive pain has on the quality of life (QOL) in patients with low back pain (LBP) using the Japanese Orthopedic Association Back Pain Evaluation Questionnaire (JOABPEQ) and the Japanese version of the PainDETECT Questionnaire (PDQ-J). Between June 2012 and December 2013, 650 new patients were treated at our institution for LBP. All patients between the ages of 20 and 79 were asked to complete a set of questionnaires including the PDQ-J, a pain visual analog scale (VAS), the JOABPEQ, and the Short Form 36 (SF-36). Based on the PDQ-J scores, participants were classified into three groups: a neuropathic pain group, a nociceptive pain group, and an intermediate mixed pain group. Among them, patients with clear neuropathic and nociceptive LBP were selected. To investigate the differences between neuropathic and nociceptive LBP, diagnosis of spinal disorder, prevalence, age, gender, duration of symptoms, VAS scores, and self-reported general health (SF-36 and JOABPEQ) were compared between the neuropathic and nociceptive pain groups. Of 650 patients with LBP, 331 completed the questionnaires and were enrolled in the study. There were 193 men (58.3 %) and 138 women (41.7 %) with a mean age of 54.5 years (range 20-79 years). From the PDQ-J survey, 49 patients (15 %) were classified as having neuropathic pain, and 190 (58 %) were categorized as having nociceptive pain. Patients in the neuropathic pain group had significantly higher VAS scores and lower SF-36 and JOABPEQ scores compared to the nociceptive pain group. We examined the impact of nociceptive or neuropathic LBP on QOL. A comparison of JOABPEQ scores between LBP patients assessed by PDQ-J as having neuropathic pain or nociceptive pain suggests that neuropathic pain affects the social and psychological well-being of LBP patients.	[Hiyama, Akihiko; Watanabe, Masahiko; Katoh, Hiroyuki; Sato, Masato; Sakai, Daisuke; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthopaed Surg Surg Sci, Isehara, Kanagawa 2591193, Japan	Hiyama, A (reprint author), Tokai Univ, Sch Med, Dept Orthopaed Surg Surg Sci, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	a.hiyama@tokai-u.jp; masahiko@is.icc.u-tokai.ac.jp; hero@tokai-u.jp; sato-m@is.icc.u-tokai.ac.jp; daisakai@is.icc.u-tokai.ac.jp; jomo@is.icc.u-tokai.ac.jp					Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Chen HP, 2004, MAYO CLIN PROC, V79, P1533; O'Connor AB, 2009, PHARMACOECONOMICS, V27, P95, DOI 10.2165/00019053-200927020-00002; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Schmidt CO, 2009, EUR J PAIN, V13, P1030, DOI 10.1016/j.ejpain.2008.12.003; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Morso L, 2011, CLIN J PAIN, V27, P535, DOI 10.1097/AJP.0b013e318208c941; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; De Andres J, 2012, CLIN J PAIN, V28, P243, DOI 10.1097/AJP.0b013e31822bb35b; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Kaki AM, 2005, REGION ANESTH PAIN M, V30, P422, DOI 10.1016/j.rapm.2005.05.013; Fukui M, 2009, J ORTHOP SCI, V14, P348, DOI 10.1007/s00776-009-1337-8; Beith ID, 2011, PAIN, V152, P1511, DOI 10.1016/j.pain.2011.02.033; Fukui M, 2007, J ORTHOP SCI, V12, P443, DOI 10.1007/s00776-007-1162-x; Ohtori S, 2010, J ORTHOP SCI, V15, P86, DOI 10.1007/s00776-009-1426-8; Gustorff B, 2008, ACTA ANAESTH SCAND, V52, P132, DOI 10.1111/j.1399-6576.2007.01486.x; Freynhagen R, 2009, CURR PAIN HEADACHE R, V13, P185, DOI 10.1007/s11916-009-0032-y; Fukui M, 2007, J ORTHOP SCI, V12, P526, DOI 10.1007/s00776-007-1168-4; Fukui M, 2008, J ORTHOP SCI, V13, P173, DOI 10.1007/s00776-008-1213-y; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Matsubayashi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068013; Taylor Rod S, 2006, Pain Pract, V6, P22, DOI 10.1111/j.1533-2500.2006.00054.x; Timmerman H, 2013, PAIN PRACT, V13, P206, DOI 10.1111/j.1533-2500.2012.00577.x; Yamashita T, 2014, J ORTHOP SCI, V19, P15, DOI 10.1007/s00776-013-0496-9	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	MAR	2015	24	3					503	512		10.1007/s00586-014-3723-y		10	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CE0SB	WOS:000351514600012		
J	Kurosawa, D; Murakami, E; Aizawa, T				Kurosawa, Daisuke; Murakami, Eiichi; Aizawa, Toshimi			Referred pain location depends on the affected section of the sacroiliac joint	EUROPEAN SPINE JOURNAL			English	Article						Sacroiliac joint; Dysfunction; Periarticular injection; Referred pain; Groin pain	LOW-BACK-PAIN; PROVOCATION TESTS; LUMBAR; BLOCKS; FUSION	Pain referred from the sacroiliac joint (SIJ) may originate in the joint's posterior ligamentous region. The site of referred pain may depend on which SIJ section is affected. This study aimed to determine the exact origin of pain referred from four SIJ sections. The study included 50 patients with SIJ dysfunction, confirmed by more than 70 % pain relief after periarticular injection of local anesthetic into the SIJ. The posterior SIJ was divided into four sections-upper, middle, lower, and other (cranial portion of the ilium outside the SIJ)-designated sections 1, 2, 3, and 0, respectively. We then inserted a needle into the periarticular SIJ under fluoroscopy. After the patient identified the area(s) in which the needle insertion produced referred pain, we injected a mixture of 2 % lidocaine and contrast medium into the corresponding SIJ section. Referred pain from SIJ section 0 was mainly located in the upper buttock along the iliac crest; pain from section 1, around the posterosuperior iliac spine; pain from section 2, in the middle buttock area; pain from section 3, in the lower buttock. In all, 22 (44.0 %) patients complained of groin pain, which was slightly relieved by lidocaine injection into SIJ sections 1 and 0. Dysfunctional upper sections of the SIJ are associated with pain in the upper buttock and lower sections with pain in the lower buttock. Groin pain might be referred from the upper SIJ sections.	[Kurosawa, Daisuke; Murakami, Eiichi] Sendai Shakaihoken Hosp, Low Back Pain & Sacroiliac Joint Ctr, Aoba Ku, Sendai, Miyagi 9818501, Japan; [Aizawa, Toshimi] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan	Kurosawa, D (reprint author), Sendai Shakaihoken Hosp, Low Back Pain & Sacroiliac Joint Ctr, Aoba Ku, 3-16-1 Tsutsumi Cho, Sendai, Miyagi 9818501, Japan.	d-kurorin@m3.dion.ne.jp					Dreyfuss P, 1996, SPINE, V21, P2594, DOI 10.1097/00007632-199611150-00009; Broadhurst NA, 1998, J SPINAL DISORD, V11, P341; Maigne JY, 2005, EUR SPINE J, V14, P654, DOI 10.1007/s00586-004-0692-6; SCHWARZER AC, 1995, SPINE, V20, P31, DOI 10.1097/00007632-199501000-00007; Murakami E, 2007, J ORTHOP SCI, V12, P274, DOI 10.1007/s00776-007-1126-1; Slipman CW, 2000, ARCH PHYS MED REHAB, V81, P334, DOI 10.1053/apmr.2000.0810334; Liliang PC, 2011, PAIN MED, V12, P565, DOI 10.1111/j.1526-4637.2011.01087.x; Maigne JY, 1996, SPINE, V21, P1889, DOI 10.1097/00007632-199608150-00012; Bernard Thomas N. Jr., 1997, P2343; Borowsky CA, 2008, ARCH PHYS MED REHAB, V89, P2048, DOI 10.1016/j.apmr.2008.06.006; Eichenseer PH, 2011, SPINE, V36, pE1446, DOI 10.1097/BRS.0b013e31820bc705; FEINSTEIN B, 1954, J BONE JOINT SURG AM, V36-A, P981; Fukui Sei, 2002, J Anesth, V16, P245, DOI 10.1007/s005400200033; Hackett GS, 1958, LIGAMENT TENDON RELA; Hakata S, 2005, MANUELLE MED, V43, P19, DOI 10.1007/s00337-005-0339-7; Jonathan NS, 2009, SPINE, V34, pE27; Kanno H, 2007, J ORTHOP SCI, V12, P254, DOI 10.1007/s00776-007-1127-0; Kurosawa D, 2011, INT MUSCULOSKELET ME, V33, P85; Luukkainen RK, 2002, CLIN EXP RHEUMATOL, V20, P31; Palsson TS, 2012, PAIN, V153, P2233, DOI 10.1016/j.pain.2012.07.013; Sakamoto N, 2001, Spine (Phila Pa 1976), V26, pE468, DOI 10.1097/00007632-200110150-00008; Vleeming A, 2007, MOVEMENT STABILITY L	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	MAR	2015	24	3					521	527		10.1007/s00586-014-3604-4		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CE0SB	WOS:000351514600014		
J	Yamanaka, A; Iwai, H; Uemura, M; Goto, T				Yamanaka, Atsushi; Iwai, Haruki; Uemura, Masanori; Goto, Tetsuya			Patterning of mammalian heterodont dentition within the upper and lower jaws	EVOLUTION & DEVELOPMENT			English	Article							UPPER LATERAL INCISOR; SHREW SUNCUS-MURINUS; HOMEOBOX GENES; TOOTH MORPHOGENESIS; FACIAL PRIMORDIA; BRANCHIAL ARCH; ORIGIN; MOUSE; MESENCHYME; MICE	Mammalian heterodont dentition is differentiated into incisors, canines, premolars, and molars in the mesial-distal direction, in both the upper and lower jaws. Although all the lower teeth are rooted in the mandible, the upper incisors are rooted in the premaxilla and the upper canine and the teeth behind it are in the maxilla. The present study uncovers ontogenetic backgrounds to these shared and differing mesiodistal patterns of the upper and lower dentition. To this end, we examined the dentition development of the house shrew, Suncus murinus, instead of the rodent model animals because the dentition of this primitive eutherian species includes all the tooth classes, and no toothless diastema region. In the shrew, the upper incisor-forming region extended over the medial nasal prominence and the mesial part of the maxillary prominence. Consequently, the maxillary and mandibular prominences were in a mirror-image relationship in terms of the mesiodistally differentiated tooth-forming regions and of the complementary gene expression pattern, with Bmp4 in the mesial and Fgf8 in the distal regions. This suggests shared molecular mechanisms regulating tooth class differentiation between the upper and lower jaws. However, the premaxillary bone appeared within the mesenchyme of the medial nasal prominence, but grew distally beyond the former epithelial boundary with the maxillary prominence to form, finally, the incisive (premaxillary-maxillary) suture just mesial to the canine. Therefore, the developmental locations of the upper incisors are not inconsistent with the classical osteological criterion of the upper canine by comparative odontologists.	[Yamanaka, Atsushi; Iwai, Haruki; Uemura, Masanori; Goto, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Anat & Cell Biol, Kagoshima 8908544, Japan	Yamanaka, A (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Anat & Cell Biol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	yamanaka@dent.kagoshima-u.ac.jp			KAKENHI from MEXT [21791794]	This work was supported by KAKENHI from MEXT (21791794 to A.Y.).	Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Fish JL, 2011, EVOL DEV, V13, P549, DOI 10.1111/j.1525-142X.2011.00511.x; Mandler M, 2001, DEV BIOL, V240, P548, DOI 10.1006/dbio.2001.0490; Depew MJ, 2005, J ANAT, V207, P501; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Depew MJ, 2008, J EXP ZOOL PART B, V310B, P315, DOI 10.1002/jez.b.21205; Kemp TS, 2006, ZOOL J LINN SOC-LOND, V147, P473, DOI 10.1111/j.1096-3642.2006.00226.x; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; RICHMAN JM, 1989, DEV BIOL, V136, P201, DOI 10.1016/0012-1606(89)90142-5; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Wei X, 2000, CLEFT PALATE-CRAN J, V37, P571, DOI 10.1597/1545-1569(2000)037<0571:TOADOT>2.0.CO;2; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Ferguson CA, 2000, DEVELOPMENT, V127, P403; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Thomas BL, 1998, EUR J ORAL SCI, V106, P48; Lu MF, 1999, NATURE, V401, P276; Depew MJ, 2006, DEV DYNAM, V235, P1256, DOI 10.1002/dvdy.20796; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Lee SH, 2004, DEV BIOL, V276, P207, DOI 10.1016/j.ydbio.2004.08.045; Hillson S., 2005, TEETH; Hovorakova M, 2006, J DENT RES, V85, P167; Hutterer R., 2005, ADV BIOL SHREWS, VII, P397; Hutterer R, 2005, MAMMAL SPECIES WORLD, V2, P220; Kemp T. S., 2005, ORIGIN EVOLUTION MAM; KINDAHL MARTHA, 1959, ACTA ODONTOL SCAND, V17, P203, DOI 10.3109/00016355908993930; Kriangkrai R, 2006, DEV DYNAM, V235, P2134, DOI 10.1002/dvdy.20875; Lin CR, 1999, NATURE, V401, P279; Liu W, 2005, DEV BIOL, V283, P282, DOI 10.1016/j.ydbio.2005.04.019; Lucas PW., 2004, DENT FUNCTIONAL MORP; Luckett W. P., 1985, EVOLUTIONARY RELATIO, P227; Meng Jin, 2001, Journal of Mammalian Evolution, V8, P1, DOI 10.1023/A:1011328616715; Miletich I, 2011, P NATL ACAD SCI USA, V108, P19270, DOI 10.1073/pnas.1112801108; Munne PM, 2010, EVOL DEV, V12, P383, DOI 10.1111/j.1525-142X.2010.00425.x; Ogi Hidenao, 2002, Cellular and Molecular Biology (Noisy-Le-Grand), V48, pOL289; Ooe T., 1968, HUMAN TOOTH DENTAL A; PETERKOVA R, 1993, INT J DEV BIOL, V37, P581; Peterkova R, 2006, J EXP ZOOL PART B, V306B, P234, DOI 10.1002/jez.b.21093; Putnova I, 2011, ARCH ORAL BIOL, V56, P1624, DOI 10.1016/j.archoralbio.2011.06.005; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Richman JM, 2006, DEV DYNAM, V235, P1230, DOI 10.1002/dvdy.20716; Sasaki C, 2001, ARCH ORAL BIOL, V46, P649, DOI 10.1016/S0003-9969(01)00007-3; Sharpe PT, 1995, CONNECT TISSUE RES, V32, P17, DOI 10.3109/03008209509013701; Thomas BL, 1998, EUR J ORAL SCI, V106, P44; Ungar P. S., 2010, MAMMAL TEETH ORIGIN; Viriot L, 2002, CONNECT TISSUE RES, V43, P129, DOI 10.1080/03008200290001168; WEDDEN SE, 1987, DEVELOPMENT, V99, P341; Wilkinson D. G., 1992, SITU HYBRIDIZATION P, P75; Yamanaka A, 2007, EUR J ORAL SCI, V115, P433, DOI 10.1111/j.1600-0722.2007.00499.x; Yamanaka A, 2010, ARCH ORAL BIOL, V55, P279, DOI 10.1016/j.archoralbio.2010.02.006; Yasui K, 2000, GENESIS, V28, P143, DOI 10.1002/1526-968X(200011/12)28:3/4<143::AID-GENE80>3.0.CO;2-T; Yates T.L., 1984, P117	58	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-541X	1525-142X		EVOL DEV	Evol. Dev.	MAR-APR	2015	17	2					127	138		10.1111/ede.12116		12	Evolutionary Biology; Developmental Biology; Genetics & Heredity	Evolutionary Biology; Developmental Biology; Genetics & Heredity	CE3RC	WOS:000351745000001		
J	Suzuki, DG; Murakami, Y; Yamazaki, Y; Wada, H				Suzuki, Daichi G.; Murakami, Yasunori; Yamazaki, Yuji; Wada, Hiroshi			Expression patterns of Eph genes in the "dual visual development" of the lamprey and their significance in the evolution of vision in vertebrates	EVOLUTION & DEVELOPMENT			English	Article							SEA LAMPREY; PHYLOGENETIC ANALYSES; GANGLION-CELLS; RETINA; INSIGHTS; LARVAL; GENOME; DIFFERENTIATION; AMPHIOXUS; ORIGIN	Image-forming vision is crucial to animals for recognizing objects in their environment. In vertebrates, this type of vision is achieved with paired camera eyes and topographic projection of the optic nerve. Topographic projection is established by an orthogonal gradient of axon guidance molecules, such as Ephs. To explore the evolution of image-forming vision in vertebrates, lampreys, which belong to the basal lineage of vertebrates, are key animals because they show unique dual visual development. In the embryonic and pre-ammocoete larval stage (the primary phase), photoreceptive ocellus-like eyes develop, but there is no retinotectal optic nerve projection. In the late ammocoete larval stage (the secondary phase), the eyes grow and form into camera eyes, and retinotectal projection is newly formed. After metamorphosis, this retinotectal projection in adult lampreys is topographic, similar to that of gnathostomes. In this study, we explored the involvement of Ephs in lamprey dual visual development and establishment of the image-form vision. We found that gnathostome-like orthogonal gradient expression was present in the retina during the secondary phase; i.e., EphB showed a gradient of expression along the dorsoventral axis, while EphC was expressed along the anteroposterior axis. However, no orthogonal gradient expression was observed during the primary phase. These observations suggest that Ephs are likely recruited de novo for the guidance of topographical second optic nerve projection. Transformations during lamprey dual visual development may represent recapitulation from a protochordate-like ancestor to a gnathostome-like vertebrate ancestor.	[Suzuki, Daichi G.; Wada, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Murakami, Yasunori] Ehime Univ, Dept Biol, Fac Sci, Matsuyama, Ehime 7908577, Japan; [Yamazaki, Yuji] Toyama Univ, Dept Biol, Fac Sci, Toyama 9308555, Japan	Suzuki, DG (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	daichi1207@gmail.com			 [13J00621];  [23128502]	The authors thank the anonymous reviewers for their constructive comments and suggestions that improved the quality of the article. This work is supported by Grant-in-Aid for JSPS Fellows 13J00621 to D. G. S., and Grant-in-Aid for Scientific Research on Innovative Areas 23128502 to H. W.	Villar-Cheda B, 2008, BRAIN RES, V1201, P60, DOI 10.1016/j.brainres.2008.01.077; Gustafsson OSE, 2008, J EXP BIOL, V211, P1559, DOI 10.1242/jeb.016048; KOSAREVA AA, 1980, J HIRNFORSCH, V21, P243; TAHARA Y, 1988, ZOOL SCI, V5, P109; Murakami Y, 2005, DEV BIOL, V280, P249, DOI 10.1016/j.ydbio.2005.02.008; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Melendez-Ferro M, 2002, J COMP NEUROL, V442, P250, DOI 10.1002/cne.10090; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Smith JJ, 2012, CURR BIOL, V22, P1524, DOI 10.1016/j.cub.2012.06.028; Yamazaki Y, 1998, ENVIRON BIOL FISH, V52, P149, DOI 10.1023/A:1007459103702; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Murakami Y, 2004, DEVELOPMENT, V131, P983, DOI 10.1242/dev.00986; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Jones MR, 2009, J COMP NEUROL, V517, P257, DOI [10.1002/cne.22203, 10.1002/cne.22154]; Lacalli TC, 2001, PHILOS T ROY SOC B, V356, P1565, DOI 10.1098/rstb.2001.0974; Yamazaki Y, 2006, J FISH BIOL, V68, P251, DOI 10.1111/j.1095-8649.2006.01070.x; DEMIGUEL E, 1990, J COMP NEUROL, V302, P529; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Richardson MK, 2010, BIOL REV, V85, P1, DOI 10.1111/j.1469-185X.2009.00092.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Darwin C., 1859, ORIGIN SPECIES; DEMIGUEL E, 1989, NEUROSCI LETT, V106, P1; Kleerekoper H, 1972, BIOL LAMPREYS, V2, P373; Ogasawara M, 2000, DEV BIOL, V223, P399, DOI 10.1006/dbio.2000.9756; Potter IC, 1992, J ZOOL, V225, P1; Suga H, 1999, J MOL EVOL, V49, P601, DOI 10.1007/PL00006581; Suzuki DG, 2015, J COMP NEUROL, V523, P251, DOI 10.1002/cne.23679; Villar-Cervino V, 2006, J COMP NEUROL, V499, P810, DOI 10.1002/cne.21136; WRIGHT GM, 1980, GEN COMP ENDOCR, V42, P187, DOI 10.1016/0016-6480(80)90187-2	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-541X	1525-142X		EVOL DEV	Evol. Dev.	MAR-APR	2015	17	2					139	147		10.1111/ede.12119		9	Evolutionary Biology; Developmental Biology; Genetics & Heredity	Evolutionary Biology; Developmental Biology; Genetics & Heredity	CE3RC	WOS:000351745000002		
J	Mizutani, S; Mizutani, E				Mizutani, S.; Mizutani, E.			New Insights into the Role of Sex Steroid Hormones in Pregnancy: Possible Therapeutic Approach by Sex Steroid Hormones for the Treatment of Both Preeclampsia and Preterm Labor	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES			English	Review						preeclampsia; preterm labor; sex steroid treatment; new role of sex steroid hormones in pregnancy	PLACENTAL LEUCINE AMINOPEPTIDASE; IN-VITRO DEGRADATION; ANGIOTENSIN-II; FETAL DEVELOPMENT; MEMBRANE AMINOPEPTIDASE; SUBCELLULAR-FRACTIONS; PROGESTERONE THERAPY; P-LAP; A AAP; SERUM	Fetal peptide hormones are essential for the development of fetus, which increase in accordance with pregnancy term. Concentration of these hormones within the feto-placental unit is normally higher than that of maternal circulation. Since these hormones are biologically active, the leakage of these hormones into the maternal circulation is regulated by degradation activity by placental aminopeptidases, in order to maintain the balance between carriage of pregnancy and onset of labor. Because the concentration of these hormones, being regulated by the amount of endogenous production and by physiological degradation by enzymes in the blood and tissue, the balance between production and degradation is a definitive element for maintaining normal gestation and term delivery. The changes of the balance between fetal angiotensin II (A-II) and vasopressin (AVP) and A-II and AVP degrading enzymes, between aminopeptidase A (APA) and placental leucine aminopeptidase( P-LAP) -in the placenta and maternal blood due to fetal stress such as hypoxia -are the provable causes of preeclampsia or preterm labor. Induction of APA and P-LAP by estradiol benzoate (E2) and progesterone (P) from placenta has been demonstrated. They are involved in the regulation of fetal peptide hormones via placental aminopeptidases in homeostasis of pregnancy. Recently it was shown that both APA and P-LAP could be potentially safe and effective drugs for preeclampsia and preterm labor. The authors' proposed sex steroid treatment with dose increasing manner by gestational week (sex steroid treatment) for severe preeclampsia and preterm labor could be candidates replacing conventional treatments. In light of lacking safe and effective medication, the proposed sex steroid treatment is worthwhile for the prospective controlled studies for the treatment of both preeclampsia and preterm labor.	[Mizutani, S.; Mizutani, E.] Daiya Bldg Ladys Clin, Nakamura Ku, Nagoya, Aichi 4500002, Japan	Mizutani, S (reprint author), Daiya Bldg Ladys Clin, Nakamura Ku, 1F,2,3-15-1 Meieki, Nagoya, Aichi 4500002, Japan.	shigehiko-m@proof.ocn.ne.jp			ministry of Education, Science and Culture of Japan	Declaration of interest: The paper was supported by a grant in aid of scientific research from the ministry of Education, Science and Culture of Japan.	ALEXANDE.DP, 1972, BIOL NEONATE, V21, P219; Johnson MP, 2007, MOL HUM REPROD, V13, P61, DOI 10.1093/molehr/gal095; Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961; Iwanaga K, 2003, FEBS LETT, V552, P120, DOI 10.1016/S0014-5793(03)00897-4; Laigaard J, 2005, OBSTET GYNECOL, V106, P144, DOI 10.1097/01.AOG.0000165829.65319.65; Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016; RINGLER GE, 1990, ENDOCR REV, V11, P105; Babischkin JS, 1997, BIOL REPROD, V56, P272, DOI 10.1095/biolreprod56.1.272; Ito N, 2004, BIOCHEM BIOPH RES CO, V314, P1008, DOI 10.1016/j.bbrc.2003.12.183; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; ASSALI NS, 1978, INT J FERTIL, V23, P219; Bimbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406; Brown CM, 2014, DRUGS, V74, P283, DOI 10.1007/s40265-014-0187-7; Brown CM, 2011, CURR HYPERTENS REP, V13, P338, DOI 10.1007/s11906-011-0214-y; CHARD T, 1971, NATURE, V234, P352, DOI 10.1038/234352a0; Cheung C Y, 1992, MED FETUS MOTHER, P155; DAVIS MH, 1987, ARCH BIOCHEM BIOPHYS, V254, P498, DOI 10.1016/0003-9861(87)90129-9; DEVANE GW, 1980, J CLIN ENDOCR METAB, V51, P1412; DIAMANT YZ, 1975, BIOCHIM BIOPHYS ACTA, V385, P257, DOI 10.1016/0304-4165(75)90353-0; ERVIN MG, 1993, REGUL PEPTIDES, V45, P203, DOI 10.1016/0167-0115(93)90207-O; FRIEDLAND J, 1977, SCIENCE, V197, P64, DOI 10.1126/science.194311; Gack S, 2005, J MOL MED-JMM, V83, P887, DOI 10.1007/s00109-005-0714-9; Gergopoulos K, 1992, SCIENCE, V258, P808; Hariyama Y, 2000, PLACENTA, V21, P621, DOI 10.1053/plac.2000.0555; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931; Horio J, 1999, BIOCHEM BIOPH RES CO, V262, P269, DOI 10.1006/bbrc.1999.1184; INO K, 1994, JPN J CANCER RES, V85, P927; Ito T, 2001, MOL HUM REPROD, V7, P887, DOI 10.1093/molehr/7.9.887; Ito T, 2002, BIOCHEM BIOPH RES CO, V290, P1048, DOI 10.1006/bbrc.2001.6325; IWASAKI Y, 1991, J NEUROL SCI, V103, P151, DOI 10.1016/0022-510X(91)90158-4; Iwase A, 2001, ARCH BIOCHEM BIOPHYS, V393, P163, DOI 10.1006/abbi.2001.2489; Katsumata Y, 2001, PLACENTA, V22, P831, DOI 10.1053/plac.2001.0741; KINGDOM JCP, 1993, BRIT J OBSTET GYNAEC, V100, P476, DOI 10.1111/j.1471-0528.1993.tb15276.x; Kozaki H, 2001, INT J GYNECOL OBSTET, V73, P207, DOI 10.1016/S0020-7292(01)00372-1; KURAUCHI O, 1989, EXP CLIN ENDOCRINOL, V93, P90; Likis FE, 2012, OBSTET GYNECOL, V120, P897, DOI 10.1097/AOG.0b013e3182699a15; Matsuura S, 2004, EARLY HUM DEV, V77, P47, DOI 10.1016/j.earhumdev.2004.01.006; MCDONOUGH PG, 1985, FERTIL STERIL, V44, P13; MIURA S, 1983, GASTROENTEROLOGY, V85, P1340; MIZUTANI S, 1987, ARCH GYNECOL OBSTET, V240, P27, DOI 10.1007/BF02134061; MIZUTANI S, 1985, ARCH GYNECOL, V236, P165, DOI 10.1007/BF02133960; Mizutani S, 2013, EXPERT OPIN INV DRUG, V22, P1425, DOI 10.1517/13543784.2013.825248; MIZUTANI S, 1985, EXP CLIN ENDOCRINOL, V86, P310; MIZUTANI S, 1988, EXP CLIN ENDOCRINOL, V92, P161; MIZUTANI S, 1985, ACTA ENDOCRINOL-COP, V110, P135; MIZUTANI S, 1981, BIOCHIM BIOPHYS ACTA, V662, P168, DOI 10.1016/0005-2744(81)90240-0; Mizutani S, 2009, EXPERT OPIN MED DIAG, V3, P471; Mizutani S, 1979, ACTA OBSTET GYN JPN, V31, P493; Naruki M, 1995, MED SCI RES, V23, P797; OOSTERBAAN HP, 1989, EARLY HUM DEV, V19, P253, DOI 10.1016/0378-3782(89)90060-1; PHAT VN, 1981, LAB INVEST, V45, P387; PIPKIN FB, 1977, CLIN SCI MOL MED, V52, P449; RESNIK R, 1974, ENDOCRINOLOGY, V94, P1192; ROBERTS RM, 1976, ARCH BIOCHEM BIOPHYS, V177, P499, DOI 10.1016/0003-9861(76)90461-6; Rogi T, 1996, J BIOL CHEM, V271, P257; Rozenberg P, 2012, AM J OBSTET GYNECOL, V206, p206 e1 206 e9; Ryan K J, 1980, MATERNAL FETAL ENDOC, P3; Safwat A M, 1995, MED SCI RES, V23, P123; SAKURA H, 1981, BIOCHEM INT, V2, P173; Sammour MB, 2005, J STEROID BIOCHEM, V97, P439, DOI 10.1016/j.jsbmb.2005.08.014; SAMMOUR MB, 1982, CLIN EXP HYPERTENS B, V1, P455; Smith GVS, 1941, J CLIN ENDOCRINOL, V1, P477; YASUDA Y, 1992, HORM METAB RES, V24, P110, DOI 10.1055/s-2007-1003270	63	0	0	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0947-7349	1439-3646		EXP CLIN ENDOCR DIAB	Exp. Clin. Endocrinol. Diabet.	MAR	2015	123	3					159	164		10.1055/s-0034-1398622		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CE2QP	WOS:000351660700002		
J	Shimodaira, M; Niwa, T; Nakajima, K; Kobayashi, M; Hanyu, N; Nakayama, T				Shimodaira, M.; Niwa, T.; Nakajima, K.; Kobayashi, M.; Hanyu, N.; Nakayama, T.			The Relationship between Serum Calcium Level and Early-phase Insulin Secretion in Normoglycemic and Pre-diabetic Individuals	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES			English	Article						diabetes; insulinogenic index; insulin secretion; prediabetes; serum calcium	BETA-CELL FUNCTION; FASTING PLASMA-GLUCOSE; DIABETES-MELLITUS; PRIMARY HYPERPARATHYROIDISM; CARDIOVASCULAR-DISEASE; RISK-FACTORS; RESISTANCE; TOLERANCE; HOMEOSTASIS; PHOSPHATE	Introduction: Type 2 diabetes mellitus (T2DM) is linked to altered calcium metabolism. However, little is known about the relationship between serum calcium levels and early-phase insulin secretion in subjects with normoglycemic tolerance (NGT) or prediabetes (preDM). Methods: In this gender-separated crosssectional study, 352 subjects with NGT (215 men and 137 women; age: 48.8 +/- 9.1 years and 51.6 +/- 6.7 years, respectively) and 316 subjects with preDM (231 men and 85 women; age: 52.5 +/- 8.6 years and 54.2 +/- 8.0 years, respectively) were examined. Following a 75-g oral glucose tolerance test, early-phase insulin secretion was estimated using the insulinogenic index (IGI) [Delta Insulin((30-0 min))/Delta Glucose((30-0 min))]. Results: Simple linear regression analysis showed that IGI was positively correlated with serum calcium and albumin-adjusted calcium levels in men with NGT and preDM. However, IGI was not correlated with calcium levels in women with NGT and preDM. Multivariate linear regression analysis of men with NGT revealed that the albumin-adjusted calcium level was the major predictor of IGI, responsible for 5.1 % of its variation (P = 0.003). In addition, in men with preDM, the albumin-adjusted calcium level was one of the predictors of IGI, responsible for 3.8 % of its variation (P = 0.004). These associations were independent of age, BMI, and HbA1c. Conclusions: In non-diabetic Japanese men, serum calcium levels significantly correlate with early-phase insulin secretion. Serum calcium levels may be an independent predictor of beta-cell function in men.	[Shimodaira, M.; Niwa, T.; Nakajima, K.; Kobayashi, M.; Hanyu, N.] Iida Municipal Hosp, Dept Internal Med, Nagano, Japan; [Shimodaira, M.; Nakayama, T.] Nihon Univ, Sch Med, Div Lab Med, Dept Pathol & Microbiol, Tokyo, Japan	Shimodaira, M (reprint author), Iida Municipal Hosp, Dept Internal Med, 438 Yawata Machi, Iida, Nagano 3958502, Japan.	masanori19810813@yahoo.co.jp					American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Wareham NJ, 1997, METABOLISM, V46, P1171, DOI 10.1016/S0026-0495(97)90212-2; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; CURRY DL, 1968, AM J PHYSIOL, V214, P174; SERGEEV IN, 1995, ENDOCRINOLOGY, V136, P2852, DOI 10.1210/en.136.7.2852; Hitman GA, 1998, DIABETES, V47, P688, DOI 10.2337/diabetes.47.4.688; Hagstrom E, 2007, DIABETOLOGIA, V50, P317, DOI 10.1007/s00125-006-0532-9; Liu SH, 2010, ENDOCRINOLOGY, V151, P859, DOI 10.1210/en.2009-1107; LIND L, 1988, BRIT MED J, V297, P960; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Taylor WH, 2001, DIABETES METAB RES, V17, P175, DOI 10.1002/dmrr.199; Baird GS, 2011, CLIN CHIM ACTA, V412, P696, DOI 10.1016/j.cca.2011.01.004; Tassone F, 2009, DIABETIC MED, V26, P968, DOI 10.1111/j.1464-5491.2009.02804.x; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; LEE S, 1994, ENDOCRINOLOGY, V134, P1602, DOI 10.1210/en.134.4.1602; CADE C, 1986, ENDOCRINOLOGY, V119, P84; AOKI K, 1990, J HYPERTENS, V8, P579, DOI 10.1097/00004872-199006000-00012; Faerch K, 2013, DIABETES CARE, V36, P3691, DOI 10.2337/dc13-0592; GUYNN RW, 1972, ANAL BIOCHEM, V45, P277, DOI 10.1016/0003-2697(72)90028-0; Haglin L, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-116; Lind L, 1997, J CLIN EPIDEMIOL, V50, P967, DOI 10.1016/S0895-4356(97)00104-2; Lorenzo C, 2014, DIABETOLOGIA, V57, P1366, DOI 10.1007/s00125-014-3241-9; Saltevo J, 2011, EUR J ENDOCRINOL, V165, P429, DOI 10.1530/EJE-11-0066; SORVA A, 1990, GERONTOLOGY, V36, P212; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; Yamaguchi T, 2011, METABOLISM, V60, P1334, DOI 10.1016/j.metabol.2011.02.003	32	1	1	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0947-7349	1439-3646		EXP CLIN ENDOCR DIAB	Exp. Clin. Endocrinol. Diabet.	MAR	2015	123	3					165	169		10.1055/s-0034-1394382		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CE2QP	WOS:000351660700003		
J	Xu, HM; Arita, Y; Chen, BX; Wang, M				Xu, Hai-Ming; Arita, Yutaka; Chen, Bingxu; Wang, Min			Description of Pyrophleps bicella (Lepidoptera: Sesiidae), a new Chinese species of clearwing moth	FLORIDA ENTOMOLOGIST			English	Article						clearwing moths; new species; Pyrophleps; South China		A new species of clearwing moth, Pyrophleps bicella Xu & Arita sp. nov., found in southern China, is described. Photos of the adult and of male genitalia are provided. A key to species of Pyrophleps is also provided. The type specimens are deposited in Department of Entomology, South China Agricultural University, Guangzhou, China and National Museum of Nature and Science, Tsukuba, Japan.	[Xu, Hai-Ming; Chen, Bingxu] Guangdong Acad Agr Sci, Plant Protect Res Inst, Guangdong Prov Key Lab High Technol Plant Protect, Guangzhou 510640, Guangdong, Peoples R China; [Xu, Hai-Ming; Wang, Min] South China Agr Univ, Dept Entomol, Guangzhou 510642, Guangdong, Peoples R China; [Arita, Yutaka] Meijo Univ, Zool Lab, Fac Agr, Tempaku Ku, Nagoya, Aichi 4688502, Japan	Wang, M (reprint author), South China Agr Univ, Dept Entomol, Guangzhou 510642, Guangdong, Peoples R China.	minwang@scau.edu.cn			China Litchi and Longan Research System Foundation from the Ministry of Agriculture of China [CARS-33]	We thank the administrators of Nanling National Nature Reserve and Shimentai National Nature Reserve. We thank Dr. A. Kallies for his kindness in correcting the manuscript, and Guoyi Wu and Liusheng Chen for collecting materials. This study was funded by the China Litchi and Longan Research System Foundation (Award no. CARS-33) from the Ministry of Agriculture of China.	Arita Yutaka, 2000, Transactions of the Lepidopterological Society of Japan, V51, P49; Le Cerf F., 1912, B SOC ENTOMOLOGIQUE, P54; Puhringer F., 2004, MITT ENTOMOL ARBGEME, V3, P1; ROBINSON G S, 1976, Entomologist's Gazette, V27, P127; Rothschild LW., 1912, NOVITATES ZOOLOGICAE, V19, P122; Swinhoe C., 1896, ANN MAGAZINE NATURAL, V17, P357	6	0	0	FLORIDA ENTOMOLOGICAL SOC	LUTZ	16125 E LAKE BURRELL DR, LUTZ, FL 33548 USA	0015-4040	1938-5102		FLA ENTOMOL	Fla. Entomol.	MAR	2015	98	1					149	151				3	Entomology	Entomology	CE8JD	WOS:000352087500024		
J	Huang, LL; Owada, M; Wang, M				Huang, Lan-Lan; Owada, Mamoru; Wang, Min			Discovery of the male of Canaea bibarra (Lepidoptera: Thyrididae: Striglininae)	FLORIDA ENTOMOLOGIST			English	Article						Lepidoptera; Thyrididae; Striglininae; Canaea; Hainan; China; Vietnam		The male of Canaea bibarra (Chu & Wang, 1991) (Lepidoptera: Thyrididae: Striglininae) was discovered in Hainan, China for the first time. The male adult is very similar to female except for the paler ground color and monopectinate antenna. The male adults and the genitalia are described, with notes on their distribution and how they differ from related species.	[Huang, Lan-Lan; Wang, Min] South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou 510642, Guangdong, Peoples R China; [Owada, Mamoru] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Wang, M (reprint author), South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou 510642, Guangdong, Peoples R China.	minwang@scau.edu.cn					Chu H.F., 1991, Sinozoologia, V8, P325; Konvicka M, 1998, TROP ZOOL, V11, P1; Robinson G.S., 1994, FIELD GUIDE SMALLER; Shaffer Michael, 1996, Monographs on Australian Lepidoptera, V4, P161; WHALLEY P E S, 1971, Bulletin of the British Museum (Natural History) Entomology, V26, P161; Zhu Chu HF, 1996, FAUNA SINICA INSECTA, V5	6	0	0	FLORIDA ENTOMOLOGICAL SOC	LUTZ	16125 E LAKE BURRELL DR, LUTZ, FL 33548 USA	0015-4040	1938-5102		FLA ENTOMOL	Fla. Entomol.	MAR	2015	98	1					200	201				2	Entomology	Entomology	CE8JD	WOS:000352087500033		
J	Hazir, C; Kanzaki, N; Gulcu, B; Hazir, S; Giblin-Davis, RM				Hazir, Canan; Kanzaki, Natsumi; Gulcu, Baris; Hazir, Selcuk; Giblin-Davis, Robin M.			Reverse taxonomy reveals Pristionchus maupasi (Diplogasterida: Diplogastridae) association with the soil-dwelling bee Andrena optata (Hymenoptera: Andrenidae) in Turkey	FLORIDA ENTOMOLOGIST			English	Editorial Material						Andrena optata; bee; commensalism; dauer; host-specificity; necromeny; nematode-insect association; Pristionchus maupasi; Turkey	PHYLOGENETIC-RELATIONSHIPS; RHABDITIDA DIPLOGASTRIDAE; GENUS PRISTIONCHUS; NEMATODES; EVOLUTION; RECOGNITION; DIVERSITY	Previous molecular operational taxonomic unit (MOTU) survey work with diplogastrid dauers from the abdominal glands of adult female soil- dwelling andrenid bees in Turkey had suggested commensal relationships between species of the genus Andrena and a new species of Koerneria and several species from an unidentified nematode clade near "Mononchoides" (based upon comparisons with GenBank at the time). We used reverse taxonomy on dauer nematodes from Andrena optata from Turkey to successfully culture, morphotype, and sequence adult nematodes that fully matched Pristionchus maupasi and one of the MOTUs previously isolated as dauers from the abdominal glands of A. limata and A. flavipes, and previously designated as belonging to the clade near "Mononchoides." This study demonstrates the value of reverse taxonomy for resolving MOTU identification issues as the depth of the reference sequence database increases and successful cultures or environmental samples of adults are made available for morphotypic and genotypic comparisons. In addition, it has helped expand our knowledge of the potential host range and biogeographical distribution of P. maupasi which was originally thought to be relatively host specific on scarab beetles, and has raised questions about the chemical ecology of dauers for this species in the wild.	[Hazir, Canan; Hazir, Selcuk] Adnan Menderes Univ, Aydin Vocat Sch Hlth Serv, TR-09100 Aydin, Turkey; [Hazir, Canan; Hazir, Selcuk] Adnan Menderes Univ, Fac Arts & Sci, TR-09100 Aydin, Turkey; [Kanzaki, Natsumi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Gulcu, Baris] Duzce Univ, Dept Biol, Fac Arts & Sci, TR-81620 Duzce, Turkey; [Giblin-Davis, Robin M.] Univ Florida, IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL 33314 USA	Giblin-Davis, RM (reprint author), Univ Florida, IFAS, Ft Lauderdale Res & Educ Ctr, 3205 Coll Ave, Davie, FL 33314 USA.	giblin@ufl.edu					Altenkirch G., 1962, BONNER ZOOLOGISCHE B, V7, P161; Kanzaki N, 2013, J NEMATOL, V45, P78; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006; Atighi M. R., 2013, Journal of Nematode Morphology and Systematics, V16, P113; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kanzaki N, 2013, J NEMATOL, V45, P172; Hazir C, 2010, NEMATOLOGY, V12, P65, DOI 10.1163/156854109X448348; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; GIBLINDAVIS RM, 1990, J NEMATOL, V22, P150; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/mls044; Hong RL, 2006, CURR BIOL, V16, P2359, DOI 10.1016/j.cub.2006.10.031; Hong RL, 2008, EVOL DEV, V10, P273, DOI 10.1111/j.1525-142X.2008.00236.x; Kanzaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043865; Kanzaki Natsumi, 2013, Nematological Research, V43, P15; Mayer WE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-104; Michener CD, 2000, BEES WORLD; Potts FA, 1910, Q J MICROSC SCI, V55, P433; Stiernagle Theresa, 2006, WormBook, P1, DOI 10.1895/wormbook.1.101.1; Tanaka R, 2012, APPL ENTOMOL ZOOL, V47, P291, DOI 10.1007/s13355-012-0115-9	20	0	0	FLORIDA ENTOMOLOGICAL SOC	LUTZ	16125 E LAKE BURRELL DR, LUTZ, FL 33548 USA	0015-4040	1938-5102		FLA ENTOMOL	Fla. Entomol.	MAR	2015	98	1					364	367				4	Entomology	Entomology	CE8JD	WOS:000352087500059		
J	Wada, S; Matsushita, Y; Tazawa, H; Aoi, W; Naito, Y; Higashi, A; Ohshima, H; Yoshikawa, T				Wada, S.; Matsushita, Y.; Tazawa, H.; Aoi, W.; Naito, Y.; Higashi, A.; Ohshima, H.; Yoshikawa, T.			Loss of p53 in stromal fibroblasts enhances tumor cell proliferation through nitric-oxide-mediated cyclooxygenase 2 activation	FREE RADICAL RESEARCH			English	Article						deficiency; carcinogenesis; prostaglandin E-2; stromal cells; colorectal caner	COLON-CANCER; COLORECTAL-CANCER; GENE-EXPRESSION; MICRODISSECTED STROMA; CARCINOMA; GROWTH; COX-2; SYNTHASE; SUPPRESSION; ACCUMULATION	Overexpression of cyclooxygenase 2 (COX-2) by stromal fibroblasts plays a critical role in the early stage of carcinogenesis. COX-2 expression is thought to be positively or negatively regulated by inflammatory chemical mediators or tumor suppressors. In this study, the contributions of inducible nitric oxide synthase (iNOS) and p53 to COX-2 expression were examined using mouse embryonic fibroblasts (MEFs) from wild-type, p53-deficient, iNOS-deficient, and p53/iNOS-deficient mice. These MEFs were treated with 1 mu g/mL of lipopolysaccharide and 100 IU/mL of interferon gamma for up to 72 h. iNOS and COX-2 expression were analyzed by Western blotting. iNOS was induced earlier (16 h) in p53-deficient MEFs than in wild-type MEFs (48 h). Elevated expression of COX-2 was sustained for a longer duration in the p53-deficient MEFs. In contrast, COX-2 expression was reduced earlier in the iNOS-deficient MEFs. Addition of an exogenous NO donor (0.8 mM of S-nitroso-L-glutathione) to the iNOS-deficient MEFs augmented COX-2 expression. Co-culture with stimulated p53-deficient MEFs promoted cell proliferation of mouse rectal polyploid carcinoma CMT93 cells, but treatment with a COX-2-specific inhibitor counteracted this effect. These results suggest that loss of function of the p53 gene in stromal fibroblasts enhances COX-2 expression by enhancing iNOS expression and the resultant production of NO, contributing to the promotion of tumor growth.	[Wada, S.; Matsushita, Y.; Aoi, W.; Higashi, A.] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Shimogamo, Japan; [Tazawa, H.] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Naito, Y.; Yoshikawa, T.] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan; [Ohshima, H.] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Grad Program Food & Nutr Sci, Biochem Lab, Shizuoka 4228526, Japan	Wada, S (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Kyoto 6068522, Japan.	poisson@kpu.ac.jp	TAZAWA, Hiroshi/B-2247-2011	TAZAWA, Hiroshi/0000-0003-4658-1050	JSPS [60420709]	This work was supported by a JSPS Grant-in-Aid for Young Scientists (B) to Sayori Wada (Grant no. 60420709).	Ristimaki A, 2002, CANCER RES, V62, P632; Connelly L, 2001, J IMMUNOL, V166, P3873; Liu Q, 2003, CARCINOGENESIS, V24, P637, DOI 10.1093/carcin/bgg014; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Murata M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/623019; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Moon Y, 2002, TOXICOL SCI, V69, P373, DOI 10.1093/toxsci/69.2.373; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Kibbe MR, 2000, J VASC SURG, V31, P364, DOI 10.1016/S0741-5214(00)90166-6; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Niki T, 2002, AM J PATHOL, V160, P1129, DOI 10.1016/S0002-9440(10)64933-4; Paterson RF, 2003, CANCER, V98, P1830, DOI 10.1002/cncr.11747; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Iniguez MA, 2003, TRENDS MOL MED, V9, P73, DOI 10.1016/S1471-4914(02)00011-4; Tazawa H, 2007, CARCINOGENESIS, V28, P191, DOI 10.1093/carcin/bgl128; Fukino K, 2007, JAMA-J AM MED ASSOC, V297, P2103, DOI 10.1001/jama.297.19.2103; Adegboyega PA, 2004, CLIN CANCER RES, V10, P5870, DOI 10.1158/1078-0432.CCR-0431-03; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Cook T, 2004, CANCER RES, V64, P8015, DOI 10.1158/0008-5472.CAN-04-2212; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Schneiderhan N, 2003, ONCOGENE, V22, P2857, DOI 10.1038/sj.onc.1206431; MacKenzie KF, 2013, MOL CELL BIOL, V33, P1456, DOI 10.1128/MCB.01690-12; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Han JA, 2002, EMBO J, V21, P5635, DOI 10.1093/emboj/cdf591; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Singh S, 2011, CANCER CHEMOTH PHARM, V67, P1211, DOI 10.1007/s00280-011-1654-4; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; Hope ME, 2005, FEMS MICROBIOL LETT, V244, P1, DOI 10.1016/j.femsle.2005.01.029; Asting AG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-238; Cressey R, 2006, CANCER LETT, V233, P232, DOI 10.1016/j.canlet.2005.03.023; Davel L, 2002, J BIOL REG HOMEOS AG, V16, P181; Duarte ML, 2009, CANCER LETT, V279, P57, DOI 10.1016/j.canlet.2009.01.021; Goodman JE, 2004, ENVIRON MOL MUTAGEN, V44, P3, DOI 10.1002/em.20024; Goulart JAV, 2009, AM J OTOLARYNG, V30, P89, DOI 10.1016/j.amjoto.2008.02.012; Hao NB, 2012, CLIN DEV IMMUNOL, V2012, DOI [10.1155/2012/948098, DOI 10.1155/2012/948098]; Kawabe A, 2002, ONCOLOGY-BASEL, V62, P46, DOI 10.1159/000048246; Kisley LR, 2002, CANCER RES, V62, P6850; Ko SC, 2002, ONCOGENE, V21, P7175, DOI 10.1038/sj.onc.1205869; Lim SC, 2007, YONSEI MED J, V48, P495, DOI 10.3349/ymj.2007.48.3.495; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mira-Pascual L, 2014, J GASTROENTEROL; Shin IY, 2014, GUT LIVER, V8, P13, DOI [10.5009/gnl.2014.8.1.13, 10.5009/gn1.2014.8.1.13]; Subbaramaiah K, 1999, J BIOL CHEM, V274, P10911, DOI 10.1074/jbc.274.16.10911; Tatemichi M, 2004, INT J CANCER, V111, P819, DOI 10.1002/ijc.20350; Tatemichi M, 2008, ANTICANCER RES, V28, P2101; TETSUKA T, 1994, P NATL ACAD SCI USA, V91, P12168, DOI 10.1073/pnas.91.25.12168; Wernert N, 2001, ANTICANCER RES, V21, P2259; Zaric J, 2005, J BIOL CHEM, V280, P1077, DOI 10.1074/jbc.M410006200	60	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	MAR	2015	49	3					269	278		10.3109/10715762.2014.997230		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CE1WS	WOS:000351604200006		
J	Afrin, R; Arumugam, S; Soetikno, V; Thandavarayan, RA; Pitchaimani, V; Karuppagounder, V; Sreedhar, R; Harima, M; Suzuki, H; Miyashita, S; Nomoto, M; Suzuki, K; Watanabe, K				Afrin, R.; Arumugam, S.; Soetikno, V.; Thandavarayan, R. A.; Pitchaimani, V.; Karuppagounder, V.; Sreedhar, R.; Harima, M.; Suzuki, H.; Miyashita, S.; Nomoto, M.; Suzuki, K.; Watanabe, K.			Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats	FREE RADICAL RESEARCH			English	Article						curcumin; diabetes mellitus; liver; endoplasmic reticulum stress; apoptosis	UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; BETA-CELL FUNCTION; NECROSIS-FACTOR-ALPHA; ER STRESS; OXIDATIVE STRESS; PROINFLAMMATORY CYTOKINES; HEPATIC STEATOSIS; MAMMALIAN-CELLS; MESSENGER-RNAS	We investigated the effect of curcumin on liver injury in diabetic rats induced by streptozotocin (STZ) through modulation of endoplasmic reticulum stress (ERS) and unfolded protein response (UPR). Experimental diabetes was induced by a single intraperitoneal injection of STZ (55 mg/kg), and curcumin was given at 100 mg/kg by gavage for 56 days. We observed that curcumin improved the morphological and histopathological changes, significantly decreased hepatic ERS marker protein: glucose-regulated protein 78, and improved liver function in diabetic rats. Moreover, treatment with curcumin markedly decreased the sub-arm of the UPR signaling protein such as phospho double-stranded RNA-dependent protein kinase-like ER kinase, CCAAT/enhancer-binding protein homologous protein, tumor necrosis factor receptor-associated factor 2, and inositol-requiring enzyme1 alpha; and inhibited tumor necrosis factor alpha, interleukin 1 beta, phospho-p38 mitogen-activated protein kinase, and apoptosis signal-regulating kinase 1 in liver tissues of diabetic rats. Apoptotic and anti-apoptotic signaling proteins, such as cleaved caspase-3 and B-cell lymphoma 2, were significantly increased and decreased, respectively in diabetic rats; curcumin treatment prevented all of these alterations. In summary, our results indicate that curcumin has the potential to protect the diabetic liver by modulating hepatic ERS-mediated apoptosis, and provides a novel therapeutic strategy for the diabetic liver damage.	[Afrin, R.; Arumugam, S.; Soetikno, V.; Thandavarayan, R. A.; Pitchaimani, V.; Karuppagounder, V.; Sreedhar, R.; Harima, M.; Suzuki, H.; Miyashita, S.; Nomoto, M.; Watanabe, K.] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Thandavarayan, R. A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Suzuki, H.] Niigata Univ, Dept Hematol Endocrinol & Metab, Niigata, Japan; [Suzuki, K.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol, Niigata, Japan	Watanabe, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Akiha Ku, 265-1 Higashijima, Niigata 9568603, Japan.	watanabe@nupals.ac.jp			Ministry of Education, Culture, Sports, Sciences and Technology, Japan; promotion and mutual aid corporation for private schools, Japan [23602012, 26460239]	This research was supported by Ministry of Education, Culture, Sports, Sciences and Technology, Japan and by a grant from the promotion and mutual aid corporation for private schools, Japan (23602012 and 26460239), respectively.	Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Lakshmanan AP, 2013, INT J BIOCHEM CELL B, V45, P438, DOI 10.1016/j.biocel.2012.09.017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; de Cavanagh EMV, 2001, HYPERTENSION, V38, P1130, DOI 10.1161/hy1101.092845; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119; Choi H, 2006, MOL PHARMACOL, V70, P1664, DOI 10.1124/mol.106.025817; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x; Watanabe K, 2000, BRIT J PHARMACOL, V130, P1489, DOI 10.1038/sj.bjp.0703450; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Reyes-Gordillo K, 2007, BBA-GEN SUBJECTS, V1770, P989, DOI 10.1016/j.bbagen.2007.02.004; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Nanji AA, 2003, AM J PHYSIOL-GASTR L, V284, pG321, DOI 10.1152/ajpgi.00230.2002; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Harrison SA, 2006, J CLIN GASTROENTEROL, V40, P68, DOI 10.1097/01.mcg.0000190774.91875.d2; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Mahmmoud YA, 2005, BRIT J PHARMACOL, V145, P236, DOI 10.1038/sj.bjp.0706185; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; SINGH S, 1995, J BIOL CHEM, V270, P24995; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Chanpoo M, 2010, J MED ASSOC THAI, V93, pS152; Das Ani V., 1996, Indian Journal of Experimental Biology, V34, P341; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Guven A, 2006, ACTA HISTOCHEM, V108, P85, DOI 10.1016/j.acthis.2006.03.005; Hattori K, 2009, CELL COMMUN SIGNAL, V7, P1; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; LATRY P, 1987, HUM PATHOL, V18, P775, DOI 10.1016/S0046-8177(87)80050-3; LIU JY, 1993, CARCINOGENESIS, V14, P857, DOI 10.1093/carcin/14.5.857; Meghana K, 2007, EUR J PHARMACOL, V577, P183, DOI 10.1016/j.ejphar.2007.09.002; Mito S, 2011, FREE RADICAL RES, V45, P1223, DOI 10.3109/10715762.2011.607252; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Rouse M, 2014, J ENDOCRINOL, V223, P107, DOI 10.1530/JOE-14-0335; Shams Mohamed E E, 2011, Sci Pharm, V79, P623, DOI 10.3797/scipharm.1104-21; Soetikno V, 2012, INTERNATIONAL CONFER; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35	70	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.	MAR	2015	49	3					279	289		10.3109/10715762.2014.999674		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CE1WS	WOS:000351604200007		
J	Fujiya, M; Tanaka, K; Dokoshi, T; Tominaga, M; Ueno, N; Inaba, Y; Ito, T; Moriichi, K; Kohgo, Y				Fujiya, Mikihiro; Tanaka, Kazuyuki; Dokoshi, Tatsuya; Tominaga, Motoya; Ueno, Nobuhiro; Inaba, Yuhei; Ito, Takahiro; Moriichi, Kentaro; Kohgo, Yutaka			Efficacy and adverse events of EMR and endoscopic submucosal dissection for the treatment of colon neoplasms: a meta-analysis of studies comparing EMR and endoscopic submucosal dissection	GASTROINTESTINAL ENDOSCOPY			English	Article							COLORECTAL EPITHELIAL NEOPLASMS; MUCOSAL RESECTION; LARGE SESSILE; CLINICAL-OUTCOMES; SPREADING TUMORS; LEARNING-CURVE; POLYPS; CANCER; FLAT; LESIONS	Background: EMR and endoscopic submucosal dissection (ESD) are used frequently to remove colon neoplasms. However, the predominance of these procedures has not yet been thoroughly explored. Objective: To compare the efficacy and adverse events related to EMR with those related to ESD for colon neoplasms. Design: A meta-analysis of 8 studies published between 2005 and 2013. Setting: Multicenter review. Patients: Patients from 8 studies yielding 2299 lesions. Interventions: EMR or ESD. Main Outcome Measurements: En bloc resection, curative resection, recurrence, and adverse events. Results: The pooled odds ratios (OR) (OR [95% confidence interval]) for the tumor size, length of the procedure, en bloc resection, curative resection, recurrence, additional surgery, delayed bleeding, and perforation by ESD versus EMR were 7.38 (6.42-8.34), 58.07 (36.27-79.88), 6.84 (3.30-14.18), 4.26 (3.77-6.57), 0.08 (0.04-0.17), 2.16 (1.16-4.03), 0.85 (0.45-1.60), and 4.96 (2.79-8.85), respectively. Limitations: This analysis included only nonrandomized studies. Conclusion: The size of the tumor and rate of en bloc resection and curative resection were higher, and the rate of recurrence was lower in the ESD group versus the EMR group. However, in the ESD group, the procedure was longer, and the rate of additional surgery and perforation was higher, suggesting that the indications for ESD should therefore be rigorously determined in order to avoid such problems.	[Fujiya, Mikihiro; Tanaka, Kazuyuki; Dokoshi, Tatsuya; Tominaga, Motoya; Ueno, Nobuhiro; Inaba, Yuhei; Ito, Takahiro; Moriichi, Kentaro; Kohgo, Yutaka] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido 0788510, Japan	Fujiya, M (reprint author), Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	fjym@asahikawa-med.ac.jp					Probst A, 2012, ENDOSCOPY, V44, P660, DOI 10.1055/s-0032-1309403; Saito Y, 2010, SURG ENDOSC, V24, P343, DOI 10.1007/s00464-009-0562-8; Cao Y, 2009, ENDOSCOPY, V41, P751, DOI 10.1055/s-0029-1215053; Tajika M, 2011, EUR J GASTROEN HEPAT, V23, P1042, DOI 10.1097/MEG.0b013e32834aa47b; Kim ES, 2011, ENDOSCOPY, V43, P573, DOI 10.1055/s-0030-1256339; Terasaki M, 2012, J GASTROEN HEPATOL, V27, P734, DOI 10.1111/j.1440-1746.2011.06977.x; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Kobayashi N, 2012, J GASTROEN HEPATOL, V27, P728, DOI 10.1111/j.1440-1746.2011.06942.x; Zhou PH, 2009, SURG ENDOSC, V23, P1546, DOI 10.1007/s00464-009-0395-5; Higaki S, 2003, ENDOSCOPY, V35, P845; Matsumoto A, 2010, SCAND J GASTROENTERO, V45, P1329, DOI 10.3109/00365521.2010.495416; Niimi K, 2010, ENDOSCOPY, V42, P723, DOI 10.1055/s-0030-1255675; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; WALSH RM, 1992, GASTROINTEST ENDOSC, V38, P303; [Anonymous], 2003, GASTROINTEST ENDO S6, V58, pS3; Nakajima T, 2013, SURG ENDOSC, V27, P3262, DOI 10.1007/s00464-013-2903-x; Yoshida N, 2010, WORLD J GASTROENTERO, V16, P4180, DOI 10.3748/wjg.v16.i33.4180; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lee EJ, 2012, SURG ENDOSC, V26, P1587, DOI 10.1007/s00464-011-2075-5; Fujishiro M, 2007, CLIN GASTROENTEROL H, V5, P678, DOI 10.1016/j.cgh.2007.01.006; Tamegai Y, 2007, ENDOSCOPY, V39, P418, DOI 10.1055/s-2007-966427; Gotoda T, 1999, GASTROINTEST ENDOSC, V50, P560, DOI 10.1016/S0016-5107(99)70084-2; Yoshida N, 2009, ENDOSCOPY, V41, P758, DOI 10.1055/s-0029-1215028; Hotta K, 2010, DIGEST ENDOSC, V22, P302, DOI 10.1111/j.1443-1661.2010.01005.x; Puli SR, 2009, ANN SURG ONCOL, V16, P2147, DOI 10.1245/s10434-009-0520-7; Isomoto H, 2009, ENDOSCOPY, V41, P679, DOI 10.1055/s-0029-1214979; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Arebi N, 2007, SCAND J GASTROENTERO, V42, P859, DOI 10.1080/00365520601137280; BEDOGNI G, 1986, DIS COLON RECTUM, V29, P831, DOI 10.1007/BF02555357; Binmoeller KF, 1996, GASTROINTEST ENDOSC, V43, P183; Bories E, 2006, ENDOSCOPY, V38, P231, DOI 10.1055/s-2005-921206; Derry S, 2001, BMC Med Res Methodol, V1, P7, DOI 10.1186/1471-2288-1-7; Doniec JM, 2003, DIS COLON RECTUM, V46, P340, DOI 10.1097/01.DCR.0000049422.26694.8B; Axon A, 2005, ENDOSCOPY, V37, P570, DOI 10.1055/s-2005-861352; Hurlstone DP, 2004, GUT, V53, P1334, DOI 10.1136/gut.2003.036913; Hurlstone DP, 2007, BRIT J SURG, V94, P1536, DOI 10.1002/bjs.5720; Iishi H, 2000, GASTROINTEST ENDOSC, V51, P697, DOI 10.1067/mge.2000.104652; Iizuka H, 2009, GASTROEN CLIN BIOL, V33, P1004, DOI 10.1016/j.gcb.2009.02.039; Kanamori T, 1996, GASTROINTEST ENDOSC, V43, P189; Kim YJ, 2013, DIGEST DIS SCI, V58, P1727, DOI 10.1007/s10620-013-2560-x; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Lee EJ, 2012, SURG ENDOSC, V26, P2220, DOI 10.1007/s00464-012-2164-0; Luigiano C, 2009, ENDOSCOPY, V41, P829, DOI 10.1055/s-0029-1215091; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Saito Y, 2009, DIGEST ENDOSC, V21, pS7, DOI 10.1111/j.1443-1661.2009.00870.x; Seitz U, 2003, ENDOSCOPY, V35, pS41; Shono T, 2011, INT J SURG ONCOLOGY, V2011, DOI DOI 10.1155/2011/948293; Toyonaga T, 2010, Acta Chir Iugosl, V57, P41; Wells G, NEWCASTLE OTTAWA SCA	50	5	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAR	2015	81	3					583	595		10.1016/j.gie.2014.07.034		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SI	WOS:000351666800012		
J	Mori, Y; Kudo, S; Wakamura, K; Misawa, M; Ogawa, Y; Kutsukawa, M; Kudo, T; Hayashi, T; Miyachi, H; Ishida, F; Inoue, H				Mori, Yuichi; Kudo, Shin-ei; Wakamura, Kunihiko; Misawa, Masashi; Ogawa, Yushi; Kutsukawa, Makoto; Kudo, Toyoki; Hayashi, Takemasa; Miyachi, Hideyuki; Ishida, Fumio; Inoue, Haruhiro			Novel computer-aided diagnostic system for colorectal lesions by using endocytoscopy (with videos)	GASTROINTESTINAL ENDOSCOPY			English	Article							IN-VIVO; COLONOSCOPIC POLYPECTOMY; SERRATED ADENOMAS; POLYPS; CLASSIFICATION; HISTOLOGY; CANCER; CHROMOENDOSCOPY; MAGNIFICATION; SURVEILLANCE	Background: Endocytoscopy enables in vivo observation of nuclei at 450x magnification during GI endoscopy, thus allowing precise prediction of lesion pathology. However, because it requires training and experience, it may be beneficial only when performed by expert endoscopists. Objective: To develop and evaluate a novel computer-aided diagnosis system for endocytoscopic imaging (EC-CAD) of colorectal lesions. Design: Pilot study. Setting: University hospital. Patients: One hundred fifty-two patients with small colorectal polyps (<= 10 mm) who had undergone endocytoscopy. Intervention: Test sets of white-light endoscopic images and endocytoscopic images from 176 small colorectal polyps (137 neoplastic and 39 non-neoplastic polyps) were assessed by EC-CAD, 2 expert endoscopists, and 2 trainee endoscopists. Main Outcome Measurement: Sensitivity, specificity, and accuracy in predicting neoplastic change by EC-CAD comparing expert and trainee endoscopists. Results: EC-CAD had a sensitivity of 92.0% and an accuracy of 89.2%; these were comparable to those achieved by expert endoscopists (92.7% and 92.3%; P = .868 and .256, respectively) and significantly higher than those achieved by trainee endoscopists (81.8% and 80.4%; P < .001 and .002, respectively). EC-CAD achieved a specificity of 79.5%; this did not differ significantly from that achieved by the experts and trainees. EC-CAD also enabled instant diagnosis, taking only 0.3 seconds for each lesion with perfect reproducibility. Limitations: No sample size calculation. Conclusions: EC-CAD provides fully automated instant classification of colorectal polyps with excellent sensitivity, accuracy, and objectivity. Thus, it can be a powerful tool for facilitating decision making during routine colonoscopy.	[Mori, Yuichi; Kudo, Shin-ei; Wakamura, Kunihiko; Misawa, Masashi; Ogawa, Yushi; Kutsukawa, Makoto; Kudo, Toyoki; Hayashi, Takemasa; Miyachi, Hideyuki; Ishida, Fumio] Showa Univ, Northern Yokohama Hosp, Ctr Digest Dis, Yokohama, Kanagawa 2248503, Japan; [Inoue, Haruhiro] Showa Univ, Ctr Digest Dis, Koto Toyosu Hosp, Tokyo, Japan	Mori, Y (reprint author), Showa Univ, Yokohama Northern Hosp, Ctr Digest Dis, Tsuzuki Ku, 35-1 Chigasaki Chuo, Yokohama, Kanagawa 2248503, Japan.	ibusiginjp@hotmail.com		Mori, Yuichi/0000-0003-2262-0334	Japan Society for the Promotion of Science [25860564]	All authors disclosed no financial relationships relevant to this article. This study was supported by a Grant-in-Aid for Scientific Research (Yuichi Mori, number 25860564) from the Japan Society for the Promotion of Science.	Pohl J, 2008, AM J GASTROENTEROL, V103, P562, DOI 10.1111/j.1572-0241.2007.01670.x; Rex DK, 2009, AM J GASTROENTEROL, V104, P149, DOI 10.1038/ajg.2008.35; Neumann H, 2011, ALIMENT PHARM THER, V33, P1183, DOI 10.1111/j.1365-2036.2011.04647.x; Hassan C, 2013, ENDOSCOPY, V45, P842, DOI 10.1055/s-0033-1344548; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Rex DK, 2011, GASTROINTEST ENDOSC, V73, P419, DOI 10.1016/j.gie.2011.01.023; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; Kudo SE, 2011, ENDOSCOPY, V43, P869, DOI 10.1055/s-0030-1256663; Inoue H, 2005, NAT CLIN PRACT GASTR, V2, P31, DOI 10.1038/ncpgasthep0072; Huang CS, 2004, AM J GASTROENTEROL, V99, P2242, DOI 10.1111/j.1572-0241.2004.40131.x; East JE, 2007, GASTROINTEST ENDOSC, V66, P310, DOI 10.1016/j.gie.2007.02.026; Kumagai Y, 2004, ENDOSCOPY, V36, P590, DOI 10.1055/s-2004-814533; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Rotondano G, 2010, INT J COLORECTAL DIS, V25, P1111, DOI 10.1007/s00384-010-0969-7; Rastogi A, 2009, AM J GASTROENTEROL, V104, P2422, DOI 10.1038/ajg.2009.403; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Mori Y, 2013, ENDOSCOPY, V45, P98, DOI 10.1055/s-0032-1325932; Lu FI, 2010, AM J SURG PATHOL, V34, P927, DOI 10.1097/PAS.0b013e3181e4f256; Wada Y, 2009, GASTROINTEST ENDOSC, V70, P522, DOI 10.1016/j.gie.2009.01.040; Baba H., 2003, GASTROINTEST ENDOSC, V58, pS3; Gross S, 2011, GASTROINTEST ENDOSC, V74, P1354, DOI 10.1016/j.gie.2011.08.001; Inoue H, 2004, GASTROINTEST ENDOSC, V14, px; Inoue Haruhiro, 2004, Gastrointest Endosc Clin N Am, V14, P589, DOI 10.1016/j.giec.2004.03.013; Kudo SE, 2013, J GASTROEN HEPATOL, V29, P83; Kutsukawa M, 2014, GASTROINTEST ENDOSC, V79, P648, DOI 10.1016/j.gie.2013.08.029; Neumann H, 2010, GASTROENTEROLOGY, V139; Otsu N., 1982, Proceedings of the 6th International Conference on Pattern Recognition; Singh R, 2013, DIGEST ENDOSC, V25, P16, DOI 10.1111/den.12075; Takemura Y, 2012, GASTROINTEST ENDOSC, V75, P179, DOI 10.1016/j.gie.2011.08.051; Tischendorf JJW, 2010, ENDOSCOPY, V42, P203, DOI 10.1055/s-0029-1243861; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; Yasushi Sano MM, 2005, DIGEST ENDOSC, V17, pS43	34	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAR	2015	81	3					621	629		10.1016/j.gie.2014.09.008		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SI	WOS:000351666800016		
J	Mukae, M; Kobayashi, K; Sada, M; Yokoyama, K; Koizumi, W; Saegusa, M				Mukae, Miyuki; Kobayashi, Kiyonori; Sada, Miwa; Yokoyama, Kaoru; Koizumi, Wasaburo; Saegusa, Makoto			Diagnostic performance of EUS for evaluating the invasion depth of early colorectal cancers	GASTROINTESTINAL ENDOSCOPY			English	Article							MAGNIFICATION CHROMOSCOPIC COLONOSCOPY; ENDOSCOPIC ULTRASOUND; MINIPROBE ULTRASONOGRAPHY; MAGNIFYING COLONOSCOPY; RECTAL-CANCER; EFFICACY; CHROMOENDOSCOPY; NEOPLASMS; LESIONS; TUMORS	Background: EUS is one technique used to estimate the invasion depth of early colorectal cancer (CRC), but its diagnostic accuracy remains a matter of debate. Objective: To assess the accuracy of EUS for estimating the invasion depth of early CRC. Design: Retrospective analysis. Setting: Tertiary-care academic medical center. Patients: The invasion depth of early CRC was estimated by EUS from 1989 through 2012. Interventions: EUS. Main Outcome Measurements: Accuracy of EUS diagnosis, risk factors for misdiagnosis, and characteristics of lesions that were difficult to image. Results: We estimated the invasion depth of 714 cases of early CRC on EUS. Of the lesions able to be visualized on EUS, the overall diagnostic accuracy of EUS for differentiating between lesions that could be resected endoscopically (Tis and T1a cancers), and those that required colectomy (T1b cancers) was 89%. Submucosal cancer and a macroscopic classification of superficial type were independent risk factors for misdiagnosis. Ninety lesions (13%) were difficult to image. Risk factors for difficulty in imaging were protruding-type morphology and tumor location in the sigmoid colon or from the descending colon to the cecum. Limitations: Single center, retrospective. Experienced endoscopists performed EUS. Conclusions: Although some lesions that were protruding or located in the proximal colon were difficult to visualize, EUS is considered a useful technique for the diagnosis of invasion depth and the selection of treatment in patients with early CRC.	[Mukae, Miyuki; Sada, Miwa; Yokoyama, Kaoru; Koizumi, Wasaburo] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 2520380, Japan; [Kobayashi, Kiyonori] Kitasato Univ, Sch Med, Res & Dev Ctr New Med Frontiers, Sagamihara, Kanagawa 2520380, Japan; [Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2520380, Japan	Mukae, M (reprint author), Kitasato Univ, Sch Med, Dept Gastroenterol, Minami Ku, 2-1-1 Asamizodai, Sagamihara, Kanagawa 2520380, Japan.						Akahoshi K, 2001, BRIT J RADIOL, V74, P1017; Akasu T, 2000, WORLD J SURG, V24, P1061; Kudo SE, 2008, GASTROINTEST ENDOSC, V68, pS3, DOI 10.1016/j.gie.2008.07.052; Obrocea F, 2011, ROM J MORPHOL EMBRYO, V52, P537; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Saitoh Y, 1998, GASTROINTEST ENDOSC, V48, P362, DOI 10.1016/S0016-5107(98)70004-5; Hurlstone DP, 2004, GUT, V53, P284, DOI 10.1136/gut.2003.027623; Matsuda T, 2008, AM J GASTROENTEROL, V103, P2700, DOI 10.1111/j.1572-0241.2008.02190.x; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Fu KI, 2008, DIGEST DIS SCI, V53, P1886, DOI 10.1007/s10620-007-0104-y; Hamada S, 1998, SURGERY, V123, P264, DOI 10.1016/S0039-6060(98)70178-3; Haruki S, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/621512; Hizawa K, 1996, AM J GASTROENTEROL, V91, P768; Hunerbein M, 2004, SURG ENDOSC, V18, P601, DOI 10.1007/s00464-003-8925-z; Hunerbein M, 2000, ANN SURG, V232, P46, DOI 10.1097/00000658-200007000-00007; Hurlstone DP, 2005, GUT, V54, P1585, DOI 10.1136/gut.2005.069849; Hurlstone DP, 2005, ENDOSCOPY, V37, P710, DOI 10.1055/s-870142; Japanese Society for Cancer of the Colon Rectum, 2013, JAP CLASS COL CARC; Kikuchi Y, 1997, STOMACH INTEST, V32, P1651; Kobayashi K, 2003, DIGEST ENDOSC, V15, P298, DOI 10.1046/j.1443-1661.2003.t01-3-00262.x; Matsumoto T, 2002, GASTROINTEST ENDOSC, V56, P354, DOI 10.1067/mge.2002.127156; Matsunaga A., 2002, Journal of the Japan Society of Coloproctology, V55, P841; Matsunaga A, 1996, GSTROENTEROL ENDOSC, V38, P279; Saitoh Y, 2001, DIG ENDOSC S, V13, pS14, DOI 10.1046/j.1443-1661.2001.0130s1S14.x; Saitoh Y, 1996, GASTROINTEST ENDOSC, V44, P34, DOI 10.1016/S0016-5107(96)70226-2; Tseng LJ, 2002, ENDOSCOPY, V34, P564, DOI 10.1055/s-2002-33218; Watanabe H, 1997, GASTROINTEST ENDOSC, V45, P508, DOI 10.1016/S0016-5107(97)70182-2; YAMASHITA Y, 1988, DIS COLON RECTUM, V31, P617, DOI 10.1007/BF02556798; Yoshimoto K, 2001, DIGEST ENDOSC, V13, pS22, DOI 10.1046/j.1443-1661.2001.0130s1S22.x	29	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAR	2015	81	3					682	690		10.1016/j.gie.2014.10.027		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SI	WOS:000351666800023		
J	Tamai, N; Fukami, N				Tamai, Naoto; Fukami, Norio			Endoscopic submucosal dissection for a flat colorectal neoplasia with severe fibrosis	GASTROINTESTINAL ENDOSCOPY			English	Editorial Material									[Tamai, Naoto] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Fukami, Norio] Univ Colorado, Anschutz Med Ctr, Div Gastroenterol & Hepatol, Intervent Endoscopy Sect, Aurora, CO USA	Tamai, N (reprint author), Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan.							0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAR	2015	81	3					759	759		10.1016/j.gie.2014.07.018		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SI	WOS:000351666800036		
J	Osera, S; Ikematsu, H; Odagaki, T; Oono, Y; Yano, T; Kobayashi, A; Ito, M; Saito, N; Kaneko, K				Osera, Shozo; Ikematsu, Hiroaki; Odagaki, Tomoyuki; Oono, Yasuhiro; Yano, Tomonori; Kobayashi, Akihiro; Ito, Masaaki; Saito, Norio; Kaneko, Kazuhiro			Efficacy and safety of endoscopic radial incision and cutting for benign severe anastomotic stricture after surgery for lower rectal cancer (with video)	GASTROINTESTINAL ENDOSCOPY			English	Article							BALLOON DILATATION; DILATION		[Osera, Shozo; Ikematsu, Hiroaki; Odagaki, Tomoyuki; Oono, Yasuhiro; Yano, Tomonori; Kaneko, Kazuhiro] Natl Canc Ctr Hosp East, Dept Gastroenterol, Endoscopy Div, Kashiwa, Chiba 2778577, Japan; [Kobayashi, Akihiro; Ito, Masaaki; Saito, Norio] Natl Canc Ctr Hosp East, Dept Surg Oncol, Colorectal & Pelv Div, Kashiwa, Chiba 2778577, Japan	Ikematsu, H (reprint author), Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Endoscopy Div, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.						Truong S, 1997, ENDOSCOPY, V29, P845, DOI 10.1055/s-2007-1004319; Ragg J, 2012, DIGEST SURG, V29, P287, DOI 10.1159/000341657; Brandimarte G, 2000, ENDOSCOPY, V32, P461, DOI 10.1055/s-2000-651; Muto M, 2012, GASTROINTEST ENDOSC, V75, P965, DOI 10.1016/j.gie.2012.01.012; Yano T, 2013, ENDOSCOPY, V45, P316, DOI 10.1055/s-0032-1326016; Konanz J, 2013, INT J COLORECTAL DIS, V28, P679, DOI 10.1007/s00384-013-1683-z; Lemberg B, 2007, AM J GASTROENTEROL, V102, P2123, DOI 10.1111/j.1572-0241.2007.01356.x; Di ZH, 2005, J VASC INTERV RADIOL, V16, P75, DOI 10.1097/01.RVI.0000142595.83630.EE; Geller A, 2001, Gastrointest Endosc, V54, P277; Schlegel RD, 2001, DIS COLON RECTUM, V44, P1464, DOI 10.1007/BF02234598; Suchan KL, 2003, SURG ENDOSC, V17, P1110, DOI 10.1007/s00464-002-8926-3	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0016-5107	1097-6779		GASTROINTEST ENDOSC	Gastrointest. Endosc.	MAR	2015	81	3					770	773		10.1016/j.gie.2014.11.011		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2SI	WOS:000351666800042		
J	Okamura, M; Inose, H; Masuda, S				Okamura, Masumi; Inose, Haruko; Masuda, Seiji			RNA Export through the NPC in Eukaryotes	GENES			English	Review							NUCLEAR-PORE COMPLEX; CONSTITUTIVE TRANSPORT ELEMENT; REV RESPONSE ELEMENT; BOX PROTEIN DBP5; YEAST SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC TRANSFER-RNA; DEPENDENT MESSENGER-RNA; HUMAN TREX COMPLEX; RIBOSOMAL-SUBUNITS; MICRORNA BIOGENESIS	In eukaryotic cells, RNAs are transcribed in the nucleus and exported to the cytoplasm through the nuclear pore complex. The RNA molecules that are exported from the nucleus into the cytoplasm include messenger RNAs (mRNAs), ribosomal RNAs (rRNAs), transfer RNAs (tRNAs), small nuclear RNAs (snRNAs), micro RNAs (miRNAs), and viral mRNAs. Each RNA is transported by a specific nuclear export receptor. It is believed that most of the mRNAs are exported by Nxf1 (Mex67 in yeast), whereas rRNAs, snRNAs, and a certain subset of mRNAs are exported in a Crm1/Xpo1-dependent manner. tRNAs and miRNAs are exported by Xpot and Xpo5. However, multiple export receptors are involved in the export of some RNAs, such as 60S ribosomal subunit. In addition to these export receptors, some adapter proteins are required to export RNAs. The RNA export system of eukaryotic cells is also used by several types of RNA virus that depend on the machineries of the host cell in the nucleus for replication of their genome, therefore this review describes the RNA export system of two representative viruses. We also discuss the NPC anchoring-dependent mRNA export factors that directly recruit specific genes to the NPC.	[Okamura, Masumi; Inose, Haruko; Masuda, Seiji] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan	Okamura, M (reprint author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.	okamura.masumi.66z@st.kyoto-u.ac.jp; inose.haruko.24n@st.kyoto-u.ac.jp; masuda@kais.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Asahi Group Foundation; Takano Life Science Research Foundation; Tojuro Iijima Foundation for Food Science; Novozymes Japan Research Fund and Technology; Uehara Memorial Foundation	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Asahi Group Foundation, the Takano Life Science Research Foundation, the Tojuro Iijima Foundation for Food Science, the Novozymes Japan Research Fund and Technology, and the Uehara Memorial Foundation to Seiji Masuda.	Alavian CN, 2004, BIOCHEM BIOPH RES CO, V313, P351, DOI 10.1016/j.bbrc.2003.11.126; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Xie MY, 2013, CELL, V155, P1568, DOI 10.1016/j.cell.2013.11.027; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; Li JJ, 2003, PLANT PHYSIOL, V132, P1913, DOI 10.1104/pp.103.023291; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Barhoom S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr601; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Topisirovic I, 2009, EMBO J, V28, P1087, DOI 10.1038/emboj.2009.53; Sarkar S, 1998, MOL BIOL CELL, V9, P3041; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Takano A, 2005, SCIENCE, V309, P140, DOI 10.1126/science.1113346; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Yelina NE, 2010, P NATL ACAD SCI USA, V107, P13948, DOI 10.1073/pnas.0911341107; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Shaheen HH, 2005, P NATL ACAD SCI USA, V102, P11290, DOI 10.1073/pnas.0503836102; Chi BK, 2013, NUCLEIC ACIDS RES, V41, P1294, DOI 10.1093/nar/gks1188; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; HOPPER AK, 1980, CELL, V19, P741, DOI 10.1016/S0092-8674(80)80050-X; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Wickramasinghe VO, 2014, NUCLEIC ACIDS RES, V42, P5059, DOI 10.1093/nar/gku095; Oeffinger M, 2004, GENE DEV, V18, P196, DOI 10.1101/gad.285604; Yoon JH, 2000, MOL CELL BIOL, V20, P8767, DOI 10.1128/MCB.20.23.8767-8782.2000; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Dieppois G, 2010, J CELL SCI, V123, P1989, DOI 10.1242/jcs.053694; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Garcia-Oliver E, 2012, BBA-GENE REGUL MECH, V1819, P555, DOI 10.1016/j.bbagrm.2011.11.011; Fassio CA, 2010, GENETICS, V185, P199, DOI 10.1534/genetics.110.115584; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Iwasaki YW, 2013, RNA, V19, P490, DOI 10.1261/rna.036608.112; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; BROWN JA, 1995, J BIOL CHEM, V270, P7411; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Wickramasinghe VO, 2010, CURR BIOL, V20, P25, DOI 10.1016/j.cub.2009.10.078; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757; Faza MB, 2009, J CELL BIOL, V184, P833, DOI 10.1083/jcb.200810059; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Taniguchi I, 2014, NUCLEIC ACIDS RES, V42, P6645, DOI 10.1093/nar/gku304; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Kopytova DV, 2010, GENE DEV, V24, P86, DOI 10.1101/gad.550010; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Umlauf D, 2013, J CELL SCI, V126, P2656, DOI 10.1242/jcs.118000; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Murthi A, 2010, MOL BIOL CELL, V21, P639, DOI 10.1091/mbc.E09-07-0551; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; HURT DJ, 1987, MOL CELL BIOL, V7, P1208; Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Lei HX, 2011, P NATL ACAD SCI USA, V108, P17985, DOI 10.1073/pnas.1113076108; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Kramer EB, 2013, P NATL ACAD SCI USA, V110, P21042, DOI 10.1073/pnas.1316579110; Yamazaki T, 2010, MOL BIOL CELL, V21, P2953, DOI 10.1091/mbc.E09-10-0913; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Natalizio BJ, 2013, TRENDS CELL BIOL, V23, P365, DOI 10.1016/j.tcb.2013.03.006; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; Black BE, 2001, J CELL BIOL, V152, P141, DOI 10.1083/jcb.152.1.141; Black BE, 1999, MOL CELL BIOL, V19, P8616; Booth DS, 2014, ELIFE, V3, DOI 10.7554/eLife.04121; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Caporilli S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003526; Chang CT, 2013, EMBO J, V32, P473, DOI 10.1038/emboj.2012.342; Chen M, 2014, GENE DEV, V28, P959, DOI 10.1101/gad.236729.113; Ciufo LF, 2000, CURR BIOL, V10, P1256, DOI 10.1016/S0960-9822(00)00743-0; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Dez C, 2007, RNA, V13, P1516, DOI 10.1261/rna.609807; Ernst RK, 1997, MOL CELL BIOL, V17, P135; Ernst RK, 1997, RNA, V3, P210; Eswara MBK, 2009, MOL BIOL CELL, V20, P5007, DOI 10.1091/mbc.E09-06-0490; Faza MB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002915; Folkmann AW, 2011, NUCLEUS-AUSTIN, V2, P540, DOI 10.4161/nucl.2.6.17881; Forler D, 2004, MOL CELL BIOL, V24, P1155, DOI 10.1128/MCB.24.3.1155-1167.2004; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Grosshans H, 2000, GENE DEV, V14, P830; Henras A. K., 2014, REV RNA, V6, P225, DOI [10.1002/wrna.126925346433, DOI 10.1002/WRNA.126925346433]; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Hodge CA, 2011, GENE DEV, V25, P1052, DOI 10.1101/gad.2041611; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Hsin P. J., 2012, GENE DEV, V26, P2119, DOI [10.1101/gad.200303.11223028141, DOI 10.1101/GAD.200303.11223028141]; Hunter CA, 2003, PLANT PHYSIOL, V132, P2135, DOI 10.1104/pp.103.023309; Kabachinski G, 2015, J CELL SCI, V128, P423, DOI 10.1242/jcs.083246; KALLAND KH, 1994, MOL CELL BIOL, V14, P7436; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Katahira J, 2011, TRAFFIC, V12, P1468, DOI 10.1111/j.1600-0854.2011.01211.x; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; Lee SJ, 2011, CURR OPIN STRUC BIOL, V21, P101, DOI 10.1016/j.sbi.2010.11.004; Levesque L, 2001, J BIOL CHEM, V276, P44953, DOI 10.1074/jbc.M106558200; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Light WH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001524; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Lin HF, 1997, DEVELOPMENT, V124, P2463; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; Lipowsky G, 1999, RNA, V5, P539, DOI 10.1017/S1355838299982134; Lippai M, 2000, GENETICS, V156, P1889; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; MADORE SJ, 1994, VIROLOGY, V202, P186, DOI 10.1006/viro.1994.1334; Miyagawa R, 2012, BIOCHEM BIOPH RES CO, V418, P149, DOI 10.1016/j.bbrc.2011.12.150; Moriggi G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004836; Nappi F, 2001, J VIROL, V75, P4558, DOI 10.1128/JVI.75.10.4558-4569.2001; Niepel M, 2013, MOL BIOL CELL, V24, P3920, DOI 10.1091/mbc.E13-07-0412; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; Ossareh-Nazari B, 2000, MOL CELL BIOL, V20, P4562, DOI 10.1128/MCB.20.13.4562-4571.2000; Pallesen J, 2009, FEBS J, V276, P4223, DOI 10.1111/j.1742-4658.2009.07130.x; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Shaheen HH, 2007, P NATL ACAD SCI USA, V104, P8845, DOI 10.1073/pnas.0700765104; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Sleeman J, 2013, BIOCHEM SOC T, V41, P871, DOI 10.1042/BST20120016; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Takeiwa T, 2015, GENES CELLS, V20, P281, DOI 10.1111/gtc.12218; TEMIN HM, 1982, CELL, V28, P3, DOI 10.1016/0092-8674(82)90367-1; Thakurta AG, 2005, EMBO J, V24, P2512, DOI 10.1038/sj.emboj.7600713; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Vanrobays E, 2008, RNA, V14, P2061, DOI 10.1261/rna.1176708; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Whitney ML, 2007, MOL BIOL CELL, V18, P2678, DOI 10.1091/mbc.E07-10-0006; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Yang J, 2001, MOL CELL, V8, P397, DOI 10.1016/S1097-2765(01)00303-3; Yoshihisa T, 2007, GENES CELLS, V12, P285, DOI 10.1111/j.1365-2443.2007.01056.x; Zaitseva L, 2006, PLOS BIOL, V4, P1689, DOI 10.1371/journal.pbio.0040332; ZASLOFF M, 1983, P NATL ACAD SCI-BIOL, V80, P6436, DOI 10.1073/pnas.80.21.6436; Zhang H, 2014, GENES-BASEL, V5, P982, DOI 10.3390/genes5040982; Zhou J, 2011, MOL REPROD DEV, V78, P241, DOI 10.1002/mrd.21291; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782	191	1	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4425			GENES-BASEL	Genes	MAR	2015	6	1					124	149		10.3390/genes6010124		26	Genetics & Heredity	Genetics & Heredity	CE7XQ	WOS:000352055600006		
J	Tomizawa, H; Matsuzawa, D; Ishii, D; Matsuda, S; Kawai, K; Mashimo, Y; Sutoh, C; Shimizu, E				Tomizawa, H.; Matsuzawa, D.; Ishii, D.; Matsuda, S.; Kawai, K.; Mashimo, Y.; Sutoh, C.; Shimizu, E.			Methyl-donor deficiency in adolescence affects memory and epigenetic status in the mouse hippocampus	GENES BRAIN AND BEHAVIOR			English	Article						Adolescence; AMPA receptor; choline; contextual fear conditioning; DNA methylation; epigenetics; fear extinction; folate; methionine; novel object recognition	CONTEXTUAL FEAR EXTINCTION; CALORIC RESTRICTION; PERINATAL EXPOSURE; PREFRONTAL CORTEX; DNA METHYLATION; AMPA RECEPTORS; D-CYCLOSERINE; BISPHENOL-A; BRAIN; RAT	DNA methylation is one of the essential factors in the control of gene expression. Alteration of the DNA methylation pattern has been linked to various neurological, behavioral and neurocognitive dysfunctions. Recent studies have pointed out the importance of epigenetics in brain development and functions including learning and memory. Nutrients related to one-carbon metabolism are known to play important roles in the maintenance of genomic DNA methylation. Previous studies have shown that the long-term administration of a diet lacking essential one-carbon nutrients such as methionine, choline and folic acid (methyl donors) caused global DNA hypermethylation in the brain. Therefore, the long-term feeding of a methyl-donor-deficient diet may cause abnormal brain development including learning and memory. To confirm this hypothesis, 3-week-old mice were maintained on a folate-, methionine- and choline-deficient (FMCD) or control (CON) diet for 3 weeks. We found that the methyl-donor deficiency impaired both novel object recognition and fear extinction after 3 weeks of treatment. The FMCD group showed spontaneous recovery of fear that differed from that in CON. In addition, we found decreased Gria1 gene expression and specific CpG hypermethylation of the Gria1 promoter region in the FMCD hippocampus. Our data suggest that a chronic dietary lack of methyl donors in the developmental period affects learning, memory and gene expressions in the hippocampus.	[Tomizawa, H.; Matsuzawa, D.; Ishii, D.; Matsuda, S.; Kawai, K.; Sutoh, C.; Shimizu, E.] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba 2608670, Japan; [Matsuzawa, D.; Sutoh, C.; Shimizu, E.] Chiba Univ, Grad Sch Med, Res Ctr Child Mental Dev, Chiba 2608670, Japan; [Matsuda, S.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 1870031, Japan; [Mashimo, Y.] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba 2608670, Japan	Matsuzawa, D (reprint author), Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Res Ctr Child Mental Dev, 1-8-1 Inohana, Chiba 2608670, Japan.	dmatsuzawa@faculty.chiba-u.jp			Urakami Foundation; JSPS KAKENHI [24791196]	This work was supported by grants from the Urakami Foundation and from the JSPS KAKENHI grant number 24791196.	Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Szyf M, 2013, J GENET GENOMICS, V40, P331, DOI 10.1016/j.jgg.2013.06.004; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Kim I, 2005, NEUROBIOL AGING, V26, P1073, DOI 10.1016/j.neurobiolaging.2004.09.005; Ishii D, 2010, PROG NEURO-PSYCHOPH, V34, P183, DOI 10.1016/j.pnpbp.2009.10.023; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; Rossato JI, 2010, P NATL ACAD SCI USA, V107, P21801, DOI 10.1073/pnas.1016254107; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Uslaner JM, 2009, NEUROPHARMACOLOGY, V57, P531, DOI 10.1016/j.neuropharm.2009.07.022; Matsuda S, 2012, PROG NEURO-PSYCHOPH, V39, P273, DOI 10.1016/j.pnpbp.2012.06.016; Yajnik CS, 2012, REV ENDOCR METAB DIS, V13, P121, DOI 10.1007/s11154-012-9214-8; Vervliet B, 2008, ACTA PSYCHOL, V127, P601, DOI 10.1016/j.actpsy.2007.07.001; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Herrmann W, 2011, CLIN CHEM LAB MED, V49, P435, DOI 10.1515/CCLM.2011.084; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Matsuda S, 2013, HORM BEHAV, V63, P709, DOI 10.1016/j.yhbeh.2013.03.016; Jiang XY, 2014, TRENDS ENDOCRIN MET, V25, P263, DOI 10.1016/j.tem.2014.02.001; Myers KM, 2012, BIOL PSYCHIAT, V71, P947, DOI 10.1016/j.biopsych.2012.02.030; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Schmidt MV, 2010, J NEUROSCI, V30, P16949, DOI 10.1523/JNEUROSCI.4668-10.2010; Borges K, 2001, J BIOL CHEM, V276, P25929, DOI 10.1074/jbc.M009105200; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; Nicoll RA, 2013, NEUROPHARMACOLOGY, V74, P18, DOI 10.1016/j.neuropharm.2013.02.010; Albani SH, 2014, NEUROSCI BIOBEHAV R, V43, P183, DOI 10.1016/j.neubiorev.2014.04.009; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Zhou M, 2009, EUR J NEUROSCI, V30, P1559, DOI 10.1111/j.1460-9568.2009.06951.x; Vervliet B, 2013, BIOL PSYCHOL, V92, P51, DOI 10.1016/j.biopsycho.2012.01.006; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; BACHEVALIER J, 1978, TOHOKU J EXP MED, V126, P111; Bagnyukova TV, 2008, BRAIN RES, V1237, P44, DOI 10.1016/j.brainres.2008.07.073; Cleva RM, 2010, CURR NEUROPHARMACOL, V8, P394, DOI 10.2174/157015910793358169; Crowe SF, 1997, PHARMACOL BIOCHEM BE, V56, P189, DOI 10.1016/S0091-3057(96)00175-X; desLima MN, 2006, NEUROSCI LETT, V405, P142; Dori IE, 1998, EXP NEUROL, V154, P113, DOI 10.1006/exnr.1998.6937; Feng J., 2007, PEDIATR RES, V61, P58; Friso S, 2002, J NUTR, V132, p2382S; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; GOULD E, 1991, BRAIN RES BULL, V27, P767, DOI 10.1016/0361-9230(91)90209-3; Ishii D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105750; James SJ, 2003, J NUTR, V133, p3740S; KHALIL AA, 1968, J NUTR, V96, P337; Matsuda S, 2014, NEUROSCI LETT, V578, P139, DOI 10.1016/j.neulet.2014.06.054; Moore E, 2012, INT PSYCHOGERIATR, V24, P541, DOI 10.1017/S1041610211002511; Reynolds E H, 2014, Handb Clin Neurol, V120, P927, DOI 10.1016/B978-0-7020-4087-0.00061-9; Singh S, 2011, NEUROCHEM RES, V36, P1931, DOI 10.1007/s11064-011-0515-1; Szyf M., 2014, NEUROPSYCHO IN PRESS; Yilmaz N, 2011, J RECEPT SIG TRANSD, V31, P214, DOI 10.3109/10799893.2011.569724; Zushida K, 2007, J NEUROSCI, V27, P158, DOI 10.1523/JNEUROSCI.3842-06.2007	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1601-1848	1601-183X		GENES BRAIN BEHAV	Genes Brain Behav.	MAR	2015	14	3					301	309		10.1111/gbb.12207		9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CE4ZT	WOS:000351840000008		
J	Morshed, MM; Asami, Y				Morshed, Md. Manjur; Asami, Yasushi			The role of NGOs in public and private land development: The case of Dhaka city	GEOFORUM			English	Article						Urban planning; Land; Housing; NGOs; Dhaka; Bangladesh	DEVELOPING-COUNTRIES; ENVIRONMENTAL NGOS; URBAN LAND; BANGLADESH; MANAGEMENT; GOVERNANCE; ACCOUNTABILITY; CITIES; INDIA; CONSEQUENCES	Through a series of case studies, this paper discusses the three stakeholders in land development for housing in Dhaka city: the public and private sectors, and NGOs. In a scenario in which urban planning merely serves to the fulfil formal requirements and benefit certain groups, in which the public sector is an accomplice to the private sector, and where NGOs have their own private interests; urban planning in the public interest is interlocked with private interests. NGOs are important tertiary stakeholders in planning and service provision. While they vary in their types and objectives, environment NGOs in particular often find themselves in an antagonistic position concerning public and private land development. However, the interventions to the public and private sectors placed by the NGOs can provide a platform for future negotiation and participation in policy formulation. (c) 2015 Elsevier Ltd. All rights reserved.	[Morshed, Md. Manjur] Khulna Univ Engn & Technol, Dept Urban & Reg Planning, Khulna 9203, Bangladesh; [Asami, Yasushi] Univ Tokyo, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan	Morshed, MM (reprint author), Khulna Univ Engn & Technol, Dept Urban & Reg Planning, Room IEM 204, Khulna 9203, Bangladesh.	mmorshed05@yahoo.ca; asami@csis.u-tokyo.ac.jp			Japanese Government (Monbukagakusho) Scholarship program	The study period was supported by the Japanese Government (Monbukagakusho) Scholarship program. Many thanks to Kate Harris, for her assistance in English proof reading. Finally, we would like to extend our gratitude to the four anonymous reviewers, to Dr. Harvey Neo, the Editor, Geoforum, and to Professor P. Carmody, the Editor in Chief, Geoforum for their comments on the earlier draft of this paper.	Abbey E.M., 2008, Q REV ECON FINANC, V48, P370, DOI 10.1016/j.qref.2006.12.014; Ahsan DA, 2009, INT J ENVIRON RES, V3, P23; Lane MB, 2006, J RURAL STUD, V22, P232, DOI 10.1016/j.jrurstud.2005.11.009; Varley A, 2013, ENVIRON PLANN D, V31, P4, DOI 10.1068/d14410; Firman T, 2004, HABITAT INT, V28, P349, DOI 10.1016/S0197-3975(03)00037-7; Firman T, 2009, HABITAT INT, V33, P327, DOI 10.1016/j.habitatint.2008.08.005; Ackerman J, 2004, WORLD DEV, V32, P447, DOI 10.1016/j.worlddev.2003.06.015; Jepson P, 2005, ENVIRON SCI POLICY, V8, P515, DOI 10.1016/j.envsci.2005.06.006; [Anonymous], 2010, WEEKLY THOUGHTS BENG; [Anonymous], 1998, ECONOMIST; [Anonymous], 2012, GUARDIAN; Kombe WJ, 2000, HABITAT INT, V24, P167, DOI 10.1016/S0197-3975(99)00036-3; Sengupta U, 2006, HABITAT INT, V30, P448, DOI 10.1016/j.habitatint.2004.12.002; Walker M, 2008, GEOFORUM, V39, P527, DOI 10.1016/j.geoforum.2007.10.009; Kabeer N, 2012, WORLD DEV, V40, P2044, DOI 10.1016/j.worlddev.2012.05.011; [Anonymous], 2012, DEM KOR SLUM; Roy A, 2009, PLAN THEOR, V8, P76, DOI 10.1177/1473095208099299; Fekade W, 2000, HABITAT INT, V24, P127, DOI 10.1016/S0197-3975(99)00034-X; Roy A, 2011, INT J URBAN REGIONAL, V35, P223, DOI 10.1111/j.1468-2427.2011.01051.x; [Anonymous], 2013, DAILY STAR; [Anonymous], 2010, ANGER RUPGANJ FIRE M; [Anonymous], 2011, ONE EYE POLICY ENV G; Bangladesh Bureau of Statistics (BBS), 1991, CENS REP POP CENS 19; Bangladesh Bureau of Statistics (BBS), 2008, STAT YB 2008; Bangladesh Rural Advancement Committee (BRAC), 2012, FORC EV KOR SLUM; Baud I, 2001, CITIES, V18, P3, DOI 10.1016/S0264-2751(00)00049-4; Baud I, 2007, CITIES, V24, P133, DOI 10.1016/j.cities.2006.11.003; Carson ED, 2002, NONPROF VOLUNT SEC Q, V31, P429, DOI 10.1177/0899764002313007; Chatterjee P., 2004, POLITICS GOVERNED RE; Cheung S. N. S., 1978, 82 I EC AFF; Choguill C.L., 2009, DHAKA PRESENT FUTURE, P523; CHOGUILL CL, 1988, HABITAT INT, V12, P29, DOI 10.1016/0197-3975(88)90059-8; Cohen J. L., 1992, CIVIL SOC POLITICAL; Daily Star, 2009, DAILY STAR; Deegan C., 2009, ACC FIN ASS AUSTR NZ; Devas N., 1993, MANAGING FAST GROWIN, P41; ETCNEWSBD, 2011, DAP IS NOT IMPLEMENT; Gauri V, 2005, WORLD DEV, V33, P2045, DOI 10.1016/j.worlddev.2005.05.009; Gilbert A, 2009, HABITAT INT, V33, P425, DOI 10.1016/j.habitatint.2009.01.003; GILBERT A, 1981, WORLD DEV, V9, P657, DOI 10.1016/0305-750X(81)90069-3; Glaeser E., 2003, ECON POLICY REV, V9; Government of Bangladesh (GOB), 1978, FOR DON VOL ACT REG; HARDOY JE, 1986, HABITAT INT, V10, P245; Islam N., 2004, DHAKA NOW CONT URBAN; Jamil M.I., 1998, ADM CULTURE PUBLIC A; Jones G., 1994, HABITAT INT, V18, P33, DOI 10.1016/0197-3975(94)90003-5; Kim KJ, 2011, CSUR UT SER LIB SUST, V10, P43; Leat D., 2004, AUST J PUBL ADMIN, V63, P96; Lee S, 2007, NEO-LIBERALISM, STATE POWER AND GLOBAL GOVERNANCE, P1, DOI 10.1007/978-1-4020-6220-9_1; Lehman G., 2007, CRIT PERSPECT, V18, P645, DOI DOI 10.1016/J.CPA.2006.04.002; Mattingly M, 1996, LAND USE POLICY, V13, P115, DOI 10.1016/0264-8377(95)00036-4; Mehta B., 1989, CITIES, V6, P50, DOI 10.1016/0264-2751(89)90006-1; Momin M.A., 2013, ACCOUNT FORUM, V37, P150; Naher A, 2010, WOMEN STUD INT FORUM, V33, P316, DOI 10.1016/j.wsif.2010.02.005; Oommen T.K., 2003, DOES CIVIL SOC MATTE, P125; Pierre J., 1998, PARTNERSHIP URBAN GO; PUGH C, 1994, CITIES, V11, P159, DOI 10.1016/0264-2751(94)90057-4; Rahman MM, 2001, HABITAT INT, V25, P49, DOI 10.1016/S0197-3975(00)00026-6; Rahman MM, 2002, HABITAT INT, V26, P433, DOI 10.1016/S0197-3975(02)00017-6; Rajdhani Unnyan Katripakha (RAJUK), 2006, STRUCTURE PLAN, V1; Rajdhani Unnyan Katripakha (RAJUK), 2010, PLANNING; Rakodi C, 2003, HABITAT INT, V27, P523, DOI 10.1016/S0197-3975(03)00004-3; Roy S, 2006, THESIS; Sengupta U, 2010, HABITAT INT, V34, P323, DOI 10.1016/j.habitatint.2009.11.009; Seraj T.M., 2009, DHAKA PRESENT FUTURE, P506; Shidlo G., 1990, SOCIAL POLICY NONDEM; Sivam A, 2002, HABITAT INT, V26, P523, DOI 10.1016/S0197-3975(02)00025-5; SMITH M., 2011, PROGR HUMAN GEOGRAPH, V36, P490; Steeley G., 1998, INT SEM MAN GREENB A; Stiles K, 2002, WORLD DEV, V30, P835, DOI 10.1016/S0305-750X(02)00012-8; Stroker G., 1998, PARTNERSHIPS URBAN G, P34; Swilling M., 1997, GOVERNING AFRICAS CI, P1; Tankel S.B., 1963, CITY SPACE FUTURE US, P57; Tilt C.A., 2004, SCH COMMERCE RES PAP; Ullah S., 1994, EARTH, V01, P6; UNCHS, 1992, GLOB SHELT STRAT YEA; World Bank (WB), 2007, BANGL DEV SER, V17; World Bank (WB), 1993, HOUS EN MARK WORK TE; World Bank (WB), 1991, URB POL EC DEV AG 19; World Bank (WB), 2006, EC GOV NONG ORG BANG; World Bank (WB), 2003, WORLD DEV REP 2004 M; Young R.D., 2000, NONPROF VOLUNT SECTO, V29, P149; Zanetta C, 2001, HABITAT INT, V25, P513, DOI 10.1016/S0197-3975(01)00022-4	83	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7185	1872-9398		GEOFORUM	Geoforum	MAR	2015	60						4	13		10.1016/j.geoforum.2015.01.001		10	Geography	Geography	CE4II	WOS:000351793900002		
J	Akiyama, J; Seong, H				Akiyama, Jin; Seong, Hyunwoo			A Criterion for a Pair of Convex Polygons to be Reversible	GRAPHS AND COMBINATORICS			English	Article						Reversibility; Dudeney's haberdasher's puzzle; Equidecomposability; Tiling; Trunk	DUDENEY DISSECTIONS	A pair of convex polygons and is said to be reversible if has a dissection into a finite number of hinged pieces which can be rearranged to form under some conditions. In this paper, we give a necessary and sufficient condition for a given pair of polygons , to be reversible.	[Akiyama, Jin] Tokyo Univ Sci, Res Ctr Math Educ, Shinjuku Ku, Tokyo 1628601, Japan; [Seong, Hyunwoo] Univ Tokyo, Dept Math, Meguro Ku, Tokyo 1538914, Japan	Akiyama, J (reprint author), Tokyo Univ Sci, Res Ctr Math Educ, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	ja@jin-akiyama.com; hwseong@hotmail.com					Akiyama J, 2014, DISCRETE APPL MATH, V178, P19, DOI 10.1016/j.dam.2014.06.015; Akiyama J, 2003, ALGORITHM COMBINAT, V25, P43; Akiyama J, 2001, LECT NOTES COMPUT SC, V2098, P1; Akiyama J., 2013, LECT NOTES COMPUTER, V8296, P1; Boltyanskii V. G., 1963, EQUIVALENT EQUIDECOM; Bolyai F., 1832, TENTAMEN JUVENTUTEM; Dehn M, 1902, MATH ANN, V55, P465; Dudeney H. E., 1907, CANTERBURY PUZZLES O; Frederickson G. N., 2006, PIANO HINGED DISSECT; Frederickson G. N., 2002, HINGED DISSECTIONS S; Frederickson G. N., 1997, DISSECTIONS PLANE FA; Gerwien P., 1833, J REINE ANGEW MATH, V10, P228; Hilbert D., 1900, GOTTINGER NACHRICHTE, P253; Mirman R., 1999, POINT GROUPS SPACE G	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	MAR	2015	31	2			SI		347	360		10.1007/s00373-015-1544-3		14	Mathematics	Mathematics	CE3TW	WOS:000351752900004		
J	Garcia, A; Hurtado, F; Korman, M; Matos, I; Saumell, M; Silveira, RI; Tejel, J; Toth, CD				Garcia, Alfredo; Hurtado, Ferran; Korman, Matias; Matos, Ines; Saumell, Maria; Silveira, Rodrigo I.; Tejel, Javier; Toth, Csaba D.			Geometric Biplane Graphs I: Maximal Graphs	GRAPHS AND COMBINATORICS			English	Article						Geometric graphs; Biplane graphs; Maximal biplane graphs; k-Connected graphs; Graph augmentation	PLANAR GRAPHS; CONNECTIVITY	We study biplane graphs drawn on a finite planar point set in general position. This is the family of geometric graphs whose vertex set is and can be decomposed into two plane graphs. We show that two maximal biplane graphs-in the sense that no edge can be added while staying biplane-may differ in the number of edges, and we provide an efficient algorithm for adding edges to a biplane graph to make it maximal. We also study extremal properties of maximal biplane graphs such as the maximum number of edges and the largest maximum connectivity over -element point sets.	[Garcia, Alfredo; Tejel, Javier] Univ Zaragoza, IUMA, Dept Metodos Estadist, Zaragoza, Spain; [Hurtado, Ferran; Silveira, Rodrigo I.] UPC, Dept Matemat Aplicada 2, Barcelona, Spain; [Korman, Matias] NII, Erato Kawarabayashi Large Graph Project, JST, Tokyo, Japan; [Matos, Ines] Univ Aveiro, Dept Matemat, P-3800 Aveiro, Portugal; [Matos, Ines] Univ Aveiro, CIDMA, P-3800 Aveiro, Portugal; [Saumell, Maria] Univ W Bohemia, Dept Math, Plzen, Czech Republic; [Saumell, Maria] Univ W Bohemia, European Ctr Excellence NTIS New Technol Informat, Plzen, Czech Republic; [Toth, Csaba D.] Calif State Univ Northridge, Dept Math, Los Angeles, CA USA	Garcia, A (reprint author), Univ Zaragoza, IUMA, Dept Metodos Estadist, Zaragoza, Spain.	olaverri@unizar.es; ferran.hurtado@upc.edu; korman@nii.ac.jp; ipmatos@ua.pt; saumell@kma.zcu.cz; rodrigo.silveira@upc.edu; jtejel@unizar.es; cdtoth@acm.org	Silveira, Rodrigo/H-7609-2015; Tejel, Javier/H-8836-2015; Garcia, Alfredo/H-8895-2015	Silveira, Rodrigo/0000-0003-0202-4543; Tejel, Javier/0000-0002-9543-7170; Garcia, Alfredo/0000-0002-6519-1472	ESF EURO-CORES Programme EuroGIGA, CRP ComPoSe [EUI-EURC-2011-4306]; Project Gen. Cat. [DGR 2009SGR1040]; Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia; European Union; FEDER funds through COMPETE-Operational Programme Factors of Competitiveness; CIDMA; FCT [PEst-C/MAT/UI4106/2011]; COMPETE [FCOMP-01-0124-FEDER-022690]; European Social Fund; state budget of the Czech Republic; ESF EuroGIGA Project ComPoSe as F.R.S.-FNRS-EUROGIGA [13604]; Portuguese Funds through CIDMA (Center for Research and Development in Mathematics and Applications); FCT (Fundacao para a Ciencia e a Tecnologia) [PEst-OE/MAT/UI4106/2014, SFRH/BPD/88455/2012];  [MINECO MTM2012-30951/FEDER];  [E58-DGA];  [NEXLIZ - CZ.1.07/2.3.00/30.0038]	A. G., F. H., M. K., R. I. S. and J. T. were partially supported by ESF EURO-CORES Programme EuroGIGA, CRP ComPoSe: Grant EUI-EURC-2011-4306, and by Project MINECO MTM2012-30951/FEDER. F. H., and R. I. S. were also supported by Project Gen. Cat. DGR 2009SGR1040. A. G. and J. T. were also supported by Project E58-DGA. M. K. was supported by the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia and the European Union. I. M. was supported by FEDER funds through COMPETE-Operational Programme Factors of Competitiveness, CIDMA and FCT within project PEst-C/MAT/UI4106/2011 with COMPETE number FCOMP-01-0124-FEDER-022690. M. S. was supported by the Project NEXLIZ - CZ.1.07/2.3.00/30.0038, which is co-financed by the European Social Fund and the state budget of the Czech Republic, and by ESF EuroGIGA Project ComPoSe as F.R.S.-FNRS-EUROGIGA NR 13604. R. S. was funded by Portuguese Funds through CIDMA (Center for Research and Development in Mathematics and Applications) and FCT (Fundacao para a Ciencia e a Tecnologia), within Project PEst-OE/MAT/UI4106/2014, and by FCT Grant SFRH/BPD/88455/2012.	Ajtai M., 1982, ANN DISCRETE MATH, V12, P9; Al-Jubeh M., 2013, 30 ESSAYS GEOMETRIC, P49; Al-Jubeh M, 2011, ALGORITHMICA, V61, P971, DOI 10.1007/s00453-011-9551-0; Doslic T, 2003, J MATH CHEM, V33, P103, DOI 10.1023/A:1023299815308; Abellanas M, 2008, COMP GEOM-THEOR APPL, V40, P220, DOI 10.1016/j.comgeo.2007.09.001; Barnette D., 1974, Discrete Mathematics, V7, DOI 10.1016/S0012-365X(74)80001-4; Beineke LW, 1997, COMPUT MATH APPL, V34, P1, DOI 10.1016/S0898-1221(97)00214-9; Brinkmann G, 2012, J CHEM INF MODEL, V52, P2910, DOI 10.1021/ci3003107; Chartrand G., 2005, GRAPHS DIGRAPHS; Dillencourt M.B., 2000, J GRAPH ALGORITHMS A, V4, P5; Eades P., 2012, LECT NOTES COMPUTER, V7434, P335; Eppstein D, 2009, ACM T ALGORITHMS, V5, DOI 10.1145/1497290.1497291; Fary I., 1948, ACTA SCI MATH SZEGED, V11, P229; Garcia A., 2013, P MEX C DISCR MATH C, P123; Hoffmann M., 2013, 30 ESSAYS GEOMETRIC, P303; Hurtado F., 2013, 30 ESSAYS GEOMETRIC, P327; Hutchinson JP, 1999, COMP GEOM-THEOR APPL, V13, P161, DOI 10.1016/S0925-7721(99)00018-8; Korzhik VP, 2009, LECT NOTES COMPUT SC, V5417, P302, DOI 10.1007/978-3-642-00219-9_29; LEE DT, 1986, DISCRETE COMPUT GEOM, V1, P201, DOI 10.1007/BF02187695; Gimenez O, 2009, J AM MATH SOC, V22, P309; Rutter Ignaz, 2012, Journal of Graph Algorithms and Applications, V16, DOI 10.7155/jgaa.00275; Sharir M., 2011, ELECTRON J COMB, V18, P1; Toth CD, 2012, EUR J COMBIN, V33, P408, DOI 10.1016/j.ejc.2011.09.002	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	MAR	2015	31	2			SI		407	425		10.1007/s00373-015-1546-1		19	Mathematics	Mathematics	CE3TW	WOS:000351752900007		
J	Garcia, A; Hurtado, F; Korman, M; Matos, I; Saumell, M; Silveira, RI; Tejel, J; Toth, CD				Garcia, Alfredo; Hurtado, Ferran; Korman, Matias; Matos, Ines; Saumell, Maria; Silveira, Rodrigo I.; Tejel, Javier; Toth, Csaba D.			Geometric Biplane Graphs II: Graph Augmentation	GRAPHS AND COMBINATORICS			English	Article						Geometric graphs; Biplane graphs; k-connected graphs; Graph augmentation	COMMON ANCESTORS; CONNECTIVITY	We study biplane graphs drawn on a finite point set in the plane in general position. This is the family of geometric graphs whose vertex set is and which can be decomposed into two plane graphs. We show that every sufficiently large point set admits a 5-connected biplane graph and that there are arbitrarily large point sets that do not admit any 6-connected biplane graph. Furthermore, we show that every plane graph (other than a wheel or a fan) can be augmented into a 4-connected biplane graph. However, there are arbitrarily large plane graphs that cannot be augmented to a 5-connected biplane graph by adding pairwise noncrossing edges.	[Garcia, Alfredo; Tejel, Javier] Univ Zaragoza, IUMA, Dept Metodos Estadist, Zaragoza, Spain; [Hurtado, Ferran; Silveira, Rodrigo I.] UPC, Dept Matemat Aplicada 2, Barcelona, Spain; [Korman, Matias] NII, Erato Kawarabayashi Large Graph Project, JST, Tokyo, Japan; [Matos, Ines] Univ Aveiro, Dept Matemat, P-3800 Aveiro, Portugal; [Matos, Ines] Univ Aveiro, CIDMA, P-3800 Aveiro, Portugal; [Saumell, Maria] Univ W Bohemia, Dept Math, Plzen, Czech Republic; [Saumell, Maria] Univ W Bohemia, European Ctr Excellence NTIS New Technol Informat, Plzen, Czech Republic; [Toth, Csaba D.] Calif State Univ Northridge, Dept Math, Los Angeles, CA USA	Tejel, J (reprint author), Univ Zaragoza, IUMA, Dept Metodos Estadist, Zaragoza, Spain.	olaverri@unizar.es; ferran.hurtado@upc.edu; korman@nii.ac.jp; ipmatos@ua.pt; saumell@kma.zcu.cz; rodrigo.silveira@upc.edu; jtejel@unizar.es; cdtoth@acm.org	Silveira, Rodrigo/H-7609-2015; Tejel, Javier/H-8836-2015; Garcia, Alfredo/H-8895-2015	Silveira, Rodrigo/0000-0003-0202-4543; Tejel, Javier/0000-0002-9543-7170; Garcia, Alfredo/0000-0002-6519-1472	ESF EUROCORES programme EuroGIGA, CRP ComPoSe [EUI-EURC-2011-4306]; Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia; European Union; FEDER funds through COMPETE-Operational Programme Factors of Competitiveness; CIDMA; FCT [PEst-C/MAT/UI4106/2011]; COMPETE [FCOMP-01-0124-FEDER-022690]; European Social Fund; state budget of the Czech Republic; ESF EuroGIGA project ComPoSe as F.R.S.-FNRS-EUROGIGA [13604]; Portuguese funds through CIDMA (Center for Research and Development in Mathematics and Applications); FCT (Fundacao para a Ciencia e a Tecnologia) [PEst-OE/MAT/UI4106/2014, SFRH/BPD/88455/2012]; NSERC [RGPIN 35586]; NSF [CCF-0830734];  [MINECO MTM2012-30951/FEDER];  [Gen. Cat. DGR 2009SGR1040];  [E58(ESF)-DGA];  [NEXLIZ - CZ. 1.07/2.3.00/30.0038]	A. G., F. H., M. K., R. I. S. and J. T. were partially supported by ESF EUROCORES programme EuroGIGA, CRP ComPoSe: grant EUI-EURC-2011-4306, and by project MINECO MTM2012-30951/FEDER. F. H., and R. I. S. were also supported by project Gen. Cat. DGR 2009SGR1040. A. G. and J. T. were also supported by project E58(ESF)-DGA. M. K. was supported by the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia and the European Union. I. M. was supported by FEDER funds through COMPETE-Operational Programme Factors of Competitiveness, CIDMA and FCT within project PEst-C/MAT/UI4106/2011 with COMPETE number FCOMP-01-0124-FEDER-022690. M. S. was supported by the project NEXLIZ - CZ. 1.07/2.3.00/30.0038, which is co-financed by the European Social Fund and the state budget of the Czech Republic, and by ESF EuroGIGA project ComPoSe as F.R.S.-FNRS-EUROGIGA NR 13604. R. S. was funded by Portuguese funds through CIDMA (Center for Research and Development in Mathematics and Applications) and FCT (Fundacao para a Ciencia e a Tecnologia), within project PEst-OE/MAT/UI4106/2014, and by FCT grant SFRH/BPD/88455/2012. C. T. was supported in part by NSERC (RGPIN 35586) and NSF (CCF-0830734).	Al-Jubeh M., 2013, 30 ESSAYS GEOMETRIC, P49; Al-Jubeh M, 2011, ALGORITHMICA, V61, P971, DOI 10.1007/s00453-011-9551-0; HERSHBERGER J, 1992, BIT, V32, P249, DOI 10.1007/BF01994880; BERNHART F, 1979, J COMB THEORY B, V27, P320, DOI 10.1016/0095-8956(79)90021-2; Bender MA, 2000, LECT NOTES COMPUT SC, V1776, P88, DOI 10.1007/10719839_9; BUTLER JW, 1974, CAN J MATH, V26, P686, DOI 10.4153/CJM-1974-065-6; Abellanas M, 2008, COMP GEOM-THEOR APPL, V40, P220, DOI 10.1016/j.comgeo.2007.09.001; Barnette D., 1974, Discrete Mathematics, V7, DOI 10.1016/S0012-365X(74)80001-4; Brinkmann G, 2005, DISCRETE MATH, V301, P147, DOI 10.1016/j.disc.2005.06.019; Chvatal V., 1985, TRAVELING SALESMAN P, P403; Dey TK, 1997, COMP GEOM-THEOR APPL, V8, P39, DOI 10.1016/S0925-7721(96)00003-X; Diwan A. A., 2013, ARXIV13101726; Dobrev S, 2012, LECT NOTES COMPUT SC, V7256, P255, DOI 10.1007/978-3-642-29344-3_22; Eswaran K. P., 1976, SIAM Journal on Computing, V5, DOI 10.1137/0205044; Fary I., 1948, ACTA SCI MATH SZEGED, V11, P229; Garcia A., 2014, COMMUNICATION; Garcia A., 2013, P MEX C DISCR MATH C, P123; Garcia A., 2013, P MEX C DISCR MATH C, P223; Garcia A, 2009, COMP GEOM-THEOR APPL, V42, P913, DOI 10.1016/j.comgeo.2009.03.005; Hurtado F., 2013, 30 ESSAYS GEOMETRIC, P327; Hutchinson JP, 1999, COMP GEOM-THEOR APPL, V13, P161, DOI 10.1016/S0925-7721(99)00018-8; Kranakis E., 2012, DISCRETE MATH ALGEBR, V4, P385; Rutter Ignaz, 2012, Journal of Graph Algorithms and Applications, V16, DOI 10.7155/jgaa.00275; SCHIEBER B, 1988, SIAM J COMPUT, V17, P1253, DOI 10.1137/0217079; HAREL D, 1984, SIAM J COMPUT, V13, P338, DOI 10.1137/0213024; Toth CD, 2012, EUR J COMBIN, V33, P408, DOI 10.1016/j.ejc.2011.09.002; Toth G., 2005, COMBINATORIAL COMPUT, V52, P557; Tutte William T., 1956, T AM MATH SOC, V82, P99, DOI 10.2307/1992980; Wigderson A., 1982, 298 PRINC U EECS DEP	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	MAR	2015	31	2			SI		427	452		10.1007/s00373-015-1547-0		26	Mathematics	Mathematics	CE3TW	WOS:000351752900008		
J	Basti, L; Nagai, S; Go, J; Okano, S; Nagai, K; Watanabe, R; Suzuki, T; Tanaka, Y				Basti, Leila; Nagai, Satoshi; Go, Jiyoji; Okano, Sho; Nagai, Kiyohito; Watanabe, Ryuichi; Suzuki, Toshiyuki; Tanaka, Yuji			Differential inimical effects of Alexandrium spp. and Karenia spp. on cleavage, hatching, and two larval stages of Japanese pearl oyster Pinctada fucata martensii	HARMFUL ALGAE			English	Article						Harmful algal blooms; Japanese pearl oyster; Alexandrium spp.; Karenia spp.; Cleavage; Larvae	HARMFUL ALGAL BLOOMS; RED TIDE DINOFLAGELLATE; QUAHOG MERCENARIA-MERCENARIA; PARALYTIC SHELLFISH TOXINS; GYMNODINIUM CF. MIKIMOTOI; GATED SODIUM-CHANNELS; FATTY-ACID 18/5N3; HETEROCAPSA-CIRCULARISQUAMA; CRASSOSTREA-VIRGINICA; SUPEROXIDE-PRODUCTION	The effects of four harmful and potentially harmful dinoflagellates, Alexandrium affine, Alexandrium catenella, Karenia mikimotoi and Karenia papilionacea, on the early-life development of Japanese pearl oyster, Pinctada fucata martensii, were assessed. Density- and time-dependent, mild to severe effects on cleavage, hatching, D-larvae, and pre-settling larvae of pearl oysters were found. The non-PST-producer A. affine was highly toxic to both cleavage and hatching with potent lytic activity at a density of 2.5 x 10(2) cells ml(-1). The PST-producer A. catenella also affected cleavage and reduced hatching, but at 2-fold higher density with lytic activity only at the highest density tested (2 x 10(3) cells ml(-1)). Cleavage was affected by K. mikimotoi and K. papilionacea at 1.5 x 10(4) cells ml(-1), but hatching was only affected by K. mikimotoi. Mortalities in both larval stages were not observed. D-larvae were not affected by K. papilionacea, but their activity decreased following exposure to A. affine, A. catenella, and mainly K. mikimotoi. Pre-settling larvae were more sensitive to all four harmful algae than were D-larvae. The dinoflagellate A. catenella had the highest effect on the activity of pre-settling larvae (10 cells ml(-1)), followed by K. mikimotoi (5 x 10(2) cells ml(-1)), A. affirm (5 x 10(2) cells ml(-1)), and K. papilionacea (1.5 x 10(4) cells ml(-1)). The results of this study suggest that complex mechanisms, including paralytic shellfish toxins (PST), brevetoxins (PbTx) and a variety of lytic and membrane-disruptive toxins and/or other metabolites, could have been involved in such inimical stage-specific effects. It also highlight the threat posed by harmful algae on the recruitment of Japanese pearl oysters and potentially other bivalve species, and show that they could exert subchronic to chronic effects at realistically low cell densities, and impact bivalve populations through altered reproductive and recruitment processes, ultimately hampering both wild populations and aquaculture industries. (C) 2015 Elsevier B.V. All rights reserved.	[Basti, Leila; Nagai, Satoshi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Metagen Res Grp, Kanazawa Ku, Yokohama, Kanagawa 2368684, Japan; [Go, Jiyoji; Okano, Sho; Nagai, Kiyohito] K Mikimoto & Co Ltd, Shima, Mie 5170403, Japan; [Watanabe, Ryuichi; Suzuki, Toshiyuki] Fisheries Res Agcy, Res Ctr Biochem & Food Technol, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368684, Japan; [Tanaka, Yuji] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Lab Planktol, Minato Ku, Tokyo 1088477, Japan	Basti, L (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Metagen Res Grp, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 2368684, Japan.	leilabasti@affrc.go.jp			Tokyo University of Marine Science and Technology	The research was supported by Tokyo University of Marine Science and Technology under the program, Strategic Young Researcher, to Leila Basti and Yuji Tanaka.[SS]	Allen J.I., 2006, 4 GEOHAB IOC SCOR, ppp; Anderson D.M., 1995, ECOLOGY OCEANOGRAPHY, P66; Anderson D.M., 1989, P11; OSHIMA Y, 1995, J AOAC INT, V78, P528; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Satake M, 2005, TETRAHEDRON LETT, V46, P3537, DOI 10.1016/j.tetlet.2005.03.115; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133; Zingone A, 2000, OCEAN COAST MANAGE, V43, P725, DOI 10.1016/S0964-5691(00)00056-9; SHUMWAY SE, 1987, AQUAT TOXICOL, V10, P9, DOI 10.1016/0166-445X(87)90024-5; Emura A, 2004, HARMFUL ALGAE, V3, P29, DOI 10.1016/j.hal.2003.08.004; Zou YN, 2010, HARMFUL ALGAE, V9, P367, DOI 10.1016/j.hal.2010.01.005; Wiese M, 2010, MAR DRUGS, V8, P2185, DOI 10.3390/md8072185; Mooney BD, 2007, J PHYCOL, V43, P101, DOI 10.1111/j.1529-8817.2006.00312.x; Brand LE, 2012, HARMFUL ALGAE, V14, P156, DOI 10.1016/j.hal.2011.10.020; Fossat B, 1999, J APPL TOXICOL, V19, P275, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<275::AID-JAT578>3.0.CO;2-B; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Tang YZ, 2007, MAR BIOL, V150, P541, DOI 10.1007/s00227-006-0396-z; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Munday R, 2004, TOXICON, V44, P173, DOI 10.1016/j.toxicon.2004.05.017; Nagai S, 2008, J PHYCOL, V44, P909, DOI 10.1111/j.1529-8817.2008.00544.x; CHEN LCM, 1969, J PHYCOL, V5, P211, DOI 10.1111/j.1529-8817.1969.tb02605.x; Nagai S, 2012, MAR GENOM, V7, P51, DOI 10.1016/j.margen.2012.03.002; Lundholm N, 2005, MAR ECOL PROG SER, V288, P21, DOI 10.3354/meps288021; Chang FH, 2011, HARMFUL ALGAE, V10, P181, DOI 10.1016/j.hal.2010.09.004; Fistarol GO, 2004, AQUAT MICROB ECOL, V35, P45, DOI 10.3354/ame035045; Tillmann U, 2002, MAR ECOL PROG SER, V230, P47, DOI 10.3354/meps230047; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Basti L, 2013, MAR BIOL, V160, P211, DOI 10.1007/s00227-012-2079-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Yamasaki Y, 2008, J BIOCHEM MOL TOXIC, V22, P405, DOI 10.1002/jbt.20253; Satake M, 2002, TETRAHEDRON LETT, V43, P5829, DOI 10.1016/S0040-4039(02)01171-1; Ma HY, 2011, TOXICON, V58, P247, DOI 10.1016/j.toxicon.2011.06.004; Ma HY, 2009, MAR DRUGS, V7, P497, DOI 10.3390/md7040497; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Watkins SM, 2008, MAR DRUGS, V6, P431, DOI 10.3390/md20080021; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Capper A, 2013, HARMFUL ALGAE, V28, P1, DOI 10.1016/j.hal.2013.04.009; Haywood AJ, 2004, J PHYCOL, V40, P165, DOI 10.1111/j.0022-3646.2004.02-149.x; Sola F, 1999, J APPL TOXICOL, V19, P279, DOI 10.1002/(SICI)1099-1263(199907/08)19:4<279::AID-JAT579>3.0.CO;2-X; Miles CO, 2003, J AGR FOOD CHEM, V51, P4838, DOI 10.1021/jf030101r; Gentien P, 2007, PHILOS T R SOC B, V362, P1937, DOI 10.1098/rstb.2007.2079; Graneli E, 2008, HARMFUL ALGAE, V8, P94, DOI 10.1016/j.hal.2008.08.011; HALL S, 1990, ACS SYM SER, V418, P29; Wang JX, 2003, J GEN PHYSIOL, V121, P583, DOI 10.1085/jgp.200308812; Marshall JA, 2005, MAR BIOL, V147, P533, DOI 10.1007/s00227-005-1596-7; Arzul G., 2006, Algal cultures, analogues of blooms and applications, Volume 1, P131; Arzul G., 1995, TOXICON, V33, P1119, DOI 10.1016/0041-0101(95)93830-N; Arzul G., 2000, Marine lipids. Proceedings of the symposium held in Brest, France, 19-20 November 1998, P53; Basti L, 2011, J SHELLFISH RES, V30, P177, DOI 10.2983/035.030.0125; Bodennec G., 1995, P407; Burkholder JM, 2006, AFR J MAR SCI, V28, P177, DOI 10.2989/18142320609504143; Catterall A., 2007, TOXICON, V49, P124; Cusick KD, 2012, ENVIRON SCI TECHNOL, V46, P2959, DOI 10.1021/es204027m; Falconer I.R., 2008, ADV EXP MED BIOL, V619, P207; Flores HS, 2012, AQUAT MICROB ECOL, V66, P199, DOI 10.3354/ame01570; Fukuyo Y., 2002, 23 PICES N PAC MAR S; Furey A, 2007, PHYCOTOXINS CHEM BIO, P19, DOI 10.1002/9780470277874.ch2; GAINEY LF, 1991, BIOL BULL, V181, P298, DOI 10.2307/1542101; GENTIEN P, 1990, J MAR BIOL ASSOC UK, V70, P571; HONJO T, 1990, TOXIC MARINE PHYTOPLANKTON, P165; Imai Ichiro, 2006, Plankton & Benthos Research, V1, P71; Jenkinson I., 2001, HARMFUL ALGAL BLOOMS, P461; Kao C.Y., 1993, P75; Lefebvre KA, 2010, HARMFUL ALGAE, V9, P374, DOI 10.1016/j.hal.2010.01.007; Leverone JR, 2006, TOXICON, V48, P75, DOI 10.1016/j.toxicon.2006.04.012; Lush G, 2001, HARMFUL ALGAL BLOOMS, P268; MacKenzie L, 2004, HARMFUL ALGAE 2002, P160; Marshall JA, 2005, MAR BIOL, V147, P541, DOI 10.1007/s00227-005-1597-6; Matsuyama Y, 2001, HARMFUL ALGAL BLOOMS, P411; Matsuyama Y., 1998, HARMFUL ALGAE, P422; Matsuyama Y, 2009, BASICS, P580, DOI 10.1533/9781845696474.3.580; Matsuyama Y, 2012, HARMFUL ALGAE, V14, P144, DOI 10.1016/j.hal.2011.10.019; Molgo J., 2007, PHYCOTOXINS CHEM BIO, P319, DOI 10.1002/9780470277874.ch18; Mu CM, 2013, J SHELLFISH RES, V32, P689, DOI 10.2983/035.032.0310; Munday R., 2008, SEAFOOD FRESHWATER T, P582; Nagai K, 2007, AQUACULTURE, V262, P192, DOI 10.1016/j.aquaculture.2006.10.040; Nagai S, 2011, J PHYCOL, V47, P703, DOI 10.1111/j.1529-8817.2011.00976.x; Nagasaki Prefectural Institute of Fisheries, 1992, REP RED TID SHELLF P, P11; Neely T, 2006, HARMFUL ALGAE, V5, P592, DOI 10.1016/j.hal.2005.11.006; Oda M., 1935, ZOOL MAG, V47, P35; Okaichi T, 2004, OCEAN SCIENCES RES, V4, P7; Okaichi T., 1997, SUSTAINABLE DEV SETO, P251; Ono C., 1996, HARMFUL TOXIC ALGAL, P23; Ramsdell John S., 2008, P519; Ravn H, 1995, J APPL PHYCOL, V7, P589, DOI 10.1007/BF00003947; RENSEL JE, 1993, DEV MAR BIO, V3, P625; Rolton A, 2014, AQUAT TOXICOL, V155, P199, DOI 10.1016/j.aquatox.2014.06.023; Shi F, 2012, NEW ZEAL J MAR FRESH, V46, P149, DOI 10.1080/00288330.2011.616210; Shumway Sandra E., 1995, Reviews in Fisheries Science, V3, P1; Shumway S.E., 1990, J WORLD AQUACULT SOC, V21, P60; Silke J., 2005, MAR ENV HLTH SER, V21, P44; Smayda T. J., 1990, P 4 INT C TOX MAR PH, P29; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137; Smayda T.J., 1992, FOOD CHAINS MODELS M, P257; STEIDINGER KAREN A., 1966, FLA STATE BOARD CONSERV MAR LAB PROF PAP SER, V8, P8; Sugg LM, 1999, J PHYCOL, V35, P93, DOI 10.1046/j.1529-8817.1999.3510093.x; Tang YZ, 2012, MAR BIOL, V159, P199, DOI 10.1007/s00227-011-1800-x; Tillmann U., 2007, P 2007 INT HARMF ALG; Twarog B.M., 1974, P 1 INT C TOX DIN BL, P381; Wada K.T., 2007, PEARL OYSTER HLTH MA, V503, P95; Wang D.Z., 2008, MAR DRUGS, V6, P371; Yamasaki Y, 2004, J BIOSCI BIOENG, V97, P212, DOI 10.1016/S1389-1723(04)70193-0; Yan T, 2003, AQUACULTURE, V217, P167, DOI 10.1016/S0044-8486(02)00117-5; Yan T, 2001, TOXICON, V39, P1239, DOI 10.1016/S0041-0101(01)00080-0	107	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9883	1878-1470		HARMFUL ALGAE	Harmful Algae	MAR	2015	43						1	12		10.1016/j.hal.2014.12.004		12	Marine & Freshwater Biology	Marine & Freshwater Biology	CE6SQ	WOS:000351968900001		
J	Doi, H; Nishitani, S; Shinohara, K				Doi, Hirokazu; Nishitani, Shota; Shinohara, Kazuyuki			Sex difference in the relationship between salivary testosterone and inter-temporal choice	HORMONES AND BEHAVIOR			English	Article						Inter-temporal choice; Discounting; Testosterone; Sex difference; Reward	HIGHER DISCOUNT RATES; DECISION-MAKING; PROBABILISTIC REWARDS; DELAYED REWARDS; INDIVIDUAL-DIFFERENCES; INTERTEMPORAL CHOICE; IMPULSIVE BEHAVIOR; PREFRONTAL CORTEX; SENSATION-SEEKING; WORKING-MEMORY	Humans often prefer a small immediate reward to large reward in the future. This myopic tendency in intertemporal choice is termed delay discounting, and has been the focus of intensive research in the past decades. Recent studies indicate that the neural regions underlying delay discounting are influenced by the gonadal steroids. However, the specific relationship between the testosterone levels and delay discounting is unclear at this point, especially in females. The present study investigated the relationship between salivary testosterone concentrations and discounting rates in delay- and probability-discounting tasks with healthy males and females. The results revealed a positive correlation between testosterone concentrations and delay-discounting rates in females and a negative correlation in males. Testosterone concentrations were unrelated to probability-discounting rates. Although causal effects of testosterone cannot be certain in this correlational study, if testosterone directly influenced this behavior, observed sex differences in delay discounting may be evidence of a curvilinear effect of testosterone. Alternatively, the findings may reflect inverse pattern of responsiveness to testosterone between male and female neural systems, or basic sex-difference in the neural mechanism underlying delay-discounting independent of testosterone itself. (C) 2014 Elsevier Inc. All rights reserved.	[Doi, Hirokazu; Nishitani, Shota; Shinohara, Kazuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Shinohara, K (reprint author), 1-12-4 Sakamoto Cho, Nagasaki 8528523, Japan.	kazuyuki@nagasaki-u.ac.jp			JSPS KAKENHI [24791218]	This work was partly supported by JSPS KAKENHI Grant Number 24791218 to HD.	Kirby KN, 2002, J ECON PSYCHOL, V23, P291, DOI 10.1016/S0167-4870(02)00078-8; Rubinow DR, 1996, AM J PSYCHIAT, V153, P974; Estle SJ, 2006, MEM COGNITION, V34, P914, DOI 10.3758/BF03193437; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3578, DOI 10.1210/jc.81.10.3578; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Appelhans BM, 2011, OBESITY, V19, P2175, DOI 10.1038/oby.2011.57; GOUCHIE C, 1991, PSYCHONEUROENDOCRINO, V16, P323, DOI 10.1016/0306-4530(91)90018-O; van Wingen G, 2010, PSYCHONEUROENDOCRINO, V35, P105, DOI 10.1016/j.psyneuen.2009.09.007; KOURI EM, 1995, DRUG ALCOHOL DEPEN, V40, P73, DOI 10.1016/0376-8716(95)01192-7; Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Moffat SD, 1996, PSYCHONEUROENDOCRINO, V21, P323, DOI 10.1016/0306-4530(95)00051-8; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Kojima M, 2002, PSYCHIAT RES, V110, P291, DOI 10.1016/S0165-1781(02)00106-3; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Luhmann CC, 2008, J NEUROSCI, V28, P14459, DOI 10.1523/JNEUROSCI.5058-08.2008; Kumar RC, 2004, NEUROBIOL AGING, V25, P925, DOI 10.1016/j.neurobiolaging.2003.10.011; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wood RI, 1996, TRENDS ENDOCRIN MET, V7, P338, DOI 10.1016/S1043-2760(96)00155-5; Kirby KN, 2005, LEARN INDIVID DIFFER, V15, P213, DOI 10.1016/j.lindif.2005.01.003; Jimura K, 2009, PSYCHON B REV, V16, P1071, DOI 10.3758/PBR.16.6.1071; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; Granger DA, 2004, PSYCHONEUROENDOCRINO, V29, P1229, DOI 10.1016/j.psyneuen.2004.02.005; Durdiakova J, 2013, STEROIDS, V78, P1325, DOI 10.1016/j.steroids.2013.09.002; Trumble BC, 2012, P ROY SOC B-BIOL SCI, V279, P2907, DOI 10.1098/rspb.2012.0455; Bayless DW, 2013, HORM BEHAV, V64, P764, DOI 10.1016/j.yhbeh.2013.10.003; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Rosenblitt JC, 2001, HORM BEHAV, V40, P396, DOI 10.1006/hbeh.2001.1704; Madden GJ, 2009, EXP CLIN PSYCHOPHARM, V17, P283, DOI 10.1037/a0016806; Wilson M, 2004, P ROY SOC B-BIOL SCI, V271, pS177, DOI 10.1098/rsbl.2003.0134; Swann AC, 2002, BIOL PSYCHIAT, V51, P988, DOI 10.1016/S0006-3223(01)01357-9; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Dabbs JM, 1997, PSYCHOSOM MED, V59, P477; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P390, DOI 10.1007/s002130000542; Gonzalez R, 1999, COGNITIVE PSYCHOL, V38, P129, DOI 10.1006/cogp.1998.0710; Green L, 2004, J EXP ANAL BEHAV, V81, P39, DOI 10.1901/jeab.2004.81-39; Lopez HH, 2009, HORM BEHAV, V56, P84, DOI 10.1016/j.yhbeh.2009.03.004; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Hermans EJ, 2010, NEUROIMAGE, V52, P277, DOI 10.1016/j.neuroimage.2010.04.019; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Papacosta E, 2011, J SCI MED SPORT, V14, P424, DOI 10.1016/j.jsams.2011.03.004; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Packard MG, 1998, HORM BEHAV, V34, P39, DOI 10.1006/hbeh.1998.1461; Yi R, 2012, NICOTINE TOB RES, V14, P547, DOI 10.1093/ntr/ntr252; Abela AR, 2013, EUR J NEUROSCI, V37, P640, DOI 10.1111/ejn.12071; Worthy DA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00591; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Campbell BC, 2010, PHYSIOL BEHAV, V99, P451, DOI 10.1016/j.physbeh.2009.12.011; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Santesso DL, 2011, PSYCHOPHYSIOLOGY, V48, P1481, DOI 10.1111/j.1469-8986.2011.01229.x; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; Rounds JS, 2007, BEHAV RES THER, V45, P729, DOI 10.1016/j.brat.2006.06.007; Myerson J, 2011, J EXP ANAL BEHAV, V95, P175, DOI 10.1901/jeab.2011.95-175; Beck RC, 2009, EXP CLIN PSYCHOPHARM, V17, P345, DOI 10.1037/a0017078; Bjork JM, 2001, PHYSIOL BEHAV, V73, P217, DOI 10.1016/S0031-9384(01)00474-7; Booth A, 1999, J BEHAV MED, V22, P1, DOI 10.1023/A:1018705001117; DABBS JM, 1990, PHYSIOL BEHAV, V48, P83, DOI 10.1016/0031-9384(90)90265-6; DORNER G, 1983, PSYCHONEUROENDOCRINO, V8, P205, DOI 10.1016/0306-4530(83)90057-4; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fernandez-Guasti A., 2005, PSYCHONEUROENDOCRINO, V30, P762; Imhoff S, 2014, DRUG ALCOHOL DEPEN, V135, P152, DOI 10.1016/j.drugalcdep.2013.11.014; Jimenez M, 2012, PSYCHONEUROENDOCRINO, V37, P1577, DOI 10.1016/j.psyneuen.2012.02.011; Lucas M, 2010, PERS INDIV DIFFER, V48, P182, DOI 10.1016/j.paid.2009.10.002; MAZUR JE, 1995, J EXP ANAL BEHAV, V63, P139, DOI 10.1901/jeab.1995.63-139; Michaelson L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00355; MISCHEL W, 1961, J ABNORM SOC PSYCH, V63, P116, DOI 10.1037/h0046877; Moeller SK, 2010, PERS INDIV DIFFER, V48, P283, DOI 10.1016/j.paid.2009.10.017; Morley JE, 2003, J STEROID BIOCHEM, V85, P367, DOI 10.1016/S0960-0760(03)00203-6; Nishiyama K., 2009, JPN J BEHAV THER, V35, P145; Onoda K, 2011, EXP BRAIN RES, V212, P593, DOI 10.1007/s00221-011-2771-3; Op de Macks Z. A., 2011, DEV COGNITIVE NEUROS, V1, P506, DOI [10.1016/j.dcn.2011.06.003, DOI 10.1016/J.DCN.2011.06.003]; Ortner GR, 2013, PSYCHONEUROENDOCRINO, V38, P1814, DOI 10.1016/j.psyneuen.2012.12.014; Phoenix CH, 2009, HORM BEHAV, V55, P566, DOI 10.1016/j.yhbeh.2009.01.004; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Reynolds B, 2004, PHARMACOL BIOCHEM BE, V79, P17, DOI 10.1016/j.pbb.2004.06.011; SANNIKKA E, 1983, INT J ANDROL, V6, P319, DOI 10.1111/j.1365-2605.1983.tb00546.x; Shibata Y, 2013, PERS INDIV DIFFER, V55, P766, DOI 10.1016/j.paid.2013.06.011; Spielberger C. D., 1983, MANUAL STATE TRAIT A; Stanton SJ, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00009; Takahashi T, 2006, NEUROENDOCRINOL LETT, V27, P439; Takahashi T, 2010, NEUROENDOCRINOL LETT, V31, P616; Tan U, 1998, INT J NEUROSCI, V95, P77, DOI 10.3109/00207459809000651; Wang H., 2014, PSYCHONEUROENDOCRINO, V8, P246; Wirth MM, 2012, PSYCHONEUROENDOCRINO, V37, P1587, DOI 10.1016/j.psyneuen.2012.05.010; Zilioli S, 2014, HORM BEHAV, V65, P461, DOI 10.1016/j.yhbeh.2014.04.006	91	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0018-506X	1095-6867		HORM BEHAV	Horm. Behav.	MAR	2015	69						50	58		10.1016/j.yhbeh.2014.12.005		9	Behavioral Sciences; Endocrinology & Metabolism	Behavioral Sciences; Endocrinology & Metabolism	CE8UB	WOS:000352118500006		
J	Inagaki, H; Mori, Y				Inagaki, Hideaki; Mori, Yuji			The emission of stress-induced 22-kHz calls in female rats is independent of testosterone levels	HORMONES AND BEHAVIOR			English	Article						Sex difference; Sex hormone; Stress response; Ultrasonic vocalization; Vocal communication	ULTRASONIC VOCALIZATIONS; ANXIETY; RESILIENCE; STATES; SWIM	Although emission of ultrasonic calls in rats induced by stress, referred to as "22-kHz calls," is dependent on circulating testosterone levels in males, it is still unknown whether the same testosterone-based regulation is applicable to female rats. In this study, we investigated the sex difference in the emission of air-puff-induced 22-kHz calls in rats on the basis of the hypothesis that female rats would emit fewer 22-kHz calls, and assessed whether male-like circulating testosterone levels can also influence the emission of 22-kHz calls in females. The experimental results showed that female rats emit significantly fewer 22-kHz calls than male rats. However, male-like circulating testosterone levels have little effect on the emission of 22-kHz calls in females. Hence, it is suggested that there is a sex difference in stress-induced 22-kHz calls in rats and, in contrast to male rats, the emission of 22-kHz calls in female rats may be independent of circulating testosterone levels, as tested in response to air-puff stimulation. (C) 2015 Elsevier Inc. All rights reserved.	[Inagaki, Hideaki; Mori, Yuji] Univ Tokyo, Lab Vet Ethol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Inagaki, H (reprint author), Nagoya Univ, Ctr Anim Res & Educ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	inagald@care.nagoya-u.ac.jp			JSPS KAKENHI [22500382]	This work was supported by JSPS KAKENHI grant number 22500382.	Ter Horst GJ, 2009, PHYSIOL BEHAV, V97, P239, DOI 10.1016/j.physbeh.2009.02.036; LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193; Litvin Y, 2007, BEHAV BRAIN RES, V182, P166, DOI 10.1016/j.bbr.2006.11.038; Brudzynski SM, 2009, ILAR J, V50, P43; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Sanchez C, 2003, EUR J PHARMACOL, V463, P133, DOI 10.1016/S0014-2999(03)01277-9; Sakuma Y, 2009, J NEUROENDOCRINOL, V21, P410, DOI 10.1111/j.1365-2826.2009.01856.x; Jelen P, 2003, BEHAV BRAIN RES, V141, P63, DOI 10.1016/S0166-4328(02)00321-2; Brudzynski SM, 2007, BEHAV BRAIN RES, V182, P261, DOI 10.1016/j.bbr.2007.03.004; Brudzynski SM, 1996, BEHAV BRAIN RES, V80, P145, DOI 10.1016/0166-4328(96)00029-0; BRUDZYNSKI SM, 1994, BEHAV BRAIN RES, V63, P133, DOI 10.1016/0166-4328(94)90084-1; Burman OHP, 2007, APPL ANIM BEHAV SCI, V104, P116, DOI 10.1016/j.applanim.2006.04.028; Drugan RC, 2014, BEHAV BRAIN RES, V259, P41, DOI 10.1016/j.bbr.2013.10.029; Drugan RC, 2009, BEHAV BRAIN RES, V202, P142, DOI 10.1016/j.bbr.2009.03.021; DUPON C, 1973, J ENDOCRINOL, V59, P653, DOI 10.1677/joe.0.0590653; Inagaki H, 2014, HORM BEHAV, V65, P42, DOI 10.1016/j.yhbeh.2013.11.003	16	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0018-506X	1095-6867		HORM BEHAV	Horm. Behav.	MAR	2015	69						116	118		10.1016/j.yhbeh.2015.01.001		3	Behavioral Sciences; Endocrinology & Metabolism	Behavioral Sciences; Endocrinology & Metabolism	CE8UB	WOS:000352118500013		
J	Mondal, B; Thomas, TA; Visotsky, E; Vook, FW; Ghosh, A; Nam, YH; Li, Y; Zhang, JZ; Zhang, M; Luo, QL; Kakishima, Y; Kitao, K				Mondal, Bishwarup; Thomas, Timothy A.; Visotsky, Eugene; Vook, Frederick W.; Ghosh, Amitava; Nam, Young-Han; Li, Yang; Zhang, Jianzhong (Charlie); Zhang, Min; Luo, Qinglin; Kakishima, Yuichi; Kitao, Koshiro			3D CHANNEL MODEL IN 3GPP	IEEE COMMUNICATIONS MAGAZINE			English	Article								Multi-antenna techniques capable of exploiting the elevation dimension are anticipated to be an important air-interface enhancement targeted to handle the expected growth in mobile traffic. In order to enable the development and evaluation of such multi-antenna techniques, the 3rd Generation Partnership Project (3GPP) has recently developed a three-dimensional (3D) channel model. The existing two-dimensional (2D) channel models do not capture the elevation channel characteristics, making them insufficient for such studies. This article describes the main components of the newly developed 3D channel model and the motivations behind introducing them. One key factor is the ability to model channels for users located on different floors of a building (at different heights). This is achieved by capturing a user height dependency in modelling some channel characteristics including pathloss, line-of-sight (LOS) probability, etc. In general, this 3D channel model follows the framework of WINNERII/WINNER+ while also extending the applicability and the accuracy of the model by introducing some height dependent and distance dependent elevation related parameters.	[Mondal, Bishwarup; Thomas, Timothy A.; Visotsky, Eugene; Vook, Frederick W.] Nokia Networks, Espoo, Finland; [Ghosh, Amitava] Nokia Networks, North Amer Radio Syst Res, Technol & Innovat Off, Espoo, Finland; [Nam, Young-Han; Li, Yang] Samsung Res Amer, Dallas, TX USA; [Zhang, Jianzhong (Charlie)] Samsung Res Amer, Wireless Commun Lab, Dallas, TX USA; [Zhang, Min; Luo, Qinglin] Alcatel Lucent Shanghai Bell, Alcatel Lucent, Shanghai, Peoples R China; [Kakishima, Yuichi] NTT DOCOMO INC, Res & Dev Wireless Access Technol, Kawasaki, Kanagawa, Japan; [Kitao, Koshiro] NTT DOCOMO INC, Res Labs, Kawasaki, Kanagawa, Japan	Mondal, B (reprint author), Nokia Networks, Espoo, Finland.	bishwarup@gmail.com					3GPP, 2010, 36814 3GPP TR; [Anonymous], 2013, R1124813 3GPP; [Anonymous], 2013, R1131248 3GPP; [Anonymous], 2012, RP122034 3GPP; [Anonymous], 2013, R1134036 3GPP; [Anonymous], 2010, WINNER FINAL CHANNEL; [Anonymous], 2013, R1133273 3GPP; [Anonymous], 2009, ITURM21351; [Anonymous], 2014, 36873V200 3GPP TR; [Anonymous], 2013, 37840V1210 3GPP TR; [Anonymous], 2013, R1134221 3GPP; [Anonymous], 2012, 25996V1100 3GPP TR; [Anonymous], 1999, 231 COST; IST-WINNER I.I, 2008, WINNER 2 CHANNEL MOD; Nam Y.-H., 2013, IEEE COMMUN MAG, V51; Osseiran A., 2013, VTC SPRING 2013 JUN	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	MAR	2015	53			S			16	23				8	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3OA	WOS:000351735000005		
J	Sacchi, C; Bhasin, K; Kadowaki, N; Vong, F				Sacchi, Claudio; Bhasin, Kul; Kadowaki, Naoto; Vong, Fred			TOWARD THE "SPACE 2.0" ERA	IEEE COMMUNICATIONS MAGAZINE			English	Editorial Material									[Sacchi, Claudio] Univ Trento, Fac Engn, Trento, Italy; [Bhasin, Kul] NASA, Glenn Res Ctr, Cleveland, OH USA; [Bhasin, Kul] NASA GRC, Space Commun Projects, Cleveland, OH USA; [Bhasin, Kul] AIAA, Cleveland, OH USA; [Bhasin, Kul] Soc Int Opt Engineers SPIE, Bellingham, WA USA; [Kadowaki, Naoto] NICT, Strateg Planning Dept, Yokosuka, Kanagawa, Japan; [Kadowaki, Naoto] NICT, Wireless Network Res Inst, Yokosuka, Kanagawa, Japan; [Vong, Fred] Asia Satellite Telecommun Co Ltd, Hong Kong, Hong Kong, Peoples R China	Sacchi, C (reprint author), Univ Trento, Dept Informat Engn & Comp Sci, Trento, Italy.						Baldini G., 2014, IEEE COMM SURVEYS TU, V16; Clarke A. C., 1945, WIRELESS WORLD, P305; Finnie G., 2012, FTTH COUNC E C 2012; Integral SatCom Initiative (ISI), 2009, FUT INT POS PAP	4	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	MAR	2015	53	3					16	17				2	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3NV	WOS:000351734400004		
J	Araniti, G; Bezirgiannidis, N; Birrane, E; Bisio, I; Burleigh, S; Caini, C; Feldmann, M; Marchese, M; Segui, J; Suzuki, K				Araniti, Giuseppe; Bezirgiannidis, Nikolaos; Birrane, Edward; Bisio, Igor; Burleigh, Scott; Caini, Carlo; Feldmann, Marius; Marchese, Mario; Segui, John; Suzuki, Kiyohisa			Contact Graph Routing in DTN Space Networks: Overview, Enhancements and Performance	IEEE COMMUNICATIONS MAGAZINE			English	Article							INTERPLANETARY; DELAY	Delay-and Disruption Tolerant Networks (DTNs) are based on an overlay protocol and on the store-carry-forward paradigm. In practice, each DTN node can store information for a long time before forwarding it. DTNs are particularly suited to cope with the challenges imposed by the space environment. This paper is focused on routing in space DTNs, and in particular on contact graph routing (CGR) and its most representative enhancements, available in the literature, which are briefly surveyed in this work. Moreover, the applicability and the obtained performance of the DTN protocol stack and of the CGR have been evaluated by presenting results from real experimental experiences such as the Deep Impact Network experiment (employing the EPOXI space cruise), the JAXA jointly performed space link demonstrations with NASA (where the JAXA's GEO relay satellite called Data Relay Test Satellite has been used), the Space Data Routers European Project, and the pilot operation of a DTN implementation on the International Space Station (ISS).	[Araniti, Giuseppe] Univ Mediterranea Reggio Calabria, Telecommun, Reggio Di Calabria, Italy; [Bezirgiannidis, Nikolaos] Democritus Univ Thrace, Dept Elect & Comp Engn, Xanthi, Greece; [Birrane, Edward] Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD 21218 USA; [Bisio, Igor] Univ Genoa, I-16126 Genoa, Italy; [Marchese, Mario] Univ Genoa, DITEN Dept, I-16126 Genoa, Italy; [Burleigh, Scott] CALTECH, Pasadena, CA 91125 USA; [Segui, John] Speedy Packets Inc, Marblehead, MA USA; [Segui, John] Pasadena City Coll, Pasadena, CA USA; [Caini, Carlo] Univ Bologna, Dept Elect Elect & Informat Engn DEI, Telecommun, I-40126 Bologna, Italy; [Feldmann, Marius] Tech Univ Dresden, Dresden, Germany; [Suzuki, Kiyohisa] Japan Aerosp Explorat Agcy, Chofu, Tokyo, Japan	Araniti, G (reprint author), Univ Mediterranea Reggio Calabria, Telecommun, Reggio Di Calabria, Italy.	araniti@unirc.it; nbezirgi@ee.duth.gr; Edward.Birrane@jhuapl.edu; igor.bisio@unige.it; Scott.Burleigh@jpl.nasa.gov; carlo.caini@unibo.it; marius.feldmann@tu-dresden.de; mario.marchese@unige.it; John.Segui@jpl.nasa.gov; suzuki.kiyohisa@jaxa.jp	Marchese, Mario/K-7153-2015; Bisio, Igor/L-9799-2015	Marchese, Mario/0000-0002-9626-3483; Bisio, Igor/0000-0003-3198-7306	National Aeronautics and Space Administration	This research was carried out in part at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. Government sponsorship is acknowledged.	Birrane E, 2012, ACTA ASTRONAUT, V75, P108, DOI 10.1016/j.actaastro.2012.02.004; Caini C, 2011, P IEEE, V99, P1980, DOI 10.1109/JPROC.2011.2158378; Jain S, 2004, ACM SIGCOMM COMP COM, V34, P145, DOI 10.1145/1030194.1015484; Bezirgiannidis N., 2013, P ACM CHANTS, P43; Bezirgiannidis N., 2014, P ASMS 2014 LIV IT S, P17; Burleigh S., 2007, 5050 RFC; Burleigh S, 2010, CONTACT GRA IN PRESS; Cerf V., 2007, 4838 RFC; Goetzelmann M., 2012, P SPACEOPS 2012 C; Marchese M, 2011, IEEE AERO EL SYS MAG, V26, P12, DOI 10.1109/MAES.2011.5739484; Suzuki K., 2014, AIAA 2014 P SPACEOPS	11	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	MAR	2015	53	3					38	46				9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3NV	WOS:000351734400008		
J	Kafle, VP; Fukushima, Y; Harai, H				Kafle, Ved P.; Fukushima, Yusuke; Harai, Hiroaki			DESIGN AND IMPLEMENTATION OF DYNAMIC MOBILE SENSOR NETWORK PLATFORM	IEEE COMMUNICATIONS MAGAZINE			English	Article								This article presents the design and implementation of a dynamic mobile sensor network platform consisting of stationary sensors, mobile sensors, mobile sensor gateways, and sink servers. The sensor network platform supports heterogeneous protocols in the network layer and performs ID-based communications to deliver sensor data from the sensors to the sinks, as well as to send control and monitoring commands from the sensor owner or administrator to the mobile sensors and mobile sensor gateways. To provide sensor data reliably irrespective of the sensor locations, the mobile sensors and mobile sensor gateways natively support mobility and multihoming and possess network access authentication and data transport security functions. The sensor owners can freely install new applications over already-deployed mobile sensors and mobile sensor gateways. They can configure the mobile sensors to operate in lightweight or full-function modes depending on the sensor application requirements or available networking environments. The technical feasibility of the proposed mobile sensor network platform has been demonstrated by implementing a prototype system.	[Kafle, Ved P.; Fukushima, Yusuke; Harai, Hiroaki] Natl Inst Informat & Commun Technol, Tokyo, Japan	Kafle, VP (reprint author), Natl Inst Informat & Commun Technol, Tokyo, Japan.	kafle@nict.go.jp					[Anonymous], 2010, REQ SUPP UB SENS NET; [Anonymous], 2011, FUT NETW OBJ DES GOA; [Anonymous], 2012, ID FRAM FUT NETW; Akyildiz IF, 2002, IEEE COMMUN MAG, V40, P102, DOI 10.1109/MCOM.2002.1024422; Yick J, 2008, COMPUT NETW, V52, P2292, DOI 10.1016/j.comnet.2008.04.002; Kafle V. P., 2012, IEICE T INFORM SYS E, VE96-D, P226; Kafle V.P., 2010, IEICE T COMMUN, VE93-B, P478; Kafle V.P., 2014, P IEEE CONS COMM NET; Montenegro G., 2007, 4944 IETF RFC	9	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	MAR	2015	53			S			48	57				10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CE3OA	WOS:000351735000009		
J	Nawa, K; Chandrasiri, NP				Nawa, Kazunari; Chandrasiri, Naiwala P.			Information Analysis and Natural Presentation Based on a Cyber-Physical System for Automobiles	IEEE INTERNET COMPUTING			English	Article								The proposed system describes expected continuous spiral information flow for vehicles and drivers. In the data center, intelligent information processing technology analyzes accumulated information, and then a human-machine interface presents trusted information to drivers. The authors introduce several potential applications here, mainly based on personal adaptation and Big Data analysis. They also introduce a tactile sense device, as an experimental challenge to presenting instructions in a natural, intuitive manner.	[Nawa, Kazunari] Toyota InfoTechnol Ctr, Tech Res Div, Toyota, Japan; [Chandrasiri, Naiwala P.] Kogakuin Univ, Fac Informat, Tokyo 160, Japan	Nawa, K (reprint author), Toyota InfoTechnol Ctr, Tech Res Div, Toyota, Japan.	nawa@jp.toyota-itc.com; chandrasiri@cc.kogakuin.ac.jp					CALABRESE F, 2011, PERVAS COMPUT IEEE, V10, P36, DOI DOI 10.1109/MPRV.2011.41; Froehlich J., 2008, P SOC AUT ENG 2008 W; Krumm J., 2006, P SOC AUT ENG 2006 W; Miyata H., 2008, P AT INT; Nawa K., 2012, P 2 ANN IEEE INT C C, P135; Sakaki T., 2012, P IEEE INT C CYB TEC, P221; Singh M, 2013, IEEE INTERNET COMPUT, V17, P66, DOI 10.1109/MIC.2013.107; Yanagihara Tadashi, 2013, Proceedings of the 2013 IEEE International Conference on Cyber Technology in Automation, Control and Intelligent Systems (CYBER), DOI 10.1109/CYBER.2013.6705425	8	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1089-7801	1941-0131		IEEE INTERNET COMPUT	IEEE Internet Comput.	MAR-APR	2015	19	2					78	82				5	Computer Science, Software Engineering	Computer Science	CE4BA	WOS:000351774200012		
J	Sutoh, M; Otsuki, M; Wakabayashi, S; Hoshino, T; Hashimoto, T				Sutoh, Masataku; Otsuki, Masatsugu; Wakabayashi, Sachiko; Hoshino, Takeshi; Hashimoto, Tatsuaki			The Right Path Comprehensive Path Planning for Lunar Exploration Rovers	IEEE ROBOTICS & AUTOMATION MAGAZINE			English	Article									[Sutoh, Masataku; Otsuki, Masatsugu; Wakabayashi, Sachiko; Hoshino, Takeshi; Hashimoto, Tatsuaki] Japan Aerosp Explorat Agcy, Lunar & Planetary Explorat Program Grp, Sagamihara, Kanagawa, Japan	Sutoh, M (reprint author), Japan Aerosp Explorat Agcy, Lunar & Planetary Explorat Program Grp, Sagamihara, Kanagawa, Japan.	sutoh.masataku@jaxa.jp; otsuki@isas.jaxa.jp; wakabayashi.sachiko@jaxa.jp; hoshino.takeshi@jaxa.jp; hashimoto.tatsuaki@jaxa.jp					Ferguson D, 2006, J FIELD ROBOT, V23, P79, DOI 10.1002/rob.20109; Wakabayashi S, 2009, J TERRAMECHANICS, V46, P105, DOI 10.1016/j.jterra.2008.09.002; Acton CH, 1996, PLANET SPACE SCI, V44, P65, DOI 10.1016/0032-0633(95)00107-7; Carsten J., 2007, P IEEE AER C BIG SKY, P1; Iagnemma K, 2000, LECT NOTES CONTR INF, V250, P319; Inotsume H, 2013, J FIELD ROBOT, V30, DOI 10.1002/rob.21479; Ishigami G, 2013, J FIELD ROBOT, V30, P536, DOI 10.1002/rob.21462; Ishigami G, 2011, IEEE INT C INT ROBOT, P601, DOI 10.1109/IROS.2011.6048429; Kanamori H., 2005, P 6 ASCE INT C EXP E, P462; lagnemma K., 1999, P IEEE INT C ROB AUT, V3, P2286, DOI 10.1109/ROBOT.1999.770446; Lavalle SM, 2000, ALGORITHMIC COMPUTAT, P293; LaValle S.M., 2006, PLANNING ALGORITHM; Ohki T., 2013, THESIS TOHOKU U SEND; Singh S., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), DOI 10.1109/ROBOT.2000.844761; Stentz A., 1995, P INT JOINT C ART IN, V14, P1652; Teti F., 2005, P INT S ART INT ROB, P5; Tompkins P., 2001, P INT S ART INT ROB; Wettergreen D, 2005, IEEE INT CONF ROBOT, P873; Wettergreen D., 2001, INT S ART INT ROB AU; Wong J Y, 2001, THEORY GROUND VEHICL	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1070-9932	1558-223X		IEEE ROBOT AUTOM MAG	IEEE Robot. Autom. Mag.	MAR	2015	22	1					22	33		10.1109/MRA.2014.2381359		12	Automation & Control Systems; Robotics	Automation & Control Systems; Robotics	CE7OG	WOS:000352030600006		
J	Ma, JX; Zhang, Y; Cichocki, A; Matsuno, F				Ma, Jiaxin; Zhang, Yu; Cichocki, Andrzej; Matsuno, Fumitoshi			A Novel EOG/EEG Hybrid Human-Machine Interface Adopting Eye Movements and ERPs: Application to Robot Control	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Electroencephalogram (EEG); electrooculogram (EOG); event-related potential (ERP); human-machine interface (HMI); robot control	BRAIN-COMPUTER-INTERFACE; NEAR-INFRARED SPECTROSCOPY; ERROR-RELATED POTENTIALS; BCI SYSTEM; COMBINING P300; CLASSIFICATION; SIGNALS; SSVEP; PERFORMANCE; SPELLER	This study presents a novel human-machine interface (HMI) based on both electrooculography (EOG) and electroencephalography (EEG). This hybrid interface works in two modes: an EOG mode recognizes eye movements such as blinks, and an EEG mode detects event related potentials (ERPs) like P300. While both eye movements and ERPs have been separately used for implementing assistive interfaces, which help patients with motor disabilities in performing daily tasks, the proposed hybrid interface integrates them together. In this way, both the eye movements and ERPs complement each other. Therefore, it can provide a better efficiency and a wider scope of application. In this study, we design a threshold algorithm that can recognize four kinds of eye movements including blink, wink, gaze, and frown. In addition, an oddball paradigm with stimuli of inverted faces is used to evoke multiple ERP components including P300, N170, and VPP. To verify the effectiveness of the proposed system, two different online experiments are carried out. One is to control a multifunctional humanoid robot, and the other is to control four mobile robots. In both experiments, the subjects can complete tasks effectively by using the proposed interface, whereas the best completion time is relatively short and very close to the one operated by hand.	[Ma, Jiaxin; Matsuno, Fumitoshi] Kyoto Univ, Dept Mech Engn & Sci, Sch Engn, Kyoto 6158530, Japan; [Zhang, Yu] E China Univ Sci & Technol, Key Lab Adv Control & Optimizat Chem Proc, Minist Educ, Shanghai 200237, Peoples R China; [Cichocki, Andrzej] RIKEN Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama 3510198, Japan; [Cichocki, Andrzej] Polish Acad Sci, Syst Res Inst, PL-00901 Warsaw, Poland	Ma, JX (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Sch Engn, Kyoto 6158530, Japan.	ma.jiaxin.62c@st.kyoto-u.ac.jp; yuzhang@ecust.edu.cn; a.cichocki@riken.jp; matsuno@me.kyoto-u.ac.jp			Nation Nature Science Foundation of China [61305028]; Fundamental Research Funds for the Central Universities [WH1314023]	This work was supported in part by the Nation Nature Science Foundation of China under Grant 61305028, Fundamental Research Funds for the Central Universities under Grant WH1314023.	Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Amiri S, 2013, BRAIN-COMPUTER INTERFACE SYSTEMS - RECENT PROGRESS AND FUTURE PROSPECTS, P195, DOI 10.5772/56135; Li YQ, 2013, IEEE T BIO-MED ENG, V60, P3156, DOI 10.1109/TBME.2013.2270283; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Pfurtscheller G, 2010, IEEE T NEUR SYS REH, V18, P409, DOI 10.1109/TNSRE.2010.2040837; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Zhang Y, 2013, IEEE T NEUR SYS REH, V21, P233, DOI 10.1109/TNSRE.2013.2243471; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Spuler M, 2012, CLIN NEUROPHYSIOL, V123, P1328, DOI 10.1016/j.clinph.2011.11.082; Bulling A, 2011, IEEE T PATTERN ANAL, V33, P741, DOI 10.1109/TPAMI.2010.86; Barea R, 2002, IEEE T NEUR SYS REH, V10, P209, DOI 10.1109/TNSRE.2002.806829; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Yin EW, 2014, IEEE T BIO-MED ENG, V61, P473, DOI 10.1109/TBME.2013.2281976; Zhang Y, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026018; Li J, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500142; Allison B, 2010, IEEE T NEUR SYS REH, V18, P107, DOI 10.1109/TNSRE.2009.2039495; Panicker RC, 2011, IEEE T BIO-MED ENG, V58, P1781, DOI 10.1109/TBME.2011.2116018; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; Li YQ, 2010, IEEE T BIO-MED ENG, V57, P2495, DOI 10.1109/TBME.2010.2055564; Itier RJ, 2006, NEUROIMAGE, V29, P667, DOI 10.1016/j.neuroimage.2005.07.041; Allison BZ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026007; Naseer N, 2014, EXP BRAIN RES, V232, P555, DOI 10.1007/s00221-013-3764-1; Allison BZ, 2003, IEEE T NEUR SYS REH, V11, P110, DOI 10.1109/TNSRE.2003.814448; Lee JH, 2009, NEUROSCI LETT, V450, P1, DOI 10.1016/j.neulet.2008.11.024; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Barea R, 2002, J INTELL ROBOT SYST, V34, P279, DOI 10.1023/A:1016359503796; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Brunner C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025010; Combaz A, 2012, NEUROCOMPUTING, V80, P73, DOI 10.1016/j.neucom.2011.09.013; Deng LY, 2010, EXPERT SYST APPL, V37, P3337, DOI 10.1016/j.eswa.2009.10.017; Edlinger G, 2011, LECT NOTES COMPUT SC, V6762, P417; Jammes B., 2008, SOMNOLOGIE, V12, P227, DOI 10.1007/s11818-008-0351-y; Khan M. J., 2014, FRONTIERS HUMAN NEUR, V8; Leeb R, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025011; Ma JX, 2013, IEEE INT C INT ROBOT, P859; Mak JN, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026014; Mussa-Ivaldi FA, 2003, TRENDS NEUROSCI, V26, P329, DOI 10.1016/S0166-2236(03)00121-8; Punsawad Y, 2010, IEEE ENG MED BIO, P1360, DOI 10.1109/IEMBS.2010.5626745; Rebsamen B., 2008, P 2 INT CONV REH ENG, P51; Riechmann H, 2011, I IEEE EMBS C NEUR E, P412; Savic A, 2012, IFMBE PROC, V37, P806; Su Y, 2011, J ZHEJIANG U-SCI C, V12, P351, DOI 10.1631/jzus.C1000208; Turnip A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-83; Turnip A, 2012, INT J INNOV COMPUT I, V8, P6429; Wolpaw JR, 2006, IEEE T NEUR SYS REH, V14, P138, DOI 10.1109/TNSRE.2006.875583	53	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	MAR	2015	62	3					876	889		10.1109/TBME.2014.2369483		14	Engineering, Biomedical	Engineering	CE3ZI	WOS:000351768500009		
J	Kuwahara, T; Yoshida, K; Hanamoto, K; Sato, K; Kuroki, T; Okubo, M				Kuwahara, Takuya; Yoshida, Keiichiro; Hanamoto, Kenichi; Sato, Kazutoshi; Kuroki, Tomoyuki; Okubo, Masaaki			A Pilot-Scale Experiment for Total Marine Diesel Emission Control Using Ozone Injection and Nonthermal Plasma Reduction	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article						Adsorbent; aftertreatment; diesel particulate filters (DPFs); marine diesel engine; marine diesel oil (MDO); nonthermal plasma (NTP); NOx; ozone; particulate matter (PM)	SELECTIVE CATALYTIC-REDUCTION; UREA-SCR; PARTICULATE FILTER; NOX REDUCTION; EXHAUST-GAS; DESORPTION; ENGINE; REGENERATION; REMOVAL	Due to the fact that it is difficult to fulfill the recent stringent regulations governing marine diesel engine emission by means of combustion improvement alone, an effective aftertreatment technology is required to achieve the efficient simultaneous removal of NOx and particulate matter (PM). In the present study, we designed and investigated an effective aftertreatment system that employs a combination of ozone injection and nonthermal plasma (NTP) reduction for a marine diesel engine. The proposed technology offers the advantage of not requiring precious-metal catalysts and harmful heavy-metal catalysts as well as urea solution. In this aftertreatment system, PM in the exhaust gas is first captured by a ceramic diesel particulate filter. Subsequently, the deposited PM is oxidized and removed by NTP-induced ozone injection. After the PM treatment, NOx in the exhaust gas is treated by adsorption followed by NTP-combined desorption and reduction processes. These processes are repeated periodically, and total emission control is achieved. Since the deposited PM and the desorbed NOx are treated at a high-concentration state by ozone and oxygen-lean NTP, a higher performance for total marine diesel emission control is recorded. The maximum efficiencies of NOx and PM reduction were 94% and 95%, respectively.	[Kuwahara, Takuya] Nippon Inst Technol, Dept Prod Engn & Environm Management, Saitama 3458501, Japan; [Yoshida, Keiichiro] Osaka Inst Technol, Dept Elect & Elect Syst Engn, Osaka 5358585, Japan; [Hanamoto, Kenichi; Sato, Kazutoshi] Daihatsu Diesel MFG Co Ltd, Moriyama Div, Moriyama 5240035, Japan; [Kuroki, Tomoyuki; Okubo, Masaaki] Osaka Prefecture Univ, Dept Mech Engn, Sakai, Osaka 5998531, Japan	Kuwahara, T (reprint author), Nippon Inst Technol, Dept Prod Engn & Environm Management, Saitama 3458501, Japan.	takuya.k@nit.ac.jp; k.yoshida@ee.oit.ac.jp; kenichi.hanamoto@dhtd.co.jp; kazutoshi.sato@dhtd.co.jp; kuroki@me.osakafu-u.ac.jp; mokubo@me.osakafu-u.ac.jp			Regional R&D Resources Utilization Program of the Japan Science and Technology Agency (JST); JSPS KAKENHI [24246145, 249848]	This work was supported in part by the Regional R&D Resources Utilization Program of the Japan Science and Technology Agency (JST) and in part by JSPS KAKENHI Grant Numbers 24246145 and 249848.	Adelman BJ, 1996, J CATAL, V158, P327, DOI 10.1006/jcat.1996.0031; Obradovic BM, 2011, J HAZARD MATER, V185, P1280, DOI 10.1016/j.jhazmat.2010.10.043; Kamasamudram K, 2010, CATAL TODAY, V151, P212, DOI 10.1016/j.cattod.2010.03.055; Yamamoto T, 1998, IEEE IND APPLIC SOC, P1877, DOI 10.1109/IAS.1998.729839; Okubo M, 2008, PLASMA CHEM PLASMA P, V28, P173, DOI 10.1007/s11090-008-9121-7; Kuwahara T, 2012, IEEE T IND APPL, V48, P1649, DOI 10.1109/TIA.2012.2209389; Magnusson M, 2012, APPL CATAL B-ENVIRON, V111, P20, DOI 10.1016/j.apcatb.2011.09.010; Rallo M, 2010, J HAZARD MATER, V174, P28, DOI 10.1016/j.jhazmat.2009.09.011; Kuwahara T, 2013, APPL ENERG, V111, P652, DOI 10.1016/j.apenergy.2013.05.041; Koebel M, 2004, TOP CATAL, V30-1, P43, DOI 10.1023/B:TOCA.0000029726.38961.2b; Devadas M, 2007, CATAL TODAY, V119, P137, DOI 10.1016/j.cattod.2006.08.018; Fino D, 2007, SCI TECHNOL ADV MAT, V8, P93, DOI 10.1016/j.stam.2006.11.012; Okubo M, 2005, IEEE T IND APPL, V41, P891, DOI 10.1109/TIA.2005.851565; Yoshida K, 2008, IEEE T IND APPL, V44, P1403, DOI 10.1109/TIA.2008.2002216; Holub M, 2010, POL J ENVIRON STUD, V19, P1199; Baik JH, 2004, TOP CATAL, V30-1, P37, DOI 10.1023/B:TOCA.0000029725.88068.97; Petzold A, 2011, ENVIRON SCI TECHNOL, V45, P10394, DOI 10.1021/es2021439; Blatcher DJ, 2013, MAR POLLUT BULL, V74, P10, DOI 10.1016/j.marpolbul.2013.07.010; Gabrielsson PLT, 2004, TOP CATAL, V28, P177, DOI 10.1023/B:TOCA.0000024348.34477.4c; Holub M, 2013, IEEE T PLASMA SCI, V41, P1562, DOI 10.1109/TPS.2013.2254133; Kato T., 2010, J JPN I MARINE ENG, V45, P962; Koebel M., 2001, SAE PAPER; Kuroki T, 2010, CARBON, V48, P184, DOI 10.1016/j.carbon.2009.09.002; Kuwahara T, 2014, PLASMA CHEM PLASMA P, V34, P65, DOI 10.1007/s11090-013-9486-0; Kuwahara T, 2011, IEEE T IND APPL, V47, P2359, DOI 10.1109/TIA.2011.2168590; Kuwahara T, 2012, J JPN I MARINE ENG, V47, P379; Okubo M, 2002, IEEE T IND APPL, V38, P1196, DOI 10.1109/TIA.2002.802916; Otsuka T., 2008, J POWER ENERGY SYST, V2, P1009, DOI 10.1299/jpes.2.1009; Peng H., 2002, IEEJ T ELECT INF SYS, V122, P1940; Petzold A, 2010, ENVIRON SCI TECHNOL, V44, P3800, DOI 10.1021/es903681z; Schmidt M, 2013, PLASMA CHEM PLASMA P, V33, P323, DOI 10.1007/s11090-012-9424-6; Shimizu KI, 2007, APPL CATAL B-ENVIRON, V77, P202, DOI 10.1016/j.apcatb.2007.07.021; Yoshida K., 2007, APPL PHYS LETT, V90; Yoshida K, 2009, THIN SOLID FILMS, V518, P987, DOI 10.1016/j.tsf.2009.07.171	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-9994	1939-9367		IEEE T IND APPL	IEEE Trans. Ind. Appl.	MAR-APR	2015	51	2					1168	1178		10.1109/TIA.2014.2358798		11	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	CE3WJ	WOS:000351760400007		
J	Yamamoto, S; Hirahara, H; Tanaka, A; Ara, T; Matsuse, K				Yamamoto, Shu; Hirahara, Hideaki; Tanaka, Akira; Ara, Takahiro; Matsuse, Kouki			Universal Sensorless Vector Control of Induction and Permanent-Magnet Synchronous Motors Considering Equivalent Iron Loss Resistance	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article						Equivalent iron loss resistance; induction motor (IM); permanent-magnet synchronous motor (PMSM); sensorless vector control	RELUCTANCE MOTORS; FLUX ESTIMATION	This paper presents a novel encoder-less vector control strategy which is universally applicable to both induction motors (IMs) and permanent-magnet synchronous motors (PMSMs). A fast rotor flux linkage phase estimator using stator flux linkage information obtained by a high-precision approximation voltage integral with error compensation is shown. Using this estimator, the authors construct a unified position/speed sensorless vector control algorithm taking equivalent iron loss resistance into account. All electrical motor parameters used for the control can be measured from unified off-line tests. The proposed universal sensorless vector control is implemented on a 0.4-kW squirrel-cage IM, a 0.4-kW interior PMSM with concentrated winding, and a 0.3-kW surface PMSM with distributed winding. Experimental results of several driving tests demonstrate the validity of the proposed.	[Yamamoto, Shu; Hirahara, Hideaki; Tanaka, Akira; Ara, Takahiro] Polytech Univ, Tokyo 1870035, Japan; [Hirahara, Hideaki] Tokyo Metropolitan Univ, Hachioji, Tokyo 1920397, Japan; [Tanaka, Akira] Toyo Univ, Kawagoe, Saitama 3508585, Japan; [Matsuse, Kouki] Meiji Univ, Kawasaki, Kanagawa 2148571, Japan	Yamamoto, S (reprint author), Polytech Univ, Tokyo 1870035, Japan.	yamamoto@uitec.ac.jp; hirahara@uitec.ac.jp; tanaka@uitec.ac.jp; ara@uitec.ac.jp; matsuse@isc.meiji.ac.jp			Japan Society for the Promotion of Science through KAKENHI [25420278]	This work was supported in part by the Japan Society for the Promotion of Science through the Grants-in-Aid for Scientific Research (KAKENHI) under Grant 25420278.	Shin MH, 2000, IEEE T POWER ELECTR, V15, P312; Hinkkanen M, 2003, IEEE T IND ELECTRON, V50, P818, DOI 10.1109/TIE.2003.814996; Harnefors L, 2003, IEEE T IND ELECTRON, V50, P153, DOI 10.1109/TIE.2002.807653; Kondo M, 2007, IEEJ T ELECTR ELECTR, V2, P109, DOI 10.1002/tee.20117; Ohnishi T., 2005, M SPC IEE JAP, P17; Shinnaka Shinji, 2008, IEEJ Transactions on Industry Applications, V128, DOI 10.1541/ieejias.128.340; Takahashi I., 1999, NATL CONV REC IEE JP, P424; Yamamoto S, 2007, IEEE T IND APPL, V43, P47, DOI 10.1109/TIA.2006.887234; Yamamoto S, 2013, IEEE T IND APPL, V49, P2543, DOI 10.1109/TIA.2013.2265071; Yamamoto S, 2010, ELECTR ENG JPN, V171, P41, DOI 10.1002/eej.20969; Yamamoto S., 2010, IEEJ T IND APPL, V130, P699	11	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-9994	1939-9367		IEEE T IND APPL	IEEE Trans. Ind. Appl.	MAR-APR	2015	51	2					1259	1267		10.1109/TIA.2014.2360962		9	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	CE3WJ	WOS:000351760400015		
J	Uno, M; Kukita, A				Uno, Masatoshi; Kukita, Akio			Two-Switch Voltage Equalizer Using an LLC Resonant Inverter and Voltage Multiplier for Partially Shaded Series-Connected Photovoltaic Modules	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article						LLC resonant inverter; partial shading; photovoltaic (PV) system; voltage equalizer; voltage multiplier	VEHICLE-BATTERY SYSTEM; LITHIUM-ION CELLS; CHARGE EQUALIZATION; SWITCHED-CAPACITOR; POWER ELECTRONICS; PERFORMANCE; DESIGN; ARCHITECTURES; CONVERTERS; TOPOLOGY	Various kinds of differential power processing converters and voltage equalizers have been proposed for series-connected photovoltaic (PV) modules to prevent negative influences of partial shading, such as significant reduction in power generation and the occurrence of multiple maximum power points (MPPs), including local and global MPPs, that hinders and confuses MPP tracking algorithms to operate properly. However, since conventional topologies are based on multiple individual dc-dc converters, the required switch count increases proportionally to the number of modules connected in series, increasing the complexity. A two-switch voltage equalizer using an LLC resonant inverter and voltage multiplier is proposed in this paper. The circuitry can be dramatically simplified compared with conventional topologies due to the two-switch configuration. Detailed operation analyses for the LLC resonant inverter and voltage multiplier are separately performed. Experimental equalization tests emulating partially shaded conditions were performed for four PV modules connected in series. With the proposed voltage equalizer, local MPPs successfully disappeared, and extractable maximum power increased compared with those without equalization, demonstrating the effectiveness and performance of the proposed voltage equalizer.	[Uno, Masatoshi; Kukita, Akio] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki 3058505, Japan	Uno, M (reprint author), Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki 3058505, Japan.	uno.masatoshi@jaxa.jp; kukita.akio@jaxa.jp			Ministry of Education, Culture, Sports, Science and Technology [25820118]	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology under Grant-in-Aid for Young Scientists (B) 25820118.	Olalla C, 2015, IEEE T POWER ELECTR, V30, P618, DOI 10.1109/TPEL.2014.2312980; Poshtkouhi S, 2012, APPL POWER ELECT CO, P86, DOI 10.1109/APEC.2012.6165802; Shimizu T, 2001, IEEE T POWER ELECTR, V16, P293, DOI 10.1109/63.923760; Kimball JW, 2007, 2007 IEEE VEHICLE POWER AND PROPULSION CONFERENCE, VOLS 1 AND 2, P323, DOI 10.1109/VPPC.2007.4544145; Vitelli M, 2014, PROG PHOTOVOLTAICS, V22, P283, DOI 10.1002/pip.2256; Olalla C, 2013, IEEE T POWER ELECTR, V28, P2980, DOI 10.1109/TPEL.2012.2219073; KUTKUT NH, 1995, IEEE T IND APPL, V31, P562, DOI 10.1109/28.382117; Poshtkouhi S, 2012, IEEE T POWER ELECTR, V27, P4656, DOI 10.1109/TPEL.2011.2173353; Kim MY, 2014, IEEE T IND ELECTRON, V61, P3989, DOI 10.1109/TIE.2013.2288195; Cassani PA, 2010, IEEE T IND ELECTRON, V57, P3956, DOI 10.1109/TIE.2010.2050750; Phung TH, 2014, IEEE T POWER ELECTR, V29, P4603, DOI 10.1109/TPEL.2013.2284797; Bergveld HJ, 2013, IEEE T POWER ELECTR, V28, P2005, DOI 10.1109/TPEL.2012.2195331; Shimizu T, 2003, IEEE T POWER ELECTR, V18, P704, DOI 10.1109/TPEL.2003.809375; Baughman AC, 2008, IEEE T IND ELECTRON, V55, P2277, DOI [10.1109/TIE.2008.918401, 10.1109/TIE.2007.918401]; [Anonymous], 2013, P IEEE EN CONV C EXP; Cassani PA, 2009, IEEE T VEH TECHNOL, V58, P3938, DOI 10.1109/TVT.2009.2031553; Stauth JT, 2013, IEEE T POWER ELECTR, V28, P1189, DOI 10.1109/TPEL.2012.2206056; Qin SB, 2013, APPL POWER ELECT CO, P101; Du J, 2013, APPL POWER ELECT CO, P92; Shenoy PS, 2013, IEEE T POWER ELECTR, V28, P2968, DOI 10.1109/TPEL.2012.2211082; Park HS, 2009, IEEE T IND ELECTRON, V56, P1464, DOI 10.1109/TIE.2009.2012456; Uno M, 2011, IEEE T VEH TECHNOL, V60, P1505, DOI 10.1109/TVT.2011.2127500; Kutkut NH, 1999, IEEE T IND APPL, V35, P28, DOI 10.1109/28.740842; Villa LFL, 2013, IEEE T IND ELECTRON, V60, P1179, DOI 10.1109/TIE.2012.2201431; Bossche A. V. D., 2005, INDUCTORS TRANSFORME; Cao J., 2008, P IEEE VEH POW PROP, P1; Choi H., 2007, P FAIRCH POW SEM, pA; Giral R., 2011, P INT C CLEAN EL POW, P94; Giral R., 2010, P IEEE INT C IND TEC, P943; Guo K. Z., 2006, IEEE POW EL SPEC C J, P1; Kadri R., 2011, P INT C POW ENG EN E, P1; Kim CH, 2009, J POWER ELECTRON, V9, P472; Kutkut NH, 1998, IEEE T AERO ELEC SYS, V34, P235, DOI 10.1109/7.640281; NIMNI Y, 2010, P 2010 IEEE INT S CI, P2191, DOI 10.1109/ISCAS.2010.5537199; Nishijima K, 2000, IEEE POWER ELECTRON, P517; Olalla C., 2012, P IEEE 13 WORKSH CON, P1; SALAM Z, 2012, P IEEE EN CONV C EXP, P1622; Villa LFL, 2014, IEEE T POWER ELECTR, V29, P1447, DOI 10.1109/TPEL.2013.2260177; Yaakov S. B., 2012, P IEEE EN CONV C EXP, P4129; Yuanmao Y., 2012, IEEE T POWER ELECTR, V27, P3234; Zhang Q., 2009, POW EL MOT CONTR C, P2130	41	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-9994	1939-9367		IEEE T IND APPL	IEEE Trans. Ind. Appl.	MAR-APR	2015	51	2					1587	1601		10.1109/TIA.2014.2336980		15	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	CE3WJ	WOS:000351760400052		
J	Itoh, K; Ishigaki, M; Yanagizawa, N; Tomura, S; Umeno, T				Itoh, Kenichi; Ishigaki, Masanori; Yanagizawa, Naoki; Tomura, Shuji; Umeno, Takaji			Analysis and Design of a Multiport Converter Using a Magnetic Coupling Inductor Technique	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article						Isolated bi-directional dc/dc converter; magnetic coupling inductor; multiport converter	DC-DC CONVERTER; ENERGY-STORAGE; PERFORMANCE	A novel multiport dc-dc converter with a coupling magnetic inductor is analyzed and designed. The proposed circuit integrates two multiphase converters and one isolated dc-dc converter. These converters can be controlled independently in one circuit by adjusting the duty ratio and phase angle difference. There are four dc ports in the circuit, and the dc power can be delivered multidirectionally among the four dc ports. In this paper, a 1.5-kW prototype of the multiport converter was constructed and successfully operated under full power. The experimental results confirm the theoretical analysis, and the conversion efficiency is above 90% over a wide range of output power. In addition, an example of a multifunctional power conversion system using the multiport converter is demonstrated.	[Itoh, Kenichi; Ishigaki, Masanori; Yanagizawa, Naoki; Tomura, Shuji; Umeno, Takaji] Toyota Cent Res & Dev Labs Inc, Elect Device Res Div, Nagakute, Aichi 4801192, Japan	Itoh, K (reprint author), Toyota Cent Res & Dev Labs Inc, Elect Device Res Div, Nagakute, Aichi 4801192, Japan.	e1479@mosk.tytlabs.co.jp; e1396@mosk.tytlabs.co.jp; e1553@mosk.tytlabs.co.jp; e1176@mosk.tytlabs.co.jp; e0953@mosk.tytlabs.co.jp					Morita T, 2011, APPL POWER ELECT CO, P481, DOI 10.1109/APEC.2011.5744640; Zhao CH, 2008, IEEE T POWER ELECTR, V23, P2443, DOI 10.1109/TPEL.2008.2002056; Wong PL, 2001, IEEE T POWER ELECTR, V16, P499; Tao H, 2008, IEEE POWER ELECTRON, P3412; Zhang W, 2011, 2011 IEEE ENERGY CONVERSION CONGRESS AND EXPOSITION (ECCE), P3270; Ishigaki M, 2013, APPL POWER ELECT CO, P1068, DOI 10.1109/APEC.2013.6520432; Inoue S, 2007, APPL POWER ELECT CO, P761, DOI 10.1109/APEX.2007.357601; DEDONCKER RWAA, 1991, IEEE T IND APPL, V27, P63, DOI 10.1109/28.67533; Krismer F, 2010, IEEE T IND ELECTRON, V57, P881, DOI 10.1109/TIE.2009.2025284; Barton JP, 2004, IEEE T ENERGY CONVER, V19, P441, DOI 10.1109/TEC.2003.822305; Itoh K., 2013, P ECCE, P4713; Jain AK, 2012, MATER SCI FORUM, V717-720, P1237, DOI 10.4028/www.scientific.net/MSF.717-720.1237; Lee FC, 2013, APPL POWER ELECT CO, P679, DOI 10.1109/APEC.2013.6520283; Qian ZJ, 2011, 2011 IEEE ENERGY CONVERSION CONGRESS AND EXPOSITION (ECCE), P1454; Snyder K., 2009, SOC AUT ENG INT WARR; TAKAO K, 2010, APPL POWER ELECT CO, P2030; Zhang Z., 2011, P INT C POW EL DRIV, P706	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-9994	1939-9367		IEEE T IND APPL	IEEE Trans. Ind. Appl.	MAR-APR	2015	51	2					1713	1721		10.1109/TIA.2014.2354401		9	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	CE3WJ	WOS:000351760400064		
J	Horiguchi, T; Kinouchi, S; Nakayama, Y; Oi, T; Urushibata, H; Okamoto, S; Tominaga, S; Akagi, H				Horiguchi, Takeshi; Kinouchi, Shin-ichi; Nakayama, Yasushi; Oi, Takeshi; Urushibata, Hiroaki; Okamoto, Shoji; Tominaga, Shinji; Akagi, Hirofumi			A High-Speed Protection Circuit for IGBTs Subjected to Hard-Switching Faults	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article						Hard-switching faults (HSFs); insulated-gate bipolar transistor (IGBT) model; protection	PARAMETER EXTRACTION; SIMULATOR IGBT; MODEL; BEHAVIOR	This paper describes a high-speed protection circuit for insulated-gate bipolar transistors (IGBTs) subjected to hard-switching faults (HSFs). The reverse transfer capacitance depends on the collector-emitter voltage, and it produces a significant effect on the switching behavior not only under normal conditions but also under HSF conditions. A gate charge characteristic under HSF conditions differs from that under normal turn-on conditions. Hence, an HSF can be detected by monitoring both the gate-emitter voltage and the amount of gate charge during the turn-on transient period. IGBTs can be rapidly protected from destruction by using this method because a blanking time is unnecessary. Simulation and experiment verify the validity of the proposed high-speed protection circuit.	[Horiguchi, Takeshi; Kinouchi, Shin-ichi; Nakayama, Yasushi; Oi, Takeshi] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan; [Urushibata, Hiroaki] Kanazawa Inst Technol, Dept Elect & Elect Engn, Nonoichi, Ishikawa 9218501, Japan; [Okamoto, Shoji] Tokyo Inst Technol, Tokyo 1528550, Japan; [Tominaga, Shinji] Mitsubishi Electr Corp, Amagasaki, Hyogo 6618661, Japan; [Tominaga, Shinji; Akagi, Hirofumi] Tokyo Inst Technol, Dept Elect & Elect Engn, Tokyo 1528550, Japan	Horiguchi, T (reprint author), Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan.	horiguchi.takeshi@aj.mitsubishielectric.co.jp; kinouchi.shinichi@bx.MitsubishiElectric.co.jp; Nakayama.Yasushi@cj.MitsubishiElectric.co.jp; Oi.Takeshi@cj.MitsubishiElectric.co.jp; urushibata.h@neptune.kanazawa-it.ac.jp; okamoto.s@akg.ee.titech.ac.jp; tominaga@ee.titech.ac.jp; akagi@ee.titech.ac.jp					Rodriguez-Blanco MA, 2011, IEEE T IND ELECTRON, V58, P1625, DOI 10.1109/TIE.2010.2098355; Yuasa K, 2010, PROC INT SYMP POWER, P37; CHOKHAWALA RS, 1995, IEEE T IND APPL, V31, P256, DOI 10.1109/28.370271; Bryant AT, 2008, IEEE T IND APPL, V44, P904, DOI 10.1109/TIA.2008.921384; Bryant AT, 2006, IEEE T POWER ELECTR, V21, P295, DOI 10.1109/TPEL.2005.869742; HEFNER AR, 1988, SOLID STATE ELECTRON, V31, P1513, DOI 10.1016/0038-1101(88)90025-1; Igic PM, 2002, MICROELECTRON RELIAB, V42, P1045, DOI 10.1016/S0026-2714(02)00016-1; Ishikawa K, 2005, INT SYM POW SEMICOND, P59; Kang X, 2003, APPL POWER ELECT CO, P946; Kang X, 2002, APPL POWER ELECT CO, P452, DOI 10.1109/APEC.2002.989284; Leturcq P., 1997, EPE, V1, P494; Leturcq P., 1995, EPE, V1, P222; Musumeci S, 2002, IEEE IND APPLIC SOC, P2614, DOI 10.1109/IAS.2002.1042816; Nakayama Y., 2003, EPE; Park B.-G., 2008, IEEE IAS ANN M EDM A, P1; Schlangenotto H., 1969, SOLID STATE ELECTRON, V12, P265; Tanimura T, 2011, PROC INT SYMP POWER, P60, DOI 10.1109/ISPSD.2011.5890790	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-9994	1939-9367		IEEE T IND APPL	IEEE Trans. Ind. Appl.	MAR-APR	2015	51	2					1774	1781		10.1109/TIA.2014.2354402		8	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	CE3WJ	WOS:000351760400070		
J	Xie, K; He, ZS; Cichocki, A				Xie, Kan; He, Zhaoshui; Cichocki, Andrzej			Convergence Analysis of the FOCUSS Algorithm	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Auxiliary function; convergence; Focal Underdetermined System Solver (FOCUSS) algorithm; global convergence theorem	BLIND SOURCE SEPARATION; NONNEGATIVE MATRIX FACTORIZATION; RECURRENT NEURAL-NETWORKS; MINIMUM NORM ALGORITHM; TIME-VARYING DELAYS; SPARSE REPRESENTATION; MINIMIZATION; RECONSTRUCTION; STABILITY; SELECTION	Focal Underdetermined System Solver (FOCUSS) is a powerful and easy to implement tool for basis selection and inverse problems. One of the fundamental problems regarding this method is its convergence, which remains unsolved until now. We investigate the convergence of the FOCUSS algorithm in this paper. We first give a rigorous derivation for the FOCUSS algorithm by exploiting the auxiliary function. Following this, we further prove its convergence by stability analysis.	[Xie, Kan; He, Zhaoshui] Guangdong Univ Technol, Sch Automat, Guangzhou 510006, Guangdong, Peoples R China; [He, Zhaoshui; Cichocki, Andrzej] RIKEN Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama 3510198, Japan; [Cichocki, Andrzej] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland	Xie, K (reprint author), Guangdong Univ Technol, Sch Automat, Guangzhou 510006, Guangdong, Peoples R China.	kanxiegdut@gmail.com; zhaoshuihe@gmail.com; a.cichocki@brain.riken.jp			National Natural Science Foundation of China [61322306, 61333013, 61304140, 61271210, 61273192]; Natural Science Foundation of Guangdong Province [S2011030002886]; Program for New Century Excellent Talents in University [NCET-11-0911]; Special Scientific Funds for the Recruited Talents through the Guangdong Provincial universities; SRF through the ROCS and SEM	This work was supported in part by the National Natural Science Foundation of China under Grant 61322306, Grant 61333013, Grant 61304140, Grant 61271210, and Grant 61273192, in part by the Natural Science Foundation of Guangdong Province under Grant S2011030002886, in part by the Program for New Century Excellent Talents in University under Grant NCET-11-0911, in part by the Special Scientific Funds approved in 2011 and 2014 for the Recruited Talents through the Guangdong Provincial universities, and in part by the SRF through the ROCS and SEM.	Saab R, 2007, IEEE T SIGNAL PROCES, V55, P4004, DOI 10.1109/TSP.2007.895998; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Lai ZH, 2012, IEEE T NEUR NET LEAR, V23, P1948, DOI 10.1109/TNNLS.2012.2217154; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Rao BD, 2003, IEEE T SIGNAL PROCES, V51, P760, DOI 10.1109/TSP.2002.808076; Bofill P, 2001, SIGNAL PROCESS, V81, P2353, DOI 10.1016/S0165-1684(01)00120-7; Li YQ, 2004, NEURAL COMPUT, V16, P1193, DOI 10.1162/089976604773717586; Xu ZB, 2012, IEEE T NEUR NET LEAR, V23, P1013, DOI 10.1109/TNNLS.2012.2197412; Needell D, 2009, APPL COMPUT HARMON A, V26, P301, DOI 10.1016/j.acha.2008.07.002; Ye JC, 2007, MAGN RESON MED, V57, P764, DOI 10.1002/mrm.21202; GORODNITSKY IF, 1995, ELECTROEN CLIN NEURO, V95, P231, DOI 10.1016/0013-4694(95)00107-A; Yang ZY, 2011, IEEE T IMAGE PROCESS, V20, P1112, DOI 10.1109/TIP.2010.2081678; Zhou GX, 2011, IEEE T NEURAL NETWOR, V22, P550, DOI 10.1109/TNN.2011.2109396; Zdunek R, 2008, IEEE T SIGNAL PROCES, V56, P4752, DOI 10.1109/TSP.2008.928160; Kreutz-Delgado K, 2003, NEURAL COMPUT, V15, P349, DOI 10.1162/089976603762552951; Xie SL, 2012, IEEE T NEUR NET LEAR, V23, P306, DOI 10.1109/TNNLS.2011.2177475; Jung H, 2007, PHYS MED BIOL, V52, P3201, DOI 10.1088/0031-9155/52/11/018; Gorodnitsky IF, 1997, IEEE T SIGNAL PROCES, V45, P600, DOI 10.1109/78.558475; Shen Y, 2008, IEEE T NEURAL NETWOR, V19, P528, DOI 10.1109/TNN.2007.911751; Zhang HG, 2008, IEEE T NEURAL NETWOR, V19, P855, DOI 10.1109/TNN.2007.912319; Bach F., 2010, P ECML PKDD TUTS; Balavoine A, 2012, IEEE T NEUR NET LEAR, V23, P1377, DOI 10.1109/TNNLS.2012.2202400; Cichocki A., 2003, ADAPTIVE BLIND SIGNA; Donoho DL, 2003, P NATL ACAD SCI USA, V100, P2197, DOI 10.1073/pnas.0437847100; Donoho D. L., 2006, 200618 STANF U DEP S; Fletcher R, 1987, PRACTICAL METHODS OP; Fuchs JJ, 2007, IEEE J-STSP, V1, P598, DOI 10.1109/JSTSP.2007.909363; Garg R., 2009, P 26 ANN INT C MACH, P337; GORODNITSKY IF, 1999, ACOUST SPEECH SIG PR, P1697; Han J, 2004, P ANN INT IEEE EMBS, V26, P122; He R., 2013, IEEE T NEUR NET LEAR, V24, P1023; He ZS, 2009, IEEE T SIGNAL PROCES, V57, P399, DOI 10.1109/TSP.2008.2007605; Li YQ, 2008, IEEE T NEURAL NETWOR, V19, P2009, DOI 10.1109/TNN.2008.2003980; Petersen K. B., 2008, MATRIX COOKBOOK VERS; Rangan S., 2009, P ADV NEUR INF PROC, P540; Rao BD, 1999, IEEE T SIGNAL PROCES, V47, P187, DOI 10.1109/78.738251; Rao B. D., 1998, P 8 IEEE DIG SIGN PR; Rao B. D., 1997, P 31 AS C SIGN SYST, V1, P955; RAO BD, 1998, ACOUST SPEECH SIG PR, P1861; Saunders M. A., 2002, PDCO PRIMAL DUAL INT; Lee DD, 2001, ADV NEUR IN, V13, P556; Yang J., 2013, IEEE T NEUR NET LEAR, V24, P35; Zhang HG, 2009, IEEE T CIRCUITS-I, V56, P616, DOI 10.1109/TCSI.2008.2002556	43	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	MAR	2015	26	3					601	613		10.1109/TNNLS.2014.2323985		13	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CE4XT	WOS:000351834400015		
J	Liu, Q; Wang, XD; Han, B; Wang, XD; Zhou, XM				Liu, Quan; Wang, Xudong; Han, Biao; Wang, Xiaodong; Zhou, Xingming			Access Delay of Cognitive Radio Networks Based on Asynchronous Channel-Hopping Rendezvous and CSMA/CA MAC	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Asynchronous channel-hopping (CH) rendezvous; channel access delay; cognitive radio networks (CRNs); rendezvous delay; 802.11 distributed coordination function (DCF)	OPPORTUNISTIC SPECTRUM ACCESS; PERFORMANCE ANALYSIS; WIRELESS NETWORKS; STRATEGIES; SCHEME	As a promising approach to the rendezvous problem in cognitive radio networks (CRNs), a blind rendezvous paradigm has recently spawned various asynchronous channel-hopping (CH) rendezvous schemes that enable any two neighboring secondary users to meet among multiple channels within a finite time, even with no synchronization. However, the rendezvous delay that was derived in existing work is unable to reflect the actual channel access delay performance in multiuser CRNs, as it only relies on hopping patterns of the elaborately designed CH sequences (CHSs) and ignores the impact of network factors (e.g., channel availability and multiuser contention). In this paper, channel access delay is investigated by jointly considering asynchronous CH rendezvous schemes, channel availability, and a medium-access control (MAC) protocol in a single-hop multiuser CRN. To coordinate multiuser contention, a carrier sense multiple access with collision avoidance (CSMA/CA) MAC is adopted by tailoring the IEEE 802.11 distributed coordination function (DCF) properly to the operation features of existing asynchronous CH rendezvous schemes. The channel access delay is analyzed based on a modified Bianchi model and an absorbing Markov chain model, which captures the aggregate effect of hopping patterns of CHSs, the dynamic nature of channel availability, and the behavior of the MAC protocol. The analytical results are verified through extensive simulations. Both simulation and analytical results reveal that the rendezvous delay in existing asynchronous CH rendezvous schemes is insufficient to ensure satisfactory channel access delay in multiuser CRNs.	[Liu, Quan; Wang, Xudong; Zhou, Xingming] Natl Univ Def Technol, Sch Comp Sci, Sci & Technol Parallel & Distributed Proc Lab, Changsha 410073, Hunan, Peoples R China; [Wang, Xiaodong] Shanghai Jiao Tong Univ, Univ Michigan, Joint Inst, Shanghai 200240, Peoples R China; [Han, Biao] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan	Wang, XD (reprint author), Natl Univ Def Technol, Sch Comp Sci, Sci & Technol Parallel & Distributed Proc Lab, Changsha 410073, Hunan, Peoples R China.	liuquan@nudt.edu.cn; xdwang@nudt.edu.cn; hanbiao@osdp.cs.tsukuba.ac.jp; wxudong@ieee.org; xmzhou@nudt.edu.cn			National Natural Science Foundation of China [61070203, 61172066]; Ministry of Education Program for New Century Excellent Talents; Oriental Scholar Program of the Shanghai Municipal Education Commission	Manuscript received August 3, 2013; revised February 10, 2014; accepted April 30, 2014. Date of publication May 20, 2014; date of current version March 10, 2015. This work was supported in part by the National Natural Science Foundation of China under Grant 61070203 and Grant 61172066, by the Ministry of Education Program for New Century Excellent Talents, and by the Oriental Scholar Program of the Shanghai Municipal Education Commission. The review of this paper was coordinated by Prof. O. B. Akan. (Corresponding author: Xudong Wang.)	Chong JW, 2009, J COMMUN NETW-S KOR, V11, P175; Tan K, 2011, COMMUN ACM, V54, P99, DOI 10.1145/1866739.1866760; Liu H, 2012, IEEE T PARALL DISTR, V23, P1867, DOI 10.1109/TPDS.2012.22; Akyildiz IF, 2006, COMPUT NETW, V50, P2127, DOI 10.1016/j.comnet.2006.05.001; Bian KG, 2009, FIFTEENTH ACM INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING (MOBICOM 2009), P25; Pawelczak P, 2009, IEEE T VEH TECHNOL, V58, P3014, DOI 10.1109/TVT.2008.2009350; De Domenico A, 2012, IEEE COMMUN SURV TUT, V14, P21, DOI 10.1109/SURV.2011.111510.00108; Zhao Q, 2007, IEEE J SEL AREA COMM, V25, P589, DOI 10.1109/JSAC.2007.070409; Shin J, 2010, IEEE COMMUN LETT, V14, P954, DOI 10.1109/LCOMM.2010.091010.100904; Theis NC, 2011, IEEE T MOBILE COMPUT, V10, P216, DOI 10.1109/TMC.2010.60; Hasan R, 2012, UEEE INT SYM PERS IN, P178, DOI 10.1109/PIMRC.2012.6362640; Zhang YF, 2011, IEEE INFOCOM SER, P2471; Liu Q, 2012, 2012 IEEE INTERNATIONAL SYMPOSIUM ON DYNAMIC SPECTRUM ACCESS NETWORKS, P529; Yang D, 2010, ELECTRON LETT, V46, P1402, DOI 10.1049/el.2010.1990; Park J, 2011, IEEE T MOBILE COMPUT, V10, P1011, DOI 10.1109/TMC.2010.255; Su H, 2008, IEEE J SEL AREA COMM, V26, P118, DOI 10.1109/JSAC.2008.080111; Bae YH, 2010, IEEE COMMUN LETT, V14, P975, DOI 10.1109/LCOMM.2010.082310.100322; Bahl P., 2004, P 10 ANN INT C MOB C, P216, DOI 10.1145/1023720.1023742; Bian KG, 2013, IEEE T MOBILE COMPUT, V12, P1294, DOI 10.1109/TMC.2012.103; Bianchi G, 2000, IEEE J SEL AREA COMM, V18, P535, DOI 10.1109/49.840210; Cordeiro C., 2006, Journal of Communications, V1; DaSilva L. A., 2008, P 3 IEEE S NEW FRONT, P1, DOI 10.1145/1621087.1621126; Gast M., 2006, 802 11 WIRELESS NETW; Grinstead C. M., 1998, INTRO PROBABILITY; Haykin S., 2007, COGNITIVE WIRELESS C, P1, DOI 10.1007/978-0-387-68832-9_1; Hoang A., 2009, P IEEE WIR COMM NETW, P1; Kim KJ, 2013, J COMMUN NETW-S KOR, V15, P77, DOI 10.1109/JCN.2013.000013; Kumar S, 2013, IEEE T WIREL COMMUN, V12, P1006, DOI 10.1109/TWC.2013.012413.112118; Laourine A., 2010, P IEEE INFOCOM 2010, P1; Lee CM, 2012, IEEE T MOBILE COMPUT, V11, P1569, DOI 10.1109/TMC.2011.205; Liang YC, 2011, IEEE T VEH TECHNOL, V60, P3386, DOI 10.1109/TVT.2011.2158673; Liu H., 2012, P INT C COMP NETW CO, P645; Mo J., 2005, P 8 ACM INT S MOD AN, P209, DOI 10.1145/1089444.1089480; Su H, 2008, 2008 42ND ANNUAL CONFERENCE ON INFORMATION SCIENCES AND SYSTEMS, VOLS 1-3, P197; Wang S.-H., 2010, P IEEE INFOCOM, P1, DOI DOI 10.1109/DYSPAN.2010.5457905	35	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	MAR	2015	64	3					1105	1119		10.1109/TVT.2014.2325832		15	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CD9ZC	WOS:000351459600021		
J	Xia, F; Liu, L; Li, J; Ahmed, AM; Yang, LT; Ma, JH				Xia, Feng; Liu, Li; Li, Jie; Ahmed, Ahmedin Mohammed; Yang, Laurence Tianruo; Ma, Jianhua			BEEINFO: Interest-Based Forwarding Using Artificial Bee Colony for Socially Aware Networking	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Artificial bee colony; interest; routing and forwarding; socially aware networking (SAN); vehicle social networks (VSNs)	MANETS	Socially aware networking (SAN) provides a promising paradigm for routing and forwarding data packets by exploiting social properties of involved entities, for example, in vehicular social networks (VSNs). The mobility of individuals often features some regularity in location and time, particularly in vehicular environments. However, individuals' learning capability and awareness to the dynamic environments have not been well explored in the literature. Inspired by the artificial bee colony, we present BEEINFO, which is a set of interest-based forwarding schemes for SAN, which consists of BEEINFO-D, BEEINFO-S, and BEEINFO-D&S. BEEINFO adopts the food foraging behavior of bees to detect the environment information and to optimize the forwarding procedure. BEEINFO takes advantage of individuals' perceiving and learning capability to gather information of density and social ties. BEEINFO-D, BEEINFO-S, and BEEINFO-D&S are distinct from each other according to different utilization of density and social ties. This enhances the adaptability to dynamic environments. Additionally, BEEINFO performs message scheduling and buffer management to improve the forwarding performance. Extensive simulations have been conducted to compare BEEINFO with two representative protocols, i.e., PRoPHET and Epidemic. The results illustrate that BEEINFO outperforms PRoPHET and Epidemic with higher message delivery ratio, less overhead, and fewer hop counts.	[Xia, Feng; Liu, Li; Li, Jie; Ahmed, Ahmedin Mohammed] Dalian Univ Technol, Sch Software, Dalian 116620, Peoples R China; [Liu, Li] Shandong Jiaotong Univ, Jinan 250357, Peoples R China; [Yang, Laurence Tianruo] Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan 430074, Peoples R China; [Yang, Laurence Tianruo] St Francis Xavier Univ, Dept Comp Sci, Antigonish, NS B2G 2W5, Canada; [Ma, Jianhua] Hosei Univ, Fac Comp & Informat Sci, Tokyo 1028160, Japan	Xia, F (reprint author), Dalian Univ Technol, Sch Software, Dalian 116620, Peoples R China.	f.xia@ieee.org; ltyang@stfx.ca; jianhua@hosei.ac.jp			National Natural Science Foundation of China [60903153, 61203165]; Liaoning Provincial Natural Science Foundation of China [201202032]; Fundamental Research Funds for the Central Universities [DUT12JR10]	Manuscript received May 2, 2013; revised September 21, 2013; accepted January 26, 2014. Date of publication February 10, 2014; date of current version March 10, 2015. This work was supported in part by the National Natural Science Foundation of China under Grant 60903153 and Grant 61203165, by the Liaoning Provincial Natural Science Foundation of China under Grant 201202032, and by the Fundamental Research Funds for the Central Universities under Grant DUT12JR10. The review of this paper was coordinated by Dr. J. D. Panagiotis Papadimitratos.	Schurgot MR, 2012, IEEE COMMUN MAG, V50, P155, DOI 10.1109/MCOM.2012.6231292; Pelusi L, 2006, IEEE COMMUN MAG, V44, P134, DOI 10.1109/MCOM.2006.248176; Daly EM, 2009, IEEE T MOBILE COMPUT, V8, P606, DOI 10.1109/TMC.2008.161; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Conti M, 2010, COMPUTER, V43, P42, DOI 10.1109/MC.2010.19; Hui P, 2008, MOBIHOC'08: PROCEEDINGS OF THE NINTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P241, DOI 10.1145/1374618.1374652; Musolesi M, 2005, I S WORLD WIREL MOBI, P183, DOI 10.1109/WOWMOM.2005.17; Zeadally S, 2012, TELECOMMUN SYST, V50, P217, DOI 10.1007/s11235-010-9400-5; Kachroudi S, 2012, IEEE T VEH TECHNOL, V61, P3909, DOI 10.1109/TVT.2012.2212735; Chen K, 2014, IEEE T MOBILE COMPUT, V13, P235, DOI 10.1109/TMC.2012.239; Karaboga D, 2009, APPL MATH COMPUT, V214, P108, DOI 10.1016/j.amc.2009.03.090; Daly E, 2007, MOBIHOC'07: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P32; Lee SB, 2012, IEEE T VEH TECHNOL, V61, P2715, DOI 10.1109/TVT.2012.2197031; Boldrini Chiara, 2008, Pervasive and Mobile Computing, V4, DOI 10.1016/j.pmcj.2008.04.003; Bonabeau E., 1999, SWARM INTELLIGENCE N; Mohan BC, 2012, EXPERT SYST APPL, V39, P4618, DOI 10.1016/j.eswa.2011.09.076; Hui P., 2007, P 5 ANN IEEE INT C P, P65, DOI [DOI 10.1109/PERCOMW.2007.55, 10.1109/PERCOMW.2007.55]; Ioannidis S., 1997, P 2 ACM EUROSYS WORK, P290; Jain R., 2011, RR7694 INRIA; Keranen Ari, 2010, Journal of Communications, V5, DOI 10.4304/jcm.5.2.92-105; Li F., 2009, P 6 ANN IEEE COMM SO, P1, DOI 10.1109/ICUT.2009.5405702; Li J., 2013, P 19 ACM MOBICOM 13, P175; Liu Xu, 2003, SIGMOBILE MOB COMPUT, DOI DOI 10.1145/961268.961272; Mershad K, 2013, IEEE T VEH TECHNOL, V62, P536, DOI 10.1109/TVT.2012.2226613; Musolesi M., 2008, P IEEE WOWMOM NEWP B, P1; Popovici D., 2013, SOCIAL NETWORK ANAL, V3, P329; Rahmatizadeh S., 2009, J APPL SCI, V9, P938; Sha W., 2013, P 14 WORKSH MOB COMP, P16; Smaldone S., 2008, P 1 WORKSH SOCIALNET, P43, DOI 10.1145/1435497.1435505; Vahdat A., 2000, CS200006 DUK U; Warthman F., 2008, DELAY TOLERANT NETWO; WEDDE H. F., 2005, P 2005 C GEN EV COMP, P153, DOI DOI 10.1145/1068009.1068034	32	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	MAR	2015	64	3					1188	1200		10.1109/TVT.2014.2305192		13	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CD9ZC	WOS:000351459600027		
J	Liu, JJ; Kato, N; Ma, JF; Sakano, T				Liu, Jiajia; Kato, Nei; Ma, Jianfeng; Sakano, Toshikazu			Throughput and Delay Tradeoffs for Mobile Ad Hoc Networks With Reference Point Group Mobility	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						Mobile ad hoc networks; throughput; delay; capacity; correlated mobility; reference point group mobility	WIRELESS NETWORKS; RESTRICTED MOBILITY; CAPACITY; INCREASES; DIRECTION	In this paper, we explore the throughput-delay tradeoff in a mobile ad hoc network (MANET) operating under the practical reference point group mobility model and also a general setting of node moving speed. In particular, we consider a MANET with unit area and n nodes being divided evenly into Theta(n(alpha)) groups, alpha is an element of [0, 1], where the center of each group moves according to a random direction model with speed of no more than nu is an element of [0, 1]. We determine the regions of per-node throughput and average delay and their tradeoffs that can be achieved (in order sense) in such a network. For the regime of nu = 0, we first prove that the per-node throughput capacity is Theta(n(-alpha/2)) and then develop a routing scheme to achieve this capacity, resulting in an average delay of Theta(max{n(1/2), n(1-alpha)}) for any alpha is an element of [0, 1]. Regarding the regime of nu > 0, we prove that the per-node throughput capacity can be improved to Theta(1), which is achievable by adopting a new routing scheme with an average delay of Theta(max{n(1-alpha), n(alpha/2)/nu}) for nu = o(1) and Theta(n) for nu = Theta(1). The results in this paper help us to have a deep understanding on the fundamental performance scaling laws and also enable an efficient throughput-delay tradeoff to be achieved in MANETs with correlated mobility.	[Liu, Jiajia; Ma, Jianfeng] Xidian Univ, Sch Comp Sci & Technol, State Key Lab Integrated Serv Networks, Xian 710071, Peoples R China; [Kato, Nei] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 9808579, Japan; [Sakano, Toshikazu] NTT Network Innovat Labs, Yokosuka, Kanagawa 2390847, Japan	Liu, JJ (reprint author), Xidian Univ, Sch Comp Sci & Technol, State Key Lab Integrated Serv Networks, Xian 710071, Peoples R China.	liujiajia@xidian.edu.cn; kato@it.ecei.tohoku.ac.jp; sakano.toshikazu@lab.ntt.co.jp			National Natural Science Foundation of China [61372073, 61373043, 61202394]; NSFC-Guangdong Union Foundation [U1135002]	This work was supported in part by the National Natural Science Foundation of China under Grants 61372073, 61373043, and 61202394 and in part by the Key Program of NSFC-Guangdong Union Foundation U1135002. The associate editor coordinating the review of this paper and approving it for publication was H. Hassanein.	Garetto M, 2010, IEEE T INFORM THEORY, V56, P5016, DOI 10.1109/TIT.2010.2059510; Grossglauser M, 2002, IEEE ACM T NETWORK, V10, P477, DOI 10.1109/TNET.2002.801403; Gupta P, 2000, IEEE T INFORM THEORY, V46, P388, DOI 10.1109/18.825799; Lin XJ, 2006, IEEE T INFORM THEORY, V52, P2777, DOI 10.1109/TIT.2006.874544; Sharma G, 2007, IEEE ACM T NETWORK, V15, P981, DOI 10.1109/TNET.2007.905154; Ciullo D, 2011, IEEE ACM T NETWORK, V19, P1745, DOI 10.1109/TNET.2011.2140128; Lu N, 2014, IEEE COMMUN SURV TUT, V16, P642, DOI 10.1109/SURV.2013.081313.00039; Diggavi SN, 2005, IEEE T INFORM THEORY, V51, P3947, DOI 10.1109/TIT.2005.856966; Mammen J, 2007, IEEE T INFORM THEORY, V53, P1108, DOI 10.1109/TIT.2006.890720; Zhang RN, 2011, AD HOC NETW, V9, P623, DOI 10.1016/j.adhoc.2010.08.012; Andrews J, 2008, IEEE COMMUN MAG, V46, P94, DOI 10.1109/MCOM.2008.4689214; Cai LX, 2009, IEEE T WIREL COMMUN, V8, P4056, DOI 10.1109/TWC.2009.080155; Goldsmith A, 2011, IEEE COMMUN MAG, V49, P195, DOI 10.1109/MCOM.2011.5762818; Iyer A, 2009, IEEE T WIREL COMMUN, V8, P2662, DOI 10.1109/TWC.2009.080720; Wang TY, 2013, IEEE J SEL AREA COMM, V31, P538, DOI 10.1109/JSAC.2013.SUP.0513048; Li P, 2012, IEEE T MOBILE COMPUT, V11, P427, DOI 10.1109/TMC.2011.54; Neely MJ, 2005, IEEE T INFORM THEORY, V51, P1917, DOI 10.1109/TIT.2005.847717; Franceschetti M, 2007, IEEE T INFORM THEORY, V53, P1009, DOI 10.1109/TIT.2006.890791; Chi KK, 2014, COMPUT NETW, V60, P101, DOI 10.1016/j.bjp.2013.12.017; De Moraes R. M., 2004, P IEEE C SENS AD HOC, P200; Gamal A. E., 2004, P INFOCOM; Gamal A. E., 2006, IEEE T INFORM THEORY, V52, P2568, DOI DOI 10.1109/TIT.2006.874379; Gamal A. E., 2006, IEEE T INFORM THEORY, V52, P5111, DOI DOI 10.1109/TIT.2006.883548; Groenevelt R., 2005, THESIS U NICE SOPHIA; Hong X., 1999, P 2 ACM INT WORKSH M, P53, DOI 10.1145/313237.313248; Lin X., 2004, P MEDHOC, P1; Liu JJ, 2013, IEEE WIREL COMMUN, V20, P51; Liu J., 2014, P INFOCOM, P2768; Liu JJ, 2011, IEEE T WIREL COMMUN, V10, P2738, DOI 10.1109/TWC.2011.062111.101976; Nain P, 2005, IEEE INFOCOM SER, P1897; Sharma G., DELAY CAPACITY TRADE; Toumpis S., 2004, P INFOCOM; Xue F., 2006, SCALING LAWS AD HOC	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	MAR	2015	14	3					1266	1279		10.1109/TWC.2014.2365553		14	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CD8TG	WOS:000351368100008		
J	Bekkali, A; Zou, SC; Kadri, A; Crisp, M; Penty, RV				Bekkali, Abdelmoula; Zou, Sicheng; Kadri, Abdullah; Crisp, Michael; Penty, Richard V.			Performance Analysis of Passive UHF RFID Systems Under Cascaded Fading Channels and Interference Effects	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						Passive UHF RFID; detection probability; cascaded fading channels; interference; reliable reading range	LINK BUDGETS; ENVIRONMENTS; RADIO; RANGE; ROOM; TAGS	In this paper, the performance of monostatic and bistatic passive ultra high frequency radio frequency identification (UHF RFID) systems under the effects of cascaded fading channels and interference is studied. The performance metric used is tag detection probability defined as the probability that the instantaneous received power is higher than the reader's sensitivity. A closed-form expression of the detection probability is derived using cascaded forward and backscatter fading channels and the reader antennas orientation relative to the tag. Furthermore, the performance of passive UHF RFID systems under reader-to-tag interference caused by both the desired RFID signal and multiple RFID interferers is analyzed, and the effect of constructive and destructive interferences is examined. In addition, the maximum reading range in ideal, multipath fading, and interfering environments is presented. To the best of our knowledge, this is the first work that provides a 3-D performance analysis of the passive UHF RFID systems under cascaded fading channels. The obtained results are very useful for the design and optimization of passive UHF RFID systems from an RF physical channel point of view.	[Bekkali, Abdelmoula; Kadri, Abdullah] QMIC, Doha, Qatar; [Zou, Sicheng; Crisp, Michael; Penty, Richard V.] Univ Cambridge, Dept Engn, Div Elect, Cambridge CB2 1TN, England	Bekkali, A (reprint author), KDDI R&D Labs, Saitama 3568502, Japan.	bekkali@ieee.org; zs271@cam.ac.uk; abdullahk@qmic.com; mjc87@cam.ac.uk; rvp11@cam.ac.uk			NPRP from the Qatar National Research Fund (a member of Qatar Foundation) [NPRP4-726-2-272]	This work was made possible by NPRP grant NPRP4-726-2-272 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. Part of this work was presented at IEEE WCNC, Istanbul, Turkey, April 2014. The associate editor coordinating the review of this paper and approving it for publication was G. D. Durgin.	Want R, 2006, IEEE PERVAS COMPUT, V5, P25, DOI 10.1109/MPRV.2006.2; Aroor SR, 2007, IEEE SYST J, V1, P168, DOI 10.1109/JSYST.2007.909179; Griffin JD, 2008, IEEE T ANTENN PROPAG, V56, P563, DOI 10.1109/TAP.2007.915423; Boyer C, 2014, IEEE T COMMUN, V62, P770, DOI 10.1109/TCOMM.2013.120713.130417; [Anonymous], 2005, EPC RAD FREQ ID PROT; Griffin JD, 2009, IEEE ANTENN PROPAG M, V51, P11, DOI 10.1109/MAP.2009.5162013; Kim D, 2003, IEEE T ANTENN PROPAG, V51, P1740, DOI 10.1109/TAP.2003.814752; Lazaro A, 2009, IEEE T ANTENN PROPAG, V57, P1241, DOI 10.1109/TAP.2009.2015818; Bekkali A, 2008, PROCEEDINGS OF THE FIRST ITU-T KALEIDOSCOPE ACADEMIC CONFERENCE INNOVATIONS IN NGN: FUTURE NETWORK AND SERVICES, P285; Chau Y., 2012, P 21 ANN WOCC APR, p[81, 82]; Dimitriou AG, 2011, RADIOENGINEERING, V20, P387; Dimitriou AG, 2014, IEEE ANTENN WIREL PR, V13, P623, DOI 10.1109/LAWP.2014.2313350; Dimitriou AG, 2011, IEEE ANTENN PROPAG M, V53, P175, DOI 10.1109/MAP.2011.5773609; Electromagnetic Compatibility and Radio Spectrum Matters (ERM), 2004, 3022081V111 ETSI EN; Engels D., 2002, P IEEE INT C SYST MA, V3, P370; Finkenzeller K., 2000, RFID HDB RADIO FREQU; Gradsheteyn I., 1994, TABLE INTEGRALS SERI; Greene C. E., 2006, THESIS U PITTSBURGH; Impinj Inc, 2007, GRAND PRIX APPL SER; Jain S., 2006, P 1 INT WORKSH WIR N, P49, DOI 10.1145/1160987.1160997; Kim DY, 2010, IEEE T IND ELECTRON, V57, P1468, DOI 10.1109/TIE.2009.2030134; Kim DY, 2009, IEEE T IND ELECTRON, V56, P2337, DOI 10.1109/TIE.2009.2012451; Lazaro A, 2009, PROG ELECTROMAGN RES, V98, P425; Leong K. S., 2006, J COMMUN, V1, P9; Loo CH, 2009, J ELECTROMAGNET WAVE, V23, P747; Marrocco G, 2009, IEEE ANTENN PROPAG M, V51, P44, DOI 10.1109/MAP.2009.5433096; Nikitin P. V., 2006, P IEEE ANT PROP SOC, P1011; Nikitin PV, 2009, IEEE RFID: 2009 IEEE INTERNATIONAL CONFERENCE ON RFID, P117; Pillai V., 2006, P IEEE ANT PROP SOC, P3505; Rappaport T., 2001, WIRELESS COMMUNICATI; Sabesan S, 2014, IEEE T ANTENN PROPAG, V62, P878, DOI 10.1109/TAP.2013.2290114; Simon M. K., 2002, PROBABILITY DISTRIBU; Smietanka G., 2012, Proceedings of the 2012 Federated Conference on Computer Science and Information Systems (FedCSIS); Tjhung TT, 1997, IEEE T VEH TECHNOL, V46, P400	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	MAR	2015	14	3					1421	1433		10.1109/TWC.2014.2366142		13	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CD8TG	WOS:000351368100019		
J	Hai, VD; Do, TV; Trieu, DT; Sato, T; Kozan, O				Vo Dai Hai; Tran Van Do; Dang Thinh Trieu; Sato, Tamotsu; Kozan, Osamu			Carbon stocks in tropical evergreen broadleaf forests in Central Highland, Vietnam	INTERNATIONAL FORESTRY REVIEW			English	Article						big tree biomass; carbon stock; necromass; soil carbon; tropical evergreen broadleaf forest	SECONDARY FORESTS; EASTERN AMAZONIA; COSTA-RICA; BIOMASS; SOIL; DYNAMICS; POOLS; REGION; CHRONOSEQUENCE; ACCUMULATION	This is the first study on carbon stock estimation in the tropical evergreen broadleaf forests in Central Highland, Vietnam. As result of selective logging and shifting cultivation, remaining forests are silviculturally classified to five categories by governmental standard basing on standing volume (V), including very poor forest (V <= 10 m(3)/ha), poor forest (10 < V <= 100 m(3)/ha), medium forest (100 < V <= 200 m(3)/ha), rich (200 < V <= 300 m(3)/ha), and very rich forest (V > 300 m(3)/ha). Carbon stock of four pools including big trees (diameter at breast height/dbh >= 5 cm), short vegetation layer (dbh < 5 cm), necromass, and soil was measured by using 150 plots of 50 m x 50 m each. Soil carbon stock was assessed from soil samples taken to 30 cm depth. The results indicated total carbon stock increased from 75 tons C/ha in very poor forest to 199 tons C/ha in medium forest, and to 255 tons C/ha in very rich forest. Carbon stock in necromass was significant different (ANOVA; F-(4,F- 145) = 61.70, p < 0.001) among forest categories (from 4 to 8 tons C/ha). Meanwhile, there were no differences of carbon stock in soil and short vegetation layer among forest categories, which ranged 59-64 tons C/ha and 3-4 tons C/ha, respectively. There was a linear positive relationship between carbon in big trees and that in necromass (R-(149) = 0.61, p < 0.01). It is concluded that the degree of human disturbance had significant impacts on carbon sink in the present study forests.	[Vo Dai Hai] Vietnamese Acad Forest Sci, Hanoi, Vietnam; [Tran Van Do; Kozan, Osamu] Kyoto Univ, Ctr Southeast Asian Studies, Kyoto, Japan; [Tran Van Do; Dang Thinh Trieu] Vietnamese Acad Forest Sci, Silviculture Res Inst, Hanoi, Vietnam; [Sato, Tamotsu] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan	Hai, VD (reprint author), Vietnamese Acad Forest Sci, Hanoi, Vietnam.	vohai_vafs@yahoo.com			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106-NN.06-2013.01]	This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106-NN.06-2013.01. Comments from anonymous reviewers on an earlier version of this manuscript were highly appreciated.	Fonseca W, 2011, FOREST ECOL MANAG, V262, P1400, DOI 10.1016/j.foreco.2011.06.036; Veldkamp E, 2003, GLOBAL CHANGE BIOL, V9, P1171, DOI 10.1046/j.1365-2486.2003.00656.x; Sommer R, 2000, PLANT SOIL, V219, P231, DOI 10.1023/A:1004772301158; Ostertag R, 2008, ECOSYSTEMS, V11, P701, DOI 10.1007/s10021-008-9152-1; Ngo KM, 2013, FOREST ECOL MANAG, V296, P81, DOI 10.1016/j.foreco.2013.02.004; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Sierra CA, 2007, FOREST ECOL MANAG, V243, P299, DOI 10.1016/j.foreco.2007.03.026; Clark DA, 2007, BIOTROPICA, V39, P4, DOI 10.1111/j.1744-7429.2006.00227.x; Baishya R, 2011, ANN FOREST SCI, V68, P727, DOI 10.1007/s13595-011-0089-8; Hendri, 2012, Forestry Studies in China, V14, DOI 10.1007/s11632-012-0105-6; Schedlbauer JL, 2008, FOREST ECOL MANAG, V255, P1326, DOI 10.1016/j.foreco.2007.10.039; [Anonymous], 1999, RES TECHNICAL MEASUR; Peichl M, 2006, AGR FOREST METEOROL, V140, P51, DOI 10.1016/j.agrformet.2006.08.004; Ruiz-Peinado R, 2013, EUR J FOREST RES, V132, P253, DOI 10.1007/s10342-012-0672-z; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Djomo AN, 2011, FOREST ECOL MANAG, V261, P1448, DOI 10.1016/j.foreco.2011.01.031; Marin-Spiotta E, 2009, GLOBAL CHANGE BIOL, V15, P1584, DOI 10.1111/j.1365-2486.2008.01805.x; Wunder S, 2008, ENVIRON DEV ECON, V13, P279, DOI 10.1017/S1355770X08004282; TRUMBORE SE, 1995, GLOBAL BIOGEOCHEM CY, V9, P515, DOI 10.1029/95GB02148; Hughes RF, 1999, ECOLOGY, V80, P1892; Basu P, 2009, NATURE, V457, P144, DOI 10.1038/457144a; BRAHEN K.A., 2004, J VEG SCI, V15, P653; CANNELL M.G.R., 1982, WORLD FOREST BIOMASS, P391; Cerri CC, 2000, ADV SOIL S, P33; Clark DA, 2004, FRONT ECOL ENVIRON, V2, P73, DOI 10.2307/3868213; de Camargo PB, 1999, GLOB CHANGE BIOL, V5, P693, DOI 10.1046/j.1365-2486.1999.00259.x; FAO, 2006, GLOB FOR RES ASS 200; FIPS, 2011, SCI RES REP CENTR HI; Fonseca W, 2012, NEW FOREST, V43, P197, DOI 10.1007/s11056-011-9273-9; HINH V., 2012, METHOD CONSTRUCT STA; HOEN HF, 1994, FOREST SCI, V40, P429; Lasco RD, 2004, J TROP FOR SCI, V16, P35; LE M.C., 2000, FOREST TREES VIETNAM; LE S., 1996, RES FOREST STRUCTURE, P129; Lu XT, 2010, FOREST ECOL MANAG, V260, P1798, DOI 10.1016/j.foreco.2010.08.024; MA M., 2009, FRONTIERS FORESTRY C, V4, P140; Manrique S, 2011, BIOMASS BIOENERG, V35, P2184, DOI 10.1016/j.biombioe.2011.02.029; MARD (Ministry of Agriculture and Rural Development), 2009, FOR CLASS GUID DIFF; Olson J., 1983, ORNL5862; Orozco Lorena, 2002, PLANIFICACION MANEJO, P329; SAATCHI A.A., 2007, GLOBAL CHANGE BIOL, V13, P816; Saner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029642; SARMIENTO G., 2005, ECOTROPICOS, V18, P1; SAUGIER B., 2001, GLOBAL TERRESTRIAL P; Saynes V, 2005, APPL SOIL ECOL, V29, P282, DOI 10.1016/j.apsoil.2004.11.007; SHEIKH M.A., 2011, CARBON BALANCE MANAG, V2011; TRAN H., 2002, FOREST TREE RESOURCE; TRAN V.C., 1991, THESIS FOREST SCI I, P126; Tran VD, 2010, FOREST ECOL MANAG, V259, P1650, DOI 10.1016/j.foreco.2010.01.043; VO D.H., 2013, RES CARBON SEQUESTRA; Yonekura Y, 2010, PLANT SOIL, V329, P495, DOI 10.1007/s11104-009-0175-y; Zhang K, 2010, J FOREST RES-JPN, V15, P274, DOI 10.1007/s10310-009-0175-z	53	0	0	COMMONWEALTH FORESTRY ASSOC	CRAVEN ARRMS	CRIB, DINCHOPE, CRAVEN ARRMS SY7 9JJ, SHROPSHIRE, ENGLAND	1465-5489	2053-7778		INT FOREST REV	Int. For. Rev.	MAR	2015	17	1					20	29				10	Forestry	Forestry	CE2UH	WOS:000351674300003		
J	Michinaka, T; Matsumoto, M; Miyamoto, M; Yokota, Y; Sokh, H; Lao, S; Tsukada, N; Matsuura, T; Ma, V				Michinaka, T.; Matsumoto, M.; Miyamoto, M.; Yokota, Y.; Sokh, H.; Lao, S.; Tsukada, N.; Matsuura, T.; Ma, V.			Forecasting forest areas and carbon stocks in Cambodia based on socio-economic factors	INTERNATIONAL FORESTRY REVIEW			English	Article						REDD; reference emission level; Cambodia; deforestation; panel data analysis	TROPICAL DEFORESTATION; EMISSIONS	Establishing forest reference emission levels (RELs) and/or forest reference levels (RLs) is an important task for developing country parties considering taking part in the REDD+ scheme under the UNFCCC, especially for those countries experiencing corresponding economic development with land use changes. In this research, Cambodia's forest areas and forest carbon stocks from 2011 to 2018 were forecasted, which can be used as a reference for establishing forest RELs in Cambodia. Conditional to the assumptions of population growth, the growth in agricultural gross value added, and the level of economic land concession implementations, the forecasts by panel data analysis to provincial-level data showed that the forest area in Cambodia will decrease to 9.94 million ha in 2014 and 9.51 million ha in 2018 from 10.36 million ha in 2010 and that forest carbon stocks will decrease to 1.22 PgC in 2014 and 1.17 PgC in 2018 from 1.28 PgC in 2010.	[Michinaka, T.; Matsumoto, M.; Miyamoto, M.; Yokota, Y.; Tsukada, N.; Matsuura, T.] FFPRI, Tsukuba, Ibaraki 3058687, Japan; [Sokh, H.; Lao, S.; Ma, V.] Minist Agr Forestry & Fisheries, FA, Phnom Penh, Cambodia	Michinaka, T (reprint author), FFPRI, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	michinaka.t@affrc.go.jp; machan@ffpri.affrc.go.jp; motoe@ffpri.affrc.go.jp; yokotaya@affrc.go.jp; sokhhengpiny@yahoo.com; laosethaphal@gmail.com; naokotkd@affrc.go.jp; matsuu50@affrc.go.jp; vuthydalin@yahoo.com			Emergency Project to Develop the Structure for Promoting REDD+ Action - Forestry Agency of Japan	This collaborative research, conducted by the Forestry and Forest Product Research Institute (FFPRI) of Japan and the Forestry Administration (FA) of Cambodia, was supported by the Emergency Project to Develop the Structure for Promoting REDD+ Action, funded by the Forestry Agency of Japan. We gratefully acknowledge the comments of Mr. Chivin Leng of the FA of Cambodia on an earlier version and the comments of two anonymous reviewers. We also thank other FA officials and officials from other ministries for their cooperation in our field trip and data collection.	Verburg PH, 2002, ENVIRON MANAGE, V30, P391, DOI 10.1007/s00267-002-2630-x; Kiyono Y, 2010, JARQ-JPN AGR RES Q, V44, P81; Romijn E, 2013, ENVIRON SCI POLICY, V33, P246, DOI 10.1016/j.envsci.2013.06.002; Croissant Y, 2008, J STAT SOFTW, V27, P1; Qureshi A, 2012, ENVIRON SCI POLICY, V16, P81, DOI 10.1016/j.envsci.2011.11.001; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; Vieilledent G, 2013, ECOL EVOL, V3, P1702, DOI 10.1002/ece3.550; Barbier EB, 2001, J ECON SURV, V15, P413, DOI 10.1111/1467-6419.00144; BUONGIORNO J., 2013, STAFF PAPER SERIES, V78; CAMBODIA FAO UNDP UNEP, 2010, UN COLL PROGR RED EM; Forestry Administration [FA] Ministry of Agriculture Forestry and Fisheries [MAFF, 2011, CAMB FOR COV 2010; Forestry Administration [FA] Ministry of Agriculture Forestry and Fisheries [MAFF, 2008, CAMB FOR COV; Greene W. H., 2000, ECONOMETRIC ANAL; KAO D., 2005, B KYUSHU U FOREST, V86, P69; KIMMINS H., 2010, FORECASTING FOREST F; Michinaka T., 2013, J FOR PLANN, V18, P141; Michinaka T., 2013, Journal of Sustainable Development, V6, P12; Ministry of Agricultrue Forestry and Fisheries [MAFF], 2012, EC LAND CONC; NGUYEN V.P., 2007, J DEV ECON, V84, P291; NIS, 2009, GEN POP CENS CAMB 20; NIS, 2012, STAT YB CAMB 2011; NIS, 2013, CAMB INT POP SURV 20; NIS Ministry of Planning Cambodia, 2000, GEN POP CENS CAMB 19; OEUR S., 2009, INT WORKSH BEIJ CHIN; Pelletier J, 2012, FOREST POLICY ECON, V24, P3, DOI 10.1016/j.forpol.2010.05.005; R Core Team, 2014, R LANG ENV STAT COMP; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Samreth V, 2012, JARQ-JPN AGR RES Q, V46, P187; SASAKI N., 2013, AS FOR WORKSH 2013 I; Stocker T. F., 2013, CLIMATE CHANGE 2013; United Nations; Department of Economic and Social Affairs; Population Division, 2013, WORLD POP PROSP 2012; Watson C, 2013, ECOL SOC, V18, DOI 10.5751/ES-05670-180306; World Bank, 2012, GDP DEFL CAMB; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.1007/BF00379630	34	0	0	COMMONWEALTH FORESTRY ASSOC	CRAVEN ARRMS	CRIB, DINCHOPE, CRAVEN ARRMS SY7 9JJ, SHROPSHIRE, ENGLAND	1465-5489	2053-7778		INT FOREST REV	Int. For. Rev.	MAR	2015	17	1					66	75				10	Forestry	Forestry	CE2UH	WOS:000351674300006		
J	Ota, M				Ota, M.			Can Forest Management Units improve the management of state forests in Indonesia's outer islands? Institutional analysis and case studies from Lampung province of Sumatra	INTERNATIONAL FORESTRY REVIEW			English	Article						governance; institutional infrastructure; encroachment; concessions; monitoring and supervision		The present study explores the institutional design of Forest Management Units (FMUs) and its actual implementation in a locality where conflicts with local people or companies over state forests have been evident. The author reviewed related government regulations and conducted a field survey in Lampung province of an Indonesia's outer island of Sumatra. At the institutional level, establishment of FMUs and their management areas was mostly interpreted as a technical issue, and little provision for right settlements with local people was confirmed. Prescriptions of clear and adequate authority for FMUs to monitor and supervise company operations were also lacking. Accordingly, substantive measures to address the existing conflicts had not been implemented at the local level. If the government truly intends FMUs to function as part of governance processes at the local level, first of all, clear and adequate institutional provisions enabling them to function substantively should be prepared.	Kyushu Inst Technol, Learning & Teaching Ctr, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan	Ota, M (reprint author), Kyushu Inst Technol, Learning & Teaching Ctr, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.	ota@ltc.kyutech.ac.jp					ALVIVA I, 2008, JURNAL ANALISIS KEBI, V5, P101; SCHLAGER E, 1992, LAND ECON, V68, P249, DOI 10.2307/3146375; Barr C., 2006, DECENTRALIZATION FOR; Bromley D.W., 1991, ENV EC PROPERTY RIGH; FAO, 2010, GLOB FOR RES ASS 201; Geertz C, 1963, AGR INVOLUTION PROCE; Guha R., 1989, UNQUIET WOODS ECOLOG; Hurst P, 1990, RAINFOREST POLITICS; KUSUMEDI P., 2010, JURNAL ANALISIS KEBI, V7, P179; LIMBERG G, 2007, MANAGING FOREST RESO; McKean M. A., 2000, PEOPLE FORESTS COMMU; MOF, 2011, FOR MAN UN DEV CONC; NGAKAN P.O., 2005, DYNAMICS DECENTRALIZ; Ostrom E., 1990, GOVERNING COMMONS EV; Peluso N.L., 1992, RICH FORESTS POOR PE; Pender J., 2008, 00769 IFPRI; RIZAL HB A., 2011, JURNAL ANALISIS KEBI, V8, P167; RUHIMAT I.S., 2010, JURNAL ANALISIS KEBI, V7, P169; STATISTICS LAMPUNG, 2012, LAMP FIG 2012; SURYANDARI E.Y., 2012, JURNAL ANALISIS KEBI, V9, P114; SURYANDARI E.Y., 2009, JURNAL PENELITIAN SO, V6, P1; SURYANDARI E.Y., 2010, JURNAL ANALISIS KEBI, V7, P227; Yin R.K., 2009, CASE STUDY RES DESIG	23	0	0	COMMONWEALTH FORESTRY ASSOC	CRAVEN ARRMS	CRIB, DINCHOPE, CRAVEN ARRMS SY7 9JJ, SHROPSHIRE, ENGLAND	1465-5489	2053-7778		INT FOREST REV	Int. For. Rev.	MAR	2015	17	1					76	85				10	Forestry	Forestry	CE2UH	WOS:000351674300007		
J	Hashikata, T; Tojo, T; Namba, S; Kitasato, L; Hashimoto, T; Kameda, R; Shimohama, T; Yamaoka-Tojo, M; Takada, F; Ako, J				Hashikata, Takehiro; Tojo, Taiki; Namba, Sayaka; Kitasato, Lisa; Hashimoto, Takuya; Kameda, Ryo; Shimohama, Takao; Yamaoka-Tojo, Minako; Takada, Fumio; Ako, Junya			Deficiency of creatine kinase in a ST-segment elevation myocardial infarction patient with Kartagener syndrome	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Creatine kinase; Kartagener syndrome; Primary ciliary dyskinesia	GENE		[Hashikata, Takehiro; Tojo, Taiki; Namba, Sayaka; Kitasato, Lisa; Hashimoto, Takuya; Kameda, Ryo; Shimohama, Takao; Yamaoka-Tojo, Minako; Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa 2520374, Japan; [Yamaoka-Tojo, Minako] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Kanagawa 2520374, Japan; [Takada, Fumio] Kitasato Univ, Grad Sch Med Sci, Dept Med Genet, Sagamihara, Kanagawa 2520374, Japan	Ako, J (reprint author), Kitasato Univ, Sch Med, Dept Cardiovasc Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	jako@kitasato-u.ac.jp		Yamaoka-Tojo, Minako/0000-0003-3890-3777			NIGRO JM, 1987, AM J HUM GENET, V40, P115; Zhang Y, 2007, J MED GENET, V44, P233, DOI 10.1136/jmg.2006.045765; WALLIMANN T, 1992, BIOCHEM J, V281, P21; Popatia R, 2014, PEDIAT ALLER IMM PUL, V27, P51, DOI 10.1089/ped.2013.0314; SHIBUYA J, 1992, INTERNAL MED, V31, P611, DOI 10.2169/internalmedicine.31.611; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Yamamichi H, 2001, CLIN CHEM, V47, P1967; DAWSON DM, 1965, BIOCHEM BIOPH RES CO, V21, P346, DOI 10.1016/0006-291X(65)90200-7; KAYE FJ, 1987, J CLIN INVEST, V79, P1412, DOI 10.1172/JCI112969; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						31	33		10.1016/j.ijcard.2014.12.100		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600012		
J	Koyama, T; Kageyama, T; Munakata, M; Nagaoka, M; Akima, T; Kanki, H; Ishikawa, S				Koyama, Takashi; Kageyama, Toshimi; Munakata, Masahito; Nagaoka, Mika; Akima, Takashi; Kanki, Hideaki; Ishikawa, Shiro			Muscle squeezing of the culprit coronary artery in a patient with ST-elevation myocardial infarction after postconditioning with lactate-enriched blood	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Ischemia reperfusion injury; Muscle bridge; Myocardial protection; Stunning			[Koyama, Takashi; Kageyama, Toshimi; Munakata, Masahito; Nagaoka, Mika; Akima, Takashi; Kanki, Hideaki; Ishikawa, Shiro] Saitama Municipal Hosp, Div Cardiol, Midori Ku, Saitama 3368522, Japan	Koyama, T (reprint author), Saitama Municipal Hosp, Div Cardiol, Midori Ku, 2460 Mimuro, Saitama 3368522, Japan.	koyamas@me.com					Koyama T, 2014, IJC METAB ENDOCR, V2, P30; Koyama T, 2014, INT J CARDIOL, V177, P492, DOI 10.1016/j.ijcard.2014.08.075	2	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						77	78		10.1016/j.ijcard.2014.12.128		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600030		
J	Sueta, D; Hokimoto, S; Tayama, S; Tsujita, K; Sakamoto, K; Yamamoto, E; Tanaka, T; Izumiya, Y; Yamamuro, M; Yamanaga, K; Akasaka, T; Tababa, N; Arima, Y; Kaikita, K; Ogawa, H				Sueta, Daisuke; Hokimoto, Seiji; Tayama, Shinji; Tsujita, Kenichi; Sakamoto, Kenji; Yamamoto, Eiichiro; Tanaka, Tomoko; Izumiya, Yasuhiro; Yamamuro, Megumi; Yamanaga, Kenshi; Akasaka, Tomonori; Tababa, Noriaki; Arima, Yuichiro; Kaikita, Koichi; Ogawa, Hisao			Clinical significance of fecal occult blood screening in patients before percutaneous coronary intervention	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Dual anti-pletelet therapy; Fecal occult blood; Cancer	TASK-FORCE	Background: The most common reason for premature discontinuation of dual anti-platelet therapy (DAPT) after coronary stenting is the manifestation of gastrointestinal bleeding. Before percutaneous coronary interventions (PCIs), we screened patients who tested positive for fecal occult blood (fecOB). Methods and results: On 1789 consecutively admitted cardiac catheterization patients, we performed fecOB examinations; 647 of these patients received PCIs, and 232 of them were fecOB positive. Ultimately, we performed 165 colonoscopies and detected 3 early cancer lesions. Conclusions: Positive results on fecOB screening, before PCI, could indicate lower intestinal lesions. We can perform surgical cancer procedures safely, even with aspirin usage. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Sueta, Daisuke; Hokimoto, Seiji; Tayama, Shinji; Tsujita, Kenichi; Sakamoto, Kenji; Yamamoto, Eiichiro; Tanaka, Tomoko; Izumiya, Yasuhiro; Yamamuro, Megumi; Yamanaga, Kenshi; Akasaka, Tomonori; Tababa, Noriaki; Arima, Yuichiro; Kaikita, Koichi; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan	Hokimoto, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, 1-1-1 Honjo, Kumamoto 8608556, Japan.	shokimot@kumamoto-u.ac.jp					Abraham NS, 2010, J AM COLL CARDIOL, V56, P2051, DOI 10.1016/j.jacc.2010.09.010; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI 10.1056/NEJMoa1108895; Collet J.P., 2014, LANCET; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622	5	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						85	87		10.1016/j.ijcard.2014.12.143		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600033		
J	Koizumi, T; Kaneda, H; Yamasaki, T; Tamaki, T; Kikutani, T; Muramatsu, T; Sano, K; Komiyama, N; Nishimura, S				Koizumi, Tomomi; Kaneda, Hideaki; Yamasaki, Tetsuo; Tamaki, Tohru; Kikutani, Toshihiko; Muramatsu, Toshihiro; Sano, Koichi; Komiyama, Nobuyuki; Nishimura, Shigeyuki			Impact of platelet-derived growth factor-BB on ischemic myocardial injury after thrombus aspiration for ST-segment elevation myocardial infarction	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Platelet-derived factor; Myocardial ischemia; Thrombus aspiration; Cardioprotection	DELIVERY		[Koizumi, Tomomi; Yamasaki, Tetsuo; Tamaki, Tohru; Kikutani, Toshihiko; Muramatsu, Toshihiro; Sano, Koichi; Komiyama, Nobuyuki; Nishimura, Shigeyuki] Saitama Med Univ, Saitama Int Med Ctr, Div Cardiovasc Med, Hidaka, Saitama 3501298, Japan; [Kaneda, Hideaki] Okinaka Mem Inst Med Res, Tokyo, Japan	Koizumi, T (reprint author), Saitama Med Univ, Saitama Int Med Ctr, Div Cardiovasc Med, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	tomomikzm@yahoo.com					Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Edelberg Jay M, 2003, Cardiovasc Toxicol, V3, P27, DOI 10.1385/CT:3:1:27; Edelberg JM, 2002, CIRCULATION, V105, P608, DOI 10.1161/hc0502.103672; Edelberg JM, 1998, J CLIN INVEST, V102, P837, DOI 10.1172/JCI3058; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831	6	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						109	111		10.1016/j.ijcard.2014.12.097		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600041		
J	Isobe, M; Tezuka, D				Isobe, Mitsuaki; Tezuka, Daisuke			Isolated cardiac sarcoidosis: Clinical characteristics, diagnosis and treatment	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Review						Sarcoidosis; CMR; PET; Immunosuppression; Heart transplantation; Biomarker	IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; POSITRON-EMISSION-TOMOGRAPHY; GIANT-CELL MYOCARDITIS; TERM-FOLLOW-UP; CORTICOSTEROID-THERAPY; ATRIOVENTRICULAR-BLOCK; HEART-TRANSPLANTATION; JAPANESE PATIENTS; DISEASE-ACTIVITY; F-18-FDG PET	Sarcoidosis is a systemic disease characterized by the development of noncaseating epithelioid granulomas in multiple organs. Despite extensive investigations over a long period of time, the etiology of this disease remains unknown. Cardiac involvement of this disease is the most ominous complication leading to fatal outcome. Recently, attention has been focused on isolated cardiac sarcoidosis, which exists without clinically apparent sarcoidosis elsewhere. One of the critical issues of isolated cardiac sarcoidosis is difficulty in diagnosis, since existence of the cardiac lesion should be detected from cardiac manifestations alone. Because specificity of biomarkers or sensitivity of histological examination of biopsied sample is very low, diagnosis of isolated cardiac sarcoidosis mainly depends on imaging modalities. In this review article we summarized current knowledge on the pathogenesis of sarcoidosis, clinical features of cardiac sarcoidosis especially that isolated to the heart by showing some typical cases. Utilities and problems of diagnostic imaging tests for this condition including echo-cardiography, cardiac magnetic resonance imaging, and fluorodeoxyglucose-positron emission tomography are discussed. Advances in pharmacological and nonpharmacological treatment for cardiac sarcoidosis have improved the prognosis of cardiac sarcoidosis to a great deal; however, there are many issues that remain to be solved in the management of isolated cardiac sarcoidosis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Isobe, Mitsuaki; Tezuka, Daisuke] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo 1138519, Japan	Isobe, M (reprint author), Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	isobemi.cvm@tmd.ac.jp					AGOSTINI C, 1993, AM J MED, V95, P466, DOI 10.1016/0002-9343(93)90328-M; Sehgal VN, 2014, CLIN DERMATOL, V32, P351, DOI 10.1016/j.clindermatol.2013.11.002; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; Ohira H, 2008, EUR J NUCL MED MOL I, V35, P933, DOI 10.1007/s00259-007-0650-8; Grutters JC, 2006, EUR RESPIR J, V28, P627, DOI 10.1183/09031936.06.00105805; Grutters JC, 2003, CHEST, V124, P186, DOI 10.1378/chest.124.1.186; Nishiyama Y, 2006, J NUCL MED, V47, P1571; Tahara N, 2010, JACC-CARDIOVASC IMAG, V3, P1219, DOI 10.1016/j.jcmg.2010.09.015; Kandolin R, 2011, J INTERN MED, V270, P461, DOI 10.1111/j.1365-2796.2011.02396.x; Schuller JL, 2012, J CARDIOVASC ELECTR, V23, P925, DOI 10.1111/j.1540-8167.2012.02350.x; SHARMA OP, 1993, CHEST, V103, P253, DOI 10.1378/chest.103.1.253; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204; MATSUI Y, 1976, ANN NY ACAD SCI, V278, P455, DOI 10.1111/j.1749-6632.1976.tb47058.x; Sekiguchi M, 1996, CARDIOVASC DRUG THER, V10, P495, DOI 10.1007/BF00050989; Birnie DH, 2014, HEART RHYTHM, V11, P1304, DOI 10.1016/j.hrthm.2014.03.043; Okura Y, 2003, J AM COLL CARDIOL, V41, P322, DOI 10.1016/S0735-1097(02)02715-8; Schatka I, 2014, J NUCL MED, V55, P99, DOI 10.2967/jnumed.112.115121; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; Sweiss NJ, 2010, SARCOIDOSIS VASC DIF, V27, P49; Langah R, 2009, J NUCL CARDIOL, V16, P801, DOI 10.1007/s12350-009-9110-0; Yodogawa K, 2011, ANN NONINVAS ELECTRO, V16, P140, DOI 10.1111/j.1542-474X.2011.00418.x; Yazaki Y, 2001, AM J CARDIOL, V88, P1006, DOI 10.1016/S0002-9149(01)01978-6; Chiu CZ, 2005, AM J CARDIOL, V95, P143, DOI 10.1016/j.amjcard.2004.08.083; Nazarian S, 2011, ANN INTERN MED, V155, P415, DOI 10.7326/0003-4819-155-7-201110040-00004; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Sekhri V, 2011, ARCH MED SCI, V7, P546, DOI 10.5114/aoms.2011.24118; Betensky BP, 2012, HEART RHYTHM, V9, P884, DOI 10.1016/j.hrthm.2012.02.010; Zaidi AR, 2007, J HEART LUNG TRANSPL, V26, P714, DOI 10.1016/j.healun.2007.05.006; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Chang TI, 2012, TRANSPL P, V44, P903, DOI 10.1016/j.transproceed.2012.01.087; Dubrey SW, 2010, PROG CARDIOVASC DIS, V52, P336, DOI 10.1016/j.pcad.2009.11.010; OKAYAMA K, 1995, CHEST, V107, P330, DOI 10.1378/chest.107.2.330; Sahoo DH, 2011, EUR RESPIR J, V38, P1145, DOI 10.1183/09031936.00195010; Sadek MM, 2013, CAN J CARDIOL, V29, P1034, DOI 10.1016/j.cjca.2013.02.004; Exner DV, 2001, CIRCULATION, V103, P2066; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; Tezuka D, 2012, JACC-CARDIOVASC IMAG, V5, P422, DOI 10.1016/j.jcmg.2012.01.013; Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Kosuge H, 2001, JPN HEART J, V42, P265, DOI 10.1536/jhj.42.265; Mohsen A, 2014, J CARDIOVASC ELECTR, V25, P171, DOI 10.1111/jce.12302; Kandolin R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P303, DOI 10.1161/CIRCEP.110.959254; Kato Y, 2003, SARCOIDOSIS VASC DIF, V20, P133; Negi M, 2012, MODERN PATHOL, V25, P1284, DOI 10.1038/modpathol.2012.80; Wyplosz B, 2010, ACTA CARDIOL, V65, P83, DOI 10.2143/AC.65.1.2045894; Barnard J, 2001, CURR OPIN RHEUMATOL, V13, P84, DOI 10.1097/00002281-200101000-00014; Okumura W, 2004, J NUCL MED, V45, P1989; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Naruse Y, 2014, CIRC-ARRHYTHMIA ELEC, V7, P407, DOI 10.1161/CIRCEP.113.000734; Baba Y, 2012, INT HEART J, V53, P287; Yazaki Y, 1998, AM J CARDIOL, V82, P537, DOI 10.1016/S0002-9149(98)00377-4; Lagana SM, 2010, ARCH PATHOL LAB MED, V134, P1039, DOI 10.1043/2009-0274-RA.1; Kouba DJ, 2003, BRIT J DERMATOL, V148, P147, DOI 10.1046/j.1365-2133.2003.05042.x; Baughman RP, 2007, SEMIN RESP CRIT CARE, V28, P128, DOI 10.1055/s-2007-970338; Darda S, 2014, TEX HEART I J, V41, P319, DOI 10.14503/THIJ-13-3208; Eishi Y., 2011, JPN J SARCOIDOSIS GR, V31, P81; Eishi Y., 2010, JPN J SARCOIDOSIS GR, V30, P86; Hance A J, 1998, Semin Respir Infect, V13, P197; Hunninghake Gary W., 1994, American Journal of Respiratory and Critical Care Medicine, V149, P893; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI [10.1056/NEJMra071714, DOI 10.1056/NEJMRA071714]; IWAI K, 1993, ACTA PATHOL JAPON, V43, P372; IWAI K, 1994, SARCOIDOSIS, V11, P26; JAMES DG, 1961, AM REV RESPIR DIS, V84, P66; JANSSON E, 1972, J CLIN PATHOL, V25, P837, DOI 10.1136/jcp.25.10.837; Kato Y., 2012, JPN J SARCOIDOSIS GR, V32, P51; Kato Y., 2010, JPN J SARCOIDOSIS GR, V30, P73; Kato Y., 2008, JPN J SARCOIDOSIS GR, V28, P15; Kiuchi S, 2007, INT J CARDIOVAS IMAG, V23, P237, DOI 10.1007/s10554-006-9134-3; Kusano K., 2011, JPN J SARCOIDOSIS GR, V31, P63; Milman N, 2008, SARCOIDOSIS VASC DIF, V25, P51; MULLERQUERNHEIM J, 1991, AM REV RESPIR DIS, V144, P1322; Mulluer-Quernheim I., 1999, EUR RESPIR J, V14, P1117; Newman L.S., 1995, SARCOIDOSIS, V12, P20; Nomura S, 2011, INT J CARDIOL, V150, pE81, DOI 10.1016/j.ijcard.2009.11.027; Ohira Hiroshi, 2011, Eur J Nucl Med Mol Imaging, V38, P1773, DOI 10.1007/s00259-011-1832-y; Shijubo N., 2007, JPN J SARCOIDOSIS GR, V27, P29; Sprince N.L., 1985, SARCOIDOSIS, V2, P57; Sugizaki Y, 2013, INTERNAL MED, V52, P71, DOI 10.2169/internalmedicine.52.8470; Tezuka D., 2014, J CARD FAIL IN PRESS; Tsuchida T., 2006, KOKYU TO JUNKAN, V54, P925; VALANTINE H, 1987, BRIT HEART J, V57, P256; White J, 2010, CIRC-HEART FAIL, V3, pE28, DOI 10.1161/CIRCHEARTFAILURE.110.939686; Yager JEE, 2005, J HEART LUNG TRANSPL, V24, P1988, DOI 10.1016/j.healun.2005.02.016; Yasutake H, 2005, INT J CARDIOL, V102, P259, DOI 10.1016/j.ijcard.2004.05.028; Yoshida Y, 1997, AM HEART J, V134, P382, DOI 10.1016/S0002-8703(97)70070-X	86	4	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						132	140		10.1016/j.ijcard.2014.12.056		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600047		
J	Hokimoto, S; Mizuno, Y; Sueta, D; Morita, S; Akasaka, T; Tabata, N; Harada, E; Arima, Y; Yamamuro, M; Tanaka, T; Yamamoto, E; Sakamoto, K; Tsujita, K; Kaikita, K; Yasue, H; Ogawa, H				Hokimoto, Seiji; Mizuno, Yuji; Sueta, Daisuke; Morita, Sumio; Akasaka, Tomonori; Tabata, Noriaki; Harada, Eisaku; Arima, Yuichiro; Yamamuro, Megumi; Tanaka, Tomoko; Yamamoto, Eiichiro; Sakamoto, Kenji; Tsujita, Kenichi; Kaikita, Koichi; Yasue, Hirofumi; Ogawa, Hisao			High incidence of coronary spasm after percutaneous coronary interventions Comparison between new generation drug-eluting stent and bare-metal stent	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Acetylcholine; Coronary spasm; Drug-eluting stent; Bare-metal stent	LONG-TERM OUTCOMES; ENDOTHELIAL FUNCTION; GUIDELINES		[Hokimoto, Seiji; Sueta, Daisuke; Akasaka, Tomonori; Tabata, Noriaki; Arima, Yuichiro; Yamamuro, Megumi; Tanaka, Tomoko; Yamamoto, Eiichiro; Sakamoto, Kenji; Tsujita, Kenichi; Kaikita, Koichi; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan; [Mizuno, Yuji; Morita, Sumio; Harada, Eisaku; Yasue, Hirofumi] Kumamoto Kinoh Hosp, Kumamoto Aging Res Inst, Div Cardiol, Kumamoto, Japan	Hokimoto, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	shokimot@kumamoto-u.ac.jp					Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Yasue H, 2008, J AM COLL CARDIOL, V51, P1742, DOI 10.1016/j.jacc.2007.12.049; Ogawa H, 2010, CIRC J, V74, P1745, DOI 10.1253/circj.CJ-10-74-0802; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lim SH, 2012, CIRC-CARDIOVASC INTE, V5, P523, DOI 10.1161/CIRCINTERVENTIONS.112.970111; Pendyala LK, 2012, JACC-CARDIOVASC INTE, V5, P436, DOI 10.1016/j.jcin.2011.11.013; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; YASUE H, 1990, CIRCULATION, V81, P482	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						171	173		10.1016/j.ijcard.2014.12.151		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600056		
J	Izawa, KP; Watanabe, S; Oka, K; Brubaker, PH; Hirano, Y; Saito, T; Omori, Y; Suzuki, N; Kida, K; Suzuki, K; Osada, N; Omiya, K; Shimizu, H; Akashi, YJ				Izawa, Kazuhiro P.; Watanabe, Satoshi; Oka, Koichiro; Brubaker, Peter H.; Hirano, Yasuyuki; Saito, Takashi; Omori, Yutaka; Suzuki, Norio; Kida, Keisuke; Suzuki, Kengo; Osada, Naohiko; Omiya, Kazuto; Shimizu, Hiroyuki; Akashi, Yoshihiro J.			Differences in maximum phonation time based on body mass index in chronic heart failure patients	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Maximum phonation time; Body mass index; Chronic heart failure			[Izawa, Kazuhiro P.] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Watanabe, Satoshi] St Marianna Univ, Sch Med Hosp, Dept Rehabil Med, Kawasaki, Kanagawa, Japan; [Oka, Koichiro] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Brubaker, Peter H.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Hirano, Yasuyuki] Tokushima Bunri Univ, Dept Phys Therapy, Tokushima, Japan; [Saito, Takashi; Omori, Yutaka] Visiting Nursing & Rehabil Networks, Kawasaki, Kanagawa, Japan; [Suzuki, Norio; Kida, Keisuke; Suzuki, Kengo; Akashi, Yoshihiro J.] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol, Kawasaki, Kanagawa, Japan; [Osada, Naohiko] St Marianna Univ, Toyoko Hosp, Div Cardiol, Kawasaki, Kanagawa, Japan; [Omiya, Kazuto] St Marianna Univ, Yokohama City Seibu Hosp, Div Cardiol, Yokohama, Kanagawa, Japan; [Shimizu, Hiroyuki] St Marianna Univ, Sch Med, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan	Izawa, KP (reprint author), Kobe Univ, Grad Sch Hlth Sci, 10-2 Tomogaoka 7 Chome Suma, Kobe, Hyogo 6540142, Japan.	izawapk@harbor.kobe-u.ac.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			Speyer R, 2010, J VOICE, V24, P281, DOI 10.1016/j.jvoice.2008.10.004; Barsties Ben, 2013, Codas, V25, P310, DOI 10.1590/S2317-17822013000400003; Christensen HM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-80; Izawa KP, 2012, EUR J PHYS REHAB MED, V48, P593; Word Health Organization, 1995, WHO TECHN REP SER, V854	5	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						200	202		10.1016/j.ijcard.2014.12.124		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600065		
J	Koyama, T; Watanabe, H; Ito, H				Koyama, Takashi; Watanabe, Hiroyuki; Ito, Hiroshi			Nocturnal effects of diurnal adaptive servo-ventilation therapy in patients with heart failure	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Letter						Diurnal ASV therapy; Sleep-disordered breathing; Heart failure	SYMPATHETIC-NERVE ACTIVITY; CARDIAC-FUNCTION		[Koyama, Takashi; Watanabe, Hiroyuki; Ito, Hiroshi] Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita 0108543, Japan	Watanabe, H (reprint author), Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Hondoh 1-1-1, Akita 0108543, Japan.	hirow@doc.med.akita-u.ac.jp					Goso Y, 2001, CIRCULATION, V104, P418, DOI 10.1161/hc2901.093111; Koyama T, 2012, CIRC J, V76, P2606, DOI 10.1253/circj.CJ-12-0328; Harada D, 2011, AUTON NEUROSCI-BASIC, V161, P95, DOI 10.1016/j.autneu.2010.12.001; Brack T, 2007, CHEST, V132, P1463, DOI 10.1378/chest.07-0121; Oldenburg O, 2011, CLIN RES CARDIOL, V100, P107, DOI 10.1007/s00392-010-0216-9; Koyama T, 2011, RESP MED, V105, P1946, DOI 10.1016/j.rmed.2011.09.001; Koyama T, 2010, CIRC J, V74, P2118, DOI 10.1253/circj.CJ-10-0082; Koyama T, 2013, EUR J HEART FAIL, V15, P902, DOI 10.1093/eurjhf/hft049; La Rovere MT, 2007, EUR J HEART FAIL, V9, P949, DOI 10.1016/j.ejheart.2007.06.009; Tamura Y, 2014, J CARDIOL	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						216	218		10.1016/j.ijcard.2014.12.149		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600069		
J	Yoshikawa, T				Yoshikawa, Tsutomu			Takotsubo cardiomyopathy, a new concept of cardiomyopathy: Clinical features and pathophysiology	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Review						Takotsubo cardiomyopathy; Coronary vasospasm; Microcirculatory disorder; Endothelial dysfunction; Pheochromocytoma	APICAL BALLOONING SYNDROME; TAKO-TSUBO CARDIOMYOPATHY; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; IN-HOSPITAL MORTALITY; EMOTIONAL-STRESS; AMPULLA CARDIOMYOPATHY; OVARIECTOMIZED RATS; CARDIAC MYOCYTES	Takotsubo cardiomyopathy, a new concept of cardiomyopathy, is characterized by transient cardiac dysfunction, commonly triggered by physical or emotional stress. Differential diagnosis is important, since takotsubo cardiomyopathy presents similar images to those shown in acute coronary syndrome, with ST-segment elevation, T-wave inversion, QT-prolongation, and others on electrocardiogram. Typically, apical involvement with hypercontraction of basal left ventricle (apical type) is predominant, but atypical types involving basal, mid-ventricular, and right ventricular myocardium are also described. In-hospital death occurs at similar level with patients with acute coronary syndrome, but it is significantly affected by underlying diseases. This disease presents diverse cardiac complications in acute phase, such as life-threatening ventricular arrhythmias, pump failure, cardiac rupture, and systemic embolism. The pathogenic mechanism of this disease is still unclear but sympathetic hyperactivity, as well as coronary vasospasm, microcirculatory disorder, and estrogen deficiency, have been considered as one of the most likely pathogenic mechanism. Long-term prognosis is also largely unknown. Issues such as establishment of acute phase treatment, prediction of cardiac complications, and prophylactic measures against recurrence need to be further explored. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	Sakakibara Heart Inst, Dept Cardiol, Fuchu, Tokyo 1830003, Japan	Yoshikawa, T (reprint author), Sakakibara Heart Inst, Dept Cardiol, 3-16-1 Asahi Cho, Fuchu, Tokyo 1830003, Japan.	tyoshi@shi.heart.or.jp					Ahmed KA, 2012, CORONARY ARTERY DIS, V23, P259, DOI 10.1097/MCA.0b013e3283526a57; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Spinelli L, 2010, EUR J HEART FAIL, V12, P13, DOI 10.1093/eurjhf/hfp173; Daaka Y, 1997, NATURE, V390, P88; Akashi YJ, 2004, J NUCL MED, V45, P1121; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Kume T, 2005, CIRC J, V69, P934, DOI 10.1253/circj.69.934; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Ueyama T, 2003, J CARDIOVASC PHARM, V42, pS117, DOI 10.1097/00005344-200312001-00024; Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4; Kawai S, 2007, CIRC J, V71, P990, DOI 10.1253/circj.71.990; Deshmukh A, 2012, AM HEART J, V164, P66, DOI 10.1016/j.ahj.2012.03.020; Yoshida T, 2007, EUR HEART J, V28, P2598, DOI 10.1093/eurheartj/ehm401; Ibanez B, 2005, HEART, V91, P102, DOI 10.1136/hrt.2004.035709; IGA K, 1989, JPN CIRC J, V53, P813; Brinjikji W, 2012, AM HEART J, V164, P215, DOI 10.1016/j.ahj.2012.04.010; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Kawano H, 2003, HEART VESSELS, V18, P32, DOI 10.1007/s003800300005; Nef HM, 2010, NAT REV CARDIOL, V7, P187, DOI 10.1038/nrcardio.2010.16; Murakami T, 2014, J CARDIOL, V63, P269, DOI 10.1016/j.jjcc.2013.09.003; Ueyama T, 2006, BRAIN RES, V1084, P67, DOI 10.1016/j.brainres.2006.02.008; Prasad A, 2009, NAT REV CARDIOL, V6, P430, DOI 10.1038/nrcardio.2009.51; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Ueyama T, 2007, CIRC J, V71, P565, DOI 10.1253/circj.71.565; Abraham J, 2009, J AM COLL CARDIOL, V53, P1320, DOI 10.1016/j.jacc.2009.02.020; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Kume T, 2008, CIRC J, V72, P106, DOI 10.1253/circj.72.106; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Nef HM, 2009, EUR HEART J, V30, P2155, DOI 10.1093/eurheartj/ehp240; Kurisu S, 2003, J AM COLL CARDIOL, V41, P743, DOI 10.1016/S0735-1097(02)02924-8; Bupha-Intr T, 2007, AM J PHYSIOL-REG I, V292, pR837, DOI 10.1152/ajpregu.00376.2006; Citro R, 2014, JACC-CARDIOVASC IMAG, V7, P119, DOI 10.1016/j.jcmg.2013.09.020; Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992; Elesber A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.007; Elesber AA, 2006, J AM COLL CARDIOL, V47, P1082, DOI 10.1016/j.jacc.2005.12.004; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Jagszewski M., 2012, EUR HEART J, V33, P1027; Kosuge M, 2012, CIRC J, V76, P32, DOI 10.1253/circj.CJ-11-1119; Palla AR, 2012, CLIN CARDIOL, V35, P478, DOI 10.1002/clc.21983; PIERPONT GL, 1984, AM J PHYSIOL, V246, pH824; Shao YZ, 2013, EUR J HEART FAIL, V15, P9, DOI 10.1093/eurjhf/hfs161; Sharkey SW, 2012, AM J CARDIOL, V110, P795, DOI 10.1016/j.amjcard.2012.04.060; Takashio S, 2012, AM J CARDIOL, V109, P1651, DOI 10.1016/j.amjcard.2012.01.393; Thawornkaiwong A, 2003, LIFE SCI, V72, P1813, DOI 10.1016/S0024-3205(02)02473-6; Ueyama T, 2002, CIRC J, V66, P712, DOI 10.1253/circj.66.712; Watanabe H, 2005, JAMA-J AM MED ASSOC, V294, P305, DOI 10.1001/jama.294.3.305; Wattanapermpool J, 2000, LIFE SCI, V66, P533, DOI 10.1016/S0024-3205(99)00623-2	49	9	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						297	303		10.1016/j.ijcard.2014.12.116		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600092		
J	Sato, A; Hoshi, T; Kakefuda, Y; Hiraya, D; Watabe, H; Kawabe, M; Akiyama, D; Koike, A; Aonuma, K				Sato, Akira; Hoshi, Tomoya; Kakefuda, Yuki; Hiraya, Daigo; Watabe, Hiroaki; Kawabe, Masayuki; Akiyama, Daiki; Koike, Akira; Aonuma, Kazutaka			In vivo evaluation of fibrous cap thickness by optical coherence tomography for positive remodeling and low-attenuation plaques assessed by computed tomography angiography	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Computed tomography angiography; Coronary plaque; Optical coherence tomography; Fibrous cap thickness	ACUTE CORONARY SYNDROMES; CT ANGIOGRAPHY; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUES; DIAGNOSTIC-ACCURACY; ARTERY-DISEASE; NONINVASIVE ASSESSMENT; ROW CT; INTERVENTION; 64-SLICE	Background: Coronary plaques with positive remodeling (PR) and low-attenuation plaques (LAP) by computed tomography angiography (CTA) might be associated with plaque vulnerability. The purpose of this study was to assess the relation between coronary plaques with PR and LAP by CTA and fibrous cap thickness measured by optical coherence tomography (OCT). Methods: We used CTA and OCT to assess 102 coronary plaques in patients with coronary artery disease (unstable angina pectoris, n = 24; stable angina pectoris, n = 78). Plaque characteristics were divided into three groups: 2-feature- positive plaques (PR and LAP; n = 32), 1-feature-positive plaques (PR or LAP; n = 20), and 2-feature-negative plaques (neither PR nor LAP; n = 50). PR was defined as remodeling index (RI) of >1.05 and LAP was defined as CT density value <50 HU. Results: There were significant differences between the three plaque groups with respect to fibrous cap thickness measured by OCT: 76 +/- 24 mu m in 2-feature-positive plaques, 154 +/- 51 mu m in 1-feature-positive plaques, and 192 +/- 49 mu m in 2-feature-negative plaques (P < 0.001). The RI (1.21 +/- 0.06, 1.14 +/- 0.05, P = 0.011) and the presence of thin cap fibroatheroma (TCFA) (<70-mu m thickness) (75%, 15%, P = 0.001) were significantly higher in UAP than in SAP patients with 2-feature-positive plaques, whereas fibrous cap thickness (68.9 +/- 24.1, 92.1 +/- 21.9 mu m, P < 0.001) was lower in the UAP patients. In UAP patients, the presence of ring-like enhancement showed higher accuracy of 88% for detection of TCFA. Conclusions: Coronary PR and LAP by CTA were associated with the degree of fibrous cap thickness measured by OCT. CTA can non-invasively provide promising information on plaque vulnerability by identifying coronary plaque with PR and LAP, especially ring-like enhancement. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Sato, Akira; Hoshi, Tomoya; Kakefuda, Yuki; Hiraya, Daigo; Watabe, Hiroaki; Kawabe, Masayuki; Akiyama, Daiki; Koike, Akira; Aonuma, Kazutaka] Univ Tsukuba, Div Cardiovasc, Fac Med, Tsukuba, Ibaraki, Japan	Sato, A (reprint author), Univ Tsukuba, Div Cardiovasc, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	asato@md.tsukuba.ac.jp					Al-Mallah MH, 2014, INT J CARDIOL, V176, P1244, DOI 10.1016/j.ijcard.2014.07.203; Watabe H, 2012, J AM COLL CARDIOL, V59, P1881, DOI 10.1016/j.jacc.2012.01.051; Sato A, 2010, AM J CARDIOL, V105, P930, DOI 10.1016/j.amjcard.2009.11.028; Schroeder S, 2001, J AM COLL CARDIOL, V37, P1430, DOI 10.1016/S0735-1097(01)01115-9; Seifarth H, 2012, ATHEROSCLEROSIS, V224, P90, DOI 10.1016/j.atherosclerosis.2012.06.021; Kashiwagi M, 2009, JACC-CARDIOVASC IMAG, V2, P1412, DOI 10.1016/j.jcmg.2009.09.012; Inoue K, 2010, JACC-CARDIOVASC IMAG, V3, P691, DOI 10.1016/j.jcmg.2010.04.011; Pundziute G, 2008, EUR HEART J, V29, P2373, DOI 10.1093/eurheartj/ehn356; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Schoenhagen P, 2000, CIRCULATION, V101, P598; Hattori K, 2012, JACC-CARDIOVASC IMAG, V5, P169, DOI 10.1016/j.jcmg.2011.11.012; Pohle K, 2007, ATHEROSCLEROSIS, V190, P174, DOI 10.1016/j.atherosclerosis.2006.01.013; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Soeda T, 2011, INT J CARDIOL, V148, P313, DOI 10.1016/j.ijcard.2009.11.019; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Tanaka A, 2008, CIRCULATION, V118, P2368, DOI 10.1161/CIRCULATIONAHA.108.782540; Sara L, 2014, INT J CARDIOL, V177, P385, DOI 10.1016/j.ijcard.2014.08.130; Cademartiri F, 2005, EUR RADIOL, V15, P1426, DOI 10.1007/s00330-005-2697-x; Puchner SB, 2014, J AM COLL CARDIOL, V64, P684, DOI 10.1016/j.jacc.2014.05.039; Habib PJ, 2013, INT J CARDIOL, V169, P112, DOI 10.1016/j.ijcard.2013.08.096; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Becker CR, 2003, EUR RADIOL, V13, P2094, DOI 10.1007/s00330-003-1889-5; Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610; Yamada R, 2010, CIRC-CARDIOVASC INTE, V3, P484, DOI 10.1161/CIRCINTERVENTIONS.109.928911; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Kitagawa T, 2007, AM HEART J, V154, P1191, DOI 10.1016/j.ahj.2007.07.020; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Raghunathan D, 2011, AM J CARDIOL, V107, P1613, DOI 10.1016/j.amjcard.2011.01.044; Schroeder S, 2001, J COMPUT ASSIST TOMO, V25, P900, DOI 10.1097/00004728-200111000-00013; Leber AW, 2004, J AM COLL CARDIOL, V43, P1241, DOI 10.1016/j.jacc.2003.10.059; Guaricci AI, 2014, INT J CARDIOL, V176, P988, DOI 10.1016/j.ijcard.2014.08.141; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Kim JB, 2014, INT J CARDIOL, V173, P570, DOI 10.1016/j.ijcard.2014.03.118; Kume T, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.030; Li SH, 2013, INT J CARDIOL, V168, P5035, DOI 10.1016/j.ijcard.2013.07.222	36	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						419	425		10.1016/j.ijcard.2015.01.021		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600118		
J	Nakamura, M; Isshiki, T; Kimura, T; Ogawa, H; Yokoi, H; Nanto, S; Takayama, M; Kitagawa, K; Ikeda, Y; Saito, S				Nakamura, Masato; Isshiki, Takaaki; Kimura, Takeshi; Ogawa, Hisao; Yokoi, Hiroyoshi; Nanto, Shinsuke; Takayama, Morimasa; Kitagawa, Kazuo; Ikeda, Yasuo; Saito, Shigeru			Optimal cutoff value of P2Y(12) reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: Post-hoc analysis of the randomized PRASFIT-ACS study	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						Prasugrel; Acute coronary syndrome; Clopidogrel; Major adverse cardiovascular event; Platelet reactivity; CYP2C19	PERCUTANEOUS CORONARY INTERVENTION; DRUG-ELUTING STENTS; ANGIOPLASTY-PLATELET REACTIVITY; OF-CARE ASSAY; CLINICAL-OUTCOMES; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CLOPIDOGREL RESPONSIVENESS; PROGNOSTIC-SIGNIFICANCE; JAPANESE PATIENTS	Background: Few studies have examined the effects of on-treatment platelet reactivity on the risk of major adverse cardiovascular events (MACE). We aimed to determine the optimal cutoff value of P2Y(12) reaction units (PRUs) to prevent MACE occurring within 3 days after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Methods: We performed post-hoc analyses of 1363 patients enrolled in PRASFIT-ACS, which compared the effects of a prasugrel regimen adjusted for Japanese patients (loading dose/maintenance dose: 20 mg/3.75 mg) with those of clopidogrel (300 mg/75 mg) on MACE and bleeding events for 24-48 weeks after PCI in ACS patients. PRU was serially measured using the VerifyNow (R) P2Y(12) assay and we assessed the relationship between PRU and MACE. Results: Receiver operating characteristic curve analysis showed that PRU <= 262 at 5-12 h after ADP receptor antagonist loading was the optimal cutoff value for preventing MACE at up to 3 days after PCI. The incidences of MACE were 5.2% and 10.8% in patients with PRU <= 262 or >262, respectively (odds ratio 0.50, 95% confidence interval 0.25-0.99, p < 0.01). Significantly more prasugrel-treated patients had lower on-treatment platelet reactivity (defined as PRU <= 262) compared with clopidogrel-treated patients (79.9% vs. 30.4%, p < 0.0001). Similar differences were observed between the prasugrel and clopidogrel groups for patients with normal or reduced function CYP2C19 alleles. Conclusions: The optimal PRU cutoff value for preventing MACE was 262 in Japanese ACS patients. Prasugrel rapidly reduced PRU with a large proportion of patients having low on-treatment platelet reactivity. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.	[Nakamura, Masato] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo 1538515, Japan; [Isshiki, Takaaki] Teikyo Univ Hosp, Div Cardiol, Tokyo, Japan; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Yokoi, Hiroyoshi] Fukuoka Sanno Hosp, Fukuoka, Japan; [Yokoi, Hiroyoshi] Int Univ Hlth & Welf, Ohtawara, Japan; [Nanto, Shinsuke] Nishinomiya Municipal Cent Hosp, Nishinomiya Hosp Affairs, Nishinomiya, Hyogo, Japan; [Takayama, Morimasa] Sakakibara Heart Inst, Tokyo, Japan; [Kitagawa, Kazuo] Tokyo Womens Med Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Ikeda, Yasuo] Waseda Univ, Fac Sci & Engn, Life Sci & Med Biosci, Tokyo, Japan; [Saito, Shigeru] Shonan Kamakura Gen Hosp, Div Cardiol, Kamakura, Kanagawa, Japan	Nakamura, M (reprint author), Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	masato@oha.toho-u.ac.jp			Daiichi Sankyo Co., Ltd. (Tokyo, Japan)	This study was sponsored by Daiichi Sankyo Co., Ltd. (Tokyo, Japan). The authors thank all investigators and research staff for their help. We also wish to acknowledge the contributions of the following members of the Independent Data Monitoring Committee: Hideki Origasa, PhD (Toyama University), Kazuhiro Sase, MD (Juntendo University), Kazuo Umemura, MD (Hamamatsu University), and Takanari Kitazono, MD (Kyushu University). We thank SOC Co Ltd, Tokyo, Japan, for providing the SAS software used in the data analysis. We would also like to thank Dr Nicholas Smith, PhD, for providing medical writing services during the preparation of this manuscript.	Ahn SG, 2012, JACC-CARDIOVASC INTE, V5, P259, DOI 10.1016/j.jcin.2011.12.009; Brar SS, 2011, J AM COLL CARDIOL, V58, P1945, DOI 10.1016/j.jacc.2011.06.059; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Cattaneo M, 2010, CIRCULATION, V121, P171, DOI 10.1161/CIRCULATIONAHA.109.853069; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Jang JS, 2012, AM J CARDIOL, V110, P502, DOI 10.1016/j.amjcard.2012.04.020; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Yokoi H, 2012, THROMB RES, V129, P623, DOI 10.1016/j.thromres.2011.11.023; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Cuisset T, 2007, THROMB HAEMOSTASIS, V97, P282, DOI 10.1160/TH06-07-0362; Sibbing D, 2010, J AM COLL CARDIOL, V56, P317, DOI 10.1016/j.jacc.2010.03.048; Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Mangiacapra F, 2012, JACC-CARDIOVASC INTE, V5, P281, DOI 10.1016/j.jcin.2012.01.009; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290	29	6	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-5273	1874-1754		INT J CARDIOL	Int. J. Cardiol.	MAR 1	2015	182						541	548		10.1016/j.ijcard.2015.01.026		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CE6DU	WOS:000351927600142		
J	Igarashi, M; Aga, M; Ikei, H; Namekawa, T; Miyazaki, Y				Igarashi, Miho; Aga, Mariko; Ikei, Harumi; Namekawa, Takafumi; Miyazaki, Yoshifumi			Physiological and Psychological Effects on High School Students of Viewing Real and Artificial Pansies	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							PREFRONTAL CORTEX ACTIVITY; HEART-RATE-VARIABILITY; OLFACTORY STIMULATION; FOREST LANDSCAPES; OLDER-PEOPLE; HEALTH; ENVIRONMENTS; HORTICULTURE; THERAPY; PROGRAM	The relaxation effects of gardening have attracted attention; however, very few studies have researched its physiological effects on humans. This study aimed to clarify the physiological and psychological effects on high school students of viewing real and artificial pansies. Forty high school students (male: 19, female: 21) at Chiba Prefectural Kashiwanoha Senior High School, Japan, participated in this experiment. The subjects were presented with a visual stimulation of fresh yellow pansies (Viola x wittrockiana "Nature Clear Lemon") in a planter for 3 min. Artificial yellow pansies in a planter were used as the control. Heart rate variability was used as a physiological measurement and the modified semantic differential method was used for subjective evaluation. Compared with artificial pansies, visual stimulation with real flowers resulted in a significant decrease in the ratio of low- to high-frequency heart rate variability component, which reflects sympathetic nerve activity. In contrast, high frequency, which reflects parasympathetic nerve activity, showed no significant difference. With regard to the psychological indices, viewing real flowers resulted in "comfortable", "relaxed", and "natural" feelings. The findings indicate that visual stimulation with real pansies induced physiological and psychological relaxation effects in high school students.	[Igarashi, Miho; Aga, Mariko; Ikei, Harumi; Miyazaki, Yoshifumi] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan; [Namekawa, Takafumi] Chiba Prefectural Kashiwanoha Senior High Sch, Kashiwa, Chiba 2770882, Japan	Miyazaki, Y (reprint author), Chiba Univ, Ctr Environm Hlth & Field Sci, 6-2-1 Kashiwa No Ha, Kashiwa, Chiba 2770882, Japan.	miho.murachi@gmail.com; marikoaga@gmail.com; ikei.harumi@gmail.com; tname2@gmail.com; ymiyazaki@faculty.chiba-u.jp			Policy Research Institute, Ministry of Agriculture, Forestry and Fisheries in Japan, "Extramural Research Program for Agricultural, Forestry and Fishery Policy Research"	This work was supported by a grant from the Policy Research Institute, Ministry of Agriculture, Forestry and Fisheries in Japan, "Extramural Research Program for Agricultural, Forestry and Fishery Policy Research". We really appreciate Hitoshi Watanabe, Associate Professor at the Centre for Environment, Health, and Field Sciences, Chiba University, who selected and prepared the pansies. We are grateful to Haruka Koizumi for her valuable contributions to data collection.	Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Joung D., 2014, Advances in Horticultural Science, V28, P90; Ikei H., 2014, Advances in Horticultural Science, V28, P111; PAGANI M, 1986, CIRC RES, V59, P178; Kingsley J, 2009, LEISURE STUD, V28, P207, DOI 10.1080/02614360902769894; Song C, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-8; Matsunaga K, 2011, J AM GERIATR SOC, V59, P2162, DOI 10.1111/j.1532-5415.2011.03651.x; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Chawla L, 2014, HEALTH PLACE, V28, P1, DOI 10.1016/j.healthplace.2014.03.001; Annerstedt M, 2011, SCAND J PUBLIC HEALT, V39, P371, DOI 10.1177/1403494810396400; Van Den Berg AE, 2011, J HEALTH PSYCHOL, V16, P3, DOI 10.1177/1359105310365577; Park BJ, 2008, SCAND J FOREST RES, V23, P278, DOI 10.1080/02827580802055978; Twenge JM, 2010, CLIN PSYCHOL REV, V30, P145, DOI 10.1016/j.cpr.2009.10.005; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Park BJ, 2011, LANDSCAPE URBAN PLAN, V102, P24, DOI 10.1016/j.landurbplan.2011.03.005; Tsunetsugu Yuko, 2010, Environmental Health and Preventive Medicine, V15, P27, DOI 10.1007/s12199-009-0091-z; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; Lee J, 2009, SCAND J FOREST RES, V24, P227, DOI 10.1080/02827580902903341; Bruxelles L, 2014, J HUM EVOL, V70, P36, DOI 10.1016/j.jhevol.2014.02.014; Tsunetsugu Y, 2013, LANDSCAPE URBAN PLAN, V113, P90, DOI 10.1016/j.landurbplan.2013.01.014; Igarashi M, 2014, J ALTERN COMPLEM MED, V20, P727, DOI 10.1089/acm.2014.0029; Armstrong D, 2000, HEALTH PLACE, V6, P319, DOI 10.1016/S1353-8292(00)00013-7; Collishaw S, 2010, J CHILD PSYCHOL PSYC, V51, P885, DOI 10.1111/j.1469-7610.2010.02252.x; Kanaya N, 2003, ANESTHESIOLOGY, V98, P34, DOI 10.1097/00000542-200301000-00009; Park BJ, 2009, SILVA FENN, V43, P291, DOI 10.14214/sf.213; Igarashi M, 2014, J ALTERN COMPLEM MED, V20, P545, DOI 10.1089/acm.2014.0100; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; Wakefield S, 2007, HEALTH PROMOT INT, V22, P92, DOI 10.1093/heapro/dam001; Barnicle T, 2003, HORTTECHNOLOGY, V13, P81; Gaillet-Torrent M, 2014, APPETITE, V76, P17, DOI 10.1016/j.appet.2014.01.009; Gigliotti C. M., 2004, DEMENTIA, V3, P161, DOI 10.1177/1471301204042335; Gigliotti CM, 2005, CAN J AGING, V24, P367, DOI 10.1353/cja.2006.0008; Gonzalez Marianne Thorsen, 2011, Issues Ment Health Nurs, V32, P73, DOI 10.3109/01612840.2010.528168; Gonzalez MT, 2010, J ADV NURS, V66, P2002, DOI 10.1111/j.1365-2648.2010.05383.x; Igarashi M., 2014, J NEUROIMAGING, V25, P127; Igarashi M, 2014, COMPLEMENT THER MED, V22, P1027, DOI 10.1016/j.ctim.2014.09.003; Ikei H, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-6; Ikei H., 2013, JPN J PHYSL ANTHR, V18, P97; Jarrott SE, 2010, AM J ALZHEIMERS DIS, V25, P657, DOI 10.1177/1533317510385810; Jarrott SE, 2002, HORTTECHNOLOGY, V12, P403; Komatsu M., 2013, JPN J PHYSL ANTHROPO, V18, P1; Lee MS, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-15; Lee Y, 2008, INT J GERIATR PSYCH, V23, P485, DOI 10.1002/gps.1920; Miyazaki Y., 2011, DESIGNING OUR FUTURE, P407; Osgood C.E., 1957, MEASUREMENT MEANING; Park B. J., 2011, FOREST MED, P55; Park B.J., ADV HORTIC IN PRESS; Relf D., 1995, HortTechnology, V5, P94; Richards H. J., 1999, J OFFENDER REHABILIT, V29, P183; Soderback I., 2004, SWEDEN DEV NEURO, V7, P245; Song CR, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-18; Takada H., 2004, HEP, V31, P547; Camm AJ, 1996, CIRCULATION, V93, P1043; Tse MMY, 2010, J CLIN NURS, V19, P949, DOI 10.1111/j.1365-2702.2009.02803.x; Tsunetsugu Y, 2011, FOREST MED, P169; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Wichrowski M., 2005, CARDIOPULM REHABIL P, V25, P270; Yamada Y, 2014, APPETITE, V81, P102, DOI 10.1016/j.appet.2014.06.006	59	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2015	12	3					2521	2531		10.3390/ijerph120302521		11	Environmental Sciences	Environmental Sciences & Ecology	CE6EP	WOS:000351929700012		
J	Ochiai, H; Ikei, H; Song, C; Kobayashi, M; Takamatsu, A; Miura, T; Kagawa, T; Li, Q; Kumeda, S; Imai, M; Miyazaki, Y				Ochiai, Hiroko; Ikei, Harumi; Song, Chorong; Kobayashi, Maiko; Takamatsu, Ako; Miura, Takashi; Kagawa, Takahide; Li, Qing; Kumeda, Shigeyoshi; Imai, Michiko; Miyazaki, Yoshifumi			Physiological and Psychological Effects of Forest Therapy on Middle-Aged Males with High-Normal Blood Pressure	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							NATURAL-KILLER ACTIVITY; ANTICANCER PROTEINS; SALIVARY CORTISOL; ENVIRONMENTS; EXPRESSION; CITY	Time spent walking and relaxing in a forest environment ("forest bathing" or "forest therapy") has well demonstrated anti-stress effects in healthy adults, but benefits for ill or at-risk populations have not been reported. The present study assessed the physiological and psychological effects of forest therapy (relaxation and stress management activity in the forest) on middle-aged males with high-normal blood pressure. Blood pressure and several physiological and psychological indices of stress were measured the day before and approximately 2 h following forest therapy. Both pre- and post-treatment measures were conducted at the same time of day to avoid circadian influences. Systolic and diastolic blood pressure (BP), urinary adrenaline, and serum cortisol were all significantly lower than baseline following forest therapy (p < 0.05). Subjects reported feeling significantly more "relaxed" and "natural" according to the Semantic Differential (SD) method. Profile of Mood State (POMS) negative mood subscale scores for "tension-anxiety," "confusion," and "anger-hostility," as well as the Total Mood Disturbance (TMD) score were significantly lower following forest therapy. These results highlight that forest is a promising treatment strategy to reduce blood pressure into the optimal range and possibly prevent progression to clinical hypertension in middle-aged males with high-normal blood pressure.	[Ochiai, Hiroko] Natl Hosp Org Tokyo Med Ctr, Dept Plast & Reconstruct Surg, Meguro Ku, Tokyo 1528902, Japan; [Ikei, Harumi; Song, Chorong; Miyazaki, Yoshifumi] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan; [Kobayashi, Maiko; Li, Qing] Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan; [Takamatsu, Ako] Natl Ctr Child Hlth & Dev, Dept Plast & Reconstruct Surg, Setagaya Ku, Tokyo 1578535, Japan; [Miura, Takashi] Agematsu Town Off Ind & Tourism Dept, Nagano 3995601, Japan; [Kagawa, Takahide] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Kumeda, Shigeyoshi] Nagano Prefectural Kiso Hosp, Nagano 3978555, Japan; [Imai, Michiko] Le Verseau Inc, Setagaya Ku, Tokyo 1560051, Japan	Miyazaki, Y (reprint author), Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa No Ha 6-2-1, Kashiwa, Chiba 2770882, Japan.	ochiroko@gmail.com; ikei.harumi@gmail.com; crsong1028@gmail.com; mk831111@nms.ac.jp; accodr@aol.com; syoukan@town.agematsu.nagano.jp; kagawa@ffpri.affrc.go.jp; qing-li@nms.ac.jp; kumeda@titan.ocn.ne.jp; leverseau@mvb.biglobe.ne.jp; ymiyazaki@faculty.chiba-u.jp					Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Li Q, 2008, INT J IMMUNOPATH PH, V21, P117; Yamaguchi M, 2006, J INT MED RES, V34, P152; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lee J, 2014, EVID-BASED COMPL ALT, DOI 10.1155/2014/834360; Fujiyoshi A, 2012, HYPERTENS RES, V35, P947, DOI 10.1038/hr.2012.87; Park Bum-Jin, 2007, Journal of Physiological Anthropology, V26, P123, DOI 10.2114/jpa2.26.123; Park BJ, 2011, LANDSCAPE URBAN PLAN, V102, P24, DOI 10.1016/j.landurbplan.2011.03.005; Tsunetsugu Y, 2013, LANDSCAPE URBAN PLAN, V113, P90, DOI 10.1016/j.landurbplan.2013.01.014; Frankenhauser M., 1975, EMOTIONS THEIR PARAM, P209; Kaplan R., 1989, EXPERIENCE NATURE PS; Li Q, 2010, J BIOL REG HOMEOS AG, V24, P157; McNair D. M., 1992, PROFILE MOOD STATES; Mena-Martín Francisco J, 2006, J Clin Hypertens (Greenwich), V8, P619, DOI 10.1111/j.1524-6175.2006.05569.x; Miyazaki Y., 2009, SHINRINIGAKU, P23; Osgood C.E., 1957, MEASUREMENT MEANING; Shimamoto K., 2014, HYPERTENS RES, V7, p253 ; Song CR, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-18	20	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2015	12	3					2532	2542		10.3390/ijerph120302532		11	Environmental Sciences	Environmental Sciences & Ecology	CE6EP	WOS:000351929700013		
J	Song, CR; Ikei, H; Kobayashi, M; Miura, T; Taue, M; Kagawa, T; Li, Q; Kumeda, S; Imai, M; Miyazaki, Y				Song, Chorong; Ikei, Harumi; Kobayashi, Maiko; Miura, Takashi; Taue, Masao; Kagawa, Takahide; Li, Qing; Kumeda, Shigeyoshi; Imai, Michiko; Miyazaki, Yoshifumi			Effect of Forest Walking on Autonomic Nervous System Activity in Middle-Aged Hypertensive Individuals: A Pilot Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							NATURAL-KILLER ACTIVITY; HEART-RATE-VARIABILITY; SHINRIN-YOKU; HUMAN HEALTH; CLIMATE-CHANGE; ANTICANCER PROTEINS; SALIVARY CORTISOL; BLOOD-PRESSURE; ENVIRONMENTS; ATMOSPHERE	There has been increasing attention on the therapeutic effects of the forest environment. However, evidence-based research that clarifies the physiological effects of the forest environment on hypertensive individuals is lacking. This study provides scientific evidence suggesting that a brief forest walk affects autonomic nervous system activity in middle-aged hypertensive individuals. Twenty participants (58.0 +/- 10.6 years) were instructed to walk predetermined courses in forest and urban environments (as control). Course length (17-min walk), walking speed, and energy expenditure were equal between the forest and urban environments to clarify the effects of each environment. Heart rate variability (HRV) and heart rate were used to quantify physiological responses. The modified semantic differential method and Profile of Mood States were used to determine psychological responses. The natural logarithm of the high-frequency component of HRV was significantly higher and heart rate was significantly lower when participants walked in the forest than when they walked in the urban environment. The questionnaire results indicated that, compared with the urban environment, walking in the forest increased "comfortable", "relaxed", "natural" and "vigorous" feelings and decreased "tension-anxiety," "depression," "anxiety-hostility," "fatigue" and "confusion". A brief walk in the forest elicited physiological and psychological relaxation effects on middle-aged hypertensive individuals.	[Song, Chorong; Ikei, Harumi; Miyazaki, Yoshifumi] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan; [Kobayashi, Maiko; Li, Qing] Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan; [Miura, Takashi] Agematsu Town Off Ind & Tourism Dept, Nagano 3995601, Japan; [Taue, Masao] Agematsu Town Off, Nagano 3995603, Japan; [Kagawa, Takahide] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Kumeda, Shigeyoshi] Nagano Prefectural Kiso Hosp, Nagano 3978555, Japan; [Imai, Michiko] Le Verseau Inc, Setagaya Ku, Tokyo 1560051, Japan	Miyazaki, Y (reprint author), Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan.	crsong1028@gmail.com; ikei.harumi@gmail.com; mk831111@nms.ac.jp; syoukan@town.agematsu.nagano.jp; taue@town.agematsu.nagano.jp; kagawa@ffpri.affrc.go.jp; qing-li@nms.ac.jp; kumeda-shigeyoshi@pref-nagano-hosp.jp; leverseau@mvb.biglobe.ne.jp; ymiyazaki@faculty.chiba-u.jp					Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; Li Q, 2008, INT J IMMUNOPATH PH, V21, P117; Shapiro D, 2007, EVID-BASED COMPL ALT, V4, P493, DOI [10.1093/ecam/nel114, 10.1093/ccam/nel114]; Tanaka A, 1996, URBAN STUD, V33, P879, DOI 10.1080/00420989650011645; Kinney PL, 2008, AM J PREV MED, V35, P459, DOI 10.1016/j.amepre.2008.08.025; Tsunetsugu Yuko, 2007, Journal of Physiological Anthropology, V26, P135, DOI 10.2114/jpa2.26.135; PAGANI M, 1986, CIRC RES, V59, P178; Lee JY, 2014, EUR J INTEGR MED, V6, P5, DOI 10.1016/j.eujim.2013.10.006; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Mao GX, 2012, J CARDIOL, V60, P495, DOI 10.1016/j.jjcc.2012.08.003; Morita E, 2007, PUBLIC HEALTH, V121, P54, DOI 10.1016/j.puhe.2006.05.024; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lee J, 2014, EVID-BASED COMPL ALT, DOI 10.1155/2014/834360; Sung J, 2012, CLIN EXP HYPERTENS, V34, P1, DOI 10.3109/10641963.2011.618195; Perrey S, 2008, J SPORT SCI MED, V7, P32; MCNAIR DM, 1964, J ABNORM SOC PSYCH, V69, P620, DOI 10.1037/h0040902; Shin WS, 2011, SCAND J FOREST RES, V26, P595, DOI 10.1080/02827581.2011.585996; Park Bum-Jin, 2007, Journal of Physiological Anthropology, V26, P123, DOI 10.2114/jpa2.26.123; Park BJ, 2008, SCAND J FOREST RES, V23, P278, DOI 10.1080/02827580802055978; Williams PT, 2013, ARTERIOSCL THROM VAS, V33, P1085, DOI 10.1161/ATVBAHA.112.300878; Ohtsuka Y, 1998, INT J BIOMETEOROL, V41, P125, DOI 10.1007/s004840050064; Kobayashi H, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-9; Park BJ, 2011, LANDSCAPE URBAN PLAN, V102, P24, DOI 10.1016/j.landurbplan.2011.03.005; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Lee J, 2009, SCAND J FOREST RES, V24, P227, DOI 10.1080/02827580902903341; Park Bum Jin, 2010, Environmental Health and Preventive Medicine, V15, P18, DOI 10.1007/s12199-009-0086-9; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Kanaya N, 2003, ANESTHESIOLOGY, V98, P34, DOI 10.1097/00000542-200301000-00009; Park BJ, 2009, SILVA FENN, V43, P291, DOI 10.14214/sf.213; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Li Q, 2008, J BIOL REG HOMEOS AG, V22, P45; Mao GX, 2012, BIOMED ENVIRON SCI, V25, P317, DOI 10.3967/0895-3988.2012.03.010; Kim W, 2009, PSYCHIAT INVEST, V6, P245, DOI 10.4306/pi.2009.6.4.245; Brunet M., 2002, CENTRAL AFRICA NATUR, V418, P141; Buttagat Vitsarut, 2011, J Bodyw Mov Ther, V15, P15, DOI 10.1016/j.jbmt.2009.06.005; Craig B., 1984, TECHNOSTRESS HUMAN C; Delaney J. P., 2002, J ADV NURS, V3, P7364; Frumkin Howard, 2001, American Journal of Preventive Medicine, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; Iwane M, 2000, HYPERTENS RES, V23, P573, DOI 10.1291/hypres.23.573; Lee J., 2012, PUBLIC HLTH SOCIAL B, P325; Li Q, 2007, Int J Immunopathol Pharmacol, V20, P3; McNair D. M., 1992, PROFILE MOOD STATES; Osgood C.E., 1957, MEASUREMENT MEANING; Padulo J, 2013, J STRENGTH COND RES, V27, P1964, DOI 10.1519/JSC.0b013e3182752d5e; Pronczuka J., 2008, N Y ACAD SCI, V1140, P143; Shin Won Sop, 2010, Environmental Health and Preventive Medicine, V15, P38, DOI 10.1007/s12199-009-0114-9; Song CR, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-18; Camm AJ, 1996, CIRCULATION, V93, P1043; Tsunetsugu Y., 2013, URBAN PLAN, V11, P390; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Yokoyama K., 2005, POMS SHORTENED VERSI	51	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2015	12	3					2687	2699		10.3390/ijerph120302687		13	Environmental Sciences	Environmental Sciences & Ecology	CE6EP	WOS:000351929700023		
J	Ogai, Y; Senoo, E; Gardner, FC; Haraguchi, A; Saito, T; Morita, N; Ikeda, K				Ogai, Yasukazu; Senoo, Eiichi; Gardner, Fumiyuki Chin; Haraguchi, Ayako; Saito, Tamaki; Morita, Nobuaki; Ikeda, Kazutaka			Association between Experience of Child Abuse and Severity of Drug Addiction Measured by the Addiction Severity Index among Japanese Drug-Dependent Patients	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							SEXUAL-ABUSE; SUBSTANCE USE; ALCOHOL; YOUTHS; RISK; VICTIMIZATION; OFFENDERS; VERSION	The aim of the present study was to clarify the association between child abuse experiences and drug addiction severity among Japanese drug-dependent patients using the Addiction Severity Index-Japanese version (ASI-J). One hundred and eleven inpatients and outpatients with drug dependence participated in the study. Some of the questions on the ASI-J asked about lifetime experiences of abuse. A higher percentage of female participants experienced child abuse compared with male participants. Male participants who experienced child abuse (MEA) had a significantly higher severity of drug use than men who did not experience it (MNEA). Female participants who experienced child abuse (FEA) had significantly more serious problems in family/social relationships than female participants who did not experience it (FNEA). Patients in the MEA group were arrested less frequently for drug charges, experienced more serious problems with their fathers, and experienced more severe anxiety in their lifetime compared with the MNEA group. The FEA group experienced more serious troubles with their sexual partners, close friends, and families and experienced more severe psychiatric problems in their lifetime compared with the FNEA group. These results suggest gender differences in the problems experienced by drug-dependent patients with child abuse experiences, and gender-specific interventions may be more effective in treating their drug dependence.	[Ogai, Yasukazu; Saito, Tamaki; Morita, Nobuaki] Univ Tsukuba, Social Psychiat & Mental Hlth, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Ogai, Yasukazu; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Setagaya Ku, Tokyo 1568506, Japan; [Senoo, Eiichi] Ibaraki Prefectural Med Ctr Psychiat, Kasama, Ibaraki 3091717, Japan; [Gardner, Fumiyuki Chin] Penn State Univ, Coll Med, Hershey, PA 17033 USA; [Haraguchi, Ayako] Hanamizuki Geriatr Hlth Serv Facil, Chofu, Tokyo 1820011, Japan	Ogai, Y (reprint author), Univ Tsukuba, Social Psychiat & Mental Hlth, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	ogai.ys@md.tsukuba.ac.jp; senoo12001@yahoo.co.jp; fumiyuki.c.gardner@gmail.com; mako.haraguchi@nifty.ne.jp; hhd02063@nifty.ne.jp; nobuakim@nifty.ne.jp; ikeda-kz@igakuken.or.jp			MHLW KAKENHI [H25-Iyaku-020]; MEXT KAKENHI [23730687, 26380917]; Mitsubishi Foundation for Social Welfare Activities	We acknowledge Michael Arends for his assistance with editing the manuscript. This work was supported by grants from the MHLW KAKENHI (H25-Iyaku-020), MEXT KAKENHI (23730687, 26380917), and Mitsubishi Foundation for Social Welfare Activities.	Leander L, 2010, CHILD ABUSE NEGLECT, V34, P192, DOI 10.1016/j.chiabu.2009.09.011; Ballon BC, 2001, CAN J PSYCHIAT, V46, P617; McClellan DS, 1997, CRIM JUSTICE BEHAV, V24, P455, DOI 10.1177/0093854897024004004; Epstein JN, 1998, CHILD ABUSE NEGLECT, V22, P223, DOI 10.1016/S0145-2134(97)00133-6; Harden KP, 2012, DEVELOPMENTAL SCI, V15, P150, DOI 10.1111/j.1467-7687.2011.01115.x; Gunnarsdottir ED, 2000, ADDICT BEHAV, V25, P641, DOI 10.1016/S0306-4603(99)00043-X; Maniglio R, 2011, J ADDICT DIS, V30, P216, DOI 10.1080/10550887.2011.581987; BROWN GR, 1991, AM J PSYCHIAT, V148, P55; BAKER TB, 1987, NEBR SYM MOTIV, V34, P257; DEMBO R, 1988, INT J ADDICT, V23, P1101; Fujino K., 2007, ADDICT FAM, V24, P160; Funk Rodney R, 2003, Child Maltreat, V8, P36, DOI 10.1177/1077559502239607; Ikeda K., 2004, SEISHIN IGAKU, V46, P57; IRELAND T, 1994, INT J ADDICT, V29, P235; Locke TF, 2004, J FAM PSYCHOL, V18, P120, DOI 10.1037/0893-3200.18.1.120; Logan JE, 2009, PUBLIC HEALTH REP, V124, P234; Ministry of Health Labour and Welfare, 2012, REP SOC WELF ADM SER; Ministry of Justice Research and Training Institute, 2004, WHIT PAP CRIM JAP 20, P305; Morita Y., 2010, JPN J PSYCHIAT TREAT, V25, P597; Nakatani Y., 1995, ALCOHOL DEPEND ADDIC, V12, P195; Ogai Y, 2007, DRUG ALCOHOL DEPEN, V88, P174, DOI 10.1016/j.drugalcdep.2006.10.005; Senoo Eiichi, 2006, Japanese Journal of Alcohol Studies & Drug Dependence, V41, P368; Sugaya N, 2011, INT J ENV RES PUB HE, V8, P3922, DOI 10.3390/ijerph8103922; Sugiyama T., 2004, SODACHI, V2, P2; Swogger MT, 2011, ADDICT BEHAV, V36, P1205, DOI 10.1016/j.addbeh.2011.07.025; Toker T, 2011, TURK PSIKIYATR DERG, V22, P83; Ujiie Y., 1997, J TOKYO WOMENS MED U, V67, P69; Umeno Mitsuru, 2009, Japanese Journal of Alcohol Studies & Drug Dependence, V44, P623; Wada Kiyoshi, 2010, Nihon Rinsho, V68, P1437; Watanabe T, 2009, INT J ENV RES PUB HE, V6, P3056, DOI 10.3390/ijerph6123056	30	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2015	12	3					2781	2792		10.3390/ijerph120302781		12	Environmental Sciences	Environmental Sciences & Ecology	CE6EP	WOS:000351929700029		
J	Shirato, S; Iizuka, A; Mizukoshi, A; Noguchi, M; Yamasaki, A; Yanagisawa, Y				Shirato, Shintaro; Iizuka, Atsushi; Mizukoshi, Atsushi; Noguchi, Miyuki; Yamasaki, Akihiro; Yanagisawa, Yukio			Optimized Arrangement of Constant Ambient Air Monitoring Stations in the Kanto Region of Japan	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							CLUSTER-ANALYSIS; SURFACE OZONE; PRINCIPAL COMPONENT; QUALITY; MANAGEMENT; POLLUTION	Continuous ambient air monitoring systems have been introduced worldwide. However, such monitoring forces autonomous communities to bear a significant financial burden. Thus, it is important to identify pollutant-monitoring stations that are less efficient, while minimizing loss of data quality and mitigating effects on the determination of spatiotemporal trends of pollutants. This study describes a procedure for optimizing a constant ambient air monitoring system in the Kanto region of Japan. Constant ambient air monitoring stations in the area were topologically classified into four groups by cluster analysis and principle component analysis. Then, air pollution characteristics in each area were reviewed using concentration contour maps and average pollution concentrations. We then introduced three simple criteria to reduce the number of monitoring stations: (1) retain the monitoring station if there were similarities between its data and average data of the group to which it belongs; (2) retain the station if its data showed higher concentrations; and (3) retain the station if the monitored concentration levels had an increasing trend. With this procedure, the total number of air monitoring stations in suburban and urban areas was reduced by 36.5%. The introduction of three new types of monitoring stations is proposed, namely, mobile, for local non-methane hydrocarbon pollution, and O-x-prioritized.	[Shirato, Shintaro; Iizuka, Atsushi; Mizukoshi, Atsushi; Noguchi, Miyuki; Yanagisawa, Yukio] Univ Tokyo, Inst Frontier Sci, Dept Environm Syst, Kashiwa, Chiba 2778563, Japan; [Iizuka, Atsushi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Res Ctr Sustainable Sci & Engn, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Mizukoshi, Atsushi] Tokyo Metropolitan Ind Technol Res Inst, Koto Ku, Tokyo 1350064, Japan; [Mizukoshi, Atsushi] Kinki Univ, Dept Environm Med & Behav Sci, Fac Med, Osaka 5898511, Japan; [Noguchi, Miyuki; Yamasaki, Akihiro] Seikei Univ, Fac Sci & Technol, Dept Mat & Life Sci, Musashino, Tokyo 1808633, Japan	Iizuka, A (reprint author), Univ Tokyo, Inst Frontier Sci, Dept Environm Syst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778563, Japan.	hcrmh221@ybb.ne.jp; iizuka@tagen.tohoku.ac.jp; mizukoshi@med.kindai.ac.jp; noguchi@ejs.seikei.ac.jp; akihiro@st.seikei.ac.jp; yukio@k.u-tokyo.ac.jp					AIRPARIF, AIR QUAL MON NETW; Ibarra-Berastegi G, 2009, ATMOS ENVIRON, V43, P3829, DOI 10.1016/j.atmosenv.2009.05.010; Pires JCM, 2008, ATMOS ENVIRON, V42, P1249, DOI 10.1016/j.atmosenv.2007.10.044; Dominick D, 2012, ATMOS ENVIRON, V60, P172, DOI 10.1016/j.atmosenv.2012.06.021; Lau J, 2009, ATMOS ENVIRON, V43, P769, DOI 10.1016/j.atmosenv.2008.11.008; [Anonymous], 2007, EFFECTIVE DISTRIBUTI; Latif MT, 2014, SCI TOTAL ENVIRON, V482, P336, DOI 10.1016/j.scitotenv.2014.02.132; Pires JCM, 2009, ATMOS ENVIRON, V43, P3837, DOI 10.1016/j.atmosenv.2009.05.013; Pires JCM, 2008, ATMOS ENVIRON, V42, P1261, DOI 10.1016/j.atmosenv.2007.10.041; Azid A, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2063-1; DEFRA, MON NETW; Funabashi shi Environment Council, 2006, REP PLANN RES EFF DI; Hiroshima Prefectural Environmental Citizen Office Environment Division, 2008, REP PLAN RED NETW AI; Iizuka A, 2014, INT J ENV RES PUB HE, V11, P6844, DOI 10.3390/ijerph110706844; Li P, 2013, INT J ENV RES PUB HE, V10, P1048, DOI 10.3390/ijerph10031048; Lu WZ, 2011, BUILD ENVIRON, V46, P577, DOI 10.1016/j.buildenv.2010.09.004; Lu WZ, 2011, BUILD ENVIRON, V46, P2562, DOI 10.1016/j.buildenv.2011.06.011; MOE Government of Japan, 2007, MAN ENV AIR CONST MO; MOE Government of Japan, ATM ENV REG OBS SYST; Tarasova OA, 2007, ATMOS CHEM PHYS, V7, P6099; UBA, MEAS OBS MON; U.S. EPA, TECHN TRANSF NETW AM; Zvyagintsev AM, 2008, IZV ATMOS OCEAN PHY+, V44, P474, DOI 10.1134/S0001433808040087	23	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2015	12	3					2950	2966		10.3390/ijerph120302950		17	Environmental Sciences	Environmental Sciences & Ecology	CE6EP	WOS:000351929700042		
J	Makizako, H; Shimada, H; Doi, T; Tsutsumimoto, K; Lee, S; Hotta, R; Nakakubo, S; Harada, K; Lee, S; Bae, S; Harada, K; Suzuki, T				Makizako, Hyuma; Shimada, Hiroyuki; Doi, Takehiko; Tsutsumimoto, Kota; Lee, Sangyoon; Hotta, Ryo; Nakakubo, Sho; Harada, Kazuhiro; Lee, Sungchul; Bae, Seongryu; Harada, Kenji; Suzuki, Takao			Cognitive Functioning and Walking Speed in Older Adults as Predictors of Limitations in Self-Reported Instrumental Activity of Daily Living: Prospective Findings from the Obu Study of Health Promotion for the Elderly	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							MINI-MENTAL STATE; SUBSEQUENT DISABILITY; PHYSICAL PERFORMANCE; MORTALITY; DECLINE; IMPAIRMENT; DEMENTIA; WOMEN; INDEPENDENCE; DEPRESSION	Our aim was to determine whether baseline measures of cognitive functioning, walking speed, and depressive status are independent predictors of limitations in instrumental activities of daily living (IADL) in older adults. The cross-sectional study involved 1329 community-dwelling adults, aged 75 years or older. At baseline, the Mini-Mental State Examination (MMSE), Symbol Digit Substitution Test (SDST), Geriatric Depressive Scale (GDS), and a word list memory task were completed, and self-reported IADLs and walking speed were recorded. The longitudinal study involved 948 participants without baseline IADL limitation, which was assessed at baseline and 15-month follow up, using the three Kihon Checklist subitems. In cross-sectional analyses, participants with IADL limitation demonstrated greater GDS scores, slower walking speeds, and lower MMSE, word list memory task, and SDST (only for women) scores relative to those without IADL limitation. In the longitudinal analyses, baseline walking speed (men: OR 0.98; women: OR 0.97, p < 0.05) and word list memory task scores (men: OR 0.84; women: OR 0.83, p < 0.05) in both sexes and SDST scores in women (OR 0.96, p = 0.04) were independent predictors of subsequent IADL limitation. Walking speed, memory, and processing speed may be independent predictors of IADL limitation in older adults.	[Makizako, Hyuma; Shimada, Hiroyuki; Doi, Takehiko; Tsutsumimoto, Kota; Lee, Sangyoon; Hotta, Ryo; Nakakubo, Sho; Harada, Kazuhiro; Lee, Sungchul; Bae, Seongryu; Harada, Kenji] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, Obu, Aichi 4748511, Japan; [Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi 4748511, Japan	Makizako, H (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, 7-430 Morioka Cho, Obu, Aichi 4748511, Japan.	makizako@ncgg.go.jp; shimada@ncgg.go.jp; take-d@ncgg.go.jp; k-tsutsu@ncgg.go.jp; sylee@ncgg.go.jp; ryo-h@ncgg.go.jp; sho-n@ncgg.go.jp; haradak@ncgg.go.jp; leesuys@ncgg.go.jp; bae-sr@ncgg.go.jp; harada-k@ncgg.go.jp; suzutaka@ncgg.go.jp			Japanese Ministry of Health, Labour and Welfare [B-3]; National Center for Geriatrics and Gerontology [22-16]	We would like to thank the Obu city office for the help provided with regard to participant recruitment. This work was supported by the Japanese Ministry of Health, Labour and Welfare (Project for optimizing long-term care) (grant number B-3); and the National Center for Geriatrics and Gerontology (Research Funding for Longevity Sciences) (grant number 22-16).	Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664; Barberger-Gateau P, 1999, J GERONTOL B-PSYCHOL, V54, pP293; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; Johnson JK, 2007, J GERONTOL A-BIOL, V62, P1134; Carbonare LD, 2009, AM J GERIAT PSYCHIAT, V17, P144, DOI 10.1097/JGP.0b013e31818af817; Dodge HH, 2006, J GERONTOL A-BIOL, V61, P1330; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Reppermund S, 2013, PSYCHOL MED, V43, P2437, DOI 10.1017/S003329171200308X; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Woo J, 1999, J AM GERIATR SOC, V47, P1257; Judge JO, 1996, J AM GERIATR SOC, V44, P1332; Idland G, 2013, ARCH GERONTOL GERIAT, V56, P501, DOI 10.1016/j.archger.2012.12.005; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Hybels CF, 2009, PSYCHOL MED, V39, P1677, DOI 10.1017/S0033291709005650; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; Seidel D, 2011, AGE AGEING, V40, P463, DOI 10.1093/ageing/afr054; Fukutomi E, 2013, GERIATR GERONTOL INT, V13, P654, DOI 10.1111/j.1447-0594.2012.00959.x; Lee Y, 2000, J EPIDEMIOL COMMUN H, V54, P123, DOI 10.1136/jech.54.2.123; Razani J, 2007, J AM GERIATR SOC, V55, P1415, DOI 10.1111/j.1532-5415.2007.01307.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179; Billis A. S., 2015, J BIOMED HLTH INFORM, V19, P199; Farias ST, 2009, CLIN NEUROPSYCHOL, V23, P446, DOI DOI 10.1080/13854040802360558; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ishizaki J, 1998, J GERONTOL B-PSYCHOL, V53, pP359; Konstantinidis E., 2015, J BIOMED HLTH INFORM, DOI [10.1109/JBHI.2014.2378814, DOI 10.1109/JBHI.2014.2378814]; Millan-Calenti JC, 2012, ARCH GERONTOL GERIAT, V54, P197, DOI 10.1016/j.archger.2011.02.010; Ministry of Health Labour and Welfare, LAT INF LONG TERM CA; Nourhashemi F, 2001, J GERONTOL A-BIOL, V56, pM448; Reppermund S, 2011, INT J GERIATR PSYCH, V26, P843, DOI 10.1002/gps.2612; Shimada H., 2013, BMJ OPEN, DOI [10.1136/bmjopen-2012-002424, DOI 10.1136/BMJ0PEN-2012-002424]; Suzuki T, 2003, GERIATR GERONTOL INT, V3, pS6, DOI 10.1111/j.1444-0594.2003.00090.x	34	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2015	12	3					3002	3013		10.3390/ijerph120303002		12	Environmental Sciences	Environmental Sciences & Ecology	CE6EP	WOS:000351929700045		
J	Takahashi, N; Nakao, R; Ueda, K; Ono, M; Kondo, M; Honda, Y; Hashizume, M				Takahashi, Noriko; Nakao, Rieko; Ueda, Kayo; Ono, Masaji; Kondo, Masahide; Honda, Yasushi; Hashizume, Masahiro			Community Trial on Heat Related-Illness Prevention Behaviors and Knowledge for the Elderly	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article							WARNING SYSTEMS; HOSPITAL ADMISSIONS; WAVE; CHICAGO; HEATWAVES; MORTALITY; DEATH	This study aims to explore whether broadcasting heat health warnings (HHWs), to every household and whether the additional home delivery of bottled water labeled with messages will be effective in improving the behaviors and knowledge of elderly people to prevent heat-related illness. A community trial on heat-related-illness-prevention behaviors and knowledge for people aged between 65 and 84 years was conducted in Nagasaki, Japan. Five hundred eight subjects were selected randomly from three groups: heat health warning (HHW), HHW and water delivery (HHW+W), and control groups. Baseline and follow-up questionnaires were conducted in June and September 2012, respectively. Of the 1524 selected subjects, the 1072 that completed both questionnaires were analyzed. The HHW+W group showed improvements in nighttime AC use (p = 0.047), water intake (p = 0.003), cooling body (p = 0.002) and reduced activities in heat (p = 0.047) compared with the control, while the HHW group improved hat or parasol use (p = 0.008). An additional effect of household water delivery was observed in water intake (p = 0.067) and cooling body (p = 0.095) behaviors. HHW and household bottled water delivery improved heat-related-illness-prevention behaviors. The results indicate that home water delivery in addition to a HHW may be needed to raise awareness of the elderly.	[Takahashi, Noriko; Hashizume, Masahiro] Nagasaki Univ, Inst Trop Med, Dept Paediat Infect Dis, Nagasaki 8528523, Japan; [Takahashi, Noriko; Hashizume, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Takahashi, Noriko] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo 1578535, Japan; [Nakao, Rieko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nursing, Nagasaki 8528520, Japan; [Ueda, Kayo; Ono, Masaji] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Kondo, Masahide] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Honda, Yasushi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki 3058575, Japan	Hashizume, M (reprint author), Nagasaki Univ, Inst Trop Med, Dept Paediat Infect Dis, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	pediatric.nagasaki@gmail.com; rieko@nagasaki-u.ac.jp; ueda.kayo.8x@kyoto-u.ac.jp; onomasaj@nies.go.jp; mkondo@md.tsukuba.ac.jp; honda@taiiku.tsukuba.ac.jp; hashizum@nagasaki-u.ac.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-8]	We are grateful to Goto city office, Goto city Council of Social Welfare, and local welfare commissioners (Minsei-iin) in Goto for their support in collecting the data. We thank Professors Sumihisa Honda and Akiko Matsuyama for their insightful comments at the design and analysis stage of the study. This study was supported by the Environment Research and Technology Development Fund (S-8) of the Ministry of the Environment, Japan. The views expressed in this article are those of the individual authors and do not necessarily reflect those of the Ministry of the Environment, Japan.	Lowe D, 2011, INT J ENV RES PUB HE, V8, P4623, DOI 10.3390/ijerph8124623; Weinstein ND, 1998, HEALTH PSYCHOL, V17, P290, DOI 10.1037//0278-6133.17.3.290; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Flynn A, 2005, QJM-INT J MED, V98, P227, DOI 10.1093/qjmed/hci025; Toloo G, 2013, INT J PUBLIC HEALTH, V58, P667, DOI 10.1007/s00038-013-0465-2; Wang XY, 2012, OCCUP ENVIRON MED, V69, P163, DOI 10.1136/oem.2010.062141; Hajat S, 2010, AM J PUBLIC HEALTH, V100, P1137, DOI 10.2105/AJPH.2009.169748; D'Ippoliti D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-37; Gupta S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009888.pub2; Ibrahim JE, 2012, INT J PUBLIC HEALTH, V57, P297, DOI 10.1007/s00038-011-0243-y; Kaiser R, 2001, AM J FOREN MED PATH, V22, P303, DOI 10.1097/00000433-200109000-00022; KILBOURNE EM, 1982, JAMA-J AM MED ASSOC, V247, P3332, DOI 10.1001/jama.247.24.3332; Knowlton K, 2014, INT J ENV RES PUB HE, V11, P3473, DOI 10.3390/ijerph110403473; Laurence S., 1996, B AM METEOROL SOC, V77, P1519; Naughton MP, 2002, AM J PREV MED, V22, P221, DOI 10.1016/S0749-3797(02)00421-X; Pirard P, 2005, Euro Surveill, V10, P153; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037//0278-6133.7.4.355	20	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2015	12	3					3188	3214		10.3390/ijerph120303188		27	Environmental Sciences	Environmental Sciences & Ecology	CE6EP	WOS:000351929700056		
J	Ito, T; Kawamuro, K				Ito, Tetsuya; Kawamuro, Keiko			Overtwisted discs in planar open books	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article						Overtwisted contact structure; open book foliation; fractional Dehn twist coefficient	TIGHT CONTACT STRUCTURES; STUDYING LINKS; CLOSED BRAIDS; THEOREM; CLASSIFICATION; STABILIZATION; 3-MANIFOLDS; FOLIATIONS	Using open book foliations we show that an overtwisted disc in a planar open book can be put in a topologically nice position. As a corollary, we prove that a planar open book whose fractional Dehn twist coefficients greater than one for all the boundary components supports a tight contact structure.	[Ito, Tetsuya] Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan; [Kawamuro, Keiko] Univ Iowa, Dept Math, Iowa City, IA 52242 USA	Ito, T (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan.	tetitoh@kurims.kyoto-u.ac.jp; kawamuro@iowa.uiowa.edu			JSPS Research [25887030]; NSF [DMS-1206770]	The authors would like to thank Joan Birman, Bill Menasco for useful conversations and John Etnyre for informing us of an example that is included in Remark 1.3. They also thank the referee for careful reading and numerous comments and suggestions. T.I. was supported by JSPS Research Grant-in-Aid for Research Activity Start-up, Grant Number 25887030. K.K. was partially supported by NSF grant DMS-1206770.	Ozsvath P, 2005, DUKE MATH J, V129, P39, DOI 10.1215/S0012-7094-04-12912-4; ELIASHBERG Y, 1992, ANN I FOURIER, V42, P165; Colin V, 2013, J EUR MATH SOC, V15, P443, DOI 10.4171/JEMS/365; Honda K, 2007, INVENT MATH, V169, P427, DOI 10.1007/s00222-007-0051-4; ELIASHBERG Y, 1989, INVENT MATH, V98, P623, DOI 10.1007/BF01393840; GIROUX E, 1991, COMMENT MATH HELV, V66, P637, DOI 10.1007/BF02566670; Baldwin JA, 2013, MATH ANN, V357, P441, DOI 10.1007/s00208-013-0911-8; BENNEQUIN D, 1983, ASTERISQUE, P87; BIRMAN JS, 1991, TOPOL APPL, V40, P71, DOI 10.1016/0166-8641(91)90059-U; BIRMAN JS, 1992, PAC J MATH, V156, P265; BIRMAN JS, 1990, INVENT MATH, V102, P115, DOI 10.1007/BF01233423; BIRMAN JS, 1992, PAC J MATH, V154, P17; BIRMAN JS, 1994, TOPOLOGY, V33, P525, DOI 10.1016/0040-9383(94)90027-2; Birman JS, 2006, GEOM TOPOL, V10, P1425, DOI 10.2140/gt.2006.10.1425; BIRMAN JS, 1993, PAC J MATH, V161, P25; Birman JS, 2006, GEOM TOPOL, V10, P413, DOI 10.2140/gt.2006.10.359; BIRMAN JS, 1992, T AM MATH SOC, V329, P585, DOI 10.2307/2153953; Eliashberg Y., 1998, U LECT SERIES, V13; Giroux E., 2002, P INT C MATH, VII, P405; Honda K, 2000, GEOM TOPOL, V4, P219, DOI 10.2140/gt.2000.4.219; Honda K, 2000, J DIFFER GEOM, V55, P83; Ito T, 2014, ALGEBR GEOM TOPOL, V14, P2983, DOI 10.2140/agt.2014.14.2983; Ito T., 2012, PREPRINT; Ito T, 2014, PUBL RES I MATH SCI, V50, P169, DOI 10.4171/PRIMS/128	24	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-167X	1793-6519		INT J MATH	Int. J. Math.	MAR	2015	26	3							1550027	10.1142/S0129167X15500275		29	Mathematics	Mathematics	CE8QQ	WOS:000352109400006		
J	Kaki, K				Kaki, Kaori			Neutron density distributions analyzed in terms of relativistic impulse approximation for nickel isotopes	INTERNATIONAL JOURNAL OF MODERN PHYSICS E-NUCLEAR PHYSICS			English	Article						Relativistic impulse approximation; relativistic mean field; unstable nuclei	NUCLEUS ELASTIC-SCATTERING; UNSTABLE NUCLEI; CROSS-SECTIONS; FIELD-THEORY; PROTON; NI-58; MODEL	Observables of proton elastic scattering from nickel isotopes (Ni48-82) are calculated based on relativistic impulse approximation (RIA), and nuclear density distributions are provided by relativistic mean-field (RMF) calculations. Contributions of a medium effect and multiple scattering to observables are evaluated and shown to be small at incident proton energies from 200 MeV through 500 MeV so that it is confirmed to perform a model analysis based on the fundamental RIA calculation. For Ni-58,Ni-60,Ni-62,Ni-64 isotopes, are considered proton distributions which are obtained by means of unfolding the charge form factor of proton from charge densities determined by the experiments of electron scattering. Through comparisons between results for the different proton densities, contributions of proton form factor to proton distributions and to elastic scattering observables at 300 MeV are discussed. It is shown that the neutron distribution is determined from the restricted observables, reaction cross-section and the first dip of differential cross-section, based on a model analysis of Woods-Saxon distribution in the case of Ni-64 target at 300 MeV. Contributions of tensor density and empirical proton density are shown to obtaining the neutron distribution with the model analysis. Compared with the similar studies for Ca-40,Ca-60 and Pb-208, problems of the model analysis, which arise out of errors in observables, are discussed.	Shizuoka Univ, Dept Phys, Shizuoka 4228529, Japan	Kaki, K (reprint author), Shizuoka Univ, Dept Phys, Shizuoka 4228529, Japan.	spkkaki@ips.shizuoka.ac.jp					SIMON GG, 1980, NUCL PHYS A, V333, P381, DOI 10.1016/0375-9474(80)90104-9; HOROWITZ CJ, 1981, NUCL PHYS A, V368, P503, DOI 10.1016/0375-9474(81)90770-3; Geng LS, 2005, PROG THEOR PHYS, V113, P785, DOI 10.1143/PTP.113.785; Sick I, 2003, PHYS LETT B, V576, P62, DOI 10.1016/j.physletb.2003.09.092; SUGAHARA Y, 1994, NUCL PHYS A, V579, P557, DOI 10.1016/0375-9474(94)90923-7; Kelkar NG, 2012, NUCL PHYS B, V864, P382, DOI 10.1016/j.nuclphysb.2012.06.015; Arellano HF, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.034602; Auce A, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.064606; COMPARAT V, 1974, NUCL PHYS A, V221, P403, DOI 10.1016/0375-9474(74)90327-3; DEVRIES H, 1987, ATOM DATA NUCL DATA, V36, P495, DOI 10.1016/0092-640X(87)90013-1; FESHBACH H, 1971, ANN PHYS-NEW YORK, V66, P20, DOI 10.1016/0003-4916(71)90183-7; Geng L. S., 2005, THESIS OSAKA U; HOFFMANN GW, 1978, PHYS LETT B, V79, P376, DOI 10.1016/0370-2693(78)90386-6; INGEMARSSON A, 1981, NUCL PHYS A, V365, P426, DOI 10.1016/0375-9474(81)90400-0; KAKI K, 1990, NUCL PHYS A, V516, P603; Kaki K, 2004, INT J MOD PHYS E, V13, P787, DOI 10.1142/S0218301304002466; Kaki K, 1999, INT J MOD PHYS E, V8, P167, DOI 10.1142/S0218301399000136; Kaki K., 2009, PHYS REV C, V79; KERMAN AK, 1959, ANN PHYS-NEW YORK, V8, P551, DOI 10.1016/0003-4916(59)90076-4; Kohama A, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.024602; Li ZP, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.014001; Li ZP, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.014603; LUMPE JD, 1987, PHYS REV C, V35, P1040, DOI 10.1103/PhysRevC.35.1040; Melnikov K, 2000, PHYS REV LETT, V84, P1673, DOI 10.1103/PhysRevLett.84.1673; OSET E, 1984, NUCL PHYS A, V426, P456, DOI 10.1016/0375-9474(84)90158-1; Sakaguchi H, 1998, PHYS REV C, V57, P1749, DOI 10.1103/PhysRevC.57.1749; TJON JA, 1987, PHYS REV C, V35, P280, DOI 10.1103/PhysRevC.35.280; TJON JA, 1987, PHYS REV C, V36, P1085, DOI 10.1103/PhysRevC.36.1085	28	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-3013	1793-6608		INT J MOD PHYS E	Int. J. Mod. Phys. E-Nucl. Phys.	MAR	2015	24	3							1550015	10.1142/S0218301315500159		25	Physics, Nuclear; Physics, Particles & Fields	Physics	CE3MO	WOS:000351730800002		
J	Liu, YY; Iwashita, H; Hu, CH				Liu, Yingyi; Iwashita, Hidetsugu; Hu, Changhong			A calculation method for finite depth free-surface green function	INTERNATIONAL JOURNAL OF NAVAL ARCHITECTURE AND OCEAN ENGINEERING			English	Article						Boundary element method; Free-surface green function; Fast numerical solution	EQUATION; SPHERE	An improved boundary element method is presented for numerical analysis of hydrodynamic behavior of marine structures. A new algorithm for numerical solution of the finite depth free-surface Green function in three dimensions is developed based on multiple series representations. The whole range of the key parameter R/h is divided into four regions, within which different representation is used to achieve fast convergence. The well-known epsilon algorithm is also adopted to accelerate the convergence. The critical convergence criteria for each representation are investigated and provided. The proposed method is validated by several well-documented benchmark problems.	[Liu, Yingyi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 816, Japan; [Iwashita, Hidetsugu] Hiroshima Univ, Fac Engn, Higashihiroshima 724, Japan; [Hu, Changhong] Kyushu Univ, Res Inst Appl Mech, Kasuga, Fukuoka 816, Japan	Hu, CH (reprint author), Kyushu Univ, Res Inst Appl Mech, Kasuga, Fukuoka 816, Japan.	hu@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015		MEXT Scholarship of Japanese Government	The first author gratefully acknowledges the financial support provided by MEXT Scholarship of Japanese Government during the three-year PhD research.	Abramowitz M., 1965, HDB MATH FUNCTIONS; GARRETT CJR, 1971, J FLUID MECH, V46, P129, DOI 10.1017/S0022112071000430; JOHN F, 1949, COMMUN PUR APPL MATH, V2, P13, DOI 10.1002/cpa.3160020102; Linton CM, 1999, P ROY SOC A-MATH PHY, V455, P1767, DOI 10.1098/rspa.1999.0379; JOHN F, 1950, COMMUN PUR APPL MATH, V3, P45, DOI 10.1002/cpa.3160030106; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; HAVELOCK T, 1955, PROC R SOC LON SER-A, V231, P1, DOI 10.1098/rspa.1955.0152; Kashiwagi M., 2003, FLUID DYNAMICS FLO 1; LAU SM, 1989, INT J NUMER METH FL, V9, P763, DOI 10.1002/fld.1650090703; LINTON C. M., 2001, HDB MATH TECHNIQUES; Liu Y.Y., 2012, THESIS DALIAN U TECH; Liu YY, 2012, OCEAN ENG, V51, P129, DOI 10.1016/j.oceaneng.2012.05.004; MEI C. C., 1989, ADV SERIES OCEAN ENG, V1; Newman J.N., 1992, WAVE ASYMPTOTICS, P107; NEWMAN JN, 1986, J ENG MATH, V20, P113, DOI 10.1007/BF00042771; NEWMAN JN, 1985, J ENG MATH, V19, P57, DOI 10.1007/BF00055041; PIDCOCK MK, 1985, INT J NUMER METH FL, V5, P891, DOI 10.1002/fld.1650051004; Thome R.C., 1953, P CAMBRIDGE PHILOS S, V49, P707; Ursell F., 1949, Quarterly Journal of Mechanics and Applied Mathematics, V2, DOI 10.1093/qjmam/2.2.218; Wehausen J. V., 1960, ENCY PHYS, VIX; Wynn P., 1956, MTAC, V10, P91, DOI 10.2307/2002183	21	0	0	SOC NAVAL ARCHITECTS KOREA	SEOUL	SCI & TECHNOL BLDG, RM 508, 635-4, YEOKSAM-DONG, GANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	2092-6782	2092-6790		INT J NAV ARCH OCEAN	Int. J. Nav. Archit. Ocean Eng.	MAR	2015	7	2					375	389		10.1515/ijnaoe-2015-0026		15	Engineering, Marine	Engineering	CE7UX	WOS:000352048400011		
J	Yoshino, K; Nishibori, M; Fujiseki, M; Ito, K; Kuroda, M; Matsukubo, T				Yoshino, Koichi; Nishibori, Masakazu; Fujiseki, Masatsugu; Ito, Koji; Kuroda, Masahiko; Matsukubo, Takashi			Loss of Teeth in Positions Mesially Adjacent to Implant-Supported Fixed Dentures: A Retrospective Clinical Survey	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article							SINGLE-TOOTH IMPLANTS	The aim of this study was to investigate the loss of teeth in positions mesially adjacent to implant-supported fixed dentures (IFDs) after insertion of IFDs in unilateral free-end edentulous spaces in the mandible at dental clinics. There were a total of 157 adjacent teeth. Nine adjacent teeth (5.73%, 9 of 157), 9 opposing teeth (2.59%, 9 of 348), 38 posterior teeth (1.93%, 38 of 1,964), and 3 anterior teeth (0.22%, 3 of 1,380) were lost during the observation period. The percentage of lost adjacent teeth was higher than that of posterior teeth (P = .002). Teeth in positions adjacent to the IFDs require more attention than other remaining teeth.	[Yoshino, Koichi; Matsukubo, Takashi] Tokyo Dent Coll, Dept Epidemiol & Publ Hlth, Tokyo 1010061, Japan; [Yoshino, Koichi] Kyushikai, Kuroda Dent Clin, Tokyo, Japan; [Nishibori, Masakazu; Fujiseki, Masatsugu; Ito, Koji; Kuroda, Masahiko] Kyushikai, Kuroda Dent Clin, Private Practice, Tokyo, Japan	Yoshino, K (reprint author), Tokyo Dent Coll, Dept Epidemiol & Publ Hlth, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	ko-yoshi@d8.dion.ne.jp					Misch CE, 2008, J PERIODONTOL, V79, P2378, DOI 10.1902/jop.2008.080188 ; Krennmair G, 2003, INT J PROSTHODONT, V16, P524; Priest G, 1999, INT J ORAL MAX IMPL, V14, P181; Tamse A, 1999, J ENDODONT, V25, P506, DOI 10.1016/S0099-2399(99)80292-1; Yamazaki S, 2013, INT J PROSTHODONT, V26, P260, DOI 10.11607/ijp.3120	5	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	MAR-APR	2015	28	2					158	160				3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE5QF	WOS:000351890000008		
J	Kurushima, Y; Matsuda, K; Enoki, K; Ikebe, K; Maeda, Y				Kurushima, Yuko; Matsuda, Ken-ichi; Enoki, Kaori; Ikebe, Kazunori; Maeda, Yoshinobu			Does Case Severity Make a Difference to Clinical Improvement Following Complete Denture Treatment?	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article							HEALTH IMPACT PROFILE; QUALITY-OF-LIFE; MASTICATORY PERFORMANCE; RESIDUAL RIDGE; OLDER-ADULTS; WEARERS; SATISFACTION; RELIABILITY; RESORPTION; VERSION	Purpose: The aim of this study was to investigate the effect of case severity on clinical outcomes when fabricating new complete dentures. Materials and Methods: Participants were separated into severe and moderate groups using the index of case difficulty for edentulous patients developed by the Japan Prosthodontic Society. Before and after treatment, self-assessed masticatory ability and oral health-related quality of life (OHRQoL) were examined, and the authors compared them according to case severity using the Mann-Whitney U test. To compare findings before and after treatment, the authors used the Wilcoxon signed rank test. Results: In the severe group, both scores were significantly improved after treatment (P < .01). However, in the moderate group, there was no significant difference in self-assessed masticatory ability as measured by the food acceptance score before and after treatment (P = .11). Before treatment, OHRQoL as measured by the Oral Health Impact Profile score was significantly higher in the severe group than in the moderate group (P < .01). However, after treatment, there was no significant difference between the two groups (P = .92). Conclusions: The authors concluded that case severity makes a difference in the edentulous patient's OHRQoL and self-assessed masticatory ability during complete denture treatment. Evaluating case severity with the index before treatment is a useful tool for patients and clinicians to predict clinical outcomes.	[Kurushima, Yuko; Matsuda, Ken-ichi; Enoki, Kaori; Ikebe, Kazunori; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan	Matsuda, K (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	digiflex@dent.osaka-u.ac.jp					Allen P Finbarr, 2003, Health Qual Life Outcomes, V1, P40, DOI 10.1186/1477-7525-1-40; Viola AP, 2013, J PROSTHODONT RES, V57, P36, DOI 10.1016/j.jpor.2012.08.003; Anastassiadou Vassiliki, 2006, Gerodontology, V23, P23, DOI 10.1111/j.1741-2358.2006.00094.x; Carlsson GE, 2010, J ORAL REHABIL, V37, P143, DOI 10.1111/j.1365-2842.2009.02039.x; Allen F, 2002, INT J PROSTHODONT, V15, P446; Shigli K, 2010, GERODONTOLOGY, V27, P167, DOI 10.1111/j.1741-2358.2009.00323.x; KAPUR K, 1964, J PROSTHET DENT, V14, P483, DOI 10.1016/S0022-3913(64)80016-0; TALLGREN A, 1972, J PROSTHET DENT, V27, P120, DOI 10.1016/0022-3913(72)90188-6; ATWOOD DA, 1962, J PROSTHET DENT, V12, P441, DOI 10.1016/0022-3913(62)90125-7; De Marchi RJ, 2011, J ORAL REHABIL, V38, P533, DOI 10.1111/j.1365-2842.2010.02189.x; Ellis Janice S, 2007, J Prosthodont, V16, P37, DOI 10.1111/j.1532-849X.2006.00152.x; Forgie Andrew H, 2005, Gerodontology, V22, P137, DOI 10.1111/j.1741-2358.2005.00066.x; Ichikawa T, 2006, J JPN ASS DENT SCI, V25, P63; Ikebe K, 2007, INT J PROSTHODONT, V20, P161; Koshino H, 2002, INT J PROSTHODONT, V15, P295; Kuboki T, 2012, J PROSTHODONT RES, V56, P71, DOI 10.1016/j.jpor.2012.02.007; Locker D, 2002, J ORAL REHABIL, V29, P1021, DOI 10.1046/j.1365-2842.2002.00977.x; Locker D, 1988, Community Dent Health, V5, P3; Mazurat Randall D, 2003, J Can Dent Assoc, V69, P511; McGarry T J, 1999, J Prosthodont, V8, P27, DOI 10.1111/j.1532-849X.1999.tb00005.x; ORTMAN HR, 1962, J PROSTHET DENT, V12, P429, DOI 10.1016/0022-3913(62)90124-5; Owen PC, 2004, INT J PROSTHODONT, V17, P261; Sato Y, 2012, GERODONTOLOGY, V29, pE1033, DOI 10.1111/j.1741-2358.2011.00606.x; Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x	24	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	MAR-APR	2015	28	2					161	166				6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE5QF	WOS:000351890000009		
J	Takahashi, T; Mizuno, Y; Gonda, T; Maeda, Y				Takahashi, Toshihito; Mizuno, Yoko; Gonda, Tomoya; Maeda, Yoshinobu			Metal Reinforcement of a Complete Maxillary Denture Without a Palate: A Preliminary Report	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article							STRAIN	This preliminary study examined laboratory-simulated differences between maxillary complete dentures with and without a palate (palateless) as well as the effect of reinforcement of the latter design. Five types of experimental dentures and three types of reinforcements were made. Strain gauges were attached, and a vertical load was applied. The strain was statistically compared using analysis of variance (P = .05). Strain recordings on the palatal side of palateless dentures without reinforcement were significantly higher than in complete dentures and palateless dentures with reinforcement (P < .05). These preliminary observations suggest that such reinforcement with a palatal bar or metal-based palate may reduce the risk of fracture and deformation.	[Takahashi, Toshihito; Mizuno, Yoko; Gonda, Tomoya; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan	Takahashi, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	toshi-t@dent.osaka-u.ac.jp					Mizuno Y, 2013, INT J PROSTHODONT, V26, P419, DOI 10.11607/ijp.3489; Takahashi T, 2011, INT J PROSTHODONT, V24, P273; Takahashi T, 2013, ACTA ODONTOL SCAND, V71, P307, DOI 10.3109/00016357.2012.680903; Wada Junichiro, 2011, J Prosthodont Res, V55, P234, DOI 10.1016/j.jpor.2011.03.003; Watanabe T, 1990, Kokubyo Gakkai Zasshi, V57, P16	5	0	0	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	MAR-APR	2015	28	2					188	190				3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE5QF	WOS:000351890000014		
J	Urano, S; Hotta, Y; Miyazaki, T; Baba, K				Urano, Shinjiro; Hotta, Yasuhiro; Miyazaki, Takashi; Baba, Kazuyoshi			Bending Properties of Ce-TZP/A Nanocomposite Clasps for Removable Partial Dentures	INTERNATIONAL JOURNAL OF PROSTHODONTICS			English	Article							FINITE-ELEMENT-ANALYSIS; CAST CLASPS; RESIN; DIMENSIONS; CURVATURE	Purpose: Ceria-stabilized zirconia/alumina nanocomposite (Ce-TZP/A) has excellent fracture toughness and bending strength that could be useful for partial denture framework application. The aim of this study was to investigate the effects of three-dimensional (3D) geometry on the bending and fatigue properties of a model simulation of Ce-TZP/A clasps. Materials and Methods: Half oval-shaped Ce-TZP/A rods were prepared in six 3D designs. Specimens were either of standard (width divided by thickness: 2.0/1.0 mm) or flat type (2.5/0.8 mm) cross-sectional areas with taper ratios of 1.0, 0.8, or 0.6. As a comparison, cobalt-chromium (Co-Cr) alloy rods of the same shape as the Ce-TZP/A standard shape rod were prepared. All specimens were subjected to the cantilever test and loaded until fracture. They were also cyclically loaded 10(6) times with various constant displacements, and the maximum displacement prior to fracture was determined for each specimen. Three-dimensional finite element analysis (3D FEA), simulating the cantilever test, was performed to determine the stress distribution during loading. Results: Specimens with the standard cross-sectional shape exhibited higher rigidity and higher fracture loads than the flat specimens by the cantilever test. In addition, lower taper ratios were consistently associated with larger displacements at fracture. Fatigue tests revealed that the maximum displacement prior to fracture of Ce-TZP/A specimens was comparable to that of Co-Cr alloy specimens. The 3D FEA showed that specimens with a taper ratio of 0.6 had the least stress concentration. Conclusions: Ce-TZP/A clasp specimens with a standard cross-sectional shape and a 0.6 taper ratio exhibited the best bending properties among those tested.	[Urano, Shinjiro; Baba, Kazuyoshi] Showa Univ, Dept Prosthodont, Sch Dent, Ohta Ku, Tokyo 1458515, Japan; [Hotta, Yasuhiro; Miyazaki, Takashi] Showa Univ, Sch Dent, Dept Conservat Dent,Div Oral Biomat & Technol, Shinagawa Ku, Tokyo 1458515, Japan	Baba, K (reprint author), Showa Univ, Dept Prosthodont, Sch Dent, Oota Ku, Kitasenzoku 2-1-1, Tokyo 1458515, Japan.	kazuyoshi@dent.showa-u.ac.jp					Arda T, 2005, J PROSTHET DENT, V94, P267, DOI 10.1016/j.prosdent.2005.06.009; Ozcan M, 2002, J PROSTHET DENT, V87, P469, DOI 10.1067/mpr.2002.124365; Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5; FITTON JS, 1994, CLIN MATER, V17, P125, DOI 10.1016/0267-6605(94)90135-X; Fueki K, 2014, J PROSTHODONT RES, V58, P3, DOI 10.1016/j.jpor.2013.12.002; Bates JF, 1978, REMOVABLE PARTIAL DE, P29; Bates J F, 1965, Br Dent J, V119, P389; Carr AB, 1981, MCCRACKENS REMOVABLE, P88; Cheng H, 2010, J PROSTHET DENT, V104, P389, DOI 10.1016/S0022-3913(10)60173-4; DEDELGADO MM, 1986, J PROSTHET DENT, V55, P656, DOI 10.1016/0022-3913(86)90050-8; Goiato Marcelo Coelho, 2008, Dent Today, V27, P116; Jelenko JF, 1966, PARTIAL DENTURES SUR, P22; Jiao T, 2009, AUST DENT J, V54, P31, DOI 10.1111/j.1834-7819.2008.01085.x; JOHNSON DL, 1983, J DENT RES, V62, P833, DOI 10.1177/00220345830620071501; Kaplan Paul, 2008, Dent Today, V27, P122; MORRIS HF, 1983, J PROSTHET DENT, V50, P319, DOI 10.1016/S0022-3913(83)80084-5; Ney JM, 1963, PLANNED PARTIALS, P84; Sato Y, 1999, J ORAL REHABIL, V26, P554, DOI 10.1046/j.1365-2842.1999.00422.x; Sato Y, 1997, J PROSTHET DENT, V78, P22, DOI 10.1016/S0022-3913(97)70083-0; Sato Y, 1995, Int J Prosthodont, V8, P392; Snyder H A, 1991, Int J Prosthodont, V4, P364; Turner J W, 1999, J Prosthodont, V8, P188, DOI 10.1111/j.1532-849X.1999.tb00034.x; WARR J A, 1959, J Dent Res, V38, P1066, DOI 10.1177/00220345590380060301; Wiskott H W, 1995, Int J Prosthodont, V8, P105; YUASA Y, 1990, J DENT RES, V69, P1664, DOI 10.1177/00220345900690100701	25	1	1	QUINTESSENCE PUBLISHING CO INC	HANOVER PARK	4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA	0893-2174	1942-4426		INT J PROSTHODONT	Int. J. Prosthodont.	MAR-APR	2015	28	2					191	197				7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE5QF	WOS:000351890000015		
J	Naatanen, R; Shiga, T; Asano, S; Yabe, H				Naatanen, Risto; Shiga, Tetsuya; Asano, Satoko; Yabe, Hirooki			Mismatch negativity (MMN) deficiency: A break-through biomarker in predicting psychosis onset	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Mismatch negativity (MMN); Event related potential (ERP); Schizophrenia; Psychosis; At-risk mental state (ARMS); Ultra-high risk; Prediction	ULTRA-HIGH-RISK; AUDITORY SENSORY MEMORY; EVENT-RELATED POTENTIALS; SCHIZOPHRENIA-PATIENTS; 1ST-EPISODE PSYCHOSIS; COGNITIVE PERFORMANCE; STIMULUS DEVIANCE; PUTATIVE ANTECEDENTS; SELECTIVE-ATTENTION; PROCESSING DEFICITS	Currently, the mismatch negativity (MMN) deficit is one of the most robust and replicable findings in schizophrenia, reflecting cognitive and functional decline, psychosocial and socio-occupational impairment, and executive dysfunction in these patients. An important break-through has very recently taken place here in the prediction of conversion to psychosis when the MMN in particular to change in tone duration was recorded in clinically at risk-mental state (ARMS) individuals. Attenuations in the MMN in these patients may be very useful in helping clinicians determine who are most likely to develop a psychotic disorder, as we will review in the present article. (C) 2015 Elsevier B.V. All rights reserved.	[Naatanen, Risto] Univ Tartu, Dept Psychol, EE-50090 Tartu, Estonia; [Naatanen, Risto] Aarhus Univ, CFIN, Aarhus, Denmark; [Naatanen, Risto] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Shiga, Tetsuya; Asano, Satoko; Yabe, Hirooki] Fukushima Med Univ, Dept Neuropsychiat, Fukushima 9601295, Japan	Shiga, T (reprint author), Fukushima Med Univ, Dept Neuropsychiat, Hikarigaoka 1, Fukushima 9601295, Japan.	tetsuya3@fmu.ac.jp					Pekkonen E, 2002, NEUROREPORT, V13, P177, DOI 10.1097/00001756-200201210-00040; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Atkinson RJ, 2012, BIOL PSYCHIAT, V71, P98, DOI 10.1016/j.biopsych.2011.08.023; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; Simon AE, 2011, SCHIZOPHR RES, V132, P8, DOI 10.1016/j.schres.2011.07.002; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Dulude L, 2010, J CLIN PSYCHOPHARM, V30, P541, DOI 10.1097/JCP.0b013e3181f0c9c6; Alain C, 1998, BIOL PSYCHIAT, V44, P1151, DOI 10.1016/S0006-3223(97)00478-2; Naatanen R, 2014, BRAIN TOPOGR, V27, P451, DOI 10.1007/s10548-014-0374-6; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Ehrlichman RS, 2009, BRAIN RES, V1294, P116, DOI 10.1016/j.brainres.2009.07.065; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; CATTS SV, 1995, AM J PSYCHIAT, V152, P213; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Laurens KR, 2010, BIOL PSYCHIAT, V67, P238, DOI 10.1016/j.biopsych.2009.07.030; Ruhrmann S, 2010, ARCH GEN PSYCHIAT, V67, P241, DOI 10.1001/archgenpsychiatry.2009.206; Inami R, 2005, PHARMACOL BIOCHEM BE, V80, P453, DOI 10.1016/j.pbb.2005.01.001; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Toyomaki A, 2008, PROG NEURO-PSYCHOPH, V32, P95, DOI 10.1016/j.pnpbp.2007.07.020; Banati R, 2009, MED J AUSTRALIA, V190, pS26; Caspi A, 2003, SCHIZOPHR RES, V65, P87, DOI 10.1016/S0920-9964(03)00056-2; Perez VB, 2014, BIOL PSYCHIAT, V75, P459, DOI 10.1016/j.biopsych.2013.07.038; Lawrie SM, 2011, WORLD PSYCHIATRY, V10, P19; Rissling AJ, 2010, CURR TOP BEHAV NEURO, V4, P283, DOI 10.1007/7854_2010_59; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Umbricht D, 2002, BIOL PSYCHIAT, V51, P400, DOI 10.1016/S0006-3223(01)01242-2; Kawakubo Y, 2007, PSYCHIAT RES, V152, P261, DOI 10.1016/j.psychres.2006.02.010; Thonnessen H, 2008, BIOL PSYCHOL, V77, P205, DOI 10.1016/j.biopsycho.2007.10.009; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Baldeweg T, 2006, INT J PSYCHOPHYSIOL, V59, P49, DOI 10.1016/j.ijpsycho.2005.07.014; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Rossler W, 2011, SCHIZOPHR RES, V131, P18, DOI 10.1016/j.schres.2011.06.019; Shaikh M, 2012, SCHIZOPHR RES, V134, P42, DOI 10.1016/j.schres.2011.09.022; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Gil-Da-Costa R, 2013, P NATL ACAD SCI USA, V110, P15425, DOI 10.1073/pnas.1312264110; Higuchi Y, 2010, J CLIN PSYCHOPHARM, V30, P732, DOI 10.1097/JCP.0b013e3181faa57d; Kaur M, 2011, SCHIZOPHR RES, V130, P203, DOI 10.1016/j.schres.2011.03.025; Heekeren K, 2008, PSYCHOPHARMACOLOGY, V199, P77, DOI 10.1007/s00213-008-1129-4; Martin LF, 2009, NICOTINE TOB RES, V11, P698, DOI 10.1093/ntr/ntp052; Laurens KR, 2007, SCHIZOPHR RES, V90, P130, DOI 10.1016/j.schres.2006.11.006; Coyle Joseph T, 2006, Cell Mol Neurobiol, V26, P365, DOI 10.1007/s10571-006-9062-8; Kayser J, 2014, INT J PSYCHOPHYSIOL, V91, P104, DOI 10.1016/j.ijpsycho.2013.12.003; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037//0278-7393.19.4.909; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Javitt DC, 2012, SCHIZOPHRENIA BULL, V38, P958, DOI 10.1093/schbul/sbs069; Egerton A, 2013, BIOL PSYCHIAT, V74, P106, DOI 10.1016/j.biopsych.2012.11.017; Turetsky BI, 2009, PSYCHIAT RES, V165, P27, DOI 10.1016/j.psychres.2008.04.013; Kahkonen S, 2005, PSYCHIAT RES-NEUROIM, V138, P61, DOI 10.1016/j.pscychresns.2004.09.006; Kasai K, 2002, CLIN NEUROPHYSIOL, V113, P141, DOI 10.1016/S1388-2457(01)00710-6; Butler PD, 2012, SCHIZOPHRENIA BULL, V38, P81, DOI 10.1093/schbul/sbr106; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Schmidt A, 2012, NEUROPSYCHOPHARMACOL, V37, P865, DOI 10.1038/npp.2011.261; Luck SJ, 2011, BIOL PSYCHIAT, V70, P28, DOI 10.1016/j.biopsych.2010.09.021; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024; Keshavan MS, 2011, SCHIZOPHR RES, V126, P1, DOI 10.1016/j.schres.2010.10.006; Hsieh MH, 2012, SCHIZOPHR RES, V140, P243, DOI 10.1016/j.schres.2012.06.021; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Shalgi S, 2007, NEUROPSYCHOLOGIA, V45, P1878, DOI 10.1016/j.neuropsychologia.2006.11.023; Pakarinen S, 2007, CLIN NEUROPHYSIOL, V118, P177, DOI 10.1016/j.clinph.2006.09.001; Javitt DC, 1997, J ABNORM PSYCHOL, V106, P315, DOI 10.1037/0021-843X.106.2.315; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; HARI R, 1984, NEUROSCI LETT, V50, P127, DOI 10.1016/0304-3940(84)90474-9; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI [10.1016/j.brainresbull.2010.04.006, 10.1016/j.brainresbull.2010.06.006]; Rissling AJ, 2010, CURR PSYCHIAT REP, V12, P572, DOI 10.1007/s11920-010-0149-z; Leung S, 2007, PSYCHOPHARMACOLOGY, V194, P443, DOI 10.1007/s00213-007-0865-1; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; Michie PT, 2001, INT J PSYCHOPHYSIOL, V42, P177, DOI 10.1016/S0167-8760(01)00166-0; Rasser PE, 2011, SCHIZOPHRENIA BULL, V37, P131, DOI 10.1093/schbul/sbp060; Wienberg M, 2010, J PSYCHOPHARMACOL, V24, P1183, DOI 10.1177/0269881109102606; Stone JM, 2009, BIOL PSYCHIAT, V66, P533, DOI 10.1016/j.biopsych.2009.05.006; Javitt DC, 2000, ARCH GEN PSYCHIAT, V57, P1131, DOI 10.1001/archpsyc.57.12.1131; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Brewer WJ, 2005, AM J PSYCHIAT, V162, P71, DOI 10.1176/appi.ajp.162.1.71; Magno E, 2008, BIOL PSYCHIAT, V64, P385, DOI 10.1016/j.biopsych.2008.03.019; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Dunbar G, 2007, PSYCHOPHARMACOLOGY, V191, P919, DOI 10.1007/s00213-006-0675-x; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Baker K, 2005, ART NEWS, V104, P158; Baldeweg T., 2014, INT J PSYCHOPHYSIOL; Bar-Haim Y, 2003, BIOL PSYCHIAT, V54, P17, DOI 10.1016/S0006-3223(03)00175-6; Belger A, 2012, BIOL PSYCHIAT, V71, P94, DOI 10.1016/j.biopsych.2011.11.009; Bodatsch Mitja, 2013, Front Psychiatry, V4, P170, DOI 10.3389/fpsyt.2013.00170; Bodatsch Mitja, 2013, Front Psychiatry, V4, P93, DOI 10.3389/fpsyt.2013.00093; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; Devrim-Ucok M, 2008, EUR ARCH PSY CLIN N, V258, P179, DOI 10.1007/s00406-007-0772-9; Egerton A, 2012, CURR PHARM BIOTECHNO, V13, P1500; Fisher DJ, 2012, SCHIZOPHR RES, V139, P237, DOI 10.1016/j.schres.2012.06.004; Fisher DJ, 2012, PSYCHIAT RES, V196, P181, DOI 10.1016/j.psychres.2012.01.026; Fisher DJ, 2011, INT J PSYCHOPHYSIOL, V81, P245, DOI 10.1016/j.ijpsycho.2011.06.018; Hayakawa YK, 2013, NEUROPSYCHOBIOLOGY, V68, P197, DOI 10.1159/000355296; Higuchi Y, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00172; Higuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054080; Horton J, 2011, SCHIZOPHR RES, V126, P202, DOI 10.1016/j.schres.2010.11.028; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; JAVITT DC, 1993, BIOL PSYCHIAT, V33, P513, DOI 10.1016/0006-3223(93)90005-X; Kantrowitz Joshua T, 2010, Clin Schizophr Relat Psychoses, V4, P189, DOI 10.3371/CSRP.4.3.6; Kasai K, 1999, SCHIZOPHR RES, V35, P141, DOI 10.1016/S0920-9964(98)00116-9; Kaur M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051871; Kaur M, 2013, PROG NEURO-PSYCHOPH, V46, P161, DOI 10.1016/j.pnpbp.2013.07.002; Kawakubo Y, 2006, NEUROREPORT, V17, P1043, DOI 10.1097/01.wnr.0000221828.10846.ba; Kawakubo Y, 2006, PROG NEURO-PSYCHOPH, V30, P1367, DOI 10.1016/j.pnpbp.2006.03.003; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Knott V, 2014, HUM PSYCHOPHARM CLIN, V29, P446, DOI 10.1002/hup.2418; Kreitschmann-Andermahr I, 1999, SCHIZOPHR RES, V35, P121, DOI 10.1016/S0920-9964(98)00115-7; Lee SH, 2014, PROG NEURO-PSYCHOPH, V48, P213, DOI 10.1016/j.pnpbp.2013.10.010; Light GA, 2013, P NATL ACAD SCI USA, V110, P15175, DOI 10.1073/pnas.1313287110; Light GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039434; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034454; Miyanishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061152; Murphy JR, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-45; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; Nagai Tatsuya, 2013, Front Psychiatry, V4, P115, DOI 10.3389/fpsyt.2013.00115; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Niznikiewicz MA, 2009, SCHIZOPHR RES, V110, P188, DOI 10.1016/j.schres.2008.10.017; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Perez VB, 2014, BIOMARK MED, V8, P9, DOI 10.2217/bmm.13.133; Rund BR, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.036.2009; Salisbury DF, 2002, ARCH GEN PSYCHIAT, V59, P686, DOI 10.1001/archpsyc.59.8.686; SCHREIBER H, 1992, BIOL PSYCHIAT, V32, P634, DOI 10.1016/0006-3223(92)90294-A; Schwartz TL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00195; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Stafford MR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f185; Stone JM, 2010, PSYCHIAT RES-NEUROIM, V183, P174, DOI 10.1016/j.pscychresns.2010.05.004; Sumiyoshi T, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00148; Takahashi H, 2012, NEUROIMAGE C, V66, P594; Todd Juanita, 2013, Front Psychiatry, V4, P171, DOI 10.3389/fpsyt.2013.00171; Todd J, 2014, PSYCHOPHYSIOLOGY, V51, P337, DOI 10.1111/psyp.12181; Yamasue H, 2004, NEUROIMAGE, V22, P720, DOI 10.1016/j.neuroimage.2004.01.042; Zhou Z., 2013, PLOS ONE	139	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	MAR	2015	95	3					338	344		10.1016/j.ijpsycho.2014.12.012		7	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	CE6VX	WOS:000351977400012		
J	Coates, J				Coates, James			Wind Over Water: Migration in an East Asian Context.	INTERNATIONAL MIGRATION REVIEW			English	Book Review									[Coates, James] Waseda Univ, Tokyo, Japan	Coates, J (reprint author), Waseda Univ, Tokyo, Japan.						HAINES D, 2012, WIND WATER MIGRATION	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-9183	1747-7379		INT MIGR REV	Int. Migr. Rev.	SPR	2015	49	1					262	263		10.1111/imre.12180		2	Demography	Demography	CE4BB	WOS:000351774400010		
J	Nakashima, T; Kamiya, Y; Iwatsuki, M; Sato, N; Takahashi, Y; Omura, S				Nakashima, Takuji; Kamiya, Yoshiyuki; Iwatsuki, Masato; Sato, Noriko; Takahashi, Yoko; Omura, Satoshi			Mangromicin C, a new analog of mangromicin	JOURNAL OF ANTIBIOTICS			English	Article							LECHEVALIERIA-AEROCOLONIGENES K10-0216		[Nakashima, Takuji] Kitasato Univ, Res Org Infect Control Sci, Tokyo 1088641, Japan; [Kamiya, Yoshiyuki; Iwatsuki, Masato] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo 1088641, Japan; [Iwatsuki, Masato; Takahashi, Yoko; Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan; [Sato, Noriko] Kitasato Univ, Grad Sch Pharmaceut Sci, Tokyo 1088641, Japan	Nakashima, T (reprint author), Kitasato Univ, Res Org Infect Control Sci, Tokyo 1088641, Japan.	takuji@lisci.kitasato-u.ac.jp; ytakaha@lisci.kitasato-u.ac.jp			Institute for Fermentation (IFO), Osaka, Japan	This study was supported by funds from the Institute for Fermentation (IFO), Osaka, Japan. We thank Kenichiro Nagai, School of Pharmacy, Kitasato University, for measurement of MS spectra, and Takashi Iwashita, Suntory Institute for Bioorganic Research, for advice on NMR spectra.	Nakashima T, 2014, J ANTIBIOT, V67, P533, DOI 10.1038/ja.2014.34; Nakashima T, 2014, J ANTIBIOT, V67, P253, DOI 10.1038/ja.2013.129; Fridovich I., 1986, ARCH BIOCHEM BIOPHYS, V15, P1; MILLER DM, 1990, FREE RADICAL BIO MED, V8, P95, DOI 10.1016/0891-5849(90)90148-C; SLATER TF, 1987, P NUTR SOC, V46, P1, DOI 10.1079/PNS19870003	5	1	1	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	MAR	2015	68	3					220	222		10.1038/ja.2014.134		3	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CE5IJ	WOS:000351864700015		
J	Yarimizu, T; Nakamura, M; Hoshida, H; Akada, R				Yarimizu, Tohru; Nakamura, Mikiko; Hoshida, Hisashi; Akada, Rinji			Screening of accurate clones for gene synthesis in yeast	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Gene synthesis; Kluyveromyces marxianus; Non-homologous end joining-mediated DNA cloning; Luciferase; Glucoamylase; Codon optimization	SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-MARXIANUS; CANDIDA-ALBICANS; ERROR-CORRECTION; DNA-SYNTHESIS; EXPRESSION; CLONING; PCR; GENOME; METAGENOME	Methods for error-less gene synthesis are desired because synthesized genes often contain mutations. By cloning PCR-assembled oligonucleotide fragments fused to a selection marker in yeast, we developed a novel method to screen accurate clones in gene synthesis. As a model case, the 555-bp luciferase gene from Gaussia princeps (GLuc) was synthesized to contain yeast-optimized codons (called yGLuc hereafter). After standard PCR-mediated oligonucleotide assembly, many clones showed no luciferase activity. Of these clones, most contained randomly located nucleotide deletions that produced frameshifts and resulted in premature termination. To exclude clones with premature termination, the synthesized yGLuc gene was cloned in-frame to fuse with the URA3 coding sequence, which served as a selection marker in the yeast Kluyveromyces marxianus. Ura(+) transformation selection was expected to eliminate clones with frameshift errors. The results showed that in-frame marker selection increased the frequency of active yGLuc gene to 79%. We used this strategy to synthesize the 1812-bp gene from Rhizopus oryzae that encodes glucoamylase. Five out of seven Ura(+) clones exhibited amylase activity. Of the functional clones, one contained the correct sequence, and four contained sequences with nucleotide changes, suggesting that in-frame selection frequently produced functional mutants. The K. marxianus non-homologous end joining mediated cloning method for gene synthesis will be useful for synthetic biological studies. (C) 2014, The Society for Biotechnology, japan. All rights reserved.	[Yarimizu, Tohru; Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Ube, Yamaguchi 7558611, Japan; [Nakamura, Mikiko] Yamaguchi Univ, Innovat Ctr, Ube, Yamaguchi 7558611, Japan	Hoshida, H (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Tokiwadai 2-16-1, Ube, Yamaguchi 7558611, Japan.	hoshida@yamaguchi-u.ac.jp			JSPS KAKENHI [24658096]; Adaptable and Seamless Technology Transfer Program through Target-driven RD; Advanced Low Carbon Technology R&D Program (JST, Japan)	We would like to thank Yukie Misumi for technical assistance. This study was supported in part by JSPS KAKENHI (Grant No. 24658096), the Adaptable and Seamless Technology Transfer Program through Target-driven R&D, and the Advanced Low Carbon Technology R&D Program (JST, Japan).	Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Lorenz P, 2002, CURR OPIN BIOTECH, V13, P572, DOI 10.1016/S0958-1669(02)00345-2; Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Dhir A, 2010, FEBS J, V277, P841, DOI 10.1111/j.1742-4658.2009.07520.x; Brachmann CB, 1998, YEAST, V14, P115; Nakamura M, 2014, METHODS MOL BIOL, V1116, P165, DOI 10.1007/978-1-62703-764-8_12; Fuhrmann M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni058; Duarte V, 2000, NUCLEIC ACIDS RES, V28, P1555, DOI 10.1093/nar/28.7.1555; Favaro L, 2012, APPL MICROBIOL BIOT, V95, P957, DOI 10.1007/s00253-012-4001-8; Keppler-Ross S, 2008, GENETICS, V179, P705, DOI 10.1534/genetics.108.087080; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Nonklang S, 2008, APPL ENVIRON MICROB, V74, P7514, DOI 10.1128/AEM.01854-08; Yarimizu T, 2013, YEAST, V30, P485, DOI 10.1002/yea.2985; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; Rajendhran J, 2008, BIOTECHNOL ADV, V26, P576, DOI 10.1016/j.biotechadv.2008.08.002; Apte-Deshpande A, 2009, BIOTECHNOL APPL BIOC, V54, P197, DOI 10.1042/BA20090179; ASHIKARI T, 1986, AGR BIOL CHEM TOKYO, V50, P957; Au LC, 1998, BIOCHEM BIOPH RES CO, V248, P200, DOI 10.1006/bbrc.1998.8929; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Cha-aim K, 2009, GENE, V434, P43, DOI 10.1016/j.gene.2008.12.014; Cha-Aim Kamonchai, 2012, Methods Mol Biol, V852, P97, DOI 10.1007/978-1-61779-564-0_8; Chen ML, 2011, J ZHEJIANG UNIV-SC B, V12, P545, DOI 10.1631/jzus.B1000258; Cheng CY, 2014, J BIOTECHNOL, V174, P1, DOI 10.1016/j.jbiotec.2014.01.007; Cherry J, 2008, J BIOCHEM BIOPH METH, V70, P820, DOI 10.1016/j.jprot.2007.12.009; Cormack BP, 1997, MICROBIOL-UK, V143, P303; Fukunaga T, 2013, YEAST, V30, P243, DOI 10.1002/yea.2957; HATA Y, 1991, AGR BIOL CHEM TOKYO, V55, P941; He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194; Hoshida H, 2013, APPL MICROBIOL BIOT, V97, P5473, DOI 10.1007/s00253-012-4582-2; Hoshida H, 2014, YEAST, V31, P29, DOI 10.1002/yea.2993; IBORRA F, 1994, YEAST, V10, P1621, DOI 10.1002/yea.320101211; JAYARAMAN K, 1992, BIOTECHNIQUES, V12, P392; JAYARAMAN K, 1991, P NATL ACAD SCI USA, V88, P4084, DOI 10.1073/pnas.88.10.4084; Khan M A, 2010, Indian J Physiol Pharmacol, V54, P235; Kim H, 2010, CHEMBIOCHEM, V11, P2448, DOI 10.1002/cbic.201000368; Ko MSH, 2000, DEVELOPMENT, V127, P1737; Kotik M, 2009, J BIOTECHNOL, V144, P75, DOI 10.1016/j.jbiotec.2009.08.013; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Ma SY, 2012, TRENDS BIOTECHNOL, V30, P147, DOI 10.1016/j.tibtech.2011.10.002; Seo JY, 2013, J FISH DIS, V36, P763, DOI 10.1111/jfd.12037	44	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					251	259		10.1016/j.jbiosc.2014.08.006		9	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700001		
J	Shimomura, T; Kawakami, M; Okuda, H; Tatsumi, K; Morita, S; Nochioka, K; Kirita, T; Wanaka, A				Shimomura, Tadahiro; Kawakami, Masayoshi; Okuda, Hiroaki; Tatsumi, Kouko; Morita, Shoko; Nochioka, Katsunori; Kirita, Tadaaki; Wanaka, Akio			Retinoic acid regulates Lhx8 expression via FGF-8b to the upper jaw development of chick embryo	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Chick embryo; LIM homeodomain; Lhx8; Retinoic acid; Fibroblast growth factor; Craniofacial development	FACIAL MORPHOGENESIS; FGF8 EXPRESSION; HOMEOBOX GENES; NASAL PIT; INHIBITION; SUGGESTS; SIGNALS; CLEFTS; GROWTH; MICE	Expression of the LIM homeodomain transcription factor Lhx8 is restricted to and up-regulated in the mesenchyme of the upper face prominence before lip fusion. Msx1/2 acts in early development to control cell proliferation and differentiation. Deficiency of these genes is associated with nonsyndromic cleft lip with/without cleft palate. Since retinoid is a potential patterning influence on the developing face, we have examined whether retinoic acid (RA) signaling regulated Lhx8, Msxl and Msx2 transcription through fibroblast growth factor (FGF) signals in the maxillary prominence. Application of exogenous RA caused severe defects of the maxilla. Citral also induced a specific loss of derivatives from the maxillary prominences by blocking RA synthesis. Real-time RT-PCR and semi-quantitative RT-PCR analysis of the maxillary mesenchyme revealed that the expressions of Lhx8, Msxl and Msx2 were significantly downregulated by RA as well as by citral. The downregulated Lhx8 was rescued by combined treatment with FGF-8b, which indicated a downstream of RA signaling. FGF-8b induced up-regulated Lhx8 expression whereas SU5402, a pan-FGF family antagonist, down-regulated and caused defective maxillary morphogenesis and cleft lip. Our data suggest that Lhx8 is regulated by RA signaling through FGF signals and the level window of RA and FGF-8b could control the upper jaw morphogenesis. (C)) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Shimomura, Tadahiro; Kawakami, Masayoshi; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara 6348522, Japan; [Okuda, Hiroaki; Tatsumi, Kouko; Morita, Shoko; Wanaka, Akio] Nara Med Univ, Dept Anat & Neurosci, Kashihara, Nara 6348522, Japan; [Nochioka, Katsunori] Nara Med Univ, Dept Ophthalmol, Kashihara, Nara 6348522, Japan	Kawakami, M (reprint author), Nara Med Univ, Dept Oral & Maxillofacial Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	bashoudo@naramed-u.ac.jp; mkawaka@naramed-u.ac.jp; okuda@naramed-u.ac.jp; radha815@naramed-u.ac.jp; morita@naramed-u.ac.jp; drive19830224@yahoo.co.jp; tkirita@naramed-u.ac.jp; akiow@naramed-u.ac.jp			Japan Society for the Promotion of Science [19592362, 21592610, 24593106]	We thank Dr. Ryosuke Fujii for real-time RT-PCR and RT-PCR analysis, and Ms. Ian Smith for manuscript editing. This work was supported by Grants-in-Aid for Scientific Research, 19592362, 21592610 and 24593106, from the Japan Society for the Promotion of Science to MK.	Abe M, 2008, DEV GROWTH DIFFER, V50, P717, DOI 10.1111/j.1440-169X.2008.01069.x; Szabo-Rogers HL, 2008, DEV BIOL, V318, P289, DOI 10.1016/j.ydbio.2008.03.027; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Tucker AS, 1999, DEVELOPMENT, V126, P51; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002; Satokata I, 2000, NAT GENET, V24, P391; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Richman JM, 1995, J CRAN GENET DEV BIO, V15, P190; Wilson J, 2004, DEV BIOL, V266, P138, DOI 10.1016/j.ydbio.2003.10.012; Brown JM, 1997, ANAT EMBRYOL, V195, P203, DOI 10.1007/s004290050039; Kawauchi S, 2005, DEVELOPMENT, V132, P5211, DOI 10.1242/dev.02143; Inoue M, 2006, ANAT EMBRYOL, V211, P247, DOI 10.1007/s00429-006-0078-0; Kawakami M, 2006, GENESIS, V44, P105, DOI 10.1002/gene.20191; Kawakami M, 2014, J BIOSCI BIOENG, V117, P664, DOI 10.1016/j.jbiosc.2013.11.015; Kennedy AE, 2012, DEV BIOL, V365, P229, DOI 10.1016/j.ydbio.2012.02.033; RICHMAN JM, 1992, CRIT REV ORAL BIOL M, V4, P93; Song Y, 2004, DEV BIOL, V276, P313, DOI 10.1016/j.ydbio.2004.08.035; Washboume B. J., 2006, BMC DEV BIOL, V24, P6; WEDDEN SE, 1991, J CRAN GENET DEV BIO, V11, P326	21	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					260	266		10.1016/j.jbiosc.2014.08.010		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700002		
J	Sakihama, Y; Hasunuma, T; Kondo, A				Sakihama, Yuri; Hasunuma, Tomohisa; Kondo, Akihiko			Improved ethanol production from xylose in the presence of acetic acid by the overexpression of the HAA1 gene in Saccharomyces cerevisiae	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Acetic acid; Ethanol; HAA1; Saccharomyces cerevisiae; Xylose fermentation	VACUOLAR H+-ATPASE; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATOR; YEAST-STRAIN; FERMENTATION; TOLERANCE; IDENTIFICATION; STRESS; ADAPTATION; GLUCOSE	The hydrolysis of lignocellulosic biomass liberates sugars, primarily glucose and xylose, which are subsequently converted to ethanol by microbial fermentation. The rapid and efficient fermentation of xylose by recombinant Saccharomyces cerevisiae strains is limited by weak acids generated during biomass pretreatment processes. In particular, acetic acid negatively affects cell growth, xylose fermentation rate, and ethanol production. The ability of S. cerevisiae to efficiently utilize xylose in the presence of acetic acid is an essential requirement for the cost-effective production of ethanol from lignocellulosic hydrolysates. Here, an acetic acid-responsive transcriptional activator, HAA1, was overexpressed in a recombinant xylose-fermenting S. cerevisiae strain to yield BY4741X/HAA1. This strain exhibited improved cell growth and ethanol production from xylose under aerobic and oxygen limited conditions, respectively, in the presence of acetic acid. The HAA1p regulon enhanced transcript levels in BY4741X/HAA1. The disruption of PHO13, a p-nitrophenylphosphatase gene, in BY4741X/HAA1 led to further improvement in both yeast growth and the ability to ferment xylose, indicating that HAM overexpression and PHO13 deletion act by different mechanisms to enhance ethanol production. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Sakihama, Yuri; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hasunuma, Tomohisa] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Hasunuma, Tomohisa/A-1949-2015	Hasunuma, Tomohisa/0000-0002-8382-2362	New Energy and Industrial Technology Development Organization (NEDO) under Ministry of Economy, Trade and Industry (METI) of Japan [P07015]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The authors would like to thank Ms. Chikako Aoki and Ms. Yoshimi Hori for technical assistance. This work was supported by project P07015 of the New Energy and Industrial Technology Development Organization (NEDO), under the sponsorship of the Ministry of Economy, Trade and Industry (METI) of Japan. This work was also supported partly by Special Coordination Funds for Promoting Science and Technology, Creation of Innovative Centers for Advanced Interdisciplinary Research Areas (Innovative Bio-production Kobe), Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Van Vleet JH, 2008, METAB ENG, V10, P360, DOI 10.1016/j.ymben.2007.12.002; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Mira NP, 2011, NUCLEIC ACIDS RES, V39, P6896, DOI 10.1093/nar/gkr228; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Tanaka K, 2012, APPL ENVIRON MICROB, V78, P8161, DOI 10.1128/AEM.02356-12; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P303, DOI 10.1007/10_2007_063; Chung JH, 2003, J BIOL CHEM, V278, P28872, DOI 10.1074/jbc.M300943200; Bellissimi E, 2009, FEMS YEAST RES, V9, P358, DOI 10.1111/j.1567-1364.2009.00487.x; Mira NP, 2010, OMICS, V14, P587, DOI 10.1089/omi.2010.0048; Fernandes AR, 2003, BIOCHEM BIOPH RES CO, V312, P1317, DOI 10.1016/j.bbrc.2003.00.072; Hasunuma T, 2012, BIOTECHNOL ADV, V30, P1207, DOI 10.1016/j.biotechadv.2011.10.011; Casey E, 2010, FEMS YEAST RES, V10, P385, DOI 10.1111/j.1567-1364.2010.00623.x; Hahn-Hägerdal B, 2001, Adv Biochem Eng Biotechnol, V73, P53; McCartney R, 2005, CURR GENET, V47, P335, DOI 10.1007/s00294-005-0576-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Carmelo V, 1997, BBA-BIOMEMBRANES, V1325, P63, DOI 10.1016/S0005-2736(96)00245-3; Katahira S, 2006, APPL MICROBIOL BIOT, V72, P1136, DOI 10.1007/s00253-006-0402-x; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Helle SS, 2004, BIORESOURCE TECHNOL, V92, P163, DOI 10.1016/j.biortech.2003.08.011; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Eliasson A, 2000, APPL ENVIRON MICROB, V66, P3381, DOI 10.1128/AEM.66.8.3381-3386.2000; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Sakamoto T, 2012, J BIOTECHNOL, V158, P203, DOI 10.1016/j.jbiotec.2011.06.025; Ishii J, 2014, FEMS YEAST RES, V14, P399, DOI 10.1111/1567-1364.12138; Chu BCH, 2007, BIOTECHNOL ADV, V25, P425, DOI 10.1016/j.biotechadv.2007.04.001; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Fernandes AR, 2005, BIOCHEM BIOPH RES CO, V337, P95, DOI 10.1016/j.bbrc.2005.09.010; ITO H, 1983, J BACTERIOL, V153, P163; DESTRUELLE M, 1994, MOL CELL BIOL, V14, P2740; Fujitomi K., 2012, BIORESOURCE TECHNOL, V111, P161; HAHNHAGERDAL B, 1991, APPL BIOCHEM BIOTECH, V28-9, P131, DOI 10.1007/BF02922595; Haitani Y, 2012, J BIOSCI BIOENG, V114, P648, DOI 10.1016/j.jbiosc.2012.07.002; Keller G, 2001, J BIOL CHEM, V276, P38697, DOI 10.1074/jbc.M107131200; Makrantoni V, 2007, MICROBIOL-SGM, V153, P4016, DOI 10.1099/mic.0.2007/010298-0; Mira NP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-79; Sambrook J., 1989, MOL CLONING LAB MANU; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2	37	2	2	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					297	302		10.1016/j.jbiosc.2014.09.004		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700008		
J	Kawano, Y; Ohtsu, I; Tamakoshi, A; Shiroyama, M; Tsuruoka, A; Saiki, K; Takumi, K; Nonaka, G; Nakanishi, T; Hishiki, T; Suematsu, M; Takagi, H				Kawano, Yusuke; Ohtsu, Iwao; Tamakoshi, Ai; Shiroyama, Maeka; Tsuruoka, Ai; Saiki, Kyohei; Takumi, Kazuhiro; Nonaka, Gen; Nakanishi, Tsuyoshi; Hishiki, Takako; Suematsu, Makoto; Takagi, Hiroshi			Involvement of the yciW gene in L-cysteine and L-methionine metabolism in Escherichia coli	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Escherichia coli; L-Cysteine; Metabolome analysis; Monobromobimane; yciW gene	SULFUR METABOLISM; ENHANCEMENT; BIOLOGY; PATHWAY	We here analyzed a sulfur index of Escherichia coli using LC-MS/MS combined with thiol-specific derivatization by monobromobimane. The obtained sulfur index was then applied to evaluate the L-cysteine producer. E. coli cells overexpressing the yciW gene, a novel Cys regulon, accumulated L-homocysteine, suggesting that YciW is involved in L-methionine biosynthesis. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Kawano, Yusuke; Ohtsu, Iwao; Tamakoshi, Ai; Shiroyama, Maeka; Tsuruoka, Ai; Saiki, Kyohei; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Takumi, Kazuhiro; Nonaka, Gen] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa 2108681, Japan; [Nakanishi, Tsuyoshi] Shimadzu Co, MS Business Unit, Nakagyo Ku, Kyoto 6048511, Japan; [Hishiki, Takako; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjyuku Ku, Tokyo 1608582, Japan	Ohtsu, I (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama Cho, Nara 6300192, Japan.	iohtsu@bs.naist.jp	Suematsu, Makoto/I-8135-2013	Suematsu, Makoto/0000-0002-7165-6336	Biobank Japan Project from MEXT, Japan; Kyowa Hakko Bio Co., Ltd; Ajinomoto Co., Inc; Japan Society for the Promotion of Science [26450091]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	Metabolomic analyses were supported partly by Biobank Japan Project from MEXT, Japan. We thank Ajinomoto, Co., Inc. (Tokyo, Japan) for providing the plasmids. This work was supported in part by a grant from Kyowa Hakko Bio Co., Ltd and Ajinomoto Co., Inc (to I.O. and H.T.). This work was also supported by KAKENHI [Grant-in-Aid for Scientific Research (C) (26450091)] from the Japan Society for the Promotion of Science, and by Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry to I.O.	Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; Kajimura M, 2012, RESP PHYSIOL NEUROBI, V184, P139, DOI 10.1016/j.resp.2012.03.016; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ingenbleek Y, 2013, NUTR REV, V71, P413, DOI 10.1111/nure.12050; Jez JM, 2013, CURR OPIN STRUC BIOL, V23, P302, DOI 10.1016/j.sbi.2013.02.011; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Kawano Y, 2015, J BIOSCI BIOENG, V119, P176, DOI 10.1016/j.jbiosc.2014.07.006; Kredich N. M., 1983, AMINO ACIDS BIOSYNTH, P115; Nakatani T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-62; Nonaka G., 2012, Japanese patent laid-open, Patent No. [2008-99668, 200899668]; Talcumi K., 2014, European patent EP, Patent No. [2218729B1, 2218729]; Yamamoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4480	14	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					310	313		10.1016/j.jbiosc.2014.08.012		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700010		
J	Kojima, R; Arai, T; Kasumi, T; Ogihara, J				Kojima, Ryo; Arai, Teppei; Kasumi, Takafumi; Ogihara, Jun			Construction of transformation system in Penicillium purpurogenum	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Penicillium purpurogenum; Transformation; Green fluorescent protein; Protoplasts; Promoter; Terminator	SP AZ; PP-V; PIGMENTS; PURIFICATION; COLORANTS	Penicillium purpurogenum attracts attention in the food industry and biomass degradation. We expressed green fluorescent protein (GFP) with pBPE, a novel vector, and constructed a transformation system for P. purpurogenum. The accumulation of GFP was confirmed by fluorescence microscopy. In future, this system may prove useful for the genetic modification of P. purpurogenum. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Kojima, Ryo; Arai, Teppei; Kasumi, Takafumi; Ogihara, Jun] Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, Fujisawa, Kanagawa 2520880, Japan	Ogihara, J (reprint author), Nihon Univ, Coll Bioresource Sci, Dept Chem & Life Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	j-ogihara@brs.nihon-u.ac.jp					Akihisa T, 2005, J AGR FOOD CHEM, V53, P562, DOI 10.1021/jf040199p; Zheng YQ, 2010, APPL MICROBIOL BIOT, V88, P1169, DOI 10.1007/s00253-010-2834-6; Ogihara J, 2000, J BIOSCI BIOENG, V90, P549, DOI 10.1263/jbb.90.549; HIDALGO M, 1992, BIOTECHNOL APPL BIOC, V15, P185; Ogihara J, 2001, J BIOSCI BIOENG, V91, P44, DOI 10.1263/jbb.91.44; Wang YZ, 2005, FOOD MICROBIOL, V22, P145, DOI 10.1016/j.fm.2004.01.006; Dufosse L, 2014, CURR OPIN BIOTECH, V26, P56, DOI 10.1016/j.copbio.2013.09.007; Mapari SAS, 2010, TRENDS BIOTECHNOL, V28, P300, DOI 10.1016/j.tibtech.2010.03.004; Ogihara J, 2002, J BIOSCI BIOENG, V93, P54, DOI 10.1263/jbb.93.54; Kim C, 2006, FEMS MICROBIOL LETT, V264, P117, DOI 10.1111/j.1574-6968.2006.00451.x; BELANCIC A, 1995, J BIOTECHNOL, V41, P71, DOI 10.1016/0168-1656(95)00057-W; Buron-Moles G, 2012, INT J FOOD MICROBIOL, V160, P162, DOI 10.1016/j.ijfoodmicro.2012.10.005; Lopes Francis J F, 2004, Genet Mol Res, V3, P449; Schmidt-Heydt M, 2009, INT J FOOD MICROBIOL, V133, P161, DOI 10.1016/j.ijfoodmicro.2009.05.016; STAHL ULF, 1987, APPL MICROBIOL BIOT, V26, P237; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470	16	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					314	316		10.1016/j.jbiosc.2014.08.016		3	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700011		
J	Konishi, M; Yoshida, Y; Horiuchi, J				Konishi, Masaaki; Yoshida, Yuka; Horiuchi, Jun-ichi			Efficient production of sophorolipids by Starmerella bombicola using a corncob hydrolysate medium	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Lignocellulosic biomass; Biosurfactant; Corncob hydrolysate; Surface-active glycolipid; Sophorolipids; Starmerella bombicola	CANDIDA-BOMBICOLA; ATCC 22214; ACID; YEAST; BIOSURFACTANTS; BIOSYNTHESIS; BIOFUELS; GLUCOSE	Sophorolipids (SLs) are amphiphilic compounds produced from a variety of saccharides and vegetable oils by the yeast Starmerella bombicola and related strains, and they have commercial uses as detergents. In the present study, SL production was investigated using a corncob hydrolysate (CCH) medium derived from lignocellulosic feedstocks as a source of hydrophilic carbon substrates. Excess sulfuric acid concentrations during pretreatment of the corncobs increased the furfural concentrations and turned the CCH dark brown. The optimal sulfuric acid concentration was 1% (w/v), and the treated CCH, containing 45 g/I glucose, allowed the production of 33.7 g/I of SLs following 4 days of cultivation. Additional autoclaving (121 degrees C, 20 min) inhibited SL production and cell growth by 36% and 40%, respectively. Ammonium nitrate (0.1 g-N/I) restored SL production to the autoclaved CCH. Finally, a cost-effective SL production of 49.2 g/I, with a volumetric productivity of 12.3 g/I/day, was achieved using CCH medium during batch cultivation in ajar fermentor. (C) 2014, The Society for Biotechnology, japan. All rights reserved.	[Konishi, Masaaki; Yoshida, Yuka; Horiuchi, Jun-ichi] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido 0908507, Japan	Konishi, M (reprint author), Kitami Inst Technol, Dept Biotechnol & Environm Chem, 165 Koen Cho, Kitami, Hokkaido 0908507, Japan.	konishim@mail.kitami-it.ac.jp			JSPS [24681013]	This study was partly supported by JSPS KAKENHI Grant Number 24681013.	Konishi M, 2008, J OLEO SCI, V57, P359, DOI 10.5650/jos.57.359; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Lee DS, 2014, BIORESOURCE TECHNOL, V158, P239, DOI 10.1016/j.biortech.2014.02.039; Ashby RD, 2005, J AM OIL CHEM SOC, V82, P625, DOI 10.1007/s11746-005-1120-3; Chen J, 2006, APPL MICROBIOL BIOT, V72, P52, DOI 10.1007/s00253-005-0243-z; Casas JA, 1999, J BIOSCI BIOENG, V88, P488, DOI 10.1016/S1389-1723(00)87664-1; Cavalero DA, 2003, J BIOTECHNOL, V103, P31, DOI 10.1016/S0168-1656(03)00067-1; [Anonymous], 2002, J BIOSCI BIOENG; Price NPJ, 2012, CARBOHYD RES, V348, P33, DOI 10.1016/j.carres.2011.07.016; Felse PA, 2007, ENZYME MICROB TECH, V40, P316, DOI 10.1016/j.enzmictec.2006.04.013; Rosa CA, 1998, INT J SYST BACTERIOL, V48, P1413; Wadekar SD, 2012, PREP BIOCHEM BIOTECH, V42, P125, DOI 10.1080/10826068.2011.577883; Wang GQ, 2013, BIORESOURCE TECHNOL, V142, P154, DOI 10.1016/j.biortech.2013.05.033; Hirata Y, 2009, J BIOSCI BIOENG, V108, P142, DOI 10.1016/j.jbiosc.2009.03.012; Zhou SQ, 2004, LANGMUIR, V20, P7926, DOI 10.1021/la048590s; Azim A, 2006, BIOCONJUGATE CHEM, V17, P1523, DOI 10.1021/bc060094n; HOMMEL RK, 1994, J BIOTECHNOL, V33, P147, DOI 10.1016/0168-1656(94)90107-4; Chen J., 2006, ENZYME MICROB TECHNO, V39, P501, DOI DOI 10.1016/J.ENZMICTEC.2005.12.022; CUTLER AJ, 1979, J BIOL CHEM, V254, P1944; Daniel HJ, 1999, APPL MICROBIOL BIOT, V51, P40, DOI 10.1007/s002530051360; Despande M, 1995, BIORESOURCE TECHNOL, V54, P143; Ecover Belgium N. V, 2006, EUR J LIPID SCI TECH, V108, P5; ITO S, 1982, APPL ENVIRON MICROB, V43, P1278; Kitamoto D, 2009, CURR OPIN COLLOID IN, V14, P315, DOI 10.1016/j.cocis.2009.05.009; Lang S, 2002, CURR OPIN COLLOID IN, V7, P12, DOI 10.1016/S1359-0294(02)00007-9; Ma XJ, 2014, APPL MICROBIOL BIOT, V98, P475, DOI 10.1007/s00253-013-4856-3; Ogawa S, 2000, BIOSCI BIOTECH BIOCH, V64, P2466, DOI 10.1271/bbb.64.2466; Tada K, 2004, J BIOSCI BIOENG, V98, P228, DOI 10.1016/S1389-1723(04)00273-7; Tada K, 2007, J ECOTECHNOL RES, V13, P29; TULLOCK AP, 1968, CAN J CHEMISTRY, V46, P3337, DOI 10.1139/v68-551	30	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					317	322		10.1016/j.jbiosc.2014.08.007		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700012		
J	Eryuruk, K; Yang, SY; Suzuki, D; Sakaguchi, I; Akatsuka, T; Tsuchiya, T; Katayama, A				Eryueruek, Kagan; Yang, Suyin; Suzuki, Daisuke; Sakaguchi, Iwao; Akatsuka, Tetsuji; Tsuchiya, Takayuki; Katayama, Arata			Reducing hydraulic conductivity of porous media using CaCO3 precipitation induced by Sporosarcina pasteurii	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Microbial clogging; Glass beads; CaCO3; Hydraulic conductivity; Sporosarcina pasteurii; Kozeny-Carman equation	GEOSYNTHETIC CLAY LINERS; CARBONATE PRECIPITATION; CALCIUM-CARBONATE; IN-SITU; PERFORMANCE; UREOLYSIS; SOIL; PERMEABILITY; GROUNDWATER; COMMUNITY	The effect on hydraulic conductivity in porous media of CaCO3 precipitation induced by Sporosarcina pasteurii (ATCC 11859) was investigated using continuous-flow columns containing glass beads between 0.01 mm and 3 mm in diameter. Resting S. pasteurii cells and a precipitation solution composed of 0.5 M CaCl2 and 0.5 M urea were introduced into the columns, and it was shown that the subsequent formation of CaCO3 precipitation reduced hydraulic conductivity from between 8.38 x 10(-1) and 3.27 x 10(-4) cm/s to between 3.70 x 10(-1) and 3.07 x 10(-5) cm/s. The bacterial cells themselves did not decrease the hydraulic conductivity. The amount of precipitation was proportional with the bacterial number in the column. The specific CaCO3 precipitation rate of the resting cells was estimated as 4.0 +/- 0.1 x 10(-3) mu g CaCO3/cell. Larger amounts of CaCO3 precipitation were deposited in columns packed with small glass beads than in those packed with large glass beads, resulting in a greater reduction in the hydraulic conductivity of the columns containing small glass beads. Analysis using the Kozeny-Carman equation suggested that the effect of microbially induced CaCO3 precipitation on hydraulic conductivity was not due to the formation of individual CaCO3 crystals but instead that the precipitate aggregated with the glass beads, thus increasing their diameter and consequently decreasing the pore size in the column. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Eryueruek, Kagan; Tsuchiya, Takayuki; Katayama, Arata] Nagoya Univ, Dept Civil Engn, Grad Sch Engn, Nagoya, Aichi 4648601, Japan; [Yang, Suyin; Suzuki, Daisuke; Sakaguchi, Iwao; Akatsuka, Tetsuji; Katayama, Arata] Nagoya Univ, EcoTopia Sci Inst, Div Environm Res, Nagoya, Aichi 4648603, Japan	Katayama, A (reprint author), Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	a-katayama@esi.nagoya-u.ac.jp			Environmental Technology Development Fund in the Ministry of the Environment [ZB-1205]	This research was partly supported by the Environmental Technology Development Fund in the Ministry of the Environment (ZB-1205).	Mitchell AC, 2006, GEOMICROBIOL J, V23, P213, DOI 10.1080/01490450600724233; Chu J, 2012, GEOMICROBIOL J, V29, P544, DOI 10.1080/01490451.2011.592929; Mitchell AC, 2005, GEOCHIM COSMOCHIM AC, V69, P4199, DOI 10.1016/j.gca.2005.03.014; DeJong JT, 2010, ECOL ENG, V36, P197, DOI 10.1016/j.ecoleng.2008.12.029; Comiti J, 2000, CHEM ENG SCI, V55, P3057, DOI 10.1016/S0009-2509(99)00556-4; Kolstad DC, 2004, J GEOTECH GEOENVIRON, V130, P1236, DOI 10.1061/(ASCE)1090-0241(2004)130:12(1236); Roling WFM, 2001, APPL ENVIRON MICROB, V67, P4619, DOI 10.1128/AEM.67.10.4619-4629.2001; Ivanov Volodymyr, 2008, Reviews in Environmental Science and Bio/Technology, V7, P139, DOI 10.1007/s11157-007-9126-3; GOLLAPUDI UK, 1995, CHEMOSPHERE, V30, P695, DOI 10.1016/0045-6535(94)00435-W; Okwadha GDO, 2010, CHEMOSPHERE, V81, P1143, DOI 10.1016/j.chemosphere.2010.09.066; Nemati M, 2003, ENZYME MICROB TECH, V33, P635, DOI 10.1016/S0141-0229(03)00191-1; Petrov RJ, 1997, CAN GEOTECH J, V34, P863, DOI 10.1139/cgj-34-6-863; Yasuhara H, 2012, SOILS FOUND, V52, P539, DOI 10.1016/j.sandf.2012.05.011; Chou CW, 2011, J GEOTECH GEOENVIRON, V137, P1179, DOI 10.1061/(ASCE)GT.1943-5606.0000532; Benson CH, 2007, J GEOTECH GEOENVIRON, V133, P814, DOI 10.1061/(ASCE)1090-0241(2007)133:7(814); Stocks-Fischer S, 1999, SOIL BIOL BIOCHEM, V31, P1563, DOI 10.1016/S0038-0717(99)00082-6; Gleason MH, 1997, J GEOTECH GEOENVIRON, V123, P438, DOI 10.1061/(ASCE)1090-0241(1997)123:5(438); Egloffstein TA, 2001, GEOTEXT GEOMEMBRANES, V19, P427, DOI 10.1016/S0266-1144(01)00017-6; De Muynck W, 2008, CEMENT CONCRETE RES, V38, P1005, DOI 10.1016/j.cemconres.2008.03.005; Benson CH, 1999, J GEOTECH GEOENVIRON, V125, P390, DOI 10.1061/(ASCE)1090-0241(1999)125:5(390); Cho H., 1995, B FAC AGR SAGA U, V79, P37; Dallavalle J. M., 1948, MICROMERITICS TECHNO, P273; Daniel E. D., 1993, J GEOTECH ENG, V119, P223; Goel A., 2006, STATES OF MATTER, P21; Hasegawa S., 1977, B FAC AGR HOKKAIDO U, V10, P183; Taniguchi M., 1983, J JPN ASS GROUNDW HY, V25, P139; Tobler DJ, 2011, GEOCHIM COSMOCHIM AC, V75, P3290, DOI 10.1016/j.gca.2011.03.023; WALL DK, 1995, J ENVIRON ENG-ASCE, V121, P214, DOI 10.1061/(ASCE)0733-9372(1995)121:3(214); Whiffin V., 2004, THESIS MURDOCH U PER	29	2	2	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					331	336		10.1016/j.jbiosc.2014.08.009		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700014		
J	Hori, T; Haruta, S; Sasaki, D; Hanajima, D; Ueno, Y; Ogata, A; Ishii, M; Igarashi, Y				Hori, Tomoyuki; Haruta, Shin; Sasaki, Daisuke; Hanajima, Dai; Ueno, Yoshiyuki; Ogata, Atsushi; Ishii, Masaharu; Igarashi, Yasuo			Reorganization of the bacterial and archaeal populations associated with organic loading conditions in a thermophilic anaerobic digester	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Methanogenic population; Organic loading condition; Anaerobic digester; Reorganization; 16S rRNA gene-based molecular approach	WASTE-WATER TREATMENT; COMPLETE GENOME SEQUENCE; SP-NOV.; GEN. NOV.; METHANOMASSILIICOCCUS-LUMINYENSIS; COPROTHERMOBACTER-PROTEOLYTICUS; SYMBIOBACTERIUM-THERMOPHILUM; CLOSTRIDIUM ULTUNENSE; METHANOGENIC ARCHAEA; MICROBIAL COMMUNITY	Organic loading conditions are an important factor influencing reactor performances in methanogenic bioreactors. Yet the underlying microbiological basis of the process stability, deterioration, and recovery remains to be understood. Here, structural responses of the bacterial and archaeal populations to the change of organic loading conditions in a thermophilic anaerobic digester were investigated by process analyses and 16S rRNA gene-based molecular approaches. The biogas was produced stably without the accumulation of volatile fatty acids (VFAs) at low organic loading rates (OLRs) in the beginning of reactor operation. Increasing OLR in stages disrupted the stable reactor performance, and high OLR conditions continued the deteriorated performance with slight biogas production and high accumulation of VFAs. Thereafter, the gradual decrease of OLR resulted in the recovery from the deterioration, giving rise to the stable performance again. The stable performances before and after the high OLR conditions conducted were associated with compositionally similar but not identical methanogenic consortia. The bacterial and archaeal populations were synchronously changed at both the transient phases toward the deteriorated performance and in recovery process, during which the dynamic shift of aceticlastic and hydrogenotrophic methanogens including the recently identified Methanomassinicoccus might contribute to the maintenance of the methanogenic activity. The distinctive bacterial population with a high predominance of Methanobacterium formicicum as archaeal member was found for the deteriorated performance. The results in this study indicate the coordinated reorganization of the bacterial and archaeal populations in response to functional states induced by the change of organic loading conditions in the anaerobic digester. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Hori, Tomoyuki; Haruta, Shin; Sasaki, Daisuke; Ishii, Masaharu; Igarashi, Yasuo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Hori, Tomoyuki; Ogata, Atsushi] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki 3058569, Japan; [Haruta, Shin] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Sasaki, Daisuke] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6758501, Japan; [Hanajima, Dai] Natl Agr & Food Res Org, Natl Agr Res Ctr Hokkaido Reg, Daily Res Div, Sapporo, Hokkaido 0628555, Japan; [Ueno, Yoshiyuki] Kajima Tech Res Inst, Chofu, Tokyo 1820036, Japan; [Igarashi, Yasuo] Southwest Univ, Res Ctr Bioenergy & Bioremediat, Chongqing 400715, Peoples R China	Hori, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	hori-tomo@aist.go.jp	SASAKI, Daisuke/F-9597-2015				AHRING BK, 1995, ANTON LEEUW INT J G, V67, P91, DOI 10.1007/BF00872197; Angenent L. T., 2002, P 7 LAT AM WORKSH S, P244; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Lu F, 2014, APPL MICROBIOL BIOT, V98, P969, DOI 10.1007/s00253-013-4977-8; Schnurer A, 1997, FEMS MICROBIOL LETT, V154, P331, DOI 10.1016/S0378-1097(97)00350-9; Akuzawa M, 2011, MICROB ECOL, V61, P595, DOI 10.1007/s00248-010-9788-1; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Hori T, 2011, MICROBIOL-SGM, V157, P1980, DOI 10.1099/mic.0.049189-0; LETTINGA G, 1995, ANTON LEEUW INT J G, V67, P3, DOI 10.1007/BF00872193; Fernandez AS, 2000, APPL ENVIRON MICROB, V66, P4058, DOI 10.1128/AEM.66.9.4058-4067.2000; Gorlas A, 2012, J BACTERIOL, V194, P4745, DOI 10.1128/JB.00956-12; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Steinberg LM, 2011, BIORESOURCE TECHNOL, V102, P8790, DOI 10.1016/j.biortech.2011.07.017; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262; JETTEN MSM, 1992, FEMS MICROBIOL LETT, V88, P181, DOI 10.1111/j.1574-6968.1992.tb04987.x; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; De Vrieze J, 2012, BIORESOURCE TECHNOL, V112, P1, DOI 10.1016/j.biortech.2012.02.079; Sasaki K, 2011, J BIOSCI BIOENG, V112, P469, DOI 10.1016/j.jbiosc.2011.07.003; ZHU H, 1993, NUCLEIC ACIDS RES, V21, P5279, DOI 10.1093/nar/21.22.5279; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; Ueno Y, 2001, APPL MICROBIOL BIOT, V57, P65; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee C, 2009, WATER RES, V43, P157, DOI 10.1016/j.watres.2008.09.032; Hori T, 2006, APPL ENVIRON MICROB, V72, P1623, DOI 10.1128/AEM.72.2.1623-1630.2006; Narihiro T, 2007, CURR OPIN BIOTECH, V18, P273, DOI 10.1016/j.copbio.2007.04.003; Lu F, 2014, ISME J, V8, P88, DOI 10.1038/ismej.2013.120; Elias DA, 1999, APPL ENVIRON MICROB, V65, P5541; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Ueno Y, 2006, J APPL MICROBIOL, V101, P331, DOI 10.1111/j.1365-2672.2006.02939.x; CordRuwisch R, 1997, BIOTECHNOL BIOENG, V56, P626, DOI 10.1002/(SICI)1097-0290(19971220)56:6&lt;626::AID-BIT5&gt;3.0.CO;2-P; Sekiguchi Y, 2006, INT J SYST EVOL MICR, V56, P1621, DOI 10.1099/ijs.0.64112-0; Hashsham SA, 2000, APPL ENVIRON MICROB, V66, P4050, DOI 10.1128/AEM.66.9.4050-4057.2000; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Talbot G, 2008, WATER RES, V42, P513, DOI 10.1016/j.watres.2007.08.003; Ohno M, 2000, INT J SYST EVOL MICR, V50, P1829; Menes RJ, 2002, INT J SYST EVOL MICR, V52, P157; Mechichi T, 1999, INT J SYST BACTERIOL, V49, P1201; Slobodkin AI, 2006, INT J SYST EVOL MICR, V56, P369, DOI 10.1099/ijs.0.63694-0; Schnurer A, 1996, INT J SYST BACTERIOL, V46, P1145; Ben Hania W, 2012, INT J SYST EVOL MICR, V62, P1377, DOI 10.1099/ijs.0.033720-0; Hori T, 2006, J MICROBIOL METH, V66, P165, DOI 10.1016/j.mimet.2005.11.007; Jabari L, 2012, INT J SYST EVOL MICR, V62, P550, DOI 10.1099/ijs.0.030700-0; lino T., 2013, MICROBES ENVIRON, V28, P244; Mavromatis K, 2013, STAND GENOMIC SCI, V8, P47, DOI 10.4056/sigs.3547050; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; Sasaki D, 2011, J BIOSCI BIOENG, V111, P41, DOI 10.1016/j.jbiosc.2010.08.011; Sasaki K, 2006, J BIOSCI BIOENG, V101, P271, DOI 10.1263/jbb.101.271; Schoen MA, 2009, BIORESOURCE TECHNOL, V100, P5648, DOI 10.1016/j.biortech.2009.06.033; Sousa DZ, 2013, APPL ENVIRON MICROB, V79, P4239, DOI 10.1128/AEM.00035-13; Speece R. E., 1996, ANAEROBIC BIOTECHNOL; Tekedar HC, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00755-13, DOI 10.1128/GEN0MEA.00755-13]; Toplak A, 2013, APPL ENVIRON MICROB, V79, P5625, DOI 10.1128/AEM.01479-13	56	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					337	344		10.1016/j.jbiosc.2014.09.003		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700015		
J	Giannelli, L; Yamada, H; Katsuda, T; Yamaji, H				Giannelli, Luca; Yamada, Hiroyuki; Katsuda, Tomohisa; Yamaji, Hideki			Effects of temperature on the astaxanthin productivity and light harvesting characteristics of the green alga Haematococcus pluvialis	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Haematococcus pluvialis; Photobioreactor; Astaxanthin; Photosynthetic efficiency	PHOTOSYSTEM-II; STRESS-RESPONSE; GROWTH; PHOTOSYNTHESIS; CAROTENOIDS; FLUORESCENCE; OXYGEN; PHOTOBIOREACTOR; CHLOROPHYCEAE; PIGMENTATION	The green alga Haematococcus pluvialis, which accumulates astaxanthin at an optimal temperature of 20 degrees C, was cultivated under temperatures of 20 degrees C, 23.5 degrees C, 27 degrees C, and 30.5 degrees C, in order to assess the effects on algal metabolism during the growth phase. The culture growth rate declined with above-optimal increases in temperature, and the final maximum cell concentration at 30.5 degrees C reached only 35% of that attained at 20 degrees C. On the contrary, the biomass productivity was increased under all the high-temperature conditions, probably reflecting the metabolism switch from cell duplication to energy accumulation that is typically observed in algal cultures subjected to environmental stress. Moreover, an increase in the light-harvesting capability of the alga was observed by means of the total pigment balance and the photosynthesis-intensity (PI) curve measured under the different cultivation conditions. Cultures kept at higher temperatures were able to better harvest and utilize the impinging light due to photo-acclimation. Finally, the differences in the astaxanthin metabolism were elucidated by subjecting the cultures to nitrogen starvation at 20 degrees C and 27 degrees C. In the culture at 27 degrees C, a 1.4-fold increase in the astaxanthin productivity was observed when compared to that at 20 degrees C, and the latter required almost two-fold more energy for the astaxanthin production compared with the 27 degrees C culture. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Giannelli, Luca; Yamada, Hiroyuki; Katsuda, Tomohisa; Yamaji, Hideki] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Katsuda, T (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	katsuda@kobe-u.ac.jp					TJAHJONO AE, 1994, BIOTECHNOL LETT, V16, P133, DOI 10.1007/BF01021659; FOSS P, 1984, AQUACULTURE, V41, P213, DOI 10.1016/0044-8486(84)90284-9; Torzillo G, 1998, J PHYCOL, V34, P504, DOI 10.1046/j.1529-8817.1998.340504.x; MIKI W, 1991, PURE APPL CHEM, V63, P141, DOI 10.1351/pac199163010141; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; Boussiba S, 2000, PHYSIOL PLANTARUM, V108, P111, DOI 10.1034/j.1399-3054.2000.108002111.x; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Gratani L, 1998, PHOTOSYNTHETICA, V35, P445, DOI 10.1023/A:1006924621078; Torzillo G, 2003, J APPL PHYCOL, V15, P127, DOI 10.1023/A:1023854904163; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; KOBAYASHI M, 1992, J FERMENT BIOENG, V74, P61, DOI 10.1016/0922-338X(92)90271-U; Evens TJ, 2008, J APPL PHYCOL, V20, P411, DOI 10.1007/s10811-007-9277-1; DALE MP, 1992, FUNCT ECOL, V6, P190, DOI 10.2307/2389754; FAN L, 1994, J PHYCOL, V30, P829, DOI 10.1111/j.0022-3646.1994.00829.x; KOBAYASHI M, 1993, APPL ENVIRON MICROB, V59, P867; Marutani Y, 2012, PLANTA, V236, P753, DOI 10.1007/s00425-012-1647-5; Hata N, 2001, J APPL PHYCOL, V13, P395, DOI 10.1023/A:1011921329568; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; ARMSTRONG FAJ, 1963, ANAL CHEM, V35, P1292, DOI 10.1021/ac60202a036; BALL S, 2002, AUS J CHEM, V15, P55; Bocanegra D. A. R., 2004, BIORESOURCE TECHNOL, V92, P209; BONAVENT.C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Fabregas J, 1998, BIOTECHNOL LETT, V20, P623, DOI 10.1023/A:1005322416796; Falkowski P. G., 2007, AQUATIC PHOTOSYNTHES; GOLDMAN JC, 1974, LIMNOL OCEANOGR, V19, P756; Ichimura T, 1971, P 7 INT SEAW S, P208; Imamoglu E, 2009, NEW BIOTECHNOL, V26, P199, DOI 10.1016/j.nbt.2009.08.007; Katsuda T, 2006, J BIOSCI BIOENG, V102, P442, DOI 10.1263/jbb.102.442; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; KOBAYASHI M, 1991, J FERMENT BIOENG, V71, P335, DOI 10.1016/0922-338X(91)90346-I; Latala A., 1991, OCEANOLOGIA, V31, P119; LICHTENTHALER H. K., 1987, METHOD ENZYMOL, V148, P349, DOI DOI 10.1016/0076-6879(87)48036-1; MIMURO M, 1991, PURE APPL CHEM, V63, P123, DOI 10.1351/pac199163010123; NAKAMURA Y, 1982, PLANT SCI LETT, V27, P1, DOI 10.1016/0304-4211(82)90065-7; Nguyen K. D., 2013, CHEM BIOMOLECULAR EN; Ranjbar R, 2008, J BIOSCI BIOENG, V106, P204, DOI 10.1263/jbb.106.204; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Roldan A. J. M., 2014, J APPL PHYCOL, V26, P115; Solovchenko AE, 2009, J APPL PHYCOL, V21, P361, DOI 10.1007/s10811-008-9377-6; Tolasa S., 2005, European Food Research and Technology, V221, P787, DOI 10.1007/s00217-005-0071-5; Vonshak A., 2004, Handbook of microalgal culture: biotechnology and applied phycology, P57	42	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					345	350		10.1016/j.jbiosc.2014.09.002		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700016		
J	Toki, T; Nakamura, K; Kurauchi, M; Kanno, T; Katsuda, Y; Ikai, H; Hayashi, E; Egusa, H; Sasaki, K; Niwano, Y				Toki, Toshihide; Nakamura, Keisuke; Kurauchi, Michiko; Kanno, Taro; Katsuda, Yusuke; Ikai, Hiroyo; Hayashi, Eisei; Egusa, Hiroshi; Sasaki, Keiichi; Niwano, Yoshimi			Synergistic interaction between wavelength of light and concentration of H2O2 in bactericidal activity of photolysis of H2O2	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Wavelength; Ultraviolet A; Hydrogen peroxide; Hydroxyl radical; Photolysis; Disinfection; Bactericidal activity	SYSTEM UTILIZING PHOTOLYSIS; HYDROGEN-PEROXIDE; DISINFECTION SYSTEM; DENTISTRY; PSORIASIS; SKIN; UV	The present study aimed to evaluate the interaction between wavelength of light in the range of ultra violet A-visible and concentration of H2O2 in the reaction of photolysis of H2O2 from the point of view of hydroxyl radical (OH) generation and the bactericidal activity. Light emitting diodes (LEDs) emitting the light at wavelengths of 365, 385, 400 and 465 nm were used at an irradiance of 1000 mW/cm(2). H2O2 was used at the final concentrations of 0, 250, 500, and 1000 mM. Quantitative analysis of OH generated by the LED irradiation of 11202 were performed using an electron spin resonance-spin trapping technique. In a bactericidal assay, a bacterial suspension of Staphylococcus aureus prepared in sterile physiological saline was irradiated with the LEDs. The bactericidal activity of each test condition was evaluated by viable counts. When H2O2 was irradiated with the LEDs, "OH was generated and bacteria were killed dependently on the concentration of H2O2 and the wavelength of LED. The two-way analysis of variance revealed that the wavelength, the H2O2 concentration and their interaction significantly affected the yield of OH and the bactericidal activity of the photolysis of H2O2. Therefore, it is suggested that bactericidal activity of photolysis of H2O2 could be enhanced by controlling the wavelength and the concentration of H2O2, which may contributes to shortening the treatment time and/or to reducing the concentration of H2O2. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Toki, Toshihide; Nakamura, Keisuke; Kurauchi, Michiko; Kanno, Taro; Katsuda, Yusuke; Ikai, Hiroyo; Hayashi, Eisei; Egusa, Hiroshi; Sasaki, Keiichi; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan	Nakamura, K (reprint author), Tohoku Univ, Grad Sch Dent, Aoba Ku, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	keisuke@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25861820]	The authors would like to thank Dr. Odashima Y, Dr. Oyamada A and Dr. Yamada Y for their assistance in the experiments. This research was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant-in-Aid for Young Scientists (B), 25861820, 2013.	Konopka K, 2007, J DENT RES, V86, P694; Walsh LJ, 2000, AUST DENT J, V45, P257, DOI 10.1111/j.1834-7819.2000.tb00261.x; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657; Ikai H, 2010, ANTIMICROB AGENTS CH, V54, P5086, DOI 10.1128/AAC.00751-10; Hayashi E, 2012, J BIOSCI BIOENG, V114, P193, DOI 10.1016/j.jbiosc.2012.03.020; Nakamura K, 2010, B CHEM SOC JPN, V83, P1037, DOI 10.1246/bcsj.20100078; Black J. G., 2013, MICROBIOLOGY PRINCIP, P298; DIFFEY BL, 1986, BRIT J DERMATOL, V115, P67, DOI 10.1111/j.1365-2133.1986.tb06221.x; DORMAN HL, 1970, ORAL SURG ORAL MED O, V29, P38, DOI 10.1016/0030-4220(70)90409-3; Food and Drug Administration, 2003, FED REGISTER, V68, P32232; Halliwell B., 2007, FREE RADICAL BIO MED, P341; Ikai H, 2013, BIOCONTROL SCI, V18, P137, DOI 10.4265/bio.18.137; International Organization for Standardization, 2007, 21348 ISO; Kanno T, 2012, J CLIN BIOCHEM NUTR, V51, P9, DOI 10.3164/jcbn.11-105; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Maverakis E, 2010, J AUTOIMMUN, V34, pJ247, DOI 10.1016/j.jaut.2009.11.011; Rees T., 1986, J PERIODONTOL, V57, P692; Shirato M, 2012, ANTIMICROB AGENTS CH, V56, P295, DOI 10.1128/AAC.05158-11; Turner RJ, 2000, BRIT J DERMATOL, V143, P957, DOI 10.1046/j.1365-2133.2000.03827.x; Walker SL, 2007, P NATL ACAD SCI USA, V104, P19051, DOI 10.1073/pnas.0703385104; Weatherhead SC, 2013, PHOTOCH PHOTOBIO SCI, V12, P47, DOI 10.1039/c2pp25116g; Yamada Y, 2012, J TOXICOL SCI, V37, P329	23	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					358	362		10.1016/j.jbiosc.2014.08.015		5	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700018		
J	Sugawara, A; Matsui, D; Yamada, M; Asano, Y; Isobe, K				Sugawara, Asami; Matsui, Daisuke; Yamada, Miwa; Asano, Yasuhisa; Isobe, Kimiyasu			New enzymatic methods for selective assay of L-lysine using an L-lysine specific decarboxylase/oxidase from Burkholderia sp AIU 395	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						L-Lysine; Cadaverine; L-Lysine oxidase; L-Lysine decarboxylase; Putrescine oxidase; Burkholderia	PERFORMANCE LIQUID-CHROMATOGRAPHY; EPSILON-OXIDASE; PURIFICATION; ELECTRODE	We developed new enzymatic methods for the selective assay of L-lysine by utilizing an oxidase reaction and a decarboxylation reaction by the L-lysine-specific decarboxylase/oxidase (L-Lys-DC/OD) from Burkholderia sp. AIU 395. The method utilizing the oxidase reaction of this enzyme was useful for determination of high concentrations of L-lysine. The method utilizing the decarboxylase reaction, which proceeded via the combination of the L-Lys-DC/OD and putrescine oxidase (PUO) from Micrococcus rubens, was effective for determination of low concentrations of L-lysine. Both methods showed good linearity, and neither was affected by other amino acids or amines. In addition, the within-assay and between-assay precisions of both methods were within the allowable range. The coupling of L-Lys-DC/OD with PUO was also useful for the differential assay of L-lysine and cadaverine. These newly developed methods were applied to the assay of L-lysine in biological samples and found to be effective. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Sugawara, Asami; Yamada, Miwa; Isobe, Kimiyasu] Iwate Univ, Fac Agr, Dept Biol Chem & Food Sci, Morioka, Iwate 0208550, Japan; [Matsui, Daisuke; Asano, Yasuhisa] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan; [Matsui, Daisuke; Asano, Yasuhisa] Toyama Prefectural Univ, Dept Biotechnol, Toyama 9390398, Japan; [Matsui, Daisuke; Asano, Yasuhisa] JST, ERATO, Asano Act Enzyme Mol Project, Toyama 9390398, Japan	Isobe, K (reprint author), JST, ERATO, Asano Act Enzyme Mol Project, 5180 Kurokawa, Toyama 9390398, Japan.	kiso@iwate-u.ac.jp					ADACHI O, 1966, AGR BIOL CHEM TOKYO, V30, P1202; FABREGAS JL, 1980, J PHARM SCI, V69, P1378, DOI 10.1002/jps.2600691206; Gomez D, 2006, BBA-PROTEINS PROTEOM, V1764, P1577, DOI 10.1016/j.bbapap.2006.08.014; Isobe K, 2012, J BIOSCI BIOENG, V114, P257, DOI 10.1016/j.jbiosc.2012.04.020; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; KUSAKABE H, 1980, J BIOL CHEM, V255, P976; Chauhan N, 2013, ENZYME MICROB TECH, V52, P265, DOI 10.1016/j.enzmictec.2013.01.006; DEIBLER GE, 1973, J BIOL CHEM, V248, P2387; ISOBE K, 1987, CLIN BIOCHEM, V20, P157, DOI 10.1016/S0009-9120(87)80113-3; Matsuda M, 2010, ANAL BIOCHEM, V406, P19, DOI 10.1016/j.ab.2010.06.045; ROMETTE JL, 1983, BIOTECHNOL BIOENG, V25, P2557, DOI 10.1002/bit.260251106; Sugawara A, 2014, J BIOSCI BIOENG, V117, P263, DOI 10.1016/j.jbiosc.2013.08.019; Sugawara A, 2014, J BIOSCI BIOENG, V118, P496, DOI 10.1016/j.jbiosc.2014.04.013	13	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	MAR	2015	119	3					369	374		10.1016/j.jbiosc.2014.08.013		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CE4OA	WOS:000351808700020		
J	Nohara, Y; Hanamura, N; Zaha, H; Kimura, H; Kashikura, Y; Nakamura, T; Noro, A; Imai, N; Shibusawa, M; Ogawa, T				Nohara, Yuki; Hanamura, Noriko; Zaha, Hisamitsu; Kimura, Hiroko; Kashikura, Yumi; Nakamura, Takashi; Noro, Aya; Imai, Nao; Shibusawa, Mai; Ogawa, Tomoko			Cosmetic Evaluation Methods Adapted to Asian Patients after Breast-Conserving Surgery and Examination of the Necessarily Elements for Cosmetic Evaluation	JOURNAL OF BREAST CANCER			English	Article						Asian continental ancestry group; Esthetics; Outcome assessment; Segmental mastectomy	CANCER CONSERVATIVE TREATMENT; AESTHETIC EVALUATION; OBJECTIVE EVALUATION; BCCT.CORE SOFTWARE; MAMMARY-CANCER; THERAPY; COSMESIS; SYSTEM	Purpose: Although various strategies have been reported, there are no defined criteria for cosmetic evaluation methods after breast-conserving surgery (BCS). Since Asians tend to have smaller breasts, indistinct inframammary folds, and conspicuous scars, differences in the cosmetic results are expected. So we examined two subjective methods and one objective method to determine the differences, and elements necessary for a cosmetic evaluation after BCS. Methods: Frontal photographs of 190 Japanese were evaluated using the Harris scale (Harris) and the evaluation method proposed by the Japanese Breast Cancer Society Sawai group (Sawai group) as the subjective methods, and the Breast Cancer Conservation Treatment cosmetic results (BCCT.core) as the objective method, respectively. In order to examine the necessary elements for developing a new ideal method, 100 out of 190 were selected and assessed separately by six raters using both the Harris and modified Sawai group methods in the observer assessment. The correlation between the two methods was examined using the Spearman rank-correlation co-efficient. Results: The results of the BCCT.core and the other two methods were clearly different. In the observer assessment, the consensuses of the six raters were evaluated as follows: 27, 27, 26, and 20 cases were evaluated as "excellent," "good," "fair;" and "poor," respectively. For the Spearman rank-correlation coefficient, values higher than 0.7 indicated a strong correlation, as seen by the values of 0.909 for the breast shape and 0.345 for the scar. The breast shape accounted for the most significant part of the evaluation, and the scar had very little correlation. Conclusion: In this study, we recognized a clear difference between the subjective and objective evaluation methods, and identified the necessary elements for cosmetic evaluation. We would like to continue developing an ideal cosmetic evaluation that is similar to subjective one and is independent from raters.	[Nohara, Yuki; Hanamura, Noriko; Kimura, Hiroko; Kashikura, Yumi; Nakamura, Takashi; Noro, Aya; Imai, Nao; Shibusawa, Mai; Ogawa, Tomoko] Mie Univ Hosp, Dept Breast Surg, Tsu, Mie 5148507, Japan; [Zaha, Hisamitsu] Nakagami Hosp, Dept Surg, Okinawa, Japan	Nohara, Y (reprint author), Mie Univ Hosp, Dept Breast Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	y-nohara@clin.medic.mie-u.ac.jp					AARONSON NK, 1988, EUR J SURG ONCOL, V14, P133; Viera AJ, 2005, FAM MED, V37, P360; VANLIMBERGEN E, 1989, RADIOTHER ONCOL, V16, P253, DOI 10.1016/0167-8140(89)90037-6; HARRIS JR, 1979, INT J RADIAT ONCOL, V5, P257; Cardoso MJ, 2007, BREAST, V16, P456, DOI 10.1016/j.breast.2007.05.002; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; Preuss J, 2012, BREAST, V21, P597, DOI 10.1016/j.breast.2012.05.012; Cardoso MJ, 2012, BREAST CANCER RES TR, V135, P629, DOI 10.1007/s10549-012-1978-8; Cardso JS, 2007, ARTIF INTELL MED, V40, P115, DOI 10.1016/j.artmed.2007.02.007; Cardoso MJ, 2008, BREAST CANCER RES TR, V112, P565, DOI 10.1007/s10549-008-9896-5; Cardoso MJ, 2009, BREAST CANCER RES TR, V116, P149, DOI 10.1007/s10549-008-0173-4; Eder M, 2012, BREAST, V21, P152, DOI 10.1016/j.breast.2011.07.016; Fitzal F, 2009, EJSO-EUR J SURG ONC, V35, P222, DOI 10.1016/j.ejso.2008.01.013; Fitzal F, 2007, BREAST, V16, P429, DOI 10.1016/j.breast.2007.01.013; Hau E, 2012, INT J RADIAT ONCOL, V82, P682, DOI 10.1016/j.ijrobp.2010.11.025; Heil J, 2011, ANN SURG ONCOL, V18, P134, DOI 10.1245/s10434-010-1252-4; Heil J, 2012, BREAST, V21, P61, DOI 10.1016/j.breast.2011.07.013; Oliveira HP, 2013, CURR MED IMAGING REV, V9, P32; Oliveira HP, 2010, IEEE ENG MED BIO, P6158, DOI 10.1109/IEMBS.2010.5627778; PEZNER RD, 1985, INT J RADIAT ONCOL, V11, P575; Sawai K, 2004, 12 ANN M JAP BREAST, P12; TSOUSKAS LI, 1990, BREAST CANCER RES TR, V15, P185, DOI 10.1007/BF01806355; VANLIMBERGEN E, 1989, RADIOTHER ONCOL, V16, P159, DOI 10.1016/0167-8140(89)90016-9	23	0	0	KOREAN BREAST CANCER SOC	SEOUL	163 SINMUNRO 1-GA JONGRO-GU, OFFICIA  BUILDING, SUITE 2024, SEOUL, 110-999, SOUTH KOREA	1738-6756	2092-9900		J BREAST CANCER	J. Breast Canc.	MAR	2015	18	1					80	86		10.4048/jbc.2015.18.1.80		7	Oncology	Oncology	CE9TB	WOS:000352185200012		
J	Takikawa, Y; Kida, S; Asayama, F; Nonomura, T; Matsuda, Y; Kakutani, K; Toyoda, H				Takikawa, Yoshihiro; Kida, Satomi; Asayama, Fuji; Nonomura, Teruo; Matsuda, Yoshinori; Kakutani, Koji; Toyoda, Hideyoshi			Defence responses of Aphanoregma patens (Hedw.) Lindb. to inoculation with Pythium aphanidermatum	JOURNAL OF BRYOLOGY			English	Article						Aphanoregma patens; Bryophyte pathology; Moss; Oomycete; Physcomitrella patens; Pythium aphanidermatum; Zoospore	PHYSCOMITRELLA-PATENS; SCLEROCONIDIOMA-SPHAGNICOLA; FUNGAL ELICITOR; SPHAGNUM-FUSCUM; MOSS PLANTS; PATHOGENS; PEROXIDASE; INFECTION; DISEASE; LEAVES	We examined the defensive responses of leaf surfaces, rhizoids, and protonemata of the moss Aphanoregma patens (Hedw.) Lindb. to inoculation with zoospores and encysted zoospores (cysts) of the oomycete Pythium aphanidermatum OPU849. Aphanoregma patens infected with Pythium exhibited extensive browning of the leaves and stems 4 days after inoculation. The zoospore infection sites were rhizoids and protonemata. Cysts on the rhizoids and protonemata germinated and formed elongated hyphae that invaded the cells of the moss, forming oospores and lobed sporangia. The subsequent production of new zoospores on infected plants indicates that A. patens is a suitable host for manipulating the life cycle of Pythium. However, cysts inoculated onto leaf surfaces did not germinate, and they began to show signs of disruption after only 3 hours. After 2 days, more than 80% of the cysts on leaf surfaces were completely disrupted, possibly due to the secretion of degrading enzymes. Cyst disruption was not observed on rhizoids nor on protonemata.	[Takikawa, Yoshihiro] Kinki Univ, Plant Ctr, Inst Adv Technol, Wakayama, Japan; [Kida, Satomi; Asayama, Fuji; Nonomura, Teruo; Matsuda, Yoshinori; Toyoda, Hideyoshi] Kinki Univ, Fac Agr, Dept Agr Sci & Technol, Lab Plant Protect & Biotechnol, Nara 631, Japan; [Kakutani, Koji] Kinki Univ, Pharmaceut Res & Technol Inst, Osaka 5778502, Japan	Kakutani, K (reprint author), Kinki Univ, Pharmaceut Res & Technol Inst, Osaka 5778502, Japan.	kakutani@msa.kindai.ac.jp					Akita M, 2002, J MOL EVOL, V55, P595, DOI 10.1007/s002369-002-2355-8; Andersson Robert A., 2005, Journal of General Plant Pathology, V71, P23, DOI 10.1007/s10327-004-0154-3; Latijnhouwers M, 2003, TRENDS MICROBIOL, V11, P462, DOI 10.1016/j.tim.2003.08.002; Lehtonen MT, 2012, MOL PLANT MICROBE IN, V25, P363, DOI 10.1094/MPMI-10-11-0265; Akita M, 2011, SCI TOTAL ENVIRON, V409, P3166, DOI 10.1016/j.scitotenv.2011.05.009; ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Tsuneda A, 2000, CAN J BOT, V78, P1294, DOI 10.1139/cjb-78-10-1294; MILLER PM, 1955, PHYTOPATHOLOGY, V45, P461; Oliver JP, 2009, PLANTA, V230, P569, DOI 10.1007/s00425-009-0969-4; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Tojo M, 2012, FUNGAL BIOL-UK, V116, P756, DOI 10.1016/j.funbio.2012.04.005; Dobbeler P, 1997, BIODIVERS CONSERV, V6, P721, DOI 10.1023/A:1018370304090; Lehtonen MT, 2012, ANN APPL BIOL, V160, P298, DOI 10.1111/j.1744-7348.2012.00543.x; Tojo M, 2012, FUNGAL ECOL, V5, P395, DOI 10.1016/j.funeco.2012.01.003; de Leon IP, 2013, INT J MOL SCI, V14, P3178, DOI 10.3390/ijms14023178; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Tsuneda A, 2001, CAN J BOT, V79, P1217, DOI 10.1139/cjb-79-10-1217; Tsuneda A, 2001, CAN J BOT, V79, P93, DOI 10.1139/cjb-79-1-93; Barker EI, 2013, J BRYOL, V35, P185, DOI 10.1179/1743282013Y.0000000058; Cuming A.C., 2011, FIELD BRYOL, V103, P9; Davey ML, 2009, AM J BOT, V96, P1274, DOI 10.3732/ajb.0800239; Davey ML, 2010, BOTANY, V88, P258, DOI 10.1139/B10-004; Dobbeler P, 2003, NOVA HEDWIGIA, V76, P1, DOI 10.1127/0029-5035/2003/0076-0001; Folman LB, 2003, MICROBIAL ECOL, V45, P72, DOI 10.1007/s00248-002-2013-0; Hoshino T., 1999, POLAR BIOSCI, V12, P68; Lee S, 2010, MYCOLOGIA, V102, P774, DOI 10.3852/09-018; Lehtonen MT, 2014, J PROTEOME RES, V13, P447, DOI 10.1021/pr400827a; Lehtonen MT, 2009, NEW PHYTOL, V183, P432, DOI 10.1111/j.1469-8137.2009.02864.x; Martinez-Abaigar J, 2005, J BRYOL, V27, P47, DOI 10.1179/174328205X40572; Matsuda Y, 2005, PHYTOPATHOLOGY, V95, P1137, DOI 10.1094/PHYTO-95-1137; Nonomura T, 2010, FUNGAL BIOL-UK, V114, P917, DOI 10.1016/j.funbio.2010.08.008; Nonomura T, 2009, MYCOL RES, V113, P364, DOI 10.1016/j.mycres.2008.11.012; Oichi Wataru, 2004, Journal of General Plant Pathology, V70, P329, DOI 10.1007/s10327-004-0136-5; de Leon IP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-52; Takikawa Y, 2014, PLANT BIOLOGY, V16, P291, DOI 10.1111/plb.12089; Takikawa Y, 2011, MYCOSCIENCE, V52, P198, DOI 10.1007/s10267-010-0102-3; Takikawa Y, 2011, MYCOSCIENCE, V52, P204, DOI 10.1007/s10267-010-0105-0; Tanigaki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095118; Tsuneda A, 2001, MYCOLOGIA, V93, P1164, DOI 10.2307/3761676; VANDERPLAATSNITERINK AJ, 1981, STUD MYCOL, P1; van West P, 2003, PHYSIOL MOL PLANT P, V62, P99, DOI 10.1016/S0885-5765(03)00044-4	41	2	2	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0373-6687	1743-2820		J BRYOL	J. Bryol.	MAR	2015	37	1					1	7		10.1179/1743282014Y.0000000124		7	Plant Sciences	Plant Sciences	CE3ZG	WOS:000351768300001		
J	Matsuoka, S; Yamashiro, T; Matsushita, S; Fujikawa, A; Kotoku, A; Yagihashi, K; Kurihara, Y; Nakajima, Y				Matsuoka, Shin; Yamashiro, Tsuneo; Matsushita, Shoichiro; Fujikawa, Atsuko; Kotoku, Akiyuki; Yagihashi, Kunihiro; Kurihara, Yasuyuki; Nakajima, Yasuo			Morphological Disease Progression of Combined Pulmonary Fibrosis and Emphysema: Comparison With Emphysema Alone and Pulmonary Fibrosis Alone	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						combined pulmonary fibrosis and emphysema; computed tomography; densitometry; CT quantification; disease progression	PHYSIOLOGICAL TESTS; COMPUTED-TOMOGRAPHY; VISUAL SCORES; HYPERTENSION; TISSUE; LUNG; COLLAGEN; INDEXES	Objectives: The purpose of this study was to evaluate the differences in 5-year morphological changes among the patients with combined pulmonary fibrosis and emphysema (CPFE), emphysema alone, and fibrosis alone using quantitative computed tomography evaluation. Methods: This study involved 42 patients with CPFE, 45 patients with emphysema alone, and 35 patients with fibrosis alone who underwent computed tomography scans twice (initial and 5 years after the initial scan). The extent of emphysematous lesions was obtained by calculating the percentage of low attenuation area (% LAA) lower than -950 Hounsfield units. Fibrotic lesion was defined as a high attenuation area (HAA) using thresholds with pixels between 0 and -700 Hounsfield units, and the extent of fibrosis was obtained by calculating the mean percentage of HAA (% HAA). For the quantitative evaluation of the total area of emphysematous change and fibrosis, the percentage of destructed lung area (% DA) was obtained by summing % LAA and % HAA. The 5-year changes of % LAA, % HAA, and % DA were calculated. Differences were evaluated by 1-way analysis of variance, which was followed by the Tukey-Kramer test. Results: The mean change of % LAA was significantly higher in CPFE (7.4% +/- 3.8%) than in emphysema alone (P < 0.05). The mean change of % DA was significantly higher in CPFE (12.9% +/- 5.8%) than in emphysema alone (4.9% +/- 2.8%) and fibrosis alone (7.1% +/- 5.7%). Conclusions: Morphological disease progression in CPFE differed from that in emphysema alone or fibrosis alone. In particular, the increase in emphysematous low-attenuation lesions was significantly higher in CPFE.	[Matsuoka, Shin; Yamashiro, Tsuneo; Matsushita, Shoichiro; Fujikawa, Atsuko; Kotoku, Akiyuki; Yagihashi, Kunihiro; Nakajima, Yasuo] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa 2168511, Japan; [Yamashiro, Tsuneo] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Okinawa, Japan; [Kurihara, Yasuyuki] St Lukes Int Hosp, Dept Radiol, Tokyo, Japan	Matsuoka, S (reprint author), St Marianna Univ, Sch Med, Dept Radiol, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	shin4114@mac.com					Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Kawabata Y, 2008, HISTOPATHOLOGY, V53, P707, DOI 10.1111/j.1365-2559.2008.03183.x; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Cottin V, 2011, ARTHRITIS RHEUM-US, V63, P295, DOI 10.1002/art.30077; Wright JL, 2011, HISTOPATHOLOGY, V58, P517, DOI 10.1111/j.1365-2559.2010.03648.x; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; LANG MR, 1994, THORAX, V49, P319, DOI 10.1136/thx.49.4.319; Kitaguchi Y, 2013, RESP MED, V107, P1986, DOI 10.1016/j.rmed.2013.06.015; Cottin V, 2010, EUR RESPIR J, V35, P105, DOI 10.1183/09031936.00038709; WIGGINS J, 1990, RESP MED, V84, P365, DOI 10.1016/S0954-6111(08)80070-4; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Shin KE, 2011, J COMPUT ASSIST TOMO, V35, P266, DOI 10.1097/RCT.0b013e31820ccf18; Chemla D, 2002, EUR RESPIR J, V20, P1314, DOI 10.1183/09031936.02.00068002; Akagi T, 2009, RESP MED, V103, P1209, DOI 10.1016/j.rmed.2009.02.001; Kitaguchi Y, 2010, RESPIROLOGY, V15, P265, DOI 10.1111/j.1440-1843.2009.01676.x; CARDOSO WV, 1993, AM REV RESPIR DIS, V147, P975; Grubstein A, 2005, RESP MED, V99, P948, DOI 10.1016/j.rmed.2004.12.010; Inomata M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-104; Jankowich MD, 2008, RESPIRATION, V75, P411, DOI 10.1159/000107048; Mura M, 2006, RESPIR CARE, V51, P257; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rogliani P, 2008, RESP MED, V102, P1753, DOI 10.1016/j.rmed.2008.07.010; Sakai F, 2012, PULM MED, V2012; Usui K, 2011, RESPIROLOGY, V16, P326, DOI 10.1111/j.1440-1843.2010.01907.x	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	MAR-APR	2015	39	2					153	159				7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE2VC	WOS:000351677000003		
J	Matsubayashi, RN; Matsuo, Y; Nakazono, T; Momosaki, S; Muranaka, T				Matsubayashi, Roka Namoto; Matsuo, Yoshitomo; Nakazono, Takahiko; Momosaki, Seiya; Muranaka, Toru			Magnetic Resonance Imaging Manifestations of Ovarian Mullerian Mixed Epithelial Borderline Tumors: Imaging and Histologic Features in Comparison With Mullerian Mucinous Borderline Tumors	JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY			English	Article						Mullerian mixed epithelial borderline tumor; MRI; ovary; borderline tumor; endometriosis	CLINICOPATHOLOGIC ANALYSIS; PAPILLARY CYSTADENOMAS; MALIGNANCY	We illustrate the magnetic resonance imaging features of 3 cases of rare ovarian Mullerian mixed epithelial borderline tumor (MEBT) and identify important diagnostic clues based on their detailed histologic, morphologic, and clinical features. Mullerian mixed epithelial borderline tumor has good prognosis, and adequate management is essential. In order to avoid unnecessary aggressive treatment, radiologists should become familiar with the imaging findings of MEBT. To the best of our knowledge, no articles have described the detailed images of MEBT.	[Matsubayashi, Roka Namoto] Natl Kyushu Med Ctr, Breast Care Ctr, Chuo Ku, Fukuoka, Japan; [Matsubayashi, Roka Namoto; Muranaka, Toru] Natl Kyushu Med Ctr, Dept Radiol, Chuo Ku, Fukuoka, Japan; [Matsuo, Yoshitomo] E Site Healthcare Co, Chiyoda Ku, Tokyo, Japan; [Nakazono, Takahiko] Saga Univ, Fac Med, Dept Radiol, Saga 840, Japan; [Momosaki, Seiya] Natl Kyushu Med Ctr, Dept Pathol, Chuo Ku, Fukuoka, Japan; [Muranaka, Toru] Natl Kyushu Med Ctr, Clin Res Inst, Chuo Ku, Fukuoka, Japan	Matsubayashi, RN (reprint author), Natl Kyushu Med Ctr, Breast Care Ctr, Chuo Ku, Fukuoka, Japan.	rokan@kyumed.jp					Tanaka YO, 2000, AM J ROENTGENOL, V175, P1423; RUTGERS JL, 1988, CANCER, V61, P546, DOI 10.1002/1097-0142(19880201)61:3<546::AID-CNCR2820610321>3.0.CO;2-I; RUTGERS JL, 1988, CANCER, V61, P340, DOI 10.1002/1097-0142(19880115)61:2<340::AID-CNCR2820610225>3.0.CO;2-U; Burger CW, 2000, INT J GYNECOL CANCER, V10, P181, DOI 10.1046/j.1525-1438.2000.010003181.x; Fischerova D, 2012, ONCOLOGIST, V17, P1515, DOI 10.1634/theoncologist.2012-0139; Kataoka M, 2002, J COMPUT ASSIST TOMO, V26, P532, DOI 10.1097/01.RCT.0000029303.97333.67; Tavassoli FA, 2003, PATHOLOGY GENETICS T	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-8715	1532-3145		J COMPUT ASSIST TOMO	J. Comput. Assist. Tomogr.	MAR-APR	2015	39	2					276	280				5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CE2VC	WOS:000351677000024		
J	Johnson, G; Gardner, J; Fukai, T; Goto, K				Johnson, Gina; Gardner, Jerad; Fukai, Takao; Goto, Keisuke			Cutaneous Sparganosis: A Rare Parasitic Infection	JOURNAL OF CUTANEOUS PATHOLOGY			English	Article						sparganosis; Spirometra; parasitic infection; palisading granuloma	UNITED-STATES; THAILAND		[Johnson, Gina] Emory Univ, Dept Pathol, Atlanta, GA USA; [Gardner, Jerad] Univ Arkansas Med Sci, Dept Dermatol, Little Rock, AR 72205 USA; [Gardner, Jerad] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Fukai, Takao] IMS Fujimi Gen Hosp, Dept Plast Surg, Fujimi City, Saitama, Japan; [Goto, Keisuke] Kainan Hosp, Dept Diagnost Pathol, Yatomi City, Aichi, Japan	Johnson, G (reprint author), 1364 Clifton Rd NE,Room N104, Atlanta, GA 30322 USA.						TAYLOR RL, 1976, AM J CLIN PATHOL, V66, P560; Griffin MP, 1996, AM J DERMATOPATH, V18, P70, DOI 10.1097/00000372-199602000-00011; TORRES JR, 1981, T ROY SOC TROP MED H, V75, P846, DOI 10.1016/0035-9203(81)90428-4; Li MW, 2011, INT J INFECT DIS, V15, pE154, DOI 10.1016/j.ijid.2010.10.001; NORMAN SH, 1980, SOUTHERN MED J, V73, P297; Wiwanitkit V, 2005, INT J INFECT DIS, V9, P312, DOI 10.1016/j.ijid.2004.08.003; Chung SW, 2012, BRAZ J INFECT DIS, V16, P200, DOI 10.1590/S1413-86702012000200018; Anantaphruti MT, 2011, ACTA TROP, V118, P171, DOI 10.1016/j.actatropica.2011.03.011; Kimura S, 2003, BRIT J DERMATOL, V148, P369, DOI 10.1046/j.1365-2133.2003.05097_6.x; Koo M, 2011, WORLD J SURG, V35, P573, DOI 10.1007/s00268-010-0942-1; CHO C, 1978, NEW YORK STATE J MED, V78, P1456; Dunn IJ, 1998, SEMIN ROENTGENOL, V33, P86, DOI 10.1016/S0037-198X(98)80034-5; Kim DG, 1996, J NEUROSURG, V85, P1066, DOI 10.3171/jns.1996.85.6.1066; Kim SH, 2001, INT J DERMATOL, V40, P656, DOI 10.1046/j.1365-4362.2001.01287-5.x; OH SJ, 1993, J UROLOGY, V149, P581; SARMA DP, 1986, J AM ACAD DERMATOL, V15, P1145, DOI 10.1016/S0190-9622(86)70284-3; STRAUSS W G, 1964, Dermatol Trop Ecol Geogr, V28, P73; SWARTZWELDER JC, 1964, AM J TROP MED HYG, V13, P43; Tappe D, 2013, AM J TROP MED HYG, V88, P198, DOI 10.4269/ajtmh.2012.12-0406; Yoon KC, 2004, AM J OPHTHALMOL, V138, P873, DOI 10.1016/j.ajo.2004.05.055	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6987	1600-0560		J CUTAN PATHOL	J. Cutan. Pathol.	MAR	2015	42	3					159	163		10.1111/cup.12480		5	Dermatology; Pathology	Dermatology; Pathology	CE3RH	WOS:000351745500001		
J	Kondo, M; Morimoto, M; Ishii, T; Nozaki, A; Fukuda, H; Numata, K; Kobayashi, S; Ohkawa, S; Hidaka, H; Nakazawa, T; Shibuya, A; Okuse, C; Suzuki, M; Sakamaki, K; Morita, S; Maeda, S; Tanaka, K				Kondo, Masaaki; Morimoto, Manabu; Ishii, Tomohiro; Nozaki, Akito; Fukuda, Hiroyuki; Numata, Kazushi; Kobayashi, Satoshi; Ohkawa, Shinichi; Hidaka, Hisashi; Nakazawa, Takahide; Shibuya, Akitaka; Okuse, Chiaki; Suzuki, Michihiro; Sakamaki, Kentaro; Morita, Satoshi; Maeda, Shin; Tanaka, Katsuaki			Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting	JOURNAL OF DIGESTIVE DISEASES			English	Article						cisplatin; hepatocellular carcinoma; propensity score; sorafenib	RAF/MEK/ERK PATHWAY; PHASE-II; SURVIVAL; EFFICACY; THERAPY; ANGIOGENESIS; PROGRESSION; GUIDELINES	ObjectiveWe aimed to evaluate the efficacy and tolerability of hepatic arterial infusion chemotherapy (HAIC) using cisplatin as an alternative to sorafenib for the treatment of hepatocellular carcinoma (HCC) patients who had not responded to transarterial chemoembolization (TACE). MethodsMedical records of 127 consecutive HCC patients without extrahepatic metastasis (cisplatin, n=44; sorafenib, n=83) who had not responded to prior TACE at four institutions were retrospectively reviewed. An inverse probability of treatment weighting using propensity scoring was used to adjust for the selection bias. ResultsSevere adverse events accounting for treatment discontinuation occurred in 2.3% of the patients in the cisplatin group and 32.5% of those in the sorafenib group. The median overall survival (OS) period was 11.2 months (95% CI 4.8-17.7) in the cisplatin group and 10.2 months (95% CI 8.8-11.5) in the sorafenib group, respectively. After an inverse probability of treatment weighting adjustment, the survival outcome of the HAIC treatment group was not inferior to that of the sorafenib treatment group (hazard ratio 0.758; 95% CI 0.471-1.219, P=0.253). ConclusionHAIC with cisplatin can be an alternative treatment for the selection of HCC patients who have not responded to prior TACE and cannot tolerate sorafenib.	[Kondo, Masaaki; Morimoto, Manabu; Ishii, Tomohiro; Nozaki, Akito; Fukuda, Hiroyuki; Numata, Kazushi; Tanaka, Katsuaki] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Yokohama, Kanagawa 2320024, Japan; [Sakamaki, Kentaro; Morita, Satoshi; Tanaka, Katsuaki] Yokohama City Univ, Clin Res Coordinating Ctr, Med Ctr, Yokohama, Kanagawa 2320024, Japan; [Morimoto, Manabu; Kobayashi, Satoshi; Ohkawa, Shinichi] Kanagawa Canc Ctr Hosp, Hepatobiliary & Pancreat Med Oncol, Yokohama, Kanagawa, Japan; [Sakamaki, Kentaro; Morita, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 2320024, Japan; [Maeda, Shin] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 2320024, Japan; [Hidaka, Hisashi; Nakazawa, Takahide; Shibuya, Akitaka] Kitasato Univ, East Hosp, Gastroenterol Div Internal Med, Sagamihara, Kanagawa 228, Japan; [Okuse, Chiaki; Suzuki, Michihiro] St Marianna Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Kawasaki, Kanagawa, Japan	Kondo, M (reprint author), Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	mkondou@yokohama-cu.ac.jp					Ikeda M, 2014, J GASTROENTEROL, V49, P932, DOI 10.1007/s00535-013-0853-7; Ando E, 2002, CANCER, V95, P588, DOI 10.1002/cncr.10694; Jeong SW, 2012, ASIA-PAC J CLIN ONCO, V8, P164, DOI 10.1111/j.1743-7563.2012.01543.x; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Morimoto M, 2011, HEPATOL RES, V41, P296, DOI 10.1111/j.1872-034X.2011.00778.x; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Grieco A, 2005, GUT, V54, P411, DOI 10.1136/gut.2004.048124; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Yoshikawa M, 2008, HEPATOL RES, V38, P474, DOI 10.1111/j.1872-034X.2008.00338.x; Ogasawara S, 2011, HEPATOL INT, V5, P850, DOI 10.1007/s12072-010-9249-4; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Kim HY, 2011, J GASTROEN HEPATOL, V26, P1612, DOI 10.1111/j.1440-1746.2011.06751.x; Monden M, 2012, HEPATOL RES, V42, P150, DOI 10.1111/j.1872-034X.2011.00905.x; Uka K, 2007, J GASTROENTEROL, V42, P845, DOI 10.1007/s00535-007-2099-8; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Kaneko S, 2012, HEPATOL RES, V42, P523, DOI 10.1111/j.1872-034X.2012.00981.x; Hiramine Y, 2011, EXP THER MED, V2, P433, DOI 10.3892/etm.2011.237; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Shariff Mohamed I F, 2009, Expert Rev Gastroenterol Hepatol, V3, P353, DOI 10.1586/egh.09.35	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-2972	1751-2980		J DIGEST DIS	J. Dig. Dis.	MAR	2015	16	3					143	151		10.1111/1751-2980.12221		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE4ZV	WOS:000351840300005		
J	Fujisaki, K; Morita, Y; Kajitani, T; Yokota, S; Okuyama, T; Muroi, T; Hori, M				Fujisaki, Koichi; Morita, Yasutomo; Kajitani, Toshio; Yokota, Shigeru; Okuyama, Tadahiro; Muroi, Toshiaki; Hori, Muneo			Survey on Railway Operator Actions and Preparedness in Transportation Against 2010 Chile Earthquake Tsunami and 2011 Tohoku Earthquake Tsunami (vol 8, 1450006, 2014)	JOURNAL OF EARTHQUAKE AND TSUNAMI			English	Correction									[Fujisaki, Koichi; Morita, Yasutomo; Kajitani, Toshio; Yokota, Shigeru; Okuyama, Tadahiro; Muroi, Toshiaki] Inst Transport Policy Studies, Minato Ku, Tokyo 1050001, Japan; [Hori, Muneo] Univ Tokyo, Res Ctr Large Scale Earthquake, Tsunami & Disaster Earthquake Res Inst, Bunkyo Ku, Tokyo 1138654, Japan	Fujisaki, K (reprint author), Inst Transport Policy Studies, Minato Ku, 3-18-19 Toranomon, Tokyo 1050001, Japan.	fujisakiyk@gmail.com; yas.morita@jrtt.go.jp; toshio.kajitani@tkk.tokyu.co.jp; yokota-shigeru83@hankyu-group.jp; okuyama@sun.ac.jp; muroi@jterc.or.jp; hori@eri.u-tokyo.ac.jp					FUJISAKI K, 2014, INT J EARTHQUAKE TSU, V8	1	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-4311	1793-7116		J EARTHQ TSUNAMI	J. Earthq. Tsunami	MAR	2015	9	1							1592001	10.1142/S1793431115920013		1	Geochemistry & Geophysics	Geochemistry & Geophysics	CE8HD	WOS:000352081600004		
J	Sun, FT; Tanaka, S; Hori, M				Sun, Fangtao; Tanaka, Seizo; Hori, Muneo			Large-Scale Numerical Simulation of an RC Tunnel Junction Member Using Particle Discretization Scheme FEM	JOURNAL OF EARTHQUAKE AND TSUNAMI			English	Article						Multiple cracking; PDS; nonlinear solid FE analysis; variability of cracking pattern	FINITE-ELEMENT-METHOD; CRACK-GROWTH	This paper presents a large-scale numerical simulation of a reinforced concrete (RC) tunnel junction member using solid FEM. Particle discretization scheme (PDS), which uses two sets of non-overlapping characteristic functions to discretize displacement field and strain/stress field respectively, is employed to represent the multiple-cracking configurations of concrete. An efficient parallel FE program, called ADVENTURE, is used to implement PDS as well as a reformulated nonlinear concrete constitutive relation. A simplified tunnel junction member, in order to reveal its multiple-cracking behavior under the static load, is studied and the stochastic behavior of cracking is investigated; good agreements are achieved between the simulation results and experimental observations regarding the multiple cracking configurations.	[Sun, Fangtao] Leslie E Robertson Associates, Shanghai 200040, Peoples R China; [Tanaka, Seizo; Hori, Muneo] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Sun, FT (reprint author), Leslie E Robertson Associates, 1701 Beijing West Rd,Jingan China Tower, Shanghai 200040, Peoples R China.	sunft1986@gmail.com					RASHID YR, 1968, NUCL ENG DES, V7, P334, DOI 10.1016/0029-5493(68)90066-6; Sukumar N, 2000, INT J NUMER METH ENG, V48, P1549, DOI 10.1002/1097-0207(20000820)48:11<1549::AID-NME955>3.0.CO;2-A; Moes N, 1999, INT J NUMER METH ENG, V46, P131, DOI 10.1002/(SICI)1097-0207(19990910)46:1<131::AID-NME726>3.0.CO;2-J; Daux C, 2000, INT J NUMER METH ENG, V48, P1741, DOI 10.1002/1097-0207(20000830)48:12<1741::AID-NME956>3.0.CO;2-L; Hori M, 2005, J MECH PHYS SOLIDS, V53, P681, DOI 10.1016/j.jmps.2004.08.005; XU XP, 1994, J MECH PHYS SOLIDS, V42, P1397, DOI 10.1016/0022-5096(94)90003-5; Dobashi H., 2009, J STRUCT MECH EARTHQ, V65, P718; Loehnert S, 2011, INT J NUMER METH ENG, V86, P431, DOI 10.1002/nme.3045; Maekawa K, 2003, NONLINEAR MECH REINF; Nakajima Y, 1997, P 30 AUT M SOC CHEM, P229; Oguni K, 2009, MECH MATER, V41, P1242, DOI 10.1016/j.mechmat.2009.07.003; Potyondy DO, 1996, ROCK MECHANICS TOOLS AND TECHNIQUES, VOLS 1 AND 2, P1937; Scordelis AC, 1967, J AM CONCRETE I, V64, P152; Swenson DV, 1988, COMPUT MECH, V3, P381, DOI 10.1007/BF00301139; Wijerathne MLL, 2009, INT J NUMER METH ENG, V80, P46, DOI 10.1002/nme.2620; Yamashita T., 2011, J JAPAN SOC CIVIL EN, V67, P145	16	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-4311	1793-7116		J EARTHQ TSUNAMI	J. Earthq. Tsunami	MAR	2015	9	1							1550001	10.1142/S1793431115500013		21	Geochemistry & Geophysics	Geochemistry & Geophysics	CE8HD	WOS:000352081600001		
J	Kuwabara, T; Nishizawa, B; Nakamura, K; Ikeda, Y; Yamaguchi, T; Takahashi, K				Kuwabara, Takayuki; Nishizawa, Bungo; Nakamura, Kenta; Ikeda, Yasuo; Yamaguchi, Takahiro; Takahashi, Kohshin			Electrocatalytic activity of electrodeposited cobalt oxide films to produce oxygen gas from water	JOURNAL OF ELECTROANALYTICAL CHEMISTRY			English	Article						Water oxidation; Cobalt oxide; Electrochemical deposition; Electrochemical catalysis; pH dependency; Electrolyte dependency	EVOLUTION REACTION; EVOLVING CATALYST; ALKALINE-SOLUTIONS; ANODIC EVOLUTION; OXIDATION; CO3O4; PHOSPHATE; NI; PH; CU	An electrocatalytic cobalt oxide film for water oxidation was prepared on an indium tin oxide (ITO)coated substrate by anodic electrodeposition. Atomic force microscopy measurements revealed that numerous particles with a diameter of 100-250 nm were uniformly dispersed on the ITO substrate and the particle size increased when prepared at higher temperature. Cyclic voltammograms of the Co oxide-coated ITO electrodes were measured in alkaline and neutral aqueous solutions to examine their redox characteristics and ability to catalyze water oxidation. When Co oxide was electrodeposited from solutions kept at 10, 25 and 50 degrees C, the amount of electroactive Co oxide per unit area (Gamma(ea)) was 1.06 x 10(-8), 1.72 x 10(-8), and 2.31 x 10(-8) mol cm(-2), respectively. The increase in Gamma(ea) accompanied the increase in particle size observed with rising deposition temperature. Quantitative analyses of O-2 gas produced by water electrolysis were carried out under potentiostatic conditions using these Co oxide-modified electrodes and a bare ITO electrode for comparison. For the Co oxide-coated electrode prepared at 10 degrees C, the amount of O-2 evolved by electrolysis for 2 h at 1.3 V vs. Ag/AgCl was 1.3 x 10(-5) mol cm(-2) in alkaline electrolyte solution and 1.52 x 10(-5) mol cm(-2) in neutral electrolyte solution containing phosphate ions. In addition, when the Co oxide-coated electrode treated at 450 degrees C was used, the amount of 02 evolved by the electrolysis increased to 2.58 x 10(-5) mol cm(-2) in the neutral electrolyte solution containing phosphate ions, resulting from a stable catalytic current. (C) 2014 Elsevier B.V. All rights reserved.	[Kuwabara, Takayuki; Nishizawa, Bungo; Nakamura, Kenta; Ikeda, Yasuo; Yamaguchi, Takahiro; Takahashi, Kohshin] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Kuwabara, Takayuki; Takahashi, Kohshin] Kanazawa Univ, Res Ctr Sustainable Energy & Technol, Kanazawa, Ishikawa 9201192, Japan	Kuwabara, T (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tkuwabar@se.kanazawa-u.ac.jp	TAKAHASHI, Kohshin/L-3519-2015; Kuwabara, Takayuki/C-3424-2015; Yamaguchi, Takahiro/C-9709-2015	TAKAHASHI, Kohshin/0000-0001-8659-4054; 	Kanazawa University	This work was supported by a Grant for Scientific Research from Kanazawa University. We thank Mr. Sawai, and Prof. Hasegawa (Kanazawa University) for carrying out elemental analysis by ICP-AES.	Rossmeisl J, 2007, J ELECTROANAL CHEM, V607, P83, DOI 10.1016/j.jelechem.2006.11.008; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Yeo BS, 2011, J AM CHEM SOC, V133, P5587, DOI 10.1021/ja200559j; Trasatti S, 2000, ELECTROCHIM ACTA, V45, P2377, DOI 10.1016/S0013-4686(00)00338-8; Surendranath Y, 2012, J AM CHEM SOC, V134, P6326, DOI 10.1021/ja3000084; Yagi M, 2005, J ELECTROANAL CHEM, V579, P83, DOI 10.1016/j.jelechem.2005.01.030; Nikolov I, 1997, J ELECTROANAL CHEM, V429, P157, DOI 10.1016/S0022-0728(96)05013-9; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Liu DN, 2013, ACS APPL MATER INTER, V5, P4046, DOI 10.1021/am400351m; Singh RN, 2000, ELECTROCHIM ACTA, V45, P1911, DOI 10.1016/S0013-4686(99)00413-2; Wee TL, 2011, J AM CHEM SOC, V133, P16742, DOI 10.1021/ja206280g; Yagi M, 2005, J PHYS CHEM B, V109, P21489, DOI 10.1021/jp0550208; Surendranath Y, 2010, J AM CHEM SOC, V132, P16501, DOI 10.1021/ja106102b; Bocca C, 1999, INT J HYDROGEN ENERG, V24, P699, DOI 10.1016/S0360-3199(98)00120-7; TRASATTI S, 1980, J ELECTROANAL CHEM, V111, P125, DOI 10.1016/S0022-0728(80)80084-2; Lutterman DA, 2009, J AM CHEM SOC, V131, P3838, DOI 10.1021/ja900023k; BRONOEL G, 1980, ELECTROCHIM ACTA, V25, P1015, DOI 10.1016/0013-4686(80)87007-1; IWAKURA C, 1981, ELECTROCHIM ACTA, V26, P1319, DOI 10.1016/0013-4686(81)85116-X; Singh SP, 1996, INT J HYDROGEN ENERG, V21, P171, DOI 10.1016/0360-3199(95)00062-3; Gerken JB, 2011, J AM CHEM SOC, V133, P14431, DOI 10.1021/ja205647m; TRASATTI S, 1984, ELECTROCHIM ACTA, V29, P1503, DOI 10.1016/0013-4686(84)85004-5; Casella IG, 2002, J ELECTROANAL CHEM, V534, P31, DOI 10.1016/S0022-0728(02)01100-2; BEHL WK, 1971, J ELECTROANAL CHEM, V31, P63, DOI 10.1016/0368-1874(71)80008-4; Kajita M, 2010, GREEN CHEM, V12, P2150, DOI 10.1039/c0gc00476f; Kuwabara T, 2008, J PHYS CHEM C, V112, P3774, DOI 10.1021/jp7098416; Musiani M, 1998, ELECTROCHIM ACTA, V44, P1499, DOI 10.1016/S0013-4686(98)00273-4; OLEKSY M, 1994, ELECTROCHIM ACTA, V39, P2439, DOI 10.1016/0013-4686(94)00201-0	27	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1572-6657	1873-2569		J ELECTROANAL CHEM	J. Electroanal. Chem.	MAR 1	2015	740						14	20		10.1016/j.jelechem.2014.11.019		7	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	CE7UN	WOS:000352047400003		
J	Nomura, T; Itouga, M; Kojima, M; Kato, Y; Sakakibara, H; Hasezawa, S				Nomura, Toshihisa; Itouga, Misao; Kojima, Mikiko; Kato, Yukari; Sakakibara, Hitoshi; Hasezawa, Seiichiro			Copper mediates auxin signalling to control cell differentiation in the copper moss Scopelophila cataractae	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Auxin; bryophytes; cell differentiation; copper; copper mosses; heavy metal; metallophyte	HEAVY-METAL DETOXIFICATION; PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; PLANTS; BIOSYNTHESIS; TRANSITION; GROWTH; TRANSPORTERS; HOMEOSTASIS; ELONGATION	The copper (Cu) moss Scopelophila cataractae (Mitt.) Broth. is often found in Cu-enriched environments, but it cannot flourish under normal conditions in nature. Excess Cu is toxic to almost all plants, and therefore how this moss species thrives in regions with high Cu concentration remains unknown. In this study, we investigated the effect of Cu on gemma germination and protonemal development in S. cataractae. A high concentration of Cu (up to 800 A mu M) did not affect gemma germination. In the protonemal stage, a low concentration of Cu promoted protonemal gemma formation, which is the main strategy adopted by S. cataractae to expand its habitat to new locations. Cu-rich conditions promoted auxin accumulation and induced differentiation of chloronema into caulonema cells, whereas it repressed protonemal gemma formation. Under low-Cu conditions, auxin treatment mimicked the effects of high-Cu conditions. Furthermore, Cu-induced caulonema differentiation was severely inhibited in the presence of the auxin antagonist alpha-(phenylethyl-2-one)-indole-3-acetic acid, or the auxin biosynthesis inhibitor l-kynurenine. These results suggest that S. cataractae flourishes in Cu-rich environments via auxin-regulated cell differentiation. The copper moss might have acquired this mechanism during the evolutionary process to benefit from its advantageous Cu-tolerance ability.	[Nomura, Toshihisa; Itouga, Misao; Kojima, Mikiko; Kato, Yukari; Sakakibara, Hitoshi] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Nomura, Toshihisa; Hasezawa, Seiichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	Nomura, T (reprint author), RIKEN Ctr Sustainable Resource Sci, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	toshihisa.nomura@riken.jp	Sakakibara, Hitoshi/A-6040-2010	Sakakibara, Hitoshi/0000-0001-5449-6492	JSPS KAKENHI [11J06080]; Nara Institute of Science and Technology; Ministry of Education	We thank Ken-ichiro Hayashi (Okayama University of Science) for kindly providing the PEO-IAA. We also thank Zenpukuji temple in Ibaraki Prefecture and Tsurumi shrine in Kanagawa Prefecture in Japan for permission to collect the soil samples of the S. cataractae habitat. This work was supported by JSPS KAKENHI (Grant number 11J06080) and a Grant in-Aid for Scientific Research for Plant Graduate Student from the Nara Institute of Science and Technology, supported by The Ministry of Education (TN). The hormone analysis was supported by the Japan Advanced Plant Science Network.	Aikawa Y, 1999, SOIL SCI PLANT NUTR, V45, P835; SHAW J, 1987, AM J BOT, V74, P813, DOI 10.2307/2443862; Franklin KA, 2011, P NATL ACAD SCI USA, V108, P20231, DOI 10.1073/pnas.1110682108; Yuan HM, 2013, PLANT CELL PHYSIOL, V54, P766, DOI 10.1093/pcp/pct030; Aoyama T, 2012, DEVELOPMENT, V139, P3120, DOI 10.1242/dev.076091; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Sun JQ, 2013, PLANT CELL, V25, P2102, DOI 10.1105/tpc.113.112417; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Thelander M, 2005, J EXP BOT, V56, P653, DOI 10.1093/jxb/eri040; HALLIWELL B, 1984, BIOCHEM J, V219, P1; Hayashi K, 2012, ACS CHEM BIOL, V7, P590, DOI 10.1021/cb200404c; Nomoto Y, 2012, PLANT CELL PHYSIOL, V53, P1950, DOI 10.1093/pcp/pcs137; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Haydon MJ, 2007, NEW PHYTOL, V174, P499, DOI 10.1111/j.1469-8137.2007.02051.x; Eklund DM, 2010, PLANT CELL, V22, P349, DOI 10.1105/tpc.108.064816; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195; COVE DJ, 1993, PLANT CELL, V5, P1483; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Hall JL, 2003, J EXP BOT, V54, P2601, DOI 10.1093/jxb/erg303; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Lilley JLS, 2012, PLANT PHYSIOL, V160, P2261, DOI 10.1104/pp.112.205575; Sudo E, 2008, J EXP BOT, V59, P3465, DOI 10.1093/jxb/ern196; Hayashi K, 2012, PLANT CELL PHYSIOL, V53, P965, DOI 10.1093/pcp/pcs035; Decker EL, 2006, PLANT BIOLOGY, V8, P397, DOI 10.1055/s-2006-923952; He WR, 2011, PLANT CELL, V23, P3944, DOI 10.1105/tpc.111.089029; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; Cove D, 2006, ANNU REV PLANT BIOL, V57, P497, DOI 10.1146/annurev.arplant.57.032905.105338; Eklund DM, 2010, DEVELOPMENT, V137, P1275, DOI 10.1242/dev.039594; Jang GP, 2011, NEW PHYTOL, V192, P319, DOI 10.1111/j.1469-8137.2011.03805.x; JOHRI MM, 1973, NATURE-NEW BIOL, V245, P223; Konno H, 2010, J PLANT PHYSIOL, V167, P358, DOI 10.1016/j.jplph.2009.09.011; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Nomura T, 2011, J PLANT RES, V124, P631, DOI 10.1007/s10265-010-0389-3; PERSSON HERMAN, 1956, JOUR HATTORI BOT LAB, V17, P1; RUMSEY FJ, 1989, J BRYOL, V15, P519; Sakurai K., 1934, SHOKUBUTSUGAKU ZASSH, V48, P383; SATAKE K, 1988, J BRYOL, V15, P353; Schumaker KS, 1998, ANNU REV PLANT PHYS, V49, P501, DOI 10.1146/annurev.arplant.49.1.501; Shaff JE, 2009, PLANT SOIL, V330, P207; Shaw A, 1995, FRAGMENTA FLORISTICA, V40, P188; SHAW AJ, 1994, ENVIRON HEALTH PERSP, V102, P105	46	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAR	2015	66	5					1205	1213		10.1093/jxb/eru470		9	Plant Sciences	Plant Sciences	CE2RJ	WOS:000351663300006		
J	Hirabayashi, H; Sasaki, K; Kambe, T; Gannaban, RB; Miras, MA; Mendioro, MS; Simon, EV; Lumanglas, PD; Fujita, D; Takemoto-Kuno, Y; Takeuchi, Y; Kaji, R; Kondo, M; Kobayashi, N; Ogawa, T; Ando, I; Jagadish, KSV; Ishimaru, T				Hirabayashi, Hideyuki; Sasaki, Kazuhiro; Kambe, Takashi; Gannaban, Ritchel B.; Miras, Monaliza A.; Mendioro, Merlyn S.; Simon, Eliza V.; Lumanglas, Patrick D.; Fujita, Daisuke; Takemoto-Kuno, Yoko; Takeuchi, Yoshinobu; Kaji, Ryota; Kondo, Motohiko; Kobayashi, Nobuya; Ogawa, Tsugufumi; Ando, Ikuo; Jagadish, Krishna S. V.; Ishimaru, Tsutomu			qEMF3, a novel QTL for the early-morning flowering trait from wild rice, Oryza officinalis, to mitigate heat stress damage at flowering in rice, O-sativa	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						Early-morning flowering (EMF); flower opening time (FOT); global warming; heat stress; quantitative trait locus (QTL); rice (Oryza sativa L; ); spikelet sterility	INDUCED SPIKELET STERILITY; HIGH-TEMPERATURE STRESS; L. CULTIVARS; JAPONICA-RICE; TOLERANCE; ANTHESIS; YIELD; FERTILITY; CLIMATE; FUTURE	A decline in rice (Oryza sativa L.) production caused by heat stress is one of the biggest concerns resulting from future climate change. Rice spikelets are most susceptible to heat stress at flowering. The early-morning flowering (EMF) trait mitigates heat-induced spikelet sterility at the flowering stage by escaping heat stress during the daytime. We attempted to develop near-isogenic lines (NILs) for EMF in the indica-type genetic background by exploiting the EMF locus from wild rice, O. officinalis (CC genome). A stable quantitative trait locus (QTL) for flower opening time (FOT) was detected on chromosome 3. A QTL was designated as qEMF3 and it shifted FOT by 1.5-2.0h earlier for cv. Nanjing 11 in temperate Japan and cv. IR64 in the Philippine tropics. NILs for EMF mitigated heat-induced spikelet sterility under elevated temperature conditions completing flower opening before reaching 35A degrees C, a general threshold value leading to spikelet sterility. Quantification of FOT of cultivars popular in the tropics and subtropics did not reveal the EMF trait in any of the cultivars tested, suggesting that qEMF3 has the potential to advance FOT of currently popular cultivars to escape heat stress at flowering under future hotter climates. This is the first report to examine rice with the EMF trait through marker-assisted breeding using wild rice as a genetic resource.	[Hirabayashi, Hideyuki; Kambe, Takashi; Takemoto-Kuno, Yoko; Takeuchi, Yoshinobu; Kondo, Motohiko; Kobayashi, Nobuya; Ando, Ikuo; Ishimaru, Tsutomu] NARO, NARO Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Sasaki, Kazuhiro; Kobayashi, Nobuya; Ishimaru, Tsutomu] JIRCAS, Tsukuba, Ibaraki 3058686, Japan; [Sasaki, Kazuhiro; Gannaban, Ritchel B.; Simon, Eliza V.; Lumanglas, Patrick D.; Fujita, Daisuke; Kobayashi, Nobuya; Jagadish, Krishna S. V.; Ishimaru, Tsutomu] IRRI, Manila, Philippines; [Sasaki, Kazuhiro] Univ Tokyo, Grad Sch Agr & Life Sci, ISAS, Tokyo 1880002, Japan; [Miras, Monaliza A.; Mendioro, Merlyn S.] Univ Philippines, Los Banos, Laguna, Philippines; [Kaji, Ryota] NARO, NARO Tohoku Agr Res Ctr TARC, Akita 0140102, Japan; [Ogawa, Tsugufumi] Miyazaki Univ, Fac Agr, Miyazaki, Miyazaki 8892192, Japan	Ishimaru, T (reprint author), NARO, NARO Inst Crop Sci, 2-1-18 Kannondai, Tsukuba, Ibaraki 3058518, Japan.	t.ishimaru@irri.org			Ministry of Foreign Affairs; Ministry of Agriculture, Forestry, and Fisheries of Japan; Federal Ministry for Economic Cooperation and Development, Germany; National Agricultural and Food Research Organization (NARO), Japan	This study was supported by the Ministry of Foreign Affairs and the Ministry of Agriculture, Forestry, and Fisheries of Japan to T.I. and N.K., Federal Ministry for Economic Cooperation and Development, Germany to K.S.V.J., and the National Agricultural and Food Research Organization (NARO), Japan to T.I. and H.H.	Teixeira EI, 2013, AGR FOREST METEOROL, V170, P206, DOI 10.1016/j.agrformet.2011.09.002; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Matsui T, 2002, ANN BOT-LONDON, V89, P683, DOI 10.1093/aob/mcf112; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Matsui T, 2001, PLANT PROD SCI, V4, P36; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Hasegawa Toshihiro, 2011, Journal of Agricultural Meteorology, V67, P225, DOI 10.2480/agrmet.67.4.3; MACKILL DJ, 1982, CROP SCI, V22, P730; SATAKE T, 1978, JPN J CROP SCI, V47, P6; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Julia C, 2012, EUR J AGRON, V43, P166, DOI 10.1016/j.eja.2012.06.007; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Ye CR, 2012, PLANT BREEDING, V131, P33, DOI 10.1111/j.1439-0523.2011.01924.x; Ishimaru T, 2010, ANN BOT-LONDON, V106, P515, DOI 10.1093/aob/mcq124; Oh-e I, 2007, PLANT PROD SCI, V10, P412, DOI 10.1626/pps.10.412; Jagadish SVK, 2008, CROP SCI, V48, P1140, DOI 10.2135/cropsci2007.10.0559; Matsui T, 2001, PLANT PROD SCI, V4, P90; Matsui T, 1997, JPN J CROP SCI, V66, P449; Carriger S, 2007, RICE TODAY, V6, P10; IPCC, 2013, 5 IPCC; KHUSH GS, 1987, J GENET, V66, P195, DOI 10.1007/BF02927713; Kim HY, 1996, JPN J CROP SCI, V65, P644; Kobayasi K, 2010, PLANT PROD SCI, V13, P21, DOI 10.1626/pps.13.21; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Maclean J. L., 2002, RICE ALMANAC SOURCE; MATSUSHIMA S, 1982, JPN J TROP AGR, V26, P19; McCouch R, 2002, DNA RES, V9, P199; Osada A., 1973, Proceedings of the Crop Science Society of Japan, V42, P103; Satake T., 1972, P CROP SCI SOC JPN, V41, P361; Sheehy JE, 2005, J AGROMETEOROL, V60, P463; Thanh Pham Thien, 2010, Genes Genet Syst, V85, P273, DOI 10.1266/ggs.85.273; Tian XH, 2010, PLANT PROD SCI, V13, P243, DOI 10.1626/pps.13.243; Wang S, 2007, WINDOWS QTL CARTOGRA	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAR	2015	66	5					1227	1236		10.1093/jxb/eru474		10	Plant Sciences	Plant Sciences	CE2RJ	WOS:000351663300008		
J	Acheampong, AK; Hu, JH; Rotman, A; Zheng, CL; Halaly, T; Takebayashi, Y; Jikumaru, Y; Kamiya, Y; Lichter, A; Sun, TP; Or, E				Acheampong, Atiako Kwame; Hu, Jianhong; Rotman, Ariel; Zheng, Chuanlin; Halaly, Tamar; Takebayashi, Yumiko; Jikumaru, Yusuke; Kamiya, Yuji; Lichter, Amnon; Sun, Tai-Ping; Or, Etti			Functional characterization and developmental expression profiling of gibberellin signalling components in Vitis vinifera	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						F-box proteins; GA receptors; gibberellins (GAs); gibberellin signalling; grapevine (Vitis vinifera); VvDELLA proteins	THOMPSON SEEDLESS GRAPES; ARABIDOPSIS-THALIANA; FRUIT-SET; INDUCED DEGRADATION; BERRY DEVELOPMENT; GENE ENCODES; ACID; PLANTS; RECEPTOR; GID1	Gibberellins (GAs) regulate numerous developmental processes in grapevine (Vitis vinifera) such as rachis elongation, fruit set, and fruitlet abscission. The ability of GA to promote berry enlargement has led to its indispensable use in the sternospermocarpic ('seedless') table grape industry worldwide. However, apart from VvGAI1 (VvDELLA1), which regulates internode elongation and fruitfulness, but not berry size of seeded cultivars, little was known about GA signalling in grapevine. We have identified and characterized two additional DELLAs (VvDELLA2 and VvDELLA3), two GA receptors (VvGID1a and VvGID1b), and two GA-specific F-box proteins (VvSLY1a and VvSLY1b), in cv. Thompson seedless. With the exception of VvDELLA3-VvGID1b, all VvDELLAs interacted with the VvGID1s in a GA-dependent manner in yeast two-hybrid assays. Additionally, expression of these grape genes in corresponding Arabidopsis mutants confirmed their functions in planta. Spatiotemporal analysis of VvDELLAs showed that both VvDELLA1 and VvDELLA2 are abundant in most tissues, except in developing fruit where VvDELLA2 is uniquely expressed at high levels, suggesting a key role in fruit development. Our results further suggest that differential organ responses to exogenous GA depend on the levels of VvDELLA proteins and endogenous bioactive GAs. Understanding this interaction will allow better manipulation of GA signalling in grapevine.	[Acheampong, Atiako Kwame; Rotman, Ariel; Zheng, Chuanlin; Halaly, Tamar; Or, Etti] Volcani Ctr, Agr Res Org, Dept Fruit Tree Sci, Inst Plant Sci, IL-50250 Bet Dagan, Israel; [Acheampong, Atiako Kwame; Zheng, Chuanlin] Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Hu, Jianhong; Sun, Tai-Ping] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Takebayashi, Yumiko; Jikumaru, Yusuke; Kamiya, Yuji] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Lichter, Amnon] Volcani Ctr, Agr Res Org, Dept Postharvest Sci Fresh Produce, Inst Postharvest & Food Sci, IL-50250 Bet Dagan, Israel	Or, E (reprint author), Volcani Ctr, Agr Res Org, Dept Fruit Tree Sci, Inst Plant Sci, IL-50250 Bet Dagan, Israel.	vettior@agri.gov.il	Kamiya, Yuji/F-9420-2010	Kamiya, Yuji/0000-0003-4415-520X	United States-Israel Binational Agricultural Research and Development Fund (BARD) [IS-4018-07]; USDA National Institute of Food and Agriculture (Research Initiative Competitive) [2010-65116-2046, 2014-67013-21548]	This research was supported by the United States-Israel Binational Agricultural Research and Development Fund (BARD grant no. IS-4018-07 to EO, AL, and T-PS), and the USDA National Institute of Food and Agriculture (Research Initiative Competitive Grant no. 2010-65116-2046 and 2014-67013-21548 to T-PS).	Acheampong AK, 2010, METHODOLOGIES AND RESULTS IN GRAPEVINE RESEARCH, P301, DOI 10.1007/978-90-481-9283-0_20; Aguero C, 2000, PLANT GROWTH REGUL, V30, P9, DOI 10.1023/A:1006207614388; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; SRINIVASAN C, 1981, AM J ENOL VITICULT, V32, P47; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Steber CM, 1998, GENETICS, V149, P509; WEAVER RJ, 1958, NATURE, V181, P851, DOI 10.1038/181851b0; Itoh H, 1999, PLANT J, V20, P15, DOI 10.1046/j.1365-313X.1999.00568.x; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Dill A, 2001, GENETICS, V159, P777; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; MacMillan J, 2001, J PLANT GROWTH REGUL, V20, P387, DOI 10.1007/s003440010038; Giacomelli L, 2013, J EXP BOT, V64, P4403, DOI 10.1093/jxb/ert251; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; COOMBE BG, 1960, PLANT PHYSIOL, V35, P241, DOI 10.1104/pp.35.2.241; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Perez FJ, 2000, AM J ENOL VITICULT, V51, P315; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc010827; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yamamoto Y, 2010, PLANT CELL, V22, P3589, DOI 10.1105/tpc.110.074542; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; BENTAL Y, 1990, AM J ENOL VITICULT, V41, P142; Boll S, 2009, MITT KLOSTERNEUBG, V59, P129; Chundawat BS, 1971, J JAPAN SOC HORT SCI, V40, P5; Conde C., 2007, FOOD, V1, P1; Coombe B. G., 1995, AUSTR J GRAPE WINE R, V1, P100; DENNIS FG, 1966, NATURE, V211, P781, DOI 10.1038/211781a0; Dereeper A., 2008, NUCLEIC ACIDS RES, V36, P465, DOI DOI 10.1093/NAR/GKN180; Dokoozlian NK, 2001, HORTSCIENCE, V36, P706; HARRELL DC, 1987, AM J ENOL VITICULT, V38, P83; Iwahori S, 1967, PLANT PHYSIOL, V43, P333; KAUFMAN PB, 1976, PLANT PHYSIOL, V58, P131, DOI 10.1104/pp.58.2.131; Kuderova A, 1999, PROTEIN EXPRES PURIF, V16, P405, DOI 10.1006/prep.1999.1079; Lavee S., 1986, ACTA HORTIC, V206, P89; LAVEE S, 1960, NATURE, V185, P395, DOI 10.1038/185395a0; Lu Guoqing, 2004, Brief Bioinform, V5, P378, DOI 10.1093/bib/5.4.378; MOSESIAN RM, 1968, AM J ENOL VITICULT, V19, P37; Mullins MG, 1992, BIOLOGY OF THE GRAPE; NIJJAR GS, 1969, J HORTIC SCI BIOTECH, V44, P91; Ravivi M, 1987, TREE PHYSIOL, V3, P115; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Voegele A, 2011, J EXP BOT, V62, P5131, DOI 10.1093/jxb/err214; WEAVER R. J., 1965, CALIF AGR, V19, P14; Wolf E. E. H., 1992, South African Journal for Enology and Viticulture, V13, P57	61	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAR	2015	66	5					1463	1476		10.1093/jxb/eru504		14	Plant Sciences	Plant Sciences	CE2RJ	WOS:000351663300026		
J	Zheng, CL; Halaly, T; Acheampong, AK; Takebayashi, Y; Jikumaru, Y; Kamiya, Y; Or, E				Zheng, Chuanlin; Halaly, Tamar; Acheampong, Atiako Kwame; Takebayashi, Yumiko; Jikumaru, Yusuke; Kamiya, Yuji; Or, Etti			Abscisic acid (ABA) regulates grape bud dormancy, and dormancy release stimuli may act through modification of ABA metabolism	JOURNAL OF EXPERIMENTAL BOTANY			English	Article						ABA 8'-hydroxylase; abscisic acid; bud; 9-cis-epoxycarotenoid dioxygenase; dormancy; grapevine	POTATO MICROTUBER DORMANCY; SOLANUM-TUBEROSUM-L; SEED DORMANCY; ARABIDOPSIS-THALIANA; DROUGHT TOLERANCE; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; SIGNAL-TRANSDUCTION; HYDROGEN CYANAMIDE; BETULA-PENDULA; VITIS-VINIFERA	In warm-winter regions, induction of dormancy release by hydrogen cyanamide (HC) is mandatory for commercial table grape production. Induction of respiratory stress by HC leads to dormancy release via an uncharacterized biochemical cascade that could reveal the mechanism underlying this phenomenon. Previous studies proposed a central role for abscisic acid (ABA) in the repression of bud meristem activity, and suggested its removal as a critical step in the HC-induced cascade. In the current study, support for these assumptions was sought. The data show that ABA indeed inhibits dormancy release in grape (Vitis vinifera) buds and attenuates the advancing effect of HC. However, HC-dependent recovery was detected, and was affected by dormancy status. HC reduced VvXERICO and VvNCED transcript levels and induced levels of VvABA8'OH homologues. Regulation of these central players in ABA metabolism correlated with decreased ABA and increased ABA catabolite levels in HC-treated buds. Interestingly, an inhibitor of ethylene signalling attenuated these effects of HC on ABA metabolism. HC also modulated the expression of ABA signalling regulators, in a manner that supports a decreased ABA level and response. Taken together, the data support HC-induced removal of ABA-mediated repression via regulation of ABA metabolism and signalling. Expression profiling during the natural dormancy cycle revealed that at maximal dormancy, the HC-regulated VvNCED1 transcript level starts to drop. In parallel, levels of VvA8H-CYP707A4 transcript and ABA catabolites increase sharply. This may provide initial support for the involvement of ABA metabolism also in the execution of natural dormancy.	[Zheng, Chuanlin; Halaly, Tamar; Acheampong, Atiako Kwame; Or, Etti] Volcani Ctr, Agr Res Org, Inst Plant Sci, Dept Fruit Tree Sci, IL-50250 Bet Dagan, Israel; [Zheng, Chuanlin; Acheampong, Atiako Kwame] Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Takebayashi, Yumiko; Jikumaru, Yusuke; Kamiya, Yuji] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Or, E (reprint author), Volcani Ctr, Agr Res Org, Inst Plant Sci, Dept Fruit Tree Sci, IL-50250 Bet Dagan, Israel.	vettior@agri.gov.il	Kamiya, Yuji/F-9420-2010	Kamiya, Yuji/0000-0003-4415-520X			SHULMAN Y, 1983, SCI HORTIC-AMSTERDAM, V19, P97, DOI 10.1016/0304-4238(83)90049-3; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; RINNE P, 1994, TREE PHYSIOL, V14, P549; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Perez FJ, 2005, J PLANT PHYSIOL, V162, P301, DOI 10.1016/j.jplph.2004.07.011; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; SUTTLE JC, 1994, PLANT PHYSIOL, V105, P891; JI ZL, 1988, J PLANT GROWTH REGUL, V7, P37, DOI 10.1007/BF02054160; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Perez FJ, 2008, PLANT GROWTH REGUL, V55, P149, DOI 10.1007/s10725-008-9269-4; Arc E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00063; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Frey A, 2004, PLANTA, V218, P958, DOI 10.1007/s00425-003-1180-7; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Szostkiewicz I, 2010, PLANT J, V61, P25, DOI 10.1111/j.1365-313X.2009.04025.x; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; Liu YG, 2010, J EXP BOT, V61, P2979, DOI 10.1093/jxb/erq125; Ophir R, 2009, PLANT MOL BIOL, V71, P403, DOI 10.1007/s11103-009-9531-9; Suttle JC, 2012, J EXP BOT, V63, P5717, DOI 10.1093/jxb/ers146; Toh S, 2008, PLANT PHYSIOL, V146, P1368, DOI 10.1104/pp.107.113738; Wang YN, 2007, PLANT MOL BIOL, V64, P633, DOI 10.1007/s11103-007-9182-7; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Sisler EC, 2003, PLANT BIOLOGY, V5, P473, DOI 10.1055/s-2003-44782; Debast S, 2011, PLANT PHYSIOL, V156, P1754, DOI 10.1104/pp.111.179903; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; Martinez-Andujar C, 2011, P NATL ACAD SCI USA, V108, P17225, DOI 10.1073/pnas.1112151108; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Steffens B, 2006, PLANTA, V223, P604, DOI 10.1007/s00425-005-0111-1; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Sarath G, 2007, PLANTA, V226, P697, DOI 10.1007/s00425-007-0517-z; Ruonala R, 2006, PLANT J, V46, P628, DOI 10.1111/j.1365-313X.2006.02722.x; Arora R, 2003, HORTSCIENCE, V38, P911; Chiwocha SDS, 2005, PLANT J, V42, P35, DOI 10.1111/j.1365-313X.2005.02359.x; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI [10.1104/pp.010663, 10.1104/pp.128.2.544]; Frey A, 2012, PLANT J, V70, P501, DOI 10.1111/j.1365-313X.2011.04887.x; Seo M, 2011, METHODS MOL BIOL, V773, P99, DOI 10.1007/978-1-61779-231-1_7; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Boneh U, 2012, PLANT CELL REP, V31, P311, DOI 10.1007/s00299-011-1166-z; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; KARSSEN CM, 1983, PLANTA, V157, P158, DOI 10.1007/BF00393650; Or E, 1999, VITIS, V38, P1; Hellman E, 2006, J AM POMOL SOC, V60, P178; Cheng WH, 2009, PLANT MOL BIOL, V71, P61, DOI 10.1007/s11103-009-9509-7; Vergara R, 2012, J EXP BOT, V63, P4123, DOI 10.1093/jxb/ers094; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; VANDENBERG JH, 1991, J PLANT PHYSIOL, V139, P86; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Or E, 2000, PLANT MOL BIOL, V43, P483, DOI 10.1023/A:1006450516982; Argyris J, 2011, THEOR APPL GENET, V122, P95, DOI 10.1007/s00122-010-1425-3; BARROS RS, 1989, ACTA PHYSIOL PLANT, V11, P117; Benschop JJ, 2006, PLANT PHYSIOL, V141, P1644, DOI 10.1104/pp.106.082636; Biemelt S, 2000, POTATO RES, V43, P371, DOI 10.1007/BF02360541; Boneh U, 2012, PLANT SCI, V187, P89, DOI 10.1016/j.plantsci.2012.01.015; Crabbe J., 1994, ENCY AGR SCI, V1, P597; Cutler AJ, 2007, ENCY LIFE SCI, DOI [10.1002/9780470015902.a9780470020088, DOI 10.1002/9780470015902.A9780470020088]; Destefano-Beltran L, 2006, J EXP BOT, V57, P2879, DOI 10.1093/jxb/erl050; Destefano-Beltran L, 2006, PLANT MOL BIOL, V61, P687, DOI 10.1007/s11103-006-0042-7; DURING H, 1975, PHYSIOL PLANTARUM, V34, P201, DOI 10.1111/j.1399-3054.1975.tb03821.x; DUTCHER RD, 1972, J AM SOC HORTIC SCI, V97, P511; Footitt S, 2011, P NATL ACAD SCI USA, V108, P20236, DOI 10.1073/pnas.1116325108; Horvath DP, 2006, WEED SCI, V54, P821, DOI 10.1614/WS-06-06R1.1; Keilin T, 2007, PLANT SCI, V173, P446, DOI 10.1016/j.plantsci.2007.07.004; KORABLEVA NP, 1980, FIZIOL RAST, V27, P441; KOUSSA T, 1994, VITIS, V33, P63; LANG GA, 1987, HORTSCIENCE, V22, P817; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Lavee S., 1997, Australian Journal of Grape and Wine Research, V3, P31, DOI 10.1111/j.1755-0238.1997.tb00114.x; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Leymarie Juliette, 2009, Plant Signal Behav, V4, P205; Li CY, 2003, TREE PHYSIOL, V23, P481; Li CY, 2004, PLANT SCI, V167, P165, DOI 10.1016/j.plantsci.2004.03.015; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; LIONAKIS SM, 1984, ANN BOT-LONDON, V54, P467; Liu Yinggao, 2009, Plant Signal Behav, V4, P905; Matakiadis T, 2009, PLANT PHYSIOL, V149, P949, DOI 10.1104/pp.108.126938; MIELKE EA, 1978, J AM SOC HORTIC SCI, V103, P446; Or E, 2000, J HORTIC SCI BIOTECH, V75, P190; Or E., 2009, GRAPEVINE MOL PHYSL, P1, DOI DOI 10.1007/978-90-481-2305-6_1; Pang XQ, 2007, J EXP BOT, V58, P3249, DOI 10.1093/jxb/erm172; Perez FJ, 2009, PLANT GROWTH REGUL, V59, P145, DOI 10.1007/s10725-009-9397-5; Powell L. E., 1987, Plant hormones and their role in plant growth and development., P539; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; RINNE P, 1994, PHYSIOL PLANTARUM, V90, P451; Rohde A, 2002, PLANT CELL, V14, P1885, DOI 10.1105/tpc.003186; Saure M. C., 1985, Horticultural Reviews, V7, P239; Tamura F, 2002, ACTA HORTIC, P325; Ye N, 2011, J EXPT BOT, V63, P1809; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Young PR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-243	101	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0957	1460-2431		J EXP BOT	J. Exp. Bot.	MAR	2015	66	5					1527	1542		10.1093/jxb/eru519		16	Plant Sciences	Plant Sciences	CE2RJ	WOS:000351663300031		
J	Doanh, PN; Thaenkham, U; An, PT; Hien, HV; Horii, Y; Nawa, Y				Doanh, P. N.; Thaenkham, U.; An, P. T.; Hien, H. V.; Horii, Y.; Nawa, Y.			Metacercarial polymorphism and genetic variation of Paragonimus heterotremus (Digenea: Paragonimidae), and a re-appraisal of the taxonomic status of Paragonimus pseudoheterotremus	JOURNAL OF HELMINTHOLOGY			English	Article							MOLECULAR PHYLOGENETIC STATUS; NORTHEASTERN INDIA; WESTERMANI COMPLEX; GENUS PARAGONIMUS; NORTHERN VIETNAM; IDENTIFICATION; DISCOVERY; EVOLUTIONARY; INFECTION; TREMATODA	Paragonimus heterotremus, which is an important pathogen for human paragonimiasis in Asia, is recognized as having the smallest metacercariae (maximum diameter <300 mu m) of any previously reported Paragonimus species. Recently, P. pseudoheterotremus has been described from Thailand as a new species having metacercariae (about 200 mu m) slightly smaller than those of Thai P. heterotremus. In fact, the small size of P. pseudoheterotremus metacercariae is compatible with those of P. heterotremus from India and China. In this study in Vietnam, we found variably sized small metacercariae which are expected to consist of both P. heterotremus and P. pseudoheterotremus. Contrary to expectation, the adult flukes obtained by separate infection of experimental cats with different sized metacercariae were all identified as P. heterotremus, using bothmorphological and molecular characteristics. The molecular analyses of an extensive collection of P. heterotremus/ P. pseudoheterotremus isolates from Asian countries also indicated that genetic distances between different populations of P. heterotremus are even larger than that between P. pseudoheterotremus and P. heterotremus. The haplotype network showed that all P. heterotremus and P. pseudoheterotremus isolates formed a P. heterotremus complex consisting of three groups with strong geographical origins. In addition, the Indian P. heterotremus group is the root of the other P. heterotremus and P. pseudoheterotremus populations. Based on the observed metacercarial polymorphisms and genetic variation in P. heterotremus, P. pseudoheterotremus should be considered a geographically isolated population of the P. heterotremus complex.	[Doanh, P. N.; Hien, H. V.] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam; [Thaenkham, U.] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand; [Horii, Y.] Miyazaki Univ, Fac Agr, Lab Vet Parasit Dis, Miyazaki 88921, Japan; [Nawa, Y.] Khon Kaen Univ, Fac Med, Res Affairs, Khon Kaen, Thailand	Doanh, PN (reprint author), Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam.	horii@cc.miyazaki-u.ac.jp			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.12-2012.52]	This research is funded by the Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.12-2012.52.	Blair D, 1999, ADV PARASIT, V42, P113, DOI 10.1016/S0065-308X(08)60149-9; BOWLES J, 1993, ACTA TROP, V55, P217, DOI 10.1016/0001-706X(93)90079-Q; Doanh PN, 2007, PARASITOL RES, V100, P1075, DOI 10.1007/s00436-006-0411-9; Doanh PN, 2007, PARASITOL RES, V101, P1495, DOI 10.1007/s00436-007-0666-9; Blair D, 2005, SYST PARASITOL, V60, P1, DOI 10.1007/s11230-004-1378-5; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BOWLES J, 1995, MOL PHYLOGENET EVOL, V4, P103, DOI 10.1006/mpev.1995.1011; Chung Huei lan, 1964, Chinese Medical Journal, V83, P641; CHUNG H-L, 1975, Acta Zoologica Sinica, V21, P155; Devi KR, 2013, PARASITOLOGY, V140, P76, DOI 10.1017/S0031182012001229; Devi KR, 2007, T ROY SOC TROP MED H, V101, P786, DOI 10.1016/j.trstmh.2007.02.028; Doanh PN, 2008, PARASITOL RES, V102, P677, DOI 10.1007/s00436-007-0811-5; Doanh PN, 2013, J HELMINTHOL, V87, P450, DOI 10.1017/S0022149X1200065X; Doanh PN, 2012, PARASITOL INT, V61, P399, DOI 10.1016/j.parint.2012.01.011; Doanh PN, 2009, PARASITOL RES, V104, P1149, DOI 10.1007/s00436-008-1302-z; Hu Wenqing, 1998, Chinese Journal of Parasitology and Parasitic Diseases, V16, P347; Intapan PM, 2012, AM J TROP MED HYG, V87, P706, DOI 10.4269/ajtmh.2012.12-0235; Kunz W, 2002, TRENDS PARASITOL, V18, P121, DOI 10.1016/S1471-4922(01)02210-3; Le TH, 2006, ACTA TROP, V98, P25, DOI 10.1016/j.actatropica.2006.01.008; PARIYANONDA S, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P103; Singh T. S., 2007, SE ASIAN J TROP M S1, V38, P82; Sugiyama H., 2007, SE ASIAN J TROP MED, V38, P87; Thaenkham Urusa, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P217; Waikagul J, 2007, J PARASITOL, V93, P1496, DOI 10.1645/GE-1054.1; Yahiro S, 2008, J PARASITOL, V94, P1176, DOI 10.1645/GE-1457.1	27	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0022-149X	1475-2697		J HELMINTHOL	J. Helminthol.	MAR	2015	89	2					182	188		10.1017/S0022149X13000734		7	Parasitology; Zoology	Parasitology; Zoology	CE7FJ	WOS:000352003100006		
J	Ohnuma, A; Nagata, T; Komura, K; Ando, H; Ishihara, H; Koketsu, M				Ohnuma, Akira; Nagata, Tomohiro; Komura, Kenichi; Ando, Hiromune; Ishihara, Hideharu; Koketsu, Mamoru			Preparation of 2H-5,6-Dihydroselenines Using alpha-Alkoxy Carbonylselenoacetamide	JOURNAL OF HETEROCYCLIC CHEMISTRY			English	Article							SELENIUM-CONTAINING HETEROCYCLES; AROMATIC PRIMARY SELENOAMIDES; NITRIC-OXIDE PRODUCTION; 1,3-SELENAZOL-4-ONE DERIVATIVES; ORGANOSELENIUM COMPOUNDS; CELLS; ISOSELENOCYANATES; MECHANISMS; APOPTOSIS	Various 2H-5,6-dihydroselenine derivatives were synthesized by the reaction of -alkoxy carbonylselenoacetamides with ,-unsaturated ketones in the presence of BF3 center dot Et2O.	[Ohnuma, Akira; Ishihara, Hideharu] Gifu Univ, Dept Chem, Fac Engn, Gifu 5011193, Japan; [Ohnuma, Akira] Hokkaido Univ, Inst Adv Higher Educ, Sapporo, Hokkaido 0600817, Japan; [Nagata, Tomohiro; Komura, Kenichi; Koketsu, Mamoru] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan; [Ando, Hiromune] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Gifu 5011193, Japan	Koketsu, M (reprint author), Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan.	koketsu@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15550030, 17550099]	This work was supported by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (nos. 15550030 and 17550099) to which we are grateful.	Lee EH, 2010, J PHARM PHARMACOL, V62, P352, DOI [10.1211/jpp.62.03.0010, 10.1211/jpp/62.03.0010]; Nishina A, 2007, BIOCHEM BIOPH RES CO, V352, P360, DOI 10.1016/j.bbrc.2006.11.025; Ahn HJ, 2006, J CELL BIOCHEM, V99, P807, DOI 10.1002/jcb.20973; Koketsu M, 2006, CHEM LETT, V35, P626, DOI 10.1246/cl.2006.626; Nam KN, 2008, EUR J PHARMACOL, V589, P53, DOI 10.1016/j.ejphar.2008.03.034; Fujiwara S, 2002, J ORG CHEM, V67, P6275, DOI 10.1021/jo025707d; Ninomiya M, 2011, COORDIN CHEM REV, V255, P2968, DOI 10.1016/j.ccr.2011.07.009; Tsukagoshi H, 2007, FEBS J, V274, P6046, DOI 10.1111/j.1742-4658.2007.06125.x; El-Bayoumy K, 2004, MUTAT RES-FUND MOL M, V551, P181, DOI 10.1016/j.mrfmmm.2004.02.023; Choi SY, 2009, J KOREAN SOC APPL BI, V52, P371, DOI 10.3839/jksabc.2009.066; Garud DR, 2009, TETRAHEDRON, V65, P4775, DOI 10.1016/j.tet.2009.04.004; ISHIHARA H, 1976, CHEM LETT, P203, DOI 10.1246/cl.1976.203; Ishihara H, 1998, CHEM LETT, P1287, DOI 10.1246/cl.1998.1287; Ishiharas H., 1987, SYNTHESIS, V371; Kanohs K., 2007, SYNTHESIS, V2617; Kataokas T., 1999, J CHEM SOC P1, V1155; Katritzkys A. R., 2008, COMPREHENSIVE HETERO, V1-14; Koketsu M, 2002, CHEM PHARM BULL, V50, P1594, DOI 10.1248/cpb.50.1594; Koketsu M, 2007, J HETEROCYCLIC CHEM, V44, P231; Koketsu M, 2003, CURR ORG CHEM, V7, P175, DOI 10.2174/1385272033373102; Koketsus M., 1999, J CHEM SOC P1, V453; Koketsus M., 2001, SYNTHESIS, V731; Ninomiya M, 2010, HETEROCYCLES, V81, P2027, DOI 10.3987/REV-10-677; Park YJ, 2003, BIOL PHARM BULL, V26, P1657, DOI 10.1248/bpb.26.1657; Patrick Lyn, 2004, Altern Med Rev, V9, P239; Sekiguchi A, 2005, CHEM PHARM BULL, V53, P1439, DOI 10.1248/cpb.53.1439; Sekiguchi A, 2006, BIOL PHARM BULL, V29, P1404, DOI 10.1248/bpb.29.1404; Sommen GL, 2007, HELV CHIM ACTA, V90, P472, DOI 10.1002/hlca.200790051; Sommens G. L., 2005, EUR J ORG CHEM, V3128; Wirth T, 2012, ORGANOSELENIUM CHEMISTRY: SYNTHESIS AND REACTIONS, P1; Wu WJ, 1999, ANTICANCER RES, V19, P5375	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-152X	1943-5193		J HETEROCYCLIC CHEM	J. Heterocycl. Chem.	MAR	2015	52	2					513	517		10.1002/jhet.2086		5	Chemistry, Organic	Chemistry	CE2EG	WOS:000351626200029		
J	Saito, K; Miyado, M; Kobori, Y; Tanaka, Y; Ishikawa, H; Yoshida, A; Katsumi, M; Saito, H; Kubota, T; Okada, H; Ogata, T; Fukami, M				Saito, Kazuki; Miyado, Mami; Kobori, Yoshitomo; Tanaka, Yoko; Ishikawa, Hiromichi; Yoshida, Atsumi; Katsumi, Momori; Saito, Hidekazu; Kubota, Toshiro; Okada, Hiroshi; Ogata, Tsutomu; Fukami, Maki			Copy-number variations in Y-chromosomal azoospermia factor regions identified by multiplex ligation-dependent probe amplification	JOURNAL OF HUMAN GENETICS			English	Article							SPERMATOGENIC IMPAIRMENT; MOLECULAR DIAGNOSIS; MALE-INFERTILITY; HAN CHINESE; AZFC; DELETION; DUPLICATIONS; POPULATION; MEN; EXPRESSION	Although copy-number variations (CNVs) in Y-chromosomal azoospermia factor (AZF) regions have been associated with the risk of spermatogenic failure (SF), the precise frequency, genomic basis and clinical consequences of these CNVs remain unclear. Here we performed multiplex ligation-dependent probe amplification (MLPA) analysis of 56 Japanese SF patients and 65 control individuals. We compared the results of MLPA with those of conventional sequence-tagged site PCR analyses. Eleven simple and complex CNVs, including three hitherto unreported variations, were identified by MLPA. Seven of the 11 CNVs were undetectable by conventional analyses. CNVs were widely distributed in AZF regions and shared by similar to 60% of the patients and similar to 40% of the controls. Most breakpoints resided within locus-specific repeats. The majority of CNVs, including the most common gr/gr deletion, were identified in the patient and control groups at similar frequencies, whereas simple duplications were observed exclusively in the patient group. The results imply that AZF-linked CNVs are more frequent and heterogeneous than previously reported. Non-allelic homologous recombination likely underlies these CNVs. Our data confirm the functional neutrality of the gr/gr deletion in the Japanese population. We also found a possible association between AZF-linked simple duplications and SF, which needs to be evaluated in future studies.	[Saito, Kazuki; Miyado, Mami; Katsumi, Momori; Ogata, Tsutomu; Fukami, Maki] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo 1578535, Japan; [Saito, Kazuki; Kubota, Toshiro] Tokyo Med & Dent Univ, Dept Comprehens Reprod Med, Tokyo, Japan; [Saito, Kazuki; Saito, Hidekazu] Natl Med Ctr Children & Mothers, Ctr Maternal Fetal Neonatal & Reprod Med, Div Reprod Med, Tokyo, Japan; [Kobori, Yoshitomo; Okada, Hiroshi] Dokkyo Med Univ, Koshigaya Hosp, Dept Urol, Koshigaya, Japan; [Tanaka, Yoko] Tokyo Dent Coll, Ichikawa Gen Hosp, Dept Pediat, Ichikawa, Japan; [Ishikawa, Hiromichi] Tokyo Dent Coll, Ichikawa Gen Hosp, Reprod Ctr, Ichikawa, Japan; [Yoshida, Atsumi] Kiba Pk Clin, Reprod Ctr, Tokyo, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	Fukami, M (reprint author), Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Setagaya Ku, 2-10-1 Ohkura, Tokyo 1578535, Japan.	fukami-m@ncchd.go.jp			Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare (Tokyo, Japan) [H26-062, 082]; National Center for Child Health and Development (Tokyo, Japan) [26-11, 26-19]; Takeda foundation	We are grateful to the participants of this study. The study was supported by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology and from the Japan Society for the Promotion of Science and by the Grants from the Ministry of Health, Labor and Welfare (Grant Numbers: H26-062, 082, Tokyo, Japan) from National Center for Child Health and Development (Grant Numbers: 26-11, 26-19, Tokyo, Japan) and from Takeda foundation. The sponsors had no role in study design, in the collection, analysis or interpretation of data, in the writing of the report or in the decision to submit the article for publication.	Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Sun C, 1999, NAT GENET, V23, P429; Lu CC, 2011, HUM MOL GENET, V20, P4411, DOI 10.1093/hmg/ddr369; Krausz C, 2014, ANDROLOGY-US, V2, P5, DOI 10.1111/j.2047-2927.2013.00173.x; Cram DS, 2000, FERTIL STERIL, V74, P909, DOI 10.1016/S0015-0282(00)01568-5; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Stuppia L, 2012, INT J MOL SCI, V13, P3245, DOI 10.3390/ijms13033245; Lin YW, 2007, HUM MUTAT, V28, P486, DOI 10.1002/humu.20473; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Giachini C, 2008, HUM GENET, V124, P399, DOI 10.1007/s00439-008-0561-1; Ye JJ, 2013, J ZHEJIANG UNIV-SC B, V14, P807, DOI 10.1631/jzus.B1200301; Bunyan David J, 2012, J Reprod Infertil, V13, P174; Carvalho C. M. B., 2006, J HUM GENET, V51, P794, DOI 10.1007/s10038-006-0024-2; Carvalho CMB, 2011, SYST BIOL REPROD MEC, V57, P3, DOI 10.3109/19396368.2010.527427; Coughlin CR, 2012, GENOME MED, V4, DOI 10.1186/gm381; Giacco D. L., 2014, EUR J HUM GENET, V22, P754; Kihaile Paul E, 2005, J Exp Clin Assist Reprod, V2, P9, DOI 10.1186/1743-1050-2-9; Kleiman SE, 2003, HUM GENET, V113, P486, DOI 10.1007/s00439-003-0990-9; Kuroda-Kawaguchi Tomoko, 2001, Nature Genetics, V29, P279, DOI 10.1038/ng757; Liu X. H., 2013, REPROD FERT DEVELOP, V26, P778; Lu CC, 2014, MOL HUM REPROD, V20, P836, DOI 10.1093/molehr/gau043; Rosen S. G., 2012, AM J HUM GENET, V91, P890; Shen Y, 2013, HUM MOL GENET, V22, P1679, DOI 10.1093/hmg/ddt004; Stahl PJ, 2012, ASIAN J ANDROL, V14, P676, DOI 10.1038/aja.2012.55	26	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	MAR	2015	60	3					127	131		10.1038/jhg.2014.115		5	Genetics & Heredity	Genetics & Heredity	CE3WQ	WOS:000351761200004		
J	Nishiyama, M; Yan, J; Yotsumoto, J; Sawai, H; Sekizawa, A; Kamei, Y; Sago, H				Nishiyama, Miyuki; Yan, Jim; Yotsumoto, Junko; Sawai, Hideaki; Sekizawa, Akihiko; Kamei, Yoshimasa; Sago, Haruhiko			Chromosome abnormalities diagnosed in utero: a Japanese study of 28 983 amniotic fluid specimens collected before 22 weeks gestations	JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL-DIAGNOSIS; MATERNAL AGE; AMNIOCENTESES; PREVALENCE; RATES; TRENDS	To investigate the frequency and type of abnormal karyotype in Japan by amniocentesis before 22 weeks of gestation. We performed a retrospective analysis of 28 983 amniotic fluid specimens in a local population collected before 22 weeks gestations for fetal karyotyping. The incidence of abnormal karyotype was 6.0%. The main indication was advanced maternal age (AMA) of 35 years and older, which represented over half of the clinical indications. Abnormal karyotype was most frequently reported among the referrals for abnormal ultrasound findings (21.8%), followed by positive maternal serum screen results (5.3%). Three-fourths of abnormal karyotype was either autosomal aneuploidy (64.0%) or sex chromosome aneuploidy (11.6%). Abnormal karyotype was detected in 2.8% of pregnant women referred for AMA. Clinically significant abnormal karyotype increased with advancing maternal age. The frequency and type of abnormal karyotype detected by amniocentesis for various indications were determined. Amniocentesis was mainly performed among the referrals for AMA, which is a characteristic distribution of indications of Japan.	[Nishiyama, Miyuki; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Dept Maternal Fetal Neonatal & Reprod Med, Tokyo 1578535, Japan; [Yan, Jim] Lab Corp Amer Holdings, Dept Compan Diagnost, LabCorp Clin Trials, Burlington, NC USA; [Yotsumoto, Junko; Sekizawa, Akihiko] Showa Univ, Dept Obstet & Gynecol, Tokyo, Japan; [Sawai, Hideaki] Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo 6638501, Japan; [Kamei, Yoshimasa] Saitama Med Univ, Dept Obstet & Gynecol, Saitama, Japan	Sago, H (reprint author), Natl Ctr Child Hlth & Dev, Dept Maternal Fetal Neonatal & Reprod Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	sagou-h@ncchd.go.jp					Han SH, 2008, KOREAN J LAB MED, V28, P378, DOI 10.3343/kjlm.2008.28.5.378; Chetty S, 2013, PRENATAL DIAG, V33, P542, DOI 10.1002/pd.4125; Mademont-Soler I, 2011, EUR J OBSTET GYN R B, V157, P156, DOI 10.1016/j.ejogrb.2011.03.016; Shaffer LG, 2012, PRENATAL DIAG, V32, P986, DOI 10.1002/pd.3943; Wray AM, 2005, PRENATAL DIAG, V25, P350, DOI 10.1002/pd.1144; Wellesley D, 2012, EUR J HUM GENET, V20, P521, DOI 10.1038/ejhg.2011.246; Karaoguz MY, 2006, GENET COUNSEL, V17, P219; Chang YW, 2012, TAIWAN J OBSTET GYNE, V51, P206, DOI 10.1016/j.tjog.2012.04.007; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Forabosco A, 2009, EUR J HUM GENET, V17, P897, DOI 10.1038/ejhg.2008.265; FERGUSONSMITH MA, 1984, PRENATAL DIAG, V4, P5, DOI 10.1002/pd.1970040704; Kajii T, 2008, AM J MED GENET A, V146A, P1387, DOI 10.1002/ajmg.a.32323; Lichtenbelt KD, 2011, PRENATAL DIAG, V31, P765, DOI 10.1002/pd.2764; Nakata N, 2010, PRENATAL DIAG, V30, P198, DOI 10.1002/pd.2434; Nishiyama M, 2013, J GENET COUNS, V22, P795, DOI 10.1007/s10897-013-9632-0; Sago H., 2004, J MAMM OVA RES, V21, P18, DOI 10.1274/jmor.21.18; Sasaki A, 2011, PRENATAL DIAG, V31, P1007, DOI 10.1002/pd.2816	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	MAR	2015	60	3					133	137		10.1038/jhg.2014.116		5	Genetics & Heredity	Genetics & Heredity	CE3WQ	WOS:000351761200005		
J	Doi, H				Doi, Hisashi			Pd-mediated rapid cross-couplings using [C-11]methyl iodide: groundbreaking labeling methods in C-11 radiochemistry	JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS			English	Review						C-11-labeling; [C-11]methyl iodide; Pd; cross-coupling; C-C bond formation	POSITRON-EMISSION-TOMOGRAPHY; (CH3)-C-11-LABELED PET TRACERS; LIVING HUMAN BRAIN; METHYL-IODIDE; ALKYL-HALIDES; SEROTONIN TRANSPORTER; GRIGNARD-REAGENTS; BIOLOGICAL EVALUATION; CARBON FRAMEWORKS; HEPATOBILIARY TRANSPORT	Prof. Bengt Langstrom is a pioneer in the field of chemistry-driven positron emission tomography (PET) imaging. He has developed a variety of excellent radiolabeling methodologies using the methods of organic chemistry, with the aim of widening the potential of PET in the study of life. Among his groundbreaking achievements in C-11 radiochemistry, there is the discovery of the Pd-mediated rapid cross-coupling reaction using [C-11]methyl iodide. It was first reported by his Uppsala group in 1994-1995 and was further investigated by his and other groups with a view of enhancing its generality and practicability. This reaction is currently considered one of the basic methods for C-11-labeling of low-weight organic compounds. This paper presents a short summary of the background and the development of Pd-mediated rapid cross-couplings of [C-11]methyl iodide, with a focus not only on organostannanes, but also on organoboranes, organozincs, and terminal acetylene compounds. All these reactions have proven to be dependable C-11-labeling methodologies that use chemically reliable carbon-carbon bond formation reactions.	RIKEN Ctr Life Sci Technol CLST, Labeling Chem Team, Div Biofunct Dynam Imaging, Chuo Ku, Kobe, Hyogo 6500047, Japan	Doi, H (reprint author), RIKEN Ctr Life Sci Technol CLST, Labeling Chem Team, Div Biofunct Dynam Imaging, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	hisashi.doi@riken.jp					Andersen VL, 2013, TETRAHEDRON LETT, V54, P213, DOI 10.1016/j.tetlet.2012.11.001; ANDERSSON Y, 1995, ACTA CHEM SCAND, V49, P683, DOI 10.3891/acta.chem.scand.49-0683; Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048; Wust F, 2000, J LABELLED COMPD RAD, V43, P1289, DOI 10.1002/1099-1344(200011)43:13<1289::AID-JLCR420>3.0.CO;2-Q; OTSUKA S, 1976, J AM CHEM SOC, V98, P5850, DOI 10.1021/ja00435a017; Negishi EI, 2011, ANGEW CHEM INT EDIT, V50, P6738, DOI 10.1002/anie.201101380; Maleczka RE, 2000, J AM CHEM SOC, V122, P384; Zhang ZE, 2014, J LABELLED COMPD RAD, V57, P540, DOI 10.1002/jlcr.3213; Larsen P, 1997, APPL RADIAT ISOTOPES, V48, P153, DOI 10.1016/S0969-8043(96)00177-7; Bernhardt S, 2011, ANGEW CHEM INT EDIT, V50, P9205, DOI 10.1002/anie.201104291; GILLIE A, 1980, J AM CHEM SOC, V102, P4933, DOI 10.1021/ja00535a018; Samuelsson L, 2003, J LABELLED COMPD RAD, V46, P263, DOI 10.1002/jlcr.668; Andersen VL, 2014, BIOORG MED CHEM LETT, V24, P2408, DOI 10.1016/j.bmcl.2014.04.044; Suzuki M, 2000, TETRAHEDRON, V56, P8263, DOI 10.1016/S0040-4020(00)00734-1; Hostetler ED, 2005, J LABELLED COMPD RAD, V48, P629, DOI 10.1002/jlcr.953; Frisch AC, 2005, ANGEW CHEM INT EDIT, V44, P674, DOI 10.1002/anie.200461432; Toyohara J, 2008, NUCL MED BIOL, V35, P67, DOI 10.1016/j.nucmedbio.2007.10.001; Takahashi K, 2014, J NUCL MED, V55, P852, DOI 10.2967/jnumed.113.131474; Kawamura K, 2012, NUCL MED BIOL, V39, P89, DOI 10.1016/j.nucmedbio.2011.06.001; Yu MX, 2005, NUCL MED BIOL, V32, P631, DOI 10.1016/j.nucmedbio.2005.05.004; Forngren T, 2004, J LABELLED COMPD RAD, V47, P71, DOI 10.1002/jlcr.798; Fujinaga M, 2012, J MED CHEM, V55, P11042, DOI 10.1021/jm301597s; Bjorkman M, 2000, J LABELLED COMPD RAD, V43, P1327, DOI 10.1002/1099-1344(200012)43:14<1327::AID-JLCR419>3.0.CO;2-D; FARINA V, 1994, J ORG CHEM, V59, P5905, DOI 10.1021/jo00099a018; Kealey S, 2013, CHEM COMMUN, V49, P11326, DOI 10.1039/c3cc47203e; TOLMAN CA, 1977, CHEM REV, V77, P313, DOI 10.1021/cr60307a002; MORITA DK, 1995, J AM CHEM SOC, V117, P8576, DOI 10.1021/ja00138a012; LOUIE J, 1995, J AM CHEM SOC, V117, P11598, DOI 10.1021/ja00151a033; Kambe N, 2011, CHEM SOC REV, V40, P4937, DOI 10.1039/c1cs15129k; Hamill TG, 2005, SYNAPSE, V56, P205, DOI 10.1002/syn.20147; Gallagher WP, 2001, J AM CHEM SOC, V123, P3194, DOI 10.1021/ja0035295; Tarkiainen J, 2001, J LABELLED COMPD RAD, V44, P1013, DOI 10.1002/jlcr.523; Hosoya T, 2006, ORG BIOMOL CHEM, V4, P410, DOI 10.1039/b515215a; Espinet P, 2004, ANGEW CHEM INT EDIT, V43, P4704, DOI 10.1002/anie.200300638; Chinchilla R, 2011, CHEM SOC REV, V40, P5084, DOI 10.1039/c1cs15071e; Sore HF, 2012, CHEM SOC REV, V41, P1845, DOI 10.1039/c1cs15181a; Stathakis CI, 2012, ANGEW CHEM INT EDIT, V51, P9428, DOI 10.1002/anie.201204526; [Anonymous], 1994, 5 INT S SYNTH APPL I; Toyohara J, 2009, ANN NUCL MED, V23, P301, DOI 10.1007/s12149-009-0240-x; LANGSTROM B, 1976, INT J APPL RADIAT IS, V27, P357, DOI 10.1016/0020-708X(76)90088-0; Bennacef I, 2007, J ORG CHEM, V72, P2161, DOI 10.1021/jo062285p; Bjorkman M, 1998, ACTA CHEM SCAND, V52, P635, DOI 10.3891/acta.chem.scand.52-0635; CROUZEL C, 1987, APPL RADIAT ISOTOPES, V38, P601; Devasagayaraj A, 1995, ANGEW CHEM INT EDIT, V34, P2723; Doi H, 2012, B CHEM SOC JPN, V85, P1233, DOI 10.1246/bcsj.20120151; Doi H, 2009, CHEM-EUR J, V15, P4165, DOI 10.1002/chem.200801974; Gerasimov MR, 2002, LIFE SCI, V70, P2811, DOI 10.1016/S0024-3205(02)01542-4; Gerasimov MR, 2002, NUCL MED BIOL, V29, P607, DOI 10.1016/S0969-8051(02)00315-3; Goossen L. J., 2004, APPL ORGANOMET CHEM, V18, P602; Hansen HD, 2014, J NUCL MED, V55, P640, DOI 10.2967/jnumed.113.128983; HECK RF, 1982, ORG REACTIONS, V27, P345; Hosoya T, 2004, ORG BIOMOL CHEM, V2, P24, DOI 10.1039/b311532a; Hostetler ED, 1998, J ORG CHEM, V63, P1348, DOI 10.1021/jo9718657; Huang YY, 2005, J MED CHEM, V48, P5096, DOI 10.1021/jm050263+; Huiban M, 2006, CHEM COMMUN, P97, DOI 10.1039/b510286c; Iida Y, 2004, J NUCL MED, V45, P878; Ijuin R, 2012, BIOORGAN MED CHEM, V20, P3703, DOI 10.1016/j.bmc.2012.04.051; ISHIYAMA T, 1992, CHEM LETT, P691, DOI 10.1246/cl.1992.691; Kanazawa M, 2011, BIOORG MED CHEM LETT, V21, P2017, DOI 10.1016/j.bmcl.2011.02.018; Karimi F, 2002, J LABELLED COMPD RAD, V45, P423, DOI 10.1002/jlcr.569; Kawamura K, 2010, NUCL MED BIOL, V37, P625, DOI 10.1016/j.nucmedbio.2010.02.013; Kawamura K, 2006, ANN NUCL MED, V20, P417; KIHLBERG T, 1994, ACTA CHEM SCAND, V48, P570, DOI 10.3891/acta.chem.scand.48-0570; Kimura T, 2013, CHEMMEDCHEM, V8, P1035, DOI 10.1002/cmdc.201300167; Johansson Seechurn Carin C C, 2012, Angew Chem Int Ed Engl, V51, P5062, DOI 10.1002/anie.201107017; Koyama H, 2011, ORG BIOMOL CHEM, V9, P4287, DOI 10.1039/c0ob01249a; Koyama H, 2013, RSC ADV, V3, P9391, DOI 10.1039/c3ra40815a; Langer O, 2003, J LABELLED COMPD RAD, V46, P55, DOI 10.1002/jlcr.642; Link JM, 1997, NUCL MED BIOL, V24, P93, DOI 10.1016/S0969-8051(96)00181-3; Madsen J, 2003, BIOORGAN MED CHEM, V11, P3447, DOI 10.1016/S0968-0896(03)00307-9; MARAZANO C, 1977, INT J APPL RADIAT IS, V28, P49, DOI 10.1016/0020-708X(77)90159-4; Miyazaki S, 2013, EUR J PHARMACOL, V710, P120, DOI 10.1016/j.ejphar.2012.10.023; Neu H, 1997, J LABELLED COMPD RAD, V39, P509, DOI 10.1002/(SICI)1099-1344(199706)39:6<509::AID-JLCR996>3.0.CO;2-H; Neu H, 1997, J LABELLED COMPD RAD, V39, P607, DOI 10.1002/(SICI)1099-1344(199707)39:7<607::AID-JLCR7>3.0.CO;2-A; Paul F., 1995, ORGANOMETALLICS, V14, P3030, DOI DOI 10.1021/OM00006A053; Prabhakaran J, 2005, J LABELLED COMPD RAD, V48, P887, DOI 10.1002/jlcr.1002; SAA JM, 1993, J ORG CHEM, V58, P1963, DOI 10.1021/jo00059a064; Sandell J, 2002, NUCL MED BIOL, V29, P651, DOI 10.1016/S0969-8051(02)00318-9; Sandell J, 2002, BIOORG MED CHEM LETT, V12, P3611, DOI 10.1016/S0960-894X(02)00787-4; STILLE JK, 1986, ANGEW CHEM INT EDIT, V25, P508, DOI 10.1002/anie.198605081; Suzuki A., 2011, ANGEW CHEM INT EDIT, V50, P6723; Suzuki M, 2009, CHEM-EUR J, V15, P12489, DOI 10.1002/chem.200901145; Suzuki M, 2012, TETRAHEDRON, V68, P2336, DOI 10.1016/j.tet.2012.01.033; Suzuki M, 2004, TRAC-TREND ANAL CHEM, V23, P595, DOI 10.1016/j.trac.2004.06.003; Suzuki M, 1996, ANGEW CHEM INT EDIT, V35, P334, DOI 10.1002/anie.199603341; Suzuki M, 1997, CHEM-EUR J, V3, P2039, DOI 10.1002/chem.19970031219; Suzuki M., BIOORG MED CHEM LETT, V24, P3622; Takashima T, 2010, J PHARMACOL EXP THER, V335, P314, DOI 10.1124/jpet.110.170092; Takashima T, 2012, J NUCL MED, V53, P741, DOI 10.2967/jnumed.111.098681; Takashima-Hirano M, 2011, BIOORGAN MED CHEM, V19, P2997, DOI 10.1016/j.bmc.2011.03.020; TAMURA M, 1971, J AM CHEM SOC, V93, P1485; TAMURA M, 1971, J AM CHEM SOC, V93, P1483; TAMURA M, 1972, J ORGANOMET CHEM, V42, P205, DOI 10.1016/S0022-328X(00)81848-3; Wuest FR, 2006, J LABELLED COMPD RAD, V49, P91, DOI 10.1002/jlcr.1044; Wust F, 2003, J LABELLED COMPD RAD, V46, P333, DOI 10.1002/jlcr.674; Yamasaki Tomoteru, 2014, Am J Nucl Med Mol Imaging, V4, P260; Zeng FX, 2009, J MED CHEM, V52, P62, DOI 10.1021/jm800817h; Zhang MR, 2005, APPL RADIAT ISOTOPES, V62, P447, DOI 10.1016/j.apradiso.2004.07.003	98	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0362-4803	1099-1344		J LABELLED COMPD RAD	J. Label. Compd. Radiopharm.	MAR	2015	58	3			SI		73	85		10.1002/jlcr.3253		13	Biochemical Research Methods; Chemistry, Medicinal; Chemistry, Analytical	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CE3XV	WOS:000351764300005		
J	Suzuki, C; Kato, K; Tsuji, AB; Zhang, MR; Arano, Y; Saga, T				Suzuki, Chie; Kato, Koichi; Tsuji, Atsushi B.; Zhang, Ming-Rong; Arano, Yasushi; Saga, Tsuneo			Inhibition of radical reactions for an improved potassium tert-butoxide-promoted C-11-methylation strategy for the synthesis of alpha-C-11-methyl amino acids	JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS			English	Article						-methylation; amino acid; Schiff base; potassium tert-butoxide; PET; electron transfer; radical	METHYL-L-TRYPTOPHAN; BIOLOGICAL EVALUATION; TYROSINE	alpha-C-11-Methyl amino acids are useful tools for biological imaging studies. However, a robust procedure for the labeling of amino acids has not yet been established. In this study, the C-11-methylation of Schiff-base-activated -amino acid derivatives has been optimized for the radiosynthesis of various -C-11-methyl amino acids. The benzophenone imine analog of methyl 2-amino butyrate was C-11-methylated with [C-11]methyl iodide following its initial deprotonation with potassium tert-butoxide (KOtBu). The use of an alternative base such as tetrabutylammonium fluoride, triethylamine, and 1,8-diazabicyclo[5.4.0]undec-7-ene did not result in the C-11-methylated product. Furthermore, the KOtBu-promoted C-11-methylation of the Schiff-base-activated amino acid analog was enhanced by the addition of 1,2,4,5-tetramethoxybenzene or 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) and inhibited by the addition of 1,10-phenanthroline. These results suggest that inhibition of radical generation induced by KOtBu improves the -C-11-methylation of the Schiff-base-activated amino acids. The addition of a mixture of KOtBu and TEMPO to a solution of Schiff-base-activated amino acid ester and [C-11]methyl iodide provided optimal results, and the tert-butyl ester and benzophenone imine groups could be readily hydrolyzed to give the desired -C-11-methyl amino acids with a high radiochemical conversion. This strategy could be readily applied to the synthesis of other -C-11-methyl amino acids.	[Suzuki, Chie; Tsuji, Atsushi B.; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Inage Ku, Chiba 2638555, Japan; [Suzuki, Chie; Arano, Yasushi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chuo Ku, Chiba 2608675, Japan; [Kato, Koichi] Natl Ctr Neurol & Psychiat, Dept Integrat Brain Imaging, Kodaira, Tokyo 1875551, Japan; [Kato, Koichi; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Grp, Chiba 2638555, Japan	Kato, K (reprint author), Natl Ctr Neurol & Psychiat, Dept Integrat Brain Imaging, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1875551, Japan.	katok@ncnp.go.jp		Tsuji, Atsushi/0000-0003-2726-288X	MEXT [KAKENHI 23510289, 24591803]; JSPS	We would like to thank the staff of the Cyclotron Operation and Radiochemistry sections for the production of the radioisotope, technical support for the remote-controlled synthesis, and the identification of compounds by mass spectral analysis. This work was supported in part by KAKENHI 23510289 and 24591803 from MEXT and JSPS.	Tomiyoshi K, 1997, NUCL MED COMMUN, V18, P169, DOI 10.1097/00006231-199702000-00013; Shirakawa E, 2010, J AM CHEM SOC, V132, P15537, DOI 10.1021/ja1080822; Kato K, 2011, BIOORG MED CHEM LETT, V21, P2437, DOI 10.1016/j.bmcl.2011.02.065; Huang CF, 2013, J NUCL MED, V54, P1007, DOI 10.2967/jnumed.112.113100; Yu WP, 2007, J MED CHEM, V50, P6718, DOI 10.1021/jm070476u; Chugani DC, 2011, BIOMARK MED, V5, P567, DOI [10.2217/bmm.11.73, 10.2217/BMM.11.73]; Jager PL, 2001, J NUCL MED, V42, P432; BENINGTON F, 1955, J ORG CHEM, V20, P102, DOI 10.1021/jo01119a017; BIERSACK HJ, 1989, J NUCL MED, V30, P110; CAMMARATA PS, 1950, J BIOL CHEM, V187, P439; CHALY T, 1988, J NUCL MED, V29, P370; DUNZENDORFER U, 1981, EUR J NUCL MED, V6, P535; Inoue T, 1998, J NUCL MED, V39, P663; Kim B. R., 2013, TETRAHEDRON, V36, P10331; MARAZANO C, 1977, INT J APPL RADIAT IS, V28, P49, DOI 10.1016/0020-708X(77)90159-4; McConathy J, 2002, J MED CHEM, V45, P2240, DOI 10.1021/jm010241x; McConathy J, 2003, NUCL MED BIOL, V30, P477, DOI 10.1016/S0969-8051(03)00025-8; MIYASHI T, 1987, J AM CHEM SOC, V109, P2780, DOI 10.1021/ja00243a035; ODONNELL MJ, 1978, TETRAHEDRON LETT, P2641; ODONNELL MJ, 1988, J AM CHEM SOC, V110, P8520, DOI 10.1021/ja00233a031; ROBERTS DD, 1964, J ORG CHEM, V29, P2714, DOI 10.1021/jo01032a058	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0362-4803	1099-1344		J LABELLED COMPD RAD	J. Label. Compd. Radiopharm.	MAR	2015	58	3			SI		127	132		10.1002/jlcr.3259		6	Biochemical Research Methods; Chemistry, Medicinal; Chemistry, Analytical	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CE3XV	WOS:000351764300009		
J	Fujihara, A; Maeda, N; Hayakawa, S				Fujihara, Akimasa; Maeda, Naoto; Hayakawa, Shigeo			Quantitative chiral analysis of tryptophan using enantiomer-selective photolysis of cold non-covalent complexes in the gas phase	JOURNAL OF MASS SPECTROMETRY			English	Letter						chirality recognition; photolysis; amino acid; cluster; quantitative analysis	MASS-SPECTROMETRY; RECOGNITION; ACID		[Fujihara, Akimasa; Maeda, Naoto; Hayakawa, Shigeo] Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Naka Ku, Sakai, Osaka 5998531, Japan	Fujihara, A (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	fujihara@c.s.osakafu-u.ac.jp					SAWADA M, 1995, J AM CHEM SOC, V117, P7726, DOI 10.1021/ja00134a017; Fujihara A, 2014, CHEM PHYS LETT, V610, P228, DOI 10.1016/j.cplett.2014.07.045; Tao WA, 2000, J AM CHEM SOC, V122, P10598, DOI 10.1021/ja000127o; Scuderi D, 2010, J PHYS CHEM A, V114, P3306, DOI 10.1021/jp9094497; Scriba GKE, 2012, CHROMATOGRAPHIA, V75, P815, DOI 10.1007/s10337-012-2261-1; Zehnacker A, 2008, ANGEW CHEM INT EDIT, V47, P6970, DOI 10.1002/anie.200800957; CHU IH, 1993, J AM CHEM SOC, V115, P4318, DOI 10.1021/ja00063a056; Fujihara A, 2014, ORIGINS LIFE EVOL B, V44, P67, DOI 10.1007/s11084-014-9370-9; Fuke K, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4742768; Gerbaux P, 2008, CHEM-EUR J, V14, P11039, DOI 10.1002/chem.200801372; Nagata H, 2009, B CHEM SOC JPN, V82, P219, DOI 10.1246/bcsj.82.219	11	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1076-5174	1096-9888		J MASS SPECTROM	J. Mass Spectrom.	MAR	2015	50	3					451	453		10.1002/jms.3547		3	Biochemical Research Methods; Chemistry, Analytical; Spectroscopy	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	CE2WP	WOS:000351682100003		
J	Kusano, M; Zaitsu, K; Nakayama, H; Nakajima, J; Hisatsune, K; Moriyasu, T; Matsuta, S; Katagi, M; Tsuchihashi, H; Ishii, A				Kusano, Maiko; Zaitsu, Kei; Nakayama, Hiroshi; Nakajima, Junichi; Hisatsune, Kazuaki; Moriyasu, Takako; Matsuta, Shuntaro; Katagi, Munehiro; Tsuchihashi, Hitoshi; Ishii, Akira			Positional isomer differentiation of synthetic cannabinoid JWH-081 by GC-MS/MS	JOURNAL OF MASS SPECTROMETRY			English	Article						synthetic cannabinoids; JWH-081; positional isomers; GC-MS; MS	CHROMATOGRAPHY-MASS SPECTROMETRY; REGIOISOMERIC DIFFERENTIATION; MS-MS; IDENTIFICATION; SPICE; DISCRIMINATION	Like many new designer drugs of abuse, synthetic cannabinoids (SC) have structural or positional isomers which may or may not all be regulated under law. Differences in acute toxicity may exist between isomers which impose further burden in the fields of forensic toxicology, medicine and legislation. Isomer differentiation therefore becomes crucial from these standpoints as new designer drugs continuously emerge with just minor positional modifications to their preexisting analogs. The aim of this study was to differentiate the positional isomers of JWH-081. Purchased standard compounds of JWH-081 and its positional isomers were analyzed by gas chromatography-electron ionization-mass spectrometry (GC-EI-MS) first in scan mode to investigate those isomers who could be differentiated by EI scan spectra. Isomers with identical or near-identical EI spectra were further subjected to GC-tandem mass spectrometry (MS/MS) analysis with appropriate precursor ions. EI scan was able to distinguish 3 of the 7 isomers: 2-methoxy, 7-methoxy and 8-methoxy. The remaining isomers exhibited near-identical spectra; hence, MS/MS was performed by selecting m/z 185 and 157 as precursor ions. 3-Methoxy and 5-methoxy isomers produced characteristic product ions that enabled the differentiation between them. Product ion spectrum of 6-methoxy isomer resembled that of JWH-081; however, the relative ion intensities were clearly different from one another. The combination of EI scan and MS/MS allowed for the regioisomeric differentiation of the targeted compounds in this study. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Kusano, Maiko; Zaitsu, Kei; Nakayama, Hiroshi; Tsuchihashi, Hitoshi; Ishii, Akira] Nagoya Univ, Dept Legal Med & Bioeth, Nagoya, Aichi 4648601, Japan; [Nakajima, Junichi; Moriyasu, Takako] Tokyo Metropolitan Inst Publ Hlth, Tokyo 1690073, Japan; [Hisatsune, Kazuaki] Aichi Prefectural Police Headquarters, Forens Sci Lab, Nagoya, Aichi, Japan; [Matsuta, Shuntaro; Katagi, Munehiro] Osaka Prefectural Police Headquarters, Forens Sci Lab, Osaka, Japan; [Tsuchihashi, Hitoshi] Osaka Med Coll, Dept Legal Med, Osaka, Japan	Zaitsu, K (reprint author), Nagoya Univ Grad Sch Med, Dept Legal Med & Bioeth, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kzaitsu@med.nagoya-u.ac.jp	Ishii, Akira/I-1965-2012				A. C. o. t. M. o. Drugs, 2009, ACMD DRUG SPECIFIC R; Aalberg L, 2003, J CHROMATOGR SCI, V41, P227; Lindigkeit R, 2009, FORENSIC SCI INT, V191, P58, DOI 10.1016/j.forsciint.2009.06.008; Uchiyama N, 2010, FORENSIC SCI INT, V198, P31, DOI 10.1016/j.forsciint.2010.01.004; Seely KA, 2013, FORENSIC SCI INT, V233, P416, DOI 10.1016/j.forsciint.2013.10.002; Harris DN, 2014, INT J MASS SPECTROM, V368, P23, DOI 10.1016/j.ijms.2014.05.005; Zaitsu K, 2008, FORENSIC TOXICOL, V26, P45, DOI 10.1007/s11419-008-0050-1; German CL, 2014, LIFE SCI, V97, P2, DOI 10.1016/j.lfs.2013.07.023; HAMMERUM S, 1988, MASS SPECTROM REV, V7, P123, DOI 10.1002/mas.1280070202; Lewin AH, 2014, LIFE SCI, V97, P9, DOI 10.1016/j.lfs.2013.09.026; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; KARNI M, 1980, ORG MASS SPECTROM, V15, P53, DOI 10.1002/oms.1210150202; Zaitsu K, 2013, FORENSIC TOXICOL, V31, P292, DOI 10.1007/s11419-013-0193-6; Zaitsu K, 2008, FORENSIC SCI INT, V177, P77, DOI 10.1016/j.forsciint.2007.11.001; Borth S, 2000, J MASS SPECTROM, V35, P705, DOI 10.1002/1096-9888(200006)35:6<705::AID-JMS997>3.0.CO;2-3; Borth S, 2000, FORENSIC SCI INT, V114, P139, DOI 10.1016/S0379-0738(00)00296-6; Clark CR, 1996, J CHROMATOGR SCI, V34, P34; Kikura-Hanajiri R, 2014, DRUG TEST ANAL, V6, P832, DOI 10.1002/dta.1584; Kikura-Hanajiri R, 2008, YAKUGAKU ZASSHI, V128, P971, DOI 10.1248/yakushi.128.971; Mazzarino M, 2014, ANAL CHIM ACTA, V837, P70, DOI 10.1016/j.aca.2014.06.003; Moosmann B, 2012, FORENSIC SCI INT, V220, pE17, DOI 10.1016/j.forsciint.2011.12.010; Shevyrin V, 2014, FORENSIC SCI INT, V244, P263, DOI 10.1016/j.forsciint.2014.09.013; U. S. D. o. J. D. E. Administration, 2012, FED REG, V77, P7; Uchiyama N, 2011, FORENSIC TOXICOL, V29, P25, DOI 10.1007/s11419-010-0100-3; UNODC, 2011, SYNTH CANN HERB PROD; Westphal F, 2010, FORENSIC SCI INT, V194, P53, DOI 10.1016/j.forsciint.2009.10.007; Zaitsu K, 2008, J MASS SPECTROM, V43, P528, DOI 10.1002/jms.1347	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1076-5174	1096-9888		J MASS SPECTROM	J. Mass Spectrom.	MAR	2015	50	3					586	591		10.1002/jms.3565		6	Biochemical Research Methods; Chemistry, Analytical; Spectroscopy	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	CE2WP	WOS:000351682100018		
J	Choi, JC; Uyama, H; Lee, CH; Sung, MH				Choi, Jae-Chul; Uyama, Hiroshi; Lee, Chul-Hoon; Sung, Moon-Hee			In Vivo Hair Growth Promotion Effects of Ultra-High Molecular Weight Poly-gamma-Glutamic Acid from Bacillus subtilis (Chungkookjang)	JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Ultra-high molecular weight poly-gamma-glutamic acid (UHMW gamma-PGA); hair growth; alopecia; 5-alpha reductase	ALOPECIA; MICE; DIAGNOSIS; ANTIGEN; MODEL	We investigated the effect of ultra-high molecular weight poly-gamma-glutamic acid (UHMW gamma-PGA) on hair loss in vitro and in vivo. 5-Alpha reductase is an enzyme that metabolizes the male hormone testosterone into dihydrotestosterone. By performing an in vitro experiment to analyze the inhibitory effects of UHMW gamma-PGA on 5-alpha reductase activity, we determined that UHMW gamma-PGA did in fact inhibit 5-alpha reductase activity, indicating the use of UHMW gamma-PGA as a potential 5-alpha reductase inhibitor in the treatment of men with androgenetic alopecia. To evaluate the promotion of hair growth in vivo, we topically applied UHMW gamma-PGA and minoxidil on the shaved dorsal skin of telogenic C57BL/6 mice for 4 weeks. At 4 weeks, the groups treated with UHMW gamma-PGA showed hair growth on more than 50% of the shaved skin, whereas the control group showed less hair growth. To investigate the progression of hair follicles in the hair cycle, hematoxylin and eosin staining was performed. Histological observations revealed that the appearance of hair follicles was earlier in the UHMW gamma-PGA-treated group than in the control group. The number of hair follicles on the relative area of shaved skin in the UHMW gamma-PGA-treated group was higher than that observed on the shaved skin in the control group. These results indicate that UHMW gamma-PGA can promote hair growth by effectively inducing the anagen phase in telogenic C57BL/6 mice.	[Choi, Jae-Chul; Sung, Moon-Hee] BioLeaders Corp, Taejon 305500, South Korea; [Choi, Jae-Chul; Sung, Moon-Hee] Kookmin Univ, Dept Bio & Fermentat Convergence Technol, Seoul 136702, South Korea; [Uyama, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Lee, Chul-Hoon] Hanyang Univ, Coll Pharm, Dept Pharm, Kyeonggi Do 426791, South Korea	Sung, MH (reprint author), BioLeaders Corp, Taejon 305500, South Korea.	chhlee@hanyang.ac.kr; smoonhee@kookmin.ac.kr			Technological Innovation R&D Program - Small and Medium Business Administration (SMBA, Korea) [S2058537]; Kookmin University in Korea	This work was supported by the Technological Innovation R&D Program (S2058537) funded by the Small and Medium Business Administration (SMBA, Korea) and by the 2012 research fund of Kookmin University in Korea.	Adam ET, 2010, J BIOMED OPT, V15; Kim TW, 2007, J IMMUNOL, V179, P775; Moon HJ, 2012, ANTIVIR RES, V94, P98, DOI [10.1016/j.antiviral.2012.02.010, 10.1016/j.antivira1.2012.02.010]; Stefanato CM, 2010, HISTOPATHOLOGY, V56, P24, DOI 10.1111/j.1365-2559.2009.03439.x; Zhao J, 2011, GROWTH HORM IGF RES, V21, P260, DOI 10.1016/j.ghir.2011.07.003; Hillmann K, 2009, SEMIN CUTAN MED SURG, V28, P33, DOI 10.1016/j.sder.2008.12.005; Ashiuchi M, 2001, APPL MICROBIOL BIOT, V57, P764; Wosicka H, 2010, J DERMATOL SCI, V57, P83, DOI 10.1016/j.jdermsci.2009.12.005; Gregoriou S, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/928030; D'Amico AV, 2007, LANCET ONCOL, V8, P21, DOI 10.1016/S1470-2045(06)70981-0; Gelfuso GM, 2013, J PHARM SCI-US, V102, P1488, DOI 10.1002/jps.23485; TARLOW JK, 1994, J INVEST DERMATOL, V103, P387, DOI 10.1111/1523-1747.ep12395398; Park HJ, 2011, J ETHNOPHARMACOL, V135, P369, DOI 10.1016/j.jep.2011.03.028; Gordon Katherine A, 2011, Clin Cosmet Investig Dermatol, V4, P101, DOI 10.2147/CCID.S10182; Kaufman K D, 1999, Expert Opin Investig Drugs, V8, P403, DOI 10.1517/13543784.8.4.403; Lee TY, 2009, CANCER IMMUNOL IMMUN, V58, P1783, DOI 10.1007/s00262-009-0689-4; Lim YT, 2011, SMALL, V7, P3281, DOI 10.1002/smll.201101836; Park C, 2009, POLYM SCI TECHNOL, V20, P440; Shin HS, 2013, PHYTOTHER RES, V27, P1352, DOI 10.1002/ptr.4870; Stenn KS, 2001, PHYSIOL REV, V71, P450; Sun ZY, 1998, METHOD FIND EXP CLIN, V20, P283; Tosti A, 2009, Minerva Ginecol, V61, P445	22	0	0	KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY	SEOUL	KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL 135-703, SOUTH KOREA	1017-7825	1738-8872		J MICROBIOL BIOTECHN	J. Microbiol. Biotechnol.	MAR	2015	25	3					407	412		10.4014/jmb.1411.11076		6	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CE6VH	WOS:000351975800015		
J	Murata, D				Murata, Daisuke			The Kogei Tragedy	JOURNAL OF MODERN CRAFT			English	Article						kogei; crafts; museology; contemporary art; curation; national identity; nationalism; art and globalization		The Japanese word kogei, which has been translated as "craft" in English by art historians and museum curators, is a term that developed in Japan during the process of modernization in the early years of the Meiji period (1868-1912). Under this name, Japanese handicrafts were exported to the West in the second half of the nineteenth century, to satiate the demand among artists, scholars, and metropolitan middle-class audiences for all things Japanese (commonly known as Japonisme). Exported handicrafts boosted national prestige and brought in foreign money, in line with the Meiji government's policy of bolstering the export industry. Since then, the meaning of kogei has changed in accordance with government ideology. This article examines the current "kogei campaign" and exposes the business logic found in its rhetoric, which emphasizes the economic value of the object above all else. The champions of the campaign use terms like "international" and "future" as key words, and ensnare famous figures and artists to broaden their audience. By delineating Japanese "uniqueness," their activities reveal nationalistic overtones. I refer to this as the kogei tragedy, a situation in which kogei campaigns exploit the same framework of handicraft production and promotion established in the Meiji period, without reexamining its true artistic value from the perspective of kogei itself. In conclusion, this article suggests ways to move beyond this tragedy by discussing exhibitions that emphasize the notion of an object's intrinsic, rather than economic, value.(1)	[Murata, Daisuke] Toyama Glass Art Museum, Planning Off, Toyama, Japan; [Murata, Daisuke] 21st Century Museum Contemporary Art, Kanazawa, Ishikawa, Japan	Murata, D (reprint author), Toyama Glass Art Museum, Planning Off, Toyama, Japan.						[Anonymous], 2014, BRUNO TAUT KOGEI NIP; [Anonymous], 2012, 8 CONV INT ASS JAP S; [Anonymous], 2012, KAIGAI AATO MAAKETTO; [Anonymous], 2014, COMMEMORATION 60 JAP; Aoyagi Masanori, 2010, LKKAI KANAZAWA SEKAI; Aoyagi Masanori, 2012, KOGEI SEKAIKA WA KAN; Buddhism Zen, 2013, J CONT ART CULTURE 1, V5, P13; Fudo's Misato, 2005, ALTERNATIVE PARADISE, P12; Gallery Craft, 2009, POWER DECORATION VIE; Gallery Craft, 2004, COLL LIGHT NEW SPIRI; Gallery Craft, 1994, DOMAIN MEDIUM NEW AP; Gallery Crafts, 2014, CHOZETSU GIKO MEIJI; Kaneko Kenji, 2001, GENDAI TOGEI ZOKEI S, P29; Karasawa Masahiro, 2013, COMMEMORATION 60 JAP, P128; Kida T, 2012, J DES HIST, V25, P379, DOI 10.1093/jdh/eps033; Kitazawa Noriaki, 2012, BIJUTSU TECHO, V64, P178; Kitazawa Noriaki, 2013, BIJUTSU POLITIKUSU K; Koyama Tomio, 2008, GENNDAI AATO BIJINES, P30; Mason's Penelope, 1993, HIST JAPANESE ART; Murata Daisuke, 2013, J CONT ART CULTURES, V5, P158; Murata Daisuke, 2008, RON MUECK, P79; Murata Daisuke, 2008, KOGEI FORMATION INCL; Nara Yoshitomo, 2010, CERAMIC WORKS, P87; Said's Edward W, 1994, CULTURE IMPERIALISM, P262; Sato Doshin, 2011, MODERN JAPANESE ART; Sutcliffe Bob, 1975, STUDIES THEORY IMPER, P118; Tsuchida Maki, 2007, SAMAYOERU KOGEI YANA; Varley Paul, 1999, JAPANESE CULTURE; Varley's Paul, 1999, JAPANESE CULTURE; Yamasaki's Akiko, 2012, J MODERN CRAFT, V5	30	0	0	BLOOMSBURY PUBLISHING  PLC	LONDON	50 BEDFORD SQ, LONDON, WC1B 3DP, ENGLAND	1749-6772	1749-6780		J MOD CRAFT	J. Mod. Craft	MAR	2015	8	1					9	28		10.2752/174967715X14213400209836		20	Art	Art	CE5PZ	WOS:000351889400002		
J	Ingxay, P; Yokoyama, S; Hirota, I				Ingxay, Phanxay; Yokoyama, Satoshi; Hirota, Isao			Livelihood factors and household strategies for an unexpected climate event in upland northern Laos	JOURNAL OF MOUNTAIN SCIENCE			English	Article						Climate events; Livelihood factors; Livelihood change; Household strategy; Swidden	COPING STRATEGIES; CHANGE IMPACTS; SOUTH-AFRICA; ADAPTATION; VULNERABILITY; LIVESTOCK; AGRICULTURE; VARIABILITY; RESILIENCE; TRANSITION	Climate events pose major challenges to food production and the livelihoods of rural inhabitants in northern Laos, where upland rice using swidden production is an important crop. The onset of the rainy season in this area is one such climate event, and it has occurred earlier and with less regularity in recent years. Not all households are able to cope with these changes. This study examines the ability of local farmers to cope with rice insufficiency. This investigation also clarifies household strategies in dealing with the climate event. We randomly interviewed 63 of 95 household heads, and performed a paired sample t test to examine the significance of differences in three household groups between the 2010 normal climate and the 2011 climate event. The groups were categorized according to rice self-sufficiency in 2011: groups I are households with rice self-sufficiency, group II are those facing a rice shortage of up to 3 months, and group III are those with insufficient rice for over 3 months. We also conducted a one-way ANOVA to examine the significance of differences in livelihood strategies among the three groups. We found that the household labor force was the most important factor in enhancing the villagers' ability to deal with the climate event and that the level of impact of that event shaped their coping strategies. Households with substantial labor force had more options for coping strategies than those with smaller ones. The villagers faced different levels of impact and adopted different coping strategies accordingly. Non-timber forest product collection was the principle livelihood strategy in response to non-climate factors such as education, access to health services, provision of equipment and clothing, and overcoming the impact of the climate event. Households heavily affected by the early rainy season onset tended to engage in intensive activities such as off-farm activity and outside work, rather than their major livelihood activities in the village (upland crop and livestock production).	[Ingxay, Phanxay; Yokoyama, Satoshi] Nagoya Univ, Grad Sch Environm Studies, Dept Geog, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hirota, Isao] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4644601, Japan	Ingxay, P (reprint author), Nagoya Univ, Grad Sch Environm Studies, Dept Geog, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	phanxay_@hotmail.com; s-yokoyama@nagoya-u.jp; isao@nagoya-u.jp			Japan Society for the Promotion of Science; Kakenhi	We are grateful for the support and information provided by the Kachet residents during our field survey. We also thank all the reviewers for their valuable suggestions and comments on this paper. This research was funded by Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (Kakenhi), Scientific Research (A). Principal Investigator: Tomoya AKIMICHI, Research Institute for Humanity and Nature, and Ministry of Education, Culture, Sports, Science and Technology, Global Center of Excellence (GCOE) Program. Principal Investigator: Tetsuzo YASUNARI, Nagoya University.	Adger WN, 1999, WORLD DEV, V27, P249, DOI 10.1016/S0305-750X(98)00136-3; Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Adger WN, 2001, 8 U E ANG TYND CTR C; Adger WN, 1996, GLOBAL ENV CHANGE WO, V96-05; Alexander KS, 2009, SUSTAIN DEV, V18, P62, DOI [10.1002/sd.428, DOI 10.1002/SD.428]; Eriksen S, 2009, ENVIRON SCI POLICY, V12, P33, DOI 10.1016/j.envsci.2008.10.007; Paavola J, 2008, ENVIRON SCI POLICY, V11, P642, DOI 10.1016/j.envsci.2008.06.002; Lebel L, 2011, REG ENVIRON CHANGE, V11, P45, DOI 10.1007/s10113-010-0118-4; Adger WN, 2005, GLOBAL ENVIRON CHANG, V15, P77, DOI [10.1016/j.gloenvcha.2004.12.005, 10.1016/j.gloenvcha.2005.03.001]; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Nguyen Q, 2013, CLIMATIC CHANGE, V117, P241, DOI 10.1007/s10584-012-0550-1; Sissoko K, 2011, REG ENVIRON CHANGE, V11, pS119, DOI 10.1007/s10113-010-0164-y; McPeak J, 2004, OXFORD ECON PAP, V56, P263, DOI 10.1093/oep/gpf040; Sivakumar MVK, 2005, CLIMATIC CHANGE, V70, P31, DOI 10.1007/s10584-005-5937-9; Kelly PM, 2000, CLIMATIC CHANGE, V47, P325, DOI 10.1023/A:1005627828199; van Aalst MK, 2008, GLOBAL ENVIRON CHANG, V18, P165, DOI 10.1016/j.gloenvcha.2007.06.002; Reid P, 2006, GLOBAL ENVIRON CHANG, V16, P195, DOI 10.1016/j.gloenvcha.2006.01.003; Thongmanivong S, 2006, MT RES DEV, V26, P237, DOI 10.1659/0276-4741(2006)26[237:RLUALT]2.0.CO;2; Ali A, 1999, CLIMATE RES, V12, P109, DOI 10.3354/cr012109; Stringer LC, 2009, ENVIRON SCI POLICY, V12, P748, DOI 10.1016/j.envsci.2009.04.002; Kazianga H, 2006, J DEV ECON, V79, P413, DOI 10.1016/j.jdeveco.2006.01.011; Adger WN, 2000, ANN ASSOC AM GEOGR, V90, P738, DOI 10.1111/0004-5608.00220; Shrestha B, 2013, HYDROL EARTH SYST SC, V17, P1, DOI 10.5194/hess-17-1-2013; Mertz O, 2009, ENVIRON MANAGE, V43, P804, DOI 10.1007/s00267-008-9197-0; Pike A, 2010, CAMB J REG ECON SOC, V3, P59, DOI 10.1093/cjres/rsq001; Jansen L, 2003, J CLEAN PROD, V11, P231, DOI 10.1016/S0959-6526(02)00073-2; Eriksen SH, 2005, GEOGR J, V171, P287, DOI 10.1111/j.1475-4959.2005.00174.x; Lestrelin G, 2007, LAND DEGRAD DEV, V18, P55, DOI 10.1002/ldr.756; Thomas DSG, 2007, CLIMATIC CHANGE, V83, P301, DOI 10.1007/s10584-006-9205-4; Ng'ang'a SK, 2011, AFR J AGR RES, V6, P560; Schreider SY, 2000, CLIMATIC CHANGE, V47, P91, DOI 10.1023/A:1005621523177; Bastakoti RC, 2014, REG ENVIRON CHANGE, V14, P207, DOI 10.1007/s10113-013-0485-8; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Booij MJ, 2005, J HYDROL, V303, P176, DOI 10.1016/j.jhydrol.2004.07.013; Daskon C, 2009, COMMUNITY DEV J, V45, P494, DOI 10.1093/cdj/bsp019; DFID, 1999, SUST LIV GUID SHEETS; DFID, 2001, SUST LIV GUID SHEETS; DFID [Department for International Development], 2004, IMP CLIM CHANG VULN; DMH, 2012, ANN RAINF LUANG PHAB; Downing TE, 1991, RR911 BROWN U WORLD; Duan M, 2009, INT C GEOSP SOL EM M; Elasha B.O., 2005, 17 AIACC; Gaillard J. C., 2009, Journal of Coastal Conservation, V13, P119, DOI 10.1007/s11852-009-0054-y; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Hoekman BM, 2005, WORLD DEV, V33, P1587, DOI 10.1016/j.worlddev.2005.05.005; Ingxay P, 2005, THESIS KHON KAEN U T; Kanemaru K, 2014, ADV ASIAN HUM-ENV RE, P85, DOI 10.1007/978-4-431-54956-7_5; Kurukulasuriya P, 2006, WORLD BANK ECON REV, V20, P367, DOI 10.1093/wber/lhl004; Lebel L., 2009, CLIMATE CHANGE ADAPT, P125; Marten GG, 1986, TRADITIONAL AGR SE A; NSC, 2005, 2005 POP HOUS CENS; Ozturk I, 2009, EUR J DEV RES, V21, P250, DOI 10.1057/ejdr.2008.21; Rigg J, 1997, J DEV STUD, V33, P725; Roder W, 1997, MT RES DEV, V17, P1, DOI 10.2307/3673908; Simana S, 1997, KMHMUS LIVELIHOOD FA; Smithers J, 1997, GLOBAL ENVIRON CHANG, V7, P129, DOI 10.1016/S0959-3780(97)00003-4; Southavilay B, 2013, SUSTAINABLE AGR RES, V2, P70, DOI [10.5539/sar.v2nlp70, DOI 10.5539/SAR.V2NLP70]; Turner MD, 2002, WORLD DEV, V30, P683, DOI 10.1016/S0305-750X(01)00133-4; Yokoyama S, 2004, SE ASIAN STUD, V42, P132; Yokoyama S, 2010, SE ASIAN STUD, V47, P374; Yusuf A A, 2009, CLIMATE CHANGE VULNE	62	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1672-6316	1993-0321		J MT SCI-ENGL	J Mt. Sci.	MAR	2015	12	2					483	500		10.1007/s11629-013-2879-y		18	Environmental Sciences	Environmental Sciences & Ecology	CE2RQ	WOS:000351664200018		
J	Nakamura, K; Kitamura, K; Oshiki, R; Kobayashi, R; Saito, T; Nishiwaki, T				Nakamura, K.; Kitamura, K.; Oshiki, R.; Kobayashi, R.; Saito, T.; Nishiwaki, T.			Prolonged occupational activity and 6-year changes in postural sway in elderly women	JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS			English	Article						Cohort Studies; Occupational Activity; Physical Fitness; Postural Balance; Elderly Women	BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; POSTMENOPAUSAL WOMEN; JAPANESE WOMEN; STABILITY; FARMERS; BALANCE	Objectives: Prolonged occupational work such as farm work has been reported to adversely affect mobility in elderly women. The purpose of this study was to investigate possible relationships between prolonged occupational work and 6-year changes in postural sway in elderly women. Methods: Subjects were 392 women aged >= 69 years who participated in a 6-year follow-up examination of the Muramatsu Cohort Study. Handgrip strength and postural sway, measured as gravity-center velocity (cm/s), were evaluated at baseline and 6-year follow-up. Interviews were conducted to determine the time spent on moderate occupational activity (3-5 metabolic equivalents) such as farm work. Activity levels were defined as: 1, no-activity; 2, "short" (>0, <= 17.75 h/wk); and 3, "long" (>= 17.75 h/wk). Results: At baseline, mean values for age, handgrip strength, and postural sway were 73.3 years (SD 3.7), 20.3 kg (SD 4.1), and 2.0 cm/s (SD 0.8), respectively, and 32.5% of participants engaged in occupational activity. The change in postural sway was significantly greater in the long-activity group (median, 35.0 h/wk) than the no-activity group (0.56 vs. 0.27 cm/s, P=0.021). Conclusions: Prolonged occupational work may be detrimental to the control of body balance. Accordingly, elderly individuals are not recommended to engage in prolonged occupational activity.	[Nakamura, K.; Kitamura, K.] Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Med, Chuo Ku, Niigata 9518510, Japan; [Oshiki, R.; Kobayashi, R.] Niigata Univ Hlth & Welf, Dept Phys Therapy, Kita Ku, Niigata 9503198, Japan; [Saito, T.] Niigata Univ Hlth & Welf, Dept Hlth & Nutr, Kita Ku, Niigata 9503198, Japan; [Nishiwaki, T.] Hlth Sci Univ, Fac Nursing, Yamanashi 4010380, Japan	Nakamura, K (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Med, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kazun@med.niigata-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [21590722]	We would like to thank the staff at the Muramatsu Health Center for their help in data collection. This study was supported in part by a Grant-in-Aid for Scientific Research (C)No. 21590722 from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; Thapa PB, 1996, J GERONTOL A-BIOL, V51, pM239; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Nakamura K, 2006, OSTEOPOROSIS INT, V17, P1202, DOI 10.1007/s00198-006-0132-z; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Palmer KT, 2012, BRIT MED BULL, V102, P147, DOI 10.1093/bmb/lds012; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; Harbourne RT, 2009, PHYS THER, V89, P267, DOI 10.2522/ptj.20080130; Brooke-Wavell K, 2001, MATURITAS, V37, P167, DOI 10.1016/S0378-5122(00)00182-1; Holmberg S, 2003, ANN AGR ENV MED, V10, P179; Kitamura K, 2011, MATURITAS, V70, P80, DOI 10.1016/j.maturitas.2011.06.014; Maeda A, 1998, ARCH PHYS MED REHAB, V79, P994, DOI 10.1016/S0003-9993(98)90100-9; Nakamura K, 2011, AGE AGEING, V40, P132, DOI 10.1093/ageing/afq148; Walker-Bone K, 2002, OCCUP MED-OXFORD, V52, P441, DOI 10.1093/occmed/52.8.441	15	0	0	JMNI	NAFPLION	7 SPILIADOU SQ, NAFPLION, 21 100, GREECE	1108-7161			J MUSCULOSKEL NEURON	J. Musculoskelet. Neuronal Interact.	MAR	2015	15	1					78	82				5	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CE7GS	WOS:000352007200009		
J	Kadohata, A; Watanabe, A; Hirano, A				Kadohata, Akihiro; Watanabe, Atsushi; Hirano, Akira			Sub-lambda and Wavelength Path Reconfiguration in Multi-layer Transport Networks	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Defragmentation; Multi-layer transport networks; Reconfiguration; Regrooming	OPTICAL NETWORKS; WDM NETWORKS; DEFRAGMENTATION; TECHNOLOGIES; DISRUPTION; LAYER	We investigate adaptive reconfiguration of sub-lambda and wavelength paths to deal with unpredictable traffic demands. To accommodate traffic effectively, wavelength paths need to be reconfigured cooperatively with sub-lambda paths while minimizing the number of migration sequences. Therefore, we propose a scheme for sub-lambda and wavelength path reconfiguration based on wavelength resource management in multi-layer transport networks. Three steps comprise the proposed scheme: wavelength resource management, reconfiguration trigger, and reconfiguration. First, management of the number of wavelength paths that can be accommodated between all node pairs is calculated for each path accommodated. Second, if that number is less than the threshold value set in advance for some node pair, reconfiguration is performed. Third, the sub-lambda and wavelength paths are reconfigured. In this scheme, we also propose a sub-lambda path reconfiguration algorithm that reconfigures multi-hop sub-lambda paths to single-hop paths first, and two wavelength path reconfiguration algorithms that reduce wavelength fragmentation and the number of migration sequences considering the accommodation rate. Numerical evaluation shows that the number of fibers is suppressed by 12%-14% and that the equipment cost is reduced by approximately 8%-9% compared to when no reconfiguration is used. The results also show that the number of migration sequences for the wavelength defragmentation algorithms is reduced by approximately 23%-35% compared to that for the conventional algorithm.	[Kadohata, Akihiro; Watanabe, Atsushi; Hirano, Akira] NTT Corp, NTT Network Innovat Labs, Atsugi, Kanagawa, Japan	Kadohata, A (reprint author), NTT Corp, NTT Network Innovat Labs, Atsugi, Kanagawa, Japan.	kadohata.akihiro@lab.ntt.co.jp			National Institute of Information and Communications Technology (NICT) under Research and Development of Elastic Optical Network Technology	This work was partly supported by the National Institute of Information and Communications Technology (NICT) under the Research and Development of Elastic Optical Network Technology.	SATO K, 1994, IEEE J SEL AREA COMM, V12, P159, DOI 10.1109/49.265715; Gencata AE, 2003, IEEE ACM T NETWORK, V11, P236, DOI 10.1109/TNET.2003.810319; Chu XW, 2007, IEEE ICC, P2400, DOI 10.1109/ICC.2007.403; Gerstel O, 2012, IEEE COMMUN MAG, V50, pS12, DOI 10.1109/MCOM.2012.6146481; Saad M, 2005, J LIGHTWAVE TECHNOL, V23, P3092, DOI 10.1109/JLT.2005.856152; Kadohata A, 2013, J OPT COMMUN NETW, V5, P751, DOI 10.1364/JOCN.5.000751; Jinno M, 2009, IEEE COMMUN MAG, V47, P66, DOI 10.1109/MCOM.2009.5307468; Zhu KY, 2002, IEEE J SEL AREA COMM, V20, P122; Banerjee D, 2000, IEEE ACM T NETWORK, V8, P598, DOI 10.1109/90.879346; Bouillet E, 2005, IEEE ACM T NETWORK, V13, P437, DOI 10.1109/TNET.2005.845540; Yamazaki E, 2012, IEEE COMMUN MAG, V50, pS43, DOI 10.1109/MCOM.2012.6146484; Solano F, 2010, J OPT COMMUN NETW, V2, P1010, DOI 10.1364/JOCN.2.001010; Cugini F, 2013, J LIGHTWAVE TECHNOL, V31, P125, DOI 10.1109/JLT.2012.2225600; Kadohata A, 2012, IEEE COMMUN LETT, V16, P530, DOI 10.1109/LCOMM.2012.022112.111855; [Anonymous], 2012, INTERFACES OPTICAL T; Zhang YB, 2005, J LIGHTWAVE TECHNOL, V23, P2854, DOI 10.1109/jlt.2005.855663; Bryant S., 2009, 5317 IETF RFC; Christodoulopoulos K., 2010, P IEEE GLOBECOM; Jose N., 2003, IEEE DESIGN RELIABLE, P23; Kadohata A., 2014, P OFC; LABOURDETTE JFP, 1994, IEEE T COMMUN, V42, P2822, DOI 10.1109/26.328952; Narula-Tam A, 2000, IEEE J SEL AREA COMM, V18, P1972, DOI 10.1109/49.887917; Patel A. N., 2011, P OFC NFOEC MAR; Yao W., 2005, P IEEE BROADNETS, P165; Zang H., 2000, OPTICAL NETWORKS MAG, V1, P47; Zhang M., 2013, P ECOC	26	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	MAR	2015	7	3					A432	A439		10.1364/JOCN.7.00A432		8	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CE3OD	WOS:000351735300009		
J	Kaneko, S; Yoshida, T; Furusawa, S; Sarashina, M; Tamai, H; Suzuki, A; Mukojima, T; Kimura, S; Yoshimoto, N				Kaneko, Shin; Yoshida, Tomoaki; Furusawa, Satoshi; Sarashina, Masahiro; Tamai, Hideaki; Suzuki, Akiya; Mukojima, Toshiaki; Kimura, Shunji; Yoshimoto, Naoto			Scalability of a Hitless lambda-Tuning Sequence to Upstream Transmission at Dynamic Wavelength Allocation in WDM/TDM-PON	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Dynamic wavelength allocation; Optical access network; Optical access system; Passive optical network (PON); Wavelength-division-multiplexing/time-division-multiplexing passive optical network (WDM/TDM-PON)		This paper clarifies the scalability of the hitless wavelength-tuning (lambda-tuning) sequence for dynamic wavelength allocation (DWA) on a lambda-tunable wavelength-division-multiplexing/time-division-multiplexing passive optical network (WDM/TDM-PON). The lambda-tuning that induces no data-frame loss, i.e., hitless lambda-tuning, is essential in DWA. We derive requirements to prevent two types of upstream data-frame loss that the lambda-tuning causes. To clarify the scalability of the hitless lambda-tuning sequence against system parameters, we theoretically analyze the maximum input data rate to the optical network units (ONUs) to achieve lambda-tuning without upstream data-frame loss while varying values for buffer size and lambda-tuning time of the transceivers in ONUs and the DWA cycle. Then, using media access control boards that we developed for symmetric 40 Gbit/s lambda-tunable WDM/TDM-PONs, we demonstrate hitless lambda-tuning and confirm the validity of the theoretical analysis.	[Kaneko, Shin; Yoshida, Tomoaki; Kimura, Shunji; Yoshimoto, Naoto] NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan; [Furusawa, Satoshi; Suzuki, Akiya; Mukojima, Toshiaki] Oki Elect Ind Co Ltd, Chiba 2618501, Japan; [Sarashina, Masahiro; Tamai, Hideaki] Oki Elect Ind Co Ltd, Warabi, Saitama 3358510, Japan	Kaneko, S (reprint author), NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan.	kaneko.shin@lab.ntt.co.jp			Ministry of Internal Affairs and Communications of Japan	This work was supported in part by the Ministry of Internal Affairs and Communications of Japan.	[Anonymous], 2009, 8023AV IEEE; Buus J, 2006, J LIGHTWAVE TECHNOL, V24, P5, DOI 10.1109/JLT.2005.859839; [Anonymous], 2013, 40 GIG CAP PASS OPT; Kani J, 2010, IEEE J SEL TOP QUANT, V16, P1290, DOI 10.1109/JSTQE.2009.2035640; Cheng N., 2014, P OFC; Kaneko S., 2014, P OECC; Kaneko S., 2014, P OFC; Kimura S., 2010, P OECC; O'Byrne V., 2014, P OFC; Senoo Y., 2013, IEICE COMMUN EXP, V2, P501; Taguchi K., 2013, P ECOC; Yoshida T., 2013, P COIN; Yoshida T., 2013, P ECOC	13	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	MAR	2015	7	3					A492	A497		10.1364/JOCN.7.00A492		6	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CE3OD	WOS:000351735300016		
J	Nishitani, T; Mizuguchi, J; Mukai, H				Nishitani, T.; Mizuguchi, J.; Mukai, H.			Experimental Study of Type B Protection for a TWDM-PON System	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Optical access system; Optical communication; Protection; TWDM-PON		A passive optical network (PON) protection scheme is needed to ensure the system reliability required for business use, as PON is based on sharing a single fiber via an optical distribution network. Protection switching time is an important factor for business applications because it defines the service outage duration when a failure occurs. In this paper, we propose a PON protection scheme that enables the service outage duration to be reduced. We demonstrate Type B protection for a time and wavelength division multiplexed PON system and discuss the service outage duration.	[Nishitani, T.; Mizuguchi, J.; Mukai, H.] Mitsubishi Electr Corp, Informat Technol R&D Ctr, Kamakura, Kanagawa 2478501, Japan	Nishitani, T (reprint author), Mitsubishi Electr Corp, Informat Technol R&D Ctr, 5-1-1 Ofuna, Kamakura, Kanagawa 2478501, Japan.	Nishitani.Takashi@dw.MitsubishiElectric.co.jp					[Anonymous], 2013, 10 GIG CAP PASS OPT; Mitsui T, 2011, ASIA-PAC CONF COMMUN, P224; [Anonymous], 2012, 8023 IEEE; [Anonymous], 2013, 40 GIG CAP PASS OPT; [Anonymous], 2008, GIG CAP PASS OPT NET; Hajduczenia M, 2012, IEEE COMMUN MAG, V50, P118, DOI 10.1109/MCOM.2012.6295721; Nishitani T., 2014, OFC NFOEC; Rafel A., 2013, ECOC; Sakamoto K., 2013, OFC NFOEC; Tanaka K., 2008, OFC NFOEC	10	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	MAR	2015	7	3					A414	A420		10.1364/JOCN.7.00A414		7	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CE3OD	WOS:000351735300007		
J	Shahpari, A; Luis, RS; Ribeiro, V; Reis, JD; Ferreira, R; Mendinueta, JMD; Vujicic, Z; Puttnam, BJ; Lima, M; Wada, N; Teixeira, A				Shahpari, A.; Luis, R. S.; Ribeiro, V.; Reis, J. D.; Ferreira, R.; Mendinueta, J. M. D.; Vujicic, Z.; Puttnam, B. J.; Lima, M.; Wada, N.; Teixeira, A.			Spectrally Efficient Enhanced-Performance Bidirectional Coherent PON With Laserless 10 Gb/s ONU	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Nyquist-pulse shaping; Passive optical networks (PON); Self-homodyne detection; Stimulated Raman scattering; UDWDM-PON	ACCESS NETWORKS; TECHNOLOGY; CROSSTALK; UPSTREAM; SYSTEMS; POWER; BAND	We present and experimentally characterize a spectrally efficient, bidirectional, ultradense wavelength-division multiplexing passive optical network (PON) (2 x 120 Gb/s at 50 GHz) over 30 km standard single-mode fiber. This is achieved using a 4 GHz grid with partial spectrum overlapping, Nyquist-shaped 16-ary quadrature amplitude modulation, and digital frequency shifting. This scheme is based on a laserless, self-homodyne PON with centralized wavelength control. We achieve reduced impact of the Rayleigh back-scattering effect due to Nyquist-pulse shaping and frequency upshifting. Self-homodyne detection relaxes the laser linewidth requirement and digital signal processing complexity at the optical network unit. To demonstrate the extra benefit of the proposed PON system, we also experimentally and theoretically evaluate the impact of nonlinear Raman crosstalk in video overlay. Compared to a baseband Nyquist signal and baud rate non-return-to-zero equivalent, the proposed system improves the carrier-to-Raman crosstalk ratio of video overlay by 4 and 6 dB, respectively.	[Shahpari, A.; Ribeiro, V.; Ferreira, R.; Vujicic, Z.; Lima, M.; Teixeira, A.] Univ Aveiro, Dept Elect Telecommun & Informat, Aveiro, Portugal; [Shahpari, A.; Ribeiro, V.; Ferreira, R.; Vujicic, Z.; Lima, M.; Teixeira, A.] Inst Telecomun, Aveiro, Portugal; [Luis, R. S.; Mendinueta, J. M. D.; Puttnam, B. J.; Wada, N.] Natl Inst Informat & Commun Technol, Photon Network Syst Lab, Tokyo, Japan; [Reis, J. D.] Div Opt Technol, CPqD, Campinas, SP, Brazil	Shahpari, A (reprint author), Univ Aveiro, Dept Elect Telecommun & Informat, Aveiro, Portugal.	Ali@ua.pt	Reis, Jacklyn/C-6739-2011; 	Shahpari, Ali/0000-0001-7163-6493	Instituto de Telecomunicacoes (Aveiro, Portugal); National Institute of Information and Communications Technology (Tokyo, Japan); National Funds through Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/71667/2010, SFRH/BD/71691/2010, SFRH/BD/69 577/2010]; National Funds through the Fundacao para a Ciencia e a Tecnologia (FCT) under Real-PON; National Funds through the Fundacao para a Ciencia e a Tecnologia (FCT) under NGPON2	This work was jointly supported by the Instituto de Telecomunicacoes (Aveiro, Portugal) and the National Institute of Information and Communications Technology (Tokyo, Japan) and was funded in part by National Funds through the Fundacao para a Ciencia e a Tecnologia (FCT) under the grants SFRH/BD/71667/2010, SFRH/BD/71691/2010, and SFRH/BD/69 577/2010 and the Real-PON and NGPON2 projects.	Agmon A, 2014, J OPT COMMUN NETW, V6, P225, DOI 10.1364/JOCN.6.000225; Reis JD, 2012, J LIGHTWAVE TECHNOL, V30, P234, DOI 10.1109/JLT.2011.2180698; Chang F, 2010, IEEE COMMUN MAG, V48, pS48, DOI 10.1109/MCOM.2010.5434378; Fatadin I, 2011, IEEE PHOTONIC TECH L, V23, P1246, DOI 10.1109/LPT.2011.2158994; Wong E, 2012, J LIGHTWAVE TECHNOL, V30, P597, DOI 10.1109/JLT.2011.2177960; Luis RS, 2014, IEEE PHOTONIC TECH L, V26, P686, DOI 10.1109/LPT.2014.2302000; Mehedy L, 2011, J OPT COMMUN NETW, V3, P881, DOI 10.1364/JOCN.3.000881; Piehler D, 2014, ELECTRON LETT, V50, P687, DOI 10.1049/el.2014.0806; Rohde H, 2014, J LIGHTWAVE TECHNOL, V30, P2041, DOI 10.1109/JLT.2014.2316369; Miyazaki T, 2005, IEEE PHOTONIC TECH L, V17, P1334, DOI 10.1109/LPT.2005.846619; Presi M, 2014, IEEE PHOTONIC TECH L, V26, P107, DOI 10.1109/LPT.2013.2285732; Phillips MR, 1999, J LIGHTWAVE TECHNOL, V17, P1782, DOI 10.1109/50.793751; Ataie V., 2014, OPT FIB COMM C OFC S; Buset J. M., 2013, EUR C OPT COMM ECOC; Carney K, 2013, OPT EXPRESS, V21, P7180, DOI 10.1364/OE.21.007180; Cheng N., 2014, OPT FIB COMM C OFC S; Colella B., 2006, OPT FIB COMM C OFC A; Coppinger F., 2003, OPT FIB COMM C OFC A; Cvijetic N, 2012, J LIGHTWAVE TECHNOL, V30, P384, DOI 10.1109/JLT.2011.2166375; International Telecommunications Union, 2012, SPECTR GRIDS WDM APP; Kim H., 2008, OPT FIB COMM C OFC S; Kim H, 2001, IEEE PHOTONIC TECH L, V13, P1118, DOI 10.1109/68.950754; Kottke C., 2013, OPT FIB COMM C OFC A; Lavery D., 2013, OPT FIB COMM C OFC A; Mendinueta J. M. D., 2013, OPT FIB COMM C OFC A; Nakamura M., 2007, OPT FIB COMM C OFC A; Prat J., 2013, 15 INT C TRANSP OPT; Reis JD, 2014, J LIGHTWAVE TECHNOL, V32, DOI 10.1109/JLT.2013.2283017; Sakamoto T., 2007, IEEE INT TOP M MICR, P50; Shahpari A., 2013, EUR C OPT COMM ECOC; Shahpari A., 2014, EUR C OPT COMM ECOC; Shahpari A., 2014, OPT FIB COMM C OFC S; Shahpari A., 2013, OPT FIB COMM C OFC A; Sjodin M, 2010, IEEE PHOTONIC TECH L, V22, P91, DOI 10.1109/LPT.2009.2036376; Taguchi K, 2013, J OPT COMMUN NETW, V5, pA144, DOI 10.1364/JOCN.5.00A144; Tanaka A., 2014, OPT FIB COMM C OFC S; Villarruel F., 2007, 1550 VIDEO OVERLAY F	37	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	MAR	2015	7	3					A403	A413		10.1364/JOCN.7.00A403		11	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CE3OD	WOS:000351735300006		
J	Shibata, N; Kuwano, S; Terada, J; Kimura, H				Shibata, Naotaka; Kuwano, Shigeru; Terada, Jun; Kimura, Hideaki			Dynamic IQ Data Compression Using Wireless Resource Allocation for Mobile Front-Haul With TDM-PON	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Digitized RoF; IQ Data Compression; Mobile Front-Haul; TDM-PON		The time-division multiplexed-passive optical network (TDM-PON) architecture can efficiently accommodate densely deployed small cells in a centralized radio access network (C-RAN)-based future radio access (FRA). C-RAN is a type of mobile front-haul network, which connects multiple remote radio heads to a baseband unit pool by optical links. The required optical bandwidth in the mobile front-haul of FRA is very large, so it is necessary to efficiently use the optical bandwidth by using in-phase and quadrature-phase (IQ) data compression techniques. This paper proposes an IQ data compression technique that dynamically reduces the required optical bandwidth based on wireless resource allocation, and provides TDM-PON with statistical multiplexing gain. Simulation results showed the achievable compression ratio of the proposed IQ data compression technique. The feasibility of our technique was confirmed by experiments. The reduction in the average TDM-PON bandwidth was 50% when there were 60 mobile terminals, all of which required 0.18 Mbps bandwidth.	[Shibata, Naotaka; Kuwano, Shigeru; Terada, Jun; Kimura, Hideaki] NTT Corp, NTT Access Network Serv Syst Lab, Yokosuka, Kanagawa 2390847, Japan	Shibata, N (reprint author), NTT Corp, NTT Access Network Serv Syst Lab, 1-1 Hikarinooka, Yokosuka, Kanagawa 2390847, Japan.	shibata.naotaka@lab.ntt.co.jp					Baker M, 2012, IEEE COMMUN MAG, V50, P116, DOI 10.1109/MCOM.2012.6146490; Nakamura T, 2013, IEEE COMMUN MAG, V51, P98, DOI 10.1109/MCOM.2013.6461192; Samardzija D, 2012, IEEE T WIREL COMMUN, V11, P3216, DOI 10.1109/TWC.2012.062012.111359; Xu J, 2014, IEEE COMMUN MAG, V52, P61; [Anonymous], 2013, C RAN ROAD GREEN RAN; Ramli HAM, 2009, 2009 IEEE 9TH MALAYSIA INTERNATIONAL CONFERENCE ON COMMUNICATIONS (MICC), P815, DOI 10.1109/MICC.2009.5431383; [Anonymous], 2008, 1588 IEEE; [Anonymous], 2013, CPRI SPEC V6 0; Tanaka K, 2010, J LIGHTWAVE TECHNOL, V28, P651, DOI 10.1109/JLT.2009.2038722; ETSI, 2014, 001 ETSI GS ORI; ETSI, 2012, 36104 ETSI 3GPP TS; ETSI, 2012, 36211 ETSI 3GPP TS; NANBA S, 2013, P PIMRC SEPT 8 11, P210; Nieman K. F., 2013, P IEEE GLOBALSIP DEC; OBSAI, 2010, OBSAI REF POINT 3 SP; Okumura Y., 2014, P OFC; Pokhariyal A., 2006, P IEEE PIMRC SEP, P1; Shibata N., 2014, P OFC; Shibata N., 2013, IEICE COMEX, V2, P186; Tashiro T., 2014, P OFC	20	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	MAR	2015	7	3					A372	A378		10.1364/JOCN.7.00A372		7	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	CE3OD	WOS:000351735300002		
J	Yoshikawa, H				Yoshikawa, Hideki			The torch of Koan: passing on the flame to the future	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Editorial Material									Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka 5650871, Japan	Yoshikawa, H (reprint author), Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yhideki@ort.med.osaka-u.ac.jp					Shiba R, 1999, YOU WHO WILL LIVE 21, P23; Tashiro S, 1928, JAMA-J AM MED ASSOC, V90, P1151	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					237	238		10.1007/s00776-015-0702-z		2	Orthopedics	Orthopedics	CE5HV	WOS:000351862900001		
J	Koga, Y				Koga, Yoshio			Three-dimensional motion analysis and its application in total knee arthroplasty: what we know, and what we should analyze	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Review							POSTERIOR CONDYLAR OFFSET; IN-VIVO DETERMINATION; COORDINATE SYSTEM; LIFT-OFF; KINEMATICS; FLEXION; ALIGNMENT; TKA	This paper will review three-dimensional (3D) motion analysis studies done in my laboratory to present an overview of what we have found. We have looked at parameters such as roll-back, rotation, the pivot center of rotation etc. using a 2D-3D registration technique by evaluating knees before and after implantation of a total knee arthroplasty. This technique allows comparison of preoperative motion to that after total knee surgery. We have found the phenomenon of "reverse screw-home" to be a common motion pattern in osteoarthritis and it is often present after implantation of a total knee prosthesis.	Ninohji Onsen Hosp, Dept Orthopaed Surg, Niigata 9570332, Japan	Koga, Y (reprint author), Ninohji Onsen Hosp, Dept Orthopaed Surg, Niigata 9570332, Japan.	koga-y@ka2.so-net.ne.jp					Andriacchi TP, 2003, CLIN ORTHOP RELAT R, P44, DOI 10.1097/01.blo.0000062383.79828.f5; Bellemans J, 2002, J BONE JOINT SURG BR, V84B, P50, DOI 10.1302/0301-620X.84B1.12432; Scuderi GR, 2003, CLIN ORTHOP RELAT R, P148, DOI 10.1097/01.blo.0000063603.67412.ca; Banks SA, 1997, J ARTHROPLASTY, V12, P297, DOI 10.1016/S0883-5403(97)90026-7; Tanifuji O, 2013, KNEE SURG SPORT TR A, V21, P2301, DOI 10.1007/s00167-012-2010-x; Dennis DA, 2004, CLIN ORTHOP RELAT R, P180, DOI 10.1097/01.blo.0000148777.98244.84; Kobayashi K, 2009, J BIOMECH, V42, P2818, DOI 10.1016/j.jbiomech.2009.08.022; Ishii Y, 2013, CLIN ORTHOP RELAT R, V471, P2995, DOI 10.1007/s11999-013-2999-2; Sato T, 2004, J ARTHROPLASTY, V19, P620, DOI 10.1016/j.arth.2003.12.063; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; Takemae T, 2006, J ORTHOP SCI, V11, P601, DOI 10.1007/s00776-006-1066-1; Dennis DA, 1996, CLIN ORTHOP RELAT R, P107; Kai S, 2014, J BIOMECH, V47, P1229, DOI 10.1016/j.jbiomech.2013.12.013; Banks S, 2003, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000063121.39522.19; Zingde SM, 2014, CLIN ORTHOP RELAT R, V472, P254, DOI 10.1007/s11999-013-3257-3; Banks SA, 2004, CLIN ORTHOP RELAT R, P187, DOI 10.1097/01.blo.0000138956.04316.ac; Dennis DA, 2001, J BONE JOINT SURG BR, V83B, P33, DOI 10.1302/0301-620X.83B1.10632; Gejo R, 2009, J ORTHOP SCI, V14, P51, DOI 10.1007/s00776-008-1286-7; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; Ishii Y, 1999, CLIN ORTHOP RELAT R, P181; Ishii Y, 1997, CLIN ORTHOP RELAT R, P144; Koga Y., 2008, OSTEOARTHRITIS KNEE, P42; Koga Y, 1998, BIO-MED MATER ENG, V8, P197; Komistek RD, 2008, J ARTHROPLASTY, V23, P41, DOI 10.1016/j.arth.2007.01.016; Neumann DA., 2010, KINESIOLOGY MUSCULSK, P520; NILSSON KG, 1990, CLIN ORTHOPAEDICS, V256, P147; Omori G, 2003, KNEE, V10, P75, DOI 10.1016/S0968-0160(02)00062-5; Parratte S, 2010, J BONE JOINT SURG AM, V92, P2043; Sato T, 2007, J ARTHROPLASTY, V22, P560, DOI 10.1016/j.arth.2006.06.020	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					239	249		10.1007/s00776-014-0681-5		11	Orthopedics	Orthopedics	CE5HV	WOS:000351862900002		
J	Ozaki, T				Ozaki, Toshifumi			Diagnosis and treatment of Ewing sarcoma of the bone: a review article	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Review							CHILDRENS ONCOLOGY GROUP; PRIMITIVE NEUROECTODERMAL TUMOR; PRECLINICAL TESTING PROGRAM; CHROMOSOME-TRANSLOCATION; STANDARD CHEMOTHERAPY; MULTIMODAL THERAPY; EWS GENE; 99 TRIAL; FAMILY; IFOSFAMIDE	Ewing sarcoma (ES) is rare in Japanese people, and only 30-40 patients develop the disease annually. To diagnose ES, molecular techniques that aim to detect characteristic fusion genes are commonly used in combination with conventional histological and immunohistochemical examinations. The treatment strategy for ES is characterized by multi-disciplinary collaboration between pediatric oncologists, medical oncologists, radiation oncologists, and orthopedic surgeons. In recent years, numerous large-scale national or international multi-institutional studies of ES have been performed. Pre- and postoperative intensive systemic chemotherapy with multiple anticancer drugs is the standard treatment method for ES. Depending on the obtained surgical margin, postoperative radiation might also be performed. If preoperative radiological examinations indicate that surgical excision would be difficult, preoperative radiation can be administered. As the treatment outcomes of ES have improved, late complications and secondary malignancies have become a problem. After treatment, patients with ES require very long-term follow-up in order to detect secondary malignancies and growth-related musculoskeletal complications.	Okayama Univ, Dept Orthopaed Surg, Grad Sch Med, Dent,Pharmaceut Sci,Kita Ku, Okayama 7008558, Japan	Ozaki, T (reprint author), Okayama Univ, Dept Orthopaed Surg, Grad Sch Med, Dent,Pharmaceut Sci,Kita Ku, Shikata Cho 2-5-1, Okayama 7008558, Japan.	tozaki@md.okayama-u.ac.jp			Health and Labor Sciences Research Expenses Commission; Ministry of Health, Labor, and Welfare [H26-084, H26-062]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25293323]	This study was supported in part by the Health and Labor Sciences Research Expenses Commission; an Applied Research for Innovative Treatment of Cancer grant from the Ministry of Health, Labor, and Welfare (H26-084, H26-062); and a Grant-in-Aid for Scientific Research (B) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Grant Number 25293323)	Akiyama T, 2010, J BONE JOINT SURG BR, V92B, P999, DOI 10.1302/0301-620X.92B7.23497; Granowetter L, 2009, J CLIN ONCOL, V27, P2536, DOI 10.1200/JCO.2008.19.1478; Le Deley MC, 2010, J CLIN ONCOL, V28, P1982, DOI 10.1200/JCO.2009.23.3585; HASHIMOTO H, 1983, AM J SURG PATHOL, V7, P309, DOI 10.1097/00000478-198306000-00002; Paulussen M, 1998, ANN ONCOL, V9, P275, DOI 10.1023/A:1008208511815; Meyers PA, 2001, J CLIN ONCOL, V19, P2812; Tsuchiya H, 2005, J BONE JOINT SURG BR, V87B, P218, DOI 10.1302/0301-620X.87B2.15325; Urano F, 1996, BIOCHEM BIOPH RES CO, V219, P608, DOI 10.1006/bbrc.1996.0281; ANGERVALL L, 1975, CANCER, V36, P240, DOI 10.1002/1097-0142(197507)36:1<240::AID-CNCR2820360127>3.0.CO;2-H; BURGERT EO, 1990, J CLIN ONCOL, V8, P1514; Paulussen M, 2001, ANN ONCOL, V12, P1619, DOI 10.1023/A:1013148730966; Folpe AL, 2005, AM J SURG PATHOL, V29, P1025; Van Winkle P, 2005, PEDIATR BLOOD CANCER, V44, P338, DOI 10.1002/pbc.20227; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Paulussen M, 2001, J CLIN ONCOL, V19, P1818; Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Paulussen M, 2008, J CLIN ONCOL, V26, P4385, DOI 10.1200/JCO.2008.16.5720; Hunold A, 2006, PEDIATR BLOOD CANCER, V47, P795, DOI 10.1002/pbc.20719; FRAUMENI JF, 1970, LANCET, V1, P366; Hoffmann C, 1999, CANCER, V85, P869, DOI 10.1002/(SICI)1097-0142(19990215)85:4<869::AID-CNCR14>3.0.CO;2-8; WILKINS RM, 1986, CANCER, V58, P2551, DOI 10.1002/1097-0142(19861201)58:11<2551::AID-CNCR2820581132>3.0.CO;2-Y; Kolb EA, 2013, PEDIATR BLOOD CANCER, V60, P1325, DOI 10.1002/pbc.24517; Kaneko Y, 1996, GENE CHROMOSOME CANC, V15, P115, DOI 10.1002/(SICI)1098-2264(199602)15:2<115::AID-GCC6>3.0.CO;2-6; Wagner LM, 2007, PEDIATR BLOOD CANCER, V48, P132, DOI 10.1002/pbc.20697; JURGENS H, 1988, CANCER, V61, P23, DOI 10.1002/1097-0142(19880101)61:1<23::AID-CNCR2820610106>3.0.CO;2-M; Schuck A, 2003, INT J RADIAT ONCOL, V55, P168, DOI 10.1016/S0360-3016(02)03797-5; Longhi A, 2012, CANCER-AM CANCER SOC, V118, P5050, DOI 10.1002/cncr.27493; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; NESBIT ME, 1990, J CLIN ONCOL, V8, P1664; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Zoubek A, 1996, J CLIN ONCOL, V14, P1245; ASKIN FB, 1979, CANCER, V43, P2438, DOI 10.1002/1097-0142(197906)43:6<2438::AID-CNCR2820430640>3.0.CO;2-9; JENSEN RD, 1970, LANCET, V1, P777; Wexler LH, 1996, CANCER, V78, P901; JEON IS, 1995, ONCOGENE, V10, P1229; AMBROS IM, 1991, CANCER, V67, P1886, DOI 10.1002/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U; Ginsberg JP, 1999, J CLIN ONCOL, V17, P1809; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; GIOVANNINI M, 1994, J CLIN INVEST, V94, P489, DOI 10.1172/JCI117360; Obata H, 2007, CANCER, V109, P767, DOI 10.1002/cncr.22481; de Alava E, 1998, J CLIN ONCOL, V16, P1248; Le Deley MC, 2014, J CLIN ONCOL, V32, P2440, DOI 10.1200/JCO.2013.54.4833; BACCI G, 1989, CANCER, V63, P1477, DOI 10.1002/1097-0142(19890415)63:8<1477::AID-CNCR2820630805>3.0.CO;2-8; Baruchel S, 2012, EUR J CANCER, V48, P579, DOI 10.1016/j.ejca.2011.09.027; Bolling T, 2008, STRAHLENTHER ONKOL, V184, P193, DOI 10.1007/s00066-008-1810-x; CARLEI F, 1984, VIRCHOWS ARCH A, V404, P313, DOI 10.1007/BF00694896; Cripe Timothy P., 2011, Sarcoma, P457532, DOI 10.1155/2011/457532; de Alava E, 2013, WHO CLASSFICATION TU, P305; DUNST J, 1991, CANCER, V67, P2818, DOI 10.1002/1097-0142(19910601)67:11<2818::AID-CNCR2820671118>3.0.CO;2-Y; Ewing J, 1921, P NEW YORK PATHOLOGI, V7, P17; Gebert C, 2011, J SURG ONCOL, V103, P269, DOI 10.1002/jso.21820; Gurney JG, 1999, NIH PUB; Gyorke T, 2006, NUCL MED COMMUN, V27, P17; Huvos AG, 1991, BONE TUMORS DIAGNOSI, P523; JAFFE R, 1984, AM J SURG PATHOL, V8, P885, DOI 10.1097/00000478-198412000-00001; JOA Musculoskeletal Tumor Committee, 2011, BON TUM REG JAP; JOA Musculoskeletal Tumor Committee, 2011, SOFT TISS TUM REG JA; KAWAGUCHI N, 2004, CLIN ORTHOP RELA FEB, P165, DOI DOI 10.1097/01.BLO.0000116308.86761.F5; Keir ST, 2012, PEDIATR BLOOD CANCER, V59, P586, DOI 10.1002/pbc.24016; Kunisada T, 2010, P 43 ANN MUSC TUM M, V84, pS977; Lau L, 2005, CLIN CANCER RES, V11, P672; LI FP, 1980, LANCET, V1, P1255; Lucke A., 1866, VIRCHOWS ARCH PATH A, V35, P524; Murakami H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064818; NASCIMENTO AG, 1980, AM J SURG PATHOL, V4, P29, DOI 10.1097/00000478-198004010-00003; NESBITT KA, 1976, CANCER, V37, P1562, DOI 10.1002/1097-0142(197603)37:3<1562::AID-CNCR2820370346>3.0.CO;2-M; Olsen SH, 2006, MODERN PATHOL, V19, P659, DOI 10.1038/modpathol.3800569; Ozaki T, 1998, J PEDIATR ORTHOPED, V18, P350, DOI 10.1097/00004694-199805000-00015; Ozaki T, 2001, GENE CHROMOSOME CANC, V32, P164, DOI 10.1002/gcc.1178; Ozaki T, 1996, CANCER, V78, P892, DOI 10.1002/(SICI)1097-0142(19960815)78:4<892::AID-CNCR29>3.0.CO;2-P; Ozaki Toshifumi, 2004, Cancer Genomics & Proteomics, V1, P275; Patterson FR, 2007, ORTHOPAEDIC KNOWLEDG, V2, P175; Rodl RW, 2003, J SURG ONCOL, V83, P154, DOI 10.1002/jso.10256; Rosen G, 1982, Prog Clin Cancer, V8, P267; Rosen G, 1981, NATL CANC I MONOGR, V56, P289; Serizawa I, 2009, INT J RADIAT ONCOL, V75, P1105, DOI 10.1016/j.ijrobp.2008.12.019; Stout Arthur Purdy, 1942, REV CANADIENNE BIOL, V1, P651; Stout AP, 1918, P NY PATHOL SOC, V18, P2; TURCCAREL C, 1983, CR ACAD SCI III-VIE, V296, P1101	81	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					250	263		10.1007/s00776-014-0687-z		14	Orthopedics	Orthopedics	CE5HV	WOS:000351862900003		
J	Hashizume, H; Konno, S; Takeshita, K; Fukui, M; Takahashi, K; Chiba, K; Miyamoto, M; Matsumoto, M; Kasai, Y; Kanamori, M; Matsunaga, S; Hosono, N; Kanchiku, T; Taneichi, H; Tanaka, N; Kanayama, M; Shimizu, T; Kawakami, M				Hashizume, Hiroshi; Konno, Shin-ichi; Takeshita, Katsushi; Fukui, Mitsuru; Takahashi, Kazuhisa; Chiba, Kazuhiro; Miyamoto, Masabumi; Matsumoto, Morio; Kasai, Yuichi; Kanamori, Masahiko; Matsunaga, Shunji; Hosono, Noboru; Kanchiku, Tsukasa; Taneichi, Hiroshi; Tanaka, Nobuhiro; Kanayama, Masahiro; Shimizu, Takachika; Kawakami, Mamoru			Japanese orthopaedic association back pain evaluation questionnaire (JOABPEQ) as an outcome measure for patients with low back pain: reference values in healthy volunteers	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							POPULATION-BASED COHORT; LUMBAR SPINAL STENOSIS; QUALITY-OF-LIFE; WAKAYAMA SPINE; PREVALENCE; SCALE	In 2007, the Japanese orthopaedic association back pain evaluation questionnaire (JOABPEQ) was established to overcome the limitations of the original JOA scoring system developed in 1986. Although this new self-administered questionnaire is a more accurate outcome measure for evaluating patients with low back pain, physicians were unable to as certain the exact status of a patient at a single time point because of a lack of reference values. This study aimed to establish the reference values of JOABPEQ in different age and gender groups using data obtained from healthy volunteers. This study was conducted in 21 university hospitals and affiliated hospitals from October 2012 to July 2013. The JOABPEQ includes 25 questions that yield five domains to evaluate individuals with low back pain from five different perspectives. A total of 1,456 healthy volunteers (719 men, 737 women; age range, 20-89 years) answered the questionnaire. The differences in scores according to age and gender were examined by non-parametric tests. The JOABPEQ scores significantly decreased with age in the domains of lumbar spine dysfunction, gait disturbance, and social life dysfunction. In these three domains, the median scores approached the 100 possible points in individuals aged 20-70 for both genders. However, the median scores for lumbar spine dysfunction and social life dysfunction decreased to 83.0 and 65.0-78.0 points, respectively, in individuals in their 80 s and 70-80 s, respectively; and the scores for gait disturbance decreased to 93.0 and 71.0 points for males and females in their 80 s. Overall, the median scores for pain-related and psychological disorders were 100 and 60.0-72.0 points, respectively. The reference values for JOABPEQ according to age and gender were established herein. Patients with low back pain should be evaluated with this new self-administered questionnaire taking these reference values into account.	[Hashizume, Hiroshi] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama 6418510, Japan; [Konno, Shin-ichi] Fukushima Med Univ, Dept Orthopaed Surg, Sch Med, Fukushima, Japan; [Takeshita, Katsushi] Univ Tokyo, Dept Orthopaed Surg, Tokyo, Japan; [Fukui, Mitsuru] Osaka City Univ, Fac Med, Stat Lab, Osaka 558, Japan; [Takahashi, Kazuhisa] Chiba Univ, Dept Orthoped Surg, Grad Sch Med, Chiba, Japan; [Chiba, Kazuhiro] Kitasato Univ, Dept Orthopaed Surg, Kitasato Inst Hosp, Tokyo, Japan; [Miyamoto, Masabumi] Tama Nagayama Hosp, Dept Orthoped Surg, Nippon Med Sch, Tokyo, Japan; [Matsumoto, Morio] Keio Univ, Dept Orthopaed Surg, Tokyo, Japan; [Kasai, Yuichi] Mie Univ, Grad Sch Med, Dept Spinal Surg & Med Engn, Tsu, Mie, Japan; [Kanamori, Masahiko] Toyama Univ, Fac Med, Dept Human Sci 1, Toyama 930, Japan; [Matsunaga, Shunji] Imakiire Gen Hosp, Dept Orthopaed Surg, Kagoshima, Japan; [Hosono, Noboru] Osaka Kosei Nenkin Hosp, Dept Orthopaed Surg, Osaka, Japan; [Kanchiku, Tsukasa] Yamaguchi Univ, Dept Orthopaed Surg, Grad Sch Med, Yamaguchi, Japan; [Taneichi, Hiroshi] Dokkyo Med Univ, Sch Med, Dept Orthopaed Surg, Mibu, Tochigi, Japan; [Tanaka, Nobuhiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Orthopaed Surg, Hiroshima, Japan; [Kanayama, Masahiro] Hakodate Cent Gen Hosp, Spine Ctr, Hakodate, Hokkaido, Japan; [Shimizu, Takachika] Harunaso Hosp, Gunma Spine Ctr, Dept Orthopaed Surg, Takasaki, Gumma, Japan; [Kawakami, Mamoru] Wakayama Med Univ, Dept Orthopaed Surg, Kihoku Hosp, Wakayama 6418510, Japan	Hashizume, H (reprint author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418510, Japan.	hashizum@wakayama-med.ac.jp					Airaksinen O, 2004, EUROPEAN GUIDELINES; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Yoshimura N, 2014, J BONE MINER METAB, V32, P524, DOI 10.1007/s00774-013-0522-1; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Yamada K, 2014, MOD RHEUMATOL, V24, P343, DOI 10.3109/14397595.2013.854067; Fukui M, 2009, J ORTHOP SCI, V14, P348, DOI 10.1007/s00776-009-1337-8; TAKAHASHI K, 1990, SPINE, V15, P1211, DOI 10.1097/00007632-199011010-00022; Fukui M, 2007, J ORTHOP SCI, V12, P443, DOI 10.1007/s00776-007-1162-x; Yoshimura N, 2008, OSTEOPOROSIS INT, V19, P21, DOI 10.1007/s00198-007-0474-1; Ohtori S, 2010, J ORTHOP SCI, V15, P86, DOI 10.1007/s00776-009-1426-8; Fukuhara S, 2011, MANUAL SF 36V2 JAPAN; Fukui M, 2007, J ORTHOP SCI, V12, P526, DOI 10.1007/s00776-007-1168-4; Fukui M, 2008, J ORTHOP SCI, V13, P173, DOI 10.1007/s00776-008-1213-y; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; Izumida S, 1986, J JPN ORTHOP ASSOC, V60, P391; Jeong Gerard K, 2003, Spine J, V3, P242, DOI 10.1016/S1529-9430(02)00445-X; Kopec JA, 2000, SPINE, V25, P3110, DOI 10.1097/00007632-200012150-00005; Tiusanen H, 1996, Eur Spine J, V5, P288, DOI 10.1007/BF00304342; World Medical Association, WMA DECL HELS ETH PR	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					264	280		10.1007/s00776-014-0693-1		17	Orthopedics	Orthopedics	CE5HV	WOS:000351862900004		
J	Tetsunaga, T; Tetsunaga, T; Tanaka, M; Ozaki, T				Tetsunaga, Tomoko; Tetsunaga, Tomonori; Tanaka, Masato; Ozaki, Toshifumi			Efficacy of tramadol-acetaminophen tablets in low back pain patients with depression	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							REFRACTORY MAJOR DEPRESSION; CATASTROPHIZING SCALE; PARACETAMOL; ANTIDEPRESSANT; COMBINATION; SYMPTOMS	Tramadol-acetaminophen tablets are currently used to treat pain, including that of degenerative lumbar disease. Although there are many reports on tramadol-acetaminophen tablets, treatment outcomes in low back pain (LBP) patients with depression remain uncertain. This study investigated the outcomes of LBP patients with depression treated with tramadol-acetaminophen tablets. Of 95 patients with chronic LBP, 70 (26 men, 44 women; mean age 64 years) who were judged as having depression by the Self-Rating Depression Scale (SDS) were included in this study. In this trial, patients received one of two randomly assigned 8-week treatment regimes: tramadol-acetaminophen (Tramadol group, n = 35) and non-steroidal anti-inflammatory drugs (NSAIDs) (NSAID group, n = 35). In addition to completing self-report questionnaires, patients provided demographic and clinical information. All patients were assessed using a Numerical Rating Scale (NRS), Oswestry Disability Index (ODI), Pain Disability Assessment Scale (PDAS), Hospital Anxiety and Depression Scale (HADS), SDS, and Pain Catastrophizing Scale (PCS). After 8 weeks' treatment, the NRS and SDS scores were lower in the Tramadol group than in the NSAID group (p < 0.05). There were no significant differences in the ODI, PDAS, and PCS scores between the groups (p = 0.47, 0.09, 0.47). Although there was no difference in the anxiety component of the HADS between the groups (p = 0.36), the depression component was lower in the Tramadol group than in the NSAID group (p < 0.05). There was no significant difference between groups in the percentage of patients with treatment-associated adverse events. This investigation found that tramadol-acetaminophen is effective for reducing LBP and provided a prophylactic antidepressant effect in chronic LBP patients with depression.	[Tetsunaga, Tomoko; Tanaka, Masato; Ozaki, Toshifumi] Okayama Univ Hosp, Dept Orthopaed Surg, Kita Ku, Okayama 7008558, Japan; [Tetsunaga, Tomoko] Kurashiki Municipal Hosp, Dept Orthopaed Surg, Kurashiki, Okayama 7110921, Japan; [Tetsunaga, Tomonori] Okayama Med Ctr, Dept Orthopaed Surg, Kita Ku, Okayama 7011192, Japan	Tetsunaga, T (reprint author), Okayama Med Ctr, Dept Orthopaed Surg, Kita Ku, 1711-1 Tamasu, Okayama 7011192, Japan.	tomonori_t31@yahoo.co.jp					ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63; Carragee EJ, 2000, SPINE, V25, P1803, DOI 10.1097/00007632-200007150-00011; Raffa RB, 2001, J CLIN PHARM THER, V26, P257, DOI 10.1046/j.1365-2710.2001.00355.x; Chan HN, 2009, ANN ACAD MED SINGAP, V38, P974; Raffa RB, 2000, J PHARMACOL EXP THER, V295, P291; Reeves RR, 2008, SOUTH MED J, V101, P193, DOI 10.1097/SMJ.0b013e3181616e66; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; BODKIN JA, 1995, J CLIN PSYCHOPHARM, V15, P49, DOI 10.1097/00004714-199502000-00008; Adams EH, 2006, J PAIN SYMPTOM MANAG, V31, P465, DOI 10.1016/j.jpainsymman.2005.10.006; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Sandrini M, 2001, NEUROPEPTIDES, V35, P110, DOI 10.1054/npep.2001.0852; Mejjad O, 2011, CURR MED RES OPIN, V27, P1013, DOI 10.1185/03007995.2011.565045; Bonnefont J, 2003, DRUGS, V63, P1, DOI 10.2165/00003495-200363992-00002; Yamashiro K, 2011, CLIN J PAIN, V27, P338, DOI 10.1097/AJP.0b013e318204858a; Barber J, 2011, EXP CLIN PSYCHOPHARM, V19, P123, DOI 10.1037/a0022721; Chowta Mukta N, 2011, J Pharmacol Pharmacother, V2, P281, DOI 10.4103/0976-500X.85947; Fairbank JC, 1980, PHYSIOTHERAPY, V66, P271; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kalra Bhupinder Singh, 2008, Indian J Psychiatry, V50, P51, DOI 10.4103/0019-5545.39760; Medve R A, 2001, Anesth Prog, V48, P79; Morris LD, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-137; Susan H, 2002, AM J EPIDEMIOL, V156, P1028, DOI 10.1093/aje/kwf136; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Rojas-Corrales MO, 1998, LIFE SCI, V63, pPL175, DOI 10.1016/S0024-3205(98)00369-5; Shapira NA, 2001, J CLIN PSYCHIAT, V62, P205; Stoll AL, 1999, AM J PSYCHIAT, V156, P2017; Tarride JE, 2006, CLIN THER, V28, P1922, DOI 10.1016/j.clinthera.2006.11.017; Tetsunaga T, 2013, J ORTHOP SCI, V18, P374, DOI 10.1007/s00776-013-0363-8; Thurber S, 2002, ASSESSMENT, V9, P401, DOI 10.1177/1073191102238471; Yalcin I, 2007, BEHAV PHARMACOL, V18, P623; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZUNG WWK, 1969, AM J PSYCHIAT, V126, P116	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					281	286		10.1007/s00776-014-0674-4		6	Orthopedics	Orthopedics	CE5HV	WOS:000351862900005		
J	Yamada, H; Terada, M; Iwasaki, H; Endo, T; Okada, M; Nakao, S; Hashizume, H; Minamide, A; Nakagawa, Y; Nishi, H; Tsutsui, S; Oka, H; Yoshida, M				Yamada, Hiroshi; Terada, Masaki; Iwasaki, Hiroshi; Endo, Toru; Okada, Motohiro; Nakao, Shinichi; Hashizume, Hiroshi; Minamide, Akihito; Nakagawa, Yukihiro; Nishi, Hideto; Tsutsui, Syunji; Oka, Hiroyuki; Yoshida, Munehito			Improved accuracy of diagnosis of lumbar intra and/or extra-foraminal stenosis by use of three-dimensional MR imaging: comparison with conventional MR imaging	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							NERVE ROOT ENTRAPMENT; SPINAL STENOSIS; OBSERVER VARIABILITY; LUMBOSACRAL SPINE; RESONANCE; POPULATION; LIGAMENTS; SCANS; ROC	The purposes of this study were to assess the reliability of 3-dimensional magnetic resonance (MR) imaging (3D MRI) and conventional MRI (CMRI) for detection of lumbar intra and/or extra-foraminal stenosis (LIEFS) and to compare the diagnostic accuracy of the 2 imaging modalities. A total of 60 sets of 3D MR and CMR images from 20 healthy volunteers and 40 LIEFS patients were qualitatively rated according to defined criteria by 3 independent, blinded readers. Kappa statistics were used to characterize intra and inter-reader reliability for qualitative rating of data. Multireader, multicase analysis was used to compare lumbar foraminal stenosis detection between the 2 modalities. Intra-reader agreement for 3D MRI was excellent, with kappa = 0.90; that for CMRI was good, with kappa = 0.78. Average inter-reader agreement for 3D MRI was good, with kappa = 0.79, whereas that for CMRI was moderate, with kappa = 0.41. Average area under the ROC curve values (1st reading/2nd reading) for detection of lumbar foraminal stenosis using 3D MRI and CMRI were 0.99/0.99 and 0.94/0.92, respectively. Detection of LIEFS with 3D MRI was significantly better than with CMRI (P = 0.0408/0.0294). These results suggest that CMRI was of limited use for detection of the presence of LIEFS. Isolated imaging with CMRI may risk overlooking the presence of LIEFS. In contrast, reliability of 3D MRI for detection of LIEFS was good. Furthermore, readers' performance in the diagnosis of LIEFS can be improved by use of 3D MRI. Therefore, 3D MRI is recommended when using imaging for diagnosis of LIEFS.	[Yamada, Hiroshi; Iwasaki, Hiroshi; Endo, Toru; Okada, Motohiro; Nakao, Shinichi; Hashizume, Hiroshi; Minamide, Akihito; Nakagawa, Yukihiro; Nishi, Hideto; Tsutsui, Syunji; Yoshida, Munehito] Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Wakayama 6418510, Japan; [Terada, Masaki] Wamayama Minami Radiol Clin, Wakayama, Japan; [Oka, Hiroyuki] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, Century Med & Res Ctr 22, Grad Sch Med,Bunkyo Ku, Tokyo 1138654, Japan	Yamada, H (reprint author), Wakayama Med Univ, Dept Orthoped Surg, 811-1 Kimiidera, Wakayama, Wakayama 6418510, Japan.	yamacha@wakayama-med.ac.jp					Ando M, 2013, EUR SPINE J, V22, P833, DOI 10.1007/s00586-012-2592-5; Jenis LG, 2000, SPINE, V25, P389, DOI 10.1097/00007632-200002010-00022; Baba H, 1996, SPINAL CORD, V34, P644; Hillis SL, 2008, ACAD RADIOL, V15, P647, DOI 10.1016/j.acra.2007.12.015; Lurie JD, 2008, SPINE, V33, P1605, DOI 10.1097/BRS.0b013e3181791af3; KUNOGI J, 1991, SPINE, V16, P1312, DOI 10.1097/00007632-199111000-00012; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364; Aota Y, 2007, SPINE, V32, P896, DOI 10.1097/01.brs.0000259809.75760.d5; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403; TRANSFELDT EE, 1993, J SPINAL DISORD, V6, P507; MACNAB I, 1971, J BONE JOINT SURG AM, VA 53, P891; Cramer GD, 2003, J MANIP PHYSIOL THER, V26, P160, DOI 10.1016/S0161-4754(02)54109-9; RAININKO R, 1995, SPINE, V20, P1029, DOI 10.1097/00007632-199505000-00009; WILTSE LL, 1984, SPINE, V9, P31, DOI 10.1097/00007632-198401000-00008; DORFMAN DD, 1992, INVEST RADIOL, V27, P723, DOI 10.1097/00004424-199209000-00015; Speciale AC, 2002, SPINE, V27, P1082, DOI 10.1097/00007632-200205150-00014; Burton R, 1981, CLIN ORTHOP RELAT R, V157, P191; Byun WM, 2012, SPINE, V37, P840, DOI 10.1097/BRS.0b013e3182374465; Eguchi Y, 2010, EUR SPINE J, V19, P1874, DOI [10.1007/s00586-010-1520-9, 10.1007/s00586.010.1520.9]; Gur D, 2005, RADIOLOGY, V234, P659, DOI 10.1148/radiol.2343041147; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd, P143; Iwasaki Hiroshi, 2014, Asian Spine J, V8, P145, DOI 10.4184/asj.2014.8.2.145; KORNBERG M, 1987, SPINE, V12, P586, DOI 10.1097/00007632-198707000-00015; Matsumoto M, 2002, SPINE, V27, pE169, DOI 10.1097/00007632-200203150-00020; NATHAN H, 1982, INT ORTHOP, V6, P197, DOI 10.1007/BF00267730; OLSEWSKI JM, 1991, SPINE, V16, P336, DOI 10.1097/00007632-199103000-00014; Taira G, 1998, J Orthop Sci, V3, P18, DOI 10.1007/s007760050017	28	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					287	294		10.1007/s00776-014-0677-1		8	Orthopedics	Orthopedics	CE5HV	WOS:000351862900006		
J	Ogon, I; Takebayashi, T; Takashima, H; Tanimoto, K; Ida, K; Yoshimoto, M; Fujiwara, H; Kubo, T; Yamashita, T				Ogon, Izaya; Takebayashi, Tsuneo; Takashima, Hiroyuki; Tanimoto, Katsumasa; Ida, Kazunori; Yoshimoto, Mitsunori; Fujiwara, Hiroyoshi; Kubo, Toshikazu; Yamashita, Toshihiko			Analysis of chronic low back pain with magnetic resonance imaging T2 mapping of lumbar intervertebral disc	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; MECHANOSENSITIVE AFFERENT UNITS; RAT VERTEBRAL COLUMN; RELAXATION-TIMES; ACETYLCHOLINESTERASE HISTOCHEMISTRY; SENSORY INNERVATION; DORSAL PORTION; DEGENERATION; DISCOGRAPHY; PREVALENCE	Magnetic resonance imaging (MRI) T2 mapping utilizes the T2 values for quantification of moisture content and collagen sequence breakdown. Recently, attempts at quantification of lumbar disc degeneration through MRI T2 mapping have been reported. We conducted an analysis of the relationship between T2 values of degenerated intervertebral discs (IVD) and chronic low back pain (CLBP). The subjects who had CLBP comprised 28 patients (15 male, 13 female; mean age 48.9 +/- A 9.6 years; range 22-60 years). All subjects underwent MRI and filled out the low back pain visual analog scale (VAS) and Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ). The disc was divided into the anterior annulus fibrosus (AF), the nucleus pulposus (NP), and the posterior AF, and each T2 value was measured. This study involved 25 asymptomatic control participants matched with the CLBP group subjects for gender and age (13 male, 12 female; mean age 43.8 +/- A 14.5 years; range 23-60 years). These subjects had no low back pain, and constituted the control group. T2 values for IVD tended to be lower in the CLBP group than in the control group, and these values were significantly different within the posterior AF. The correlation coefficients between the VAS scores and T2 values of anterior AF, NP and posterior AF were r = 0.30, -0.15 and -0.50. The correlation coefficient between the JOABPEQ scores (low back pain) and T2 values of anterior AF, NP and posterior AF were r = -0.0041, 0.11 and 0.42. Similarly, the JOABPEQ scores (lumbar function) were r = -0.22, -0.12 and 0.57. The results indicated a correlation between posterior AF degeneration and CLBP. This study suggests that MRI T2 mapping could be used as a quantitative method for diagnosing discogenic pain.	[Ogon, Izaya; Takebayashi, Tsuneo; Takashima, Hiroyuki; Tanimoto, Katsumasa; Ida, Kazunori; Yoshimoto, Mitsunori; Yamashita, Toshihiko] Sapporo Med Univ, Dept Orthopaed Surg, Sch Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Fujiwara, Hiroyoshi; Kubo, Toshikazu] Kyoto Prefectural Univ, Dept Orthopaed Surg, Sch Med, Kyoto 6028566, Japan	Ogon, I (reprint author), Sapporo Med Univ, Dept Orthopaed Surg, Sch Med, Chuo Ku, Soutn 1 West 16, Sapporo, Hokkaido 0608543, Japan.	ogon.izaya@sapmed.ac.jp					Borthakur A, 2011, SPINE, V36, P2190, DOI 10.1097/BRS.0b013e31820287bf; Karakida O, 2003, CLIN RADIOL, V58, P389, DOI 10.1016/S0009-9260(02)00583-4; SCHWARZER AC, 1995, SPINE, V20, P31, DOI 10.1097/00007632-199501000-00007; Hurri H, 2004, PAIN, V112, P225, DOI 10.1016/j.pain.2004.08.016; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Ohtori S, 2001, SPINE, V26, P946, DOI 10.1097/00007632-200104150-00020; Modic MT, 2007, RADIOLOGY, V245, P43, DOI 10.1148/radiol.2451051706; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Fukui M, 2009, J ORTHOP SCI, V14, P348, DOI 10.1007/s00776-009-1337-8; BOGDUK N, 1981, J ANAT, V132, P39; BOGDUK N, 1983, SPINE, V8, P286, DOI 10.1097/00007632-198304000-00009; Carragee EJ, 2000, SPINE, V25, P2987, DOI 10.1097/00007632-200012010-00005; YAMASHITA T, 1993, SPINE, V18, P2252, DOI 10.1097/00007632-199311000-00018; Marinelli NL, 2010, AM J NEURORADIOL, V31, P1278, DOI 10.3174/ajnr.A2080; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Trattnig S, 2010, EUR RADIOL, V20, P2715, DOI 10.1007/s00330-010-1843-2; Blumenkrantz Gabrielle, 2010, Magn Reson Med, V63, P1193, DOI 10.1002/mrm.22362; Carragee EJ, 1999, SPINE, V24, P2542, DOI 10.1097/00007632-199912010-00017; Carragee EJ, 2004, ORTHOP CLIN N AM, V35, P7, DOI 10.1016/S0030-5898(03)00099-3; Inoue G, 2006, SPINE, V31, P1433, DOI 10.1097/01.brs.0000219946.25103.db; KOJIMA Y, 1990, J ANAT, V169, P237; KOJIMA Y, 1990, J ANAT, V169, P247; Krueger EC, 2007, AM J NEURORADIOL, V28, P1237, DOI 10.3174/ajnr.A0546; Nakamura S, 1996, SPINE, V21, P917, DOI 10.1097/00007632-199604150-00003; Ohtori S, 1999, SPINE, V24, P2295, DOI 10.1097/00007632-199911150-00002; Perry J, 2006, AM J NEURORADIOL, V27, P337; SCHWARZER AC, 1994, SPINE, V19, P801, DOI 10.1097/00007632-199404000-00013; SCHWARZER AC, 1995, SPINE, V20, P1878, DOI 10.1097/00007632-199509000-00007; Sekine M, 2001, SPINE, V26, P1516, DOI 10.1097/00007632-200107150-00003; Takashima H, 2012, SKELETAL RADIOL, V41, P163, DOI 10.1007/s00256-011-1144-0; Takebayashi T, 2006, J BONE JOINT SURG BR, V88B, P554, DOI 10.1302/0301-620X.8884.17194; URBAN JPG, 1988, SPINE, V13, P179; Wang YXJ, 2013, EUR RADIOL, V23, P228, DOI 10.1007/s00330-012-2591-2; Zou J, 2009, SPINE, V34, P2545, DOI 10.1097/BRS.0b013e3181b32998; Zuo J, 2012, SPINE, V37, P214, DOI 10.1097/BRS.0b013e3182294a63	36	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					295	301		10.1007/s00776-014-0686-0		7	Orthopedics	Orthopedics	CE5HV	WOS:000351862900007		
J	Hayashi, M; Uchiyama, S; Nakamura, K; Itsubo, T; Momose, T; Kato, H				Hayashi, Masanori; Uchiyama, Shigeharu; Nakamura, Koichi; Itsubo, Toshiro; Momose, Toshimitsu; Kato, Hiroyuki			Arthrodesis of the carpometacarpal joint of the thumb with plate fixation and bone grafting: a retrospective review	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							POWER STAPLE FIXATION; TRAPEZIOMETACARPAL ARTHRODESIS; LIGAMENT RECONSTRUCTION; OSTEOARTHRITIS; ARTHRITIS; ARTHROPLASTY; MANAGEMENT; ARTHROSIS; SCREW	Arthrodesis of the carpometacarpal (CM) joint of the thumb has been recognized as a common technique that gives pain relief, stability, and strength, but it has some disadvantages, such as nonunion, pantrapezial osteoarthritis, and reduced mobility. Thirteen thumbs of 12 patients with CM joint arthritis who underwent CM joint arthrodesis were reviewed retrospectively. The average age of the patients was 61.0 years. The follow-up period ranged from 2 to 5 years. Arthrodesis was performed with a T-plate and an autogenous iliac cancellous bone graft for all patients. All thumbs had radiographic evidence of union, and there was no nonunion. No reduction of motion of the interphalangeal and metacarpophalangeal joint of the thumb was found after surgery. Postoperatively, scaphotrapeziotrapezoid arthritis and metacarpophalangeal arthritis progressed in two joints each. The Disabilities of the Arm, Shoulder, and Hand score improved from 39.9 (range 8-69) to 11.1 (range 0-23.1). All patients had no or slight problems of the thumb and no complaints related to the pelvis in daily living and were either very satisfied or satisfied with the surgery. Arthrodesis of the thumb CM joint with a plate and bone graft achieved satisfactory results in all cases with very few complications. This procedure is a valuable tool in middle-aged and elderly patients with thumb CM joint arthritis.	[Hayashi, Masanori; Uchiyama, Shigeharu; Kato, Hiroyuki] Shinshu Univ, Dept Orthopaed Surg, Sch Med, Matsumoto, Nagano 3908621, Japan; [Nakamura, Koichi] Azumi Gen Hosp, Dept Orthopaed Surg, Nagano, Japan; [Itsubo, Toshiro] Aizawa Hosp, Ctr Sports Med, Matsumoto, Nagano, Japan; [Momose, Toshimitsu] Suwa Red Cross Hosp, Dept Orthopaed Surg, Nagano, Japan	Hayashi, M (reprint author), Shinshu Univ, Dept Orthopaed Surg, Sch Med, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	mhayashi@shinshu-u.ac.jp					SIGFUSSON R, 1991, SCAND J PLAST RECONS, V25, P73; Rizzo M, 2009, J HAND SURG-AM, V34A, P20, DOI 10.1016/j.jhsa.2008.09.022; Forseth MJ, 2003, J HAND SURG-AM, V28A, P342, DOI 10.1053/jhsu.2003.50042; Hartigan BJ, 2001, J BONE JOINT SURG AM, V83A, P1470; BAMBERGER HB, 1992, J HAND SURG-AM, V17A, P605, DOI 10.1016/0363-5023(92)90302-6; EATON RG, 1984, J HAND SURG-AM, V9A, P692; Vermeulen GM, 2011, J HAND SURG-AM, V36A, P157, DOI 10.1016/j.jhsa.2010.10.028; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Kenniston JA, 2008, HAND CLIN, V24, P285, DOI 10.1016/j.hcl.2008.03.006; ARMSTRONG AL, 1994, J HAND SURG-BRIT EUR, V19B, P340, DOI 10.1016/0266-7681(94)90085-X; CAPUTO RJ, 1993, J HAND SURG-AM, V18A, P926, DOI 10.1016/0363-5023(93)90067-D; CARROLL RE, 1987, CLIN ORTHOP RELAT R, P106; Carroll R E, 1973, J Bone Joint Surg Br, V55, P292; Catalano Louis, 2008, Orthopedics, V31, P228; CAVALLAZZI RM, 1986, J HAND SURG-BRIT EUR, V11B, P250; CHAMAY A, 1994, J HAND SURG-BRIT EUR, V19B, P489, DOI 10.1016/0266-7681(94)90215-1; CLOUGH DA, 1990, J HAND SURG-AM, V15A, P706, DOI 10.1016/0363-5023(90)90141-D; Crosby E B, 1978, J Hand Surg Am, V3, P223; Damen A, 2001, SCAND J PLAST RECONS, V35, P407; Fulton DB, 2001, J HAND SURG-AM, V26A, P109, DOI 10.1053/jhsu.2001.20964; Ishida O, 2000, SCAND J PLAST RECONS, V34, P245; Kapandji AI, 1985, ANN CHIR MAIN, V5, P67; Kapoutsis DV, 2011, J HAND SURG-AM, V36A, P354, DOI 10.1016/j.jhsa.2010.11.047; Lisanti M, 1997, J HAND SURG-BRIT EUR, V22B, P576, DOI 10.1016/S0266-7681(97)80348-8; Minami Akio, 2005, Hand Surg, V10, P77, DOI 10.1142/S0218810405002607; Gervis W H, 1973, J Bone Joint Surg Br, V55, P56	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					302	306		10.1007/s00776-014-0685-1		5	Orthopedics	Orthopedics	CE5HV	WOS:000351862900008		
J	Nakamura, Y; Yokoya, S; Mochizuki, Y; Harada, Y; Kikugawa, K; Ochi, M				Nakamura, Yoshihiro; Yokoya, Shin; Mochizuki, Yu; Harada, Yohei; Kikugawa, Kazuhiko; Ochi, Mitsuo			Monitoring of progression of nonsurgically treated rotator cuff tears by magnetic resonance imaging	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							NATURAL-HISTORY; FOLLOW-UP; REPAIR INTEGRITY; MASSIVE TEARS; SUPRASPINATUS; SHOULDERS; CRESCENT; BRIDGE	Nonsurgically treated rotator cuff tears sometimes become irreparable in the lead up to surgical repair. The purposes of our study were to identify predictive factors in the progression of tear size, and determine the changes in tear location. Eighty shoulders from 71 patients (mean age 69.4 years) diagnosed with rotator cuff tears by MRI were treated nonsurgically. MRI was repeated after more than 1 year of initial diagnosis. Tear size was measured from the edge of the tear to the lateral aspect of the greater tuberosity. Tears were classified into 5 groups based on tear size and 4 groups based on tear location. Changes in tear size and location were examined. The mean follow-up period was 22.3 months. The average progression of tear size was 5 mm during follow-up, averaging 3 mm per year. Tears that were initially < 1 or a parts per thousand yen4 cm were unlikely to progress in tear size. On the other hand, 1- to 2-cm tears on the initial MRI exhibited the greatest progression in tear size, followed by 2- to 3-cm tears. Furthermore, 62.5 % of localized tears in the posterior of the superior facet spread anteriorly, whereas 88.9 % of localized tears in the anterior of the superior facet did not change. Medium-sized tears are at high risk of tear progression. In contrast, there is little risk of early development of irreparable damage in partial tear or small full-thickness tears. In addition, typical tears may start in the posterior of the superior facet, and subsequently spread anteriorly. Our present findings may serve as a useful reference in determining the treatment course for rotator cuff tears. Level IV, Case Series, Prognosis Study.	[Nakamura, Yoshihiro; Yokoya, Shin; Harada, Yohei; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, Hiroshima 7348551, Japan; [Mochizuki, Yu] Hiroshima Prefectural Hosp, Dept Orthopaed, Hiroshima, Japan; [Kikugawa, Kazuhiko] Mazda Hosp, Dept Orthopaed, Hiroshima, Japan	Nakamura, Y (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nakamurayoshihiro0419@gmail.com					Kim HM, 2010, J BONE JOINT SURG AM, V92A, P1088, DOI 10.2106/JBJS.I.00686; Sugaya H, 2007, J BONE JOINT SURG AM, V89A, P953, DOI 10.2106/JBJS.F.00512; Maman E, 2009, J BONE JOINT SURG AM, V91A, P1898, DOI 10.2106/JBJS.G.01335; Wolf BR, 2007, AM J SPORT MED, V35, P1007, DOI 10.1177/0363546506295079; ITOI E, 1995, J ORTHOPAED RES, V13, P578, DOI 10.1002/jor.1100130413; ROCKWOOD CA, 1995, J BONE JOINT SURG AM, V77A, P857; Mall NA, 2010, J BONE JOINT SURG AM, V92A, P2623, DOI 10.2106/JBJS.I.00506; Moosmayer S, 2013, J BONE JOINT SURG AM, V95A, P1249, DOI [10.2106/JBJS.L.00185, 10.2106/JBJS.L00185]; BURKHART SS, 1993, ARTHROSCOPY, V9, P611, DOI 10.1016/S0749-8063(05)80496-7; Tashjian RZ, 2012, CLIN SPORT MED, V31, P589, DOI 10.1016/j.csm.2012.07.001; Kijima H, 2012, J SHOULDER ELB SURG, V21, P491, DOI 10.1016/j.jse.2011.10.012; YAMANAKA K, 1994, CLIN ORTHOP RELAT R, P68; Dunn WR, 2005, J BONE JOINT SURG AM, V87A, P1978, DOI 10.2106/JBJS.D.02944; Cho NS, 2011, AM J SPORT MED, V39, P2108, DOI 10.1177/0363546510397171; Burkhart SS, 2006, J AM ACAD ORTHOP SUR, V14, P333; Mochizuki T, 2008, J BONE JOINT SURG AM, V90A, P962, DOI 10.2106/JBJS.G.00427; Fucentese SF, 2012, J BONE JOINT SURG AM, V94A, P801, DOI 10.2106/JBJS.I.01286; Yamakawa S, 2001, ACTA MED OKAYAMA, V55, P261; Sano H, 2013, AM J SPORT MED, V41, P2262, DOI 10.1177/0363546513497565; Safran O, 2011, AM J SPORT MED, V39, P710, DOI 10.1177/0363546510393944; Yamaguchi K, 2001, J SHOULDER ELB SURG, V10, P199, DOI 10.1067/mse.2001.113086; GERBER C, 1988, CLIN ORTHOP RELAT R, P51; Gulotta LV, 2011, J SHOULDER ELB SURG, V20, P941, DOI 10.1016/j.jse.2011.03.028; ITOI E, 1995, J ANAT, V186, P429; Ogawa K, 2005, J SHOULDER ELB SURG, V14, P591, DOI 10.1016/j.jse.2005.03.007; Sugihara T, 2003, J SHOULDER ELB SURG, V12, P222, DOI 10.1016/S1058-2746(02)86888-4; Tanaka M, 2010, UPSALA J MED SCI, V115, P193, DOI 10.3109/03009734.2010.493246; Vanhove Benoit, 2004, Acta Orthop Belg, V70, P219; Verma NN, 2010, ARTHROSCOPY, V26, P1273, DOI 10.1016/j.arthro.2010.01.031; Vitale MG, 1999, J BONE JOINT SURG AM, V81A, P763	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					314	320		10.1007/s00776-014-0680-6		7	Orthopedics	Orthopedics	CE5HV	WOS:000351862900010		
J	Takigami, I; Otsuka, H; Yamamoto, K; Iwase, T; Fujita, H; Matsuda, S; Akiyama, H				Takigami, Iori; Otsuka, Hiromi; Yamamoto, Koji; Iwase, Toshiki; Fujita, Hiroshi; Matsuda, Shuichi; Akiyama, Haruhiko			Proximal femoral reconstruction with impaction bone grafting and circumferential metal mesh	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							TOTAL HIP-ARTHROPLASTY; FOLLOW-UP; SURGICAL TECHNIQUE; CANCELLOUS GRAFT; REVISION; FEMUR; ALLOGRAFT; CEMENT; STEM; CLASSIFICATION	Impaction bone grafting (IBG) using a circumferential metal mesh is one of the options that allow restoration of the femoral bone stock and stability of the implant in revision hip arthroplasty. Here we examine the clinical and radiographic outcome of this procedure using a cemented stem, including experimental analysis of the initial stability of mesh-grafted bone-cemented stem complexes. We retrospectively reviewed six hips (six patients) that had undergone femoral revisions with a circumferential metal mesh, impacted bone allografts, and a cemented stem. The mean follow-up period was 3.9 years (range 2.4-4.8 years). Hip joint function was evaluated using the Japanese Orthopaedic Association hip score, and radiographic changes were determined from radiographs. The initial resistance of mesh-grafted bone-cemented stem complexes to axial and rotational force was measured in a composite bone model with various segmental losses of the proximal femur. The hip score improved from 50 (range 10-84) preoperatively to a mean of 74 (range 67-88) at the final follow-up. The overall implant survival rate was 100 % at five years when radiological loosening or revision for any reason was used as the endpoint. No stem subsided more than 3 mm vertically within one year after implantation. Computed tomography showed reconstitution of the femoral canal in a metal mesh. In mechanical analyses, there was no relationship between IBG reconstruction rates under axial compression and stem subsidence or failure load. In contrast, under rotational load, the rotation angles of the stem to the stainless steel mesh were strongly affected by the IBG reconstruction rate. The short-term results show good outcomes for reconstruction of proximal bone loss with IBG and a circumferential mesh. The procedure should be applied in cases where the circumferential proximal bone loss is less than half the length of the implanted stem.	[Takigami, Iori; Akiyama, Haruhiko] Gifu Univ, Dept Orthopaed Surg, Gifu 511194, Japan; [Otsuka, Hiromi] Aichi Med Univ, Dept Orthopaed, Nagakute, Aichi 4801195, Japan; [Yamamoto, Koji; Matsuda, Shuichi] Kyoto Univ, Dept Orthopaed, Sakyo Ku, Kyoto 6068507, Japan; [Iwase, Toshiki] Hamamatsu Med Ctr, Dept Orthopaed, Naka Ku, Hamamatsu, Shizuoka 4328580, Japan; [Fujita, Hiroshi] Kyoto Katsura Hosp, Dept Orthoped Surg, Nishikyo Ku, Kyoto 6158256, Japan	Akiyama, H (reprint author), Gifu Univ, Dept Orthopaed Surg, 1-1 Yanagido, Gifu 511194, Japan.	hakiyama@gifu-u.ac.jp					Halliday BR, 2003, J BONE JOINT SURG BR, V85B, P809, DOI 10.1302/0301-620X.85B6.13806; Tsiridis E, 2004, J BONE JOINT SURG BR, V86B, P1124, DOI 10.1302/0301-620X.86B8.14854; Henderson ER, 2011, J BONE JOINT SURG AM, V93A, P418, DOI [10.2106/JBJS.J.00834, 10.2106/JBJSJ.00834]; Park YS, 2007, J ARTHROPLASTY, V22, P993, DOI 10.1016/j.arth.2007.03.017; LING RSM, 1993, J BONE JOINT SURG BR, V75, P693; Schreurs BW, 2001, CLIN ORTHOP RELAT R, P202; Ullmark G, 1999, J ARTHROPLASTY, V14, P1019, DOI 10.1016/S0883-5403(99)90019-0; HARRIS WH, 1982, J BONE JOINT SURG AM, V64, P1063; Akiyama H, 2011, J BONE JOINT SURG BR, V93B, P1194, DOI 10.1302/0301-620X.93B9.26598; Farid Y, 2006, CLIN ORTHOP RELAT R, P223, DOI 10.1097/01.blo.0000181491.39048.fe; Rogers BA, 2012, J ARTHROPLASTY, V27, P829, DOI 10.1016/j.arth.2011.10.014; Della Valle CJ, 2004, CLIN ORTHOP RELAT R, P55; Paprosky WG, 1999, CLIN ORTHOP RELAT R, P230; LAWRENCE JM, 1994, J BONE JOINT SURG AM, V76A, P965; Pekkarinen J, 2000, J BONE JOINT SURG BR, V82B, P103, DOI 10.1302/0301-620X.82B1.9802; GIE GA, 1993, J BONE JOINT SURG BR, V75, P14; Regis D, 2011, J BONE JOINT SURG BR, V93B, P1320, DOI 10.1302/0301-620X.93B10.25927; Eldridge JDJ, 1997, J ARTHROPLASTY, V12, P535, DOI 10.1016/S0883-5403(97)90176-5; Sporer SM, 2003, CLIN ORTHOP RELAT R, P203, DOI 10.1097/01.blo.0000096803.78689.0c; Knight JL, 2000, J ARTHROPLASTY, V15, P159, DOI 10.1016/S0883-5403(00)90088-3; Lamberton TD, 2011, J ARTHROPLASTY, V26, P1154, DOI 10.1016/j.arth.2011.03.028; Parvizi J, 2004, CLIN ORTHOP RELAT R, P169; Buttaro MA, 2009, CLIN ORTHOP RELAT R, V467, P2325, DOI 10.1007/s11999-009-0777-y; Cabanela ME, 2003, CLIN ORTHOP RELAT R, P175, DOI 10.1097/01.blo.0000096817.78689.ac; Callaghan J J, 2000, Instr Course Lect, V49, P103; CHANDLER H, 1994, CLIN ORTHOP RELAT R, P67; Farfalli GL, 2007, CLIN ORTHOP RELAT R, P130, DOI 10.1097/BLO.0b013e31837968c; GIE GA, 1993, ORTHOP CLIN N AM, V24, P717; Gross AE, 1998, ORTHOPEDICS, V21, P999; GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17; Guala AJ, 2008, INT ORTHOP, V32, P605, DOI 10.1007/s00264-007-0362-5; Hachiya Y, 1999, TRANSPLANT P, V31, P2032, DOI 10.1016/S0041-1345(99)00257-2; Iwase T, 2013, NAGOYA J MED SCI, V75, P287; Iwase T, 2012, ARCH ORTHOP TRAUM SU, V132, P1487, DOI 10.1007/s00402-012-1561-0; Leone WA, 2008, J ARTHROPLASTY, V23, P383, DOI 10.1016/j.arth.2007.02.017; Linder L, 2000, ACTA ORTHOP SCAND, V71, P543, DOI 10.1080/000164700317362154; Ling RSM, 1997, J BONE JOINT SURG BR, V79B, P874; Piccaluga F, 2002, J BONE JOINT SURG BR, V84B, P544, DOI 10.1302/0301-620X.84B4.12484; Schreurs B Willem, 2006, J Bone Joint Surg Am, V88 Suppl 1 Pt 2, P259, DOI 10.2106/JBJS.F.00340; Van Kleunen JP, 2006, J ARTHROPLASTY, V21, P362, DOI 10.1016/j.arth.2005.04.041	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					331	339		10.1007/s00776-014-0675-3		9	Orthopedics	Orthopedics	CE5HV	WOS:000351862900012		
J	Inoue, D; Kabata, T; Maeda, T; Kajino, Y; Fujita, K; Hasegawa, K; Yamamoto, T; Tsuchiya, H				Inoue, Daisuke; Kabata, Tamon; Maeda, Toru; Kajino, Yoshitomo; Fujita, Kenji; Hasegawa, Kazuhiro; Yamamoto, Takashi; Tsuchiya, Hiroyuki			Value of computed tomography-based three-dimensional surgical preoperative planning software in total hip arthroplasty with developmental dysplasia of the hip	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							ACCURACY; STEM; NAVIGATION	Preoperative planning with computed tomography (CT)-based three-dimensional templating has been expanded to achieve more precise placement of hip components. However, few reports have addressed the utility of three-dimensional surgical planning software for secondary osteoarthritis cases. This study therefore investigated the value of CT-based three-dimensional templating software for preoperative planning in primary total hip arthroplasty (THA), with an emphasis on developmental dysplasia of the hip. We performed a retrospective review of 65 hips in 57 patients who underwent cementless primary THA. The preoperative diagnosis was secondary osteoarthritis in all cases due to developmental dysplasia of the hip. All preoperative planning and postoperative evaluations were completed using CT-based three-dimensional templating software. We analyzed the accuracy of stem size prediction and cup size prediction, the reproducibility of preoperative and postoperative stem anteversion, and the absolute error in preoperative and postoperative stem anteversion using CT-based three-dimensional templating software. The sizes of 65 % of the femoral stems (42/65) were estimated exactly, and 98 % (63/65) were accurately estimated to within one stem size. The final acetabular cup sizes corresponded exactly to the preoperatively planned size in 92 % of all cases (62/65). 100 % of the cup size estimates were accurate to within one cup size. There was strong reproducibility of preoperative and postoperative stem anteversion (r = 0.88, P < 0.05). The absolute error in stem anteversion was 4.0A degrees A A +/- A 3.6A degrees. Using CT-based three-dimensional templating software made it possible to achieve reproducible stem anteversion and choose accurate stem and cup sizes in patients with developmental dysplasia of the hip.	[Inoue, Daisuke; Kabata, Tamon; Maeda, Toru; Kajino, Yoshitomo; Fujita, Kenji; Hasegawa, Kazuhiro; Yamamoto, Takashi; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan	Kabata, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	tamonkabata@yahoo.co.jp			Zimmer, Holdings, Inc.	The authors declare that we received research funding from Zimmer, Holdings, Inc.	Huppertz A, 2011, EUR J RADIOL, V78, P406, DOI 10.1016/j.ejrad.2009.11.024; Issa K, 2012, ORTHOPEDICS, V35, P1028, DOI 10.3928/01477447-20121120-03; Widmer KH, 2004, J ORTHOPAED RES, V22, P815, DOI 10.1016/j.orthres.2003.11.001; Sariali E, 2009, J BONE JOINT SURG BR, V91B, P333, DOI 10.1302/0301-620X.91B3.21390; Gamble P, 2010, J ARTHROPLASTY, V25, P529, DOI 10.1016/j.arth.2009.04.011; DORR LD, 1993, BONE, V14, P231, DOI 10.1016/8756-3282(93)90146-2; Shaarani SR, 2013, J ARTHROPLASTY, V28, P331, DOI 10.1016/j.arth.2012.06.009; Kitada M, 2011, J ARTHROPLASTY, V26, P674, DOI 10.1016/j.arth.2010.08.001; Devane PA, 2012, CLIN ORTHOP RELAT R, V470, P3003, DOI 10.1007/s11999-012-2323-6; Eckrich S G, 1994, J Arthroplasty, V9, P419, DOI 10.1016/0883-5403(94)90053-1; Sariali E, 2012, ORTHOP TRAUMATOL-SUR, V98, P151, DOI 10.1016/j.otsr.2011.09.023; The B, 2007, J ARTHROPLASTY, V22, P866, DOI 10.1016/j.arth.2006.07.013; Haddad FS, 1999, ORTHOP CLIN N AM, V30, P191, DOI 10.1016/S0030-5898(05)70074-2; Hirata M, 2013, J ARTHROPLASTY, V28, P1648, DOI 10.1016/j.arth.2013.03.006; Kajino Y, 2013, J ORTHOP SCI, V18, P290, DOI 10.1007/s00776-012-0351-4; Kuroda K, 2014, INT ORTHOP, V38, P711, DOI 10.1007/s00264-013-2166-0; Sugano N, 1998, Comput Aided Surg, V3, P320, DOI 10.3109/10929089809148153; Viceconti M., 2003, Medical Engineering & Physics, V25, P371, DOI 10.1016/S1350-4533(03)00018-3	18	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					340	346		10.1007/s00776-014-0683-3		7	Orthopedics	Orthopedics	CE5HV	WOS:000351862900013		
J	Fujita, H; Okumura, T; Hara, H; Toda, H; Harada, H; Nishimura, R; Tominaga, T				Fujita, Hiroshi; Okumura, Tomoo; Hara, Hiroaki; Toda, Hiroshi; Harada, Hideto; Nishimura, Ryuuichi; Tominaga, Tomohiro			Monitoring of blood pressure during total hip arthroplasty using the interface bioactive bone cement (IBBC) technique	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							HYDROXYAPATITE GRANULES; FEMORAL COMPONENT; ECHOCARDIOGRAPHY; HEMIARTHROPLASTY	Cement implantation syndrome, which is characterized by hypotension, hypoxemia, and cardiac arrhythmia or arrest, has been reported in the literature. The purpose of the present study was to monitor the blood pressure changes that occur after cementing during primary total hip arthroplasty (THA). The present study examined 178 cases in which 204 joints were treated with primary THA. Study subjects had a mean age at the time of surgery of 64.5 years (range 35-89). Under general anesthesia, both hip components were cemented in place using an anterolateral approach. After cementing, systolic arterial blood pressure was measured at 1-min intervals for 5 min and then again at 10 min. The maximum regulation ratio (MRR) was calculated as follows: (maximum change in blood pressure - blood pressure before cement application) divided by blood pressure before cement application. No major complications, such as cardiac arrest, occurred in most cases; blood pressure increased until 4 mins on the acetabular side and until 2 min on the femoral side, and then gradually returned to the level observed prior to cement application. On the acetabular side, the mean MRR was 11.2 % [standard deviation (SD): 15.9; range -26 to -80], whereas it was 6.4 % (SD: 14.9; range -31 to -65) on the femoral side. Correlations were detected between MRR classification on the acetabular side and the subject's age at the time of the operation or bleeding control status on the acetabular side. When bleeding control was judged as complete, the tendency for blood pressure to decrease was reduced. Conversely, when bleeding control was judged as good, blood pressure showed a greater tendency to decrease. In the present study, no episodes of major hypotension occurred. During THA involving the interface bioactive bone cement (IBBC) technique, when bleeding control on the acetabular side was judged as complete the tendency for blood pressure to decrease was reduced.	[Fujita, Hiroshi; Okumura, Tomoo; Harada, Hideto; Nishimura, Ryuuichi; Tominaga, Tomohiro] Kyoto Katsura Hosp, Inst Joint Replacement, Dept Orthoped Surg, Nishikyo Ku, Kyoto 6158256, Japan; [Hara, Hiroaki] Kyoto Katsura Hosp, Dept Rehabil, Nishikyo Ku, Kyoto 6158256, Japan; [Toda, Hiroshi] Kyoto Katsura Hosp, Dept Anesthesiol, Nishikyo Ku, Kyoto 6158256, Japan	Fujita, H (reprint author), Kyoto Katsura Hosp, Inst Joint Replacement, Dept Orthoped Surg, Nishikyo Ku, Yamada Hirao Cho 17, Kyoto 6158256, Japan.	hfshoot@aol.com					American Society of Anesthesiologists INC, 1963, ANESTHESIOLOGY, V24, P111; CHRISTIE J, 1995, J BONE JOINT SURG BR, V77B, P450; Sierra RJ, 2009, J ARTHROPLASTY, V24, P325, DOI 10.1016/j.arth.2008.01.301; CHRISTIE J, 1994, J BONE JOINT SURG BR, V76B, P409; Arroyo J S, 1994, J Arthroplasty, V9, P449, DOI 10.1016/0883-5403(94)90057-4; Carrington NC, 2009, J BONE JOINT SURG BR, V91B, P730, DOI 10.1302/0301-620X.91B6.21627; CHRISTIE J, 1995, J BONE JOINT SURG BR, V77B, P456; DALL D, 1986, J BONE JOINT SURG BR, V68, P382; Fujita H, 2008, J ARTHROPLASTY, V23, P689, DOI 10.1016/j.arth.2007.05.042; Fujita H, 2012, J ORTHOP SCI, V17, P370, DOI 10.1007/s00776-012-0237-5; Iida H, 2000, J BONE JOINT SURG BR, V82B, P176, DOI 10.1302/0301-620X.82B2 .10278; NOLAN JP, 1994, ANAESTHESIA, V49, P293, DOI 10.1111/j.1365-2044.1994.tb14176.x; Oonishi H, 2001, J ARTHROPLASTY, V16, P784, DOI 10.1054/arth.2001.23724; Oonishi H, 2008, CLIN ORTHOP RELAT R, V466, P373, DOI 10.1007/s11999-007-0057-7; RINECKER H, 1980, ARCH ORTHOP TRAUM SU, V97, P263, DOI 10.1007/BF00380707; Timperley AJ, 2009, J BONE JOINT SURG BR, V91B, P851, DOI 10.1302/0301-620X.91B7.22617	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					347	356		10.1007/s00776-014-0691-3		10	Orthopedics	Orthopedics	CE5HV	WOS:000351862900014		
J	Morii, T; Aoyagi, T; Tajima, T; Yoshiyama, A; Ichimura, S; Mochizuki, K				Morii, Takeshi; Aoyagi, Takayuki; Tajima, Takashi; Yoshiyama, Akira; Ichimura, Shouichi; Mochizuki, Kazuo			Unplanned resection of a soft tissue sarcoma: clinical characteristics and impact on oncological and functional outcomes	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							RE-EXCISION; LOCAL RECURRENCE; RESIDUAL DISEASE; EXTREMITY; INFECTION; TUMORS	Over the past three decades, several studies have reported worse outcomes with unplanned resection for malignant soft tissue tumors. However, the impact of these studies on preventing unnecessary unplanned resection remains unknown. In a retrospective survey on the treatment of soft tissue sarcomas, we compared cases of unplanned resection with cases of planned resection in terms of the properties of unplanned resection and the oncological and functional outcomes. For the unplanned resection cases, an additional wide resection was performed. Of 92 cases, unplanned resection was performed in 24 (26 %). Small or subcutaneous tumors were significantly more frequently subjected to unplanned resection. In 17 of 24 unplanned resection cases, residual tumors (70.8 %) were noted. Plastic surgery was more frequently needed for unplanned resection cases. There was no significant difference between the unplanned resection and control cases with regard to oncological outcome. However, as to local recurrence and overall survival, the events occurred only in the cases with residual tumors in the additional wide resection specimen in the unplanned resection group. There was no significant difference in functional evaluation, except for emotional acceptance, which had a better score in the unplanned resection group. Despite repeated cautions regarding unplanned resection in terms of its inadequate procedure which contradicts the principles of soft tissue sarcoma treatment, unplanned resections are still frequently performed. Perhaps the small size and subcutaneous location of the sarcomas in the unplanned resection group did not evoke the probability of malignancy for the surgeons who initially managed them. Even though an additional wide resection was performed, a residual tumor would lead to a worse outcome. An effective awareness program to avoid unnecessary unplanned resections for soft tissue sarcoma should be considered.	[Morii, Takeshi; Aoyagi, Takayuki; Tajima, Takashi; Yoshiyama, Akira; Ichimura, Shouichi; Mochizuki, Kazuo] Kyorin Univ, Dept Orthoped Surg, Mitaka, Tokyo 1618611, Japan	Morii, T (reprint author), Kyorin Univ, Dept Orthoped Surg, 6-20-2 Shinwaka, Mitaka, Tokyo 1618611, Japan.	t-morii@gb3.so-net.ne.jp			Health and Labor Sciences Research Expenses for Commission; Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labor and Welfare [H26-084]	This study was supported in part by the Health and Labor Sciences Research Expenses for Commission, and the Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labor and Welfare (H26-084).	Guillou L, 1997, J CLIN ONCOL, V15, P350; Noria S, 1996, J BONE JOINT SURG AM, V78A, P650; Lewis JJ, 2000, ANN SURG, V231, P655, DOI 10.1097/00000658-200005000-00005; Venkatesan M, 2012, EJSO-EUR J SURG ONC, V38, P346, DOI 10.1016/j.ejso.2011.12.011; Alamanda VK, 2013, ANN SURG ONCOL, V20, P2808, DOI 10.1245/s10434-013-2995-5; Fiore M, 2006, ANN SURG ONCOL, V13, P110, DOI 10.1245/ASO.2006.03.030; Chandrasekar CR, 2008, J BONE JOINT SURG BR, V90B, P203, DOI 10.1302/0301-620X.90B2.19760; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Davis AM, 1997, J SURG ONCOL, V66, P81, DOI 10.1002/(SICI)1096-9098(199710)66:2<81::AID-JSO2>3.0.CO;2-H; Arai E, 2010, CLIN ORTHOP RELAT R, V468, P3028, DOI 10.1007/s11999-010-1392-7; GIULIANO AE, 1985, J CLIN ONCOL, V3, P1344; Hoshi M, 2008, JPN J CLIN ONCOL, V38, P701, DOI 10.1093/jjco/hyn093; KAWAGUCHI N, 2004, CLIN ORTHOP RELA FEB, P165, DOI DOI 10.1097/01.BLO.0000116308.86761.F5; Manoso MW, 2005, J SURG ONCOL, V91, P153, DOI 10.1002/jso.20323; Morii T, 2012, J ORTHOP SCI, V17, P51, DOI 10.1007/s00776-011-0179-3; Morii T, 2013, J ORTHOP SCI, V18, P605, DOI 10.1007/s00776-013-0389-y; Morii T, 2008, OPEN ORTHOP J, V30, P126; Potter BK, 2008, CLIN ORTHOP RELAT R, V466, P3093, DOI 10.1007/s11999-008-0529-4; Rehders A, 2009, WORLD J SURG, V33, P2599, DOI 10.1007/s00268-009-0262-5; Siegel Herrick J, 2009, J Surg Orthop Adv, V18, P93; Tanaka K, 2009, JPN J CLIN ONCOL, V39, P271, DOI 10.1093/jjco/hyn153; Umer Hafiz Muhammad, 2013, Sarcoma, P498604, DOI 10.1155/2013/498604; ZORNIG C, 1995, BRIT J SURG, V82, P278, DOI 10.1002/bjs.1800820247	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					373	379		10.1007/s00776-014-0689-x		7	Orthopedics	Orthopedics	CE5HV	WOS:000351862900017		
J	Omachi, T; Sakai, T; Hiraiwa, H; Hamada, T; Ono, Y; Nakashima, M; Ishizuka, S; Matsukawa, T; Oda, T; Takamatsu, A; Yamashita, S; Ishiguro, N				Omachi, Takaaki; Sakai, Tadahiro; Hiraiwa, Hideki; Hamada, Takashi; Ono, Yohei; Nakashima, Motoshige; Ishizuka, Shinya; Matsukawa, Tetsuya; Oda, Tomoyuki; Takamatsu, Akira; Yamashita, Satoshi; Ishiguro, Naoki			Expression of tenocyte lineage-related factors in regenerated tissue at sites of tendon defect	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							GROWTH-FACTOR VEGF; EXTRACELLULAR-MATRIX; CHONDROMODULIN-I; ACHILLES-TENDON; GENE; OSSIFICATION; MODEL; SOX9; ANGIOGENESIS; TENDINOPATHY	The healing mechanism of ruptured or injured tendons is poorly understood. To date, some lineage-specific factors, such as scleraxis and tenomodulin, have been reported as markers of tenocyte differentiation. Because few studies have focused on tenocyte lineage-related factors with respect to the repaired tissue of healing tendons, the aim of this study was to investigate their expression during the tendon healing process. Defects were created in the patellar tendons of rats, and the patellae and patellar tendons were harvested at 3 days and at 1, 2, 3, 6, 12, and 20 weeks after surgery. They were studied using micro-computed tomography, and paraffin-embedded sections were then prepared for histological evaluation. Reverse transcription-polymerase chain reactions were performed to analyze the expression of genes related to the tenocyte lineage, chondrogenesis, and ossification. Repaired tissue became increasingly fibrous over time and contained a greater number of vessels than normal tendons, even in the later period. Safranin O staining revealed the existence of proteoglycan at 1 week and its persistence through 20 weeks. Ossification was detected in all tendons at 12 weeks. The expression of tenocyte lineage-related genes was high at 1 and 2 weeks. Chondrogenic genes were up-regulated until 6 weeks. Runt-related transcription factor 2, an osteogenic gene, was up-regulated at 20 weeks. In our tendon defect model, cells participating in the tendon healing process appeared to differentiate toward tenocyte lineage only in the early phase, and chondrogenesis seemed to occur from the early phase onward. To improve tendon repair, it will be necessary to promote and maintain tenogenesis and to inhibit chondrogenesis, especially in the early phase, in order to avoid erroneous differentiation of stem cells.	[Omachi, Takaaki; Sakai, Tadahiro; Hiraiwa, Hideki; Hamada, Takashi; Ono, Yohei; Nakashima, Motoshige; Ishizuka, Shinya; Matsukawa, Tetsuya; Oda, Tomoyuki; Takamatsu, Akira; Yamashita, Satoshi; Ishiguro, Naoki] Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Omachi, T (reprint author), Nagoya Univ, Dept Orthopaed Surg, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ohmachita@gmail.com; tadsakai@med.nagoya-u.ac.jp			KAKENHI [22659271, 24659672]; MEISEI-KAI fund	No benefits in any form have been received from any commercial party directly related to the subject of this article. Funding was supported by the Grants-in-Aid for Scientific Research (KAKENHI) 22659271 and 24659672, and the MEISEI-KAI fund. We sincerely thank Prof. Kawai for permitting us to use the R_mCT unit at Aichi Gakuin University, School of Dentistry, Department of Dental Materials and Devices.	Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; Boyer MI, 2001, J ORTHOPAED RES, V19, P869, DOI 10.1016/S0736-0266(01)00017-1; Maffulli N, 2006, CLIN J SPORT MED, V16, P329, DOI 10.1097/00042752-200607000-00008; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; Gerber HP, 1999, NAT MED, V5, P623; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336; Bi WM, 1999, NAT GENET, V22, P85; Brandau O, 2001, DEV DYNAM, V221, P72, DOI 10.1002/dvdy.1126; Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Berglund ME, 2011, J ORTHOP RES, V29, P886, DOI 10.1002/jor.21330; Dourte LM, 2008, J ORTHOP RES, V26, P1297, DOI 10.1002/jor.20646; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017531; Lui PPY, 2012, J ORTHOP RES, V30, P37, DOI 10.1002/jor.21495; Lui PPY, 2011, J ORTHOP RES, V29, P816, DOI 10.1002/jor.21313; Lui PPY, 2009, J HISTOCHEM CYTOCHEM, V57, P91, DOI 10.1369/jhc.2008.952143; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; PACIFICI M, 1991, EXP CELL RES, V192, P266, DOI 10.1016/0014-4827(91)90185-W; Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P475, DOI 10.1007/s00402-003-0490-3; Petersen W, 2004, J ORTHOPAED RES, V22, P847, DOI 10.1016/j.orthres.2003.11.009; Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P168, DOI 10.1007/s00402-002-0462-z; Shukunami C, 2001, BIOCHEM BIOPH RES CO, V280, P1323, DOI 10.1006/bbrc.2001.4271; Yokota A, 2005, J SHOULDER ELB SURG, V14, p72S, DOI 10.1016/j.jse.2004.09.021	30	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					380	389		10.1007/s00776-014-0684-2		10	Orthopedics	Orthopedics	CE5HV	WOS:000351862900018		
J	Yano, K; Yasuda, H; Takaoka, K; Takahashi, M; Nakamura, H; Imai, Y; Wakitani, S				Yano, Koichi; Yasuda, Hiroyuki; Takaoka, Kunio; Takahashi, Masafumi; Nakamura, Hiroaki; Imai, Yuuki; Wakitani, Shigeyuki			Fate, origin and roles of cells within free bone grafts	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							FRACTURE REPAIR; CELLULAR CONTRIBUTION; BMP RECEPTORS; MODEL; EXPRESSION; MARROW; CONTRIBUTE; NOGGIN; FUSION; MICE	The efficacy of autologous bone grafting in repairing nonunion fractures, large bone defects and spinal instability is widely accepted. However, the cellular and molecular mechanisms underlying new bone formation in bone grafting have yet to be fully elucidated. The purpose of this study was to clarify the fate, origin and the contribution of the cells within the grafted bone. This study was designed to investigate the role and fate of cells contained in the grafted bone and their contribution to new bone formation in the graft in an animal model. Middiaphyseal cylindrical bone samples obtained from green fluorescent protein (GFP) transgenic and wild-type rats were transplanted into the back muscle of wild-type and GFP rats, respectively. The transplanted bones were evaluated by immunohistochemistry, in situ hybridization and quantitative reverse transcription polymerase chain reaction. Immunohistochemical analyses showed that all the cells in the newly formed bone originated from the grafted bone, and osteoblasts were gradually replaced by host cells. Conversely, osteoclasts were immediately replaced by host cells 2 weeks after the bone graft. In addition, expression of bone morphogenetic protein (Bmp)-4, Bmp receptors and Noggin in the grafted bone was significantly upregulated before new bone formation occurred, indicating that the grafted cells might contribute to the recruitment of mesenchymal cells into the graft bed. This study revealed the possible molecular mechanisms of the contribution of cells contained in grafted bone to facilitate new bone formation.	[Yano, Koichi; Yasuda, Hiroyuki; Takaoka, Kunio; Nakamura, Hiroaki; Imai, Yuuki; Wakitani, Shigeyuki] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka, Osaka 5458585, Japan; [Takahashi, Masafumi] Jichi Med Univ, Div Inflammat Res, Ctr Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Imai, Yuuki] Ehime Univ, Div Integrat Pathophysiol, Proteosci Ctr, Grad Sch Med, Toon, Ehime 7910295, Japan; [Wakitani, Shigeyuki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Artificial Joint & Biomat, Minami Ku, Hiroshima 7398553, Japan	Imai, Y (reprint author), Ehime Univ, Div Integrat Pathophysiol, Proteosci Ctr, Grad Sch Med, Toon, Ehime 7910295, Japan.	y-imai@m.ehime-u.ac.jp; swakitani44@gmail.com			Japan Society for the Promotion of Science [21591954]	We thank Dr. Amu Kawaguchi and Ms Kanako Hata for their technical assistance and PhoenixBio Co. (Tochigi, Japan) for providing GFP-transgenic rats. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (no. 21591954 to KT).	Ames CP, 2005, SPINE, V30, P2585, DOI 10.1097/01.brs.0000188294.01845.20; Nakamura Y, 2003, J BONE MINER RES, V18, P1854, DOI 10.1359/jbmr.2003.18.10.1854; Kubota K, 2008, CARCINOGENESIS, V29, P448, DOI 10.1093/carcin/bgm279; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Imai Y, 2005, J BONE MINER RES, V20, P1723, DOI 10.1359/JBMR.050607; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; Colnot C, 2006, BIOCHEM BIOPH RES CO, V350, P557, DOI 10.1016/j.bbrc.2006.09.079; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300; BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165; BOUCHARD JA, 1994, SPINE, V19, P1836, DOI 10.1097/00007632-199408150-00008; Burwell R G, 1966, J Bone Joint Surg Br, V48, P532; ELVES MW, 1976, CLIN ORTHOP RELAT R, P232; Gould SE, 2000, J ORTHOPAED RES, V18, P920, DOI 10.1002/jor.1100180611; Liu RJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-288; Marx Robert E, 2007, Oral Maxillofac Surg Clin North Am, V19, P455, DOI 10.1016/j.coms.2007.07.008; Nakashima T, 2009, J BONE MINER METAB, V27, P519, DOI 10.1007/s00774-009-0089-z; Yoshimura Y, 2001, J BONE MINER RES, V16, P876, DOI 10.1359/jbmr.2001.16.5.876	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					390	396		10.1007/s00776-014-0673-5		7	Orthopedics	Orthopedics	CE5HV	WOS:000351862900019		
J	Hagiwara, Y; Izumi, T; Yabe, Y; Sato, M; Sonofuchi, K; Kanazawa, K; Koide, M; Saijo, Y; Itoi, E				Hagiwara, Yoshihiro; Izumi, Takuya; Yabe, Yutaka; Sato, Mika; Sonofuchi, Kazuaki; Kanazawa, Kenji; Koide, Masashi; Saijo, Yoshifumi; Itoi, Eiji			Simultaneous evaluation of articular cartilage and subchondral bone from immobilized knee in rats by photoacoustic imaging system	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							FEMORAL CONDYLAR CARTILAGE; OSTEOARTHRITIS; JOINT; TOMOGRAPHY; PAIN	Osteoarthritis is not only a disease of articular cartilage, but also of subchondral bone. It is difficult for ultrasound to evaluate subchondral bone because of permeability. This study aimed to evaluate sequential osteoarthritic changes of articular cartilage and subchondral bone from immobilized knees in rats with a photoacoustic (PA) imaging system. The unilateral knee joints of adult male rats were immobilized with an internal fixator (IM group) for 4 and 8 weeks. Sham operated animals had holes drilled in the femur and tibia and screws inserted without a plate (control group). A whole proximal third of the tibia was obtained. The specimens were immersed in normal saline and scanned by the PA imaging system, which can create both ultrasound (US) and PA imaging. After the scanning, specimens were fixed with paraformaldehyde, decalcified and embedded in paraffin. Thinly sliced tissues were prepared for histological evaluation. PA signals from the articular cartilage and subchondral bone were independently evaluated. Gross observations showed that fibrillation occurred in the superficial layers and permeability of the articular cartilage increased. Histological observations showed that the articular cartilage became thicker and the bone marrow space expanded during immobilization. US images by the PA imaging system could evaluate the articular cartilage. PA signals from the articular cartilage and subchondral bone increased with the duration of immobilization and the difference, compared to the control group, was significant. The PA imaging system could evaluate articular cartilage and subchondral bone simultaneously.	[Hagiwara, Yoshihiro; Yabe, Yutaka; Sonofuchi, Kazuaki; Kanazawa, Kenji; Koide, Masashi; Itoi, Eiji] Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Izumi, Takuya; Sato, Mika; Saijo, Yoshifumi] Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Imaging, Aoba Ku, Sendai, Miyagi 9808575, Japan	Hagiwara, Y (reprint author), Tohoku Univ, Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	hagi@med.tohoku.ac.jp			Ministry of Education, Science, Sports and Culture	This research was supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (B).	Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00; Hagiwara Y, 2009, J ORTHOP RES, V27, P236, DOI 10.1002/jor.20724; Tsai CY, 2007, OSTEOARTHR CARTILAGE, V15, P245, DOI 10.1016/j.joca.2006.08.009; Burr DB, 2003, RHEUM DIS CLIN N AM, V29, P675, DOI 10.1016/S0889-857X(03)00061-9; Sharma AR, 2013, INT J MOL SCI, V14, P19805, DOI 10.3390/ijms141019805; Thambyah A, 2009, OSTEOARTHR CARTILAGE, V17, P456, DOI 10.1016/j.joca.2008.09.005; DeGroot J, 2004, ARTHRITIS RHEUM, V50, P1207, DOI 10.1002/art.20170; O'Reilly SC, 1998, ANN RHEUM DIS, V57, P588, DOI 10.1136/ard.57.10.588; Lajeunesse D, 2003, CURR OPIN RHEUMATOL, V15, P628, DOI 10.1097/00002281-200309000-00018; Pufe T, 2001, ARTHRITIS RHEUM, V44, P1082, DOI 10.1002/1529-0131(200105)44:5<1082::AID-ANR188>3.0.CO;2-X; Vanwanseele B, 2002, ARTHRITIS RHEUM, V46, P2073, DOI 10.1002/art.10462; LAWRENCE JS, 1966, ANN RHEUM DIS, V25, P1; Brandt KD, 2006, ANN RHEUM DIS, V65, P1261, DOI 10.1136/ard.2006.058347; Castaneda S, 2012, BIOCHEM PHARMACOL, V83, P315, DOI 10.1016/j.bcp.2011.09.018; Sun Y, 2011, MED PHYS, V38, P4009, DOI 10.1118/1.3598113; Aula AS, 2010, OSTEOARTHR CARTILAGE, V18, P1570, DOI 10.1016/j.joca.2010.09.009; Bevers K, 2014, RHEUMATOLOGY, V53, P1625, DOI 10.1093/rheumatology/keu030; Hagiwara Y, 2012, INT ORTHOP, V36, P185, DOI 10.1007/s00264-011-1263-1; Izumi Takuya, 2013, Conf Proc IEEE Eng Med Biol Soc, V2013, P1116, DOI 10.1109/EMBC.2013.6609701; Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004; Liu PY, 1998, PHYS MED BIOL, V43, P667, DOI 10.1088/0031-9155/43/3/017; MCCUNE WJ, 1990, CLIN ORTHOP RELAT R, P230; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					397	402		10.1007/s00776-014-0692-2		6	Orthopedics	Orthopedics	CE5HV	WOS:000351862900020		
J	Takasawa, E; Yamamoto, A; Kobayashi, T; Tajika, T; Shitara, H; Ichinose, T; Mieda, T; Iizuka, Y; Iizuka, H; Takagishi, K				Takasawa, Eiji; Yamamoto, Atsushi; Kobayashi, Tsutomu; Tajika, Tsuyoshi; Shitara, Hitoshi; Ichinose, Tsuyoshi; Mieda, Tokue; Iizuka, Yoichi; Iizuka, Haku; Takagishi, Kenji			Characteristics of neck and shoulder pain in the Japanese general population	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							2000-2010 TASK-FORCE; DISORDERS; DETERMINANTS; OXYGENATION; EXPERIENCE; TRAPEZIUS; FEMALES; FATIGUE; MUSCLES; FOREARM	Neck and shoulder pain (NSP) is very common in the general population. However, little is known about the epidemiology of this condition. The purpose of this study was to investigate the characteristics and the factors associated with NSP and to reveal its effect on health-related quality of life (HRQOL). Medical checkups were conducted among the residents of a mountain village where agroforestry and tourism are the main industries. The participants comprised 863 residents, including 308 males and 555 females. NSP was defined as the symptoms of muscle tension, stiffness, pressure or dull pain extending from the neck to the scapular arch. The participants completed a questionnaire including information on the presence of NSP, age, gender, musculoskeletal pain at other anatomical sites and medical complications. The NSP-associated factors obtained by the questionnaire were investigated using univariate and multivariate analyses. The EuroQol (i.e., EQ-5D and EQ-VAS) was also assessed. The prevalence of NSP was 48.3 %, and NSP was more common in females than males. The prevalence was higher in the generation from 20 to 50 years of age and decreased with age. NSP was associated with pain in the upper extremities and lower EuroQol scores, but not with pain in the lower extremities or medical complications. A multivariate logistic regression analysis showed that female gender and pain in the upper extremities were independently associated with NSP. We used a general concept of NSP, which allowed us to collect the unified data about this condition among the participants. NSP was a prevalent health problem that led to deterioration of the HRQOL in the general population. Female gender and pain in the upper extremities were the factors associated with NSP. The characteristics of NSP clarified in this study may provide a basis for the prevention and/or effective management of NSP.	[Takasawa, Eiji; Yamamoto, Atsushi; Tajika, Tsuyoshi; Shitara, Hitoshi; Ichinose, Tsuyoshi; Mieda, Tokue; Iizuka, Yoichi; Iizuka, Haku; Takagishi, Kenji] Gunma Univ, Dept Orthopaed Surg, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Kobayashi, Tsutomu] Takasaki Univ Hlth & Welf, Dept Phys Therapy, Takasaki, Gunma 3700033, Japan	Takasawa, E (reprint author), Gunma Univ, Dept Orthopaed Surg, Grad Sch Med, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	eijitakasawa@yahoo.co.jp		Ichinose, Tsuyoshi/0000-0003-2663-5314			Iizuka Y, 2012, J ORTHOP SCI, V17, P46, DOI 10.1007/s00776-011-0177-5; Cassou B, 2002, OCCUP ENVIRON MED, V59, P537, DOI 10.1136/oem.59.8.537; Fransen M, 1999, RHEUMATOLOGY, V38, P807, DOI 10.1093/rheumatology/38.9.807; Sjogaard G, 2010, EUR J APPL PHYSIOL, V108, P657, DOI 10.1007/s00421-009-1268-2; Carroll LJ, 2004, PAIN, V107, P134, DOI 10.1016/j.pain.2003.10.009; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; REKOLA KE, 1993, J EPIDEMIOL COMMUN H, V47, P153, DOI 10.1136/jech.47.2.153; Nussbaum MA, 2001, EUR J APPL PHYSIOL, V85, P299, DOI 10.1007/s004210100454; Ektor-Andersen J, 1999, PAIN, V82, P289, DOI 10.1016/S0304-3959(99)00053-6; Hogg-Johnson S, 2008, SPINE, V33, pS39, DOI 10.1097/BRS.0b013e31816454c8; Dennerlein JT, 2003, AIHA J-J SCI OCCUP E, V64, P799; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Hurwitz EL, 2005, SPINE, V30, P1477, DOI 10.1097/01.brs.0000167821.39373.c1; Tsunoda D, 2013, J ORTHOP SCI, V18, P216, DOI 10.1007/s00776-012-0341-6; Binderup AT, 2010, BMC MUSCULOSKEL DIS, V12, P234; Bliss SJ, 2004, NEW ENGL J MED, V350, P1037, DOI 10.1056/NEJMcps032253; Chang WH, 2009, ARCH PHYS MED REHAB, V90, P279, DOI 10.1016/j.apmr.2008.07.027; Cote P, 2000, SPINE, V25, P1109; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; Elcadi GH, 2011, EUR J APPL PHYSIOL, V111, P647, DOI 10.1007/s00421-010-1688-z; Fältström Anne, 2013, Am J Sports Med, V41, P2805, DOI 10.1177/0363546513502309; Grubb SA, 2000, SPINE, V25, P1382, DOI 10.1097/00007632-200006010-00010; Iijima K, 1992, NIHON IJISHINNPOU, V3547, P30; Nakamura T, 2006, ANN ANAT, V188, P243, DOI 10.1016/j.aanat.2005.11.011; Roatta S, 2008, J PHYSIOL-LONDON, V586, P5561, DOI 10.1113/jphysiol.2008.160770; Shinozaki T, 2007, RINSHO SEIKEI GEKA, V42, P409; Statistics and Information Department Ministry of Health Labour and Welfare, 2010, COMPR SURV LIV COND; Swenson Rand S, 2003, Phys Med Rehabil Clin N Am, V14, P605, DOI 10.1016/S1047-9651(03)00038-X; Takagishi K., 2008, J JPN ORTHOP ASSOC, V82, P901; Tanaka N, 2014, J ORTHOP SCI, V19, P33, DOI 10.1007/s00776-013-0494-y; Tanaka Y, 2006, SPINE, V31, pE568, DOI 10.1097/01.brs.0000229261.02816.48; Uehara M, 2013, SPINE J, V13, P391, DOI 10.1016/j.spinee.2012.11.012; Yabuki S, 2001, RINSHO SEIKEI GEKA, V36, P1241; Yokogushi K, 1994, E JPN J CLIN ORHOP, V6, P419; Zakaria D, 2002, AM J IND MED, V42, P258, DOI 10.1002/ajim.10100	35	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					403	409		10.1007/s00776-014-0676-2		7	Orthopedics	Orthopedics	CE5HV	WOS:000351862900021		
J	Hagiwara, Y; Iwata, S; Yonemoto, T; Ishii, T				Hagiwara, Yoko; Iwata, Shintaro; Yonemoto, Tsukasa; Ishii, Takeshi			Rotational valgus osteotomy for shepherd's crook deformity: a case report	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							FIBROUS DYSPLASIA; FEMUR; NECK		[Hagiwara, Yoko] Tokyo Womens Med Univ, Dept Orthopaed, Tokyo, Japan; [Iwata, Shintaro; Yonemoto, Tsukasa; Ishii, Takeshi] Chiba Canc Ctr, Div Orthoped Surg, Chuo Ku, Chiba 2608717, Japan	Iwata, S (reprint author), Chiba Canc Ctr, Div Orthoped Surg, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	siwata@chiba-cc.jp					Jung ST, 2006, ACTA ORTHOP, V77, P469, DOI 10.1080/17453670610046415; Ogilvie CM, 2009, CLIN ORTHOP RELAT R, V467, P2685, DOI 10.1007/s11999-009-0726-9; Guille JT, 1998, J BONE JOINT SURG AM, V80A, P648; Araki N, 1999, CLIN ORTHOP RELAT R, P196; ENNEKING WF, 1986, J BONE JOINT SURG AM, V68A, P1415; Eralp L, 2004, J BONE JOINT SURG BR, V86B, P1065, DOI 10.1302/0301-620X.86B7.14923; FUNK FJ, 1973, CLIN ORTHOP RELAT R, P77; Kataria Himanshu, 2009, J Orthop Surg (Hong Kong), V17, P245; PALEY D, 1992, CLIN ORTHOP RELAT R, P65; Sakurakichi K, 2008, J Orthop Surg (Hong Kong), V16, P254	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					422	424		10.1007/s00776-013-0463-5		3	Orthopedics	Orthopedics	CE5HV	WOS:000351862900024		
J	Fukuda, Y; Watanabe, K; Toyama, Y; Mikami, S; Matsumoto, M				Fukuda, Yoshitsugu; Watanabe, Kota; Toyama, Yoshiaki; Mikami, Shuji; Matsumoto, Morio			Metastasis of intracranial meningeal hemangiopericytoma to thoracic spine 17 years after surgical excision: a case report	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EN-BLOC SPONDYLECTOMY; ANGIOBLASTIC MENINGIOMA; HYPOGLYCEMIA; TUMORS		[Fukuda, Yoshitsugu; Toyama, Yoshiaki; Matsumoto, Morio] Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Watanabe, Kota] Keio Univ, Dept Adv Therapy Spine & Spinal Cord Disorders, Tokyo, Japan; [Mikami, Shuji] Keio Univ, Div Diagnost Pathol, Tokyo, Japan	Matsumoto, M (reprint author), Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	morio@a5.keio.jp					Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Stout AP, 1942, ANN SURG, V116, P26, DOI 10.1097/00000658-194207000-00004; Matsumoto M, 2011, J NEUROSURG-SPINE, V15, P320, DOI 10.3171/2011.5.SPINE10813; Tomita K, 2006, J ORTHOP SCI, V11, P3, DOI 10.1007/s00776-005-0964-y; BACKWINK.KD, 1970, CANCER, V25, P896, DOI 10.1002/1097-0142(197004)25:4<896::AID-CNCR2820250423>3.0.CO;2-N; Chung J, 1996, J CLIN ENDOCR METAB, V81, P919, DOI 10.1210/jc.81.3.919; Cole CD, 2009, RARE TUMORS, V43, P132; GEISINGER KR, 1990, ARCH PATHOL LAB MED, V114, P705; KRUSE F, 1961, NEUROLOGY, V11, P771; Lee JK, 2006, ACTA NEUROCHIR, V148, P787, DOI 10.1007/s00701-006-0766-9; MENA H, 1991, HUM PATHOL, V22, P84, DOI 10.1016/0046-8177(91)90067-Y; Miyamoto S, 2004, NEUROL SURG TOKYO, V32, P367; Nonaka M, 1998, CLIN NEUROL NEUROSUR, V100, P228, DOI 10.1016/S0303-8467(98)00035-3; SCOTT M, 1974, SURG NEUROL, V2, P35; Taniura S, 2007, SPINE J, V7, P371, DOI 10.1016/j.spinee.2006.05.011; Woitzik J, 2003, CLIN NEUROL NEUROSUR, V105, P159, DOI 10.1016/S0303-8467(02)00140-3	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					425	429		10.1007/s00776-013-0450-x		5	Orthopedics	Orthopedics	CE5HV	WOS:000351862900025		
J	Cao, K; Watanabe, K; Hosogane, N; Toyama, Y; Matsumoto, M				Cao, Kai; Watanabe, Kota; Hosogane, Naobumi; Toyama, Yoshiaki; Matsumoto, Morio			Surgical correction of severe kyphoscoliosis resulting in a neurological complication in Marshall-Smith syndrome	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							NATURAL-HISTORY		[Cao, Kai; Watanabe, Kota; Hosogane, Naobumi; Toyama, Yoshiaki; Matsumoto, Morio] Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Cao, Kai] Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang 330006, Peoples R China	Matsumoto, M (reprint author), Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	morio@a5.keio.jp					Adam MP, 2005, AM J MED GENET A, V137A, P117, DOI 10.1002/ajmg.a.30580; EICH GF, 1991, RADIOLOGY, V181, P183; Malan V, 2010, AM J HUM GENET, V87, P189, DOI 10.1016/j.ajhg.2010.07.001; Butler MG, 2004, AM J MED GENET A, V126A, P329, DOI 10.1002/ajmg.a.20603; Diab M, 2003, AM J MED GENET A, V119A, P218, DOI 10.1002/ajmg.a.10173; MARSHALL RE, 1971, J PEDIATR-US, V78, P95, DOI 10.1016/S0022-3476(71)80269-X; PAPPAS CTE, 1991, J NEUROSURG, V75, P317, DOI 10.3171/jns.1991.75.2.0317; Shaw AC, 2010, AM J MED GENET A, V152A, P2714, DOI 10.1002/ajmg.a.33709; SPERLI D, 1993, J MED GENET, V30, P877, DOI 10.1136/jmg.30.10.877; Summers DA, 1999, CLIN DYSMORPHOL, V8, P207	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					430	433		10.1007/s00776-013-0452-8		4	Orthopedics	Orthopedics	CE5HV	WOS:000351862900026		
J	Hisatsugu, K; Shigeru, H; Makoto, M; Iwao, Y; Kazuaki, Y; Takashi, M				Hisatsugu, Kurimoto; Shigeru, Hirabayashi; Makoto, Miura; Iwao, Yamamoto; Kazuaki, Yamada; Takashi, Matsushita			A case report of nocardiosis at the cauda equina	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							TRANSPLANT RECIPIENTS; INFECTIONS		[Hisatsugu, Kurimoto; Shigeru, Hirabayashi; Makoto, Miura; Iwao, Yamamoto; Kazuaki, Yamada; Takashi, Matsushita] Teikyo Univ Hosp, Dept Orthopaed Surg, Itabashi Ku, Tokyo, Japan	Hisatsugu, K (reprint author), Teikyo Univ Hosp, Dept Orthopaed Surg, Itabashi Ku, 11-1 Kaga 2 Chome, Tokyo, Japan.	kurimoto0.82.7@gmail.com					Moylett EH, 2003, CLIN INFECT DIS, V36, P313, DOI 10.1086/345907; Lerner PI, 1996, CLIN INFECT DIS, V22, P891; Patel R, 1997, CLIN MICROBIOL REV, V10, P86; BEAMAN BL, 1994, CLIN MICROBIOL REV, V7, P213; Graat Harm C A, 2002, Spine (Phila Pa 1976), V27, pE253, DOI 10.1097/00007632-200205150-00021; Hamdad F, 2007, J CLIN MICROBIOL, V45, P262, DOI 10.1128/JCM.0669-06; Lederman ER, 2004, MEDICINE, V83, P300, DOI 10.1097/01.md.0000141100.30871.39; Lee J, 2010, J CLIN NEUROSCI, V17, P1194, DOI 10.1016/j.jocn.2009.12.022; WILSON JP, 1989, MEDICINE, V68, P38	9	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					434	438		10.1007/s00776-013-0460-8		5	Orthopedics	Orthopedics	CE5HV	WOS:000351862900027		
J	Hosaka, S; Katagiri, H; Wasa, J; Murata, H; Takahashi, M				Hosaka, Seiichi; Katagiri, Hirohisa; Wasa, Jyunji; Murata, Hideki; Takahashi, Mitsuru			Solitary fibrous tumor in the pelvis: induced hypoglycemia associated with insulin-like growth factor II	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article							RADIATION-THERAPY; PLEURA		[Hosaka, Seiichi; Katagiri, Hirohisa; Wasa, Jyunji; Murata, Hideki; Takahashi, Mitsuru] Shizuoka Canc Ctr Hosp, Dept Orthoped Surg, Nagaizumi, Shizuoka 4118777, Japan	Hosaka, S (reprint author), Shizuoka Canc Ctr Hosp, Dept Orthoped Surg, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	s.hosaka@scchr.jp					Akisue T, 2003, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000065839.77325.b4; Pervaiz N, 2008, CANCER, V113, P573, DOI [10.1002/cncr.23592, 10.1002/cncr23592]; Kawamura S, 2007, PATHOL INT, V57, P213, DOI 10.1111/j.1440-1827.2007.02083.x; ENGLAND DM, 1989, AM J SURG PATHOL, V13, P640, DOI 10.1097/00000478-198908000-00003; Hasegawa T, 1999, HUM PATHOL, V30, P1464, DOI 10.1016/S0046-8177(99)90169-7; Kepka L, 2005, INT J RADIAT ONCOL, V63, P852, DOI 10.1016/j.ijrobp.2005.03.004; BRISELLI M, 1981, CANCER, V47, P2678, DOI 10.1002/1097-0142(19810601)47:11<2678::AID-CNCR2820471126>3.0.CO;2-9; Rabbani A, 2007, AM J CLIN ONCOL-CANC, V30, P283, DOI 10.1097/01.coc.0000258118.38177.74; Feuvret L, 2007, INT J RADIAT ONCOL, V69, P944, DOI 10.1016/j.ijrobp.2007.07.2326; FU KK, 1985, CANCER, V55, P2123, DOI 10.1002/1097-0142(19850501)55:9+<2123::AID-CNCR2820551415>3.0.CO;2-O; Fukasawa Y, 1998, PATHOL INT, V48, P47, DOI 10.1111/j.1440-1827.1998.tb03827.x; Klemperer P, 1931, ARCH PATH, V11, P385; Leahy M, 2012, ANN ONCOL; Lloyd RV, 1999, ENDOCR PATHOL, V10, P291, DOI 10.1007/BF02739771; Safra T, 2006, ISRAEL MED ASSOC J, V8, P27; Takizawa I, 2008, UROL ONCOL-SEMIN ORI, V26, P254, DOI 10.1016/j.urolonc.2007.03.024; Vallat-Decouvelaere AV, 1998, AM J SURG PATHOL, V22, P1501, DOI 10.1097/00000478-199812000-00007; Yamakawa F, 2010, CLIN MED RES, V3, P159	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0949-2658	1436-2023		J ORTHOP SCI	J. Orthop. Sci.	MAR	2015	20	2					439	443		10.1007/s00776-013-0462-6		5	Orthopedics	Orthopedics	CE5HV	WOS:000351862900028		
J	Xing, HL; Taguchi, Y; Komasa, S; Yamawaki, I; Sekino, T; Umeda, M; Okazaki, J				Xing, Helin; Taguchi, Yoichiro; Komasa, Satoshi; Yamawaki, Isao; Sekino, Tohru; Umeda, Makoto; Okazaki, Joji			Effect of Porphyromonas gingivalis Lipopolysaccharide on Bone Marrow Mesenchymal Stem Cell Osteogenesis on a Titanium Nanosurface	JOURNAL OF PERIODONTOLOGY			English	Article						Lipopolysaccharides; mesenchymal stromal cells; nanostructures; osseointegration; Porphyromonas gingivalis; titanium	OSTEOBLAST GENE-EXPRESSION; IN-VITRO; PERI-IMPLANTITIS; SURFACE; BIOMATERIALS; ADHERENT; VIVO	Background: Titanium (Ti) dental implants have been widely used for prosthetic reconstruction of dentition. Unfortunately, peri-implantitis can result in failure of dental implant osseointegration. Lipopolysaccharide (LPS) acts as a chronic inflammatory stimulus and maintains peri-implant inflammation, worsening the prognosis for implant osseointegration. The purpose of this study is to determine the effects of 10 M NaOH-modified Ti surface with nanonetwork structure on the proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells (BMMSCs) in the context of Porphyromonas gingivalis LPS exposure. Methods: Titanium disks treated with 10 M NaOH solution and control were incubated with BMMSCs and exposed to P. gingivalis LPS (0, 0.1, or 1 mg/mL). The effects of the modified nanonetwork structure on osteogenic differentiation of rat BMMSCs were evaluated in the context of different concentrations of P. gingivalis LPS exposure. Results: Rat BMMSCs on the 10 M NaOH-modified Ti surface with nanonetwork structure had higher levels of osteogenesis-related gene expression and significantly greater cell proliferation, alkaline phosphatase activity, and extracellular matrix deposition and mineralization than cells on the untreated Ti surfaces, in all the groups with different doses of P. gingivalis LPS exposure. Conclusion: The 10 M NaOH-modified Ti surface with nanonetwork structure has better endotoxin tolerance under P. gingivalis LPS exposure than the non-modified surface.	[Xing, Helin] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthet Dent, Xian 710032, Peoples R China; [Xing, Helin; Komasa, Satoshi; Okazaki, Joji] Osaka Dent Univ, Dept Removable Prosthodont & Occlus, Hirakata, Osaka 5731121, Japan; [Taguchi, Yoichiro; Yamawaki, Isao; Umeda, Makoto] Osaka Dent Univ, Dept Periodontol, Hirakata, Osaka 5731121, Japan; [Sekino, Tohru] Osaka Univ, Inst Sci & Ind Res, Adv Hard Mat, Osaka, Japan	Xing, HL (reprint author), Osaka Dent Univ, Dept Removable Prosthodont & Occlus, 8-1 Kuzuhahanazonocho, Hirakata, Osaka 5731121, Japan.	elieenxing@hotmail.com			Japan Society for the Promotion of Science [24792345, 26861664]	This work was supported by Grants-in-Aid for Scientific Research (B) for young researchers (24792345 to YT, 26861664 to SK) from the Japan Society for the Promotion of Science. The authors report no conflicts of interest related to this study.	Xing HL, 2014, INT J NANOMED, V9, P1741, DOI 10.2147/IJN.S58502; Naert I, 2012, CLIN ORAL IMPLAN RES, V23, P95, DOI 10.1111/j.1600-0501.2012.02550.x; Zhang WJ, 2012, INT J NANOMED, V7, P4459, DOI 10.2147/IJN.S33575; Masaki C, 2005, CLIN ORAL IMPLAN RES, V16, P650, DOI 10.1111/j.1600-0501.2005.01170.x; Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021; Francetti L, 2014, CLIN IMPLANT DENT R, V16, P81, DOI 10.1111/j.1708-8208.2012.00466.x; Irshad M, 2013, J CLIN PERIODONTOL, V40, P841, DOI 10.1111/jcpe.12136; Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425; Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x; Stadelmann VA, 2008, BONE, V42, P358, DOI 10.1016/j.bone.2007.09.055; Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Yamamoto Y, 2003, J DENT RES, V82, P962; Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Shibli JA, 2008, CLIN ORAL IMPLAN RES, V19, P975, DOI 10.1111/j.1600-0501.2008.01566.x; Barão Valentim Adelino Ricardo, 2013, J Prosthet Dent, V110, P462, DOI 10.1016/j.prosdent.2013.04.004; Bobia F, 2010, CURR HLTH SCI J, V36, P171; Bonsignore LA, 2011, BONE, V49, P923, DOI 10.1016/j.bone.2011.07.013; Brånemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1; Dam HG, 2014, CLIN ORAL IMPLAN RES, V25, pE159, DOI 10.1111/clr.12083; Giannelli M, 2009, J PERIODONTOL, V80, P977, DOI 10.1902/jop.2009.080648; Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150; Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032; Jiang YL, 2002, INFECT IMMUN, V70, P3143, DOI 10.1128/IAI.70.6.3143-3148.2002; Kruger TE, 2013, SCI WORLD J, DOI 10.1155/2013/812718; Mendonca G, 2010, J BIOMED MATER RES A, V94A, P169, DOI 10.1002/jbm.a.32701; Nelson SK, 1997, J PROSTHET DENT, V77, P76, DOI 10.1016/S0022-3913(97)70210-5; PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x; Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25	30	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	MAR	2015	86	3					448	455		10.1902/jop.2014.140386		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9EO	WOS:000352146900012		
J	Nagahara, T; Yoshimatsu, S; Shiba, H; Kawaguchi, H; Takeda, K; Iwata, T; Mizuno, N; Fujita, T; Kurihara, H				Nagahara, Takayosi; Yoshimatsu, Shinichiro; Shiba, Hideki; Kawaguchi, Hiroyuki; Takeda, Katsuhiro; Iwata, Tomoyuki; Mizuno, Noriyoshi; Fujita, Tsuyoshi; Kurihara, Hidemi			Introduction of a Mixture of beta-Tricalcium Phosphate Into a Complex of Bone Marrow Mesenchymal Stem Cells and Type I Collagen Can Augment the Volume of Alveolar Bone Without Impairing Cementum Regeneration	JOURNAL OF PERIODONTOLOGY			English	Article						Beta-tricalcium phosphate; bone marrow; cementum; mesenchymal stromal cells; regeneration; periodontal bone loss	PERIODONTAL TISSUE REGENERATION; STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; PROTEIN-KINASE; DEFECT MODEL; DOGS; TRANSPLANTATION; HYDROXYAPATITE; CALCIFICATION; PROLIFERATION	Background: The purpose of this study is to evaluate whether beta-tricalcium phosphate (beta-TCP) could be a promising modality to help augment alveolar bone in periodontal tissue regeneration by bone marrow mesenchymal stem cells (BMMSCs). Methods: Expanded BMMSCs and atelocollagen (Col) were mixed together (MSC/Col). A combination of beta-TCP with MSC/Col was also prepared (MSC/Col/TCP). MSC/Col/TCP or MSC/Col was transplanted into experimental periodontal Class III furcation defects that had been exposed to inflammation in beagle dogs. Periodontal tissue regeneration was evaluated by histologic and morphometric analyses at 4 and 8 weeks after transplantation. Results: MSC/Col and MSC/Col/TCP enhanced periodontal tissue regeneration compared to Col and TCP/Col according to hematoxylin and eosin staining. The percentage of new cementum length in the MSC/Col/TCP group was not significantly different from that in the MSC/Col group at 4 and 8 weeks. On the other hand, the percentage of new bone area in the MSC/Col/TCP group was much higher than that in the MSC/TCP group at 4 weeks. However, at 8 weeks, no significant difference in new bone area was found between the two groups. In the MSC/Col/TCP group, beta-TCP was surrounded by newly formed bone. Multinucleated cells, which were positive for osteopontin and tartrate-resistant acid phosphatase, were present in the interconnected macropores of beta-TCP. Conclusion: These findings suggest that beta-TCP is applicable as a scaffold for BMMSCs transplantation and helps augment alveolar bone without impairing regeneration of cementum.	[Nagahara, Takayosi; Yoshimatsu, Shinichiro; Shiba, Hideki; Kawaguchi, Hiroyuki; Takeda, Katsuhiro; Iwata, Tomoyuki; Mizuno, Noriyoshi; Fujita, Tsuyoshi; Kurihara, Hidemi] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Periodontal Med, Hiroshima, Japan	Takeda, K (reprint author), Inst Biomed & Hlth Sci, Dept Periodontal Med, Appl Life Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	takepon@hiroshima-u.ac.jp					Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jang BJ, 2008, J VET SCI, V9, P387; Kon E, 2000, J BIOMED MATER RES, V49, P328; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094; Stavropoulos A, 2010, J PERIODONTOL, V81, P325, DOI 10.1902/jop.2009.090386; Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027; Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706; Hasegawa N, 2006, J PERIODONTOL, V77, P1003, DOI 10.1902/jop.2006.050341; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Guo ZK, 2001, ZHONGGUO SHI YAN XUE, V9, P91; Kawaguchi H, 2001, J PERIODONTAL RES, V36, P205, DOI 10.1034/j.1600-0765.2001.036004205.x; Liu GP, 2007, BIOMED MATER, V2, P78, DOI 10.1088/1748-6041/2/2/004; Mizuno N, 2008, J PERIODONTOL, V79, P2361, DOI 10.1902/jop.2008.070577 ; NADE S, 1983, CLIN ORTHOP RELAT R, P255; Neamat A, 2009, ARCH ORAL BIOL, V54, P1083, DOI 10.1016/j.archoralbio.2009.09.003; Sugawara A, 2008, DENT MATER J, V27, P787; Takeda K, 2011, TISSUE ENG PT A, V17, P955, DOI [10.1089/ten.TEA.2010.0070, 10.1089/ten.tea.2010.0070]; Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P; Zambonin G, 2000, J BIOMED MATER RES, V49, P120, DOI 10.1002/(SICI)1097-4636(200001)49:1<120::AID-JBM15>3.0.CO;2-Q	36	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	MAR	2015	86	3					456	464		10.1902/jop.2014.140384		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9EO	WOS:000352146900013		
J	Oka, H; Kitagawa, M; Takata, T				Oka, Hiroko; Kitagawa, Masae; Takata, Takashi			F-Spondin Inhibits Differentiation of Clastic Precursors via Lipoprotein Receptor-Related Protein 8 (LRP8)	JOURNAL OF PERIODONTOLOGY			English	Article						Bone and bones; dental cementum; osteoclasts; periodontitis	NF-KAPPA-B; OSTEOCLAST DIFFERENTIATION; BONE-RESORPTION; EXPRESSION; CELLS; IL-6; ACTIVATION; MIGRATION; MOLECULE; CEMENTUM	Background: F-spondin, known to be a secreted neuronal glycoprotein, is highly expressed on the tooth root surface. The authors previously reported that F-spondin is one of the specific markers of cementoblasts in periodontal tissue. In chronic periodontitis, significant cemental resorption rarely occurs on the root side, although alveolar bone resorption by osteoclasts is one of the major pathologic changes. Thus, it was hypothesized that secretory F-spondin from cementoblasts might be involved in differentiation of clastic cells on the root surface. The authors studied effects of secretory F-spondin from F-spondin-expressing cells and its pathway on receptor activator of nuclear factor-kB ligand (RANKL)-mediated differentiation of clastic cells. Methods: Osteoclast precursors were used in this study. With a chamber assay, the authors examined effects of secretory molecules from F-spondin-expressing cells of transgenic mice on RANKL-induced clastic cell differentiation. Results: Secretorymolecules from F-spondin-overexpressing cells significantly inhibited the RANKL-mediated tartrate-resistant acid phosphatase (TRAP)-positive cells from primary progenitor cells with the chamber system. F-spondin suppressed RANKL-mediated nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1); TRAP; cathepsin K; and dendritic cell-specific transmembrane protein (DC-STAMP) expression in the cells. The suppressive effect of F-spondin on RANKL-induced differentiation of clastic cells was partially blocked by knockdown of low-density lipoprotein receptor-related protein 8 (LRP8). Conclusions: These findings indicate that secretory factors from F-spondin-expressing cells, including F-spondin, down-regulate differentiation of clastic precursors. Moreover, F-spondin inhibits RANKL-mediated differentiation of clastic cells partially via LRP8. It is suggested that secretory F-spondin may act protectively from cemental resorption partially via LRP8 in periodontal tissue.	[Oka, Hiroko] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Int Collaborat Dev Dent, Hiroshima 7348553, Japan; [Kitagawa, Masae] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan	Oka, H (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Int Collaborat Dev Dent, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	okhiroko@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23792103, 25462854]	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI) Grant Nos. 23792103 and 25462854 from the Japan Society for the Promotion of Science. The authors report no conflicts of interest related to this study.	Zisman S, 2007, J CELL BIOL, V178, P1237, DOI 10.1083/jcb.200702184; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; Leung R, 2011, BLOOD, V117, P2044, DOI 10.1182/blood-2010-05-282574; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Quinn KL, 2011, ARTERIOSCL THROM VAS, V31, P2070, DOI 10.1161/ATVBAHA.111.227116; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Ghayor C, 2011, J BIOL CHEM, V286, P24458, DOI 10.1074/jbc.M111.223297; Soysa NS, 2009, J BONE MINER METAB, V27, P131, DOI 10.1007/s00774-008-0026-6; Li YL, 2009, EMBO J, V28, P286, DOI 10.1038/emboj.2008.288; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Kitagawa M, 2006, BIOCHEM BIOPH RES CO, V349, P1050, DOI 10.1016/j.bbrc.2006.08.142; Miyamoto K, 2001, ARCH BIOCHEM BIOPHYS, V390, P93, DOI 10.1006/abbi.2001.2367; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Hashizume M, 2008, RHEUMATOLOGY, V47, P1635, DOI 10.1093/rheumatology/ken363; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Kwok SK, 2012, J IMMUNOL, V189, P1062, DOI 10.4049/jimmunol.1102706; Attur MG, 2009, FASEB J, V23, P79, DOI 10.1096/fj.08-114363; Oka H, 2011, J PERIODONTOL, V82, P1776, DOI 10.1902/jop.2011.110111; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Palmer GD, 2010, J ORTHOP RES, V28, P1323, DOI 10.1002/jor.21130; DErrico JA, 1997, BONE, V20, P117, DOI 10.1016/S8756-3282(96)00348-1; Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200; Bosshardt DD, 1998, ANAT REC, V250, P13, DOI 10.1002/(SICI)1097-0185(199801)250:1<13::AID-AR3>3.0.CO;2-F; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; Divekar SD, 2014, J BIOL CHEM, V289, P15894, DOI 10.1074/jbc.M113.537548; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Kim WS, 2013, EXP CELL RES, V319, P436, DOI 10.1016/j.yexcr.2012.12.004; Kitagawa M, 2012, BIOCHEM BIOPH RES CO, V418, P229, DOI 10.1016/j.bbrc.2011.12.155; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Oka H, 2007, J DENT RES, V86, P974; Oka H, 2012, J PERIODONTOL, V83, P506, DOI 10.1902/jop.2011.110301; Palmer GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098388; Salmon CR, 2013, J PROTEOMICS, V91, P544, DOI 10.1016/j.jprot.2013.08.016; Sriarj W, 2015, ODONTOLOGY, V103, P9, DOI 10.1007/s10266-013-0140-3	38	1	1	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	MAR	2015	86	3					465	472		10.1902/jop.2014.140419		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE9EO	WOS:000352146900014		
J	Kivi, IR; Ameri, MJ; Ghassemi, A				Kivi, Iman Rahimzadeh; Ameri, Mohammad Javad; Ghassemi, Ahmad			Chemoporoelastic characterization of Ghom shale	JOURNAL OF PETROLEUM SCIENCE AND ENGINEERING			English	Article						shale; chemo-poroelastic; solute diffusion coefficient; swelling coefficient; osmotic pressure	POROELASTICITY; DIFFUSION; STABILITY; HYDRATION; ROCKS	Swelling and deterioration of shales are the main causes of wellbore instability and associated problems in the drilling of hydrocarbon exploration and production wells. Shales have some unique characteristics that impact the wellbore stability. A few physiochemical theories are proposed for describing drilling fluid-shale interactions. The main problem in using these theoretical developments for evaluating potential borehole instability problems and developing realistic predictive models is the lack of experimental data on the shale properties. This paper presents results of study to characterize the chemo-poroelastic parameters of the illite rich Ghom shale in the laboratory. These parameters include a wide range of mechanical properties, porosity, permeability, solute diffusion coefficient, swelling coefficient and reflection coefficient. The required samples are prepared from an undisturbed outcrop block of Ghom formation. The nitrogen gas injection method was utilized to measure the porosity of the shale sample. The pore volume was determined using the Boyles law technique. The permeability of the sample was calculated from transient analysis of the water injection pressure data. Consolidated drained and undrained triaxial tests were carried out to evaluate the required mechanical properties of Ghom shale. A diffusion cell was designed to measure the diffusion coefficient based on the concept of solute flow due to chemical potential gradient. A free swelling test was also conducted to investigate the swelling behavior of the rock samples in fresh water. Finally, a pore pressure transmission test was performed to quantify the osmotic properties of the shale in contact with a water-based fluid through calculation of the reflection coefficient. (C) 2015 Elsevier B.V. All rights reserved.	[Kivi, Iman Rahimzadeh; Ameri, Mohammad Javad] Amirkabir Univ Technol, Dept Petr Engn, Tehran, Iran; [Ghassemi, Ahmad] Okayama Univ, Mewbourne Sch Petr & Geol Engn, Okayama 7008530, Japan	Ameri, MJ (reprint author), Amirkabir Univ Technol, Dept Petr Engn, Tehran, Iran.	iman.rahimzadeh@aut.ac.ir; ameri@aut.ac.ir; ahmad.ghassemi@ou.edu					Al-Bazali T.M., 2005, THESIS U TEXAS AUSTI; Horsrud P, 1998, INT J ROCK MECH MIN, V35, P1009, DOI 10.1016/S0148-9062(98)00162-4; Chen GZ, 2003, J PETROL SCI ENG, V38, P167, DOI 10.1016/S0920-4105(03)00030-5; Sarout J, 2011, INT J ROCK MECH MIN, V48, P759, DOI 10.1016/j.ijrmms.2011.04.009; vanOort E, 1996, SPE DRILL COMPLETION, V11, P137, DOI 10.2118/28309-PA; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; van Oort E, 2003, J PETROL SCI ENG, V38, P213, DOI 10.1016/S0920-4105(03)00034-2; Zhou XX, 2009, INT J ROCK MECH MIN, V46, P769, DOI 10.1016/j.ijrmms.2008.11.009; Descostes M, 2008, APPL GEOCHEM, V23, P655, DOI 10.1016/j.apgeochem.2007.11.003; Aoki T., 1995, P 8 ISRM C TOK JAP, P172; Bell FG, 2007, ENG GEOLOGY; Cave L., 2010, TR201004 NUCL WAST M; Cave L, 2009, J CONTAM HYDROL, V103, P1, DOI 10.1016/j.jconhyd.2008.08.001; Darley H., 1988, COMPOSITION PROPERTI; Ewy RT, 2001, P 38 US ROCK MECH S, P77; Ghassemi A, 2009, J PETROL SCI ENG, V67, P57, DOI 10.1016/j.petrol.2009.02.015; Ghassemi A, 2003, J PETROL SCI ENG, V38, P199, DOI 10.1016/S0920-4105(03)00033-0; Hale A.H., 1992, IADC SPE DRILL C FEB; Heidug WK, 1996, INT J NUMER ANAL MET, V20, P403, DOI 10.1002/(SICI)1096-9853(199606)20:6<403::AID-NAG832>3.0.CO;2-7; Jaeger J.C., 2007, FUNDAMENTALS ROCK ME; Josh M., 2012, J PETROL SCI ENG, V88-89, P107; Katachalsky A., 1965, NONEQUILIBRIUM THERM; KRANZ RL, 1989, GEOPHYS RES LETT, V16, P1113, DOI 10.1029/GL016i010p01113; LO KY, 1978, CAN GEOTECH J, V15, P537, DOI 10.1139/t78-057; Micic S., 2010, TR0716; Muniz E.S., 2005, P 40 US S ROCK MECH; Sedman A, 2012, ENG GEOL, V131, P37, DOI 10.1016/j.enggeo.2012.02.002; SHACKELFORD C D, 1991, Journal of Contaminant Hydrology, V7, P177, DOI 10.1016/0169-7722(91)90028-Y; SHERWOOD JD, 1993, P ROY SOC LOND A MAT, V440, P365, DOI 10.1098/rspa.1993.0021; Skempton A.W., 1954, GEOTECHNIQUE, V4, P143, DOI DOI 10.1680/GEOT.1954.4.4.143; STAVERMAN AJ, 1951, RECL TRAV CHIM PAY B, V70, P344; Steiger R.P., 1997, 32 US S ROCK MECH JU; Steiger RP, 1992, SPE DRILLING ENG SEP, P181; Tan C.P., 1999, P 37 US S ROCK MECH, P225; Tare U.A., 2002, CAN INT PETR C JUN; Ulusay R., 2007, COMPLETE ISRM SUGGES; Van Loon L.R., 2010, TR0722; Vilks P., 2007, TR200711 NUCL WAST M; Wu B., 1997, INT J ROCK MECH MIN, V34, P3; Yu M., 2001, SPE ANN TECHN C EXH; Zhang J., 2001, 41 US S ROCK MECH GO	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-4105	1873-4715		J PETROL SCI ENG	J. Pet. Sci. Eng.	MAR	2015	127						115	123		10.1016/j.petrol.2015.01.007		9	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	CE4DX	WOS:000351782400011		
J	Suzuki, K; Harada, A; Shiraishi, E; Kimura, H				Suzuki, Kazunori; Harada, Akina; Shiraishi, Eri; Kimura, Haruhide			In Vivo Pharmacological Characterization of TAK-063, a Potent and Selective Phosphodiesterase 10A Inhibitor with Antipsychotic-Like Activity in Rodents	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							BASAL GANGLIA; IMMUNOHISTOCHEMICAL LOCALIZATION; MESSENGER-RNA; RAT-BRAIN; SCHIZOPHRENIA; PDE10A; COGNITION; DISORDERS; STRIATUM; FAMILY	Phosphodiesterase 10A (PDE10A) is a cAMP/cGMP phosphodiesterase highly expressed in medium spiny neurons (MSNs) in the striatum. We evaluated the in vivo pharmacological profile of a potent and selective PDE10A inhibitor, TAK-063 (1-[2-fluoro-4(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4-(1H)-one). TAK-063 at 0.3 and 1 mg/kg p.o., increased cAMP and cGMP levels in the rodent striatum and upregulated phosphorylation levels of key substrates of cAMP-and cGMP-dependent protein kinases. TAK-063 at 0.3 and 1 mg/kg p. o., strongly suppressed MK-801 [(5R, 10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a, d]cyclohepten-5,10-imine]-induced hyperlocomotion, which is often used as a predictive model for antipsychotic-like activity in rodents. Upregulation of striatal cAMP/cGMP levels and the antipsychotic-like effect of TAK-063 were not attenuated after 15 days of pretreatment with TAK-063 in mice. The potential side effect profile of TAK-063 was assessed in rats using the clinical antipsychotics haloperidol, olanzapine, and aripiprazole as controls. TAK-063 did not affect plasma prolactin or glucose levels at doses up to 3 mg/kg p.o. At 3 mg/kg p.o., TAK-063 elicited a weak cataleptic response compared with haloperidol and olanzapine. Evaluation of pathway-specific markers (substance P mRNA for the direct pathway and enkephalin mRNA for the indirect pathway) revealed that TAK-063 activated both the direct and indirect pathways of MSNs. These findings suggest that TAK063 represents a promising drug for the treatment of schizophrenia with potential for superior safety and tolerability profiles.	[Suzuki, Kazunori; Harada, Akina; Shiraishi, Eri; Kimura, Haruhide] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, CNS Drug Discovery Unit, Fujisawa, Kanagawa 2518555, Japan	Kimura, H (reprint author), Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	haruhide.kimura@takeda.com			Takeda Pharmaceutical Company Limited	This work was funded by Takeda Pharmaceutical Company Limited. The authors are employees of Takeda Pharmaceutical Company Limited.	Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Grauer SM, 2009, J PHARMACOL EXP THER, V331, P574, DOI 10.1124/jpet.109.155994; Harvey PD, 2004, J CLIN PSYCHIAT, V65, P361; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(09)60995-8; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kunitomo J, 2014, J MED CHEM, V57, P9627, DOI 10.1021/jm5013648; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Perez-Costas E, 2010, J NEUROCHEM, V113, P287, DOI 10.1111/j.1471-4159.2010.06604.x; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Giampa C, 2009, NEUROBIOL DIS, V34, P450, DOI 10.1016/j.nbd.2009.02.014; Johansson EM, 2012, NEUROSCI LETT, V525, P1, DOI 10.1016/j.neulet.2012.07.050; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Menniti FS, 2007, CURR OPIN INVESTIG D, V8, P54; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; Harada A, 2015, NUCL MED BIOL, V42, P146, DOI 10.1016/j.nucmedbio.2014.09.005; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Smith SM, 2013, NEUROPHARMACOLOGY, V64, P215, DOI 10.1016/j.neuropharm.2012.06.013; O'Neill MF, 1999, PSYCHOPHARMACOLOGY, V145, P237, DOI 10.1007/s002130051055; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Kehler J, 2011, CURR PHARM DESIGN, V17, P137; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Assie MB, 2008, EUR J PHARMACOL, V592, P160, DOI 10.1016/j.ejphar.2008.06.105; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Krebs M, 2006, EXPERT OPIN PHARMACO, V7, P1005, DOI 10.1517/14656566.7.8.1005; Sano H, 2008, J NEUROCHEM, V105, P546, DOI 10.1111/j.1471-4159.2007.05152.x; SIMPSON JN, 1995, SYNAPSE, V19, P151, DOI 10.1002/syn.890190302	38	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	MAR	2015	352	3					471	479		10.1124/jpet.114.218552		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CD4EW	WOS:000351036400007		
J	Miki, S; Wada, KC; Takeno, K				Miki, Satomi; Wada, Kaede C.; Takeno, Kiyotoshi			A possible role of an anthocyanin filter in low-intensity light stress-induced flowering in Perilla frutescens var. crispa	JOURNAL OF PLANT PHYSIOLOGY			English	Article						Anthocyanin; Flowering; Low-intensity light; Perilla frutescens; Stress	PHENYLALANINE AMMONIA-LYASE; SHORT-DAY PLANT; SALICYLIC-ACID; SHADE-AVOIDANCE; PHARBITIS-NIL; DNA DEMETHYLATION; GENE-EXPRESSION; POOR-NUTRITION; ARABIDOPSIS-THALIANA; HYDROGEN-PEROXIDE	The red-leaved form of Perilla frutescens var. crispa was induced to flower by low-intensity light stress. The leaves of this form are normally red, but turned green under low-intensity light due to anthocyanin depletion in the epidermis. Flowering did not occur when plants were grown under light passed through a red-colored cellophane paper, which has an absorption spectrum similar to that of anthocyanins. High-concentration anthocyanins may play the role of a red-colored optical filter under normal light conditions, and this filter effect may be lost under low-intensity light, causing a change in the wavelength characteristics of the light with which the mesophyll cells are irradiated. This change may induce a photobiological effect leading to flowering. The gene expression and enzyme activity of phenylalanine ammonia-lyase (PAL), the key enzyme for anthocyanin biosynthesis, decreased under low-intensity light. L-2-aminooxy-3- phenylpropionic acid (AOPP), which is widely used as a PAL inhibitor, inhibited low-intensity light stress-induced flowering and increased PAL activity and anthocyanin content. The inhibition of flowering by AOPP in P. frutescens may be through different mechanisms than PAL inhibition. (C) 2014 Elsevier GmbH. All rights reserved.	[Miki, Satomi; Wada, Kaede C.; Takeno, Kiyotoshi] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Takeno, Kiyotoshi] Niigata Univ, Dept Biol, Fac Sci, Niigata 9502181, Japan	Takeno, K (reprint author), Machiyahara 124,Shimizu Ku, Shizuoka, Shizuoka 4213105, Japan.	wada-403@qj9.so-net.ne.jp					Adams P, 1998, NEW PHYTOL, V138, P171, DOI 10.1046/j.1469-8137.1998.00111.x; AMRHEIN N, 1979, PLANT CELL PHYSIOL, V20, P1635; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1562/0031-8655(1999)070<0001:ESOAIP>2.3.CO;2; Xu MY, 2014, J EXP BOT, V65, P89, DOI 10.1093/jxb/ert353; Scott IM, 2004, PLANT PHYSIOL, V135, P1040, DOI 10.1104/pp.104.041293; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; Yamazaki M, 2003, BIOCHEM ENG J, V14, P191, DOI 10.1016/S1369-703X(02)00222-X; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Gould KS, 2010, J EXP BOT, V61, P2707, DOI 10.1093/jxb/erq106; Soeno K, 2010, PLANT CELL PHYSIOL, V51, P524, DOI 10.1093/pcp/pcq032; Wang YH, 2013, PLANTA, V237, P225, DOI 10.1007/s00425-012-1767-y; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Yamazaki M, 2003, PHYTOCHEMISTRY, V62, P987, DOI 10.1016/S0031-9422(02)00721-5; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Riboni M, 2013, PLANT PHYSIOL, V162, P1706, DOI 10.1104/pp.113.217729; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Zhang TT, 2011, PLANT PHYSIOL, V157, P1528, DOI 10.1104/pp.111.180661; Appert C, 2003, PHYTOCHEMISTRY, V62, P415, DOI 10.1016/S0031-9422(02)00561-7; Berletch Joel B, 2007, Methods Mol Biol, V371, P81; Chen CS, 2013, PHYSIOL PLANTARUM, V149, P354, DOI 10.1111/ppl.12043; CHRISTIE R.J., 1994, PLANTA, V194, P541; De Zeeuw D., 1953, P K NED AKAD C BIOL, V56, P418; Ferrarese MLL, 2000, PLANT BIOLOGY, V2, P152, DOI 10.1055/s-2000-9162; GAILLOCHET J, 1962, CR HEBD ACAD SCI, V255, P2501; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Hatayama T, 2003, J PLANT PHYSIOL, V160, P461, DOI 10.1078/0176-1617-01041; HIRAI N, 1994, PLANT CELL PHYSIOL, V35, P691; Iwase Y, 2010, PHYSIOL PLANTARUM, V139, P118, DOI [10.1111/j.1399-3054.2010.01345.x, 10.1111/.1399-3054.2009.01345.x, 10.1111/j.1399-3054.2009.01345.x]; KESSMANN H, 1990, PLANT PHYSIOL, V94, P227, DOI 10.1104/pp.94.1.227; Kolar J, 2008, J PLANT PHYSIOL, V165, P1601, DOI 10.1016/j.jplph.2007.11.010; Kondo H, 2006, PHYSIOL PLANTARUM, V127, P130, DOI 10.1111/j.1399-3054.2005.00635.x; Kondo H, 2010, PLANT SCI, V178, P321, DOI 10.1016/j.plantsci.2010.01.012; Kondo H, 2007, PHYSIOL PLANTARUM, V131, P462, DOI 10.1111/j.1399-3054.2007.00965.x; Koshio A, 2015, J PLANT PHYSIOL, V173, P82, DOI 10.1016/j.jplph.2014.09.004; NEUENSCHWANDER U, 1995, PLANT J, V8, P227, DOI 10.1046/j.1365-313X.1995.08020227.x; PURSE JG, 1984, J EXP BOT, V35, P227, DOI 10.1093/jxb/35.2.227; Shimakawa A, 2012, J PLANT PHYSIOL, V169, P987, DOI 10.1016/j.jplph.2012.02.009; SHINOZAKI M, 1988, PLANT CELL PHYSIOL, V29, P605; Takeno K, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P331, DOI 10.1007/978-1-4614-0634-1_17; TAKIMOTO A, 1973, PLANT CELL PHYSIOL, V14, P1217; Wada KC, 2010, PHYSIOL PLANTARUM, V138, P339, DOI 10.1111/j.1399-3054.2009.01337.x; Wada Kaede C, 2010, Plant Signal Behav, V5, P944; Wada KC, 2014, J PLANT PHYSIOL, V171, P895, DOI 10.1016/j.jplph.2014.03.008; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Wimalasekera R, 2011, PLANT SCI, V81, P593	49	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0176-1617	1618-1328		J PLANT PHYSIOL	J. Plant Physiol.	MAR 1	2015	175						157	162		10.1016/j.jplph.2014.12.002		6	Plant Sciences	Plant Sciences	CE9FT	WOS:000352150100018		
J	Guan, QJ; Wang, ZJ; Wang, XH; Takano, T; Liu, SK				Guan, Qingjie; Wang, Zhenjuan; Wang, Xuhui; Takano, Tetsuo; Liu, Shenkui			A peroxisomal APX from Puccinellia tenuiflora improves the abiotic stress tolerance of transgenic Arabidopsis thaliana through decreasing of H2O2 accumulation	JOURNAL OF PLANT PHYSIOLOGY			English	Article						Puccinellia tenuiflora; Arabidopsis thaliana; APX (ascorbate peroxidase); Transgenic plant; Salt-alkali and oxidative stresses	PLANT SALT TOLERANCE; ASCORBATE PEROXIDASE; OXIDATIVE STRESS; ANTIOXIDANT ENZYME; HYDROGEN-PEROXIDE; OXYGEN; GENE; CHLOROPLASTS; EXPRESSION; RESPONSES	Ascorbate peroxidase (APX, EC 1.11.1.11) is one of the major members of the ROS scavenging system that plays an important role in improving saline-alkali tolerance. Puccinellia tenuiflora, as a perennial wild grass, is able to grow in extreme saline-alkali soil environments. In this study, we investigated the relationship between the Puccinellia tenuiflora ascorbate peroxidase (PutAPX) gene and saline-alkali tolerance. A phylogenetic analysis indicated that PutAPX is closely related to AtAPX3 and OsAPX4 and that these genes are on the same branch. The PutAPX-GFP fusion protein is located in the peroxisome in onion epidermal cells. The transcriptional expression of PutAPX increased with prolonged exposure to NaCl, NaHCO3, PEG6000 and H2O2 stresses in Puccinellia tenuiflora. The overexpression of PutAPX in Arabidopsis thaliana significantly increased the tolerance of plants treated with 150 and 175 mM NaCl and decreased the extent of lipid peroxidation. The transgenic seedlings presented higher chlorophyll content than wild type (WT) seedlings treated with 1, 3, and 5 mM NaHCO3 and 3 mM H2O2. The DAB staining results revealed that the H2O2 content in transgenic seedlings was significantly lower than that in WT plants under both normal conditions and 200 mM NaCl stress. Moreover, the expression of APX proteins and enzyme activity in the transgenic seedlings increased to level that were greater than twofold higher than those found in WT plants exposed to 200 mM NaCl. The saline-alkali tolerance conferred by the PutAPX gene may provide a reliable basis for the use of molecular breeding techniques to improve plant tolerance and obtain a better understanding of the physiological mechanism of anti-oxidative and ROS stresses. (C) 2015 Published by Elsevier GmbH.	[Guan, Qingjie; Wang, Zhenjuan; Wang, Xuhui; Liu, Shenkui] Northeast Forestry Univ, ASNESC, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Harbin 150040, Peoples R China; [Guan, Qingjie] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Lab Soybean Mol Biol & Mol Breeding, Harbin 150081, Peoples R China; [Takano, Tetsuo] Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo 1880002, Japan	Liu, SK (reprint author), Northeast Forestry Univ, ASNESC, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, 26 Hexing Rd, Harbin 150040, Peoples R China.	shenkuiliu@nefu.edu.cn			Fundamental Research Funds for the Central Universities [DL11CA05]; Innovative Research Team in University [IRT13053]; National Science Foundation [31372369]	This work was supported by the Fundamental Research Funds for the Central Universities (Grant No. DL11CA05), Innovative Research Team in University (IRT13053) and National Science Foundation (31372369). The funders had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Alinsug MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030846; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)004948-8; Giacomelli L, 2007, PLANT MOL BIOL, V65, P627, DOI 10.1007/s11103-007-9227-y; Wang CX, 2011, J EXP BOT, V62, P1299, DOI 10.1093/jxb/erq377; Lisenbee CS, 2003, PLANT PHYSIOL, V132, P870, DOI 10.1104/pp.103.019976; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Lu ZQ, 2007, PLANT CELL REP, V26, P1909, DOI 10.1007/s00299-007-0395-7; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Begara-Morales JC, 2014, J EXP BOT, V65, P527, DOI 10.1093/jxb/ert396; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; TANAKA K, 1985, PLANT CELL PHYSIOL, V26, P1425; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Caverzan A, 2012, GENET MOL BIOL, V35, P1011, DOI 10.1590/S1415-47572012000600016; Bunkelmann JR, 1996, PLANT PHYSIOL, V110, P589, DOI 10.1104/pp.110.2.589; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; CHEN GX, 1989, PLANT CELL PHYSIOL, V30, P987; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Danna CH, 2003, PLANT PHYSIOL, V132, P2116, DOI 10.1104/pp.103.021717; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Sato Y, 2011, PLANT CELL REP, V30, P399, DOI 10.1007/s00299-010-0985-7; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Bechtold N, 1998, ARABIDOPSIS PROTOCOL, P59; BENDER J, 1994, ENVIRON POLLUT, V84, P15, DOI 10.1016/0269-7491(94)90065-5; Dunajska-Ordak K, 2014, PLANT MOL BIOL REP, V32, P162, DOI 10.1007/s11105-013-0636-6; Gonzalez AM, 2010, PLOS ONE, V5; Guan Q, 2011, GENOM APP BIOL, V28, P631; Guan QJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041233; Gupta Ashima Sen, 1993, Plant Physiology (Rockville), V103, P1067; Konieczny R, 2014, PLANT CELL REP, V33, P165, DOI 10.1007/s00299-013-1520-4; Laxa M, 2007, BIOCHEM J, V401, P287, DOI 10.1042/BJ20061092; Li JianDong, 2004, Acta Prataculturae Sinica, V13, P32; Liu SK, 2007, PLANT MOL BIOL, V64, P49, DOI 10.1007/s11103-007-9133-3; Narendra S, 2006, J EXP BOT, V57, P3033, DOI 10.1093/jxb/erl060; Sambrook J, 2001, MOL CLONING LAB MANU; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029	48	2	2	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0176-1617	1618-1328		J PLANT PHYSIOL	J. Plant Physiol.	MAR 1	2015	175						183	191		10.1016/j.jplph.2014.10.020		9	Plant Sciences	Plant Sciences	CE9FT	WOS:000352150100021		
J	Pu, SH; Nakagome, K; Yamada, T; Yokoyama, K; Matsumura, H; Nagata, I; Kaneko, K				Pu, Shenghong; Nakagome, Kazuyuki; Yamada, Takeshi; Yokoyama, Katsutoshi; Matsumura, Hiroshi; Nagata, Izumi; Kaneko, Koichi			Prefrontal activation predicts social functioning improvement after initial treatment in late-onset depression	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Late-onset depression; Near-infrared spectroscopy; Social Adaptation Self-Evaluation Scale; Prefrontal cortex	NEAR-INFRARED SPECTROSCOPY; VERBAL-FLUENCY TASK; REDUCED FRONTOPOLAR ACTIVATION; OBSESSIVE-COMPULSIVE DISORDER; UNIPOLAR DEPRESSION; MAJOR DEPRESSION; VOLUNTARY SUPPRESSION; MOOD DISORDERS; CORTEX; PSYCHOTHERAPY	The activation of oxygenated hemoglobin (oxy-Hb) has been shown to be lacking in the prefrontal cortex (PFC) of patients with late-onset depression (LOD), in verbal fluency task (VFT)-related near-infrared spectroscopy (NIRS). In our previous studies, we have emphasized the connection between the lack of activation in the frontopolar cortex and social functioning disorder in patients with LOD. In this study, we investigated whether the responsiveness to medical treatment of untreated patients with LOD, particularly social functioning improvements, could be predicted by NIRS findings at the initial examination. The subjects were 29 patients with LOD who were diagnosed with major depression at 65 years or older at the initial examination (mean age +/- standard deviation, 72.4 +/- 5.71 years). We measured the changes in hemoglobin concentration in the prefrontal and temporal cortex regions during a VFT by using 52-channel NIRS. In addition, depression status and social functioning were evaluated with the Hamilton Depression Rating Scale and the Social Adaptation Self-evaluation Scale, respectively, at the initial examination and 8 weeks after the treatment. A negative correlation was found between the NIRS activation in the right ventrolateral PFC region before treatment and the improvement in social functioning. These results suggested that the social functioning improvements were greater in LOD with initially lower NIRS activation in the right ventrolateral PFC region. NIRS is a simple technique that can be used before treatment to evaluate the social functioning levels of patients with LOD, and predict social functioning improvement after treatment. (C) 2015 Elsevier Ltd. All rights reserved.	[Pu, Shenghong; Yamada, Takeshi; Yokoyama, Katsutoshi; Matsumura, Hiroshi; Nagata, Izumi; Kaneko, Koichi] Tottori Univ, Fac Med, Div Neuropsychiat, Dept Brain & Neurosci, Yonago, Tottori 6838504, Japan; [Nakagome, Kazuyuki] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo 1878551, Japan	Pu, SH (reprint author), Tottori Univ, Fac Med, Div Neuropsychiat, Dept Brain & Neurosci, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	pshh0517@yahoo.co.jp		Nakagome, Kazuyuki/0000-0003-2919-8180	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [23-10]	This study was supported by Intramural Research Grant (23-10) for Neurological and Psychiatric Disorders of NCNP. The authors thank all the participants in this study. The authors also thank the Hitachi Medical Corporation for providing us with technical advice.	Alexopoulos GS, 1989, INT J GERIATR PSYCH, V4, P181; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Moritz S, 2002, ARCH CLIN NEUROPSYCH, V17, P477, DOI 10.1016/S0887-6177(01)00130-5; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Pu SH, 2014, BEHAV BRAIN RES, V272, P32, DOI 10.1016/j.bbr.2014.06.052; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Hirschfeld RMA, 2002, BIOL PSYCHIAT, V51, P123, DOI 10.1016/S0006-3223(01)01291-4; Eschweiler GW, 2000, PSYCHIAT RES-NEUROIM, V99, P161, DOI 10.1016/S0925-4927(00)00062-7; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Heinzel S, 2013, NEUROBIOL AGING, V34, P439, DOI 10.1016/j.neurobiolaging.2012.05.021; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Yamashita Y, 1996, OPT ENG, V35, P1046, DOI 10.1117/1.600721; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Okada G, 2003, NEUROPSYCHOBIOLOGY, V47, P21, DOI 10.1159/000068871; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Matsuo K, 2000, J NEUROPSYCH CLIN N, V12, P465, DOI 10.1176/appi.neuropsych.12.4.465; Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Okada G, 2009, PSYCHIAT CLIN NEUROS, V63, P423, DOI 10.1111/j.1440-1819.2009.01952.x; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Beats BC, 1996, PSYCHOL MED, V26, P591; Noda T, 2012, J PSYCHIATR RES, V46, P905, DOI 10.1016/j.jpsychires.2012.04.001; Bosc M, 2000, COMPR PSYCHIAT, V41, P63, DOI 10.1016/S0010-440X(00)90133-0; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Herrmann MJ, 2003, BRAIN RES BULL, V61, P51, DOI 10.1016/S0361-9230(03)00066-2; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0002-3223(03)01817-6; Zhao HJ, 2002, PHYS MED BIOL, V47, P2075, DOI 10.1088/0031-9155/47/12/306; BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0; Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Herrmann MJ, 2006, NEUROBIOL AGING, V27, P888, DOI 10.1016/j.neurobiolaging.2005.04.013; Matsuo K, 2005, NEUROIMAGE, V26, P234, DOI 10.1016/j.neuroimage.2005.01.024; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Pu SH, 2008, PSYCHIAT CLIN NEUROS, V62, P728, DOI 10.1111/j.1440-1819.2008.01882.x; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; BLAZER D, 1989, NEW ENGL J MED, V320, P164, DOI 10.1056/NEJM198901193200306; Bosc M, 1997, EUR NEUROPSYCHOPHARM, V7, pS57, DOI 10.1016/S0924-977X(97)00420-3; COHEN RM, 1992, ARCH GEN PSYCHIAT, V49, P545; Degl'Innocenti A, 1998, ACTA PSYCHIAT SCAND, V97, P182, DOI 10.1111/j.1600-0447.1998.tb09985.x; Goto M, 2005, CLIN PSYCHIATR, V47, P483; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kennedy N, 2007, BIPOLAR DISORD, V9, P25, DOI 10.1111/j.1399-5618.2007.00326.x; Matsuo K, 2003, PSYCHIAT RES-NEUROIM, V124, P1, DOI 10.1016/S0925-4927(03)00093-3; Mimura M, 2005, ANN REP MITSUBISHI P, V37, P248; FRIEDHOFF AJ, 1992, JAMA-J AM MED ASSOC, V268, P1018; Nobler Mitchell S, 2002, Curr Psychiatry Rep, V4, P51, DOI 10.1007/s11920-002-0013-x; Pu SH, 2012, J PSYCHIATR RES, V46, P1427, DOI 10.1016/j.jpsychires.2012.08.001; Strangman S, 2002, NEUROIMAGE, V17, P719; Takizawa R, 2014, NEUROIMAGE, V85, P498, DOI 10.1016/j.neuroimage.2013.05.126; WHO, 2004, GLOB BURD DIS 2004 U; World Health Organization, 2008, GLOB BURD DEPR 2004	64	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	MAR	2015	62						62	70		10.1016/j.jpsychires.2015.01.009		9	Psychiatry	Psychiatry	CE4GS	WOS:000351789700008		
J	Xue, J; Wang, WX; Zhang, JZ; Wu, SJ				Xue, Jia; Wang, Wen-Xue; Zhang, Jia-Zheng; Wu, Su-Jun			Progressive failure analysis of the fiber metal laminates based on chopped carbon fiber strands	JOURNAL OF REINFORCED PLASTICS AND COMPOSITES			English	Article						Hybrid; laminates; discontinuous reinforcement; strength	COHESIVE ZONE MODELS; RESIDUAL-STRESS; DAMAGE MODEL; DELAMINATION; BEHAVIOR; JOINTS; COMPOSITES; SIMULATION; CRITERIA; ELEMENTS	In this study, we propose a new fiber metal laminate based on unidirectionally arrayed chopped strand (UACS) reinforced aluminum sheets, referred to as UACS/Al laminate. UACS is made by introducing slits into unidirectional carbon fiber-reinforced plastic (CFRP) prepreg. Due to the presence of discontinuous fibers, the microstructure of the UACS/Al laminate is much more complicated than the conventional fiber metal laminate, which also results in a failure progression that is more complicated. Tensile failure of the UACS/Al laminate might occur as combination of intra-laminar damage at the slits, inter-laminar damage at the interfaces, in-ply damage of the CFRP, and plastic deformation of the aluminum plies. Fabrication and tensile tests of UACS/Al laminate specimens were performed. A two-dimensional finite element model was developed with intra-laminar cohesive elements inserted into the slits of the UACS plies and with inter-laminar cohesive elements inserted into the interfaces between all laminas in the modelled UACS/Al laminates. A numerical study is conducted to investigate the influence of the shape of the cohesive laws on the FEA predictions. The combined experimental and numerical studies provide a detailed understanding of the failure progression of UACS/Al laminates under tensile load.	[Xue, Jia; Zhang, Jia-Zheng] Beijing Aeronaut Sci & Technol Res Inst COMAC, Beijing, Peoples R China; [Xue, Jia; Wu, Su-Jun] Beihang Univ, Mat Sci & Engn Sch, Beijing 100191, Peoples R China; [Wang, Wen-Xue] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 816, Japan	Xue, J (reprint author), Beijing Aeronaut Sci & Technol Res Inst COMAC, Future Sic Tech Pk, Beijing, Peoples R China.	xuejia@comac.cc	Kyushu, RIAM/F-4018-2015		 [22360052]	This work was partially supported by Grant-in-Aid for Scientific Research (B) (22360052) of Japan.	Alderliesten RC, 2015, MATER DESIGN, V66, P421, DOI 10.1016/j.matdes.2014.06.068; Xue J, 2011, COMPOS PART A-APPL S, V42, P986, DOI 10.1016/j.compositesa.2011.04.001; Chen JF, 2014, COMPOS PART A-APPL S, V61, P185, DOI 10.1016/j.compositesa.2014.02.013; Cortes P, 2006, COMPOS PART B-ENG, V37, P163, DOI 10.1016/j.compositesb.2005.06.002; Gustafson PA, 2009, INT J SOLIDS STRUCT, V46, P2201, DOI 10.1016/j.ijsolstr.2008.11.016; HASHIN Z, 1980, J APPL MECH-T ASME, V47, P329; Turon A, 2007, ENG FRACT MECH, V74, P1665, DOI 10.1016/j.engfracmech.2006.08.025; Frizzell RM, 2011, COMPOS SCI TECHNOL, V71, P1225, DOI 10.1016/j.compscitech.2011.04.006; Campilho RDSG, 2013, INT J ADHES ADHES, V44, P48, DOI 10.1016/j.ijadhadh.2013.02.006; Turon A, 2010, COMPOS STRUCT, V92, P1857, DOI 10.1016/j.compstruct.2010.01.012; Khan SU, 2009, COMPOS SCI TECHNOL, V69, P396, DOI 10.1016/j.compscitech.2008.11.006; LIN CT, 1991, COMPOSITES, V22, P135, DOI 10.1016/0010-4361(91)90672-4; Benzeggagh ML, 1996, COMPOS SCI TECHNOL, V56, P439, DOI 10.1016/0266-3538(96)00005-X; Bocciarelli M, 2009, ENG FRACT MECH, V76, P299, DOI 10.1016/j.engfracmech.2008.10.005; Chen JF, 2014, COMPOS STRUCT, V114, P64, DOI 10.1016/j.compstruct.2014.03.046; Feraboli P, 2009, COMPOS PART A-APPL S, V40, P289, DOI 10.1016/j.compositesa.2008.12.012; Feraboli P, 2010, COMPOS PART A-APPL S, V41, P888, DOI 10.1016/j.compositesa.2010.03.002; Hausmann J, 2013, PROC MAT SCI, V2, P68, DOI 10.1016/j.mspro.2013.02.009; Li H, 2014, COMPOS PART A-APPL S, V57, P108, DOI 10.1016/j.compositesa.2013.11.003; Li H, 2013, COMPOS PART A-APPL S, V45, P127, DOI 10.1016/j.compositesa.2012.09.009; Shin DK, 2014, COMPOS PART B-ENG, V56, P397, DOI 10.1016/j.compositesb.2013.08.030; Spronk SWF, 2015, INT J FATIGUE, V70, P428, DOI 10.1016/j.ijfatigue.2014.07.004; Taketa I, 2008, COMPOS PART A-APPL S, V39, P1884, DOI 10.1016/j.compositesa.2008.09.012; Taketa I, 2011, COMPOS PART B-ENG, V42, P1764, DOI 10.1016/j.compositesb.2011.01.021; Vlot A., 2001, FIBRE METAL LAMINATE; Vlot A, 2001, GLARE HIST DEV NEW A; Wang W, 2007, ADV MULTIMEDIA, P1; Xue J., 2012, TENSILE STRENGTH THE; Yashiro S, 2009, COMPOS PART A-APPL S, V40, P938, DOI 10.1016/j.compositesa.2009.04.023	29	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0731-6844	1530-7964		J REINF PLAST COMP	J. Reinf. Plast. Compos.	MAR	2015	34	5					364	376		10.1177/0731684415571659		13	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	CE8DH	WOS:000352071000002		
J	Kinefuchi, K; Okita, K; Funaki, I; Abe, T				Kinefuchi, Kiyoshi; Okita, Koichi; Funaki, Ikkoh; Abe, Takashi			Prediction of In-Flight Radio Frequency Attenuation by a Rocket Plume	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article							EXHAUSTS	During rocket flights, ionized exhaust plumes from solid rocket motors may interfere with radio frequency transmission under certain conditions. A computational fluid dynamics and finite difference time-domain method coupling approach was established for predicting interference and radio frequency attenuation levels during an actual rocket flight. The detailed plasma flowfield and radio frequency transmission characteristics were revealed in the calculations. The calculated far-field received levels were compared with the in-flight attenuation data at different look angles (angles between the vehicle axis and the line of sight of the antennas), and the calculated results showed good agreement with the flight data over a wide range of look angles. An adaptation of the model, based on the diffraction theory, proved appropriate both for rough estimation of attenuation and for conducting a preliminary analysis of signal/rocket plume interactions.	[Kinefuchi, Kiyoshi] Japan Aerosp Explorat Agcy, Space Transportat Mission Directorate, Space Transportat Syst Res & Dev Ctr, Tsukuba, Ibaraki 3058505, Japan; [Okita, Koichi] Japan Aerosp Explorat Agcy, Space Transportat Miss Directorate, Space Transportat Prop Res & Dev Ctr, Tsukuba, Ibaraki 3058505, Japan; [Funaki, Ikkoh; Abe, Takashi] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Space Flight Syst, Chuo Ku, Sagamihara, Kanagawa 2298510, Japan	Kinefuchi, K (reprint author), Japan Aerosp Explorat Agcy, Space Transportat Mission Directorate, Space Transportat Syst Res & Dev Ctr, 2-1-1 Sengen, Tsukuba, Ibaraki 3058505, Japan.						Abe T., 2000, 31 AIAA PLASM DYN LA; Kinefuchi K, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4762857; SHIH TH, 1995, COMPUT FLUIDS, V24, P227, DOI 10.1016/0045-7930(94)00032-T; Bianchi S., 2012, INT ASTR C; Blevins J. A., 1994, 32 AER SCI M EXH; Boynton F. P., 1978, CR161099 NASA; Capener E. L., 1965, SOL PROP ROCK C; Kinefuchi K, 2010, IEEE T ANTENN PROPAG, V58, P3282, DOI 10.1109/TAP.2010.2055796; Kinefuchi K, 2013, J SPACECRAFT ROCKETS, V50, P150, DOI 10.2514/1.A32223; Kinefuchi K, 2010, J SPACECRAFT ROCKETS, V47, P627, DOI 10.2514/1.48173; Lawton J., 1969, ELECT ASPECTS COMBUS, P186; Magnussen BF, 1981, 19 AIAA AER SCI M; Onoda J., 2004, INT ASTR C; Sakai T., 2008, I ELECT INFORM COMMU, V108, P17; Smoot L. D., 1975, J SPACECRAFT, V4, P774, DOI 10.2514/3.28950; SMOOT LD, 1975, J SPACECRAFT ROCKETS, V12, P179, DOI 10.2514/3.27825; SMOOT LD, 1966, J SPACECRAFT ROCKETS, V3, P302, DOI 10.2514/3.28444; Taflove A., 2005, COMPUTATIONAL ELECTR, P353; VICENTE FA, 1967, J SPACECRAFT ROCKETS, V4, P1069; Wood W. A., 1965, AIAA 6 SOL PROP ROCK	20	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAR	2015	52	2					340	349		10.2514/1.A32957		10	Engineering, Aerospace	Engineering	CE2CS	WOS:000351621400004		
J	Tsutsumi, S; Ishii, T; Ui, K; Tokudome, S; Wada, K				Tsutsumi, S.; Ishii, T.; Ui, K.; Tokudome, S.; Wada, K.			Study on Acoustic Prediction and Reduction of Epsilon Launch Vehicle at Liftoff	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article							SUPERSONIC JET; WAVES; TESTS; MODEL; FLOW	Subscale model tests and a numerical investigation are performed to predict and attenuate the acoustic level of the Epsilon launch vehicle at liftoff. Requirements for the subscale model test to predict a full-scale acoustic environment are investigated, and then the scale size of the model test is set at 1/42. The launch pads employed herein are designed to attenuate reflection of the Mach wave radiated from the free jet and the acoustic wave due to the jet's impinging on the flame deflector. When comparing the acoustic result taken at the fairing location with that at three different altitudes, 9D(e), 14D(e), and 22D(e), where D-e represents the nozzle exit diameter, the acoustic level observed at 14De is the highest and exceeds the design requirement at all frequencies. It is revealed from the numerical analysis that the reflection of Mach waves radiating from the free jet within the flame path is the dominant acoustic source. A front cover is attached to the vertical flame path to shield the Mach wave radiation, and 3 dB attenuation in the overall sound pressure level is achieved. The design methods and the knowledge obtained in this study are valid for the design of the launch pad to attenuate liftoff acoustics.	[Tsutsumi, S.] Japan Aerosp Explorat Agcy, JAXAs Engn Digital Innovat JEDI Ctr, Sagamihara, Kanagawa 2525210, Japan; [Ishii, T.] Japan Aerosp Explorat Agcy, Inst Aeronaut Technol, Chofu, Tokyo 1828522, Japan; [Ui, K.] Japan Aerosp Explorat Agcy, Space Transportat Mission Directorate, Tsukuba, Ibaraki 3058505, Japan; [Tokudome, S.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Wada, K.] Sci Serv Inc, Tokyo Off, Chuuou Ku, Tokyo 1030012, Japan	Tsutsumi, S (reprint author), Japan Aerosp Explorat Agcy, JAXAs Engn Digital Innovat JEDI Ctr, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.						Akamine M, 2014, 20140879 AIAA; Krothapalli A, 1999, J FLUID MECH, V392, P155, DOI 10.1017/S0022112099005406; Tam CKW, 2009, AIAA J, V47, P2440, DOI 10.2514/1.42644; Gaitonde DV, 2000, AIAA J, V38, P2103, DOI 10.2514/2.872; [Anonymous], 1996, ISO96131; Bodony D. J., 2006, 20060486 AIAA; Cacqueray N., 2011, AIAA J, V49, P2171; Casalino D, 2009, AIAA J, V47, P1445, DOI 10.2514/1.38634; Dougherty N. S., 1984, 19842351 AIAA; Eldred K. M., 1971, NASA; Fukuda K., 2009, 20093368 AIAA; Fukuda K, 2011, T JPN SOC AERONAUT S, V54, P120, DOI 10.2322/tjsass.54.120; Gely D., 2005, 2005148 ONERA TP; Gely D., 2000, 20002026 AIAA; Haynes J., 2009, 20093160 AIAA; Horne W. C., 2009, 20093323 AIAA; Imaizumi H., 2004, J INCE JAPAN, V28, P264; James M. M., 2012, J ACOUST SOC AM, V132, P1991; Kobayashi M. H., 1999, J COMP PHYS, V156, P127; Koudriavtsev V. V., 2001, P 30 INT C EXH NOIS, P139; Lyrintzis A. S., 2003, International Journal of Aeroacoustics, V2, DOI 10.1260/147547203322775498; Maekawa Z., 1968, APPL ACOUST, V1, P157, DOI 10.1016/0003-682X(68)90020-0; Nonomura T., 2010, 20104019 AIAA; Nonomura T, 2011, AIAA J, V49, P2282, DOI 10.2514/1.J051054; Nonomura T, 2011, INT J AEROACOUST, V10, P401; Onoda J., 1997, P JSASS JSME STRUCT, P229; Panda J, 2013, J SPACECRAFT ROCKETS, V50, P1002, DOI 10.2514/1.A32433; Plotkin K., 2012, J ACOUST SOC AM, V132, P1991, DOI [10.1121/1.4755352, DOI 10.1121/1.4755352]; Shima E., 1997, P 29 FLUID DYN S, P325; Shima E., 2011, AIAA J, V49, P584; Spalart P.R., 1992, 19920439 AIAA; Sutherland C. L., 1993, 19934383 AIAA; TROUTT TR, 1982, J FLUID MECH, V116, P123, DOI 10.1017/S0022112082000408; Tsutsumi S., 2010, J ACOUST SOC AM, V127, P1742, DOI [10.1121/1.3383512, DOI 10.1121/1.3383512]; Tsutsumi S., 2009, 20090328 AIAA; Tsutsumi S., 2014, 20140882 AIAA; Tsutsumi S., 2008, 20085148 AIAA; Tsutsumi S., 2012, P INT C COMP FLUID D; Tsutsumi S., 2008, 20080390 AIAA; Varnier J, 2001, AIAA J, V39, P1851, DOI 10.2514/2.1199; Varnier J, 2002, AIAA J, V40, P825, DOI 10.2514/2.1746; Varnier J., 1996, 19961721 AIAA; Visbal M. R., 2005, 20051265 AIAA	43	1	1	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAR	2015	52	2					350	361		10.2514/1.A33010		12	Engineering, Aerospace	Engineering	CE2CS	WOS:000351621400005		
J	Ogino, Y; Terata, I; Nakajima, K; Ohnishi, N; Fujita, K				Ogino, Yousuke; Terata, Ippei; Nakajima, Keisuke; Ohnishi, Naofumi; Fujita, Kazuhisa			Study of Capsule Geometry for Dust Sample Acquisition During Mars Atmospheric Entry	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article							PARTICLES; DRAG	This paper explores an appropriate position for the dust-capturing device on the surface of an aeroflyby capsule traveling at a velocity of 4.4 km/s in the Martian atmosphere at an altitude of 36 km. The equation of motion and the heat-transfer equation for dust particles are solved for particle sizes of 0.5 and 0.1 mu m. A thermochemical nonequilibrium flowfield over the vehicle is computed using a prismatic unstructured mesh method. Analysis indicates that placing a dust-capturing device on the leeward frustum edge results in less aerodynamic drag and lower surface heat flux than placing the same device on the windward frustum edge. The lower heat flux exerted on the surface of the dust-capturing device is preferable because the aerogel on the surface of the device is less damaged. The temperature of dust particles of 0.5 mu m diameter is elevated to almost the phase-change temperature when the dust-capturing device is on the leeward frustum edge, due to longer flight time in the high-temperature shock layer. The temperature of dust particles reaching the device on the windward frustum edge is well below the phase-change temperature. However, this study could not find any position to capture dust particles of 0.1 mu m diameter before reaching the phase-change temperature, regardless of the position of the dust-capturing device.	[Ogino, Yousuke; Terata, Ippei; Nakajima, Keisuke; Ohnishi, Naofumi] Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan; [Fujita, Kazuhisa] Japan Aerosp Explorat Agcy, Aerosp Res & Dev Directorate, Tokyo 1828522, Japan	Ogino, Y (reprint author), Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan.	yogi@cfd.mech.tohoku.ac.jp			Japan Aerospace Exploration Agency	The authors thank Michiko Ahn Furudate, Chungnam University in Korea, for providing the computational fluid dynamics code used in this study. This work is partially supported by a research contract of the Japan Aerospace Exploration Agency for predicting aerodynamic performance of an aerocapturing system in the planetary atmosphere with real gas effects.	TOON OB, 1977, ICARUS, V30, P663, DOI 10.1016/0019-1035(77)90088-4; MILLAT J, 1988, PHYSICA A, V148, P153, DOI 10.1016/0378-4371(88)90139-2; VANLEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; Ozawa T, 2011, J THERMOPHYS HEAT TR, V25, P341, DOI 10.2514/1.50714; CLANCY RT, 1995, J GEOPHYS RES-PLANET, V100, P5251, DOI 10.1029/94JE01885; CROWE CT, 1967, AIAA J, V5, P1021, DOI 10.2514/3.4119; Eberhardt S., 1991, J THERMOPHYS HEAT TR, V5, P257, DOI [10.2514/3.259, DOI 10.2514/3.259]; Fujita K., 2009, 20095614 AIAA; Fujita K., 2009, P 27 INT S SPAC TECH; Kavanau L. L., 1955, T ASME, V77, P617; Kitazawa Y, 1999, J GEOPHYS RES-PLANET, V104, P22035, DOI 10.1029/1998JE000554; Kubota T., 2009, P 27 INT S SPAC TECH; Ogawa N., 2009, P 27 INT S SPAC TECH; Ozawa T., 2012, 20120876 AIAA; Ozawa T., 2013, 20132684 AIAA; Park C., 1989, NONEQUILIBRIUM HYPER, P1; Satoh T., 2009, P 27 INT S SPAC TECH; Suzuki T., 2011, 20110133 AIAA; Suzuki T., 2013, 20130905 AIAA; Uno Y., 1986, J MINER SOC JAPAN, V17, P155, DOI 10.2465/gkk1952.17.Special_155; Wada Y., 1994, 19940083 AIAA	21	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAR	2015	52	2					375	382		10.2514/1.A32827		8	Engineering, Aerospace	Engineering	CE2CS	WOS:000351621400007		
J	Iwai, S; Masui, H; Iwata, M; Toyoda, K; Cho, M				Iwai, Shunsuke; Masui, Hirokazu; Iwata, Minoru; Toyoda, Kazuhiro; Cho, Mengu			Flight Results of Arcing Experiment Onboard High-Voltage Technology Demonstration Satellite Horyu-2	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article								The High-Voltage Technology Demonstration Satellite Horyu-2 is a nanosatellite (30 cm cubic shape, 7 kg) developed by the Kyushu Institute of Technology. It is known that high-voltage power generation above 200 V in low Earth orbit induces arcing. The main mission of Horyu-2 is to demonstrate various high-voltage technologies. The satellite was launched on 18 May 2012 to the sun-synchronous orbit at an altitude of 680 km. The satellite succeeded in generating 350V of photovoltaic power via a specially designed solar array. Using the generated voltage, experiments on arc inception on various types of solar arrays were conducted. The solar arrays tested consisted of a conventional design and two new designs that aimed at preventing arc inception. They were connected to the negative end of a 350V solar array circuit. A semiconductive cover glass coating was the most effective at preventing arcing. Covering the solar array with a transparent film was effective at low latitudes but it suffered arcs at higher latitudes near the polar region.	[Iwai, Shunsuke] Kyushu Inst Technol, Dept Elect Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan; [Masui, Hirokazu; Iwata, Minoru; Toyoda, Kazuhiro; Cho, Mengu] Kyushu Inst Technol, Lab Spacecraft Environm Interact Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan	Iwai, S (reprint author), Kyushu Inst Technol, Dept Elect Engn, Tobata Ku, 1-1 Sensui, Kitakyushu, Fukuoka 8048550, Japan.				Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative Research and Development on Science and Technology	The ground testing of Horyu-2 was partially supported by the New grant from the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative Research and Development on Science and Technology, initiated by the Council for Science and Technology Policy. The authors wish to thank the Japan Aerospace Exploration Agency for providing the piggyback launch opportunity onboard an H2A rocket.	Bogorad A, 1995, IEEE T NUCL SCI, V42, P2051, DOI 10.1109/23.489252; Brophy J. R., 2011, 20115514 AIAA; Cho M, 2011, PROGR ASTRONAUTICS A, P75; Cho M, 2014, J SPACECRAFT ROCKETS, V51, P379, DOI 10.2514/1.A32559; Ferguson D. C., 1986, TM87259 NASA; Hosoda S, 2006, IEEE T PLASMA SCI, V34, P1986, DOI 10.1109/TPS.2006.883287; KUNINAKA H, 1995, J SPACECRAFT ROCKETS, V32, P894, DOI 10.2514/3.26702; Okumura T., 2011, 9 EUR SPAC POW C EUR; delaCruz CP, 1996, J SPACECRAFT ROCKETS, V33, P438; Soldi JD, 1997, J SPACECRAFT ROCKETS, V34, P92, DOI 10.2514/2.3177; Takahashi A, 2014, IEEE T PLASMA SCI, V42, P384, DOI 10.1109/TPS.2013.2295627; Yoke T, 2013, IEEE T PLASMA SCI, V41, P3477, DOI 10.1109/TPS.2013.2276439	12	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAR	2015	52	2					544	552		10.2514/1.A33007		9	Engineering, Aerospace	Engineering	CE2CS	WOS:000351621400022		
J	Matsumoto, N; Tanaka, A; Khan, AR; Iwata, M; Toyoda, K; Cho, M				Matsumoto, Naoki; Tanaka, Atomu; Khan, Arifur R.; Iwata, Minoru; Toyoda, Kazuhiro; Cho, Mengu			Flight Experiment Results of Electron-Emitting Film for Spacecraft Charging Mitigation	JOURNAL OF SPACECRAFT AND ROCKETS			English	Article								Spacecraft charging poses a serious threat to satellite operation. An encounter with energetic electrons causes the spacecraft potential to become highly negative. The potential difference between the spacecraft's chassis and the surface insulator can lead to an electrostatic discharge. If the negative potential of the satellite can be raised to near 0V by emitting electrons from the satellite chassis, spacecraft charging can be mitigated. An electron-emitting film uses the electric field concentration near a triple junction and emits electrons in a completely passive manner. This emitter was mounted onboard the high-voltage technology demonstration satellite HORYU-II, a 30 cm cubical nanosatellite weighing 7.1 kg. HORYU-II was launched to a sun-synchronous orbit of 680 km altitude in May 2012. Experiments were conducted to measure the emission current from the emitter and the surface potential of an insulator similar to the emitter. Twenty-four trials were carried out over the aurora zone, mostly above Antarctica, from July 2012 to November 2012. Of the 24 trials, electron emission was observed in three trials. The electron emission, as high as 6 mu A with 1 min duration, was confirmed from this emitter, along with charging of the insulator from 1000-2000 V over the aurora zone.	[Matsumoto, Naoki; Toyoda, Kazuhiro] Kyushu Inst Technol, Dept Elect & Elect Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan; [Tanaka, Atomu; Iwata, Minoru; Cho, Mengu] Kyushu Inst Technol, Dept Appl Sci Integrated Syst Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan; [Khan, Arifur R.] Kyushu Inst Technol, Lab Spacecraft Environm Interact Engn, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan	Matsumoto, N (reprint author), Mitsubishi Elect Engn Co Ltd, Tokyo, Japan.	naoki.matsumoto6@gmail.com; n350912a@mail.kyutech.jp; markhan@ele.kyutech.ac.jp; iwata@ele.kyutech.ac.jp; toyoda@ele.kyutech.ac.jp; cho@ele.kyutech.ac.jp			Japan Society for the Promotion of Science (JSPS) (Kakenhi) [22246104, 19206090, 16360426]; "New Paradigm of Space Development and Utilization by Nano-Satellite" by the Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid (Kakenhi) grants 22246104, 19206090, and 16360426. The ground testing of HORYU-II was partially supported by the "New Paradigm of Space Development and Utilization by Nano-Satellite" granted by the Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy. The authors thank Janet Green of National Oceanic and Atmospheric Administration for providing the aurora oval data and Iwaki Coating Technology, Ltd., for their assistance in the manufacturing of the electron-emitting film and surface charging monitor. The authors also wish to thank the Japan Aerospace Exploration Agency for providing the piggyback launch opportunity onboard an H2A rocket.	Anderson PC, 2001, ESA SP PUBL, V476, P331; LATHAM RV, 1982, VACUUM, V32, P137, DOI 10.1016/0042-207X(82)80043-2; Bogorad A, 1995, IEEE T NUCL SCI, V42, P2051, DOI 10.1109/23.489252; Cho M., 2011, SPACECRAFT CHARGING, P75; Cho M, 2014, J SPACECRAFT ROCKETS, V51, P379, DOI 10.2514/1.A32559; Cooke D. L., 2002, 20024049 AIAA; Dichter B. K., 2000, 6 SPAC CHARG TECHN C, P329; Iwata M, 2012, J SPACECRAFT ROCKETS, V49, P546, DOI 10.2514/1.50735; Katz I., 1998, 19981002 AIAA; Khan AR, 2013, J SPACECRAFT ROCKETS, V50, P853, DOI 10.2514/1.A32370; Maejima H., 2004, 20045657 AIAA; Mandell M.J., 2007, 20070284 AIAA	12	0	0	AMER INST AERONAUTICS  ASTRONAUTICS	RESTON	1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091-4344 USA	0022-4650	1533-6794		J SPACECRAFT ROCKETS	J. Spacecr. Rockets	MAR	2015	52	2					553	559		10.2514/1.A32829		7	Engineering, Aerospace	Engineering	CE2CS	WOS:000351621400023		
J	Kono, S; Kurata, T; Sato, K; Omote, Y; Hishikawa, N; Yamashita, T; Deguchi, K; Abe, K				Kono, Syoichiro; Kurata, Tomoko; Sato, Kota; Omote, Yoshio; Hishikawa, Nozomi; Yamashita, Toru; Deguchi, Kentaro; Abe, Koji			Neurovascular Protection by Telmisartan via Reducing Neuroinflammation in Stroke-Resistant Spontaneously Hypertensive Rat Brain after Ischemic Stroke	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Spontaneously hypertensive rat; neurovascular unit; inflammasome; telmisartan; Alzheimer disease	FOCAL CEREBRAL-ISCHEMIA; ANGIOTENSIN-II; PPAR-GAMMA; MATRIX METALLOPROTEINASES; RECEPTOR ANTAGONIST; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; NEURONAL INJURY; BLOOD-PRESSURE; CANDESARTAN	Telmisartan is a highly lipid-soluble angiotensin receptor blocker (ARB), which improves insulin sensitivity and reduces triglyceride levels and, thus, is called metabo-sartan. We examined the effects of telmisartan on neurovascular unit (N-acetylglucosamine oligomer [NAGO], collagen IV, and glial fibrillary acidic protein [GFAP]) and neuroinflammation (matrix metalloproteinase-9 [MMP-9] and inflammasome) in brain of stroke-resistant spontaneously hypertensive rat (SHR-SR). At 12 weeks of age, SHR-SR received transient middle cerebral artery occlusion (tMCAO) for 90 minutes and were divided into the following 3 groups, that is, vehicle group, low-dose telmisartan group (.3 mg/kg/d), and high-dose telmisartan group (3 mg/kg/d, postoral). Immunohistologic analysis at ages 6, 12, and 18 months showed progressive decreases of NAGO-positive endothelium and collagen IV-positive basement membrane and progressive increases of MMP-9-positive neurons, GFAP-positive astrocytes, and NLRP3-positive inflammasome in the cerebral cortex of vehicle group. Low-dose telmisartan reduced such changes without lowering blood pressure (BP), and high-dose telmisartan further improved such changes with lowering BP. The present findings suggest that a persistent hypertension caused a long-lasting inflammation after tMCAO in SHR-SR, which accelerated neurovascular disruption and emergent inflammasome, and that telmisartan greatly reduced such inflammation and protected the neurovascular unit via its pleiotropic effects in living hypertensive rat brain after ischemic stroke.	[Kono, Syoichiro; Kurata, Tomoko; Sato, Kota; Omote, Yoshio; Hishikawa, Nozomi; Yamashita, Toru; Deguchi, Kentaro; Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharm, Dept Neurol, Kita Ku, Okayama, Japan	Abe, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharm, Dept Neurol, 2-5-1 Shikata Cho, Okayama, Japan.	skono@cc.okayama-u.ac.jp			Ministry of Health, Labour, and Welfare of Japan [21390267, 24591263, 24659651]	This work was partly supported by a Grant-in-Aid for Scientific Research (B) 21390267, (C) 24591263, and Challenging Research 24659651 and by Grants-in-Aid from the Research Committees (Mizusawa H, Nakano I, Nishizawa M, Sasaki H, and Aoki M) from the Ministry of Health, Labour, and Welfare of Japan.	Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Lou M, 2004, J CEREBR BLOOD F MET, V24, P536; Gohlke P, 2001, J PHARMACOL EXP THER, V298, P62; Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80; Faure S, 2006, J HYPERTENS, V24, P2255, DOI 10.1097/01.hjh.0000249704.34607.4c; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Hamai M, 2006, NEUROPHARMACOLOGY, V51, P822, DOI 10.1016/j.neuropharm..2006.05.029; NAGASAWA H, 1989, STROKE, V20, P1037; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Lee SR, 2004, J CEREBR BLOOD F MET, V24, P720, DOI 10.1097/01.WCB.0000122747.72175.47; Mogi M, 2008, BIOCHEM BIOPH RES CO, V375, P446, DOI 10.1016/j.bbrc.2008.08.032; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/01.hjh.0000059028.82022.89; Kozak W, 2008, J PHARMACOL EXP THER, V326, P773, DOI 10.1124/jpet.108.139618; Hu Q, 2011, BRAIN RES, V1367, P347, DOI 10.1016/j.brainres.2010.10.002; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132532; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Sabbatini M, 2002, MECH AGEING DEV, V123, P547, DOI 10.1016/S0047-6374(01)00362-1; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Wienen W, 2001, J RENIN-ANGIO-ALDO S, V2, P123; Forder JP, 2005, AM J PHYSIOL-HEART C, V288, pH1989, DOI 10.1152/ajpheart.00839.2004; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Suzuki H, 2005, HYPERTENS RES, V28, P307, DOI 10.1291/hypres.28.307; Luchtefeld M, 2005, BIOCHEM BIOPH RES CO, V328, P183, DOI 10.1016/j.bbrc.2004.12.152; Rosen ED, 2001, J BIOL CHEM, V276, P37731; Walther T, 2002, FASEB J, V16, P169, DOI 10.1096/fj.01-0601com; Hosomi N, 2005, NEUROSCIENCE, V134, P225, DOI 10.1016/j.neuroscience.2005.03.054; Pravenec M, 2003, PHYSIOL RES, V52, P681; Maillard MP, 2002, J PHARMACOL EXP THER, V302, P1089, DOI 10.1124/jpet.102.036772; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; AUGUSTIN HG, 1995, AM J PATHOL, V147, P339; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/01.hjh.0000098126.00558.9b; Chen JW, 2004, J CARDIOVASC PHARM, V44, P446, DOI 10.1097/01.fjc.0000140205.74180.3c; Cipollone F, 2004, CIRCULATION, V109, P1482, DOI 10.1161/01.CIR.0000121735.52471.AC; Dai WJ, 1999, STROKE, V30, P2398; Dai WJ, 1999, STROKE, V30, P2391; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Iwai M, 2008, HYPERTENS RES, V31, P161, DOI 10.1291/hypres.31.161; Kumai Y, 2008, EXP NEUROL, V210, P441, DOI 10.1016/j.expneurol.2007.11.028; Kurata T, 2014, TRANSL STROKE RES; Lukic-Panin V, 2010, CURR NEUROVASC RES, V7, P319; Maier CM, 2006, BIOCHEM SOC T, V34, P1366; Pravenec M, 2000, FOLIA BIOL-PRAGUE, V46, P233; Pravenec M, 1999, J CLIN INVEST, V103, P1651, DOI 10.1172/JCI6691; Yusuf S, 2000, NEW ENGL J MED, V342, P145	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAR	2015	24	3					537	547		10.1016/j.jstrokecerebrovasdis.2014.09.037		11	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FB	WOS:000351855000012		
J	Sugimoto, T; Hosomi, N; Nezu, T; Takahashi, T; Aoki, S; Takeda, I; Mukai, T; Ochi, K; Kitamura, T; Ohtsuki, T; Matsumoto, M				Sugimoto, Takamichi; Hosomi, Naohisa; Nezu, Tomohisa; Takahashi, Tetsuya; Aoki, Shiro; Takeda, Ikuko; Mukai, Tomoya; Ochi, Kazuhide; Kitamura, Takeshi; Ohtsuki, Toshiho; Matsumoto, Masayasu			CD34+/CD144+Circulating Endothelial Cells as an Indicator of Carotid Atherosclerosis	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Atherosclerosis; carotid intima-media thickness; carotid ultrasound; circulating endothelial cells; circulating-endothelial progenitor cells	INTIMA-MEDIA THICKNESS; CIRCULATING PROGENITOR CELLS; ACUTE ISCHEMIC-STROKE; DISEASE; ARTERY; BLOOD; RISK; PROTOCOL; MARKERS; INDEX	Background: The relationships between the number of circulating endothelial cells (CECs) or endothelial progenitor cells (EPCs) and indicators of carotid atherosclerosis, such as the intima-media thickness (IMT) and plaque score are not well characterized in patients with chronic ischemic stroke. The objective of this study was to investigate these relationships in patients with chronic ischemic stroke and in patients with risk factors for stroke. Methods: A total of 58 patients (69.6 +/- 10.0 years, 21 females) with chronic ischemic stroke or with risk factors for stroke were included in this study. IMT was measured using an IntimaScope, and the numbers of CECs and EPCs were measured using flow cytometry. CECs and EPCs were defined as CD34+/CD144+ and CD34+/CD133+ cells, respectively. Results: The number of CECs in patients with large artery atherosclerosis was higher than that in patients with cardioembolism or small vessel occlusion (P < .05). In contrast, there were no significant differences in the number of EPCs between groups. A positive correlation was also observed between the plaque score and the number of CECs (r(2) = .139, P < .05, n = 36). Moreover, the number of CECs in patients with moderate and severe atherosclerosis (.32 +/- .11/mu L, n = 22) was higher than that in patients with no plaque and mild atherosclerosis (.25 +/- .07/mu L, n = 34, P < .05). Conclusions: The number of CECs was high in patients with large artery atherosclerosis who experienced chronic ischemic stroke. And this number may reflect severity of carotid atherosclerosis.	[Sugimoto, Takamichi; Hosomi, Naohisa; Nezu, Tomohisa; Takahashi, Tetsuya; Aoki, Shiro; Takeda, Ikuko; Mukai, Tomoya; Ochi, Kazuhide; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima 7348551, Japan; [Sugimoto, Takamichi; Kitamura, Takeshi] Chugoku Rosai Hosp, Dept Neurol, Kure, Japan; [Ohtsuki, Toshiho] Kindai Univ Hosp, Stroke Ctr, Osaka, Japan	Hosomi, N (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nhosomi@hiroshima-u.ac.jp			Ministry of Health, Labour and Welfare, Japan; Japan Science and Technology Agency; Smoking Research Foundation; Tsuchiya Foundation; Japan Heart Foundation	This study was supported in part by research grants from the Ministry of Health, Labour and Welfare, Japan, the Japan Science and Technology Agency, the Smoking Research Foundation, the Tsuchiya Foundation, and the Japan Heart Foundation.	PERSSON J, 1994, ARTERIOSCLER THROMB, V14, P261; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; BURKE GL, 1995, STROKE, V26, P386; Nezu T, 2013, J NEUROL, V260, P2642, DOI 10.1007/s00415-013-7040-x; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Woywodt A, 2006, ANN RHEUM DIS, V65, P164, DOI 10.1136/ard.2005.040980; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Hosomi N, 2012, CEREBROVASC DIS, V34, P385, DOI 10.1159/000343659; HANDA N, 1990, STROKE, V21, P1567; Bots ML, 1997, CIRCULATION, V96, P1432; GROBBEE DE, 1994, J INTERN MED, V236, P567; Duda DG, 2007, NAT PROTOC, V2, P805, DOI 10.1038/nprot.2007.111; Blann AD, 2006, ATHEROSCLEROSIS, V188, P12, DOI 10.1016/j.atherosclerosis.2005.12.024; Allan PL, 1997, STROKE, V28, P348; Goon P, 2009, NEOPLASIA, V11, P771, DOI 10.1593/neo.09490; Gao Y, 2008, CAN J NEUROL SCI, V35, P638; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789; Hosomi N, 2001, STROKE, V32, P1539; Japanese Committee for Clinical Laboratory Standards, 2003, RINSHO BYORI, V51, P910; Nagai Y, 2002, ULTRASOUND MED BIOL, V28, P1231, DOI 10.1016/S0301-5629(02)00578-1; Ozdogu H, 2007, AM J HEMATOL, V82, P706, DOI 10.1002/ajh.20904; Pelosi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051109; SALONEN JT, 1993, CIRCULATION, V87, P56; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Woywodt A, 2012, J STROKE CEREBROVASC, V21, P452, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.003	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAR	2015	24	3					583	590		10.1016/j.jstrokecerebrovasdis.2014.10.001		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FB	WOS:000351855000018		
J	Fukuoka, Y; Hosomi, N; Hyakuta, T; Omori, T; Ito, Y; Uemura, J; Kimura, K; Matsumoto, M; Moriyama, M				Fukuoka, Yasuko; Hosomi, Naohisa; Hyakuta, Takeshi; Omori, Toyonori; Ito, Yasuhiro; Uemura, Jyunichi; Kimura, Kazumi; Matsumoto, Masayasu; Moriyama, Michiko		DMP Stroke Trial Investigators	Baseline Feature of a Randomized Trial Assessing the Effects of Disease Management Programs for the Prevention of Recurrent Ischemic Stroke	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Stroke; disease management programs; self-management; prevention of recurrence; primary care setting; risk factor control	HEART-FAILURE; INTERVENTION; GUIDELINES	Background: Comprehensive and long-term patient education programs designed to improve self-management can help patients better manage their medical condition. Using disease management programs (DMPs) that were created for each of the risk factor according to clinical practice guidelines, we evaluate their influence on the prevention of stroke recurrence. Methods: This is a randomized study conducted with ischemic stroke patients within 1 year from their onset. Subjects in the intervention group received a 6-month DMPs that included self-management education provided by a nurse along with support in collaboration with the primary care physician. Those in the usual care group received ordinary outpatient care. The primary end points are stroke recurrence and stroke death. Patients were enrolled for 2 years with plans for a 2-year follow-up after the 6-month education period (total of 30 months). Results: A total of 321 eligible subjects (average age, 67.3 years; females, 96 [29.9%]), including 21 subjects (6.5%) with transient ischemic attack, were enrolled in this study. Regarding risk factors for stroke, 260 subjects (81.0%) had hypertension, 249 subjects (77.6%) had dyslipidemia, 102 subjects (31.8%) had diabetes mellitus, 47 subjects (14.6%) had atrial fibrillation, and 98 subjects (30.5%) had chronic kidney disease. There were no significant differences between the 2 groups with respect to subject characteristics. Conclusions: This article describes the rationale, design, and baseline features of a randomized controlled trial that aimed to assess the effects of DMPs for the secondary prevention of stroke. Subject follow-up is in progress and will end in 2015. (C) 2015 by National Stroke Association	[Fukuoka, Yasuko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Nursing Sci, Hiroshima 7348553, Japan; [Hosomi, Naohisa; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima 7348553, Japan; [Hyakuta, Takeshi] Japanese Red Cross Hiroshima Coll Nursing, Fac Nursing, Hiroshima, Japan; [Omori, Toyonori] Natl Inst Hlth & Nutr, Tokyo, Japan; [Ito, Yasuhiro] TOYOTA Mem Hosp, Dept Neurol, Toyota, Japan; [Uemura, Jyunichi; Kimura, Kazumi] Kawasaki Med Sch Hosp, Dept Stroke Med, Kurashiki, Okayama, Japan; [Moriyama, Michiko] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Nursing Sci, Hiroshima 7348553, Japan	Fukuoka, Y (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Nursing Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	yasukofukuoka@hotmail.com			Ministry of Health, Labour and Welfare, Japan	This study was initially supported by the Ministry of Health, Labour and Welfare, Japan. K.K. received speakers' bureau from Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Company Limited, and Boehringer Ingelheim Japan Incorporated. M.M. is a chairperson of DPP Health Partners Company Limited and received cooperative research fund. The other authors declare no conflicts of interest.	Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS31, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.004; Herttua K, 2013, EUR HEART J, V34, P2933, DOI 10.1093/eurheartj/eht219; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Stewart S, 2012, J AM COLL CARDIOL, V60, P1239, DOI 10.1016/j.jacc.2012.06.025; Wolfe CDA, 2010, STROKE, V41, P2470, DOI 10.1161/STROKEAHA.110.588046; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; [Anonymous], 2012, TREATM GUID DIAB 201; Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786; Cadilhac DA, 2011, STROKE, V42, P1673, DOI 10.1161/STROKEAHA.110.601997; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037//0033-295X.84.2.191; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38; Iestra JA, 2005, CIRCULATION, V112, P924, DOI 10.1161/CIRCULATIONAHA.104.503995; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Hata J, 2005, J NEUROL NEUROSUR PS, V76, P368, DOI 10.1136/jnnp.2004.038166; Howe RS., 2005, DIS MANAGERS HDB; Imai Y, 1994, HONG KONG COLL PSYCH, V4, P20; Ogawa S, 2010, CIRC J, V74, P2479, DOI 10.1253/circj.CJ-88-0001; Kazawa K, 2013, NEPHROL NURS J, V40, P141; National Institute of Neurological Disorders and Stroke Committee, 1990, STROKE, V21, P637; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sasaki S, 2009, CLIN EXP NEPHROL, V13, P533, DOI 10.1007/s10157-009-0235-x; Teramoto T, 2012, J ATHEROSCLER THROMB, V20, P655; vanVeenendaal H, 1996, PATIENT EDUC COUNS, V28, P265, DOI 10.1016/0738-3991(95)00853-5	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAR	2015	24	3					610	617		10.1016/j.jstrokecerebrovasdis.2014.10.007		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FB	WOS:000351855000021		
J	Kato, H; Takeda, T; Ohara, K; Tei, H; Nishizawa, E				Kato, Hidetaka; Takeda, Takahiro; Ohara, Kuniko; Tei, Hideaki; Nishizawa, Etsuko			Rostrocaudal Thickness on Sagittal Diffusion-weighted Imaging as a Predictor of Motor Deficits in an Acute Isolated Pontine Infarction	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Branch atheromatous disease; diffusion-weighted image; pontine infarction; predictive value	BRANCH ATHEROMATOUS DISEASE; STROKE; SUBTYPE	Background: The relationship between infarct dimensions and neurologic severity in patients with acute pontine infarctions remains unclear. This study aimed to clarify the morphometric predictive value of magnetic resonance imaging for motor deficits in pontine infarction. Methods: Nineteen patients with an acute pontine infarction (12 males and 7 females, 70.6 +/- 13.5 years [mean age +/- SD]) had ventrodorsal length and rostrocaudal thickness and width retrospectively measured as parameters of infarct size on axial and sagittal diffusion-weighted imaging (DWI). Each patient's functional score (FS) based on Brunnstrom scale (upper limb, hand, and lower limb) was assessed. The functional score of bulbar symptoms was coded as follows: 2, none; 1, dysarthria or dysphasia; and 0, both. The mean FS was compared with each infarct size parameter and the patients' clinical features. Results: Rostrocaudal thickness on sagittal DWI was the parameter most closely correlated with FS (Spearman rank correlation coefficient (r(s)) = 2.474, P = .040). However, there is apparently no association between FS and infarct size with correction for age. FS was most severe in patients with an atherothrombotic infarction; it was mildest in patients with a lacunar infarction (value of K [Kruskal-Wallis] = 9.0, P = .015). Conclusions: The branch orifices of the pontine paramedian arteries could be narrowed by atheromatous plaques within the basilar artery. These atheromatous lesions involving multiple branching paramedian arteries probably cause rostrocaudally thick infarctions. A pontine infarction extending rostrocaudally along the corticospinal tract may cause severe motor impairments. (C) 2015 by National Stroke Association	[Kato, Hidetaka; Takeda, Takahiro; Ohara, Kuniko; Tei, Hideaki; Nishizawa, Etsuko] Todachuo Gen Hosp, Dept Neurol, Toda, Saitama 3358555, Japan; [Kato, Hidetaka; Takeda, Takahiro] Tokyo Womens Med Univ, Dept Neurol, Tokyo, Japan	Takeda, T (reprint author), Todachuo Gen Hosp, Dept Neurol, 1-19-3 Hon Cho, Toda, Saitama 3358555, Japan.	ttakeda@nij.twmu.ac.jp					Lee LJ, 2000, STROKE, V31, P1081; Vemmos KN, 2005, J NEUROL, V252, P212, DOI 10.1007/s00415-005-0639-9; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Grueter BE, 2012, POSTGRAD MED J, V88, P79, DOI 10.1136/postgradmedj-2011-130307; CAPLAN LR, 1989, NEUROLOGY, V39, P1246; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; FISHER CM, 1971, NEUROLOGY, V21, P900; Lenehan B, 2009, EUR SPINE J, V18, P1458, DOI 10.1007/s00586-009-1107-5; Brunnstrom S, 1970, MOVEMENT THERAPY HEM, P34; Deguchi I, 2013, J STROKE CEREBROVASC, V22, pE168, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.012; Field Thalia S, 2011, Rev Neurol Dis, V8, P30; Gauthier LV, 2012, STROKE, V43, P453, DOI 10.1161/STROKEAHA.111.633255; Groisser BN, 2014, NEUROREHAB NEURAL RE, V28, P751, DOI 10.1177/1545968314521896; Hallevi H, 2012, CEREBROVASC DIS, V33, P64, DOI 10.1159/000333388; Jang SH, 2008, ANN NEUROL, V64, P460, DOI 10.1002/ana.21444; Kim JS, 2009, ACTA NEUROL SCAND, V120, P88, DOI 10.1111/j.1600-0404.2008.01124.x; Kumral E, 2002, J NEUROL, V249, P1659, DOI 10.1007/s00415-002-0879-x; Saia V, 2009, ACTA NEUROL SCAND, V120, P213, DOI 10.1111/j.1600-0404.2009.01161.x; Seo JP, 2013, YONSEI MED J, V54, P785, DOI 10.3349/ymj.2013.54.3.785; TOYODA K, 1994, STROKE, V25, P2171; Weier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086916	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAR	2015	24	3					622	628		10.1016/j.jstrokecerebrovasdis.2014.10.012		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FB	WOS:000351855000023		
J	Takahashi, S; Tanizaki, Y; Kimura, H; Akaji, K; Kano, T; Suzuki, K; Takayama, Y; Kanzawa, T; Shidoh, S; Nakazawa, M; Yoshida, K; Mihara, B				Takahashi, Satoshi; Tanizaki, Yoshio; Kimura, Hiroaki; Akaji, Kazunori; Kano, Tadashige; Suzuki, Kentaro; Takayama, Youhei; Kanzawa, Takao; Shidoh, Satoka; Nakazawa, Masaki; Yoshida, Kazunari; Mihara, Ban			Comparison of Cerebral Blood Flow Data Obtained by Computed Tomography (CT) Perfusion with that Obtained by Xenon CT Using 320-Row CT	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Cerebral blood flow; CT perfusion; xenon CT; automated ROI; hemodynamic stress distribution	ACUTE ISCHEMIC-STROKE; MOYAMOYA-DISEASE; PENUMBRA	Cerebral blood flow (CBF) data obtained by computed tomography perfusion (CTP) imaging have been shown to be qualitative data rather than quantitative, in contrast with data obtained by other imaging methods, such as xenon CT (XeCT) imaging. Thus, interpatient comparisons of CBF values themselves obtained by CTP maybe inaccurate. In this study, we have compared CBF ratios as well as CBF values obtained from CTP-CBF data to those obtained from XeCT-CBF data for the same patients to determine CTP-CBF parameters that can be used for interpatient comparisons. The data used in the present study were obtained as volume data using 320-row CT. The volume data were applied to an automated region of interest-determining software (3DSRT, version 3.5.2) and converted to 59 slices of 2 mm interval standardized images. In the present study, we reviewed 10 patients with occlusive cerebrovascular diseases (CVDs) undergoing both CTP and XeCT in the same period. Our study shows that ratios of CBF measurements, such as hemodynamic stress distribution (perforator-to-cortical flow ratio of middle cerebral artery [MCA] region) or the left/right ratio for the region of the MCA, calculated using CTP data have been shown to correlate well with the same ratios calculated using XeCT data. These results suggest that such CBF ratios could be useful for generating interpatient comparisons of CTP-CBF data obtained by 320-row CT among patients with occlusive CVD. (C) 2015 by National Stroke Association	[Takahashi, Satoshi; Tanizaki, Yoshio; Akaji, Kazunori; Kano, Tadashige; Shidoh, Satoka] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Neurosurg, Isesaki, Japan; [Takahashi, Satoshi; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Tokyo 1068582, Japan; [Kimura, Hiroaki; Mihara, Ban] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Neurol, Isesaki, Japan; [Suzuki, Kentaro; Takayama, Youhei] Nippon Med Sch, Dept Neurol, Tokyo 113, Japan; [Suzuki, Kentaro; Takayama, Youhei; Kanzawa, Takao] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Stroke Med, Isesaki, Japan; [Nakazawa, Masaki] Mihara Mem Hosp, Inst Brain & Blood Vessels, Dept Image Diag, Isesaki, Japan	Takahashi, S (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, Shinano Machi 35, Tokyo 1068582, Japan.	satoshi710@mac.com					Marushima A, 2011, WORLD NEUROSURG, V76, P304, DOI 10.1016/j.wneu.2011.02.004; Bandera E, 2006, STROKE, V37, P1334, DOI 10.1161/01.STR.0000217418.29609.22; Schubert GA, 2014, STROKE, V45, P101, DOI 10.1161/STROKEAHA.113.003370; ASTRUP J, 1981, STROKE, V12, P723; Honda M, 2012, NEUROL MED-CHIR, V52, P488; Schubert GA, 2009, J NEUROTRAUM, V26, P2225, DOI 10.1089/neu.2009.0924; Fisher M, 2012, NEUROLOGY, V79, pS79, DOI 10.1212/WNL.0b013e3182695814; Wintermark M, 2001, AM J NEURORADIOL, V22, P905; Garcia-Bermejo P, 2012, CEREBROVASC DIS, V34, P31, DOI 10.1159/000338778; Furukawa M, 2002, J COMPUT ASSIST TOMO, V26, P272, DOI 10.1097/00004728-200203000-00019; Kashiwagi S, 1996, Acta Neurol Scand Suppl, V166, P85; Nakamura T, 2013, ACTA NEUROCHIR SUPPL, V115, P81, DOI 10.1007/978-3-7091-1192-5_18; Sase S, 2005, J COMPUT ASSIST TOMO, V29, P270, DOI 10.1097/01.rct.0000156400.40836.68; Takeuchi Ryo, 2006, Radiat Med, V24, P538, DOI 10.1007/s11604-006-0054-x	14	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAR	2015	24	3					635	641		10.1016/j.jstrokecerebrovasdis.2014.10.010		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FB	WOS:000351855000025		
J	Arishima, H; Neishi, H; Kodera, T; Kitai, R; Kikuta, K				Arishima, Hidetaka; Neishi, Hiroyuki; Kodera, Toshiaki; Kitai, Ryuhei; Kikuta, Ken-ichiro			Cerebral Amyloid Angiopathy Causing Large Contralateral Hemorrhage During Surgery for Lobar Hemorrhage: A Case Report	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Cerebral amyloid angiopathy; intraoperative computed tomography; intraoperative hemorrhage; lobar hemorrhage; recurrent hemorrhage	CORTICAL SUBARACHNOID HEMORRHAGE	We report a rare case of cerebral amyloid angiopathy (CAA) causing large contralateral hemorrhage during surgery for lobar hemorrhage. A 62-year-old woman presented with lobar hemorrhage in the left frontal and parietal lobes recurring over the previous 1 month. Because we could not detect the origin of the lobar hemorrhage, we performed a biopsy around the lobar hemorrhage site with the removal of a hematoma. During the surgery, we identified acute brain swelling without bleeding from the operative field. Intraoperative computed tomography demonstrated new large lobar hemorrhage of the right parietal lobe, which we could promptly remove. Specimens around hematomas on both sides were pathologically diagnosed as CAA on immunohistochemical examination. After the surgery, she suffered from lobar hemorrhage three times in the space of only 3 months. To the best of our knowledge, there has been no reported case of CAA causing intracranial hemorrhage of another lesion during surgery. Neurosurgeons should know a possibility of intraoperative hemorrhage in surgeries for lobar hemorrhage caused by CAA.	[Arishima, Hidetaka; Neishi, Hiroyuki; Kodera, Toshiaki; Kitai, Ryuhei; Kikuta, Ken-ichiro] Univ Fukui, Dept Neurosurg, Eiheiji, Fukui 9101193, Japan	Arishima, H (reprint author), Univ Fukui, Dept Neurosurg, 23-3 Matsuokashi Moaizuki, Eiheiji, Fukui 9101193, Japan.	ari@u-fukui.ac.jp					Revesz T, 2003, J NEUROPATH EXP NEUR, V62, P885; Hirohata M, 2010, EUR J NEUROL, V17, P823, DOI 10.1111/j.1468-1331.2009.02940.x; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Raposo N, 2011, EUR J NEUROL, V18, P597, DOI 10.1111/j.1468-1331.2010.03214.x; Apoil M, 2013, CEREBROVASC DIS, V36, P139, DOI 10.1159/000353676; Fujisawa Mutsuo, 2013, Acta Neurochir Suppl, V118, P175, DOI 10.1007/978-3-7091-1434-6_32; Izumihara A, 2005, SURG NEUROL, V64, P160, DOI 10.1016/j.surneu.2004.09.010; Pezzini A, 2009, CURR MED CHEM, V16, P2498	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAR	2015	24	3					E83	E85		10.1016/j.jstrokecerebrovasdis.2014.11.015		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FB	WOS:000351855000008		
J	Ozaki, K; Irioka, T; Ishikawa, K; Mizusawa, H				Ozaki, Kokoro; Irioka, Takashi; Ishikawa, Kinya; Mizusawa, Hidehiro			CADASIL with a Novel NOTCH3 Mutation (Cys478Tyr)	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						CADASIL; cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; NOTCH3; mutation; Cys478Tyr; C478Y	DIAGNOSTIC STRATEGIES; SPECTRUM	Recently, an increasing number of NOTCH3 mutations have been described to cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Here, we report 2 CADASIL patients from a Japanese family, who were found to possess a novel NOTCH3 mutation. The proband only had chronic headache, and her mother had previously suffered a minor stroke. Although the patients' clinical symptoms were mild, their distinctive magnetic resonance imaging (MRI) features suggested CADASIL. Genetic analysis revealed that both patients had a novel heterozygous NOTCH3 mutation (p.Cys478Tyr) leading to stereotypical cysteine loss. The present finding suggests that genetic testing for NOTCH3 mutations in patients with distinctive MRI features, even if the symptoms are as mild as chronic headache, should help to broaden the mutational and clinical spectrum of CADASIL.	[Ozaki, Kokoro; Ishikawa, Kinya; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Irioka, Takashi] Yokosuka Kyosai Hosp, Dept Neurol, Yokosuka, Kanagawa, Japan	Ozaki, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Neurol & Neurol Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	k-oznuro@tmd.ac.jp					Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Desmond DW, 1999, STROKE, V30, P1230; Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Markus HS, 2002, NEUROLOGY, V59, P1134; Peters N, 2005, ARCH NEUROL-CHICAGO, V62, P1091, DOI 10.1001/archneur.62.7.1091	7	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	MAR	2015	24	3					E61	E62		10.1016/j.jstrokecerebrovasdis.2014.11.022		2	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CE5FB	WOS:000351855000001		
J	Soreng, RJ; Gillespie, LJ; Koba, H; Boudko, E; Bull, RD				Soreng, Robert J.; Gillespie, Lynn J.; Koba, Hidehisa; Boudko, Ekaterina; Bull, Roger D.			Molecular and morphological evidence for a new grass genus, Dupontiopsis (Poaceae tribe Poeae subtribe Poinae s.l.), endemic to alpine Japan, and implications for the reticulate origin of Dupontia and Arctophila within Poinae s.l.	JOURNAL OF SYSTEMATICS AND EVOLUTION			English	Review						Arctophila; DNA; Dupontia; Japan; leaf anatomy; phylogeny; Poa; polyploidy; reticulate evolution; taxonomy	CHLOROPLAST DNA-SEQUENCES; CHROMOSOME-NUMBERS; POA POACEAE; PHYLOGENETIC-RELATIONSHIPS; NORTH-AMERICA; TAXONOMIC IMPLICATIONS; DISSANTHELIUM POACEAE; CLASSIFICATION; POOIDEAE; NUCLEAR	Phylogenetic analyses within Poaceae tribe Poeae subtribes Puccinellinae (=Coleanthinae), Phleinae, Poinae s.l. (including Alopecurinae), and Miliinae (PPAM clade), revealed that one species formerly placed in Poa represents a new monotypic genus belonging to subtribe Poinae s.l., Dupontiopsis gen. nov., D. hayachinensis comb. nov. (based on Poa hayachinensis), endemic to wet, gravelly, serpentine, alpine habitats in northern Japan. This genus forms a strongly supported clade (DAD) with two circumarctic Poinae genera, Arctophila and Dupontia, in phylogenetic analyses of plastid and nuclear ribosomal DNA sequence data. Both morphology and DNA sequence analyses provide support for D. hayachinensis as a lineage distinct from either Arctophila or Dupontia, with moderate DNA support for a position as sister to these two genera. Dupontiopsis resembles these other monotypic genera in its several-flowered spikelets, lemmas usually 3-nerved, with frequently awned attenuate scarious apices (as in Dupontia) and calluses with a crown of hairs around the base of the lemma, but differs in its keeled lemmas, scabrous palea keels, glumes shorter than the first lemma. Our investigation suggests that the most recent shared ancestor of the DAD clade evolved from a single hybridization event, as a hexaploid, probably in western Beringia. The probable parentage of the ancestor is considered to be within the Poinae-Alopecurinae clade excluding Poa. We provide evidence for possible secondary hybridization and introgression of duodecaploid Dupontia fisheri with Puccinellia. A key to perennial genera of PPAM with hairy calluses, and a supplemental table of morphological characters in the genera accepted in PPAM are provided.	[Soreng, Robert J.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20013 USA; [Gillespie, Lynn J.; Boudko, Ekaterina; Bull, Roger D.] Canadian Museum Nat, Res & Collect, Ottawa, ON 3443, Canada; [Koba, Hidehisa] JF Oberlin Univ, Div Nat Sci, Machida, Tokyo 1940294, Japan	Soreng, RJ (reprint author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20013 USA.	sorengr@si.edu			Smithsonian Institution; Canadian Museum of Nature	Our thanks are extended to Marina Olonova, Evren Cabi, Musa Dogan, Laurie Consaul, Doug Johnson, Paul Peterson, Surrey Jacobs, Michel Paradis, Alicia Alonso, the curators of CAN, K, TI, US, for their various contributions of specimens, assistance with field or laboratory work, or loans; Stephen Darbyshire for permission to use Agriculture and Agri-Food Canada photos; Anne Brysting for sharing unpublished Dupontia fisheri cloned ITS sequences; Konstantin Romaschenko for assistance with and discussion of MrBayes; Jerrold Davis for discussions of analytical issues related to Parsimony and BI analyses; Alice Tangerini for assistance with images; Stephen Darbyshire, Lynn Clark, and anonymous reviewers and editors for helpful comments on the manuscript; the Smithsonian Institution for support of RJS's research activities; and the Canadian Museum of Nature for financial assistance with the molecular research. With regard to this publication we have no conflicts of interest.	Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Schneider J, 2012, ORG DIVERS EVOL, V12, P113, DOI 10.1007/s13127-012-0077-3; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Consaul LL, 2010, AM J BOT, V97, P324, DOI 10.3732/ajb.0900180; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Doering Elke, 2007, Kew Bulletin, V62, P407; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kim ES, 2009, RUSS J GENET+, V45, P1329, DOI 10.1134/S1022795409110076; Schneider J, 2009, TAXON, V58, P405; Gillespie LJ, 2008, BOTANY, V86, P938, DOI 10.1139/B08-076; [Anonymous], INDEX HERBARIORUM GL; Alexander PJ, 2007, MOL ECOL NOTES, V7, P5, DOI 10.1111/j.1471-8286.2006.01549.x; Stace CA, 2005, TAXON, V54, P999; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Boudko E., 2014, THESIS U OTTAWA OTTA; BOWDEN WRAY M., 1960, CANADIAN JOUR BOT, V38, P117; Brysting AK, 2004, TAXON, V53, P365, DOI 10.2307/4135615; Brysting AK, 2003, CAN J BOT, V81, P769, DOI [10.1139/B03-067, 10.1139/b03-067]; CAYOUETTE J, 1993, NORD J BOT, V13, P615, DOI 10.1111/j.1756-1051.1993.tb00106.x; Cayouette J, 1997, NEWSLETTER INT ORG P, V28, P14; Cayouette J., 2007, FLORA N AM N MEXICO, V24, P602; Clayton W.D., 1986, KEW B ADDIT SER, V13, P1; DARBYSHIRE SJ, 1992, TAXON, V41, P737, DOI 10.2307/1222401; DARBYSHIRE SJ, 1992, PLANT SYST EVOL, V181, P57, DOI 10.1007/BF00937587; Darbyshire SJ, 2007, FLORA N AM, V24, P601; Davidse G., 1987, GRASS SYSTEMATICS EV, P143; Davis PH., 1985, FLORA TURKEY E AEGEA, V9, P1; Doring E., 2009, THESIS NATURWISSENSC; Edmondson JR., 1980, FLORA EUROPAEA, V5, P159; ELLIS R P, 1979, Bothalia, V12, P641; ELLIS R P, 1976, Bothalia, V12, P65; Engelskjon T., 1979, OPERA BOT, V52, P1; Flovik K, 1938, HEREDITAS, V24, P265; Flovik K, 1940, HEREDITAS, V26, P430; Gillespie LJ, 2005, SYST BOT, V30, P84, DOI 10.1600/0363644053661940; Gillespie Lynn J., 2007, Aliso, V23, P420; Gillespie LJ, 2009, AUST SYST BOT, V22, P413, DOI 10.1071/SB09016; Gillespie Lynn J., 2010, P589; Giussani LM, 2012, MONOCOTYLEDONEAE POA, V3, P288; Global Species Programme Red List Unit, 2014, IUCN RED LIST THER P; HEDBERG O, 1967, ARK BOT, V6, P309; Hoffmann MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060061; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V109, P12794; Jacobs SWL, 2008, TELOPEA, V12, P273; JORGENSEN C. A., 1958, BIOL SKRIFT DANSKE VIDENSKAB SELSKAB, V9, P1; KAWANO SHOICHI, 1961, JOUR JAPANESE BOT, V36, P337; Kawase Daiju, 2009, APG Acta Phytotaxonomica et Geobotanica, V60, P19; KELLOGG EA, 1993, BOT REV, V59, P273, DOI 10.1007/BF02857419; KITAMURA SIRO, 1952, ACTA PHYTOTAX ET GEOBOT, V14, P177; Kizirian D, 2004, MOL PHYLOGENET EVOL, V32, P1072, DOI 10.1016/j.ympev.2004.05.001; Koyama T., 1987, GRASSES JAPAN ITS NE; Krogulevich RE., 1976, FLORA PUTORANA, P217; Lohauss K., 1905, BIBLIOTHECA BOT, V13, P1; LOVE A, 1966, CAN J BOTANY, V44, P429; Metcalfe CR, 1960, ANATOMY MONOCOTYLEDO, P1; Nixon KC, 2002, WINCLADA VER 1 0000; Ohwi J., 1965, FLORA JAPAN, p[i, 1]; Osada T., 1993, ILLUSTRATED GRASSES; PETROVSKII V V, 1978, Botanicheskii Zhurnal (St. Petersburg), V63, P1258; PETROVSKII V V, 1981, Botanicheskii Zhurnal (St. Petersburg), V66, P380; Probatova NS., 1974, NOVOSTI SISTEMATIKI, V11, P44; Probatova NS, 1984, BOT ZH MOSCOW LENING, V69, P409; Probatova NS., 2003, KOMAROVSKIE CTENIJA, V49, P89; Rajbhandari K. R., 1991, B U MUSEUM U TOKYO, V2, P169; Rambaut A., 2006, FIGTREE FIGURE DRAWI; Refulio-Rodriguez NF, 2012, SYST BOT, V37, P122, DOI 10.1600/036364412X616701; Rogers Ackermann R, 2006, J HUM EVOL, P1; Romaschenko K., 2013, MOL PHYLOGENET EVOL, V70, P244; Ronquist F, 2011, DRAFTMRBAYES 3 2 MAN, P15; Rosengurtt B., 1972, B FACULTAD AGRONOMIA, V124, P3; SOKOLOVSKAYA A. P., 1960, BOT ZHUR, V45, P369; Soreng RJ, 2003, ON LINE TAXONOMIC NO, V48; Soreng Robert J., 2007, Kew Bulletin, V62, P425; Soreng R. J., 2000, Grasses: systematics and evolution., P61; Soreng RJ, 2009, AUST SYST BOT, V22, P401, DOI 10.1071/SB09003; Soreng RJ, 1998, NOVON, V8, P187, DOI 10.2307/3391995; SORENG R.J., 2003, CONTRIBUTIONS US NAT, V48, P505; Soreng RJ, 2003, ON LINE TAXONOMIC NO, V46; Soreng RJ, 2014, WORLD WIDE PHYLOGENE; Soreng RJ, 2007, ANN MO BOT GARD, V94, P821, DOI 10.3417/0026-6493(2007)94[821:NPPANS]2.0.CO;2; Soreng Robert J., 2010, P619; Soreng RJ, 2007, FLORA N AM N MEXICO, V24, P486; Soreng RJ, 2003, ON LINE TAXONOMIC NO, V39; SORENG RJ, 1990, AM J BOT, V77, P1383, DOI 10.2307/2444749; Soreng RJ, 2011, INT BOT C, P17; Soreng RJ, 2003, ON LINE TAXONOMIC NO, V41; Stebbins GL, 1950, VARIATION EVOLUTION; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tateoka T, 1955, ANN REPORT NATL I GE, V5, P68; TATEOKA T, 1985, BOT MAG TOKYO, V98, P413, DOI 10.1007/BF02488505; Tzvelev NN, 1983, LENINGRAD 1 NAUKA PU, p[1, i, 1]; VELDKAMP JF, 1994, BLUMEA, V38, P409; Watson L., 1992, GRASS GENERA WORLD D; Zhu G, 2006, FLORA CHINA, V22, P266; ZHUKOVA P. G., 1967, Botanicheskii Zhurnal, V52, P983; ZHUKOVA P G, 1972, Botanicheskii Zhurnal (St. Petersburg), V57, P554; ZHUKOVA P. G., 1966, BOT ZH, V51, P1511; ZHUKOVA P. G., 1969, Botanicheskii Zhurnal, V54, P1985; ZHUKOVA P G, 1980, Botanicheskii Zhurnal (St. Petersburg), V65, P51	100	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1674-4918	1759-6831		J SYST EVOL	J. Syst. Evol.	MAR	2015	53	2					138	162		10.1111/jse.12146		25	Plant Sciences	Plant Sciences	CE2XT	WOS:000351686000002		
J	Huh, JY; Ross, GW; Chen, RD; Abbott, RD; Bell, C; Willcox, B; Launer, L; Petrovitch, H; Kaya, B; Masaki, K				Huh, Ji Young; Ross, George Webster; Chen, Randi; Abbott, Robert D.; Bell, Christina; Willcox, Bradley; Launer, Lenore; Petrovitch, Helen; Kaya, Brock; Masaki, Kamal			Total and Differential White Blood Cell Counts in Late Life Predict 8-Year Incident Stroke: The Honolulu Heart Program	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						white blood cell count; differential WBC counts; incident stroke; Japanese-American men; longitudinal cohort study	LEUKOCYTE COUNT; PROSPECTIVE COHORT; ISCHEMIC-STROKE; ATHEROSCLEROSIS; DISEASE; INFLAMMATION; MEN; MORTALITY; EVENTS; RISK	ObjectivesTo study the association between total and differential white blood cell (WBC) count and incident stroke in an older Asian population. DesignProspective population-based study with 8years of follow-up. SettingThe Honolulu Heart Program, Oahu, Hawaii. ParticipantsJapanese-American men aged 71 to 93 who were free of stroke and had baseline WBC counts measured in 1991-93 (N=3,342). MeasurementsParticipants were divided into quartiles of total and differential WBC count for analysis and were followed for incident stroke (thromboembolic and hemorrhagic (hemorrhagic)) for 8years using data from a comprehensive hospital surveillance system. ResultsAge-adjusted incident stroke rates increased significantly with increasing WBC quartile (Q1, 7.68; Q2, 9.04; Q3, 9.26; Q4, 14.10 per 1,000 person-years of follow-up, P=.001). Hazard ratios (HRs) for stroke for each quartile of total and differential WBC count were obtained using Cox regression analysis, with the lowest quartile as the reference group. After full adjustment, including age; cardiovascular risk factors; fibrinogen; prevalent coronary heart disease, cancer, or chronic obstructive pulmonary disease, and nonsteroidal anti-inflammatory drug use, HRs were 1.62 (95% confidence interval (CI)=1.04-2.52, P=.03) in the highest quartile of total WBC and 2.19 (95% CI=1.41-3.39, P<.001) in the highest quartile of neutrophil counts. Significant associations were also seen for thromboembolic but not for hemorrhagic strokes. No significant associations were found between lymphocyte or monocyte counts and incident stroke or subtypes. ConclusionIn elderly Japanese-American men, higher total WBC and neutrophil counts were independent predictors of overall stroke, as well as thromboembolic stroke.	[Huh, Ji Young; Ross, George Webster; Abbott, Robert D.; Bell, Christina; Willcox, Bradley; Petrovitch, Helen; Masaki, Kamal] Univ Hawaii, John A Burns Sch Med, John A Hartford Fdn Ctr Excellence Geriatr, Dept Geriatr Med, Honolulu, HI 96822 USA; [Ross, George Webster; Petrovitch, Helen] Vet Affairs Pacific Isl Hlth Care Syst, Honolulu, HI USA; [Chen, Randi; Willcox, Bradley; Masaki, Kamal] Kuakini Med Ctr, Honolulu, HI USA; [Abbott, Robert D.] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan; [Launer, Lenore] NIA, Bethesda, MD 20892 USA; [Kaya, Brock] Univ Hawaii, John A Burns Sch Med, Dept Pathol, Honolulu, HI 96822 USA	Huh, JY (reprint author), 347 N Kuakini St,HPM-9, Honolulu, HI 96817 USA.	huhjfm@gmail.com			John A. Hartford Center of Excellence in Geriatrics, Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii; Kuakini Medical Center; National Institutes of Health (NIH) from the National Institute on Aging [N01-AG-4-2149, U01 AG019349, R01AG027060, R01AG038707]; National Institutes of Health (NIH) from the National Heart, Lung, and Blood Institute [N01-HC-05102]; Hawaii Community Foundation [2004-0463]; Office for Research and Development, Department of Veterans Affairs	This study was supported by the John A. Hartford Center of Excellence in Geriatrics, Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii; the Kuakini Medical Center; the National Institutes of Health (NIH) (Contract N01-AG-4-2149, Grants U01 AG019349, R01AG027060, and R01AG038707 from the National Institute on Aging, and Contract N01-HC-05102 from the National Heart, Lung, and Blood Institute); Hawaii Community Foundation grant 2004-0463; and the Office for Research and Development, Department of Veterans Affairs. The views expressed in this paper do not necessarily represent those of the federal government.	Abbott RD, 2012, NEUROBIOL AGING, V33, P914, DOI 10.1016/j.neurobiolaging.2010.06.023; ABBOTT RD, 1994, AM J EPIDEMIOL, V139, P881; Holme I, 2010, ATHEROSCLEROSIS, V213, P299, DOI 10.1016/j.atherosclerosis.2010.08.049; Lee CD, 2001, AM J EPIDEMIOL, V154, P758; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; HANSEN LK, 1990, INT J EPIDEMIOL, V19, P881, DOI 10.1093/ije/19.4.881; Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Dixon JB, 2006, OBES SURG, V16, P251, DOI 10.1381/096089206776116453; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; Zia E, 2012, J INTERN MED, V272, P298, DOI 10.1111/j.1365-2796.2012.02526.x; Libby P, 2010, EUR HEART J, V31, P777, DOI 10.1093/eurheartj/ehq022; Legein B, 2013, CELL MOL LIFE SCI, V70, P3847, DOI 10.1007/s00018-013-1289-1; Manduteanu I, 2012, J CELL MOL MED, V16, P1978, DOI 10.1111/j.1582-4934.2012.01552.x; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; BOLLINGER PB, 1987, AM J CLIN PATHOL, V87, P71; Elkind MSV, 2005, NEUROLOGY, V64, P2121, DOI 10.1212/01.WNL.0000165989.12122.49; GILLUM RF, 1994, AM J EPIDEMIOL, V139, P894; Li CR, 2010, ATHEROSCLEROSIS, V209, P545, DOI 10.1016/j.atherosclerosis.2009.09.029; Nakanishi N, 2002, OCCUP MED-OXFORD, V52, P213, DOI 10.1093/occmed/52.4.213; PRENTICE RL, 1982, J CHRON DIS, V35, P703, DOI 10.1016/0021-9681(82)90094-7; ROSS DW, 1986, ARCH PATHOL LAB MED, V110, P803; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6; Wu TH, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-7; YANO K, 1984, AM J EPIDEMIOL, V119, P653	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	MAR	2015	63	3					439	446		10.1111/jgs.13298		8	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CE3PO	WOS:000351740400003		
J	Mizuno, Y; Arai, Y				Mizuno, Yoko; Arai, Yumiko			DRIVERS WITH DEMENTIA IN JAPAN: REQUIRED PUBLIC SUPPORT UNDER STRICT LEGAL RESTRICTIONS	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							INCREASED DEPRESSIVE SYMPTOMS; COGNITIVE IMPAIRMENT; DRIVING CESSATION; OLDER		[Mizuno, Yoko; Arai, Yumiko] Natl Ctr Geriatr & Gerontol, Dept Gerontol Policy, Obu, Aichi, Japan	Mizuno, Y (reprint author), Natl Ctr Geriatr & Gerontol, Dept Gerontol Policy, Obu, Aichi, Japan.				Ministry of Health, Labour and Welfare, Japan [23-4]	This study was supported by a grant from the Ministry of Health, Labour and Welfare, Japan (No. 23-4; principal investigator: Dr. Yumiko Arai). The editor in chief has reviewed the conflict of interest check-list provided by the authors and has determined that the authors have no financial or any other kind of personal conflicts with this paper.	Marottoli RA, 1997, J AM GERIATR SOC, V45, P202; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399; Carr DB, 2010, JAMA-J AM MED ASSOC, V303, P1632, DOI 10.1001/jama.2010.481; Carr DB, 2006, AM FAM PHYSICIAN, V73, P1029; Mizuno Y, 2010, J AM GERIATR SOC, V58, P2048, DOI 10.1111/j.1532-5415.2010.03097.x	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	MAR	2015	63	3					611	612		10.1111/jgs.13313		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CE3PO	WOS:000351740400037		
J	Matsuo, S; Saiki, Y; Adachi, O; Kawamoto, S; Fukushige, S; Horii, A; Saiki, Y				Matsuo, Satoshi; Saiki, Yuriko; Adachi, Osamu; Kawamoto, Shunsuke; Fukushige, Shinichi; Horii, Akira; Saiki, Yoshikatsu			Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							ISCHEMIA/REPERFUSION INJURY; CARDIOPULMONARY BYPASS; SIMVASTATIN; EXPRESSION; PROTEIN; MODEL; ATORVASTATIN; ARGININE; STATINS; PATHWAY	Objective: Lung ischemia-reperfusion (IR) injury during cardiopulmonary surgery is associated with postoperative morbidity and mortality, particularly in patients with pulmonary hypertension (PH). Using a rat model for monocrotaline-induced PH, we investigated the protective effect of rosuvastatin against IR injury in lungs affected by PH and attempted to elucidate its mechanism of action. Methods: Male Sprague-Dawley monocrotaline-treated rats were divided into 4 groups (n = 8-9): sham, control + IR, statin + IR, and statin + mevalonolactone + IR. Lung ischemia was induced by left pulmonary artery occlusion (1 hour), followed by reperfusion (4 hours). Rosuvastatin (2 mg/kg) was injected 18 hours before reperfusion and mevalonolactone (1 mg/kg) was injected immediately before reperfusion. The arterial oxygen tension/inspired oxygen fraction ratio was used as a measure of lung oxygenation. Left lung tissue was analyzed for the wet-to-dry lung weight ratio and protein expression of endothelial nitric oxide synthase(eNOS) and phospho-eNOS. Macrophage recruitment was assessed by CD68 immunostaining. Results: Our results showed that rosuvastatin decreased IR lung injury (control + IR vs statin + IR) in terms of the arterial oxygen tension/inspired oxygen fraction ratio (272 +/- 43 vs 442 +/- 13), wet-to-dry ratio (5.7 +/- 0.7 vs 4.8 +/- 0.6), and macrophage infiltration (8.0 +/- 0.6/field vs 4.0 +/- 0.5/field) (P < .05 for all). eNOS and phospho-eNOS were downregulated by IR, which was blocked by rosuvastatin. Effects of rosuvastatin were blunted by mevalonolactone. Conclusions: Single-dose rosuvastatin decreased IR injury in lungs affected by PH via 2 anti-inflammatory mechanisms: preserving eNOS function and inhibiting macrophage infiltration.	[Matsuo, Satoshi; Adachi, Osamu; Kawamoto, Shunsuke; Saiki, Yoshikatsu] Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Sendai, Miyagi 9808574, Japan; [Saiki, Yuriko; Fukushige, Shinichi; Horii, Akira] Tohoku Univ, Grad Sch Med, Dept Mol Pathol, Sendai, Miyagi 9808574, Japan	Saiki, Y (reprint author), Tohoku Univ, Grad Sch Med, Div Cardiovasc Surg, Aoba Ku, 1-1 Seiryocho, Sendai, Miyagi 9808574, Japan.	yoshisaiki@med.tohoku.ac.jp					Alexander V, 2007, ARCH PHYSIOL BIOCHEM, V113, P1; Die J, 2010, BRAIN RES, V1346, P251, DOI 10.1016/j.brainres.2010.05.068; Mason NA, 1998, J PATHOL, V185, P313, DOI 10.1002/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8; Di Napoli P, 2005, CARDIOVASC RES, V66, P462, DOI 10.1016/j.cardiores.2005.02.008; Tanaka S, 2013, ARTERIOSCL THROM VAS, V33, P1591, DOI 10.1161/ATVBAHA.112.300922; Lai IR, 2008, TRANSPLANTATION, V85, P732, DOI 10.1097/TP.0b013e3181664e70; Murata T, 2005, ARTERIOSCL THROM VAS, V25, P2335, DOI 10.1161/01.ATV.0000186184.33537.48; Kones R, 2010, DRUG DES DEV THER, V4, P383, DOI 10.2147/DDDT.S10812; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Trocha M, 2010, PHARMACOL REP, V62, P343; Naidu BV, 2003, J THORAC CARDIOV SUR, V126, P482, DOI 10.1016/S0022-5223(03)00699-8; Ovechkin Alexander V., 2007, Archives of Physiology and Biochemistry, V113, P1, DOI 10.1080/13813450601118976; Kaminski A, 2004, AM J PATHOL, V164, P2241, DOI 10.1016/S0002-9440(10)63780-7; Gurevitch J, 1997, J AM COLL CARDIOL, V30, P1554, DOI 10.1016/S0735-1097(97)00328-8; Balakumar P, 2012, J MOL CELL CARDIOL, V52, P83, DOI 10.1016/j.yjmcc.2011.09.014; Pei YZ, 2011, EUR J PHARMACOL, V666, P165, DOI 10.1016/j.ejphar.2011.05.035; Melby SJ, 2011, J THORAC CARDIOV SUR, V141, P1424, DOI 10.1016/j.jtcvs.2011.02.028; Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X; Naidu BV, 2004, J THORAC CARDIOV SUR, V127, P1502, DOI 10.1016/j.jtcvs.2003.07.037; Camara-Lemarroy CR, 2014, ARCH MED RES, V45, P210, DOI 10.1016/j.arcmed.2014.02.001; Chang LT, 2008, CIRC J, V72, P825, DOI 10.1253/circj.72.825; Hiraoka M, 2004, LIFE SCI, V75, P1333, DOI 10.1016/j.lfs.2004.02.028; Inman SR, 2005, AM J MED SCI, V329, P13, DOI 10.1097/00000441-200501000-00003; Kaminski A, 2007, RESP PHYSIOL NEUROBI, V155, P280, DOI 10.1016/j.resp.2006.06.005; Kondo E, 1999, J BIOCHEM-TOKYO, V125, P818; Kostapanos MS, 2008, J CARDIOVASC PHARM T, V13, P157, DOI 10.1177/1074248408318628; Schlensak C, 2002, J THORAC CARDIOV SUR, V123, P1199, DOI 10.1067/mtc.2002.121977; Suda T, 2000, J THORAC CARDIOV SUR, V119, P297, DOI 10.1016/S0022-5223(00)70185-1; Wang JY, 2005, LIFE SCI, V76, P2257, DOI 10.1016/j.lfs.2004.12.003; Wassmann S, 2001, MOL PHARMACOL, V59, P646; Yamada Y, 2014, J ANESTH, V28, P26, DOI 10.1007/s00540-013-1663-z	31	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	MAR	2015	149	3					902	909		10.1016/j.jtcvs.2014.10.030		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE6EX	WOS:000351930600074		
J	Kikkawa, T; Kanzaki, M; Isaka, T; Onuki, T				Kikkawa, Takuma; Kanzaki, Masato; Isaka, Tamami; Onuki, Takamasa			Complete thoracoscopic S9 or S10 segmentectomy through a pulmonary ligament approach	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material									[Kikkawa, Takuma; Kanzaki, Masato; Isaka, Tamami; Onuki, Takamasa] Tokyo Womens Med Univ, Dept Surg 1, Tokyo 1628666, Japan	Kanzaki, M (reprint author), Tokyo Womens Med Univ, Dept Surg 1, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	kanzaki@twmu.ac.jp					Tsutani Y, 2013, J THORAC CARDIOV SUR, V146, P358, DOI 10.1016/j.jtcvs.2013.02.008; Kanzaki M, 2013, THORAC CARDIOV SURG, V61, P144, DOI 10.1055/s-0032-1328923; BERKMEN YM, 1992, RADIOLOGY, V185, P389; Kanzaki Masato, 2013, Asian J Endosc Surg, V6, P110, DOI 10.1111/ases.12015; Oizumi H, 2011, J THORAC CARDIOV SUR, V141, P678, DOI 10.1016/j.jtcvs.2010.08.027	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	MAR	2015	149	3					937	939		10.1016/j.jtcvs.2014.10.111		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE6EX	WOS:000351930600083		
J	Oki, M; Saka, H				Oki, Masahide; Saka, Hideo			TWO TECHNIQUES ARE BETTER THAN ONE Reply	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Letter							FINE-NEEDLE-ASPIRATION; CELL LUNG-CANCER		[Oki, Masahide; Saka, Hideo] Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan	Oki, M (reprint author), Nagoya Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan.						Hwangbo B, 2010, CHEST, V138, P795, DOI 10.1378/chest.09-2100; Szlubowski A, 2010, EUR J CARDIO-THORAC, V37, P1175, DOI 10.1016/j.ejcts.2009.11.015; Klapper JA, 2014, J THORAC CARDIOV SUR, V148, P1177, DOI 10.1016/j.jtcvs.2014.09.001; Oki M, 2014, J THORAC CARDIOV SUR, V148, P1169, DOI 10.1016/j.jtcvs.2014.05.023; Oki M, 2014, CHEST; Shingyoji M, 2014, ANN THORAC SURG, V98, P1762, DOI 10.1016/j.athoracsur.2014.05.078; Silvestri GA, 2013, CHEST S, V143, pe211S	7	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	MAR	2015	149	3					942	943		10.1016/j.jtcvs.2014.12.010		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE6EX	WOS:000351930600087		
J	Oto, T; Miyoshi, K; Sugimoto, S; Yamane, M				Oto, Takahiro; Miyoshi, Kentaroh; Sugimoto, Seiichiro; Yamane, Masaomi			Living related donor middle lobe lung transplant in a pediatric patient	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Editorial Material									[Oto, Takahiro; Miyoshi, Kentaroh; Sugimoto, Seiichiro; Yamane, Masaomi] Okayama Univ, Grad Sch Med Dent & Pharmacol Sci, Dept Thorac Surg, Okayama, Japan	Oto, T (reprint author), 2-5-1 Shikata Cho,Kita Ku, Okayama 7008558, Japan.	oto@md.okayama-u.ac.jp					Oto Takahiro, 2013, Gen Thorac Cardiovasc Surg, V61, P208, DOI 10.1007/s11748-013-0215-7; Oto T, 2013, ISHLT MONOGRAPH SERI, P220; STARNES VA, 1994, J THORAC CARDIOV SUR, V108, P403; Starnes VA, 1994, J THORAC CARDIOVASC, V108, P410	4	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	MAR	2015	149	3					E42	E44				4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CE6EX	WOS:000351930600009		
J	Lu, K; Gordon, R; Cao, T				Lu, Kai; Gordon, Richard; Cao, Tong			Reverse engineering the mechanical and molecular pathways in stem cell morphogenesis	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						embryogenesis; embryonic stem cell; mechanobiology; morphogenesis; organogenesis; reverse engineering; self-organize; tissue engineering	DEVELOPMENTAL BIOLOGY; FORCE MICROSCOPY; OPTIC VESICLE; TRANSPLANTATION; SHAPE; MECHANOBIOLOGY; ADHESION; EMBRYO; MECHANOTRANSDUCTION; DIFFERENTIATION	The formation of relevant biological structures poses a challenge for regenerative medicine. During embryogenesis, embryonic cells differentiate into somatic tissues and undergo morphogenesis to produce three-dimensional organs. Using stem cells, we can recapitulate this process and create biological constructs for therapeutic transplantation. However, imperfect imitation of nature sometimes results in in vitro artifacts that fail to recapitulate the function of native organs. It has been hypothesized that developing cells may self-organize into tissue-specific structures given a correct in vitro environment. This proposition is supported by the generation of neo-organoids from stem cells. We suggest that morphogenesis may be reverse engineered to uncover its interacting mechanical pathway and molecular circuitry. By harnessing the latent architecture of stem cells, novel tissue-engineering strategies may be conceptualized for generating self-organizing transplants. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Lu, Kai] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Gordon, Richard] Gulf Specimen Marine Lab, Embryogenesis Ctr, Panacea, FL 32346 USA; [Cao, Tong] Natl Univ Singapore, Fac Dent, Stem Cell Lab, Singapore 117548, Singapore	Lu, K (reprint author), Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan.	lukai83@gmail.com	CAO, Tong/B-1008-2008	CAO, Tong/0000-0002-7994-9627	Ministry of Education of Singapore [R221000026112, R221000023112]	This work was partially supported by the Ministry of Education of Singapore (Grant Nos R221000026112 and R221000023112) and is dedicated to Ed Carriere.	Alis RR, 2011, NATURE, V472, P42; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; McGuigan AP, 2006, NAT PROTOC, V1, P2963, DOI 10.1038/nprot.2006.443; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; HOBBS JR, 1981, LANCET, V2, P709; Csete ME, 2002, SCIENCE, V295, P1664, DOI 10.1126/science.1069981; Martinez-Morales JR, 2009, CURR OPIN GENET DEV, V19, P511, DOI 10.1016/j.gde.2009.08.003; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Koch L, 2012, BIOTECHNOL BIOENG, V109, P1855, DOI 10.1002/bit.24455; Othmer HG, 2009, MATH MODEL NAT PHENO, V4, P3, DOI 10.1051/mmnp/20094401; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159; Wang N, 1995, BIOCHEM CELL BIOL, V73, P327; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Gordon R, 2006, INT J DEV BIOL, V50, P245, DOI 10.1387/ijdb.052103rg; Horst M, 2013, J TISSUE ENG REGEN M, V7, P515, DOI 10.1002/term.547; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Hutson MS, 2009, BIOPHYS J, V97, P3075, DOI 10.1016/j.bpj.2009.09.034; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/nmat2563, 10.1038/NMAT2563]; Steinberg MS, 1996, DEV BIOL, V180, P377, DOI 10.1006/dbio.1996.0312; Mellough CB, 2012, STEM CELLS, V30, P673, DOI 10.1002/stem.1037; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Dean DM, 2007, FASEB J, V21, P4005, DOI 10.1096/fj.07-8710com; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Aschheim K, 2011, NAT BIOTECHNOL, V29, P409, DOI 10.1038/nbt.1874; Atalas A, 2006, LANCET, V15, P1241; Badylaks SF, 2012, LANCET, V10, P943; Beloussovs LV, 2006, INT J DEV BIOL, V50, P79, DOI DOI 10.1387/IJDB.052137LB; Brodland GW, 2010, HFSP J, V4, P142, DOI 10.2976/1.3338713; Brodland W. G., 2000, J BIOMECH, V33, P845; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228; Cranston PG, 2010, ANN BIOMED ENG, V38, P2937, DOI 10.1007/s10439-010-9998-1; Davidson LA, 2012, TRENDS CELL BIOL, V22, P82, DOI 10.1016/j.tcb.2011.10.005; Dus Y, 2008, P NATL ACAD SCI USA, V105, P9522; Eirakus M, 2011, BIOESSAYS, V34, P17; Fleury V, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021920; Fleurys V, 2012, ORIGINS DESIGN NATUR, P385; Fus X, 2011, TISSUE ENG PART C-ME, V17, P927; GORDON R, 1978, SCI AM, V238, P106; Gordons R, 1975, MATH MODELS CELL REA, P196; Gordons R, 1999, HIERARCHICAL GENOME; Gordon R, 2003, INT J DEV BIOL, V47, P183; GORDON R, 1987, CELL BIOPHYS, V11, P177; Gordon Richard, 2011, Micro and Nanosystems, V3, DOI 10.2174/1876402911103040284; Guduric-Fuchs J, 2011, MOL VIS, V17, P2580; Ingber DE, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P207, DOI 10.1016/B978-012370615-7/50019-6; Jungebluths P, 2011, LANCET, V10, P1997; Jus XJ, 2009, EXPERT OPIN THERAPEU, V19, P493; KESSINGER A, 1989, BONE MARROW TRANSPL, V4, P643; Krupinski P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001128; Lees DA, 2011, J CELL BIOCHEM, V112, P1; Lele TP, 2007, METHOD CELL BIOL, V83, P443, DOI 10.1016/S0091-679X(07)83019-6; Lus K, 2012, BIOSYSTEMS, V109, P390; Mahmood A, 2007, LANCET NEUROL, V6, P687, DOI 10.1016/S1474-4422(07)70177-1; Martins GR, 1981, SCIENCES, V78, P7634, DOI DOI 10.1073/PNAS.78.12.7634); Mas X, 2009, PHYS BIOL, V6; Matthewss BD, 2004, BIOCHEM BIOPH RES CO, V3, P758; Nerem RM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P7, DOI 10.1016/B978-012370615-7/50006-8; NICHOLS J, 2009, NATION, V288, P5; Pohs M, 2005, LANCET, V365, P2122; Raman T, 2006, EXPERT OPIN PHARMACO, V7, P307, DOI 10.1517/14656566.7.3.307; STEINBERG MS, 1962, SCIENCE, V137, P762, DOI 10.1126/science.137.3532.762; STEIN MB, 1982, J THEOR BIOL, V97, P625, DOI 10.1016/0022-5193(82)90363-0; SVOBODA KKH, 1987, DEVELOPMENT, V100, P185; tens Berges D, 2008, CELL STEM CELL, V3, P508; Titushkin Igor A., 2010, Critical Reviews in Biomedical Engineering, V38, P393; Umulis David M, 2010, Dev Cell, V18, P260, DOI 10.1016/j.devcel.2010.01.006; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; WITKOWSKI J, 1985, TRENDS BIOCHEM SCI, V10, P379, DOI 10.1016/0968-0004(85)90058-1; Xies Q, 2011, J BIOL CHEM, V286, P43259; Yehs J, 2006, BIOMATERIALS, V27, P5391	83	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	MAR	2015	9	3					169	173		10.1002/term.1672		5	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CE4WV	WOS:000351831900001		
J	Kasuya, J; Sudo, R; Masuda, G; Mitaka, T; Ikeda, M; Tanishita, K				Kasuya, Junichi; Sudo, Ryo; Masuda, Genta; Mitaka, Toshihiro; Ikeda, Mariko; Tanishita, Kazuo			Reconstruction of hepatic stellate cell-incorporated liver capillary structures in small hepatocyte tri-culture using microporous membranes	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						liver sinusoid; hepatic stellate cell; small hepatocyte; endothelial cell; three-dimensional; tri-culture; poly(d; l-lactide-co-glycolide); microporous membrane	SINUSOIDAL ENDOTHELIAL-CELLS; RAT SMALL HEPATOCYTES; EXTRACELLULAR-MATRIX; IN-VITRO; COCULTURE; MODEL; REGENERATION; PHENOTYPE; SHEETS	In liver sinusoids, hepatic stellate cells (HSCs) locate the outer surface of microvessels to form a functional unit with endothelia and hepatocytes. To reconstruct functional liver tissue in vitro, formation of the HSC-incorporated sinusoidal structure is essential. We previously demonstrated capillary formation of endothelial cells (ECs) in tri-culture, where a polyethylene terephthalate (PET) microporous membrane was intercalated between the ECs and hepatic organoids composed of small hepatocytes (SHs), i.e. hepatic progenitor cells, and HSCs. However, the high thickness and low porosity of the membranes limited heterotypic cell-cell interactions, which are essential to form HSC-EC hybrid structures. Here, we focused on the effective use of the thin and highly porous poly( d, l-lactide-co-glycolide) (PLGA) microporous membranes in SH-HSC-EC tri-culture to reconstruct the HSC-incorporated liver capillary structuresin vitro. First, the formation of EC capillary-like structures was induced on Matrigel-coated PLGA microporous membranes. Next, the membranes were stacked on hepatic organoids composed of small SHs and HSCs. When the pore size and porosity of the membranes were optimized, HSCs selectively migrated to the EC capillary-like structures. This process was mediated in part by platelet-derived growth factor (PDGF) signalling. In addition, the HSCs were located along the outer surface of the EC capillary-like structures with their long cytoplasmic processes. In the HSC-incorporated capillary tissues, SHs acquired high levels of differentiated functions, compared to those without ECs. This model will provide a basis for the construction of functional, thick, vascularized liver tissues in vitro. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Kasuya, Junichi; Sudo, Ryo; Masuda, Genta; Tanishita, Kazuo] Keio Univ, Sch Integrated Design Engn, Ctr Syst Integrat Engn, Yokohama, Kanagawa 2230061, Japan; [Sudo, Ryo; Ikeda, Mariko; Tanishita, Kazuo] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa 2230061, Japan; [Mitaka, Toshihiro] Sapporo Med Univ, Res Inst Frontier Med, Dev & Regenerat, Sch Med, Sapporo, Hokkaido 0608556, Japan	Kasuya, J (reprint author), Keio Univ, Sch Integrated Design Engn, Ctr Syst Integrat Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	kasuya@sudo.sd.keio.ac.jp	Mitaka, Toshihiro/K-9424-2013	Mitaka, Toshihiro/0000-0001-9467-4871	Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research (A) and for Young Scientists (A) and by a Grant-in-Aid for the Global Centre of Excellence Programme for the 'Centre for Education and Research of Symbiotic, Safe and Secure System Design' from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103; Jindal R, 2009, FASEB J, V23, P2288, DOI 10.1096/fj.08-114934; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909; Ohno M, 2009, J BIOCHEM, V145, P591, DOI 10.1093/jb/mvp019; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Bader A, 1996, EXP CELL RES, V226, P223, DOI 10.1006/excr.1996.0222; Soto-Gutierrez A, 2010, CELL TRANSPLANT, V19, P815, DOI 10.3727/096368910X508933; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; Ohno M, 2008, TISSUE ENG PT A, V14, P1861, DOI 10.1089/ten.tea.2007.0160; Semela D, 2008, GASTROENTEROLOGY, V135, P671, DOI 10.1053/j.gastro.2008.04.010; Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228; Nahmias Y, 2006, TISSUE ENG, V12, P1627, DOI 10.1089/ten.2006.12.1627; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108; Kasuya J, 2011, TISSUE ENG PT A, V17, P361, DOI 10.1089/ten.TEA.2010.0033; Edwards S, 2005, HEPATOLOGY, V41, P451, DOI 10.1002/hep.20585; Huis EE, 2007, P NATL ACAD SCI USA, V104, P5722; Hwas AJ, 2007, FASEB J, V21, P2564; Itos A, 2008, YAKUGAKU ZASSHI, V128, P21; Kasuyas J, 2011, TISSUE ENG PART A, V18, P1045; Kasuyas J, 2011, BIOMATERIALS, V33, P2693; Kinard F, 1997, IN VITRO CELL DEV-AN, V33, P92; Lees JS, 2007, HEPATOLOGY, V45, P817; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401; MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P77, DOI 10.1007/BF01606580; Rosines E, 2010, TISSUE ENG PT A, V16, P2441, DOI 10.1089/ten.TEA.2009.0548; Sato M, 1998, CELL BIOL INT, V22, P115, DOI 10.1006/cbir.1998.0234; Sudo R, 2005, FASEB J, V19, P1695, DOI 10.1096/fj.04-3269fje; Takahashi T, 2001, BIOCHEM BIOPH RES CO, V280, P415, DOI 10.1006/bbrc.2000.4123; Talamini MA, 1998, AM J PHYSIOL-REG I, V275, pR203; Wirz W, 2008, DIFFERENTIATION, V76, P784, DOI 10.1111/j.1432-0436.2007.00260.x; Zhang SF, 2008, BIOMATERIALS, V29, P3993, DOI 10.1016/j.biomaterials.2008.06.024	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	MAR	2015	9	3					247	256		10.1002/term.1630		10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CE4WV	WOS:000351831900007		
J	Yagyuu, T; Kirita, T; Hattori, K; Tadokoro, M; Ohgushi, H				Yagyuu, Takahiro; Kirita, Tadaaki; Hattori, Koji; Tadokoro, Mika; Ohgushi, Hajime			Unique and reliable rat model for the assessment of cell therapy: bone union in the rat mandibular symphysis using bone marrow stromal cells	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						rat mandibular symphysis; bone defect model; bone marrow stromal cells; cell therapy	MESENCHYMAL STEM-CELLS; SEGMENTAL BONE; IN-VIVO; DIFFERENTIATION; OSTEOGENESIS; CERAMICS; COLLAGEN; DEFECTS; CLEFTS; BETA	Many kinds of bone graft materials have been developed and reported to repair various bone defects. The defects are usually created by surgical resection of pre-existing bone tissue. However, spontaneous healing of bone defects without implantation of materials could be seen, because bone tissue possesses inherent repairing property. The central portion of the lower jaw bone in many animals consists of fibrous tissue and is called the mandibular symphysis. It persists even in old animals and thus can be interpreted as a physiological bone gap or a non-healing bone defect. We implanted calcium phosphate porous ceramics alone or composites of the ceramics and bone marrow stromal cells (BMSCs) into the bone defect (mandibular symphysis) to examine whether it could be filled with new bone tissue, resulting in bone union. Eight weeks after implantation, micro-computed tomography (micro-CT) and histological and biomechanical analyses demonstrated that bone union of the mandibles occurred in all rats with composites but in none of those with ceramics alone. These results showed that the rat mandibular symphysis is a unique bone defect site for the evaluation of bone graft materials. These analyses demonstrated that ceramics alone could not contribute to bone healing in the defect; however, supplementation with BMSCs drastically changed the properties of the ceramics (turning them into osteogenic ceramics), which completely healed the defect. As BMSCs can be culture-expanded using small amounts of bone marrow, the use of the composites might have clinical significance for the reconstruction of various bone tissues, including facial bone. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Yagyuu, Takahiro; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Nara, Japan; [Yagyuu, Takahiro; Tadokoro, Mika; Ohgushi, Hajime] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tissue Engn Res Grp, Amagasaki, Hyogo 6610974, Japan; [Hattori, Koji] Konan Womens Univ, Dept Nursing & Rehabil, Kobe, Hyogo, Japan	Ohgushi, H (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tissue Engn Res Grp, 3-11-46 Nakoji, Amagasaki, Hyogo 6610974, Japan.	hajime-ohgushi@aist.go.jp			Health and Labour Sciences Research Grant of Japan	This work was partially supported by a Health and Labour Sciences Research Grant of Japan.	Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803; Kotobuki N, 2008, CELL TRANSPLANT, V17, P705, DOI 10.3727/096368908786092793; Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x; Ikeuchi M, 2002, J BIOMED MATER RES, V60, P61, DOI 10.1002/jbm.1281; Matsumoto T, 2011, TISSUE ENG PT A, V17, P171, DOI 10.1089/ten.TEA.2010.0077; Stoll C, 2000, CLEFT PALATE-CRAN J, V37, P41, DOI 10.1597/1545-1569(2000)037<0041:AMICWO>2.3.CO;2; Kolambkar YM, 2011, BONE, V49, P485, DOI 10.1016/j.bone.2011.05.010; Kawate K, 2006, ARTIF ORGANS, V30, P960, DOI 10.1111/j.1525-1594.2006.00333.x; Burastero G, 2010, BONE, V47, P117, DOI 10.1016/j.bone.2010.03.023; Shimizu T, 2001, ANAT REC, V264, P72, DOI 10.1002/ar.1126; OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415; Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T; Yabana T, 2009, J PATHOL, V218, P350, DOI 10.1002/path.2535; Blumenfeld I, 2002, ARCH GERONTOL GERIAT, V35, P59, DOI 10.1016/S0167-4943(02)00004-3; Bohenskys F, 2002, SKELETAL SYSTEM PHOT; BORKAR AS, 1993, BRIT J PLAST SURG, V46, P673, DOI 10.1016/0007-1226(93)90198-K; CAPLAN AI, 1991, J ORTHOPAED RES, V9, P641, DOI 10.1002/jor.1100090504; Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819; tens Koppels PG, 2001, BIOMATERIALS, V22, P1407	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	MAR	2015	9	3					276	285		10.1002/term.1674		10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CE4WV	WOS:000351831900010		
J	Nakatsu, H; Ueno, T; Oga, A; Nakao, M; Nishimura, T; Kobayashi, S; Oka, M				Nakatsu, Hiroki; Ueno, Tomio; Oga, Atsunori; Nakao, Mitsuhiro; Nishimura, Taku; Kobayashi, Sei; Oka, Masaaki			Influence of mesenchymal stem cells on stomach tissue engineering using small intestinal submucosa	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						small intestinal submucosa; SIS; stomach tissue engineering; mesenchymal stem cell; extracellular matrix; GFP	MARROW-DERIVED CELLS; SMOOTH-MUSCLE-CELLS; SMALL-BOWEL; BLADDER REGENERATION; RATS; RECONSTRUCTION; INDUCTION; SCAFFOLD; GROWTH; REPAIR	Small intestinal submucosa (SIS) is a biodegradable collagen-rich matrix containing functional growth factors. We have previously reported encouraging outcomes for regeneration of an artificial defect in the rodent stomach using SIS grafts, although the muscular layer was diminutive. In this study, we investigated the feasibility of SIS in conjunction with mesenchymal stem cells (MSCs) for regeneration of the gastrointestinal tract. MSCs from the bone marrow of green fluorescence protein (GFP)-transgenic Sprague-Dawley (SD) rats were isolated and expanded ex vivo. A 1cm whole-layer stomach defect in SD rats was repaired using: a plain SIS graft without MSCs (group 1, control); a plain SIS graft followed by intravenous injection of MSCs (group 2); a SIS graft co-cultured with MSCs (group 3); or a SIS sandwich containing an MSC sheet (group 4). Pharmacological, electrophysiological and immunohistochemical examination was performed to evaluate the regenerated stomach tissue. Contractility in response to a muscarinic receptor agonist, a nitric oxide precursor or electrical field stimulation was observed in all groups. SIS grafts seeded with MSCs (groups 3 and 4) appeared to support improved regeneration compared with SIS grafts not seeded with MSCs (groups 1 and 2), by enabling the development of well-structured smooth muscle layers of significantly increased length. GFP expression was detected in the regenerated interstitial tissue, with fibroblast-like cells in the seeded-SIS groups. SIS potently induced pharmacological and electrophysiological regeneration of the digestive tract, and seeded MSCs provided an enriched environment that supported tissue regeneration by the SIS graft in the engineered stomach. (c) 2013 The Authors. Journal of Tissue Engineering and Regenerative Medicine published by John Wiley & Sons, Ltd.	[Nakatsu, Hiroki; Ueno, Tomio; Nakao, Mitsuhiro; Nishimura, Taku; Oka, Masaaki] Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, Dept Surg 2, Ube, Yamaguchi 7558505, Japan; [Oga, Atsunori] Yamaguchi Univ, Grad Sch Med, Dept Mol Pathol, Ube, Yamaguchi 7558505, Japan; [Kobayashi, Sei] Yamaguchi Univ, Grad Sch Med, Dept Mol Physiol & Med Bioregulat, Ube, Yamaguchi 7558505, Japan	Ueno, T (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol, Dept Surg 2, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	tommy@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [17591405]; Takeda Science Foundation	The authors wish to thank the staff of Institute of Laboratory Animals, Yamaguchi University, for their administrative and technical support during this study. This research was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (Grant No. 17591405 to T.U.) and by funding from the Takeda Science Foundation (to T.U.). No support was received from the Cook Company (who manufacture SIS).	Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1; Shukla D, 2008, WORLD J UROL, V26, P341, DOI 10.1007/s00345-008-0311-y; Hodde J, 2007, J MATER SCI-MATER M, V18, P545, DOI 10.1007/s10856-007-2301-9; Hori Y, 2002, J SURG RES, V102, P156, DOI 10.1006/jsre.2001.6294; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Ueno T, 2007, J GASTROINTEST SURG, V11, P918, DOI 10.1007/s11605-007-0171-6; de la Fuente SG, 2003, J GASTROINTEST SURG, V7, P96, DOI 10.1016/S1091-255X(02)00050-1; Nakase Y, 2006, TISSUE ENG, V12, P403, DOI 10.1089/ten.2006.12.403; Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199; Zhang YY, 2005, BJU INT, V96, P1120, DOI 10.1111/j.1464-410X.2005.05741.x; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; Ueno T, 2007, SURGERY, V142, P376, DOI 10.1016/j.surg.2007.04.019; Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X; Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835; Doede T, 2009, ARTIF ORGANS, V33, P328, DOI 10.1111/j.1525-1594.2009.00727.x; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Araki M, 2009, ARTIF ORGANS, V33, P818, DOI 10.1111/j.1525-1594.2009.00808.x; Frimberger D, 2005, UROLOGY, V65, P827, DOI 10.1016/j.urology.2004.11.024; Hayashi Y, 2008, AM J PHYSIOL-GASTR L, V294, pG778, DOI 10.1152/ajpgi.00468.2007; Hoeppner J, 2009, INT J COLORECTAL DIS, V24, P543, DOI 10.1007/s00384-009-0637-y; Komori M, 2005, J GASTROENTEROL, V40, P591, DOI 10.1007/s00535-005-1593-0; Lees M, 2008, J SURG RES, V147, P168; Lus SH, 2005, BIOMATERIALS, V26, P443; McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144; Nishimura T, 2010, TISSUE ENG PT A, V16, P1761, DOI 10.1089/ten.TEA.2009.0485; Qins HH, 2011, J SURG RES, V171, pe21; Wang ZQ, 2005, J PEDIATR SURG, V40, P1898, DOI 10.1016/j.jpedsurg.2005.08.031; Wang ZQ, 2003, J PEDIATR SURG, V38, P1596, DOI 10.1016/S0022-3468(03)00567-0; Wus S, 2011, BIOMATERIALS, V32, P1317	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	MAR	2015	9	3					296	304		10.1002/term.1794		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CE4WV	WOS:000351831900012		
J	Yamada, Y; Nakamura, S; Ueda, M; Ito, K				Yamada, Yoichi; Nakamura, Sayaka; Ueda, Minoru; Ito, Kenji			Papilla regeneration by injectable stem cell therapy with regenerative medicine: long-term clinical prognosis	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						aesthetic improvement; clinical application; papilla regeneration; mesenchymal stem cells; regenerative medicine	SOFT-TISSUE AUGMENTATION; PLATELET-RICH PLASMA; SURGICAL APPROACH; STROMAL CELLS; MARROW; FIBROBLASTS; SKIN; REPAIR; VIVO	Black triangle (BT), an open interproximal space between teeth, can cause aesthetic concerns, food impaction, phonetic difficulties and periodontitis. The aim of this study was to determine the possibility and long-term prognosis of novel papilla regeneration with regenerative medicine, i.e. tissue-engineered papilla (TEP), and to investigate the potential of a tissue-engineering method for soft-tissue augmentation, especially aesthetic improvement of BT, with mesenchymal stem cells (MSCs) as the isolated cells, platelet-rich plasma (PRP) as the growth factor and hyaluronic acid (HA) as the scaffold. The parameters were assessed from a clinical point of view by measuring the distance from the tip of the interproximal papilla to the base of the contact area in each study region. The mean volumes, operation times and follow-up periods of TEP were 1.32 +/- 0.25ml, 2.2 +/- 1.62 times and 55.3 +/- 17.7months; the mean improved BT values were 2.55 +/- 0.89mm. An aesthetic improvement was achieved. TEP was able to provide aesthetic improvement of black triangle and predictable results, and could emerge as another novel option for periodontal regenerative therapy in periodontal diseases. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Yamada, Yoichi] Nagoya Univ, Sch Med, Ctr Genet & Regenerat Med, Nagoya, Aichi 4648601, Japan; [Yamada, Yoichi] Aichi Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Nagakute, Aichi 4801195, Japan; [Nakamura, Sayaka; Ueda, Minoru; Ito, Kenji] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4648601, Japan; [Nakamura, Sayaka] Aichi Gakuin Univ, Sch Dent, Dept Biochem, Nagoya, Aichi 464, Japan; [Ito, Kenji] Hamamatsu Kita Hosp, Dept Oral & Maxillofacial Surg, Hamamatsu, Shizuoka, Japan	Yamada, Y (reprint author), Aichi Med Univ, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	yyamada@aichi-med-u.ac.jp					Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Honig JF, 2003, J CRANIOFAC SURG, V14, P197; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Soparkar CNS, 2004, OPHTHAL PLAST RECONS, V20, P317, DOI 10.1097/01.IOP.0000132164.44343.1A; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Yamada Y, 2008, TISSUE ENG PT A, V14, P1699, DOI 10.1089/ten.tea.2007.0189; VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Duranti F, 1998, DERMATOL SURG, V24, P1317; CORTELLINI P, 1995, J PERIODONTOL, V66, P261; Cortellini P, 1999, INT J PERIODONT REST, V19, P589; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Lamme EN, 2002, WOUND REPAIR REGEN, V10, P152, DOI 10.1046/j.1524-475X.2002.10901.x; Beagle J R, 1992, Int J Periodontics Restorative Dent, V12, P145; Blatz MB, 1999, INT J PERIODONT REST, V19, P395; Boss WK, 2000, CLIN PLAST SURG, V27, P613; Hans TJ, 2000, PERIODONTOL, V11, P65; Hasegawa T, 2005, J DERMATOL, V32, P715; Markowicz M, 2006, CELL TRANSPLANT, V15, P723, DOI 10.3727/000000006783464408; McGuire MK, 2007, J PERIODONTOL, V78, P4, DOI 10.1902/jop.2007.060105; Okabe K, 2009, CYTOTHERAPY, V11, P307, DOI 10.1080/14653240902824773; VACANTI JP, 1988, ARCH SURG-CHICAGO, V123, P545; Wus Y, 2007, STEM CELLS, V25, P2648	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	MAR	2015	9	3					305	309		10.1002/term.1737		5	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	CE4WV	WOS:000351831900013		
J	Houdayer, C; Raum, S				Houdayer, Cyril; Raum, Sven			Baumslag-Solitar groups, relative profinite completions and measure equivalence rigidity	JOURNAL OF TOPOLOGY			English	Article							MEASURE PRESERVING TRANSFORMATIONS; LARGE-SCALE GEOMETRY; MALLEABLE ACTIONS; COHOMOLOGY; SUPERRIGIDITY; INVARIANTS; ALGEBRAS	We introduce an algebraic invariant for aperiodic inclusions of probability measure preserving (pmp) equivalence relations. We use this invariant to prove that every stable orbit equivalence between free pmp actions of direct products of non-amenable Baumslag-Solitar groups whose canonical subgroup acts aperiodically, forces the number of factors of the products to be the same and the factors to be isomorphic after permutation. This generalizes some of the results obtained by Kida ['Invariants of orbit equivalence relations and Baumslag-Solitar groups', Tohoku Math. J. (2) 66 (2014) 205-258] and, moreover, provides new measure equivalence rigidity phenomena for Baumslag-Solitar groups. We also obtain a complete classification of direct products of relative profinite completions of Baumslag-Solitar groups, continuing recent work of Elder and Willis ['Totally disconnected groups from Baumslag-Solitar groups', Preprint, 2013, arXiv:1301.4775].	[Houdayer, Cyril] CNRS Univ Paris Est Marne la Vallee, LAMA UMR 8050, F-77454 Marne La Vallee 2, France; [Raum, Sven] RIMS, Sakyo Ku, Kyoto 6068502, Japan	Houdayer, C (reprint author), CNRS Univ Paris Est Marne la Vallee, LAMA UMR 8050, F-77454 Marne La Vallee 2, France.	cyril.houdayer@u-pem.fr; sven.raum@gmail.com			ANR Grant NEUMANN; KU Leuven BOF [OT/08/032]	Cyril Houdayer was supported by ANR Grant NEUMANN. Sven Raum was supported by KU Leuven BOF research grant OT/08/032.	FELDMAN J, 1977, T AM MATH SOC, V234, P289, DOI 10.2307/1997924; DYE HA, 1959, AM J MATH, V81, P119, DOI 10.2307/2372852; Shalom Y, 2004, ACTA MATH-DJURSHOLM, V192, P119, DOI 10.1007/BF02392739; WILLIS G, 1994, MATH ANN, V300, P341, DOI 10.1007/BF01450491; Monod N, 2006, ANN MATH, V164, P825; ORNSTEIN DS, 1980, B AM MATH SOC, V2, P161, DOI 10.1090/S0273-0979-1980-14702-3; Farb B, 1998, INVENT MATH, V131, P419, DOI 10.1007/s002220050210; Popa S, 2008, J AM MATH SOC, V21, P981; DYE HA, 1963, AM J MATH, V85, P551, DOI 10.2307/2373108; Gaboriau D, 2000, INVENT MATH, V139, P41; Furman A, 1999, ANN MATH, V150, P1083, DOI 10.2307/121063; Kida Y, 2010, ANN MATH, V171, P1851; BAUMSLAG G, 1962, B AM MATH SOC, V68, P199, DOI 10.1090/S0002-9904-1962-10745-9; BRITTON JL, 1963, ANN MATH, V77, P16, DOI 10.2307/1970200; Connes A., 1981, ERGOD THEOR DYN SYST, V1, P431; ELDER M., 2013, ARXIV13014775; FELDMAN J, 1989, ERGOD THEOR DYN SYST, V9, P239; Furman A., 2011, SURVEY MEASURED GROU, P296; Gaboriau D., 2010, P ICM, VIII, P1501; Gaboriau D, 2002, PUBL MATH-PARIS, P93; Gromov M., 1993, LONDON MATH SOC LECT, V2, P1; Kaimanovich V. A., 2000, PREPRINT; Kida Y, 2014, TOHOKU MATH J, V66, P205; Kida Y., 2009, HDB TEICHMULLER THEO, VII; Kida Y, 2013, ERGOD THEOR DYN SYST, V33, P499, DOI 10.1017/S0143385711000964; Meesschaert N, 2014, DOC MATH, V19, P629; Moldavanskii D.I., 1991, UKR MATH J, V43, P1569, DOI 10.1007/BF01066696; Nathanial P, 2008, GRADUATE STUDIES MAT, V88; Popa S., 2007, P INT C MATH MADR 20, VI, P445; Popa S, 2007, INVENT MATH, V170, P243, DOI 10.1007/s00222-007-0063-0; SCHLICHTING G, 1980, ARCH MATH, V34, P97, DOI 10.1007/BF01224936; Serre J., 1980, TREES; Van Dantzig D., 1936, COMPOS MATH, V3, P408; Whyte K, 2001, GEOM FUNCT ANAL, V11, P1327, DOI 10.1007/s00039-001-8232-6; Zimmer R. J., 1984, MONOGRAPHS MATH, V81	35	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1753-8416	1753-8424		J TOPOL	J. Topol.	MAR	2015	8	1					295	313		10.1112/jtopol/jtu026		19	Mathematics	Mathematics	CE2GZ	WOS:000351634400011		
J	Kanamaru, Y; Ando, M; Shirakashi, J				Kanamaru, Yuma; Ando, Masazumi; Shirakashi, Jun-ichi			Ultrafast feedback-controlled electromigration using a field-programmable gate array	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							SINGLE-ELECTRON TRANSISTORS; CONTROLLED FABRICATION; METALLIC ELECTRODES; CONDUCTANCE; SEPARATION; JUNCTIONS	Feedback-controlled electromigration (FCE) has been a useful technique for creating nanoscale gaps between metal electrodes. In general, it is considered that the fabrication of nanogaps by the conventional FCE method using a microprocessor-based control system is a very time consuming and slow process. Here, the authors propose an ultrafast FCE method using a field-programmable gate array (FPGA) to immediately and precisely control the channel resistance of metal nanowires at room temperature. Using the ultrafast FCE method based on an FPGA, the channel resistance of Au micrometer wires was precisely controlled from 10(2) to 10(4) Omega within 1 s at room temperature, and without catastrophic breaks of the Au micrometer wires. Furthermore, the total process time of the FPGA-based ultrafast FCE procedure was considerably shortened without degradation of the controllability of the channel resistance of the Au micrometer wires, and is 10(3) to 10(4) times shorter than that of conventional FCE. These results imply that ultrafast FCE using an FPGA can precisely and stably control the channel resistance of Au micrometer wires with a shortened process time. (C) 2014 American Vacuum Society.	[Kanamaru, Yuma; Ando, Masazumi; Shirakashi, Jun-ichi] Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, Koganei, Tokyo 1848588, Japan	Kanamaru, Y (reprint author), Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, 2-24-16 Nakacho, Koganei, Tokyo 1848588, Japan.	shrakash@cc.tuat.ac.jp	SHIRAKASHI, Jun-ichi/G-1157-2013				Hoffmann R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2965121; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Strachan DR, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857095; Rattalino I, 2012, RSC ADV, V2, P10985, DOI 10.1039/c2ra21484a; Taychatanapat T, 2007, NANO LETT, V7, P652, DOI 10.1021/nl062631i; Itami S, 2010, J NANOSCI NANOTECHNO, V10, P7464, DOI 10.1166/jnn.2010.2865; Campbell JM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4775695; Wu ZM, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2760150; Motto P, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-113; Rattalino I, 2012, PHYS LETT A, V376, P2134, DOI 10.1016/j.physleta.2012.05.020; Umeno A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3124654; Heersche HB, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767149; SIMMONS JG, 1963, J APPL PHYS, V34, P1793, DOI 10.1063/1.1702682; Bolotin KI, 2004, APPL PHYS LETT, V84, P3154, DOI 10.1063/1.1695203; Dimonte A, 2012, BIOMACROMOLECULES, V13, P3503, DOI 10.1021/bm301063m; Umeno A, 2010, PHYSICA E, V42, P2826, DOI 10.1016/j.physe.2009.12.057; Carrara S, 2006, MATER LETT, V60, P3682, DOI 10.1016/j.matlet.2006.03.084; Morpurgo AF, 1999, APPL PHYS LETT, V74, P2084, DOI 10.1063/1.123765; Strachan DR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.056805; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Diaz M, 2010, SURF SCI, V604, P1420, DOI 10.1016/j.susc.2010.05.003; Fujii A., 2004, e-Journal of Surface Science and Nanotechnology, V2, DOI 10.1380/ejssnt.2004.125; Keane ZK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172232; Kiguchi M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125406	24	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAR	2015	33	2							02B106	10.1116/1.4903929		5	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CE3TF	WOS:000351751100006		
J	Koops, HWP; Fukuda, H				Koops, Hans W. P.; Fukuda, Hiroshi			Giant current density via indirect exciton orbit overlapping in polarized nanogranular materials	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							BOSE-EINSTEIN CONDENSATION; BEAM-INDUCED DEPOSITION; QUANTUM-WELLS; POLARITONS; TEMPERATURE; MICROCAVITY; PROBE; DOTS	Anomalous charge transport in nanogranular material (NGM), closely packed 2-4 nm diameter metal nanoparticle-carbon matrix composite, is modeled using a cluster of electron-hole pairs (super-atom) or indirect excitons produced among locally polarized composite. The observed conductivity and T-1/2 temperature dependence of its logarithm suggests variable range hopping or cotunneling via overlapping orbits among adjacent particles limited by electron-hole interaction. Further, electron-hole liquid is expected from predicted high densities of charge carriers, allowing a giant current carrying capacity. The Bose-Hubbard phase diagram and an interexciton distance shorter than the thermal de Broglie wavelength suggests the possibility of NGM as a platform for excitonic quantum condensate. (C) 2014 American Vacuum Society.	[Koops, Hans W. P.] HaWilKo GmbH, D-64372 Ober Ramstadt, Germany; [Fukuda, Hiroshi] Hitachi High Technol Corp, Tokyo 1058717, Japan	Koops, HWP (reprint author), HaWilKo GmbH, Ernst Ludwig Str 16, D-64372 Ober Ramstadt, Germany.	fukuda-hiroshi@nst.hitachi-hitec.com					Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; BLATT JM, 1962, PHYS REV, V126, P1691, DOI 10.1103/PhysRev.126.1691; Edinger K, 2001, J VAC SCI TECHNOL B, V19, P2856, DOI 10.1116/1.1420580; Demokritov SO, 2006, NATURE, V443, P430, DOI 10.1038/nature05117; Remeika M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3682302; Tsukatani Y, 2005, JPN J APPL PHYS 1, V44, P5683, DOI 10.1143/JJAP.44.5683; Butov LV, 2002, NATURE, V417, P47, DOI 10.1038/417047a; Rangelow IW, 2001, MICROELECTRON ENG, V57-8, P737, DOI 10.1016/S0167-9317(01)00466-X; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Floreani F, 2002, NUCL INSTRUM METH A, V483, P488, DOI 10.1016/S0168-9002(02)00367-4; Byrnes T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.186402; Beloborodov IS, 2007, REV MOD PHYS, V79, P469, DOI 10.1103/RevModPhys.79.469; STAFFORD CA, 1994, PHYS REV LETT, V72, P3590, DOI 10.1103/PhysRevLett.72.3590; Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; Yang S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187402; Cudazzo P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.226804; Huth M, 2012, BEILSTEIN J NANOTECH, V3, P597, DOI 10.3762/bjnano.3.70; SNOKE DW, 1990, PHYS REV B, V41, P11171, DOI 10.1103/PhysRevB.41.11171; Wei BQ, 2001, APPL PHYS LETT, V79, P1172, DOI 10.1063/1.1396632; Feng M, 2008, SCIENCE, V320, P359, DOI 10.1126/science.1155866; Averin D. V., 1992, MESOSCOPIC PHENOMENA; Berman OL, 2010, PHILOS T R SOC A, V368, P5459, DOI 10.1098/rsta.2010.0208; Capogrosso-Sansone B, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.134302; COMTE C, 1982, J PHYS-PARIS, V43, P1069, DOI 10.1051/jphys:019820043070106900; KELDYSH LV, 1968, SOV PHYS JETP-USSR, V27, P521; KOOPS HWP, 1988, J VAC SCI TECHNOL B, V6, P477, DOI 10.1116/1.584045; Koops HWP, 1996, J VAC SCI TECHNOL B, V14, P4105, DOI 10.1116/1.588600; KOOPS HWP, 1994, JPN J APPL PHYS 1, V33, P7099, DOI 10.1143/JJAP.33.7099; KRETZ J, 1994, MICROELECTRON ENG, V23, P477, DOI 10.1016/0167-9317(94)90199-6; Mahmud KW, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054302; NEUBERGER H, 1978, PHYS REV D, V17, P498, DOI 10.1103/PhysRevD.17.498; Nozieres P., 1985, LOW TEMP PHYS, V59, P195; Schoessler C, 1998, J VAC SCI TECHNOL B, V16, P862, DOI 10.1116/1.589921; Schossler C, 1996, MICROELECTRON ENG, V30, P471, DOI 10.1016/0167-9317(95)00290-1; Stolz H, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.081302; Utke I., 2012, NANOFABRICATION USIN	36	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAR	2015	33	2							02B108	10.1116/1.4904732		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CE3TF	WOS:000351751100008		
J	Toyonaka, T; Morihara, K; Takikawa, K; Ito, M; Shirakashi, J				Toyonaka, Takahiro; Morihara, Kohei; Takikawa, Kazuki; Ito, Mitsuki; Shirakashi, Jun-ichi			Controlling the tunnel resistance of suspended Ni nanogaps using field-emission-induced electromigration	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							METALLIC ELECTRODES; FABRICATION; SEPARATION	The authors report on the ability to control the tunnel resistance of suspended Ni nanogaps by field-emission-induced electromigration. This method is called "activation." Suspended Ni nanogaps are ideal for investigating activation because the leakage currents flowing through the substrates are suppressed in these structures. The tips of suspended Ni nanogap electrodes are isolated from the SiO2 substrates, so it is expected that the suspended Ni nanogaps act as isolated tunnel junctions during activation. After undergoing activation, the suspended Ni nanogaps clearly exhibited tunneling I-V properties. Furthermore, the authors were able to tune the tunnel resistance of the suspended Ni nanogaps using the activation method. When the applied voltage was swept, the device current switched between high-and low-resistance states. The results imply that activation is a viable method for modulating the electrical properties of suspended Ni nanogaps at the nanometer scale. (C) 2014 American Vacuum Society.	[Toyonaka, Takahiro; Morihara, Kohei; Takikawa, Kazuki; Ito, Mitsuki; Shirakashi, Jun-ichi] Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, Koganei, Tokyo 1848588, Japan	Toyonaka, T (reprint author), Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, 2-24-16 Nakacho, Koganei, Tokyo 1848588, Japan.	shrakash@cc.tuat.ac.jp	SHIRAKASHI, Jun-ichi/G-1157-2013				Anantram MP, 2006, REP PROG PHYS, V69, P507, DOI 10.1088/0034-4885/69/3/R01; Klein DL, 1996, APPL PHYS LETT, V68, P2574, DOI 10.1063/1.116188; Bezryadin A, 1997, APPL PHYS LETT, V71, P1273, DOI 10.1063/1.119871; Tomoda Y, 2009, J VAC SCI TECHNOL B, V27, P813, DOI 10.1116/1.3039683; Kayashima S, 2007, JPN J APPL PHYS 2, V46, pL907, DOI 10.1143/JJAP.46.L907; Kayashima S, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/5/052022; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Tombler TW, 2000, NATURE, V405, P769; Nagase T, 2006, THIN SOLID FILMS, V499, P279, DOI 10.1016/j.tsf.2005.07.031; Lambert MF, 2003, NANOTECHNOLOGY, V14, P772, DOI 10.1088/0957-4484/14/7/313; Schirm C, 2013, NAT NANOTECHNOL, V8, P645, DOI [10.1038/nnano.2013.170, 10.1038/NNANO.2013.170]; Im H, 2010, NANO LETT, V10, P2231, DOI 10.1021/nl1012085; Morpurgo AF, 1999, APPL PHYS LETT, V74, P2084, DOI 10.1063/1.123765; Yao J, 2009, SMALL, V5, P2910, DOI 10.1002/smll.200901100; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Keane ZK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172232; Roch N, 2008, PHYS STATUS SOLIDI B, V245, P1994, DOI 10.1002/pssb.200879621; Takikawa Kazuki, 2014, Proceedings of the 14th IEEE International Conference on Nanotechnology (IEEE-NANO), DOI 10.1109/NANO.2014.6968014; Takiya K, 2012, APPL SURF SCI, V258, P2029, DOI 10.1016/j.apsusc.2011.04.114; Yao J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00242	20	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAR	2015	33	2							02B107	10.1116/1.4904731		4	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CE3TF	WOS:000351751100007		
J	Yamazaki, T; Kato, T; Uemura, T; Matsuyama, H; Tada, Y; Yamazaki, K; Soeda, T; Miyajima, T; Kataoka, Y				Yamazaki, Takashi; Kato, Takashi; Uemura, Taiki; Matsuyama, Hideya; Tada, Yoko; Yamazaki, Kazutoshi; Soeda, Takeshi; Miyajima, Toyoo; Kataoka, Yuji			Origin analysis of thermal neutron soft error rate at nanometer scale	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY B			English	Article							ATOM-PROBE TOMOGRAPHY; DOPANT DISTRIBUTIONS; MASS; OXIDE	Recently, thermal neutrons have been identified as a cause of soft errors in advanced electronic devices. To analyze the origin of such errors, dynamic secondary ion mass spectrometry (SIMS), time-of-flight (TOF)-SIMS, and three-dimensional atom probe (3DAP) methods have been used systematically. TOF-SIMS results showed that the existence region of B-10, the source of soft errors, has a high correlation to the existence region of W. Furthermore, 3DAP results for the sample extracted from the area near the W-plug revealed high B-10 concentration at the W-plug. (C) 2015 American Vacuum Society.	[Yamazaki, Takashi; Tada, Yoko; Soeda, Takeshi; Miyajima, Toyoo; Kataoka, Yuji] Fujitsu Labs Ltd, Prod & Syst Engn Labs, Atsugi, Kanagawa 2430197, Japan; [Kato, Takashi; Uemura, Taiki; Matsuyama, Hideya] Fujitsu Semicond Ltd, Reliabil Engn Dept, Akiruno 1970833, Japan; [Yamazaki, Kazutoshi] Fujitsu Labs Ltd, Devices & Mat Labs, Atsugi, Kanagawa 2430197, Japan	Yamazaki, T (reprint author), Fujitsu Labs Ltd, Prod & Syst Engn Labs, 10-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430197, Japan.	yamazakit@jp.fujitsu.com					Adusumilli P, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3099970; Dirk JD, 2003, IEEE T NUCL SCI, V50, P2060, DOI 10.1109/TNS.2003.821587; Gordon MS, 2004, IEEE T NUCL SCI, V51, P3427, DOI 10.1109/TNS.2004.839134; Inoue K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3186788; Thompson K, 2006, J VAC SCI TECHNOL B, V24, P421, DOI 10.1116/1.2141621; Norrman K, 2006, SOL ENERG MAT SOL C, V90, P213, DOI 10.1016/j.solmat.2005.03.004; Kirchhofer R, 2013, J NUCL MATER, V436, P23, DOI 10.1016/j.jnucmat.2012.12.052; Iltgen K, 1997, J VAC SCI TECHNOL A, V15, P460, DOI 10.1116/1.580874; HONO K, 1991, APPL PHYS LETT, V58, P2180, DOI 10.1063/1.104968; BANERJEE I, 1993, APPL PHYS LETT, V62, P1541, DOI 10.1063/1.108634; Baumann RC, 2001, MICROELECTRON RELIAB, V41, P211, DOI 10.1016/S0026-2714(00)00218-3; Borucki L, 2008, INT REL PHY, P482, DOI 10.1109/RELPHY.2008.4558933; Cerezo A, 2007, MATER TODAY, V10, P36, DOI 10.1016/S1369-7021(07)70306-1; Fang YP, 2014, IEEE T DEVICE MAT RE, V14, P583, DOI 10.1109/TDMR.2013.2287699; Ibe E., 2012, ON LIN TEST S IOLTS, P49; Ibe E. H., 2014, TERRESTRIAL RAD EFFE; Moore JS, 2008, ULTRAMICROSCOPY, V108, P536, DOI 10.1016/j.ultramic.2007.08.008; MULLER EW, 1951, Z PHYS, V131, P136, DOI 10.1007/BF01329651; Slayman C, 2011, FRONT ELECTRON TEST, V41, P55, DOI 10.1007/978-1-4419-6993-4_3; Takamizawa H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730437; Tosaka Y, 2006, JPN J APPL PHYS 1, V45, P3185, DOI 10.1143/JJAP.45.3185; Uemura T, 2013, IEEE T NUCL SCI, V60, P4362, DOI 10.1109/TNS.2013.2288989; Wen S. J., 2010, IRW STANF SIERR CA O, P31; Yeo KL, 2003, J VAC SCI TECHNOL B, V21, P193, DOI 10.1116/1.1535925	24	0	0	A V S AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	1071-1023			J VAC SCI TECHNOL B	J. Vac. Sci. Technol. B	MAR	2015	33	2							020604	10.1116/1.4907400		4	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	CE3TF	WOS:000351751100015		
J	Sasaki, H; Watanabe, K; Toyama, T; Koyata, Y; Hamada, N				Sasaki, Haruka; Watanabe, Kiyoko; Toyama, Toshizo; Koyata, Yasunori; Hamada, Nobushiro			Porphyromonas gulae 41-kDa fimbriae induced osteoclast differentiation and cytokine production	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						cytokine production; fimbria; osteoclast differentiation; periodontitis; Porphyromonas gulae	GINGIVALIS FIMBRIAE; PERIODONTAL-DISEASE; BONE-RESORPTION; ANIMAL-MODELS; IN-VITRO; CELLS; COMPONENTS; BACTERIA; DOGS; PATHOGENESIS	Porphyromonas gulae is considered to be associated with canine periodontitis. We have previously reported that the P gulae American Type Culture Collection (ATCC) 51700 comprised 41-kDa fimbriae. The purpose of the present study was to demonstrate the roles of 41-kDa fimbrial protein in periodontal disease. In this study, we examined the involvement of the 41-kDa fimbrial protein in osteoclast differentiation and cytokine production in murine macrophages. Furthermore, alveolar bone resorption induced by P gulae infection in rats was evaluated. To estimate osteoclast differentiation, bone marrow cells and MC3T3-G2/PA6 cells were cultured with or without the 41-kDa fimbrial protein for 7 days. BALB/c mouse peritoneal macrophages were stimulated with the 41-kDa fimbrial protein, and the levels of interleukin (IL)-1 beta and tumor necrosis factor (TNF)-alpha production were determined by enzyme-linked immunosorbent assay. Osteoclast differentiation was significantly enhanced by treatment with the 41-kDa fimbrial protein in a dose-dependent manner. The total area of pits formed on the dentine slices with osteoclasts incubated with the 41-kDa fimbrial protein was significantly greater than that of the control. The purified 41-kDa fimbrial protein induced IL-1 beta and TNF-alpha production in BALB/c mouse peritoneal macrophages after 6 hr of incubation in a dose-dependent manner. The bone loss level in rats infected with P gulae was significantly higher than that of the sham-infected rats. These results suggest that P gulae 41-kDa fimbriae play important roles in the pathogenesis of periodontal disease.	[Sasaki, Haruka; Watanabe, Kiyoko; Toyama, Toshizo; Koyata, Yasunori; Hamada, Nobushiro] Kanagawa Dent Univ, Dept Microbiol, Yokosuka, Kanagawa 2388580, Japan	Hamada, N (reprint author), Kanagawa Dent Univ, Dept Microbiol, 82 Inaoka Cho, Yokosuka, Kanagawa 2388580, Japan.	hamada@kdu.ac.jp			Japan Society for the Promotion of Science [26462801]	This study was supported by Grant-in-Aid for Scientific Research (C) No. 26462801 from the Japan Society for the Promotion of Science.	Allaker RP, 1997, VET REC, V140, P147; Hamada S, 1998, ORAL MICROBIOL IMMUN, V13, P129, DOI 10.1111/j.1399-302X.1998.tb00724.x; Genco CA, 1998, TRENDS MICROBIOL, V6, P444, DOI 10.1016/S0966-842X(98)01363-8; Amano A, 2010, PERIODONTOL 2000, V52, P12, DOI 10.1111/j.1600-0757.2009.00307.x; LEE HJ, 1995, J CLIN PERIODONTOL, V22, P885, DOI 10.1111/j.1600-051X.1995.tb01788.x; Umemoto T, 2003, J PERIODONTOL, V74, P119, DOI 10.1902/jop.2003.74.1.119; Hamada N, 2008, VET MICROBIOL, V128, P108, DOI 10.1016/j.vetmic.2007.09.014; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Nomura R, 2012, J VET MED SCI, V74, P885, DOI 10.1292/jvms.11-0564; Weinberg MA, 1999, J CLIN PERIODONTOL, V26, P335, DOI 10.1034/j.1600-051X.1999.260601.x; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; ROODMAN GD, 1985, P NATL ACAD SCI USA, V82, P8213, DOI 10.1073/pnas.82.23.8213; Hardham J, 2005, VET MICROBIOL, V106, P119, DOI 10.1016/j.vetmic.2004.12.018; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; HANAZAWA S, 1991, INFECT IMMUN, V59, P1972; Nakagawa I, 2006, INFECT IMMUN, V74, P3773, DOI 10.1128/IAI.01902-05; Hajishengallis G, 2008, ADV EXP MED BIOL, V632, P203, DOI 10.1007/978-0-387-78952-1_15; KAWATA Y, 1994, INFECT IMMUN, V62, P3012; Fournier D, 2001, INT J SYST EVOL MICR, V51, P1179; Hamada N, 2007, J PERIODONTOL, V78, P933, DOI 10.1902/jop.2007.060245; HANAZAWA S, 1988, INFECT IMMUN, V56, P272; Harvey C., 1993, SMALL ANIMAL DENT, P104; HOLT S C, 1991, Critical Reviews in Oral Biology and Medicine, V2, P177; Koide M, 2010, PERIODONTOL 2000, V54, P235, DOI 10.1111/j.1600-0757.2010.00355.x; Landi L, 1997, CURR OPIN PERIODONT, V4, P3; Ozaki K, 2001, INFECT IMMUN, V69, P4944, DOI 10.1128/IAI.69.8.4944-4950.2001; Penman S., 1990, Manual of small animal dentistry.., P37; SARKIALA EM, 1993, VET MICROBIOL, V36, P273, DOI 10.1016/0378-1135(93)90094-N; Tani-Ishii N, 2002, J PERIODONTAL RES, V37, P184, DOI 10.1034/j.1600-0765.2002.00610.x; VANWINKELHOFF AJ, 1991, J CLIN PERIODONTOL, V18, P406; Zambon J J, 1996, Ann Periodontol, V1, P879, DOI 10.1902/annals.1996.1.1.879	34	1	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					265	271		10.1292/jvms.14-0463		7	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000001		
J	Umar, MA; Fukui, S; Kawase, K; Itami, T; Yamashita, K				Umar, Mohammed Ahmed; Fukui, Sho; Kawase, Kodai; Itami, Takaharu; Yamashita, Kazuto			Cardiovascular effects of total intravenous anesthesia using ketamine-medetomidine-propofol (KMP-TIVA) in horses undergoing surgery	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						cardiovascular function; equine; ketamine; medetomidine; propofol	PERFORMANCE LIQUID-CHROMATOGRAPHY; HALOTHANE-ANESTHETIZED HORSES; POSTANESTHETIC MYOPATHY; PONIES; CARDIOPULMONARY; COMBINATION; INFUSION; DETOMIDINE; XYLAZINE; BLOOD	Cardiovascular effects of total intravenous anesthesia using ketamine-medetomidine-propofol drug combination (KMP-TIVA) were determined in 5 Thoroughbred horses undergoing surgery. The horses were anesthetized with intravenous administration (IV) of ketamine (2.5 mg/kg) and midazolam (0.04 mg/kg) following premedication with medetomidne (5 mu g/kg, IV) and artificially ventilated. Surgical anesthesia was maintained by controlling propofol infusion rate (initially 0.20 mu g/kg/min following an IV loading dose of 0.5 mg/kg) and constant rate infusions of ketamine (1 mg/kg/hr) and medetomidine (1.25 mu g/kg/hr). The horses were anesthetized for 175 +/- 14 min (range from 160 to 197 min). Propofol infusion rates ranged from 0.13 to 0.17 mg/kg/min, and plasma concentration (Cpl) of propofol ranged from 11.4 to 13.3 mu g/ml during surgery. Cardiovascular measurements during surgery remained within clinically acceptable ranges in the horses (heart rate: 33 to 37 beats/min, mean arterial blood pressure: 111 to 119 mmHg, cardiac index: 48 to 53 ml/kg/min, stroke volume: 650 to 800 ml/beat and systemic vascular resistance: 311 to 398 dynes/sec/cm(5)). The propofol Cpl declined rapidly after the cessation of propofol infusion and was significantly lower at 10 min (4.5 +/- 1.5 mu g/ml), extubation (4.0 +/- 1.2 mu g/ml) and standing (2.4 +/- 0.9 mu g/ml) compared with the Cpl at the end of propofol administration (11.4 2.7 pg/ml). All the horses recovered uneventfully and stood at 74 +/- 28 min after the cessation of anesthesia. KMP-TIVA provided satisfactory quality and control of anesthesia with minimum cardiovascular depression in horses undergoing surgery.	[Umar, Mohammed Ahmed] Univ Maiduguri, Fac Vet Med, Dept Vet Surg & Theriogenol, Maiduguri, Borno State, Nigeria; [Itami, Takaharu] Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Sapporo, Hokkaido 0600819, Japan; [Fukui, Sho; Kawase, Kodai; Yamashita, Kazuto] Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan	Yamashita, K (reprint author), Rakuno Gakuen Univ, Sch Vet Med, Dept Small Anim Clin Sci, Ebetsu, Hokkaido 0698501, Japan.	yamasita@rakuno.ac.jp			Monbukagakusho, Tokyo, Japan	Dr. Umar was supported by a study fellowship awarded by Monbukagakusho, Tokyo, Japan.	MAMA KR, 1995, VET SURG, V24, P188, DOI 10.1111/j.1532-950X.1995.tb01317.x; KLEPSTAD P, 1990, EUR J PHARMACOL, V187, P513, DOI 10.1016/0014-2999(90)90379-K; GREENE SA, 1986, AM J VET RES, V47, P2364; Duke T, 2006, VET ANAESTH ANALG, V33, P122, DOI 10.1111/j.1467-2995.2005.00189.x; Flaherty D, 1997, RES VET SCI, V62, P179, DOI 10.1016/S0034-5288(97)90143-0; DAY TK, 1995, VET SURG, V24, P266, DOI 10.1111/j.1532-950X.1995.tb01330.x; Umar MA, 2007, AM J VET RES, V68, P121, DOI 10.2460/ajvr.68.2.121; NOLAN AM, 1985, EQUINE VET J, V17, P394; Mama KR, 2005, AM J VET RES, V66, P1002, DOI 10.2460/ajvr.2005.66.1002; MUIR WW, 1976, AM J VET RES, V37, P697; STEFFEY EP, 1980, AM J VET RES, V41, P821; YOUNG SS, 1993, EQUINE VET J, V25, P147; Bettschart-Wolfensberger R, 2003, EQUINE VET J, V35, P308, DOI 10.2746/042516403776148354; Bettschart-Wolfensberger R, 2001, AM J VET RES, V62, P500, DOI 10.2460/ajvr.2001.62.500; Bettschart-Wolfensberger R, 2005, VET ANAESTH ANALG, V32, P348, DOI 10.1111/j.1467-2995.2005.00202.x; Bettschart-Wolfensberger R, 2001, AM J VET RES, V62, P1428, DOI 10.2460/ajvr.2001.62.1428; BRYANT CE, 1991, VET REC, V129, P421; England GCW, 1996, BRIT VET J, V152, P641, DOI 10.1016/S0007-1935(96)80118-7; FAN SZ, 1995, ANESTH ANALG, V81, P175, DOI 10.1097/00000539-199507000-00036; GRANDY JL, 1987, AM J VET RES, V48, P192; HODGSON DS, 1986, AM J VET RES, V47, P992; LINDSAY WA, 1989, AM J VET RES, V50, P404; Luna SPL, 1996, J VET PHARMACOL THER, V19, P251, DOI 10.1111/j.1365-2885.1996.tb00046.x; Mama KR, 1998, AM J VET RES, V59, P1292; Matthews NS, 1999, VET SURG, V28, P196; Muir W. W., 2009, EQUINE ANESTHESIA MO, P397, DOI 10.1016/B978-1-4160-2326-5.00022-5; Nolan A, 1996, RES VET SCI, V60, P262, DOI 10.1016/S0034-5288(96)90051-X; PLUMMER GF, 1987, J CHROMATOGR-BIOMED, V421, P171, DOI 10.1016/0378-4347(87)80394-8; Rogovik A, 2008, EMERG MED CLIN N AM, V26, P941, DOI 10.1016/j.emc.2008.08.002; Schwartzward C. C., 2009, EQUINE ANESTHESIA, P37, DOI 10.1016/B978-1-4160-2326-5.00003-1; TAYLOR PM, 1995, RES VET SCI, V59, P17, DOI 10.1016/0034-5288(95)90024-1; Umar MA, 2006, JAVMA-J AM VET MED A, V228, P1221, DOI 10.2460/javma.228.8.1221; Yamashita K, 2009, J VET MED SCI, V71, P1465, DOI 10.1292/jvms.001465; Yamashita K., 1999, Journal of the Japan Veterinary Medical Association, V52, P498; Yamashita K, 2007, J VET MED SCI, V69, P7, DOI 10.1292/jvms.69.7; Yamashita K., 2009, EQUINE ANESTHESIA MO, P260, DOI 10.1016/B978-1-4160-2326-5.00013-4	36	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					281	288		10.1292/jvms.14-0370		8	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000003		
J	Tamura, J; Ishizuka, T; Fukui, S; Oyama, N; Kawase, K; Miyoshi, K; Sano, T; Pasloske, K; Yamashita, K				Tamura, Jun; Ishizuka, Tomohito; Fukui, Sho; Oyama, Norihiko; Kawase, Kodai; Miyoshi, Kenjiro; Sano, Tadashi; Pasloske, Kirby; Yamashita, Kazuto			The pharmacological effects of the anesthetic alfaxalone after intramuscular administration to dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						alfaxalone; anesthetic effect; canine; intramuscular	CONTINUOUS RATE INFUSIONS; MEDETOMIDINE-BUTORPHANOL; PROPOFOL; CATS; INDUCTION; DEXMEDETOMIDINE; METABOLISM; ISOFLURANE; SEDATION; QUALITY	The pharmacological effects of the anesthetic alfaxalone were evaluated after intramuscular (IM) administration to 6 healthy beagle dogs. The dogs received three IM doses each of alfaxalone at increasing dose rates of 5 mg/kg (IM5), 7.5 mg/kg (IM7.5) and 10 mg/kg (IM10) every other day. Anesthetic effect was subjectively evaluated by using an ordinal scoring system to determine the degree of neuro-depression and the quality of anesthetic induction and recovery from anesthesia. Cardiorespiratory variables were measured using noninvasive methods. Alfaxalone administered IM produced dose-dependent neuro-depression and lateral recumbency (i.e., 36 +/- 28 mm, 87 +/- 26 mm and 115 +/- 29 mm after the IM5, IM7.5 and IM10 treatments, respectively). The endotracheal tube was tolerated in all dogs for 46 +/- 20 and 58 +/- 21 mm after the IM7.5 and IM10 treatments, respectively. It was not possible to place endotracheal tubes in 5 of the 6 dogs after the IM5 treatment. Most cardiorespiratory variables remained within clinically acceptable ranges, but hypoxemia was observed by pulse oximetry for 5 to 10 mm in 2 dogs receiving the IM10 treatment. Dose-dependent decreases in rectal temperature, respiratory rate and arterial blood pressure also occurred. The quality of recovery was considered satisfactory in all dogs receiving each treatment; all the dog exhibited transient muscular tremors and staggering gait. In conclusion, IM alfaxalone produced a dose-dependent anesthetic effect with relatively mild cardiorespiratory depression in dogs. However, hypoxemia may occur at higher IM doses of alfaxalone.	[Tamura, Jun; Ishizuka, Tomohito; Fukui, Sho; Oyama, Norihiko; Kawase, Kodai; Miyoshi, Kenjiro; Yamashita, Kazuto] Rakuno Gakuen Univ, Dept Small Anim Clin Sci, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan; [Sano, Tadashi] Rakuno Gakuen Univ, Dept Vet Nursing Sci, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan; [Pasloske, Kirby] Jurox Pty Ltd, Rutherford, NSW 2320, Australia	Yamashita, K (reprint author), Rakuno Gakuen Univ, Dept Small Anim Clin Sci, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan.	yamasita@rakuno.ac.jp					ALBERTSON TE, 1992, ANESTHESIOLOGY, V77, P488, DOI 10.1097/00000542-199209000-00014; Ambros B, 2008, AM J VET RES, V69, P1391, DOI 10.2460/ajvr.69.11.1391; YOUNG LE, 1990, J SMALL ANIM PRACT, V31, P554, DOI 10.1111/j.1748-5827.1990.tb00685.x; Psatha E, 2011, VET ANAESTH ANALG, V38, P24, DOI 10.1111/j.1467-2995.2010.00577.x; Muir WW, 1999, J AM VET MED ASSOC, V215, P1116; Karas AZ, 1999, CLIN TECH SMALL AN P, V14, P15, DOI 10.1016/S1096-2867(99)80023-1; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Maney JK, 2013, VET ANAESTH ANALG, V40, P237, DOI 10.1111/vaa.12006; Sawyer DC, 2004, VET ANAESTH ANALG, V31, P27, DOI 10.1111/j.1467-2995.2004.00141.x; Bertelsen MF, 2011, VET ANAESTH ANALG, V38, P461, DOI 10.1111/j.1467-2995.2011.00640.x; BRANSON K. R., 2007, LUMB JONES VET ANEST, P273; Carmona SQ, 2014, RES VET SCI, V97, P132, DOI 10.1016/j.rvsc.2014.03.022; CHILD KJ, 1971, BRIT J ANAESTH, V43, P2, DOI 10.1093/bja/43.1.2-a; Cullen LK, 1996, BRIT VET J, V152, P519, DOI 10.1016/S0007-1935(96)80005-4; DODMAN NH, 1980, VET REC, V107, P481; Ferre PJ, 2006, VET ANAESTH ANALG, V33, P229, DOI 10.1111/j.1467-2995.2005.00264.x; Goodchild CS, 2000, PAIN, V88, P23, DOI 10.1016/S0304-3959(00)00301-8; Grubb TL, 2013, J FELINE MED SURG, V15, P858, DOI 10.1177/1098612X13478265; Hansen LL, 2013, VET ANAESTH ANALG, V40, pE68, DOI 10.1111/vaa.12045; Hartsfield S. M., 2007, LUMB JONES VET ANEST, P453; Herbert GL, 2013, VET ANAESTH ANALG, V40, P124, DOI 10.1111/j.1467-2995.2012.00752.x; JACOBSON JD, 1992, AM J VET RES, V53, P537; Jimenez CP, 2012, VET ANAESTH ANALG, V39, P151, DOI 10.1111/j.1467-2995.2011.00678.x; Keates H, 2012, RES VET SCI, V93, P904, DOI 10.1016/j.rvsc.2011.10.003; Kischinovsky M, 2013, VET ANAESTH ANALG, V40, P13, DOI 10.1111/j.1467-2995.2012.00745.x; Ko JCH, 2000, J AM VET MED ASSOC, V216, P1578, DOI 10.2460/javma.2000.216.1578; Mathis A, 2012, VET ANAESTH ANALG, V39, P282, DOI 10.1111/j.1467-2995.2011.00707.x; Michou JN, 2012, VET ANAESTH ANALG, V39, P275, DOI 10.1111/j.1467-2995.2012.00709.x; Muir W, 2009, VET ANAESTH ANALG, V36, P42, DOI 10.1111/j.1467-2995.2008.00428.x; Muir W, 2008, VET ANAESTH ANALG, V35, P451, DOI 10.1111/j.1467-2995.2008.00406.x; Mutoh T, 2001, AM J VET RES, V62, P311, DOI 10.2460/ajvr.2001.62.311; NOVELLI GP, 1975, BRIT J ANAESTH, V47, P913, DOI 10.1093/bja/47.9.913; Robinson KJ, 2001, J SMALL ANIM PRACT, V42, P444, DOI 10.1111/j.1748-5827.2001.tb02498.x; SEAR JW, 1981, BRIT J ANAESTH, V53, P417, DOI 10.1093/bja/53.4.417; STRUNIN L, 1977, BRIT J ANAESTH, V49, P609, DOI 10.1093/bja/49.6.609; Taboada FM, 2010, VET REC, V167, P85, DOI 10.1136/vr.b4872; Thomas AA, 2012, LAB ANIM-UK, V46, P71, DOI 10.1258/la.2011.011092; Tomizawa N, 1997, J VET MED A, V44, P189; Ueyama Yukie, 2008, Vet Anaesth Analg, V35, P480, DOI 10.1111/j.1467-2995.2008.00415.x; Zaki S, 2009, AUST VET J, V87, P82, DOI 10.1111/j.1751-0813.2009.00390.x	41	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					289	296		10.1292/jvms.14-0368		8	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000004		
J	Ishibashi, M; Hayashi, A; Akiyoshi, H; Ohashi, F				Ishibashi, Maki; Hayashi, Akiyoshi; Akiyoshi, Hideo; Ohashi, Fumihito			The influences of hyperbaric oxygen therapy with a lower pressure and oxygen concentration than previous methods on physiological mechanisms in dogs	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						autonomic nervous system; blood gas parameter; canine; glutathione peroxidase; hyperbaric oxygen therapy	BLOOD-GAS; STRESS; HYPEROXIA; TOXICITY; EXPOSURE; EMBOLISM; VALUES; RATS	Recently, hyperbaric oxygen therapy with a lower pressure and oxygen concentration (L-HBOT) than previous methods has been used for dogs in Japan; however, the influences of L-HBOT on dogs have not been clarified. To verify the influences of L-HBOT on physiological mechanism in dogs, we investigated blood gas parameters, glutathione peroxidase (GPx) activity, heart rate variability, stress-related hormones and skin conductance (SC) in 4 clinically normal beagle dogs with catheters in their carotid arteries and jugular veins when they were quiet, after running, after receiving L-HBOT (30% oxygen concentration, 1.3 atmospheres absolute, 30 min) or after not receiving L-HBOT. The results showed there were no changes in blood gas parameters, heart rate variability and catecholamine levels after L-HBOT. GPx activity was significantly higher, and the SC and cortisol level were lower in dogs that received L-HBOT than those when they were quiet. These results suggested that L-HBOT may have a small influence on oxygenation dynamics, activate antioxidant enzymes such as GPx, restrain autonomic nervous activity and control the balance between oxidation and antioxidation inside the body.	[Ishibashi, Maki; Hayashi, Akiyoshi; Akiyoshi, Hideo; Ohashi, Fumihito] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Clin Med, Izumisano, Osaka 5988531, Japan	Ishibashi, M (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Clin Med, 1-58 Rinku Ohrai Kita, Izumisano, Osaka 5988531, Japan.	m.bridge8484@gmail.com	Ishibashi, Maki/K-3313-2013				AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Schaal S, 2003, INVEST OPHTH VIS SCI, V44, P3476, DOI 10.1167/iovs.03-0122; ILKIW JE, 1991, J VET INTERN MED, V5, P294; Lund V, 2000, ACTA PHYSIOL SCAND, V170, P39; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Bednarski R, 2011, J AM ANIM HOSP ASSOC, V47, P377, DOI 10.5326/JAAHA-MS-5846; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Matwichuk CL, 1999, AM J VET RES, V60, P88; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Van Meter KW, 2005, UNDERSEA HYPERBAR M, V32, P61; TSUJI H, 1994, CIRCULATION, V90, P878; Ay H, 2007, CLIN EXP PHARMACOL P, V34, P787, DOI 10.1111/j.1440-1681.2007.04645.x; Bantseev V, 2004, EXP EYE RES, V78, P925, DOI 10.1016/j.exer.2004.01.002; Benedetti S, 2004, CLIN BIOCHEM, V37, P312, DOI 10.1016/j.clinbiochem.2003.12.001; COOPER NA, 1976, J SMALL ANIM PRACT, V17, P759, DOI 10.1111/j.1748-5827.1976.tb06940.x; Daichi R, 2007, TXB PHYSL, P341; DENNIS RC, 1980, CLIN CHEM, V26, P1304; Edamura K, 2007, HDB SMALL ANIMAL SUR, P84; Edwards ML, 2010, J VET EMERG CRIT CAR, V20, P284, DOI 10.1111/j.1476-4431.2010.00535.x; Edwards ML, 2010, J VET EMERG CRIT CAR, V20, P289, DOI 10.1111/j.1476-4431.2010.00535_1.x; Feldman C. L., 1991, Proceedings. Computers in Cardiology (Cat. No.91CH3116-1), DOI 10.1109/CIC.1991.169093; Flohe L., 1979, TRACE METALS HLTH DI, P263; Ganther H. E., 1976, TRACE ELEMENTS HUMAN, P165; Ishibashi M, 2013, J VET MED SCI, V75, P809, DOI 10.1292/jvms.12-0478; Jung S, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-29; Kindwall E. P, 2008, HYPERBARIC MED PRACT, P25; Koike T., 2007, J TOXICOL SCI, V32, pS168; Koyama H, 2010, J VET MED SCI, V72, P1209, DOI 10.1292/jvms.09-0464; Ledowski T, 2010, INT J OBSTET ANESTH, V19, P282, DOI 10.1016/j.ijoa.2010.01.001; Leslie-Mazwi TM, 2009, NEUROCRIT CARE, V11, P247, DOI 10.1007/s12028-009-9211-2; Lund V, 1999, UNDERSEA HYPERBAR M, V26, P87; Manens J, 2014, J VET INTERN MED, V28, P371, DOI 10.1111/jvim.12260; Matsunami Tokio, 2009, Int J Clin Exp Pathol, V3, P177; Mendel V, 1999, UNDERSEA HYPERBAR M, V26, P169; Mensack S, 1999, COMP CONT EDUC PRACT, V21, P341; Muhonen A, 2004, INT J ORAL MAX SURG, V33, P173, DOI 10.1054/ijom.2003.0489; NARKOWICZ CK, 1993, FREE RADICAL RES COM, V19, P71, DOI 10.3109/10715769309056501; Nelson W. R., 2008, SMALL ANIMAL INTERNA, P242; Orton E. C, 2003, TXB SMALL ANIMAL SUR, P955; Paglia D. E., 1989, CC/CLIN MED, V8, P16; Pelaia P., 1992, J HYPERBARIC MED, V7, P229; Sahni T, 2004, MED UPDATE, V14, P632; Storm H, 2002, ACTA ANAESTH SCAND, V46, P887, DOI 10.1034/j.1399-6576.2002.460721.x; STUHR LEB, 1994, AVIAT SPACE ENVIR MD, V65, P531; ter Laan M, 2009, EUR J GASTROEN HEPAT, V21, P833, DOI 10.1097/MEG.0b013e328310aefc; Uhrikova I, 2013, AUST VET J, V91, P452, DOI 10.1111/avj.12117; Waddell S. L., 2013, TODAYS VET PRACT, V3, P43; Wang CC, 2003, ARCH SURG-CHICAGO, V138, P272, DOI 10.1001/archsurg.138.3.272; Yoles E, 2000, NEUROL RES, V22, P404; Yukioka H, 1996, REGION ANESTH, V21, P327	52	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					297	304		10.1292/jvms.14-0316		8	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000005		
J	Hiyama, M; Kusakabe, KT; Takeshita, A; Sugi, S; Kuniyoshi, N; Imai, H; Kano, K; Kiso, Y				Hiyama, Masato; Kusakabe, Ken Takeshi; Takeshita, Ai; Sugi, Sinji; Kuniyoshi, Nobue; Imai, Hiroyuki; Kano, Kiyoshi; Kiso, Yasuo			Nutrient starvation affects expression of LC3 family at the feto-maternal interface during murine placentation	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						autophagy; LC3; mTOR; placenta; starvation	METABOLIC CHECKPOINT; IN-VIVO; AUTOPHAGY; PROTEIN; MICE; KINASE; MODULATOR; MAP1LC3B; DISEASE; CANCERS	LC3 - the mammalian homolog of Atg8 - was found as autophagosome membrane binding protein in mammals and widely used as an autophagosomal marker. LC3A, B and C show different expression patterns in each tissue. The aim of this study was to reveal the differences of expression patterns among LC3 families in mouse placenta under normal condition and nutrient starving condition. LC3A and B were highly expressed in decidual cells. LC3A and B were increased in D14 compared with D12 and D16 in mouse placenta, while LC3C was decreased. Starvation induced increase in LC3B expression specifically. Immunohistochemistry showed different expression patterns among LC3A, B and C. LC3A expression in syncytiotrophoblast was vanished by starvation. The results of real time RT-PCR suggested differences between D12 and D16 in autophagic cascade induced by starvation. Taken together, this study suggests that autophagy could play a role in placental invasion system and that nutrient starvation affects LC3B expression.	[Hiyama, Masato; Kusakabe, Ken Takeshi; Sugi, Sinji; Kuniyoshi, Nobue; Kano, Kiyoshi; Kiso, Yasuo] Yamaguchi Univ, United Grad Sch Vet Sci, Lab Basic Vet Sci, Yamaguchi 7538515, Japan; [Kusakabe, Ken Takeshi; Imai, Hiroyuki; Kano, Kiyoshi; Kiso, Yasuo] Yamaguchi Univ, Fac Agr, Lab Vet Anat, Yamaguchi 7538515, Japan; [Takeshita, Ai] Osaka Prefecture Univ, Div Vet Sci, Grad Sch Life & Environm Sci, Dept Integrated Struct Biosci, Osaka 5988531, Japan	Kiso, Y (reprint author), Yamaguchi Univ, United Grad Sch Vet Sci, Lab Basic Vet Sci, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	ykiso@yamaguchi-u.ac.jp			JSPS KAKENHI [24.5017, 26450445, 24380159]	This study was supported by JSPS KAKENHI, Grant No. 24.5017 (to M.H.), No. 26450445 (to K-T.K.) and No. 24380159 (to Y.K)	Mortensen M, 2010, CELL CYCLE, V9, P1901; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Tanida I, 2006, FEBS J, V273, P2553, DOI 10.1111/j.1742-4658.2006.05260.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Bai H, 2012, ONCOGENE, V31, P4397, DOI 10.1038/onc.2011.613; El-Hashash AHK, 2010, MECH DEVELOP, V127, P1, DOI 10.1016/j.mod.2009.09.004; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Sumpter R, 2010, SEMIN CELL DEV BIOL, V21, P699, DOI 10.1016/j.semcdb.2010.04.003; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Othman EQG, 2009, J CLIN LAB ANAL, V23, P249, DOI 10.1002/jcla.20309; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Choi Jong-Ho, 2012, Clin Exp Reprod Med, V39, P73, DOI 10.5653/cerm.2012.39.2.73; Donehower LA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001081; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Hung TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083475; Kim BW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2606; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; von Muhlinen N, 2013, AUTOPHAGY, V9, P784, DOI 10.4161/auto.23698; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264	37	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					305	311		10.1292/jvms.14-0490		7	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000006		
J	Ohnishi, H; Mizuno, S; Mizuno-Horikawa, Y; Kato, T				Ohnishi, Hiroyuki; Mizuno, Shinya; Mizuno-Horikawa, Yoko; Kato, Takashi			Stromal cell-derived factor-1 (SDF1)-dependent recruitment of bone marrow-derived renal endothelium-like cells in a mouse model of acute kidney injury	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						acute kidney injury; bone marrow-derived cell; chemokine (C-X-C motif) receptor-4; endothelial cell; stromal cell-derived factor-1	MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; FAILURE; HYPOXIA; VITRO; RATS; NEOVASCULARIZATION; TRANSPLANTATION; PROLIFERATION; MOBILIZATION	Ischemic acute kidney injury (ART) is the most key pathological event for accelerating progression to chronic kidney disease through vascular endothelial injury or dysfunction. Thus, it is critical to elucidate the molecular mechanism of endothelial protection and regeneration. Emerging evidence indicates that bone marrow-derived cells (BMCs) contribute to tissue reconstitution in several types of organs post-injury, but little is known whether and how BMCs contribute to renal endothelial reconstitution, especially in an early-stage of AKI. Using a mouse model of ischemic AKI, we provide evidence that incorporation of BMCs in vascular components (such as endothelial and smooth muscle cells) becomes evident within four days after renal ischemia and reperfusion, associated with an increase in stromal cell-derived factor-1 (SDF1) in endothelium and that in CXCR4/SDF1-receptor in BMCs. Notably, anti-CXCR4 antibody decreased the numbers of infiltrated BMCs and BMC-derived endothelium-like cells, but not of BMC-derived smooth muscle cell-like cells. These results suggest that reconstitution of renal endothelium post-ischemia partially depends on a paracrine loop of SDF1-CXCR4 between resident endothelium and BMCs. Such a chemokine ligand-receptor system may be attributable for selecting a cellular lineage (s), required for renal vascular protection, repair and homeostasis, even in an earlier phase of AKI.	[Ohnishi, Hiroyuki; Mizuno, Shinya; Mizuno-Horikawa, Yoko; Kato, Takashi] Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan; [Ohnishi, Hiroyuki] Kinjo Gakuin Univ, Coll Pharm, Moriyama Ku, Nagoya, Aichi 4638521, Japan; [Mizuno, Shinya] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Div Virol, Suita, Osaka 5650871, Japan; [Kato, Takashi] Kinki Univ, Fac Med, Dept Pathol, Osaka 5898511, Japan	Mizuno, S (reprint author), Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mizuno@onbich.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23590458, 20590398]	This work was, in part, supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 23590458 and No. 20590398 to SM).	Mizuno S, 2005, AM J PATHOL, V166, P1895, DOI 10.1016/S0002-9440(10)62498-4; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171; Basile DP, 2011, AM J PHYSIOL-RENAL, V300, pF721, DOI 10.1152/ajprenal.00546.2010; Xia YF, 2014, KIDNEY INT, V86, P327, DOI 10.1038/ki.2014.64; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; MILLER SB, 1992, P NATL ACAD SCI USA, V89, P11876, DOI 10.1073/pnas.89.24.11876; Xu X, 2013, CELLS TISSUES ORGANS, V197, P103, DOI 10.1159/000342921; Fleissner F, 2011, ANTIOXID REDOX SIGN, V15, P933, DOI 10.1089/ars.2010.3502; Gehling UM, 2000, BLOOD, V95, P3106; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Chen B, 2013, TRANSPL P, V45, P2034, DOI 10.1016/j.transproceed.2013.01.096; Leonard EC, 2008, AM J PHYSIOL-RENAL, V295, pF1648, DOI 10.1152/ajprenal.00099.2008; Ebrahimi B, 2012, AM J PHYSIOL-RENAL, V302, pF1478, DOI 10.1152/ajprenal.00563.2011; Basile DP, 2004, CURR OPIN NEPHROL HY, V13, P1, DOI 10.1097/01.mnh.0000109576.66112.70; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Iwasaki M, 2005, J AM SOC NEPHROL, V16, P658, DOI 10.1681/ASN.2004010067; Kanellis J, 2002, KIDNEY INT, V61, P1696, DOI 10.1046/j.1523-1755.2002.00329.x; Lagaaij EL, 2001, LANCET, V357, P33, DOI 10.1016/S0140-6736(00)03569-8; Li JH, 2006, J AM SOC NEPHROL, V17, P2799, DOI 10.1681/ASN.2006020130; Liu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034608; Ohnishi H, 2008, AM J PHYSIOL-RENAL, V294, pF326, DOI 10.1152/ajprenal.00480.2007; Patschan D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-227; Pelosi E, 2014, BLOOD CELL MOL DIS, V52, P186, DOI 10.1016/j.bcmd.2013.11.004; Vannay A, 2004, EXP PHYSIOL, V89, P435, DOI 10.1113/expphysiol.2004.027516; van Oostrom O, 2009, CURR STEM CELL RES T, V4, P131; Wang DH, 2010, RENAL FAILURE, V32, P863, DOI 10.3109/0886022X.2010.494806; Zemecke A., 2005, CIRC RES, V96, P784	33	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					313	319		10.1292/jvms.14-0562		7	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000007		
J	Thanasarasakulpong, A; Poolperm, P; Tankaew, P; Sawada, T; Sthitmatee, N				Thanasarasakulpong, Arunee; Poolperm, Pichayanut; Tankaew, Pallop; Sawada, Takuo; Sthitmatee, Nattawooti			Protectivity conferred by immunization with intranasal recombinant outer membrane protein H from Pasteurella multocida serovar A:1 in chickens	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						intranasal vaccine; Pasteurella multocida; recombinant outer membrane protein H	IMMUNE-RESPONSES; VACCINATION; DELIVERY	Recombinant outer membrane protein H (rOmpH) is a potential fowl cholera vaccine candidate. The present study was aimed at developing rOmpH formulations for intranasal administration. The rOmpH was purified and formulated with either Escherichia coli entero-toxin B (LTB) or CpG oligodeoxynucleotides (ODN) as an adjuvant. Antibody responses in chickens intranasally immunized with rOmpH in combination with 2 different adjuvants were significantly increased (P<0.05) post immunization. Chicken survival rates showed that rOmpH formulated with ODN and LTB elicited 90% and 70% protection, respectively. Our findings indicated that rOmpH formulated with ODN elicited protection better than that formulated with LTB. Therefore, the vaccines formulations in the present study can be considered new intranasal vaccine formulations for fowl cholera in chickens.	[Thanasarasakulpong, Arunee; Tankaew, Pallop; Sthitmatee, Nattawooti] Chiang Mai Univ, Fac Vet Med, Chiang Mai 50100, Thailand; [Poolperm, Pichayanut] Payap Univ, Fac Pharm, Chiang Mai 50000, Thailand; [Sawada, Takuo] Nippon Vet & Life Sci Univ, Lab Vet Microbiol, Tokyo 1808602, Japan	Sthitmatee, N (reprint author), Chiang Mai Univ, Fac Vet Med, Dept Vet Biosci & Vet Publ Hlth, Chiang Mai 50100, Thailand.	drneaw@gmail.com			National Science and Technology Development Agency (NSTDA); Ministry of Science and Technology, Thailand [P-10-11170]; Faculty of Veterinary Medicine, Chiang Mai University	The authors would like to express their appreciation to the staff of the Central Laboratory, Faculty of Veterinary Medicine, Chiang Mai University, for the assistance provided for the experiment. This research was financially supported by the National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology, Thailand, grant No. P-10-11170, and partially supported by the Faculty of Veterinary Medicine, Chiang Mai University.	Ahmad TA, 2014, VACCINE, V32, P909, DOI 10.1016/j.vaccine.2013.11.068; Boyce JD, 2006, PROTEOMICS, V6, P870, DOI 10.1002/pmic.200401342; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Mutwiri G, 2003, VET IMMUNOL IMMUNOP, V91, P89, DOI 10.1016/S0165-2427(02)00246-5; Roier S, 2013, INT J MED MICROBIOL, V303, P247, DOI 10.1016/j.ijmm.2013.05.001; Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Conceicao FR, 2006, VACCINE, V24, P5734, DOI 10.1016/j.vaccine.2006.04.036; Woodrow KA, 2012, ANNU REV BIOMED ENG, V14, P17, DOI 10.1146/annurev-bioeng-071811-150054; Harper M, 2006, FEMS MICROBIOL LETT, V265, P1, DOI 10.1111/j.1574-6968.2006.00442.x; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Glisson J. R., 2003, DIS POULTRY, P657; Gong Q, 2013, VET IMMUNOL IMMUNOP, V152, P317, DOI 10.1016/j.vetimm.2013.01.001; Kharb S, 2011, VET RES COMMUN, V35, P457, DOI 10.1007/s11259-011-9484-8; Linghua L., 2007, RES VET SCI, V83, P171; Luo YG, 1997, J BACTERIOL, V179, P7856; Marandi MV, 1996, MICROBIOL-UK, V142, P199; RHOADES KR, 1987, AVIAN DIS, V31, P895, DOI 10.2307/1591048; Rimler R. B., 1997, DIS POULTRY, P143; Rimler RB, 1989, PASTEURELLA PASTEURE, P37; Sthitmatee N, 2008, VACCINE, V26, P2398, DOI 10.1016/j.vaccine.2008.02.051	22	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					321	326		10.1292/jvms.14-0532		6	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000008		
J	Aoki, T; Sunahara, H; Sugimoto, K; Ito, T; Kanai, E; Fujii, Y				Aoki, Takuma; Sunahara, Hiroshi; Sugimoto, Keisuke; Ito, Tetsuro; Kanai, Eiichi; Fujii, Yoko			Infective endocarditis of the aortic valve in a Border collie dog with patent ductus arteriosus	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						canine; infective endocarditis; patent ductus arteriosus	DISEASE; STENOSIS; BLOOD; LIGATION	Infective endocarditis (IE) in dogs with cardiac shunts has not been reported previously. However, we encountered a dog with concurrent patent ductus arteriosus (PDA) and IE. The dog was a 1-year-old, 13.9-kg female Border collie and presented with anorexia, weight loss, pyrexia (40.4 degrees C) and lameness. A continuous murmur with maximal intensity over the left heart base (Levine 5/6) was detected on auscultation. Echocardiography revealed a PDA and severe aortic stenosis (AS) caused by aortic-valve vegetative lesions. Corynebacterium spp. and Bacillus subtilis were isolated from blood cultures. The dog responded to aggressive antibiotic therapy, and the PDA was subsequently surgically corrected. After a series of treatments, the dog showed long-term improvement in clinical status.	[Aoki, Takuma; Sunahara, Hiroshi; Sugimoto, Keisuke; Fujii, Yoko] Azabu Univ, Sch Vet Med, Lab Vet Surg 1, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Ito, Tetsuro] Azabu Univ, Sch Vet Med, Lab Small Anim Clin, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Kanai, Eiichi] Azabu Univ, Sch Vet Med, Lab Vet Radiol, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan	Aoki, T (reprint author), Azabu Univ, Sch Vet Med, Lab Vet Surg 1, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	t-aoki@azabu-u.ac.jp					Angus JC, 1997, J AM VET MED ASSOC, V210, P55; Connelly MS, 1998, CAN J CARDIOL, V14, P395; YORK MK, 1990, J CLIN MICROBIOL, V28, P2114; KIENLE RD, 1994, J VET INTERN MED, V8, P423; Saint-Andre C, 2012, CIRCULATION, V125, P840, DOI 10.1161/CIRCULATIONAHA.111.024521; Cornell CC, 2004, J VET INTERN MED, V18, P311, DOI 10.1892/0891-6640(2004)18<311:ASOMCM>2.0.CO;2; Rushani D, 2013, CIRCULATION, V128, P1412, DOI 10.1161/CIRCULATIONAHA.113.001827; Aoki T, 2013, J VET MED SCI, V75, P199, DOI 10.1292/jvms.12-0322; Barker CW, 2003, AM J VET RES, V64, P694, DOI 10.2460/ajvr.2003.64.694; BIRCHARD SJ, 1990, J AM VET MED ASSOC, V196, P2011; BUCHANAN JW, 1995, J AM VET MED ASSOC, V206, P194; BUCKNALL TE, 1981, J ROY SOC MED, V74, P580; CALVERT CA, 1982, J AM VET MED ASSOC, V180, P1080; CILIBERTO G R, 1986, Giornale Italiano di Cardiologia, V16, P795; Dib EG, 2003, EMERG INFECT DIS, V9, P1013; EYSTER GE, 1976, J AM VET MED ASSOC, V168, P435; Fine DM, 2007, J VET INTERN MED, V21, P1265, DOI 10.1892/07-019.1; FIORETTI P, 1982, AM J CARDIOL, V49, P1728, DOI 10.1016/0002-9149(82)90252-1; Kienle R. D, SMALL ANIMAL CARDIOV, P260; Kittleson M. D, SMALL ANIMAL CARDIOV, P402; MacDonald K, 2010, VET CLIN N AM-SMALL, V40, P665, DOI 10.1016/j.cvsm.2010.03.010; MacDonald KA, 2004, J VET INTERN MED, V18, P56, DOI 10.1892/0891-6640(2004)18<56:APSOCI>2.0.CO;2; Meurs KM, 2005, JAVMA-J AM VET MED A, V227, P420, DOI 10.2460/javma.2005.227.420; Miller M. W., 2009, KIRKS CURRENT VET TH, VXIV, P744; Orton EC, 2000, J AM VET MED ASSOC, V216, P364, DOI 10.2460/javma.2000.216.364; Oyama MA, 2001, J AM ANIM HOSP ASSOC, V37, P519; Pekarkova M, 2008, J SMALL ANIM PRACT, V49, P44, DOI 10.1111/j.1748-5827.2007.00425.x; RELLER LB, 1973, AM J CLIN PATHOL, V60, P714; Saunders AB, 2014, J VET INTERN MED, V28, P401, DOI 10.1111/jvim.12267; SISSON D, 1984, J AM VET MED ASSOC, V184, P570; Sykes JE, 2006, JAVMA-J AM VET MED A, V228, P1735, DOI 10.2460/javma.228.11.1735; WASHINGTON JA, 1975, MAYO CLIN PROC, V50, P91; Weinstein MP, 1996, CLIN INFECT DIS, V23, P40; Wood AC, 2006, JAVMA-J AM VET MED A, V228, P1901, DOI 10.2460/javma.228.12.1901	34	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					331	336		10.1292/jvms.14-0384		6	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000010		
J	Fushimi, Y; Takagi, M; Kawaguchi, H; Miyoshi, N; Tsuka, T; Deguchi, E				Fushimi, Yasuo; Takagi, Mitsuhiro; Kawaguchi, Hiroaki; Miyoshi, Noriaki; Tsuka, Takeshi; Deguchi, Eisaburo			Three cases of idiopathic eosinophilic enteritis with chronic obstinate diarrhea in Japanese Black fattening cattle	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						eosinophilic enteritis; inflammatory bowel disease; Japanese Black cattle	GASTROENTERITIS; DISEASE; OBSTRUCTION; CATS	Eosinophilic enteritis (EOE) is a type of inflammatory bowel disease and is characterized clinically by chronic obstinate diarrhea. Three Japanese Black (JB) fattening cattle (2 males and 1 female) on different cattle farms presented with chronic episodic diarrhea without fever or dehydration. Soft reddish spherical cameous tissues (1-3 cm) were occasionally excreted within the diarrheic feces. Administration of antibiotics, antidiarrheal drugs and vermicides had no therapeutic effect, but dexamethasone improved the fecal characteristics. The symptoms persisted until the animals were slaughtered at 27-30 months of age. Histopathological examination of the intestines revealed marked eosinophilic infiltration in the lamina propria and submucosa. From these findings, we diagnosed these cattle as the first cases of EOE in JB cattle.	[Fushimi, Yasuo; Takagi, Mitsuhiro; Kawaguchi, Hiroaki; Miyoshi, Noriaki; Tsuka, Takeshi; Deguchi, Eisaburo] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan; [Fushimi, Yasuo] Shepherd Cent Livestock Clin, Kagoshima 8991611, Japan; [Takagi, Mitsuhiro; Kawaguchi, Hiroaki; Miyoshi, Noriaki; Deguchi, Eisaburo] Kagoshima Univ, Joint Fac Vet Med, Kagoshima 8900065, Japan; [Tsuka, Takeshi] Tottori Univ, Fac Agr, Tottori 6808553, Japan	Takagi, M (reprint author), Kagoshima Univ, Joint Fac Vet Med, Kagoshima 8900065, Japan.	mtakagi@agri.kagoshima-u.ac.jp					PASS DA, 1982, VET PATHOL, V19, P486; Makinen PE, 2008, EQUINE VET J, V40, P386, DOI 10.2746/042516408X284646; Archer DC, 2006, VET J, V171, P504, DOI 10.1016/j.tvjl.2005.02.031; Cebra ML, 1998, J AM VET MED ASSOC, V212, P258; CELLO JP, 1979, AM J MED, V67, P1097, DOI 10.1016/0002-9343(79)90652-1; GRIFFIN HE, 1990, J AM VET MED ASSOC, V197, P619; HENDRICK M, 1981, VET PATHOL, V18, P188; JERGENS AE, 1992, J AM VET MED ASSOC, V201, P1603; LEE CM, 1993, AM J GASTROENTEROL, V88, P70; QUIGLEY PJ, 1981, J COMP PATHOL, V91, P387, DOI 10.1016/0021-9975(81)90009-8; Uenishi T, 2003, DIGEST SURG, V20, P326, DOI 10.1159/000071759	11	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					337	340		10.1292/jvms.14-0460		4	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000011		
J	Tamura, T; Mine, J; Torii, S; Fujimoto, Y; Okamatsu, M; Sakoda, Y				Tamura, Tomokazu; Mine, Junki; Torii, Shiho; Fujimoto, Yuri; Okamatsu, Masatoshi; Sakoda, Yoshihiro			Pathogenicity of border disease virus FNK2012-1 strain isolated from a pig in the natural host, sheep	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						border disease virus; host; pathogenicity; sheep	SERUM-FREE CULTURE; CELL-LINE; JAPAN; ESTABLISHMENT; PESTIVIRUSES	A first isolation of border disease virus (BDV) in Japan was from a pig on a farm without keeping any ruminants. Our previous study showed that this BDV, termed the FNK2012-1 strain, replicated inefficiently in swine-derived cells compared with those of ruminant origin. Pigs inoculated with this virus showed neither clinical symptoms nor viremia. In this study, we evaluated the pathogenicity of the FNK2012-1 strain in sheep, its natural host. The inoculated sheep showed clinical symptoms and transient viremia. Seroconversion was observed in the inoculated sheep. These results suggest that the FNK2012-1 strain was introduced from sheep and has not yet adapted to swine. Therefore, surveillance of border disease in Japan is necessary among both the swine and ruminant populations.	[Tamura, Tomokazu; Mine, Junki; Torii, Shiho; Fujimoto, Yuri; Okamatsu, Masatoshi; Sakoda, Yoshihiro] Hokkaido Univ, Microbiol Lab, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Sakoda, Yoshihiro] Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ GICoRE, Sapporo, Hokkaido 0010020, Japan	Sakoda, Y (reprint author), Hokkaido Univ, Microbiol Lab, Dept Dis Control, Grad Sch Vet Med,Kita Ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	sakoda@vetmed.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25-1199]; Program for Leading Graduate Schools from JSPS [F01]; JSPS Research Fellowships for young scientists	We thank Kenhoku Ibaraki Prefectural Livestock Hygiene Service Center for providing the BDV strain FNK2012-1. We also thank Osamu Ichii and Yuri Abe for excellent technical support. The present work was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant number 25-1199 and in part by the Program for Leading Graduate Schools (F01) from JSPS. TT is supported by JSPS Research Fellowships for young scientists.	Sakoda Y, 1998, J VIROL METHODS, V75, P59, DOI 10.1016/S0166-0934(98)00098-6; Kameyama K, 2006, J VIROL METHODS, V138, P140, DOI 10.1016/j.jviromet.2006.08.005; MOENNIG V, 1992, ADV VIRUS RES, V41, P53, DOI 10.1016/S0065-3527(08)60035-4; La Rocca SA, 2009, J VIROL METHODS, V161, P122, DOI 10.1016/j.jviromet.2009.06.005; EDWARDS S, 1995, BRIT VET J, V151, P181, DOI 10.1016/S0007-1935(95)80008-5; Giangaspero M, 2011, J VET MED SCI, V73, P1629, DOI 10.1292/jvms.11-0072; Kawanishi N, 2014, VET MICROBIOL, V171, P210, DOI 10.1016/j.vetmic.2014.03.032; REED L. J., 1938, AMER JOUR HYG, V27, P493; Nagai M, 2014, J VET DIAGN INVEST, V26, P547, DOI 10.1177/1040638714541837; PATON DJ, 1995, J COMP PATHOL, V112, P215, DOI 10.1016/S0021-9975(05)80076-3; Sakoda Y, 1998, IN VITRO CELL DEV-AN, V34, P53; Simmonds P., 2011, VIRUS TAXONOMY, P1003; Vilcek S, 2006, VET MICROBIOL, V116, P1, DOI 10.1016/j.vetmic.2006.06.003	13	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					341	343		10.1292/jvms.14-0434		3	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000012		
J	Niimi, K; Oguchi, A; Nishio, K; Okano, Y; Takahashi, E				Niimi, Kimie; Oguchi, Ayaka; Nishio, Kenji; Okano, Yasushi; Takahashi, Eiki			Congenital malformation of the vaginal orifice, imperforate vagina, in the common marmoset (Callithrix jacchus)	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						common marmoset; congenital malformation; imperforate vagina; ovarian cycle	BIOMEDICAL-RESEARCH; MONKEY CALLITHRIX	The following is a report on a congenital vaginal malformation, imperforate vagina, in the common marmoset (Callithrix jacchus). This anomaly was observed for the first time in an adult female in our research colony. There was no uterine and vaginal aplasia or atresia in her grossly normal genital tract. The plasma progesterone concentration suggested that the ovarian cycle had ceased. However, this may not be related to a functional anomaly, but rather to suppressed ovulation resulting from subordination to cagemates considering the various stages of follicular development observed.	[Niimi, Kimie; Oguchi, Ayaka; Nishio, Kenji; Okano, Yasushi; Takahashi, Eiki] RIKEN Brain Sci Inst, Support Unit Anim Resources Dev, Res Resources Ctr, Wako, Saitama 3510198, Japan	Niimi, K (reprint author), RIKEN Brain Sci Inst, Support Unit Anim Resources Dev, Res Resources Ctr, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kimie@brain.riken.jp					ABBOTT DH, 1988, J ENDOCRINOL, V117, P329, DOI 10.1677/joe.0.1170329; ABBOTT DH, 1981, J REPROD FERTIL, V63, P335; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Abbott DH, 2003, COMPARATIVE MED, V53, P339; ABBOTT DH, 1978, J REPROD FERTIL, V53, P155; Simpson JL, 1999, AM J MED GENET, V89, P224, DOI 10.1002/(SICI)1096-8628(19991229)89:4<224::AID-AJMG7>3.0.CO;2-C; GRIFFIN JE, 1976, ANN INTERN MED, V85, P224; BARRETT J, 1990, J REPROD FERTIL, V90, P411; Beindorff N, 2010, REPRODUCTION, V139, P923, DOI 10.1530/REP-09-0257; CUI KH, 1994, J ANAT, V185, P481; Dell'Mour V, 2009, AM J PRIMATOL, V71, P503, DOI 10.1002/ajp.20682; Folch M, 2000, OBSTET GYNECOL SURV, V55, P644, DOI 10.1097/00006254-200010000-00023; Isachenko EF, 2002, J MED PRIMATOL, V31, P350, DOI 10.1034/j.1600-0684.2002.t01-1-02002.x; LOPATA A, 1988, FERTIL STERIL, V50, P503; McFadden D. E., 1992, GENITAL SYSTEM, P605; Morcel K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-13; Pittock ST, 2005, AM J MED GENET A, V135A, P314, DOI 10.1002/ajmg.a.30721; Richer C. B., 1984, LAB ANIMAL MED, P353; Saito A, 2011, PRIMATES, V52, P43, DOI 10.1007/s10329-010-0205-7; SUMMERS PM, 1985, J REPROD FERTIL, V73, P133; SUMMERS PM, 1987, J REPROD FERTIL, V79, P241	22	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					345	348		10.1292/jvms.14-0378		4	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000013		
J	Suto, J				Suto, Jun-ichi			Genetic analysis of litter size in mice	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						litter size; quantitative trait locus (QTL); RR/Sgn mouse; stillbirth	QUANTITATIVE TRAIT LOCI; AFFECTING REPRODUCTION; PROTEIN; DEFICIENT; ABLATION; HORMONE; MOUSE; PIGS; QTL	We performed quantitative trait locus (QTL) mapping analysis for litter size (total number of pups born and/or number of pups born alive) in 255 backcross mice derived from C57BL/6J and RR/Sgn inbred mice. We identified one significant QTL on chromosome 7 and 4 suggestive QTLs on chromosomes 3, 5, 10 and 13. In addition, two suggestive QTLs were identified on chromosomes 1 and 4 for the number of stillbirth. These results suggested that both litter size and number of stillbirth were heritable traits, although they were controlled by distinct genes. The RR allele was associated with reduced litter size and increased stillbirth at all QTLs. Therefore, RR mothers were observed to have reduced prolificacy in this particular genetic cross.	Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058634, Japan	Suto, J (reprint author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki 3058634, Japan.	jsuto@affrc.go.jp			National Institute of Agrobiological Sciences.	This work was supported by an institutional grant from the National Institute of Agrobiological Sciences.	Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Amable L, 2011, J BIOL CHEM, V286, P40413, DOI 10.1074/jbc.M111.244053; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Holl JW, 2004, J ANIM SCI, V82, P3421; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Kimmins S, 2007, MOL ENDOCRINOL, V21, P726, DOI 10.1210/me.2006-0332; Bidanel JP, 2011, GENETICS OF THE PIG, 2ND EDITION, P218, DOI 10.1079/9781845937566.0218; Smith CL, 2002, MOL CELL BIOL, V22, P525, DOI 10.1128/MCB.22.2.525-535.2002; Flodby P, 1996, J BIOL CHEM, V271, P24753; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Knol EF, 2002, LIVEST PROD SCI, V78, P47, DOI 10.1016/S0301-6226(02)00184-7; Cassady JP, 2001, J ANIM SCI, V79, P623; Reed DR, 2008, OBESITY, V16, P483, DOI 10.1038/oby.2007.26; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Ashe A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r182; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Chen CY, 2010, J ANIM SCI, V88, P3800, DOI 10.2527/jas.2009-2413; Finkenzeller D, 2003, MOL CELL BIOL, V23, P272, DOI 10.1128/MCB.23.1.272-279.2003; Herzog M, 2011, DEV BIOL, V350, P548, DOI 10.1016/j.ydbio.2010.12.014; HUNT DM, 1971, J EMBRYOL EXP MORPH, V26, P111; Lehman AL, 1998, P NATL ACAD SCI USA, V95, P9436, DOI 10.1073/pnas.95.16.9436; Li K, 2009, ANIM GENET, V40, P963, DOI 10.1111/j.1365-2052.2009.01931.x; Mackay T. F. C., 1996, INTRO QUANTITATIVE G; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Morley BJ, 2004, BRAIN RES, V1023, P41, DOI 10.1016/j.brainres.2004.07.006; Suto J, 2002, Reproduction, V123, P52; Suto J, 2004, J VET MED SCI, V66, P1033, DOI 10.1292/jvms.66.1033	27	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					353	358		10.1292/jvms.14-0350		6	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000015		
J	Izumi, Y; Hoshino, Y; Hosoya, K; Takagi, S; Okumura, M				Izumi, Yusuke; Hoshino, Yuki; Hosoya, Kenji; Takagi, Satoshi; Okumura, Masahiro			Isolation and characterization of canine tumor endothelial cells	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						angiogenesis; canine; tumor endothelial cell	RESISTANCE; CARCINOMA; GROWTH; CANCER; MARKER; CXCR7	The present study involved the isolation and characterization of canine tumor endothelial cells (TECs) from 2 malignancies. TECs were isolated using magnetic cell sorting following FITC labeling with UEA1 lectin, and they were characterized by measuring genetic and histopathological endothelial markers. Isolated TECs exhibited a cobblestone-like morphology and expressed both vascular endothelial growth factor receptor 2 (VEGFR2) and Von Willebrand factor (vWF). Further, both TECs and tumor cells derived from a seminoma exhibited increased C-X-C chemokine receptor type 7 (CXCR7) expression. However, CXCR7 expression was not detected in TECs and tumor cells derived from a hepatocellular carcinoma. Understanding TEC specific traits may be important in the development of more efficacious anti-angiogenic therapies that do not induce adverse effects.	[Izumi, Yusuke; Hosoya, Kenji; Okumura, Masahiro] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg, Sapporo, Hokkaido 0600818, Japan; [Hoshino, Yuki; Takagi, Satoshi] Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Sapporo, Hokkaido 0600818, Japan	Hoshino, Y (reprint author), Hokkaido Univ, Grad Sch Vet Med, Vet Teaching Hosp, Kita Ku, Kita 18 Jo Nishi 9 Cho Me, Sapporo, Hokkaido 0600818, Japan.	yhoshino@vetmed.hokudai.ac.jp					Akiyama K, 2013, PATHOL INT, V63, P37, DOI 10.1111/pin.12031; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Akiyama K, 2012, AM J PATHOL, V180, P1283, DOI 10.1016/j.ajpath.2011.11.029; Matsuda K, 2010, BIOCHEM BIOPH RES CO, V394, P947, DOI 10.1016/j.bbrc.2010.03.089; Wicki A, 2012, CLIN CANCER RES, V18, P454, DOI 10.1158/1078-0432.CCR-11-1102; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Kader KN, 2001, MICROVASC RES, V61, P220, DOI 10.1006/mvre.2001.2296; Maishi N, 2012, PATHOL INT, V62, P309, DOI 10.1111/j.1440-1827.2012.02792.x; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Mutsaers A. J., 2012, SMALL ANIMAL CLIN ON, P229; NABORS MW, 1991, J NEUROSURG, V75, P941, DOI 10.3171/jns.1991.75.6.0941	12	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					359	363		10.1292/jvms.14-0347		5	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000016		
J	Thongtharb, A; Chambers, JK; Uchida, K; Watanabe, K; Takahashi, A; Mochizuki, M; Nishimura, R; Nakayama, H				Thongtharb, Atigan; Chambers, James K.; Uchida, Kazuyuki; Watanabe, Ken-ichi; Takahashi, Ayaka; Mochizuki, Manabu; Nishimura, Ryohei; Nakayama, Hiroyuki			Lymphangiosarcoma with systemic metastases in a Japanese domestic cat	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						feline; lymphangiosarcoma; metastases	STEWART-TREVES-SYNDROME; DOG	A 4-year-2-month-old female Japanese domestic cat was diagnosed with lymphangiosarcoma through tissue biopsy of an amputated leg. Two months later, the cat was euthanized, and postmortem findings revealed edema, and bruising at the caudal region of the trunk, pulmonary hemorrhage, pulmonary nodules and mediastinal lymphadenopathy. Microscopically, neoplastic tissues were observed in the dermis and subcutis of the trunk, lung, mediastinal lymph nodes, diaphragm, omentum and mesentery. The tumor cells were spindle to polygonal-shaped with nuclear pleomorphism aligning along pre-existing collagen bundles and forming irregular vascular channels in which the erythrocytes were rarely observed. These cells were immunopositive for vimentin, von Willebrand factor and CD31. Based on the histopathological and immunohistochemical features, the neoplasia was diagnosed as lymphangiosarcoma with systemic metastases.	[Thongtharb, Atigan; Chambers, James K.; Uchida, Kazuyuki; Watanabe, Ken-ichi; Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan; [Takahashi, Ayaka] Univ Tokyo, Grad Sch Agr & Life Sci, Ctr Vet Med, Bunkyo Ku, Tokyo 1138657, Japan; [Mochizuki, Manabu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Emergency Med, Bunkyo Ku, Tokyo 1138657, Japan; [Nishimura, Ryohei] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Surg, Bunkyo Ku, Tokyo 1138657, Japan	Chambers, JK (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	achamber@mail.ecc.u-tokyo.ac.jp					Galeotti F, 2004, VET DERMATOL, V15, P13, DOI 10.1111/j.1365-3164.2004.00354.x; Sugiyama A, 2007, J COMP PATHOL, V137, P174, DOI 10.1016/j.jcpa.2007.06.004; Fossum TW, 1998, J AM ANIM HOSP ASSOC, V34, P301; Sanchez B, 2002, VET PATHOL, V39, P266, DOI 10.1354/vp.39-2-266; RUGGLES AJ, 1992, J AM VET MED ASSOC, V200, P1987; SWAYNE DE, 1989, J COMP PATHOL, V100, P91, DOI 10.1016/0021-9975(89)90093-5; Barnes JC, 1997, CAN VET J, V38, P42; Junginger J, 2010, J COMP PATHOL, V143, P57, DOI 10.1016/j.jcpa.2009.11.005; Hinrichs U, 1999, VET PATHOL, V36, P164, DOI 10.1354/vp.36-2-164; KELLY WR, 1981, VET PATHOL, V18, P224; Sharma A, 2012, J AM ACAD DERMATOL, V67, P1342, DOI 10.1016/j.jaad.2012.04.028; WALSH KM, 1984, J COMP PATHOL, V94, P611, DOI 10.1016/0021-9975(84)90066-5; Arslan H, 2007, J ORTHOP SCI, V12, P578, DOI 10.1007/s00776-007-1175-5; Chung KC, 2000, J HAND SURG-AM, V25A, P1163, DOI 10.1053/jhsu.2000.18490; Diessler ME, 2003, J VET MED A, V50, P452, DOI 10.1046/j.1439-0442.2003.00573.x; Ijzer J., 2000, Journal of Comparative Pathology, V122, P312, DOI 10.1053/jcpa.1999.0374; KOPPERMA.M, 1974, AM J ROENTGENOL, V121, P118; Lenard ZM, 2007, J FELINE MED SURG, V9, P161, DOI 10.1016/j.jfms.2006.09.005; Marcinowska A, 2013, J SMALL ANIM PRACT, V54, P334, DOI 10.1111/jsap.12054; Sánchez-Medina M T, 2012, Actas Dermosifiliogr, V103, P545, DOI 10.1016/j.ad.2011.10.011; Sleeckx N, 2013, J COMP PATHOL, V148, P307, DOI 10.1016/j.jcpa.2012.09.007; Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209; Williams JH, 2005, J S AFR VET ASSOC, V76, P165	23	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					371	374		10.1292/jvms.14-0502		4	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000018		
J	Yoshida, M; Onda, K; Wada, Y; Kuwahara, M				Yoshida, Masumi; Onda, Ken; Wada, Yasunori; Kuwahara, Masayoshi			Influence of sickness condition on diurnal rhythms of heart rate and heart rate variability in cows	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						autonomic nervous system; cattle; diurnal rhythms; heart rate	POWER-SPECTRAL-ANALYSIS; AUTONOMIC NERVOUS FUNCTION; STRESS; CATTLE	Parameters of heart rate variability would explain changes in heart rate during the disease status in cows and to evaluate whether such changes might provide a more sensitive and quantitative indicator of these conditions than crude indices. For this purpose, we recorded electrocardiograms for 24 hr using a Holter-type electrocardiograph and applied power spectral analysis of heart rate variability in both five clinically healthy and four hospitalized cows. The significant findings of the current investigation were that the diurnal variations of autonomic nervous function are abolished in cows that are sick. This abnormal rhythm was induced by predominant parasympathetic inhibition in these cows. Therefore, the heart rate variability may be a useful indicator of sickness condition in cows.	[Yoshida, Masumi; Kuwahara, Masayoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathophysiol & Anim Hlth, Tokyo 1138657, Japan; [Yoshida, Masumi; Onda, Ken; Wada, Yasunori] Azabu Univ, Sch Vet Med, Lab Internal Med 3, Sagamihara, Kanagawa 2525201, Japan	Kuwahara, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathophysiol & Anim Hlth, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akuwam@mail.ecc.u-tokyo.ac.jp					Akita M, 2002, EXP ANIM TOKYO, V51, P1, DOI 10.1538/expanim.51.1; Hagen K, 2005, PHYSIOL BEHAV, V85, P195, DOI 10.1016/j.physbeh.2005.03.019; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; PAGANI M, 1986, CIRC RES, V59, P178; DILLON JF, 1994, AM J GASTROENTEROL, V89, P1544; Kuwahara M, 1996, J AUTONOM NERV SYST, V60, P43, DOI 10.1016/0165-1838(96)00028-8; Mohr E, 2002, PHYSIOL BEHAV, V75, P251, DOI 10.1016/S0031-9384(01)00651-5; YERAGANI VK, 1993, PSYCHIAT RES, V46, P89, DOI 10.1016/0165-1781(93)90011-5; Griffin MP, 2001, PEDIATRICS, V107, P97, DOI 10.1542/peds.107.1.97; GOLDSTEIN B, 1995, CRIT CARE MED, V23, P1694, DOI 10.1097/00003246-199510000-00014; Ishii K, 1996, LAB ANIM, V30, P359, DOI 10.1258/002367796780739880; Konold Timm, 2011, BMC Res Notes, V4, P259, DOI 10.1186/1756-0500-4-259; Kuwahara M, 1999, EQUINE VET J S, V30, P178; KUWAHARA M, 1994, J ELECTROCARDIOL, V27, P333, DOI 10.1016/S0022-0736(05)80272-9; Kuwahara M, 1999, LAB ANIM SCI, V49, P202; Camm AJ, 1996, EUR HEART J, V17, P354; Minero M, 2001, VET REC, V149, P772; Ohmura H, 2006, AM J VET RES, V67, P455, DOI 10.2460/ajvr.67.3.455; Pomfrett CJD, 2004, VET REC, V154, P687; Watson JP, 1999, EUR RESPIR J, V13, P1097, DOI 10.1034/j.1399-3003.1999.13e26.x	20	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					375	379		10.1292/jvms.14-0402		5	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000019		
J	Mase, M; Kanehira, K				Mase, Masaji; Kanehira, Katsushi			Surveillance of avian paramyxovirus serotype-1 in migratory waterfowls in Japan between 2011 and 2013	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						avian paramyxovirus type 1; genotype; phylogeny	NEWCASTLE-DISEASE VIRUS; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; KOREA; DIVERSITY; CHICKENS; REGION; BIRDS	To further understand the epidemiology of avian paramyxovirus serotype-1 (APMV-1) in migratory waterfowls in Japan, we conducted the surveillance of this virus from feces derived from the migratory waterfowls collected in 41 Japanese prefectures between October 2011 and March 2013. Six APMV-1 viruses were isolated from total 661 samples. All isolates were identified as the avirulent (lentogenic) type on the basis of intracerebral pathogenicity tests. Genetic analysis showed that these viruses possessed the deduced amino acid sequence of (112)GKQGR-L-117 or (112)ERGER-L-117 at the cleavage site of the F0 protein, which was identical to the motif in the avirulent type. Phylogenetic analysis based on the partial fusion protein gene classified these APMV-1 isolates into 2 major genetic groups. Four isolates were classified as class II genotype I, and they were genetically closely related to strains isolated in Asian countries, including Japan. In contrast, two isolates were classified as class I, and they were genetically closely related to strains mainly isolated in the U.S.A.	[Mase, Masaji; Kanehira, Katsushi] Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan; [Mase, Masaji] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan	Mase, M (reprint author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	masema@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan	This study was supported by a Grant- in- Aid from the Regulatory Research Project (for Food Safety, Animal Health and Plant Protection) of the Ministry of Agriculture, Forestry and Fisheries of Japan. We thank the staff in each prefecture that collected fecal samples. The authors wish to thank Mr. T. Inoue for his technical assistance in this study.	Hu BX, 2010, VET MICROBIOL, V144, P82, DOI 10.1016/j.vetmic.2010.01.003; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/0307945031000097831; Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Lee EK, 2009, VET MICROBIOL, V134, P241, DOI 10.1016/j.vetmic.2008.08.020; Lee YJ, 2004, AVIAN PATHOL, V33, P482, DOI 10.1080/03079450400003700; Mase M, 2005, MICROBIOL IMMUNOL, V49, P871; Mase M, 2009, J VET MED SCI, V71, P1101, DOI 10.1292/jvms.71.1101; Mase M, 2002, J CLIN MICROBIOL, V40, P3826, DOI 10.1128/JCM.40.10.3826-3830.2002; Miller P.J., 2013, DIS POULTRY, P89; Qin ZM, 2008, J CLIN MICROBIOL, V46, P601, DOI 10.1128/JCM.01356-07; Ramey AM, 2013, ARCH VIROL, V158, P2495, DOI 10.1007/s00705-013-1761-0; Ruenphet S, 2011, AVIAN DIS, V55, P230, DOI 10.1637/9589-102510-Reg.1; Rui Zhang, 2010, Vet Microbiol, V141, P246, DOI 10.1016/j.vetmic.2009.09.020; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Umali DV, 2014, J VET MED SCI, V76, P423, DOI 10.1292/jvms.13-0539	19	0	0	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250	1347-7439		J VET MED SCI	J. Vet. Med. Sci.	MAR	2015	77	3					381	385		10.1292/jvms.14-0550		5	Veterinary Sciences	Veterinary Sciences	CE6SR	WOS:000351969000020		
J	Fujimoto, T; Ito, S; Sujino, T; Kanazawa, H				Fujimoto, Takahiro; Ito, Shinobu; Sujino, Toshio; Kanazawa, Hideko			COMPARISON STUDY OF RAPID REPETITION RATE AND CONTINUOUS NEAR INFRARED (NIR) LIGHT DEVICES: DETECTION OF THE DIFFERENT REACTIVE OXYGEN SPECIES INDUCED OXIDATIVE STRESS IN SKIN DURING IRRADIATION, RESPECTIVELY	LASERS IN SURGERY AND MEDICINE			English	Meeting Abstract									ClinicF, Tokyo, Japan; ITO Co Ltd, Tokyo, Japan; Tokyo Univ Technol, Sch Biosci, Tokyo, Japan; Keio Univ, Sch Pharm, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0196-8092	1096-9101		LASER SURG MED	Lasers Surg. Med.	MAR	2015	47			26		9	3	4				2	Surgery	Surgery	CE8NN	WOS:000352099900010		
J	Akita, H; Morita, Y; Ito, N; Sasaki, R; Negishi, K; Matsunaga, K				Akita, Hirotaka; Morita, Yusuke; Ito, Naoko; Sasaki, Ryosuke; Negishi, Kei; Matsunaga, Kayoko			COMPARISON OF THE INCIDENCE OF POST-INFLAMMATORY HYPERPIGMENTATION FROM 3 TYPES OF Q-SWITCHED LASER TREATMENT FOR SENILE LENTIGINES IN ASIAN SKIN	LASERS IN SURGERY AND MEDICINE			English	Meeting Abstract									Fujita Hlth Univ, Sch Med, Toyoake, Aichi 47011, Japan; Kariya Toyota Gen Hosp, Kariya, Aichi, Japan; Tokyo Womens Med Univ, Aoyama Inst Womens Med, Aoyama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0196-8092	1096-9101		LASER SURG MED	Lasers Surg. Med.	MAR	2015	47			26		75	26	26				1	Surgery	Surgery	CE8NN	WOS:000352099900075		
J	Kono, T; Kotaro, I; Mariko, F; Muneo, M				Kono, Taro; Kotaro, Imagawa; Mariko, Fujibayashi; Muneo, Miyasaka			MICROPULSE ALEXANDRITE LASER TREATMENT OF SOLAR LENTIGINES IN ASIANS	LASERS IN SURGERY AND MEDICINE			English	Meeting Abstract									[Kono, Taro; Kotaro, Imagawa; Mariko, Fujibayashi; Muneo, Miyasaka] Tokai Univ, Isehara, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0196-8092	1096-9101		LASER SURG MED	Lasers Surg. Med.	MAR	2015	47			26		80	27	28				2	Surgery	Surgery	CE8NN	WOS:000352099900080		
J	Chen, X; Tang, SA; Lee, E; Qiu, YL; Wang, R; Duan, HQ; Dan, SG; Jin, MH; Kong, DX				Chen, Xi; Tang, Sheng-An; Lee, Eunkyung; Qiu, Yuling; Wang, Ran; Duan, Hong-Quan; Dan, Shingo; Jin, Meihua; Kong, Dexin			IVSE, isolated from Inula japonica,suppresses LPS-induced NO production via NF-kappa B and MAPK inactivation in RAW264.7 cells	LIFE SCIENCES			English	Article						I. japonica; IVSE; NO; NF-kappa 13; MAPK	TOLL-LIKE RECEPTORS; INULA-JAPONICA; NITRIC-OXIDE; SIGNALING NETWORKS; AERIAL PARTS; INFLAMMATION; ACTIVATION; EXPRESSION; KINASE; INOS	Aims: Our previous study showed that the extract of Inula japonica Thunb. (I. japonica) has anti-inflammatory and anti-asthmatic activities. In an attempt to find anti-inflammatory compounds from I. japonica, we recently isolated 1,6 alpha-dihydroxy-4 alpha H-1,10-secoeudesma-5(10),11(13)-dien-12,8 beta-olide (SE), 6 alpha-isobutyryloxy-1-hydroxy-4 alpha H-1,10-secoeudesma-5(10),11(13)-dien-12,8 beta-olide (IBSE), and 6 alpha-isovaleryloxy-1-hydroxy-4 alpha H-1,10-secoeudesma-5(10),11(13)-dien-12,8 beta-olide (IVSE) from the extract of I. japonica, and investigated their inhibitory effects on nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Main methods: The inhibitory effect of IVSE, SE and IBSE on NO production in LPS-induced RAW264.7 cells was examined using Griess reagent, and the effects of IVSE on the expressions of inducible nitric oxide synthase (iNOS) and its upstream signal proteins including I kappa B kinase (IKK)/inhibitor kappa B (I kappa B)-alpha/nuclear factor kappa B (NF-kappa B) and mitogen-activated protein kinases (MAPKs) were investigated by Western blot. Key findings: Among the 3 compounds isolated, SE, IBSE, and IVSE inhibited NO production at 2.5 mu M with 5.1%, 40.4%, and 52.8%, respectively. IVSE displayed the most potent inhibition of NO production. Mechanism analysis indicated that IVSE dramatically decreased the expression of iNOS, reduced the translocation of the NF-kappa B subunit p65 into the nucleus by interrupting the phosphorylation and degradation of I kappa B-alpha, and inhibited the activation of the upstream mediator IKK alpha/beta. Furthermore, our results showed that IVSE inhibited the phosphorylation of MAPKs including extracellular regulated kinases (ERK1/2), c-Jun N-terminal kinases (JNK) and p38. Significance: IVSE exhibited anti-inflammatory activity by inhibiting NO production, in which inactivation of NE-kappa B and MAPKs might be involved. Our results suggest that IVSE might become an anti-inflammatory drug candidate. (C) 2015 Elsevier Inc. All rights reserved.	[Chen, Xi; Qiu, Yuling; Wang, Ran; Duan, Hong-Quan; Jin, Meihua; Kong, Dexin] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China; [Chen, Xi] Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin 300020, Peoples R China; [Lee, Eunkyung] Korean Promot Inst Tradit Med, Div Res & Dev, Gyongsan 712210, South Korea; [Duan, Hong-Quan; Kong, Dexin] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China; [Dan, Shingo; Kong, Dexin] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Pharmacol, Koto Ku, Tokyo 1358550, Japan	Jin, MH (reprint author), Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China.	jinmeihua@tijmu.edu.cn; kongdexin@tijmu.edu.cn			National Natural Science Foundation of China [81373441, 81202542, 81402901]; Natural Science Foundation of Tianjin [12JCZDJC25800, 13JCYBJC24800]; New Teachers' Fund for Doctor Stations from Ministry of Education, China [20121202120009]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China Postdoctoral Science Foundation Funded Project [2014M551035, 2014M551037]; Tianjin Medical University Research Fund [2013ky07]; Japan Society for the Promotion of Science [FY2013, BR131302]	This work was supported by grants from the National Natural Science Foundation of China (81373441, 81202542, 81402901), the Natural Science Foundation of Tianjin (12JCZDJC25800, 13JCYBJC24800), the New Teachers' Fund for Doctor Stations from Ministry of Education, China (20121202120009), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China Postdoctoral Science Foundation Funded Project (2014M551035, 2014M551037), the Tianjin Medical University Research Fund (2013ky07), and the Japan Society for the Promotion of Science (FY2013, BR131302).	Lu Y, 2012, J ETHNOPHARMACOL, V143, P151, DOI 10.1016/j.jep.2012.06.015; Virdis A, 2014, MATURITAS, V78, P179, DOI 10.1016/j.maturitas.2014.04.012; Ji LL, 2007, APPL PHYSIOL NUTR ME, V32, P930, DOI 10.1139/H07-098; Selmi C, 2014, IMMUNOL RES, V60, P277, DOI 10.1007/s12026-014-8565-5; Shin JS, 2011, BRIT J PHARMACOL, V164, P145, DOI 10.1111/j.1476-5381.2011.01351.x; Jin M, 2010, FOOD CHEM TOXICOL, V48, P3073, DOI 10.1016/j.fct.2010.07.048; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Jin MH, 2008, BIOL PHARM BULL, V31, P1312, DOI 10.1248/bpb.31.1312; Gong HQ, 2011, HELV CHIM ACTA, V94, P1269, DOI 10.1002/hlca.201000417; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Park HH, 2013, INT IMMUNOPHARMACOL, V15, P296, DOI 10.1016/j.intimp.2012.12.005; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Yang C, 2003, PLANTA MED, V69, P662, DOI 10.1055/s-2003-41123; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI126322; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Qin JJ, 2010, TETRAHEDRON, V66, P9379, DOI 10.1016/j.tet.2010.09.091; Park YN, 2011, BIOSCI BIOTECH BIOCH, V75, P871, DOI 10.1271/bbb.100787; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Choi Jeon Hyeun, 2010, Immune Netw, V10, P145, DOI 10.4110/in.2010.10.5.145; Hagerling C., 2015, TRENDS CELL BIOL; JESKE F, 1993, PHYTOCHEMISTRY, V34, P1647, DOI 10.1016/S0031-9422(00)90865-3; Jiang A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024960; Jin M, 2010, BIOL PHARM BULL, V33, P1; Jin MH, 2014, INFLAMMATION, V37, P1254, DOI 10.1007/s10753-014-9852-y; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Lee Tae-Hyeong, 2014, Asia Pac Allergy, V4, P187, DOI 10.5415/apallergy.2014.4.4.187; Mohamed M. R., 2009, CELL CYCLE, V8, P3125; Müller-Ladner Ulf, 2002, Curr Rheumatol Rep, V4, P201, DOI 10.1007/s11926-002-0066-1; Qin JJ, 2009, ARCH PHARM RES, V32, P1369, DOI 10.1007/s12272-009-2004-5; Su X, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/275178, DOI 10.1155/2014/275178]; Tang SA, 2014, PLANTA MED, V80, P583, DOI 10.1055/s-0034-1368353; Uusitupa M, 2013, CAN J DIABETES, V37, P327, DOI 10.1016/j.jcjd.2013.07.029; Zhiqin Wong, 2014, Intest Res, V12, P194, DOI 10.5217/ir.2014.12.3.194	39	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	MAR 1	2015	124						8	15		10.1016/j.lfs.2015.01.008		8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CE8TX	WOS:000352118100002		
J	Horibe, S; Matsuda, A; Tanahashi, T; Inoue, J; Kawauchi, S; Mizuno, S; Ueno, M; Takahashi, K; Maeda, Y; Maegouchi, T; Murakami, Y; Yumoto, R; Nagai, J; Takano, M				Horibe, Sayo; Matsuda, Akira; Tanahashi, Toshihito; Inoue, Jun; Kawauchi, Shoji; Mizuno, Shigeto; Ueno, Masaki; Takahashi, Kyohei; Maeda, Yusaku; Maegouchi, Tatsuya; Murakami, Yoshiki; Yumoto, Ryoko; Nagai, Junya; Takano, Mikihisa			Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins	LIFE SCIENCES			English	Article						Cisplatin; Drug resistance; Cross resistance; A549; Cdc2; Cdc25C	CIS-DIAMMINEDICHLOROPLATINUM(II); OXALIPLATIN; TOXICITY; REPAIR; KINASE; LINES	Aims: Cisplatin (CDDP) is a platinum-based drug that is widely used in cancer chemotherapy, but the development of resistance in tumor cells is a major weakness of these treatments. Several mechanisms have been proposed to explain cisplatin resistance, and disruption of certain cellular pathways could modulate drug sensitivity to cisplatin. A lower level of cross-resistance to cisplatin leads to better outcomes in clinical use. Main methods: Cross-resistance was assessed using cisplatin resistant lung cancer cell line A549/CDDP. Cell cycle analysis was used to examine the effect of cisplatin on cell signaling pathways regulating G2/M transition in cisplatin resistant cells. Key findings: A549/CDDP cells exhibited cross-resistance to carboplatin, but not oxaliplatin, which is often found in platinum analogues. Flow cytometry showed that nocodazole treatment caused a G2/M block in both A549/ CDDP cells and cisplatin susceptible cells. However, A549/CDDP cells escaped the G2/M block following exposure to cisplatin. Activation of the Cdc2/CyclinB complex is required for transition from G2 to M phase, and the inactive form of phosphorylated Cdc2 is activated by Cdc25C dephosphorylation of Tyr15. In the cisplatin-treated susceptible cells, the levels of phosphorylated Cdc2 and Cdc25C were markedly decreased, leading to a loss of Cdc2 activity and G2/M arrest. In A549/CDDP cells, however, Cdc2 activity was supported by the expression of Cdc2 and Cdc25C after the addition of cisplatin, which resulted in G2/M progression. Significance: The resistance phenotype of G2/M progression has been correlated with dysregulation of Cdc2 in a human lung cancer cell line selected for cisplatin. (C) 2015 Elsevier Inc. All rights reserved.	[Horibe, Sayo; Matsuda, Akira; Ueno, Masaki; Takahashi, Kyohei; Maeda, Yusaku; Maegouchi, Tatsuya] Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Med & Biochem Anal, Kure, Hiroshima 7370112, Japan; [Horibe, Sayo; Tanahashi, Toshihito; Inoue, Jun; Kawauchi, Shoji; Mizuno, Shigeto] Kobe Pharmaceut Univ, Dept Med Pharmaceut, Kobe, Hyogo 6588558, Japan; [Murakami, Yoshiki] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan; [Yumoto, Ryoko; Nagai, Junya; Takano, Mikihisa] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmaceut & Therapeut, Hiroshima 7348553, Japan	Tanahashi, T (reprint author), Kobe Pharmaceut Univ, Dept Med Pharmaceut, Higashinada Ku, 4-19-1 Motoyama Kita, Kobe, Hyogo 6588558, Japan.	tana@kobepharma-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26460212, 25860568]; KOSEI-KAKENHI [H25-B sou-Kan-en-general-018]; Hyogo Science and Technology Association	This study was supported by a Grant-in-Aid (no. 26460212) to TT and a Grant-in-Aid for Young Scientists (B) (no. 25860568) to JI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. TT and YM were financially supported by KOSEI-KAKENHI (H25-B sou-Kan-en-general-018). TT was also supported by a Grant-in-Aid from Hyogo Science and Technology Association.	Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; TASHIRO T, 1989, BIOMED PHARMACOTHER, V43, P251, DOI 10.1016/0753-3322(89)90004-8; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Komatsu M, 2000, CANCER RES, V60, P1312; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Doree M, 2002, J CELL SCI, V115, P2461; Raymond E, 2002, MOL CANCER THER, V1, P227; Kurokawa K, 2012, J GASTROENTEROL, V47, P883, DOI 10.1007/s00535-012-0547-6; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Dan S, 2001, BIOCHEM BIOPH RES CO, V280, P861, DOI 10.1006/bbrc.2000.4231; Horibe S, 2011, J PHARM SCI-US, V100, P3010, DOI 10.1002/jps.22501; LAI GM, 1989, J NATL CANCER I, V81, P535, DOI 10.1093/jnci/81.7.535; Lopez-Girona A, 1999, NATURE, V397, P172; NISHIO K, 1993, INT J CANCER, V55, P616, DOI 10.1002/ijc.2910550417; ORMEROD MG, 1994, BRIT J CANCER, V69, P93, DOI 10.1038/bjc.1994.14; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; SORENSON CM, 1988, CANCER RES, V48, P4484; SORENSON CM, 1988, CANCER RES, V48, P6703; Zeng-Rong Nie, 1995, Cancer Research, V55, P4760	20	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	MAR 1	2015	124						31	40		10.1016/j.lfs.2015.01.011		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CE8TX	WOS:000352118100005		
J	Nishiguchi, A; Matsusaki, M; Akashi, M				Nishiguchi, Akihiro; Matsusaki, Michiya; Akashi, Mitsuru			Cell-Cell Crosslinking by Bio-Molecular Recognition of Heparin-Based Layer-by-Layer Nanofilms	MACROMOLECULAR BIOSCIENCE			English	Article						cell surface; crosslinking; molecular recognition; thin films; tissue engineering	EXTRACELLULAR-MATRIX; COLLOIDAL-GELATION; SURFACE; PARTICLES; ENCAPSULATION; BIOMATERIALS; CHEMISTRY; TISSUES; FILMS	When bio-molecular recognition between nanofilms and proteins occurs on cell surfaces, rapid cellular assembly takes place. Cells coated with layer-by-layer nanofilms composed of fibronectin and heparin form aggregates after centrifugation and nanofilms induce attractive forces between cells through bio-molecular recognition between membrane proteins and heparin. Cell aggregates display network structures of cells as seen in colloidal gels with high viscosity. Cellcell crosslinking allows for the construction of 3D-tissues with rich glycosaminoglycan. This cellcell crosslinking process that uses a layer-by-layer technique has enormous potential for in vitro tissue applications in regenerative medicine and cell signaling assays.	[Nishiguchi, Akihiro; Matsusaki, Michiya; Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	akashi@chem.eng.osaka-u.ac.jp			NEXT Program [LR026]; SENTAN-JST Program [13A1204];  [A232250040];  [24.622]	This work was supported by the NEXT Program (LR026), a Grant-in-Aid for Scientific Research (S) (A232250040), the SENTAN-JST Program (13A1204), and Grand-in-Aid for JSPS Fellows (24.622). We also thank Dr. H. Uyama and Dr. T. Tsujimoto in Osaka University for the viscosity measurements and A. Kimura for her technical assistance of histological experiments.	Neu B, 2001, J MICROENCAPSUL, V18, P385; Yang SH, 2009, ANGEW CHEM INT EDIT, V48, P9160, DOI 10.1002/anie.200903010; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Segre PN, 2001, PHYS REV LETT, V86, P6042, DOI 10.1103/PhysRevLett.86.6042; Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631; Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/nchem.1090, 10.1038/NCHEM.1090]; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Gartner ZJ, 2009, P NATL ACAD SCI USA, V106, P4606, DOI 10.1073/pnas.0900717106; Matsusaki M, 2009, TISSUE ENG PT A, V15, P55, DOI 10.1089/ten.tea.2007.0424; Russell ER, 2012, SOFT MATTER, V8, P8697, DOI 10.1039/c2sm25901j; Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006; De Bank PA, 2007, BIOTECHNOL BIOENG, V97, P1617, DOI 10.1002/bit.21343; Lu PJ, 2008, NATURE, V453, P499, DOI 10.1038/nature06931; Pulsipher A, 2014, J AM CHEM SOC, V136, P6794, DOI 10.1021/ja5005174; Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050; Swiston AJ, 2008, NANO LETT, V8, P4446, DOI 10.1021/nl802404h; Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787; Kadowaki K, 2010, LANGMUIR, V26, P5670, DOI 10.1021/la903738n; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; Zhao WA, 2010, MATER TODAY, V13, P14; Costa RR, 2014, CHEM SOC REV, V43, P3453, DOI 10.1039/c3cs60393h; Dutta D, 2011, J AM CHEM SOC, V133, P8704, DOI 10.1021/ja2022569; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P390, DOI DOI 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.C0;2-B; Conrad H. E., 1998, HEPARIN BINDING PROT, P3; DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145; Kadowaki K, 2012, CHEM LETT, V41, P523, DOI 10.1246/cl.2012.523; Koyfman AY, 2009, J AM CHEM SOC, V131, P14237, DOI 10.1021/ja9015638; Lee KY, 2003, ADV MATER, V15, P1828, DOI 10.1002/adma.200305406; Sauerbrey G. Z., 1959, PHYSIK, V155, P206; Saxon E, 2000, SCIENCE, V287, P2000; TARSIO JF, 1987, BIOCHEMISTRY-US, V26, P1014, DOI 10.1021/bi00378a006; Veerabadran G. N., 2007, MACROMOL BIOSCI, V7, P877; Wilson J. T., 2008, NANO LETT, P8	39	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1616-5187	1616-5195		MACROMOL BIOSCI	Macromol. Biosci.	MAR	2015	15	3					312	317		10.1002/mabi.201400415		6	Biochemistry & Molecular Biology; Materials Science, Biomaterials; Polymer Science	Biochemistry & Molecular Biology; Materials Science; Polymer Science	CE3PF	WOS:000351739100002		
J	Zhang, W; Oda, T; Yu, Q; Jin, JO				Zhang, Wei; Oda, Tatsuya; Yu, Qing; Jin, Jun-O			Fucoidan from Macrocystis pyrifera Has Powerful Immune-Modulatory Effects Compared to Three Other Fucoidans	MARINE DRUGS			English	Article							ASCOPHYLLUM-NODOSUM; DENDRITIC CELLS; SCAVENGER RECEPTOR; ADAPTIVE IMMUNITY; BROWN SEAWEEDS; MATURATION; NEUTROPHILS; CYTOKINES; INNATE; POLYSACCHARIDE	Fucoidan, a sulfated polysaccharide purified from brown algae, has a variety of immune-modulation effects, such as promoting activation of dendritic cells (DCs), natural killer (NK) cells and T cells, and enhancing anti-viral and anti-tumor responses. However, the immune-modulatory effect of fucoidan from different seaweed extracts has not been thoroughly analyzed and compared. We analyzed fucoidans obtained from Ascophyllum nodosum (A. nodosum), Macrocystis pyrifera (M. pyrifera), Undaria pinnatifida (U. pinnatifida) and Fucus vesiculosus (F. vesiculosus) for their effect on the apoptosis of human neutrophils, activation of mouse NK cells, maturation of spleen DCs, proliferation and activation of T cells, and the adjuvant effect in vivo. Fucoidans from M. pyrifera and U. pinnatifida strongly delayed human neutrophil apoptosis at low concentration, whereas fucoidans from A. nodosum and F. vesiculosus delayed human neutrophil apoptosis at higher concentration. Moreover, fucoidan from M. pyrifera promoted NK cell activation and cytotoxic activity against YAC-1 cells. In addition, M. pyrifera fucoidan induced the strongest activation of spleen DCs and T cells and ovalbumin (OVA) specific immune responses compared to other fucoidans. These data suggest that fucoidan from M. pyrifera can be potentially useful as a therapeutic agent for infectious diseases, cancer and an effective adjuvant for vaccine.	[Zhang, Wei; Jin, Jun-O] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China; [Oda, Tatsuya] Nagasaki Univ, Div Biochem, Fac Fisheries, Nagasaki, Nagasaki 8528521, Japan; [Yu, Qing] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA	Jin, JO (reprint author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China.	weiwei061215@126.com; t-oda@nagasaki-u.ac.jp; qyu@forsyth.org; junojin1@gmail.com			Research fund for International Young Scientists from National Natural Science Foundation of China [81450110090]; Nagasaki University Major Research Project (Research Initiative for Adaptation to Future Ocean Change)	We thank the Shanghai Public Health Clinical Center animal facility for maintaining animals. This study was supported by Research fund for International Young Scientists from National Natural Science Foundation of China (81450110090). Tatsuya Oda was supported by a fund from Nagasaki University Major Research Project (Research Initiative for Adaptation to Future Ocean Change).	Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Jin JO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099396; Carvalho ACS, 2014, PANCREAS, V43, P82, DOI 10.1097/MPA.0b013e3182a63b9d; Nakayasu S, 2009, BIOSCI BIOTECH BIOCH, V73, P961, DOI 10.1271/bbb.80845; Azuma K, 2012, MAR DRUGS, V10, P2337, DOI 10.3390/md10102337; Jin JO, 2009, BLOOD, V113, P5839, DOI 10.1182/blood-2008-10-184796; Tan JKH, 2005, J LEUKOCYTE BIOL, V78, P319, DOI 10.1189/jlb.1104664; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Jamieson AM, 2004, J IMMUNOL, V172, P864; Zhang W, 2014, MAR DRUGS, V12, P4148, DOI 10.3390/md12074148; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Thelen T, 2010, J IMMUNOL, V185, P4328, DOI 10.4049/jimmunol.1000989; Kwak JY, 2014, MAR DRUGS, V12, P851, DOI 10.3390/md12020851; Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Yang M, 2008, INT IMMUNOPHARMACOL, V8, P1754, DOI 10.1016/j.intimp.2008.08.007; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Chevolot L, 1999, CARBOHYD RES, V319, P154, DOI 10.1016/S0008-6215(99)00127-5; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Wang Y, 2010, J IMMUNOL, V184, P4447, DOI 10.4049/jimmunol.0902925; Eguizabal C, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00439; Hayashi K, 2008, INT IMMUNOPHARMACOL, V8, P109, DOI 10.1016/j.intimp.2007.10.017; Jiang ZD, 2011, NITRIC OXIDE-BIOL CH, V25, P407, DOI 10.1016/j.niox.2011.10.001; Jin J., 2014, INT J BIOL MACROMO C, V73C, P65, DOI [10.1016/j.ijbiomac.2014.10.05925445688, DOI 10.1016/J.IJBIOMAC.2014.10.05925445688]; Maggini J, 2009, FRONT BIOSCI, V14, P2372, DOI 10.2741/3384	28	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-3397			MAR DRUGS	Mar. Drugs	MAR	2015	13	3					1084	1104		10.3390/md13031084		21	Chemistry, Medicinal	Pharmacology & Pharmacy	CE6EW	WOS:000351930500001		
J	Jood, P; Ohta, M				Jood, Priyanka; Ohta, Michihiro			Hierarchical Architecturing for Layered Thermoelectric Sulfides and Chalcogenides	MATERIALS			English	Review							BAND-STRUCTURE CALCULATIONS; LOW-THERMAL-CONDUCTIVITY; PERFORMANCE BULK THERMOELECTRICS; ELECTRONIC-STRUCTURE; PHOTOELECTRON-SPECTRA; CRYSTAL-STRUCTURE; STRUCTURAL EVOLUTION; TRANSPORT-PROPERTIES; PHYSICAL-PROPERTIES; PANOSCOPIC APPROACH	Sulfides are promising candidates for environment-friendly and cost-effective thermoelectric materials. In this article, we review the recent progress in all-length-scale hierarchical architecturing for sulfides and chalcogenides, highlighting the key strategies used to enhance their thermoelectric performance. We primarily focus on TiS2-based layered sulfides, misfit layered sulfides, homologous chalcogenides, accordion-like layered Sn chalcogenides, and thermoelectric minerals. CS2 sulfurization is an appropriate method for preparing sulfide thermoelectric materials. At the atomic scale, the intercalation of guest atoms/layers into host crystal layers, crystal-structural evolution enabled by the homologous series, and low-energy atomic vibration effectively scatter phonons, resulting in a reduced lattice thermal conductivity. At the nanoscale, stacking faults further reduce the lattice thermal conductivity. At the microscale, the highly oriented microtexture allows high carrier mobility in the in-plane direction, leading to a high thermoelectric power factor.	[Jood, Priyanka; Ohta, Michihiro] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan	Ohta, M (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan.	p.jood@aist.go.jp; ohta.michihiro@aist.go.jp	Ohta, Michihiro/J-8460-2015	Ohta, Michihiro/0000-0002-9093-7117	Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies - Ministry of Economy, Trade and Industry (METI); JSPS KAKENHI Grant [25420699]	The authors thank Atsushi Yamamoto (AIST), Shinji Hirai (Muroran IT), Toshihiro Kuzuya (Muroran IT), Oleg I. Lebedev (CRISMAT), David Berthebaud (CRISMAT), Duck Young Chung (ANL), Mercouri G. Kanatzidis (Northwestern University and ANL), Mikio Koyano (JAIST), Koichiro Suekuni (Hiroshima University), and Toshiro Takabatake (Hiroshima University) for helpful discussions and fruitful collaborations. Financial support from the Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies funded by the Ministry of Economy, Trade and Industry (METI) and JSPS KAKENHI Grant Number 25420699 is gratefully acknowledged.	Abbott E. E., 2006, APPL PHYS LETT, V88; Crane DT, 2010, J ELECTRON MATER, V39, P2142, DOI 10.1007/s11664-009-0991-0; SUZUKI K, 1991, SOLID STATE COMMUN, V78, P73, DOI 10.1016/0038-1098(91)90256-U; Tan Q, 2014, J ELECTRON MATER, V43, P2435, DOI 10.1007/s11664-014-3127-0; Koumoto K, 2010, ANNU REV MATER RES, V40, P363, DOI 10.1146/annurev-matsci-070909-104521; Fang CM, 1996, J PHYS-CONDENS MAT, V8, P5367, DOI 10.1088/0953-8984/8/29/012; THOMPSON AH, 1975, MATER RES BULL, V10, P915, DOI 10.1016/0025-5408(75)90071-9; Kuznetsova LA, 2000, J PHYS CHEM SOLIDS, V61, P1269, DOI 10.1016/S0022-3697(99)00423-0; Kobayashi H, 1997, PHYSICA B, V237, P169, DOI 10.1016/S0921-4526(97)00086-0; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Beaumale M, 2014, ACTA MATER, V78, P86, DOI 10.1016/j.actamat.2014.06.032; Olvera A, 2015, INORG CHEM, V54, P746, DOI 10.1021/ic501327u; Makovicky E, 2006, REV MINERAL GEOCHEM, V61, P7, DOI 10.2138/rmg.2006.61.2; Ohta M, 2012, ADV ENERGY MATER, V2, P1117, DOI 10.1002/aenm.201100756; Barbier T, 2015, J ALLOY COMPD, V634, P253, DOI 10.1016/j.jallcom.2015.02.045; Biswas K, 2011, NAT CHEM, V3, P160, DOI [10.1038/nchem.955, 10.1038/NCHEM.955]; Suekuni K, 2013, J APPL PHYS, V113, DOI 10.1063/1.4789389; Mrotzek A, 2003, ACCOUNTS CHEM RES, V36, P111, DOI 10.1021/ar020099; Putri YE, 2014, J ELECTRON MATER, V43, P1870, DOI 10.1007/s11664-013-2894-3; Wan CL, 2010, MATERIALS, V3, P2606, DOI 10.3390/ma3042606; Wan CL, 2011, J ELECTRON MATER, V40, P1271, DOI 10.1007/s11664-011-1565-5; WASSCHER JD, 1963, SOLID STATE ELECTRON, V6, P261, DOI 10.1016/0038-1101(63)90083-2; Nolas GS, 1998, APPL PHYS LETT, V73, P178, DOI 10.1063/1.121747; Jood P, 2014, CHEM MATER, V26, P2684, DOI 10.1021/cm5004559; Ohta M, 2006, J ALLOY COMPD, V408, P551, DOI 10.1016/j.jallcom.2004.12.071; Masset AC, 2000, PHYS REV B, V62, P166, DOI 10.1103/PhysRevB.62.166; Sales BC, 1996, SCIENCE, V272, P1325, DOI 10.1126/science.272.5266.1325; Carrete J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895770; Chen S, 2012, PHYSICA B, V407, P4154, DOI 10.1016/j.physb.2012.06.041; Zhao LD, 2014, ENERG ENVIRON SCI, V7, P251, DOI 10.1039/c3ee43099e; Suekuni K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.051201; Ohta M, 2012, ACTA MATER, V60, P7232, DOI 10.1016/j.actamat.2012.09.035; KOYANO M, 1986, PHYS STATUS SOLIDI B, V138, P357, DOI 10.1002/pssb.2221380137; Guilmeau E, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3621834; Salvador JR, 2014, PHYS CHEM CHEM PHYS, V16, P12510, DOI 10.1039/c4cp01582g; Koumoto K, 2006, MRS BULL, V31, P206, DOI 10.1557/mrs2006.46; Lu X, 2015, CHEM MATER, V27, P408, DOI 10.1021/cm502570b; Gascoin F, 2012, J ALLOY COMPD, V521, P121, DOI 10.1016/j.jallcom.2012.01.067; Kuropatwa BA, 2013, Z ANORG ALLG CHEM, V639, P2411, DOI 10.1002/zaac.201300325; Lefebvre I, 1998, PHYS REV B, V58, P1896, DOI 10.1103/PhysRevB.58.1896; Terasaki I, 1997, PHYS REV B, V56, P12685; Hirai S, 1998, J AM CERAM SOC, V81, P145; Hebert S, 2013, PHYS STATUS SOLIDI A, V210, P69, DOI 10.1002/pssa.201228505; Beaumale M, 2014, J ELECTRON MATER, V43, P1590, DOI 10.1007/s11664-013-2802-x; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; WIEGERS GA, 1992, J ALLOY COMPD, V178, P351, DOI 10.1016/0925-8388(92)90276-F; Parker D, 2010, J APPL PHYS, V108, DOI 10.1063/1.3496661; HAN SH, 1995, AIP CONF PROC, P66; He JQ, 2013, MATER TODAY, V16, P166, DOI 10.1016/j.mattod.2013.05.004; Lu X, 2013, ADV ENERGY MATER, V3, P342, DOI 10.1002/aenm.201200650; PETERS MJ, 1990, PHYS REV B, V41, P5893, DOI 10.1103/PhysRevB.41.5893; Koumoto K, 2013, J AM CERAM SOC, V96, P1, DOI 10.1111/jace.12076; Li D, 2005, SOLID STATE COMMUN, V135, P237, DOI 10.1016/j.ssc.2005.04.029; Zhang YG, 2005, J APPL CRYSTALLOGR, V38, P433, DOI 10.1107/S0021889805005686; Ohta M, 2014, J MATER CHEM A, V2, P20048, DOI 10.1039/c4ta05135a; Chen CL, 2014, J MATER CHEM A, V2, P11171, DOI 10.1039/c4ta01643b; Tan Q, 2014, J MATER CHEM A, V2, P17302, DOI 10.1039/c4ta04462b; Medlin DL, 2013, JOM-US, V65, P390, DOI 10.1007/s11837-012-0530-y; Zhao LD, 2013, ENERG ENVIRON SCI, V6, P3346, DOI 10.1039/c3ee42187b; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184; Li D, 2006, PHYS LETT A, V348, P379, DOI 10.1016/j.physleta.2005.08.039; Bera C, 2014, PHYS CHEM CHEM PHYS, V16, P19894, DOI 10.1039/c4cp02871f; CHATTOPADHYAY T, 1986, J PHYS CHEM SOLIDS, V47, P879, DOI 10.1016/0022-3697(86)90059-4; AMARA A, 1987, PHYS REV B, V36, P6415, DOI 10.1103/PhysRevB.36.6415; Nolas GS, 1999, ANNU REV MATER SCI, V29, P89, DOI 10.1146/annurev.matsci.29.1.89; Chetty R, 2015, PHYS CHEM CHEM PHYS, V17, P1716, DOI 10.1039/c4cp04039b; Sassi S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880817; MEERSCHAUT A, 1989, J SOLID STATE CHEM, V78, P35, DOI 10.1016/0022-4596(89)90125-4; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Chung DY, 2000, SCIENCE, V287, P1024, DOI 10.1126/science.287.5455.1024; Aoki T, 2011, J CERAM SOC JPN, V119, P382, DOI 10.2109/jcersj2.119.382; Barin I., 1973, THERMOCHEMICAL PROPE; Barin I., 1977, THERMOCHEMICAL PROPE; Beaumale M, 2014, J APPL PHYS, V115, DOI 10.1063/1.4863141; Caillat T., 2000, P 19 INT C THERM CAR, P151; CHO N, 1993, SOLID STATE IONICS, V63-5, P696, DOI 10.1016/0167-2738(93)90182-3; Chung DY, 1997, CHEM MATER, V9, P3060, DOI 10.1021/cm970397e; Chung DY, 2004, J AM CHEM SOC, V126, P6414, DOI 10.1021/ja039885f; CUTLER M, 1964, PHYS REV, V133, P1143; Fadavieslam MR, 2011, PHYS SCRIPTA, V84, DOI 10.1088/0031-8949/84/03/035705; Fang CM, 1996, J PHYS-CONDENS MAT, V8, P1663, DOI 10.1088/0953-8984/8/11/011; FANG CM, 1995, PHYS REV B, V52, P2336, DOI 10.1103/PhysRevB.52.2336; Funahashi R, 2000, JPN J APPL PHYS 2, V39, pL1127, DOI 10.1143/JJAP.39.L1127; GUITTARD M, 1991, T F ELEM CH, V2, P321; Guo JQ, 2012, J ELECTRON MATER, V41, P1036, DOI 10.1007/s11664-012-1958-0; HENDERSO.JR, 1967, J CHEM PHYS, V47, P3347, DOI 10.1063/1.1712397; Hirai S, 2003, J JPN I MET, V67, P15; Imai H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.241104; Kajikawa T., 2005, THERMOELECTRICS HDB, P50; Kanatzidis MG, 2005, ACCOUNTS CHEM RES, V38, P359, DOI 10.1021/ar040176w; Kanatzidis M. G., 2003, CHEM PHYS MAT SCI TH, P35; KATO K, 1977, ACTA CRYSTALLOGR B, V33, P3437, DOI 10.1107/S0567740877011157; Kauzlarich SM, 2007, DALTON T, P2099, DOI 10.1039/b702266b; Koumoto K., 2005, THERMOELECTRICS HDB, P35; KUKKONEN CA, 1981, PHYS REV B, V24, P1691, DOI 10.1103/PhysRevB.24.1691; Kuropatwa BA, 2012, Z ANORG ALLG CHEM, V638, P2640, DOI 10.1002/zaac.201200284; Li D, 2006, J MATER RES, V21, P480, DOI 10.1557/JMR.2006.0055; LOGOTHETIS EM, 1980, PHYSICA B & C, V99, P193, DOI 10.1016/0378-4363(80)90231-4; MAKOVICKY E, 1981, FORTSCHR MINERAL, V59, P137; Matsubara K., 2005, THERMOELECTRICS HDB, P52; May AF, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125205; Miyazaki Y, 2004, JPN J APPL PHYS 2, V43, pL1202, DOI 10.1143/JJAP.43.L1202; Miyazaki Y, 2013, J ELECTRON MATER, V42, P1335, DOI 10.1007/s11664-012-2443-5; Murray J. L., 1986, J PHASE EQUILIB, V7, P156; Putri YE, 2012, SCRIPTA MATER, V66, P895, DOI 10.1016/j.scriptamat.2012.02.010; Qin X. Y., 2007, J APPL PHYS, V102; RIMMINGT.HP, 1974, J CRYST GROWTH, V21, P171, DOI 10.1016/0022-0248(74)90001-3; Rogl G, 2014, ACTA MATER, V63, P30, DOI 10.1016/j.actamat.2013.09.039; Rowe D.M., 1995, CRC HDB THERMOELECTR, P407; Segawa K, 2015, J SOLID STATE CHEM, V221, P196, DOI 10.1016/j.jssc.2014.09.034; Shelimova LE, 2010, INORG MATER+, V46, P120, DOI 10.1134/S0020168510020068; Suekuni K, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896998; SUZUKI K, 1993, PHYS REV B, V48, P11077, DOI 10.1103/PhysRevB.48.11077; Takabatake T., 2013, THERMOELECTRIC NANOM, P33; Takeuchi S., 1970, J JAPAN I METALS, V34, P758; TERASHIMA T, 1994, J PHYS SOC JPN, V63, P658, DOI 10.1143/JPSJ.63.658; Toide T., 1973, B TOKYO I TECHNOL, V117, P41; Tsujii N., 2014, MRS P, P1680, DOI [10.1557/opl.2014.744, DOI 10.1557/OPL.2014.744]; VANSMAALEN S, 1991, J PHYS-CONDENS MAT, V3, P1247, DOI 10.1088/0953-8984/3/10/003; Wan C. L., 2012, APPL PHYS LETT, V100; WIEGERS GA, 1990, ACTA CRYSTALLOGR B, V46, P324, DOI 10.1107/S0108768190001252; Wiegers GA, 1996, PROG SOLID STATE CH, V24, P1, DOI 10.1016/0079-6786(95)00007-0; Wu H. J., 2014, NAT COMMUN, V5, P4515; Yang J., 2012, THERMOELECTRICS ITS, P25; Zemskov V. S., 2011, Inorganic Materials: Applied Research, V2, DOI 10.1134/S2075113311050224; Zemskov V. S., 2012, Inorganic Materials: Applied Research, V3, DOI 10.1134/S2075113312010133; Zhang J, 2009, J ALLOY COMPD, V479, P816, DOI 10.1016/j.jallcom.2009.01.052; Zhang J, 2006, J PHYS D APPL PHYS, V39, P1230, DOI 10.1088/0022-3727/39/6/033; Zhang J, 2011, J ELECTRON MATER, V40, P980, DOI 10.1007/s11664-010-1474-z	129	6	6	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1944			MATERIALS	Materials	MAR	2015	8	3					1124	1149		10.3390/ma8031124		26	Materials Science, Multidisciplinary	Materials Science	CE6KN	WOS:000351945400019		
J	Wang, BZ; Anzai, J				Wang, Baozhen; Anzai, Jun-ichi			Recent Progress in Electrochemical HbA1c Sensors: A Review	MATERIALS			English	Review							GLYCATED HEMOGLOBIN HBA(1C); MONOLAYER-MODIFIED ELECTRODES; FRUCTOSYL AMINE OXIDASE; GLASSY-CARBON ELECTRODE; REDUCED GRAPHENE OXIDE; BY-LAYER ASSEMBLIES; BORONIC ACID; FERROCENEBORONIC ACID; PHENYLBORONIC ACID; HYDROGEN-PEROXIDE	This article reviews recent progress made in the development of electrochemical glycated hemoglobin (HbA1c) sensors for the diagnosis and management of diabetes mellitus. Electrochemical HbA1c sensors are divided into two categories based on the detection protocol of the sensors. The first type of sensor directly detects HbA1c by binding HbA1c on the surface of an electrode through bio-affinity of antibody and boronic acids, followed by an appropriate mode of signal transduction. In the second type of sensor, HbA1c is indirectly determined by detecting a digestion product of HbA1c, fructosyl valine (FV). Thus, the former sensors rely on the selective binding of HbA1c to the surface of the electrodes followed by electrochemical signaling in amperometric, voltammetric, impedometric, or potentiometric mode. Redox active markers, such as ferrocene derivatives and ferricyanide/ferrocyanide ions, are often used for electrochemical signaling. For the latter sensors, HbA1c must be digested in advance by proteolytic enzymes to produce the FV fragment. FV is electrochemically detected through catalytic oxidation by fructosyl amine oxidase or by selective binding to imprinted polymers. The performance characteristics of HbA1c sensors are discussed in relation to their use in the diagnosis and control of diabetic mellitus.	[Wang, Baozhen] Shandong Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Jinan 250012, Shandong, Peoples R China; [Wang, Baozhen; Anzai, Jun-ichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Anzai, J (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	bzhenw@hotmail.com; junanzai@mail.pharm.tohoku.ac.jp			Japan Society for the Promotion of Science [26670010]	This work was supported in part by a Grant-in-Aid (26670010) from the Japan Society for the Promotion of Science.	Adamczyk M, 2006, BIOORG MED CHEM LETT, V16, P1324, DOI 10.1016/j.bmcl.2005.11.062; Ang SH, 2015, CLIN CHIM ACTA, V439, P202, DOI 10.1016/j.cca.2014.10.019; Pundir CS, 2014, ANAL BIOCHEM, V444, P47, DOI 10.1016/j.ab.2013.09.023; Halamek J, 2007, ANAL LETT, V40, P1434, DOI 10.1080/00032710701327096; Egawa Y, 2011, MAT SCI ENG C-MATER, V31, P1257, DOI 10.1016/j.msec.2011.05.007; Watahiki R, 2014, J MATER CHEM B, V2, P5809, DOI 10.1039/c4tb00676c; Hsieh KM, 2013, BIOSENS BIOELECTRON, V49, P450, DOI 10.1016/j.bios.2013.05.059; Saraoglu HM, 2013, IEEE SENS J, V13, P4229, DOI 10.1109/JSEN.2013.2265233; Xue QN, 2012, MICROCHIM ACTA, V176, P65, DOI 10.1007/s00604-011-0675-3; Song SY, 2009, SENSOR ACTUAT B-CHEM, V140, P233, DOI 10.1016/j.snb.2009.04.057; Lux CD, 2012, J AM CHEM SOC, V134, P15758, DOI 10.1021/ja303372u; Liu GZ, 2013, ELECTROANAL, V25, P881, DOI 10.1002/elan.201200333; Chen C, 2013, RSC ADV, V3, P4473, DOI 10.1039/c2ra22351a; Takahashi S, 2013, MATERIALS, V6, P5742, DOI 10.3390/ma6125742; Qu L, 2009, BIOSENS BIOELECTRON, V24, P3419, DOI 10.1016/j.bios.2008.07.077; Liu JT, 2008, ANAL BIOCHEM, V375, P90, DOI 10.1016/j.ab.2008.01.004; Xia N, 2013, INT J ELECTROCHEM SC, V8, P9714; Zhao W, 2006, ELECTROANAL, V18, P1737, DOI 10.1002/elan.200603630; Queralto N, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027112; Takahashi S, 2005, LANGMUIR, V21, P5102, DOI 10.1021/la050171n; Kim DM, 2013, ANAL CHEM, V85, P6536, DOI 10.1021/ac401411y; Song CC, 2013, ACS MACRO LETT, V2, P273, DOI 10.1021/mz4000392; Chuang SW, 2009, BIOSENS BIOELECTRON, V24, P3170, DOI 10.1016/j.bios.2009.02.033; Schumacher S, 2011, ELECTROCHIM ACTA, V56, P6607, DOI 10.1016/j.electacta.2011.04.081; Chawla S, 2011, BIOSENS BIOELECTRON, V26, P3438, DOI 10.1016/j.bios.2011.01.021; Chien HC, 2011, ELECTROANAL, V23, P402, DOI 10.1002/elan.201000426; Huang YJ, 2010, J MATER CHEM, V20, P8305, DOI 10.1039/c0jm01510e; Yan J, 2004, TETRAHEDRON, V60, P11205, DOI 10.1016/j.tet.2004.08.051; Wang B, 2012, J MATER CHEM, V22, P17954, DOI 10.1039/c2jm33070a; Chawla S, 2012, ANAL BIOCHEM, V430, P156, DOI 10.1016/j.ab.2012.08.002; Agnihotri N, 2015, BIOSENS BIOELECTRON, V63, P212, DOI 10.1016/j.bios.2014.07.037; Moore ANJ, 1999, CAN J CHEM, V77, P681, DOI 10.1139/cjc-77-5-6-681; Zhang D, 2013, ELECTROCHIM ACTA, V107, P656, DOI 10.1016/j.electacta.2013.06.015; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Fang L, 2009, SENSOR ACTUAT B-CHEM, V137, P235, DOI 10.1016/j.snb.2008.09.045; Fang YX, 2012, ELECTROCHIM ACTA, V70, P266, DOI 10.1016/j.electacta.2012.03.105; Bertok T, 2013, TALANTA, V108, P11, DOI 10.1016/j.talanta.2013.02.052; Ferri S, 2012, ELECTROCHEMISTRY, V80, P293, DOI 10.5796/electrochemistry.80.293; Yamazaki T, 2003, ANAL LETT, V36, P75, DOI 10.1081/AL-120017264; Li YC, 2002, J CHROMATOGR B, V776, P149, DOI 10.1016/S1570-0232(02)00162-9; Stollner D, 2002, ANAL CHIM ACTA, V470, P111, DOI 10.1016/S0003-2670(02)00779-1; Takahashi S, 2011, J ENVIRON SCI-CHINA, V23, P1027, DOI 10.1016/S1001-0742(10)60509-8; Pribyl J, 2005, ANAL CHIM ACTA, V530, P75, DOI 10.1016/j.aca.2004.08.059; Rajkumar R, 2008, BIOSENS BIOELECTRON, V23, P1195, DOI 10.1016/j.bios.2007.09.015; Pribyl J, 2006, BIOSENS BIOELECTRON, V21, P1952, DOI 10.1016/j.bios.2005.09.007; Sato K, 2005, LANGMUIR, V21, P797, DOI 10.1021/la048059x; Zaidi SA, 2014, INT J ELECTROCHEM SC, V9, P4598; Koval D, 2011, ANAL BIOCHEM, V413, P8, DOI 10.1016/j.ab.2011.01.048; Wangoo N, 2010, CHEM COMMUN, V46, P5755, DOI 10.1039/c0cc00224k; Zhou YL, 2015, BIOSENS BIOELECTRON, V64, P442, DOI 10.1016/j.bios.2014.09.058; Kato D, 2007, BIOSENS BIOELECTRON, V22, P1527, DOI 10.1016/j.bios.2006.05.020; Chuang YC, 2012, SENSOR ACTUAT B-CHEM, V171, P1222, DOI 10.1016/j.snb.2012.06.084; Liu SQ, 2006, SENSOR ACTUAT B-CHEM, V113, P623, DOI 10.1016/j.snb.2005.07.011; Kiran MS, 2010, ANAL CHEM, V82, P1342, DOI 10.1021/ac902364h; Huang JD, 2006, MAT SCI ENG C-BIO S, V26, P113, DOI 10.1016/j.msec.2005.06.002; Lu P, 2015, SENSOR ACTUAT B-CHEM, V208, P90, DOI 10.1016/j.snb.2014.10.140; Wang JY, 2015, BIOSENS BIOELECTRON, V63, P317, DOI 10.1016/j.bios.2014.07.058; Shumyantseva VV, 2014, BIOSENS BIOELECTRON, V61, P131, DOI 10.1016/j.bios.2014.05.001; Chen XM, 2014, MICROCHIM ACTA, V181, P689, DOI 10.1007/s00604-013-1098-0; Li M, 2015, SENSOR ACTUAT B-CHEM, V207, P614, DOI 10.1016/j.snb.2014.10.092; Takahashi S, 2012, ANAL BIOANAL CHEM, V402, P1749, DOI 10.1007/s00216-011-5317-4; Sato K, 2014, LANGMUIR, V30, P9247, DOI 10.1021/la501750s; Tanaka T, 2001, BIOSENS BIOELECTRON, V16, P1089, DOI 10.1016/S0956-5663(01)00187-7; Anzai J, 1998, SENSOR ACTUAT B-CHEM, V52, P3, DOI 10.1016/S0925-4005(98)00248-2; Basu PS, 2012, J CLIN LAB ANAL, V26, P45, DOI 10.1002/jcla.20503; Bian C, 2011, BIOMED MICRODEVICES, V13, P345, DOI 10.1007/s10544-010-9498-y; Chien HC, 2010, ELECTROANAL, V22, P688, DOI 10.1002/elan.200900384; Chopra A, 2013, BIOSENS BIOELECTRON, V44, P132, DOI 10.1016/j.bios.2013.01.018; del Castillo E, 2011, J PROTEOMICS, V74, P35, DOI 10.1016/j.jprot.2010.07.011; GAMOH K, 1990, J CHROMATOGR, V515, P227, DOI 10.1016/S0021-9673(01)89317-1; Guan Y, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40918; Halamek J, 2007, ELECTROCHIM ACTA, V53, P1127, DOI 10.1016/j.electacta.2007.03.059; Hoshi T, 2002, LANGMUIR, V18, P7024, DOI 10.1021/la0203685; Hu WL, 2014, SENSOR ACTUAT B-CHEM, V203, P736, DOI 10.1016/j.snb.2014.07.015; Lee SC, 2011, CLIN BIOCHEM, V44, P1338, DOI 10.1016/j.clinbiochem.2011.08.907; Lenters-Westra E, 2013, DIABETES RES CLIN PR, V99, P75, DOI 10.1016/j.diabres.2012.10.007; Liu AH, 2003, LANGMUIR, V19, P4043, DOI 10.1021/la0209740; Liu GZ, 2012, ANALYST, V137, P829, DOI 10.1039/c2an16034j; Liu H, 2013, ANAL CHEM, V85, P1834, DOI 10.1021/ac3032228; Liu L, 2013, INT J ELECTROCHEM SC, V8, P11161; Liu LM, 2008, CLIN BIOCHEM, V41, P576, DOI 10.1016/j.clinbiochem.2008.01.013; Marinova M, 2013, CLIN CHIM ACTA, V424, P207, DOI 10.1016/j.cca.2013.06.014; Nielsen MJ, 2013, J BIOL CHEM, V288, P18834, DOI 10.1074/jbc.M113.471060; Ogawa K, 2002, ANAL BIOANAL CHEM, V373, P211, DOI 10.1007/s00216-002-1319-6; Peterson KP, 1998, CLIN CHEM, V44, P1951; Rajkumar R, 2007, BIOSENS BIOELECTRON, V22, P3318, DOI 10.1016/j.bios.2007.03.001; Sakaguchi A, 2003, ELECTROCHEMISTRY, V71, P442; Shi WX, 2014, J AOAC INT, V97, P1742, DOI 10.5740/jaoacint.13-366; Siren H, 2002, J CHROMATOGR A, V979, P201, DOI 10.1016/S0021-9673(02)01403-6; Siva Rama Krishna V., 2011, P 2011 IEEE NIH LIF, P1; Soda K., 2003, BIOSENS BIOELECTRON, V18, P1485; Sode K, 2001, ANAL CHIM ACTA, V435, P151, DOI 10.1016/S0003-2670(00)01304-0; Song SY, 2012, BIOSENS BIOELECTRON, V35, P355, DOI 10.1016/j.bios.2012.03.017; Springsteen G., 2001, CHEM COMMUN, V17, P1068; Suwa K, 2015, COLLOID POLYM SCI, V293, P1043, DOI 10.1007/s00396-014-3490-7; Szunerits S, 2014, REV ANAL CHEM, V33, P153, DOI 10.1515/revac-2014-0011; Takahashi S, 2008, ELECTROANAL, V20, P816, DOI 10.1002/elan.200704097; Takahashi S, 2011, SENSOR LETT, V9, P1845, DOI 10.1166/sl.2011.1737; Tanna S, 2006, BIOMATERIALS, V27, P1586, DOI 10.1016/j.biomaterials.2005.08.011; Thevarajah M, 2009, CLIN BIOCHEM, V42, P430, DOI 10.1016/j.clinbiochem.2008.10.015; Tsugawa W, 2000, ELECTROCHEMISTRY, V68, P869; Tuantranont A, 2011, ANAL CHIM ACTA, V687, P114, DOI 10.1016/j.aca.2010.12.022; Yamazaki T, 2012, ELECTROCHEMISTRY, V80, P353, DOI 10.5796/electrochemistry.80.353; Yamazaki T, 2008, ELECTROCHEMISTRY, V76, P590	104	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1944			MATERIALS	Materials	MAR	2015	8	3					1187	1203		10.3390/ma8031187		17	Materials Science, Multidisciplinary	Materials Science	CE6KN	WOS:000351945400023		
J	Seki, T; Namiki, M; Egawa, Y; Miki, R; Juni, K; Seki, T				Seki, Tomohiro; Namiki, Misato; Egawa, Yuya; Miki, Ryotaro; Juni, Kazuhiko; Seki, Toshinobu			Sugar-Responsive Pseudopolyrotaxane Composed of Phenylboronic Acid-Modified Polyethylene Glycol and gamma-Cyclodextrin	MATERIALS			English	Article							SUSTAINED-RELEASE SYSTEM; BORONIC ACID; PROTEIN PEGYLATION; PHYSIOLOGICAL PH; GLUCOSE; SENSORS; POLYPSEUDOROTAXANES; COMPLEXATION; PEPTIDE; INSULIN	We have designed a sugar-responsive pseudopolyrotaxane (PPRX) by combining phenylboronic acid-modified polyethylene glycol (PBA-PEG) and gamma-cyclodextrin. Phenylboronic acid (PBA) was used as a sugar-recognition motif in the PPRX because PBA reacts with a diol portion of the sugar molecule and forms a cyclic ester. When D-fructose or D-glucose was added to a suspension of PPRX, PPRX disintegrated, depending on the concentration of the sugars. Interestingly, catechol does not show a response although catechol has a high affinity for PBA. We analyzed the response mechanism of PPRX by considering equilibria.	[Seki, Tomohiro; Namiki, Misato; Egawa, Yuya; Miki, Ryotaro; Juni, Kazuhiko; Seki, Toshinobu] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan	Egawa, Y (reprint author), Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan.	gyd1203@josai.ac.jp; yy09237@josai.ac.jp; yegawa@josai.ac.jp; rmiki@josai.ac.jp; kjuni@josai.ac.jp; sekt1042@josai.ac.jp			JSPS KAKENHI [25860027]	This work was supported by JSPS KAKENHI Grant Number 25860027.	Abu Hashim II, 2010, INT J PHARMACEUT, V392, P83, DOI 10.1016/j.ijpharm.2010.03.026; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Egawa Y, 2011, MAT SCI ENG C-MATER, V31, P1257, DOI 10.1016/j.msec.2011.05.007; Lapeyre V, 2008, J COLLOID INTERF SCI, V327, P316, DOI 10.1016/j.jcis.2008.08.039; Matsumoto A, 2004, BIOMACROMOLECULES, V5, P1038, DOI 10.1021/bm0345413; Higashi T, 2009, INT J PHARMACEUT, V374, P26, DOI 10.1016/j.ijpharm.2009.02.017; Wu X, 2013, CHEM SOC REV, V42, P8032, DOI 10.1039/c3cs60148j; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; HARADA A, 1994, NATURE, V370, P126, DOI 10.1038/370126a0; Harada A, 2009, CHEM REV, V109, P5974, DOI 10.1021/cr9000622; Wang HC, 2013, ANALYST, V138, P7146, DOI 10.1039/c3an01234d; Huang FH, 2005, PROG POLYM SCI, V30, P982, DOI 10.1016/j.progpolymsci.2005.07.003; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Li JJ, 2011, APPL MICROBIOL BIOT, V90, P427, DOI 10.1007/s00253-010-3037-x; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Fang H, 2004, J FLUORESC, V14, P481, DOI 10.1023/B:JOFL.0000039336.51399.3b; Fossey JS, 2012, CHEM REC, V12, P464, DOI 10.1002/tcr.201200006; Eggert H, 1999, J ORG CHEM, V64, P3846, DOI 10.1021/jo9819279; Wu X, 2012, CHEM COMMUN, V48, P4362, DOI 10.1039/c2cc30463e; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; De Geest BG, 2006, LANGMUIR, V22, P5070, DOI 10.1021/la053368o; Uekama K, 2004, CHEM PHARM BULL, V52, P900, DOI 10.1248/cpb.52.900; James TD, 1996, ANGEW CHEM INT EDIT, V35, P1910, DOI 10.1002/anie.199619101; Liu P, 2010, J PHYS CHEM LETT, V1, P1776, DOI 10.1021/jz100414j; Egawa Y, 2014, MATERIALS, V7, P1201, DOI 10.3390/ma7021201; Harada A, 2001, ACCOUNTS CHEM RES, V34, P456, DOI 10.1021/ar000174l; Higashi T, 2007, BIOORG MED CHEM LETT, V17, P1871, DOI 10.1016/j.bmcl.2007.01.029; JAMES TD, 1995, J AM CHEM SOC, V117, P8982, DOI 10.1021/ja00140a013; Nakamura K, 2013, CHEM PHARM BULL, V61, P1188; Ohya Y, 2009, BIOMACROMOLECULES, V10, P2261, DOI 10.1021/bm900440v; Ozawa R., 2007, J INCL PHENOM MACRO, V60, P253, DOI DOI 10.1007/S10847-007-9373-5; Suzuki I, 2007, ANAL SCI, V23, P1167, DOI 10.2116/analsci.23.1167; TABUSHI I, 1982, ACCOUNTS CHEM RES, V15, P66, DOI 10.1021/ar00075a001	33	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1944			MATERIALS	Materials	MAR	2015	8	3					1341	1349		10.3390/ma8031341		9	Materials Science, Multidisciplinary	Materials Science	CE6KN	WOS:000351945400031		
J	Masuda, T; Asoh, H; Haraguchi, S; Ono, S				Masuda, Tatsuya; Asoh, Hidetaka; Haraguchi, Satoshi; Ono, Sachiko			Fabrication and Characterization of Single Phase alpha-Alumina Membranes with Tunable Pore Diameters	MATERIALS			English	Article							ANODIC POROUS ALUMINA; STRUCTURAL-CHARACTERIZATION; HEAT-TREATMENT; ACID-SOLUTION; OXIDE-FILMS; ARRAYS	Nanoporous and single phase alpha-alumina membranes with pore diameters tunable over a wide range of approximately 60-350 nm were successfully fabricated by optimizing the conditions for anodizing, subsequent detachment, and heat treatment. The pore diameter increased and the cell diameter shrunk upon crystallization to alpha-alumina by approximately 20% and 3%, respectively, in accordance with the 23% volume shrinkage resulting from the change in density associated with the transformation from the amorphous state to alpha-alumina. Nevertheless, flat alpha-alumina membranes, each with a diameter of 25 mm and a thickness of 50 mu m, were obtained without thermal deformation. The alpha-alumina membranes exhibited high chemical resistance in various concentrated acidic and alkaline solutions as well as when exposed to high temperature steam under pressure. The Young's modulus and hardness of the single phase alpha-alumina membranes formed by heat treatment at 1250 degrees C were notably decreased compared to the corresponding amorphous membranes, presumably because of the nodular crystallite structure of the cell walls and the substantial increase in porosity. Furthermore, when used for filtration, the alpha-alumina membrane exhibited a level of flux higher than that of the commercial ceramic membrane.	[Masuda, Tatsuya; Asoh, Hidetaka; Ono, Sachiko] Kogakuin Univ, Grad Sch Engn, Hachioji, Tokyo 1920015, Japan; [Haraguchi, Satoshi] Toshiba Co Ltd, Power & Ind Syst Res & Dev Ctr, Fuchu, Tokyo 1838511, Japan	Ono, S (reprint author), Kogakuin Univ, Grad Sch Engn, 2665-1 Nakano, Hachioji, Tokyo 1920015, Japan.	bd12002@ns.kogakuin.ac.jp; asoh@cc.kogakuin.ac.jp; satoshi.haraguchi@toshiba.co.jp; sachiono@cc.kogakuin.ac.jp			Japan Society for the Promotion of Science [20241026, 25289263]; Light Metal Education Foundation of Japan; Aluminum Research Foundation from the Japan Aluminum Association; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was partly financed by a Grant-in-Aid for Scientific Research (A, 20241026 and B, 25289263) from the Japan Society for the Promotion of Science, the Light Metal Education Foundation of Japan, and the Aluminum Research Foundation Grant-aided Project in 2013 from the Japan Aluminum Association. We also acknowledge a Strategic Research Foundation Grant-aided Project for Private Universities matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Kirchner A, 2007, J MEMBRANE SCI, V287, P264, DOI 10.1016/j.memsci.2006.10.045; Yuan JH, 2004, CHEM MATER, V16, P1841, DOI 10.1021/cm049971u; Ono S, 2005, ELECTROCHIM ACTA, V51, P827, DOI 10.1016/j.electacta.2005.05.058; KELLER F, 1953, J ELECTROCHEM SOC, V100, P411, DOI 10.1149/1.2781142; MARDILOVICH PP, 1995, J MEMBRANE SCI, V98, P131, DOI 10.1016/0376-7388(94)00184-Z; Li AP, 1998, J APPL PHYS, V84, P6023, DOI 10.1063/1.368911; Ono S, 2004, ELECTROCHEM SOLID ST, V7, pB21, DOI 10.1149/1.1738553; Molchan IS, 2010, ELECTROCHEM COMMUN, V12, P693, DOI 10.1016/j.elecom.2010.03.008; MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961; DIGGLE JW, 1969, CHEM REV, V69, P365, DOI 10.1021/cr60259a005; DEKKER A, 1970, J ELECTROCHEM SOC, V117, P440, DOI 10.1149/1.2407539; Chang Y, 2012, J MATER CHEM, V22, P7445, DOI 10.1039/c2jm15279g; Choudhari KS, 2012, J POROUS MAT, V19, P1053, DOI 10.1007/s10934-012-9568-z; Masuda H, 1998, JPN J APPL PHYS 2, V37, pL1340, DOI 10.1143/JJAP.37.L1340; Masuda T, 2014, ELECTROCHEMISTRY, V82, P448, DOI 10.5796/electrochemistry.82.448; Kouklin N, 2001, APPL PHYS LETT, V79, P4423, DOI 10.1063/1.1427156; FURNEAUX RC, 1989, NATURE, V337, P147, DOI 10.1038/337147a0; McQuaig MK, 2011, J MATER SCI, V46, P243, DOI 10.1007/s10853-010-4966-6; ONO S, 1992, CORROS SCI, V33, P503, DOI 10.1016/0010-938X(92)90078-H; Asoh H., 2002, J SURF FINISH SOC JP, V53, P777, DOI [10.4139/sfj.53.777, DOI 10.4139/SFJ.53.777]; Ebihara K., 1983, J MET FINISH SOC JPN, V34, P548; Fernandez-Romero L, 2008, MATER CHEM PHYS, V111, P542, DOI 10.1016/j.matchemphys.2008.05.003; FUKUDA Y, 1980, B CHEM SOC JPN, V53, P366, DOI 10.1246/bcsj.53.366; Masuda H, 1997, J ELECTROCHEM SOC, V144, pL127, DOI 10.1149/1.1837634; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466; Masuda H, 1996, JPN J APPL PHYS 2, V35, pL126, DOI 10.1143/JJAP.35.L126; OSULLIVA.JP, 1970, PROC R SOC LON SER-A, V317, P511, DOI 10.1098/rspa.1970.0129; Ono S., 1994, J SURF FINISH SOC JP, V45, P1070, DOI [10.4139/sfj.45.1070, DOI 10.4139/SFJ.45.1070]; Ono S., 1993, J LIGHT METAL SOC JP, V43, P453, DOI 10.2464/jilm.43.453; Ono Sachiko, 2014, Materials Science Forum, V783-786, DOI 10.4028/www.scientific.net/MSF.783-786.1470; Ono S, 2004, J ELECTROCHEM SOC, V151, pB473, DOI 10.1149/1.1767838; Ono S., 1993, J LIGHT METAL SOC JP, V43, P447, DOI 10.2464/jilm.43.447; ONO S, 1991, J ELECTROCHEM SOC, V138, P3705, DOI 10.1149/1.2085484; Ozao R, 2001, J THERM ANAL CALORIM, V64, P915, DOI 10.1023/A:1011566811961; Rashidi F, 2013, SURF INTERFACE ANAL, V45, P1490, DOI 10.1002/sia.5285; TAKAHASH.H, 1973, J ELECTRON MICROSC, V22, P149; Wefers K., 1987, OXIDES HYDROXIDES AL, V47; Yanagishita T, 2004, LANGMUIR, V20, P554, DOI 10.1021/la030314a	38	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1944			MATERIALS	Materials	MAR	2015	8	3					1350	1368		10.3390/ma8031350		19	Materials Science, Multidisciplinary	Materials Science	CE6KN	WOS:000351945400032		
J	Gaffney, EA; Lee, SS				Gaffney, E. A.; Lee, S. Seirin			The sensitivity of Turing self-organization to biological feedback delays: 2D models of fish pigmentation	MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA			English	Article						fish skin patterns; biological feedback delays; Turing pattern formation	PATTERN-FORMATION; ZEBRAFISH; DIFFUSION; CELLS; ENDOCYTOSIS; APOPTOSIS; GENE; MORPHOGENESIS; DROSOPHILA; MECHANISM	Turing morphogen models have been extensively explored in the context of large-scale self-organization in multicellular biological systems. However, reconciling the detailed biology of morphogen dynamics, while accounting for time delays associated with gene expression, reveals aberrant behaviours that are not consistent with early developmental self-organization, especially the requirement for exquisite temporal control. Attempts to reconcile the interpretation of Turing's ideas with an increasing understanding of the mechanisms driving zebrafish pigmentation suggests that one should reconsider Turing's model in terms of pigment cells rather than morphogens (Nakamasu et al., 2009, PNAS, 106, 8429-8434; Yamaguchi et al., 2007, PNAS, 104, 4790-4793). Here the dynamics of pigment cells is subject to response delays implicit in the cell cycle and apoptosis. Hence we explore simulations of fish skin patterning, focussing on the dynamical influence of gene expression delays in morphogen-based Turing models and response delays for cell-based Turing models. We find that reconciling the mechanisms driving the behaviour of Turing systems with observations of fish skin patterning remains a fundamental challenge.	[Gaffney, E. A.] Univ Oxford, Wolfson Ctr Math Biol, Math Inst, Oxford OX2 6GG, England; [Lee, S. Seirin] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Lee, SS (reprint author), Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima 7398626, Japan.	seirin.lee@gmail.com	Gaffney, Eamonn/N-6403-2015		King Abdullah University of Science and Technology (KAUST) [KUK-C1-013-04]; Japan Society for The Promotion of Science (JSPS)	This publication is based on work supported in part by Award No. KUK-C1-013-04, made by King Abdullah University of Science and Technology (KAUST) and Grant-in-Aid for JSPS Young Research Fellow from The Japan Society for The Promotion of Science (JSPS).	Abdreeff M., 2000, HOLLAND FREI CANC ME; Alberts B., 2002, MOL BIOL CELL; Piddini E, 2003, CURR OPIN CELL BIOL, V15, P474, DOI 10.1016/S0955-0674(03)00072-3; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; SEGEL LA, 1972, J THEOR BIOL, V37, P545, DOI 10.1016/0022-5193(72)90090-2; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Pelling AE, 2009, CELL MOTIL CYTOSKEL, V66, P409, DOI 10.1002/cm.20391; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; BARD J, 1974, J THEOR BIOL, V45, P501, DOI 10.1016/0022-5193(74)90128-3; Kondo S, 2009, INT J DEV BIOL, V53, P851, DOI 10.1387/ijdb.072502sk; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; BRUNE D, 1993, P NATL ACAD SCI USA, V90, P3835, DOI 10.1073/pnas.90.9.3835; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Uriu K, 2007, B MATH BIOL, V69, P2515, DOI 10.1007/s11538-007-9230-0; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; ARCURI P, 1986, J MATH BIOL, V24, P141; Asai R, 1999, MECH DEVELOP, V89, P87, DOI 10.1016/S0925-4773(99)00211-7; BUNOW B, 1980, J THEOR BIOL, V84, P629, DOI 10.1016/S0022-5193(80)80024-5; EATON RC, 1974, COPEIA, P204; Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205; Gaffney EA, 2006, B MATH BIOL, V68, P99, DOI 10.1007/s11538-005-9066-z; Kondo S, 2009, SEMIN CELL DEV BIOL, V20, P82, DOI 10.1016/j.semcdb.2008.10.008; Kondo S., 2009, SYSTEMS BIOL CHALLEN; MEINHARDT H, 1989, DEVELOPMENT, V107, P169; Moreira J, 2005, DEV DYNAM, V232, P33, DOI 10.1002/dvdy.20199; Morton K. W., 1994, NUMERICAL SOLUTION P; Nakamura M, 2010, FISHERIES SCI, V76, P243, DOI 10.1007/s12562-009-0209-7; Painter K. J., 1997, THESIS U OXFORD UK; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; ROSEN P, 1980, P NATL ACAD SCI-BIOL, V77, P4760, DOI 10.1073/pnas.77.8.4760; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Seirin Lee S, 2010, Bull Math Biol, V72, P2139, DOI 10.1007/s11538-010-9532-5; Seirin Lee S, 2011, Bull Math Biol, V73, P2527, DOI 10.1007/s11538-011-9634-8; Seirin Lee S, 2010, Bull Math Biol, V72, P2161, DOI 10.1007/s11538-010-9533-4; Shoji H, 2005, J THEOR BIOL, V237, P104, DOI 10.1016/j.jtbi.2005.04.003; Shoji H, 2003, DEV DYNAM, V226, P627, DOI 10.1002/dvdy.10277; Solnica-Krezel L, 2003, CURR BIOL, V13, pR7, DOI 10.1016/S0960-9822(02)01378-7; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wyllie AH, 1997, BRIT MED BULL, V53, P451	45	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1477-8599	1477-8602		MATH MED BIOL	Math. Med. Biol.	MAR	2015	32	1					56	78		10.1093/imammb/dqt017		23	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CE4ZX	WOS:000351840500003		
J	Izawa, KP; Watanabe, S; Hirano, Y; Matsushima, S; Suzuki, T; Oka, K; Kida, K; Suzuki, K; Osada, N; Omiya, K; Brubaker, PH; Shimizu, H; Akashi, YJ				Izawa, Kazuhiro P.; Watanabe, Satoshi; Hirano, Yasuyuki; Matsushima, Shinya; Suzuki, Tomohiro; Oka, Koichiro; Kida, Keisuke; Suzuki, Kengo; Osada, Naohiko; Omiya, Kazuto; Brubaker, Peter H.; Shimizu, Hiroyuki; Akashi, Yoshihiro J.			Gender-related Differences in Maximum Gait Speed and Daily Physical Activity in Elderly Hospitalized Cardiac Inpatients A Preliminary Study	MEDICINE			English	Article							LOWER-EXTREMITY FUNCTION; HEART-FAILURE; OLDER-ADULTS; CLINICAL CHARACTERISTICS; JAPANESE PATIENTS; MEASURING STEPS; WALKING SPEED; LEISURE-TIME; REHABILITATION; DISABILITY	Maximum gait speed and physical activity (PA) relate to mortality and morbidity, but little is known about gender-related differences in these factors in elderly hospitalized cardiac inpatients. This study aimed to determine differences in maximum gait speed and daily measured PA based on sex and the relationship between these measures in elderly cardiac inpatients. A consecutive 268 elderly Japanese cardiac inpatients (mean age, 73.3 years) were enrolled and divided by sex into female (n = 75,28%) and male (n = 193, 72%) groups. Patient characteristics and maximum gait speed, average step count, and PA energy expenditure (PAEE) in kilocalorie per day for 2 days assessed by accelerometer were compared between groups. Gait speed correlated positively with in-hospital PA measured by average daily step count (r = 0.46, P<0.001) and average daily PAEE (r = 0.47, P<0.001) in all patients. After adjustment for left ventricular ejection fraction, step counts and PAEE were significantly lower in females than males (2651.35 +/- 1889.92 vs 4037.33 +/- 1866.81 steps, P<0.001; 52.74 +/- 51.98 vs 99.33 +/- 51.40 kcal, P<0.001), respectively. Maximum gait speed was slower and PA lower in elderly female versus male inpatients. Minimum gait speed and step count values in this study might be minimum target values for elderly male and female Japanese cardiac inpatients.	[Izawa, Kazuhiro P.] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Watanabe, Satoshi; Matsushima, Shinya; Suzuki, Tomohiro] St Marianna Univ, Sch Med Hosp, Dept Rehabil Med, Kawasaki, Kanagawa, Japan; [Hirano, Yasuyuki] Tokushima Bunri Univ, Dept Phys Therapy, Tokushima, Japan; [Oka, Koichiro] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Osada, Naohiko] St Marianna Univ, Toyoko Hosp, Div Cardiol, Kawasaki, Kanagawa, Japan; [Omiya, Kazuto] St Marianna Univ, Yokohama City Seibu Hosp, Div Cardiol, Yokohama, Kanagawa, Japan; [Brubaker, Peter H.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Shimizu, Hiroyuki] St Marianna Univ, Sch Med, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan; [Kida, Keisuke; Suzuki, Kengo; Akashi, Yoshihiro J.] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol, Kawasaki, Kanagawa, Japan	Izawa, KP (reprint author), Kobe Univ, Grad Sch Hlth Sci, 10-2 Tomogaoka 7 Chome Suma, Kobe, Hyogo 6540142, Japan.	izawapk@ga2.so-net.ne.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			Ayabe M, 2008, CIRC J, V72, P299, DOI 10.1253/circj.72.299; Bock BC, 2001, ANN BEHAV MED, V23, P79, DOI 10.1207/S15324796ABM2302_2; Menezes AR, 2012, J GERIATR CARDIOL, V9, P68, DOI 10.3724/SP.J.1263.2012.00068; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Schneider PL, 2003, MED SCI SPORT EXER, V35, P1779, DOI 10.1249/01.MSS.0000089342.96098.C4; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Visser M, 1998, J GERONTOL A-BIOL, V53, pM214; Yasunaga A, 2008, J AGING PHYS ACTIV, V16, P3; MARCUS BH, 1994, MED SCI SPORT EXER, V26, P1400; Walsh JT, 1997, AM J CARDIOL, V79, P1364, DOI 10.1016/S0002-9149(97)00141-0; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Crespo CJ, 2000, AM J PREV MED, V18, P46, DOI 10.1016/S0749-3797(99)00105-1; Muramoto A, 2013, J ORTHOP SCI, V18, P618, DOI 10.1007/s00776-013-0382-5; Purser JL, 2005, J REHABIL RES DEV, V42, P535, DOI 10.1682/JRRD.2004.07.0087; Purser JL, 2006, J AM GERIATR SOC, V54, P1674, DOI 10.1111/j.1532-5415.2006.00914.x; GURALNIK JM, 1994, J GERONTOL, V49, pM85; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Izawa KP, 2004, AM J PHYS MED REHAB, V83, P884, DOI 10.1097/01.PHM.0000143404.59050.11; Temfemo A, 2011, CARDIOL J, V18, P632, DOI 10.5603/CJ.2011.0026; Dumurgier J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4460; Furuna T, 1998, J Jpn Phys Ther Assoc, V1, P1, DOI 10.1298/jjpta.1.1; Gardner AW, 2008, CLIN MED GERIATR, V1, P1; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Izawa KP, 2013, AM J CARDIOL, V111, P1767, DOI 10.1016/j.amjcard.2013.02.034; Izawa KP, 2008, J REHABIL MED, V40, P225, DOI 10.2340/16501977-0156; Nery RM, 2010, REV BRAS CIR CARDIOV, V25, P73, DOI 10.1590/S0102-76382010000100016; Prochaska JO, 2002, JPN HLTH PSYCHOL, V10, P1; Sadeghi M, 2012, J RES MED SCI, V17, P787; Takahashi S, 1989, RIGAKU RYOHO GAKU, V16, P261; Tsuchihashi M, 2000, JPN CIRC J, V64, P953, DOI 10.1253/jcj.64.953; Yamada AT, 2007, ARQ BRAS CARDIOL, V88, P285, DOI 10.1590/S0066-782X2007000300006	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR	2015	94	11								10.1097/MD.0000000000000623		6	Medicine, General & Internal	General & Internal Medicine	CE2UJ	WOS:000351674500012		
J	Nakamura, T; Ueda, T; Oishi, M; Nakanishi, H; Shiraishi, T; Fujihara, A; Naito, Y; Kamoi, K; Naya, Y; Hongo, F; Okihara, K; Miki, T				Nakamura, Terukazu; Ueda, Takashi; Oishi, Masakatsu; Nakanishi, Hiroyuki; Shiraishi, Takumi; Fujihara, Atsuko; Naito, Yasuyuki; Kamoi, Kazumi; Naya, Yoshio; Hongo, Fumiya; Okihara, Koji; Miki, Tsuneharu			Importance of Continuous Sequential Chemotherapy and Multimodal Treatment for Advanced Testicular Cancer A High-Volume Japanese Center Experience	MEDICINE			English	Article							GERM-CELL TUMORS; HIGH-DOSE CHEMOTHERAPY; SALVAGE CHEMOTHERAPY; PHASE-II; PLUS CISPLATIN; PACLITAXEL; THERAPY; IFOSFAMIDE; GEMCITABINE; TRIAL	Patients with "difficult-to-treat'' advanced testicular cancer can require multiple therapies. We retrospectively assessed our patients with advanced germ cell tumors (GCTs) and characterized the clinical efficacy, outcomes, and factors affecting overall survival (OS). Two hundred fifty-three patients with advanced GCTs were treated at Kyoto Prefectural University of Medicine, Kyoto, Japan, from June 1998 to September 2013. Of 253 patients, 142 patients had salvage chemotherapy. As first-line therapy, bleomycin, etoposide, and cisplatin, and etoposide and cisplatin therapies were performed in 234 cases (92.5%). As second-line therapy, etoposide, ifosfamide, and cisplatin/vinblastine, ifosfamide, and cisplatin, and paclitaxel, ifosfamide, and cisplatin/paclitaxel, ifosfamide, and nedaplatin therapies were carried out in 44 and 59 cases, respectively. Furthermore, 111, 72, 44, and 28 cases had third, fourth, fifth, and sixth-or-later-line chemotherapy, respectively. Five-year OS rate stratified by chemotherapy line was 95.5% in the first line, 89.4% in the second line, 82.1% in the third line, 45.1% in the fourth line, and 58.9% in the fifth or after line. A statistical significant difference was found when comparing fourth-or-after-line versus first to third-line therapy. Additional procedures were performed, including retroperitoneal lymph node dissection (RPLND) (n = 168), extra-RPLN resection (n = 114), and external beam radiotherapy/ stereotactic radiotherapy (n = 78). Multivariate analysis showed that factors predicting better outcomes were in serum tumor marker (STM) normalization, RPLND, and extra-RPLN resection. Good outcomes were obtained in patients who completed chemotherapy up to third line. After fourth-line chemotherapy, approximately 50% of "difficult-to-treat'' patients could be cured with normalization of STM levels and residual mass resection. Continuous or sequential chemotherapy with multimodality therapy is important for patients with "difficult-to-treat'' advanced GCTs. Effective chemotherapy after third line should be developed.	[Nakamura, Terukazu; Ueda, Takashi; Oishi, Masakatsu; Nakanishi, Hiroyuki; Shiraishi, Takumi; Fujihara, Atsuko; Naito, Yasuyuki; Kamoi, Kazumi; Naya, Yoshio; Hongo, Fumiya; Okihara, Koji; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kyoto 6028566, Japan	Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kamigyo Ku, 465 Kajii Cho,Kawaramachi Hirokoji, Kyoto 6028566, Japan.	teru@koto.kpu-m.ac.jp					Miki T, 2002, CANCER, V95, P1879, DOI 10.1002/cncr.10918; Lorch A, 2011, J CLIN ONCOL, V29, P2178, DOI 10.1200/JCO.2010.32.6678; Oldenburg J, 2003, J CLIN ONCOL, V21, P3310, DOI 10.1200/JCO.2003.03.184; Olofsson SE, 2011, J CLIN ONCOL, V29, P2032, DOI 10.1200/JCO.2010.29.1278; Oechsle K, 2011, EUR UROL, V60, P850, DOI 10.1016/j.eururo.2011.06.019; [Anonymous], 2012, GUID TEST CANC; Farhat F, 1996, CANCER, V77, P1193, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1193::AID-CNCR28>3.0.CO;2-W; Loehrer PJ, 1998, J CLIN ONCOL, V16, P2500; [Anonymous], 2012, NCCN CLIN PRACT GUID; Lorch A, 2007, J CLIN ONCOL, V25, P2778, DOI 10.1200/JCO.2006.09.2148; Eggener SE, 2007, CANCER, V109, P528, DOI 10.1002/cncr.22440; Pico JL, 2005, ANN ONCOL, V16, P1152, DOI 10.1093/annonc/mdi228; Motzer RJ, 2000, J CLIN ONCOL, V18, P2413; Nicolai N, 2009, BJU INT, V104, P340, DOI 10.1111/j.1464-410X.2009.08453.x; Carver BS, 2010, UROLOGY, V75, P1431, DOI 10.1016/j.urology.2009.11.076; Mead GM, 2005, BRIT J CANCER, V93, P178, DOI 10.1038/sj.bjc.6602682; Mead GM, 1997, J CLIN ONCOL, V15, P594; Necchi A, 2013, ANN ONCOL, V24, P2887, DOI 10.1093/annonc/mdt271; Necchi A, 2014, CLIN GENITOURIN CANC, V12, P63, DOI 10.1016/j.clgc.2013.07.005; Nonomura N, 2007, INT J UROL, V14, P527, DOI 10.1111/j.1442-2042.2006.01702.x; OLDENBURG J, 2013, ANN ONCOL S, V24, P25; Pectasides D, 2004, EUR UROL, V46, P216, DOI 10.1016/j.eururo.2004.03.001; Porcu P, 2000, J CLIN ONCOL, V18, P1181; Rashid S, 2012, CURR TREAT OPTION ON, V13, P201, DOI 10.1007/s11864-012-0199-z; Shamash J, 2007, ANN ONCOL, V18, P925, DOI 10.1093/annonc/mdm002; Shiraishi T, 2009, INT J CLIN ONCOL, V14, P436, DOI 10.1007/s10147-009-0899-y; Spiess EP, 2007, CANCER, V110, P2700	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR	2015	94	11								10.1097/MD.0000000000000653		7	Medicine, General & Internal	General & Internal Medicine	CE2UJ	WOS:000351674500019		
J	Ozawa, H; Imanishi, Y; Ito, F; Watanabe, Y; Kato, T; Nameki, H; Isobe, K; Ogawa, K				Ozawa, Hiroyuki; Imanishi, Yorihisa; Ito, Fumihiro; Watanabe, Yoshihiro; Kato, Takashi; Nameki, Hideo; Isobe, Kiyoshi; Ogawa, Kaoru			PiCO(2) Monitoring of Transferred Jejunum Perfusion Using an Air Tonometry Technique After Hypopharyngeal Cancer Surgery	MEDICINE			English	Article							CHRONIC GASTROINTESTINAL ISCHEMIA; FREE TISSUE TRANSFER; FREE-FLAP; RECONSTRUCTION; AUTOTRANSPLANTATION; MODEL	This study aimed to investigate the usefulness of intraluminal PCO2 (PiCO(2)) monitoring by air tonometry for the assessment of the vascular condition of the transferred jejunum after surgery for hypopharyngeal cancer. PiCO(2) in the transplanted jejunum of 24 patients was monitored using air tonometry after radical surgery for hypopharyngeal cancer from 2003 to 2010. All but 1 patient, who removed the catheter before monitoring began, were monitored safely. PiCO(2) in the transferred jejunum correlated with arterial PCO2 (PaCO2) that was measured concurrently, and dissociation of PiCO(2) from PaCO2 was observed in cases with vascular complication. In those cases without postoperative vascular complication, the PiCO(2) value gradually increased for 3 hours but then decreased by 12 hours after surgery. Three patients experienced major vascular complication. All 3 patients had continuous elevation of PiCO(2) >100mm Hg, although vascular flow in 1 patient recovered by removal of a venous thrombosis and reanastomosis of the vein 7.5 hours after surgery. Four other patients who experienced elevation of PiCO(2) had their skin suture released for decompression of their neck wound, resulting in a decrease in PiCO(2) after treatment. The current results demonstrated that continuous monitoring of PiCO(2) by air tonometry accurately reflects the vascular condition of the transferred jejunum, and this method is one of the best options for postoperative monitoring of jejunum blood perfusion.	[Ozawa, Hiroyuki; Ito, Fumihiro; Watanabe, Yoshihiro; Ogawa, Kaoru] Keio Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo 1608582, Japan; [Imanishi, Yorihisa] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan; [Kato, Takashi; Nameki, Hideo] Shizuoka Red Cross Hosp, Dept Otolaryngol Head & Neck Surg, Shizuoka, Japan; [Isobe, Kiyoshi] Shizuoka Red Cross Hosp, Dept Surg, Shizuoka, Japan	Ozawa, H (reprint author), Keio Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	ozakky@cb.mbn.or.jp					Hikida S, 1998, TRANSPLANT P, V30, P3446, DOI 10.1016/S0041-1345(98)01095-1; Bui DT, 2007, PLAST RECONSTR SURG, V119, P2092, DOI 10.1097/01.prs.0000260598.24376.e1; Kolkman JJ, 2000, BRIT J ANAESTH, V84, P74; Otte JA, 2001, J APPL PHYSIOL, V91, P866; Chen KT, 2007, PLAST RECONSTR SURG, V120, P187, DOI 10.1097/01.prs.0000264077.07779.50; Pohlenz P, 2012, INT J ORAL MAX SURG, V41, P739, DOI 10.1016/j.ijom.2012.02.012; Clark JR, 2006, LARYNGOSCOPE, V116, P173, DOI 10.1097/01.mlg.0000191459.40059.fd; GUTIERREZ G, 1992, LANCET, V339, P195, DOI 10.1016/0140-6736(92)90002-K; OLDING M, 1994, PLAST RECONSTR SURG, V94, P167, DOI 10.1097/00006534-199407000-00019; Julieron M, 1998, ANN OTO RHINOL LARYN, V107, P581; Disa JJ, 2003, PLAST RECONSTR SURG, V111, P652, DOI 10.1097/01.PRS.0000041987.53831.23; Disa JJ, 1999, PLAST RECONSTR SURG, V104, P97, DOI 10.1097/00006534-199907000-00013; Cho BC, 2002, PLAST RECONSTR SURG, V110, P1249; Correa-Martin L, 2013, J SURG RES, V184, P1028, DOI 10.1016/j.jss.2013.04.041; Cruz RJ, 2006, J SURG RES, V130, P13, DOI 10.1016/j.jss.2005.06.014; HAUGHEY BH, 1994, OTOLARYNG CLIN N AM, V27, P1159; Huang WY, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-37; Imanishi Y, 2003, PLAST RECONSTR SURG, V112, P1247, DOI 10.1097/01.PRS.0000080727.74314.34; Kamiya K, 2007, DIGEST SURG, V24, P214, DOI 10.1159/000102902; Kim S, 2001, HEAD NECK-J SCI SPEC, V23, P713, DOI 10.1002/hed.1101; Mensink PBF, 2008, DIGEST DIS SCI, V53, P133, DOI 10.1007/s10620-007-9833-1; van Noord D, 2013, EUR J GASTROEN HEPAT, V25, P719, DOI 10.1097/MEG.0b013e32835ddc45	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR	2015	94	11								10.1097/MD.0000000000000632		6	Medicine, General & Internal	General & Internal Medicine	CE2UJ	WOS:000351674500014		
J	Zhong, W; Li, X; Tao, GL; Kagawa, T				Zhong, Wei; Li, Xin; Tao, Guoliang; Kagawa, Toshiharu			Measurement and Determination of Friction Characteristic of Air Flow through Porous Media	METALS			English	Article							PRESSURE-DROP; PACKED-BEDS; FLUID-FLOW; METAL FOAM; LATTICE-BOLTZMANN; ERGUN EQUATION; SPHERES; MATRICES; PERMEABILITY; COEFFICIENTS	Sintered metal porous media currently plays an important role in air bearing systems. When flowing through porous media, the flow properties are generally represented by incompressible Darcy-Forchheimer regime or Ergun regime. In this study, a modified Ergun equation, which includes air compressibility effects, is developed to describe friction characteristic. Experimental and theoretical investigations on friction characteristic are conducted with a series of metal-sintered porous media. Re = 10 is selected as the boundary for a viscous drag region and a form drag region. Experimental data are first used to determine the coefficient alpha in the viscous drag region, and then the coefficient beta in the form drag region, rather than both simultaneously. Also, the theoretical mass flow rate in terms of the modified Ergun equation provides close approximations to the experimental data. Finally, it is also known that both the air compressibility and inertial effects can obviously enhance the pressure drop.	[Zhong, Wei] Jiangsu Univ Sci & Technol, Sch Mech Engn, Zhenjiang 212003, Peoples R China; [Zhong, Wei] Wuxi Pneumat Technol Res Inst, Wuxi 214072, Peoples R China; [Li, Xin; Tao, Guoliang] Zhejiang Univ, State Key Lab Fluid Power Transmiss & Control, Hangzhou 310027, Peoples R China; [Kagawa, Toshiharu] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan	Zhong, W (reprint author), Jiangsu Univ Sci & Technol, Sch Mech Engn, Zhenjiang 212003, Peoples R China.	zhongwei@just.edu.cn; vortexdoctor@zju.edu.cn; gltao@zju.edu.cn; kagawa.t.aa@m.titech.ac.jp	Li, Xin/E-7846-2012		National Natural Science Foundation of China [51205174]; Postdoctoral Science Foundation of China [2014M550309]; Open Foundation of the State Key Laboratory of Fluid Power Transmission and Control [GZKF-201407]; Youth Funds of the State Key Laboratory of Fluid Power Transmission and Control [SKLoFP_QN_1304]	The authors wish to thank the financial support of the National Natural Science Foundation of China (Grant No. 51205174), the Postdoctoral Science Foundation of China (Grant No. 2014M550309), the Open Foundation of the State Key Laboratory of Fluid Power Transmission and Control (Grant No. GZKF-201407) and the Youth Funds of the State Key Laboratory of Fluid Power Transmission and Control (SKLoFP_QN_1304).	Amano K., 2001, PRECIS ENG, V35, P58; FAND RM, 1987, J FLUID ENG-T ASME, V109, P268; MACDONALD IF, 1979, IND ENG CHEM FUND, V18, P199, DOI 10.1021/i160071a001; Rong LW, 2013, CHEM ENG SCI, V99, P44, DOI 10.1016/j.ces.2013.05.036; Dukhan N, 2006, EXP FLUIDS, V41, P665, DOI 10.1007/s00348-006-0194-x; [Anonymous], 2013, 635812013 ISO 1; Machado R, 2012, CHEM ENG SCI, V69, P628, DOI 10.1016/j.ces.2011.11.037; Dukhan N, 2011, J POROUS MAT, V18, P417, DOI 10.1007/s10934-010-9393-1; COMITI J, 1989, CHEM ENG SCI, V44, P1539, DOI 10.1016/0009-2509(89)80031-4; Medraj M, 2007, J MATER SCI, V42, P4372, DOI 10.1007/s10853-006-0602-x; Dukhan N, 2010, AIP CONF PROC, V1254, P299, DOI 10.1063/1.3453828; ERGUN S, 1952, CHEM ENG PROG, V48, P89; Montillet A, 2007, CHEM ENG PROCESS, V46, P329, DOI 10.1016/j.cep.2006.07.002; Dukhan N, 2012, TRANSPORT POROUS MED, V91, P225, DOI 10.1007/s11242-011-9841-7; Andrade JS, 1999, PHYS REV LETT, V82, P5249, DOI 10.1103/PhysRevLett.82.5249; Mancin S, 2010, INT J HEAT MASS TRAN, V53, P3121, DOI 10.1016/j.ijheatmasstransfer.2010.03.015; BEAVERS GS, 1973, J APPL MECH-T ASME, V40, P655; Antohe BV, 1997, J FLUID ENG-T ASME, V119, P404, DOI 10.1115/1.2819148; BEAVERS GS, 1969, J APPL MECH, V36, P711; Belforte G, 2009, TRIBOL INT, V42, P600, DOI 10.1016/j.triboint.2008.06.001; Belforte G., 2015, FEEDING SYSTEM AEROS; Boomsma K, 2002, J FLUID ENG-T ASME, V124, P263, DOI 10.1115/1.1429637; DUPLESSIS JP, 1994, TRANSPORT POROUS MED, V16, P189; Dukhan N, 2014, EXP THERM FLUID SCI, V57, P425, DOI 10.1016/j.expthermflusci.2014.06.011; Dybbs A., 1984, NATO ASI SER, V82, P199; Kim T., 2008, J FLUIDS ENG, V130; Lage JL, 1997, J FLUID ENG-T ASME, V119, P700, DOI 10.1115/1.2819301; Nield D.A., 2006, CONVECTION POROUS ME; Oiwa N, 2012, TRIBOL INT, V48, P2, DOI 10.1016/j.triboint.2011.08.014; Oneyama N., 2003, P 4 INT S POW TRANSM, P326; Dukhan N, 2011, J POROUS MAT, V18, P655, DOI 10.1007/s10934-010-9423-z; Jin LW, 2008, TRANSPORT POROUS MED, V72, P37, DOI 10.1007/s11242-007-9134-3; Liu JF, 2006, EXP THERM FLUID SCI, V30, P329, DOI 10.1016/j.expthermflusci.2005.07.007; Zhong W, 2014, TRANSPORT POROUS MED, V101, P53, DOI 10.1007/s11242-013-0230-2	34	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2075-4701			METALS-BASEL	Metals	MAR	2015	5	1					336	349		10.3390/met5010336		14	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CF1CW	WOS:000352282200017		
J	Minh, SH; Kimura, E; Minh, DH; Honjoh, K; Miyamoto, T				Son Hoang Minh; Kimura, Etsuko; Duc Hoang Minh; Honjoh, Ken-ichi; Miyamoto, Takahisa			Virulence characteristics of Shiga toxin-producing Escherichia coli from raw meats and clinical samples	MICROBIOLOGY AND IMMUNOLOGY			English	Article						Escherichia coli O157:H7; STEC; stx-subtypes; Verotoxin	HEMOLYTIC-UREMIC SYNDROME; SUBTILASE CYTOTOXIN; LISTERIA-MONOCYTOGENES; GROUND-BEEF; ENTEROCYTE EFFACEMENT; MOLECULAR ANALYSIS; INTESTINAL MUCUS; STRAINS; PREVALENCE; GENES	Shiga toxin producing Escherichia coli (STEC) are dangerous foodborne pathogens. Foods are considered as important sources for STEC infection in human. In this study, STEC contamination of raw meats was investigated and the virulence factors of 120 clinical STEC strains characterized. STEC was detected in 4.4% of tested samples. Among 25 STEC strains from meats, five strains (20%) were positive for the eae gene, which encodes intimin, an important binding protein of pathogenic STEC. The remaining strains (80%) were eae-negative. However, 28% of them possessed the saa gene, which encodes STEC agglutinating adhesin. The ehxA gene encoding for enterohemolysin was found in 75% of the meat strains and the subAB gene, the product is of which subtilase cytotoxin, was found in 32% of these strains. The stx(2a) gene, a subtype of Shiga toxin gene (stx), was the most prevalent subtype among the identified meat STEC bacteria. None of the meat STEC was O157:H7 serotype. Nevertheless, 92% of them produced Shiga toxin (Stx). Among 120 clinical STEC strains, 30% and 70% strains harbored single and multiple stx subtypes, respectively. Most clinical STEC bacteria possessed eae (90.8%) and ehxA (96.7%) genes and 92.5% of them showed Stx productivity. Our study shows that some raw meat samples contain non-O157 STEC bacteria and some strains have virulence factors similar to those of clinical strains.	[Son Hoang Minh; Kimura, Etsuko; Duc Hoang Minh; Honjoh, Ken-ichi; Miyamoto, Takahisa] Kyushu Univ, Dept Biosci & Biotechnol, Lab Food Hygien Chem, Fac Agr,Higashi Ku, Fukuoka 8128581, Japan	Miyamoto, T (reprint author), Kyushu Univ, Dept Biosci & Biotechnol, Lab Food Hygien Chem, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tmiyamot@agr.kyushu-u.ac.jp					Amaral MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070431; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Barlow RS, 2006, INT J FOOD MICROBIOL, V111, P1, DOI 10.1016/j.ijfoodmicro.2006.04.039; Miko A, 2009, APPL ENVIRON MICROB, V75, P6462, DOI 10.1128/AEM.00904-09; Wang H, 2007, J INFECT DIS, V196, P1093, DOI 10.1086/521364; Sanchez S, 2012, VET MICROBIOL, V159, P531, DOI 10.1016/j.vetmic.2012.04.036; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Burk C, 2003, J CLIN MICROBIOL, V41, P2106, DOI 10.1128/JCM.41.5.2106-2112.2003; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Rhoades JR, 2009, FOOD MICROBIOL, V26, P357, DOI 10.1016/j.fm.2008.10.012; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Prager R, 2011, INT J MED MICROBIOL, V301, P181, DOI 10.1016/j.ijmm.2010.06.003; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; MeltonCelsa AR, 1996, INFECT IMMUN, V64, P1569; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450; Beutin L, 2007, APPL ENVIRON MICROB, V73, P4769, DOI 10.1128/AEM.00873-07; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Kumar A, 2012, J APPL MICROBIOL, V113, P1208, DOI 10.1111/j.1365-2672.2012.05415.x; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Zhang WL, 2002, J CLIN MICROBIOL, V40, P1441, DOI 10.1128/JCM.40.4.1441-1446.2002; Newton HJ, 2009, EMERG INFECT DIS, V15, P372, DOI [10.3201/eid1503.080631, 10.3201/eid1502.080631]; Gerhardt E, 2013, INFECT IMMUN, V81, P2931, DOI 10.1128/IAI.00287-13; Samadpour M, 2006, J FOOD PROTECT, V69, P441; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Slanec T, 2009, APPL ENVIRON MICROB, V75, P6187, DOI 10.1128/AEM.00874-09; Pradel N, 2000, J CLIN MICROBIOL, V38, P1023; Smith JL, 2014, ADV APPL MICROBIOL, V86, P145, DOI 10.1016/B978-0-12-800262-9.00003-2; Ju WT, 2012, FOOD MICROBIOL, V32, P371, DOI 10.1016/j.fm.2012.07.017; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Li R, 2010, MICROB PATHOGENESIS, V49, P246, DOI 10.1016/j.micpath.2010.06.005; Leung PHM, 2003, APPL ENVIRON MICROB, V69, P7549, DOI 10.1128/AEM.69.12.7549-7553.2003; Erickson MC, 2007, J FOOD PROTECT, V70, P2426; Fantelli K, 2001, INT J FOOD MICROBIOL, V70, P63, DOI 10.1016/S0168-1605(01)00515-3; Funk J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-230; Hara-Kudo Y., 2012, FOOD ADDIT CONTAM A, V30, P1450; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Lee GY, 2009, INT J FOOD MICROBIOL, V134, P196, DOI 10.1016/j.ijfoodmicro.2009.06.013; Quinones B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00061; Schmidt H, 1996, EUR J BIOCHEM, V241, P594, DOI 10.1111/j.1432-1033.1996.00594.x; Xia XD, 2010, APPL ENVIRON MICROB, V76, P1709, DOI 10.1128/AEM.01968-09; Zhang W, 2005, APPL ENVIRON MICROB, V71, P558, DOI 10.1128/AEM.71.1.558-561.2005; Zweifel C, 2010, J FOOD PROTECT, V73, P88	47	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	MAR	2015	59	3					114	122		10.1111/1348-0421.12235		9	Immunology; Microbiology	Immunology; Microbiology	CE4WJ	WOS:000351830700002		
J	Soma, T; Nakagomi, O; Nakagomi, T; Mochizuki, M				Soma, Takehisa; Nakagomi, Osamu; Nakagomi, Toyoko; Mochizuki, Masami			Detection of Norovirus and Sapovirus from diarrheic dogs and cats in Japan	MICROBIOLOGY AND IMMUNOLOGY			English	Article						cat; dog; Norovirus; Sapovirus	POLYMERASE-CHAIN-REACTION; MOLECULAR CHARACTERIZATION; CANINE CALICIVIRUS; FELINE CALICIVIRUS; RT-PCR; GASTROENTERITIS; TRANSMISSION; INFECTIONS; OUTBREAK; VIRUS	Norovirus (NoV) and sapovirus (SaV) are important causes of human diarrhea. In this study, between 2007 and 2014 fecal samples were collected from 97 dogs and 83 cats with diarrhea and examined to determine the prevalence of NoV and SaV infections in Japan. To detect caliciviruses, approximately 300 bases targeting the polymerase gene were amplified using RT-PCR and subjected to phylogenetic and homology analyses. Specific PCR products were obtained from four canine and nine feline samples: two canine and one feline isolate were classified as NoV, two canine isolates as SaV and the remaining eight feline isolates as vesivirus (VeV). The three NoV isolates were classified into the same clade as that of known canine and feline NoVs; their homologies (75.9-92.3%) were higher than those with human genogroup IV (GIV) NoVs (59.1-65.9%). The homology of the feline NoV isolate with previously reported feline NoV isolates was particularly high (91.7-92.3%). Regarding SaV, the two canine isolates were classified into the same clade as known canine SaVs and their homologies (72.5-86.5%) were higher than those with other mammal SaVs (20.7-58.0%). The eight feline VeV isolates were assumed to be feline calicivirus. The present study is the first report of the presence of NoV- and SaV-infected dogs and cats in Japan. The findings suggest there are species-specific circulations of NoV and SaV among dogs and cats, in Japan.	[Soma, Takehisa] Marupi Lifetech, Vet Diagnost Lab, Ikeda, Osaka 5630011, Japan; [Nakagomi, Osamu; Nakagomi, Toyoko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, Nagasaki 8528523, Japan; [Mochizuki, Masami] Kagoshima Univ, Joint Fac Vet Med, Infect Dis Lab, Kagoshima 8900065, Japan	Soma, T (reprint author), Marupi Lifetech, Vet Diagnost Lab, 103 Fushiocho, Ikeda, Osaka 5630011, Japan.	takehisa-soma@ah.ds-pharma.co.jp					Addie DD, 2003, J GEN VIROL, V84, P2735, DOI 10.1099/vir.0.19129-0; Scheuer KA, 2013, J CLIN MICROBIOL, V51, P2344, DOI 10.1128/JCM.00865-13; Bank-Wolf BR, 2010, VET MICROBIOL, V140, P204, DOI 10.1016/j.vetmic.2009.08.021; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Mesquita JR, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-176; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Summa M, 2012, J CLIN VIROL, V53, P244, DOI 10.1016/j.jcv.2011.12.014; Tse H, 2012, J VIROL, V86, P9531, DOI 10.1128/JVI.01312-12; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Hu RL, 2001, VET RES COMMUN, V25, P77, DOI 10.1023/A:1006417203856; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Radford AD, 2007, VET RES, V38, P319, DOI 10.1051/vetres:20069056; MOCHIZUKI M, 1993, VET REC, V132, P221; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Dye C, 2008, J FELINE MED SURG, V10, P167, DOI 10.1016/j.jfms.2007.10.010; Frisk AL, 1999, J CLIN MICROBIOL, V37, P3634; HUMPHREY TJ, 1984, J HYG-CAMBRIDGE, V93, P293; Jang HK, 2003, VET REC, V153, P150; Martella V, 2011, VET CLIN N AM-SMALL, V41, P1171, DOI 10.1016/j.cvsm.2011.08.002; Matsuura Y, 2002, VIRUS GENES, V25, P67, DOI 10.1023/A:1020174225622; Mesquita JR, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-107; Mochizuki M, 2002, J CLIN MICROBIOL, V40, P2629, DOI 10.1128/JCM.40.7.2629-2631.2002; MOCHIZUKI M, 1992, VET MICROBIOL, V31, P297, DOI 10.1016/0378-1135(92)90087-A; Ntafis V, 2010, J CLIN MICROBIOL, V48, P2605, DOI 10.1128/JCM.02528-09; Pereira CAD, 2000, VET MICROBIOL, V75, P127, DOI 10.1016/S0378-1135(00)00214-5; Pinto P., 2012, PLOS ONE, V32739; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Tran Hoa, 2013, J CLIN VIROL, V56, P185; Vinje J., 2014, J CLIN MICROBIOL; Zheng D. P., 2005, VIROLOGY, V15, P312	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	MAR	2015	59	3					123	128		10.1111/1348-0421.12223		6	Immunology; Microbiology	Immunology; Microbiology	CE4WJ	WOS:000351830700003		
J	Yamamoto, T; Hayashi, A; Tsukuura, R; Goto, A; Yoshimatsu, H; Koshima, I				Yamamoto, Takumi; Hayashi, Akitatsu; Tsukuura, Reiko; Goto, Aya; Yoshimatsu, Hidehiko; Koshima, Isao			TRANSVERSELY-INSET GREAT TOE HEMI-PULP FLAP TRANSFER FOR THE RECONSTRUCTION OF A THUMB-TIP DEFECT	MICROSURGERY			English	Article							REPAIR; NAIL	Thumb-tip defect is a common traumatic disease, and replantation of an amputated thumb-tip is the first choice of treatment when available. When an amputee is not available, local flaps such as volar advancement flap are used for reconstruction. However, it is difficult to cover whole defect area by a local flap when a defect is relatively large. In this report, we present a case of the use of a free great toe hemi-pulp flap transfer to reconstruct a thumb-tip defect. A 69-year-old right-handed male suffered from the right thumb-tip crush amputation in Tamai Zone 2. The distal phalanx and the nail matrix were preserved, and the defect size was 5 cm x 4 cm. The thumb-tip was reconstructed with a free great toe hemi-pulp flap under local anesthesia. The flap included extended subcutaneous adiposal tissue (skin size 4.5 cm x 3 cm; fat size 4.5 cm x 5.5 cm) to reconstruct the nail bed, and was transversely inset at the recipient site to cover the whole area of the defect. The donor site could be primarily closed without skin grafting. At postoperative 6 months, the patient was satisfied with good results of the reconstructed thumb-tip and the donor site. Transversely-inset great toe hemi-pulp flap may be useful to reconstruct a thumb-tip defect, which allows relatively wide defect reconstruction. (c) 2014 Wiley Periodicals, Inc. Microsurgery 35:235-238, 2015.	[Yamamoto, Takumi; Hayashi, Akitatsu; Tsukuura, Reiko; Goto, Aya; Yoshimatsu, Hidehiko; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo 1138655, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Tang JB, 2014, CLIN PLAST SURG, V41, P325, DOI 10.1016/j.cps.2014.04.004; KOSHIMA I, 1993, PLAST RECONSTR SURG, V92, P1331; Koshima I, 2000, PLAST RECONSTR SURG, V105, P1666, DOI 10.1097/00006534-200004050-00011; Chen KK, 2014, MICROSURG, V34, P535, DOI 10.1002/micr.22291; Friedrich JB, 2011, CLIN PLAST SURG, V38, P697, DOI 10.1016/j.cps.2011.08.002; Harenberg PS, 2012, OPER ORTHOP TRAUMATO, V24, P116, DOI 10.1007/s00064-011-0081-3; KOSHIMA I, 1992, BRIT J PLAST SURG, V45, P591, DOI 10.1016/0007-1226(92)90025-S; MINAMI A, 1984, J HAND SURG-BRIT EUR, V9B, P239, DOI 10.1016/0266-7681(84)90032-9; MORRISON WA, 1980, J HAND SURG-AM, V5, P575; Yamamoto T, 2014, MICROSURG, V34, P481, DOI 10.1002/micr.22239; ZOOK EG, 1990, HAND CLIN, V6, P59	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	MAR	2015	35	3					235	238		10.1002/micr.22347		4	Surgery	Surgery	CE8PM	WOS:000352105800011		
J	Hayashida, K; Hiroto, S; Morooka, S; Kuwabara, K; Fujioka, M				Hayashida, Kenji; Hiroto, Saijo; Morooka, Shin; Kuwabara, Kaoru; Fujioka, Masaki			THE VASCULARIZED SURAL NERVE GRAFT BASED ON A PERONEAL ARTERY PERFORATOR FOR RECONSTRUCTION OF THE INFERIOR ALVEOLAR NERVE DEFECT	MICROSURGERY			English	Article							NEUROFASCIOCUTANEOUS FLAP; FASCIOCUTANEOUS FLAP; LOWER LEG; ANKLE; FOOT; REGENERATION; EXPERIENCE	The sural nerve has been described for nerve reconstruction of the maxillofacial region since it provides many advantages. We report a case of a vascularized sural nerve graft based on a peroneal artery perforator for immediate reconstruction after the removal of intraosseous neuroma originating in the inferior alveolar nerve. The patient had a neuroma caused by iatrogenic injury to the inferior alveolar nerve. A 4-cm long neuroma existed in the inferior alveolar nerve and was resected. A peroneal perforator was chosen as the pedicle of the vascularized sural nerve graft for the nerve gap. The graft including the skin paddle for monitoring the perfusion supplied by this perforator was transferred to the lesion. The nerve gap between the two stumps of the inferior alveolar nerve was repaired using the 6-cm long vascularized sural nerve. The perforator of the peroneal artery was anastomosed to the branch of the facial artery in a perforator-to-perforator fashion. There was no need to sacrifice any main arteries. The skin paddle with 1 cm x 3 cm in size was inset into the incised medial neck. Perceptual function tests with a Semmes-Weinstein pressure esthesiometer and two-point discrimination in the lower lip and chin at 10 months after surgery showed recovery almost to the level of the normal side. This free vascularized sural nerve graft based on a peroneal artery perforator may be a good alternative for reconstruction of inferior alveolar nerve defects. (c) 2014 Wiley Periodicals, Inc. Microsurgery 35:244-248, 2015.	[Hayashida, Kenji; Hiroto, Saijo; Morooka, Shin; Kuwabara, Kaoru; Fujioka, Masaki] Natl Nagasaki Med Ctr, Div Plast & Reconstruct Surg, Ohmura City, Japan	Hayashida, K (reprint author), Natl Nagasaki Med Ctr, 1001-1 Kubara 2, Ohmura City 8568562, Japan.	k.hayashida@nagasaki-mc.com					KOSHIMA I, 1985, ANN PLAS SURG, V14, P235, DOI 10.1097/00000637-198503000-00008; Strauss ER, 2006, J ORAL MAXIL SURG, V64, P1767, DOI 10.1016/j.joms.2005.11.111; YOSHIMURA M, 1990, PLAST RECONSTR SURG, V85, P917, DOI 10.1097/00006534-199006000-00012; Chang YM, 2012, J PLAST RECONSTR AES, V65, P757, DOI 10.1016/j.bjps.2011.12.028; Zhu YL, 2013, MICROSURG, V33, P600, DOI 10.1002/micr.22177; Chai YM, 2007, ANN PLAS SURG, V59, P526, DOI 10.1097/01.sap.0000258969.13723.68; Bagheri SC, 2010, J ORAL MAXIL SURG, V68, P2770, DOI 10.1016/j.joms.2010.05.065; Shimizu F, 2009, MICROSURG, V29, P253, DOI 10.1002/micr.20626; Yamamoto T, 2014, MICROSURG, V34, P145, DOI 10.1002/micr.22135; KANAYA F, 1992, PLAST RECONSTR SURG, V89, P924, DOI 10.1097/00006534-199205000-00024; Koshima I, 2010, CLIN PLAST SURG, V37, P683, DOI 10.1016/j.cps.2010.06.009; Pogrel MA, 2001, J ORAL MAXIL SURG, V59, P985, DOI 10.1053/joms.2001.25821; Chang SM, 1998, PLAST RECONSTR SURG, V101, P2013, DOI 10.1097/00006534-199806000-00061; Kallal RH, 2007, INT J ORAL MAX SURG, V36, P453, DOI 10.1016/j.ijom.2006.10.017; Lin CT, 2013, MICROSURG, V33, P191, DOI 10.1002/micr.22064; Mundinger GS, 2012, PLAST RECONSTR SURG, V129, p110E, DOI 10.1097/PRS.0b013e3182362a87; OZCAN G, 1993, PLAST RECONSTR SURG, V91, P1322, DOI 10.1097/00006534-199306000-00020; Pogrel MA, 2001, J ORAL MAXILLOFAC SU, V59, P988; Schaverien M, 2008, PLAST RECONSTR SURG, V122, P161, DOI 10.1097/PRS.0b013e3181774386; SVANE TJ, 1986, J ORAL MAXIL SURG, V44, P431; Wang CY, 2011, PLAST RECONSTR SURG, V127, P293, DOI 10.1097/PRS.0b013e3181f95cb1; Wei JW, 2014, J RECONSTR MICROSURG, V30, P249, DOI 10.1055/s-0033-1357274; Ziccardi V B, 2001, Atlas Oral Maxillofac Surg Clin North Am, V9, P1	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	MAR	2015	35	3					244	248		10.1002/micr.22346		5	Surgery	Surgery	CE8PM	WOS:000352105800013		
J	Yamamoto, T; Furuya, M; Harima, M; Hayashi, A; Koshima, I				Yamamoto, Takumi; Furuya, Megumi; Harima, Mitsunobu; Hayashi, Akitatsu; Koshima, Isao			TRIPLE SUPERMICROSURGICAL SIDE-TO-SIDE LYMPHATICOLYMPHATIC ANASTOMOSES ON A LYMPHATIC VESSEL END-TO-END ANASTOMOSED TO A VEIN	MICROSURGERY			English	Letter									[Yamamoto, Takumi; Furuya, Megumi; Harima, Mitsunobu; Hayashi, Akitatsu; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Yamamoto T, 2013, MICROSURG, V33, P130, DOI 10.1002/micr.22040; Yamamoto T, 2014, ANN PLAS SURG, V73, P46, DOI 10.1097/SAP.0b013e31826caff1; Yamamoto T, 2015, MICROSURG, V35, P129, DOI 10.1002/micr.22272; Yamamoto T, 2014, MICROSURG, V34, P404, DOI 10.1002/micr.22215	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0738-1085	1098-2752		MICROSURG	Microsurgery	MAR	2015	35	3					249	250		10.1002/micr.22296		2	Surgery	Surgery	CE8PM	WOS:000352105800014		
J	Rowlands, D; Sugahara, K; Kwok, JCF				Rowlands, Daire; Sugahara, Kazuyuki; Kwok, Jessica C. F.			Glycosaminoglycans and Glycomimetics in the Central Nervous System	MOLECULES			English	Review							HEPARAN-SULFATE PROTEOGLYCANS; SPINAL-CORD-INJURY; PROMOTES FUNCTIONAL RECOVERY; CELL-ADHESION MOLECULE; MAMMALIAN HYALURONAN SYNTHASES; PERINEURONAL NETS PROTECT; ALZHEIMERS-DISEASE BRAIN; LONG-TERM POTENTIATION; CHONDROITIN-SULFATE; EXTRACELLULAR-MATRIX	With recent advances in the construction of synthetic glycans, selective targeting of the extracellular matrix (ECM) as a potential treatment for a wide range of diseases has become increasingly popular. The use of compounds that mimic the structure or bioactive function of carbohydrate structures has been termed glycomimetics. These compounds are mostly synthetic glycans or glycan-binding constructs which manipulate cellular interactions. Glycosaminoglycans (GAGs) are major components of the ECM and exist as a diverse array of differentially sulphated disaccharide units. In the central nervous system (CNS), they are expressed by both neurons and glia and are crucial for brain development and brain homeostasis. The inherent diversity of GAGs make them an essential biological tool for regulating a complex range of cellular processes such as plasticity, cell interactions and inflammation. They are also involved in the pathologies of various neurological disorders, such as glial scar formation and psychiatric illnesses. It is this diversity of functions and potential for selective interventions which makes GAGs a tempting target. In this review, we shall describe the molecular make-up of GAGs and their incorporation into the ECM of the CNS. We shall highlight the different glycomimetic strategies that are currently being used in the nervous system. Finally, we shall discuss some possible targets in neurological disorders that may be addressed using glycomimetics.	[Rowlands, Daire; Kwok, Jessica C. F.] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge CB2 0PY, England; [Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Proteoglycan Signaling & Therapeut Res Grp, Sapporo, Hokkaido 0010021, Japan	Kwok, JCF (reprint author), Univ Cambridge, John van Geest Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	dr401@cam.ac.uk; k-sugar@sci.hokudai.ac.jp; jcfk2@cam.ac.uk			Wings for Life-Spinal Cord Research Foundation	JCFK is supported by the Wings for Life-Spinal Cord Research Foundation.	AKIYAMA H, 1993, BRAIN RES, V632, P249, DOI 10.1016/0006-8993(93)91160-T; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958; Varga N, 2014, BIOMATERIALS, V35, P4175, DOI 10.1016/j.biomaterials.2014.01.014; Bannerman DM, 2001, EXP BRAIN RES, V141, P281; Ashioti M, 2007, BRAIN RES, V1145, P177, DOI 10.1016/j.brainres.2007.01.111; Pearson BL, 2013, BEHAV BRAIN RES, V243, P138, DOI 10.1016/j.bbr.2012.12.062; Bushman J, 2014, NEUROPHARMACOLOGY, V79, P456, DOI 10.1016/j.neuropharm.2013.09.014; Arpicco S, 2014, MOLECULES, V19, P3193, DOI 10.3390/molecules19033193; Lappalainen RS, 2008, NEUROSCI LETT, V440, P246, DOI 10.1016/j.neulet.2008.05.090; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Mauney SA, 2013, BIOL PSYCHIAT, V74, P427, DOI 10.1016/j.biopsych.2013.05.007; Bekku Y, 2009, J NEUROCHEM, V108, P1266, DOI 10.1111/j.1471-4159.2009.05873.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Okamoto M, 2003, EXP NEUROL, V184, P179, DOI 10.1016/S0014-4886(03)00251-6; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; SNOW AD, 1988, AM J PATHOL, V133, P456; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Irintchev A, 2011, J NEUROTRAUM, V28, P1295, DOI 10.1089/neu.2011.1775; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Pomin VH, 2015, INT J BIOL MACROMOL, V72, P282, DOI 10.1016/j.ijbiomac.2014.08.029; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235; Chandran PL, 2012, ACTA BIOMATER, V8, P3, DOI 10.1016/j.actbio.2011.08.011; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; Kaksonen M, 2002, MOL CELL NEUROSCI, V21, P158, DOI 10.1006/mcne.2002.1167; Kumar-Singh S, 2002, AM J PATHOL, V161, P507, DOI 10.1016/S0002-9440(10)64207-1; Ogata M, 2009, BIOCONJUGATE CHEM, V20, P538, DOI 10.1021/bc800460p; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Vo T, 2013, MOL CELL NEUROSCI, V56, P186, DOI 10.1016/j.mcn.2013.04.009; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; van Horssen J, 2006, NEUROBIOL DIS, V24, P484, DOI 10.1016/j.nbd.2006.08.005; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; SNOW AD, 1990, AM J PATHOL, V137, P1253; Gibbs P, 2011, CANCER CHEMOTH PHARM, V67, P153, DOI 10.1007/s00280-010-1303-3; Dick G, 2013, J BIOL CHEM, V288, P27384, DOI 10.1074/jbc.M111.310029; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Eastwood SL, 2003, MOL PSYCHIATR, V8, P148, DOI 10.1038/sj.mp.4001233; Simova O, 2006, ANN NEUROL, V60, P430, DOI 10.1002/ana.20948; Dhamoon MS, 2010, NEUROLOGY, V75, P328, DOI 10.1212/WNL.0b013e3181ea9f03; Matthews RT, 2002, J NEUROSCI, V22, P7536; Baleux F, 2009, NAT CHEM BIOL, V5, P743, DOI 10.1038/nchembio.207; Irie F, 2012, P NATL ACAD SCI USA, V109, P5052, DOI 10.1073/pnas.1117881109; Marino P, 2009, EXP NEUROL, V219, P163, DOI 10.1016/j.expneurol.2009.05.009; Faroni A, 2015, ADV DRUG DELIVER REV, V82-83, P160, DOI 10.1016/j.addr.2014.11.010; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Pietersen CY, 2014, J NEUROGENET, V28, P53, DOI 10.3109/01677063.2014.882918; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540290114478; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; GALLAGHER JT, 1985, BIOCHEM J, V230, P665; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Morawski M, 2010, NEUROSCIENCE, V169, P1347, DOI 10.1016/j.neuroscience.2010.05.022; CHOAY J, 1983, BIOCHEM BIOPH RES CO, V116, P492; Meyza KZ, 2012, BEHAV BRAIN RES, V228, P247, DOI 10.1016/j.bbr.2011.11.004; Lauri SE, 1999, J NEUROSCI, V19, P1226; WIELENGA VJM, 1993, CANCER RES, V53, P4754; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Beurdeley M, 2012, J NEUROSCI, V32, P9429, DOI 10.1523/JNEUROSCI.0394-12.2012; Lander C, 1998, J NEUROSCI, V18, P174; Miyata S, 2007, BRAIN RES, V1150, P200, DOI 10.1016/j.brainres.2007.02.066; Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062; Richardson TP, 2001, J CELL SCI, V114, P1613; Kwok JCF, 2010, J NEUROCHEM, V114, P1447, DOI 10.1111/j.1471-4159.2010.06878.x; Muto J, 2009, MOL IMMUNOL, V47, P449, DOI 10.1016/j.molimm.2009.08.026; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Belichenko PV, 1997, NEUROBIOL DIS, V4, P301, DOI 10.1006/nbdi.1997.0143; Belichenko PV, 1999, NEUROBIOL DIS, V6, P269, DOI 10.1006/nbdi.1999.0245; Brook S., 1995, J NEUROSCI, V15, P8053; CASSARO CMF, 1977, J BIOL CHEM, V252, P2254; Chanana B, 2009, P NATL ACAD SCI USA, V106, P11984, DOI 10.1073/pnas.0901148106; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Cripps JG, 2005, INT IMMUNOPHARMACOL, V5, P1622, DOI 10.1016/j.intimp.2005.04.010; Di Meo C, 2008, MACROMOL BIOSCI, V8, P670, DOI 10.1002/mabi.200700304; Donahue JE, 1999, P NATL ACAD SCI USA, V96, P6468, DOI 10.1073/pnas.96.11.6468; Tselnicker IF, 2014, BIOCHEM SOC T, V42, P1263, DOI 10.1042/BST20140166; Ford-Perriss M, 2003, DEV DYNAM, V227, P170, DOI 10.1002/dvdy.10298; Forsberg E., 1999, NATURE, V400, P2; Fournier M, 2014, SCHIZOPHRENIA BULL, V40, P973, DOI 10.1093/schbul/sbu053; Ishigami S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-106; Katagihallimath N, 2010, EUR J CELL BIOL, V89, P77, DOI 10.1016/j.ejcb.2009.10.007; KAUFMANN M, 1995, LANCET, V345, P615, DOI 10.1016/S0140-6736(95)90521-9; Kizuka Y, 2012, CELL MOL LIFE SCI, V69, P4135, DOI 10.1007/s00018-012-1036-z; Larner AJ, 1997, NEUROSCI RES COMMUN, V20, P147, DOI 10.1002/(SICI)1520-6769(199705)20:3<147::AID-NRC196>3.0.CO;2-B; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Liu P, 2015, CHEM SCI, V6, P450, DOI 10.1039/c4sc02553a; Louboutin JP, 2011, EUR J NEUROSCI, V34, P2015, DOI 10.1111/j.1460-9568.2011.07908.x; Matthews M. B., 1971, BIOCHIM BIOPHYS ACTA, V244, P30, DOI 10.1016/0304-4165(71)90117-64256269; Mizumoto S., 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/65631924459669, DOI 10.1155/2013/656319]; Morawski M., 2013, BRAIN PATHOL, V22, P547, DOI 10.1111/j.1750-3639.2011.00557.x; Oertli B, 1998, J IMMUNOL, V161, P3431; Pan HC, 2014, NEUROSCIENCE, V277, P356, DOI 10.1016/j.neuroscience.2014.06.069; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Pantazopoulos H, 2013, SCHIZOPHR RES, V150, P366, DOI 10.1016/j.schres.2013.08.013; Raman K, 2013, MOL PHARMACEUT, V10, P1442, DOI 10.1021/mp300679a; Sanmarti Montserrat, 2014, J Mol Psychiatry, V2, P2, DOI 10.1186/2049-9256-2-2; Sarrazin S, 2011, COLD SPRING HARB PER, V3, P1, DOI DOI 10.1101/CSHPERSPECT.A004952; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; Suttkus Anne, 2012, Am J Neurodegener Dis, V1, P122; Trowbridge J. M., 2002, GLYCOBIOLOGY, V12, p117R; van Horssen Jack, 2007, J Neurochem, V103, P1293, DOI 10.1111/j.1471-4159.2007.04897.x; Verbeek MM, 1999, AM J PATHOL, V155, P2115, DOI 10.1016/S0002-9440(10)65529-0; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Wu YJ, 2013, NEUROSCI LETT, V533, P77, DOI 10.1016/j.neulet.2012.10.058; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289, DOI 10.2174/157016308786733564; Yuan W, 2002, NEUROSCIENCE, V114, P1091, DOI 10.1016/S0306-4522(02)00347-0	131	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	MAR	2015	20	3					3527	3548		10.3390/molecules20033527		22	Chemistry, Organic	Chemistry	CF3TL	WOS:000352471300003		
J	Murayama, K; Ishikawa, D; Genkawa, T; Sugino, H; Komiyama, M; Ozaki, Y				Murayama, Kodai; Ishikawa, Daitaro; Genkawa, Takuma; Sugino, Hiroyuki; Komiyama, Makoto; Ozaki, Yukihiro			Image Monitoring of Pharmaceutical Blending Processes and the Determination of an End Point by Using a Portable Near-Infrared Imaging Device Based on a Polychromator-Type Near-Infrared Spectrometer with a High-speed and High-Resolution Photo Diode Array Detector	MOLECULES			English	Article							DRUG-RELEASE; SPECTROSCOPY; TABLETS; DISSOLUTION; HOMOGENEITY; REFLECTANCE; GRANULATION; CALIBRATION; MODELS	In the present study we have developed a new version (ND-NIRs) of a polychromator-type near-infrared (NIR) spectrometer with a high-resolution photo diode array detector, which we built before (D-NIRs). The new version has four 5 W halogen lamps compared with the three lamps for the older version. The new version also has a condenser lens with a shorter focal point length. The increase in the number of the lamps and the shortening of the focal point of the condenser lens realize high signal-to-noise ratio and high-speed NIR imaging measurement. By using the ND-NIRs we carried out the in-line monitoring of pharmaceutical blending and determined an end point of the blending process. Moreover, to determinate a more accurate end point, a NIR image of the blending sample was acquired by means of a portable NIR imaging device based on ND-NIRs. The imaging result has demonstrated that the mixing time of 8 min is enough for homogeneous mixing. In this way the present study has demonstrated that ND-NIRs and the imaging system based on a ND-NIRs hold considerable promise for process analysis.	[Murayama, Kodai; Sugino, Hiroyuki; Komiyama, Makoto] Yokogawa Elect Corp, Innovat Headquarters, Musashino, Tokyo 1808750, Japan; [Ishikawa, Daitaro] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Ishikawa, Daitaro; Genkawa, Takuma; Ozaki, Yukihiro] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda, Hyogo 6691337, Japan; [Genkawa, Takuma] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Murayama, K (reprint author), Yokogawa Elect Corp, Innovat Headquarters, 2-9-32 Nakacho, Musashino, Tokyo 1808750, Japan.	Koudai.Murayama@jp.yokogawa.com; daitaroishikawa@m.tohoku.ac.jp; genkawa.takuma.fm@u.tsukuba.ac.jp; H.Sugino@jp.yokogawa.com; Makoto.Komiyama@jp.yokogawa.com; ozaki@kwansei.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Ministry of Economy, Trade and Industry, Tokyo, Japan	The study was supported by "Innovation Promotion Program" of New Energy and Industrial Technology Development Organization (NEDO), Ministry of Economy, Trade and Industry, Tokyo, Japan.	Murayama K, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4790413; Ishikawa D, 2013, ANAL BIOANAL CHEM, V405, P9401, DOI 10.1007/s00216-013-7355-6; Otsuka M, 2007, J PHARM SCI-US, V96, P788, DOI 10.1002/jps.20704; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; El-Hagrasy AS, 2006, J PHARM SCI-US, V95, P407, DOI 10.1002/jps.20466; Rantanen J, 2000, EUR J PHARM BIOPHARM, V50, P271, DOI 10.1016/S0939-6411(00)00096-5; van der Weerd J, 2004, J CONTROL RELEASE, V98, P295, DOI 10.1016/j.jconrel.2004.05.007; Ishikawa D, 2014, J NEAR INFRARED SPEC, V22, P189, DOI 10.1255/jnirs.1116; Sekulic SS, 1996, ANAL CHEM, V68, P509, DOI 10.1021/ac950964m; El-Hagrasy AS, 2001, J PHARM SCI, V90, P1298, DOI 10.1002/jps.1082; Lewis EN, 2004, SPECTROSCOPY, V19, P26; [Anonymous], ICH HARM TRIP GUID P; Kogermann K, 2008, J PHARM SCI-US, V97, P4983, DOI 10.1002/jps.21357; Andersson M, 2000, ANAL CHEM, V72, P2099, DOI 10.1021/ac990256r; Ozaki Y, 2012, ANAL SCI, V28, P545; Bakeev K.A., 2005, PROCESS ANAL TECHNOL, P13; Cogdill R.P., 2005, AAPS PHARMSCITECH, V6, P262; Gao P, 1996, J PHARM SCI, V85, P725, DOI 10.1021/js950458c; Ishikawa D., 2012, NIR NEWS, V23, P14; Kazarian SG, 2008, PHARM RES, V25, P853, DOI 10.1007/s11095-007-9375-4; Li WY, 2005, J PHARM SCI-US, V94, P2800, DOI 10.1002/jps.20501; Li WY, 2008, INT J PHARM, V350, P369, DOI 10.1016/j.ijpharm.2007.08.055; Lui H., 2006, J MOL STRUCT, V794, P12; Ozaki Y., 2000, NEAR INFRARED SPECTR, P53; Sasic S, 2010, RAMAN, INFRARED, AND NEAR-INFRARED CHEMICAL IMAGING, P1, DOI 10.1002/9780470768150; Shinzawa H, 2011, J NEAR INFRARED SPEC, V19, P15, DOI 10.1255/jnirs.918; Trafford AD, 1999, ANALYST, V124, P163, DOI 10.1039/a806629i; Ufret C, 2001, DRUG DEV IND PHARM, V27, P719, DOI 10.1081/DDC-100107329; Unger M, 2011, APPL SPECTROSC, V65, P1051, DOI 10.1366/11-06309; US Food Drug Administration, GUID IND PAT FRAM IN	30	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	MAR	2015	20	3					4007	4019		10.3390/molecules20034007		13	Chemistry, Organic	Chemistry	CF3TL	WOS:000352471300029		
J	Liu, Y; Kobayashi, A; Maeda, T; Fu, QB; Oikawa, M; Yang, G; Konishi, T; Uchihori, Y; Hei, TK; Wang, YG				Liu, Yu; Kobayashi, Alisa; Maeda, Takeshi; Fu, Qibin; Oikawa, Masakazu; Yang, Gen; Konishi, Teruaki; Uchihori, Yukio; Hei, Tom K.; Wang, Yugang			Target irradiation induced bystander effects between stem-like and non stem-like cancer cells	MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS			English	Article						Radiation-induced Bystander Effect (RIBE); Cancer stem-like cells (CSCs); 53BP1; c-PTIO; Proton microbeam	GLIOMA-CELLS; DRUG-RESISTANCE; RADIORESISTANCE; HETEROGENEITY; FIBROBLASTS; POPULATIONS; MICROBEAM; THERAPY; STRESS; ALDH1	Tumors are heterogeneous in nature and consist of multiple cell types. Among them, cancer stem-like cells (CSCs) are suggested to be the principal cause of tumor metastasis, resistance and recurrence. Therefore, understanding the behavior of CSCs in direct and indirect irradiations is crucial for clinical radiotherapy. Here, the CSCs and their counterpart non stem-like cancer cells (NSCCs) in human HT1080 fibrosarcoma cell line were sorted and labeled, then the two cell subtypes were mixed together and chosen separately to be irradiated via a proton microbeam. The radiation-induced bystander effect (RIBE) between the CSCs and NSCCs was measured by imaging 53BP1 foci, a widely used indicator for DNA double strand break (DSB). CSCs were found to be less active than NSCCs in both the generation and the response of bystander signals. Moreover, the nitric oxide (NO) scavenger c-PTIO can effectively alleviate the bystander effect in bystander NSCCs but not in bystander CSCs, indicating a difference of the two cell subtypes in NO signal response. To our knowledge, this is the first report shedding light on the RIBE between CSCs and NSCCs, which might contribute to a further understanding of the out-of-field effect in cancer radiotherapy. (C) 2015 Elsevier B.V. All rights reserved.	[Liu, Yu; Fu, Qibin; Yang, Gen; Wang, Yugang] Peking Univ, Sch Phys, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China; [Liu, Yu; Kobayashi, Alisa; Yang, Gen; Konishi, Teruaki; Uchihori, Yukio; Hei, Tom K.] Natl Inst Radiol Sci, Space Radiat Res Unit, Int Open Lab, Chiba 2638555, Japan; [Kobayashi, Alisa; Maeda, Takeshi; Oikawa, Masakazu; Konishi, Teruaki; Uchihori, Yukio] Natl Inst Radiol Sci, Dept Tech Support & Dev, Chiba 2638555, Japan; [Hei, Tom K.] Ctr Radiol Res, New York, NY 10032 USA	Yang, G (reprint author), Peking Univ, Sch Phys, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China.	gen.yang@pku.edu.cn; tkonishi@nirs.go.jp	Konishi, Teruaki/B-9638-2008	Konishi, Teruaki/0000-0002-2485-9659	National Grand Instrument Program [2012YQ030142]; International Open Laboratory Program of NIRS	This work was supported by grants from the National Grand Instrument Program (2012YQ030142) and also supported by International Open Laboratory Program of NIRS. Microbeam irradiation experiments were conducted as part of Joint-use Research Facility for Collaborative Project with NIRS-SPICE (Proposal#: S13-YG01). The authors would like to thank Ms. Keiko Warren for her administrative management support.	Honoki K, 2010, ONCOL REP, V24, P501, DOI 10.3892/or_00000885; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Konishi T, 2013, J RADIAT RES, V54, P736, DOI 10.1093/jrr/rrs132; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Morgan SC, 2011, NAT REV CLIN ONCOL, V8, P504, DOI 10.1038/nrclinonc.2011.88; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P669, DOI 10.1016/j.biopha.2013.04.005; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Lomax ME, 2013, CLIN ONCOL-UK, V25, P578, DOI 10.1016/j.clon.2013.06.007; Shao C, 2005, INT J CANCER, V116, P45, DOI 10.1002/ijc.21003; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Kim RK, 2013, CANCER SCI, V104, P1172, DOI 10.1111/cas.12207; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Shao C, 2003, CANCER RES, V63, P8437; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Sokolov MV, 2007, CELL CYCLE, V6, P2210; Yang G, 2012, BRIT J CANCER, V106, P1512, DOI 10.1038/bjc.2012.126; Gomez-Millan J, 2012, RADIOTHER ONCOL, V102, P450, DOI 10.1016/j.radonc.2011.11.002; de Bruin EC, 2013, GENOME MED, V5, DOI 10.1186/gm505; Desai A., 2014, RADIOTHER ONCOL; FitzGerald J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014714; Hei Tom K, 2011, Curr Mol Pharmacol, V4, P96; Iliopoulos D., 2011, P NATL ACAD SCI USA, V108, P397; Kirk Rebecca, 2012, Nat Rev Clin Oncol, V9, P552, DOI 10.1038/nrclinonc.2012.149; Knopf AC, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/R131; Liu S., 2013, STEM CELL REP, V2, P78, DOI DOI 10.1016/J.STEMCR.2013.11.009; Matsumoto Hideki, 2011, Curr Mol Pharmacol, V4, P126; Pont L.M. Berghauser, 2014, CANC LETT; Shao C, 2008, MUTAT RES-FUND MOL M, V638, P139, DOI 10.1016/j.mrfmmm.2007.09.007; Sokolov M.V., 2010, PLOS ONE, V5	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0027-5107	1873-135X		MUTAT RES-FUND MOL M	Mutat. Res.-Fundam. Mol. Mech. Mutagen.	MAR	2015	773						43	47		10.1016/j.mrfmmm.2015.01.012		5	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	CE6WP	WOS:000351979200007		
J	Hashimoto, A; Sato, G; Matsuda, T; Matsumura, M; Hatakeyama, S; Harada, Y; Ikeda, H; Tanaka, K				Hashimoto, Akira; Sato, Genki; Matsuda, Takahiro; Matsumura, Misato; Hatakeyama, Satoshi; Harada, Yukio; Ikeda, Hiroshi; Tanaka, Kazuaki			Taxonomic revision of Pseudolachnea and Pseudolachnella and establishment of Neopseudolachnella and Pseudodinemasporium gen. nov.	MYCOLOGIA			English	Article						Ascomycota; Chaetosphaeriaceae; coelomycetes; systematics; taxonomy	BAMBUSICOLOUS FUNGI; STELLATE CONIDIA; ALLIED GENERA; PHYLOGENY; CHAETOSPHAERIA; NUCLEAR; MODEL; JAPAN; ASTEROSPORIUM; PROSTHEMIUM	The taxonomy of Pseudolachnea and Pseudolachnella is controversial. Some authors have regarded them as congeneric, whereas others have considered them to be distinct genera differentiated merely on the number of conidial septa. A total of 26 isolates of Pseudolachnea-like fungi were subjected to morphological examination and phylogenetic analyses of nuc rDNA internal transcribed spacers 1 and 2 and partial 28S sequences and partial sequence of the translation elongation factor la gene. The results indicated that our materials should be classified in four genera: Pseudolachnea, Pseudolachnella, and two new genera, Neopseudolachnella and Pseudodinemasporium. Although the monophyly of both Pseudolachnea and Pseudolachnella was confirmed, it was concluded that differences observed in the conidiomatal structure, such as thickness of basal stroma and the excipulum, were more reliable for their circumscription, instead of conidial septation. Neopseudolachnella was similar to Pseudolachnea and Pseudolachnella in conidial morphology but was characterized by the conidiomata lacking an excipulum, unlike members of the latter two genera. Pseudodinemasporium bore conidia morphologically similar to those of Dinemasporium but was differentiated from the latter by the conidiomata, which was composed of a well developed peridial structure. A total of 12 new species, namely three in Neopseudolachnella (N. acutispora, N. magnisfain:forme) and eight in Pseudolachnella (P. asymmetrica, P. botulispora, P. brevicoronata, P. campylospora, P. complanata, P. falcatispara, P. fusiformis and P. pachyderma) are described and illustrated.	[Hashimoto, Akira; Sato, Genki; Matsuda, Takahiro; Matsumura, Misato; Hatakeyama, Satoshi; Harada, Yukio; Ikeda, Hiroshi; Tanaka, Kazuaki] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; [Hashimoto, Akira] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan	Tanaka, K (reprint author), Hirosaki Univ, Fac Agr & Life Sci, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	k-tanaka@cc.hirosaki-u.ac.jp	Ikeda, Hiroshi/B-3940-2011		Japan Society for the Promotion of Science (JSPS) [25440199]	This work was partially supported by grant from the Japan Society for the Promotion of Science (JSPS, 25440199). The authors thank these individuals for their help with collection of fungal specimens: H. Araki, T. Hosoya, T. Iijima and H. Yonezawa. The authors gratefully acknowledge S. Tanaka for the loan of material in YAM. We wish to thank V.A. Mel'nik for providing valuable information about Pseudolachnella longiciliata.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Wijayawardene DNN, 2012, MYCOSPHERE, V3, P157, DOI 10.5943/mycosphere/3/2/5; REHNER SA, 1994, MYCOL RES, V98, P625; Prabhugaonkar A, 2009, MYCOTAXON, V108, P217, DOI 10.5248/108.217; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Tanaka K, 2010, BOTANY, V88, P1057, DOI 10.1139/B10-078; Kamiyama M, 2009, MYCOSCIENCE, V50, P438, DOI 10.1007/s10267-009-0497-x; Hirayama K, 2011, MYCOSCIENCE, V52, P401, DOI 10.1007/s10267-011-0126-3; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Fernandez FA, 2006, MYCOLOGIA, V98, P121, DOI 10.3852/mycologia.98.1.121; [Anonymous], 2000, STUDIES MYCOLOGY; Hirooka Y, 2012, STUD MYCOL, P1, DOI 10.3114/sim0001; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Reblova M, 2000, MYCOLOGIA, V92, P939, DOI 10.2307/3761589; Crous PW, 2014, PERSOONIA, V32, P184, DOI [10.3767/003158514X682395, 10.3767/003158514X68239]; Crous PW, 2012, PERSOONIA, V28, P126, DOI 10.3767/003158512X652624; Tanaka K, 2011, PERSOONIA, V26, P85, DOI 10.3767/003158511X576666; Endo Mai, 2008, Nippon Kingakukai Kaiho, V49, P115; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Atkinson TJ, 2007, NEW ZEAL J BOT, V45, P685; Castaneda RF, 1987, FUNGI CUBENSES 2; Hashimoto A, 2015, MYCOSCIENCE, V56, P86, DOI 10.1016/j.myc.2014.04.001; Hatakeyama S, 2008, MYCOSCIENCE, V49, P211, DOI 10.1007/s10267-008-0409-5; HINO IWAO, 1958, JOUR JAPANESE BOT, V33, P233; Jeewon R, 2009, CAN J MICROBIOL, V55, P680, DOI [10.1139/wo8-148t, 10.1139/W08-148]; Jobb G., 2011, TREEFINDER       MAR; Kiffer E, 1999, MITOSPORIC FUNGI CLA; Kirk PM, 2008, AINSWORTH BISBYS DIC; Mel'nik VA, 1997, DEFINITORIUM FUNGORU, V1; MUTHUMARY J, 1987, CURR SCI INDIA, V56, P306; Nag Raj TR, 1993, COELOMYCETOUS ANAMOR; Rambaut A., 2014, TRACER 1 6; Ranojevic N., 1910, ANN MYCOL, V8, P347; Rayner RW, 1970, MYCOLOGICAL COLOR CH; Sato G, 2008, MYCOSCIENCE, V49, P392, DOI 10.1007/s10267-008-0439-z; Somrithipol S, 2008, MYCOLOGIA, V100, P735, DOI 10.3852/07-040; Sutton BC, 1980, COELOMYCETES FUNGI I; Sutton BC, 1977, MYCOL PAP, V141, P1; TENG S. C., 1933, Contrib. Biol. Lab. Sci. Soc. of China, V8, P253; Teng SC, 1936, SINENSIA, V7, P752; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; Yonezawa H, 2008, MYCOSCIENCE, V49, P152, DOI 10.1007/s10267-007-0398-9; Zhao RL, 2004, FUNGAL DIVERS, V15, P255	44	3	3	ALLEN PRESS INC	LAWRENCE	810 E 10TH ST, LAWRENCE, KS 66044 USA	0027-5514	1557-2536		MYCOLOGIA	Mycologia	MAR-APR	2015	107	2					383	408		10.3852/14-171		26	Mycology	Mycology	CE5RF	WOS:000351892600011		
J	Aoki, T; Vaughan, MM; McCormick, SP; Busman, M; Ward, TJ; Kelly, A; O'Donnell, K; Johnston, PR; Geiser, DM				Aoki, Takayuki; Vaughan, Martha M.; McCormick, Susan P.; Busman, Mark; Ward, Todd J.; Kelly, Amy; O'Donnell, Kerry; Johnston, Peter R.; Geiser, David M.			Fusarium dactylidis sp nov., a novel nivalenol toxin-producing species sister to F. pseudograminearum isolated from orchard grass (Dactylis glomerata) in Oregon and New Zealand	MYCOLOGIA			English	Article						cock's foot; crown rot; forage; Fusarium head blight; genotyping; morphology; mycotoxins; pathogenicity; phylogenetics; RPB1; RPB2; trichothecene; zearalenone	HEAD BLIGHT PATHOGEN; GIBBERELLA-ZEAE; GENEALOGICAL CONCORDANCE; NORTH-AMERICA; GENE-CLUSTER; GRAMINEARUM; COMPLEX; CLADE; DEOXYNIVALENOL; RECOGNITION	The B trichothecene toxin-producing clade (B clade) of Fusarium includes the etiological agents of Fusarium head blight, crown rot of wheat and barley and stem and ear rot of maize. B clade isolates also have been recovered from several wild and cultivated grasses, including Dactylis glomerata (orchard grass or cock's foot), one of the world's most important forage grasses. Two isolates from the latter host are formally described here as F. dactylidis. Phenotypically F. dactylidis most closely resembles F. ussurianum from the Russian Far East. Both species produce symmetrical sporodochial conidia that are similar in size and curved toward both ends. However, conidia of F. ussurianum typically end in a narrow apical beak while the apical cell of F. dactylidis is acute. Fusarium dactylidis produced nivalenol mycotoxin in planta as well as low but detectable amounts of the estrogenic mycotoxin zearalenone in vitro. Results of a pathogenicity test revealed that F. dactylidis induced mild head blight on wheat.	[Aoki, Takayuki] Natl Inst Agrobiol Sci, Genet Resources Ctr MAFF, Tsukuba, Ibaraki 3058602, Japan; [Vaughan, Martha M.; McCormick, Susan P.; Busman, Mark; Ward, Todd J.; Kelly, Amy; O'Donnell, Kerry] ARS, USDA, Bacterial Foodborne Pathogens & Mycol Res Unit, Natl Ctr Agr Utilizat Res, Peoria, IL 60604 USA; [Johnston, Peter R.] Landcare Res Manaaki Whenua, Auckland 1142, New Zealand; [Geiser, David M.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA	Aoki, T (reprint author), Natl Inst Agrobiol Sci, Genet Resources Ctr MAFF, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	taoki@nias.affrc.go.jp					O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; Boutigny AL, 2011, FUNGAL GENET BIOL, V48, P914, DOI 10.1016/j.fgb.2011.05.005; Desjardins AE, 2000, MICROBIOL-UK, V146, P2059; Yli-Mattila T, 2009, MYCOLOGIA, V101, P841, DOI 10.3852/08-217; Ward TJ, 2008, FUNGAL GENET BIOL, V45, P473, DOI 10.1016/j.fgb.2007.10.003; Creppy EE, 2002, TOXICOL LETT, V127, P19, DOI 10.1016/S0378-4274(01)00479-9; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Geiser DM, 2013, PHYTOPATHOLOGY, V103, P400, DOI 10.1094/PHYTO-07-12-0150-LE; Kimura M, 2003, FEBS LETT, V539, P105, DOI 10.1016/S0014-5793(03)00208-4; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Stewart AV, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P73, DOI 10.1007/978-3-642-14255-0_5; Lee T, 2002, APPL ENVIRON MICROB, V68, P2148, DOI 10.1128/AEM.68.5.2148-2154.2002; Aoki T, 2003, MYCOLOGIA, V95, P660, DOI 10.2307/3761942; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; Xie WG, 2010, BIOCHEM SYST ECOL, V38, P740, DOI 10.1016/j.bse.2010.06.009; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Abbas HK, 2013, TOXICON, V74, P68, DOI 10.1016/j.toxicon.2013.07.026; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Sarver BAJ, 2011, FUNGAL GENET BIOL, V48, P1096, DOI 10.1016/j.fgb.2011.09.002; Teasdale JR, 2004, AGRON J, V96, P1429; O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004; Aoki Takayuki, 2001, Mycoscience, V42, P461, DOI 10.1007/BF02464343; Aoki T., 2012, Mycotoxins, V62, P91, DOI 10.2520/myco.62.91; Aoki T, 1999, MYCOLOGIA, V91, P597, DOI 10.2307/3761245; Aoki Takayuki, 2005, Mycoscience, V46, P162, DOI 10.1007/s10267-005-0235-y; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Gerlach W., 1982, MITT BIOL BUNDESANST, V209, P1; GREENHALGH R, 1986, J AGR FOOD CHEM, V34, P98, DOI 10.1021/jf00067a027; Kornerup A., 1978, METHUEN HDB COLOR; Mounds RD, 2005, MYCOL RES, V109, P410, DOI [10.1017/S0953756204002217, DOI 10.1017/S0953756204002217]; Nelson P., 1983, FUSARIUM SPECIES ILL; NIRENBERG HI, 1990, STUD MYCOL, P91; Roux J, 2001, MYCOLOGIA, V93, P704, DOI 10.2307/3761824; STEVENS R., 1974, MYCOLOGY GUIDEBOOK; Swofford DL, 2003, PAUP 4 0B10 PHYLOGEN; Zwickl D.J., 2006, THESIS	38	1	1	ALLEN PRESS INC	LAWRENCE	810 E 10TH ST, LAWRENCE, KS 66044 USA	0027-5514	1557-2536		MYCOLOGIA	Mycologia	MAR-APR	2015	107	2					409	418		10.3852/14-213		10	Mycology	Mycology	CE5RF	WOS:000351892600012		
J	Cervantes-Salguero, K; Hamada, S; Nomura, SM; Murata, S				Cervantes-Salguero, Keitel; Hamada, Shogo; Nomura, Shin-ichiro M.; Murata, Satoshi			Polymorphic Ring-Shaped Molecular Clusters Made of Shape-Variable Building Blocks	NANOMATERIALS			English	Article							DNA NANOSTRUCTURES; NANOPARTICLES; PARTICLES; COLLOIDS; ROBOTS	Self-assembling molecular building blocks able to dynamically change their shapes, is a concept that would offer a route to reconfigurable systems. Although simulation studies predict novel properties useful for applications in diverse fields, such kinds of building blocks, have not been implemented thus far with molecules. Here, we report shape-variable building blocks fabricated by DNA self-assembly. Blocks are movable enough to undergo shape transitions along geometrical ranges. Blocks connect to each other and assemble into polymorphic ring-shaped clusters via the stacking of DNA blunt-ends. Reconfiguration of the polymorphic clusters is achieved by the surface diffusion on mica substrate in response to a monovalent salt concentration. This work could inspire novel reconfigurable self-assembling systems for applications in molecular robotics.	[Cervantes-Salguero, Keitel; Nomura, Shin-ichiro M.; Murata, Satoshi] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan; [Hamada, Shogo] Cornell Univ, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Murata, S (reprint author), Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan.	cervantes@molbot.mech.tohoku.ac.jp; sh964@cornell.edu; nomura@molbot.mech.tohoku.ac.jp; murata@molbot.mech.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT [22220001, 24104005]	Keitel Cervantes-Salguero is grateful to the Monbukagakusho scholarship given by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. This work was supported by two Grants-in-Aid for Scientific Research (No. 22220001 and No. 24104005) by MEXT to S. Murata.	Lee KJ, 2012, P NATL ACAD SCI USA, V109, P16057, DOI 10.1073/pnas.1213669109; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Sacanna S, 2013, SOFT MATTER, V9, P8096, DOI 10.1039/c3sm50500f; Torring T, 2011, CHEM SOC REV, V40, P5636, DOI 10.1039/c1cs15057j; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; Hagiya M, 2014, ACCOUNTS CHEM RES, V47, P1681, DOI 10.1021/ar400318d; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yoo JW, 2010, P NATL ACAD SCI USA, V107, P11205, DOI 10.1073/pnas.1000346107; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/nchem.1070, 10.1038/NCHEM.1070]; Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/nnano.2010.107, 10.1038/NNANO.2010.107]; Zhou LF, 2014, ACS NANO, V8, P27, DOI 10.1021/nn405408g; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Cademartiri L, 2012, PHILOS T R SOC A, V370, P2824, DOI 10.1098/rsta.2011.0254; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Wickham SFJ, 2012, NAT NANOTECHNOL, V7, P169, DOI [10.1038/nnano.2011.253, 10.1038/NNANO.2011.253]; Han DR, 2010, NAT NANOTECHNOL, V5, P712, DOI 10.1038/nnano.2010.193; Nguyen TD, 2011, ACS NANO, V5, P8892, DOI 10.1021/nn203067y; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Rafat AA, 2014, ANGEW CHEM INT EDIT, V53, P7665, DOI 10.1002/anie.201403965; Nguyen TD, 2010, ACS NANO, V4, P2585, DOI 10.1021/nn901725b; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Sacanna S, 2012, J AM CHEM SOC, V134, P6112, DOI 10.1021/ja301344n; Kim JW, 2011, ANGEW CHEM INT EDIT, V50, P9185, DOI 10.1002/anie.201102342; Walker DA, 2013, NAT NANOTECHNOL, V8, P676, DOI [10.1038/nnano.2013.158, 10.1038/NNANO.2013.158]; Gang O, 2011, ACS NANO, V5, P8459, DOI 10.1021/nn2041363; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Klavins E, 2007, IEEE CONTR SYST MAG, V27, P43, DOI 10.1109/MCS.2007.384126; Zhang C, 2013, NAT MATER, V12, P741, DOI [10.1038/nmat3647, 10.1038/NMAT3647]; Goodman RP, 2008, NAT NANOTECHNOL, V3, P93, DOI 10.1038/nnano.2008.3; Kohlstedt KL, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032305; Bombelli FB, 2008, J PHYS CHEM B, V112, P15283, DOI 10.1021/jp804544u; Campolongo MJ, 2011, J MATER CHEM, V21, P6113, DOI 10.1039/c0jm03854g; Guo RH, 2013, J PHYS CHEM LETT, V4, P1221, DOI 10.1021/jz4003789; Hamada S., 2009, ANGEW CHEM, V121, P6952, DOI DOI 10.1002/ANGE.200902662; Kuzuya A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1452; Mao CD, 2002, J AM CHEM SOC, V124, P14508, DOI 10.1021/ja021043d; Murata S, 2007, IEEE ROBOT AUTOM MAG, V14, P71, DOI 10.1109/MRA.2007.339607; Pietrement O, 2003, LANGMUIR, V19, P2536, DOI 10.1021/la026942u; Woo S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5889; Wei B., 2014, ANGEW CHEM, V126, P7605	40	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2079-4991			NANOMATERIALS-BASEL	Nanomaterials	MAR	2015	5	1					208	217		10.3390/nano5010208		10	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CF2DX	WOS:000352358800007		
J	Zinchenko, A; Taki, Y; Sergeyev, VG; Murata, S				Zinchenko, Anatoly; Taki, Yosuke; Sergeyev, Vladimir G.; Murata, Shizuaki			DNA-Assisted Solubilization of Carbon Nanotubes and Construction of DNA-MWCNT Cross-Linked Hybrid Hydrogels	NANOMATERIALS			English	Article							SALMON MILT DNA; FOLDING DNA; NANOPARTICLES; NANOMATERIALS; EXTRACTION; TEMPLATE; DELIVERY; ORIGAMI	A simple method for preparation of DNA-carbon nanotubes hybrid hydrogel based on a two-step procedure including: (i) solubilization of multi-walled carbon nanotubes (MWCNT) in aqueous solution of DNA, and (ii) chemical cross-linking between solubilized MWCNT via adsorbed DNA and free DNA by ethylene glycol diglycidyl ether is reported. We show that there exists a critical concentration of MWCNT below which a homogeneous dispersion of MWCNT in hybrid hydrogel can be achieved, while at higher concentrations of MWCNT the aggregation of MWCNT inside hydrogel occurs. The strengthening effect of carbon nanotube in the process of hydrogel shrinking in solutions with high salt concentration was demonstrated and significant passivation of MWCNT adsorption properties towards low-molecular-weight aromatic binders due to DNA adsorption on MWCNT surface was revealed.	[Zinchenko, Anatoly; Taki, Yosuke; Murata, Shizuaki] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Sergeyev, Vladimir G.] Moscow MV Lomonosov State Univ, Dept Polymer Sci, Fac Chem, Moscow 119899, Russia	Zinchenko, A (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	zinchenko@urban.env.nagoya-u.ac.jp; vegetable.day.831@gmail.com; sergeyev@genebee.msu.ru; murata@urban.env.nagoya-u.ac.jp			KAKENHI [24710106]; RFBR [14-03-00696]	Maruha Nichiro Holdings, Inc. (Tokyo, Japan) is acknowledged for free DNA samples extracted from salmon milt. This work was supported in part by KAKENHI 24710106 (Grant-in-Aid for Young Scientists (B) type) and RFBR 14-03-00696. High Voltage Electron Microscope Laboratory at EcoTopia Science Institute, Nagoya University, is gratefully acknowledged for the assistance with TEM observations.	Xu YX, 2010, ACS NANO, V4, P7358, DOI 10.1021/nn1027104; Daniel S, 2007, SENSOR ACTUAT B-CHEM, V122, P672, DOI 10.1016/j.snb.2006.06.014; Hughes ME, 2007, NANO LETT, V7, P1191, DOI 10.1021/nl062906u; Schreiber R, 2014, NAT NANOTECHNOL, V9, P74, DOI [10.1038/nnano.2013.253, 10.1038/NNANO.2013.253]; Hur J, 2013, J MATER CHEM A, V1, P14460, DOI 10.1039/c3ta13382f; Schreiber R, 2011, SMALL, V7, P1795, DOI 10.1002/smll.201100465; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Cheng EJ, 2011, CHEM COMMUN, V47, P5545, DOI 10.1039/c1cc11028d; Klumpp C, 2006, BBA-BIOMEMBRANES, V1758, P404, DOI 10.1016/j.bbamem.2005.10.008; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Monson CF, 2003, NANO LETT, V3, P359, DOI 10.1021/nl034016+; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Zinchenko AA, 2012, POLYM SCI SER C+, V54, P80, DOI 10.1134/S1811238212070077; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Niemeyer CM, 1997, ANGEW CHEM INT EDIT, V36, P585, DOI 10.1002/anie.199705851; Ren XM, 2011, CHEM ENG J, V170, P395, DOI 10.1016/j.cej.2010.08.045; Cathcart H, 2008, J AM CHEM SOC, V130, P12734, DOI 10.1021/ja803273s; Li HY, 2004, J AM CHEM SOC, V126, P418, DOI 10.1021/ja0383367; Zinchenko A, 2014, ACS APPL MATER INTER, V6, P3226, DOI 10.1021/am5008886; Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j; Sacca B, 2012, ANGEW CHEM INT EDIT, V51, P58, DOI 10.1002/anie.201105846; Costa D, 2014, COLLOID SURFACE A, V442, P181, DOI 10.1016/j.colsurfa.2013.02.048; HEMMINKI K, 1979, CHEM-BIOL INTERACT, V28, P269, DOI 10.1016/0009-2797(79)90167-4; Hur J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01282; Kuzuya A, 2009, CHEM COMMUN, P4182, DOI 10.1039/b907800b; Maeda Y, 2013, CHEMPLUSCHEM, V78, P619, DOI 10.1002/cplu.201300047; Pyrzynska K, 2008, SEP PURIF REV, V37, P374, DOI 10.1080/15422110802178843; Sanchez-Pomales G., 2010, CARBON NANOTUBES; Sasaki Y, 2010, APPL BIOCHEM BIOTECH, V160, P2458, DOI 10.1007/s12010-009-8697-6; Shen XR, 2008, J MATER SCI-MATER M, V19, P3473, DOI 10.1007/s10856-008-3512-4; Takeshima T, 2014, POLYM J, V46, P36, DOI 10.1038/pj.2013.58	32	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2079-4991			NANOMATERIALS-BASEL	Nanomaterials	MAR	2015	5	1					270	283		10.3390/nano5010270		14	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CF2DX	WOS:000352358800012		
J	Takeshima, T; Tada, Y; Sakaguchi, N; Watari, F; Fugetsu, B				Takeshima, Tomomi; Tada, Yuya; Sakaguchi, Norihito; Watari, Fumio; Fugetsu, Bunshi			DNA/Ag Nanoparticles as Antibacterial Agents against Gram-Negative Bacteria	NANOMATERIALS			English	Article							SILVER NANOPARTICLES; ESCHERICHIA-COLI; AG NANOPARTICLES; TEMPLATE; GROWTH; IONS	Silver (Ag) nanoparticles were produced using DNA extracted from salmon milt as templates. Particles spherical in shape with an average diameter smaller than 10 nm were obtained. The nanoparticles consisted of Ag as the core with an outermost thin layer of DNA. The DNA/Ag hybrid nanoparticles were immobilized over the surface of cotton based fabrics and their antibacterial efficiency was evaluated using E. coli as the typical Gram-negative bacteria. The antibacterial experiments were performed according to the Antibacterial Standard of Japanese Association for the Functional Evaluation of Textiles. The fabrics modified with DNA/Ag nanoparticles showed a high enough inhibitory and killing efficiency against E. coli at a concentration of Ag >= 10 ppm.	[Takeshima, Tomomi; Fugetsu, Bunshi] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Takeshima, Tomomi; Tada, Yuya] Nissei Bio Co Ltd, Sapporo, Hokkaido 0611374, Japan; [Sakaguchi, Norihito] Hokkaido Univ, Div Engn & Mat Sci, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Watari, Fumio] Hokkaido Univ, Grad Sch Dent Med, Sapporo, Hokkaido 0608586, Japan; [Fugetsu, Bunshi] Univ Tokyo, Policy Alternat Res Inst, Tokyo 1130032, Japan	Takeshima, T (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan.	tomomi.takeshima@utsouthwestern.edu; tada@nisseibio.co.jp; sakaguchi@eng.hokudai.ac.jp; watari@den.hokudai.ac.jp; bunshifugetsu@pari.u-tokyo.ac.jp			Northern Advancement Center for Science & Technology of Hokkaido Japan; Ministry of Agriculture, Forestry and Fishery of Japan	This study was supported in part by Grant-in-Aid Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan; this study was also supported in part by Grant-in-Aid "Development of high-performance-materials through cooperation with engineering technologies by using materials derived from agriculture, forestry and fishery products as the functioning element" program from the Ministry of Agriculture, Forestry and Fishery of Japan.	Duran N, 2007, J BIOMED NANOTECHNOL, V3, P203, DOI 10.1166/jbn.2007.022; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; [Anonymous], 2008, L19022008 JIS; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Inoue Y, 2002, J INORG BIOCHEM, V92, P37, DOI 10.1016/S0162-0134(02)00489-0; Liu YS, 2009, RADIAT PHYS CHEM, V78, P251, DOI 10.1016/j.radphyschem.2009.01.003; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Zhang YW, 2008, J COLLOID INTERF SCI, V325, P371, DOI 10.1016/j.jcis.2008.05.063; [Anonymous], 2012, JEC301; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Huang HZ, 2004, COLLOID SURFACE B, V39, P31, DOI 10.1016/j.colsurfb.2004.08.014; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Kasyutich O, 2010, J AM CHEM SOC, V132, P3621, DOI 10.1021/ja910918b; Tankhiwale R, 2009, COLLOID SURFACE B, V69, P164, DOI 10.1016/j.colsurfb.2008.11.004; Galdiero S, 2011, MOLECULES, V16, P8894, DOI 10.3390/molecules16108894; Radzig MA, 2013, COLLOID SURFACE B, V102, P300, DOI 10.1016/j.colsurfb.2012.07.039; Toshima N, 1998, NEW J CHEM, V22, P1179, DOI 10.1039/a805753b; Petty JT, 2004, J AM CHEM SOC, V126, P5207, DOI 10.1021/ja031931o; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Chernousova S., 2012, ANGEW CHEM INT EDIT, V51, P2, DOI 10.1002/anie.201107584; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Lan GY, 2011, RSC ADV, V1, P802, DOI 10.1039/c1ra00181g; Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6; Molotsky T, 2010, J PHYS CHEM C, V114, P15951, DOI 10.1021/jp911968x; Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711; Takeshima T, 2014, POLYM J, V46, P36, DOI 10.1038/pj.2013.58; Zhang XL, 2011, MATER LETT, V65, P719, DOI 10.1016/j.matlet.2010.11.019; Zheng L, 2010, CATAL LETT, V139, P145, DOI 10.1007/s10562-010-0419-8; Zinchenko AA, 2008, BIOMACROMOLECULES, V9, P1981, DOI 10.1021/bm800235j	33	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2079-4991			NANOMATERIALS-BASEL	Nanomaterials	MAR	2015	5	1					284	297		10.3390/nano5010284		14	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CF2DX	WOS:000352358800013		
J	Umemura, K				Umemura, Kazuo			Hybrids of Nucleic Acids and Carbon Nanotubes for Nanobiotechnology	NANOMATERIALS			English	Review							SINGLE-STRANDED-DNA; ATOMIC-FORCE MICROSCOPY; THIN-FILM TRANSISTORS; AQUEOUS-SOLUTION; NONCOVALENT FUNCTIONALIZATION; COVALENT FUNCTIONALIZATION; WATER-SOLUBILIZATION; MOLECULAR-DYNAMICS; RAMAN-SPECTROSCOPY; ELECTROCHEMICAL OXIDATION	Recent progress in the combination of nucleic acids and carbon nanotubes (CNTs) has been briefly reviewed here. Since discovering the hybridization phenomenon of DNA molecules and CNTs in 2003, a large amount of fundamental and applied research has been carried out. Among thousands of papers published since 2003, approximately 240 papers focused on biological applications were selected and categorized based on the types of nucleic acids used, but not the types of CNTs. This survey revealed that the hybridization phenomenon is strongly affected by various factors, such as DNA sequences, and for this reason, fundamental studies on the hybridization phenomenon are important. Additionally, many research groups have proposed numerous practical applications, such as nanobiosensors. The goal of this review is to provide perspective on biological applications using hybrids of nucleic acids and CNTs.	Tokyo Univ Sci, Biophys Sect, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan	Umemura, K (reprint author), Tokyo Univ Sci, Biophys Sect, Dept Phys, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	meicun2006@163.com			Japan Society for the Promotion of Science (JSPS) [26400436]	This work was supported by Grant-in-Aid for Scientific Research (26400436) of the Japan Society for the Promotion of Science (JSPS).	Dodziuk H, 2003, CHEM COMMUN, P986, DOI 10.1039/b211365a; Fu KF, 2003, J NANOSCI NANOTECHNO, V3, P351, DOI 10.1166/jnn.2003.225; Deng XY, 2009, CARBON, V47, P1421, DOI 10.1016/j.carbon.2008.12.032; Star A, 2002, MACROMOLECULES, V35, P7516, DOI 10.1021/ma0204150; Daniel S, 2007, SENSOR ACTUAT B-CHEM, V122, P672, DOI 10.1016/j.snb.2006.06.014; Gong JL, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4773569; Wang RR, 2010, J MATER CHEM, V20, P6903, DOI 10.1039/c0jm00670j; Cveticanin J, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/1/015102; Gigliotti B, 2006, NANO LETT, V6, P159, DOI 10.1021/nl0518775; Alidori S, 2013, J PHYS CHEM C, V117, P5982, DOI 10.1021/jp312416d; Akdim B, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/16/165703; Zhao W, 2006, CHEM COMMUN, P3582, DOI 10.1039/b606518j; Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a; Antonelli A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/42/425101; Liu JB, 2010, J MATER CHEM, V20, P900, DOI 10.1039/b917752c; Ensafi AA, 2013, COLLOID SURFACE B, V109, P45, DOI 10.1016/j.colsurfb.2013.03.031; Vogel SR, 2007, CHEM-EUR J, V13, P1815, DOI 10.1002/chem.200600988; Iliafar S, 2014, J AM CHEM SOC, V136, P12947, DOI 10.1021/ja5055498; Umadevi D, 2011, J PHYS CHEM LETT, V2, P1572, DOI 10.1021/jz200705w; Guo QY, 2011, ELECTROCHIM ACTA, V56, P1432, DOI 10.1016/j.electacta.2010.10.064; Zhang QA, 2010, CHEM-EUR J, V16, P8133, DOI 10.1002/chem.201000684; Yamamoto Y, 2010, NANOSCALE, V2, P1767, DOI 10.1039/c0nr00145g; Hu CG, 2005, J PHYS CHEM B, V109, P20072, DOI 10.1021/jp0550457; Bergler FF, 2013, J PHYS CHEM C, V117, P13318, DOI 10.1021/jp403711e; Jung DH, 2004, LANGMUIR, V20, P8886, DOI 10.1021/la0485778; Liu ZB, 2014, J MATER SCI-MATER M, V25, P1033, DOI 10.1007/s10856-013-5128-6; Shoda M, 2009, J PHYS CHEM C, V113, P6033, DOI 10.1021/jp8109572; Xiao ZT, 2011, J PHYS CHEM C, V115, P21546, DOI 10.1021/jp204017u; Badaire S, 2005, ADV MATER, V17, P1673, DOI 10.1002/adma.200401741; Hopkins AR, 2007, SURF COAT TECH, V202, P1282, DOI 10.1016/j.surfcoat.2007.07.110; Roxbury D, 2012, NANO LETT, V12, P1464, DOI 10.1021/nl204182b; Hobbie EK, 2005, LANGMUIR, V21, P10284, DOI 10.1021/la051827f; Wu N, 2013, CARBON, V59, P229, DOI 10.1016/j.carbon.2013.03.013; Tavares AM, 2014, TOXICOL IN VITRO, V28, P60, DOI 10.1016/j.tiv.2013.06.009; Qin WL, 2011, COLLOID SURFACE B, V84, P206, DOI 10.1016/j.colsurfb.2011.01.001; Fujigaya T, 2011, NANOSCALE, V3, P4352, DOI 10.1039/c1nr10635j; Roxbury D, 2011, J AM CHEM SOC, V133, P13545, DOI 10.1021/ja204413v; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Nii D, 2013, COLLOID SURFACE B, V106, P234, DOI 10.1016/j.colsurfb.2013.01.054; Zhao XC, 2011, J PHYS CHEM C, V115, P6181, DOI 10.1021/jp110013r; Xu Y, 2007, J PHYS CHEM C, V111, P8638, DOI 10.1021/jp0709611; Yan YM, 2005, CHEM MATER, V17, P3457, DOI 10.1021/cm0504182; Gladchenko GO, 2006, MOL PHYS, V104, P3193, DOI 10.1080/00268970601061220; Hu CW, 2014, SOIL BIOL BIOCHEM, V70, P123, DOI 10.1016/j.soilbio.2013.12.018; Premkumar T, 2012, PROG POLYM SCI, V37, P515, DOI 10.1016/j.progpolymsci.2011.08.003; Makarucha AJ, 2011, EUR BIOPHYS J BIOPHY, V40, P103, DOI 10.1007/s00249-010-0651-6; Awasthi KK, 2013, MICRON, V44, P359, DOI 10.1016/j.micron.2012.08.008; Asada Y, 2010, ADV MATER, V22, P2698, DOI 10.1002/adma.200904006; Albertorio F, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/39/395101; Guo CX, 2014, PHYS CHEM CHEM PHYS, V16, P4672, DOI 10.1039/c3cp54911a; Takahashi H, 2006, CHEM PHYS LETT, V418, P535, DOI 10.1016/j.cplett.2005.10.150; Wang YW, 2012, J SOLID STATE ELECTR, V16, P3227, DOI 10.1007/s10008-012-1763-y; Sanchez-Pomales G, 2009, J NANOSCI NANOTECHNO, V9, P2175, DOI 10.1166/jnn.2009.SE47; D'Souza F, 2011, J AM CHEM SOC, V133, P19922, DOI 10.1021/ja208380b; Wang LY, 2012, ANALYST, V137, P3667, DOI 10.1039/c2an35396b; Ostojic GN, 2008, LANGMUIR, V24, P9784, DOI 10.1021/la801311j; Toita S, 2008, DIAM RELAT MATER, V17, P1389, DOI 10.1016/j.diamond.2008.01.010; Cooper L, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3271768; Vetcher AA, 2006, NANOTECHNOLOGY, V17, P4263, DOI 10.1088/0957-4484/17/16/043; Liu F, 2010, CHEM COMMUN, V46, P2844, DOI 10.1039/b923656b; Simpson JR, 2009, CARBON, V47, P3238, DOI 10.1016/j.carbon.2009.07.037; Alegret N, 2012, CHEM PHYS LETT, V525-26, P120, DOI 10.1016/j.cplett.2011.12.077; Gao HJ, 2003, NANO LETT, V3, P471, DOI 10.1021/nl025967a; Haggenmueller R, 2008, LANGMUIR, V24, P5070, DOI 10.1021/la703008r; Ito M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863272; Wang D, 2007, NANO LETT, V7, P1480, DOI 10.1021/nl070172v; Bauer BJ, 2007, J PHYS CHEM C, V111, P17914, DOI [10.1021/jp071494q, 10.1021/jp07l494q]; Sanchez-Pomales G, 2007, PHYS STATUS SOLIDI A, V204, P1791, DOI 10.1002/pssa.200675314; Han XG, 2007, ADV MATER, V19, P1518, DOI 10.1002/adma.200602861; Su HC, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/50/505502; Tu XM, 2007, J PHYS CHEM C, V111, P17227, DOI 10.1021/jp075966c; Chun J, 2008, ANAL CHEM, V80, P2514, DOI 10.1021/ac7023624; Primo EN, 2013, COLLOID SURFACE B, V108, P329, DOI 10.1016/j.colsurfb.2013.02.028; Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Zhang LB, 2010, CHEM COMMUN, V46, P1476, DOI 10.1039/b921191h; Thuy NT, 2012, CURR APPL PHYS, V12, P1553, DOI 10.1016/j.cap.2012.04.035; Mangalum A, 2013, J AM CHEM SOC, V135, P2451, DOI 10.1021/ja312191a; Nam CW, 2011, ARCH PHARM RES, V34, P661, DOI 10.1007/s12272-011-0417-4; Cao CF, 2008, MATER CHEM PHYS, V112, P738, DOI 10.1016/j.matchemphys.2008.07.129; Barisci JN, 2004, ADV FUNCT MATER, V14, P133, DOI 10.1002/adfm.200304500; Chen RJ, 2006, J PHYS CHEM B, V110, P54, DOI 10.1021/jp055044e; Singh KV, 2006, CARBON, V44, P1730, DOI 10.1016/j.carbon.2005.12.048; Gowtham S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.033401; Petrov P, 2003, CHEM COMMUN, P2904, DOI 10.1039/b307751a; Zimmerli U, 2008, BIOPHYS J, V94, P2546, DOI 10.1529/biophysj.106.102467; Lei JP, 2010, WIRES NANOMED NANOBI, V2, P496, DOI 10.1002/wnan.94; Chen W, 2014, NEURAL REGEN RES, V9, P285, DOI 10.4103/1673-5374.128225; Pividori MI, 2005, TOP CURR CHEM, V260, P1, DOI 10.1007/b136064; Zhang MG, 2004, ANAL CHEM, V76, P5045, DOI 10.1021/ac049519u; Folkmann JK, 2009, ENVIRON HEALTH PERSP, V117, P703, DOI 10.1289/ehp.11922; Jeng ES, 2006, NANO LETT, V6, P371, DOI 10.1021/nl051829k; Jin H, 2007, MACROMOLECULES, V40, P6731, DOI 10.1021/ma070608t; Wei W, 2007, J NANOSCI NANOTECHNO, V7, P1284, DOI 10.1166/jnn.2007.655; Zhang JQ, 2011, J AM CHEM SOC, V133, P567, DOI 10.1021/ja1084942; O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0; Enyashin AN, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/24/245702; Qian H, 2008, NANO LETT, V8, P2706, DOI 10.1021/nl801038t; Cathcart H, 2008, J AM CHEM SOC, V130, P12734, DOI 10.1021/ja803273s; Luszczyn J, 2010, CHEM-EUR J, V16, P4870, DOI 10.1002/chem.200903277; Cathcart H, 2007, J PHYS CHEM C, V111, P66, DOI 10.1021/jp065503r; Pei QX, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2981798; Bauer BJ, 2008, J PHYS CHEM C, V112, P1842, DOI 10.1021/jp077364z; Le D, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/42/424210; Liu P, 2005, EUR POLYM J, V41, P2693, DOI 10.1016/j.eurpolymj.2005.05.017; Handy RD, 2012, ECOTOXICOLOGY, V21, P933, DOI 10.1007/s10646-012-0862-y; Lima ACDA, 2010, CHEMOSPHERE, V81, P884, DOI 10.1016/j.chemosphere.2010.08.003; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r; Sinani VA, 2005, J AM CHEM SOC, V127, P3463, DOI 10.1021/ja045670+; Huang WJ, 2002, NANO LETT, V2, P231, DOI 10.1021/nl010083x; Noguchi Y, 2008, CHEM PHYS LETT, V455, P249, DOI 10.1016/j.cplett.2008.02.089; Weizmann Y, 2010, J AM CHEM SOC, V132, P14009, DOI 10.1021/ja106352y; Ao GY, 2014, J AM CHEM SOC, V136, P10383, DOI 10.1021/ja504078b; Iijima M, 2005, CHEM PHYS LETT, V414, P520, DOI 10.1016/j.cplett.2005.09.032; Santosh M, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3682780; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Becerril HA, 2009, CHEM SOC REV, V38, P329, DOI 10.1039/b718440a; Hazani M, 2003, NANO LETT, V3, P153, DOI 10.1021/nl025874t; Wu M, 2011, LANGMUIR, V27, P2731, DOI 10.1021/la1037926; Shi J, 2011, ANALYST, V136, P4916, DOI 10.1039/c1an15179g; Zhao C, 2010, CHEM-EUR J, V16, P8147, DOI 10.1002/chem.201000306; Frischknecht AL, 2008, J PHYS CHEM C, V112, P6271, DOI 10.1021/jp077522m; Lin Y, 2004, J MATER CHEM, V14, P527, DOI 10.1039/b314481j; Arnett CM, 2010, LANGMUIR, V26, P613, DOI 10.1021/la902564n; Tang LH, 2011, ACS NANO, V5, P3817, DOI 10.1021/nn200147n; Mogurampelly S, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4742189; Mao HL, 2013, BIOMATERIALS, V34, P2472, DOI 10.1016/j.biomaterials.2013.01.002; Onoa B, 2006, PHYS STATUS SOLIDI A, V203, P1124, DOI 10.1002/pssa.200566158; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; Shekar SC, 2014, J PHYS CHEM C, V118, P4516, DOI 10.1021/jp412791v; Wang J, 2003, J AM CHEM SOC, V125, P2408, DOI 10.1021/ja028951v; Tu XM, 2008, NANO RES, V1, P185, DOI 10.1007/s12274-008-8022-7; Zhang X, 2013, MAT SCI ENG C-MATER, V33, P3851, DOI 10.1016/j.msec.2013.05.022; Karachevtsev VA, 2006, CARBON, V44, P1292, DOI 10.1016/j.carbon.2005.08.008; Fu KF, 2002, J NANOSCI NANOTECHNO, V2, P457, DOI 10.1166/jnn.2002.135; Yoon D, 2008, J NANOSCI NANOTECHNO, V8, P5135, DOI 10.1166/jnn.2008.1134; Jeng ES, 2007, SMALL, V3, P1602, DOI 10.1002/smll.200700141; Ghosh S, 2009, ACS NANO, V3, P2667, DOI 10.1021/nn900368b; Zhang LY, 2012, CHEM-EUR J, V18, P15693, DOI 10.1002/chem.201201571; Qu KG, 2012, ACS APPL MATER INTER, V4, P5001, DOI 10.1021/am301376m; He PG, 2005, LANGMUIR, V21, P6086, DOI 10.1021/la050581b; Cheung W, 2009, J MATER CHEM, V19, P6465, DOI 10.1039/b823065j; Kim JS, 2012, TOXICOL SCI, V128, P439, DOI 10.1093/toxsci/kfs161; Karachevtsev VA, 2007, CHEM PHYS LETT, V435, P104, DOI 10.1016/j.cplett.2006.12.052; Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005; Zhang XQ, 2011, ACS NANO, V5, P6962, DOI 10.1021/nn201446c; Lv W, 2010, J MATER CHEM, V20, P6668, DOI 10.1039/c0jm01066a; Stevens JL, 2003, NANO LETT, V3, P331, DOI 10.1021/nl025944w; Ikeda A, 2006, ORG LETT, V8, P1153, DOI 10.1021/ol053089s; Vogel SR, 2007, PHYS STATUS SOLIDI B, V244, P4026, DOI 10.1002/pssb.200776108; Ao GY, 2011, ACS NANO, V5, P1450, DOI 10.1021/nn103225r; Asada Y, 2011, J PHYS CHEM C, V115, P270, DOI 10.1021/jp107361n; Asada Y, 2007, NANO, V2, P295, DOI 10.1142/S1793292007000672; Asada Y, 2009, J NANOMATER, DOI 10.1155/2009/257892; Asakura M, 2010, J OCCUP HEALTH, V52, P155; Bertoncini P, 2007, DIG J NANOMATER BIOS, V2, P293; Bobadilla AD, 2011, J PHYS CHEM C, V115, P3466, DOI 10.1021/jp110155z; Campbell JF, 2010, J PHYS CHEM B, V114, P8861, DOI 10.1021/jp101809e; Campbell JF, 2008, J AM CHEM SOC, V130, P10648, DOI 10.1021/ja801720c; Canete-Rosales P, 2014, ELECTROCHIM ACTA, V140, P489, DOI 10.1016/j.electacta.2014.06.004; Cao SR, 2011, SENSOR LETT, V9, P1636, DOI 10.1166/sl.2011.1722; Amirani MC, 2013, PHYSICA E, V54, P65, DOI 10.1016/j.physe.2013.05.024; Chen Z, 2010, J NANOSCI NANOTECHNO, V10, P8538, DOI 10.1166/jnn.2010.2484; Chhikara BS, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/6/065101; Clavier A, 2013, J BIOTECHNOL, V164, P13, DOI 10.1016/j.jbiotec.2012.12.008; Clichici S, 2014, J APPL TOXICOL, V34, P332, DOI 10.1002/jat.2883; Contreras-Torres FF, 2011, WIRES COMPUT MOL SCI, V1, P902, DOI 10.1002/wcms.60; Ding ZJ, 2011, FRONT PHYS-BEIJING, V6, P294, DOI 10.1007/s11467-011-0163-6; Dolash BD, 2013, CHEM PHYS, V413, P11, DOI 10.1016/j.chemphys.2012.07.004; Dong PX, 2012, NANOTOXICOLOGY, V6, P288, DOI 10.3109/17435390.2011.573101; Fagan JA, 2006, J PHYS CHEM B, V110, P23801, DOI 10.1021/jp0647434; Fujigaya T, 2010, ELECTROCHEMISTRY, V78, P2; Glamazda AY, 2006, FULLER NANOTUB CAR N, V14, P221, DOI 10.1080/15363830600728090; Han SP, 2012, NANO LETT, V12, P1129, DOI 10.1021/nl201818u; Hasegawa T, 2004, CHEM COMMUN, P2150, DOI 10.1039/b407409b; Hayashida T, 2013, COLLOID SURFACE B, V101, P49, DOI 10.1016/j.colsurfb.2012.06.018; Hayashida T, 2013, CHEM LETT, V42, P666, DOI 10.1246/cl.130121; Hughes JM, 2010, J PHYS CHEM C, V114, P11741, DOI 10.1021/jp101834t; Ignatova T, 2011, ACS NANO, V5, P6052, DOI 10.1021/nn201911b; Ishibashi A, 2006, CHEM PHYS LETT, V419, P574, DOI 10.1016/j.cplett.2005.11.122; Jiang LQ, 2003, J COLLOID INTERF SCI, V260, P89, DOI 10.1016/S0021-9797(02)00176-5; Jin WJ, 2004, NEW CARBON MATER, V19, P312; Joseph D, 2014, ACS APPL MATER INTER, V6, P3347, DOI 10.1021/am405378x; Jovanovic SP, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/44/445602; Judkins J, 2013, J BIOMED NANOTECHNOL, V9, P1065, DOI 10.1166/jbn.2013.1527; Kabelac M, 2012, PHYS CHEM CHEM PHYS, V14, P4217, DOI 10.1039/c2cp23540d; Kamiya K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.155444; Kaneko T, 2007, CONTRIB PLASM PHYS, V47, P57, DOI 10.1002/cttp.200710009; Karachevtsev MV, 2008, J NANOSCI NANOTECHNO, V8, P1473, DOI 10.1166/jnn.2008.032; Kaufmann A, 2014, J MATER CHEM B, V2, P7000, DOI 10.1039/c4tb00915k; Kawaguchi M, 2012, INT J NANOMED, V7, P4363, DOI 10.2147/IJN.S34202; Ke C. H., 2009, J PHYS D, V42, P8; Kim JH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3039790; Lacerda L, 2006, ADV FUNCT MATER, V16, P1839, DOI 10.1002/adfm.200500569; Li ZH, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/19/195301; Lulevich V, 2011, NANO LETT, V11, P1171, DOI 10.1021/nl104116s; Manna AK, 2013, J MATER CHEM B, V1, P91, DOI 10.1039/c2tb00184e; Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988; Martinez MT, 2012, J PHYS CHEM C, V116, P22579, DOI 10.1021/jp306535d; McShan D, 2014, TOXICOL IND HEALTH, V30, P489, DOI 10.1177/0748233712459914; Moghaddam MJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/42/425503; Gong X, 2014, ACS NANO, V8, P9126, DOI 10.1021/nn5026912; Nakashima N, 2006, SCI TECHNOL ADV MAT, V7, P609, DOI 10.1016/j.stam.2006.08.004; Nakashima N, 2003, CHEM LETT, V32, P456, DOI 10.1246/cl.2003.456; Nii D, 2014, COLLOID SURFACE B, V121, P325, DOI 10.1016/j.colsurfb.2014.06.008; Noguchi Y, 2008, CHEM-EUR J, V14, P5966, DOI 10.1002/chem.200800070; Okada T, 2006, CHEM PHYS LETT, V417, P288, DOI 10.1016/j.cplett.2005.10.030; Okada T, 2006, JPN J APPL PHYS 1, V45, P8335, DOI 10.1143/JJAP.45.8335; Ozturk SA, 2013, J RAMAN SPECTROSC, V44, P183, DOI 10.1002/jrs.4185; Park JJ, 2010, SOFT MATTER, V6, P5581, DOI 10.1039/c0sm00368a; Pease LF, 2009, SMALL, V5, P2894, DOI 10.1002/smll.200900928; Plisko TV, 2014, COLLOID POLYM SCI, V292, P2571, DOI 10.1007/s00396-014-3305-x; Qiu XY, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.048301; Raffa V, 2010, NANOMEDICINE-UK, V5, P89, DOI [10.2217/nnm.09.95, 10.2217/NNM.09.95]; Aravind SSJ, 2011, SENSOR ACTUAT B-CHEM, V155, P679, DOI 10.1016/j.snb.2011.01.029; Rao R, 2004, APPL PHYS LETT, V85, P4228, DOI 10.1063/1.1813631; Sabuncu AC, 2010, COLLOID SURFACE B, V78, P36, DOI 10.1016/j.colsurfb.2010.02.005; Sanz V, 2011, CARBON, V49, P1775, DOI 10.1016/j.carbon.2010.12.064; Schmucker W, 2013, RSC ADV, V3, P6331, DOI 10.1039/c3ra00163f; Sha JJ, 2013, ACS NANO, V7, P8857, DOI 10.1021/nn403323k; Shakhmaeva II, 2011, J BIOTECHNOL, V152, P102, DOI 10.1016/j.jbiotec.2011.01.022; Shao JY, 2011, TRANSIT METAL CHEM, V36, P499, DOI 10.1007/s11243-011-9495-x; Shin SR, 2012, SENSOR ACTUAT B-CHEM, V162, P173, DOI 10.1016/j.snb.2011.12.063; Singh P, 2013, CHEM-ASIAN J, V8, P1472, DOI 10.1002/asia.201300116; Tardani F, 2013, RSC ADV, V3, P25917, DOI 10.1039/c3ra44920c; Tardani F, 2014, J PHYS CHEM C, V118, P9268, DOI 10.1021/jp501792j; Tardani F, 2014, SOFT MATTER, V10, P1024, DOI 10.1039/c3sm52073k; Tardani F, 2012, J PHYS CHEM C, V116, P9888, DOI 10.1021/jp300691w; van Berlo D, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13698; Wang X, 2006, SMALL, V2, P1356, DOI 10.1002/smll.200600056; Wei LL, 2011, MICROCHIM ACTA, V173, P439, DOI 10.1007/s00604-011-0580-9; Williams RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094117; Wise AJ, 2008, J BIOMED NANOTECHNOL, V4, P67, DOI 10.1166/jbn.2008.003; Xu YQ, 2009, NANO LETT, V9, P1609, DOI 10.1021/nl803861c; Yamazaki T, 2012, J PHYS CHEM C, V116, P15087, DOI 10.1021/jp3026804; Yan W, 2005, ANAL LETT, V38, P2579, DOI 10.1080/0032710500369778; Yang WR, 2007, CHEM PHYS LETT, V443, P169, DOI 10.1016/j.cplett.2007.06.079; Yu T, 2012, RSC ADV, V2, P1466, DOI 10.1039/c1ra00581b; Yuan WK, 2006, CHINESE J ORG CHEM, V26, P1508; Zhang L, 2008, J PHYS CHEM B, V112, P7120, DOI 10.1021/jp800092r; Zhang WX, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-555; Zhang YL, 2013, J MOL MED, V91, P117, DOI 10.1007/s00109-012-0940-x; Zhao YL, 2009, ACCOUNTS CHEM RES, V42, P1161, DOI 10.1021/ar900056z; Zhou ZP, 2009, SMALL, V5, P2149, DOI 10.1002/smll.200801932	245	4	4	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2079-4991			NANOMATERIALS-BASEL	Nanomaterials	MAR	2015	5	1					321	350		10.3390/nano5010321		30	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CF2DX	WOS:000352358800015		
J	Kondo, N; Nakamura, F; Yamazaki, S; Yamamoto, Y; Akizawa, T; Akiba, T; Saito, A; Kurokawa, K; Fukuhara, S				Kondo, Naoya; Nakamura, Fumiaki; Yamazaki, Shin; Yamamoto, Yosuke; Akizawa, Tadao; Akiba, Takashi; Saito, Akira; Kurokawa, Kiyoshi; Fukuhara, Shunichi			Prescription of potentially inappropriate medications to elderly hemodialysis patients: prevalence and predictors	NEPHROLOGY DIALYSIS TRANSPLANTATION			English	Article						adverse drug events; DOPPS; elderly patients; hemodialysis; potentially inappropriate medication	BEERS CRITERIA; SURVIVAL; OUTCOMES; DOPPS	In elderly hemodialysis (HD) patients, the risk of medication-related problems is particularly high. Thus, certain medications should generally not be prescribed to those patients. The Beers criteria for potentially inappropriate medications (PIMs) have been publicized. Still, with regard to elderly HD patients, the prevalence and risk factors for prescription of PIMs are unknown. This was a cross-sectional study of data from the Japan Dialysis Outcomes and Practice Patterns Study (2002-08). Patients were included if they were 65 years old or older and were currently receiving HD treatment at a hospital or clinic. We counted the number of patients who were prescribed at least one PIM, as defined by the modified Beers criteria. We used multiple logistic regression analysis to determine which patient characteristics and facility characteristics were associated with prescription of PIMs. Data from 1367 elderly patients were analyzed. More than half of the patients (57%) had been prescribed a PIM. The three most frequently prescribed PIMs were H2 blockers (33%), antiplatelet agents (19%) and alpha-blockers (13%). PIM prescriptions were less likely at facilities that conducted multidisciplinary rounds {adjusted odds ratio (AOR): 0.67 [95% confidence interval (CI): 0.48-0.93]} and at teaching hospitals [AOR: 0.59 (95% CI, 0.39-0.90)]. PIM prescriptions are more likely if more than one physician has clearance to alter the HD regimen [AOR: 1.65 (95% CI, 1.12-2.44)]. PIMs were prescribed to many elderly HD patients in Japan. Nephrologists should become more aware of PIMs. Multidisciplinary rounds could benefit patients by reducing the prescription of PIMs.	[Kondo, Naoya; Yamazaki, Shin; Yamamoto, Yosuke; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Nakamura, Fumiaki] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Akiba, Takashi] Tokyo Womens Med Univ, Dept Blood Purificat & Internal Med, Kidney Ctr, Tokyo, Japan; [Saito, Akira] Tokai Univ, Sch Med, Dept Med, Div Nephrol & Metab, Kanagawa 2591100, Japan; [Kurokawa, Kiyoshi] Natl Grad Inst Policy Studies, Tokyo, Japan; [Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Clin Evaluat Sci, Fukushima, Japan; [Fukuhara, Shunichi] Inst Hlth Outcomes & Proc Evaluat Res, Tokyo, Japan	Fukuhara, S (reprint author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.	fukuhara.shunichi.6m@kyoto-u.ac.jp			Amgen, Inc.; Kyowa Hakko Kirin Co., Ltd	The DOPPS is supported by research grants from Amgen, Inc., and Kyowa Hakko Kirin Co., Ltd, without restriction on publication.	Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Gurwitz JH, 2005, AM J MED, V118, P251, DOI 10.1016/j.amjmed.2004.09.018; Efrati S, 2002, AM J KIDNEY DIS, V40, P1023, DOI 10.1053/ajkd.2002.36340; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; O'Mahony D, 2008, AGE AGEING, V37, P138, DOI [10.1093/ageing/afm189, 10.1093/ageing/Afm189]; Young EW, 2000, KIDNEY INT, V57, pS74; Akazawa M, 2010, AM J GERIATR PHARMAC, V8, P146, DOI 10.1016/j.amjopharm.2010.03.005; KOECHELER JA, 1989, AM J HOSP PHARM, V46, P729; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; Bailie George R, 2006, Hemodial Int, V10, P180, DOI 10.1111/j.1542-4758.2006.00092.x; Cardone KE, 2010, ADV CHRONIC KIDNEY D, V17, P404, DOI 10.1053/j.ackd.2010.06.004; Gray SL, 1999, DRUG SAFETY, V21, P101, DOI 10.2165/00002018-199921020-00004; Lopes AA, 2009, NEPHROL DIAL TRANSPL, V24, P2809, DOI 10.1093/ndt/gfp212; Manley HJ, 2003, AM J KIDNEY DIS, V41, P386, DOI 10.1053/ajkd.2003.50048; MYERS AH, 1991, AM J EPIDEMIOL, V133, P1179; Pisoni Ronald L, 2004, Am J Kidney Dis, V44, P7, DOI 10.1016/S0272-6386(04)01099-6; Redmond AM, 2005, AM J MED SCI, V330, P8, DOI 10.1097/00000441-200507000-00002; STRAND LM, 1990, DICP ANN PHARMAC, V24, P1093	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0931-0509	1460-2385		NEPHROL DIAL TRANSPL	Nephrol. Dial. Transplant.	MAR	2015	30	3					498	505		10.1093/ndt/gfu070		8	Transplantation; Urology & Nephrology	Transplantation; Urology & Nephrology	CE2QL	WOS:000351660300025		
J	De Bleecker, JL; De Paepe, B; Aronica, E; de Visser, M; Amato, A; Aronica, E; Benveniste, O; De Bleecker, J; de Boer, O; De Paepe, B; de Visser, M; Dimachkie, M; Gherardi, R; Goebel, HH; Hilton-Jones, D; Holton, J; Lundberg, IE; Mammen, A; Mastaglia, F; Nishino, I; Rushing, E; Schroder, HD; Selcen, D; Stenzel, W				De Bleecker, Jan L.; De Paepe, Boel; Aronica, Eleonora; de Visser, Marianne; Amato, Anthony; Aronica, Eleonora; Benveniste, Olivier; De Bleecker, Jan; de Boer, Onno; De Paepe, Boel; de Visser, Marianne; Dimachkie, Mazen; Gherardi, Romain; Goebel, Hans Hilmar; Hilton-Jones, David; Holton, Janice; Lundberg, Ingrid E.; Mammen, Andrew; Mastaglia, Frank; Nishino, Ichizo; Rushing, Elisabeth; Schroder, Henrik Daa; Selcen, Duygu; Stenzel, Werner		ENMC Myositis Muscle Biopsy Study	205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28-30 March 2014, Naarden, The Netherlands	NEUROMUSCULAR DISORDERS			English	Article							INCLUSION-BODY MYOSITIS; CYTOSOLIC 5'-NUCLEOTIDASE 1A; OVERDIAGNOSED ENTITY; MUSCLE BIOPSY; POLYMYOSITIS; DERMATOMYOSITIS		[De Bleecker, Jan L.; De Paepe, Boel] Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium; [Aronica, Eleonora] Acad Med Ctr, Dept Neuro Pathol, NL-1105 AZ Amsterdam, Netherlands; [de Visser, Marianne] Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Amato, Anthony] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Aronica, Eleonora; de Boer, Onno; Dimachkie, Mazen] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Benveniste, Olivier] Hop La Pitie Salpetriere, Paris, France; [De Bleecker, Jan; De Paepe, Boel] Ghent Univ Hosp, Edegem, Belgium; [Dimachkie, Mazen] Univ Kansas, Med Ctr, Kansas City, KS USA; [Gherardi, Romain] Univ Paris Est, Creteil, France; [Goebel, Hans Hilmar] Johannes Gutenberg Univ Mainz, Med Ctr, D-55122 Mainz, Germany; [Hilton-Jones, David] John Radcliffe Hosp, Oxford OX3 9DU, England; [Holton, Janice] UCL, London, England; [Lundberg, Ingrid E.] Karolinska Inst, Stockholm, Sweden; [Mammen, Andrew] Johns Hopkins Univ, Baltimore, MD USA; [Mastaglia, Frank] Univ Western Australia, Perth, WA 6009, Australia; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan; [Rushing, Elisabeth] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Schroder, Henrik Daa] Odense Univ Hosp, DK-5000 Odense, Denmark; [Selcen, Duygu] Mayo Clin, Rochester, MN USA; [Stenzel, Werner] Charite, D-13353 Berlin, Germany	De Bleecker, JL (reprint author), Ghent Univ Hosp, Dept Neurol, De Pintelaan 185, B-9000 Ghent, Belgium.	jan.debleecker@ugent.be	De Paepe, Boel/B-7548-2013; Schroder, Henrik Daa/E-2077-2013	Lundberg, Ingrid/0000-0002-6068-9212; Schroder, Henrik Daa/0000-0001-7588-235X	European Neuromuscular Centre (ENMC); Association Francaise contre les Myopathies; Deutsche Gesellschaft fur Muskelkrankheiten; U.K. Muscular Dystrophy Campaign; Muskelsindfonden Denmark; Prinses Beatrix Spierfonds and Vereniging Spierziekten Nederland; Schweizerische Stiftung fur die Erforschung der Muskelkrankheiten; Telethon Foundation Italy; Finnish Neuromuscular Association; European Science Foundation; Dutch ZonMW; CAF DCF	This workshop was made possible by the financial support of the European Neuromuscular Centre (ENMC) and its main sponsors: Association Francaise contre les Myopathies, Deutsche Gesellschaft fur Muskelkrankheiten, the U.K. Muscular Dystrophy Campaign, Muskelsindfonden Denmark, Prinses Beatrix Spierfonds and Vereniging Spierziekten Nederland, Schweizerische Stiftung fur die Erforschung der Muskelkrankheiten, Telethon Foundation Italy, and the associate member The Finnish Neuromuscular Association. Our special thanks also go to the European Science Foundation and the Dutch ZonMW for their generous support, and last but not least to the ENMC staff: Annelies Zittersteijn, Alexandra Breukel and Prof. George Padberg. Jan De Bleecker received a grant from CAF DCF.	Brady S, 2013, J NEUROL NEUROSUR PS, V84, P1240, DOI 10.1136/jnnp-2013-305690; van der Meulen MFG, 2003, NEUROLOGY, V61, P316; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Cox FM, 2011, BRAIN, V134, P3167, DOI 10.1093/brain/awr217; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840; Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213; Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8; Wedderburn LR, 2007, ARTHRIT RHEUM-ARTHR, V57, P1192, DOI 10.1002/art.23012; Pestronk A, 2011, CURR OPIN RHEUMATOL, V23, P595, DOI 10.1097/BOR.0b013e32834bab42; Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe; Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822; CARPENTER S, 1978, NEUROLOGY, V28, P8; Benveniste Olivier, 2010, Neuromuscul Disord, V20, P414, DOI 10.1016/j.nmd.2010.03.014; Brady S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004552; De Bleecker JL, 2013, NEUROMUSCULAR DISORD, V23, P945, DOI 10.1016/j.nmd.2013.07.007; Dubourg O, 2011, Acta Myol, V30, P103; Griggs RC, 1995, EVALUATION TREATMENT; Hilton-Jones David, 2011, Presse Med, V40, pe199, DOI 10.1016/j.lpm.2010.10.035; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Miller FW, 2004, NEUROLOGY, V63, P402; Rose MR, 2013, NEUROMUSCULAR DISORD, V23, P1044, DOI 10.1016/j.nmd.2013.08.007; Varsani H, 2015, ANN RHEUM DIS, V74, P204, DOI 10.1136/annrheumdis-2013-203396; Verschuuren JJ, 1997, DIAGNOSTIC CRITERIA, P81	25	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966	1873-2364		NEUROMUSCULAR DISORD	Neuromusc. Disord.	MAR	2015	25	3					268	272		10.1016/j.nmd.2014.12.001		5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CE4OE	WOS:000351809100013		
J	Basner, M; Brink, M; Bristow, A; de Kluizenaar, Y; Finegold, L; Hong, J; Janssen, SA; Klaeboe, R; Leroux, T; Liebl, A; Matsui, T; Schwela, D; Sliwinska-Kowalska, M; Sorqvist, P				Basner, Mathias; Brink, Mark; Bristow, Abigail; de Kluizenaar, Yvonne; Finegold, Lawrence; Hong, Jiyoung; Janssen, Sabine A.; Klaeboe, Ronny; Leroux, Tony; Liebl, Andreas; Matsui, Toshihito; Schwela, Dieter; Sliwinska-Kowalska, Mariola; Sorqvist, Patrik			ICBEN review of research on the biological effects of noise 2011-2014	NOISE & HEALTH			English	Review						Annoyance; health; hearing loss; noise; performance; pollution; sleep	ROAD-TRAFFIC NOISE; INDUCED HEARING-LOSS; WIND TURBINE NOISE; WORKING-MEMORY CAPACITY; LONG-TERM EXPOSURE; QUALITY-OF-LIFE; INDUCED COCHLEAR NEUROPATHY; PERSONAL LISTENING DEVICES; SELF-REPORTED HYPERTENSION; CHILDRENS BLOOD-PRESSURE	The mandate of the International Commission on Biological Effects of Noise (ICBEN) is to promote a high level of scientific research concerning all aspects of noise-induced effects on human beings and animals. In this review, ICBEN team chairs and co-chairs summarize relevant findings, publications, developments, and policies related to the biological effects of noise, with a focus on the period 2011-2014 and for the following topics: Noise-induced hearing loss; nonauditory effects of noise; effects of noise on performance and behavior; effects of noise on sleep; community response to noise; and interactions with other agents and contextual factors. Occupational settings and transport have been identified as the most prominent sources of noise that affect health. These reviews demonstrate that noise is a prevalent and often underestimated threat for both auditory and nonauditory health and that strategies for the prevention of noise and its associated negative health consequences are needed to promote public health.	[Basner, Mathias] Univ Penn, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA; [Brink, Mark] Noise & NIR Div, Fed Off Environm, Bern, Switzerland; [Bristow, Abigail] Univ Loughborough, Sch Civil & Bldg Engn, Loughborough, Leics, England; [de Kluizenaar, Yvonne; Janssen, Sabine A.] Netherlands Org Appl Sci Res TNO, Dept Urban Environm & Safety, Delft, Netherlands; [Finegold, Lawrence] Finegold & So Consultants, Centerville, OH 45459 USA; [Hong, Jiyoung] Korea Railrd Res Inst, Ecotransport Res Div, Uiwang, South Korea; [Klaeboe, Ronny] Inst Transport Econ TOI, Dept Safety Secur & Environm, Oslo, Norway; [Leroux, Tony] Univ Montreal, Sch Speech Language & Audiol, Montreal, PQ, Canada; [Liebl, Andreas] Fraunhofer Inst Bldg Phys IBP, Dept Acoust, Stuttgart, Germany; [Matsui, Toshihito] Hokkaido Univ, Dept Environm Engn, Sapporo, Hokkaido 060, Japan; [Schwela, Dieter] Univ York, Dept Environm, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England; [Sliwinska-Kowalska, Mariola] Nofer Inst Occupat Med, Dept Audiol & Phoniatr, Lodz, Poland; [Sorqvist, Patrik] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden; [Sorqvist, Patrik] Linkoping Univ, Linnaeus Ctr HEAD, Swedish Inst Disabil Res, Linkoping, Sweden	Basner, M (reprint author), Univ Penn, Dept Psychiat, Div Sleep & Chronobiol, Perelman Sch Med, 1013 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	basner@mail.med.upenn.edu	Sliwinska-Kowalska, Mariola/F-6119-2010	Sliwinska-Kowalska, Mariola/0000-0001-7569-3882			Agglomeration Noise Action Plan, 2014, AGGL NOIS ACT PLAN A; Akin FW, 2012, EAR HEARING, V33, P458, DOI 10.1097/AUD.0b013e3182498c5f; Alagic Z, 2011, ACTA OTO-LARYNGOL, V131, P802, DOI 10.3109/00016489.2011.564652; Anderson GS, 2011, NOISE CONTROL ENG J, V59, P519; Watts GR, 2011, ENVIRON PLANN B, V38, P585, DOI 10.1068/b36131; [Anonymous], 2013, RAIL INFR NOIS GUID; [Anonymous], 2011, QUANT LINKS ENV NOIS; [Anonymous], 2014, NOIS ACT PLAN AGGL; Kalsch H, 2014, EUR HEART J, V35, P853, DOI 10.1093/eurheartj/eht426; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; de Kluizenaar Y, 2013, INT J ENV RES PUB HE, V10, P2258, DOI 10.3390/ijerph10062258; Paviotti M, 2012, SCI TOTAL ENVIRON, V430, P223, DOI 10.1016/j.scitotenv.2012.05.010; [Anonymous], CONS INPL REP ENV NO; Morata TC, 2011, INT J AUDIOL, V50, P652, DOI 10.3109/14992027.2011.588965; Marsh JE, 2012, J EXP PSYCHOL LEARN, V38, P1377, DOI 10.1037/a0027849; de Kluizenaar Y, 2013, NOISE HEALTH, V15, P388, DOI 10.4103/1463-1741.121230; Halin N, 2014, J APPL RES MEM COGN, V3, P31, DOI 10.1016/j.jarmac.2014.01.003; Foraster M, 2013, INT J PUBLIC HEALTH, V58, P647, DOI 10.1007/s00038-013-0500-3; [Anonymous], 2012, REV NOIS NAT PARKS, V1; Fields JM, 2001, J SOUND VIB, V242, P641, DOI 10.1006/jsvi.2000.3384; van Kempen E, 2012, J HYPERTENS, V30, P1075, DOI 10.1097/HJH.0b013e328352ac54; Niu YG, 2013, J NEUROSCI RES, V91, P292, DOI 10.1002/jnr.23152; Bakker RH, 2012, SCI TOTAL ENVIRON, V425, P42, DOI 10.1016/j.scitotenv.2012.03.005; Heinonen-Guzejev M, 2013, J OCCUP ENVIRON MED, V55, P365, DOI 10.1097/JOM.0b013e318285f433; Hope AJ, 2013, J LARYNGOL OTOL, V127, P233, DOI 10.1017/S002221511200299X; Waddington DC, 2014, J ACOUST SOC AM, V135, P182, DOI 10.1121/1.4836496; Hughes H, 2013, NOISE HEALTH, V15, P379, DOI 10.4103/1463-1741.121224; [Anonymous], 2012, EUR CITAC GUID CG4 Q, p[1, 3]; Portnuff CDF, 2011, J AM ACAD AUDIOL, V22, P663, DOI 10.3766/jaaa.22.10.5; Buxton OM, 2012, ANN INTERN MED, V157, P170, DOI [10.7326/0003-4819-157-3-201208070-00472, 10.7326/0003-4819-156-12-201208070-00472]; Meinke DK, 2013, NOISE HEALTH, V15, P315, DOI 10.4103/1463-1741.116575; [Anonymous], 2012, 374312010 ISO; Schmidt FP, 2013, EUR HEART J, V34, P3508, DOI 10.1093/eurheartj/eht269; Huang Y, 2012, J ACOUST SOC AM, V131, P4558, DOI 10.1121/1.4705285; Jahncke H, 2013, APPL ACOUST, V74, P307, DOI 10.1016/j.apacoust.2012.08.007; Basner M, 2011, SLEEP, V34, P11; Clark C, 2013, J ENVIRON PSYCHOL, V35, P1, DOI 10.1016/j.jenvp.2013.03.002; Babisch W, 2013, SCI TOTAL ENVIRON, V452, P50, DOI 10.1016/j.scitotenv.2013.02.034; Botteldooren D, 2011, INT J ENV RES PUB HE, V8, P777, DOI 10.3390/ijerph8030777; Sulaiman AH, 2013, PUBLIC HEALTH, V127, P710, DOI 10.1016/j.puhe.2013.01.007; Johnson O, 2014, J LARYNGOL OTOL, V128, P29, DOI 10.1017/S0022215113003241; Huang J, 2013, J EXPO SCI ENV EPID, V23, P559, DOI 10.1038/jes.2013.21; Kang TS, 2013, J ACOUST SOC AM, V134, P822, DOI 10.1121/1.4807810; Sorqvist P, 2012, J COGNITIVE NEUROSCI, V24, P2147; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Miedema HME, 2001, ENVIRON HEALTH PERSP, V109, P409, DOI 10.2307/3454901; Banerjee D, 2013, NOISE HEALTH, V15, P342, DOI 10.4103/1463-1741.116583; [Anonymous], 2010, AONRAIL COMP MOD CAL; [Anonymous], 2012, 263142001 ISO; [Anonymous], 2012, INV EFF HIST NOSIS P; Birk M, 2011, J ENVIRON MONITOR, V13, P3237, DOI 10.1039/c1em10347d; [Anonymous], 2014, IMPL ROUND ACT PLANT; Steinle S, 2013, SCI TOTAL ENVIRON, V443, P184, DOI 10.1016/j.scitotenv.2012.10.098; Breinbauer HA, 2012, LARYNGOSCOPE, V122, P2549, DOI 10.1002/lary.23596; Selander J, 2013, SCAND J WORK ENV HEA, V39, P195, DOI 10.5271/sjweh.3324; Gan WQ, 2012, AM J EPIDEMIOL, V175, P898, DOI 10.1093/aje/kwr424; Seixas NS, 2012, OCCUP ENVIRON MED, V69, P643, DOI 10.1136/oemed-2011-100578; [Anonymous], 2014, EUR ENV AG; Roer JP, 2014, MEM COGNITION, V42, P609, DOI 10.3758/s13421-013-0381-y; Lee PJ, 2013, J ACOUST SOC AM, V133, P2126, DOI 10.1121/1.4793271; Parthasarathy S, 2004, INTENS CARE MED, V30, P197, DOI 10.1007/s00134-003-2030-6; Sorqvist P, 2012, SCAND J PSYCHOL, V53, P97, DOI 10.1111/j.1467-9450.2011.00936.x; Watts GR, 2013, APPL ACOUST, V74, P1094, DOI 10.1016/j.apacoust.2013.03.007; [Anonymous], 2014, NOISE EUR ENV AG; [Anonymous], 2013, REV AUSTR STAND 2021; Pierrette M, 2012, J ENVIRON PSYCHOL, V32, P178, DOI 10.1016/j.jenvp.2012.01.006; Ljung R, 2013, APPL COGNITIVE PSYCH, V27, P198, DOI 10.1002/acp.2896; Dratva J, 2012, ENVIRON HEALTH PERSP, V120, P50, DOI 10.1289/ehp.1103448; Masterson EA, 2013, AM J IND MED, V56, P670, DOI 10.1002/ajim.22082; Schomer P, 2013, J ACOUST SOC AM, V134, P767, DOI 10.1121/1.4808075; Nissenbaum MA, 2012, NOISE HEALTH, V14, P237, DOI 10.4103/1463-1741.102961; de Kluizenaar Y, 2011, J ACOUST SOC AM, V130, P1936, DOI 10.1121/1.3621180; [Anonymous], 2012, 37442010 ISO; Tiesler CMT, 2013, ENVIRON RES, V123, P1, DOI 10.1016/j.envres.2013.01.009; Lo WC, 2013, NEUROSCIENCE, V254, P222, DOI 10.1016/j.neuroscience.2013.09.027; Van Renterghem T, 2012, INT J ENV RES PUB HE, V9, P4292, DOI 10.3390/ijerph9124292; Hughes RW, 2013, J EXP PSYCHOL HUMAN, V39, P539, DOI 10.1037/a0029064; Chang TY, 2013, AM J EPIDEMIOL, V177, P818, DOI 10.1093/aje/kws300; Hongisto V, 2005, INDOOR AIR, V15, P458, DOI 10.1111/j.1600-0668.2005.00391.x; Van Renterghem T, 2013, SCI TOTAL ENVIRON, V456, P333, DOI 10.1016/j.scitotenv.2013.03.095; Claeson AS, 2013, INT ARCH OCC ENV HEA, V86, P367, DOI 10.1007/s00420-012-0770-8; Widen SE, 2013, INT J AUDIOL, V52, P57, DOI 10.3109/14992027.2012.728724; [Anonymous], 2010, NOIS POL STAT ENGL N; [Anonymous], 2011, NSW ROAD NOIS POL; Elmenhorst EM, 2012, SCI TOTAL ENVIRON, V424, P48, DOI 10.1016/j.scitotenv.2012.02.024; Welch D, 2013, NOISE HEALTH, V15, P224, DOI 10.4103/1463-1741.113513; Kroesen M, 2011, J ACOUST SOC AM, V129, P200, DOI 10.1121/1.3514542; [Anonymous], 2008, SCI OP POT HLTH RISK; Mahboubi H, 2013, EUR ARCH OTO-RHINO-L, V270, P461, DOI 10.1007/s00405-012-1979-6; Laszlo HE, 2012, SCI TOTAL ENVIRON, V435, P551, DOI 10.1016/j.scitotenv.2012.06.112; Yang F, 2011, INT J ENV RES PUB HE, V8, P1032, DOI 10.3390/ijerph8041032; Figueiredo RR, 2011, BRAZ J OTORHINOLAR, V77, P293, DOI 10.1590/S1808-86942011000300004; Kroesen M, 2011, J ENVIRON PSYCHOL, V31, P147, DOI 10.1016/j.jenvp.2010.09.004; Neitzel RL, 2011, ANN OCCUP HYG, V55, P906, DOI 10.1093/annhyg/mer050; Fuks K, 2011, ENVIRON HEALTH PERSP, V119, P1706, DOI 10.1289/ehp.1103564; Jahncke H, 2011, J ENVIRON PSYCHOL, V31, P373, DOI 10.1016/j.jenvp.2011.07.002; Schomer P, 2012, J ACOUST SOC AM, V131, P2772, DOI 10.1121/1.3688762; Urban J, 2013, INT J ENV RES PUB HE, V10, P1895, DOI 10.3390/ijerph10051895; [Anonymous], 2012, 134742009 ISO; [Anonymous], 2012, 48662010 ISO; [Anonymous], 2014, COPNS DRAFT NOIS ACT; [Anonymous], 2014, NOIS ACT PLAN RAILW; Waye KP, 2013, SLEEP MED, V14, P1334, DOI 10.1016/j.sleep.2013.07.011; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; [Anonymous], 2014, NOIS ACT PLAN ROADS; [Anonymous], 2011, NAT ENV PAP IMPL UPD; Ortmann M, 2011, EUR J NEUROSCI, V33, P568, DOI 10.1111/j.1460-9568.2010.07542.x; Moser T, 2013, OTOL NEUROTOL, V34, P995, DOI 10.1097/MAO.0b013e3182814d4a; Liu C, 2014, INT J HYG ENVIR HEAL, V217, P499, DOI 10.1016/j.ijheh.2013.09.008; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P1542, DOI 10.1037/a0028459; Janssen SA, 2011, J ACOUST SOC AM, V130, P3746, DOI 10.1121/1.3653984; Hohmann C, 2013, INT J HYG ENVIR HEAL, V216, P217, DOI 10.1016/j.ijheh.2012.06.001; De Coensel B, 2009, J ACOUST SOC AM, V126, P656, DOI 10.1121/1.3158601; Terroir J, 2013, ACTA ACUST UNITED AC, V99, P389, DOI 10.3813/AAA.918620; Mace BL, 2013, J ENVIRON PSYCHOL, V35, P30, DOI 10.1016/j.jenvp.2013.04.001; Leensen MCJ, 2011, INT ARCH OCC ENV HEA, V84, P577, DOI 10.1007/s00420-010-0606-3; Fields JM, 1997, J SOUND VIB, V206, P685, DOI 10.1006/jsvi.1997.1144; Henderson E, 2011, PEDIATRICS, V127, pE39, DOI 10.1542/peds.2010-0926; Morel J, 2012, ACTA ACUST UNITED AC, V98, P286, DOI 10.3813/AAA.918512; Ali SA, 2011, APPL ACOUST, V72, P221, DOI 10.1016/j.apacoust.2010.11.001; Amundsen AH, 2013, J ACOUST SOC AM, V133, P3921, DOI 10.1121/1.4802824; [Anonymous], 2011, EC VAL QUIEF AR; Miedema HME, 2004, J ACOUST SOC AM, V116, P949, DOI 10.1121/1.1766305; [Anonymous], 2011, EST PROD IMP NOIS; [Anonymous], 2012, 37462010 ISO; Dons E, 2012, ATMOS ENVIRON, V55, P392, DOI 10.1016/j.atmosenv.2012.03.020; Honold J, 2012, J ENVIRON PSYCHOL, V32, P305, DOI 10.1016/j.jenvp.2012.05.002; Sorqvist P, 2013, PSYCHON B REV, V20, P897, DOI 10.3758/s13423-013-0419-y; [Anonymous], 2010, NOIS ENV PROT POL CA; Pilati N, 2012, P NATL ACAD SCI USA, V109, P8292, DOI 10.1073/pnas.1116981109; Fidell S, 2011, J ACOUST SOC AM, V130, P791, DOI 10.1121/1.3605673; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Hart JE, 2013, EPIDEMIOLOGY, V24, P734, DOI 10.1097/EDE.0b013e31829d5dae; Tetreault LF, 2013, INT J PUBLIC HEALTH, V58, P649, DOI 10.1007/s00038-013-0489-7; Babisch W, 2014, NOISE HEALTH, V16, P1, DOI 10.4103/1463-1741.127847; Shepherd D, 2011, NOISE HEALTH, V13, P333, DOI 10.4103/1463-1741.85502; Hecht M, 2012, NOTES NUMER FLUID ME, V118, P515; [Anonymous], 2013, FIN REP ENNAK EUR NE; [Anonymous], 2012, 263152004 ISO; Sorensen M, 2012, ENVIRON HEALTH PERSP, V120, P418, DOI 10.1289/ehp.1103631; Sorqvist P, 2012, PSYCHON B REV, V19, P245, DOI 10.3758/s13423-011-0203-9; Muzet A, 2007, SLEEP MED REV, V11, P135, DOI 10.1016/j.smrv.2006.09.001; Beach EF, 2013, INT J AUDIOL, V52, pS20, DOI 10.3109/14992027.2012.743050; Halin N, 2014, J EXP PSYCHOL-APPL, V20, P69, DOI 10.1037/xap0000002; Marks A, 2008, NOISE CONTROL ENG J, V56, P52, DOI 10.3397/1.2828211; Rewerska A, 2013, EUR ARCH OTO-RHINO-L, V270, P1513, DOI 10.1007/s00405-012-2265-3; [Anonymous], 2010, NAT ENV WHIT PAP DIS; McIlvaine D, 2012, MED PROBL PERFORM AR, V27, P31; Gilles A, 2012, OTOL NEUROTOL, V33, P899, DOI 10.1097/MAO.0b013e31825d640a; Axelsson G, 2013, INT J ENV RES PUB HE, V10, P1418, DOI 10.3390/ijerph10041418; [Anonymous], 2012, 263122003 ISO; Argalasova-Sobotova L, 2013, NOISE HEALTH, V15, P22, DOI 10.4103/1463-1741.107149; Aslund MLW, 2013, ENERG POLICY, V62, P44, DOI 10.1016/j.enpol.2013.07.070; Autenrieth DA, 2012, J OCCUP ENVIRON HYG, V9, P592, DOI 10.1080/15459624.2012.713768; Babisch W, 2012, ENVIRON BEHAV, V44, P68, DOI 10.1177/0013916510387400; Babisch W, 2012, J ACOUST SOC AM, V132, P3788, DOI 10.1121/1.4764881; Barlow C, 2012, NOISE HEALTH, V14, P86, DOI 10.4103/1463-1741.95137; Barlow C, 2011, MED PROBL PERFORM AR, V26, P96; Basner M, 2013, LANCET, V383, P1325; Basner M, 2013, APPL ACOUST, V74, P812, DOI 10.1016/j.apacoust.2013.01.002; Beach E, 2013, EAR HEARING, V34, P75, DOI 10.1097/AUD.0b013e318262ac6c; Belojevic G, 2012, J ACOUST SOC AM, V132, P1403, DOI 10.1121/1.4739449; Bendokiene I, 2011, NOISE HEALTH, V13, P371, DOI 10.4103/1463-1741.90288; Bilenko N, 2015, EUR J PREV CARDIOL, V22, P4, DOI 10.1177/2047487313505821; Bodin T, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-14; Bolin K, 2012, ACTA ACUST UNITED AC, V98, P741, DOI 10.3813/AAA.918555; Bonde JP, 2012, SCAND J WORK ENV HEA, V38, P1, DOI 10.5271/sjweh.3261; Brink M., 2012, INT NOIS 201 P 41 IN, P9935; Campo P, 2013, DM-DIS MON, V59, P119, DOI 10.1016/j.disamonth.2013.01.003; Cassel W, 2008, SOMNOLOGIE, V12, P158, DOI 10.1007/s11818-008-0346-8; Chang TY, 2012, ENVIRON RES, V118, P112, DOI 10.1016/j.envres.2012.06.008; Chang TY, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-35; Choi CH, 2011, FREE RADICAL RES, V45, P1162, DOI 10.3109/10715762.2011.605360; Correia AW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5561; Croy I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002655; Cui B, 2013, MED HYPOTHESES, V81, P623, DOI 10.1016/j.mehy.2013.07.017; Deguen S, 2012, RISK ANAL, V32, P2043, DOI 10.1111/j.1539-6924.2012.01862.x; Di GQ, 2012, SCI TOTAL ENVIRON, V432, P189, DOI 10.1016/j.scitotenv.2012.05.034; Ellermeier W, 2014, ACOUSTICAL SCI TECHN, V35, P10; Elmehdi Hussein M., 2012, Acoustical Science and Technology, V33, DOI 10.1250/ast.33.6; Eriksson C, 2012, NOISE HEALTH, V14, P140, DOI 10.4103/1463-1741.99864; European Commission, 2002, POS PAP DOS RESP REL; Ferrite S, 2013, AM J IND MED, V56, P1213, DOI 10.1002/ajim.22142; Fidell S, 2012, NOISE CONTROL ENG J, V60, P62, DOI 10.3397/1.3677792; Fidell S, 2013, J ACOUST SOC AM, V134, P3645, DOI 10.1121/1.4823838; Finegold L, 2012, NOISE HEALTH, V14, P307, DOI 10.4103/1463-1741.104899; Floud S, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-89; Folmer RL, 2011, J REHABIL RES DEV, V48, P503, DOI 10.1682/JRRD.2010.07.0138; Frei P, 2014, INT J HYG ENVIR HEAL, V217, P188, DOI 10.1016/j.ijheh.2013.04.003; Fritschi L, 2011, BURDEN DIS ENVG NOIS, P1; Gidlof-Gunnarsson A, 2012, NOISE HEALTH, V14, P190, DOI 10.4103/1463-1741.99895; Gilles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070297; Girard SA, 2014, CAN J AGING, V33, P84, DOI 10.1017/S0714980813000664; Gundersen H, 2013, ARCH ENVIRON OCCUP H, V68, P153, DOI 10.1080/19338244.2012.676103; Halonen JI, 2012, ENVIRON HEALTH PERSP, V120, P1391, DOI 10.1289/ehp.1205026; Hammer MS, 2014, ENVIRON HEALTH PERSP, V122, P115, DOI 10.1289/ehp.1307272; Hanninen O, 2011, EBODE REPORT ENV PER; Hansell AL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5432; Hansell AL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7464; Heinonen-Guzejev M, 2012, NOISE HEALTH, V14, P215, DOI 10.4103/1463-1741.102956; Helleman HW, 2012, INT J AUDIOL, V51, P362, DOI 10.3109/14992027.2011.653447; Henry P, 2012, J AM ACAD AUDIOL, V23, P182, DOI 10.3766/jaaa.23.3.5; Heritier H, 2014, SIRENE INT STUD HLTH; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Hume KI, 2012, NOISE HEALTH, V14, P297, DOI 10.4103/1463-1741.104897; Hwang BF, 2012, OCCUP ENVIRON MED, V69, P236, DOI 10.1136/oemed-2011-100060; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS STUD 2; International Civil Aviation Organization, 2013, DAIL PRESS CLIPP SER, P1; Jansen S, 2013, EAR HEARING, V34, P773, DOI 10.1097/AUD.0b013e318297920b; Janssen N.A.H., 2012, HLTH EFFECTS BLACK C, P1; Janssen SA, 2011, J ACOUST SOC AM, V129, P1953, DOI 10.1121/1.3533739; Jiang B, 2012, ACTA ACUST UNITED AC, V98, P135, DOI 10.3813/AAA.918499; Keith SE, 2011, J ACOUST SOC AM, V130, P2756, DOI 10.1121/1.3641406; Keith Wilson D, 2013, J ACOUST SOC AM, V133, pEL195; Kelly AC, 2012, NOISE HEALTH, V14, P148, DOI 10.4103/1463-1741.99868; Kolstad HA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7444; Kraus U, 2013, ENVIRON HEALTH PERSP, V121, P607, DOI 10.1289/ehp.1205606; Kroesen M, 2013, J ACOUST SOC AM, V133, P238, DOI 10.1121/1.4768795; Kuhn P, 2013, ACTA PAEDIATR, V102, P949, DOI 10.1111/apa.12330; Lavandier C, 2012, APPL ACOUST, V73, P66, DOI 10.1016/j.apacoust.2011.06.003; Lavandier C, 2011, APPL ACOUST, V72, P169, DOI 10.1016/j.apacoust.2010.11.005; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Lee PJ, 2014, SCI TOTAL ENVIRON, V482, P432, DOI 10.1016/j.scitotenv.2013.07.026; Lee S, 2011, NOISE CONTROL ENG J, V59, P38; Lekaviciute J, 2013, NOISE HEALTH, V15, P42, DOI 10.4103/1463-1741.107153; Le Prell CG, 2011, TRANSL RES, V158, P54, DOI 10.1016/j.trsl.2011.02.003; Lercher P, 2013, NOISE HEALTH, V15, P205, DOI 10.4103/1463-1741.113502; Lercher P, 2014, INT J ENV RES PUB HE, V11, P8661, DOI 10.3390/ijerph110908661; Lercher P, 2013, J ACOUST SOC AM, V134, P773, DOI 10.1121/1.4807808; Lercher P, 2011, NOISE HEALTH, V13, P234, DOI 10.4103/1463-1741.80160; Lercher P., 2011, COMINED NOISE EXOLOS, P764; Lercher P, 2012, J ACOUST SOC AM, V131, P3223, DOI DOI 10.1121/1.4708019; Leroux T, 2012, NOISE HEALTH, V14, P313, DOI 10.4103/1463-1741.104900; Lewis RC, 2013, ENVIRON SCI TECHNOL, V47, P6393, DOI 10.1021/es305161z; Li HN, 2012, J ACOUST SOC AM, V131, P2131, DOI 10.1121/1.3681936; Li ZG, 2013, APPL ACOUST, V75, P37, DOI 10.1016/j.apacoust.2013.06.011; Liang MJ, 2012, J ACOUST SOC AM, V131, P4526, DOI 10.1121/1.4707457; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu C, 2013, NOISE HEALTH, V15, P165, DOI 10.4103/1463-1741.112364; Maffei L, 2013, SCI TOTAL ENVIRON, V445, P41, DOI 10.1016/j.scitotenv.2012.12.025; Marlenga B, 2011, PEDIATRICS, V128, pE1139, DOI 10.1542/peds.2011-0770; Meline J, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-44; Metwally FM, 2012, TOXICOL IND HEALTH, V28, P901, DOI 10.1177/0748233711427051; Morihara T, 2013, INTERNOISE NOISE CON, V247, P1358; Muchnik C, 2012, INT J AUDIOL, V51, P287, DOI 10.3109/14992027.2011.631590; National Academy of Engineering, 2013, PROT NAT PARK SOUNDS; Neitze RL, 2012, ENVIRON SCI TECHNOL, V46, P500, DOI 10.1021/es2025406; Nguyen TL, 2012, APPL ACOUST, V73, P952, DOI 10.1016/j.apacoust.2012.04.005; Nguyen TL, 2011, APPL ACOUST, V72, P814, DOI 10.1016/j.apacoust.2011.05.002; Notbohm G, 2013, NOISE HEALTH, V15, P355, DOI 10.4103/1463-1741.116585; Nykaza ET, 2013, J ACOUST SOC AM, V133, P2690, DOI 10.1121/1.4795781; O'Brien I, 2014, J OCCUP ENVIRON HYG, V11, P450, DOI 10.1080/15459624.2013.875187; O'Brien I, 2013, J ACOUST SOC AM, V134, P2748, DOI 10.1121/1.4820900; Ollson CA, 2013, NOISE HEALTH, V15, P148, DOI 10.4103/1463-1741.110302; Omlin S, 2013, NOISE HEALTH, V15, P332, DOI 10.4103/1463-1741.116582; Park M, 2013, J ACOUST SOC AM, V134, P1970, DOI 10.1121/1.4816939; Patil ML, 2013, OCCUP MED-OXFORD, V63, P281, DOI 10.1093/occmed/kqt026; Paunovic K, 2014, ENVIRON RES, V129, P52, DOI 10.1016/j.envres.2014.01.001; Paunovic K, 2013, NOISE HEALTH, V15, P253, DOI 10.4103/1463-1741.113521; Pellegrino E, 2013, Ann Ig, V25, P367, DOI 10.7416/ai.2013.1938; Peris E, 2012, J ACOUST SOC AM, V131, pEL191, DOI 10.1121/1.3679390; Pettersson H, 2012, NOISE HEALTH, V14, P159, DOI 10.4103/1463-1741.99887; Poll MK, 2014, APPL ACOUST, V81, P15; Portnuff CDF, 2013, INT J AUDIOL, V52, pS33, DOI 10.3109/14992027.2012.745649; Preis A, 2011, NOISE CONTROL ENG J, V59, P408, DOI 10.3397/1.3590172; Raaschou-Nielsen O, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-60; Rabinowitz PM, 2012, NOISE HEALTH, V14, P21, DOI 10.4103/1463-1741.93326; Rabinowitz PM, 2011, OCCUP ENVIRON MED, V68, P414, DOI 10.1136/oem.2010.055905; Rahma MS, 2013, NOISE HEALTH, V15, P375, DOI 10.4103/1463-1741.121223; Riedel N, 2015, J ENVIRON PLANN MAN, V58, P336, DOI 10.1080/09640568.2013.859129; Rönnberg Jerker, 2013, Front Syst Neurosci, V7, P31, DOI 10.3389/fnsys.2013.00031; Ryu JK, 2011, APPL ACOUST, V72, P336, DOI 10.1016/j.apacoust.2010.12.005; Schreckenberg D, 2012, LAMBERKAMPFUNG, V6, P107; Schreckenberg D, 2011, 10 INT C NOIS PUBL H, P390; Seong Y, 2013, J RENEW SUSTAIN ENER, V5, DOI 10.1063/1.4821811; Shepherd D, 2013, INT J ENV RES PUB HE, V10, P1284, DOI 10.3390/ijerph10041284; Sliwinska-Kowalska M, 2013, MUTAT RES-REV MUTAT, V752, P61, DOI 10.1016/j.mrrev.2012.11.001; Smith MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055829; Sorensen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039283; Sorensen M, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-92; Sorensen M, 2014, INT J CANCER, V134, P2691, DOI 10.1002/ijc.28592; Sorqvist P, 2014, SCAND J PSYCHOL, V55, P91, DOI 10.1111/sjop.12115; Spah Moritz, 2013, Building Acoustics, V20; Stansfeld S, 2012, J ACOUST SOC AM, V131, P3295; Stokholm ZA, 2013, EPIDEMIOLOGY, V24, P135, DOI 10.1097/EDE.0b013e31826b7f76; Stokholm ZA, 2014, PSYCHONEUROENDOCRINO, V39, P21, DOI 10.1016/j.psyneuen.2013.09.028; Stokholm ZA, 2013, STROKE, V44, P3214, DOI 10.1161/STROKEAHA.113.002798; Suadicani P, 2012, SCAND J WORK ENV HEA, V38, P19, DOI 10.5271/sjweh.3200; Tao LY, 2013, NOISE HEALTH, V15, P67, DOI 10.4103/1463-1741.107159; Tassi P, 2013, J ENVIRON PSYCHOL, V33, P45, DOI 10.1016/j.jenvp.2012.10.003; Taylor J, 2013, RENEW ENERG, V55, P120, DOI 10.1016/j.renene.2012.11.031; Tomei G, 2013, ARCH ENVIRON OCCUP H, V68, P196, DOI 10.1080/19338244.2012.701245; US Department of Transportation, 2012, HIGH SPEED GROUND TR; Verheijen E, 2011, NOISE HEALTH, V13, P459, DOI 10.4103/1463-1741.90331; Vogel I, 2011, HEALTH EDUC RES, V26, P254, DOI 10.1093/her/cyq091; Vos J, 2013, J ACOUST SOC AM, V134, P2011, DOI 10.1121/1.4817923; Vyskocil A, 2012, TOXICOL IND HEALTH, V28, P796, DOI 10.1177/0748233711425067; Wahl C, 2012, IATSS RES, V35, P111; Watts G, 2013, ENVIRON PLANN B, V40, P170, DOI 10.1068/b38061; Waye K. P., 2011, ENCY ENV HLTH, P240; Weichbold V, 2012, INT J AUDIOL, V51, P650, DOI 10.3109/14992027.2012.679747; Weinmann T, 2012, INT ARCH OCC ENV HEA, V85, P363, DOI 10.1007/s00420-011-0679-7; WHO Regional Office for Europe, 2011, BURD DIS ENV NOIS QU; Williams SC, 2012, ANN OCCUP HYG, V56, P925, DOI 10.1093/annhyg/mes028; Wilson WJ, 2013, J OCCUP ENVIRON HYG, V10, P590, DOI 10.1080/15459624.2013.818227; World Health Organization, 2009, NIGHT NOIS GUID EUR; Xie H, 2009, CRIT CARE, V13, DOI 10.1186/cc7154; Yano T, 2012, NOISE HEALTH, V14, P303, DOI 10.4103/1463-1741.104898; Zhai Yi-biao, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P849; Zuniga MG, 2012, OTOL NEUROTOL, V33, P1586, DOI 10.1097/MAO.0b013e31826bedbc	310	1	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1463-1741	1998-4030		NOISE HEALTH	Noise Health	MAR-APR	2015	17	75					57	82		10.4103/1463-1741.153373		26	Audiology & Speech-Language Pathology; Public, Environmental & Occupational Health	Audiology & Speech-Language Pathology; Public, Environmental & Occupational Health	CE3TR	WOS:000351752400001		
J	Go, K				Go, Kenji			Bottom's Dream Revisited	NOTES AND QUERIES			English	Editorial Material									Kanagawa Univ, Tokyo, Japan	Go, K (reprint author), Kanagawa Univ, Tokyo, Japan.							0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0029-3970	1471-6941		NOTES QUERIES	Notes Queries	MAR	2015	62	1					98	103		10.1093/notesj/gju243		6	Literature	Literature	CE1OP	WOS:000351581600033		
J	Arie, F				Arie, Fumie			Multicultural dialogue on dignity from a Japanese perspective	NURSING ETHICS			English	Editorial Material									Sophia Univ Inst Bioeth, Tokyo, Japan	Arie, F (reprint author), Sophia Univ Inst Bioeth, Tokyo, Japan.	nursing-ethics@surrey.ac.uk					Abe T, 2007, SOCIOSCIENCE, V13, P17; Aoki N, 2004, LIFE ETHICS HIST CUL; Baertschi B, 2014, J BIOETHIC INQ, V11, P201, DOI 10.1007/s11673-014-9512-9; Dozono T, 2014, TETSUGAKUSHI, V56, P1; Hiro A, 2003, ANN GIFU SHOTOKU GAK, V42, P1; Matsuda J, 2010, MORALIA, V17, P23; Matui F, 2003, BIOETHICS, V13, P58; Shimizu T, 2007, PALLIATIVE CARE, V17, P3; Tannemura K, 2001, CULT SOC SCI, V53, P105; Watsuji T, 2000, WATSUJI TETSUR NINGE	10	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0969-7330	1477-0989		NURS ETHICS	Nurs. Ethics	MAR	2015	22	2					273	275		10.1177/0969733015569841		3	Nursing	Nursing	CE3CV	WOS:000351703000013		
J	Hasegawa, Y; Ando, M; Maemondo, M; Yamamoto, S; Isa, S; Saka, H; Kubo, A; Kawaguchi, T; Takada, M; Rosell, R; Kurata, T; Ou, SHI				Hasegawa, Yoshikazu; Ando, Masahiko; Maemondo, Makoto; Yamamoto, Satomi; Isa, Shun-ichi; Saka, Hideo; Kubo, Akihito; Kawaguchi, Tomoya; Takada, Minoru; Rosell, Rafael; Kurata, Takayasu; Ou, Sai-Hong Ignatius			The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chemotherapy: A Meta-Analysis of Prospective Randomized Trials	ONCOLOGIST			English	Article						Meta-analysis; EGFR TKIs; Smoking status; EGFR mutant non-small cell lung cancer; Gefitinib; Erlotinib; Afatinib	OPEN-LABEL; CARBOPLATIN-PACLITAXEL; INCREASED SENSITIVITY; ASIAN PATIENTS; NEVER-SMOKERS; PHASE-3 TRIAL; ERLOTINIB; ADENOCARCINOMA; GEFITINIB; MULTICENTER	Background. Univariate analyses from several randomized phase III trials seemed to suggest ever-smokers with advanced mutated epidermal growth factor receptor (EGFRm) non-small cell lung cancer (NSCLC) did not seem to benefit from EGFR tyrosine kinase inhibitors (TKIs) as first-line treatment when compared with platinum-doublet chemotherapy as measured by progression-free survival (PFS). Methods. A literature-based meta-analysis of PFS outcomes as measured by log-transformed pooled hazard ratio (HR) was performed using a random-effect model. Pooled HRs for smoking status, age, gender, ethnicity, type of EGFR mutation, and EGFR TKI were obtained. Comparison of the pooled HR was performed by metaregression analysis. Results. Among the 1,649 EGFRm NSCLC patients analyzed from 7 prospective randomized trials (WJTOG3405, NEJ002, EURTAC, OPTIMAL, LUX Lung-3, LUX Lung-6, and ENSURE), 83.7% were Asians, and 30.0% were ever-smokers. An equal percentage of ever-smokers received doublet chemotherapy (30.2%) or EGFR TKI (30.0%). The pooled HR for PFS was 0.29 (95% confidence interval [CI]: 0.21-0.39) for never-smokers and 0.54 (95% CI: 0.38-0.76) for ever-smokers (p < .007 by metaregression). The pooled PFS HR for exon 19 deletion was 0.25 (95% CI: 0.19-0.31) and 0.44 for exon 21 substitution (95% CI: 0.34-0.57) (p < .001 by metaregression analysis). The pooled PFS HR was 0.33 (95% CI: 0.24-0.46) for Asians and 0.48 for non-Asians (95% CI: 0.28-0.84) (p = .261 by metaregression analysis). Conclusion. EGFRm NSCLC patients derived significant PFS benefit from TKI over platinum-doublet chemotherapy as first-line treatment regardless of smoking status; however, PFS benefit is significantly better in never-smokers by metaregression analysis.	[Hasegawa, Yoshikazu] Izumi Municipal Hosp, Osaka, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Nagoya, Aichi, Japan; [Maemondo, Makoto] Miyagi Canc Ctr, Natori, Miyagi, Japan; [Yamamoto, Satomi] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Isa, Shun-ichi] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka, Japan; [Saka, Hideo] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Kubo, Akihito] Aichi Med Univ, Sch Med, Nagoya, Aichi, Japan; [Kawaguchi, Tomoya] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Takada, Minoru] Koyo Hosp, Wakayama, Japan; [Rosell, Rafael] Catalan Inst Oncol, Barcelona, Spain; [Kurata, Takayasu] Kansai Med Univ, Hirakata Hosp, Osaka, Japan; [Ou, Sai-Hong Ignatius] Univ Calif Irvine, Sch Med, Chao Family Comprehens Canc Ctr, Orange, CA 92868 USA	Ou, SHI (reprint author), Univ Calif Irvine, Sch Med, Div Hematol Oncol, Dept Med,Chao Family Comprehens Canc Ctr, Orange, CA 92868 USA.	mando@med.nagoya-u.ac.jp; Ignatius.ou@uci.edu					Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Filosto S, 2013, MOL CANCER THER, V12, P1579, DOI 10.1158/1535-7163.MCT-12-1029; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Kim MH, 2014, LUNG CANCER, V84, P196, DOI 10.1016/j.lungcan.2014.01.022; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Oizumi S, 2012, ONCOLOGIST, V17, P863, DOI 10.1634/theoncologist.2011-0426; Wang S, 2013, J THORAC ONCOL, V8, P719, DOI 10.1097/JTO.0b013e31828b51d4; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Hughes AN, 2009, J CLIN ONCOL, V27, P1220, DOI 10.1200/JCO.2008.19.3995; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Ou SHI, 2013, J CLIN PATHOL, V66, P839, DOI 10.1136/jclinpath-2012-201296; Wu YL, 2013, J THORAC ONCOL, V8, pS603; Liam CK, 2013, J THORAC ONCOL, V8, P766, DOI 10.1097/JTO.0b013e31828b5228; Liang W, 2014, J CLIN ONCOL S, V32, p8107a; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang JC, 2015, LANCET ONCOL	27	4	4	ALPHAMED PRESS	DURHAM	318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA	1083-7159	1549-490X		ONCOLOGIST	Oncologist	MAR	2015	20	3					307	315		10.1634/theoncologist.2014-0285		9	Oncology	Oncology	CE6BB	WOS:000351919500014		
J	Alexandrova, AS; Tzoganis, V; Welsch, CP				Alexandrova, Alexandra S.; Tzoganis, Vasilis; Welsch, Carsten P.			Laser diode self-mixing interferometry for velocity measurements	OPTICAL ENGINEERING			English	Article						self-mixing; velocity measurement; velocimetry; semiconductor laser; optical feedback; laser sensors; laser interferometry; gas-jet profile measurement	OPTICAL FEEDBACK INTERFEROMETRY; DOPPLER-VELOCIMETER; SENSING APPLICATIONS; FLOW; TRACKING; SPECKLE; INTERFERENCE; DISPLACEMENT; SCATTERING; SYSTEM	A diode laser velocimeter based on laser self-mixing has been developed and characterized as a reliable, precise, comparably cheap, and compact monitor. The resolution of this sensor at different incident angles and for a variety of solid and liquid targets moving at velocities between 0.1 and 50 m/s is presented. This includes a theoretical analysis of the underlying measurement principle, highlighting possibilities to extend the measurement capabilities to even higher velocities by altering the sensor design. Finally, an outlook on future applications of the sensor for detailed studies of supersonic gas jets used in beam diagnostics and atomic physics applications is given. (C) The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI.	[Alexandrova, Alexandra S.; Tzoganis, Vasilis; Welsch, Carsten P.] Sci Tech Daresbury, Daresbury Lab, Cockcroft Inst, Warrington WA4 4AD, Cheshire, England; [Alexandrova, Alexandra S.; Tzoganis, Vasilis; Welsch, Carsten P.] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England; [Tzoganis, Vasilis] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan	Alexandrova, AS (reprint author), Sci Tech Daresbury, Daresbury Lab, Cockcroft Inst, Warrington WA4 4AD, Cheshire, England.	A.Alexandrova@liverpool.ac.uk		Tzoganis, Vasilis/0000-0003-0756-7600	European Union [289191]; HGF; GSI [VH-NG-328]; STFC under the Cockcroft Institute [ST/G008248/1]	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under Grant Agreement No. 289191. Work supported by HGF and GSI under contract VH-NG-328 and STFC under the Cockcroft Institute Core Grant No. ST/G008248/1. The authors would like to thank Dr. Massimiliano Putignano for his help with the initial setup, as well as Professor Gaetano Scamarcio and his group from the University of Bari for their introduction to the self-mixing technique.	Adrian R. J., 2011, PARTICLE IMAGE VELOC, P165; Kliese R, 2012, OPT EXPRESS, V20, P18757, DOI 10.1364/OE.20.018757; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Norgia M, 2001, IEEE J QUANTUM ELECT, V37, P800, DOI 10.1109/3.922778; Scalise L, 2004, IEEE T INSTRUM MEAS, V53, P223, DOI 10.1109/TIM.2003.822194; Zakian C, 2005, J OPT A-PURE APPL OP, V7, pS445, DOI 10.1088/1464-4258/7/6/029; Plantier G, 2004, IEEE T INSTRUM MEAS, V53, P109, DOI 10.1109/TIM.2003.821488; Campagnolo L, 2013, MICROFLUID NANOFLUID, V14, P113, DOI 10.1007/s10404-012-1029-0; Michalski MC, 2001, LAIT, V81, P787, DOI 10.1051/lait:2001105; Norgia M, 2012, IEEE SENS J, V12, P552, DOI 10.1109/JSEN.2011.2131646; Miles RB, 2001, MEAS SCI TECHNOL, V12, pR33, DOI 10.1088/0957-0233/12/5/201; Bosch T, 2001, OPT ENG, V40, P20, DOI 10.1117/1.1330701; Ozdemir SK, 2001, OPT ENG, V40, P38, DOI 10.1117/1.1331268; Fan YL, 2011, APPL OPTICS, V50, P5064, DOI 10.1364/AO.50.005064; Giuliani G, 2002, J OPT A-PURE APPL OP, V4, pS283, DOI 10.1088/1464-4258/4/6/371; RUDD MJ, 1968, J PHYS E SCI INSTRUM, V1, P723, DOI 10.1088/0022-3735/1/7/305; Otsuka K, 2011, SENSORS-BASEL, V11, P2195, DOI 10.3390/s110202195; LANG R, 1980, IEEE J QUANTUM ELECT, V16, P347, DOI 10.1109/JQE.1980.1070479; Nikolic M, 2013, APPL OPTICS, V52, P8128, DOI 10.1364/AO.52.008128; ACKET GA, 1984, IEEE J QUANTUM ELECT, V20, P1163, DOI 10.1109/JQE.1984.1072281; Buchmann NA, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1842-1; CHURNSIDE JH, 1984, APPL OPTICS, V23, P61; Fomin N. A., 1998, SPECKLE PHOTOGRAPHY, P129; Goodman J. W., 2007, SPECKLE PHENOMENA OP; Huang W, 2008, OPT COMMUN, V281, P1662, DOI 10.1016/j.optcom.2007.11.029; Kerker M, 1969, SCATTERING LIGHT OTH, P27; Magnani A, 2013, IEEE J QUANTUM ELECT, V49, P765, DOI 10.1109/JQE.2013.2273562; Morris SC, 2003, MEAS SCI TECHNOL, V14, P251, DOI 10.1088/0957-0233/14/3/302; NISHIDA M, 1985, EXP FLUIDS, V3, P181, DOI 10.1007/BF00280458; Ottonelli S, 2009, SENSORS-BASEL, V9, P3527, DOI 10.3390/s90503527; Ozdemir SK, 2000, OPT REV, V7, P550; Ozdemir SK, 1999, APPL OPTICS, V38, P1968, DOI 10.1364/AO.38.001968; Putignano M, 2012, NUCL INSTRUM METH A, V667, P44, DOI 10.1016/j.nima.2011.11.054; Raffel M, 2007, EXP FLUID MECH, P259, DOI 10.1007/978-3-540-72308-0_9; Raoul X, 2004, IEEE T INSTRUM MEAS, V53, P95, DOI 10.1109/TIM.2003.821483; RASIAH IJ, 1994, REV SCI INSTRUM, V65, P1603, DOI 10.1063/1.1144899; SHIMIZU ET, 1987, APPL OPTICS, V26, P4541, DOI 10.1364/AO.26.004541; Kane DM, 2005, UNLOCKING DYNAMICAL DIVERSITY: OPTICAL FEEDBACK EFFECTS ON SEMICONDUCTOR LASERS, P1, DOI 10.1002/0470856211.ch1; Silfvast W. T., 2004, LASER FUNDAMENTALS, P402; Tzoganis V, 2014, VACUUM, V109, P417, DOI 10.1016/j.vacuum.2014.07.009; Tzoganis V, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4879285; WANG WM, 1994, J LIGHTWAVE TECHNOL, V12, P1577, DOI 10.1109/50.320940	42	0	0	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	0091-3286	1560-2303		OPT ENG	Opt. Eng.	MAR	2015	54	3							034104	10.1117/1.OE.54.3.034104		9	Optics	Optics	CE1QR	WOS:000351587500020		
J	Uchida, T; Inuzuka, Y; Hasegawa, M; Hirobayashi, S; Misawa, T				Uchida, Tetsuya; Inuzuka, Yuya; Hasegawa, Masaya; Hirobayashi, Shigeki; Misawa, Tadanobu			Numerical simulation validation of nonuniform, nonharmonic analysis of spectral-domain optical coherence tomography	OPTICAL ENGINEERING			English	Article						image reconstruction techniques; optical coherence tomography	DISCRETE FOURIER-TRANSFORM; WAVE-NUMBER SPECTROMETER; SWEPT-SOURCE; HIGH-SPEED; OCT	In spectral-domain optical coherence tomography (SD-OCT), the limited resolution of the spectrometer causes nonuniformity of the interference signal. The latter, in turn, causes the sensitivity of SD-OCT to decrease, thereby limiting the imaging range and decreasing the axial resolution. We addressed this problem by applying nonuniform, nonharmonic analysis (NUNHA) with software that features high-frequency resolution without interpolation. We demonstrate the application of NUNHA in SD-OCT and compare it with conventional frequency analysis methods by simulating nonuniform interference signals. The results suggest that application of NUNHA in SD-OCT can provide acquisition of a clearer tomographic image, accurate analysis of fine and complex structures, and preservation of resolution and sensitivity at regions deep within a sample. This is because it reduces the influence of nonuniformity caused by the spectrometer and is unaffected by distortion due to interpolation. (C) 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Uchida, Tetsuya; Inuzuka, Yuya; Hasegawa, Masaya] Toyama Univ, Grad Sch Sci & Engn Educ, Toyama 9308555, Japan; [Hirobayashi, Shigeki; Misawa, Tadanobu] Toyama Univ, Dept Intellectual Informat Syst Engn, Fac Technol, Toyama 9308555, Japan	Hirobayashi, S (reprint author), Toyama Univ, Dept Intellectual Informat Syst Engn, Fac Technol, 3190 Gofuku, Toyama 9308555, Japan.	hirobays@eng.u-toyama.ac.jp					Ahsen OO, 2013, OPT EXPRESS, V21, P18021, DOI 10.1364/OE.21.018021; Cao X, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.022503; de Boer JF, 2003, OPT LETT, V28, P2067, DOI 10.1364/OL.28.002067; Adhi M, 2013, CURR OPIN OPHTHALMOL, V24, P213, DOI 10.1097/ICU.0b013e32835f8bf8; Bajraszewski T, 2008, OPT EXPRESS, V16, P4163, DOI 10.1364/OE.16.004163; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Wang K, 2009, OPT EXPRESS, V17, P12121, DOI 10.1364/OE.17.012121; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; Wojtkowski M, 2002, J BIOMED OPT, V7, P457, DOI 10.1117/1.1482379; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Liu XA, 2010, OPT EXPRESS, V18, P24331, DOI 10.1364/OE.18.024331; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Hu Z, 2007, OPT LETT, V32, P3525, DOI 10.1364/OL.32.003525; Wieser W, 2010, OPT EXPRESS, V18, P14685, DOI 10.1364/OE.18.014685; Chi TT, 2012, OPT EXPRESS, V20, P28418, DOI 10.1364/OE.20.028418; Fercher F., 1995, OPT COMMUN, V117, P43; Gelikonov VM, 2009, OPT SPECTROSC+, V106, P459, DOI 10.1134/S0030400X09030242; Huang SW, 2007, OPT EXPRESS, V15, P6210, DOI 10.1364/OE.15.006210; Jeong HW, 2012, OPT EXPRESS, V20, P19148, DOI 10.1364/OE.20.019148; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Rao KD, 2003, OPT LETT, V28, P340, DOI 10.1364/OL.28.000340; Uchida T., 2013, NONLINEAR THEORY ITS, V4, P172; Wu T, 2009, CHIN OPT LETT, V7, P941, DOI 10.3788/COL20090710.0941; Yaqoob Zahid, 2005, Biotechniques, V39, pS6, DOI 10.2144/000112090; Yoshizawa T., 2011, EURASIP J AUDIO SPEE, V5; Zhang K, 2010, OPT EXPRESS, V18, P23472, DOI 10.1364/OE.18.023472; Zhang YD, 2009, OPT LETT, V34, P1849; Zurauskas M, 2013, BIOMED OPT EXPRESS, V4, P778, DOI 10.1364/BOE.4.000778	28	0	0	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	0091-3286	1560-2303		OPT ENG	Opt. Eng.	MAR	2015	54	3							033108	10.1117/1.OE.54.3.033108		12	Optics	Optics	CE1QR	WOS:000351587500016		
J	Nilsson, N; Sjolander, S; Baar, A; Berthold, M; Pahr, S; Vrtala, S; Valenta, R; Morita, E; Hedlin, G; Borres, MP; Nilsson, C				Nilsson, Nora; Sjolander, Sigrid; Baar, Alexandra; Berthold, Malin; Pahr, Sandra; Vrtala, Susanne; Valenta, Rudolf; Morita, Eishin; Hedlin, Gunilla; Borres, Magnus P.; Nilsson, Caroline			Wheat allergy in children evaluated with challenge and IgE antibodies to wheat components	PEDIATRIC ALLERGY AND IMMUNOLOGY			English	Article						allergy; children; food challenge; gliadin; glutenin; IgE; wheat; omega-5 gliadin	EXERCISE-INDUCED ANAPHYLAXIS; MOLECULAR-WEIGHT-GLUTENIN; OMEGA-5 GLIADIN; FOOD ALLERGY; HYPERSENSITIVITY; REACTIVITY; DIAGNOSIS; SYMPTOMS; TRI	IntroductionWheat sensitization is common but IgE antibodies (IgE-abs) to wheat are not predictive of clinical symptoms in children with suspected wheat allergy. Wheat allergen components other than -5gliadin have not been well studied. Our aim was to characterize the clinical profile and investigate the value of adding measurements of IgE-abs to wheat components in a group of children with a doctor's diagnosed wheat allergy. MethodSixty-three children with a doctor's diagnosis of wheat allergy confirmed sensitization to wheat and, on a wheat elimination diet, went through oral wheat challenges or had a convincing recent history of wheat allergy. IgE-ab to -5 gliadin, low molecular weight glutenin (LMW-glutenin), high molecular weight glutenin (HMW-glutenin) and a native gliadin preparation containing -, -, -, and -gliadin (gliadin) were analyzed. ResultsTwenty-six children were positive in challenge, while six children were regarded as wheat allergic due to recent anaphylactic reactions. The IgE-ab levels to all four wheat components were significantly higher in the group with wheat allergy compared to the group with no wheat allergy (p<0.0001). Also, the severity of symptoms at challenge correlated with the IgE-ab levels to all four components (p<0.05). IgE-ab levels to -5 gliadin correlated best with challenge outcome, and by additional analysis of gliadin, HMW- and LMW-glutenin IgE-abs all challenge positive children could be identified. ConclusionMany children diagnosed as wheat allergic have outgrown their allergy and are unnecessarily on a wheat-free diet. The levels of IgE-ab to wheat gluten-derived components correlated well with wheat challenge outcome and severity.	[Nilsson, Nora; Hedlin, Gunilla] Astrid Lindgren Childrens Hosp, Karolinska Inst, Lung Allergy Dept Q204, S-17176 Stockholm, Sweden; [Nilsson, Nora; Hedlin, Gunilla] Astrid Lindgren Childrens Hosp, Karolinska Univ Hosp, S-17176 Stockholm, Sweden; [Nilsson, Nora; Hedlin, Gunilla; Nilsson, Caroline] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Sjolander, Sigrid; Berthold, Malin; Borres, Magnus P.] ImmunoDiagnostics, Thermo Fisher Sci, Uppsala, Sweden; [Baar, Alexandra; Pahr, Sandra; Vrtala, Susanne; Valenta, Rudolf] Med Univ Vienna, Christian Doppler Lab Dev Allergen Chips, Vienna, Austria; [Baar, Alexandra; Pahr, Sandra; Vrtala, Susanne; Valenta, Rudolf] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Morita, Eishin] Shimane Univ, Fac Med, Dept Dermatol, Matsue, Shimane, Japan; [Borres, Magnus P.] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Nilsson, Caroline] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Nilsson, Caroline] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden	Nilsson, N (reprint author), Astrid Lindgren Childrens Hosp, Karolinska Univ Hosp, Lung Allergy Dept Q204, S-17176 Stockholm, Sweden.	nora.nilsson@ki.se			Swedish Asthma and Allergy Association; Centre for Allergy Research at Karolinska Institute; Hesselman Foundation	This study was supported by the Swedish Asthma and Allergy Association, Centre for Allergy Research at Karolinska Institute and Hesselman Foundation. ImmunoCAP assays were performed by Thermo Fisher Scientific, Uppsala, Sweden.	Hofmann SC, 2012, ALLERGY, V67, P1457, DOI 10.1111/all.12020; Matricardi PM, 2008, CLIN EXP ALLERGY, V38, P493, DOI 10.1111/j.1365-2222.2007.02912.x; Constantin C, 2009, ALLERGY, V64, P1030, DOI 10.1111/j.1398-9995.2009.01955.x; Takahashi H, 2012, CLIN EXP ALLERGY, V42, P1293, DOI 10.1111/j.1365-2222.2012.04039.x; Ito K, 2008, ALLERGY, V63, P1536, DOI 10.1111/j.1398-9995.2008.01753.x; Simonato B, 2001, CLIN EXP ALLERGY, V31, P1771, DOI 10.1046/j.1365-2222.2001.01200.x; JONES SM, 1995, J ALLERGY CLIN IMMUN, V96, P341, DOI 10.1016/S0091-6749(95)70053-6; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Beyer K, 2008, J ALLERGY CLIN IMMUN, V122, P419, DOI 10.1016/j.jaci.2008.06.006; Zuidmeer L, 2008, J ALLERGY CLIN IMMUN, V121, P1210, DOI 10.1016/j.jaci.2008.02.019; Baar A, 2012, J IMMUNOL, V189, P3018, DOI 10.4049/jimmunol.1200438; Inomata N, 2009, CURR OPIN ALLERGY CL, V9, P238, DOI 10.1097/ACI.0b013e32832aa5bc; Morita Eishin, 2009, Allergology International, V58, P493, DOI 10.2332/allergolint.09-RAI-0125; Palosuo K, 1999, J ALLERGY CLIN IMMUN, V103, P912, DOI 10.1016/S0091-6749(99)70438-0; Keet CA, 2009, ANN ALLERG ASTHMA IM, V102, P410, DOI 10.1016/S1081-1206(10)60513-3; Astier C, 2006, J ALLERGY CLIN IMMUN, V118, P250, DOI 10.1016/j.jaci.2006.04.053; Baar A, 2014, J ALLERGY CLIN IMMUN, V133, P585, DOI 10.1016/j.jaci.2013.10.044; Palosuo K, 2001, J ALLERGY CLIN IMMUN, V108, P634, DOI 10.1067/mai.2001.118602; Daengsuwan T, 2005, ALLERGY, V60, P506, DOI 10.1111/j.1398-9995.2004.00656.x; Ebisawa M, 2011, INT ARCH ALLERGY IMM, V158, P71; Kotaniemi-Syrjanen A, 2010, PEDIAT ALLERG IMM-UK, V21, pE421, DOI 10.1111/j.1399-3038.2009.00946.x; Marknell D. A., 2002, CLIN EXP ALLERGY, V32, P1329, DOI 10.1046/j.1365-2222.2002.01467.x; Nilsson N, 2013, INT ARCH ALLERGY IMM, V162, P50, DOI 10.1159/000350923; Park HJ, 2012, INT ARCH ALLERGY IMM, V157, P147, DOI 10.1159/000327549; Tatham AS, 2008, CLIN EXP ALLERGY, V38, P1712, DOI 10.1111/j.1365-2222.2008.03101.x	25	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-6157	1399-3038		PEDIAT ALLERG IMM-UK	Pediatr. Allergy Immunol.	MAR	2015	26	2					119	125		10.1111/pai.12334		7	Allergy; Immunology; Pediatrics	Allergy; Immunology; Pediatrics	CE2EM	WOS:000351626800006		
J	Shido, H; Tamada, I				Shido, Hirokazu; Tamada, Ikkei			Colored Pencil-Core Granuloma on the Forehead	PEDIATRIC DERMATOLOGY			English	Article								We often encounter injuries caused by pencils or colored pencils in toddlers and young children, but subsequent segmental tumor formation is rare. Here we report the case of a 4-year-old boy who had been stabbed under his left eyebrow with a red pencil. Colored pencil-core granuloma, a foreign body granuloma arising from an injury with a colored pencil, was diagnosed on the basis of intraoperative and histopathologic findings. Because of the severe tissue damage that the colorant causes, this type of tumor grows rapidly within a few days and may be accompanied by resorption of the skull if it occurs on the head or face.	[Shido, Hirokazu; Tamada, Ikkei] Tokyo Metropolitan Childrens Med Ctr, Fuchu, Tokyo 1838561, Japan	Shido, H (reprint author), Tokyo Metropolitan Childrens Med Ctr, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	hikkydream1_1_3@yahoo.co.jp					GRANICK MS, 1992, PLAST RECONSTR SURG, V89, P136, DOI 10.1097/00006534-199289010-00030; Hayashi J, 1995, J JPN ORTHOP ASSOC, V69, pS1656; MORIYAMA H, 1985, ANN OTO RHINOL LARYN, V94, P60; Watanabe S, 2012, J PEDIAT DERMATOL, V31, P185	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-8046	1525-1470		PEDIATR DERMATOL	Pediatr. Dermatol.	MAR-APR	2015	32	2					e58	e59		10.1111/pde.12524		2	Dermatology; Pediatrics	Dermatology; Pediatrics	CE3RZ	WOS:000351747500005		
J	Wang, Q; Itoh, Y; Tsuruoka, T; Ohtsuka, S; Shimizu, T; Shingubara, S; Hasegawa, T; Aono, M				Wang, Qi; Itoh, Yaomi; Tsuruoka, Tohru; Ohtsuka, Shintaro; Shimizu, Tomohiro; Shingubara, Shoso; Hasegawa, Tsuyoshi; Aono, Masakazu			Dynamic moderation of an electric field using a SiO2 switching layer in TaOx-based ReRAM	PHYSICA STATUS SOLIDI-RAPID RESEARCH LETTERS			English	Article						atomic switches; Ta2O5; SiO2; resistive random-access memories; oxygen vacancies; tunneling; on/off ratio	ATOMIC SWITCH; NANOIONICS; MEMORIES; DEVICES	ReRAMs using oxygen vacancy drift in their resistive switching are promising candidates as next generation memory devices. One remaining issue is degradation of the on/off ratio down to 102 or less with an increased number of switching cycles. Such degradation is caused by a local hard breakdown in a set process due to a very high electric field formed just before the completion of a conductive filament formation. We found that introducing an ultra-thin SiO2 layer prevents the hard breakdown by dynamical moderation of the electric field formed in the TaOx matrix, resulting in repeated switching while retaining a higher on/off ratio of about 105. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Wang, Qi; Itoh, Yaomi; Tsuruoka, Tohru; Hasegawa, Tsuyoshi; Aono, Masakazu] Natl Inst Mat Sci, World Premier Int WPI Ctr Mat Nanoarchitecton MAN, Tsukuba, Ibaraki 3050044, Japan; [Wang, Qi; Itoh, Yaomi; Tsuruoka, Tohru; Hasegawa, Tsuyoshi] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ohtsuka, Shintaro; Shimizu, Tomohiro; Shingubara, Shoso] Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan	Wang, Q (reprint author), Natl Inst Mat Sci, World Premier Int WPI Ctr Mat Nanoarchitecton MAN, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan.	wangqi77@lzu.edu.cn; HASEGAWA.Tsuyoshi@nims.go.jp			JST/CREST	A part of this study was supported by the JST/CREST. Device fabrication was supported by MANA.	Hasegawa T, 2009, MRS BULL, V34, P929, DOI 10.1557/mrs2009.215; Lu W, 2012, MRS BULL, V37, P124, DOI 10.1557/mrs.2012.5; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]; Linn E, 2010, NAT MATER, V9, P403, DOI [10.1038/nmat2748, 10.1038/NMAT2748]; Tsuruoka T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/42/425205; Kim DC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2204649; Akinaga H, 2010, P IEEE, V98, P2237, DOI 10.1109/JPROC.2010.2070830; Sakamoto T, 2003, APPL PHYS LETT, V82, P3032, DOI 10.1063/1.1572964; Xiao B, 2014, NANOSCALE, V6, P10169, DOI 10.1039/c4nr02173h; Yang JJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524521; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Torrezan AC, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/48/485203; Sakamoto T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2777170; Hasegawa T, 2012, ADV MATER, V24, P252, DOI 10.1002/adma.201102597; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Chen B., 2011, IEDM, P283; Hsu C. W., 2013, VLSI S, P166; Hutchby J., 2010, ITRS ASS POT MAT SEL; International Technology Roadmap for Semiconductors (ITRS), 2013, TABL 2013; Lee F. M., 2013, VLSI S, P104; Lee M., 2010, NAT MATER, V10, P625; Maikap S, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-292; Park GS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3382; Prakash A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-527; Wang Q, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811122	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6254	1862-6270		PHYS STATUS SOLIDI-R	Phys. Status Solidi-Rapid Res. Lett.	MAR	2015	9	3					166	170		10.1002/pssr.201409531		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CE2UK	WOS:000351674600003		
J	Hayashi, H; Katayama, S; Huang, R; Kurushima, K; Tanaka, I				Hayashi, Hiroyuki; Katayama, Shota; Huang, Rong; Kurushima, Kosuke; Tanaka, Isao			Selective fabrication of n- and p-type SnO films without doping	PHYSICA STATUS SOLIDI-RAPID RESEARCH LETTERS			English	Article						SnO; thin films; pulsed laser deposition; oxide semiconductors; epitaxial growth; optical transmission; oxygen partial pressure	TIN MONOXIDE; OXIDE SEMICONDUCTORS; ROOM-TEMPERATURE; SOLAR-CELLS; ZNO; TRANSISTORS; CONDUCTION; EPITAXY	Undoped n- and p-type tin monoxide (SnO) films have been selectively fabricated by pulsed laser deposition with a Sn target and careful control of oxygen partial pressure. The films are epitaxially grown in optimal growth conditions on yttria-stabilized zirconia (YSZ) substrates with out-of-plane and in-plane orientation relationships of (001)SnO//(001)YSZ and [110]SnO//[100]YSZ, respectively. Both Seebeck and Hall measurements show consistent results on the carrier types of the films. The electron Hall mobility is approximately 11 cm2/Vs at room temperature and the carrier activation energy is 0.14 eV for the n-type film. The growth at increased oxygen partial pressure yields p-type films, demonstrating the selective fabrication of both n- and p-type SnO films without doping. (C) 2015 WILEY-VCH Verlag GmbH &Co. KGaA, Weinheim)	[Hayashi, Hiroyuki] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Katayama, Shota; Tanaka, Isao] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Huang, Rong] E China Normal Univ, Key Lab Polar Mat & Devices, Minist Educ, Shanghai 200062, Peoples R China; [Kurushima, Kosuke] Toray Res Ctr Ltd, Otsu, Shiga 5208567, Japan	Hayashi, H (reprint author), Kyoto Univ, Res Ctr Low Temp & Mat Sci, Sakyo Ku, Kyoto 6068501, Japan.	hayashi.hiroyuki.5w@gmail.com	Tanaka, Isao/B-5941-2009; Huang, Rong/A-9684-2008		JSPS [242558, 25106005]	This work was supported by Grants-in-Aid for JSPS fellows (Grant No. 242558) and Scientific Research on Innovative Areas "Nano Informatics" (Grant No. 25106005) from JSPS.	PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; Liang LY, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/8/085101; Duan ZQ, 2012, SOL ENERG MAT SOL C, V96, P292, DOI 10.1016/j.solmat.2011.09.047; Liang LY, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4731271; Ogo Y, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2964197; Quackenbush NF, 2013, CHEM MATER, V25, P3114, DOI 10.1021/cm401343a; Allen JP, 2011, J PHYS CHEM C, V115, P19916, DOI 10.1021/jp205148y; Look DC, 2002, APPL PHYS LETT, V81, P1830, DOI 10.1063/1.1504875; Varley JB, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819068; Nomura K, 2011, ADV MATER, V23, P3431, DOI 10.1002/adma.201101410; Allen JP, 2013, J MATER CHEM C, V1, P8194, DOI 10.1039/c3tc31863j; Yabuta H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3478213; Yang MJ, 2013, J ALLOY COMPD, V578, P143, DOI 10.1016/j.jallcom.2013.05.033; Hoffman RL, 2003, APPL PHYS LETT, V82, P733, DOI 10.1063/1.1542677; Guo W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3277153; Ohta H, 2003, APPL PHYS LETT, V83, P1029, DOI 10.1063/1.1598624; Togo A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195128; OLSEN LC, 1979, APPL PHYS LETT, V34, P47, DOI 10.1063/1.90593; Okamura K, 2012, J MATER CHEM, V22, P4607, DOI 10.1039/c2jm16426d; Ogo Y, 2009, PHYS STATUS SOLIDI A, V206, P2187, DOI 10.1002/pssa.200881792; Caraveo-Frescas JA, 2013, ACS NANO, V7, P5160, DOI 10.1021/nn400852r; Minami T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.044101; Fortunato EMC, 2005, ADV MATER, V17, P590, DOI 10.1002/adma.200400368; Tsukazaki A, 2005, NAT MATER, V4, P42, DOI 10.1038/nmat1284; Hosono H, 2011, ELECTROCHEM SOLID ST, V14, pII13, DOI 10.1149/1.3505288; IZUMI F, 1981, J SOLID STATE CHEM, V38, P381, DOI 10.1016/0022-4596(81)90068-2; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Ohta H., 2000, APPL PHYS LETT, V77; Yanagi H, 2001, APPL PHYS LETT, V78, P1583, DOI 10.1063/1.1355673	29	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6254	1862-6270		PHYS STATUS SOLIDI-R	Phys. Status Solidi-Rapid Res. Lett.	MAR	2015	9	3					192	196		10.1002/pssr.201510016		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CE2UK	WOS:000351674600008		
J	Imamura, M				Imamura, Masao			Rethinking frontier and frontier studies	POLITICAL GEOGRAPHY			English	Editorial Material						Frontier; Imaginary; Metaphor; Narrative			[Imamura, Masao] Kyoto Univ, Kyoto, Japan; [Imamura, Masao] Natl Univ Singapore, Singapore 117548, Singapore; [Imamura, Masao] Kyoto Univ, Ctr Southeast Asian Studies, Kyoto, Japan	Imamura, M (reprint author), Kyoto Univ, Kyoto, Japan.	imamuramasao@gmail.com					Johnson C, 2011, POLIT GEOGR, V30, P61, DOI 10.1016/j.polgeo.2011.01.002; Blacksell M., 2000, THE DICTIONARY OF HU, P282; Fawcett C. B., 1918, FRONTIERS A STUDY IN; Lamar H. R., 1981, THE FRONTIER IN HIST; LIVINGSTONE DN, 1981, ANN ASSOC AM GEOGR, V71, P95, DOI 10.1111/j.1467-8306.1981.tb01343.x; Parker B. J., 2005, UNTAMING THE FRONTIE; Prescott J. R. V., 2008, INTERNATIONAL FRONTI; RICOEUR P, 1978, CRIT INQUIRY, V5, P143, DOI 10.1086/447977; Rodseth L., 2005, UNTAMING FRONTIER AN, P3; Wittgenstein L, 2001, PHILOSOPHICAL INVEST	10	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0962-6298	1873-5096		POLIT GEOGR	Polit. Geogr.	MAR	2015	45						96	97		10.1016/j.polgeo.2014.09.014		2	Geography; Political Science	Geography; Government & Law	CE2KU	WOS:000351645300011		
J	Hu, AX; Meehl, GA; Han, WQ; Otto-Bliestner, B; Abe-Ouchi, A; Rosenbloom, N				Hu, Aixue; Meehl, Gerald A.; Han, Weiqing; Otto-Bliestner, Bette; Abe-Ouchi, Ayako; Rosenbloom, Nan			Effects of the Bering Strait closure on AMOC and global climate under different background climates	PROGRESS IN OCEANOGRAPHY			English	Review							LAST GLACIAL MAXIMUM; ATLANTIC THERMOHALINE CIRCULATION; OCEAN-ATMOSPHERE MODEL; DEEP-WATER FORMATION; SEA-LEVEL CHANGES; NORTH-ATLANTIC; FRESH-WATER; OVERTURNING CIRCULATION; COUPLED MODEL; SYSTEM MODEL	Previous studies have suggested that the status of the Bering Strait may have a significant influence on global climate variability on centennial, millennial, and even longer time scales. Here we use multiple versions of the National Center for Atmospheric Research (NCAR) Community Climate System Model (CCSM, versions 2 and 3) to investigate the influence of the Bering Strait closure/opening on the Atlantic Meridional Overturning Circulation (AMOC) and global mean climate under present-day, 15 thousand-year before present (kyr BP), and 112 kyr BP climate boundary conditions. Our results show that regardless of the version of the model used or the widely different background climates, the Bering Strait's closure produces a robust result of a strengthening of the AMOC, and an increase in the northward meridional heat transport in the Atlantic. As a consequence, the climate becomes warmer in the North Atlantic and the surrounding regions, but cooler in the North Pacific, leading to a seesaw-like climate change between these two basins. For the first time it is noted that the absence of the Bering Strait throughflow causes a slower motion of Arctic sea ice, a reduced upper ocean water exchange between the Arctic and North Atlantic, reduced sea ice export and less fresh water in the North Atlantic. These changes contribute positively to the increased upper ocean density there, thus strengthening the AMOC. Potentially these changes in the North Atlantic could have a significant effect on the ice sheets both upstream and downstream in ice age climate, and further influence global sea level changes. (C) 2014 Elsevier Ltd. All rights reserved.	[Hu, Aixue; Meehl, Gerald A.; Otto-Bliestner, Bette; Rosenbloom, Nan] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA; [Han, Weiqing] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80301 USA; [Abe-Ouchi, Ayako] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778568, Japan	Hu, AX (reprint author), Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA.	ahu@ucar.edu			Regional Climate Modeling Program (RGCM) of the U.S. Department of Energy's, Office of Science (BER) [DE-FC02-97ER62402]; National Science Foundation	This research was supported by the Regional Climate Modeling Program (RGCM) of the U.S. Department of Energy's, Office of Science (BER), Cooperative Agreement DE-FC02-97ER62402. The National Center for Atmospheric Research is sponsored by the National Science Foundation.	Aagaard K., 1989, J GEOPHYS RES, V94, P485, DOI DOI 10.1029/JC094IC10P14485; ALLEY RB, 1994, PALEOCEANOGRAPHY, V9, P503, DOI 10.1029/94PA01008; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Hu AX, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050567; Stocker TF, 2000, P NATL ACAD SCI USA, V97, P1362, DOI 10.1073/pnas.97.4.1362; Kiehl JT, 2004, J CLIMATE, V17, P3666, DOI 10.1175/1520-0442(2004)017<3666:TCCSMV>2.0.CO;2; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1; Hu AX, 2012, P NATL ACAD SCI USA, V109, P6417, DOI 10.1073/pnas.1116014109; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; Lambeck K, 2010, BOREAS, V39, P410, DOI 10.1111/j.1502-3885.2010.00140.x; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Schmittner A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024368; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Hu AX, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028906; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; KEIGWIN LD, 1994, J GEOPHYS RES-OCEANS, V99, P12397, DOI 10.1029/94JC00525; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Dickson RR, 2000, J CLIMATE, V13, P2671, DOI 10.1175/1520-0442(2000)013<2671:TAORTT>2.0.CO;2; Timmermann A, 1998, J CLIMATE, V11, P1906, DOI 10.1175/1520-0442-11.8.1906; Saenko OA, 2004, J CLIMATE, V17, P2033, DOI 10.1175/1520-0442(2004)017<2033:TAS>2.0.CO;2; Levermann A, 2005, CLIM DYNAM, V24, P347, DOI 10.1007/s00382-004-0505-y; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; Mikolajewicz U, 2007, CLIM DYNAM, V28, P599, DOI 10.1007/s00382-006-0204-v; De Boer AM, 2004, DEEP-SEA RES PT I, V51, P1347, DOI 10.1016/j.dsr.2004.05.003; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; Kwok R, 2009, J CLIMATE, V22, P2438, DOI 10.1175/2008JCLI2819.1; Hu AX, 2008, J CLIMATE, V21, P2239, DOI 10.1175/2007JCLI1985.1; Otto-Bliesner BL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029475; Zahn R, 1997, PALEOCEANOGRAPHY, V12, P696, DOI 10.1029/97PA00581; Fleming K, 2004, QUATERNARY SCI REV, V23, P1053, DOI 10.1016/j.quascirev.2003.11.001; Hu AX, 2013, J CLIMATE, V26, P3087, DOI 10.1175/JCLI-D-12-00102.1; Okazaki Y, 2010, SCIENCE, V329, P200, DOI 10.1126/science.1190612; Dahl K, 2005, CLIM DYNAM, V24, P325, DOI 10.1007/s00382-004-0499-5; Ohlmann JC, 2003, J CLIMATE, V16, P1337, DOI 10.1175/1520-0442-16.9.1337; Weber SL, 2007, CLIM PAST, V3, P51; Marincovich L, 2001, QUATERNARY SCI REV, V20, P329, DOI 10.1016/S0277-3791(00)00113-X; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Meehl GA, 2010, J CLIMATE, V23, P2959, DOI 10.1175/2010JCLI3296.1; MANABE S, 1991, J CLIMATE, V4, P785, DOI 10.1175/1520-0442(1991)004<0785:TROACO>2.0.CO;2; Sarnthein M, 2009, CLIM PAST, V5, P269; Loutre MF, 2004, EARTH PLANET SC LETT, V221, P1, DOI 10.1016/S0012-821X(04)00108-6; Hu AX, 2011, DEEP-SEA RES PT II, V58, P1914, DOI 10.1016/j.dsr2.2010.10.069; Hu AX, 2010, NAT GEOSCI, V3, P118, DOI 10.1038/NGEO729; Cunningham SA, 2010, WIRES CLIM CHANGE, V1, P180, DOI 10.1002/wcc.22; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; SHAFFER G, 1994, NATURE, V367, P354, DOI 10.1038/367354a0; Holland MM, 2006, J CLIMATE, V19, P2398, DOI 10.1175/JCLI3751.1; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Grutzner J, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001873; Timmermann A, 2005, J CLIMATE, V18, P3122, DOI 10.1175/JCLI3495.1; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2; Bonan GB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001360; Brady EC, 2011, CLIM DYNAM, V37, P1517, DOI 10.1007/s00382-010-0925-9; Briegleb B.P, 2004, NCARTN463STR; Carmack E., 2008, ARCTIC SUBARCTIC OCE; Clark P.U., 2007, GEOPHYS MONOGR SER, V173, P209, DOI DOI 10.1029/173GM15; Collins W. D., 2004, NCARTN464 STR; De Boer AM, 2004, J CLIMATE, V17, P417, DOI 10.1175/1520-0442(2004)017<0417:TEVOTN>2.0.CO;2; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; Ditlevsen PD, 2005, J CLIMATE, V18, P2594, DOI 10.1175/JCLI3437.1; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Gent P., 2002, LAUR022484 LOS AL NA; Gutjahr M, 2010, QUATERNARY SCI REV, V29, P2451, DOI 10.1016/j.quascirev.2010.02.024; Heinrich H., 1988, QUATERNARY RES, V29, P143, DOI DOI 10.1016/0033-5894(88)90057-9); Hu AX, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037998; Hu AX, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020218; Hu AX, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024424; Hu AX, 2004, J CLIMATE, V17, P4267, DOI 10.1175/JCLI3208.1; Jahn A., 2013, GEOPHYS RES LETT, V40; Johns WE, 2011, J CLIMATE, V24, P2429, DOI 10.1175/2010JCLI3997.1; Keigwin LD, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001420; Lambeck K, 1998, GEOPHYS J INT, V134, P102, DOI 10.1046/j.1365-246x.1998.00541.x; Nof D, 2000, J PHYS OCEANOGR, V30, P2650, DOI 10.1175/1520-0485(2000)030<2650:DTWCTI>2.0.CO;2; Nof D, 2003, J PHYS OCEANOGR, V33, P1324, DOI 10.1175/1520-0485(2003)033<1324:DAOPIC>2.0.CO;2; Oleson K. W., 2004, NCARTN461STR; Ortiz JD, 2012, J PHYS OCEANOGR, V42, P2014, DOI 10.1175/JPO-D-11-0167.1; Peltier WR, 2004, QUATERNARY SCI REV, V23, P335, DOI 10.1016/j.quascirev.2003.07.003; Rahmstorf S, 1996, CLIM DYNAM, V12, P799, DOI 10.1007/s003820050144; Rahmstorf S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023655; Sakai K, 1997, J CLIMATE, V10, P949, DOI 10.1175/1520-0442(1997)010<0949:DOOIAC>2.0.CO;2; Sandal C, 2008, DEEP-SEA RES PT I, V55, P1105, DOI 10.1016/j.dsr.2008.04.005; Sandal C, 2008, J PHYS OCEANOGR, V38, P1979, DOI 10.1175/2008JPO3877.1; Sandal C, 2008, J PHYS OCEANOGR, V38, P451, DOI 10.1175/2007JPO3722.1; Schmittner A, 1999, J CLIMATE, V12, P1117, DOI 10.1175/1520-0442(1999)012<1117:TSOTTC>2.0.CO;2; Seidov D, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016564; Seidov D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022559; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; Stocker TF, 2000, QUATERNARY SCI REV, V19, P301, DOI 10.1016/S0277-3791(99)00067-0; Stocker TF, 2002, SCIENCE, V297, P1814, DOI 10.1126/science.1075870; STOCKER TF, 1994, J GEOPHYS RES-OCEANS, V99, P12317, DOI 10.1029/94JC00956; Stouffer RJ, 2007, J CLIMATE, V20, P436, DOI 10.1175/JCLI4015.1; Timmermann A, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001090; Woodgate RA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021880; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	103	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0079-6611			PROG OCEANOGR	Prog. Oceanogr.	MAR	2015	132				SI		174	196		10.1016/j.pocean.2014.02.004		23	Oceanography	Oceanography	CE7RE	WOS:000352038700006		
J	Kano, Y; Kono, T; Matsuda, N; Nonaka, M; Kuwabara, H; Shimada, T; Shishikura, K; Konno, C; Ohta, M				Kano, Yukiko; Kono, Toshiaki; Matsuda, Natsumi; Nonaka, Maiko; Kuwabara, Hitoshi; Shimada, Takafumi; Shishikura, Kurie; Konno, Chizue; Ohta, Masataka			The impact of tics, obsessive-compulsive symptoms, and impulsivity on global functioning in Tourette syndrome	PSYCHIATRY RESEARCH			English	Article						Obsessive-compulsive disorder (OCD); Dimensions; Comorbidities	DEFICIT HYPERACTIVITY DISORDER; QUALITY-OF-LIFE; DIMENSIONS; CHILDREN; ADOLESCENTS; ADHD	This study investigated the relationships between tics, obsessive-compulsive symptoms (OCS), and impulsivity, and their effects on global functioning in Japanese patients with Tourette syndrome (TS), using the dimensional approach for OCS. Fifty-three TS patients were assessed using the Yale Global Tic Severity Scale, the Dimensional Yale-Brown Obsessive-Compulsive Scale, the Impulsivity Rating Scale, and the Global Assessment of Functioning Scale. Although tic severity scores were significantly and positively correlated with OCS severity scores, impulsivity severity scores were not significantly correlated with either. The global functioning score was significantly and negatively correlated with tic and OCS severity scores. Of the 6 dimensional OCS scores, only aggression scores had a significant negative correlation with global functioning scores. A stepwise multiple regression analysis showed that only OCS severity scores were significantly associated with global functioning scores. Despite a moderate correlation between tic severity and OCS severity, the impact of OCS on global functioning was greater than that of tics. Of the OCS dimensions, only aggression had a significant impact on global functioning. Our findings suggest that it is important to examine OCS using a dimensional approach when analyzing global functioning in TS patients. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kano, Yukiko] Univ Tokyo, Grad Sch Med, Dept Child Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan; [Kono, Toshiaki] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Forens Psychiat, Tokyo, Japan; [Matsuda, Natsumi] Tokyo Univ Hosp, Dept Child Psychiat, Tokyo 113, Japan; [Nonaka, Maiko] Univ Tokyo, Course Clin Psychol, Tokyo 1138655, Japan; [Kuwabara, Hitoshi] Univ Tokyo, Disabil Serv Off, Tokyo 1138655, Japan; [Shimada, Takafumi] Univ Tokyo, Div Counseling & Support, Tokyo 1138655, Japan; [Shishikura, Kurie] Komagino Hosp, Tokyo, Japan; [Konno, Chizue] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan; [Ohta, Masataka] Inst Dev Mind & Behav, Tokyo, Japan	Kano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Child Neuropsychiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kano-tity@umin.ac.jp			Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labour and Welfare, Japan [H17-004]; Comprehensive Research on Disability, Health and Welfare from the Ministry of Health, Labour and Welfare, Japan [H20-006, H22-004]; Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare, Japan [17A-2, 20B-6]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP from the Ministry of Health, Labour and Welfare, Japan [23-1]; Kitasato University [26118704]	The present study was partly supported by a Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H17-004), Comprehensive Research on Disability, Health and Welfare (H20-006 and H22-004), Research Grant for Nervous and Mental Disorders (17A-2 and 20B-6), and an Intramural Research Grant (23-1) for Neurological and Psychiatric Disorders of NCNP, all from the Ministry of Health, Labour and Welfare, Japan. Further support was received from a Grant of Project Research from Kitasato University and Grant-in-Aid for Scientific Research on Innovative Areas Grant number 26118704.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Pringsheim T, 2009, DEV MED CHILD NEUROL, V51, P468, DOI 10.1111/j.1469-8749.2008.03168.x; Gorman DA, 2010, BRIT J PSYCHIAT, V197, P36, DOI 10.1192/bjp.bp.109.071050; Eddy CM, 2012, J NEUROPSYCH CLIN N, V24, P458, DOI 10.1176/appi.neuropsych.11080181; Freeman RD, 2007, EUR CHILD ADOLES PSY, V16, P15, DOI 10.1007/s00787-007-1003-7; Leckman JF, 2003, AM J MED GENET B, V116B, P60, DOI 10.1002/ajmg.b.10001; Stewart SE, 2007, BIOL PSYCHIAT, V61, P285, DOI 10.1016/j.biopsych.2006.08.040; Lebowitz ER, 2012, EUR CHILD ADOLES PSY, V21, P451, DOI 10.1007/s00787-012-0278-5; Budman CL, 2000, J AM ACAD CHILD PSY, V39, P1270, DOI 10.1097/00004583-200010000-00014; Kano Y, 2010, BRAIN DEV-JPN, V32, P201, DOI 10.1016/j.braindev.2009.01.005; Kano Y, 2008, CNS SPECTRUMS, V13, P325; Frank MC, 2011, J NEUROL SCI, V310, P276, DOI 10.1016/j.jns.2011.06.032; Bloch MH, 2008, AM J PSYCHIAT, V165, P1532, DOI 10.1176/appi.ajp.2008.08020320; Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798; Bernard BA, 2009, MOVEMENT DISORD, V24, P1070, DOI 10.1002/mds.22487; Labad J, 2008, DEPRESS ANXIETY, V25, P832, DOI 10.1002/da.20332; Berlin GS, 2014, CNS SPECTRUMS, V19, P62, DOI 10.1017/S1092852913000722; Cardona F, 2004, EUR CHILD ADOLES PSY, V13, P166, DOI 10.1007/s00787-004-0392-0; Cavanna AE, 2013, J CHILD NEUROL, V28, P1305, DOI 10.1177/0883073812457462; Debes N, 2010, J CHILD NEUROL, V25, P171, DOI 10.1177/0883073809336215; Hounie Ana Gabriela, 2006, Adv Neurol, V99, P22; Inoko K, 2006, JAPANESE J CHILD A S, V47, pS38; Kano Y, 2010, CNS SPECTRUMS, V15, P296; Kano Y., 2006, 47 C JAP SOC CHILD A, P300; Leckman J.F., 1989, J AM ACAD CHILD ADOL, V28, P566; Lecrubier Y, 1995, EUR PSYCHIAT, V10, P331, DOI 10.1016/0924-9338(96)80333-6; Nikolajsen KH, 2011, NORD J PSYCHIAT, V65, P244, DOI 10.3109/08039488.2010.533386	28	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	MAR	2015	226	1					156	161		10.1016/j.psychres.2014.12.041		6	Psychiatry	Psychiatry	CE6SV	WOS:000351969400022		
J	Ikeda, C; Terada, S; Oshima, E; Hayashi, S; Okahisa, Y; Takaki, M; Inagaki, M; Yokota, O; Uchitomi, Y				Ikeda, Chikako; Terada, Seishi; Oshima, Etsuko; Hayashi, Satoshi; Okahisa, Yuko; Takaki, Manabu; Inagaki, Masatoshi; Yokota, Osamu; Uchitomi, Yosuke			Difference in determinants of caregiver burden between amnestic mild cognitive impairment and mild Alzheimer's disease	PSYCHIATRY RESEARCH			English	Article						Alzheimer's disease; Caregiver; Caregiver burden; Mild cognitive impairment; Zarit Burden Interview	FAMILY CAREGIVERS; DEMENTIA; SYMPTOMS; VERSION; JAPAN	Care for the disabled elderly can be stressful and exhausting, especially in cases of dementia. There have been a number of studies on the dementia caregiver burden, but studies focusing on differences by stages of the disease are rare. The caregiver burden of 85 caregivers of patients with amnestic mild cognitive impairment (aMCI) and 106 caregivers of patients with mild Alzheimer's disease (AD) was evaluated by the short version of the Japanese version of the Zarit Burden Interview (sZBI). The caregiver burden in mild AD was more severe than that in aMCI. In mild AD, the risk factors of caregiver burden were neurobehavioral symptoms and disturbances instrumental activities of daily living (IADL), whereas the risk factors in aMCI were neurobehavioral symptoms and memory dysfunction. The severity of dementing disease affects the caregiver burden, and somewhat different factors contribute to the burden at different stages. We should pay attention to different factors in evaluating and reducing the caregiver burden in aMCI and mild AD. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Ikeda, Chikako; Terada, Seishi; Oshima, Etsuko; Hayashi, Satoshi; Okahisa, Yuko; Takaki, Manabu; Inagaki, Masatoshi; Yokota, Osamu; Uchitomi, Yosuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama 7008558, Japan	Terada, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	terada@cc.okayama-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [21591517]; Zikei Institute of Psychiatry	We thank Ms. Horiuchi, Ms. Imai, Ms. Yabe, Ms. Tsuchiyama, and Ms. Fukushima for their skillful assistance for this study. This work was supported by a Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (21591517), and the Zikei Institute of Psychiatry.	Zucchella C, 2012, ALZ DIS ASSOC DIS, V26, P55, DOI 10.1097/WAD.0b013e31821aa6de; Seeher K, 2013, ALZHEIMERS DEMENT, V9, P346, DOI 10.1016/j.jalz.2012.01.012; Gallagher D, 2011, AM J ALZHEIMERS DIS, V26, P110, DOI 10.1177/1533317510394649; Arai Y, 2011, PSYCHOGERIATRICS, V11, P183, DOI 10.1111/j.1479-8301.2011.00367.x; Yoshida H, 2012, INT PSYCHOGERIATR, V24, P28, DOI 10.1017/S1041610211001190; Garand L, 2012, ALZ DIS ASSOC DIS, V26, P159, DOI 10.1097/WAD.0b013e31822f9051; Whitebird RR, 2013, GERONTOLOGIST, V53, P676, DOI 10.1093/geront/gns126; Hayashi S, 2013, INT PSYCHOGERIATR, V25, P1357, DOI 10.1017/S1041610213000537; Fisher GG, 2011, J AM GERIATR SOC, V59, P488, DOI 10.1111/j.1532-5415.2010.03304.x; Ryan KA, 2010, ALZ DIS ASSOC DIS, V24, P171, DOI 10.1097/WAD.0b013e3181aba90d; Chan SWC, 2010, DEMENT GERIATR COGN, V30, P469, DOI 10.1159/000322086; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guerra-Silla MG, 2011, J CLIN NURS, V20, P3443, DOI 10.1111/j.1365-2702.2010.03658.x; Hirono Nobutsugu, 1997, Brain and Nerve (Tokyo), V49, P266; Kobayashi Y., 2008, RONEN SEISHIN IGAKU, V19, P681; Kugo A, 2007, PSYCHIAT RES, V153, P69, DOI 10.1016/j.psychres.2006.04.004; Kumamoto Keigo, 2004, Nihon Ronen Igakkai Zasshi, V41, P204; MCKHANN G, 1984, NEUROLOGY, V34, P939; McLaughlin PM, 2014, J INT NEUROPSYCH SOC, V20, P402, DOI 10.1017/S135561771400006X; Ornstein K, 2012, INT PSYCHOGERIATR, V24, P1536, DOI 10.1017/S1041610212000737; Papastavrou E, 2007, J ADV NURS, V58, P446, DOI 10.1111/j.1365-2648.2007.04250.x; Pfeffer RI, 1982, GERONTOLOGY, V37, P323, DOI DOI 10.1093/GER0NJ/37.3.323; Ryan KA, 2012, DEMENT GERIATR COGN, V34, P206, DOI 10.1159/000339955; Sugishita M, 2001, WECHSLER MEMORY SCAL; Wade D T, 1988, Int Disabil Stud, V10, P64; Ward Alex, 2013, Dement Geriatr Cogn Dis Extra, V3, P320, DOI 10.1159/000354370; Yeager Catherine A, 2010, Issues Ment Health Nurs, V31, P376, DOI 10.3109/01612840903434589	27	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	MAR	2015	226	1					242	246		10.1016/j.psychres.2014.12.055		5	Psychiatry	Psychiatry	CE6SV	WOS:000351969400036		
J	Yoshida, T; Kabata, Y; Ohmoto, T				Yoshida, Toshiki; Kabata, Yutaro; Ohmoto, Toru			BIFURCATION OF PLANE-TO-PLANE MAP-GERMS OF CORANK 2	QUARTERLY JOURNAL OF MATHEMATICS			English	Article							SINGULARITIES; SURFACES	We describe the bifurcation diagrams of plane-to-plane map-germs of corank 2 up to A(e)-codimension 4, and draw some new pictures. Two applications are presented: First, we study the affine differential geometry of crosscaps in 3-space by means of analyzing singularities of projections of the singular surface to the plane. Secondly, we give some new examples of generic two-dimensional bifurcations of D-4(+)-type planar caustics.	[Yoshida, Toshiki; Kabata, Yutaro; Ohmoto, Toru] Hokkaido Univ, Grad Sch Sci, Dept Math, Sapporo, Hokkaido 0600810, Japan	Ohmoto, T (reprint author), Hokkaido Univ, Grad Sch Sci, Dept Math, Sapporo, Hokkaido 0600810, Japan.	toshiki@mail.sci.hokudai.ac.jp; kabata@math.sci.hokudai.ac.jp; ohmoto@math.sci.hokudai.ac.jp			JSPS [23654028]	This work is partly supported by the JSPS grant no. 23654028.	Fukui T, 2012, TOHOKU MATH J, V64, P387; Arnold V. I., 2004, CATASTROPHE THEORY; Arnold V. I., 1991, SINGULARITIES CAUSTI; Arnold VI, 1979, RUSS MATH SURV, V34, P1, DOI 10.1070/RM1979v034n02ABEH002903; BRUCE JW, 1984, MATH SCAND, V54, P262; Gibson C. G., 1996, NZ J MATH, V25, P141; Goryunov V. V., 1984, J SOVIET MATH, V27, P2785, DOI 10.1007/BF01084821; Hasegawa M., 2012, PREPRINT; Kabata Y., 2014, THESIS HOKKAIDO U; LANDER L, 1976, P LOND MATH SOC, V33, P113; Morris RJ, 1997, VISUALIZATION AND MATHEMATICS, P53; Ohmoto T, 2006, TOPOLOGY, V45, P27, DOI 10.1016/j.top.2005.04.005; OHMOTO T, 1993, J LOND MATH SOC, V47, P157; Oset-Sinha R., 2014, REV MATH IB IN PRESS; Oset-Sinha R., 2009, THESIS U VALENCIA; Platonova O. A., 1986, J MATH SCI, V35, P2796, DOI 10.1007/BF01106075; RIEGER JH, 1987, J LOND MATH SOC, V36, P351; RIEGER JH, 1991, COMPOS MATH, V79, P99; Saji K, 2010, HIROSHIMA MATH J, V40, P229; Tari F, 2007, TOHOKU MATH J, V59, P233, DOI 10.2748/tmj/1182180735; West J. M., 1995, THESIS U LIVERPOOL; Yoshida T., 2014, THESIS HOKKAIDO U; Yoshida T., 2014, PREPRINT; Zakalyukin V. M., 1984, J SOVIET MATH, V27, P2713, DOI 10.1007/BF01084818	24	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0033-5606	1464-3847		Q J MATH	Q. J. Math.	MAR	2015	66	1					369	391		10.1093/qmath/hau013		23	Mathematics	Mathematics	CE7ES	WOS:000352001200020		
J	Odagiri, H; Iizuka, T; Ohashi, K; Yasunaga, H				Odagiri, Hiroyuki; Iizuka, Toshiro; Ohashi, Kenichi; Yasunaga, Hideo			Unusual Case of a Submucosal Tumor in the Sigmoid Colon	SAUDI JOURNAL OF GASTROENTEROLOGY			English	Editorial Material							OF-THE-LITERATURE; ELASTOSIS		[Odagiri, Hiroyuki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Iizuka, Toshiro] Toranomon Gen Hosp, Dept Gastroenterol, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Dept Pathol, Kanagawa, Japan	Odagiri, H (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hodagiri-gi@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X			Hobbs CM, 2004, AM J CLIN PATHOL, V122, P232, DOI 10.1309/LBGTCG1QCD96M3NF; Markl B, 2008, PATHOL RES PRACT, V204, P395, DOI 10.1016/j.prp.2008.01.004; Vesoulis Z, 2003, CAN J GASTROENTEROL, V17, P2002	3	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1319-3767	1998-4049		SAUDI J GASTROENTERO	Saudi J. Gastroenterol.	MAR-APR	2015	21	2					119	120		10.4103/1319-3767.153842		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE7IX	WOS:000352013700012		
J	Noguchi, M; Iwase, T; Suzuki, E; Kishimoto, Y; Takao, S				Noguchi, Masayuki; Iwase, Toshihide; Suzuki, Etsuji; Kishimoto, Yoko; Takao, Soshi			Social support and suicidal ideation in Japan: are home visits by commissioned welfare volunteers associated with a lower risk of suicidal ideation among elderly people in the community? (vol 49, pg 619, 2014)	SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY			English	Correction									[Noguchi, Masayuki] Okayama Prefectural Mental Hlth & Welf Ctr, Naka Ku, Okayama 7038278, Japan; [Iwase, Toshihide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Support Ctr Med Cooperat Human Resource Placement, Okayama 7008530, Japan; [Suzuki, Etsuji; Kishimoto, Yoko; Takao, Soshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama 7008530, Japan	Noguchi, M (reprint author), Okayama Prefectural Mental Hlth & Welf Ctr, Naka Ku, 1-1-10-101 Furugyo Cho, Okayama 7038278, Japan.	nogumasa917@gmail.com					Noguchi M, 2014, SOC PSYCH PSYCH EPID, V49, P619, DOI 10.1007/s00127-013-0752-5	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-7954	1433-9285		SOC PSYCH PSYCH EPID	Soc. Psychiatry Psychiatr. Epidemiol.	MAR	2015	50	3					505	506		10.1007/s00127-014-0967-0		2	Psychiatry	Psychiatry	CD9RR	WOS:000351436300019		
J	Sirikaew, S; Rattanachuay, P; Nakaguchi, Y; Sukhumungoon, P				Sirikaew, Siriwan; Rattanachuay, Pattamarat; Nakaguchi, Yoshitsugu; Sukhumungoon, Pharanai			IMMUNO-MAGNETIC ISOLATION, CHARACTERIZATION AND GENETIC RELATIONSHIP OF ESCHERICHIA COLI O26 FROM RAW MEATS, HAT YAI CITY, SONGKHLA, THAILAND	SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH			English	Article						Escherichia coil O26; diarrhea; phylogenetic group; raw meat; (GTG)(5)-PCR; ERIC2-PCR; Thailand	MULTIPLEX PCR ASSAY; BOVINE FECES; RETAIL BEEF; HUMANS; O157; INFECTION; SEQUENCE; DNA; DIFFERENTIATION; IDENTIFICATION	Escherichia coil O26 is the most important serotype in non-O157 group, which plays a significant role in gastrointestinal illnesses. However, information regarding the prevalence and its characteristics are lacking in Thailand. As raw meat is frequently a source of diarrheagenic E. coli, a total of 1,279 E. coli colonies were obtained from 157 raw meat samples obtained from retail markets in Hat Yai City, Songkhla Province, Thailand and E. coil O26 isolated using an immunemagnetic separation technique. Twenty-seven E. coil O26 strains were isolated from 18 samples of raw beef, chicken and pork meats. These E. coil O26 strains could not be classified into the six diarrheagenic E. coil categories and did not harbor virulence genes, except 5 strains carrying escV, encoding type III secretion system component. Phylogenetic group examination demonstrated that 26 strains belonged to phylogenetic group A, and one to group D. Antimicrobial susceptibility test revealed that the E. coli O26 strains were the multi-drug resistant strains. Genetic relatedness employing (GTG)(5)-PCR and ERIC2-PCR showed that some of O26 which isolated from different samples and different time intervals revealed the identical fingerprint pattern, suggesting that they were derived from the same clone. Examination of five stx(2)-containing phage integration sites showed that 6 strains had prophage occupancy at sbcB, suggesting that these isolates have the potential in horizontal gene transfer of virulence trait. Moreover, the intactness of yecE and wrbA, the important integration sites in E. coil O26, indicated the possibility of stx(2)-phage lysogenization in the future.	[Sukhumungoon, Pharanai] Prince Songkla Univ, Fac Sci, Food Safety & Hlth Res Unit, Hat Yai 90112, Songkhla, Thailand; [Sirikaew, Siriwan; Sukhumungoon, Pharanai] Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai 90112, Songkhla, Thailand; [Rattanachuay, Pattamarat] Prince Songkla Univ, Fac Sci & Technol, Dept Preclin, Pattani, Thailand; [Nakaguchi, Yoshitsugu] Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Dept Food Sci, Nonoichi, Ishikawa, Japan; [Nakaguchi, Yoshitsugu] Kyoto Univ, Ctr Southeast Asian Studies, Sakyo Ku, Kyoto, Japan	Sukhumungoon, P (reprint author), Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai 90112, Songkhla, Thailand.	ynaka@ishikawa-pu.ac.jp; pharanai82@gmail.com			Prince of Songkla University [SCI580246d]	This work was supported by a grant from Prince of Songkla University, fiscal year 2015 (Grant no. SCI580246d). We thank Sutima Preeprem for assistance in bacterial typing.	Adiguzel G, 2012, J PURE APPL MICROBIO, V6, P1033; Mohapatra BR, 2007, FEMS MICROBIOL LETT, V277, P98, DOI 10.1111/j.1574-6968.2007.00948.x; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Bugarel M, 2011, APPL ENVIRON MICROB, V77, P2275, DOI 10.1128/AEM.02832-10; CHAPMAN PA, 1994, J MED MICROBIOL, V40, P424; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1138/AEM.02937-06; GUNZBURG ST, 1995, J CLIN MICROBIOL, V33, P1375; GANNON VPJ, 1993, J CLIN MICROBIOL, V31, P1268; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; De Greve H, 2002, BBA-GENE STRUCT EXPR, V1579, P196, DOI 10.1016/S0167-4781(02)00539-0; Mellmann A, 2008, APPL ENVIRON MICROB, V74, P67, DOI 10.1128/AEM.01906-07; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Yamamoto T, 1996, INFECT IMMUN, V64, P1441; Brown JA, 2012, PEDIATR INFECT DIS J, V31, P379, DOI 10.1097/INF.0b013e3182457122; Ohnishi M, 2002, P NATL ACAD SCI USA, V99, P17043, DOI 10.1073/pnas.262441699; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Vidal M, 2005, J CLIN MICROBIOL, V43, P5362, DOI 10.1128/JCM.43.10.5362-5365.2005; Toth I, 2003, APPL ENVIRON MICROB, V69, P7242, DOI 10.1128/AEM.69.12.7242-7247.2003; Durso LM, 2005, APPL ENVIRON MICROB, V71, P4941, DOI 10.1128/AEM.71.8.4941-4944.2005; Rasschaert G, 2005, J CLIN MICROBIOL, V43, P3615, DOI 10.1128/JCM.43.8.3615-3623.2005; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142; Ethelberg S, 2009, CLIN INFECT DIS, V48, pE78, DOI 10.1086/597502; SETHABUTR O, 1993, J INFECT DIS, V167, P458; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; STACYPHIPPS S, 1995, J CLIN MICROBIOL, V33, P1054; CDC (Centers for Disease Control and Prevention), 2012, MULT OUTBR SHIG TOX; Clinical and Laboratory Standards Institute (CLSI), 2007, M100S17 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI; European Food Safety Authority (EFSA), 2009, EFSA J, V7, P1366, DOI DOI 10.2903/J.EFSA.2009.1366; Europian Food Safety (EFSA), 2007, EFSA J, V579, P1; Freitas Dulcecleide B, 2008, BMC Res Notes, V1, P92, DOI 10.1186/1756-0500-1-92; Heninger A, 1999, ANTIMICROB AGENT CHE, V37, P2479; Huang YD, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-215; Koch C, 2003, J BACTERIOL, V185, P6463, DOI 10.1128/JB.185.21.6463-6466.2003; Mainil JG, 2011, J APPL MICROBIOL, V111, P773, DOI 10.1111/j.1365-2672.2011.05089.x; Muller D, 2006, J CLIN MICROBIOL, V44, P2626, DOI 10.1128/JCM.00895-06; Oh JY, 2012, POULTRY SCI, V91, P2438, DOI 10.3382/ps.2012-02301; O'Hanlon KA, 2004, J APPL MICROBIOL, V96, P1013, DOI 10.1111/j.1365-2672.2004.02224.x; Pannuch M., 2014, International Food Research Journal, V21, P547; Sukhumungoon P., 2011, International Food Research Journal, V18, P381; Tsukamoto T, 1996, Kansenshogaku Zasshi, V70, P569; Van TTH, 2008, INT J FOOD MICROBIOL, V124, P217, DOI DOI 10.1016/J.IJF00DMICR0.2008.03.029; Vuddhakul V, 2000, FEMS MICROBIOL LETT, V182, P343, DOI 10.1111/j.1574-6968.2000.tb08919.x	44	0	0	SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION	BANGKOK	SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND	0125-1562			SE ASIAN J TROP MED	Southeast Asian J. Trop. Med. Public Health	MAR	2015	46	2					241	253				13	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine	CE1EG	WOS:000351554300009		
J	Odagi, M; Watanabe, T; Nagasawa, K				Odagi, Minami; Watanabe, Tatsuya; Nagasawa, Kazuo			Development of Guanidine-Bisurea Bifunctional Organocatalyst Bearing Chirality at the Inner and Outer Sides of the Urea Groups, and Application to Enantioselective alpha-Hydroxylation of Pyranoindolizine Intermediate for Camptothecin Synthesis	SYMMETRY-BASEL			English	Article							ENZYME-CATALYZED RESOLUTION; PLANT ANTITUMOR AGENTS; DNA TOPOISOMERASE-I; CELL LUNG-CANCER; ASYMMETRIC-SYNTHESIS; KEY INTERMEDIATE; 20(S)-CAMPTOTHECIN; ANALOGS; (S)-CAMPTOTHECIN; IRINOTECAN	Pyranoindolizine is a tricyclic structure found in various biologically active compounds, such as camptothecin (CPT) and its derivatives. In the case of CPTs, the chirality at the alpha-position in the alpha-hydroxyl lactone moiety of pyranoindolizine is important for the antitumor activity. This paper deals with enantioselective oxidation of the alpha-position in pyranoindolizine lactone, which corresponds at C20 in CPT, with cumene hydroperoxide (CHP) in the presence of newly synthesized guanidine-bisurea bifunctional organocatalysts bearing chirality on both the inner and outer sides of the urea groups.	[Odagi, Minami; Watanabe, Tatsuya; Nagasawa, Kazuo] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan	Nagasawa, K (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	odagi@cc.tuat.ac.jp; watanabe.tatsuya@ma.mt-pharma.co.jp; knaga@cc.tuat.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23105013]	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" (No. 23105013) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	HSIANG YH, 1988, CANCER RES, V48, P1722; JEW SS, 1995, TETRAHEDRON-ASYMMETR, V6, P1245, DOI 10.1016/0957-4166(95)00154-H; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; WANI MC, 1987, J MED CHEM, V30, P2317, DOI 10.1021/jm00395a024; Henegar KE, 1997, J ORG CHEM, V62, P6588, DOI 10.1021/jo970173f; KAWATO Y, 1991, CANCER RES, V51, P4187; SAWADA S, 1991, CHEM PHARM BULL, V39, P1446; EJIMA A, 1990, J CHEM SOC PERK T 1, P27, DOI 10.1039/p19900000027; Wiseman LR, 1996, DRUGS, V52, P606, DOI 10.2165/00003495-199652040-00013; KINGSBURY WD, 1991, J MED CHEM, V34, P98, DOI 10.1021/jm00105a017; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; NEGORO S, 1991, J NATL CANCER I, V83, P1164, DOI 10.1093/jnci/83.16.1164; EJIMA A, 1989, TETRAHEDRON LETT, V30, P2639, DOI 10.1016/S0040-4039(00)99086-5; Odagi M, 2013, CHEM-EUR J, V19, P16740, DOI 10.1002/chem.201303006; Hsiang H., 1989, CANCER RES, V49, P4385; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Imura A, 1998, TETRAHEDRON-ASYMMETR, V9, P2285, DOI 10.1016/S0957-4166(98)00198-0; Imura A, 1998, CHEM PHARM BULL, V46, P1878; Odagi M, 2014, AUST J CHEM, V67, P1017, DOI 10.1071/CH14144; Ormrod D, 1999, DRUGS, V58, P533, DOI 10.2165/00003495-199958030-00020; Riemsma R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-436; Watanabe T, 2014, CHEM-EUR J, V20, P591, DOI 10.1002/chem.201303633; Watanabe T, 2013, CHEM-ASIAN J, V8, P630, DOI 10.1002/asia.201200904	23	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-8994			SYMMETRY-BASEL	Symmetry-Basel	MAR	2015	7	1					43	52		10.3390/sym7010043		10	Multidisciplinary Sciences	Science & Technology - Other Topics	CF2CK	WOS:000352354700001		
J	Kanbe, F				Kanbe, Fumio			Can the Comparisons of Feature Locations Explain the Difficulty in Discriminating Mirror-Reflected Pairs of Geometrical Figures from Disoriented Identical Pairs?	SYMMETRY-BASEL			English	Article							MENTAL-ROTATION; TOPOLOGICAL-STRUCTURE; 3-DIMENSIONAL OBJECTS; STIMULUS COMPLEXITY; SHAPE EQUIVALENCE; PERCEPTION; ORIENTATION; TRANSFORMATIONS; FAMILIARITY; INFORMATION	The present experiment investigates whether patterns of shifts of feature locations could affect the same/different decisions of simultaneously presented pairs of geometrical figures. A shift of locations was defined as the angular distance from the location of a feature in one figure to the location of the same feature in another figure. It was hypothesized that the difficulty in discriminating mirror-reflected (or axisymmetric) pairs from disoriented identical pairs was caused by complex shifting patterns inherent in axisymmetric pairs. According to the shifts of the locations of the four structural features, five pair types were prepared. They could be ordered from completely identical to completely different in their shifts: identical 0/4 pairs, non-identical 1/4 pairs, non-identical 2/4 pairs = axisymmetric 2/4 pairs and non-identical 4/4 pairs. The latencies for non-identical pairs decreased with the increase of difference in the shifts of feature locations, indicating that serial, self-terminating comparisons of the shifts were applied to the discrimination of non-identical pairs from identical pairs. However, the longer latencies in axisymmetric 2/4 pairs than in non-identical 2/4 pairs suggested that the difficulty for axisymmetric pairs was not caused by the complex shifting patterns, and the difficulty was not satisfactorily explained by the comparisons of feature locations.	Hakuoh Univ, Fac Educ, Oyama, Tochigi 3238585, Japan	Kanbe, F (reprint author), Hakuoh Univ, Fac Educ, 1117 Daigyoji, Oyama, Tochigi 3238585, Japan.	kanbe@fc.hakuoh.ac.jp			Hakuoh University	This research was supported by an annual personal research fund granted by Hakuoh University.	[章杰兵 ZHANG Jie-bing], 2009, [药学服务与研究, Pharmaceutical Care and Research], V9, P1; HOCHBERG J, 1977, MEM COGNITION, V5, P23, DOI 10.3758/BF03209187; CORBALLIS MC, 1988, PSYCHOL REV, V95, P115, DOI 10.1037/0033-295X.95.1.115; CHEN L, 1982, SCIENCE, V218, P699, DOI 10.1126/science.7134969; Todd JT, 1998, PERCEPTION, V27, P273, DOI 10.1068/p270273; PYLYSHYN ZW, 1979, MEM COGNITION, V7, P19, DOI 10.3758/BF03196930; BETHELLFOX CE, 1988, J EXP PSYCHOL HUMAN, V14, P12, DOI 10.1037/0096-1523.14.1.12; Wagemans J, 1997, PSYCHON B REV, V4, P248, DOI 10.3758/BF03209401; Hecht H, 1998, ACTA PSYCHOL, V99, P255, DOI 10.1016/S0001-6918(98)00015-8; FOLK MD, 1987, J EXP PSYCHOL HUMAN, V13, P395, DOI 10.1037/0096-1523.13.3.395; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Bauer B, 1996, J EXP PSYCHOL HUMAN, V22, P82, DOI 10.1037/0096-1523.22.1.82; Wolfe JM, 2003, PERCEPTION, V32, P645, DOI 10.1068/p3414; COOPER LA, 1975, COGNITIVE PSYCHOL, V7, P20, DOI 10.1016/0010-0285(75)90003-1; JUST MA, 1985, PSYCHOL REV, V92, P137, DOI 10.1037/0033-295X.92.2.137; Bedford FL, 2001, CAH PSYCHOL COGN, V20, P113; Chen L, 1997, PSYCHON B REV, V4, P507, DOI 10.3758/BF03214340; CHEN L, 1985, PERCEPTION, V14, P197, DOI 10.1068/p140197; COHEN D, 1993, COGNITIVE PSYCHOL, V25, P351, DOI 10.1006/cogp.1993.1009; COOPER LA, 1976, J EXP PSYCHOL HUMAN, V2, P503, DOI 10.1037/0096-1523.2.4.503; CORBALLIS MC, 1978, CAN J PSYCHOL, V32, P186, DOI 10.1037/h0081685; CORBALLIS MC, 1986, MEM COGNITION, V14, P27, DOI 10.3758/BF03209226; CORBALLIS MC, 1978, MEM COGNITION, V6, P98, DOI 10.3758/BF03197434; Forster B, 1996, PERCEPTION, V25, P1301, DOI 10.1068/p251301; Harary F., 1969, GRAPH THEORY; Johnson-Laird P. N., 1983, MENTAL MODELS COGNIT; JOLICOEUR P, 1985, MEM COGNITION, V13, P289, DOI 10.3758/BF03202498; Kanbe F, 2013, PERCEPTION, V42, P849, DOI 10.1068/p7497; Kanbe F, 2002, JPN PSYCHOL ASS, V25-27, P568; Kanbe F, 2001, JPN PSYCHOL RES, V43, P141, DOI 10.1111/1468-5884.00170; LARSEN A, 1985, PERCEPT PSYCHOPHYS, V38, P63, DOI 10.3758/BF03202925; MCMULLEN PA, 1992, J EXP PSYCHOL HUMAN, V18, P807, DOI 10.1037/0096-1523.18.3.807; PARSONS LM, 1987, PERCEPT PSYCHOPHYS, V42, P49, DOI 10.3758/BF03211513; STEIGER JH, 1983, CAN J PSYCHOL, V37, P367, DOI 10.1037/h0080740; TAKANO Y, 1989, COGNITIVE PSYCHOL, V21, P1, DOI 10.1016/0010-0285(89)90002-9; Vanrie J, 2001, PERCEPTION, V30, P1047, DOI 10.1068/p3200; Wagemans J, 2000, J EXP PSYCHOL HUMAN, V26, P443, DOI 10.1037//0096-1523.26.2.443; YUILLE JC, 1982, PERCEPT PSYCHOPHYS, V31, P201, DOI 10.3758/BF03202524	38	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-8994			SYMMETRY-BASEL	Symmetry-Basel	MAR	2015	7	1					89	104		10.3390/sym7010089		16	Multidisciplinary Sciences	Science & Technology - Other Topics	CF2CK	WOS:000352354700004		
J	Itoyama, H; Maru, N				Itoyama, Hiroshi; Maru, Nobuhito			126 GeV Higgs Boson Associated with D-term Triggered Dynamical Supersymmetry Breaking	SYMMETRY-BASEL			English	Article							U(N) GAUGE-MODEL; STANDARD MODEL; N=2 SUPERSYMMETRY; GLUINOS; DIRAC; MASS; LHC	Continuing with our previous work on D-term triggered dynamical supersymmetry breaking, we consider a system in which our generic [GRAPHICS] action is minimally extended to include the pair of Higgs doublet superfields charged under the overall U(1) together with mu and B mu terms. The gauge group is taken to be SU(3)(C) x SU(2)(L) x U(1)(Y) x U(1). We point out, among other things, that the Higgs mass less than the Z-boson mass at tree level can be pushed up to be around 126 GeV by D-term contributions of the overall U(1). This is readily realized by taking a U(1) gauge coupling to be O(1).	[Itoyama, Hiroshi; Maru, Nobuhito] Osaka City Univ, Grad Sch Sci, Dept Math & Phys, Osaka 5588585, Japan; [Itoyama, Hiroshi] Osaka City Univ Adv Math Inst OCAMI, Sumiyoshi Ku, Osaka 5588585, Japan	Itoyama, H (reprint author), Osaka City Univ, Grad Sch Sci, Dept Math & Phys, Osaka 5588585, Japan.	itoyama@sci.osaka-cu.ac.jp; nmaru@sci.osaka-cu.ac.jp			Ministry of Education, Science and Culture, Japan [23540316, 24540283]	The work of Hiroshi Itoyama is supported in part by the Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan, No. 23540316. The work of Nobuhito Maru is supported in part by the Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan, No. 24540283.	Abel S, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2013)098; Abel S, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2011)064; Amigo S. D. L., 2009, J HIGH ENERGY PHYS, V2009; Nomura Y, 2006, NUCL PHYS B, V745, P29, DOI 10.1016/j.nuclphysb.2006.03.034; Hsieh K, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.015004; Dudas E, 2014, NUCL PHYS B, V884, P632, DOI 10.1016/j.nuclphysb.2014.05.005; HALL LJ, 1991, NUCL PHYS B, V352, P289, DOI 10.1016/0550-3213(91)90444-3; Kribs GD, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.055010; Antoniadis I, 2006, PHYS LETT B, V634, P302, DOI 10.1016/j.physletb.2006.01.010; OKADA Y, 1991, PROG THEOR PHYS, V85, P1, DOI 10.1143/PTP.85.1; Benakli K, 2009, NUCL PHYS B, V816, P185, DOI 10.1016/j.nuclphysb.2009.03.002; Ellwanger U, 2010, PHYS REP, V496, P1, DOI 10.1016/j.physrep.2010.07.001; Kribs GD, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.115010; Langacker P, 2009, REV MOD PHYS, V81, P1199, DOI 10.1103/RevModPhys.81.1199; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; FAYET P, 1978, PHYS LETT B, V78, P417, DOI 10.1016/0370-2693(78)90474-4; GROSS DJ, 1974, PHYS REV D, V10, P3235, DOI 10.1103/PhysRevD.10.3235; Antoniadis I., NEW GAUGE MEDIATION; Benakli K, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2013)073; Benakli K., GENERATING MU BMU MO; Blechman A. E., 2008, J HIGH ENERGY PHYS, V0806; Blechman AE, 2009, MOD PHYS LETT A, V24, P633, DOI 10.1142/S0217732309030795; Carpenter L. M., 2005, NMSSM ANOMALY MEDITA; Carpenter LM, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2012)102; Chacko Z, 2005, NUCL PHYS B, V706, P53, DOI 10.1016/j.nuclphysb.2004.11.021; Davies R, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2011)108; Fox P. J., 2002, J HIGH ENERGY PHYS, V2002, DOI 10.1088/1126-6708/2002/08/035; Frugiuele C, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.015016; Fujiwara K, 2005, PROG THEOR PHYS, V113, P429, DOI 10.1143/PTP.113.429; Fujiwara K, 2005, NUCL PHYS B, V723, P33, DOI 10.1016/j.nuclphysb.2005.06.023; Goodsell MD, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2013)066; Hisano J, 2007, PHYS LETT B, V644, P256, DOI 10.1016/j.physletb.2006.11.047; Itoyama H., D TERM DYNAMICAL SUS; Itoyama H, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.025012; Itoyama H., N D TERM DYNAMICAL S; Kribs Graham D, 2009, JHEP-Journal of High Energy Physics, V2009, DOI 10.1088/1126-6708/2009/01/023; Kribs GD, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.115014; Morita Y., NEUTRINO MASS PROTON; NAMBU Y, 1961, PHYS REV, V122, P345, DOI 10.1103/PhysRev.122.345; Nelson A. E., 2002, J HIGH ENERGY PHYS, V2002, DOI DOI 10.1088/1126-6708/2002/08/039; POLCHINSKI J, 1982, PHYS REV D, V26, P3661, DOI 10.1103/PhysRevD.26.3661; Aad G, 2012, PHYS LETT B, V716, P1, DOI 10.1016/j.physletb.2012.08.020; Chatrchyan S, 2012, PHYS LETT B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; Unwin J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.095002	44	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-8994			SYMMETRY-BASEL	Symmetry-Basel	MAR	2015	7	1					193	205		10.3390/sym7010193		13	Multidisciplinary Sciences	Science & Technology - Other Topics	CF2CK	WOS:000352354700010		
J	Bamba, K; Odintsov, SD				Bamba, Kazuharu; Odintsov, Sergei D.			Inflationary Cosmology in Modified Gravity Theories	SYMMETRY-BASEL			English	Review							PROBE WMAP OBSERVATIONS; LOOP QUANTUM COSMOLOGY; DARK ENERGY; SINGULARITY; MODELS; RECONSTRUCTION; PLANCK; BICEP2	We review inflationary cosmology in modified gravity such as R-2 gravity with its extensions in order to generalize the Starobinsky inflation model. In particular, we explore inflation realized by three kinds of effects: modification of gravity, the quantum anomaly, and the R-2 term in loop quantum cosmology. It is explicitly demonstrated that in these inflationary models, the spectral index of scalar modes of the density perturbations and the tensor-to-scalar ratio can be consistent with the Planck results. Bounce cosmology in F(R) gravity is also explained.	[Bamba, Kazuharu] Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 1128610, Japan; [Bamba, Kazuharu] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Phys, Tokyo 1128610, Japan; [Odintsov, Sergei D.] Fac Ciencies, ICE CSIC IEEC, CSIC, E-08193 Bellaterra, Barcelona, Spain; [Odintsov, Sergei D.] Passeig Lluis Co, ICREA, Barcelona 2308010, Spain; [Odintsov, Sergei D.] Tomsk State Pedag Univ, Tomsk 634061, Russia	Bamba, K (reprint author), Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 1128610, Japan.	bamba.kazuharu@ocha.ac.jp; odintsov@ieec.uab.es			Japan Society for the Promotion of Science (JSPS) [25800136]; Ministry of Economy and Competitiveness (MINECO) (Spain) [FIS2010-15640, FIS2013-44881]	This work was partially supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B) # 25800136 (Kazuharu Bamba) and Ministry of Economy and Competitiveness (MINECO) (Spain) project FIS2010-15640 and FIS2013-44881 (Sergei D. Odintsov).	Adam R., 2014, ARXIV14095738; Ade P. A. R., 2015, ARXIV150200612; Ade P. A. R., 2014, ARXIV14050871; Ade P. A. R., 2014, ARXIV14050874; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321569; Amoros J., 2014, ARXIV14117611; DESER S, 1976, NUCL PHYS B, V111, P45, DOI 10.1016/0550-3213(76)90480-6; Zhang XD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.171301; Khoury J, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.123522; Bamba K, 2014, PHYS LETT B, V732, P349, DOI 10.1016/j.physletb.2014.04.004; Koehn M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.025005; Bamba K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.043505; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Bojowald M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.261301; Nojiri S, 2007, INT J GEOM METHODS M, V4, P115, DOI 10.1142/S0219887807001928; Elizalde E, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.086006; Amoros J, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.104037; Nojiri S, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.063004; Sebastiani L, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.023518; Amoros J, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.104010; Nojiri S, 1998, PHYS LETT B, V444, P92, DOI 10.1016/S0370-2693(98)01351-3; De la Cruz-Dombriz A, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.087501; STAROBINSKY AA, 1980, PHYS LETT B, V91, P99, DOI 10.1016/0370-2693(80)90670-X; LINDE AD, 1983, PHYS LETT B, V129, P177, DOI 10.1016/0370-2693(83)90837-7; Linder EV, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.123528; VILENKIN A, 1985, PHYS REV D, V32, P2511, DOI 10.1103/PhysRevD.32.2511; Bamba K, 2012, ASTROPHYS SPACE SCI, V342, P155, DOI 10.1007/s10509-012-1181-8; MUKHANOV VF, 1981, JETP LETT+, V33, P532; Ashtekar A, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.024046; Zhang XD, 2013, FRONT PHYS-BEIJING, V8, P80, DOI 10.1007/s11467-013-0277-0; Ashtekar A, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.084003; MAEDA K, 1989, PHYS REV D, V39, P3159, DOI 10.1103/PhysRevD.39.3159; Cognola G, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.046009; Bojowald M, 2001, PHYS REV LETT, V86, P5227, DOI 10.1103/PhysRevLett.86.5227; Bamba K, 2014, PHYS LETT B, V737, P374, DOI 10.1016/j.physletb.2014.09.014; Ade PAR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.241101; Spergel DN, 2007, ASTROPHYS J SUPPL S, V170, P377, DOI 10.1086/513700; Ashtekar A, 2003, ADV THEOR MATH PHYS, V7, P233; Ashtekar A, 2006, CLASSICAL QUANT GRAV, V23, P391, DOI 10.1088/0264-9381/23/2/008; Thiemann T, 2003, LECT NOTES PHYS, V631, P41; Capozziello S, 2011, PHYS REP, V509, P167, DOI 10.1016/j.physrep.2011.09.003; Ashtekar A, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/21/213001; Nojiri S, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.046004; Bamba K, 2012, GEN RELAT GRAVIT, V44, P1321, DOI 10.1007/s10714-012-1342-7; Bamba K, 2014, PHYS LETT B, V731, P257, DOI 10.1016/j.physletb.2014.02.041; Nojiri S, 2011, PHYS REP, V505, P59, DOI 10.1016/j.physrep.2011.04.001; Lidsey JE, 1997, REV MOD PHYS, V69, P373, DOI 10.1103/RevModPhys.69.373; Hawking SW, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.083504; Bamba K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.124061; Mortonson Michael J., 2014, Journal of Cosmology and Astroparticle Physics, DOI 10.1088/1475-7516/2014/10/035; Gupt B, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.044011; Nojiri S, 2009, PHYS LETT B, V681, P74, DOI 10.1016/j.physletb.2009.09.045; Colley WN, 2015, MON NOT R ASTRON SOC, V447, P2034, DOI 10.1093/mnras/stu2547; Oikonomou VK, 2013, GEN RELAT GRAVIT, V45, P2467, DOI 10.1007/s10714-013-1597-7; Ashtekar A, 2007, NUOVO CIMENTO B, V122, P135, DOI 10.1393/ncb/i2007-10351-5; Bamba K., 2014, ARXIV14027114; Bamba K, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/02/008; Bamba K, 2008, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2008/10/045; Bamba K, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/01/008; Bamba K, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.083014; Bamba K., 2013, ARXIV13024831; Bamba K, 2010, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2010/08/021; Bamba K, 2014, ARXIV14113852; Bamba K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.023525; Birell N.D., 1982, QUANTUM FIELDS CURVE; Bojowald M., 2008, LIVING REV RELATIV, V11, DOI 10.12942/lrr-2008-4; Bojowald M, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/21/213001; Bojowald M, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/7/075020; Bojowald M., 2005, LIVING REV RELATIV, V8, DOI 10.12942/lrr-2005-11; Cai YF, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/08/020; Capozziello S, 2010, EINSTEIN GRAVITY; Cognola G., 2014, ARXIV14081766; Corichi A, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.024034; de Haro J, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/08/025; DUFF MJ, 1994, CLASSICAL QUANT GRAV, V11, P1387, DOI 10.1088/0264-9381/11/6/004; DUFF MJ, 1977, NUCL PHYS B, V125, P334, DOI 10.1016/0550-3213(77)90410-2; Dzierzak P, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.104001; Elizalde E, 2015, ARXIV14113475; Fujii Y., 2003, SCALAR TENSOR THEORY; George Damien P., 2014, Journal of Cosmology and Astroparticle Physics, DOI 10.1088/1475-7516/2014/02/024; Gorbunov D. S., 2011, INTRO THEORY EARLY U; Haro J, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/12/031; Haro J, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/69001; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; Joyce A., 2014, ARXIV14070059; Kaiser D. I., 2014, ARXIVASTROPH9507048; Kamionkowski M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.191303; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Liddle A.R., 2000, COSMOLOGICAL INFLATI; Linde A., 2014, ARXIV14020526; Motohashi H., 2014, ARXIV14112972; Myrzakulov R, 2015, ARXIV14121073; Nojiri S, 2011, PHYS LETT B, V696, P278, DOI 10.1016/j.physletb.2010.12.035; Nojiri S., 2011, AIP C P, V1458, P207; Nojiri S., 2007, Journal of Physics: Conference Series, V66, DOI 10.1088/1742-6596/66/1/012005; Odintsov SD, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.124083; Oikonomou V. K., 2015, ARXIV150106591; Prokopec T, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/12/031; Rinaldi M., 2015, ARXIV14100631; de la Cruz-Dombriz A, 2012, ENTROPY-SWITZ, V14, P1717, DOI 10.3390/e14091717; Singh P, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/12/125005; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Thiemann T., 2007, MODERN CANONICAL QUA; Zhang XD, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.064040; Zhang YL, 2012, INT J MOD PHYS D, V21, DOI 10.1142/S021827181250006X	106	15	15	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-8994			SYMMETRY-BASEL	Symmetry-Basel	MAR	2015	7	1					220	240		10.3390/sym7010220		21	Multidisciplinary Sciences	Science & Technology - Other Topics	CF2CK	WOS:000352354700012		
J	Kukita, K; Ohira, S; Amano, I; Naito, H; Azuma, N; Ikeda, K; Kanno, Y; Satou, T; Sakai, S; Sugimoto, T; Takemoto, Y; Haruguchi, H; Minakuchi, J; Miyata, A; Murotani, N; Hirakata, H; Tomo, T; Akizawa, T				Kukita, Kazutaka; Ohira, Seiji; Amano, Izumi; Naito, Hidemune; Azuma, Nakanobu; Ikeda, Kiyoshi; Kanno, Yutaka; Satou, Takashi; Sakai, Shinji; Sugimoto, Tokuichiro; Takemoto, Yoshiaki; Haruguchi, Hiroaki; Minakuchi, Jun; Miyata, Akira; Murotani, Noriyoshi; Hirakata, Hideki; Tomo, Tadashi; Akizawa, Tadao		Japanese Soc Dialysis Therapy	2011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis	THERAPEUTIC APHERESIS AND DIALYSIS			English	Review						Chronic hemodialysis; Clinical practice guideline; Vascular access construction; Vascular access repair	CATHETER-RELATED BACTEREMIA; RANDOMIZED CONTROLLED-TRIAL; CENTRAL VENOUS OBSTRUCTION; BLOOD-FLOW SURVEILLANCE; EXPANDED POLYTETRAFLUOROETHYLENE GRAFT; REVASCULARIZATION-INTERVAL LIGATION; FUNCTIONING ARTERIOVENOUS-FISTULA; PERCUTANEOUS BALLOON ANGIOPLASTY; ISCHEMIC MONOMELIC NEUROPATHY; CLINICAL-PRACTICE GUIDELINES		[Kukita, Kazutaka; Ohira, Seiji; Amano, Izumi; Naito, Hidemune; Azuma, Nakanobu; Ikeda, Kiyoshi; Kanno, Yutaka; Satou, Takashi; Sakai, Shinji; Sugimoto, Tokuichiro; Takemoto, Yoshiaki; Haruguchi, Hiroaki; Minakuchi, Jun; Miyata, Akira; Murotani, Noriyoshi; Hirakata, Hideki; Tomo, Tadashi; Akizawa, Tadao; Japanese Soc Dialysis Therapy] Japanese Soc Dialysis Therapy, Tokyo, Japan	Kukita, K (reprint author), Sapporo Hokuyu Hosp, Dept Surg, 003-0006 Higashi Sapporo 6 Jo 6 Chome, Sapporo, Hokkaido, Japan.	kukita@hokuyu-aoth.org					Abe R, 1988, KIDNEY DIAL, V25, P755; Agishi T, 1997, CLIN DIAL, V16, P1447; Agishi T, 2000, J JPN SOC DIAL THER, V33, P1059; Agishi T, 1995, KIDNEY DIAL, V38, P127; Agishi T, 1996, CLIN DIAL, V12, P1048; Ahmed E, 1996, ANN VASC SURG, V10, P290; Akamatsu M, 2001, J JPN SOC DIAL THER, V34, P1175; Allon M, 2005, BLOOD PURIFICAT, V23, P23, DOI 10.1159/000082007; Amano I, 1996, KIDNEY DIAL, V41, P263; Amano I, 2005, CLIN IMAGIOL, V12, P1186; Amano I, 2000, J JPN ASS DIAL PHYS, V15, P84; ANDERSON CB, 1976, ARCH INTERN MED, V136, P292, DOI 10.1001/archinte.136.3.292; ANDRASSY K, 1974, KLIN WOCHENSCHR, V52, P348, DOI 10.1007/BF01468835; Prischl FC, 1995, J AM SOC NEPHROL, V6, P1613; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; Wong V, 1996, EUR J VASC ENDOVASC, V12, P207, DOI 10.1016/S1078-5884(96)80108-0; GANZ W, 1971, AM J CARDIOL, V27, P392, DOI 10.1016/0002-9149(71)90436-X; Rooijens PPGM, 2004, EUR J VASC ENDOVASC, V28, P583, DOI 10.1016/j.ejvs.2004.08.014; BARRETT N, 1988, NEPHROL DIAL TRANSPL, V3, P423; Oliver MJ, 2001, SEMIN DIALYSIS, V14, P432, DOI 10.1046/j.1525-139x.2001.00107.x; Vesely TM, 2003, J VASC INTERV RADIOL, V14, P527, DOI 10.1097/01.RVI.0000071097.76348.72; Minion DJ, 2005, ANN VASC SURG, V19, P625, DOI 10.1007/s10016-005-5827-7; Schwab SJ, 1999, KIDNEY INT, V56, P1, DOI 10.1046/j.1523-1755.1999.00512.x; Tonelli M, 2008, AM J KIDNEY DIS, V51, P630, DOI 10.1053/j.ajkd.2007.11.025; SCHWAB SJ, 1988, KIDNEY INT, V33, P1156, DOI 10.1038/ki.1988.124; Tellioglu G, 2008, TRANSPL P, V40, P87, DOI 10.1016/j.transproceed.2007.11.059; Woods JD, 1997, AM J KIDNEY DIS, V30, P50, DOI 10.1016/S0272-6386(97)90564-3; Fadel FI, 2008, INT UROL NEPHROL, V40, P489, DOI 10.1007/s11255-007-9259-x; [Anonymous], 2010, INT MED POINTS, P453; Allon M, 2004, AM J KIDNEY DIS, V44, P779, DOI 10.1053/j.ajkd.2004.07.005; TURMELRODRIGUES L, 1993, RADIOLOGY, V187, P273; Poole CV, 2004, NEPHROL DIAL TRANSPL, V19, P1237, DOI 10.1093/ndt/gfh041; Xue JL, 2003, AM J KIDNEY DIS, V42, P1013, DOI 10.1053/50272-6386(03)01015-1; BEATHARD GA, 1992, KIDNEY INT, V42, P1390, DOI 10.1038/ki.1992.431; Chemla ES, 2007, SEMIN DIALYSIS, V20, P68, DOI 10.1111/j.1525-139X.2007.00244.x; Brimble KS, 2002, CLIN NEPHROL, V58, P122; Ram SJ, 2003, KIDNEY INT, V64, P272, DOI 10.1046/j.1523-1755.2003.00070.x; Miller PE, 1999, KIDNEY INT, V56, P275, DOI 10.1046/j.1523-1755.1999.00515.x; Bhatia DS, 1996, ANN VASC SURG, V10, P452, DOI 10.1007/BF02000591; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; Malovrh M, 1998, NEPHROL DIAL TRANSPL, V13, P125, DOI 10.1093/ndt/13.1.125; Rogers NM, 2007, NEPHROL DIAL TRANSPL, V22, P933, DOI 10.1093/ndt/gfl722; Tessitore N, 2004, NEPHROL DIAL TRANSPL, V19, P2325, DOI 10.1093/ndt/gfh316; Agharazii M, 2005, NEPHROL DIAL TRANSPL, V20, P1238, DOI 10.1093/ndt/gfh841; Malovrh M, 2002, AM J KIDNEY DIS, V39, P1218, DOI 10.1053/ajkd.2002.33394; Allon M, 2001, KIDNEY INT, V60, P2013, DOI 10.1046/j.1523-1755.2001.00031.x; Pisoni RL, 2009, AM J KIDNEY DIS, V53, P475, DOI 10.1053/j.ajkd.2008.10.043; BRESCIA MJ, 1966, NEW ENGL J MED, V275, P1089, DOI 10.1056/NEJM196611172752002; Akoh JA, 2009, J VASC ACCESS, V10, P137; Agarwal AK, 2007, SEMIN DIALYSIS, V20, P53, DOI 10.1111/j.1525-139X.2007.00242.x; SCHANZER H, 1988, J VASC SURG, V7, P770, DOI 10.1067/mva.1988.avs0070770; Powe NR, 1999, KIDNEY INT, V55, P1081, DOI 10.1046/j.1523-1755.1999.0550031081.x; Moist LM, 2003, J AM SOC NEPHROL, V14, P2645, DOI 10.1097/01.ASN.0000089562.98338.60; Goel N, 2006, KIDNEY INT, V70, P765, DOI 10.1038/sj.ki.5001554; Saad TF, 1999, AM J KIDNEY DIS, V34, P1114, DOI 10.1016/S0272-6386(99)70018-1; Tokars JI, 2002, AM J INFECT CONTROL, V30, P288, DOI 10.1067/mic.2002.120904; Donlan RM, 2002, EMERG INFECT DIS, V8, P881; Allon M, 2002, KIDNEY INT, V62, P1109; Konner K, 2002, KIDNEY INT, V62, P329, DOI 10.1046/j.1523-1755.2002.00436.x; Silva MB, 1998, J VASC SURG, V27, P302, DOI 10.1016/S0741-5214(98)70360-X; Movilli E, 2010, AM J KIDNEY DIS, V55, P682, DOI 10.1053/j.ajkd.2009.11.008; [Anonymous], 2003, 20 MAN HIGH FLOW A V; Marr KA, 1997, ANN INTERN MED, V127, P275; Amano I, 2006, THER APHER DIAL, V10, P364, DOI 10.1111/j.1744-9987.2006.00390.x; Macdonald S, 2000, J VASC INTERV RADIOL, V11, P225, DOI 10.1016/S1051-0443(07)61470-5; ENGELBERTS I, 1995, AM J NEPHROL, V15, P323, DOI 10.1159/000168857; KOVALIK EC, 1994, KIDNEY INT, V45, P1177, DOI 10.1038/ki.1994.156; Mickley V, 2008, NEPHROL DIAL TRANSPL, V23, P19, DOI 10.1093/ndt/gfm673; Unger P, 2002, TRANSPLANTATION, V74, P73, DOI 10.1097/00007890-200207150-00013; Parmar J, 2007, EUR J VASC ENDOVASC, V33, P113, DOI 10.1016/j.ejvs.2006.09.001; Ashby DR, 2009, CLIN J AM SOC NEPHRO, V4, P1601, DOI 10.2215/CJN.01840309; Keuter XHA, 2008, J VASC SURG, V47, P395, DOI 10.1016/j.jvs.2007.09.063; Iwashima Y, 2002, AM J KIDNEY DIS, V40, P974, DOI 10.1053/ajkd.2002.36329; Liangos O, 2006, SEMIN DIALYSIS, V19, P158, DOI 10.1111/j.1525-139X.2006.00143.x; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Kairaitis LK, 1999, NEPHROL DIAL TRANSPL, V14, P1710, DOI 10.1093/ndt/14.7.1710; Uhlig K, 2006, KIDNEY INT, V70, P2058, DOI 10.1038/sj.ki.5001875; Mokrzycki MH, 2001, KIDNEY INT, V59, P1935, DOI 10.1046/j.1523-1755.2001.0590051935.x; Zanow J, 2006, J VASC SURG, V44, P1273, DOI 10.1016/j.jvs.2006.08.010; Ori Y, 2002, AM J KIDNEY DIS, V40, P745, DOI 10.1053/ajkd.2002.35685; Ravani P, 2002, AM J KIDNEY DIS, V40, P1264, DOI 10.1053/ajkd.2002.36897; Voormolen EHJ, 2009, J VASC SURG, V49, P1325, DOI 10.1016/j.jvs.2008.11.059; Lay JPY, 1998, CLIN RADIOL, V53, P608, DOI 10.1016/S0009-9260(98)80155-4; Lazarides MK, 2007, J VASC SURG, V45, P420, DOI 10.1016/j.jvs.2006.10.035; Kavallieratos N, 2004, J VASC SURG, V40, P640, DOI 10.1016/j.jvs.2004.07.009; Tessitore N, 2008, NEPHROL DIAL TRANSPL, V23, P3578, DOI 10.1093/ndt/gfn275; Asano M, 2009, KIDNEY DIAL S, V66, P98; Aschwanden M, 2003, J VASC SURG, V37, P211, DOI 10.1067/mva.2003.16; Astor BC, 2000, AM J KIDNEY DIS, V36, P1126, DOI 10.1053/ajkd.2000.19816; Atray N, 2008, SEMIN DIALYSIS, V21, P97, DOI 10.1111/j.1525-139X.2007.00341.x; Ayarragaray JEF, 2003, J VASC SURG, V37, P1043, DOI 10.1067/mva.2003.215; Azuma N, 2009, CLIN DIAL, V25, P1177; Bagul A, 2007, EUR J VASC ENDOVASC, V33, P105, DOI 10.1016/j.ejvs.2006.08.004; BANDER SJ, 1992, SEMIN DIALYSIS, V5, P121, DOI 10.1111/j.1525-139X.1992.tb00129.x; BEATHARD GA, 1994, KIDNEY INT, V45, P1401, DOI 10.1038/ki.1994.183; Berman SS, 1997, J VASC SURG, V26, P393, DOI 10.1016/S0741-5214(97)70032-6; Besarab Anatole, 2004, Hemodial Int, V8, P199, DOI 10.1111/j.1492-7535.2004.01096.x; Besarab A, 2006, AM J KIDNEY DIS S, V48, pS176; BLUMENBERG RM, 1985, SURGERY, V97, P194; BOLTON W, 1981, DIALYSIS TRANSPLANT, V10, P60; BOS WJW, 1995, KIDNEY INT, V48, P1641; Bron C, 2010, J VASC ACCESS, V11, P63; Casey J, 2008, HEMODIAL INT, V12, P52, DOI 10.1111/j.1542-4758.2008.00240.x; CHAMPAGNE S, 1984, INFECT CONT HOSP EP, V5, P489; Chesser AMS, 1999, CLIN NEPHROL, V51, P228; Chia K. H., 1999, SMJ, V40, P685; Churchill DN, 1999, J AM SOC NEPHROL, V10, pS287; Clement JD, 1998, J AM SOC NEPHROL, V9, P169; Crain MR, 1996, RADIOLOGY, V198, P41; Danielle MD, 2006, J AM COLL SURGEONS, V203, P506; Davanzo W J, 2005, J Vasc Access, V6, P38; Davidson D, 2003, CAN J SURG, V46, P408; Davidson I, 2009, J VASC ACCESS, V10, P153; Degawa H, 1995, J JPN SOC DIAL THER, V28, P1359; Di Iorio BR, 2004, J NEPHROL, V17, P19; Dikow R, 2002, SEMIN DIALYSIS, V15, P14, DOI 10.1046/j.1525-139x.2002.00003.x; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; Egawa H, 2006, KIDNEY DIAL S, V60, P31; Ervo S, 2001, J Vasc Access, V2, P68; Falk A, 2005, SEMIN DIALYSIS, V18, P425, DOI 10.1111/j.1525-139X.2005.00081.x; Falk A, 2002, J Vasc Access, V3, P169; Fernandez-Cean J, 2002, NEPHROL DIAL TRANSPL, V17, P2226, DOI 10.1093/ndt/17.12.2226; FISKERSTRAND CE, 1985, ARTIF ORGANS, V9, P61, DOI 10.1111/j.1525-1594.1985.tb04349.x; Forauer AR, 2000, J VASC INTERV RADIOL, V11, P233, DOI 10.1016/S1051-0443(07)61471-7; Fukagawa M, 2010, J JPN SOC DIAL THER, V43, P347, DOI DOI 10.1038/SJ.KI.5001875; Fukuda T, 1996, CLIN DIAL S, V12, P845; Fukui H, 1999, STANDARD BLOOD ACCES, P39; Fukushima T, 2009, KIDNEY DIAL S, V66, P206; Funaki T, 2001, KIDNEY DIAL S, V50, P144; Furukawa H, 2008, KIDNEY DIAL, V64, P285; Gargiulo NJ, 2008, J VASC SURG, V48, P216, DOI 10.1016/j.jvs.2008.01.046; Glickman MH, 2001, J VASC SURG, V34, P465, DOI 10.1067/mva.2001.117330; GMELIN E, 1989, RADIOLOGY, V171, P657; Goff CD, 2000, ANN VASC SURG, V14, P138, DOI 10.1007/s100169910025; Goto J, 2005, J JPN SOC DIAL THER, V38, P105; Gotoh Y, 2002, JAPAN GERMANY MED RE, V47, P526; Gotoh Y, 2004, JAP J RADIOL, V64, P564; Gouya T, 1999, BLOOD ACCESS, P59; Gray Richard J, 2002, DIALYSIS ACCESS A MU, P111; Gray RJ, 2000, J VASC INTERV RADIOL, V11, P1121, DOI 10.1016/S1051-0443(07)61352-9; Grontoft KC, 1998, SCAND J UROL NEPHROL, V32, P276; GRONTOFT KC, 1985, SCAND J UROL NEPHROL, V19, P55; Hagiwara H, 1999, KIDNEY DIAL S, V99, P45; Hamada H, 2001, KIDNEY DIAL S, V51, P13; Haruguchi H, 2007, VASCULAR ACCESS CONS, P142; Haruguchi H, 2009, KIDNEY DIAL S, V66, P101; Haruguchi H, 2004, CLIN DIAL, V20, P43; Haruguchi H, 2005, THER ENG, V17, P137; Haruguchi H, 2001, KIDNEY DIAL S, V50, P40; Hashimoto K, 2007, VASCULAR ACCESS TROU, V1023, P983; Hatakeyama T, 2008, JPN J VASC SURG, V17, P557; Hiranaka T, 2004, KIDNEY DIAL S, V57, P15; Hiranaka T, 2005, KIDNEY DIAL, V58, P379; Hiranaka T, 2002, KIDNEY DIAL S, V53, P24; Hiranaka T, 2005, KIDNEY DIAL S, V1, P24; Hiranaka T, 2001, VASCULAR ACCESS HEMO, P219; Hiranaka T, 2003, J JPN SOC DIAL THER, V36, P1259; Hoballah JJ, 2000, ANN VASC SURG, V14, P679, DOI 10.1007/s100169910122; Horimi H, 1993, J JPN SOC DIAL THER, V26, P1521; Huber TS, 2008, J VASC SURG, V48, P926, DOI 10.1016/j.jvs.2008.05.028; Ikeda K, 2004, KIDNEY DIAL S, V55, P94; Ikeda K, 2003, KIDNEY DIAL S1, V36, P891; Ikeda K, 2005, CLIN DIAL, V21, P1607; Ikeda K, 2009, CLIN DIAL, V25, P1111; Ishikawa K, 2000, KIDNEY DIAL S, V49, P100; Itou K, 2009, KIDNEY DIAL S, V66, P31; Itou M, 2007, KIDNEY DIAL, V63, P621; Japanese Society for Dialysis Therapy, 2009, J JPN SOC DIAL THER; Japanese Society for Dialysis Therapy, 2005, J JPN SOC DIAL THER, V38, P1491; Japanese Society of Dialysis Therapy Statistics Study Committee, 1999, CURR COND CHRON DIAL; Japanese Society of Dialysis Therapy Statistics Study Committee, 2009, CURR COND CHARON DIA; Japanese Society of Nephrology, 2009, CKD TREATM GUID 2009; Jean G, 2002, NEPHRON, V91, P399, DOI 10.1159/000064279; Jindal Kailash, 2006, J Am Soc Nephrol, V17, pS1; Kaneda H, 1995, Nihon Jinzo Gakkai Shi, V37, P564; Kannou Y, 2010, KIDNEY DIAL S, V69, P284; Kashiwakura M, 2005, KIDNEY DIAL S, V59, P109; KHERLAKIAN GM, 1986, AM J SURG, V152, P238, DOI 10.1016/0002-9610(86)90249-7; Kim S, 2001, KIDNEY DIAL S, V50, P53; Kim S, 2000, CLIN DIAL, V9, P47; Kim YO, 2001, AM J NEPHROL, V21, P221, DOI 10.1159/000046251; Kimata N, 2002, KIDNEY DIAL S1, V35, P254; Klevens R Monina, 2005, Nephrol News Issues, V19, P37; Knox RC, 2002, J VASC SURG, V36, P250, DOI 10.1067/mva.2002.125025; Ko PJ, 2009, WORLD J SURG, V33, P846, DOI 10.1007/s00268-008-9912-2; Kobayashi H, 2004, KIDNEY DIAL S, V57, P118; Koga R, 2006, KIDNEY DIAL S, V61, P35; Kolbeck KJ, 2008, J VASC INTERV RADIOL, V19, P1222, DOI 10.1016/j.jvir.2008.04.025; Komaba H, 2005, J JPN SOC DIAL THER, V38, P1361; Komatsu Y, 2009, J JPN ASS DIAL PHYS, V24, P244; Korbia LP, 2007, EXPERT REV ANTI-INFE, V5, P639; KRONUNG G, 1984, DIALYSIS TRANSPLANT, V13, P635; Kubota K, 1987, JPN J ARTIF ORGANS, V16, P1580; Kubota K, 1993, SHOWA U J MED SCI, V53, P138; Kukita K, 2006, KIDNEY DIAL S, V60, P34; Kukita K, 2010, KIDNEY DIAL S, V68, P69; Kukita K, 2008, JPN ASS DIAL PHYS CO, V17, P41; Kukita K, 2000, KIDNEY DIAL S, V49, P97; Kukita K, 2008, CLIN DIAL, V24, P107; Kukita K, 2006, KIDNEY DIAL S, V55, P75; Kukita K, 2007, VASCULAR ACCESS CONS, P172; Kukita K, 1992, CLIN DIAL, V8, P661; Kumagai F, 2009, J JPN SOC DIAL THER, V42, P529; Kumano K, 1986, CLIN DIAL, V2, P1164; Kung S-C, 2001, HEMODIAL INT, V5, P32; Kurashige Y, 2007, JPN J MED ULTRASOUND, V32, P17; Kurita N, 2011, THER APHER IN PRESS; Kurita N, 2007, KIDNEY DIAL S, V63, P141; Larsen E.L., 1991, DISINFECTION STERILI, P191; Lee JY, 2006, J ANTIMICROB CHEMOTH, V57, P1110, DOI 10.1093/jac/dk1098; MacRae JM, 2006, SEMIN DIALYSIS, V19, P349, DOI 10.1111/j.1525-139X.2006.00185.x; MacRae Jennifer M, 2004, Am J Kidney Dis, V43, pe17, DOI 10.1053/j.ajkd.2004.01.016; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Matsumoto N, 2002, J JPN SOC DIAL THER, V35, P29; Matsuo K, 2001, KIDNEY DIAL S, V1, P33; Mendes RR, 2002, J VASC SURG, V36, P460, DOI 10.1067/mva.2002.126544; Meyer F, 2002, ZBL CHIR, V127, P685, DOI 10.1055/s-2002-33705; Minakuchi J, 2003, KIDNEY DIAL S, V55, P94; Miyagawa T, 2006, J JPN SOC DIAL THER, V39, P1475; Miyata A, 2004, KIDNEY DIAL S, V57, P47; Mori Y, 2007, KIDNEY DIAL S, V63, P239; Morikane K, 2008, CDC GUID CENTR LIN A, P51; Morikane K, 2010, DIALYSIS CARE, V16, P1128; Morsy AH, 1998, J SURG RES, V74, P8, DOI 10.1006/jsre.1997.5206; Moss AH, 2001, AM J KIDNEY DIS, V37, P1081; Murakami K, 2004, KIDNEY DIAL S, V57, P67; Murakami K, 2009, KIDNEY DIAL S, V66, P211; Murakami K, 2003, KIDNEY DIAL S, V56, P39; Murakami M, 2009, KIDNEY DIAL S, V66, P158; Murakami M, 2010, J JPN SOC DIAL THER, V43, P225; Murotani N, 2008, VASCULAR PAIN TROUBL, P182; Murotani N, 2006, CURRENT TREATMENT CI, P46; Murotani N, 2007, VASCULAR ACCESS CONS, P49; Mwipatayi B P, 2006, Curr Surg, V63, P130, DOI 10.1016/j.cursur.2005.04.017; Nakagawa Y, 1996, CLIN DIAL, V12, P265; Nakagawa Y, 1993, J JPN SOC DIAL THER, V26, P1777; Nakagawa Y, 2001, KIDNEY DIAL, V50, P765; Nakamoto M, 1997, KIDNEY DIAL, V42, P14; Nakamura J, 2003, J JPN SOC DIAL THER, V36, P1207; Nakamura T, 2003, KIDNEY DIAL S, V55, P130; National Kidney Foundation, 2001, AM J KIDNEY DIS S, V37, pS137, DOI [10.1053/ajkd.2001.20785, DOI 10.1016/S0272-6386(01)70007-8]; National Kidney Foundation, 2005, AM J KIDNEY DIS S, V45, pS16; Negulescu O, 2003, CLIN NEPHROL, V59, P40; Nishi T, 2006, CLIN DIAL, V22, P85; NKF-DOQI, 1997, AM J KIDNEY DIS S, V30, ps155; Noguchi R, 2009, KIDNEY DIAL S, V66, P34; Nursal TZ, 2006, WORLD J SURG, V30, P1100, DOI 10.1007/s00268-005-0586-8; Ogawa T, 2009, J JPN SOC DIAL THER, V42, P245; Ohira S, 2004, J JPN SOC DIAL THER, V37, P1959; Ohira S, 2000, J ASS DIAL PHYSICIAN, V15, P221; Ohira S, 2007, VASCULAR ACCESS CONS, P42; Ohira S, 1991, SUPERVISED TRAINING, P57; Ohira S, 2002, CLIN DIAL, V18, P835; Ohira S, 1996, CLIN DIAL, V12, P155; Ohira S, 1999, BLOOD ACCESS INTERVE, P167; Ohira S, 2000, J JPN ASS DIAL PHYS, V15, P107; Ohira S, 2008, HEMODIALYSIS SAFE GU, P19; Ohira S, 2001, CLIN DIAL, V17, P927; Ohira S, 2007, VASCULAR ACCESS CONS, P65; Ohira S, 2005, KIDNEY DIAL, V58, P452; Ohira Seiji, 2006, Hemodial Int, V10, P173, DOI 10.1111/j.1542-4758.2006.00091.x; Ohira S, 2001, KIDNEY DIAL, V51, P714; Ohira S, 2004, J JPN ASS DIAL PHYS, V19, P301; Okada H, 2004, CLIN DIAL, V20, P361; Okamoto S, 1990, J JPN SOC DIAL THER, V23, P199; Onoue A, 2001, J OSAKA SOC DIAL THE, V20, P65; Onoue A, 2001, J OSAKA SOC DIAL THE, V19, P47; Ota K, 2003, J JPN SOC DIAL THER, V36, P1693; Ota K, 2004, DIALYSIS CARE, V10, P359; Ota K, 2003, APPL GRAFTS TRANSPLA, P15; Ota K, 2006, J JPN SOC DIAL THER, V39, P1395; Ota K, 2001, KIDNEY DIAL, V51, P235; Ota K, 2003, CHARACTERISTICS VASO, P15; Ota K, 1993, SHUNT METHODS PROCED, P72; Ota K, 2001, KIDNEY DIAL, V51, P841; Otsubo S, 2002, J JPN SOC DIAL THER, V35, P1125; Padberg Jr FT, 2008, J VASC SURG S, V48, P55; Papasavas Pavlos K, 2003, Vasc Endovascular Surg, V37, P179, DOI 10.1177/153857440303700304; PAVEK K, 1973, CARDIOVASC RES, V7, P419, DOI 10.1093/cvr/7.3.419; Pecorari M, 2000, J Vasc Access, V1, P158; Perini S, 2000, RADIOLOGY, V215, P129; Peters PJ, 2009, J AM SOC ECHOCARDIOG, V22; Polkinghorne K, 2008, NEPHROLOGY, V13, pS1, DOI [10.1111/j.1440-1797.2008.00992.x, 10.1111/j.1440-1797.2008-00992]; Polkinghorne KR, 2006, NEPHROL DIAL TRANSPL, V21, P2498, DOI 10.1093/ndt/gfl242; POULAIN F, 1991, CARDIOVASC INTER RAD, V14, P98, DOI 10.1007/BF02577703; Prakas T, 2004, DIALYSIS TRANSPLANT, V13, P623; Raynaud AC, 2002, DIALYSIS ACCESS MULT, P67; Rayner HC, 2003, KIDNEY INT, V63, P323, DOI 10.1046/j.1523-1755.2003.00724.x; REDFERN AB, 1995, J HAND SURG-AM, V20A, P199, DOI 10.1016/S0363-5023(05)80007-3; Robinson D, 1998, KIDNEY INT, V53, P1792, DOI 10.1046/j.1523-1755.1998.00954.x; Sai K, 2006, J JPN SOC DIAL THER, V39, P1203; Sakai S, 2008, J JPN ASS DIAL P S17, V17, P31; Sakai S, 1996, CLIN DIAL S, V12, P896; Sakai S, 1996, CLIN DIAL, V12, P120; Sakai S, 1982, KIDNEY DIAL, V13, P41; Sakashita Y, 2002, NEUROSONOLOGY, V15, P76; Sakata H, 2005, RENAL FAILURE SURG S, V36, P48; Sakka GS, 2002, CHEST, V121, P559; Sands JJ, 1999, ASAIO J, V45, P147, DOI 10.1097/00002480-199905000-00008; Sato M, 2008, KIDNEY DIAL S, V1, P77; Sato Y, 1996, CLIN DIAL, V12, P248; Satou N, 2008, KIDNEY DIAL S, V65, P197; Schanzer A, 2006, VASC MED, V11, P227, DOI 10.1177/1358863x06072204; Schanzer Harry, 2004, Semin Vasc Surg, V17, P45, DOI 10.1053/j.semvascsurg.2003.11.003; Schenk WG, 2000, J VASC SURG, V33, P883; Schild A Frederick, 2003, Vasc Endovascular Surg, V37, P27, DOI 10.1177/153857440303700104; Sexton DJ, 2001, INFECT DIS CLIN N AM, V15, P731, DOI 10.1016/S0891-5520(05)70170-7; Shibahara H, 2010, J JPN SOC DIAL THER, V43, P189; Shiota J, 2006, KIDNEY DIAL S, V61, P109; Siegel Jeffrey B, 2008, Tech Vasc Interv Radiol, V11, P181, DOI 10.1053/j.tvir.2008.09.005; Simoni G, 1994, Cardiovasc Surg, V2, P63; Smits Johannes H. M., 2001, Kidney International, V59, P1551, DOI 10.1046/j.1523-1755.2001.0590041551.x; Soejima K, 2003, KIDNEY DIAL S, V55, P135; Soejima K, 2006, KIDNEY DIAL S, V61, P50; Sorom AJ, 2002, SURGERY, V132, P135, DOI 10.1067/msy.2002.124932; Souma I, 2003, CLIN DIAL, V19, P1008; Spies C, 2004, ARCH INTERN MED, V164, P71, DOI 10.1001/archinte.164.1.71; Sprouse LR, 2004, J VASC SURG, V39, P578, DOI 10.1016/j.jvs.2003.09.034; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; STONE WJ, 1982, NEPHRON, V31, P184, DOI 10.1159/000182642; Suda H, 2009, KIDNEY DIAL S, V66, P43; Sugimoto T, 2006, KIDNEY DIAL S, V61, P7; Sugiura S, 2009, J JPN SOC DIAL THER, V42, P148; Sumura M, 2002, J JPN SOC DIAL THER, V35, P1199; Surowiec Scott M, 2004, Vasc Endovascular Surg, V38, P349, DOI 10.1177/153857440403800407; Swab SJ, 1999, KIDNEY INT, V56, P1; Takahashi J, 2010, J JPN SOC DIAL THER, V43, P171; Tanaka I, 1993, J JPN SOC DIAL THER, V26, P1287; Tanaka S, 2009, KIDNEY DIAL S, V66, P156; Taniguchi H, 2008, DIALYSIS SURVEILLA S, P162; Tessitore N, 2003, J AM SOC NEPHROL, V14, P1623, DOI 10.1097/01.ASN.0000069218.31647.39; TIMMIS AD, 1982, INT J ARTIF ORGANS, V5, P101; Tokumoto H, 2007, KIDNEY DIAL S, V63, P59; Toma S, 2003, NEPHROL DIAL TRANSPL, V18, P2118, DOI 10.1093/ndt/gfg321; Toma S, 2008, KIDNEY DIAL S, V1, P16; Trerotola SO, 1996, J VASC INTERV RADIOL, V7, P717, DOI 10.1016/S1051-0443(96)70838-2; Tsoulfas G, 2008, WORLD J SURG, V32, P1827, DOI 10.1007/s00268-008-9514-z; Tsuru K, 2009, KIDNEY DIAL S, V66, P39; TWARDOWSKI Z, 1979, DIALYSIS TRANSPLANT, V8, P978; Twardowski ZJ, 1998, AM J KIDNEY DIS, V31, P841, DOI 10.1016/S0272-6386(98)70054-X; Twardowski ZJ, 1996, SEMIN DIALYSIS, V9, P394; Uchino K, 2004, KIDNEY DIAL S, V57, P43; Ueda S, 1980, REHABILITATION, V87, P205; Valente JH, 2003, ANN EMERG MED, V41, P609, DOI 10.1067/mem.2003.137; VALJI K, 1995, RADIOLOGY, V196, P697; VANHERWEGHEM JL, 1986, NEPHRON, V42, P116; vansDuijnhoven EC, 2001, NEPHROL DIAL TRANSPL, V16, P368; vansHoek F, 2009, SEMIN DIALYSIS, V22, P204; Vascular Access Society(Europe), 2007, MAN REN PAT CLIN ALG; White GH, 2002, PLANNING PATIENT ASS, P7; WILBOURN AJ, 1983, NEUROLOGY, V33, P447; Willms L, 2008, SEMIN DIALYSIS, V21, P71, DOI 10.1111/j.1525-139X.2007.00381.x; WISSELINK W, 1993, AM J SURG, V166, P200, DOI 10.1016/S0002-9610(05)81056-6; Woo K, 2009, J VASC SURG, V50, P1405, DOI 10.1016/j.jvs.2009.07.090; Yanaba M, 2006, KIDNEY DIAL S, V61, P120; Yanagisawa R, 1992, J JPN SOC DIAL THER, V25, P1231; Yanagisawa R, 1995, J JPN SOC DIAL THER, V28, P1075; Yanagizawa Ryozo, 1995, Japanese Journal of Clinical Urology, V49, P131; Yasunaga T, 2006, PROBLEMS DIALYSIS TH, P39; Yerdel MA, 1997, NEPHROL DIAL TRANSPL, V12, P1684, DOI 10.1093/ndt/12.8.1684; Yoshikawa K, 1999, JPN J CLIN UROL, V53, P993; ZAMPOLLO A, 1985, ITAL J NEUROL SCI, V6, P323, DOI 10.1007/BF02232010	362	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	MAR	2015	19			1	SI		1	39		10.1111/1744-9987.12296		39	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CE7KV	WOS:000352019500001		
J	Nakao, T; Inaba, M; Abe, M; Kaizu, K; Shima, K; Babazono, T; Tomo, T; Hirakata, H; Akizawa, T				Nakao, Toshiyuki; Inaba, Masaaki; Abe, Masanori; Kaizu, Kazo; Shima, Kenji; Babazono, Tetsuya; Tomo, Tadashi; Hirakata, Hideki; Akizawa, Tadao		Japanese Soc Dialysis Therapy	Best Practice for Diabetic Patients on Hemodialysis 2012	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; RESTING ENERGY-EXPENDITURE; IMPROVES GLYCEMIC CONTROL; BLOOD-GLUCOSE CONTROL; PERIPHERAL ARTERIAL-DISEASE; RANDOMIZED CONTROLLED-TRIAL; AMERICAN-HEART-ASSOCIATION; REGULAR DIALYSIS TREATMENT; GLYCATED ALBUMIN LEVELS		[Nakao, Toshiyuki; Inaba, Masaaki; Abe, Masanori; Kaizu, Kazo; Shima, Kenji; Babazono, Tetsuya; Tomo, Tadashi; Hirakata, Hideki; Akizawa, Tadao; Japanese Soc Dialysis Therapy] Japanese Soc Dialysis Therapy, Tokyo, Japan	Inaba, M (reprint author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinolody & Mol Med, Abeno Ku, 1-4-3 Sahi Machi, Osaka 5458585, Japan.	inaba-m@med.osaka-cu.ac.jp			Kyowa Hakko Kirin Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Bayer Yakuhin, Ltd.; Astellas Pharma Inc.; Tomita Pharmaceutical Co., Ltd.; Baxter Ltd.; Shionogi Co., Ltd.; Nippon Boehringer Ingelheim Co. Ltd.; Soshinsha Co., Ltd.; Meiji Co., Ltd.; Novartis Pharma K.K; Daiichi Sankyo Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; MSD K.K.; Ono Pharmaceutical Co., Ltd.; Asahi Kasei Pharma Corp.; Teijin Pharma Ltd.; Sanofi K.K.	TA: has received research funds and honoraria from Kyowa Hakko Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Astellas Pharma Inc., Tomita Pharmaceutical Co., Ltd., Baxter Ltd., Shionogi & Co., Ltd., and Nippon Boehringer Ingelheim Co. Ltd.; TN: has received research funds and advisory fee from Soshinsha Co., Ltd., Meiji Co., Ltd., and Chugai Pharmaceutical Co., Ltd.; MA: has received research funds and honoraria from Kyowa Hakko Kirin Co., Ltd., Novartis Pharma K.K., and Daiichi Sankyo Co., Ltd.; MI: has received research funds and honoraria from Kyowa Hakko Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Takeda Pharmaceutical Co., Ltd. MSD K.K., Ono Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corp., Teijin Pharma Ltd. Sanofi K.K., and Daiichi Sankyo Co., Ltd.; KS: has received transportation fee from Asahi Kasei Pharma Corp.	Abe M, 2010, EXPERT OPIN PHARMACO, V11, P169, DOI 10.1517/14656560903530683; Abe M, 2010, ENDCRINE J, V57, P581; Abe Masanori, 2008, Diabetes Res Clin Pract, V82, pe17, DOI 10.1016/j.diabres.2008.07.020; Abe M, 2007, THER APHER DIAL, V11, P280, DOI 10.1111/j.1744-9987.2007.00491.x; American Diabetes Association, 2012, DIABETES CARE S1, V35, pS11, DOI DOI 10.2337/DC12-S011; Ben-Ami H, 1999, ARCH INTERN MED, V159, P281, DOI 10.1001/archinte.159.3.281; Peacock TP, 2008, KIDNEY INT, V73, P1062, DOI 10.1038/ki.2008.25; Shinohara K, 2002, J AM SOC NEPHROL, V13, P1894, DOI 10.1097/01.ASN.0000019900.87535.43; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Ohtake T, 2005, J AM SOC NEPHROL, V16, P1141, DOI 10.1681/ASN.2004090765; Inaba M, 2005, CALCIFIED TISSUE INT, V76, P256, DOI 10.1007/s00223-004-0094-0; Seidowsky A, 2009, CRIT CARE MED, V37, P2191, DOI 10.1097/CCM.0b013e3181a02490; Fishbane S, 1996, AM J KIDNEY DIS, V27, P668, DOI 10.1016/S0272-6386(96)90101-8; Okada T, 2011, INTERNAL MED, V50, P23, DOI 10.2169/internalmedicine.50.4129; McMurray SD, 2002, AM J KIDNEY DIS, V40, P566, DOI 10.1053/ajkd.2002.34915; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Kovesdy CP, 2010, SEMIN DIALYSIS, V23, P148, DOI 10.1111/j.1525-139X.2010.00701.x; KURZ P, 1994, KIDNEY INT, V46, P855, DOI 10.1038/ki.1994.342; Lukashevich V, 2011, DIABETES OBES METAB, V13, P947, DOI 10.1111/j.1463-1326.2011.01467.x; Shorr RI, 1997, ARCH INTERN MED, V157, P1681, DOI 10.1001/archinte.157.15.1681; Schumacher S, 2001, EUR J CLIN PHARMACOL, V57, P147, DOI 10.1007/s002280100280; Kimoto E, 2006, J AM SOC NEPHROL, V17, P2245, DOI 10.1681/ASN.2005101038; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; London GM, 2008, J AM SOC NEPHROL, V19, P1827, DOI 10.1681/ASN.2007050622; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Marz W, 2011, CLIN J AM SOC NEPHRO, V6, P1316, DOI 10.2215/CJN.09121010; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Abe M, 2008, NAT CLIN PRACT NEPHR, V4, P482, DOI 10.1038/ncpneph0881; Freedman BI, 2011, CLIN J AM SOC NEPHRO, V6, P1635, DOI 10.2215/CJN.11491210; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; Linnebjerg H, 2007, BRIT J CLIN PHARMACO, V64, P317, DOI 10.1111/j.1365-2125.2007.02890.x; Ricks J, 2012, DIABETES, V61, P708, DOI 10.2337/db11-1015; McCoy RG, 2012, DIABETES CARE, V35, P1897, DOI 10.2337/dc11-2054; BOUILLON R, 1995, J CLIN ENDOCR METAB, V80, P1194, DOI 10.1210/jc.80.4.1194; Shima K, 2010, NEPHROLOGY, V15, P632, DOI 10.1111/j.1440-1797.2010.01273.x; Hasslacher C, 2003, DIABETES CARE, V26, P886, DOI 10.2337/diacare.26.3.886; Abe M, 2007, THER APHER DIAL, V11, P288, DOI 10.1111/j.1744-9987.2007.00492.x; Marbury TC, 2000, CLIN PHARMACOL THER, V67, P7, DOI 10.1067/mcp.2000.103973; SELTZER HS, 1989, ENDOCRIN METAB CLIN, V18, P163; Hase H, 2006, KIDNEY INT, V70, P1142, DOI 10.1038/sj.ki.5001726; Abe M, 2007, CLIN NEPHROL, V68, P287; Hanefeld M, 2000, DIABETES CARE, V23, P202, DOI 10.2337/diacare.23.2.202; Koga M, 2009, DIABETES RES CLIN PR, V84, P163, DOI 10.1016/j.diabres.2009.01.013; Adragao T, 2012, NEPHROL DIAL TRANSPL, V27, P318, DOI 10.1093/ndt/gfr233; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Hayashino Y, 2007, DIABETOLOGIA, V50, P1170, DOI 10.1007/s00125-007-0650-z; Joki N, 1997, NEPHROL DIAL TRANSPL, V12, P718, DOI 10.1093/ndt/12.4.718; Riveline JP, 2009, NEPHROL DIAL TRANSPL, V24, P2866, DOI 10.1093/ndt/gfp181; Nishizawa Y, 2003, AM J KIDNEY DIS, V41, pS76, DOI [10.1053/ajkd.2003.50090, 10.1016/S0272-6386(03)00411-6]; Kamimura MA, 2007, EUR J CLIN NUTR, V61, P362, DOI 10.1038/sj.ejcn.1602516; Okada T, 2007, INTERNAL MED, V46, P807, DOI 10.2169/internalmedicine.46.6355; Ishimura E, 2002, DIABETOLOGIA, V45, P1446, DOI 10.1007/s00125-002-0920-8; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Kalantar-Zadeh K, 2007, DIABETES CARE, V30, P1049, DOI 10.2337/dc06-2127; Scott LJ, 2010, DRUGS, V70, P2051, DOI 10.2165/11205080-000000000-00000; RAMSEY DE, 1983, J CARDIOVASC SURG, V24, P43; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; Shurraw S, 2010, AM J KIDNEY DIS, V55, P875, DOI 10.1053/j.ajkd.2009.12.038; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Ito M, 2011, ENDOCR J, V58, P979; Cuppari L, 2004, J AM SOC NEPHROL, V15, P2933, DOI 10.1097/01.ASN.0000141961.49723.BC; Jacobsen LV, 2009, BRIT J CLIN PHARMACO, V68, P898, DOI 10.1111/j.1365-2125.2009.03536.x; Shoji T, 2001, J AM SOC NEPHROL, V12, P2117; Yu LS, 2007, BIOCHEM PHARMACOL, V73, P1842, DOI 10.1016/j.bcp.2007.02.004; Abe M, 2011, CURR DRUG METAB, V12, P57, DOI 10.2174/138920011794520053; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Koga M, 2008, DIABETES RES CLIN PR, V81, P258, DOI 10.1016/j.diabres.2008.04.012; Fukuoka K, 2008, NEPHROLOGY, V13, P278, DOI 10.1111/j.1440-1797.2007.00864.x; Nakao T, 1998, INTERNAL MED, V37, P826, DOI 10.2169/internalmedicine.37.826; Scheen AJ, 2010, DIABETES OBES METAB, V12, P648, DOI 10.1111/j.1463-1326.2010.01212.x; Pratley RE, 2007, DIABETES CARE, V30, P3017, DOI 10.2337/dc07-1188; Hayashi H, 1998, RETINA-J RET VIT DIS, V18, P156; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Morioka T, 2001, DIABETES CARE, V24, P909, DOI 10.2337/diacare.24.5.909; SCHNEEWEISS B, 1990, AM J CLIN NUTR, V52, P596; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Huttner S, 2008, J CLIN PHARMACOL, V48, P1171, DOI 10.1177/0091270008323753; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775; Fliser D, 1998, KIDNEY INT, V53, P1343, DOI 10.1046/j.1523-1755.1998.00898.x; Araki H, 1997, J JPN SOC DIAL THER, V30, P265; AstraZeneca K.K, 2014, BYETTA EXENATIDE INJ; Avesani CM, 2004, NEPHROL DIAL TRANSPL, V19, P3091, DOI 10.1093/ndt/gfh547; Avesani CM, 2001, NEPHROL DIAL TRANSPL, V16, P556, DOI 10.1093/ndt/16.3.556; Badian M., 1996, Drug Metabolism and Drug Interactions, V13, P69; Bazanelli AP, 2006, PERITON DIALYSIS INT, V26, P697; Bonds DE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b4909; Chujo Keiko, 2006, J Med Invest, V53, P223, DOI 10.2152/jmi.53.223; SHAMOON H, 1993, NEW ENGL J MED, V329, P977; DIAZBUXO JA, 1984, INT J ARTIF ORGANS, V7, P257; El Shahat Y, 1980, Proc Eur Dial Transplant Assoc, V17, P167; Freedman BI, 2010, PERITON DIALYSIS INT, V30, P72, DOI 10.3747/pdi.2008.00243; Fujikura J, 2003, J JPN DIABET SOC, V46, P484; Fujiwara T, 2000, J JPN SOC DIAL TH S1, V33, P858; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gale EAM, 2000, DIABETIC MED, V17, P209; Hashimoto T, 2008, J JPN DIABET SOC, V51, P560; Herz M, 2002, CLIN THER, V24, P73, DOI 10.1016/S0149-2918(02)85006-8; Home PD, 2000, DIABETIC MED, V17, P762, DOI 10.1046/j.1464-5491.2000.00380.x; Horacek J, 2007, NEPHROL DIAL TRANSPL, V22, P3553, DOI 10.1093/ndt/gfm436; HORI S, 1989, Folia Ophthalmologica Japonica, V40, P205; Ichikawa K, 2001, JPN J CLIN DIAL, V17, P91; Idris I, 2007, DIABETES OBES METAB, V9, P153, DOI 10.1111/j.1463-1326.2007.00705.x; Ikizler TA, 1996, J AM SOC NEPHROL, V7, P2646; Imanaka S, 2006, KIDNEY DIALYSIS, V60, P369; Inaba M, 2002, AM J KIDNEY DIS, V39, P1261, DOI 10.1053/ajkd.2002.33400; Inaba M, 2012, CLIN NEPHROL, V78, P273, DOI 10.5414/CN106940; Inoue T, 2003, CLIN NEPHROL, V60, P90; ISHIDA H, 1988, DIABETES, V37, P702, DOI 10.2337/diabetes.37.6.702; Ishii Akiko, 2002, Journal of the Japan Diabetes Society, V45, P737; Ishimura E, 2009, DIABETES RES CLIN PR, V83, P320, DOI 10.1016/j.diabres.2008.11.038; Ishimura E, 2001, AM J KIDNEY DIS, V38, pS186, DOI 10.1053/ajkd.2001.27440; Iwamoto Yasuhiko, 2001, Journal of the Japan Diabetes Society, V44, P799; Japan Atherosclerosis Society, 2007, GUID PREV ATH CARD D; Japan Diabetes Society, TREATM GUID DIAB 201; Japanese Society for Dialysis Therapy, 2004, REP STAT SURV COMM; Japanese Society for Dialysis Therapy, 2011, J JAP SOC DIAL THER, V44, P337; Johnston PS, 1998, J CLIN ENDOCR METAB, V83, P1515, DOI 10.1210/jc.83.5.1515; Kaizu K, 2005, J JPN SOC DIAL THER, V38, P1256; Kato A, 2012, J JPN SOC DIAL TH S1, V45, P846; Kazempour-Ardebili S, 2009, DIABETES CARE, V32, P1137, DOI 10.2337/dc08-1688; Kogrima M, 2006, J MED INVEST, V53, P34; Koyama A, 2006, J JPN SOC DIAL TH S1, V39, P845; Kurata K, 2001, ICU CCU, V25, pS223; Kure M, 1991, FOLIA OPHTHALMOL JPN, V42, P1060; Kuzuya T, 2000, J CLIN THERAP MED, V16, P1613; LALAU JD, 1989, INT J CLIN PHARM TH, V27, P285; Lepantalo M, 2012, DIABETES-METAB RES, V28, P40, DOI 10.1002/dmrr.2233; Martinez I, 1998, NEPHROL DIAL TRANSPL, V13, P9, DOI 10.1093/ndt/13.suppl_3.9; Medina RA, 1996, AM J KIDNEY DIS, V28, P226, DOI 10.1016/S0272-6386(96)90306-6; Ministry of Health Labour and Welfare, 2009, DIET REF INT JAP; MONTEON FJ, 1986, KIDNEY INT, V30, P741, DOI 10.1038/ki.1986.250; Murata GH, 2004, DIABETES RES CLIN PR, V65, P61, DOI 10.1016/j.diabres.2003.11.013; Nagai T, 2003, DIABETES RES CLIN PR, V59, P191, DOI 10.1016/S0168-8227(02)00242-5; Nakai S, 2004, THER APHER DIAL, V8, P3; Nakai S, 2006, THER APHER DIAL, V10, P476, DOI 10.1111/j.1744-9987.2006.00440.x; Nakai S, 2007, J JPN SOC DIAL THER, V40, P1; National Kidney Foundation, 2005, AM J KIDNEY DIS S, V45, pS1; Nawrocki J, 1997, Eur J Ophthalmol, V7, P283; Nitta K, 2004, HYPERTENS RES, V27, P527, DOI 10.1291/hypres.27.527; Okada T, 2002, NEPHROLOGY, V7, P250, DOI 10.1046/j.1440-1797.2002.00121.x; Okada T, 2005, J JPN SOC DIAL THER, V38, P31; O'Sullivan AJ, 2002, AM J KIDNEY DIS, V39, P369, DOI 10.1053/ajkd.2002.30558; Partley RE, 2009, EXPERT OPIN PHARMACO, V10, P503; Reilly JB, 2010, SEMIN DIALYSIS, V23, P163, DOI 10.1111/j.1525-139X.2010.00703.x; Richter B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006739.pub2; RICO H, 1989, CALCIFIED TISSUE INT, V45, P71, DOI 10.1007/BF02561404; Saenz A, 2005, COCHRANE DB SYST REV, pCD00, DOI DOI 10.1002/14651858.CD002966.PUB3; Sakuda Y, 2006, OKINAWA MED J, V45, P75; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Shen Y, 2005, NEPHROLOGY, V10, P599, DOI 10.1111/j.1440-1797.2005.00490.x; Shidara K, 2008, CALCIFIED TISSUE INT, V82, P278, DOI 10.1007/s00223-008-9127-4; Shiga N, 2002, J JPN DIABET SOC, V45, P632; Nathan DM, 2005, NEW ENGL J MED, V353, P2643; Sugimoto T, 2011, CLIN GUIDELINES FRAC; SUZUKI Y, 1995, NEPHROL DIAL TRANSPL, V10, P47; Taira S, 2010, J JPN DIABET SOC S1, V53, pS; Takahashi Yoshiastu, 1998, Journal of the Japan Diabetes Society, V41, P165; Takeda M, 1989, OPHTHALMOLOGY, V31, P849; Diabet Contr Complicat Trial Res Grp, 1998, ARCH OPHTHALMOL-CHIC, V116, P874; The Japan Diabetes Society, 2010, EV BAS PRACT GUID TR; The Japanese Society of Hypertension, 2009, GUID MAN HYP JSH2009; The National Kidney Foundation-Kidney Disease Outcomes Quality Initiative, 2007, AM J KIDNEY DIS, V49, pS62; Tokuyama T, 1994, J EYE, V11, P1069; Tominaga N, 2004, J OSAKA SOC DIAL THE, V22, P102; Tomonaga Osamu, 1995, Journal of the Japan Diabetes Society, V38, P839; Turner RC, 1998, LANCET, V352, P854; Turner RC, 1998, LANCET, V352, P837; Urahama Y, 2009, J JPN SOC DIAL TH S1, V42, P643; Williams ME, 2006, KIDNEY INT, V70, P1503, DOI 10.1038/sj.ki.5001789; Wu MS, 1997, NEPHROL DIAL TRANSPL, V12, P2105, DOI 10.1093/ndt/12.10.2105; Yale JF, 2005, J AM SOC NEPHROL, V16, pS7, DOI 10.1681/ASN.2004110974; Yamada S, 2008, CLIN ENDOCRINOL, V69, P189, DOI 10.1111/j.1365-2265.2008.03187.x; Yamaguchi K, 2002, J JPN SOC DIAL TH S1, V33, P981; YOSHIDA O, 1995, MINER ELECTROL METAB, V21, P201	179	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	MAR	2015	19			1	SI		40	66		10.1111/1744-9987.12299		27	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CE7KV	WOS:000352019500002		
J	Watanabe, Y; Kawanishi, H; Suzuki, K; Nakai, S; Tsuchida, K; Tabei, K; Akiba, T; Masakane, I; Takemoto, Y; Tomo, T; Itami, N; Komatsu, Y; Hattori, M; Mineshima, M; Yamashita, A; Saito, A; Naito, H; Hirakata, H; Minakuchi, J				Watanabe, Yuzo; Kawanishi, Hideki; Suzuki, Kazuyuki; Nakai, Shigeru; Tsuchida, Kenji; Tabei, Kaoru; Akiba, Takashi; Masakane, Ikuto; Takemoto, Yoshiaki; Tomo, Tadashi; Itami, Noritomo; Komatsu, Yasuhiro; Hattori, Motoshi; Mineshima, Michio; Yamashita, Akihiro; Saito, Akira; Naito, Hidemune; Hirakata, Hideki; Minakuchi, Jun		Japanese Soc Dialysis Therapy	Japanese Society for Dialysis Therapy Clinical Guideline for "Maintenance Hemodialysis: Hemodialysis Prescriptions"	THERAPEUTIC APHERESIS AND DIALYSIS			English	Review							BODY-SURFACE AREA; NOCTURNAL HOME HEMODIALYSIS; LOW-FLUX HEMODIALYSIS; CHRONIC-RENAL-FAILURE; SERUM BETA(2)-MICROGLOBULIN LEVEL; NATIONAL COOPERATIVE DIALYSIS; LEFT-VENTRICULAR HYPERTROPHY; BLOOD-PRESSURE CONTROL; IN-CENTER HEMODIALYSIS; PROTEIN CATABOLIC RATE		[Watanabe, Yuzo; Kawanishi, Hideki; Suzuki, Kazuyuki; Nakai, Shigeru; Tsuchida, Kenji; Tabei, Kaoru; Akiba, Takashi; Masakane, Ikuto; Takemoto, Yoshiaki; Tomo, Tadashi; Itami, Noritomo; Komatsu, Yasuhiro; Hattori, Motoshi; Mineshima, Michio; Yamashita, Akihiro; Saito, Akira; Naito, Hidemune; Hirakata, Hideki; Minakuchi, Jun; Japanese Soc Dialysis Therapy] Japanese Soc Dialysis Therapy, Tokyo, Japan	Kawanishi, H (reprint author), Tsuchiya Gen Hosp, Naka Ku, 3-30 Nakajima Cho, Hiroshima 7308655, Japan.	h-kawanishi@tsuchiya-hp.jp			Chugai Pharmaceutical Co., Ltd.; Bayer Yakuhin Ltd.; Kyowa Hakko Kirin Co., Ltd.; Astellas Pharma Inc.; Nikkiso Co., Ltd.; Japan Tobacco Inc.; Novartis Pharma K.K; Toray Industries Inc.; Toray Medical Co., Ltd.; JMS Co., Ltd.	Hideki Kawanishi has received research funds and honoraria from Chugai Pharmaceutical Co., Ltd., Bayer Yakuhin Ltd., Kyowa Hakko Kirin Co., Ltd., Astellas Pharma Inc., Nikkiso Co., Ltd., and Japan Tobacco Inc.; Takashi Akiba has received research funds and honoraria from Novartis Pharma K.K, Toray Industries Inc., Kyowa Hakko Kirin Co., Ltd., Japan Tobacco Inc., Astellas Pharma Inc., and Toray Medical Co., Ltd.; Akihiro Yamashita has received advisory fee and honoraria from Nikkiso Co., Ltd., JMS Co., Ltd., and Toray Industries Inc.	Abe T, 2003, KIDNEY INT, V64, P1522, DOI 10.1046/j.1523-1755.2003.00235.x; Abu-Alfa AK, 2002, KIDNEY INT, V62, pS8; Ahrenholz P, 1997, INT J ARTIF ORGANS, V20, P81; ALFURAYH O, 1993, CLIN CARDIOL, V16, P791; Al-Hejaili F, 2003, J AM SOC NEPHROL, V14, P2322, DOI 10.1097/01.ASN.0000083044.42480.C1; Andre MB, 2002, AM J NEPHROL, V22, P473, DOI 10.1159/000065280; Ramirez SPB, 2012, CLIN J AM SOC NEPHRO, V7, P1977, DOI 10.2215/CJN.00390112; Ting GO, 2003, AM J KIDNEY DIS, V42, P1020, DOI 10.1053/S0272-6386(03)07059-X; Kjellstrand CM, 2008, NEPHROL DIAL TRANSPL, V23, P3283, DOI 10.1093/ndt/gfn210; Narita I, 2006, KIDNEY INT, V69, P1626, DOI 10.1038/sj.ki.5000251; Hoppe A, 2011, J PEDIATR-US, V158, P64, DOI 10.1016/j.jpeds.2010.06.036; Foley RN, 2002, KIDNEY INT, V62, P1784, DOI 10.1046/j.1523-1755.2002.00636.x; Agarwal R, 2003, AM J MED, V115, P291, DOI 10.1016/S0002-9343(03)00366-8; Brunet P, 1996, NEPHROL DIAL TRANSPL, V11, P46; BABB AL, 1971, T AM SOC ART INT ORG, V17, P81; VERTES V, 1969, NEW ENGL J MED, V280, P978, DOI 10.1056/NEJM196905012801802; CHARRA B, 1992, KIDNEY INT, V41, P1286, DOI 10.1038/ki.1992.191; Fischbach M, 2005, PEDIATR NEPHROL, V20, P1054, DOI 10.1007/s00467-005-1876-y; Port FK, 2002, J AM SOC NEPHROL, V13; Horl MP, 2002, AM J KIDNEY DIS, V39, P227, DOI 10.1053/ajkd.2002.30542; Luik AJ, 2001, AM J NEPHROL, V21, P471, DOI 10.1159/000046651; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; Bloembergen WE, 1996, KIDNEY INT, V50, P557, DOI 10.1038/ki.1996.349; LOWRIE EG, 1981, NEW ENGL J MED, V305, P1176, DOI 10.1056/NEJM198111123052003; Lopes AA, 2004, KIDNEY INT, V66, P2047, DOI 10.1111/j.1523-1755.2004.00977.x; Lindberg M, 2007, J PSYCHOSOM RES, V63, P167, DOI 10.1016/j.jpsychores.2007.03.013; Ramirez R, 2007, KIDNEY INT, V72, P108, DOI 10.1038/sj.ki.5002250; Marshall MR, 2006, KIDNEY INT, V69, P1229, DOI 10.1038/sj.ki.5000188; Stefanidis CJ, 2007, PEDIATR NEPHROL, V22, P1251, DOI 10.1007/s00467-007-0481-7; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Ouseph R, 2001, AM J KIDNEY DIS, V37, P316, DOI 10.1053/ajkd.2001.21296; Agarwal R, 2009, HYPERTENSION, V53, P500, DOI 10.1161/HYPERTENSIONAHA.108.125674; Daugirdas JT, 2010, CLIN J AM SOC NEPHRO, V5, P1628, DOI 10.2215/CJN.02350310; Suri RS, 2007, KIDNEY INT, V71, P349, DOI 10.1038/sj.ki.5002032; Spalding EM, 2002, KIDNEY INT, V61, P655, DOI 10.1046/j.1523-1755.2002.00146.x; Locatelli F, 2010, J AM SOC NEPHROL, V21, P1798, DOI 10.1681/ASN.2010030280; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Shoji T, 2004, KIDNEY INT, V66, P1212, DOI 10.1111/j.1523-1755.2004.00812.x; Pohlmeier R, 2001, Kidney Int Suppl, V78, pS190; Santoro A, 2008, AM J KIDNEY DIS, V52, P507, DOI 10.1053/j.ajkd.2008.05.011; Wizemann V, 2000, NEPHROL DIAL TRANSPL, V15, P43; Ayus JC, 2007, KIDNEY INT, V71, P336, DOI 10.1038/sj.ki.5002044; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Okuno S, 2009, NEPHROL DIAL TRANSPL, V24, P571, DOI 10.1093/ndt/gfn521; Chan CT, 2002, KIDNEY INT, V61, P2235, DOI 10.1046/j.1523-1755.2002.00362.x; Kjellstrand CM, 2011, HEMODIAL INT, V15, P226, DOI 10.1111/j.1542-4758.2011.00538.x; Tentori F, 2012, NEPHROL DIAL TRANSPL, V27, P4180, DOI 10.1093/ndt/gfs021; Inrig JK, 2007, KIDNEY INT, V71, P454, DOI 10.1038/sj.ki.5002077; Ahmad S, 2004, SEMIN DIALYSIS, V17, P284, DOI 10.1111/j.0894-0959.2004.17328.x; Daugirdas JT, 2012, J AM SOC NEPHROL, V23, P727, DOI 10.1681/ASN.2011070688; Sarkar SR, 2006, KIDNEY INT, V70, P1832, DOI 10.1038/sj.ki.5001895; Depner T, 2004, KIDNEY INT, V65, P1386, DOI 10.1111/j.1523-1755.2004.00519.x; Galland R, 2001, KIDNEY INT, V60, P1555, DOI 10.1046/j.1523-1755.2001.00959.x; Elder SJ, 2008, NEPHROL DIAL TRANSPL, V23, P998, DOI 10.1093/ndt/gfm630; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Lornoy W, 2000, NEPHROL DIAL TRANSPL, V15, P49; Mailloux LU, 2000, SEMIN DIALYSIS, V13, P150, DOI 10.1046/j.1525-139x.2000.00040.x; Brunelli SM, 2010, KIDNEY INT, V77, P630, DOI 10.1038/ki.2009.523; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Port FK, 2004, AM J KIDNEY DIS, V43, P1014, DOI 10.1053/j.ajkd.2004.02.014; SHINZATO T, 1994, NEPHRON, V67, P280; BARTH RH, 1993, KIDNEY INT, V43, pS252; Vilar E, 2009, CLIN J AM SOC NEPHRO, V4, P1944, DOI 10.2215/CJN.05560809; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; McGregor DO, 2001, BLOOD PURIFICAT, V19, P293, DOI 10.1159/000046957; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Kopple JD, 1999, KIDNEY INT, V56, P1136, DOI 10.1046/j.1523-1755.1999.00615.x; Suri RS, 2013, J AM SOC NEPHROL, V24, P498, DOI 10.1681/ASN.2012060595; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Uhlig K, 2006, KIDNEY INT, V70, P2058, DOI 10.1038/sj.ki.5001875; DESTRIHOU CV, 1991, KIDNEY INT, V39, P1012, DOI 10.1038/ki.1991.128; Marshall MR, 2011, AM J KIDNEY DIS, V58, P782, DOI 10.1053/j.ajkd.2011.04.027; Eloot S, 2008, KIDNEY INT, V73, P765, DOI 10.1038/sj.ki.5002750; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Penne EL, 2010, CLIN J AM SOC NEPHRO, V5, P80, DOI 10.2215/CJN.03340509; Jain SR, 2001, PEDIATR NEPHROL, V16, P15; Vaithilingam I, 2004, AM J KIDNEY DIS, V43, P85, DOI 10.1053/j.ajkd.2003.09.016; Canaud B, 2006, KIDNEY INT, V69, P2087, DOI 10.1038/sj.ki.5000447; Saran R, 2006, KIDNEY INT, V69, P1222, DOI 10.1038/sj.ki.5000186; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; Cianciolo G, 2007, INT J ARTIF ORGANS, V30, P864; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Daugirdas JT, 2008, SEMIN DIALYSIS, V21, P415, DOI 10.1111/j.1525-139X.2008.00482.x; Spalding EM, 2008, KIDNEY INT, V74, P348, DOI 10.1038/ki.2008.185; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Panichi V, 2008, NEPHROL DIAL TRANSPL, V23, P2337, DOI 10.1093/ndt/gfm951; Koda Y, 1997, KIDNEY INT, V52, P1096, DOI 10.1038/ki.1997.434; Cheung AK, 2008, CLIN J AM SOC NEPHRO, V3, P69, DOI 10.2215/CJN.02340607; Hirakata H, 2012, THER APHER DIAL, V16, P387, DOI 10.1111/j.1744-9987.2012.01088.x; Ding F, 2002, ARTIF ORGANS, V26, P169, DOI 10.1046/j.1525-1594.2002.06877.x; Rocco MV, 2001, AM J NEPHROL, V21, P280, DOI 10.1159/000046262; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P689, DOI 10.1053/j.ajkd.2011.12.020; Chan C, 2002, NEPHROL DIAL TRANSPL, V17, P1518, DOI 10.1093/ndt/17.8.1518; Wilson J, 2004, SEMIN DIALYSIS, V17, P260, DOI 10.1111/j.0894-0959.2004.17323.x; Bammens B, 2004, AM J KIDNEY DIS, V44, P278, DOI 10.1053/j.ajkd.2004.04.033; BLUMBERG A, 1967, LANCET, V2, P69; Bosch Juan P, 2006, Hemodial Int, V10, P73, DOI 10.1111/j.1542-4758.2006.01178.x; Buoncristiani U, 1999, MINER ELECTROL METAB, V25, P90, DOI 10.1159/000057427; CALZAVARA P, 1990, INT J ARTIF ORGANS, V13, P323; Chan CT, 2005, KIDNEY INT, V68, P338, DOI 10.1111/j.1523-1755.2005.00411.x; Charra B, 1999, MINER ELECTROL METAB, V25, P391, DOI 10.1159/000057480; Chertow GM, 1999, KIDNEY INT, V56, P1872, DOI 10.1046/j.1523-1755.1999.00734.x; COLLINS AJ, 1994, AM J KIDNEY DIS, V23, P272; Committee for Preparing Hypertension Treatment Guidelines Japanese Society of Hypertension, 2009, HYP TREATM GUID 2009; Committee of the Japanese Society of Nephrology, 2007, NIHON JINZO GAKKAI S, V49, P871; Coyne DW, 1997, J AM SOC NEPHROL, V8, P1315; DAUGIRDAS JT, 1989, INT J ARTIF ORGANS, V12, P411; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; DAUGIRDAS JT, 1995, ASAIO J, V41, pM719, DOI 10.1097/00002480-199507000-00107; Daugirdas JT, 2008, SEMIN DIALYSIS, V21, P377, DOI 10.1111/j.1525-139X.2008.00483.x; Daugirdas JT, 2010, CLIN J AM SOC NEPHRO, V5, P821, DOI 10.2215/CJN.08171109; Depner TA, 2003, ADV RENAL REPLACE TH, V10, P71, DOI 10.1053/jarr.2003.50007; Drueke TB, 2000, NEPHROL DIAL TRANSPL, V15, P17; Fujimori A, 2011, CONTRIB NEPHROL, V168, P129, DOI 10.1159/000321751; Fukagawa M, 2010, J JPN SOC DIAL THER, V43, P347, DOI DOI 10.1038/SJ.KI.5001875; Gejyo F, 1995, ARTIF ORGANS, V19, P1222, DOI 10.1111/j.1525-1594.1995.tb02289.x; Goldstein SL, 2002, PEDIATR NEPHROL, V17, P531, DOI 10.1007/s00467-002-0925-z; Goldstein SL, 2008, PEDIATR NEPHROL, V23, P129, DOI 10.1007/s00467-007-0649-1; Greenbaum LA, 2011, NELSON TXB PEDIAT, P212; Gunal AI, 2001, AM J KIDNEY DIS, V37, P588, DOI 10.1053/ajkd.2001.22085; HAKIM RM, 1994, AM J KIDNEY DIS, V23, P661; Hauk M, 2000, AM J KIDNEY DIS, V35, P105, DOI 10.1016/S0272-6386(00)70308-8; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; HELD PJ, 1991, JAMA-J AM MED ASSOC, V265, P871, DOI 10.1001/jama.265.7.871; Huang ZP, 2005, SEMIN DIALYSIS, V18, P30; Jindal Kailash, 2006, J Am Soc Nephrol, V17, pS1; JOHNSON WJ, 1972, MAYO CLIN PROC, V47, P21; Juarez-Congelosi M, 2007, J RENAL NUTR, V17, P269, DOI 10.1053/j.jru.2007.04.002; Kawanishi H, 2005, J JPN SOC DIAL THER, V38, P149; Kawanishi H, 2009, THER APHER DIAL, V13, P161, DOI 10.1111/j.1744-9987.2009.00674.x; Kawanishi H, 2012, J JPN SOC DIAL THER, V45, P435; Kawanishi H, 2013, J JAP SOC DIAL THER, V46, P501; K/DOQI Workgroup, 2005, AM J KIDNEY DIS S, V45, pS1, DOI DOI 10.1053/J.AJKD.2005.02.002; Kim K, 1976, RINSHO BYORI, V24, P687; Kim ST, 2006, KIDNEY DIALYSIS S61, P23; Kim ST, 2006, KIDNEY DIALYSIS S61, P33; Kooistra MP, 1998, NEPHROL DIAL TRANSPL, V13, P2853, DOI 10.1093/ndt/13.11.2853; Kooman JP, 2003, SEMIN DIALYSIS, V16, P351, DOI 10.1046/j.1525-139X.2003.16070.x; Koshikawa S, 2003, NEPHRON CLIN PRACT, V95, pC23, DOI 10.1159/000073015; Kotanko P, 2007, INT J ARTIF ORGANS, V30, P993; Kurella M, 2005, SEMIN NEPHROL, V25, P90, DOI 10.1016/j.semnephrol.2004.09.015; Leypoldt JK, 2001, AM J KIDNEY DIS, V38, P575, DOI 10.1053/ajkd.2001.26883; Leypoldt JK, 2002, CONTRIB NEPHROL, V137, P129; Lin CL, 2002, BLOOD PURIFICAT, V20, P349, DOI 10.1159/000063103; Lindsay RM, 2011, HEMODIAL INT, V15, P15, DOI 10.1111/j.1542-4758.2010.00521.x; Lindsay RM, 2003, AM J KIDNEY DIS, V42, pS24, DOI 10.1016/S0272-6386(03)00534-1; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; Locatelli F, 1999, KIDNEY INT, V55, P286, DOI 10.1046/j.1523-1755.1999.00236.x; Locatelli F, 2012, NEPHROL DIAL TRANSPL, V27, P3594, DOI 10.1093/ndt/gfs117; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1058, DOI 10.1093/ndt/gfh103; Lowrie EG, 1999, KIDNEY INT, V56, P729, DOI 10.1046/j.1523-1755.1999.00584.x; MacLeod AM, 2001, COCHRANE DB SYST REV; Marsenic O, 2001, NEPHRON, V88, P273, DOI 10.1159/000046002; Carracedo J, 2006, J AM SOC NEPHROL, V17, P2315, DOI 10.1681/ASN.2006020105; Masakane I, 2004, BLOOD PURIFICAT, V22, P49, DOI 10.1159/000081875; Masakane I, 2011, CONTRIB NEPHROL, V168, P53, DOI 10.1159/000321744; Michael M, 2004, PEDIATR NEPHROL, V19, P432, DOI 10.1007/s00467-003-1400-1; Minakuchi J, 2008, KIDNEY DIAL, V65, P18; Mineshima M, 2010, JPN J CLIN DIAL, V26, P25; Mitsnefes MM, 2006, PEDIATR NEPHROL, V21, P1167, DOI 10.1007/s00467-006-0180-9; Movilli E, 2007, NEPHROL DIAL TRANSPL, V22, P3547, DOI 10.1093/ndt/gfm466; Muller D, 2008, PEDIATR NEPHROL, V23, P1729, DOI 10.1007/s00467-008-0783-4; Nakai S, 2001, AM J KIDNEY DIS, V38, pS212, DOI 10.1053/ajkd.2001.27449; Nakai S, 2011, J JPN SOC DIAL THER, V44, P1; National Kidney Foundation, 2001, AM J KIDNEY DIS S, V37, pS34; National Kidney Foundation, 2006, AM J KIDNEY DIS, V48, ps12; PARKER TF, 1994, AM J KIDNEY DIS, V23, P670; Pauly RP, 2010, CLIN J AM SOC NEPHRO, V5, P1815, DOI 10.2215/CJN.00300110; Pierratos A, 1999, NEPHROL DIAL TRANSPL, V14, P2835, DOI 10.1093/ndt/14.12.2835; RONCO C, 1988, INT J ARTIF ORGANS, V11, P169; Ronco C, 1988, Contrib Nephrol, V61, P46; Ronco C, 1998, NEPHROL DIAL TRANSPL, V13, P3, DOI 10.1093/ndt/13.suppl_6.3; RONCO C, 1990, NEPHROL DIAL TRANSPL, V5, P109; RossMorton A, 2007, SEMIN DIALYSIS, V20, P12, DOI 10.1111/j.1525-139X.2007.00232.x; SADOWSKI RH, 1993, J AM SOC NEPHROL, V4, P1192; SAITO A, 1986, CLIN CHEM, V32, P1938; Salahudeen AK, 2003, NEPHROL DIAL TRANSPL, V18, P1339, DOI 10.1093/ndt/gfg162; Scribner BH, 1999, NEPHROL DIAL TRANSPL, V14, P2599, DOI 10.1093/ndt/14.11.2599; Shinzato T, 1997, NEPHROL DIAL TRANSPL, V12, P884, DOI 10.1093/ndt/12.5.884; Shinzato T, 2001, J JAP SOC DIAL THER, V34, P1; SIGDELL JE, 1986, ARTIF ORGANS, V10, P219, DOI 10.1111/j.1525-1594.1986.tb02550.x; Singer MA, 2000, AM J KIDNEY DIS, V35, P306, DOI 10.1016/S0272-6386(00)70341-6; Srivaths PR, 2009, PEDIATR NEPHROL, V24, P951, DOI 10.1007/s00467-007-0728-3; Stegmayr BG, 2006, INT J ARTIF ORGANS, V29, P675; Su WS, 2011, HEMODIAL INT, V15, P219, DOI 10.1111/j.1542-4758.2011.00533.x; Suzuki K, 2010, J JAP SOC DIAL THER, V43, P551; Tattersall J, 2007, NEPHROL DIAL TRANSPL, V22, pii22; The Japanese Society for Dialysis Therapy, 2002, FACT REL 1 YEAR SURV, P560; The Japanese Society for Dialysis Therapy, 2000, FACT REL 6 YEAR PROG, P994; The Japanese Society for Dialysis Therapy, 2009, ILL OV REG DIAL TREA; The Japanese Society for Dialysis Therapy, 2008, ILL OV REG DIAL TREA; The Japanese Society for Dialysis Therapy, 2010, IND REL DIAL PRESCR, P66; The Japanese Society for Dialysis Therapy, 2008, OV REG DIAL TREATM J; The Japanese Society for Dialysis Therapy, 2010, ILL OV REG DIAL TREA; The Japanese Society of Hypertension, 2009, SECT 10 PED HYP HYP, P83; THOMSON GE, 1967, ARCH INTERN MED, V120, P153, DOI 10.1001/archinte.120.2.153; Trivedi Hariprasad S, 2007, Hemodial Int, V11, P424, DOI 10.1111/j.1542-4758.2007.00212.x; Tsuchida K, 2011, CONTRIB NEPHROL, V173, P76, DOI 10.1159/000328957; Tsuchida K, 2011, CONTRIB NEPHROL, V168, P179, DOI 10.1159/000321759; Twardowski ZJ, 2004, INT J ARTIF ORGANS, V27, P452; Twardowski ZJ, 2008, HEMODIAL INT, V12, P412, DOI 10.1111/j.1542-4758.2008.00304.x; Vanholder R, 2003, KIDNEY INT, V63, pS6; Ward R, 1999, IEEE SPECTRUM, V36, P6; Wolfe RA, 2000, AM J KIDNEY DIS, V35, P80, DOI 10.1016/S0272-6386(00)70305-2; Zucchelli P, 1988, SEMIN NEPHROL, V8, P168	212	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	MAR	2015	19			1	SI		67	92		10.1111/1744-9987.12294		26	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CE7KV	WOS:000352019500003		
J	Watanabe, Y; Yamagata, K; Nishi, S; Hirakata, H; Hanafusa, N; Saito, C; Hattori, M; Itami, N; Komatsu, Y; Kawaguchi, Y; Tsuruya, K; Tsubakihara, Y; Suzuki, K; Sakai, K; Kawanishi, H; Inaguma, D; Yamamoto, H; Takemoto, Y; Mori, N; Okada, K; Hataya, H; Akiba, T; Iseki, K; Tomo, T; Masakane, I; Akizawa, T; Minakuchi, J				Watanabe, Yuzo; Yamagata, Kunihiro; Nishi, Shinichi; Hirakata, Hideki; Hanafusa, Norio; Saito, Chie; Hattori, Motoshi; Itami, Noritomo; Komatsu, Yasuhiro; Kawaguchi, Yoshindo; Tsuruya, Kazuhiko; Tsubakihara, Yoshiharu; Suzuki, Kazuyuki; Sakai, Ken; Kawanishi, Hideki; Inaguma, Daijo; Yamamoto, Hiroyasu; Takemoto, Yoshiaki; Mori, Noriko; Okada, Kazuyoshi; Hataya, Hiroshi; Akiba, Takashi; Iseki, Kunitoshi; Tomo, Tadashi; Masakane, Ikuto; Akizawa, Tadao; Minakuchi, Jun		Japanese Soc Dialysis Therapy	Japanese Society for Dialysis Therapy Clinical Guideline for "Hemodialysis Initiation for Maintenance Hemodialysis"	THERAPEUTIC APHERESIS AND DIALYSIS			English	Review							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; PREDIALYSIS NEPHROLOGY CARE; GLOMERULAR-FILTRATION-RATE; GLOBAL OUTCOMES KDIGO; QUALITY-OF-LIFE; VASCULAR ACCESS; SERUM CREATININE; ESRD PATIENTS; PSYCHOEDUCATIONAL INTERVENTION		[Watanabe, Yuzo; Yamagata, Kunihiro; Nishi, Shinichi; Hirakata, Hideki; Hanafusa, Norio; Saito, Chie; Hattori, Motoshi; Itami, Noritomo; Komatsu, Yasuhiro; Kawaguchi, Yoshindo; Tsuruya, Kazuhiko; Tsubakihara, Yoshiharu; Suzuki, Kazuyuki; Sakai, Ken; Kawanishi, Hideki; Inaguma, Daijo; Yamamoto, Hiroyasu; Takemoto, Yoshiaki; Mori, Noriko; Okada, Kazuyoshi; Hataya, Hiroshi; Akiba, Takashi; Iseki, Kunitoshi; Tomo, Tadashi; Masakane, Ikuto; Akizawa, Tadao; Minakuchi, Jun; Japanese Soc Dialysis Therapy] Japanese Soc Dialysis Therapy, Tokyo, Japan	Watanabe, Y (reprint author), Kasugai Municipal Hosp, 1-1-1 Takagi, Kasugai, Aichi 4868510, Japan.	yuzo@hospital.kasugai.aichi.jp			Chugai Pharmaceutical Co., Ltd; Kyowa Hakko Kirin Co., Ltd; Dainihon Sumitomo Pharmaceutical Co., Ltd; Daiichi Sankyo Co., Ltd; Shionogi Pharmaceutical Co., Ltd.; Torii Pharmaceutical Co., Ltd; Fuso Pharmaceutical Co., Ltd; Takeda Pharmaceutical Co., Ltd; Baxter Co., Ltd.; Tanabe Mitsubishi Pharmaceutical Co., Ltd; Asahi-Kasei Pharmaceutical Co., Ltd; Bayer Yakuhin Ltd; Astellas Pharma Inc.; Nikkiso Co., Ltd; Japan Tobacco Inc.; Toray Industries Inc.; Otsuka Pharmaceutical Co., Ltd; Toray Medical Co., Ltd.; Teijin Pharma K.K; Shionogi Pharmaceutical Co., Ltd; Daiichi Sankyo Pharmaceutical Co., Ltd.; Japan Boehringer Ingelheim Japan Co., Ltd; Reata Pharmaceutical Co., Ltd.	The JSDT has been making the best effort to avoid any actual and potential conflicts of interest for there to be a neutral and fair process of guideline development. In 2010, the JSDT developed a new system for working group members to declare any potential conflicts of interest. All members of JSDT guideline development groups are now required to provide signed declaration forms to state any actual or potential conflicts of interest. These forms are updated yearly, or sooner if an individual member's status changes. Further information is available at: http://www.jsdt.or.jp/jsdt/1236.html (Japanese) (reviewed Jan 26 2015 by correspondent author). Conflict of interest declarations: Yuzo Watanabe has received honoraria from Chugai Pharmaceutical Co., Ltd, and Kyowa Hakko Kirin Co., Ltd. Kunihiro Yamagata has received research funds and honoraria from Chugai Pharmaceutical Co., Ltd, Kyowa Hakko Kirin Co., Ltd, Dainihon Sumitomo Pharmaceutical Co., Ltd, Daiichi Sankyo Co., Ltd, and Shionogi Pharmaceutical Co., Ltd. Shinichi Nishi has received honoraria from Kyowa Hakko Kirin Co., Ltd, Novartis Pharma K.K., Astellas Pharma Inc., and Tanabe Mitsubishi Pharmaceutical Co., Ltd. Noritomo Itami has received honoraria from Chugai Pharmaceutical Co., Ltd. Ken Sakai has received honoraria from JMS Co., Ltd. Kazuhiko Tsuruya has received research funds and honoraria from Chugai Pharmaceutical Co., Ltd, Kyowa Hakko Kirin Co., Ltd, Torii Pharmaceutical Co., Ltd, Fuso Pharmaceutical Co., Ltd, Takeda Pharmaceutical Co., Ltd, and Baxter Co., Ltd. Hideki Hirakata has received honoraria from Chugai Pharmaceutical Co., Ltd, Kyowa Hakko Kirin Co., Ltd, and Japan Tobacco Inc. Yoshiharu Tsubakihara has received research funds and honoraria from Kyowa Hakko Kirin Co., Ltd, Chugai Pharmaceutical Co., Ltd, Tanabe Mitsubishi Pharmaceutical Co., Ltd, and Asahi-Kasei Pharmaceutical Co., Ltd, and belonged to endowed courses at Osaka University. Hideki Kawanishi has received research funds and honoraria from Chugai Pharmaceutical Co., Ltd, Bayer Yakuhin Ltd, Kyowa Hakko Kirin Co., Ltd, Astellas Pharma Inc., Nikkiso Co., Ltd, and Japan Tobacco Inc. Hiroyasu Yamamoto has received honoraria from Chugai Pharmaceutical Co., Ltd, and Kyowa Hakko Kirin Co., Ltd. Takashi Akiba has received research funds and honoraria from Kyowa Hakko Kirin Co., Ltd, Japan Tobacco Inc., Toray Industries Inc., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd, Otsuka Pharmaceutical Co., Ltd, and Toray Medical Co., Ltd. Kunitoshi Iseki has received research funds and honoraria from Teijin Pharma K.K and Chugai Pharmaceutical Co., Ltd. Kazuyoshi Okada has received research funds and honoraria from Kyowa Hakko Kirin Co., Ltd, Shionogi Pharmaceutical Co., Ltd, and Daiichi Sankyo Pharmaceutical Co., Ltd. Kazuyuki Suzuki has received honoraria from Kyowa Hakko Kirin Co., Ltd, and Gambro Co., Ltd. Masashi Tomo has received research funds and honoraria from Chugai Pharmaceutical Co., Ltd, and Kyowa Hakko Kirin Co., Ltd. Ikuto Masakane has received honoraria from Toray Medical Co., Ltd, and Kyowa Hakko Kirin Co., Ltd. Tadao Akizawa has received research funds, transportation fee to attend social meetings, and honoraria from Kyowa Hakko Kirin Co., Ltd, Chugai Pharmaceutical Co., Ltd, Bayer Yakuhin Ltd, Astellas Pharma Inc., Tanabe Mitsubishi Pharmaceutical Co., Ltd, Daiichi Sankyo Co., Ltd, Baxter Co., Ltd, Japan Boehringer Ingelheim Japan Co., Ltd, and Reata Pharmaceutical Co., Ltd.	Rosansky SJ, 2011, ARCH INTERN MED, V171, P396, DOI 10.1001/archinternmed.2010.415; Pan Y, 2012, NEPHRON CLIN PRACT, V120, pC121, DOI 10.1159/000337572; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; Lassalle M, 2010, KIDNEY INT, V77, P700, DOI 10.1038/ki.2010.14; Steinman TI, 2001, TRANSPLANTATION, V71, P1189, DOI 10.1097/00007890-200105150-00001; Lacson E, 2011, AM J KIDNEY DIS, V58, P235, DOI 10.1053/j.ajkd.2011.04.015; Devins GM, 2005, AM J KIDNEY DIS, V46, P1088, DOI 10.1053/j.ajkd.2005.08.017; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Chandna SM, 1999, BRIT MED J, V318, P217; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; BONOMINI V, 1985, KIDNEY INT, pS57; Brunori G, 2007, AM J KIDNEY DIS, V49, P569, DOI 10.1053/j.ajkd.2007.02.278; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P829, DOI 10.1053/j.ajkd.2012.01.015; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Khan SS, 2005, KIDNEY INT, V67, P1038, DOI 10.1111/j.1523-1755.2005.00168.x; Churchill DN, 1997, AM J KIDNEY DIS, V30, P899, DOI 10.1016/S0272-6386(97)90102-5; Brochard L, 2010, AM J RESP CRIT CARE, V181, P1128, DOI 10.1164/rccm.200711-1664ST; [Anonymous], 2002, NEPHROL DIAL TRAN S7, V17, P10; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; Fink JC, 1999, AM J KIDNEY DIS, V34, P694, DOI 10.1016/S0272-6386(99)70395-1; Shafi T, 2010, AM J KIDNEY DIS, V56, P348, DOI 10.1053/j.ajkd.2010.03.020; Beddhu S, 2003, J AM SOC NEPHROL, V14, P1000, DOI 10.1097/01.ASN.0000057856.88335.DD; [Anonymous], 2005, NEPHROL DIAL TRAN S9, V20, pix3; Harris A, 2011, AM J KIDNEY DIS, V57, P707, DOI 10.1053/j.ajkd.2010.12.018; Korevaar JC, 2001, LANCET, V358, P1046, DOI 10.1016/S0140-6736(01)06180-3; Kausz AT, 2000, J AM SOC NEPHROL, V11, P2351; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN0000025297.40179.E8; [Anonymous], 2002, NEPHROL DIAL TRAN S7, V17, pS1; Kazmi WH, 2005, AM J KIDNEY DIS, V46, P887, DOI 10.1053/j.ajkd.2005.08.005; [Anonymous], 2006, AM J KIDNEY DIS S1, V48, pS248; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; Jungers P, 2001, NEPHROL DIAL TRANSPL, V16, P2357, DOI 10.1093/ndt/16.12.2357; Devins GM, 2003, AM J KIDNEY DIS, V42, P693, DOI 10.1053/S0272-6386(03)00835-7; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Uhlig K, 2006, KIDNEY INT, V70, P2058, DOI 10.1038/sj.ki.5001875; Zaritsky JJ, 2008, PEDIATR NEPHROL, V23, P2061, DOI 10.1007/s00467-008-0956-1; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Hasegawa T, 2009, CLIN J AM SOC NEPHRO, V4, P595, DOI 10.2215/CJN.03540708; TATTERSALL J, 1995, AM J NEPHROL, V15, P283, DOI 10.1159/000168850; Nakai S, 2009, THER APHER DIAL, V13, P457, DOI 10.1111/j.1744-9987.2009.00789.x; Grootendorst DC, 2011, NEPHROL DIAL TRANSPL, V26, P1932, DOI 10.1093/ndt/gfq667; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; Stel VS, 2009, NEPHROL DIAL TRANSPL, V24, P3175, DOI 10.1093/ndt/gfp264; Atkinson MA, 2010, PEDIATR NEPHROL, V25, P1153, DOI 10.1007/s00467-010-1459-4; BAUER JH, 1982, AM J KIDNEY DIS, V2, P30; Caskey FJ, 2003, NEPHROL DIAL TRANSPL, V18, P1330, DOI 10.1093/ndt/gfg156; Cass A, 2002, MED J AUSTRALIA, V177, P135; Chand DH, 2009, PEDIATR NEPHROL, V24, P1121, DOI 10.1007/s00467-008-0812-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SC, 2010, AM J MED SCI, V339, P123, DOI 10.1097/MAJ.0b013e3181c0678a; Chesser AMS, 1999, CLIN NEPHROL, V51, P228; Clark WF, 2011, CAN MED ASSOC J, V183, P47, DOI 10.1503/cmaj.100349; Collins Allan J, 2008, Am J Kidney Dis, V51, pS1, DOI 10.1053/j.ajkd.2007.11.001; desJager DJ, 2011, NEPHROL DIAL TRANSPL, V26, P652; desMutsert R, 2009, AM J CLIN NUTR, V89, P787; Di Micco L, 2009, NEPHROL DIAL TRANSPL, V24, P3434, DOI 10.1093/ndt/gfp281; Dombros N, 2005, NEPHROL DIAL TRAN S9, V20, P3; Fukagawa M, 2010, J JPN SOC DIAL THER, V43, P347, DOI DOI 10.1038/SJ.KI.5001875; Goransson LG, 2001, J INTERN MED, V250, P154, DOI 10.1046/j.1365-2796.2001.00869.x; Gradman WS, 2005, ANN VASC SURG, V19, P609, DOI 10.1007/s10016-005-6829-1; Haffner D, 2008, COMPREHENSIVE PEDIAT, P709; Hemodialysis Adequacy 2006 Work Group, 2006, AM J KIDNEY DIS S1, V48, pS2; Hiremath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028453; Honda K, 2012, JPN J PEDIAT NEPHROL, V25, P1; Horio M, 2011, J JSDT, V44, P55; JAGENBURG R, 1978, SCAND J UROL NEPHROL, V12, P133; Japanese Society for Dialysis Therapy, 2012, J JPN SOC DIAL THER, V45, P301; Japanese Society of Nephrology, 2012, CKD PRACT GUID 2012; Kawaguchi Y, 1995, REV CRITERIA CHRONIC, P84; Kawaguchi Y, 1992, STUDY REGARDING PREP, P125; Kawaguchi Y, 1993, STUDY ESTABLISHING G, P156; Kelly J, 2005, NEPHROLOGY, V10, pS46, DOI 10.1111/j.1440-1797.2005.00486_1.x; Kim Seoung Gu, 2009, Korean Journal of Internal Medicine, V24, P55, DOI 10.3904/kjim.2009.24.1.55; Kraut JA, 2011, PEDIATR NEPHROL, V26, P19, DOI 10.1007/s00467-010-1564-4; Lilien MR, 2009, NAT REV NEPHROL, V5, P229, DOI 10.1038/nrneph.2009.10; Lin CL, 2003, RENAL FAILURE, V25, P455, DOI 10.1081/JDI-120021158; Mendelssohn DC, 2011, NEPHROL DIAL TRANSPL, V26, P2959, DOI 10.1093/ndt/gfq843; Menon S, 2009, CLIN J AM SOC NEPHRO, V4, P1170, DOI 10.2215/CJN.05791108; Nakai S, 2013, J JPN SOC DIAL THER, V46, P1; Nakamura S, 2007, CIRC J, V71, P511, DOI 10.1253/circj.71.511; National Kidney Foundation, 2006, AM J KIDNEY DIS S, V48, pS176, DOI DOI 10.1053/J.AJKD.2006.04.029; NKF-K/DOQI, 1997, AM J KIDNEY DIS, V30, pS15; Obrador GT, 1999, KIDNEY INT, V56, P2227, DOI 10.1038/sj.ki.4491163; Okada K, 2012, J JSDT, V45, P1090; Rees L, 2008, BR ASS PAEDIAT NEPHR, V2008; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Rodrigo E, 2002, KIDNEY INT, V61, pS11; Rosansky SJ, 2009, KIDNEY INT, V76, P257, DOI 10.1038/ki.2009.161; Schroff RC, 2007, J AM SOC NEPHROL, V18, P2996; Schwenger V, 2006, NEPHROL DIAL TRANSPL, V21, P962, DOI 10.1093/ndt/gfk030; Sesso R, 1996, BRAZ J MED BIOL RES, V29, P1473; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; Stel VS, 2010, NEPHROL DIAL TRANSPL, V25, P3315, DOI 10.1093/ndt/gfq209; Stoves J, 2001, POSTGRAD MED J, V77, P586, DOI 10.1136/pmj.77.911.586; The Japanese Society for Dialysis Therapy, 2011, J JPN SOC DIAL THER, V44, P855; The Japanese Society for Dialysis Therapy, 2008, ILL PRES STAT CHRON; The Japanese Society for Dialysis Therapy, 2009, J JPN SOC DIAL THER, V42, P285; The Japanese Society for Dialysis Therapy, 2009, ILL PRES STAT CHRON; The Japanese Society for Dialysis Therapy, 2007, ILL PRES STAT CHRON; The Japanese Society for Dialysis Therapy, 2007, CURR STAT DIAL THER; The Japanese Society for Dialysis Therapy. The Japanese Society for Dialysis Therapy, 2011, J JSDT, V44, P857; Tromp WF, 2012, NEPHROL DIAL TRANSPL, V27, P1984, DOI 10.1093/ndt/gfr570; USRDS. Section I;patient survival, 2010, 2009 USRDS ANN DAT R, P671; VanDeVoorde RG, 2009, PEDIAT NEPHROLOGY, P1661, DOI 10.1007/978-3-540-76341-3_68; van Stralen KJ, 2010, NEPHROL DIAL TRANSPL, V25, P3325, DOI 10.1093/ndt/gfq215; Wesselin-Perry K, 2009, PEDIAT NEPHROLOGY, P1755, DOI 10.1007/978-3-540-76341-3_71; Wilson Barbara, 2007, Hemodial Int, V11, P263, DOI 10.1111/j.1542-4758.2007.00178.x; Winkelmayer WC, 2003, J AM SOC NEPHROL, V14, P486, DOI 10.1097/01.ASN.0000046047.66958.C3; Winkelmayer WC, 2011, ARCH INTERN MED, V171, P1371, DOI 10.1001/archinternmed.2011.360; Wu LC, 2009, KAOHSIUNG J MED SCI, V25, P521, DOI 10.1016/S1607-551X(09)70544-3; Yamagata K, 2008, CLIN EXP NEPHROL, V12, P1, DOI 10.1007/s10157-007-0010-9; Yamagata K, 2012, THER APHER DIAL, V16, P54, DOI 10.1111/j.1744-9987.2011.01005.x; Yamagata K, 2012, THER APHER DIAL, V16, P111, DOI 10.1111/j.1744-9987.2011.01052.x; Yokoyama Y, 2009, NEPHRON CLIN PRACT, V113, pC191, DOI 10.1159/000232601	121	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	MAR	2015	19			1	SI		93	107		10.1111/1744-9987.12293		15	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CE7KV	WOS:000352019500004		
J	Watanabe, Y; Hirakata, H; Okada, K; Yamamoto, H; Tsuruya, K; Sakai, K; Mori, N; Itami, N; Inaguma, D; Iseki, K; Uchida, A; Kawaguchi, Y; Ohira, S; Tomo, M; Masakane, I; Akizawa, T; Minakuchi, J				Watanabe, Yuzo; Hirakata, Hideki; Okada, Kazuyoshi; Yamamoto, Hiroyasu; Tsuruya, Kazuhiko; Sakai, Ken; Mori, Noriko; Itami, Noritomo; Inaguma, Daijo; Iseki, Kunitoshi; Uchida, Akiko; Kawaguchi, Yoshindo; Ohira, Seiji; Tomo, Masashi; Masakane, Ikuto; Akizawa, Tadao; Minakuchi, Jun		Japanese Soc Hemodialysis Therapy	Proposal for the Shared Decision-Making Process Regarding Initiation and Continuation of Maintenance Hemodialysis	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article							DIALYSIS; CARE		[Watanabe, Yuzo; Hirakata, Hideki; Okada, Kazuyoshi; Yamamoto, Hiroyasu; Tsuruya, Kazuhiko; Sakai, Ken; Mori, Noriko; Itami, Noritomo; Inaguma, Daijo; Iseki, Kunitoshi; Uchida, Akiko; Kawaguchi, Yoshindo; Ohira, Seiji; Tomo, Masashi; Masakane, Ikuto; Akizawa, Tadao; Minakuchi, Jun; Japanese Soc Hemodialysis Therapy] Japanese Soc Dialysis Therapy, Tokyo, Japan	Watanabe, Y (reprint author), Kasugai Municipal Hosp, Dept Nephrol, Takaki 1-1-1, Kasugai, Aichi 4868510, Japan.	yuzo@hospital.kasugai.aichi.jp			Kyowa Hakko Kirin Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Bayer Yakuhin, Ltd.; Astellas Pharma Co., Ltd.; Mitsubishi Tanabe Pharma Co., Ltd.; Daiichi-Sankyo Co., Ltd.; Baxter Co., Ltd.; Shionogi Co., Ltd.; Nippon Boehringer Ingelheim Corporation (Japan); Reata Pharmaceuticals (US); Kyowa Hakko Co., Ltd.; Torii Pharmaceutical Co., Ltd.; Fuso Pharmaceutical Industries Co., Ltd.; Takeda Pharmaceutical Company, Ltd.	Tadao Akizawa received fellowship grants, a salary as an organization specialist, remunerations for lectures, payments for article submissions, and travel expenses for participation in academic societies from the following companies: Kyowa Hakko Kirin Co., Ltd. (a company that manufactures and sells ethical pharmaceuticals), Chugai Pharmaceutical Co., Ltd. (a company that manufactures, sells, imports, and exports ethical pharmaceuticals), Bayer Yakuhin, Ltd. (a company that develops, imports, manufactures, and sells medical products, medical devices, and veterinary drugs), Astellas Pharma Co., Ltd. (a company that manufactures, sells, imports, and exports ethical pharmaceuticals), Mitsubishi Tanabe Pharma Co., Ltd. (a company that manufactures and sells pharmaceutical products, with a focus on ethical pharmaceuticals), Daiichi-Sankyo Co., Ltd. (a company that researches, develops, manufactures, and sells ethical pharmaceuticals), Baxter Co., Ltd. (a company that imports, manufactures, and sells dialysis products, plasma protein formulations, and drug delivery systems), Shionogi & Co., Ltd. (a company that manufactures and sells pharmaceutical products and diagnostic drugs), Nippon Boehringer Ingelheim Corporation (Japan; a company that researches, develops, imports, manufactures, and sells pharmaceutical products), and Reata Pharmaceuticals (US; a company that develops pharmaceutical products).; Kunitoshi Iseki received fellowship grants and remuneration for lectures from Chugai Pharmaceutical Co., Ltd. (a company that manufactures, sells, imports, and exports ethical pharmaceuticals), Kyowa Hakko Co., Ltd. (a company that manufactures and sells ethical pharmaceuticals), and Bayer Yakuhin, Ltd. (a company that develops, imports, manufactures, and sells medical products, medical devices, and veterinary drugs).; Kazuyoshi Okada received fellowship grants and remuneration for lectures from Kyowa Hakko Co., Ltd. (a company that manufactures and sells ethical pharmaceuticals), Shionogi & Co., Ltd. (a company that manufactures and sells pharmaceutical products and diagnostic drugs), and Daiichi-Sankyo Co., Ltd. (a company that researches, develops, manufactures, and sells ethical pharmaceuticals).; Yoshindo Kawaguchi received expenses for collecting data, fellowship grants, payments for article submissions, and travel expenses for participation in academic meetings from Baxter Co., Ltd. (a company that imports, manufactures, and sells dialysis products, plasma protein formulations, and drug delivery systems) and Chugai Pharmaceutical Co., Ltd. (a company that manufactures, sells, imports and exports ethical pharmaceuticals) and is affiliated with a lectureship financially supported by private donations.; Kazuhiko Tsuruya received a joint industrial and academic research grant and remuneration for lectures from Chugai Pharmaceutical Co., Ltd. (a company that manufactures, sells, imports, and exports ethical pharmaceuticals), Kyowa Hakko Kirin Co., Ltd. (a company that manufactures and sells ethical pharmaceuticals), Torii Pharmaceutical Co., Ltd. (a company that manufactures and sells pharmaceutical products), Fuso Pharmaceutical Industries Co., Ltd. (a company that develops and sells pharmaceutical products and medical devices), Takeda Pharmaceutical Company, Ltd. (a company that manufactures, sells, imports, and exports pharmaceutical products and quasi-pharmaceutical products), and Baxter Co., Ltd. (a company that imports, manufactures, and sells dialysis products, plasma protein formulations, and drug delivery systems) and is affiliated to a lectureship financially supported by private donations.	[Anonymous], 2011, BMJ, V22, P342; [Anonymous], 2012, THER APHER DIAL, V16, P483; Davison SN, 2007, AM J KIDNEY DIS, V49, P27, DOI 10.1053/j.ajkd.2006.09.016; Fassett RG, 2011, NEPHROLOGY, V16, P4, DOI 10.1111/j.1440-1797.2010.01409.x; Hirsch DJ, 1994, AM J KIDNEY DIS, V23, P436; Japan Association Acute Medicine, 2007, PROP TERM MED CAR EM; Japan Medical Association, 2008, 10 REP ADV PAN BIOET; Japan Pediatric Society; Pediatric Terminal Medical Care Guideline Working Group Ethics Committee, 2012, GUID COMM MED POL CH; Japanese Geriatrics Society, 2012, GUID DEC MAK PROC CA; Japanese Ministry of Labor and Welfare, 2007, COMM GUID REG DEC MA; Japanese Society for Dialysis Therapy, 2012, OV REG DIAL TREATM D; Moss AH, 2001, AM J KIDNEY DIS, V37, P1081; Renal Physician Association, 2010, CLIN PRACT GUID 2 ED; WHO, 1990, WHO TERM REP SER, V804	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	MAR	2015	19			1	SI		108	117		10.1111/1744-9987.12295		10	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	CE7KV	WOS:000352019500005		
J	Matsumoto, H; Umakoshi, K; Kikuchi, S; Uemura, S; Takahashi, K; Takeba, J; Ohboshi, M; Aibiki, M				Matsumoto, Hironori; Umakoshi, Kensuke; Kikuchi, Satoshi; Uemura, Shigeki; Takahashi, Kouji; Takeba, Jun; Ohboshi, Masaru; Aibiki, Mayuki			Full Recovery Case After 82 Minutes Out-of-Hospital Cardiac Arrest: Importance of Chain of Survival and Predicting Outcome	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article							THERAPEUTIC HYPOTHERMIA; BISPECTRAL INDEX	A middle age man underwent immediate cardiopulmonary resuscitation (CPR) for ventricular fibrillation (VF) occurred in an ambulance. After arrival in a regional hospital, return of spontaneous circulation (ROSC) was achieved 82 minutes after the collapse. He was in coma even three hours after ROSC. So, he was transferred to our university hospital to receive therapeutic hypothermia (TH). An initial bispectral index (BIS) value suggested a favorable outcome. Thus we decided to aggressive therapies including TH of 34 degrees C for 48 hours, followed by a very slow rewarming at the rate of 1 degrees C per day. Eventually he was discharged from the hospital with good neurological state. This case shows us two points: 1) the importance of the chain of survival: CPR done immediately after the collapse, persistent CPR for refractory VF, followed by coronary interventions after ROSC, continuing care to the university hospital, 2) decision making for TH using BIS monitoring.	[Matsumoto, Hironori; Umakoshi, Kensuke; Kikuchi, Satoshi; Takeba, Jun; Aibiki, Mayuki] Ehime Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Tohon, Ehime 7910295, Japan; [Takahashi, Kouji] Ehime Univ, Dept Community Emergency Med, Grad Sch Med, Tohon, Ehime 7910295, Japan; [Uemura, Shigeki] Yawatahama Gen Hosp, Dept Internal Med, Yawatahama, Ehime, Japan; [Ohboshi, Masaru] Yawatahama Fire Dept, Yawatahama, Ehime, Japan	Aibiki, M (reprint author), Ehime Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Shitsukawa 454, Tohon, Ehime 7910295, Japan.	aibiki@m.ehime-u.ac.jp					Aibiki M, 2012, RESUSCITATION, V83, pE87, DOI 10.1016/j.resuscitation.2011.09.033; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Che DF, 2011, CRIT CARE MED, V39, P1423, DOI 10.1097/CCM.0b013e318212020a; Seder DB, 2010, INTENS CARE MED, V36, P281, DOI 10.1007/s00134-009-1691-1; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; Japan Resuscitation Council, JAP RES GUID 2010; Oddo M, 2008, CRIT CARE MED, V36, P2296, DOI 10.1097/CCM.0b013e3181802599; Zimmermann S, 2014, HEART LUNG, V43, P62, DOI 10.1016/j.hrtlng.2013.10.011	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR 1	2015	5	1					17	18		10.1089/ther.2014.0021		2	Critical Care Medicine	General & Internal Medicine	CF3UR	WOS:000352474700006		
J	Liddle, B; Lung, S				Liddle, Brantley; Lung, Sidney			The endogeneity of OECD gasoline taxes: Evidence from pair-wise, heterogeneous panel long-run causality tests	TRANSPORTATION RESEARCH PART A-POLICY AND PRACTICE			English	Article						Determinants of OECD gasoline taxes; Gasoline tax/price endogeneity; Long-run panel Granger-causality; Cross-sectional dependence; Panel heterogeneity	DEMAND; FUEL; COINTEGRATION; PRICE	Despite the current interest in using fuel taxes as an instrument for climate policy, there has been little study of current automotive fuel tax regimes. We expand on two earlier cross-sectional studies on why fuel taxes differ across countries by using OECD panel data and employing heterogeneous panel cointegration and long-run panel Granger-causality techniques. We confirm some of those earlier studies' conclusions. Further, we find that governments that rely on consumption-based taxes for revenues will have higher gasoline tax rates (than governments that rely on income and wealth/property-based taxes). But more significantly, we determine that higher gasoline demand among consumers "causes" democratic governments to set lower gasoline taxes a finding with important implications for today's climate/energy policy debate. (C) 2015 Elsevier Ltd. All rights reserved.	[Liddle, Brantley] Victoria Univ, Ctr Strateg Econ Studies, Melbourne, Vic 8001, Australia; [Liddle, Brantley] Asia Pacific Energy Res Ctr, Tokyo 1040054, Japan; [Lung, Sidney] Victoria Univ, Sch Econ & Finance, Melbourne, Vic 8001, Australia	Liddle, B (reprint author), Asia Pacific Energy Res Ctr, Inst Energy Econ, Chuo Ku, Inui Bldg,Kachidoki 11F,1-13-1 Kachidoki, Tokyo 1040054, Japan.	btliddle@alum.mit.edu; Sidney.Lung@vu.edu.au	liddle, brantley/K-9542-2014	liddle, brantley/0000-0003-3199-0214			Liddle B, 2012, TRANSPORT RES D-TR E, V17, P327, DOI 10.1016/j.trd.2012.01.007; Rietveld P, 2005, ENERG ECON, V27, P79, DOI 10.1016/j.eneco.2004.10.002; Havranek T, 2012, ENERG ECON, V34, P201, DOI 10.1016/j.eneco.2011.09.003; Canning D, 2008, MANCH SCH, V76, P504, DOI 10.1111/j.1467-9957.2008.01073.x; Hammar H, 2004, ENERGY J, V25, P1; Graham DJ, 2002, J TRANSP ECON POLICY, V36, P1; Pesaran MH, 2007, J APPL ECONOM, V22, P265, DOI 10.1002/jae.951; Liddle B, 2009, TRANSPORT RES D-TR E, V14, P73, DOI 10.1016/j.trd.2008.10.006; Westerlund J, 2008, OXFORD B ECON STAT, V70, P665, DOI 10.1111/j.1468-0084.2008.00513.x; Sterner T, 2007, ENERG POLICY, V35, P3194, DOI 10.1016/j.enpol.2006.10.025; Pesaran MH, 2006, ECONOMETRICA, V74, P967, DOI 10.1111/j.1468-0262.2006.00692.x; Hughes JE, 2008, ENERG J, V29, P113; Bentzen J., 2003, 0319 AARH SCH BUS DE; Brons M., 2007, ENERG ECON, V30, P2105; Dreher A., 2008, ENERGY J, V29, P68, DOI DOI 10.5547/ISSN0195-6574-EJ-VOL29-NO1-4; Eberhardt M, 2010, EC SERIES WORKING PA, V515; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; PESARAN MH, 1995, J ECONOMETRICS, V68, P79, DOI 10.1016/0304-4076(94)01644-F; Pesaran MH, 2004, IZA DISCUSSION PAPER, V1240	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-8564			TRANSPORT RES A-POL	Transp. Res. Pt. A-Policy Pract.	MAR	2015	73						31	38		10.1016/j.tra.2014.12.009		8	Economics; Transportation; Transportation Science & Technology	Business & Economics; Transportation	CE6VO	WOS:000351976500003		
J	Yamada, T; Febri, Z				Yamada, Tadashi; Febri, Zukhruf			Freight transport network design using particle swarm optimisation in supply chain-transport supernetwork equilibrium	TRANSPORTATION RESEARCH PART E-LOGISTICS AND TRANSPORTATION REVIEW			English	Article						Discrete network design problem; Multimodal transport network; Supply chain network; Mathematical programmes with equilibrium constraints; Discrete binary particle swarm optimisation	MODELS; ALGORITHMS; SELECTION; FLOWS; OPPORTUNITIES; STRATEGY; STATE; PSO; ART	This paper presents a discrete network design problem for optimally designing freight transport network in terms of the efficiency of supply chain. Modelling is undertaken within the framework of mathematical programmes with equilibrium constraints, which first incorporates both supply chain and transport networks explicitly. The upper level determines the best set of actions for transport network improvement, while the lower-level decision is based on a supply chain-multimodal transport supernetwork equilibrium. New variants of particle swarm optimisation are developed to approximately solve the upper level. Numerical tests reveal their superior performance and the effective freight transport-related actions. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamada, Tadashi] Kyoto Univ, Grad Sch Engn, Dept Urban Management, Nishikyo Ku, Kyoto 6158540, Japan; [Febri, Zukhruf] Bandung Inst Technol, Fac Civil & Environm Engn, Dept Civil Engn, Bandung 40132, Indonesia	Yamada, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Urban Management, Nishikyo Ku, C-1 Kyotodaigaku Katsura, Kyoto 6158540, Japan.	t.yamada@kiban.kuciv.kyoto-u.ac.jp; febrizukhruf16@gmail.com					Chow JYJ, 2010, TRANSPORTATION, V37, P1011, DOI 10.1007/s11116-010-9281-1; Gunasekaran A, 2008, OMEGA-INT J MANAGE S, V36, P549, DOI 10.1016/j.omega.2006.12.002; Fernandez JE, 2003, TRANSPORT RES B-METH, V37, P615, DOI 10.1016/S0191-2615(02)00042-5; CRAINIC TG, 1990, TRANSPORT SCI, V24, P1, DOI 10.1287/trsc.24.1.1; CHEN MY, 1991, TRANSPORT SCI, V25, P215, DOI 10.1287/trsc.25.3.215; Parrott D, 2006, IEEE T EVOLUT COMPUT, V10, P440, DOI 10.1109/TEVC.2005.859468; Ukkusuri SV, 2009, TRANSPORT RES B-METH, V43, P625, DOI 10.1016/j.trb.2009.01.004; Vesterstrom J, 2004, IEEE C EVOL COMPUTAT, P1980; Menhas MI, 2012, EXPERT SYST APPL, V39, P4390, DOI 10.1016/j.eswa.2011.09.152; FRIESZ TL, 1983, TRANSPORT RES A-POL, V17, P409, DOI 10.1016/0191-2607(83)90161-9; GUELAT J, 1990, TRANSPORT SCI, V24, P25, DOI 10.1287/trsc.24.1.25; El-Abd M, 2010, APPL SOFT COMPUT, V10, P284, DOI 10.1016/j.asoc.2009.07.011; Seo JH, 2006, IEEE T MAGN, V42, P1095, DOI 10.1109/TMAG.2006.871568; Shen Q, 2004, EUR J PHARM SCI, V22, P145, DOI 10.1016/j.ejps.2004.03.002; Zhang YD, 2014, KNOWL-BASED SYST, V64, P22, DOI 10.1016/j.knosys.2014.03.015; Zhou YP, 2009, J CHEM INF MODEL, V49, P1144, DOI 10.1021/ci800374h; Apivatanagul P, 2010, TRANSPORT RES E-LOG, V46, P507, DOI 10.1016/j.tre.2009.04.004; Salman A, 2002, MICROPROCESS MICROSY, V26, P363, DOI 10.1016/S0141-9331(02)00053-4; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016; POORZAHEDY H, 1982, TRANSPORT RES B-METH, V16, P45, DOI 10.1016/0191-2615(82)90040-6; Arnold P, 2004, TRANSPORT RES E-LOG, V40, P255, DOI 10.1016/j.tre.2003.08.005; Wu C, 2011, J PURCH SUPPLY MANAG, V17, P256, DOI 10.1016/j.pursup.2011.09.002; Poorzahedy H, 2007, EUR J OPER RES, V182, P578, DOI 10.1016/j.ejor.2006.07.038; Mirjalili S, 2013, SWARM EVOL COMPUT, V9, P1, DOI 10.1016/j.swevo.2012.09.002; Luathep P, 2011, TRANSPORT RES B-METH, V45, P808, DOI 10.1016/j.trb.2011.02.002; Damart S, 2009, TRANSPORT POLICY, V16, P200, DOI 10.1016/j.tranpol.2009.06.002; Gao ZY, 2005, TRANSPORT RES B-METH, V39, P479, DOI 10.1016/j.trb.2004.06.004; Boyce D, 2004, NETW SPAT ECON, V4, P115, DOI 10.1023/B:NETS.0000015659.39216.83; Kennedy J, 1997, IEEE SYS MAN CYBERN, P4104; Tavasszy LA, 2012, TRANSPORT REV, V32, P203, DOI 10.1080/01441647.2011.644640; Beckmann M, 1955, STUDIES EC TRANSPORT; BOYCE DE, 1984, ENVIRON PLANN A, V16, P1445, DOI 10.1068/a161445; Bristow A.L., 2000, TRANSPORT POLICY, V7, P51, DOI DOI 10.1016/S0967-070X(00)00010-X; Bruynooghe M., 1972, PRES PLANN TRANSP RE; Calthrop E, 2010, TRANSPORT RES B-METH, V44, P850, DOI 10.1016/j.trb.2009.12.011; Chiou SW, 2007, INFORM SCIENCES, V177, P5754, DOI 10.1016/j.ins.2007.05.016; Christopher M., 1992, LOGISTICS SUPPLY CHA; Cooper M.C., 1993, INT J LOGIST MANAG, V4, P13, DOI DOI 10.1108/09574099310804957; El-Abd M., 2008, THESIS U WATERLOO ON; Ellram L. M., 1991, International Journal of Physical Distribution & Logistics Management, V21, DOI 10.1108/09600039110137082; Gan X., 2012, MATH PROBL ENG, P1; Hammond D, 2007, EUR J OPER RES, V183, P895, DOI 10.1016/j.ejor.2006.10.033; HARKER PT, 1986, TRANSPORT RES B-METH, V20, P139, DOI 10.1016/0191-2615(86)90004-4; Houlihan J. B., 1985, INT J PHYS DISTRIB, V15, P22, DOI 10.1108/eb014601; Jones T. C., 1987, INT J PHYS DISTRIB, V17, P94, DOI 10.1108/eb014655; Kennedy J., 1995, P IEEE INT C NEUR NE, P1942, DOI DOI 10.1109/ICNN.1995.488968; Kopczak L. R., 1997, PRODUCTION OPERATION, V6, P226; LEE HL, 1992, SLOAN MANAGE REV, V33, P65; Lee H. L., 1997, PRODUCTION OPERATION, V6, P191; Luo J. S., 1996, MATH PROGRAMS EQUILI; MAGNANTI TL, 1984, TRANSPORT SCI, V18, P1, DOI 10.1287/trsc.18.1.1; Meng Q, 2009, EUR J OPER RES, V196, P487, DOI 10.1016/j.ejor.2008.03.030; Meng Q, 2007, TRANSPORT RES E-LOG, V43, P60, DOI 10.1016/j.tre.2005.07.005; Menhas Muhammad Ilyas, 2011, International Journal of Automation and Computing, V8, DOI 10.1007/s11633-011-0572-6; Mentzer J. T., 2001, J BUSINESS LOGISTICS, V22, P1, DOI [DOI 10.1002/J.2158-1592.2001.TB00001.X, DOI 10.1016/J.TRE.2005.06.003]; Nagurney A, 2002, TRANSPORT RES E-LOG, V38, P281, DOI 10.1016/S1366-5545(01)00020-5; Nagurney A., 1999, NETWORK EC VARIATION; Oliver R.K., 1982, LOGISTICS STRATEGIC, P63; Outrata J., 1998, NONSMOOTH APPROACH O; Patriksson M., 1994, TRAFFIC ASSIGNMENT P; Potter MA, 1994, LECT NOTES COMPUT SC, V866, P249; Roh J, 2014, INT J PROD ECON, V147, P198, DOI 10.1016/j.ijpe.2013.04.013; Shen Q, 2009, COMPUT BIOL MED, V39, P646, DOI 10.1016/j.compbiomed.2009.04.008; Shi Y., 1998, P IEEE INT C EV COMP, V26, P69, DOI DOI 10.1109/ICEC.1998.699146; Stackelberg H. V., 1934, MARKETFORM GLEICHGEW; Steenbrink A., 1974, TRANSPORTATION RES B, V8, P11; Towill D. R., 1992, International Journal of Physical Distribution & Logistics Management, V22, DOI 10.1108/09600039210016995; van den Bergh F, 2004, IEEE T EVOLUT COMPUT, V8, P225, DOI [10.1109/TEVC.2004.826069, 10.1109/tevc.2004.826069]; Wang L., 2008, J SOFTWARE, V9, P28; Wardrop J. G., 1952, P I CIVIL ENGINEER 2, V2, P325; Yamada T, 2011, TRANSPORT RES E-LOG, V47, P887, DOI 10.1016/j.tre.2011.05.009; Yamada T, 2009, TRANSPORT SCI, V43, P129, DOI 10.1287/trsc.1080.0250; Yang YX, 2010, PROCEEDINGS OF 2010 INTERNATIONAL CONFERENCE ON LOGISTICS SYSTEMS AND INTELLIGENT MANAGEMENT, VOLS 1-3, P20; Yen G., 2006, P IEEE C EV COMP, P6150; Yuan SF, 2007, MECH SYST SIGNAL PR, V21, P1787, DOI 10.1016/j.ymssp.2006.07.008; Zhao LA, 2011, EXPERT SYST APPL, V38, P4972, DOI 10.1016/j.eswa.2010.09.154; Zheng YJ, 2013, APPL INTELL, V39, P202, DOI 10.1007/s10489-012-0405-5	77	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1366-5545			TRANSPORT RES E-LOG	Transp. Res. Pt. e-Logist. Transp. Rev.	MAR	2015	75						164	187		10.1016/j.tre.2015.01.001		24	Economics; Engineering, Civil; Operations Research & Management Science; Transportation; Transportation Science & Technology	Business & Economics; Engineering; Operations Research & Management Science; Transportation	CE4JP	WOS:000351797200010		
J	Inoue, S; Sakamoto, Y; Sekino, Y; Nonaka, T; Iida, H; Endo, H; Koide, T; Takahashi, H; Maeda, S; Nakajima, A; Gotoh, E; Inamori, M				Inoue, Sho; Sakamoto, Yasunari; Sekino, Yusuke; Nonaka, Takashi; Iida, Hiroshi; Endo, Hiroki; Koide, Tomoko; Takahashi, Hirokazu; Maeda, Shin; Nakajima, Atsushi; Gotoh, Eiji; Inamori, Masahiko			Low-dose ramosetron accelerates gastric emptying in the early phase: A crossover study in healthy volunteers using a continuous real-time 13C breath test (BreathID System)	TURKISH JOURNAL OF GASTROENTEROLOGY			English	Article						Ramosetron; gastric emptying; breath test	IRRITABLE-BOWEL-SYNDROME; GUINEA-PIG ILEUM; 5-HT3 RECEPTORS; 5-HYDROXYTRYPTAMINE RECEPTOR; ANTAGONIST; MOTILITY; NEURONS; LIQUIDS; RATS	Background/Aims: The aim of this study was to determine the correlation between low-dose ramosetron pretreatment and gastric emptying using a novel, non-invasive technique for measuring gastric emptying, namely, the continuous real-time 13C breath test (BreathID system: Exalenz Bioscience Ltd., Israel). Materials and Methods: Twelve healthy male volunteers participated in this randomized two-way crossover study. The subjects fasted overnight and were randomly assigned to receive the test meal (200 kcal per 200 mL) after an hour pre-treatment with 5 mu g ramosetron or the test meal alone. Gastric emptying was monitored for 4 hours after administration of the test meal with the 13C-acetic acid breath test performed continuously using the BreathID system. Using Oridion Research Software (beta version), T 1/2, T lag, GEC and the regression-estimated constants (beta and kappa) were calculated. The differences in the parameters measured at two time-points were analyzed using Wilcoxon's signed-rank test. Results: There was a significant difference in the calculated parameter beta. No significant differences in the calculated parameters T 1/2, T lag, GEC or. were observed between the test meal with ramosetron group and the test meal alone group. Conclusion: This study showed that ramosetron pre-treatment enhances the early gastric emptying of liquid nutrients.	[Inoue, Sho; Gotoh, Eiji] Yokohama City Univ, Sch Med, Dept Med Educ, Yokohama, Kanagawa 232, Japan; [Sakamoto, Yasunari; Sekino, Yusuke; Nonaka, Takashi; Iida, Hiroshi; Endo, Hiroki; Koide, Tomoko; Takahashi, Hirokazu; Maeda, Shin; Nakajima, Atsushi; Inamori, Masahiko] Yokohama City Univ Med, Div Gastroenterol, Yokohama, Kanagawa, Japan; [Inamori, Masahiko] Yokohama City Univ Med, Off Postgrad Med Educ, Yokohama, Kanagawa, Japan	Inamori, M (reprint author), Yokohama City Univ Med, Off Postgrad Med Educ, Yokohama, Kanagawa, Japan.	inamorim@med.yokohama-cu.ac.jp			Abbott Japan Co., LTD.	Masahiko Inamori: Research funding, Abbott Japan Co., LTD.	Akimoto K, 2009, HEPATO-GASTROENTEROL, V56, P918; ANDREWS PLR, 1988, TRENDS PHARMACOL SCI, V9, P334, DOI 10.1016/0165-6147(88)90106-X; NARDUCCI F, 1985, DIGEST DIS SCI, V30, P40, DOI 10.1007/BF01318369; Parkman HP, 2009, GASTROENTEROLOGY, V136, P1526, DOI 10.1053/j.gastro.2009.02.039; BRADEN B, 1995, GASTROENTEROLOGY, V108, P1048, DOI 10.1016/0016-5085(95)90202-3; BERMUDEZ J, 1988, BRIT J CANCER, V58, P644, DOI 10.1038/bjc.1988.277; Gatti C, 2000, J PEDIATR SURG, V35, P62, DOI 10.1016/S0022-3468(00)80078-0; Matsueda K, 2008, SCAND J GASTROENTERO, V43, P1202, DOI 10.1080/00365520802240255; WILLIAMS CL, 1988, GASTROENTEROLOGY, V94, P611; GHOOS YF, 1993, GASTROENTEROLOGY, V104, P1640; Kasimay O, 2005, J PHYSIOL PHARMACOL, V56, P543; Inamori M, 2009, DIGEST DIS SCI, V54, P816, DOI 10.1007/s10620-008-0427-3; Gonzalez A, 2000, EUR J NUTR, V39, P224, DOI 10.1007/s003940070015; Bromer MQ, 2002, DIGEST DIS SCI, V47, P1657, DOI 10.1023/A:1015856211261; BUCHHEIT KH, 1985, N-S ARCH PHARMACOL, V329, P36, DOI 10.1007/BF00695189; BUCHHEIT KH, 1985, J PHARM PHARMACOL, V37, P664; COSTALL B, 1987, BRIT J PHARMACOL, V91, P263; DUMUIS A, 1989, N-S ARCH PHARMACOL, V340, P403, DOI 10.1007/BF00167041; Fozard JR, 1989, PERIPHERAL ACTIONS 5, P374; Furuie H., 2007, RINSHO IYAKU, V23, P755; GIDDA JS, 1988, GASTROENTEROLOGY, V95, P867; GULLIKSON GW, 1988, GASTROENTEROLOGY, V95, P869; HENDRIKS R, 1989, N-S ARCH PHARMACOL, V339, P409, DOI 10.1007/BF00736055; Ikeda T, 2008, HEPATO-GASTROENTEROL, V55, P1905; Inamori M, 2007, J GASTROENTEROL, V42, P539, DOI 10.1007/s00535-007-2067-3; KILPATRICK GJ, 1990, MED RES REV, V10, P441, DOI 10.1002/med.2610100404; KING F D, 1989, Drugs of the Future, V14, P875; Kusano M, 2011, J GASTROEN HEPATOL, V26, P75, DOI 10.1111/j.1440-1746.2011.06627.x; MIYATA K, 1992, J PHARMACOL EXP THER, V261, P297; Nonaka T, 2011, HEPATO-GASTROENTEROL, V58, P224; Nonaka T, 2011, J NEUROGASTROENTEROL, V17, P287, DOI 10.5056/jnm.2011.17.3.287; Penttilä A, 1966, Acta Physiol Scand Suppl, V281, P1; Raybould HE, 2003, AM J PHYSIOL-GASTR L, V284, pG367, DOI 10.1152/ajpgi.00292.2001; RICHARDSON BP, 1986, TRENDS NEUROSCI, V9, P424, DOI 10.1016/0166-2236(86)90137-2; Sahamoto Y, 2011, HEPATO-GASTROENTEROL, V58, P637; Sakamoto Y, WORLD J GAS IN PRESS; Sakamoto Y, 2011, J NEUROGASTROENTEROL, V17, P174, DOI 10.5056/jnm.2011.17.2.174; THOMPSON WG, 1984, GUT, V25, P305, DOI 10.1136/gut.25.3.305; Yamanaka H, 2006, DIGESTION, V74, P238, DOI 10.1159/000100968; YANO S, 1978, JPN J PHARMACOL, V28, P607, DOI 10.1254/jjp.28.607	40	0	0	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34096, TURKEY	1300-4948			TURK J GASTROENTEROL	Turk. J. Gastroenterol.	MAR	2015	26	2					123	127		10.5152/tjg.2014.4768		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CE2JX	WOS:000351643000007		
J	Komatsubara, M; Kameda, T; Morita, T				Komatsubara, Maiko; Kameda, Tomohiro; Morita, Tatsuo			Panoramic Laparoscopic View of Transverse Testicular Ectopia	UROLOGY			English	Editorial Material							DIAGNOSIS	Transverse testicular ectopia (TTE) is a rare congenital anomaly in which both testes migrate toward the same hemiscrotum. We present a case of TTE in a 33-year-old man. Laparoscopy showed the left spermatic vessels, accompanied by parietal peritoneum, which formed a septum that divided the pelvic space into two, were extending transversely from the left lateral side of the descending colon toward the right internal inguinal ring over the sigmoid colon. A panoramic laparoscopic view of the spermatic vessels in TTE can clearly demonstrate the descending pathway and partly contribute to our understanding of the etiologic mechanisms of TTE. (C) 2015 The Authors. Published by Elsevier Inc.	[Komatsubara, Maiko; Kameda, Tomohiro; Morita, Tatsuo] Jichi Med Univ, Dept Urol, Shimotsuke, Tochigi 3290498, Japan	Morita, T (reprint author), Jichi Med Univ, Dept Urol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	moritatu@jichi.ac.jp					BALAJI KC, 1995, UROLOGY, V46, P879, DOI 10.1016/S0090-4295(99)80364-1; Dean GE, 2002, J UROLOGY, V167, P1817, DOI 10.1016/S0022-5347(05)65238-X; FAIRFAX CA, 1995, J UROLOGY, V153, P477, DOI 10.1097/00005392-199502000-00063; GORNALL PG, 1987, BRIT J UROL, V59, P283, DOI 10.1111/j.1464-410X.1987.tb04627.x; Hughes DT, 2007, J PEDIATR SURG, V42, P1620, DOI 10.1016/j.jpedsurg.2007.05.014; Naji H, 2012, PEDIATR SURG INT, V28, P703, DOI 10.1007/s00383-012-3105-7; Naouar S, 2008, UROLOGY, V71, P1070, DOI 10.1016/j.urology.2007.11.133; Takahashi M, 2008, UROLOGY, V71, P547; Thambidorai CR, 2008, PEDIATR SURG INT, V24, P371, DOI 10.1007/s00383-007-1932-8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	MAR	2015	85	3							e11	10.1016/j.urology.2014.11.015		2	Urology & Nephrology	Urology & Nephrology	CE6JJ	WOS:000351942400002		
J	Takahashi, S; Shiraishi, T; Miles, N; Trock, BJ; Kulkarni, P; Getzenberg, RH				Takahashi, Sayuri; Shiraishi, Takumi; Miles, Nancy; Trock, Bruce J.; Kulkarni, Prakash; Getzenberg, Robert H.			Nanowire Analysis of Cancer-Testis Antigens as Biomarkers of Aggressive Prostate Cancer	UROLOGY			English	Article							CANCER/TESTIS ANTIGENS; RADICAL PROSTATECTOMY; HETEROGENEITY; PROGRESSION	OBJECTIVE To demonstrate the ability of the nCounter Analysis System, a nanowire technology, to sensitively and accurately detect cancer-testis antigens (CTAs) in men with prostate cancer and correlate them with disease parameters. The clinical implementation of novel biomarkers is necessary to provide for individual disease treatment planning for men with prostate cancer. The CTAs, as cancer-associated biomarkers that may correlate with aggressive disease, have the potential to play an important role. METHODS Formalin-fixed, paraffin embedded samples were used from men undergoing radical prostatectomy for prostate cancer. The expression of CTAs along with control genes was measured from formalin-fixed, paraffin-embedded prostate cancer tissues using real-time polymerase chain reaction and the nCounter assay. RESULTS Using a nanowire-based assay, ribonucleic acid (RNA) expression levels of the CTAs CSAG2 and NOL4 were found to be significantly higher in men with Gleason score (GS) 8-10 disease than those with GS <= 4+3 disease. On the contrary, the RNA expression level of PAGE4 was lower in men with GS 8-10 disease than those with GS <= 6 group. This study demonstrates that CTAs can be detected with a nanostring assay that is translatable and that a set of CTAs correlates with the clinical characteristics of the disease. CONCLUSION CTAs represent unique, cancer-associated biomarkers with potential utility in the clinic. The nCounter nanowire technology provides an opportunity to evaluate this panel of CTAs associated with aggressive prostate cancer in a multi-institutional fashion. (C) 2015 Elsevier Inc.	Johns Hopkins Univ, Sch Med, Dept Urol, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; Univ Tokyo, Dept Urol, Tokyo 1138654, Japan	Getzenberg, RH (reprint author), GTx Inc, 175 Toyota Plaza,7th Floor, Memphis, TN 38103 USA.	rhgetzenberg@gmail.com			US Department of Defense Congressionally Directed Medical Research Programs (DOD CDMPR) [W81XWH-12-1-0535]	This study was supported in part by the US Department of Defense Congressionally Directed Medical Research Programs (DOD CDMPR) Award number W81XWH-12-1-0535.	American Cancer Society, CANC FACTS FIG 2014; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Suyama T, 2010, PROSTATE, V70, P1778, DOI 10.1002/pros.21214; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Cooperberg MR, 2013, J CLIN ONCOL, V31, P1428, DOI 10.1200/JCO.2012.46.4396; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Carlsson S, 2013, EUR UROL, V64, P693, DOI 10.1016/j.eururo.2013.04.040; Carter HB, 2012, ASIAN J ANDROL, V14, P355, DOI 10.1038/aja.2011.141; Kulkarni P, 2012, NAT REV UROL, V9, P386, DOI 10.1038/nrurol.2012.117; Nguyen CT, 2012, ASIAN J ANDROL, V14, P349, DOI 10.1038/aja.2011.140; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Shiraishi T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-153	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	MAR	2015	85	3							704.e1	10.1016/j.urology.2014.12.004		7	Urology & Nephrology	Urology & Nephrology	CE6JJ	WOS:000351942400058		
J	Wang, D; Zha, XM; Nagase, K; Akino, H; Muramatsu, I; Ito, H; Yokoyama, O				Wang, Dong; Zha, Xinmin; Nagase, Keiko; Akino, Hironobu; Muramatsu, Ikunobu; Ito, Hideaki; Yokoyama, Osamu			Effects of the 5 alpha-reductase Inhibitor Dutasteride on Rat Prostate alpha(1A)-adrenergic Receptor and Its Mediated Contractility	UROLOGY			English	Article							DUAL INHIBITOR; FINASTERIDE; TISSUE; QUANTIFICATION; EXPRESSION; CASTRATION; IDENTIFICATION; TESTOSTERONE; LOCALIZATION; HYPERPLASIA	OBJECTIVE To clarify the possible interference of the 5 alpha-reductase inhibitor dutasteride with alpha-adrenergic blockers, whose action is mainly mediated by alpha(1A)-adrenergic receptor. METHODS Male rats were divided into dutasteride and vehicle-treated groups. The drug treatment group was treated with oral dutasteride 0.5 mg/kg/d, and the control group received vehicle only for 2 months. After the 2-month treatment, the rats' ventral prostate weight changes and the testosterone and dihydrotestosterone levels in the serum were measured. In vitro organ-bath studies, real-time polymerase chain reaction, and tissue-segment binding were performed to determine the expression of alpha(1A)-adrenergic receptors and its mediated contractility. RESULTS Dutasteride treatment significantly decreased the rats' ventral prostate weight, increased their testosterone levels, and decreased the dihydrotestosterone levels in their serum. There were no marked changes in the alpha(1A)-adrenergic receptor messenger ribonucleic acid expression, relative phenylephrine-induced contractility, or nerve-mediated contractility between the groups. utasteride treatment caused no marked changes in the relative binding capacity of alpha(1A)-adrenergic receptor, whereas it greatly decreased the total protein expression of this subtype and its mediated maximal contraction in the whole ventral prostate. CONCLUSION These results suggest that dutasteride does not interfere with alpha-adrenergic blockers but otherwise has beneficial effects on their actions. Therefore, the long-term administration of the combination of dutasteride with an alpha-adrenergic blocker might be a better choice for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. (C) 2015 Elsevier Inc.	[Wang, Dong] Univ Fukui, Dept Urol, Fac Med Sci, Eiheiji, Fukui 9101193, Japan; Univ Fukui, Translat Res Ctr, Org Life Sci Adv Programs, Eiheiji, Fukui 9101193, Japan	Wang, D (reprint author), Univ Fukui, Dept Urol, Fac Med Sci, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 9101193, Japan.	dong@u-fukui.ac.jp			GlaxoSmithKline Corporate (London, United Kingdom)	This study was supported by a research grant from GlaxoSmithKline Corporate (London, United Kingdom).	Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Andersson KE, 2005, CURR PROSTATE REP, V3, P28, DOI 10.1007/s11918-996-0012-1; Yamashita K, 2009, STEROIDS, V74, P920, DOI 10.1016/j.steroids.2009.06.007; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Muramatsu I, 2005, J PHARMACOL SCI, V98, P331, DOI 10.1254/jphs.CPJ05001X; Roehrborn CG, 2008, INT J IMPOT RES, V20, pS11, DOI 10.1038/ijir.2008.55; Roehrborn CG, 2002, UROLOGY, V60, P434, DOI 10.1016/S0090-4295(02)01905-2; Keam SJ, 2008, DRUGS, V68, P463, DOI 10.2165/00003495-200868040-00008; Bramson HN, 1997, J PHARMACOL EXP THER, V282, P1496; Zhang XH, 2012, AM J PHYSIOL-ENDOC M, V302, pE243, DOI 10.1152/ajpendo.00458.2011; PRICE DT, 1993, J UROLOGY, V150, P546; FURUYA S, 1982, J UROLOGY, V128, P836; Marks LS, 1999, UROLOGY, V53, P574, DOI 10.1016/S0090-4295(98)00567-6; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; Prahalada S, 1998, PROSTATE, V35, P157; Nasu K, 1996, BRIT J PHARMACOL, V119, P797; Avila DM, 1998, J ENDOCRINOL, V159, P403, DOI 10.1677/joe.0.1590403; Homma Y, 2000, BRIT J PHARMACOL, V131, P1454, DOI 10.1038/sj.bjp.0703706; Laborde Eric E, 2009, Rev Urol, V11, pS19; Lacey JP, 1996, UROLOGY, V48, P335, DOI 10.1016/S0090-4295(96)00183-5; LIN ATL, 1995, J UROLOGY, V154, P1930; Murata S, 1999, BRIT J PHARMACOL, V127, P19, DOI 10.1038/sj.bjp.0702489; RITTMASTER RS, 1991, MOL ENDOCRINOL, V5, P1023; Rittmaster RS, 1996, J CLIN ENDOCR METAB, V81, P814, DOI 10.1210/jc.81.2.814; Smith Angela B, 2009, Ther Clin Risk Manag, V5, P535; Uygur MC, 1998, STEROIDS, V63, P208, DOI 10.1016/S0039-128X(98)00005-1; Walden PD, 1999, J UROLOGY, V161, P635, DOI 10.1016/S0022-5347(01)61986-4; Wang D, 2013, INFLUENCES 5ALPHA RE; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	MAR	2015	85	3							704.e9	10.1016/j.urology.2014.12.002		6	Urology & Nephrology	Urology & Nephrology	CE6JJ	WOS:000351942400060		
J	Nagasawa, M; Johnin, K; Hanada, E; Yoshida, T; Okamoto, K; Okada, Y; Ueba, T; Taga, T; Ohta, S; Kawauchi, A				Nagasawa, Masayuki; Johnin, Kazuyoshi; Hanada, Eiki; Yoshida, Tetsuya; Okamoto, Keisei; Okada, Yusaku; Ueba, Tomoko; Taga, Takashi; Ohta, Shigeru; Kawauchi, Akihiro			Advanced Childhood Testicular Yolk Sac Tumor With Bone Metastasis: A Case Report	UROLOGY			English	Article							GERM-CELL TUMORS; PARATESTICULAR TUMORS; STAGE-I; CANCER; CHILDREN	We report a case of advanced childhood testicular yolk sac tumor with bone metastasis, which was successfully treated by multimodal treatment. Optimal management of bone metastases from testicular yolk sac tumor in childhood is discussed. (C) 2015 Elsevier Inc.	[Johnin, Kazuyoshi] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 5202192, Japan; Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 5202192, Japan	Johnin, K (reprint author), Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 5202192, Japan.	johnin@belle.shiga-med.ac.jp					Ahmed HU, 2010, LANCET ONCOL, V11, P476, DOI 10.1016/S1470-2045(10)70012-7; Alanee S, 2009, BJU INT, V104, P1280, DOI 10.1111/j.1464-410X.2009.08524.x; Rogers PC, 2004, J CLIN ONCOL, V22, P3563, DOI 10.1200/JCO.2004.01.006; Mann JR, 2000, J CLIN ONCOL, V18, P3809; COPPES MJ, 1994, MED PEDIATR ONCOL, V22, P329, DOI 10.1002/mpo.2950220506; Ishida Y, 2010, INT J HEMATOL, V92, P95, DOI 10.1007/s12185-010-0611-z; Schlatter M, 2003, J PEDIATR SURG, V38, P319, DOI 10.1053/jpsu.2003.50101	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	MAR	2015	85	3					671	673		10.1016/j.urology.2014.11.019		3	Urology & Nephrology	Urology & Nephrology	CE6JJ	WOS:000351942400049		
J	Tazawa, S				Tazawa, Shinsei			The enumeration of labelled self-complementary graphs	UTILITAS MATHEMATICA			English	Article						Graphical enumeration; Graph; Self-complementary graph; Automorphism group		In 1973, Harary and Palmer announced an enumeration problem of labelled self-complementary graphs at the end of their book (Graphical Enumeration, Academic Press, New York and London, 1973). This paper tries to find an answer to this problem. A method for considering the problem leads to the derivation of the following formulas: (a) A formula on the number of labelled self-complementary graphs with the given order of automorphism groups of those graphs. (b) A formula on the number of unlabelled self-complementary graphs with the given order of automorphism groups of those graphs.	Kinki Univ, Fac Appl Sociol, Higashiosaka, Osaka 5778502, Japan	Tazawa, S (reprint author), Kinki Univ, Fac Appl Sociol, Higashiosaka, Osaka 5778502, Japan.	tazawa@math.kindai.ac.jp					CLAPHAM CRJ, 1984, P EDINBURGH MATH SOC, V27, P181; de Bruijn N. G., 1959, INDAG MATH, V21, P59; de Bruijn N. G., 1964, MATHEMATICS, P144; Farrugia A., 1999, SELF COMPLEMENTARY G; Harary F., 1973, GRAPHICAL ENUMERATIO; Read R. C., 1963, LONDON MATH SOC, V38, P99	6	0	0	UTIL MATH PUBL INC	WINNIPEG	UNIV MANITOBA PO BOX 7 UNIV CENT, WINNIPEG, MANITOBA R3T 2N2, CANADA	0315-3681			UTILITAS MATHEMATICA	Util. Math.	MAR	2015	96						3	16				14	Mathematics, Applied; Statistics & Probability	Mathematics	CE4ER	WOS:000351784400001		
J	Takuwa, H; Kanou, M				Takuwa, Hiroyuki; Kanou, Masamichi			Sensitive Period for the Recovery of the Response Rate of the Wind-Evoked Escape Behavior of Unilaterally Cercus-Ablated Crickets (Gryllus bimaculatus)	ZOOLOGICAL SCIENCE			English	Article						cricket; compensation; escape behavior; sensitive period; response rate	GIANT INTERNEURON SYSTEM; PRIMARY VISUAL-CORTEX; SELF-GENERATED WIND; AIR-CURRENT; COMPENSATIONAL RECOVERY; RANGE FRACTIONATION; SENSORY DEPRIVATION; CEREAL ABLATIONS; DIRECTION; ORGANIZATION	We examined the compensational recovery of the response rate (relative occurrence) of the wind-evoked escape behavior in unilaterally cercus-ablated crickets (Gryllus bimaculatus) and elucidated the existence of a sensitive period for such recovery by rearing the crickets under different conditions. In one experiment, each cricket was reared in an apparatus called a walking inducer (WI) to increase the sensory input to the remaining cercus, i.e., the self-generated wind caused by walking. In another experiment, each cricket was reared in a small plastic case separate from the outside atmosphere (wind-free: WF). In this rearing condition, the cricket did not experience self-generated wind as walking was prohibited. During the recovery period after the unilateral cercus ablation, the crickets were reared under either the WI or WF condition to investigate the role of the sensory inputs on the compensational recovery of the response rate. The compensational recovery of the response rate occurred only in the crickets reared under the WI condition during the early period after the ablation. In particular, WI rearing during the first three days after the ablation resulted in the largest compensational recovery in the response rate. In contrast, no compensational recovery was observed in the crickets reared under the WF condition during the first three days. These results suggest that a sensitive period exists in which sensory inputs from the remaining cercus affect the compensational recovery of the response rate more effectively than during other periods.	[Takuwa, Hiroyuki] Natl Inst Radiol Sci, Dept Biophys, Mol Imaging Ctr, Chiba 2638555, Japan; [Kanou, Masamichi] Ehime Univ, Grad Sch Sci & Engn, Dept Biol, Matsuyama, Ehime 7908577, Japan	Takuwa, H (reprint author), Natl Inst Radiol Sci, Dept Biophys, Mol Imaging Ctr, Chiba 2638555, Japan.	takuwa@nirs.go.jp					SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P495, DOI 10.1007/BF00611914; Li WL, 2008, DEV NEUROBIOL, V68, P1474, DOI 10.1002/dneu.20674; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419; Gordon JA, 1996, J NEUROSCI, V16, P3274; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P485, DOI 10.1007/BF00611913; BENTLEY D, 1975, SCIENCE, V187, P760, DOI 10.1126/science.1114323; Groh C, 2010, FRONT BIOSCI, P268; KANOU M, 1984, J COMP PHYSIOL, V154, P357, DOI 10.1007/BF00605235; Kanou M, 1999, ZOOL SCI, V16, P71, DOI 10.2108/zsj.16.71; Kanou M, 2002, ZOOL SCI, V19, P403, DOI 10.2108/zsj.19.403; KANOU M, 1991, EXPERIENTIA, V47, P447, DOI 10.1007/BF01959939; Kanou M, 2008, ZOOL SCI, V25, P931, DOI 10.2108/zsj.25.931; Kanou M, 1996, ZOOL SCI, V13, P35, DOI 10.2108/zsj.13.35; Kanou M, 2004, ZOOL SCI, V21, P933, DOI 10.2108/zsj.21.933; Kanou M, 2001, ZOOL SCI, V18, P791, DOI 10.2108/zsj.18.791; MASSON C, 1984, J INSECT PHYSIOL, V30, P7, DOI 10.1016/0022-1910(84)90104-5; MATSUMOTO SG, 1977, J COMP PHYSIOL, V119, P319; MATSUMOTO SG, 1978, J PHYSIOL-LONDON, V285, P159; Matsuura T, 2003, J INSECT PHYSIOL, V49, P805, DOI 10.1016/S0022-1910(03)00116-1; Matsuura T, 1998, ZOOL SCI, V15, P183, DOI 10.2108/zsj.15.183; Mimura K, 1986, SCIENCE, V232, P8385; MURPHEY RK, 1976, J COMP NEUROL, V169, P335, DOI 10.1002/cne.901690305; MURPHEY RK, 1977, J COMP PHYSIOL, V119, P285; PALKA J, 1977, J COMP PHYSIOL, V119, P301; Takuwa H, 2013, ZOOL SCI, V30, P339, DOI 10.2108/zsj.30.339; Takuwa H, 2008, ZOOL SCI, V25, P235, DOI 10.2108/zsj.25.235; Takuwa H, 2007, ZOOL SCI, V24, P331, DOI 10.2108/zsj.24.331	30	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2015	32	2					119	123		10.2108/zs140230		5	Zoology	Zoology	CE3XF	WOS:000351762700001		
J	Kitta, R; Okawa, S; Saito, M; Mase, K; Sawada, H				Kitta, Ryo; Okawa, Sin-ichiro; Saito, Miho; Mase, Keisuke; Sawada, Hiroshi			HCl Treatment for Preventing Diapause Causes Ca2+ Effluxin Bombyx mori Eggs	ZOOLOGICAL SCIENCE			English	Article						Bombyx mori; Ca2+; diapause prevention or breaking; DMSO; Embryonic diapause; HCl treatment	SILKWORM; LOCALIZATION; PROTEIN; CHORION	To elucidate the mechanism for preventing entry into embryonic diapause or breakdown of diapause in Bombyx mori by HCl and dimethyl sulfoxide (DMSO) treatment or a combination of cold and HCl treatment, we performed quantitative analysis of Ca2+ and Mg2+ in the chorion and egg content using inductively coupled plasma atomic emission spectrometry (ICP-AES). When diapause eggs that had been incubated at 25 degrees C for 2 days from oviposition and at 4 degrees C for an additional six days were treated with HCl solution, the amount of Ca2+ in the chorion and egg content after HCl treatment was reduced to one-seventh, as compared with the amount before treatment. In contrast, there was no change in the amount of Mg2+ with HCl treatment. The amount of Ca2+ in the HCl solution after the diapause eggs were treated increased 7.5-fold, as compared with that of eggs treated with water. Even when 17-day-old diapausing eggs were treated with HCl, which did not break diapause, the amount of Ca2+ in the chorion and egg content was reduced to one-fifth, as compared with the control. Meanwhile, changes in Ca2+ and Mg2+ contents were not observed in 12-hr-old diapause-destined eggs before or after treatment with DMSO, which effectively prevents diapause. These data may suggest that Ca2+ efflux from diapause eggs by HCl is not directly associated with preventing entry into diapause or breaking of diapause. In addition, we discovered that the amount of Ca2+ in diapause-destined eggs was more than 2.4-fold larger than in non-diapause-destined eggs.	[Kitta, Ryo; Saito, Miho; Mase, Keisuke; Sawada, Hiroshi] Nihon Univ, Grad Sch Integrated Basic Sci, Depertment Correlat Study Phys & Chem, Setagaya Ku, Tokyo 1568550, Japan; [Okawa, Sin-ichiro] Nihon Univ, Coll Humanities & Sci, Depertment Chem, Setagaya Ku, Tokyo 1568550, Japan; [Mase, Keisuke; Sawada, Hiroshi] Nihon Univ, Coll Humanities & Sci, Depertment Integrated Sci Phys & Biol, Setagaya Ku, Tokyo 1568550, Japan	Sawada, H (reprint author), Nihon Univ, Grad Sch Integrated Basic Sci, Depertment Correlat Study Phys & Chem, Setagaya Ku, Tokyo 1568550, Japan.	sawada@chs.nihon-u.ac.jp			Japan Society for the Promotion of Science [25450489]; Nihon University	This work was supported by the Japan Society for the Promotion of Science (25450489) and a Nihon University Research Grant for 2013.	SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; Fukuda S., 1951, Proceedings of the Japan Academy, V27, P672; Hasegawa K., 1951, Proceedings of the Japan Academy, V27, P667; NAKAGAKI M, 1991, ROUX ARCH DEV BIOL, V200, P223, DOI 10.1007/BF00361341; Niimi Teruyuki, 1993, Journal of Sericultural Science of Japan, V62, P310; Nijhout HF, 1994, INSECT HORMONES; Sawada H, 2012, ZOOL SCI, V29, P6, DOI 10.2108/zsj.29.6; Sawada H, 2006, INSECT BIOCHEM MOLEC, V36, P911, DOI 10.1016/j.ibmb.2006.09.002; SONOBE H, 1979, J INSECT PHYSIOL, V25, P381, DOI 10.1016/0022-1910(79)90003-9; SONOBE H, 1991, J INSECT PHYSIOL, V37, P727, DOI 10.1016/0022-1910(91)90106-A; Tsurumaru S, 2010, J INSECT PHYSIOL, V56, P1721, DOI 10.1016/j.jinsphys.2010.07.004; Xian Xinfu, 1997, Journal of Sericultural Science of Japan, V66, P219; YAGINUMA T, 1990, J COMP PHYSIOL B, V160, P277, DOI 10.1007/BF00302593; Yamamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064124; Yamashita O., 1985, P407; YOSHIMI T, 1990, Journal of Sericultural Science of Japan, V59, P14	16	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2015	32	2					124	128		10.2108/zs140168		5	Zoology	Zoology	CE3XF	WOS:000351762700002		
J	Shima, A; Matsuda, R				Shima, Ai; Matsuda, Ryoichi			Low Culture Temperature Inhibits Myogenic Differentiation Through Mitochondrial Activity	ZOOLOGICAL SCIENCE			English	Article						mitochondria; myogenesis; myogenin; skeletal muscle; temperature; IGF; vitamin C	SKELETAL-MUSCLE CELLS; MYOBLAST DIFFERENTIATION; STRUCTURAL ORGANIZATION; NUCLEAR GENES; EXPRESSION; ACTIVATION; MUTATION; PROTEIN; MOUSE; MYOD	A previous study by our group reported that mouse and human myoblasts fail to express myogenin and to fuse into multi-nucleate myotubes when cultured at low temperature, such as 30 degrees C, but that this activity is rescued by adding IGF-I and vitamin C to the culture medium. In the present study, we examined mitochondrial activity as a target of the inhibitory effects of the low culture temperature. It has been suggested that mitochondria regulate myogenesis. By using a mouse myoblast cell line C2C12, we demonstrate that the expression of cytochrome c oxidase subunit I (COX I), which is encoded in mitochondrial genome, increases during myogenic differentiation at the normal culture temperature (38 degrees C), but that this up-regulation is inhibited at 30 degrees C. The mitochondrial membrane potential also decreased at 30 degrees C compared to the culture at 38 degrees C. However, IGF-I and vitamin C rescued both COX I expression and mitochondrial membrane potential at 30 degrees C as promoting muscle differentiation. We also find that the rescue of mitochondrial activity by IGF-I and vitamin C at 30 degrees C occurred after the myogenin expression, which suggests that myogenin regulates mitochondrial function during myogenesis. We suggest that our low temperature-culture system may be suitable for use in studying the detailed mechanism of myogenin-related phenomena during myogenesis.	[Shima, Ai] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Shima, Ai; Matsuda, Ryoichi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Matsuda, R (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan.	cmatsuda@mail.ecc.u-tokyo.ac.jp			Ministry of Health, Labor and Welfare, Japan [19A-020, 26-8, 20B-13]; Japan Society for the Promotion of Science (JSPS) [25650106]	This work has been supported by a Health and Labor Sciences Research Grant (19A-020) for Research on Psychiatric and Neurological Diseases and Mental Health, an Intramural Research Grant (26-8) for Neurological and Psychiatric Disorders of NCNP and a Research Grant for Nervous and Mental Disorders (20B-13) from the Ministry of Health, Labor and Welfare, Japan and a Grant-in-Aid for Challenging Exploratory Research #25650106 from Japan Society for the Promotion of Science (JSPS).	BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4; De Proost I, 2008, AM J RESP CELL MOL, V39, P180, DOI 10.1165/rcmb.2008-0011OC; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Puche JE, 2008, ENDOCRINOLOGY, V149, P2620, DOI 10.1210/en.2007-1563; Pawlikowska P, 2006, CELL PROLIFERAT, V39, P127, DOI 10.1111/j.1365-2184.2006.00376.x; Shima A, 2008, ZOOL SCI, V25, P1066, DOI 10.2108/zsj.25.1066; BRUNK CF, 1981, EXP CELL RES, V136, P305, DOI 10.1016/0014-4827(81)90008-2; Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123; Lai HC, 2003, MOL CELL ENDOCRINOL, V205, P99, DOI 10.1016/S0303-7207(03)00200-4; Lenka N, 1998, PROG NUCLEIC ACID RE, V61, P309, DOI 10.1016/S0079-6603(08)60830-2; Lenka N, 1996, J BIOL CHEM, V271, P30281; MELL OC, 1994, GENE, V140, P179, DOI 10.1016/0378-1119(94)90542-8; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Shima A, 2011, EXP CELL RES, V317, P356, DOI 10.1016/j.yexcr.2010.11.001; VERTEL BM, 1977, DEV BIOL, V58, P356, DOI 10.1016/0012-1606(77)90097-5; Zhao SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055164	21	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2015	32	2					129	134		10.2108/zs140247		6	Zoology	Zoology	CE3XF	WOS:000351762700003		
J	Sakamoto, Y; Takatsuki, S				Sakamoto, Yuka; Takatsuki, Seiki			Seeds Recovered from the Droppings at Latrines of the Raccoon Dog (Nyctereutes procyonoides viverrinus): The Possibility of Seed Dispersal	ZOOLOGICAL SCIENCE			English	Article						dispersal distance; fleshy fruit; latrine; raccoon dog; seed dispersal	FRUGIVOROUS BIRDS; CARNIVOROUS MAMMALS; FLESHY FRUITS; CONSUMPTION; LANDSCAPE; SELECTION; PATTERNS; BEHAVIOR; FORESTS; TREES	Medium-sized carnivorous mammals are important seed dispersers of fleshy fruits. The raccoon dog (Nyctereutes procyonoides viverrinus) often feeds on fleshy fruits and forms latrines. This behavior may potentially lead to seed dispersal. To determine if this is the case, we studied 1) seed recovery in the droppings of raccoon dogs, and 2) the transportation of seeds between habitats using plastic markers in a western suburb of Tokyo, Japan. In total, 32,473 seeds of 50 plant taxa were recovered from 120 raccoon dog droppings during a year, and 95.7% of the seeds were found to be those of fleshy fruits. The species most frequently recovered were the eurya (Eurya japonica, 52.6%), the brambles (Rubus spp., 17.4%), and the black night shade (Solanum nigrum, 16.0%). A total of 7,412 plastic markers were embedded in baits at 14 bait plots and were recovered in the feces of the raccoon dogs at 22 latrines. The "transportation rates" were calculated in 50-m distance classes and found that most seeds (43.5%) were deposited within 50 m from the bait point, suggesting very short seed dispersal distances. Inter-habitat transportation was observed: 64.9% of the retrieved markers deposited in the forest were transported to other places within the forest. In contrast, almost all of the markers (99.4%) deposited in the open site were transported within the same habitat. These findings suggest that the seeds of forest plants bearing berries can be dispersed out of the forest to open areas by raccoon dogs.	[Sakamoto, Yuka; Takatsuki, Seiki] Azabu Univ, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 229859, Japan	Takatsuki, S (reprint author), Azabu Univ, Sch Vet Med, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 229859, Japan.	takatuki@azabu-u.ac.jp			Azabu University	The office of the Waste Treatment Plant at Hinode Town afforded us to study in the plant. Mr. Y. Yanagida at Jepro (Japan Environmental Project Forum) Co. Ltd. provided information and facility. This research was partially supported by a research project grant awarded by the Azabu University.	HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Campos CM, 1997, J ARID ENVIRON, V35, P707, DOI 10.1006/jare.1996.0196; Silva SI, 2005, AUSTRAL ECOL, V30, P739, DOI 10.1111/j.1442-9993.2005.01449.x; WILLSON MF, 1993, OIKOS, V67, P159, DOI 10.2307/3545106; Rosalino LM, 2009, MAMMAL REV, V39, P67, DOI 10.1111/j.1365-2907.2008.00134.x; Fukui AW, 1995, RES POPUL ECOL, V37, P211, DOI 10.1007/BF02515822; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Campos-Arceiz A, 2008, ECOLOGY, V89, P2684, DOI 10.1890/07-1573.1; HERRERA CM, 1989, OIKOS, V55, P250, DOI 10.2307/3565429; JOHNSON RA, 1985, ECOLOGY, V66, P819, DOI 10.2307/1940543; JORDANO P, 1995, ECOLOGY, V76, P2627, DOI 10.2307/2265833; Rosalino LM, 2010, ANN ZOOL FENN, V47, P195; Calder W. A., 1984, SIZE FUNCTION LIFE H; Chapman Colin A., 2007, P510; CLEMENS ET, 1980, J AGR SCI, V94, P735; CONNELL J H, 1971, P298; Fedriani JM, 2010, ECOGRAPHY, V33, P545, DOI 10.1111/j.1600-0587.2009.06052.x; Forget P. -M., 2005, SEED FATE PREDATION; Fukui Akiko, 2003, Ornithological Science, V2, P41, DOI 10.2326/osj.2.41; Gonzalez-Varo JP, 2013, J ANIM ECOL, V82, P562, DOI 10.1111/1365-2656.12024; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Hirasawa Mizuho, 2006, Mammal Study, V31, P9, DOI 10.3106/1348-6160(2006)31[9:SFHOTR]2.0.CO;2; IKEDA H, 1979, Japanese Journal of Ecology, V29, P35; Ikeda H, 1984, J ETHOL, V2, P77, DOI 10.1007/BF02430571; Ishikawa S, 1994, SEEDS FRUITS JAPAN; IZHAKI I, 1991, J ECOL, V79, P575, DOI 10.2307/2260654; Janzen D, 1970, OIKOS, V46, P1; Jordano P, 2011, BIOL LETTERS, V7, P321, DOI 10.1098/rsbl.2010.0986; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Juan T., 2006, Acta Oecologica, V30, P39, DOI 10.1016/j.actao.2006.01.004; Kakutani T, 2000, CHUBU SHINRIN KENKYU, V48, P5; Kato C, 2000, TOHOKU J FOR SCI, V5, P9; Kauhala K, 2012, MAMM BIOL, V77, P264, DOI 10.1016/j.mambio.2012.02.007; Koike S, 2008, J FOREST RES-JPN, V13, P215, DOI 10.1007/s10310-008-0069-5; Lopez-Bao JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014569; Martinez I, 2008, ECOSCIENCE, V15, P189, DOI 10.2980/15-2-3096; Matias L, 2008, RESTOR ECOL, V18, P1; Miyaki M, 1990, KOUJUNAIKIHOU, V81, P17; Miyata I, 1989, SANIN REGION RES NAT, V5, P109; Nakayama S, 2000, SEEDS WILD PLANTS JA; Ohdachi S. D., 2009, WILD MAMMALS JAPAN; Pereira M, 2010, J APPL ECOL, V47, P611, DOI 10.1111/j.1365-2664.2010.01804.x; Saeki M, 2007, J MAMMAL, V88, P1098, DOI 10.1644/06-MAMM-A-208R1.1; Schaefer HM, 2011, PLANT-ANIMAL COMMUNICATION, P1, DOI 10.1093/acprof:osobl/9780199563609.001.0001; Sekiya K, 1998, RECCOON DOG SHINSHU; Thoreau HD, 1993, FAITH IN A SEED; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Tsuji Y, 2011, MAMM STUDY, V36, P165; Van der Pijl L., 1969, PRINCIPLES DISPERSAL; Wall S. B. vander, 2005, Seed fate: predation, dispersal and seedling establishment, P1; Verdu M, 1998, J VEG SCI, V9, P713, DOI 10.2307/3237289; WHEELWRIGHT NT, 1985, AM NAT, V126, P777, DOI 10.1086/284453; Yamamoto Y, 1991, REPORT NATURAL ENV K, V2, P185; Yonekura K, 2003, YLIST INDEX JAPANESE; Zhou YB, 2008, FOREST ECOL MANAG, V255, P1595, DOI 10.1016/j.foreco.2007.11.018	58	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2015	32	2					157	162		10.2108/zs140107		6	Zoology	Zoology	CE3XF	WOS:000351762700007		
J	Ozawa, T; Ohta, K; Shimada, M; Okada, K; Okada, Y				Ozawa, Takane; Ohta, Kunihiro; Shimada, Masakazu; Okada, Kensuke; Okada, Yasukazu			Environmental Factors Affecting Pupation Decisionin the Horned Flour Beetle Gnatocerus cornutus	ZOOLOGICAL SCIENCE			English	Article						phenotypic plasticity; pupation inhibition; metamorphosis; anti-predation; flour beetle	TENEBRIONID BEETLES; EXAGGERATED TRAITS; TRIBOLIUM-FREEMANI; LARVAL DENSITY; COLEOPTERA; CANNIBALISM; PREDATION; POPULATION; BEHAVIOR; BIOLOGY	Social environments often affect the development of organisms. In Tenebrionidae beetles, larval development can be arrested at the final instar stage in the presence of conspecific larvae. This developmental plasticity is considered to be an anti-cannibalistic strategy but the critical environmental determinants and actual effects remain to be elucidated. In this study, we examined the effects of the heterospecific environment, conspecific sexual environment (i.e., presence of conspecific male or female), and abiotic physical stimulation on the pupation decision of the sexually dimorphic horned-flour beetle Gnatocerus cornutus. Additionally, actual anti-cannibalistic or anti-predatory effects of developmental arrest were evaluated by analyzing stage-dependent vulnerabilities. When G. cornutus larvae were maintained with a G. cornutus larva, a G. cornutus adult, or T. castaneum adult, the developmental period up to the prepupal stage was significantly elongated, suggesting that the cue is not species-specific. Sexual environment did not affect the timing of pupation in G. cornutus; however, we found that abiotic tactile stimulations by glass beads could repress pupation. We also discovered that prepupal and pupal stages were more vulnerable to cannibalism and predation than the larval stage. These data suggest that G. cornutus larvae use non-species specific tactile stimulation as a decision cue for pupation and it has broader defensive effects against heterospecific predation as well as conspecific cannibalism.	[Ozawa, Takane; Ohta, Kunihiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Shimada, Masakazu; Okada, Yasukazu] Univ Tokyo, Dept Gen Syst Studies, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Okada, Kensuke] Okayama Univ, Grad Sch Environm Sci, Lab Evolutionary Ecol, Okayama 7008530, Japan	Okada, Y (reprint author), Univ Tokyo, Dept Gen Syst Studies, Grad Sch Arts & Sci, Tokyo 1538902, Japan.	cokayasu@mail.ecc.u-tokyo.ac.jp			Kakenhi [24870006, 26870121]; Research and Education Platform for Dynamic Living States	This work was supported by Kakenhi (#24870006, 26870121) to Y.O. and by Research and Education Platform for Dynamic Living States to K.O, M.S, Y.O. We thank the editors and two anonymous referees for improving the manuscript.	SAVVIDOU N, 1994, J STORED PROD RES, V30, P17, DOI 10.1016/0022-474X(94)90268-2; Okada K, 2010, BEHAV ECOL SOCIOBIOL, V64, P361, DOI 10.1007/s00265-009-0852-0; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Alabi T, 2008, ECOL ENTOMOL, V33, P716, DOI 10.1111/j.1365-2311.2008.01020.x; Miyatake T, 2004, P ROY SOC B-BIOL SCI, V271, P2293, DOI 10.1098/rspb.2004.2858; Okada K, 2010, EVOL ECOL, V24, P1339, DOI 10.1007/s10682-010-9370-9; Okada K, 2006, J INSECT BEHAV, V19, P457, DOI 10.1007/s10905-006-9038-z; NAKAKITA H, 1982, APPL ENTOMOL ZOOL, V17, P269; BARAK AV, 1977, J STORED PROD RES, V13, P169, DOI 10.1016/0022-474X(77)90026-1; Dixon AFG, 2000, INSECT PREDATOR PREY; DYTE C. E., 1965, Journal of Stored Products Research, V1, P129, DOI 10.1016/0022-474X(65)90014-7; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Fuchikawa T, 2013, J EVOLUTION BIOL, V26, P1979, DOI 10.1111/jeb.12197; Harvell C. D., 1999, ECOLOGY EVOLUTION IN; HINTON H. E., 1955, TRANS SOC BRIT ENT, V12, P49; Hinton HE, 1946, T R ENT SOC LOND, V97, P473, DOI DOI 10.1111/J.1365-2311.1946.TB00273.X; Ichikawa T, 2009, ZOOL SCI, V26, P525, DOI 10.2108/zsj.26.525; KOTAKI T, 1995, ENTOMOL EXP APPL, V74, P145; Lucas E, 2000, ENVIRON ENTOMOL, V29, P454; Okada Y, 2012, EVOL DEV, V14, P363, DOI 10.1111/j.1525-142X.2012.00554.x; Park T, 1938, J EXP ZOOL, V79, P51, DOI 10.1002/jez.1400790105; RHAINDS M, 1995, ENTOMOL EXP APPL, V77, P183; Thomas Park DBM, 1965, PHYSIOL ZOOL, V38, P289; TSCHINKEL WR, 1981, ANIM BEHAV, V29, P990, DOI 10.1016/S0003-3472(81)80052-8; TSUDA Y, 1985, RES POPUL ECOL, V27, P77, DOI 10.1007/BF02515481; TSCHINKE.WR, 1971, J EXP ZOOL, V176, P137, DOI 10.1002/jez.1401760203; YOUNG AM, 1970, ECOLOGY, V51, P602, DOI 10.2307/1934040	27	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2015	32	2					183	187		10.2108/zs140203		5	Zoology	Zoology	CE3XF	WOS:000351762700011		
J	Ohtsuka, S; Metillo, E; Boxshall, GA				Ohtsuka, Susumu; Metillo, Ephrime; Boxshall, Geoffrey A.			First Record of Association of Copepods with Highly Venomous Box Jellyfish Chironex, with Description of New Species of Paramacrochiron (Cyclopoida: Macrochironidae)	ZOOLOGICAL SCIENCE			English	Article						association; box jellyfish; copepod; Macrochironidae; Philippines; scyphozoan	CNIDARIA CUBOZOA; EVOLUTION	Paramacrochiron chironecicola n. sp. (Copepoda: Cyclopoida: Macrochironidae) is described from the highly venomous box jellyfish Chironex sp. collected from Malampaya Sound, Palawan Island, The Philippines. This is the first record of copepods associated with cubozoan medusae, although other cnidarian groups such scyphozoans, hydrozoans, and anthozoans are common hosts for symbiotic copepods. The infection sites were on the subumbrella, pedalium, and rhopalium, but also rarely on the adradial furrow. The new species is distinguished from other congeners by a combination of the following features: (1) the fifth pedigerous somite dorsally covering the anterior part of the female genital double-somite; (2) the fine structures of the antenna (relative lengths of segments) and maxilliped (positions of terminal elements) of the female; (3) the relatively long outer spines on the exopodal segments of legs 1-4; (4) the relatively long and thick female leg 5 bearing a long protopodal seta which reaches to the distal margin of the exopod; (5) the relatively short caudal ramus in the female; and (6) the plump prosome and short urosome in the male. Since members of the genus typically parasitize scyphozoans, especially rhizostomes, the association of this parasitic copepod on cubozoans may reflect the relatively close phylogenetic relationship between cubozoans and scyphozoans.	[Ohtsuka, Susumu] Hiroshima Univ, Takehara Marine Sci Stn, Setouchi Field Ctr, Grad Sch Biosphere Sci, Hiroshima 7250024, Japan; [Metillo, Ephrime] Mindanao State Univ, Iligan Inst Technol, Dept Biol Sci, Iligan 9200, Philippines; [Boxshall, Geoffrey A.] Nat Hist Museum, Life Sci Dept, London SW7 5BD, England	Ohtsuka, S (reprint author), Hiroshima Univ, Takehara Marine Sci Stn, Setouchi Field Ctr, Grad Sch Biosphere Sci, Minato Machi 5-8-1, Hiroshima 7250024, Japan.	ohtsuka@hiroshima-u.ac.jp			Japan Society of the Promotion of Science [25304031, 26304030]	We would like to express our sincere thanks to Drs. Honorio Pagliawan (Western Philippines University) and Hiroshi Miyake (Kitasato University), Mr. Yusuke Kondo and Shuiichiro Hashimoto, and Miss Shiho Honda for their assistance in collecting the box jellyfish. Thanks are also due to Dr. Sho Toshino (Kitasato University) for identifying the host box jellyfish and providing us with the photos of the host and copepod. We are also thankful to Profs. Shuhei Nishida (University of Tokyo) and Jun Nishikawa (Tokai University) for their encouragement through this study, and to Mr. T. Chad Walter for the loan of the type specimens of Paramacrochrion pacificum deposited at the National Museum of Natural History, USA. This study was partially supported by Grant-in-Aids for Scientific Research (B) (Nos. 25304031, 26304030) and a grant-in-aid of Asian Core Program of the Japan Society of the Promotion of Science.	Huys R, 2012, INT J PARASITOL, V42, P71, DOI 10.1016/j.ijpara.2011.10.009; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; Lewis C, 2009, ZOOTAXA, P59; Boxshall G. A., 2004, INTRO COPEPOD DIVERS; Browne JG, 2005, MAR BIOL, V146, P1157, DOI 10.1007/s00227-004-1517-1; Collins, 2002, J EVOLUTION BIOL, V15, P418; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; Ho JS, 2001, HYDROBIOLOGIA, V453, P1, DOI 10.1023/A:1013139212227; HUMES AG, 1985, T AM MICROSC SOC, V104, P313, DOI 10.2307/3226484; Huys R., 1991, COPEPOD EVOLUTION; Kim Jihee, 2000, Korean Journal of Biological Sciences, V4, P257, DOI 10.1007/BF02823974; Mulyadi, 2005, CRUSTACEANA, V78, P917, DOI 10.1163/156854005775197235; Ohtsuka S, 2012, ZOOL SCI, V29, P127, DOI 10.2108/zsj.29.127; Reddiah K., 1968, Crustaceana Suppl, V1, P193; Thompson IC, 1903, REPORT GOVT CEYLON P, V7, P227; Toshino Sho, 2013, Plankton & Benthos Research, V8, P1; Tung CH, 2014, BIOL BULL-US, V226, P69; WILSON CHARLES BRANCH, 1950, BULL U S NATION MUS, V100, P141	18	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2015	32	2					195	203		10.2108/zs140216		9	Zoology	Zoology	CE3XF	WOS:000351762700013		
J	Matsui, M; Khonsue, W; Panha, S; Eto, K				Matsui, Masafumi; Khonsue, Wichase; Panha, Somsak; Eto, Koshiro			A New Tree Frog of the Genus Gracixalus from Thailand (Amphibia: Rhacophoridae)	ZOOLOGICAL SCIENCE			English	Article						Gracixalus seesom; mitochondrial phylogeny; Southeast Asia; systematics; taxonomy	ANURA RHACOPHORIDAE; NORTHERN VIETNAM; SPECIES AMPHIBIA; COMPLEX; DICROGLOSSIDAE	We report a new tree frog of the genus Gracixalus from western Thailand and describe it as a new species Gracixalus seesom based on results of morphological and molecular analyses. The new species is a small-sized Gracixalus (male snout-vent length ca. 22 mm) and is morphologically similar to G. gracilipes, but is easily distinguished from it by its dorsal tan color in life, absence of white spot on lower lip, and black markings on its foot webbing. The new species also clearly differs from all the other members of the genus by the combination of small body size, triangular snout, and light yellowish brown dorsum without distinct tuberculations. Problems of phylogeny and taxonomy of the genus Gracixalus are briefly discussed.	[Matsui, Masafumi; Eto, Koshiro] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Khonsue, Wichase; Panha, Somsak] Chulalongkorn Univ, Dept Biol, Fac Sci, Bangkok 10330, Thailand; [Eto, Koshiro] Kyoto Univ, Kyoto Univ Museum, Sakyo Ku, Kyoto 6068501, Japan	Matsui, M (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan.	fumi@zoo.zool.kyoto-u.ac.jp			Chulalongkorn Unversity; TRF/BIOTEC Special Program for Biodiversity Research and Training grant; Monbusho [04041068, 06041066, 08041144, 20405013]; TJTTP-OECF	The National Research Council of Thailand and the Royal Forest Department of Thailand kindly permitted MM to conduct the project, and Chulalongkorn University kindly provided all the facilities for conducting research. MM is indebted to K. Araya for providing samples, J.-P. Jiang for supplying literaure, H. Kuraishi and H. Kawahara for laboratory assistance, and B. T. Clarke, C. McCarthy, and T. C. Nguyen for allowing him to examine specimens under their care. MM is also grateful to K. Araya, T. Chan-ard, T. Hikida, and the late J. Nabitabhata for field companionship and/or permission to conduct research. SP would like to express the gratitude to Chulalongkorn Unversity for providing some research funding, and great thanks should go to police officers at Pilok Police Station for providing accomodation to our team while doing field work at Pilok. This work was partially supported by the TRF/BIOTEC Special Program for Biodiversity Research and Training grant to WK. Field trips by MM were made possible by grants from The Monbusho (Field Research, Nos. 04041068, 06041066, 08041144, and 20405013) and TJTTP-OECF.	Rowley JJL, 2011, ZOOTAXA, P22; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; Biju SD, 2010, CURR SCI INDIA, V98, P1119; Chanard T, 2003, PHOTOGRAPHIC GUIDE A; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Delorme Magali, 2005, Bulletin Mensuel de la Societe Linneenne de Lyon, V74, P165; Fei L., 2009, FAUNA SINICA AMPHIBI, V2; Frost D.R., 2014, AMPHIBIAN SPECIES WO; Khonsue Wichase, 2001, Natural History Journal of Chulalongkorn University, V1, P69; Kuraishi N, 2013, ZOOL SCR, V42, P54, DOI 10.1111/j.1463-6409.2012.00562.x; LIEM S S, 1970, Fieldiana Zoology, V57, P1; MATSUI M, 1994, ZOOL J LINN SOC-LOND, V111, P385, DOI 10.1111/j.1096-3642.1994.tb01489.x; Matsui M, 2010, ZOOTAXA, P1; Matsui M, 2014, ZOOL SCI, V31, P45, DOI 10.2108/zsj.31.45; Matsui M, 2006, ZOOL SCI, V23, P477, DOI 10.2108/zsj.23.477; MATSUI M, 1984, Contributions from the Biological Laboratory Kyoto University, V26, P209; Mo YM, 2013, ZOOTAXA, V3616, P61, DOI 10.11646/zootaxa.3616.1.5; Nguyen TQ, 2008, ZOOTAXA, V1925, P1; Nguyen TQ, 2013, ORG DIVERS EVOL, V13, P203, DOI 10.1007/s13127-012-0116-0; Nishikawa K, 2013, ZOOTAXA, V 3737, P261, DOI 10.11646/zootaxa.3737.3.5; Orlov Nikolai L., 2004, Russian Journal of Herpetology, V11, P51; Pansook A, 2012, ZOOL SCI, V29, P54, DOI 10.2108/zsj.29.54; Rowley JJL, 2014, ZOOTAXA, V3785, P25, DOI 10.11646/zootaxa.3785.1.2; Savage Jay M., 1997, Herpetological Review, V28, P131; TAYLOR EDWARD H., 1962, UNIV KANSAS SCI BULL, V43, P265; Yu GH, 2013, BIOCHEM SYST ECOL, V47, P31, DOI 10.1016/j.bse.2012.09.023	26	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2015	32	2					204	210		10.2108/zs140238		7	Zoology	Zoology	CE3XF	WOS:000351762700014		
J	Oji, T; Twitchett, RJ				Oji, Tatsuo; Twitchett, Richard J.			The Oldest Post-Palaeozoic Crinoid and Permian-Triassic Origins of the Articulata (Echinodermata)	ZOOLOGICAL SCIENCE			English	Article						Al Jil Formation; Articulata; Crinoidea; Early Triassic; Oman	MASS-EXTINCTION EVENT; OMAN MOUNTAINS; RECOVERY; ANOXIA; STALK	The Crinoidea are the most primitive class of living echinoderms, and suffered a severe crisis during the Late Permian mass extinction event. All post-Palaeozoic crinoids, including living species, belong to the Articulata, and morphological and recent molecular studies demonstrate that they form a monophyletic clade. The Articulata originated from Palaeozoic cladid crinoids, but the nature and timing of their origination remains obscure. Problems with understanding the origin and early evolution of the Articulata have arisen because the Permian-Triassic crinoid fossil record is particularly poor. We report on a new genus and species from the earliest Triassic, which is the oldest known post-Palaeozoic articulate crinoid and fundamentally alters our understanding of the early evolution of the Articulata. Prior to this study, the most primitive post-Palaeozoic articulate was thought to be Holocrinus of the order Isocrinida. Unexpectedly, the new taxon belongs to the order Encrinida, which reveals a previously hidden diversity of crinoids in the earliest Triassic. Its discovery implies either a dramatic radiation of crinoids in the immediate post-extinction aftermath, when environmental conditions were at their most severe, or a pre-extinction origin of the crown group articulates and survival of multiple lineages.	[Oji, Tatsuo] Nagoya Univ, Nagoya Univ Museum, Nagoya, Aichi 4648601, Japan; [Twitchett, Richard J.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Oji, T (reprint author), Nagoya Univ, Nagoya Univ Museum, Furo Cho, Nagoya, Aichi 4648601, Japan.	oji@num.nagoya-u.ac.jp	Oji, Tatsuo/A-1840-2009		JSPS [21540482, K3715]	We thank Hans Hagdorn (Muschelkalkmuseum, Ingelfingen) for reviewing an earlier draft. R.J.T. thanks Aymon Baud (Geological Museum, Lausanne University) and Leo Krystyn (Palaeontological Institute, University of Vienna) for access to the crinoid locality. This study was supported partly by the Grant-in-aid for Scientific Research by JSPS # 21540482 (for T.O.) and by a JSPS postdoctoral fellowship for foreign researchers # K3715 (for R.J.T.). We thank Tom Baumiller and an anonymous reviewer for their important comments on the manuscript.	Twitchett RJ, 2006, PALAEOGEOGR PALAEOCL, V232, P190, DOI 10.1016/j.palaeo.2005.05.019; BLENDINGER W, 1992, PALAEOGEOGR PALAEOCL, V93, P13, DOI 10.1016/0031-0182(92)90181-4; Krystyn L, 2003, PALAEOGEOGR PALAEOCL, V191, P329, DOI 10.1016/S0031-0182(02)00670-3; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; SCHUBERT JK, 1992, LETHAIA, V25, P97, DOI 10.1111/j.1502-3931.1992.tb01794.x; Hagdorn Hans, 2011, Swiss Journal of Palaeontology, V130, P91, DOI 10.1007/s13358-010-0009-9; Rouse GW, 2013, MOL PHYLOGENET EVOL, V66, P161, DOI 10.1016/j.ympev.2012.09.018; SIMMS MJ, 1993, PALAEONTOLOGY, V36, P91; Algeo TJ, 2010, GEOLOGY, V38, P1023, DOI 10.1130/G31203.1; Twitchett RJ, 2005, CR PALEVOL, V4, P531, DOI 10.1016/j.crpv.2005.02.006; Twitchett RJ, 2004, GEOLOGY, V32, P805, DOI 10.1130/G20585.1; Baumiller T. K., 2007, PALAEONTOL ELECTRON, V10, P10; BAUMILLER TK, 1992, PALEOBIOLOGY, V18, P288; Donovan SK, 2012, GEOLOGY, V40, P867, DOI 10.1130/G33262.1; Dujardin F, 1862, LIB ENCY RORET, V8, P1; Foster WJ, 2014, NAT GEOSCI, V7, P233, DOI [10.1038/ngeo2079, 10.1038/NGEO2079]; Hagdorn H, 1995, ZBL GEOL PALAONT, V2, P1; Hagdorn Hans, 1996, Geologisch-Palaeontologische Mitteilungen, V21, P19; Hess H, 2011, TREATISE INVERTEBR T, V3, P1; Holterhoff PF, 1996, PALEONTOL SOC SPEC P, V8, P1; Kashiyama Yuichiro, 2004, Paleontological Research, V8, P199, DOI 10.2517/prpsj.8.199; Matsumoto H, 1929, TOHOKU U SCI REPOR 2, V13, P27; Miller JS, 1921, NATURAL HIST CRINOID, P1; Oji T, 2009, NATL MUSEUM NATURE S, V38, P180; Rasmussen H.W., 1978, pT813; RASMUSSEN HW, 1977, LETHAIA, V10, P51, DOI 10.1111/j.1502-3931.1977.tb00591.x; Simms Michael J., 1999, P31, DOI 10.1017/CBO9780511626159.004; Wheeley JR, 2005, LETHAIA, V38, P37, DOI 10.1080/0024116051003150; Zittel KA von, 1876, HDB PALAEONTOLOGIE, P1	30	1	1	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	MAR	2015	32	2					211	215		10.2108/zs140240		5	Zoology	Zoology	CE3XF	WOS:000351762700015		
J	Sakaida, H; Takeuchi, K				Sakaida, Hiroshi; Takeuchi, Kazuhiko			Dehiscent high jugular bulb attached to the tympanic membrane	ENT-EAR NOSE & THROAT JOURNAL			English	Editorial Material									[Sakaida, Hiroshi; Takeuchi, Kazuhiko] Mie Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tsu, Mie, Japan	Sakaida, H (reprint author), Mie Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tsu, Mie, Japan.						Friedmann DR, 2012, OTOLARYNG HEAD NECK, V147, P750, DOI 10.1177/0194599812448615; El-Begermy MA, 2010, OTOLARYNG HEAD NECK, V142, P576, DOI 10.1016/j.otohns.2009.12.007; Haupert M S, 1997, Ear Nose Throat J, V76, P468; Saito T, 1999, ANN OTO RHINOL LARYN, V108, P620; Woo CK, 2012, OTOL NEUROTOL, V33, P1283, DOI 10.1097/MAO.0b013e318259b6e7	5	0	0	VENDOME GROUP LLC	NEW YORK	6 EAST 32 ST, 8 FLOOR, NEW YORK, NY 10016 USA	0145-5613	1942-7522		ENT-EAR NOSE THROAT	ENT-Ear Nose Throat J.	MAR	2015	94	3					94	+				2	Otorhinolaryngology	Otorhinolaryngology	CD3XV	WOS:000351018000002		
J	Kanazawa, T; Kodama, K; Nokubi, M; Gotsu, K; Shinnabe, A; Hasegawa, M; Kusaka, G; Iino, Y				Kanazawa, Takeharu; Kodama, Kozue; Nokubi, Mitsuhiro; Gotsu, Kazuo; Shinnabe, Akihiro; Hasegawa, Masayo; Kusaka, Gen; Iino, Yukiko			A case of solitary fibrous tumor arising from the palatine tonsil	ENT-EAR NOSE & THROAT JOURNAL			English	Article							P53; EXPRESSION	Solitary fibrous tumor (SFT) is a distinctive, relatively uncommon soft-tissue neoplasm that usually arises from the pleura. It occurs at various sites; head and neck lesions are very rare. While most of these tumors have a benign course, a small number have malignant potential. We describe a rare case of SFT arising from the left palatine tonsil in a 66-year-old Japanese woman. The mass was completely resected. Immunohistochemical studies were strongly positive for CD34 and bcl-2, mildly positive for phosphorylated protein kinase B and phosphorylated extracellular signal-regulated kinase 1/2, and negative for platelet-derived growth factor receptor alpha and p53. These findings suggested that this tumor was benign. The patient showed no evidence of recurrence during 2 years of follow-up. We believe that the candidate prognostic marker should be checked to distinguish malignant from benign SFTs.	[Kanazawa, Takeharu; Kodama, Kozue; Shinnabe, Akihiro; Hasegawa, Masayo; Iino, Yukiko] Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol Head & Neck Surg, Saitama 3308503, Japan; [Nokubi, Mitsuhiro] Jichi Med Univ, Saitama Med Ctr, Dept Pathol, Saitama 3308503, Japan; [Kusaka, Gen] Jichi Med Univ, Saitama Med Ctr, Dept Neurosurg, Saitama 3308503, Japan; [Gotsu, Kazuo] Hasuda Hosp, Dept Otolaryngol, Hasuda, Japan	Kanazawa, T (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol Head & Neck Surg, 857-1 Amanuma, Saitama 3308503, Japan.	kanatake@omiya.jichi.ac.jp					Mosquera JM, 2009, AM J SURG PATHOL, V33, P1314; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; ENGLAND DM, 1989, AM J SURG PATHOL, V13, P640, DOI 10.1097/00000478-198908000-00003; Hasegawa T, 1999, HUM PATHOL, V30, P1464, DOI 10.1016/S0046-8177(99)90169-7; Schirosi L, 2008, AM J SURG PATHOL, V32, P1627, DOI 10.1097/PAS.0b013e31817a8a89; Yokoi T, 1998, HISTOPATHOLOGY, V32, P423; Gold JS, 2002, CANCER, V94, P1057, DOI 10.1002/cncr.10328; Morimitsu Y, 2000, APMIS, V108, P617, DOI 10.1034/j.1600-0463.2000.d01-105.x; Chilosi M, 1997, J PATHOL, V181, P362; Hashimoto D, 2006, OTOLARYNG HEAD NECK, V134, P535, DOI 10.1016/j.otohns.2005.03.072; Macarenco RS, 2006, J ORAL PATHOL MED, V35, P602, DOI 10.1111/j.1600-0714.2006.00460.x; Motoori K, 2010, AM J NEURORADIOL, V31, P280, DOI 10.3174/ajnr.A1702; Rodriguez I, 2001, AM J SURG PATHOL, V25, P1424, DOI 10.1097/00000478-200111000-00011; ZUKERBERG LR, 1991, AM J SURG PATHOL, V15, P126, DOI 10.1097/00000478-199102000-00004	14	0	0	VENDOME GROUP LLC	NEW YORK	6 EAST 32 ST, 8 FLOOR, NEW YORK, NY 10016 USA	0145-5613	1942-7522		ENT-EAR NOSE THROAT	ENT-Ear Nose Throat J.	MAR	2015	94	3					117	119				3	Otorhinolaryngology	Otorhinolaryngology	CD3XV	WOS:000351018000010		
J	van Mourik, C; Katsuo, Y				van Mourik, Carien; Katsuo, Yuko			The IASB and ASBJ Conceptual Frameworks: Same Objective, Different Financial Performance Concepts	ACCOUNTING HORIZONS			English	Article						accounting conceptual frameworks; financial performance concepts; decision usefulness; income theory	FAIR VALUE	This paper illustrates that, despite their general agreement on the decision-usefulness objective of general purpose financial reporting, the Accounting Standard Board of Japan (ASBJ) and the International Accounting Standards Board (IASB)'s conceptual frameworks are based on two different concepts of financial performance. By identifying and contrasting the two financial performance concepts and their impact on the rest of the frameworks and by explaining the thinking that underpins the ASBJ's chosen financial performance concept, it contributes to a debate about the role of financial performance concepts in fulfilling the decision-usefulness objective. Such a debate is pertinent to the revision of the IASB's Conceptual Framework, which is scheduled for completion in 2015.	[van Mourik, Carien] Open Univ, Milton Keynes, Bucks, England; [Katsuo, Yuko] Gakushuin Univ, Tokyo 171, Japan	van Mourik, C (reprint author), Open Univ, Milton Keynes, Bucks, England.	carien.vanmourik@open.ac.uk			Japanese Society for the Promotion of Science (JSPS Kakenhi Grant) [24530571]	We are very grateful for the helpful comments from Tetsuyuki Kagaya, Richard Macve, Shizuki Saito, Peter Walton, and Stephen Zeff, and for the contributions from two anonymous reviewers and the editor. Carien van Mourik gratefully acknowledges the hospitality from Gakushuin University during September 2011 and February to July 2013. This research has benefited from financial support from the Japanese Society for the Promotion of Science (JSPS Kakenhi Grant No. 24530571).	Accounting Standards Board of Japan (ASBJ), 2006, DISCUSSION PAPER IN; Bromwich M, 2010, ABACUS, V46, P348, DOI 10.1111/j.1467-6281.2010.00322.x; Whittington G, 2008, ABACUS, V44, P139, DOI 10.1111/j.1467-6281.2008.00255.x; Barker R., 2004, ACCOUNT HORIZ, V18, P157, DOI 10.2308/acch.2004.18.2.157; Beaver W. H., 1989, FINANCIAL REPORTING; Bullen H. G., 2005, REVISITING THE CONCE; Camfferman Kees, 2007, FINANCIAL REPORTING; Cearns K., 1999, REPORTING FINANCIAL; Dichev I. D., 2007, CENTER FOR EXCELLENC; Edwards E. O., 1961, THE THEORY AND MEASU; Erb C., 2014, UNPUBLISHED CONFEREN; Feltham G. A., 1995, CONTEMP ACCOUNT RES, V11, P689; Financial Accounting Standards Board (FASB), 1978, STATEMENT OF FINANCI; Financial Reporting Council (FRC), 2014, DISCUSSION PAPER DP; Fukui Y, 2007, KIGYOU KAIKEI, V59, P74; Hicks J. R., 1946, VALUE CAPITAL; International Accounting Standards Board (IASB), 2013, DISCUSSION PAPER DP; International Accounting Standards Board (IASB), 2014, AGENDA PAPER 10A; International Accounting Standards Board (IASB), 2010, CONCEPTUAL FRAMEWORK; International Accounting Standards Board (IASB), 2001, FRAMEWORK FOR THE PR; International Accounting Standards Board (IASB), 2014, AGENDA PAPER 10G; Kaldor N., 1969, READINGS IN THE CONC; Katsuo Y., 1998, KAIKEI, V154, P777; Kawamura Y., 2011, THE FUNDAMENTAL CONC, P197; Lee T. A., 1985, INCOME AND VALUE MEA; Linsmeier T. J., 1997, ACCOUNT HORIZ, V11, P120; Nishikawa I., 2011, COMMUNICATION; O'Brien P. C., 2009, ACCOUNTING PERSPECTI, V8, P263; Obinata T., 2002, UNDAMENTAL CONCEPTS, P375; Ohlson J. A., 1995, CONTEMP ACCOUNT RES, V11, P661; Penman SH, 2007, ACCOUNT BUS RES, P33; Saito S., 2011, THE JAPANESE ACCOUNT, P105; Saito S., 2007, EXPLAINED THE DISCUS, P2; Saito S., 1999, KIGYO KAIKEI, V51, P170; Sanders T. H., 1938, STATEMENT ACCOUNTING; Schroeder R. G., 2001, FINANCIAL ACCOUNTING; Tsujiyama E., 1991, INCOME CONCEPTS AND; Tsujiyama E., 2002, FUNDAMENTAL CONCEPTS, P349; Yonetani T., 1998, FEDERAL RESERVE BANK, V4, P33; Yoneyama M., 2007, EXPLAINED THE DISCUS, P17	40	0	0	AMER ACCOUNTING ASSOC	SARASOTA	5717 BESSIE DR, SARASOTA, FL 34233 USA	0888-7993	1558-7975		ACCOUNT HORIZ	Account. Horiz.	MAR	2015	29	1					199	216		10.2308/acch-50902		18	Business, Finance	Business & Economics	CE2MC	WOS:000351648700009		
J	Labuta, J; Hill, JP; Ishihara, S; Hanykova, L; Ariga, K				Labuta, Jan; Hill, Jonathan P.; Ishihara, Shinsuke; Hanykova, Lenka; Ariga, Katsuhiko			Chiral Sensing by Nonchiral Tetrapyrroles	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							ABSOLUTE CONFIGURATIONAL ASSIGNMENTS; FACILE AERIAL OXIDATION; ENANTIOMERIC EXCESS; NMR-SPECTROSCOPY; ZINC PORPHYRIN; AMPLIFICATION; MACROCYCLE; MECHANISM; CATALYSIS; MOLECULE	CONSPECTUS: Enantiomeric excess (ee) is a measure of the purity of an enantiomer of a chiral compound with respect to the presence of the complementary enantiomer. It is an important aspect of chemistry, especially in the fields of pharmaceuticals and asymmetric catalysis. Existing methods for determination of enantiomeric excesses using nuclear magnetic resonance (NMR) spectroscopy mostly rely on special chiral reagents (auxiliaries) that form two or more diastereomeric complexes with a chiral compound. As a result of this, the NMR spectrum of each enantiomer is different, allowing the determination of enantiomeric excess. In this Account, we describe a molecular design process that has allowed us to prepare pro chiral solvating agents for NMR determination of ee of a wide variety of analyte types. At the outset of this work, we initially encountered the phenomenon of NMR peak splitting in the oxoporphyrinogen (OxP) host component of a supramolecular host guest complex, where the extent of the splitting is apparently proportional to the guests' ee. Upon closer examination of the mechanism of action, it was found that several complicating factors, including prototropic tautomerism, macrocyclic inversion (ring-flipping), and 1:2 host guest stoichiometry, obstruct potential applications of OxP as a chiral solvating agent. By considering the molecular conformation of the OxP host, a saddle-shaped calix[4]pyrrole, we moved to study the tetraphenylporphyrin (TPP) dication since it has a similar form, and it was found that it could also be used to probe ee. However, although TPP does not suffer from disadvantageous tautomeric processes, it is still subject to macrocyclic inversion and has the additional serious disadvantage of operating for ee sensing only at depressed temperatures. The intrinsic disadvantages of the Ox]? and TPP systems were finally overcome by covalently modifying the OxP chromophore by regioselective N-alkylation at one face of the molecule. This procedure yields a host Bz(2)OxP that undergoes 1:1 host guest interactions, cannot be protonated (and so does not suffer drawbacks due to tautomeric processes), and can interact solely through hydrogen bonding with a much wider range of analyte types, including acids, esters, amines (including amino acid derivatives), and ketones) for the determination of their ee at room temperature. Chiral sensing, in this case, can be understood by considering the breakdown of the host's symmetry when it interacts with a chiral guest under fast exchange. Furthermore, chirality discrimination (i.e., which is the major enantiomer in a sample) can be performed by addition of a small amount of one of the known enantiomers. Adaptation of a symmetrical molecule for ee sensing presents certain intrinsic advantages, including identical binding constants of each enantiomer. Our results indicate that other symmetrical molecules might also be useful as NMR probes of enantiopurity. These systems could provide insights into important chirality principles such as majority rule, intermolecular chirality transfer, and asymmetric reactions. The Bz(2)OxP system is also of note from the point of view that it does not rely on the formation of diastereomers.	[Labuta, Jan] Natl Inst Mat Sci, Int Ctr Young Scientists, Tsukuba, Ibaraki 3050047, Japan; [Hill, Jonathan P.; Ariga, Katsuhiko] Natl Inst Mat Sci, World Premier Int WPI Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Hill, Jonathan P.; Ariga, Katsuhiko] Japan Sci & Technol Agcy JST, JST CREST, Kawaguchi, Saitama 3330012, Japan; [Ishihara, Shinsuke] Natl Inst Mat Sci, Funct Geomat Grp, Tsukuba, Ibaraki 3050044, Japan; [Hanykova, Lenka] Charles Univ Prague, Fac Math & Phys, Dept Macromol Phys, CR-18000 Prague 8, Czech Republic	Labuta, J (reprint author), Natl Inst Mat Sci, Int Ctr Young Scientists, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	labuta.jan@nims.go.jp; jonathan.hill@nims.go.jp; ariga.katsuhiko@nims.go.jp	ARIGA, Katsuhiko/H-2695-2011; ISHIHARA, Shinsuke/O-4549-2014		World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan; JST, CREST	This work was in part supported by World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan, and JST, CREST.	MASON SF, 1984, NATURE, V311, P19, DOI 10.1038/311019a0; Labuta J, 2014, J AM CHEM SOC, V136, P2112, DOI 10.1021/ja4124175; Hirschberg JHKK, 2000, NATURE, V407, P167; Proni G, 2003, J AM CHEM SOC, V125, P12914, DOI 10.1021/ja036294g; Huang XF, 2002, J AM CHEM SOC, V124, P10320, DOI 10.1021/ja020520p; Mizuno Y, 2000, J AM CHEM SOC, V122, P5278, DOI 10.1021/ja000052o; Wenzel TJ, 2003, CHIRALITY, V15, P256, DOI 10.1002/chir.10190; Shundo A, 2009, J AM CHEM SOC, V131, P9494, DOI 10.1021/ja903371d; Okamoto Y, 2008, CHEM SOC REV, V37, P2593, DOI 10.1039/b808881k; ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053; Kim JH, 2011, TOXICOL SCI, V122, P1, DOI 10.1093/toxsci/kfr088; SOAI K, 1995, NATURE, V378, P767, DOI 10.1038/378767a0; Fletcher SP, 2007, CHEM COMMUN, P2578, DOI 10.1039/b702882b; Hembury GA, 2008, CHEM REV, V108, P1, DOI 10.1021/cr050005k; PARKER D, 1991, CHEM REV, V91, P1441, DOI 10.1021/cr00007a009; Balaz M, 2005, ANGEW CHEM INT EDIT, V44, P4006, DOI 10.1002/anie.200501149; Borovkov VV, 2001, J AM CHEM SOC, V123, P2979, DOI 10.1021/ja0032982; Arai T, 2006, ANGEW CHEM INT EDIT, V45, P5978, DOI 10.1002/anie.200602255; BONNER WA, 1991, ORIGINS LIFE EVOL B, V21, P59, DOI 10.1007/BF01809580; Borovkov VV, 2004, ANGEW CHEM INT EDIT, V43, P5481, DOI 10.1002/anie.200460965; DONOHUE J, 1953, P NATL ACAD SCI USA, V39, P470, DOI 10.1073/pnas.39.6.470; Eliel E.L., 1994, STEREOCHEMISTRY ORGA; GOLDER AJ, 1989, J CHEM SOC CHEM COMM, P1751, DOI 10.1039/c39890001751; Hill JP, 2004, J ORG CHEM, V69, P5861, DOI 10.1021/jo049401d; Hill JP, 2006, INORG CHEM, V45, P8288, DOI 10.1021/ic0611591; Hutt A. J, 2006, SMITH WILLIAMS INTRO; Klussmann M, 2006, NATURE, V441, P621, DOI 10.1038/nature04780; Labuta J, 2011, CHEM-EUR J, V17, P3558, DOI 10.1002/chem.201100052; Labuta J, 2014, SYMMETRY-BASEL, V6, P345, DOI 10.3390/sym6020345; Labuta J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3188; MILGROM LR, 1983, TETRAHEDRON, V39, P3895, DOI 10.1016/S0040-4020(01)90892-0; Perry RH, 2007, CHEM COMMUN, P1071, DOI 10.1039/b616196k; Powell M. E., 2012, COMPREHENSIVE CHIRAL, V8, P571; Senge MO, 1999, J PORPHYR PHTHALOCYA, V3, P99, DOI 10.1002/(SICI)1099-1409(199902)3:2<99::AID-JPP109>3.3.CO;2-Y; STONE A, 1968, J AM CHEM SOC, V90, P2735, DOI 10.1021/ja01013a001	35	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	MAR	2015	48	3					521	529		10.1021/acs.accounts.5b00005		9	Chemistry, Multidisciplinary	Chemistry	CD8EB	WOS:000351326900004		
J	Iwamura, M; Takeuchi, S; Tahara, T				Iwamura, Munetaka; Takeuchi, Satoshi; Tahara, Tahei			Ultrafast Excited-State Dynamics of Copper(I) Complexes	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							PHOTOINDUCED STRUCTURAL-CHANGE; FEMTOSECOND FLUORESCENCE SPECTROSCOPY; PHOTOPHYSICAL PROPERTIES; COORDINATION-COMPOUNDS; RELAXATION DYNAMICS; X-RAY; SYSTEMS; EMISSION; CU(I)-PHENANTHROLINES; PHENANTHROLINES	CONSPECTUS: Bis-diimine Cu(I) complexes exhibit strong absorption in the visible region owing to the metal-to-ligand charge transfer (MLCT) transitions, and the triplet MLCT ((MLCT)-M-3) states have long lifetimes. Because these characteristics are highly suitable for photosensitizers and photocatalysts, Cu(I) complexes have been attracting much interest. An intriguing feature of the Cu(I) complexes is the photoinduced structural change called "flattening". Bis-diimine Cu(I) complexes usually have tetrahedron-like D-2d structures in the ground (S-0) state, in which two ligands are perpendicularly attached to the Cu(I) ion. With MLCT excitation, the central Cu(I) ion is formally oxidized to Cu(II), which induces the structural change to the "flattened" square-planar-like structure that is seen for usual Cu(II) complexes. In this Account, we review our recent studies on ultrafast excited-state dynamics of bis-diimine Cu(I) complexes carried out using femtosecond time-resolved optical spectroscopy. Focusing on three prototypical bis-diimine Cu(I) complexes that have 1,10-phenanthroline ligands with different substituents at the 2,9-positions, i.e., [Cu(phen)(2)](+) (phen = 1,10-phenanthroline), [Cu(dmphen)(2)](+) (dmphen = 2,9-dimethyl-1,10-phenanthroline), and [Cu(dpphen)(2)](+) (dpphen = 2,9-diphenyl-1,10-phenanthroline), we examined their excited-state dynamics by time-resolved emission and absorption spectroscopies with 200 fs time resolution, observed the excited-state coherent nuclear motion with 30 fs time resolution and performed complementary theoretical calculations. This combined approach vividly visualizes excited-state processes in the MLCT state of bis-diimine Cu(I) complexes. It was demonstrated that flattening distortion, internal conversion, and intersystem crossing occur on the femtosecond early picosecond time scale, and their dynamics is clearly identified separately. The flattening distortion predominantly occurs in the S-1, state on the subpicosecond time-scale, and the precursor S-1 state retaining the initial undistorted structure appears as a metastable state before the structural change. This observation indicates that the traditional understanding based on the Jahn- Teller effect appears irrelevant for realistically discussing the photoinduced structural change of bis-diimine Cu(I) complexes. The lifetime of the precursor S-1 state significantly depends on the substituents in the three complexes, indicating that the flattering distortion requires a longer time as the substituents at 2,9-positions of the ligands become builder. It is suggested that the substituents are rotated to avoid steric repulsions to achieve the flattened structure at the global minimum of the S-1 state, implying the necessity of discussion based on a multidimensional potential energy surface to properly consider this excited-state structural change. After the flattening distortion, the S-1 states of [Cu(dmphen)(2)](+) and [Cu(dpphen)(2)](+), which have bulky substituents, relax to the T-1 state by intersystem crossing on the similar to 10 ps time scale, while the flattened S, state of [Cu(phen)(2)](+) relaxes directly to the So state on the similar to 2 ps time scale. This difference is rationalized in terms of the different magnitude of the flattening distortion and relevant changes in the potential energy surfaces. Clear understanding of the ultrafast excited-state process provides a solid basis for designing and using Cu(I) complexes, such as controlling the structural change to efficiently utilize the energy of the MLCT state in solar energy conversion.	[Iwamura, Munetaka] Toyama Univ, Dept Chem, Toyama 9308555, Japan; [Takeuchi, Satoshi; Tahara, Tahei] RIKEN, Mol Spect Lab, Wako, Saitama 3510198, Japan; [Takeuchi, Satoshi; Tahara, Tahei] RIKEN Ctr Adv Photon RAP, Ultrafast Spect Res Team, Wako, Saitama 3510198, Japan	Tahara, T (reprint author), RIKEN, Mol Spect Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tahei@riken.jp					Cannizzo A, 2006, ANGEW CHEM INT EDIT, V45, P3174, DOI 10.1002/anie.200600125; Iwamura M, 2007, J AM CHEM SOC, V129, P5248, DOI 10.1021/ja069300s; Cunningham CT, 1999, INORG CHEM, V38, P4388, DOI 10.1021/ic9906611; Damrauer NH, 1997, SCIENCE, V275, P54, DOI 10.1126/science.275.5296.54; Scaltrito DV, 2000, COORDIN CHEM REV, V208, P243, DOI 10.1016/S0010-8545(00)00309-X; Gawelda W, 2007, J AM CHEM SOC, V129, P8199, DOI 10.1021/ja070454x; Iwamura M, 2011, J AM CHEM SOC, V133, P7728, DOI 10.1021/ja108645x; Chen LX, 2003, J AM CHEM SOC, V125, P7022, DOI 10.1021/ja0294663; Takeuchi S, 1998, J PHYS CHEM A, V102, P7740, DOI 10.1021/jp982522v; Chen LX, 2001, SCIENCE, V292, P262, DOI 10.1126/science.1057063; Cunningham CT, 2000, INORG CHEM, V39, P3638, DOI 10.1021/ic000082s; Gawelda W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057401; BLASKIE MW, 1980, INORG CHEM, V19, P3519, DOI 10.1021/ic50213a062; Siddique ZA, 2003, INORG CHEM, V42, P6366, DOI 10.1021/ic034412v; Armaroli N, 2001, CHEM SOC REV, V30, P113, DOI 10.1039/b000703j; Bhasikuttan AC, 2002, J AM CHEM SOC, V124, P8398, DOI 10.1021/ja026135h; KIRCHHOFF JR, 1983, INORG CHEM, V22, P2380, DOI 10.1021/ic00159a008; Iwamura M, 2014, PHYS CHEM CHEM PHYS, V16, P4143, DOI 10.1039/c3cp54322f; Balzani V., 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI DOI 10.1002/1521-3773(2001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; Cotton F. A., 1980, ADV INORGANIC CHEM; EVERLY RM, 1991, J PHYS CHEM-US, V95, P9071, DOI 10.1021/j100176a011; Gunaratne T, 2003, CHEM COMMUN, P3010, DOI 10.1039/b306900a; GUSHURST AKI, 1989, INORG CHEM, V28, P4070, DOI 10.1021/ic00321a008; Hua L, 2015, PHYS CHEM CHEM PHYS, V17, P2067, DOI 10.1039/c4cp03843f; Kalyanasundaram K., 1992, PHOTOCHEMISTRY POLYP; Mara MW, 2015, COORDIN CHEM REV, V282, P2, DOI 10.1016/j.ccr.2014.06.013; McCusker JK, 2003, ACCOUNTS CHEM RES, V36, P876, DOI 10.1021/ar030111d; PARKER WL, 1989, J PHYS CHEM-US, V93, P5692, DOI 10.1021/j100352a012; Person R. G., 1975, P NATL ACAD SCI USA, V72, P2104; Samia ACS, 2004, J PHYS CHEM B, V108, P563, DOI 10.1021/jp036857a; Sato O, 2003, ACCOUNTS CHEM RES, V36, P692, DOI 10.1021/ar020242z; SHINOZAKI K, 1994, B CHEM SOC JPN, V67, P2435, DOI 10.1246/bcsj.67.2435; Tahara T, 2004, ADV MP PROC, V16, P1, DOI 10.1142/9789812796585_0001; Takeuchi S, 1997, J PHYS CHEM A, V101, P3052, DOI 10.1021/jp962765s; Vlcek A, 2000, COORDIN CHEM REV, V200, P933, DOI 10.1016/S0010-8545(00)00308-8; Zgierski MZ, 2003, J CHEM PHYS, V118, P4045, DOI 10.1063/1.1540614	36	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	MAR	2015	48	3					782	791		10.1021/ar500353h		10	Chemistry, Multidisciplinary	Chemistry	CD8EB	WOS:000351326900030		
J	Najafpour, MM; Fekete, M; Sedigh, DJ; Aro, EM; Carpentier, R; Eaton-Rye, JJ; Nishihara, H; Shen, JR; Allakhverdiev, SI; Spiccia, L				Najafpour, Mohammad Mahdi; Fekete, Monika; Sedigh, Davood Jafarian; Aro, Eva-Mari; Carpentier, Robert; Eaton-Rye, Julian J.; Nishihara, Hiroshi; Shen, Jian-Ren; Allakhverdiev, Suleyman I.; Spiccia, Leone			Damage Management in Water-Oxidizing Catalysts: From Photosystem II to Nanosized Metal Oxides	ACS CATALYSIS			English	Review						water oxidation catalysts; self-healing catalysts; photosystem II; manganese; cobalt; nickel	OXYGEN-EVOLVING COMPLEX; QUANTUM MECHANICS/MOLECULAR MECHANICS; SELF-HEALING MATERIALS; X-RAY CRYSTALLOGRAPHY; MANGANESE CLUSTER; OXIDATION CATALYSIS; CRYSTAL-STRUCTURE; COBALT OXIDE; NEUTRAL PH; ANODIC CHARACTERISTICS	Current energy resources largely rely on fossil fuels that are expected to be depleted in 50-200 years. On a global scale, the intensive use of this energy source has resulted in highly detrimental effects to the environment. Hydrogen production by water splitting, with sunlight as the main energy source, is a promising way to augment the production of renewable energy; however, the development of an efficient and stable water-oxidizing catalyst remains a key task before a technological breakthrough based on water splitting can be realized. A main issue hampering the development of commercially viable, non-precious-metal-based catalysts is their susceptibility to degradation. To efficiently address this major drawback, self-healing catalysts that can repair their structure without human intervention will be necessary. In this review, we focus on water oxidation by natural and artificial Mn-, Co-, and Ni-based catalysts and then discuss the self-healing properties that contribute to sustaining their catalytic activity.	[Najafpour, Mohammad Mahdi; Sedigh, Davood Jafarian] IASBS, Dept Chem, Zanjan 4513766731, Iran; [Najafpour, Mohammad Mahdi] IASBS, Ctr Climate Change & Global Warming, Zanjan 4513766731, Iran; [Fekete, Monika; Spiccia, Leone] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia; [Fekete, Monika; Spiccia, Leone] Monash Univ, ARC Ctr Excellence Electromat Sci, Clayton, Vic 3800, Australia; [Aro, Eva-Mari] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland; [Carpentier, Robert] Univ Quebec Trois Rivieres, GRBV, Trois Rivieres, PQ G9A 5H7, Canada; [Eaton-Rye, Julian J.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Nishihara, Hiroshi] Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shen, Jian-Ren] Okayama Univ, Photosynth Res Ctr, Grad Sch Nat Sci & Technol, Fac Sci, Okayama 7008530, Japan; [Allakhverdiev, Suleyman I.] Russian Acad Sci, Inst Plant Physiol, Controlled Photobiosynth Lab, Moscow 127276, Russia; [Allakhverdiev, Suleyman I.] Russian Acad Sci, Inst Basic Biol Problems, Pushchino 142290, Moscow Region, Russia; [Allakhverdiev, Suleyman I.] Moscow MV Lomonosov State Univ, Dept Plant Physiol, Fac Biol, Moscow 119991, Russia	Najafpour, MM (reprint author), IASBS, Dept Chem, Zanjan 4513766731, Iran.	mmnajafpour@iasbs.ac.ir; suleyman.allakhverdiev@gmail.com; leone.spiccia@monash.edu	Spiccia, Leone/I-8085-2013; Shen, Jian-Ren/B-2558-2011		Institute for Advanced Studies in Basic Sciences; National Elite Foundation; Russian Science Foundation [14-14-00039]; Academy of Finland [118637]; Monash Institute of Graduate Research and Faculty of Science; Australian Research Council (through the ARC Centre of Excellence for Electromaterials Science) [CE140100012]; JSPS, MEXT, Japan [24000018]	M.M.N. and D.J.S. are grateful to the Institute for Advanced Studies in Basic Sciences, and the National Elite Foundation for financial support. S.I.A. was supported by a grant from the Russian Science Foundation (No: 14-14-00039). E.M.A. was supported by the Academy of Finland (No. 118637). The Monash authors acknowledge financial support from the Monash Institute of Graduate Research and Faculty of Science in the form of scholarship support and a Postgraduate Publication Award (M.F.), and the Australian Research Council (through the ARC Centre of Excellence for Electromaterials Science, Grant No. CE140100012, L.S.). J.R.S. was supported by a grant-in-aid for Specially Promoted Research (No. 24000018) from JSPS, MEXT, Japan. The authors are grateful to Mika Keranen for his assistance with Figure 4.	Amendola V., 2011, SELF HEALING NANOSCA; Ananyev GM, 1996, BIOCHEMISTRY-US, V35, P14608, DOI 10.1021/bi960894t; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Najafpour MM, 2013, DALTON T, V42, P14603, DOI 10.1039/c3dt51406d; MACLACHLAN DJ, 1992, BIOCHEM J, V285, P569; Singh A, 2013, CHEM MATER, V25, P1098, DOI 10.1021/cm3041345; Nosonovsky M, 2009, PHILOS T R SOC A, V367, P1607, DOI 10.1098/rsta.2009.0009; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; YACHANDRA VK, 1993, SCIENCE, V260, P675, DOI 10.1126/science.8480177; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; Surendranath Y, 2012, J AM CHEM SOC, V134, P6326, DOI 10.1021/ja3000084; SINGH RN, 1994, J APPL ELECTROCHEM, V24, P149; Haddy A, 2007, PHOTOSYNTH RES, V92, P357, DOI 10.1007/s11120-007-9194-9; Gray HB, 2009, NAT CHEM, V1, P7, DOI 10.1038/nchem.141; MORITA M, 1979, ELECTROCHIM ACTA, V24, P357, DOI 10.1016/0013-4686(79)87019-X; Gao MR, 2014, J AM CHEM SOC, V136, P7077, DOI 10.1021/ja502128j; Britt RD, 2004, BBA-BIOENERGETICS, V1655, P158, DOI 10.1016/j.bbabio.2003.11.009; Chang SLY, 2014, J MATER CHEM A, V2, P3730, DOI 10.1039/c3ta14738j; HILL CL, 1995, NATURE, V373, P324, DOI 10.1038/373324a0; Yagi M, 2001, CHEM REV, V101, P21, DOI 10.1021/cr980108l; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Yin QS, 2010, SCIENCE, V328, P342, DOI 10.1126/science.1185372; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Brimblecombe R, 2010, J AM CHEM SOC, V132, P2892, DOI 10.1021/ja910055a; Dinca M, 2010, P NATL ACAD SCI USA, V107, P10337, DOI 10.1073/pnas.1001859107; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; YACHANDRA VK, 1986, BIOCHIM BIOPHYS ACTA, V850, P324, DOI 10.1016/0005-2728(86)90188-X; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Allakhverdiev SI, 2011, J PHOTOCH PHOTOBIO B, V104, P1, DOI 10.1016/j.jphotobiol.2011.03.010; Herbstova M, 2012, P NATL ACAD SCI USA, V109, P20130, DOI 10.1073/pnas.1214265109; Singh A, 2013, CATAL SCI TECHNOL, V3, P1725, DOI 10.1039/c3cy00017f; Becker K, 2011, J PHOTOCH PHOTOBIO B, V104, P204, DOI 10.1016/j.jphotobiol.2011.02.005; Du PW, 2012, J AM CHEM SOC, V134, P11096, DOI 10.1021/ja303826a; Kanan MW, 2010, J AM CHEM SOC, V132, P13692, DOI 10.1021/ja1023767; Risch M, 2009, J AM CHEM SOC, V131, P6936, DOI 10.1021/ja902121f; Murphy EB, 2010, PROG POLYM SCI, V35, P223, DOI 10.1016/j.progpolymsci.2009.10.006; Sauer K, 2008, COORDIN CHEM REV, V252, P318, DOI 10.1016/j.ccr.2007.08.009; Youngblood JP, 2008, MRS BULL, V33, P732, DOI 10.1557/mrs2008.158; Rosen J, 2013, J AM CHEM SOC, V135, P4516, DOI 10.1021/ja400555q; Yuan YC, 2008, EXPRESS POLYM LETT, V2, P238, DOI 10.3144/expresspolymlett.2008.29; Izgorodin A, 2012, AUST J CHEM, V65, P638, DOI 10.1071/CH12024; Merrill MD, 2008, J PHYS CHEM C, V112, P3655, DOI 10.1021/jp710675m; Ananyev GM, 1996, BIOCHEMISTRY-US, V35, P4102, DOI 10.1021/bi952667h; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Fihri A, 2008, ANGEW CHEM INT EDIT, V47, P564, DOI 10.1002/anie.200702953; Najafpour MM, 2010, ANGEW CHEM INT EDIT, V49, P2233, DOI 10.1002/anie.200906745; Li XH, 2011, PHYS CHEM CHEM PHYS, V13, P1162, DOI 10.1039/c0cp00993h; Hocking RK, 2011, NAT CHEM, V3, P461, DOI [10.1038/nchem.1049, 10.1038/NCHEM.1049]; Hasegawa K, 1999, CHEM PHYS LETT, V300, P9, DOI 10.1016/S0009-2614(98)01369-4; Grewe T, 2014, CHEM MATER, V26, P3162, DOI 10.1021/cm5005888; Singh A, 2013, ENERG ENVIRON SCI, V6, P579, DOI 10.1039/c2ee23862d; Brimblecombe R, 2010, CHEMSUSCHEM, V3, P1146, DOI 10.1002/cssc.201000171; Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Dau H, 1999, FEBS LETT, V457, P237, DOI 10.1016/S0014-5793(99)01045-5; Wiechen M, 2012, DALTON T, V41, P21, DOI 10.1039/c1dt11537e; Kato Y, 2012, PLANT PHYSIOL, V159, P1428, DOI 10.1104/pp.112.199042; Iyer A, 2012, J PHYS CHEM C, V116, P6474, DOI 10.1021/jp2120737; Swierk JR, 2013, CHEM SOC REV, V42, P2357, DOI 10.1039/c2cs35246j; Yachandra VK, 1996, CHEM REV, V96, P2927, DOI 10.1021/cr950052k; Najafpour MM, 2013, DALTON T, V42, P16683, DOI 10.1039/c3dt52304g; Kulik LV, 2005, J AM CHEM SOC, V127, P2392, DOI 10.1021/ja043012j; Amendola V, 2009, PHYS CHEM CHEM PHYS, V11, P3805, DOI 10.1039/b900654k; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Surendranath Y, 2010, J AM CHEM SOC, V132, P16501, DOI 10.1021/ja106102b; Khan M, 2014, J MATER CHEM A, V2, P18199, DOI 10.1039/c4ta04185b; Dau H, 2001, BBA-BIOENERGETICS, V1503, P24, DOI 10.1016/S0005-2728(00)00230-9; MORITA M, 1977, ELECTROCHIM ACTA, V22, P325, DOI 10.1016/0013-4686(77)85081-0; CORRIGAN DA, 1987, J ELECTROCHEM SOC, V134, P377, DOI 10.1149/1.2100463; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589; MANCHANDA R, 1995, COORDIN CHEM REV, V144, P1, DOI 10.1016/0010-8545(95)01147-H; Sproviero EM, 2008, J AM CHEM SOC, V130, P3428, DOI 10.1021/ja076130q; Lutterman DA, 2009, J AM CHEM SOC, V131, P3838, DOI 10.1021/ja900023k; Renger G, 2001, BBA-BIOENERGETICS, V1503, P210, DOI 10.1016/S0005-2728(00)00227-9; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g; Esswein AJ, 2011, ENERG ENVIRON SCI, V4, P499, DOI 10.1039/c0ee00518e; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Bondarava N, 2005, BBA-BIOENERGETICS, V1708, P63, DOI 10.1016/j.bbabio.2005.01.005; Najafpour MM, 2013, NEW J CHEM, V37, P2448, DOI 10.1039/c3nj00372h; Najafpour MM, 2013, DALTON T, V42, P12173, DOI 10.1039/c3dt51345a; MILLER AF, 1991, BIOCHIM BIOPHYS ACTA, V1056, P1, DOI 10.1016/S0005-2728(05)80067-2; Amendola V, 2009, NANOSCALE, V1, P74, DOI 10.1039/b9nr00146h; Gerken JB, 2011, J AM CHEM SOC, V133, P14431, DOI 10.1021/ja205647m; Urban MW, 2012, NAT CHEM, V4, P80, DOI 10.1038/nchem.1249; Rule JD, 2005, ADV MATER, V17, P205, DOI 10.1002/adma.200400607; Huynh M, 2014, J AM CHEM SOC, V136, P6002, DOI 10.1021/ja413147e; Pantazis DA, 2009, PHYS CHEM CHEM PHYS, V11, P6788, DOI 10.1039/b907038a; McAlpin JG, 2010, J AM CHEM SOC, V132, P6882, DOI 10.1021/ja1013344; Dismukes GC, 2009, ACCOUNTS CHEM RES, V42, P1935, DOI 10.1021/ar900249x; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; APPLEBY AJ, 1978, J INT J HYDROGEN ENE, V3, P21; Bockris OM, 1977, ENERGY SOLAR HYDROGE, P365; Broser M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215970; CHENIAE GM, 1971, BIOCHIM BIOPHYS ACTA, V253, P167, DOI 10.1016/0005-2728(71)90242-8; DASGUPTA J, 2008, J COORD CHEM, V252, P347; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; EVELO RG, 1989, BIOCHIM BIOPHYS ACTA, V973, P428, DOI 10.1016/S0005-2728(89)80385-8; Garche J., 2009, ENCY ELECTROCHEMICAL; Ghosh S. K., 2008, SELF HEALING MAT FUN, P10; Hall D. E. J., 1983, ELECTROCHEM SOC, V130, P317; HALPERT G, 1984, J POWER SOURCES, V12, P177, DOI 10.1016/0378-7753(84)80018-X; Han AL, 2013, PHYS CHEM CHEM PHYS, V15, P12534, DOI 10.1039/c3cp52275j; Haumann M, 2006, BIOCHEMISTRY-US, V45, P13101, DOI 10.1021/bi061308r; Hillier W, 2001, BIOCHEMISTRY-US, V40, P1503, DOI 10.1021/bi002436x; Hwang HJ, 2005, BIOCHEMISTRY-US, V44, P9766, DOI 10.1021/bi050069p; Ioannidis N, 2002, BIOCHEMISTRY-US, V41, P9589, DOI 10.1021/bi0159940; JIANG SP, 1990, J ELECTROCHEM SOC, V137, P3374, DOI 10.1149/1.2086224; JIANG SP, 1991, J ELECTROCHEM SOC, V138, P1216, DOI 10.1149/1.2085762; LU PWT, 1978, J ELECTROCHEM SOC, V125, P1416, DOI 10.1149/1.2131689; Lucas J. M., 1898, U.S. patent, Patent No. [598613, 5986131898]; Luneva N. P., 1987, J CHEM SOC CHEM COMM, P1504; MelcIcy Koua F. H., 2013, P NATL ACAD SCI USA, V110, P3889; MILLER AF, 1989, BIOCHEMISTRY-US, V28, P8181, DOI 10.1021/bi00446a033; Najafpour M. M., 2012, CHEM WORLD, V11, P43; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P942, DOI 10.1021/bi00118a041; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Olesen K, 2003, BIOCHEMISTRY-US, V42, P2025, DOI 10.1021/bi026175y; Olugebefola SC, 2010, J COMPOS MATER, V44, P2587, DOI 10.1177/0021998310371537; Pace R., 2005, INTEGRATED ARTIFICIA; PACE RJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P161, DOI 10.1016/S0005-2728(05)80233-6; Penner-Hahn JE, 1998, STRUCT BOND, V90, P1; Pirson A., 1937, Z BOT, V31, P193; Pokhrel R., 2013, COMPREHENSIVE INORGA, V3, P385; Potier F, 2014, POLYM CHEM-UK, V5, P4474, DOI 10.1039/c4py00172a; Pourbaix M., 1966, ATLAS ELECTROCHEMICA; Rehder D, 2000, J INORG BIOCHEM, V80, P115, DOI 10.1016/S0162-0134(00)00047-7; SHAFIROVICH VY, 1981, J INORG BIOCHEM, V15, P113, DOI 10.1016/S0162-0134(00)80296-2; Shcheglova I.S., 1968, KINET KATAL, V9, P461; Sproviero EM, 2007, CURR OPIN STRUC BIOL, V17, P173, DOI 10.1016/j.sbi.2007.03.015; Suredini HB, 2000, INT J HYDROGEN ENERG, V25, P415; Suzuki O., 1968, U.S. Patent, Patent No. [3399966, 3,399,966]; TAMURA N, 1987, BIOCHIM BIOPHYS ACTA, V890, P179, DOI 10.1016/0005-2728(87)90019-3; Teutloff C, 2009, PHYS CHEM CHEM PHYS, V11, P6715, DOI 10.1039/b908093g; Yamanari T, 2004, BIOCHEMISTRY-US, V43, P7479, DOI 10.1021/bi0362323; Zaltsman L, 1997, BIOCHEMISTRY-US, V36, P8914, DOI 10.1021/bi970187f; Zheludkevich M. L., 2011, SELF HEALING PROPERT	140	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAR	2015	5	3					1499	1512		10.1021/cs5015157		14	Chemistry, Physical	Chemistry	CD1OF	WOS:000350843500012		
J	Zhang, TF; Isobe, S; Matsuo, M; Orimo, S; Wang, YM; Hashimoto, N; Ohnuki, S				Zhang, Tengfei; Isobe, Shigehito; Matsuo, Motoaki; Orimo, Shin-ichi; Wang, Yongming; Hashimoto, Naoyuki; Ohnuki, Somei			Effect of Lithium Ion Conduction on Hydrogen Desorption of LiNH2-LiH Solid Composite	ACS CATALYSIS			English	Article						solid-state reactions; homogeneous catalysis; titanates; hydrogen storage; hydrides	CRYSTAL-STRUCTURES; NITROGEN SYSTEM; STORAGE; CATALYST; AMIDE; LI; NITRIDES; HYDRIDES; IMIDE	This paper presents a relationship between ionic mobility and reaction kinetics for the Li-N-H system after doping LiTi2O4. The structural characteristic of this fast ionic conductor was introduced to the complex-hydride system. On one hand, the properties of the dehydrogenation process were improved significantly. On the other hand, the relationship between lithium ionic conductivity and the catalytic effect on the dehydrogenation was investigated according to the alternating current (AC) impedance results. The lithium ionic conductivity of samples with catalyst was higher than the samples without catalyst. Especially, the conductivity of LiNH2 and LiH mixtures with LiTi2O4 was almost 1.5 times higher than that of LiNH2 and LiH. The mobility of the Li+ ions between LiH and LiNH2 solid phases was enhanced by adding LiTi2O4.	[Zhang, Tengfei; Isobe, Shigehito; Wang, Yongming; Hashimoto, Naoyuki; Ohnuki, Somei] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Isobe, Shigehito] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Matsuo, Motoaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Orimo, Shin-ichi] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Zhang, TF (reprint author), Hokkaido Univ, Grad Sch Engn, N-13,W-8, Sapporo, Hokkaido 0608628, Japan.	zhangtengfei@eng.hokudai.ac.jp; isobe@eng.hokudai.ac.jp	ORIMO, Shin-ichi/A-4971-2011	ORIMO, Shin-ichi/0000-0002-4216-0446	L-station (Hokkaido University); "Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was partially supported by L-station (Hokkaido University) and "Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Aguey-Zinsou KF, 2007, J PHYS CHEM B, V111, P12531, DOI 10.1021/jp750021; Anderson PA, 2011, FARADAY DISCUSS, V151, P271, DOI 10.1039/c0fd00027b; Chen P, 2002, NATURE, V420, P302, DOI 10.1038/nature01210; Chen P, 2003, J PHYS CHEM B, V107, P10967, DOI 10.1021/jp034149j; Matsuo M, 2009, J AM CHEM SOC, V131, P16389, DOI 10.1021/ja907249p; David WIF, 2007, J AM CHEM SOC, V129, P1594, DOI 10.1021/ja066016s; Cao HJ, 2014, J PHYS CHEM C, V118, P2344, DOI 10.1021/jp411551v; Makepeace JW, 2014, PHYS CHEM CHEM PHYS, V16, P4061, DOI 10.1039/c4cp00087k; Orimo SI, 2007, CHEM REV, V107, P4111, DOI 10.1021/cr0501846; Ohta N, 2006, ADV MATER, V18, P2226, DOI 10.1002/adma.200502604; ALLEN GC, 1982, NATURE, V295, P48, DOI 10.1038/295048a0; Wu H, 2008, CHEMPHYSCHEM, V9, P2157, DOI 10.1002/cphc.200800498; CAVA RJ, 1984, J SOLID STATE CHEM, V53, P64, DOI 10.1016/0022-4596(84)90228-7; Balogh MP, 2006, J ALLOY COMPD, V420, P326, DOI 10.1016/j.jallcom.2005.11.018; Conradi M., COMMUNICATION; JOHNSON OW, 1964, PHYS REV A-GEN PHYS, V136, pA284, DOI 10.1103/PhysRev.136.A284; Kilner J.A., 1981, NONSTOICHIOMETRIC OX, P233; KISSINGER HE, 1957, ANAL CHEM, V29, P1702, DOI 10.1021/ac60131a045; Luo WF, 2006, J ALLOY COMPD, V407, P274, DOI 10.1016/j.jallcom.2005.06.046; Matsuo M, 2010, CHEM MATER, V22, P2702, DOI 10.1021/cm1006857; Zhang TF, 2013, RSC ADV, V3, P6311, DOI 10.1039/c3ra40379c; Zhang TF, 2014, J MATER CHEM A, V2, P4361, DOI 10.1039/c3ta15294d; Zhang TF, 2014, CHEMCATCHEM, V6, P724, DOI 10.1002/cctc.201301068; Zuttel A, 2007, SCRIPTA MATER, V56, P823, DOI 10.1016/j.scriptamat.2007.01.010	24	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAR	2015	5	3					1552	1555		10.1021/cs501782y		4	Chemistry, Physical	Chemistry	CD1OF	WOS:000350843500018		
J	Maeda, K; Sahara, G; Eguchi, M; Ishitani, O				Maeda, Kazuhiko; Sahara, Go; Eguchi, Miharu; Ishitani, Osamu			Hybrids of a Ruthenium(II) Polypyridyl Complex and a Metal Oxide Nanosheet for Dye-Sensitized Hydrogen Evolution with Visible Light: Effects of the Energy Structure on Photocatalytic Activity	ACS CATALYSIS			English	Article						artificial photosynthesis; heterogeneous photocatcdysis; layered materials; light energy conversion; water splitting	TIO2 PARTICLES; RU-COMPLEX; WATER; IRRADIATION; SURFACE; SEMICONDUCTORS; EXFOLIATION; PHOSPHONATE; NANOSCROLLS; CARBOXYLATE	Hybrid materials consisting of a ruthenium(II) polypyridyl complex and a Dion-Jacobson type perovskite oxide nanosheet were studied as photocatalysts for dye-sensitized H-2 evolution under visible light with respect to the energy structure of the hybrids. Three Ru(II) complexes, Ru-II{(4,4'-X-2-bpy)2(4,4'-(CH2PO3H2)(2)-bpy)} (X = H, CH3, CF3; bpy = 2,2'-bipyridine), were used as redox photosensitizers. HCa2-xSrxNb3O10 (0 = x = 2) and HCa2Nb3-yTayO10 (0 = y = 1.5) nanosheet aggregates, having a tunable conduction band potential (ECB), were employed as the building block. Nanosheets that possess more negative ECB value were found to be preferable for the dye-sensitized H-2 evolution, unless electron injection from the excited-state sensitizer to the conduction band of a nanosheet is hindered. Among the combinations tested, the highest activity was obtained when an HCa2Nb3O10 nanosheet was sensitized by RuII{(4,4'-(CH3)(2)-bpy)(2)(4,4'-(CH2PO3H2)(2)-bpy)}, exhibiting a maximum apparent quantum yield of ca. 10% at 460 nm and a turnover number of ca. 3800 (for 20 h). This study highlighted that it is possible to maximize the performance of dye-sensitized H-2 evolution on a sensitizer/semiconductor hybrid by refining the ECB value of a semiconductor and the oxidation potential of the excited state of a photosensitizer.	[Maeda, Kazuhiko; Sahara, Go; Ishitani, Osamu] Tokyo Inst Technol, Dept Chem, Sch Sci & Engn, Meguro Ku, Tokyo 1528550, Japan; [Eguchi, Miharu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Eguchi, Miharu] Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol, Saitama 3320012, Japan	Maeda, K (reprint author), Tokyo Inst Technol, Dept Chem, Sch Sci & Engn, Meguro Ku, 2-12-1-NE-2 Ookayama, Tokyo 1528550, Japan.	maedak@chem.titech.ac.jp	Ishitani, Osamu/C-4947-2011	Ishitani, Osamu/0000-0001-9557-7854	ENEOS Hydrogen Trust Fund; AnApple [25107512]; PRESTO/JST program "Chemical Conversion of Light Energy"	This work was supported by the ENEOS Hydrogen Trust Fund, Grant-in-Aid for Scientific Research on Innovative Areas (Project No. 25107512; AnApple), and the PRESTO/JST program "Chemical Conversion of Light Energy". The authors thank Mr. Yutaro Ueda and Ms. Ayako Suzuki for assistance in emission measurements.	Abe R., 2010, PHOTOCHEM PHOTOBIO C, V11, P179; Maeda K, 2007, J PHYS CHEM C, V111, P7851, DOI 10.1021/jp070911w; Maeda K, 2009, J PHYS CHEM C, V113, P7962, DOI 10.1021/jp900842e; KELLER SW, 1994, J AM CHEM SOC, V116, P8817, DOI 10.1021/ja00098a055; Abe R, 2000, J PHOTOCH PHOTOBIO A, V137, P63, DOI 10.1016/S1010-6030(00)00351-8; Matsumoto Y, 2009, J AM CHEM SOC, V131, P6644, DOI 10.1021/ja807388t; Li QY, 2007, J PHYS CHEM C, V111, P11494, DOI [10.1021/jp072520n, 10.1021/jp072520a]; Park H, 2006, LANGMUIR, V22, P2906, DOI 10.1021/la0526176; Bae EY, 2004, J PHYS CHEM B, V108, P14093, DOI 10.1021/jp047777p; TREACY MMJ, 1990, CHEM MATER, V2, P279, DOI 10.1021/cm00009a018; Gholamkhass B, 2005, INORG CHEM, V44, P2326, DOI 10.1021/ic048779r; Hirano K, 2000, J PHOTOCH PHOTOBIO A, V136, P157, DOI 10.1016/S1010-6030(00)00342-7; Abe R, 2009, CHEM COMMUN, P3577, DOI 10.1039/b905935k; Maeda K, 2008, CHEM MATER, V20, P6770, DOI 10.1021/cm801807b; Huber R, 2000, J PHYS CHEM B, V104, P8995, DOI 10.1021/jp9944381; Osterloh FE, 2013, CHEM SOC REV, V42, P2294, DOI 10.1039/c2cs35266d; Ida S, 2012, J AM CHEM SOC, V134, P15773, DOI 10.1021/ja3043678; Maeda K, 2010, J AM CHEM SOC, V132, P5858, DOI 10.1021/ja1009025; Takanabe K, 2010, PHYS CHEM CHEM PHYS, V12, P13020, DOI 10.1039/c0cp00611d; Ida S, 2007, J AM CHEM SOC, V129, P8956, DOI 10.1021/ja073105b; Sasaki T, 1996, J AM CHEM SOC, V118, P8329, DOI 10.1021/ja960073b; Li QY, 2007, J PHYS CHEM C, V111, P8237, DOI 10.1021/jp068703b; Ikeda S, 2003, J PHOTOCH PHOTOBIO A, V160, P61, DOI 10.1016/S1010-6030(03)00222-3; Ebina Y, 2002, CHEM MATER, V14, P4390, DOI 10.1021/cm020622e; Schaak RE, 2000, CHEM MATER, V12, P3427, DOI 10.1021/cm000495r; Furube A, 2003, J PHYS CHEM B, V107, P4162, DOI 10.1021/jp034039c; Maeda K, 2014, ANGEW CHEM INT EDIT, V53, P13164, DOI 10.1002/anie.201408441; Bae E, 2006, J PHYS CHEM B, V110, P14792, DOI 10.1021/jp062540+; Wen FY, 2013, ACCOUNTS CHEM RES, V46, P2355, DOI 10.1021/ar300224u; Maeda K, 2009, CHEM MATER, V21, P3611, DOI 10.1021/cm9007766; SHIMIDZU T, 1985, J AM CHEM SOC, V107, P35, DOI 10.1021/ja00287a007; Yui T, 2014, ACS APPL MATER INTER, V6, P1992, DOI 10.1021/am405065a; Youngblood WJ, 2009, J AM CHEM SOC, V131, P926, DOI 10.1021/ja809108y; Norris MR, 2013, INORG CHEM, V52, P12492, DOI 10.1021/ic4014976; Li Q, 2014, PHYS CHEM CHEM PHYS, V16, P6550, DOI 10.1039/c4cp00626g; Fang MM, 1999, CHEM MATER, V11, P1519, DOI 10.1021/cm981065s; FURLONG DN, 1986, J PHYS CHEM-US, V90, P1107, DOI 10.1021/j100278a029; GERISCHE.H, 1972, PHOTOCHEM PHOTOBIOL, V16, P243; HOULDING VH, 1983, J AM CHEM SOC, V105, P5695, DOI 10.1021/ja00355a032; KIM YI, 1991, J AM CHEM SOC, V113, P9561, DOI 10.1021/ja00025a021; KRAEUTLER B, 1978, J AM CHEM SOC, V100, P4318; Kudo A., 2009, CHEM SOC REV, V38, P235; Maeda K., 2011, PHOTOCHEM PHOTOBIO C, V12, P237; MATSUMURA M, 1987, B CHEM SOC JPN, V60, P2001, DOI 10.1246/bcsj.60.2001; Oshima T, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400131; Reisner E, 2009, CHEM COMMUN, P550, DOI 10.1039/b817371k; Youngblood WJ, 2009, ACCOUNTS CHEM RES, V42, P1966, DOI 10.1021/ar9002398	47	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAR	2015	5	3					1700	1707		10.1021/acscatal.5b00040		8	Chemistry, Physical	Chemistry	CD1OF	WOS:000350843500037		
J	Nagao, Y; Nakahara, Y; Sato, T; Iwakura, H; Takeshita, S; Minami, S; Yoshida, H; Machida, M				Nagao, Yuki; Nakahara, Yunosuke; Sato, Takahiro; Iwakura, Hironori; Takeshita, Shoya; Minami, Saki; Yoshida, Hiroshi; Machida, Masato			Rh/ZrP2O7 as an Efficient Automotive Catalyst for NOx Reduction under Slightly Lean Conditions	ACS CATALYSIS			English	Article						three-way catalyst; rhodium; metal phosphate; lean NOx reduction; honeycomb; air-to-fuel ratio	GROUP METAL-CATALYSTS; SELECTIVE REDUCTION; ALUMINA CATALYSTS; NITROGEN MONOXIDE; THERMAL EVOLUTION; NITRIC-OXIDE; OXIDATION; EXHAUST; RH; RH/AL2O3	The three-way catalyst performances of honeycomb-coated Rh catalysts were studied on several metal phosphate supports (AlPO4, YPO4, ZrP2O7, and LaPO4) using various simulated exhausts with different air-to-fuel ratios (A/F). These supports significantly improved the NO purification (deNO(x)) efficiency under slightly lean conditions (14.6 < A/F <= 153) as compared with conventional Rh/ZrO, catalysts. The deNO(x) activity exhibited the following sequence of increasing the mean electronegativity of the supports: ZrO2 < YPO4 < LaPO4 < AlPO4 < ZrP2O7. Although both NO-CO and NO-C3H6 reactions contributed to the deNO(x) process, the latter reaction was more favored on Rh/ZrP2O7 than on Rh/ZrO2. Partially oxidized C3H6 was adsorbed on Rh/ZrP2O7 in the form of reactive aldehyde species, in contrast to the less reactive carboxylate species adsorbed on Rh/ZrO2. Furthermore, Rh oxide was more easily reduced to the active metallic state on ZrP2O7 compared with Rh/ZrO, when the atmosphere was changed from lean (A/F > 14.6) to rich (A/F < 14.6). Metallic Rh formed on ZrP2O7 was only slowly oxidized on exposure to excess O-2, whereas Rh on ZrO, was readily oxidized to less active Rh2O3. The high activity of Rh/ZrP2O7 toward C3H6 oxidation via aldehyde species as well as the resistance of metallic Rh against reoxidation are considered to be possible reasons for the enhanced deNO(x) performance of this catalyst in a slightly lean region.	[Nagao, Yuki; Nakahara, Yunosuke; Sato, Takahiro; Iwakura, Hironori] Mitsui Min & Smelting Co Ltd, Engn Mat Sector, Catalysts Strateg Div, Ageo, Saitama 3620025, Japan; [Nagao, Yuki; Takeshita, Shoya; Minami, Saki; Yoshida, Hiroshi; Machida, Masato] Kumamoto Univ, Dept Appl Chem & Biochem, Grad Sch Sci & Technol, Chuo Ku, Kumamoto 8608555, Japan; [Yoshida, Hiroshi; Machida, Masato] Kyoto Univ, Initiat Catalysts & Batteries, Unit Elements Strategy, Kyoto 6158520, Japan	Nagao, Y (reprint author), Mitsui Min & Smelting Co Ltd, Engn Mat Sector, Catalysts Strateg Div, 1013-1 Ageoshimo, Ageo, Saitama 3620025, Japan.	y_nagao@mitsui-kinzoku.co.jp; machida@kumamoto-u.ac.jp	Machida, Masato/F-2425-2013	Machida, Masato/0000-0002-6207-7914	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan; MEXT program "Elements Strategy Initiative to Form Core Research Centers"	This study was supported by the "Elements Science and Technology Project" of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan and the MEXT program "Elements Strategy Initiative to Form Core Research Centers." XAFS experiments were performed at the BL14B2 beamline of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2013A1344).	Haneda M, 2013, APPL CATAL B-ENVIRON, V142, P8, DOI 10.1016/j.apcatb.2013.04.055; TAYLOR KC, 1993, CATAL REV, V35, P457, DOI 10.1080/01614949308013915; Shelef M, 2000, CATAL TODAY, V62, P35, DOI 10.1016/S0920-5861(00)00407-7; SHELEF M, 1994, CATAL REV, V36, P433, DOI 10.1080/01614949408009468; MCCABE RW, 1995, J CATAL, V151, P385, DOI 10.1006/jcat.1995.1041; Gandhi HS, 2003, J CATAL, V216, P433, DOI 10.1016/S0021-9517(02)00067-2; Halkides TI, 2002, CATAL TODAY, V73, P213, DOI 10.1016/S0920-5861(02)00003-2; OBUCHI A, 1993, APPL CATAL B-ENVIRON, V2, P71, DOI 10.1016/0926-3373(93)80027-B; CHAUVIN C, 1990, J CATAL, V121, P56, DOI 10.1016/0021-9517(90)90216-7; [Anonymous], 2005, SYNCHROTRON RAD, DOI DOI 10.1107/S0909049505012719; Burch R, 2002, APPL CATAL B-ENVIRON, V39, P283, DOI 10.1016/S0926-3373(02)00118-2; Iwamoto M, 1991, CATAL TODAY, V10, P57, DOI 10.1016/0920-5861(91)80074-J; Takeguchi T, 2005, APPL CATAL A-GEN, V293, P91, DOI 10.1016/j.apcata.2005.07.013; SHELEF M, 1975, CATAL REV, V11, P1, DOI 10.1080/01614947508079980; BECK DD, 1993, J CATAL, V144, P311, DOI 10.1006/jcat.1993.1332; Bielansky A., 1991, OXYGEN CATALYSIS; CHEN JGG, 1990, J PHYS CHEM-US, V94, P5059, DOI 10.1021/j100375a055; CONTOUR JP, 1977, J CATAL, V48, P217, DOI 10.1016/0021-9517(77)90093-8; Dohmae K, 2008, SURF INTERFACE ANAL, V40, P1751, DOI 10.1002/sia.3003; Farrauto P. J., 1999, CATAL TODAY, V51, P351; Finocchio E, 1999, CATAL TODAY, V52, P53, DOI 10.1016/S0920-5861(99)00062-0; Fritz A, 1997, APPL CATAL B-ENVIRON, V13, P1, DOI 10.1016/S0926-3373(96)00102-6; GALLAHER G, 1991, J CATAL, V127, P719, DOI 10.1016/0021-9517(91)90194-9; Grasselli K. R., 1990, APPL CATAL, V57, P149; Grunwaldt JD, 2001, J CATAL, V200, P321, DOI 10.1006/jcat.2001.3211; HAMADA H, 1991, APPL CATAL, V75, pL1, DOI 10.1016/S0166-9834(00)83117-6; Haneda M, 2009, TOP CATAL, V52, P1868, DOI 10.1007/s11244-009-9347-5; Heck R. M., 1995, CATALYTIC AIR POLLUT; HOCEVAR S, 1982, J CATAL, V73, P205; Ikeue K, 2010, B CHEM SOC JPN, V83, P291, DOI 10.1246/bcsj.20090256; Machida M, 2015, J PHYS CHEM C, V119, P373, DOI 10.1021/jp59649r; Machida M, 2014, CHEM MATER, V26, P5799, DOI 10.1021/cm503061g; Machida M, 2009, CHEM MATER, V21, P1796, DOI 10.1021/cm9005844; Matsouka V, 2008, APPL CATAL B-ENVIRON, V84, P715, DOI 10.1016/j.apcatb.2008.06.004; MORTIER WJ, 1978, J CATAL, V55, P138, DOI 10.1016/0021-9517(78)90200-2; Nikolopoulos AA, 1999, CATAL TODAY, V54, P439, DOI 10.1016/S0920-5861(99)00207-2; Ruiz A, 2009, J CATAL, V266, P286, DOI 10.1016/j.jcat.2009.06.019; Sanderson R. T., 1976, CHEM BONDS BOND ENER; Shimizu K, 2012, APPL CATAL B-ENVIRON, V111, P509, DOI 10.1016/j.apcatb.2011.11.002; Tanaka H., 1995, SAE PAPER; VAIMAKIS TC, 1988, REACT KINET CATAL L, V37, P169, DOI 10.1007/BF02061728; Wan J, 2014, J MOL CATAL A-CHEM, V383, P194, DOI 10.1016/j.molcata.2013.12.011; WONG C, 1989, J CATAL, V119, P47, DOI 10.1016/0021-9517(89)90133-4; Xin M, 1997, CATAL TODAY, V38, P187, DOI 10.1016/S0920-5861(97)00065-5; YAO HC, 1980, J CATAL, V61, P547, DOI 10.1016/0021-9517(80)90406-6; YAO HC, 1977, J CATAL, V50, P407, DOI 10.1016/0021-9517(77)90053-7; ZHOU B, 1991, J CHEM SOC FARADAY T, V87, P3695, DOI 10.1039/ft9918703695; Zimowska M, 2006, CHEM PHYS LETT, V417, P137, DOI 10.1016/j.cplett.2005.09.112	48	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	MAR	2015	5	3					1986	1994		10.1021/cs5020157		9	Chemistry, Physical	Chemistry	CD1OF	WOS:000350843500065		
J	Qiu, F; Spring, AM; Yokoyama, S				Qiu, Feng; Spring, Andrew M.; Yokoyama, Shiyoshi			Athermal and High-Q Hybrid TiO2-Si3N4 Ring Resonator via an Etching-Free Fabrication Technique	ACS PHOTONICS			English	Article						waveguide; ring resonator; athermal	SILICON MICRORING RESONATORS; TIO2 WAVE-GUIDES; ON-INSULATOR; WAVELENGTH; POLYMER; MICRORESONATOR; GENERATION	In this work, we have demonstrated a hybrid TiO2-Si3N4 ring resonator with a high-Q and a temperature-insensitive resonance. The waveguide consists of a thermo-optic positive Si3N4 slab and a negative TiO2 overcladding. The TiO2 layer has a shallow ridge structure, which has been designed to realize an athermal operation and maintain a low scattering loss. During the fabrication of this waveguide, there was no need to utilize the dry-etching process. The method affords a straightforward fabrication and a precise control over the waveguide dimensions. As a result, the ring resonator exhibits a high Q value of 1.55 x 10(5), a low propagation loss of 0.4 dB/cm, and a small temperature-dependent wavelength shift of 0.14 pm/degrees C between 25 and 60 degrees C.	[Qiu, Feng; Spring, Andrew M.; Yokoyama, Shiyoshi] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Yokoyama, S (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	s_yokoyama@cm.kyushu-u.ac.jp			JSPS KAKENHI [26289108, 266220712]	This work was supported by JSPS KAKENHI Grant Nos. 26289108 and 266220712.	Teng J, 2009, OPT EXPRESS, V17, P14627, DOI 10.1364/OE.17.014627; Guha B, 2013, OPT EXPRESS, V21, P26557, DOI 10.1364/OE.21.026557; Kokubun Y, 1996, ELECTRON LETT, V32, P1998, DOI 10.1049/el:19961295; Gylfason KB, 2010, OPT EXPRESS, V18, P3226, DOI 10.1364/OE.18.003226; Qiu CY, 2011, OPT EXPRESS, V19, P5143, DOI 10.1364/OE.19.005143; Levy JS, 2010, NAT PHOTONICS, V4, P37, DOI 10.1038/NPHOTON.2009.259; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Qiu F, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790440; Carlborg CF, 2010, LAB CHIP, V10, P281, DOI 10.1039/b914183a; Tien MC, 2011, OPT EXPRESS, V19, P13551, DOI 10.1364/OE.19.013551; Rabiei P, 2002, J LIGHTWAVE TECHNOL, V20, P1968, DOI 10.1109/JLT.2002.803058; Bovington J, 2014, OPT EXPRESS, V22, P661, DOI 10.1364/OE.22.000661; Feng SQ, 2012, LASER PHOTONICS REV, V6, P145, DOI 10.1002/lpor.201100020; Levy JS, 2011, OPT EXPRESS, V19, P11415, DOI 10.1364/OE.19.011415; Qiu F, 2012, OPT LETT, V37, P4086, DOI 10.1364/OL.37.004086; Vollmer F, 2002, APPL PHYS LETT, V80, P4057, DOI 10.1063/1.1482797; Bradley JDB, 2012, OPT EXPRESS, V20, P23821, DOI 10.1364/OE.20.023821; Bauters JF, 2011, OPT EXPRESS, V19, P3163, DOI 10.1364/OE.19.003163; Guha B, 2010, OPT EXPRESS, V18, P3487, DOI 10.1364/OE.18.003487; Baehr-Jones T, 2004, APPL PHYS LETT, V85, P3346, DOI 10.1063/1.1781355; Furuhashi M., 2011, AIP ADV, V1, P1; Geuzebroek D, 2005, IEEE PHOTONIC TECH L, V17, P336, DOI 10.1109/LPT.2004.839451; Gulsen G, 2002, OPT MATER, V18, P373, DOI 10.1016/S0925-3467(01)00176-8; Padmaraju K., 2013, NANOPHOTONICS, V2, P1	24	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2330-4022			ACS PHOTONICS	ACS Photonics	MAR	2015	2	3					405	409		10.1021/ph500450n		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Optics; Physics, Applied; Physics, Condensed Matter	Science & Technology - Other Topics; Materials Science; Optics; Physics	CD9LK	WOS:000351419600012		
J	Mizuuchi, R; Ichihashi, N; Usui, K; Kazuta, Y; Yomo, T				Mizuuchi, Ryo; Ichihashi, Norikazu; Usui, Kimihito; Kazuta, Yasuaki; Yomo, Tetsuya			Adaptive Evolution of an Artificial RNA Genome to a Reduced Ribosome Environment	ACS SYNTHETIC BIOLOGY			English	Article						adaptation; RNA genome; self-replication; translation; RNA replicase; evolution	MESSENGER-RNA; SECONDARY STRUCTURE; TRANSLATION INITIATION; ESCHERICHIA-COLI; REPLICATION; SHAPE; EXPRESSION; ACCURATE; SEQUENCE; INFORMATION	The reconstitution of an artificial system that has the same evolutionary ability as a living thing is a major challenge in the in vitro synthetic biology. In this study, we tested the adaptive evolutionary ability of an artificial RNA genome replication system, termed the translation coupled RNA replication (TcRR) system. In a previous work, we performed a study of the long-term evolution of the genome with an excess amount of ribosome. In this study, we continued the evolution experiment in a reduced ribosome environment and observed that the mutant genorne compensated for the reduced ribosome concentration. This result demonstrated the ability of the TcRR system to adapt and may be a step toward generating living things with evolutionary ability.	[Mizuuchi, Ryo; Ichihashi, Norikazu; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Ichihashi, Norikazu; Usui, Kimihito; Kazuta, Yasuaki; Yomo, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Yomo, T (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp					Subramaniam AR, 2013, P NATL ACAD SCI USA, V110, P2419, DOI 10.1073/pnas.1211077110; Chen CL, 2013, NAT STRUCT MOL BIOL, V20, P582, DOI 10.1038/nsmb.2544; Forlin M, 2012, CURR OPIN CHEM BIOL, V16, P586, DOI 10.1016/j.cbpa.2012.10.020; Paegel BM, 2010, CHEM BIOL, V17, P717, DOI 10.1016/j.chembiol.2010.05.021; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Na D, 2010, BIOINFORMATICS, V26, P2633, DOI 10.1093/bioinformatics/btq458; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; McGinnis JL, 2009, METHOD ENZYMOL, V468, P67, DOI 10.1016/S0076-6879(09)68004-6; Studer SM, 2006, MOL CELL, V22, P105, DOI 10.1016/j.molcel.2006.02.014; Bansho Y, 2012, CHEM BIOL, V19, P478, DOI 10.1016/j.chembiol.2012.01.019; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Hosoda K, 2007, J BIOL CHEM, V282, P15516, DOI 10.1074/jbc.M700307200; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Stano P, 2013, CURR OPIN BIOTECH, V24, P633, DOI 10.1016/j.copbio.2013.01.002; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Kita H, 2008, CHEMBIOCHEM, V9, P2403, DOI 10.1002/cbic.200800360; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; Osterman IA, 2013, NUCLEIC ACIDS RES, V41, P474, DOI 10.1093/nar/gks989; Agol VI, 1999, VIRUS RES, V62, P129, DOI 10.1016/S0168-1702(99)00037-4; Deamer D, 2005, TRENDS BIOTECHNOL, V23, P336, DOI 10.1016/j.tibtech.2005.05.008; Ichihashi N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004945; Ichihashi N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3494; Jewett MC, 2010, CURR OPIN BIOTECH, V21, P697, DOI 10.1016/j.copbio.2010.06.008; KRAMER FR, 1974, J MOL BIOL, V89, P719, DOI 10.1016/0022-2836(74)90047-3; LEE N, 1987, GENE, V58, P77, DOI 10.1016/0378-1119(87)90031-X; Luisi PL, 2011, NAT CHEM, V3, P755, DOI 10.1038/nchem.1156; MaynardSmith J., 1986, PROBLEMS BIOL; Michael R., 2003, INTRO BIOSTATISTICS; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006	39	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	MAR	2015	4	3					292	298		10.1021/sb5000884		7	Biochemical Research Methods	Biochemistry & Molecular Biology	CE1IP	WOS:000351565600012		
J	Song, J; Kose, S; Watanabe, A; Son, SY; Choi, S; Hong, H; Yamashita, E; Park, IY; Imamoto, N; Lee, SJ				Song, Jinsue; Kose, Shingo; Watanabe, Ai; Son, Se-Young; Choi, Saehae; Hong, Hyerim; Yamashita, Eiki; Park, Il Yeong; Imamoto, Naoko; Lee, Soo Jae			Structural and functional analysis of Hikeshi, a new nuclear transport receptor of Hsp70s	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						Hikeshi; asymmetric homodimer; nuclear transport receptor; 70 kDa heat-shock proteins; FG-nucleoporins	FXFG NUCLEOPORIN REPEATS; E3 UBIQUITIN LIGASE; HEAT-SHOCK; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; MOLECULAR CHAPERONES; FG NUCLEOPORINS; IMPORTIN-ALPHA; EXPORT FACTOR; P-LOOP	Hikeshi is a nuclear transport receptor required for cell survival after stress. It mediates heat-shock-induced nuclear import of 70 kDa heat-shock proteins (Hsp70s) through interactions with FG-nucleoporins (FG-Nups), which are proteins in nuclear pore complexes (NPCs). Here, the crystal structure of human Hikeshi is presented at 1.8 angstrom resolution. Hikeshi forms an asymmetric homodimer that is responsible for the interaction with Hsp70s. The asymmetry of Hikeshi arises from the distinct conformation of the C-terminal domain (CTD) and the flexibility of the linker regions of each monomer. Structure-guided mutational analyses showed that both the flexible linker region and the CTD are important for nuclear import of Hsp70. Pull-down assays revealed that only full-length Hsp70s can interact with Hikeshi. The N-terminal domain (NTD) consists of a jelly-roll/beta-sandwich fold structure which contains hydrophobic pockets involved in FG-Nup recognition. A unique extended loop (E-loop) in the NTD is likely to regulate the interactions of Hikeshi with FG-Nups. The crystal structure of Hikeshi explains how Hikeshi participates in the regulation of nuclear import through the recognition of FG-Nups and which part of Hikeshi affects its binding to Hsp70. This study is the first to yield structural insight into this highly unique import receptor.	[Song, Jinsue; Son, Se-Young; Choi, Saehae; Hong, Hyerim; Park, Il Yeong; Lee, Soo Jae] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, Chungbuk, South Korea; [Kose, Shingo; Watanabe, Ai; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan; [Yamashita, Eiki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Kose, S (reprint author), RIKEN, Cellular Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	skose@riken.jp; nimamoto@riken.jp; sjlee@chungbuk.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MEST) [2008-0062275, 2011-0017405]; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program)'; Council for Science and Technology Policy (CSTP)	This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST; 2008-0062275 and 2011-0017405 to SJL) and a Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid (to SK) and funding awarded to NI by the Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program)' initiated by the Council for Science and Technology Policy (CSTP). The synchrotron-radiation experiments were performed on BL44XU at SPring-8, Japan (2012B6500, 2013A6500 and 2013B6500) and the Protein Beamline, Pohang Light Source, Republic of Korea.	Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; King DA, 1999, NAT STRUCT BIOL, V6, P64; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Milles S, 2011, BIOPHYS J, V101, P1710, DOI 10.1016/j.bpj.2011.08.025; PELHAM HRB, 1984, EMBO J, V3, P3095; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Piron M, 1999, J VIROL, V73, P5411; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Bayliss R, 2000, J STRUCT BIOL, V131, P240, DOI 10.1006/jsbi.2000.4297; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.biochem.60.1.321; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FETROW JS, 1995, FASEB J, V9, P708; Furuta M, 2004, GENES CELLS, V9, P429, DOI 10.1111/j.1365-9597.2004.00734.x; Grant RP, 2003, J MOL BIOL, V326, P849, DOI 10.1016/S0022-2836(02)01474-2; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Imamoto N, 2012, NUCLEUS-AUSTIN, V3, P422, DOI 10.4161/nucl.21713; Oda Y, 2014, FEBS LETT, V588, P1899, DOI 10.1016/j.febslet.2014.04.018; Otwinowski Z., 1997, ENZYMOLOGY, V276, P307; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Skliros A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/014001; STUART DI, 1986, NATURE, V324, P84, DOI 10.1038/324084a0; Swapna LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036688; Teplova M, 2011, NAT STRUCT MOL BIOL, V18, P990, DOI 10.1038/nsmb.2094; Via A, 2000, J MOL BIOL, V303, P455, DOI 10.1006/jmbi.2000.4151; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhang L, 1996, EMBO J, V15, P4676	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	MAR	2015	71		3				473	483		10.1107/S1399004714026881		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CD5VD	WOS:000351155400006		
J	Arai, S; Yonezawa, Y; Okazaki, N; Matsumoto, F; Shibazaki, C; Shimizu, R; Yamada, M; Adachi, M; Tamada, T; Kawamoto, M; Tokunaga, H; Ishibashi, M; Blaber, M; Tokunaga, M; Kuroki, R				Arai, Shigeki; Yonezawa, Yasushi; Okazaki, Nobuo; Matsumoto, Fumiko; Shibazaki, Chie; Shimizu, Rumi; Yamada, Mitsugu; Adachi, Motoyasu; Tamada, Taro; Kawamoto, Masahide; Tokunaga, Hiroko; Ishibashi, Matsujiro; Blaber, Michael; Tokunaga, Masao; Kuroki, Ryota			Structure of a highly acidic beta-lactamase from the moderate halophile Chromohalobacter sp 560 and the discovery of a Cs+-selective binding site	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						beta-lactamase; Chromohalobacter sp.; Sr2+ binding; Cs+ binding	EFFECTIVE IONIC-RADII; HALOMONAS SP 593; ALKALINE-PHOSPHATASE; CRYSTAL-STRUCTURE; HUMAN LYSOZYME; STABILITY; INHIBITION; REFINEMENT; MUTATIONS; BACTERIUM	Environmentally friendly absorbents are needed for Sr2+ and Cs+, as the removal of the radioactive Sr2+ and Cs+ that has leaked from the Fukushima Nuclear Power Plant is one of the most important problems in Japan. Halophilic proteins are known to have many acidic residues on their surface that can provide specific binding sites for metal ions such as Cs+ or Sr2+. The crystal structure of a halophilic beta-lactamase from Chromohalobacter sp. 560 (HaBLA) was determined to resolutions of between 1.8 and 2.9 angstrom in space group P31 using X-ray crystallography. Moreover, the locations of bound Sr2+ and Cs+ ions were identified by anomalous X-ray diffraction. The location of one Cs+-specific binding site was identified in HaBLA even in the presence of a ninefold molar excess of Na+ (90 mM Na+/10 mM Cs+). From an activity assay using isothermal titration calorimetry, the bound Sr2+ and Cs+ ions do not significantly affect the enzymatic function of HaBLA. The observation of a selective and high-affinity Cs+-binding site provides important information that is useful for the design of artificial Cs+-binding sites that may be useful in the bioremediation of radioactive isotopes.	[Arai, Shigeki; Yonezawa, Yasushi; Okazaki, Nobuo; Matsumoto, Fumiko; Shibazaki, Chie; Shimizu, Rumi; Yamada, Mitsugu; Adachi, Motoyasu; Tamada, Taro; Blaber, Michael; Kuroki, Ryota] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan; [Kawamoto, Masahide] Kyushu Synchrotron Light Res Ctr, Saga Prefectural Reg Ind Support Ctr, Tosu, Saga 8410005, Japan; [Tokunaga, Hiroko; Ishibashi, Matsujiro; Tokunaga, Masao] Kagoshima Univ, Fac Agr, Appl & Mol Microbiol, Kagoshima 8900065, Japan; [Blaber, Michael] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	Kuroki, R (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Directorate, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	kuroki.ryota@jaea.go.jp		Blaber, Michael/0000-0002-6856-1643; Okazaki, Nobuo/0000-0003-3553-2894	Ministry of Education, Culture, Sports, Science and Technology of Japan [19370046, 22390010]	The synchrotron-radiation experiments were performed at BL38B1 and BL41XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; proposal Nos. 2011B1253 and 012A1090), NW12A and NE3A of Photon Factory (proposal Nos. 2011G088 and 2012G672) and BL7 of SAGA-LS (proposal No. 1305049R). We thank the staff at SPring-8, Photon Factory and SAGA-LS. This work was supported in part by Grants-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19370046 and 22390010 to RK).	Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Tokunaga H, 2010, APPL MICROBIOL BIOT, V88, P1223, DOI 10.1007/s00253-010-2832-8; Bowman GD, 2000, J MOL BIOL, V304, P861, DOI 10.1006/jmbi.2000.4250; Powers RA, 2002, J MED CHEM, V45, P3222, DOI 10.1021/jm020002p; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Mukai H, 2014, ENVIRON SCI TECHNOL, V48, P13053, DOI 10.1021/es502849e; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; [Anonymous], 1998, ACTA CRYSTALLOGR D; Wende A, 2010, J MOL BIOL, V400, P52, DOI 10.1016/j.jmb.2010.04.057; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Tokunaga H, 2006, BIOPHYS CHEM, V119, P316, DOI 10.1016/j.bpc.2005.10.006; Blizzard TA, 2014, BIOORG MED CHEM LETT, V24, P780, DOI 10.1016/j.bmcl.2013.12.101; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Pauling L, 1929, J AM CHEM SOC, V51, P1010, DOI 10.1021/ja01379a006; AGARWAL RC, 1978, ACTA CRYSTALLOGR A, V34, P791, DOI 10.1107/S0567739478001618; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Arai S, 2014, ACTA CRYSTALLOGR D, V70, P811, DOI 10.1107/S1399004713033609; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Besir H, 2005, FEBS LETT, V579, P6595, DOI 10.1016/j.febslet.2005.10.052; Blaha G, 2008, J MOL BIOL, V379, P505, DOI 10.1016/j.jmb.2008.03.075; Cianci M, 2010, J AM CHEM SOC, V132, P2293, DOI 10.1021/ja908703c; Deswarte J, 2001, EUR J BIOCHEM, V268, P3993, DOI 10.1046/j.1432-1327.2001.02310.x; Drawz SM, 2010, BIOCHEMISTRY-US, V49, P329, DOI 10.1021/bi9015988; Hata M, 2005, J PHYS CHEM B, V109, P16153, DOI 10.1021/jp045403q; Haynes W. M., 2013, CRC HDB CHEM PHYS; IAEA, 1994, IAEA TECH REP SER, V363, P17; Immirzi A., 1966, CRYSTALLOGRAPHIC COM, P399; Inanobe A, 2011, J BIOL CHEM, V286, P41801, DOI 10.1074/jbc.M111.278531; Ishibashi M, 2011, PROTEIN EXPRES PURIF, V76, P97, DOI 10.1016/j.pep.2010.09.013; Ishibashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P1213, DOI 10.1271/bbb.69.1213; JIA YQ, 1991, J SOLID STATE CHEM, V95, P184, DOI 10.1016/0022-4596(91)90388-X; Kim JY, 2006, MOL MICROBIOL, V60, P907, DOI 10.1111/j.1365-2958.2006.05146.x; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kuroki R, 1998, J BIOL CHEM, V273, P34310, DOI 10.1074/jbc.273.51.34310; KUROKI R, 1989, P NATL ACAD SCI USA, V86, P6903, DOI 10.1073/pnas.86.18.6903; Liao DI, 2001, STRUCTURE, V9, P11, DOI 10.1016/S0969-2126(00)00550-5; Llinas P, 2006, PROTEIN SCI, V15, P1691, DOI 10.1110/ps.062123806; Michaux C, 2008, FEBS J, V275, P1687, DOI 10.1111/j.1742-4658.2008.06324.x; Otwinowski Z., 1997, ENZYMOLOGY, V276, P307; Pieper U, 1998, STRUCTURE, V6, P75, DOI 10.1016/S0969-2126(98)00009-4; RAO JKM, 1981, BIOCHEMISTRY-US, V20, P6536, DOI 10.1021/bi00526a004; Sato T., 2011, J CLAY SCI SOC JPN, V50, P26; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tokunaga H, 2010, APPL MICROBIOL BIOT, V86, P649, DOI 10.1007/s00253-009-2325-9; Tokunaga H, 2004, FEBS LETT, V558, P7, DOI 10.1016/S0014-5793(03)01508-4; Vidal M, 2001, J ENVIRON RADIOACTIV, V56, P139, DOI 10.1016/S0265-931X(01)00051-0; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	MAR	2015	71		3				541	554		10.1107/S1399004714027734		14	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CD5VD	WOS:000351155400013		
J	Bauer, R; Janowska, K; Taylor, K; Jordan, B; Gann, S; Janowski, T; Latimer, EC; Matsushita, O; Sakon, J				Bauer, Ryan; Janowska, Katarzyna; Taylor, Kelly; Jordan, Brad; Gann, Steve; Janowski, Tomasz; Latimer, Ethan C.; Matsushita, Osamu; Sakon, Joshua			Structures of three polycystic kidney disease-like domains from Clostridium histolyticum collagenases ColG and ColH	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						polycystic kidney disease-like domains; ColG; ColH; Clostridium histolyticum	CHEMOTHERAPY-INDUCED ALOPECIA; SKIN FIBROBLAST COLLAGENASE; BINDING DOMAIN; PARATHYROID-HORMONE; PKD-DOMAIN; PROTEIN; MODEL; STABILITY; COLLAGENOLYSIS; DEGRADATION	Clostridium histolyticum collagenases ColG and ColH are segmental enzymes that are thought to be activated by Ca2+-triggered domain reorientation to cause extensive tissue destruction. The collagenases consist of a collagenase module (s1), a variable number of polycystic kidney disease-like (PKD-like) domains (s2a and s2b in ColH and s2 in ColG) and a variable number of collagen-binding domains (s3 in ColH and s3a and s3b in ColG). The X-ray crystal structures of Ca2+-bound holo s2b (1.4 angstrom resolution, R = 15.0%, R-free = 19.1%) and holo s2a (1.9 angstrom resolution, R = 16.3%, R-free = 20.7%), as well as of Ca2+-free apo s2a (1.8 angstrom resolution, R = 20.7%, R-free = 27.2%) and two new forms of N-terminally truncated apo s2 (1.4 angstrom resolution, R = 16.9%, R-free = 21.2%; 1.6 angstrom resolution, R = 16.2%, R-free = 19.2%), are reported. The structurally similar PKD-like domains resemble the V-set Ig fold. In addition to a conserved beta-bulge, the PKD-like domains feature a second bulge that also changes the allegiance of the subsequent beta-strand. This beta-bulge and the genesis of a Ca2+ pocket in the archaeal PKD-like domain suggest a close kinship between bacterial and archaeal PKD-like domains. Different surface properties and indications of different dynamics suggest unique roles for the PKD-like domains in ColG and in ColH. Surface aromatic residues found on ColH s2a-s2b, but not on ColG s2, may provide the weak interaction in the biphasic collagen-binding mode previously found in s2b-s3. B-factor analyses suggest that in the presence of Ca2+ the midsection of s2 becomes more flexible but the midsections of s2a and s2b stay rigid. The different surface properties and dynamics of the domains suggest that the PKD-like domains of M9B bacterial collagenase can be grouped into either a ColG subset or a ColH subset. The conserved properties of PKD-like domains in ColG and in ColH include Ca2+ binding. Conserved residues not only interact with Ca2+, but also position the Ca2+-interacting water molecule. Ca2+ aligns the N-terminal linker approximately parallel to the major axis of the domain. Ca2+ binding also increases stability against heat and guanidine hydrochloride, and may improve the longevity in the extracellular matrix. The results of this study will further assist in developing collagen-targeting vehicles for various signal molecules.	[Bauer, Ryan; Janowska, Katarzyna; Taylor, Kelly; Jordan, Brad; Gann, Steve; Janowski, Tomasz; Latimer, Ethan C.; Sakon, Joshua] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Matsushita, Osamu] Okayama Univ, Dept Bacteriol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Sakon, J (reprint author), Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA.	jsakon@uark.edu			National Institutes of Health [GM103429, GM103450]; Arkansas Biosciences Institute; Japan Society for the Promotion of Science; Kagawa University; NSF; Honors College of UA; Arkansas Department of Higher Education; Doctoral Academy Fellowship; Department of Energy	This work has been supported by the National Institutes of Health (GM103429 and GM103450), Arkansas Biosciences Institute, a Grant-in Aid for Scientific Research (C) from the Japan Society for the Promotion of Science and Kagawa University Project Research Fund 2005-2006. SG was supported by a NSF summer fellowship. RB, KT and EL were supported by the Honors College of UA. RB was also supported by a Student Undergraduate Research Fellowship from Arkansas Department of Higher Education and a Doctoral Academy Fellowship. We thank the staff at XSD-12ID and at SBC-19ID and BM at the Advanced Photon Source, which is supported by the Department of Energy.	Akimoto M, 2013, PLAST RECONSTR SURG, V131, P717, DOI 10.1097/PRS.0b013e3182818b34; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bauer R, 2013, J BACTERIOL, V195, P318, DOI 10.1128/JB.00010-12; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Wang YK, 2010, J BIOL CHEM, V285, P14285, DOI 10.1074/jbc.M109.087023; Nagase H, 2008, CONNECT TISSUE RES, V49, P169, DOI 10.1080/03008200802151698; Ponnapakkam T, 2012, CALCIFIED TISSUE INT, V91, P196, DOI 10.1007/s00223-012-9626-1; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; MONERA OD, 1994, PROTEIN SCI, V3, P1984; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Katikaneni R, 2014, ANTI-CANCER DRUG, V25, P30, DOI 10.1097/CAD.0b013e3283650bff; Eckhard U, 2013, J BIOL CHEM, V288, P20184, DOI 10.1074/jbc.M112.448548; FRENCH MF, 1992, J PROTEIN CHEM, V11, P83, DOI 10.1007/BF01025095; Breite AG, 2011, TRANSPL P, V43, P3171, DOI 10.1016/j.transproceed.2011.09.059; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics./btl.448; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ponnapakkam T, 2011, CALCIFIED TISSUE INT, V88, P511, DOI 10.1007/s00223-011-9485-1; Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Eckhard U, 2011, BIOL CHEM, V392, P1039, DOI 10.1515/BC.2011.099; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Adhikari AS, 2012, J AM CHEM SOC, V134, P13259, DOI 10.1021/ja212170b; Duarte AS, 2014, CRIT REV MICROBIOL, DOI [http://dx.doi.org/10.3109/1040841X.2014.904270, DOI 10.3109/1040841X.2014.904270]; Fujio A, 2013, TRANSPLANTATION, V96, pS141; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Katikaneni R, 2012, INT J CANCER, V131, pE813, DOI 10.1002/ijc.27379; KELLIS JT, 1991, BIO-TECHNOL, V9, P994, DOI 10.1038/nbt1091-994; Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643; Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200; McCarthy RC, 2011, TRANSPLANTATION, V91, P137, DOI 10.1097/TP.0b013e3181ffff7d; McRee D. E., 1999, PRACTICAL PROTEIN CR; Merritt EA, 2012, ACTA CRYSTALLOGR D, V68, P468, DOI 10.1107/S0907444911028320; Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018; Ohbayashi N, 2013, BIOPHYS J, V104, P1538, DOI 10.1016/j.bpj.2013.02.022; Philominathan STL, 2009, J BIOL CHEM, V284, P10868, DOI 10.1074/jbc.M807684200; Philominathan STL, 2008, BIOMOL NMR ASSIGN, V2, P127, DOI 10.1007/s12104-008-9102-z; Philominathan STL, 2009, FEBS J, V276, P3589, DOI 10.1111/j.1742-4658.2009.07078.x; Philominathan STL, 2012, PROTEIN SCI, V21, P1554, DOI 10.1002/pro.2145; Ponnapakkam T., 2013, DRUG DISCOV TODAY, V19, P204; Ponnapakkam T, 2011, J ENDOCRINOL INVEST, V34, pE392, DOI 10.3275/7864; Saito W, 2013, J BIOMED MATER RES A, V102, P3049; SCHORMANN N, 1995, P NATL ACAD SCI USA, V92, P9490, DOI 10.1073/pnas.92.21.9490; Sides CR, 2012, J AM SOC MASS SPECTR, V23, P505, DOI 10.1007/s13361-011-0309-3; Uchida K., 2013, J BIOMED MATER RES A, V102, P1737; WELGUS HG, 1981, J BIOL CHEM, V256, P9516; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	57	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	MAR	2015	71		3				565	577		10.1107/S1399004714027722		13	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CD5VD	WOS:000351155400015		
J	Sugiyama, Y; Senda, M; Senda, T; Matsuda, T				Sugiyama, Yosuke; Senda, Miki; Senda, Toshiya; Matsuda, Tomoko			Crystallization and preliminary crystallographic analysis of acetophenone reductase from Geotrichum candidum NBRC 4597	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article						acetophenone reductase; enantioselectivity; asymmetric reduction	SUPERCRITICAL CARBON-DIOXIDE; ALCOHOL-DEHYDROGENASE; ASYMMETRIC REDUCTION; KETONES; PARAPSILOSIS	Acetophenone reductase (APRD) from Geotrichum candidium NBRC 4597 was crystallized by the hanging-drop vapour-diffusion method using PEG 3350 as a precipitant. The crystal belonged to space group P6522, with unit-cell parameters a = b = 104.5, c = 273.7 angstrom, and diffracted to 2.6 angstrom resolution. Phasing using the single-wavelength anomalous diffraction method was successful. Model building and crystallographic refinement are in progress.	[Sugiyama, Yosuke; Matsuda, Tomoko] Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Senda, Miki; Senda, Toshiya] High Energy Accelerator Res Org KEK, Photon Factory, Inst Mat Struct Sci, Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan	Matsuda, T (reprint author), Tokyo Inst Technol, Dept Bioengn, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	tmatsuda@bio.titech.ac.jp			Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI [25410189146]	This work was partly supported by the Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by JSPS KAKENHI Grant No. 25410189146 (to TM).	Wang SS, 2014, CHEM COMMUN, V50, P7770, DOI 10.1039/c4cc01752h; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Nestl BM, 2014, ANGEW CHEM INT EDIT, V53, P3070, DOI 10.1002/anie.201302195; Hiraki M, 2006, ACTA CRYSTALLOGR D, V62, P1058, DOI 10.1107/S0907444906023821; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Man H, 2014, CHEMCATCHEM, V6, P1103, DOI 10.1002/cctc.201300788; Matsuda T, 2008, TETRAHEDRON-ASYMMETR, V19, P2272, DOI 10.1016/j.tetasy.2008.09.018; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; Cao C, 2013, BIOCHEM ENG J, V76, P13, DOI 10.1016/j.bej.2013.04.005; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Matsuda T, 2000, CHEM COMMUN, P1367, DOI 10.1039/b004069j; Matsuda T, 2006, TETRAHEDRON LETT, V47, P4619, DOI 10.1016/j.tetlet.2006.04.140; Matsuda T, 2000, J ORG CHEM, V65, P157, DOI 10.1021/jo991283k; Matsuda T, 2003, CHEM COMMUN, P1198, DOI 10.1039/b301452e; Nakamura K, 1998, J ORG CHEM, V63, P8957, DOI 10.1021/jo9812779; Nakata Y, 2010, APPL MICROBIOL BIOT, V86, P625, DOI 10.1007/s00253-009-2329-5; PLAPP BV, 1983, J BIOL CHEM, V258, P5537; Tanaka T, 2009, J MOL CATAL B-ENZYM, V57, P317, DOI 10.1016/j.molcatb.2008.07.011; Vonrhein C, 2006, METHOD MOL BIOL, V364, P215, DOI DOI 10.1385/1-59745-266-1:215; Wang SS, 2014, ACTA CRYSTALLOGR F, V70, P800, DOI 10.1107/S2053230X1400908X; Yamamoto T, 2013, APPL MICROBIOL BIOT, V97, P10413, DOI 10.1007/s00253-013-4801-5	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	MAR	2015	71		3				320	323		10.1107/S2053230X15002265		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CD5VZ	WOS:000351157900012		
J	Tanabe, K; Misaki, A; Ubukata, T				Tanabe, Kazushige; Misaki, Akihiro; Ubukata, Takao			Late Cretaceous record of large soft-bodied coleoids based on lower jaw remains from Hokkaido, Japan	ACTA PALAEONTOLOGICA POLONICA			English	Editorial Material						Cephalopoda; Coleoidea; Vampyromorpha; Teuthida; jaws; Cretaceous; Hokkaido, Japan	LITHOGRAPHIC LIMESTONE; SPIRULID COLEOIDS; SW-GERMANY; CEPHALOPODS; MORPHOLOGY; PHYLOGENY; EVOLUTION; LEBANON; FOSSIL; PLATTENKALKS	The origin and phylogenetic relationships of most modern coleoid groups have not yet been explained by reliable fossil evidence, in large part because of the reduction or disappearance of a calcified chambered shell during their evolutionary history. Herein we describe two exceptionally large coleoid lower jaws from the Upper Cretaceous strata in Hokkaido, Japan. On the basis of the comparison of gross morphology and morphometric data of the lower jaws of modern and fossil coleoids, we assigned the two lower jaws to the following new taxa: Nanaimoteuthis hikidai sp. nov. of the order Vampyromorpha (superorder Octobrachia) and Haboroteuthis poseidon gen. et sp. nov. of the order Teuthida (superorder Decabrachia). The lower jaw of N. hikidai is distinguished from other species of the same genus from the Upper Cretaceous of Vancouver Island (Canada) and Hokkaido by having a broader, more anteriorly curved hood of the outer lamella. The lower jaw of H. poseidon seemingly exhibits mosaic features like those of modern teuthids and sepiids but is assigned to Teuthida on the basis of the overall shape of the outer lamella and the development of a distinct fold on the lateral wall. Because of the unusually large lower jaws, these new taxa appear to be comparable in body size to modern giant squids (Architeuthis spp.) and the Humboldt squid (Dosidicus gigas). This and other discoveries of large jaws referable to octobrachian and decabrachian coleoids from the Upper Cretaceous strata of the North Pacific fill the gap in the relatively poor fossil record of mainly soft-bodied coleoids.	[Tanabe, Kazushige] Univ Tokyo, Univ Museum, Dept Hist Geol & Palaeontol, Tokyo 1130033, Japan; [Misaki, Akihiro] Kitakyushu Museum Nat Hist & Human Hist, Kitakyushu, Fukuoka 8050071, Japan; [Ubukata, Takao] Kyoto Univ, Dept Earth & Planetary Sci, Sakyo Ku, Kyoto 6068502, Japan	Tanabe, K (reprint author), Univ Tokyo, Univ Museum, Dept Hist Geol & Palaeontol, Hongo 7-3-1, Tokyo 1130033, Japan.	tanabe@um.u-tokyo.ac.jp; misaki_a@kmnh.jp; ubukata@kueps.kyoto-u.ac.jp					Ifrim C, 2004, PALAEONTOLOGY, V47, P1575, DOI 10.1111/j.0031-0239.2004.00426.x; Strugnell J, 2006, CLADISTICS, V22, P89, DOI 10.1111/j.1096-0031.2006.00086.x; Tanabe K, 2012, NEUES JAHRB GEOL P-A, V266, P9, DOI 10.1127/0077-7749/2012/0243; Tanabe K, 2008, J PALEONTOL, V82, P398, DOI 10.1666/07-029.1; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Gupta NS, 2008, ORG GEOCHEM, V39, P1405, DOI 10.1016/j.orggeochem.2008.06.008; Tanabe K, 2006, J PALEONTOL, V80, P138, DOI 10.1666/0022-3360(2006)080[0138:TCJFTU]2.0.CO;2; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Takashima R, 2004, CRETACEOUS RES, V25, P365, DOI 10.1016/j.cretres.2004.02.004; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Kruta I, 2011, SCIENCE, V331, P70, DOI 10.1126/science.1198793; Young RE, 1998, S AFR J MARINE SCI, V20, P393; Bergmann S, 2006, J MOL EVOL, V62, P362, DOI 10.1007/s00239-005-0160-x; Tanabe K, 2013, LETHAIA, V46, P399, DOI 10.1111/let.12017; Bandel K., 1986, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1986, P129; Bather F. A., 1888, Annals of Natural History, V(6), P298; BIRKELUND TOVE, 1956, MEDDEL GRONLAND, V137, P1; Boettger C.R., 1952, ABHANDLUNGEN BRAUNSC, V4, P238; Bookstein F., 1991, MORPHOMETRIC TOOLS L; Bookstein F L, 1997, Med Image Anal, V1, P225, DOI 10.1016/S1361-8415(97)85012-8; Chun C, 1903, TIEFEN WELTMEERES, VSecond; Clarke M.R., 1962, ZOOLOGY, V8, P419; Clarke MR, 1986, HDB IDENTIFICATION C; Clarke M.R., 1988, THE MOLLUSCA, V12, P121; Cohen K.M., 2012, INT CHRONOSTRATIGRAP; Dietl G, 1999, NEUES JAHRB GEOL P-A, V211, P75; Doguzhaeva LA, 1996, PALAEONTOLOGY, V39, P681; Donovan D, 1977, S ZOOL SOC LOND, V38, P15; Donovan D.T., 1988, THE MOLLUSCA, V12, P89; Doyle P., 1994, University of Kansas Paleontological Contributions New Series, V5, P1; Doyle P., 1986, Bulletin of the British Museum (Natural History) Geology, V40, P133; ENGESER T, 1985, Palaeontologische Zeitschrift, V59, P245; Engeser T., 1988, CEPHALOPODS PRESENT, P105; Engeser T., 1983, STUTTGARTER BEITRA B, V92, P1; Engeser T., 1990, SYSTEMATICS ASS SP, V42, P119; Engeser T., 1986, STUTTGARTER BEITRA B, V124, P1; Engeser T., 1990, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V124, P123; FISCHER JC, 1982, CR ACAD SCI II, V295, P277; Fischer Jean-Claude, 2002, Annales de Paleontologie, V88, P1, DOI 10.1016/S0753-3969(02)01037-6; Fischer J.-C., 1982, ANN PALEONTOLOGIE VE, V68, P295; Fuchs D, 2013, PALAEONTOLOGY, V56, P1081, DOI 10.1111/pala.12036; Fuchs D., 2006, BERLINER PALAOBIOLOG, V8, P1; Fuchs D, 2011, J PALEONTOL, V85, P234, DOI 10.1666/10-089.1; Niesiolowski Stefan, 2006, Fragmenta Faunistica (Warsaw), V49, P1; Fuchs D., 2007, 7 INT S CEPH PRES 20, V131; Fuchs D, 2012, PALAEONTOLOGY, V55, P285, DOI 10.1111/j.1475-4983.2011.01125.x; Fuchs D., 2010, CEPHALOPODS PRESENT, P195; Fuchs D, 2009, PALAEONTOLOGY, V52, P65, DOI 10.1111/j.1475-4983.2008.00828.x; Fuchs D, 2013, PALAEONTOL Z, V87, P431, DOI 10.1007/s12542-013-0182-4; Fuchs D, 2011, J PALEONTOL, V85, P815; Haas Winfried, 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P341; Harzhauser Mathias, 1999, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V101, P123; HEWITT RA, 1991, CRETACEOUS RES, V12, P47, DOI 10.1016/0195-6671(91)90026-9; Hirano H., 1991, SAITO HOON KAI SPECI, V3, P201; House M.R., 1988, CEPHALOPODS PRESENT, P1; Jeletzky J.A., 1966, PALEONTOLOGICAL CONT, V7, P1; Klug C, 2001, ACTA PALAEONTOL POL, V46, P43; Klug C, 2005, LETHAIA, V38, P173, DOI 10.1080/00241160510013303; Kubodera T., 2005, MANUAL IDENTIFICATIO; Larson Neal L., 2010, Ferrantia, V59, P78; Lehmann U., 1976, AMMONITEN IHR LEBEN; Lehmann U., 1980, THE AMMONOIDEA, P275; Lehmann U., 1990, AMMONOIDEEN; Logan W.N, 1898, U KANSAS GEOLOGICAL, V4, P431; Lowenstam H.A., 1984, PALEOBIOLOGY, V10, P269; Mapes R.H., 2010, CEPHALOPODS PRESENT, P155; Moriya Kazuyoshi, 2001, Journal of the Geological Society of Japan, V107, P199; Naef A., 1923, CEPHALOPODEN FAUNA 1, V1; Naef A., 1921, MITTEILUNGEN ZOOLOGI, V22, P527; Naef A., 1922, FOSSILEN TINTENFISCH; Naef A., 1916, Pubblicazioni della Stazione Zoologica di Napoli Milano, V1; Neige Pascal, 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P393; NICHOLLS EL, 1987, J PALEONTOL, V61, P727; Nixon M., 1988, THE MOLLUSCA, V12, P103; HUNT S, 1981, COMP BIOCHEM PHYS B, V68, P535, DOI 10.1016/0305-0491(81)90071-7; Okamoto Takashi, 2003, Journal of the Geological Society of Japan, V109, P363; Orbigny A. d', 1834, VOYAGES AMERIQUE MER, V3; Pickford GE, 1949, DANA REP, V32, P1; Robson C. W., 1887, T P NZ I, V19, P155; Robson G.C., 1929, MONOGRAPHY RECENT CE; Rohlf F., 2010, TPSRELW THIN PLATE S; Rohlf FJ, 1996, NATO ADV SCI INST SE, V284, P117; ROHLF F.J., 1993, CONTRIBUTIONS MORPHO, V8, P131; Rohlf FJ, 2003, SYST BIOL, V52, P66, DOI 10.1080/10635150390132759; SAUNDERS W B, 1978, Palaeontology (Oxford), V21, P129; Saunders W.B., 1979, P333; Slice DE, 1996, ADV MORPHOMETRICS, P531; Starobogatov Ya.I., 1983, P4; Stilwell J.D., 1987, ANTARCT J US, V12, P9; Tanabe Kazushige, 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P157; Tanabe K, 2010, PALEONTOL RES, V14, P145, DOI 10.2517/1342-8144-14.2.145; Tanabe Kazushige, 1999, P245; Tanabe K., AMMONOID PA IN PRESS; Ubukata T, 2003, BIOL J LINN SOC, V79, P285, DOI 10.1046/j.1095-8312.2003.00144.x; Ubukata T, 2010, LETHAIA, V43, P266, DOI 10.1111/j.1502-3931.2009.00191.x; Ubukata T., 2004, GEOSCIENCE REPORTS S, V31, P65; Vecchione M, 1999, LETHAIA, V32, P113; VONBOLETZKY S, 1992, REV SUISSE ZOOL, V99, P755; von Fioroni P., 1981, ZOOLOGISCHE JB, V108, P178; WAAGE KARL M., 1965, POSTILLA [YALE PEABODY MUS], V94, P1; Warnke KM, 2011, MOL PHYLOGENET EVOL, V58, P390, DOI 10.1016/j.ympev.2010.11.024; Wetzel W., 1930, PALAEONTOGRAPHICA, V73, P49; Whiteaves J.F., 1897, CANADIAN RECORD SCI, V7, P459; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, P443	104	0	0	INST PALEOBIOLOGII PAN	WARSAW	UL TWARDA 51/55, 00-818 WARSAW, POLAND	0567-7920	1732-2421		ACTA PALAEONTOL POL	Acta Palaeontol. Pol.	MAR	2015	60	1					27	38		10.4202/app.00057.2013		12	Paleontology	Paleontology	CD4UY	WOS:000351081500003		
J	Murakami, M; Shimada, C; Hikida, Y; Hirano, H				Murakami, Mizuki; Shimada, Chieko; Hikida, Yoshinori; Hirano, Hiromichi			New fossil remains from the Pliocene Koetoi Formation of northern Japan provide insights into growth rates and the vertebral evolution of porpoises	ACTA PALAEONTOLOGICA POLONICA			English	Article						Mammalia; Phocoenidae; age estimation; growth rate; vertebral evolution; Pliocene; Japan	PHOCOENA-PHOCOENA; NEOPHOCAENA-PHOCAENOIDES; UPPER MIOCENE; CETACEA; SKELETON; ODONTOCETI; HOKKAIDO; DELPHINOIDEA; MORPHOLOGY; OSTEOLOGY	Extant porpoises (Phocoenidae) are odontocetes characterized by their small size, short and wide rostrum, late (or absent) completion of epiphyseal ankylosis in the vertebral column (= physical maturity), and short life cycles, all of which are thought to have resulted from progenetic evolution. We describe a small fossil phocoenid from the lower Pliocene Koetoi Formation of Hokkaido (northern japan), preserving a small, narrow rostrum, as well as anteroposteriorly elongate thoracic and lumbar vertebral centra with completely fused epiphyses. Physical maturity hi this specimen occurred significantly earlier than in extant phocoenids, as shown by dental data indicating that the specimen died at only four years of age. The difference between the present material and extant porpoises may be attributable to different growth rates during ontogeny. The long centra and caudally inclined neural spines of the specimen from Hokkaido are primitive characters among phocoenids. By contrast, the great height of its neural spines is highly derived, even among extant species, and suggestive of a fast swimmer. In terms of its vertebral morphology, the new specimen falls within a morphological continuum defined by the archaic Numataphocoena yamashitai and the highly derived vertebral morphology of Phocoenoides dalli. Phocoenid vertebral evolution has been complex and frequently convergent, as opposed to stepwise and unidirectional. The different vertebral morphologies of the new specimen and the contemporaneous extinct taxa Numataphocoena and Piscolithax longirostris indicate that they were adapted to different environments.	[Murakami, Mizuki] Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Earth Sci, Shinjuku Ku, Tokyo 1698050, Japan; [Shimada, Chieko] Akita Univ, Mineral Ind Museum, Akita 0108502, Japan; [Shimada, Chieko] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Hikida, Yoshinori] Nakagawa Museum Nat Hist, Nakagawa, Hokkaido 0982626, Japan; [Hirano, Hiromichi] Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Earth Sci, Tokyo 1698050, Japan	Murakami, M (reprint author), Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Earth Sci, Shinjuku Ku, Nishiwaseda 1-6-1, Tokyo 1698050, Japan.	mizuki-m@aoni.waseda.jp; c-shimada@aist.go.jp; nmhikida@coral.ocn.ne.jp			Calvert Marine Museum	The authors thank Christine Argot and Christian De Muizon (both MNHN), Lawrence Barnes, James Dine, David Janiger, Samuel MacLeod (all LACM), Giovanni Bianucci and Chiara Sorbini (both Universita di Pisa, Pisa, Italy), David Bohaska, James Mead, Charles Potter, John Ososky, Nicholas Pyenson (all USNM), Elisabetta Cioppi (Museo di Geologia e Paleontologia dell'Universita di Firenze, Firenze, Italy), Thomas Demere and Kesler Randall (both San Diego Natural History Museum, San Diego, USA), Ewan Fordyce (Otago University, New Zealand), Hitoshi Furusawa (Sapporo Museum Activity Center, Sapporo, Japan), Judith Galkin and Eileen Westwig (both American Museum of Natural History, New York, USA), Stephen Godfrey (Calvert Marine Museum, Solomons, USA), Patricia Holroyd (University of California Museum of Paleontology, Berkley, USA), Hiroto Ichishima (Fukui Prefectural Dinosaur Museum, Katsuyama, japan), Toshiyuki Kimura (Gunma Museum of Natural History, Tomioka, Japan), Yoshiki Koda (Ibaraki Nature Museum, Bando, Japan), Naoki Kohno, Nozomi Kurihara, Manami Makara, Yuko Tajima, Tadasu Yamada, Akiko Yatabe NMNS), Olivier Lambert (Institut royal des Sciences naturelles de Belgique, Brussels, Belgium), Miki Mizushima and Yuhji Soeda (both Historical Museum of Hokkaido, Sapporo, Japan), Daniele Ormezzano (Museo Geopalaeontologico, Universita di Torino, Torino, Italy), Gianluca Raineri (Museo Palaeontologico di Salsomaggiore Terme, Salsomaggiore Terme, Italy), Carlo Sarti and Gian Vai (both Museo Geopaleontologico G. Capellini, Universita di Bologna, Bologna, Italy), Satoshi Shinohara (Numata Fossil Museum, Numata, Japan), Gary Takeuchi (George C. Page Museum, Los Angeles, USA), Yasemin Tulu (Holland Museum, Holland, USA), and Roberto Zorzin (Musco Civico di Storia Naturale di Verona, Verona, Italy) for access to the specimens under their care and valuable suggestions. The authors are grateful to Ichiro Iwasaki (Saitama, Japan) for helping to prepare the thin section and Shinya Miyata and Kazuma Seike (both Waseda University, Tokyo, Japan) for counting growth layers of a tooth. The authors are thankful to Donald Hurlbert, Barbara Watanabe (both USNM), the Calvert Marine Museum, and the Clarissa and Lincoln Dryden Endowment for Paleontology at the Calvert Marine Museum for their financial support. The authors acknowledge Anders Galatius (Aarhus University, Roskilde, Denmark), an anonymous reviewer and editors Felix G. Marx (NMNS) and Mark D. Uhen (George Mason University, Virginia, USA) for reviews that greatly enhanced the manuscript.	Buchholtz EA, 2001, J ZOOL, V253, P175, DOI 10.1017/S0952836901000164; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; FISH FE, 1991, MAMMAL REV, V21, P181, DOI 10.1111/j.1365-2907.1991.tb00292.x; Hulbert RC, 1998, J PALEONTOL, V72, P907; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Buchholtz EA, 2004, ZOOL J LINN SOC-LOND, V140, P383, DOI 10.1111/j.1096-3642.2003.00105.x; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4; Racicot RA, 2014, CURR BIOL, V24, P774, DOI 10.1016/j.cub.2014.02.031; Long JH, 1997, J EXP BIOL, V200, P65; BARNES LG, 1985, MAR MAMMAL SCI, V1, P149, DOI 10.1111/j.1748-7692.1985.tb00003.x; Brisson MJ, 1762, REGNUM ANIMALE CLASS; Brownell Jr R.L., 1984, MAMMALIAN SPECIES, V227, P1; BROWNELL R L JR, 1975, Mammalian Species, V66, P1; Brownell Jr R.L., 1983, MAMMALIAN SPECIES, V193, P1; Buchholtz EA, 2005, MAR MAMMAL SCI, V21, P411, DOI 10.1111/j.1748-7692.2005.tb01241.x; Buchholtz EA, 1998, ADV VERT PALEOBIOL, P325; Burmeister H., 1865, P ZOOL SOC LOND, V1865, P228; Cuvier G., 1829, REGNE ANIMAL DISTRIB; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferrero RC, 1999, MAR MAMMAL SCI, V15, P273, DOI 10.1111/j.1748-7692.1999.tb00803.x; Flower WH, 1867, T ZOOL SOC LONDON, V6, P87; Fukusawa H., 1985, J GEOLOGICAL SOC JAP, V91, P883; Fukusawa H., 1992, MEMOIR GEOLOGICAL SO, V37, P1; Galatius A, 2011, J MORPHOL, V272, P136, DOI 10.1002/jmor.10900; Galatius A, 2003, CAN J ZOOL, V81, P1851, DOI 10.1139/Z03-181; Galatius A, 2005, J ANAT, V206, P141, DOI 10.1111/j.1469-7580.2005.00381.x; Galatius A, 2006, ACTA ZOOL-STOCKHOLM, V87, P77, DOI 10.1111/j.1463-6395.2006.00223.x; GASKIN D E, 1974, Mammalian Species, V42, P1; Gray J.E, 1825, PHILOS ANN, V26, P337; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; Gurevich V.S., 1980, INT WHALING COMMISSI, V3, P165; Heyning J.E., 1988, MAMMALIAN SPECIES, V304, P1, DOI DOI 10.2307/3504225; Hoyanagi K., 1986, ASS GEOLOGICAL COLLA, V31, P265; Ichishima H, 2006, J PALEONTOL, V80, P367, DOI 10.1666/0022-3360(2006)080[0367:TOROEC]2.0.CO;2; Ichishima H, 2000, J VERTEBR PALEONTOL, V20, P561, DOI 10.1671/0272-4634(2000)020[0561:ANFPCD]2.0.CO;2; Ichishima H, 2009, MAR MAMMAL SCI, V25, P855, DOI 10.1111/j.1748-7692.2009.00293.x; Ichishima H, 2005, J VERTEBR PALEONTOL, V25, P655, DOI 10.1671/0272-4634(2005)025[0655:HTANEP]2.0.CO;2; International Whaling Commission, 1969, REPORTS INT WHALING, V19, P131; Jefferson TA, 1988, MAMMALIAN SPECIES, V319, P1; Jefferson Thomas A., 2004, Mammalian Species, P1; Kasuya T, 1978, SCI REP WHALES RES, V30, P1; Kasuya T., 1983, SCI EXPT, V1983, P47; Kohono N., 2002, B NAKAGAWA MUSEUM NA, V5, P23; Lahille F., 1912, ANALES MUSEO NAT HIS, V23, P269; Lambert O, 2008, NEUES JAHRB GEOL P-A, V250, P157, DOI 10.1127/0077-7749/2008/0250-0157; Leatherwood S., 1986, MARINE MAMMALS E N P, P110; Linnaeus C., 1758, SYSTEMA NATURAE REGN; Maddison WP, 2010, MESQUITE MODULAR SYS; DEMUIZON C, 1983, CR ACAD SCI II, V296, P1203; Muizon C. de, 1988, I FRANCAIS ETUDES AN, V78, P1; DEMUIZON C, 1986, CR ACAD SCI II, V303, P1509; Muizon C. de, 1984, I FRANCAIS ETUDES AN, V50, P1; Murakami M, 2012, J VERTEBR PALEONTOL, V32, P1157, DOI 10.1080/02724634.2012.677299; Murakami M, 2012, J VERTEBR PALEONTOL, V32, P1172, DOI 10.1080/02724634.2012.694337; Myrick Jr A.C., 1979, THESIS U CALIFORNIA; NOBLE BA, 1971, J NAT HIST, V5, P447, DOI 10.1080/00222937100770311; NORRIS KENNETH S., 1958, JOUR MAMMAL, V39, P22, DOI 10.2307/1376606; Pallas P.S., 1776, REISE DURCH VERSCHIE, V2; Perrin WF, 1975, B SCRIPPS I OCEANOGR, V21, P1; Perrin W.F., 1980, INT WHALING COMM, V3, P1; Perrin William F., 2001, Mammalian Species, V683, P1, DOI 10.1644/1545-1410(2001)683<0001:SA>2.0.CO;2; Pierce K.V., 1980, INT WHALING COMMISSI, V3, P99; Pilleri G., 1989, P193; Sagayama T., 1993, EARTH SCI, V47, P423; Shimada C., 1998, B NAKAGAWA MUSEUM NA, V1, P103; Slijper E.J., 1961, S ZOOL SOC LOND, V5, P77; Slijper E.J., 1936, CAPITA ZOOLOGICA, V6-7, P1; Stacey Pam J., 1994, Mammalian Species, V456, P1; Stewart BE, 1989, MAMMALIAN SPECIES, V336, P1; Swofford D.L., 1998, PAUP PHYLOGENETIC AN; Tomida Y., 1992, MEMOIRS NATL SCI MUS, V25, P49; True F.W., 1885, B US NATL MUSEUM, V8, P95; True F.W., 1908, B MUS COMP ZOOL HARV, V52, P5; Uyeno T., 1992, MEMOIRS NATL SCI MUS, V25, P41; West K.L., 2011, MAMMALIAN SPECIES, V43, P177; WILSON L E, 1973, University of California Publications in Geological Sciences, V103, P1; Yanagisawa Yu., 1998, J GEOLOGICAL SOC JAP, V104, P395, DOI DOI 10.5575/GE0S0C.104.395; Yasue A., 2006, J GEOLOGICAL SOC JAP, V112, P284; YOSHIDA H, 1994, MAR MAMMAL SCI, V10, P266, DOI 10.1111/j.1748-7692.1994.tb00482.x	80	1	1	INST PALEOBIOLOGII PAN	WARSAW	UL TWARDA 51/55, 00-818 WARSAW, POLAND	0567-7920	1732-2421		ACTA PALAEONTOL POL	Acta Palaeontol. Pol.	MAR	2015	60	1					97	111		10.4202/app.2012.0127		15	Paleontology	Paleontology	CD4UY	WOS:000351081500008		
J	Oguro, M; Sakai, S				Oguro, Michio; Sakai, Satoki			RELATION BETWEEN FLOWER HEAD TRAITS AND FLORIVORY IN ASTERACEAE: A PHYLOGENETICALLY CONTROLLED APPROACH	AMERICAN JOURNAL OF BOTANY			English	Article						Asteraceae; biochemical traits; floral defense; floral display; floral herbivory; floral traits; florivory; interspecific comparison; morphological traits; phenolics	DISPERSAL SEED PREDATION; PLANT-POLLINATOR INTERACTIONS; FEMALE REPRODUCTIVE SUCCESS; FLORAL HERBIVORY; COMPARATIVE BIOLOGY; INSECT HERBIVORES; ERYSIMUM-MEDIOHISPANICUM; NEMOPHILA-MENZIESII; ANIMAL INTERACTIONS; DEFENSE STRATEGIES	Premise of the study: While much research has examined the relation between leaf traits and herbivory, very little is known about the interaction between floral traits, particularly biochemical traits, and florivory. We investigated patterns between floral traits and florivory across multiple species using phylogenetic comparative approaches to enhance our understanding of the evolution of plant-florivore interactions. Methods: The relation between the intensity of florivory and five biochemical traits (concentrations of carbon, nitrogen, phosphorus, water, and total phenolics) and two morphological traits (diameter and number of flower heads) were investigated in wild individuals of 18 native species of Asteraceae. The phylogenetic signals in the morphological traits and intensity of florivory were also tested. Key results: We found that species with higher nitrogen, water, and total phenolics and lower phosphorus concentrations in the flower heads and species with a large number and diameter of flower heads tended to be attacked by florivores. In addition, we found significant phylogenetic signals in florivory and morphological traits. Conclusions: Our results clearly show that biochemical traits also play important roles in plant-florivore interactions, as previously shown in plant-leaf herbivore interactions. The positive relationship between florivory and total phenolics implies that phenolic compounds in flower heads may not act as a defense in the species. In addition, the observed pattern of signals in florivory might not be solely explained by the signals of the measured traits and other plant traits may also play significant roles in plant-florivore interaction in these species.	[Oguro, Michio; Sakai, Satoki] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Oguro, M (reprint author), Tohoku Univ, Grad Sch Life Sci, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	mogu@biology.tohoku.ac.jp					Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; GRAFEN A, 1989, PHILOS T ROY SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Kessler A, 2011, ECOLOGY, V92, P1769, DOI 10.1890/10-1945.1; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Conner JK, 1996, OECOLOGIA, V105, P509, DOI 10.1007/BF00330014; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; SCRIBER JM, 1981, ANNU REV ENTOMOL, V26, P183, DOI 10.1146/annurev.en.26.010181.001151; ENGLISHLOEB GM, 1992, OECOLOGIA, V89, P588; Kurokawa H, 2010, FUNCT ECOL, V24, P513, DOI 10.1111/j.1365-2435.2009.01676.x; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Johnson MTJ, 2014, NEW PHYTOL, V203, P267, DOI 10.1111/nph.12763; Carr DE, 2014, ANNU REV ENTOMOL, V59, P185, DOI 10.1146/annurev-ento-011613-162049; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Schuldt A, 2012, ECOL LETT, V15, P732, DOI 10.1111/j.1461-0248.2012.01792.x; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397; Hanley ME, 2009, NEW PHYTOL, V182, P251, DOI 10.1111/j.1469-8137.2008.02709.x; Brody AK, 1997, OECOLOGIA, V110, P86, DOI 10.1007/s004420050136; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Loranger J, 2012, ECOLOGY, V93, P2674, DOI 10.1890/12-0328.1; Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Gelman A, 2006, BAYESIAN ANAL, V1, P515; Cariveau D, 2004, OIKOS, V104, P15, DOI 10.1111/j.0030-1299.2004.12641.x; Herrera CM, 2000, ECOLOGY, V81, P2170, DOI 10.1890/0012-9658(2000)081[2170:MTEOPA]2.0.CO;2; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; Chen Y, 2007, J ECON ENTOMOL, V100, P1821, DOI 10.1603/0022-0493(2007)100[1821:TSMPLD]2.0.CO;2; McCall AC, 2012, OECOLOGIA, V170, P147, DOI 10.1007/s00442-012-2278-z; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Leimu R, 2002, OECOLOGIA, V133, P510, DOI 10.1007/s00442-002-1049-7; LOUDA SM, 1995, ECOLOGY, V76, P229, DOI 10.2307/1940645; Krupnick GA, 1999, ECOLOGY, V80, P125, DOI 10.1890/0012-9658(1999)080[0125:TCOFHF]2.0.CO;2; Johnson MTJ, 2009, P NATL ACAD SCI USA, V106, P18079, DOI 10.1073/pnas.0904695106; Parachnowitsch AL, 2008, ECOLOGY, V89, P1802, DOI 10.1890/07-0555.1; Oguro M, 2014, OECOLOGIA, V174, P227, DOI 10.1007/s00442-013-2765-x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; EHRLEN J, 1992, ECOLOGY, V73, P1820, DOI 10.2307/1940033; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Chen MS, 2008, INSECT SCI, V15, P101, DOI 10.1111/j.1744-7917.2008.00190.x; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; Cornelissen T, 2006, ECOL ENTOMOL, V31, P32, DOI 10.1111/j.0307-6946.2006.00752.x; Losos JB, 2011, AM NAT, V177, P709, DOI 10.1086/660020; Held DW, 2004, OECOLOGIA, V140, P312, DOI 10.1007/s00442-004-1582-7; Goodwillie C, 2010, NEW PHYTOL, V185, P311, DOI 10.1111/j.1469-8137.2009.03043.x; Herrera CM, 2002, P NATL ACAD SCI USA, V99, P16823, DOI 10.1073/pnas.252362799; Ives AR, 2007, SYSTEMATIC BIOL, V56, P252, DOI 10.1080/10635150701313830; McCall AC, 2008, OECOLOGIA, V155, P729, DOI 10.1007/s00442-007-0934-5; Teixido AL, 2011, ACTA OECOL, V37, P418, DOI 10.1016/j.actao.2011.05.007; SCHEMSKE DW, 1988, ECOLOGY, V69, P1128, DOI 10.2307/1941267; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; McCall AC, 2006, OECOLOGIA, V146, P566, DOI 10.1007/s00442-005-0284-0; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Fenner M, 2002, OECOLOGIA, V130, P72, DOI 10.1007/s004420100773; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Gomez JM, 2003, AM NAT, V162, P242, DOI 10.1086/376574; Hadfield JD, 2010, J STAT SOFTW, V33, P1; Armbruster WS, 1997, ECOLOGY, V78, P1661; BERTNESS MD, 1992, AM J BOT, V79, P288, DOI 10.2307/2445017; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; Breadmore KN, 1998, ACTA OECOL, V19, P501, DOI 10.1016/S1146-609X(99)80004-6; BREEDLOV.DE, 1968, SCIENCE, V162, P671, DOI 10.1126/science.162.3854.671; Campbell SA, 2013, P NATL ACAD SCI USA, V110, P3973, DOI 10.1073/pnas.1213867110; CLANCY KM, 1993, ECOLOGY, V74, P442, DOI 10.2307/1939306; COLEY PD, 1987, NEW PHYTOL, V106, P251; Cornelissen T, 2006, ECOSCIENCE, V13, P66, DOI 10.2980/1195-6860(2006)13[66:RODHGT]2.0.CO;2; Eichhorn MP, 2007, BIOTROPICA, V39, P416, DOI 10.1111/j.1744-7429.2007.00264.x; Fenner M, 2001, NEW ZEAL J ECOL, V25, P95; Galen C, 1999, BIOSCIENCE, V49, P631, DOI 10.2307/1313439; Gomez JM, 2005, OECOLOGIA, V143, P412, DOI 10.1007/s00442-004-1809-7; Hanley ME, 2001, OECOLOGIA, V126, P409, DOI 10.1007/s004420000538; HEITHAUS ER, 1982, ECOLOGY, V63, P1294, DOI 10.2307/1938857; Hendriks RJJ, 1999, PLANT ECOL, V143, P141, DOI 10.1023/A:1009832621516; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; KARBAN R, 1993, ECOLOGY, V74, P39, DOI 10.2307/1939499; Krupnick GA, 1999, ECOLOGY, V80, P135, DOI 10.1890/0012-9658(1999)080[0135:TEOFHO]2.0.CO;2; Kudoh H, 1998, OECOLOGIA, V117, P70, DOI 10.1007/s004420050633; LOUDA SM, 1983, ECOLOGY, V64, P511, DOI 10.2307/1939971; Mahoro S, 2003, PLANT ECOL, V166, P37, DOI 10.1023/A:1023203325501; Maron JL, 2002, ECOLOGY, V83, P3382; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Oguro M, 2009, PLANT ECOL, V202, P221, DOI 10.1007/s11258-008-9461-7; Ohashi K, 2000, CAN J BOT, V78, P230, DOI 10.1139/cjb-78-2-230; Perez-Harguindeguy N, 2003, AUSTRAL ECOL, V28, P642, DOI 10.1046/j.1442-9993.2003.01321.x; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; R Core Team, 2014, R LANG ENV STAT COMP; REESE JC, 1982, J CHEM ECOL, V8, P1429, DOI 10.1007/BF00989100; Rey PJ, 2006, J EVOLUTION BIOL, V19, P21, DOI 10.1111/j.1420-9101.2005.00992.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sandring S, 2007, J EVOLUTION BIOL, V20, P558, DOI 10.1111/j.1420-9101.2006.01260.x; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Schoonhoven L. M., 2006, INSECT PLANT BIOL, P99; SCRIBER JM, 1979, ENTOMOL EXP APPL, V25, P240; Tanentzap AJ, 2011, ECOLOGY, V92, P994, DOI 10.1890/10-0861.1; Ushimaru Atushi, 2002, Plant Species Biology, V17, P147, DOI 10.1046/j.1442-1984.2002.00077.x; van Huis A, 2008, ENTOMOL EXP APPL, V127, P144, DOI 10.1111/j.1570-7458.2008.00682.x; WALLACE DD, 1989, OECOLOGIA, V79, P482; Wetzel R. G., 2000, LIMNOLOGICAL ANAL; Whitfeld TJS, 2012, ECOLOGY, V93, pS211, DOI 10.1890/11-0503.1; Wright JW, 2003, ECOLOGY, V84, P2062, DOI 10.1890/02-0676	105	0	0	BOTANICAL SOC AMER INC	ST LOUIS	PO BOX 299, ST LOUIS, MO 63166-0299 USA	0002-9122	1537-2197		AM J BOT	Am. J. Bot.	MAR	2015	102	3					407	416		10.3732/ajb.1400233		10	Plant Sciences	Plant Sciences	CD6OG	WOS:000351208000010		
J	Kuno, T; Kohsaka, S; Numasawa, Y; Ueda, I; Suzuki, M; Nakamura, I; Negishi, K; Ishikawa, S; Maekawa, Y; Kawamura, A; Miyata, H; Fukuda, K				Kuno, Toshiki; Kohsaka, Shun; Numasawa, Yohei; Ueda, Ikuko; Suzuki, Masahiro; Nakamura, Iwao; Negishi, Koji; Ishikawa, Shiro; Maekawa, Yuichiro; Kawamura, Akio; Miyata, Hiroaki; Fukuda, Keiichi			Location of the Culprit Coronary Lesion and Its Association With Delay in Door-to-Balloon Time (from a Multicenter Registry of Primary Percutaneous Coronary Intervention)	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; PRIMARY ANGIOPLASTY; ARTERY-DISEASE; MORTALITY; THROMBOLYSIS; DEPRESSION; GUIDELINES; MANAGEMENT; OUTCOMES	Current guidelines recommend shorter door-to-balloon times (DBTs) (<90 minutes) for patients with ST-elevation myocardial infarction (STEMI). Clinical factors, including patient or hospital characteristics, associated with prolonged DBT have been identified, but angiographic variables such as culprit lesion location have not been thoroughly investigated. We aimed to evaluate the effect of culprit artery location on DBT of patients with STEMI who underwent percutaneous coronary intervention (PCI). Data were analyzed from 1,725 patients with STEMI who underwent PCI from August 2008 to March 2014 at 16 Japanese hospitals. Patients were divided into 3 groups according to culprit artery location, right coronary artery (RCA), left anterior descending artery (LAD), and left circumflex artery (LC), and associations with DBT were assessed. The LC group had a trend toward a longer DBT among the 3 groups (97.1 [RCA] vs 98.1 [LAD] vs 105.1 [LC] minutes; p = 0.058). In-hospital mortality was also significantly higher in patients with a left coronary artery lesion (3.5% [RCA] vs 6.3% [LAD] vs 5.4% [LC]; p = 0.041). Inhospital mortality for patients with DBT >90 minutes was significantly higher compared with patients with DBT 590 minutes (6.5% vs 3.6%; p = 0.006). Multivariate logistic regression analysis revealed that the LC location was an independent predictor for DBT >90 minutes (odds ratio, 1.45; 95% confidence interval, 1.04 to 2.01; p = 0.028). In conclusion, LC location was an independent predictor of longer DBT. The difficulties in diagnosing LC-related STEMI need further evaluation. (C) 2015 Elsevier Inc. All rights reserved.	[Kuno, Toshiki; Numasawa, Yohei] Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga, Tochigi, Japan; [Kohsaka, Shun; Ueda, Ikuko; Maekawa, Yuichiro; Kawamura, Akio; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Suzuki, Masahiro] Saitanaa Natl Hosp, Dept Cardiol, Saitama, Japan; [Nakamura, Iwao] Hino City Hosp, Dept Cardiol, Tokyo, Japan; [Negishi, Koji] Yokohama Municipal Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Ishikawa, Shiro] Saitama City Hosp, Dept Cardiol, Saitama, Japan; [Miyata, Hiroaki] Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan	Kohsaka, S (reprint author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	sk@z3.keio.jp	Fukuda, Keiichi/L-3777-2013		Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI) [25460630, 25460777]	This research was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI No. 25460630 and 25460777). The Japanese Cardiovascular Database Steering Committee was responsible for overall study guidance, including the study protocol, data analyses, and interpretation of results. The Department of Healthcare Quality Assessment at Tokyo University independently managed the database. The KICS Scientific Committee managed the participating sites and provided monthly on-site monitoring services to assure data accuracy and completeness throughout the study. During the planning, implementation, and reporting of this study, there were no issues such as conflicts of interest, conflicts of responsibility, or intellectual property right concerns.	ADGEY AAJ, 1968, LANCET, V2, P1097; Anderson HV, 2007, AM J CARDIOL, V99, P189, DOI 10.1016/j.amjcard.2006.07.083; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Peterson MC, 2012, INT J CARDIOL, V157, P8, DOI 10.1016/j.ijcard.2011.06.042; Kuettner A, 2004, J AM COLL CARDIOL, V43, P831, DOI 10.1016/j.jacc.2003.05.015; Zahn R, 2005, HEART, V91, P1041, DOI 10.1136/hrt.2004.045336; Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Kim SS, 2011, J CARDIOL, V57, P290, DOI 10.1016/j.jjcc.2011.01.014; Ohno Y, 2013, J AM COLL CARDIOL, V62, P1260, DOI 10.1016/j.jacc.2013.03.086; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Krishnaswamy A, 2009, AM HEART J, V158, P706, DOI 10.1016/j.ahj.2009.08.024; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; BODEN WE, 1987, AM J CARDIOL, V59, P782, DOI 10.1016/0002-9149(87)91091-5; Kuno T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072672; Mizuno A, 2014, INT J CARDIOL, V172, P226, DOI 10.1016/j.ijcard.2013.12.225; Numasawa Yohei, 2013, Cardiovasc Interv Ther, V28, P242, DOI 10.1007/s12928-013-0162-3; Numasawa Yohei, 2013, Cardiovasc Interv Ther, V28, P148, DOI 10.1007/s12928-012-0138-8; Oraii S, 1999, J ELECTROCARDIOL, V32, P275, DOI 10.1016/S1053-0770(99)90068-X; Pride YB, 2010, JACC-CARDIOVASC INTE, V3, P806, DOI 10.1016/j.jcin.2010.05.012; Rathore SS, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1807; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Stem S., 2009, CIRCULATION, V119, P2531; Stribling WK, 2011, AM J CARDIOL, V108, P959, DOI 10.1016/j.amjcard.2011.05.027; TENENBAUM A, 1995, J AM COLL CARDIOL, V25, P1558, DOI 10.1016/0735-1097(95)00041-2; Waldo SW, 2013, J INVASIVE CARDIOL, V25, P371; Waldo SW, 2014, AM HEART J, V167, P350, DOI 10.1016/j.ahj.2013.11.011	28	1	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	MAR 1	2015	115	5					581	586		10.1016/j.amjcard.2014.12.004		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD4CG	WOS:000351029600005		
J	Al-Fiadh, AH; Wong, TY; Kawasaki, R; Clark, DJ; Patel, SK; Freeman, M; Wilson, A; Burrell, LM; Farouque, O				Al-Fiadh, Ali H.; Wong, Tien Y.; Kawasaki, Ryo; Clark, David J.; Patel, Sheila K.; Freeman, Melanie; Wilson, Andrew; Burrell, Louise M.; Farouque, Omar			Usefulness of Retinal Microvascular Endothelial Dysfunction as a Predictor of Coronary Artery Disease	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							ATHEROSCLEROSIS RISK; HEART-DISEASE; NITRIC-OXIDE; BLOOD-FLOW; COMMUNITIES; RETINOPATHY; HUMANS; WOMEN	Endothelial dysfunction is a key feature of atherosclerosis. Retinal microvascular endothelial function can be assessed using noninvasive dynamic vessel imaging techniques. Whether it is impaired in subjects with coronary artery disease (CAD) is unknown. The aim of this study was to examine the relation of retinal microvascular endothelial function with CAD. Vascular studies were performed in 197 prospectively recruited subjects divided into 2 groups: those without CAD but >= 2 cardiovascular risk factors (non-CAD controls; n = 119) and those with stable CAD (n = 78). Retinal microvascular endothelial dysfunction was assessed by measuring retinal arteriolar and venular dilatation to flicker light, a nitric oxide dependent phenomenon, expressed as percentage increase baseline diameter. Fingertip pulse-volume amplitude was measured to calculate reactive hyperaemia index and brachial artery flow-mediated dilatation assessed as measures of peripheral microvascular and conduit vessel endothelial function, respectively. Mean retinal arteriolar dilatation was attenuated in patients with CAD compared with non-CAD controls (1.51 +/- 1.51% vs 2.37 +/- 1.95%, p = 0.001). Retinal arteriolar dilatation was independently associated with CAD after adjustment for age, gender, cardiovascular risk factors, and medication use (odds ratio 1.60, 95% confidence interval 1.14 to 2.25, p = 0.007). Reactive hyperaemia index and flow-mediated dilatation were not different. In conclusion, the capacity of retinal arterioles to dilate in response to fficker light is an independent predictor of the presence of CAD and suggests that retinal microvascular endothelial dysfunction is a marker for underlying CAD. (c) 2015 Elsevier Inc. All rights reserved.	[Al-Fiadh, Ali H.; Clark, David J.; Burrell, Louise M.; Farouque, Omar] Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia; [Al-Fiadh, Ali H.; Clark, David J.; Patel, Sheila K.; Freeman, Melanie; Wilson, Andrew; Burrell, Louise M.; Farouque, Omar] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Wong, Tien Y.; Kawasaki, Ryo] Ctr Eye Res Australia, East Melbourne, Australia; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Kawasaki, Ryo] Yamagata Univ, Dept Publ Hlth, Yamagata 990, Japan	Farouque, O (reprint author), Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia.	omar.farouque@austin.org.au		Patel, Sheila/0000-0002-0626-1899	National Health and Medical Research Council (NHMRC); National Heart Foundation of Australia [567147, G 08M 3781]	Funding sources: Dr Al-Fiadh was supported by a co-funded Postgraduate Scholarship from the National Health and Medical Research Council (NHMRC) and National Heart Foundation of Australia (ID 567147). This work was supported in part by a Grant-in-Aid from the National Heart Foundation of Australia (G 08M 3781).	Al-Fiadh AH, 2014, ATHEROSCLEROSIS, V233, P478, DOI 10.1016/j.atherosclerosis.2013.12.044; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Woodman RJ, 2001, J APPL PHYSIOL, V91, P929; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Liew G, 2008, CIRC-CARDIOVASC IMAG, V1, P156, DOI 10.1161/CIRCIMAGING.108.784876; Matsuzawa Y, 2010, J AM COLL CARDIOL, V55, P1688, DOI 10.1016/j.jacc.2009.10.073; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Green DJ, 2011, HYPERTENSION, V57, P363, DOI 10.1161/HYPERTENSIONAHA.110.167015; Dorner GT, 2003, AM J PHYSIOL-HEART C, V285, pH631, DOI 10.1152/ajpheart.00111.2003; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Polak K, 2003, EXP EYE RES, V76, P633, DOI 10.1016/S0014-4835(02)00312-3; Anderson TJ, 2011, CIRCULATION, V123, P163, DOI 10.1161/CIRCULATIONAHA.110.953653; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Pemp B, 2009, DIABETES CARE, V32, P1536, DOI 10.2337/dc08-2130; Lind L, 2011, CIRCULATION, V123, P1545, DOI 10.1161/CIRCULATIONAHA.110.984047; Early Treatment Diabetic Retinopathy Study Research Group, 1991, OPHTHALMOLOGY, V98, P786; Garhofer G, 2005, AM J OPHTHALMOL, V140, P69, DOI 10.1016/j.ajo.2005.02.016; Kawasaki R, 2012, STROKE, V43, P3245, DOI 10.1161/STROKEAHA.112.673335; Kotliar KE, 2011, MICROVASC RES, V81, P123, DOI 10.1016/j.mvr.2010.11.007; Kreis AJ, 2009, MICROCIRCULATION, V16, P177, DOI 10.1080/10739680802458980; Reimann M, 2009, ATHEROSCLEROSIS SUPP, V10, P39, DOI 10.1016/S1567-5688(09)71808-2; Seifertl B U, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 2, P678, DOI 10.1515/bmte.2002.47.s1b.678; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63	27	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	MAR 1	2015	115	5					609	613		10.1016/j.amjcard.2014.12.011		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD4CG	WOS:000351029600009		
J	Nagayama, O; Koike, A; Himi, T; Sakurada, K; Kato, Y; Suzuki, S; Sato, A; Yamashita, T; Wasserman, K; Aonuma, K				Nagayama, Osamu; Koike, Akira; Himi, Tomoko; Sakurada, Koji; Kato, Yuko; Suzuki, Shinya; Sato, Akira; Yamashita, Takeshi; Wasserman, Karlman; Aonuma, Kazutaka			Clinical Significance of a Spiral Phenomenon in the Plot of CO2 Output Versus O-2 Uptake During Exercise in Cardiac Patients	AMERICAN JOURNAL OF CARDIOLOGY			English	Article							HEART-FAILURE; GAS-EXCHANGE; ANAEROBIC THRESHOLD; ASSOCIATION; SEVERITY; DISEASE	A spiral phenomenon is sometimes noted in the plots of CO2 output (VCO2) against O-2 uptake (VO2) measured during cardiopulmonary exercise testing (CPX) in patients with heart failure with oscillatory breathing. However, few data are available that elucidate the clinical significance of this phenomenon. Our group studied the prevalence of this phenomenon and its relation to cardiac and cardiopulmonary function. Of 2,263 cardiac patients who underwent CPX, 126 patients with a clear pattern of oscillatory breathing were identified. Cardiopulmonary indexes were compared between patients who showed the spiral phenomenon (n = 49) and those who did not (n = 77). The amplitudes of VO2 and VCO2 oscillations were greater and the phase difference between VO2 and VCO2 oscillations was longer in the patients with the spiral phenomenon than in those without it. Patients with the spiral phenomenon also had a lower left ventricular ejection fraction (43.4 +/- 21.4% vs 57.1 +/- 16.8%, p <0.001) and a higher level of brain natriuretic peptide (637.2 +/- 698.3 vs 228.3 +/- 351.4 pg/ml, p = 0.002). The peak VO2 was lower (14.5 +/- 5.6 vs 18.1 +/- 6.3, p = 0.002), the slope of the increase in ventilation versus VCO2 was higher (39.8 +/- 9.5 vs 33.6 +/- 6.8, p <0.001), and end-tidal PCO2 both at rest and at peak exercise was lower in the patients with the spiral phenomenon than in those without it. In conclusion, the spiral phenomenon in the VCO2-versus-VO2 plot arising from the phase difference between VCO2 and VO2 oscillations reflects more advanced cardiopulmonary dysfunction in cardiac patients with oscillatory breathing. (c) 2015 Elsevier Inc. All rights reserved.	[Nagayama, Osamu; Sakurada, Koji; Kato, Yuko; Suzuki, Shinya; Yamashita, Takeshi] Cardiovasc Inst, Tokyo, Japan; [Nagayama, Osamu; Himi, Tomoko] Univ Tsukuba, Inst Clin Med, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan; [Koike, Akira] Univ Tsukuba, Med Sci, Fac Med, Tsukuba, Ibaraki, Japan; [Koike, Akira; Sato, Akira; Aonuma, Kazutaka] Univ Tsukuba, Inst Clin Med, Cardiol Div, Fac Med, Tsukuba, Ibaraki 305, Japan; [Himi, Tomoko] Kawaguchi Kogyo Gen Hosp, Kawaguchi, Saitama, Japan; [Wasserman, Karlman] Harbor UCLA Med Ctr, Torrance, CA 90509 USA	Koike, A (reprint author), Univ Tsukuba, Med Sci, Fac Med, Tsukuba, Ibaraki, Japan.	koike@md.tsukuba.ac.jp					YAJIMA T, 1994, CHEST, V106, P142, DOI 10.1378/chest.106.1.142; Kato J, 2013, CIRC J, V77, P661, DOI 10.1253/circj.CJ-12-0925; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Chua TP, 1997, J AM COLL CARDIOL, V29, P1585; METRA M, 1992, AM J CARDIOL, V70, P622, DOI 10.1016/0002-9149(92)90202-A; Matsumoto A, 2000, J AM COLL CARDIOL, V36, P242, DOI 10.1016/S0735-1097(00)00702-6; BENDOV I, 1992, AM REV RESPIR DIS, V145, P776; CASABURI R, 1977, J APPL PHYSIOL, V42, P300; ITOH H, 1989, JPN CIRC J, V53, P146; Kano H, 2012, CIRC J, V76, P79, DOI 10.1253/circj.CJ-11-0599; Koike A, 2002, CHEST, V121, P1581, DOI 10.1378/chest.121.5.1581; Mimi T, 2013, CIRC J SI, V77, pI; Murphy RM, 2011, CIRCULATION, V124, P1442, DOI 10.1161/CIRCULATIONAHA.111.024141; Shimizu N, 1999, JPN CIRC J, V63, P459, DOI 10.1253/jcj.63.459; Wasserman K, 2012, PRINCIPLES EXERCISE	15	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9149	1879-1913		AM J CARDIOL	Am. J. Cardiol.	MAR 1	2015	115	5					691	696		10.1016/j.amjcard.2014.12.026		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CD4CG	WOS:000351029600024		
J	Tokunaga, T; Ninomiya, T; Osawa, Y; Imoto, Y; Ito, Y; Takabayashi, T; Narita, N; Kijima, A; Murota, H; Katayama, I; Fujieda, S				Tokunaga, Takahiro; Ninomiya, Takahiro; Osawa, Yoko; Imoto, Yoshimasa; Ito, Yumi; Takabayashi, Tetsuji; Narita, Norihiko; Kijima, Akiko; Murota, Hiroyuki; Katayama, Ichiro; Fujieda, Shigeharu			Superoxide dismutase reduces the inflammatory response to Aspergillus and Alternaria in human sinonasal epithelial cells derived from patients with chronic rhinosinusitis	AMERICAN JOURNAL OF RHINOLOGY & ALLERGY			English	Article							ALLERGIC RHINITIS; CHILDHOOD ISAAC; ATOPIC-DERMATITIS; WORLDWIDE VARIATIONS; JAPANESE GUIDELINE; PROPENSITY SCORE; ASTHMA; PREVALENCE; SYMPTOMS; RATIONALE	Background: Aspergillus fumigatus and Alternaria alternata are ubiquitous environmental fungal allergens that can exacerbate airway inflammation and contribute to the disease process in patients with chronic rhinosinusitis (CRS). These antigens have been shown to induce human sinonasal epithelial cells (HSNECs) to promote a proinflammatory response, but what is unclear is a means by which to reduce these effects. Inhaled pathogens can induce HSNECs to produce reactive oxygen species (ROS) that trigger cytokine production. Objective: This study aimed to determine whether the free radical scavenger superoxide dismutase (SOD) could reduce HSNEC-derived inflammation, as measured by interleukin (IL)-6 and IL-8 production, in response to Aspergillus or Alternaria exposure. Methods: Sinus tissue explants were collected at the time of surgery from control patients (n = 7) and patients with CRS with nasal polyps (CRSwNP) (n = 9). HSNECs were cultured from the explants and treated with Aspergillus, Alternaria, and SOD for 24 hours. Cell supernatants and lysates were collected, and IL-6 and IL-8 concentrations were measured using enzyme-linked immunosorbent assay. Results: In control and CRSwNP HSNECs, Aspergillus and Alternaria both increased cytokine production (p < 0.05), as measured by IL-6 and IL-8 concentration. SOD treatment reduced the inflammatory response to fungal antigen exposure from CRSwNP HSNECs but not control HSNECs. In CRSwNP patients, SOD significantly decreased IL-6 and IL-8 production after Alternaria exposure and IL-8 after Aspergillus exposure (p < 0.05). Conclusions: When HSNECs from CRSwNP patients are treated with SOD concurrently with Aspergillus or Alternaria, SOD treatment decreases the fungal antigen-induced inflammatory response. The ability to attenuate inflammation induced by common fungal allergens with SOD treatment could provide a novel therapeutic or preventative approach for patients with CRS or other allergic inflammatory airway diseases.	[Tokunaga, Takahiro; Ninomiya, Takahiro; Imoto, Yoshimasa; Ito, Yumi; Takabayashi, Tetsuji; Narita, Norihiko; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, Fukui 9101193, Japan; [Osawa, Yoko] Fukui Red Cross Hosp, Div Otorhinolaryngol, Fukui, Japan; [Kijima, Akiko; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, Osaka, Japan	Tokunaga, T (reprint author), Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, 23-3 Matsuoka Shimoaizuki,Eiheiji Cho, Fukui 9101193, Japan.	t-toku3@nifty.com			Japanese Ministry of Health, Labor, and Welfare [H25-Immunology-general-006, H25-Immunology-general-007]; Japanese Ministry of Education, Culture, Sports, Science, and Technology [23390397]	This study was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor, and Welfare (H25-Immunology-general-006, -007) and from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (23390397)	Fujieda S, 2012, AURIS NASUS LARYNX, V39, P553, DOI 10.1016/j.anl.2011.12.006; Cullinan P, 2003, EUR RESPIR J, V22, P956, DOI 10.1183/09031936.03.00039102; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Strachan DP, 1997, PEDIATR ALLERGY IMMU, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Kinra S, 2006, THORAX, V61, P48, DOI 10.1136/thx.2004.034595; STRACHAN DP, 1989, BRIT MED J, V299, P1259; Weizman Z, 2005, PEDIATRICS, V115, P5, DOI 10.1542/peds.2004-1815; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; [Anonymous], 2012, BAS SURV REP SCH JAP; Bergmann RL, 1997, ENVIRON TOXICOL PHAR, V4, P79, DOI 10.1016/S1382-6689(97)10045-X; DaVeiga SP, 2012, ALLERGY ASTHMA PROC, V33, P227, DOI 10.2500/aap.2012.33.3569; Viljanen M, 2005, ALLERGY, V60, P494, DOI 10.1111/j.1398-9995.2004.00514.x; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Caballer BD, 2012, AM J RHINOL ALLERGY, V26, P390, DOI 10.2500/ajra.2012.26.3799; Grimalt R, 2007, DERMATOLOGY, V214, P61, DOI 10.1159/000096915; Meltzer Eli O, 2012, Allergy Asthma Proc, V33 Suppl 1, pS113, DOI 10.2500/aap.2012.33.3603; Ozdemir O, 2010, ALLERGY ASTHMA PROC, V31, P103, DOI 10.2500/aap.2010.31.3313; Paunio M, 2000, JAMA-J AM MED ASSOC, V283, P343, DOI 10.1001/jama.283.3.343; PEARCE N, 1993, EUR RESPIR J, V6, P1455; Saeki H, 2009, J DERMATOL, V36, P563, DOI 10.1111/j.1346-8138.2009.00706.x; Sajić D, 2012, Skin Therapy Lett, V17, P6; The Allergic Disease Surveillance Committee, 2007, AN EV EP RES EV DIS, P14; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002	30	1	2	OCEAN SIDE PUBLICATIONS INC	PROVIDENCE	95 PITMAN ST, PROVIDENCE, RI 02906 USA	1945-8924	1945-8932		AM J RHINOL ALLERGY	Am. J. Rhinol. Allergy	MAR-APR	2015	29	2					94	99		10.2500/ajra.2015.29.4135		6	Otorhinolaryngology	Otorhinolaryngology	CE3HL	WOS:000351717200008		
J	Ono, H; Ohtani, N; Matoba, A; Kido, K; Yasui, Y; Masaki, E				Ono, Hitomi; Ohtani, Norimasa; Matoba, Atsuko; Kido, Kanta; Yasui, Yutaka; Masaki, Eiji			Efficacy of Intrathecal Esmolol on Heat-Evoked Responses in a Postoperative Pain Model	AMERICAN JOURNAL OF THERAPEUTICS			English	Article						esmolol; intrathecal; postoperative pain	SUBSTANTIA-GELATINOSA; G-PROTEINS; RAT; ANESTHESIA; PROPOFOL; BLOCKADE; NEURONS	Perioperative tachycardia and hypertension are often treated with esmolol, a short-acting (1)-adrenoceptor antagonist. Besides its cardiac effect, esmolol is reported to exert antinociceptive effects. This study examined the efficacy of intrathecal (IT) esmolol on pain responses in a postoperative pain model. Male Sprague-Dawley rats (250-300 g) were anesthetized with sevoflurane and an IT catheter was implanted. Six days after catheter implantation, a postoperative pain model was established by plantar incision under sevoflurane anesthesia. Withdrawal latencies were assessed by applying a focused radiant heat source before plantar incision; 1 day after the incision (before esmolol administration); and 5, 10, and 15 minutes after bolus administration of IT esmolol. Plantar incision produced hypersensitivity in the postoperative pain model expressed as decreased withdrawal latency to heat stimulation (before incision: 13.9 +/- 0.29 seconds and 1 day after incision: 6.3 +/- 0.26 seconds). These decreased latencies caused by incision were significantly increased by esmolol administration (40 g, 80 g) at 5 minutes (10.7 +/- 1.16 seconds, 10.5 +/- 1.16 seconds). No postoperative antinociceptive effects of esmolol were observed at 10 or 15 minutes. IT administration of esmolol produced antinociceptive effects of short duration in a rat postoperative pain model. These results suggest that IT esmolol could offer a new strategy for managing perioperative pain, although an alternative approach is necessary to lengthen the duration of the analgesia.	[Ono, Hitomi; Matoba, Atsuko; Kido, Kanta; Masaki, Eiji] Tohoku Univ Grad Sch Dent, Div Dentooral Anesthesiol, Sendai, Miyagi 9808575, Japan; [Ohtani, Norimasa] Omiya Gen Hosp, Dept Anesthesiol, Saitama, Japan; [Yasui, Yutaka] Jikei Univ Sch Med, Dept Anesthesiol, Tokyo, Japan	Masaki, E (reprint author), Tohoku Univ Grad Sch Dent, Div Dentooral Anesthesiol, Aoba Ku, 4-1 Seiryomachi, Sendai, Miyagi 9808575, Japan.	ejmasaki@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22659362, 22791951, 24593046]	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to E. Masaki (No. 22659362), A. Matoba (No. 22791951), and N. Ohtani (No. 24593046).	YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Davidson EM, 2001, CAN J ANAESTH, V48, P59; Tanahashi S, 2009, EUR J ANAESTH, V26, P196, DOI 10.1097/EJA.0b013e32831ac268; REDDY SVR, 1980, J PHARMACOL EXP THER, V213, P525; HAGELUKEN A, 1994, BIOCHEM PHARMACOL, V47, P1789, DOI 10.1016/0006-2952(94)90307-7; Collard V, 2007, ANESTH ANALG, V105, P1255, DOI 10.1213/01.ane.0000282822.07437.02; Chia YY, 2004, BRIT J ANAESTH, V93, P799, DOI 10.1093/bja/aeh268; Johansen JW, 1997, ANESTHESIOLOGY, V86, P364, DOI 10.1097/00000542-199702000-00011; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Avram MJ, 2004, J PHARMACOL EXP THER, V311, P617, DOI 10.1124/jpet.104.070094; HAYASHI Y, 1995, ANESTHESIOLOGY, V83, P816, DOI 10.1097/00000542-199510000-00022; Johansen Jay W., 1998, Anesthesia and Analgesia, V87, P671, DOI 10.1097/00000539-199809000-00034; Moon YE, 2011, J INT MED RES, V39, P1861; QUON CY, 1985, DRUG METAB DISPOS, V13, P420; SARVEY JM, 1989, J NEUROSCI METH, V28, P109, DOI 10.1016/0165-0270(89)90016-2; Takazawa T, 2009, EUR J NEUROSCI, V29, P518, DOI 10.1111/j.1460-9568.2008.06607.x; Veber D, 2008, NEUROSCI LETT, V440, P202, DOI 10.1016/j.neulet.2008.05.079; Yasui Y, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-15	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1075-2765	1536-3686		AM J THER	Am. J. Ther.	MAR-APR	2015	22	2					111	116		10.1097/MJT.0b013e318274e0a1		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CE1CP	WOS:000351549800014		
J	Agosta, F; Al-Chalabi, A; Filippi, M; Hardiman, O; Kaji, R; Meininger, V; Nakano, I; Shaw, P; Shefner, J; van den Berg, LH; Ludolph, A				Agosta, Federica; Al-Chalabi, Ammar; Filippi, Massimo; Hardiman, Orla; Kaji, Ryuji; Meininger, Vincent; Nakano, Imaharu; Shaw, Pamela; Shefner, Jeremy; van den Berg, Leonard H.; Ludolph, Albert		WFN Res Grp ALS MND	The El Escorial criteria: Strengths and weaknesses	AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION			English	Article						ALS; El Escorial	AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRESSIVE MUSCULAR-ATROPHY; MOTOR-NEURON DISEASE; III RANDOMIZED-TRIAL; DIAGNOSTIC-CRITERIA; PHASE-III; HEXANUCLEOTIDE REPEAT; AWAJI CRITERIA; ADULT-ONSET; ALS	The El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis (ALS) were established 20 years ago and have been used as inclusion criteria for clinical trials. However, concerns have been raised concerning their use as diagnostic criteria in clinical practice. Moreover, as modern genetics have shed new light on the heterogeneity of ALS and the close relationship between ALS and frontotemporal dementia (FTD) recognized, the World Federation of Neurology Research Group on ALS/MND has initiated discussions to amend and update the criteria, while preserving the essential components for clinical trial enrolment purposes.	[Agosta, Federica; Filippi, Massimo] Univ Vita Salute San Raffaele, Milan, Italy; [Agosta, Federica; Filippi, Massimo] Ist Sci San Raffaele, I-20132 Milan, Italy; [Al-Chalabi, Ammar] Kings Coll London, KHP Ctr Neurodegenerat Res, Dept Clin Neurosci, London WC2R 2LS, England; [Ludolph, Albert] Univ Ulm, Dept Neurol, D-89075 Ulm, Germany; [Hardiman, Orla] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Kaji, Ryuji] Tokushima Univ Hosp, Inst Hlth Biosci, Dept Clin Neurosci, Dept Neurol, Tokushima, Japan; [Meininger, Vincent] Hop La Pitie Salpetriere, Ctr Referent Malad Rares SLA, Paris, France; [Nakano, Imaharu] Jichi Med Univ, Dept Neurol, Shimotsuke, Tochigi, Japan; [Shaw, Pamela] Univ Sheffield, Acad Neurol, Sheffield S10 2TN, S Yorkshire, England; [Shefner, Jeremy] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [van den Berg, Leonard H.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands	Ludolph, A (reprint author), Univ Ulm, Dept Neurol, Oberer Eselsberg 45, D-89075 Ulm, Germany.	albert.ludolph@rku.de		Agosta, Federica/0000-0003-3121-4979			Chio A, 2002, NEUROLOGY, V59, P99; Ince PG, 2003, NEUROLOGY, V60, P1252; Miller RG, 1996, ANN NEUROL, V39, P256, DOI 10.1002/ana.410390215; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Elamin M, 2011, NEUROLOGY, V76, P1263, DOI 10.1212/WNL.0b013e318214359f; Turner MR, 2012, BIOMARK MED, V6, P319, DOI [10.2217/bmm.12.26, 10.2217/BMM.12.26]; Chio A, 2010, NEUROLOGY, V75, P619, DOI 10.1212/WNL.0b013e3181ed9e7c; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; van der Graaff MM, 2011, BRAIN, V134, P1211, DOI 10.1093/brain/awr016; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Pascuzzi RM, 2010, AMYOTROPH LATERAL SC, V11, P266, DOI 10.3109/17482960903307805; Mitchell JD, 2010, AMYOTROPH LATERAL SC, V11, P537, DOI 10.3109/17482968.2010.495158; Schrooten M, 2011, ANN NEUROL, V70, P79, DOI 10.1002/ana.22380; Byrne S, 2013, ANN NEUROL, V74, P699, DOI 10.1002/ana.23969; Shefner JM, 2004, NEUROLOGY, V63, P1656; Visser J, 2007, ARCH NEUROL-CHICAGO, V64, P522, DOI 10.1001/archneur.64.4.522; Aggarwal SP, 2010, LANCET NEUROL, V9, P481, DOI 10.1016/S1474-4422(10)70068-5; Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09; Chio A, 2011, MUSCLE NERVE, V43, P189, DOI 10.1002/mus.21851; Menke RAL, 2012, ARCH NEUROL-CHICAGO, V69, P1493, DOI 10.1001/archneurol.2012.1122; Wijesekera LC, 2009, NEUROLOGY, V72, P1087, DOI 10.1212/01.wnl.0000345041.83406.a2; Turner MR, 2002, AMYOTROPH LATERAL SC, V3, P15, DOI 10.1080/146608202317576499; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Kaufmann P, 2009, ANN NEUROL, V66, P235, DOI 10.1002/ana.21743; Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Raaphorst J, 2011, J NEUROL NEUROSUR PS, V82, P170, DOI 10.1136/jnnp.2009.204446; Miller RG, 2001, NEUROLOGY, V56, P843; Costa J, 2012, ARCH NEUROL-CHICAGO, V69, P1410, DOI 10.1001/archneurol.2012.254; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; van Rheenen W, 2012, NEUROLOGY, V79, P878, DOI 10.1212/WNL.0b013e3182661d14; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; Bede P, 2013, NEUROLOGY, V81, P2107, DOI 10.1212/01.wnl.0000437313.80913.2c; Byrne S, 2011, AMYOTROPH LATERAL SC, V12, P157, DOI 10.3109/17482968.2010.545420; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Cellura E, 2012, CLIN NEUROL NEUROSUR, V114, P550, DOI 10.1016/j.clineuro.2011.11.026; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; Abrahams S, 2014, AMYOTROPH LAT SCL FR, V15, P9, DOI 10.3109/21678421.2013.805784; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Elamin M, 2013, NEUROLOGY, V80, P1590, DOI 10.1212/WNL.0b013e31828f18ac; Chen A, 2010, MUSCLE NERVE, V42, P831, DOI 10.1002/mus.21841; Davenport RJ, 1996, J NEUROL NEUROSUR PS, V60, P147, DOI 10.1136/jnnp.60.2.147; De Carvalho M, 2009, AMYOTROPH LATERAL SC, V10, P53, DOI 10.1080/17482960802521126; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dornbluth O, 1889, NEUROLOGISCHES CENTR, V23, P377; Filippi M, 2010, EUR J NEUROL, V17, P520; Guennoc AM, 2013, REV NEUROL-FRANCE, V169, P470, DOI 10.1016/j.neurol.2012.10.007; Hanby Martha F, 2011, Brain, V134, P3454, DOI 10.1093/brain/awr248; Okita T, 2001, J NEUROL SCI, V302, P29; van Blitterswijk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048983; Van den Berg-Vos RM, 2009, ARCH NEUROL-CHICAGO, V66, P751, DOI 10.1001/archneurol.2009.91; Van den Berg-Vos RM, 2003, BRAIN, V126, P1036, DOI 10.1093/brain/awg117; Visser J, 2002, NEUROLOGY, V58, P1593	57	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	2167-8421	2167-9223		AMYOTROPH LAT SCL FR	Amyotroph. Lateral Scher. Frontotemp. Degenerat.	MAR	2015	16	1-2					1	7		10.3109/21678421.2014.964258		7	Clinical Neurology	Neurosciences & Neurology	CE0WV	WOS:000351531900001		
J	Connell, JJ; Sugihara, Y; Torok, S; Dome, B; Tovari, J; Fehniger, TE; Marko-Varga, G; Vegvari, A				Connell, James J.; Sugihara, Yutaka; Toeroek, Szilvia; Doeme, Balazs; Tovari, Jozsef; Fehniger, Thomas E.; Marko-Varga, Gyorgy; Vegvari, Akos			Localization of sunitinib in in vivo animal and in vitro experimental models by MALDI mass spectrometry imaging	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Mass spectrometry; MALDI; MALDI-MSI; In vivo models; Drug; Sunitinib; Colorectal adenocarcinoma	METASTATIC COLORECTAL-CANCER; ASSISTED-LASER-DESORPTION/IONIZATION; RENAL-CELL CARCINOMA; DRUG DISTRIBUTIONS; INTERNAL STANDARD; TISSUE-SECTIONS; BRAIN-TISSUE; PHASE-II; NORMALIZATION; FLUOROURACIL	The spatial distribution of an anticancer drug and its intended target within a tumor plays a major role on determining how effective the drug can be at tackling the tumor. This study provides data regarding the lateral distribution of sunitinib, an oral antiangiogenic receptor tyrosine kinase inhibitor using an in vitro animal model as well as an in vitro experimental model that involved deposition of a solution of sunitinib onto tissue sections. All tumor sections were analyzed by matrix-assisted laser desorption/ionization mass spectrometry imaging and compared with subsequent histology staining. Six tumors at four different time points after commencement of in vivo sunitinib treatment were examined to observe the patterns of drug uptake. The levels of sunitinib present in in vivo treated tumor sections increased continuously until day 7, but a decrease was observed at day 10. Furthermore, the in vitro experimental model was adjustable to produce a drug level similar to that obtained in the in vivo model experiments. The distribution of sunitinib in tissue sections treated in vitro appeared to agree with the histological structure of tumors, suggesting that this approach may be useful for testing drug update.	[Connell, James J.; Fehniger, Thomas E.; Marko-Varga, Gyorgy; Vegvari, Akos] Lund Univ, Dept Biomed Engn, Clin Prot Sci & Imaging, S-22184 Lund, Sweden; [Sugihara, Yutaka] Lund Univ, Dept Oncol, Clin Sci, S-22185 Lund, Sweden; [Sugihara, Yutaka] Skane Univ Hosp, S-22185 Lund, Sweden; [Toeroek, Szilvia; Doeme, Balazs] Natl Koranyi Inst Pulmonol, H-1121 Budapest, Hungary; [Doeme, Balazs] Semmelweis Univ, Natl Inst Oncol, Dept Thorac Surg, H-1122 Budapest, Hungary; [Doeme, Balazs] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria; [Tovari, Jozsef] Natl Inst Oncol, Dept Expt Pharmacol, H-1122 Budapest, Hungary; [Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, S-22184 Lund, Sweden; [Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Shinjuku Ku, Tokyo 1600023, Japan; [Vegvari, Akos] Lund Univ, CREATE Hlth, S-22100 Lund, Sweden	Vegvari, A (reprint author), Lund Univ, CREATE Hlth, S-22100 Lund, Sweden.	akos.vegvari@bme.lth.se		Dome, Balazs/0000-0001-8799-8624; Vegvari, Akos/0000-0002-1287-0906	CREATE Health [2011-03926]; KTIA AIK [12-1-2013-0041]; TAMOP [424A/1-11-1-2012-0001]; OTKA [K109626, K108465, K84173]; ONB Jubilaumsfondsprojekt [14043]; Vienna Fund for Innovative Interdisciplinary Cancer Research; INNO [08-3-2009-0248];  [EUREKA_HU_12-1-2012-0057]	AV is grateful for funding support Innovate Support 2011-03926 from CREATE Health. BD was supported by KTIA AIK 12-1-2013-0041, TAMOP 424A/1-11-1-2012-0001, OTKA K109626, OTKA K108465, EUREKA_HU_12-1-2012-0057, ONB Jubilaumsfondsprojekt Nr. 14043, and the Vienna Fund for Innovative Interdisciplinary Cancer Research. JT was supported by OTKA K84173 and INNO 08-3-2009-0248 (2010).	Chaurand P, 2005, TOXICOL PATHOL, V33, P92, DOI 10.1080/01926230590881862; Fehniger TE, 2011, ANAL CHEM, V83, P8329, DOI 10.1021/ac2014349; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Rohner TC, 2005, MECH AGEING DEV, V126, P177, DOI 10.1016/j.mad.2004.09.032; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Pirman DA, 2013, ANAL CHEM, V85, P1081, DOI 10.1021/ac302960j; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Troendle FJ, 1999, J AM SOC MASS SPECTR, V10, P1315, DOI 10.1016/S1044-0305(99)00103-8; Yamada Y, 2013, LANCET ONCOL, V14, P1278, DOI 10.1016/S1470-2045(13)70490-X; Saltz LB, 2007, J CLIN ONCOL, V25, P4793, DOI 10.1200/JCO.2007.12.8637; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Kallback P, 2012, J PROTEOMICS, V75, P4941, DOI 10.1016/j.jprot.2012.07.034; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Houk BE, 2010, CANCER CHEMOTH PHARM, V66, P357, DOI 10.1007/s00280-009-1170-y; Hsieh Yunsheng, 2007, Journal of Pharmacological and Toxicological Methods, V55, P193, DOI 10.1016/j.vascn.2006.06.004; Hamm G, 2012, J PROTEOMICS, V75, P4952, DOI 10.1016/j.jprot.2012.07.035; Prideaux B, 2012, J PROTEOMICS, V75, P4999, DOI 10.1016/j.jprot.2012.07.028; Groseclose MR, 2013, ANAL CHEM, V85, P10099, DOI 10.1021/ac400892z; Pirman DA, 2011, ANAL CHEM, V83, P8575, DOI 10.1021/ac201949b; Deininger SO, 2011, ANAL BIOANAL CHEM, V401, P167, DOI 10.1007/s00216-011-4929-z; Takai N, 2012, RAPID COMMUN MASS SP, V26, P1549, DOI 10.1002/rcm.6256; Kuh HJ, 1999, J PHARMACOL EXP THER, V290, P871; Goldberg RM, 2006, J CLIN ONCOL, V24, P3347, DOI 10.1200/JCO.2006.06.1317; George S, 2009, EUR J CANCER, V45, P1959, DOI 10.1016/j.ejca.2009.02.011; Reyzer ML, 2003, J MASS SPECTROM, V38, P1081, DOI 10.1002/jms.525; Novello S, 2009, BRIT J CANCER, V101, P1543, DOI 10.1038/sj.bjc.6605346; Douillard JY, 2003, ANN ONCOL, V14, P7, DOI 10.1093/annonc/mdg723; Dome B, 2002, J PATHOL, V197, P355, DOI 10.1002/path.1124; Durko L, 2014, CURR COLORECTAL CANC, V10, P45, DOI DOI 10.1007/S11888-013-0203-4; Erber Ralf, 2004, FASEB Journal, V18, P338; Fujimura Yoshinori, 2014, Metabolites, V4, P319, DOI 10.3390/metabo4020319; Kulke MH, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-29; Malvezzi M, 2014, ANN ONCOL OFF J EUR, DOI [10.1093/annonc/mdu138, DOI 10.1093/ANN0NC/MDU138]; Manea M, 2011, BIOCONJUGATE CHEM, V22, P1320, DOI 10.1021/bc100547p; Moss DM, 2014, BRIT J PHARMACOL, V171, P3963, DOI 10.1111/bph.12604; Norden Andrew D, 2007, Neurosurg Focus, V23, pE12, DOI 10.3171/FOC-07/10/E12; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schwandt A, 2009, ONCOTARGETS THER, V2, P51; Takai Nozomi, 2014, Mass Spectrom (Tokyo), V3, pA0025, DOI 10.5702/massspectrometry.A0025; Vegvari A, 2013, J PROTEOME RES, V12, P5626, DOI 10.1021/pr400581b	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	MAR	2015	407	8					2245	2253		10.1007/s00216-014-8350-2		9	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CD6JQ	WOS:000351195800022		
J	Shibata-Seki, T; Tajima, K; Takahashi, H; Seki, H; Masai, J; Goto, H; Kobatake, E; Akaike, T; Itoh, N				Shibata-Seki, Teiko; Tajima, Kazuki; Takahashi, Hiroki; Seki, Hiroya; Masai, Junji; Goto, Hiroshi; Kobatake, Eiry; Akaike, Toshihiro; Itoh, Norihiko			AFM characterization of chemically treated corneal cells	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Atomic force microscopy; Corneal epithelial and endothelial cells; Mechanical property; Young's modulus; Glutaraldehyde	ATOMIC-FORCE MICROSCOPY; LIVING CELLS; GLUTARALDEHYDE; FIXATION; METHYLMETHACRYLATE; SPECIMENS; AMINO	We present a characterization of chemically treated cells using atomic force microscopy (AFM) which can observe changes in morphology and elasticity of cells. Since AFM has the significant advantage that it does not require fixation of samples, the method is simple and can capture various properties of living cells. In this study, corneal epithelial and endothelial cells were examined. The topography images of the corneal cells without glutaraldehyde (GA) fixation were successfully obtained. The images showed a natural three-dimensional shape of these cells, which scanning electron microscope (SEM) images could not provide. The AFM images of GA-fixed cells were taken and compared with a SEM image reported in the literature. Our results show that longer time for GA fixation makes the surface of the corneal endothelial tissue stiffer. Also, longer treatment results in relatively large structural variation in samples. Combined with conventional histochemical methods, this approach helps us gain an overall understanding of the influence of such chemical treatment.	[Shibata-Seki, Teiko; Kobatake, Eiry] Tokyo Inst Technol, Dept Environm Chem & Engn, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 2268502, Japan; [Tajima, Kazuki; Takahashi, Hiroki; Goto, Hiroshi; Itoh, Norihiko] Tokyo Med Univ, Shinjuku Ku, Tokyo 1608402, Japan; [Seki, Hiroya] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Masai, Junji] Mitsubishi Chem Technores Corp, Tokyo 1600017, Japan; [Akaike, Toshihiro] Biomat Ctr Regenerat Med Engn, Tsukuba, Ibaraki 3050044, Japan; [Akaike, Toshihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Itoh, Norihiko] Tottori Univ, Ctr Vet Med, Tottori 6808553, Japan; [Itoh, Norihiko] Tokyo Inst Technol, Dainichiseika Donated Chair Res Div Innovat Bioma, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 227, Japan	Itoh, N (reprint author), Tokyo Med Univ, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	taromobile@me.com	Tajima, Kazuki/K-3127-2015		Dainichiseika Color & Chemicals Mfg. Co., Ltd. through Dainichiseika-Donated Chair of Research Division for Innovative Biomaterials in Tokyo Institute of Technology; Japan Society for the Promotion of Science (JSPS) KAKENHI [23592611]	We would like to thank Dainichiseika Color & Chemicals Mfg. Co., Ltd. for financial support through Dainichiseika-Donated Chair of Research Division for Innovative Biomaterials in Tokyo Institute of Technology. This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23592611.	Dokukin ME, 2013, BIOPHYS J, V104, P2123, DOI [10.1016/j.bpj.2013.04.019, 10.1016/j.bpj.2013.03.019]; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BUTT HJ, 1992, BIOPHYS J, V63, P578; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; DERJAGUIN BV, 1975, J COLLOID INTERF SCI, V53, P314, DOI 10.1016/0021-9797(75)90018-1; Heu C, 2012, J STRUCT BIOL, V178, P1, DOI 10.1016/j.jsb.2012.02.007; KAWAHARA J, 1992, ANAL BIOCHEM, V201, P94, DOI 10.1016/0003-2697(92)90178-A; Bart ZR, 2014, CONNECT TISSUE RES, V55, P4, DOI 10.3109/03008207.2014.923860; A-Hassan E, 1998, BIOPHYS J, V74, P1564; OKUDA K, 1991, J FERMENT BIOENG, V71, P100, DOI 10.1016/0922-338X(91)90231-5; Bohrmann B, 2001, MICRON, V32, P11, DOI 10.1016/S0968-4328(00)00029-9; Chicoine L, 1998, MICROSC RES TECHNIQ, V42, P24, DOI 10.1002/(SICI)1097-0029(19980701)42:1<24::AID-JEMT4>3.0.CO;2-R; Colton RJ, 1997, CURR OPIN CHEM BIOL, V1, P370, DOI 10.1016/S1367-5931(97)80076-2; Hannouche D, 2007, J HISTOCHEM CYTOCHEM, V55, P255, DOI 10.1369/jhc.6A7063.2006; Hansma HG, 1998, CURR OPIN CHEM BIOL, V2, P579, DOI 10.1016/S1367-5931(98)80086-0; Horimizu M, 2013, MICRON, V48, P1, DOI 10.1016/j.micron.2013.02.001; Jena BP, 2006, FORCE MICROSCOPY APP; Kadonosono K, 1998, J CATARACT REFR SURG, V24, P1377; Kuznetsova NP, 2013, RUSS CHEM B+, V62, P918, DOI 10.1007/s11172-013-0122-1; Liu BY, 2012, SCANNING, V34, P6, DOI 10.1002/sca.20269; NICHOLS B, 1983, INVEST OPHTH VIS SCI, V24, P570; Pittenger B., 2011, 128 BRUK; Pittenger B, 2013, 141 BRUK; ShibataSeki T, 1996, THIN SOLID FILMS, V273, P297, DOI 10.1016/0040-6090(95)07003-6; Troiano NW, 2009, J HISTOTECHNOL, V32, P27	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	MAR	2015	407	9					2631	2635		10.1007/s00216-015-8473-0		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CE0QU	WOS:000351510300027		
J	Yasuda, M; Akimoto, T				Yasuda, Mitsuru; Akimoto, Takuo			High-Contrast Fluorescence Imaging Based on the Polarization Dependence of the Fluorescence Enhancement Using an Optical Interference Mirror Slide	ANALYTICAL SCIENCES			English	Article						Enhanced fluorescence; biochip; polarization	PLANE-LAYERED MEDIA; MULTILAYERED SUBSTRATE; ELECTROMAGNETIC-RADIATION; EXCITATION LIGHT; MICROSCOPY; SURFACE; INHIBITION; REFLECTION; PROTEIN	High-contrast fluorescence imaging using an optical interference mirror (OIM) slide that enhances the fluorescence from a fluorophore located on top of the OIM surface is reported. To enhance the fluorescence and reduce the background light of the OIM, transverse-electric-polarized excitation light was used as incident light, and the transverse-magnetic-polarized fluorescence signal was detected. As a result, an approximate 100-fold improvement in the signal-to-noise ratio was achieved through a 13-fold enhancement of the fluorescence signal and an 8-fold reduction of the background light.	[Yasuda, Mitsuru; Akimoto, Takuo] Tokyo Univ Technol, Sch Biosci & Biotechnol, Hachioji, Tokyo 1920982, Japan	Akimoto, T (reprint author), Tokyo Univ Technol, Sch Biosci & Biotechnol, 1404-1 Katakura, Hachioji, Tokyo 1920982, Japan.	akimoto@stf.teu.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [23510138]	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant No. 23510138.	Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Mathias PC, 2007, APPL OPTICS, V46, P2351, DOI 10.1364/AO.46.002351; Choumane H, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999018; Yasuda M, 2012, ANAL SCI, V28, P947; Etoh H, 2011, ANAL SCI, V27, P1179; Cretich M, 2009, ANAL CHEM, V81, P5197, DOI 10.1021/ac900658c; HOLLAND WR, 1985, OPT LETT, V10, P414, DOI 10.1364/OL.10.000414; Matveeva EG, 2007, ANAL BIOCHEM, V363, P239, DOI 10.1016/j.ab.2007.01.030; Tawa K, 2008, OPT EXPRESS, V16, P9781, DOI 10.1364/OE.16.009781; ERIKSSON TS, 1981, APPL OPTICS, V20, P2742, DOI 10.1364/AO.20.002742; Sullivan KG, 1997, J OPT SOC AM B, V14, P1149, DOI 10.1364/JOSAB.14.001149; Akimoto T, 2010, APPL OPTICS, V49, P80, DOI 10.1364/AO.49.000080; Grandin HM, 2006, BIOSENS BIOELECTRON, V21, P1476, DOI 10.1016/j.bios.2005.06.011; SULLIVAN KG, 1994, APPL OPTICS, V33, P2447, DOI 10.1364/AO.33.002447; Akimoto T, 2008, APPL OPTICS, V47, P3789, DOI 10.1364/AO.47.003789; Ishikawa-Ankerhold HC, 2012, MOLECULES, V17, P4047, DOI 10.3390/molecules17044047; Kuwabara K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2960354; Moal E, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2722730; Moal E Le, 2007, Biophys J, V92, P2150, DOI 10.1529/biophysj.106.096750; Sullivan KG, 1997, J OPT SOC AM B, V14, P1160, DOI 10.1364/JOSAB.14.001160; Takmakov P, 2006, ANAL BIOANAL CHEM, V385, P954, DOI 10.1007/s00216-006-0504-4	21	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAR	2015	31	3					139	143				5	Chemistry, Analytical	Chemistry	CE1IW	WOS:000351566300001		
J	Rahong, S; Yasui, T; Yanagida, T; Nagashima, K; Kanai, M; Meng, G; He, Y; Zhuge, FW; Kaji, N; Kawai, T; Baba, Y				Rahong, Sakon; Yasui, Takao; Yanagida, Takeshi; Nagashima, Kazuki; Kanai, Masaki; Meng, Gang; He, Yong; Zhuge, Fuwei; Kaji, Noritada; Kawai, Tomoji; Baba, Yoshinobu			Self-assembled Nanowire Arrays as Three-dimensional Nanopores for Filtration of DNA Molecules	ANALYTICAL SCIENCES			English	Article						Nanowire; 3D nanopore structure; biomolecular filtration	TIN OXIDE NANOWIRES; SEPARATION CHIPS; MEMBRANES	Molecular filtration and purification play important roles for biomolecule analysis. However, it is still necessary to improve efficiency and reduce the filtration time. Here, we show self-assembled nanowire arrays as three-dimensional (3D) nanopores embedded in a microfluidic channel for ultrafast DNA filtration. The 3D nanopore structure was formed by a vapor-liquid-solid (VLS) nanowire growth technique, which allowed us to control pore size of the filtration material by varying the number of growth cycles. lambda DNA molecules (48.5 kbp) were filtrated from a mixture of T4 DNA (166 kbp) at the entrance of the 3D nanopore structure within 1 s under an applied electric field. Moreover, we observed single DNA molecule migration of T4 and lambda DNA molecules to clarify the filtration mechanism. The 3D nanopore structure has simplicity of fabrication, flexibility of pore size control and reusability for biomolecule filtration. Consequently it is an excellent material for biomolecular filtration.	[Rahong, Sakon] Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Rahong, Sakon; Yasui, Takao; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, FIRST Res Ctr Innovat Nanobiodevices, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yasui, Takao; Kaji, Noritada; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yanagida, Takeshi; Nagashima, Kazuki; Kanai, Masaki; Meng, Gang; He, Yong; Zhuge, Fuwei; Kawai, Tomoji] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Rahong, S (reprint author), Nagoya Univ, Inst Innovat Future Soc, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	sakon.rahong@apchem.nagoya-u.ac.jp; yasui@apchem.nagoya-u.ac.jp; babaymtt@apchem.nagoya-u.ac	Zhuge, Fuwei/I-7171-2013	Zhuge, Fuwei/0000-0003-3673-2257	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; JSPS [24241050, 25790028]	This research was supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; the JSPS Grant-in-Aid for Scientific Research (A) 24241050; and the JSPS Grant-in-Aid for Young Scientists (B) 25790028. Thanks are extended to Dr. H. Yukawa and Dr. D. Onoshima, both of Nagoya University, for valuable discussions.	BECK RE, 1970, SCIENCE, V170, P1302, DOI 10.1126/science.170.3964.1302; Tong HD, 2004, NANO LETT, V4, P283, DOI 10.1021/nl0350175; VOLKMUTH WD, 1992, NATURE, V358, P600, DOI 10.1038/358600a0; Striemer CC, 2007, NATURE, V445, P749, DOI 10.1038/nature05532; Kaji N, 2004, ANAL CHEM, V76, P15, DOI 10.1021/ac030303m; Zeng Y, 2007, ANAL CHEM, V79, P2289, DOI 10.1021/ac061931h; PORATH J, 1959, NATURE, V183, P1657, DOI 10.1038/1831657a0; Fu JP, 2007, NAT NANOTECHNOL, V2, P121, DOI 10.1038/nnano.2006.206; Meng G, 2013, J AM CHEM SOC, V135, P7033, DOI 10.1021/ja401926u; Doyle PS, 2002, SCIENCE, V295, P2237, DOI 10.1126/science.1068420; Yasui T, 2013, ACS NANO, V7, P3029, DOI 10.1021/nn4002424; Yasui T, 2011, ANAL CHEM, V83, P6635, DOI 10.1021/ac201184t; Barth S, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115705; DEEN WM, 1987, AICHE J, V33, P1409, DOI 10.1002/aic.690330902; FLEISCHE.RL, 1972, SCIENCE, V178, P255, DOI 10.1126/science.178.4058.255; Klamchuen A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3660246; Kolahi KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041717; Meng G, 2014, NANOSCALE, V6, P7033, DOI 10.1039/c4nr01016g; Meng G, 2012, RSC ADV, V2, P10618, DOI 10.1039/c2ra21643d; Pennathur S, 2007, ANAL CHEM, V79, P8316, DOI 10.1021/ac0710580; Rahong S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05252; Ruthven C. R. J., 1954, BIOCHEM J, V62, P665; Tabuchi M, 2004, NAT BIOTECHNOL, V22, P337, DOI 10.1038/nbt939	23	2	2	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAR	2015	31	3					153	157				5	Chemistry, Analytical	Chemistry	CE1IW	WOS:000351566300003		
J	Seto, H; Kamba, S; Kondo, T; Ogawa, Y; Hoshino, Y; Miura, Y				Seto, Hirokazu; Kamba, Seiji; Kondo, Takashi; Ogawa, Yuichi; Hoshino, Yu; Miura, Yoshiko			Label-free Detection of Antigen Protein Using a Metal Mesh Device Surface-modified by an Antibody	ANALYTICAL SCIENCES			English	Article						Metal mesh device; antigen-antibody; hemoglobin; label-free biosensor	PHOTONIC CRYSTAL BIOSENSOR; SENSORS	A biosensor for protein detection was developed using antibody-immobilized metal mesh devices. Antihemoglobin antibodies were covalently immobilized on a metal mesh device. Extraordinary transmission with a dipped structure was observed for a metal mesh device immobilized with antihemoglobin antibodies as well as for the original metal mesh device. Hemoglobin in the mixture solution containing albumin at a hundred-fold concentration was detectable using antihemoglobin-immobilized MMDs. The detectability using the antihemoglobin-immobilized metal mesh device was similar to that of a commercially-available kit for the qualitative determination of hemoglobin.	[Seto, Hirokazu; Hoshino, Yu; Miura, Yoshiko] Kyushu Univ, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan; [Kamba, Seiji; Kondo, Takashi] Murata Mfg Co, Nagaokakyo 6178555, Japan; [Ogawa, Yuichi] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Miura, Y (reprint author), Kyushu Univ, Grad Sch Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	miuray@chem-eng.kyushu-u.ac.jp			 [25.5206];  [26620106];  [23685027]	This work was supported by a Grant-in-Aid for JSPS Fellows (25.5206), a Grant-in-Aid for Challenging Exploratory Research (26620106), and a Grant-in-Aid for Young Scientists (A) (23685027).	Endo T, 2010, SENSOR ACTUAT B-CHEM, V148, P269, DOI 10.1016/j.snb.2010.05.036; Seto H, 2014, ACS APPL MATER INTER, V6, P13234, DOI 10.1021/am503003v; Terada Y, 2014, J MATER CHEM B, V2, P3324, DOI 10.1039/c4tb00028e; Byrne B, 2009, SENSORS-BASEL, V9, P4407, DOI 10.3390/s90604407; Yoshida H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2825411; Miyamaru F, 2006, OPT LETT, V31, P1118, DOI 10.1364/OL.31.001118; Holford TRJ, 2012, BIOSENS BIOELECTRON, V34, P12, DOI 10.1016/j.bios.2011.10.023; Skottrup PD, 2008, BIOSENS BIOELECTRON, V24, P339, DOI 10.1016/j.bios.2008.06.045; Yoshida S, 2009, J MOL SPECTROSC, V256, P146, DOI 10.1016/j.jms.2009.04.009; Endo T, 2012, LAB CHIP, V12, P1995, DOI 10.1039/c2lc40066a; Pendry JB, 2004, SCIENCE, V305, P847, DOI 10.1126/science.1098999; Eggins B. R., 2002, CHEM SENSORS BIOSENS; Kondo T, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.225; Ogawa Y., 2008, PIERS ONLINE, V4, P396, DOI 10.2529/PIERS070831051620; Seto H, 2014, CHEM LETT, V43, P408, DOI 10.1246/cl.131040; Seto H, 2013, LANGMUIR, V29, P9457, DOI 10.1021/la401068n; Suzuki T, 2013, IEEE SENS J, V13, P4972, DOI 10.1109/JSEN.2013.2278760; ULRICH R, 1967, INFRARED PHYS, V7, P37, DOI 10.1016/0020-0891(67)90028-0; Yoshida S, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.012301	19	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAR	2015	31	3					173	176				4	Chemistry, Analytical	Chemistry	CE1IW	WOS:000351566300006		
J	Okazaki, T; Imai, K; Tan, SY; Yong, YT; Rahman, FA; Hata, N; Taguchi, S; Ueda, A; Kuramitz, H				Okazaki, Takuya; Imai, Kenichiro; Tan, Shin Y.; Yong, Yun T.; Rahman, Faidz A.; Hata, Noriko; Taguchi, Shigeru; Ueda, Akira; Kuramitz, Hideki			Fundamental Study on the Development of Fiber Optic Sensor for Real-time Sensing of CaCO3 Scale Formation in Geothermal Water	ANALYTICAL SCIENCES			English	Article						Fiber optic sensor; scale; calcium carbonate; geothermal water; real-time sensing	CALCIUM-CARBONATE SCALE; CHEMICAL SENSORS; FIELD; SPECTROSCOPY; BIOSENSORS	This study proposes an optical fiber sensor for calcium carbonate (CaCO3) scale formation in water. The sensor is easily fabricated by removing the cladding of a multimode fiber to expose the core towards the surrounding medium in order to detect refractive index change. A variation of the transmittance response from the high refractive index of CaCO3 which precipitated on the fiber core surface was observed. The proposed setup can be used to analyze the transmittance response over wide range of wavelength using white light as a source and also a spectroscopy detector. The curve of the transmittance percentage over time showed that a fiber core with 200 mu m has higher sensitivity as compared to a fiber core with 400 mu m. The findings from this study showed that the sensor detection region at near infrared (NIR) wavelengths showed better sensitivity than visible light (VIS) wavelengths. Field tests were conducted using natural geothermal water at Matsushiro, Japan in order to verify the performance of the proposed sensor. The optical response was successfully evaluated and the analytical results confirmed the capability of monitoring scale formation in a geothermal water environment.	[Okazaki, Takuya; Imai, Kenichiro; Hata, Noriko; Taguchi, Shigeru; Ueda, Akira; Kuramitz, Hideki] Toyama Univ, Grad Sch Sci & Engn Res, Dept Environm Biol & Chem, Toyama 9308555, Japan; [Tan, Shin Y.; Yong, Yun T.] Univ Tunku Abdul Rahman, Fac Engn & Green Technol, Dept Elect Engn, Kampar 39100, Perak, Malaysia; [Rahman, Faidz A.] Univ Tunku Abdul Rahman, Lee Kong Chian Fac Engn & Sci, Dept Elect & Elect Engn, Kuala Lumpur 53300, Malaysia	Kuramitz, H (reprint author), Toyama Univ, Grad Sch Sci & Engn Res, Dept Environm Biol & Chem, 3190 Gofuku, Toyama 9308555, Japan.	kuramitz@sci.u-toyama.ac.jp	Abd-Rahman, Faidz/B-8839-2008	Abd-Rahman, Faidz/0000-0003-0964-9589	Grant for Geothermal Power Generation Projects from the New Energy and Industrial Technology Development Organization (NEDO)	This work was supported by a Grant for Geothermal Power Generation Projects from the New Energy and Industrial Technology Development Organization (NEDO). The authors would like to thank Prof. Masamoto Tafu, Ecotechnology Laboratory, Toyama National College of Technology, for use of the XRD equipment.	ABDULLATIF NA, 1988, IND ENG CHEM RES, V27, P1548, DOI 10.1021/ie00080a035; Dong SY, 2008, SENSOR ACTUAT B-CHEM, V129, P94, DOI 10.1016/j.snb.2007.07.078; MUCCI A, 1983, GEOCHIM COSMOCHIM AC, V47, P217, DOI 10.1016/0016-7037(83)90135-7; Yeh TS, 2006, SENSOR ACTUAT B-CHEM, V119, P701, DOI 10.1016/j.snb.2006.01.051; Wang XD, 2013, ANAL CHEM, V85, P487, DOI 10.1021/ac303159b; DEGRANDPRE MD, 1990, APPL SPECTROSC, V44, P273, DOI 10.1366/0003702904085453; McDonagh C, 2008, CHEM REV, V108, P400, DOI 10.1021/cr068102g; Ghosh G, 1999, OPT COMMUN, V163, P95, DOI 10.1016/S0030-4018(99)00091-7; Hartley AM, 1997, WATER RES, V31, P2261, DOI 10.1016/S0043-1354(97)00103-6; Wolfbeis OS, 2002, ANAL CHEM, V74, P2663, DOI 10.1021/ac020176e; DEGRANDPRE MD, 1988, ANAL CHEM, V60, P2582, DOI 10.1021/ac00174a011; Bamforth S., 1996, OILFIELD REV, V8, P44; Bharadwaj R, 2011, BIOSENS BIOELECTRON, V26, P3367, DOI 10.1016/j.bios.2010.12.014; Biirck J., 1992, FRESEN J ANAL CHEM, V342, P394; Blair DS, 1997, ANAL CHEM, V69, P2238, DOI 10.1021/ac961086a; BLAIR DS, 1995, APPL SPECTROSC, V49, P1636, DOI 10.1366/0003702953965740; Boerkamp M, 2012, J CRYST GROWTH, V361, P132, DOI 10.1016/j.jcrysgro.2012.09.011; Boerkamp M, 2010, IND ENG CHEM RES, V49, P4682, DOI 10.1021/ie901471p; Boerkamp M., 2013, SENSOR ACTUAT B-CHEM, V117, P964; Chai XS, 2003, IND ENG CHEM RES, V42, P254, DOI 10.1021/ie0204585; Dalas E, 2001, J CRYST GROWTH, V222, P287, DOI 10.1016/S0022-0248(00)00895-2; Grahn M, 2005, MICROPOR MESOPOR MAT, V81, P357, DOI 10.1016/j.micromeso.2005.02.019; Gunarathne GPP, 1996, ULTRASONICS, V34, P411, DOI 10.1016/0041-624X(96)00016-9; Gupta B. D., 2006, FIBER OPTIC SENSORS; KOUTSOUKOS PG, 1984, J CRYST GROWTH, V69, P367, DOI 10.1016/0022-0248(84)90344-0; Long F., 2011, BIOSENS BIOELECTRON, V15, P2390; MacAdam Jitka, 2004, Reviews in Environmental Science and Bio/Technology, V3, P159, DOI 10.1007/s11157-004-3849-1; Patzay G, 1998, ELECTROCHIM ACTA, V43, P137, DOI 10.1016/S0013-4686(97)00242-9; Philip-Chandy R, 2000, SENSOR ACTUAT B-CHEM, V71, P19, DOI 10.1016/S0925-4005(00)00556-6; Pillai AB, 2012, ENVIRON SCI TECHNOL, V46, P404, DOI 10.1021/es2028718; Potyrailo RA, 1998, ANAL CHEM, V70, P1639, DOI 10.1021/ac970942v; Shih WY, 2004, DESALINATION, V169, P213, DOI 10.1016/j.desal.2003.12.008; Shtoyko T, 2004, J CHEM EDUC, V81, P1617; Smith JK, 2004, SPE PROD FACIL, V19, P94; Udd E., 2011, FIBER OPTIC SENSORS; Umemura T, 2002, ANALYST, V127, P149, DOI 10.1039/b105281k; Varghese B. P, 2010, REV SCI INSTRUM, V81; Wolf U, 1999, CATAL TODAY, V49, P411, DOI 10.1016/S0920-5861(98)00446-5; Xiong Y, 2010, ANAL BIOANAL CHEM, V396, P943, DOI 10.1007/s00216-009-3246-2; Yeh TC, 2001, APPL SPECTROSC, V55, P1320, DOI 10.1366/0003702011953676	40	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAR	2015	31	3					177	183				7	Chemistry, Analytical	Chemistry	CE1IW	WOS:000351566300007		
J	Saga, M; Anamushi, T; Miyahara, W; Yamazaki, S; Saito, K				Saga, Makoto; Anamushi, Tatsuya; Miyahara, Wakayo; Yamazaki, Shigeo; Saito, Keiitsu			Fluorescent Character of Cu(I/II) Complexes with Bisquinoline-based Ligands and Fluorometric Detection of Reductants	ANALYTICAL SCIENCES			English	Article						Fluorescence ligand; copper complex; reductant	COPPER; SENSOR; CU2+; HG2+	The fluorescence ligands N,N'-bis(2-methylquinolyl)dimethylethylenediamine (BQDMEN) and N,N'-bis(2-methylquinolyl) dimethyl-1,3-propanediamine (BQDMPN) were synthesized. [Cu(II)(bqdmen)](2+) and [Cu(II)(bqdmpn)](2+) were prepared, and their reduction to [Cu(I)(bqdmen)](+) and [Cu(I)(bqdmpn)](+) was confirmed by the observed UV-Vis spectral change. Then, the fluorescence of [Cu(I/II)(bqdmen)](+/2+) and [Cu(I/II)(bqdmpn)](+/2+) in aqueous solution was characterized; [Cu(I) (bqdmen)](+) and [Cu(I)(bqdmpn)](+) were found to fluoresce in aqueous solution, whereas the fluorescence of [Cu(II) (bqdmen)](2+) and [Cu(II)(bqdmpn)](2+) was completely quenched. On the basis of these findings, fluorometric detection of reductants with a flow-injection system using a [Cu(II)(bqdmen)](2+) or [Cu(II)(bqdmpn)](2+) solution as a carrier was explored.	[Saga, Makoto; Saito, Keiitsu] Kobe Univ, Grad Sch Human Dev & Environm, Dept Human Environm Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Anamushi, Tatsuya] Kobe Univ, Fac Human Dev, Dept Human Environm Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Miyahara, Wakayo; Yamazaki, Shigeo] Okayama Univ Sci, Fac Sci, Dept Appl Sci, Kita Ku, Okayama 7000005, Japan	Saito, K (reprint author), Kobe Univ, Grad Sch Human Dev & Environm, Dept Human Environm Sci, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo 6578501, Japan.	keisaito@kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25502002]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (Grant No. 25502002) from the Japan Society for the Promotion of Science (JSPS).	Abu-Surrah AS, 2002, ASIAN J CHEM, V14, P1251; Yam VWW, 1999, CHEM SOC REV, V28, P323, DOI 10.1039/a804249g; Huang JL, 2013, J LUMIN, V141, P130, DOI 10.1016/j.jlumin.2013.03.038; Chu KH, 2013, DYES PIGMENTS, V98, P339, DOI 10.1016/j.dyepig.2013.02.019; Gao CJ, 2013, SENSOR ACTUAT B-CHEM, V185, P125, DOI 10.1016/j.snb.2013.04.110; Cooke MW, 2007, CHEM SOC REV, V36, P1466, DOI 10.1039/b609200b; Zeng L, 2006, J AM CHEM SOC, V128, P10, DOI 10.1021/ja055064u; Jang YK, 2013, DYES PIGMENTS, V99, P6, DOI 10.1016/j.dyepig.2013.04.002; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Barbieri A, 2008, CHEM COMMUN, P2185, DOI 10.1039/b716650h; Mikata Y, 2007, DALTON T, P3330, DOI 10.1039/b705080a; Mikata Y, 2009, DALTON T, P3800, DOI 10.1039/b820763a; Rapisarda VA, 2002, ANAL BIOCHEM, V307, P105, DOI 10.1016/S0003-2697(02)00031-3; RIEGER B, 1995, J ORGANOMET CHEM, V497, P73, DOI 10.1016/0022-328X(95)00119-B; Tsubomura T., 2008, B JPN SOC COORD CHEM, V52, P29; Zhang H, 2007, TETRAHEDRON LETT, V48, P3959, DOI 10.1016/j.tetlet.2007.04.045	16	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAR	2015	31	3					185	189				5	Chemistry, Analytical	Chemistry	CE1IW	WOS:000351566300008		
J	Fukui, Y; Iiguni, Y; Kitagawa, S; Ohtani, H				Fukui, Yugo; Iiguni, Yoshinori; Kitagawa, Shinya; Ohtani, Hajime			Continuous-flow Size-based Separation of Microparticles by Microchip Electromagnetophoresis	ANALYTICAL SCIENCES			English	Article						Electromagnetophoresis; microchip; microparticles; separation	CAPILLARY-ELECTROPHORESIS; SPLITT FRACTIONATION; PARTICLE SEPARATION; MAGNETIC-FIELD; SYSTEM; CHIP	A novel microchip separation method for microparticles based on electromagnetophoresis was developed. In this method, a double Y-shape microchip with two inlets and two outlets was used for particle separation. Microparticles of two different sizes were suspended in an aqueous solution and introduced into the microchannel from one inlet with a stream of the aqueous solution without particles from another inlet by a hydrodynamic flow. Then, the particles with two different sizes were migrated orthogonal to the flow by elctromagnetophoresis and separated to different outlets based on the difference in their electromagnetophoric velocities, which depended on the size of particle. Using this method, at one outlet, 89% of 3 mu m polystyrene latex particles were isolated from a mixture of 3 and 10 mu m particles. By combining hydrodynamic focusing, both 3 and 10 mu m particles were recovered at the different outlets with 100% purity and recovery, respectively. Even the separation of 3 and 6 mu m particles was also achieved with about 98% recovery and purity. Moreover, yeast cells and polystyrene particles could be separated with high separation efficiency by this technique.	[Fukui, Yugo; Iiguni, Yoshinori; Kitagawa, Shinya; Ohtani, Hajime] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Iiguni, Y (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.	iiguni.yoshinori@nitech.ac.jp			JSPS KAKENHI [20750059]	This work was supported by JSPS KAKENHI Grant No. 20750059.	Yamada M, 2004, ANAL CHEM, V76, P5465, DOI 10.1021/ac049863r; Gossett DR, 2010, ANAL BIOANAL CHEM, V397, P3249, DOI 10.1007/s00216-010-3721-9; Kanazaki T, 2012, ANAL CHEM, V84, P10750, DOI 10.1021/ac302637e; Pamme N, 2007, LAB CHIP, V7, P1644, DOI 10.1039/b712784g; KOLIN A, 1953, SCIENCE, V117, P134, DOI 10.1126/science.117.3032.134; Xu XY, 2007, J CHROMATOGR A, V1167, P35, DOI 10.1016/j.chroma.2007.07.056; Lenshof A, 2010, CHEM SOC REV, V39, P1203, DOI 10.1039/b915999c; Liu Y, 2011, LAB CHIP, V11, P3167, DOI 10.1039/c1lc20481e; Iiguni Y, 2004, J CHROMATOGR A, V1032, P165, DOI 10.1016/j.chroma.2003.10.134; Forbes TP, 2012, LAB CHIP, V12, P1471, DOI 10.1039/c2lc40113d; Pamme N, 2004, ANAL CHEM, V76, P7250, DOI 10.1021/ac049183c; Benincasa MA, 2005, ANAL CHEM, V77, P5294, DOI 10.1021/ac058013o; Choi S, 2005, LAB CHIP, V5, P1161, DOI 10.1039/b505088j; Contado C, 2010, ANAL METHODS-UK, V2, P1112, DOI 10.1039/c0ay00205d; Cui HH, 2009, LAB CHIP, V9, P2306, DOI 10.1039/b906202e; Edwards TL, 2002, ANAL CHEM, V74, P1211, DOI 10.1021/ac010653d; Fuh CB, 1998, J CHROMATOGR A, V813, P313; FUH CB, 1994, IND ENG CHEM RES, V33, P355, DOI 10.1021/ie00026a028; Giddings J. C., 1993, SCIENCE, V260, P268; Han KH, 2009, LAB CHIP, V9, P2958, DOI 10.1039/b909753h; Iiguni Y, 2007, ANAL SCI, V23, P121, DOI 10.2116/analsci.23.121; Iiguni Y, 2013, ANAL SCI, V29, P35; Iiguni Y, 2010, ANALYST, V135, P1426, DOI 10.1039/b924339a; KARNI Z, 1975, MED BIOL ENG, V13, P457, DOI 10.1007/BF02477119; KOLIN A, 1958, NATURE, V182, P510, DOI 10.1038/182510a0; Kuntaegowdanahalli SS, 2009, LAB CHIP, V9, P2973, DOI 10.1039/b908271a; Liu FK, 2005, ANAL CHIM ACTA, V528, P249, DOI 10.1016/j.aca.2004.08.052; NALBANDI.RM, 1968, EXPERIENTIA, V24, P1006, DOI 10.1007/BF02138710; RAZEE S, 1994, CHEM PHARM BULL, V42, P2376; Shendruk TN, 2013, ANAL CHEM, V85, P5981, DOI 10.1021/ac400802g	30	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAR	2015	31	3					197	203				7	Chemistry, Analytical	Chemistry	CE1IW	WOS:000351566300010		
J	Shinomiya, K; Yoshida, K; Tokura, K; Tsukidate, E; Yanagidaira, K; Ito, Y				Shinomiya, Kazufusa; Yoshida, Kazunori; Tokura, Koji; Tsukidate, Etsuhiro; Yanagidaira, Kazuhiro; Ito, Yoichiro			Countercurrent Chromatographic Separation of Proteins Using an Eccentric Coiled Column with Synchronous and Nonsynchronous Type-J Planetary Motions	ANALYTICAL SCIENCES			English	Article						Countercurrent chromatography; universal high-speed countercurrent chromatograph; eccentric coil; toroidal coil; partition efficiency; protein separation with polymer phase system	POLYMER PHASE SYSTEMS; AQUEOUS 2-PHASE SYSTEMS; CENTRIFUGE; PURIFICATION; DESIGN	Protein separation was performed using the high-speed countercurrent chromatograph (HSCCC) at both synchronous and nonsynchronous type-J planetary motions. The partition efficiency was evaluated with two different column configurations, eccentric coil and toroidal coil, on the separation of a set of stable protein samples including cytochrome C, myoglobin and lysozyme with a polymer phase system composed of 12.5% (w/w) polyethylene glycol 1000 and 12.5% (w/w) dibasic potassium phosphate. Better peak resolution was obtained by the eccentric coil than by the toroidal coil using either lower or upper phase as the mobile phase. The peak resolution was further improved using the eccentric coil by the nonsynchronous type-J planetary motion with the combination of 1066 rpm of column rotation and 1000 rpm of revolution.	[Shinomiya, Kazufusa] Nihon Univ, Sch Pharm, Funabashi, Chiba 2748555, Japan; [Yoshida, Kazunori; Tokura, Koji; Tsukidate, Etsuhiro; Yanagidaira, Kazuhiro] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba 2748501, Japan; [Ito, Yoichiro] NHLBI, Lab Bioseparat Technol, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	Shinomiya, K (reprint author), Nihon Univ, Sch Pharm, 7-7-1 Narashinodai, Funabashi, Chiba 2748555, Japan.	shinomiya.kazufusa@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	The present study was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Guan YH, 2009, SEP PURIF TECHNOL, V65, P79, DOI 10.1016/j.seppur.2008.07.016; Shinomiya K, 2006, J CHROMATOGR A, V1104, P245, DOI 10.1016/j.chroma.2005.12.046; Sutherland I, 2011, J CHROMATOGR A, V1218, P5527, DOI 10.1016/j.chroma.2011.04.013; Ignatova S, 2010, J CHROMATOGR A, V1217, P34, DOI 10.1016/j.chroma.2009.10.055; Guan YH, 2010, J CHROMATOGR A, V1217, P3525, DOI 10.1016/j.chroma.2010.03.034; Conway WD, 1990, COUNTERCURRENT CHROM; Ito Y., 1996, HIGH SPEED COUNTERCU; Mandava N. B., 1988, COUNTERCURRENT CHROM; Menet J.-M., 1999, COUNTERCURRENT CHROM; Shinomiya K, 2009, J CHROMATOGR B, V877, P955, DOI 10.1016/j.jchromb.2009.02.038; Shinomiya K, 2011, J LIQ CHROMATOGR R T, V34, P182, DOI 10.1080/10826076.2011.546151; Shinomiya K, 2013, J CHROMATOGR A, V1322, P74, DOI 10.1016/j.chroma.2013.10.096	12	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	MAR	2015	31	3					211	218				8	Chemistry, Analytical	Chemistry	CE1IW	WOS:000351566300012		
J	Dutel, H; Herrel, A; Clement, G; Herbin, M				Dutel, Hugo; Herrel, Anthony; Clement, Gael; Herbin, Marc			Redescription of the Hyoid Apparatus and Associated Musculature in the Extant Coelacanth Latimeria chalumnae: Functional Implications for Feeding	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						coelacanth; hyoid arch; hypobranchial musculature; mouth opening; intracranial joint	AQUATIC AMBYSTOMATID SALAMANDERS; PRIMITIVE ACTINOPTERYGIAN FISHES; ASTATOTILAPIA-ELEGANS TELEOSTEI; PREY CAPTURE; MOTOR PATTERNS; MORPHOLOGY; MECHANISM; EVOLUTION; ANATOMY; LEPISOSTEUS	The coelacanth Latimeria is the only extant vertebrate in which the neurocranium is divided into an anterior and a posterior portion which articulate by means of an intracranial joint. This articulation is thought to allow an elevation of the snout up to 20-degree angle, which is supposed to enhance mouth gape and velocity, in turn allowing for a powerful suction. Several functional models have been proposed to explain the skull movement in Latimeria, but they disagree on the mechanisms responsible for mandibular depression and intracranial elevation, and more precisely on the role and mobility of the hyoid apparatus during these processes. We here show that the m. coracomandibularis spans ventrally to the palate-mandible joint, and is likely involved in mandibular depression. The hyoid apparatus is sheathed by several layers of ligaments, rendering extensive movements of the hyoid bones in the anteroposterior direction unlikely. Together with the manipulation of the 3D virtual model of the skull, these observations suggest that the hyoid arch is less mobile than previously proposed, and that the movements proposed in previous models are unlikely. In the light of our new observations, we suggest that the mechanisms proposed for explaining the intracranial elevation are incomplete. Moreover, we suggest that the extensive movements of the hyoid arch elements, which were thought to accompany intracranial elevation, are unlikely. In the absence of intracranial elevation, we propose that the movements of the hyoid mainly take place in the transverse plane, allowing the lateral expansion of the orobranchial chamber. (C) 2014 Wiley Periodicals, Inc.	[Dutel, Hugo; Clement, Gael] Museum Natl Hist Nat, Dept Hist Terre, UMR CNRS MNHN UPMC 7207, Ctr Rech Paleobiodiversite & Paleoenvironm CR2P, F-75231 Paris, France; [Dutel, Hugo; Herrel, Anthony; Herbin, Marc] Museum Natl Hist Nat, UMR CNRS MNHN 7179, Mecanismes Adaptatifs Organismes Communautes, Dept Ecol & Gest Biodiversite, F-75231 Paris, France; [Dutel, Hugo] RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo, Japan; [Herrel, Anthony] Univ Ghent, Dept Biol, Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium	Dutel, H (reprint author), Museum Natl Hist Nat, Dept Hist Terre, UMR CNRS MNHN UPMC 7207, Ctr Rech Paleobiodiversite & Paleoenvironm CR2P, F-75231 Paris, France.	dutel@cdb.riken.jp	Herrel, Anthony/C-3712-2013	Herrel, Anthony/0000-0003-0991-4434	ANR TERRES Programme [ANR-2010-BLAN-607-03]	Grant sponsor: ANR TERRES Programme; Grant number: ANR-2010-BLAN-607-03 (ATM "Formes possibles, formes realisees").	Adriaens D, 2001, J MORPHOL, V208, P323; AERTS P, 1991, J MORPHOL, V208, P323, DOI 10.1002/jmor.1052080308; Aerts P, 1984, ANN MUSEE ROYAL AFRI, V262, P81; AERTS P, 1987, J MORPHOL, V194, P85, DOI 10.1002/jmor.1051940108; Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; ALEXANDE.RM, 1973, COPEIA, P156, DOI 10.2307/1442379; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; BEMIS WE, 1986, J MORPHOL, V187, P81, DOI 10.1002/jmor.1051870108; Van Wassenbergh S, 2005, J EXP BIOL, V208, P4627, DOI 10.1242/jeb.01919; Smith JLB, 1939, NATURE, V143, P455, DOI 10.1038/143455a0; Diogo R, 2008, J ANAT, V213, P391, DOI 10.1111/j.1469-7580.2008.00953.x; Carroll AM, 2003, J MORPHOL, V256, P270, DOI 10.1002/jmor.10095; LAUDER GV, 1980, J EXP BIOL, V84, P17; Bemis WE, 1986, CAN J ZOOL, V65, P2814; Bemis WE, 1986, J MORPHOL S, V1, P249; Cracraft J, 1968, AM ZOOL, V8, P354; Deban Stephen M., 2000, P65, DOI 10.1016/B978-012632590-4/50004-6; deVisser J, 1996, J MORPHOL, V228, P1, DOI 10.1002/(SICI)1097-4687(199604)228:1<1::AID-JMOR1>3.0.CO;2-B; Diogo R, 2000, BELG J ZOOL, V130, P21; Dutel H, 2013, NATURWISSENSCHAFTEN, V100, P1007, DOI 10.1007/s00114-013-1104-8; Edgeworth F. H., 1935, CRANIAL MUSCLES VERT; Edgeworth FH, 1931, P ZOOL SOC LOND, V3, P817; Forey P. L., 1998, HIST COELACANTH FISH; Grubich JR, 2001, AM ZOOL, V41, P1258, DOI 10.1668/0003-1569(2001)041[1258:PCIAFA]2.0.CO;2; Heiss E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1028; Janvier P, 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; LAUDER GV, 1985, J MORPHOL, V185, P297, DOI 10.1002/jmor.1051850304; LAUDER GV, 1988, J MORPHOL, V197, P249, DOI 10.1002/jmor.1051970302; LAUDER GV, 1982, AM ZOOL, V22, P275; Lauder GV, 1980, CHARRS SALMONID FISH, P365; LAUDER GV, 1985, FORTS ZOOL, V30, P179; LAUDER GV, 1980, COPEIA, P1; Millot J, 1978, ANATOMIE LATIMERIA C; Millot J, 1958, ANATOMIE LATIMERIA C, V1; Nulens R, 2011, SMITHIANA PUBL AQUAT, V3, P1; PATTERSON C, 1982, AM ZOOL, V22, P241; Perkins PL, 1972, THESIS YALE U; REILLY SM, 1992, BRAIN BEHAV EVOLUT, V40, P182, DOI 10.1159/000113911; ROBINEAU D, 1973, CR ACAD SCI D NAT, V276, P1305; ROBINEAU D, 1973, CR ACAD SCI D NAT, V277, P1341; SHAFFER HB, 1985, EVOLUTION, V39, P83, DOI 10.2307/2408518; THOMSON KS, 1966, SCIENCE, V153, P999, DOI 10.1126/science.153.3739.999; THOMSON KS, 1973, COPEIA, P813; THOMSON KS, 1969, BIOL REV, V44, P91, DOI 10.1111/j.1469-185X.1969.tb00823.x; Thompson K. S., 1970, Postilla, V149, P1; Thomson K.S., 1967, ZOOL J LINN SOC-LOND, V46, P223, DOI 10.1111/j.1096-3642.1967.tb00505.x; Van Wassenbergh S, 2004, ZOOMORPHOLOGY, V123, P81, DOI 10.1007/s00435-003-0090-3	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	MAR	2015	298	3					579	601		10.1002/ar.23103		23	Anatomy & Morphology	Anatomy & Morphology	CD9RO	WOS:000351436000010		
J	Hiraoka, M; Inoue, K; Senoo, H; Takada, M				Hiraoka, Mari; Inoue, Kenichi; Senoo, Haruki; Takada, Masahiko			Morphological Study of the Accommodative Apparatus in the Monkey Eye	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						accommodation; zonule; fibrillin; elastin; fibronectin; collagen	RHESUS-MONKEYS; EXTRACELLULAR-MATRIX; LENS; ZONULE	For more than a century there has been debate concerning the mechanism of accommodation-whether the lens capsule or lens material itself determines the functional relationship between ciliary muscle contractility and lens deformation during refractive adaptation. This morphological study in monkey eyes investigates the composition and distribution of several connective tissue components in the accommodative apparatus relaying muscle force to lens organization. Elastin distributes on the marginal surface of the ciliary process. A zonule is composed of fibrillin produced by epithelial cells of the process. In the progress of extension over the posterior chamber, fibrils unite into strands and possess longitudinal plasticity. By induction of the elastin network, strands extend in a concentric direction covering the equatorial region of the capsule. Upon tethering to the lens, the strand ramifies into fibrils, penetrating deeply close to the epithelial layer of the lens and binding with the collagen of the intercellular spaces. Tight linkage of the zonule with the capsule transmits precise contractility. Inside the lens, the cortical layer's elastic connective tissue network forms widely spaced lamellae of crystalline fibers. In contrast, the central nuclear lamellae are tightly opposed. The accumulation of lamellae is greater in the anterior cortex than in the posterior, yielding a more variable anterior chamber depth in the visual axis. The plasticity of the zonule and connective tissue distribution inside the lens produces an adjustable configuration. Thus, tight linkage between the dynamism of the capsule with interaction of the lenticular flexibility provides a novel understanding of accommodation. (C) 2014 The Authors The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology Published by Wiley Periodicals, Inc.	[Hiraoka, Mari] Cent Eye Infirm, Koganei, Tokyo 1840015, Japan; [Hiraoka, Mari; Inoue, Kenichi; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan; [Senoo, Haruki] Akita Univ, Dept Cell Biol, Grad Sch Med, Akita 010, Japan	Hiraoka, M (reprint author), Cent Eye Infirm, 1-24-15 Nukui Kitamachi, Koganei, Tokyo 1840015, Japan.	mari9190@true.ocn.ne.jp	Inoue, Ken-ichi/K-4103-2015	Inoue, Ken-ichi/0000-0002-5683-5280			Kuchtey J, 2014, J OCUL PHARMACOL TH, V30, P170, DOI 10.1089/jop.2013.0184; Kielty CM, 2002, J CELL SCI, V115, P2817; Lutjen-Drecoll E, 2010, INVEST OPHTH VIS SCI, V51, P1554, DOI 10.1167/iovs.09-4008; Glasser A, 2006, INVEST OPHTH VIS SCI, V47, P278, DOI 10.1167/iovs.05-0890; Muiznieks LD, 2013, BBA-MOL BASIS DIS, V1832, P866, DOI 10.1016/j.bbadis.2012.11.022; Glasser A, 1999, OPHTHALMOLOGY, V106, P863, DOI 10.1016/S0161-6420(99)00502-3; Croft MA, 2013, INVEST OPHTH VIS SCI, V54, P5035, DOI 10.1167/iovs.12-10846; Croft MA, 2006, INVEST OPHTH VIS SCI, V47, P1076, DOI 10.1167/iovs.04-1523; Croft MA, 2009, EXP EYE RES, V89, P824, DOI 10.1016/j.exer.2009.07.009; Duke-Elder S., 1970, SYSTEM OPHTHALMOLOGY, VV, P153; FINCHAM EF, 1955, J PHYSIOL-LONDON, V128, P99; Gambra D, 2013, BIOMED OPT EXP, V1, P1595; Glasser A, 2003, ADLERS PHYSL EYE CLI, P197; Hiraoka Mari, 2006, Nippon Ganka Gakkai Zasshi, V110, P370; Hiraoka M, 2010, ANAT REC, V293, P1797, DOI 10.1002/ar.21220; Hiraoka M, 2013, ANAT REC, V296, P726, DOI 10.1002/ar.22684; HIRAOKA M, 1989, NEUROSCI RES, V7, P1, DOI 10.1016/0168-0102(89)90032-1; Hiraoka M, 2002, J JAP OPHTHALMOL SOC, V106, P565; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Kaufman P. L., 1992, ADLERS PHYSL EYE CLI, P391; Ostrin LA, 2007, EXP EYE RES, V84, P302, DOI 10.1016/j.exer.2006.10.003; Sherratt MJ, 2001, MICRON, V32, P185, DOI 10.1016/S0968-4328(99)00082-7; Streeten B W, 1982, Trans Am Ophthalmol Soc, V80, P823; Traboulsi E I, 2000, Ophthalmic Genet, V21, P9, DOI 10.1076/1381-6810(200003)21:1;1-I;FT009; VANALPHEN GWHM, 1976, INVEST OPHTH VISUAL, V15, P502; Wilson R S, 1993, Trans Am Ophthalmol Soc, V91, P401	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	MAR	2015	298	3					630	636		10.1002/ar.23100		7	Anatomy & Morphology	Anatomy & Morphology	CD9RO	WOS:000351436000014		
J	Kubo, N; Cayo-Colca, IS; Miyano, T				Kubo, Naoko; Silvia Cayo-Colca, Ilse; Miyano, Takashi			Effect of estradiol-17 beta during in vitro growth culture on the growth, maturation, cumulus expansion and development of porcine oocytes from early antral follicles	ANIMAL SCIENCE JOURNAL			English	Article						blastocyst; electro-stimulation; estradiol-17; in vitro growth; porcine oocyte	GRANULOSA-CELL DIFFERENTIATION; PIG OOCYTES; MOUSE OOCYTES; MEIOTIC COMPETENCE; ER-BETA; RECEPTOR; BOVINE; OVARY; FERTILIZATION; COMPLEXES	Growing porcine oocytes from early antral follicles can acquire meiotic and developmental competence under suitable culture conditions, but at lower rates compared to full-grown oocytes. We postulated that estradiol-17 (E-2) supported the acquisition of meiotic and developmental competence as well as cumulus-expansion ability during growth culture. Growing oocytes from early antral follicles (1.2 to 1.5mm in diameter) were grown in vitro for 5 days in a medium containing 0, 10(-7), 10(-6), 10(-5) or 10(-4)mol/L E-2; after in vitro maturation, 35, 58, 47, 74 and 49% of oocytes matured to metaphase II, 25, 79, 77, 90 and 97% acquired cumulus-expansion ability, and 23, 54, 63, 89 and 64% were fully surrounded by cumulus cells, respectively. Following maturation, electro-stimulation was applied to the oocytes grown with 10(-5)mol/L E-2. After 6 days of culture, in vitro-grown oocytes developed to the blastocyst stage at a rate similar to that for full-grown oocytes (31% and 40%, respectively). Therefore, we suggest that the use of E-2 during growth culture improves the meiotic and developmental competence of oocytes, cumulus-expansion ability, and cumulus cell attachment to the oocytes.	[Kubo, Naoko; Silvia Cayo-Colca, Ilse; Miyano, Takashi] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Silvia Cayo-Colca, Ilse] Toribio Rodriguez Mendoza Natl Univ, Chachapoyas, Peru	Miyano, T (reprint author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	miyano@kobe-u.ac.jp			JSPS KAKENHI [25292192]; JASSO Follow-up Research Fellowship	The authors would like to thank the staff of the Kobe Meat Inspection Office (Kobe, Japan) for supplying porcine ovaries. This work was supported by JSPS KAKENHI Grant Number 25292192 to T.M., and by JASSO Follow-up Research Fellowship to I.S.C.-C.	AINSWORTH L, 1980, BIOL REPROD, V23, P621, DOI 10.1095/biolreprod23.3.621; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Wu D, 2006, BIOL REPROD, V75, P547, DOI 10.1095/biolreprod.106.051300; Maedomari N, 2007, THERIOGENOLOGY, V67, P983, DOI 10.1016/j.theriogenology.2006.11.012; Marei WF, 2012, THERIOGENOLOGY, V78, P670, DOI 10.1016/j.theriogenology.2012.03.013; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Hu YC, 2004, P NATL ACAD SCI USA, V101, P11209, DOI 10.1073/pnas.0404372101; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Erickson GF, 2001, FERTIL STERIL, V76, P943, DOI 10.1016/S0015-0282(01)02859-X; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555; Wongsrikeao P, 2005, REPROD DOMEST ANIM, V40, P166, DOI 10.1111/j.1439-0531.2005.00576.x; BROWER PT, 1982, DEV BIOL, V90, P144, DOI 10.1016/0012-1606(82)90219-6; MOTLIK J, 1976, J EXP ZOOL, V198, P155, DOI 10.1002/jez.1401980205; FUNAHASHI H, 1994, J REPROD FERTIL, V101, P159; Diaz FJ, 2006, DEV BIOL, V299, P91, DOI 10.1016/j.ydbio.2006.07.012; Hsieh M, 2009, SEMIN REPROD MED, V27, P52, DOI 10.1055/s-0028-1108010; Dupont S, 2000, DEVELOPMENT, V127, P4277; Takahashi T, 2006, J BIOL CHEM, V281, P37117, DOI 10.1074/jbc.M608202200; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Emmen JMA, 2005, ENDOCRINOLOGY, V146, P2817, DOI 10.1210/en.2004-1108; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Yamauchi N, 1999, BIOL REPROD, V61, P828, DOI 10.1095/biolreprod61.3.828; Nagai T, 2001, THERIOGENOLOGY, V55, P1291, DOI 10.1016/S0093-691X(01)00483-6; BABALOLA GO, 1988, J REPROD FERTIL, V84, P79; Cayo-Colca IS, 2011, THERIOGENOLOGY, V75, P1602, DOI 10.1016/j.theriogenology.2010.12.023; Couse JF, 2005, ENDOCRINOLOGY, V146, P3247, DOI 10.1210/en.2005-0213; Emori C, 2013, ENDOCRINOLOGY, V154, P4859, DOI 10.1210/en.2013-1536; Hirao Y, 2004, BIOL REPROD, V70, P83, DOI 10.1095/biolreprod.103.021238; Hirao Y, 1995, ZYGOTE, V3, P325; Kanayama N, 2002, ZYGOTE, V10, P261, DOI 10.1017/S0967199402002344; MINATO Y, 1982, Japanese Journal of Zootechnical Science, V53, P480; Miyano Takashi, 2007, Soc Reprod Fertil Suppl, V63, P531; MOTLIK J, 1986, THERIOGENOLOGY, V25, P87, DOI 10.1016/0093-691X(86)90185-8; NAGAI T, 1994, THERIOGENOLOGY, V41, P73, DOI 10.1016/S0093-691X(05)80051-2; Sugiura K, 2010, MOL ENDOCRINOL, V24, P2303, DOI 10.1210/me.2010-0260; Yamamoto K, 1999, THERIOGENOLOGY, V52, P81, DOI 10.1016/S0093-691X(99)00111-9; Yokoo M, 2004, INT REV CYTOL, V235, P251, DOI 10.1016/S0074-7696(04)35006-0	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAR	2015	86	3					251	259		10.1111/asj.12283		9	Agriculture, Dairy & Animal Science	Agriculture	CD8UE	WOS:000351371000002		
J	Ishida, K; Kishi, Y; Oishi, K; Hirooka, H; Kumagai, H				Ishida, Kyohei; Kishi, Yosuke; Oishi, Kazato; Hirooka, Hiroyuki; Kumagai, Hajime			Effects of feeding polyphenol-rich winery wastes on digestibility, nitrogen utilization, ruminal fermentation, antioxidant status and oxidative stress in wethers	ANIMAL SCIENCE JOURNAL			English	Article						antioxidant; polyphenols; wethers; winery grape pomace; winery sedimant	PLANT-EXTRACTS RICH; GRAPE POMACE; URINARY 8-HYDROXY-2-DEOXYGUANOSINE; SOLUBLE-PROTEINS; DIETARY FIBER; GRADED-LEVELS; ENERGY VALUE; BY-PRODUCTS; DNA-DAMAGE; SHEEP	Four wethers were used in a 4x4 Latin square design experiment to evaluate the availability of two types of winery wastes, winery sediment and grape pomace, as ruminant feeds possessing antioxidant activities. Each wether was assigned to one of the following four treatments: (i) 75g/kg winery sediment (WS) on a dry matter (DM) basis; (ii) 166g/kg DM winery grape pomace (WP); (iii) control diet (CD; 17g/kg DM soybean meal);and (iv) only tall fescue hay (TFH; no additive). Winery sediment and grape pomace had high levels of polyphenols and of radical scavenging activities. Feeding with winery sediment and grape pomace did not negatively affect the intake, but it depressed crude protein (CP) digestibility compared with CD (P=0.052 and P<0.01 for WS and WP, respectively). Polyphenols in winery wastes decreased ruminal ammonia production (P=0.089 and P<0.05), likely due to their inhibitive effect on microbial activities in the rumen. The addition of winery sediment and grape pomace decreased urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG; an index of oxidative damages) excretion per day (P<0.05 and P=0.059). The results indicated that winery sediment and grape pomace could alter nitrogen metabolism and/or act as new antioxidants for ruminants.	[Ishida, Kyohei; Kishi, Yosuke; Oishi, Kazato; Hirooka, Hiroyuki; Kumagai, Hajime] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources, Kyoto 6068502, Japan	Kumagai, H (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources,Sakyo Ku, Kyoto 6068502, Japan.	hkuma@kais.kyoto-u.ac.jp			Research Projects for Production of Valuable Livestock by Feeding Self-sufficient Forage Crops, Institute of Livestock and Grassland Science, National Agriculture and Food research Organization (NARO), Japan	This Study was financially supported by the Research Projects for Production of Valuable Livestock by Feeding Self-sufficient Forage Crops, Institute of Livestock and Grassland Science, National Agriculture and Food research Organization (NARO), Japan.	Alia M, 2003, NUTR RES, V23, P1251, DOI 10.1016/S0271-5317(03)00131-3; Alipour D, 2010, LIVEST SCI, V128, P87, DOI 10.1016/j.livsci.2009.11.003; Sies H, 1997, EXP PHYSIOL, V82, P291; Besharati M, 2009, ANIM FEED SCI TECH, V152, P198, DOI 10.1016/j.anifeedsci.2009.04.011; Gladine C, 2007, ANIM FEED SCI TECH, V136, P281, DOI 10.1016/j.anifeedsci.2006.09.003; Atkinson RL, 2007, J ANIM SCI, V85, P3322, DOI 10.2527/jas.2006-417; Huang XJ, 2006, SENSORS-BASEL, V6, P756, DOI 10.3390/s6070756; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; Oliveira RA, 2010, J DAIRY SCI, V93, P4280, DOI 10.3168/jds.2010-3314; Spanghero M, 2009, ANIM FEED SCI TECH, V152, P243, DOI 10.1016/j.anifeedsci.2009.04.015; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; Vinson JA, 2001, J AGR FOOD CHEM, V49, P5315, DOI 10.1021/jf0009293; Abarghuei MJ, 2010, LIVEST SCI, V132, P73, DOI 10.1016/j.livsci.2010.05.002; McSweeney CS, 2001, ANIM FEED SCI TECH, V91, P83, DOI 10.1016/S0377-8401(01)00232-2; RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279; Bustamante MA, 2008, WASTE MANAGE, V28, P372, DOI 10.1016/j.wasman.2007.01.013; Makkar HPS, 2003, SMALL RUMINANT RES, V49, P241, DOI 10.1016/S0921-4488(03)00142-1; Waghorn G, 2008, ANIM FEED SCI TECH, V147, P116, DOI 10.1016/j.anifeedsci.2007.09.013; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; HAGERMAN AE, 1992, J RANGE MANAGE, V45, P57, DOI 10.2307/4002526; Makris DP, 2007, J FOOD COMPOS ANAL, V20, P125, DOI 10.1016/j.jfca.2006.04.010; O'Grady MN, 2006, MEAT SCI, V73, P132, DOI 10.1016/j.meatsci.2005.11.008; Mizutani K, 2001, CLIN EXP PHARMACOL P, V28, P55, DOI 10.1046/j.1440-1681.2001.03415.x; Sgorlon S, 2006, SMALL RUMINANT RES, V64, P143, DOI 10.1016/j.smallrumres.2005.04.009; Gonzalez-Paramas AM, 2004, J AGR FOOD CHEM, V52, P234, DOI 10.1021/jf0348727; Gladine C, 2007, BRIT J NUTR, V98, P691, DOI 10.1017/S0007114507742666; Provenza FD, 2000, J ANIM SCI, V78, P1206; Wang H, 1997, J AGR FOOD CHEM, V45, P304, DOI 10.1021/jf960421t; BRANDWILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Lu YR, 1999, FOOD CHEM, V65, P1, DOI 10.1016/S0308-8146(98)00245-3; Greathead H, 2003, P NUTR SOC, V62, P279, DOI 10.1079/PNS2002197; AOAC, 2000, OFFICIAL METHODS ANA; Basalan M, 2011, ANIM FEED SCI TECH, V169, P194, DOI 10.1016/j.anifeedsci.2011.07.005; Baumgartel T, 2007, SMALL RUMINANT RES, V67, P302, DOI 10.1016/j.smallrumres.2005.11.002; Brooker JD, 2005, ANIM FEED SCI TECH, V121, P1, DOI 10.1016/j.anifeedsci.2005.02.004; Chen CM, 2008, ASIA PAC J CLIN NUTR, V17, P408; Conway E. J., 1962, MICRODIFFUSION ANAL; Da Silva J.M.R., 1991, J AGR FOOD CHEM, V39, P1549, DOI 10.1021/jf00009a002; Fukuda T, 2004, BIOFACTORS, V21, P251; HEANEY DP, 1963, J ANIM SCI, V22, P956; Iwasawa H, 2010, FOOD SCI TECHNOL RES, V16, P135, DOI 10.3136/fstr.16.135; Koike A, 2010, GRASSL SCI, V56, P95, DOI 10.1111/j.1744-697X.2010.00180.x; Kwon SW, 2004, J AGR FOOD CHEM, V52, P7258, DOI 10.1021/jf048940g; Lee JH, 2002, J AGR FOOD CHEM, V50, P3971, DOI 10.1021/jf011587j; Mangan J L, 1988, Nutr Res Rev, V1, P209, DOI 10.1079/NRR19880015; Melaku S, 2004, ANIM FEED SCI TECH, V117, P61, DOI 10.1016/j.anifeedsci.2004.07.016; Min BR, 2005, ANIM FEED SCI TECHNO, V123-124, P615, DOI 10.1016/j.anifeedsci.2005.04.050; National Research Council, 2007, NUTR REQ SMALL RUM; Negro C, 2003, BIORESOURCE TECHNOL, V87, P41, DOI 10.1016/S0960-8524(02)00202-X; Organisation Internationale de la vigne et du vin (OIV: International Organisation of Vine and Wine), 2007, STRUCT WORLD VIT IND; Puech JL, 1999, AM J ENOL VITICULT, V50, P469; Shi John, 2003, Journal of Medicinal Food, V6, P291, DOI 10.1089/109662003772519831; SICHEL G, 1991, FREE RADICAL BIO MED, V11, P1, DOI 10.1016/0891-5849(91)90181-2; Singh B, 2003, J AGR FOOD CHEM, V51, P5579, DOI 10.1021/jf021150r; Statistical Analysis System (SAS), 1998, SAS STAT US GUID VER; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Swanson KS, 2001, J ANIM SCI, V79, P919; TAMURA H, 1994, J AGR FOOD CHEM, V42, P1612, DOI 10.1021/jf00044a005; Vaithiyanathan S, 2007, ANIM FEED SCI TECH, V133, P177, DOI 10.1016/j.anifeedsci.2006.04.003; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583; Veskoukis AS, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/185867; YOKOTSUKA K, 1991, J FERMENT BIOENG, V71, P248, DOI 10.1016/0922-338X(91)90276-M; Yoshida R, 2002, CANCER EPIDEM BIOMAR, V11, P1076; Yuki K, 2010, ACTA OPHTHALMOL, V88, pe259, DOI 10.1111/j.1755-3768.2010.01997.x	64	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAR	2015	86	3					260	269		10.1111/asj.12280		10	Agriculture, Dairy & Animal Science	Agriculture	CD8UE	WOS:000351371000003		
J	Saleh, AA; Hayashi, K; Ijiri, D; Ohtsuka, A				Saleh, Ahmed A.; Hayashi, Kunioki; Ijiri, Daichi; Ohtsuka, Akira			Effect of feeding Aspergillus awamori and canola seed on the growth performance and muscle fatty acid profile in broiler chicken	ANIMAL SCIENCE JOURNAL			English	Article						Aspergillus awamori; broiler; canola seed; fatty acid; growth performance	LACTOBACILLUS-ACIDOPHILUS; DIETARY SUPPLEMENTATION; ANIMAL-TISSUES; BETA-MANNANASE; CHOLESTEROL; QUALITY; OIL; BEEF; MEAT; METABOLISM	The aim of this study was to examine effects of dietary supplementation with Aspergillus awamori and feeding canola seed on the growth and fatty acid profile in broilers. Twenty-eight chicks (15 days old) were assigned to the following groups: (1) control, fed a basal diet; (2) awamori, fed the basal diet supplemented with 0.05% A.awamori; (3) canola, fed a diet containing 5% canola seed; and (4) canola+awamori, fed the canola diet supplemented with A.awamori (seven birds/group). Body weight gain was increased by A.awamori but not influenced by canola seed. Breast muscle weight was increased in either awamori or canola groups. Although plasma triglyceride and cholesterol were decreased by feeding A.awamori or canola seed, fat content in the breast muscle were increased, accompanied by decrease in saturated fatty acids and increase in unsaturated fatty acids. Moreover, decreased thiobarbituric acid reactive substance and increased -tocopherol content in the breast muscle was observed in all experimental groups. In conclusion, these results suggested that feeding canola seed and A.awamori might improve growth performance, and modified muscle fatty acid profile and -tocopherol content, suggesting that they may improve meat quality.	[Saleh, Ahmed A.; Ijiri, Daichi; Ohtsuka, Akira] Kagoshima Univ, Dept Biochem Sci & Technol, Fac Agr, Kagoshima 8900065, Japan; [Hayashi, Kunioki] Biogenkoji Res Inst, Kirishima, Japan; [Saleh, Ahmed A.] Kafrelsheikh Univ, Dept Poultry Prod, Fac Agr, Kafr Al Sheikh, Egypt	Ohtsuka, A (reprint author), Kagoshima Univ, Dept Biochem Sci & Technol, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	ohtsuka@chem.agri.kagoshima-u.ac.jp					Amer M. Y., 2012, Veterinary World, V5, P160, DOI 10.5455/vetworld.2012.160-165; Rowe LJ, 2004, J ANIM SCI, V82, P785; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Noh DO, 1997, J DAIRY SCI, V80, P3107; Gracia MI, 2003, POULTRY SCI, V82, P436; Bryhni EA, 2002, MEAT SCI, V62, P1, DOI 10.1016/S0309-1740(01)00211-X; Meng X, 2005, POULTRY SCI, V84, P37; LING WH, 1995, LIFE SCI, V57, P195, DOI 10.1016/0024-3205(95)00263-6; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Assadi E, 2011, J APPL POULTRY RES, V20, P95, DOI 10.3382/japr.2010-00201; Rowe LJ, 2004, J ANIM SCI, V82, P3254; RADWAN SS, 1978, J CHROMATOGR SCI, V16, P538; FAUSTMAN C, 1989, J FOOD SCI, V54, P858, DOI 10.1111/j.1365-2621.1989.tb07899.x; Mantzioris E, 2000, AM J CLIN NUTR, V72, P42; Kurakake M, 2001, CURR MICROBIOL, V42, P377, DOI 10.1007/s002840010233; Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023; Hong KJ, 2004, J MED FOOD, V7, P430, DOI 10.1089/jmf.2004.7.430; Wakamatsu D, 2005, BIOSCI BIOTECH BIOCH, V69, P1568, DOI 10.1271/bbb.69.1568; Chegeni A, 2011, J APPL ANIM RES, V39, P261, DOI 10.1080/09712119.2011.605319; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukushima M, 1996, BRIT J NUTR, V76, P857, DOI 10.1079/BJN19960092; Garcia-Maroto F, 2002, LIPIDS, V37, P417, DOI 10.1007/s1145-002-0910-6; Hajati H, 2010, AM J ANIMAL VET SCI, V5, P155; Ignatius S, 2010, ASIAN J FOOD AGROIND, V3, P293; Kaminishi Yoshio, 1999, Journal of National Fisheries University, V47, P113; Kim S. H., 2003, Korean Journal of Poultry Science, V30, P151; Kuwahara H, 2004, J AGR FOOD CHEM, V52, P4380, DOI [10.1021/jf040045+, 10.1021/jf040045]; Liong MT, 2005, INT DAIRY J, V15, P391, DOI 10.1016/j.idairyj.2004.08.007; National Research Council (NRC), 1994, NUTR REQ POULTR; Nobar SR, 2010, J CELL ANIMAL BIOL, V4, P125; Ntanios FY, 1999, ATHEROSCLEROSIS, V143, P341, DOI 10.1016/S0021-9150(98)00321-9; Rahimi S, 2011, J AGR SCI TECH-IRAN, V13, P353; RICHARD A., 2004, MICROBIOLOGY, V150, P2881; Saleh AA, 2012, ANIM SCI J, V83, P594, DOI 10.1111/j.1740-0929.2011.00999.x; Saleh AA, 2012, BRIT J NUTR, V108, P1596, DOI 10.1017/S0007114511007069; Saleh AA, 2011, J POULT SCI, V48, P201, DOI 10.2141/jpsa.011019; Shahryar H. A., 2011, Current Research Journal of Biological Sciences, V3, P388; Talebali H., 2005, International Journal of Poultry Science, V4, P982; Taylor DL, 2000, EFFECT MATERNAL DIET; Wyke SM, 2005, CELL SIGNAL, V17, P67, DOI 10.1016/j.cellsig.2004.05.015; Yamamoto Masahiro, 2007, Journal of Poultry Science, V44, P291, DOI 10.2141/jpsa.44.291; Zanini S. F., 2006, International Journal of Poultry Science, V5, P241	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAR	2015	86	3					305	311		10.1111/asj.12281		7	Agriculture, Dairy & Animal Science	Agriculture	CD8UE	WOS:000351371000008		
J	Honda, K; Saneyasu, T; Shimatani, T; Aoki, K; Yamaguchi, T; Nakanishi, K; Kamisoyama, H				Honda, Kazuhisa; Saneyasu, Takaoki; Shimatani, Tomohiko; Aoki, Koji; Yamaguchi, Takuya; Nakanishi, Kiwako; Kamisoyama, Hiroshi			Intracerebroventricular administration of chicken glucagon-like peptide-2 potently suppresses food intake in chicks	ANIMAL SCIENCE JOURNAL			English	Article						appetite; chicken; feed intake; glucagon	MELANOCYTE-STIMULATING HORMONE; CORTICOTROPIN-RELEASING-FACTOR; PROGLUCAGON-DERIVED PEPTIDE; CENTRAL-NERVOUS-SYSTEM; BODY-WEIGHT; LIPID-METABOLISM; RECEPTOR; GENES; NEUROPEPTIDES; OXYNTOMODULIN	Glucagon-related peptides, such as glucagon-like peptide (GLP)-1, GLP-2 and oxyntomodulin (OXM), are processed from an identical precursor proglucagon. In mammals, all of these peptides are suggested to be involved in the central regulation of food intake. We previously showed that intracerebroventricular administration of chicken OXM and GLP-1 significantly suppressed food intake in chicks. Here, we show that central administration of chicken GLP-2 potently suppresses food intake in chicks. Male 8-day-old chicks (Gallus gallus domesticus) were used in all experiments. Intracerebroventricular administration of chicken GLP-2 significantly suppressed food intake in chicks. Plasma glucose concentration was significantly decreased by chicken GLP-2, whereas plasma nonesterified fatty acid concentration was significantly increased. Intracerebroventricular administration of chicken GLP-2 did not affect plasma corticosterone concentration. In addition, the anorexigenic effect of GLP-2 was not reversed by the corticotropin-releasing factor (CRF) receptor antagonist -helical CRF, suggesting that CRF is not a downstream mediator of the anorexigenic pathway of GLP-2 in chicks. Intracerebroventricular administration of an equimolar amount of GLP-1 and GLP-2, but not OXM, significantly suppressed food intake in both broiler and layer chicks. All our findings suggest that GLP-2 functions as a potent anorexigenic peptide in the brain, as well as GLP-1, in chicks.	[Honda, Kazuhisa; Saneyasu, Takaoki; Shimatani, Tomohiko; Aoki, Koji; Yamaguchi, Takuya; Nakanishi, Kiwako; Kamisoyama, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Kobe, Hyogo 6578501, Japan	Honda, K (reprint author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	honda@tiger.kobe-u.ac.jp					Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Wang YJ, 2012, ENDOCRINOLOGY, V153, P5247, DOI 10.1210/en.2012-1586; Burrin DG, 2003, DOMEST ANIM ENDOCRIN, V24, P103, DOI 10.1016/S0739-7240(02)00210-2; Saneyasu T, 2011, PEPTIDES, V32, P996, DOI 10.1016/j.peptides.2011.03.006; Honda K, 2014, PEPTIDES, V52, P98, DOI 10.1016/j.peptides.2013.12.008; Bungo T, 2011, J POULT SCI, V48, P1, DOI 10.2141/jpsa.010117; Shiraishi J, 2009, J POULT SCI, V46, P144, DOI 10.2141/jpsa.46.144; Furuse M, 1997, EUR J PHARMACOL, V339, P211, DOI 10.1016/S0014-2999(97)01391-5; Shousha S, 2007, NEUROSCI LETT, V415, P102, DOI 10.1016/j.neulet.2007.01.007; Richards MP, 2008, GEN COMP ENDOCR, V156, P323, DOI 10.1016/j.ygcen.2008.01.014; Honda K, 2012, COMP BIOCHEM PHYS A, V163, P260, DOI 10.1016/j.cbpa.2012.08.005; Honda K, 2007, NEUROSCI LETT, V416, P198, DOI 10.1016/j.neulet.2007.02.011; Pocai A, 2012, J ENDOCRINOL, V215, P335, DOI 10.1530/JOE-12-0368; Tachibana T, 2007, COMP BIOCHEM PHYS A, V147, P1104, DOI 10.1016/j.cbpa.2007.03.023; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Saneyasu T, 2013, COMP BIOCHEM PHYS B, V166, P1, DOI 10.1016/j.cbpb.2013.06.003; Richards MP, 2007, POULTRY SCI, V86, P1478; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; Honda K, 2014, NEUROSCI LETT, V564, P57, DOI 10.1016/j.neulet.2014.02.008; Kamisoyama H, 2009, NEUROSCI LETT, V458, P102, DOI 10.1016/j.neulet.2009.04.041; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; INOKUCHI A, 1984, PHYSIOL BEHAV, V33, P397, DOI 10.1016/0031-9384(84)90160-4; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Richards MP, 2009, GEN COMP ENDOCR, V163, P39, DOI 10.1016/j.ygcen.2008.09.010; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Carr JA, 2002, COMP BIOCHEM PHYS B, V132, P151, DOI 10.1016/S1096-4959(01)00545-0; Furuse M., 2002, Animal Science Journal, V73, P83, DOI 10.1046/j.1344-3941.2002.00014.x; Huang G, 2012, DOMEST ANIM ENDOCRIN, V43, P1, DOI 10.1016/j.domaniend.2012.01.005; Irwin DM, 2005, BIOSCIENCE, V55, P583, DOI 10.1641/0006-3568(2005)055[0583:EOHFPP]2.0.CO;2; Irwin DM, 2005, J HERED, V96, P205, DOI 10.1093/jhered/esi024; KUENZEL WJ, 1994, J NUTR, V124, pS1355; Tachibana T, 2006, COMP BIOCHEM PHYS A, V143, P112, DOI 10.1016/j.cbpa.2005.11.007; Tang-Christensen M, 2000, NAT MED, V6, P802, DOI 10.1038/77535	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAR	2015	86	3					312	318		10.1111/asj.12282		7	Agriculture, Dairy & Animal Science	Agriculture	CD8UE	WOS:000351371000009		
J	Kimoto-Nira, H; Yamasaki, S; Sasaki, K; Moriya, N; Takenaka, A; Suzuki, C				Kimoto-Nira, Hiromi; Yamasaki, Seishi; Sasaki, Keisuke; Moriya, Naoko; Takenaka, Akio; Suzuki, Chise			New lactic acid bacterial strains from traditional Mongolian fermented milk products have altered adhesion to porcine gastric mucin depending on the carbon source	ANIMAL SCIENCE JOURNAL			English	Article						adhesive ability; carbohydrate preference; probiotics	LACTOBACILLUS-PLANTARUM; GASTROINTESTINAL-TRACT; EXTRACELLULAR-MATRIX; INTESTINAL MUCUS; CACO-2 CELLS; IN-VITRO; SURFACE; SURVIVAL; HYDROPHOBICITY; IDENTIFICATION	Attachment of lactic acid bacteria to the mucosal surface of the gastrointestinal tract is a major property of probiotics. Here, we examined the ability of 21 lactic acid bacterial strains isolated from traditional fermented milk products in Mongolia to adhere to porcine gastric mucin in vitro. Higher attachment was observed with Lactobacillus delbrueckii subsp. bulgaricus strains 6-8 and 8-1 than with Lactobacillus rhamnosusGG (positive control). Lactococcus lactis subsp. cremoris strain 7-1 adhered to mucin as effectively as did strain GG. Heat inactivation decreased the adhesive ability of strains 6-8 and 8-1 but did not affect strain 7-1. The adhesion of strains 6-8, 7-1 and 8-1 was significantly inhibited when the cells were pretreated with periodate and trypsin, indicating that proteinaceous and carbohydrate-like cell surface compounds are involved in the adhesion of these strains. The adhesion of strain 7-1 was affected by the type of carbohydrate present in the growth medium, being higher with fructose than with lactose, galactose or xylose as the carbon source. The sugar content of 7-1 cells grown on various carbohydrates was negatively correlated with its adhesive ability. We provide new probiotic candidate strains and new information regarding carbohydrate preference that influences lactic acid bacterial adhesion to mucin.	[Kimoto-Nira, Hiromi; Sasaki, Keisuke; Moriya, Naoko; Suzuki, Chise] NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan; [Yamasaki, Seishi] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki, Japan; [Takenaka, Akio] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	Kimoto-Nira, H (reprint author), NARO Inst Livestock & Grassland Sci, Ikenodai 2, Tsukuba, Ibaraki 3050901, Japan.	anne@affrc.go.jp			JIRCAS project 'Development of a Sustainable Agro-Pastoral System in Semi-Arid Areas of Mongolia'	We thank Ms. C. Koitabashi, Ms. X. Y. Yu, and Ms. M. Nishimura for their technical assistance. We also thank Professor S. Demberel for providing us with useful information about dairy products in Mongolia. This study was supported, in part, by JIRCAS project 'Development of a Sustainable Agro-Pastoral System in Semi-Arid Areas of Mongolia'.	An Ying, 2004, Animal Science Journal, V75, P245, DOI 10.1111/j.1740-0929.2004.00183.x; Looijesteijn PJ, 1999, APPL ENVIRON MICROB, V65, P5003; Munoz-Provencio D, 2009, ARCH MICROBIOL, V191, P153, DOI 10.1007/s00203-008-0436-9; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; GREENE JD, 1994, APPL ENVIRON MICROB, V60, P4487; Tallon R, 2007, J APPL MICROBIOL, V102, P442, DOI 10.1111/j.1365-2672.2006.03086.x; KLIJN N, 1995, APPL ENVIRON MICROB, V61, P2771; CONWAY PL, 1989, J GEN MICROBIOL, V135, P1167; Moorman MA, 2008, J FOOD PROTECT, V71, P182; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; HERP A, 1979, MOL CELL BIOCHEM, V23, P27; Boonaert CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000; Kimoto-Nira H, 2010, INT J FOOD MICROBIOL, V143, P226, DOI 10.1016/j.ijfoodmicro.2010.07.033; WADSTROM T, 1987, J APPL BACTERIOL, V62, P513, DOI 10.1111/j.1365-2672.1987.tb02683.x; Ouwehand AC, 2000, LETT APPL MICROBIOL, V31, P82, DOI 10.1046/j.1472-765X.2000.00773.x; Kimoto-Nira H, 2009, INT J FOOD MICROBIOL, V131, P183, DOI 10.1016/j.ijfoodmicro.2009.02.021; MOZES N, 1988, BIOCHIM BIOPHYS ACTA, V945, P324, DOI 10.1016/0005-2736(88)90495-6; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Kimoto-Nira H, 2008, J FOOD PROTECT, V71, P2124; Azuma Y, 2001, BIOSCI BIOTECH BIOCH, V65, P2326, DOI 10.1271/bbb.65.2326; Benno Y., 1996, NUTR TODAY S, V31, p9S; Burentegusi Shuangquan, 2006, ANIMAL SCI J, V77, P235; Dufrene YF, 1997, J BACTERIOL, V179, P1023; EKWUNIFE FS, 1991, FEMS MICROBIOL LETT, V82, P257; GILLILAN.SE, 1974, APPL MICROBIOL, V27, P793; Grobben GJ, 1997, APPL MICROBIOL BIOT, V48, P516, DOI 10.1007/s002530051089; Habimana O, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-36; Havenaar R., 1992, Probiotics: the scientific basis., P209; Jonsson H, 2001, FEMS MICROBIOL LETT, V204, P19, DOI 10.1016/S0378-1097(01)00369-X; Khoo Gloria, 2005, J Calif Dent Assoc, V33, P973; Kimoto H, 2003, CAN J MICROBIOL, V49, P707, DOI [10.1139/w03-092, 10.1139/W03-092]; Lee W-K, 2005, BIOSCI MICROFLORA, V24, P11; Messner P, 1997, FEMS MICROBIOL REV, V20, P25, DOI 10.1016/S0168-6445(97)00041-7; Morata de Ambrosini V, 1998, J FOOD PROTECT, V61, P557; Narisawa N, 2005, J BIOSCI BIOENG, V99, P78, DOI 10.1263/jbb.99.78; Nishitani Y, 2009, INT IMMUNOPHARMACOL, V9, P1444, DOI 10.1016/j.intimp.2009.08.018; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; Sanchez B, 2009, LETT APPL MICROBIOL, V48, P618, DOI 10.1111/j.1472-765X.2009.02579.x; Styriak I, 2003, LETT APPL MICROBIOL, V37, P329, DOI 10.1046/j.1472-765X.2003.01402.x; Takeda S, 2011, ANIM SCI J, V82, P571, DOI 10.1111/j.1740-0929.2011.00874.x; Watanabe K, 2009, INT J SYST EVOL MICR, V59, P1535, DOI 10.1099/ijs.0.006247-0; Watanabe K, 2008, WORLD J MICROB BIOT, V24, P1313, DOI 10.1007/s11274-007-9604-3	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAR	2015	86	3					325	332		10.1111/asj.12270		8	Agriculture, Dairy & Animal Science	Agriculture	CD8UE	WOS:000351371000011		
J	Sasaki, Y; Ushijima, R; Sueyoshi, M				Sasaki, Yosuke; Ushijima, Ruri; Sueyoshi, Masuo			Field study of hind limb claw lesions and claw measures in sows	ANIMAL SCIENCE JOURNAL			English	Article						claw disorder; claw measure; foot lesion; reproductive performance; sow	REPRODUCTIVE-PERFORMANCE; LIFETIME EFFICIENCY; BREEDING HERDS; FLOOR SYSTEMS; LEG WEAKNESS; CULLING RISK; LAMENESS; DISORDERS; LONGEVITY; SWINE	We investigated the associations of hind limb claw lesions with claw measures and reproductive performance of sows on a commercial breeding farm. We used a five-point scale (score of 0-4) for each hind limb claw region to generate a claw lesion score (CLS). Of 110 sows, 1.8% had no hind claw lesions, and the remaining 98.2% had at least one. The proportions of sows with a CLS of 2 and 3 were 49.1% and 3.6%, respectively. The junction region had the highest frequency of a CLS of 2 (P<0.05). The mean toe length was 45.0 +/- 0.4 to 46.4 +/- 0.4mm. Sows with the highest CLS of 2 in the lateral claw had longer sole dimensions than did sows with the highest CLS of 1 (P<0.05). There were no significant differences in claw width or height between sows with the highest CLS of 2 and 1. There was also no difference in reproductive performance between sows with the highest CLS of 2 and 1. In conclusion, most sows had hind claw lesions. The association between CLS and claw measures indicates that the sole length can be used as an indicator of claw lesions.	[Sasaki, Yosuke] Miyazaki Univ, Org Promot Tenure Track, Miyazaki 8892192, Japan; [Sasaki, Yosuke; Sueyoshi, Masuo] Miyazaki Univ, Ctr Anim Dis Control, Miyazaki 8892192, Japan; [Ushijima, Ruri] Miyazaki Univ, Grad Sch Med & Vet Med, Lab Vet Microbiol, Miyazaki 8892192, Japan; [Sueyoshi, Masuo] Miyazaki Univ, Fac Agr, Dept Vet Sci, Lab Anim Hlth, Miyazaki 8892192, Japan	Sasaki, Y (reprint author), Miyazaki Univ, Org Promot Tenure Track, 1-1 Gakuen Kibanadai Nishi, Miyazaki 8892192, Japan.	yskssk@cc.miyazaki-u.ac.jp			Japan Society for the Promotion of Science [24-566]	The authors thank the staff on the study farm for their cooperation in this project and Dr. M. Noguchi for her technical support. The authors also thank the following research staff members who helped to collect the data: S. Kashiwabara, K. Furusho, M. Tsurita, and A. Fujita. This work was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (No. 24-566).	DALLAIRE S, 1987, CAN J VET RES, V51, P506; Jorgensen B, 2000, ACTA VET SCAND, V41, P105; Somers JGCJ, 2003, J DAIRY SCI, V86, P2082, DOI 10.3168/jds.S0022-0302(03)73797-7; Enokida M, 2011, LIVEST SCI, V136, P256, DOI 10.1016/j.livsci.2010.09.017; KRONEMAN A, 1993, VET QUART, V15, P26; Kirk RK, 2005, J VET MED A, V52, P423, DOI 10.1111/j.1439-0442.2005.00747.x; Anil SS, 2009, JAVMA-J AM VET MED A, V235, P734, DOI 10.2460/javma.235.6.734; Fitzgerald RF, 2012, LIVEST SCI, V145, P230, DOI 10.1016/j.livsci.2012.02.009; Anil SS, 2007, J SWINE HEALTH PROD, V15, P78; Sasaki Y, 2008, LIVEST SCI, V118, P140, DOI 10.1016/j.livsci.2007.12.029; DEWEY CE, 1993, CAN VET J, V34, P555; Sasaki Y, 2011, J SWINE HEALTH PROD, V19, P284; Heinonen M, 2006, VET REC, V159, P383; DAGORN J, 1979, LIVEST PROD SCI, V6, P167, DOI 10.1016/0301-6226(79)90018-6; Pluym L, 2011, VET MED-CZECH, V56, P101; Bradley CL, 2009, EFFECTS PARITY TIME; BRYANT KL, 1985, J ANIM SCI, V60, P154; Capion N, 2008, J DAIRY SCI, V91, P2089, DOI 10.3168/jds.2006-457; Clark CR, 2004, CAN VET J, V45, P585; Cramer G, 2009, J DAIRY SCI, V92, P2572, DOI 10.3168/jds.2008-1532; Deen J, 2007, P 58 ANN M EUR ASS A, P274; Enokida M., 2010, Journal of Veterinary Epidemiology, V14, P118; Gjein H, 1995, ACTA VET SCAND, V5, P85; Hultgren J, 2004, PREV VET MED, V62, P233, DOI 10.1016/j.prevetmed.2004.01.002; Jorgensen B, 2003, ANIM SCI, V77, P439; Knauer M, 2007, JAVMA-J AM VET MED A, V231, P433, DOI 10.2460/javma.231.3.433; MITCHELL CD, 1978, FARM BUILD PROGR, P7; Moran J., 2005, TROPICAL DAIRY FARMI; National Swine Improvement Federation (NSIF), 2003, GUID UN SWIN IMPR PR; Penny R. H. C., 1963, Veterinary Record, V75, P1225; Sasaki Y, 2010, THERIOGENOLOGY, V73, P587, DOI 10.1016/j.theriogenology.2009.10.014; SIMMINS PH, 1988, VET REC, V122, P431; Somers JGCJ, 2005, J DAIRY SCI, V88, P110; Stalder K. J., 2004, Pig News and Information, V25, p53N; vansAmstel S, 2010, J SWINE HEALTH PROD, V18, P239; vansRiet MMJ, 2014, LIVEST SCI, V156, P24; WEBB NG, 1984, J AGR ENG RES, V30, P71, DOI 10.1016/S0021-8634(84)80008-6; Willgert KJE, 2014, PREV VET MED, V113, P268, DOI 10.1016/j.prevetmed.2013.10.004; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAR	2015	86	3					351	357		10.1111/asj.12299		7	Agriculture, Dairy & Animal Science	Agriculture	CD8UE	WOS:000351371000015		
J	Yamashita, T; Yamamoto-Ikemoto, R; Yokoyama, H; Kawahara, H; Ogino, A; Osada, T				Yamashita, Takahiro; Yamamoto-Ikemoto, Ryoko; Yokoyama, Hiroshi; Kawahara, Hirofumi; Ogino, Akifumi; Osada, Takashi			Mitigation of nitrous oxide (N2O) emission from swine wastewater treatment in an aerobic bioreactor packed with carbon fibers	ANIMAL SCIENCE JOURNAL			English	Article						carbon fibers; denitrification; nitrous oxide emission; swine wastewater	ACTIVATED-SLUDGE; TREATMENT PLANTS; GAS EMISSIONS; DENITRIFICATION; OXYGENATION; BIOFILMS; BACTERIA; REMOVAL; SYSTEM	Mitigation of nitrous oxide (N2O) emission from swine wastewater treatment was demonstrated in an aerobic bioreactor packed with carbon fibers (CF reactor). The CF reactor had a demonstrated advantage in mitigating N2O emission and avoiding NOx (NO3+NO2) accumulation. The N2O emission factor was 0.0003g N2O-N/gTN-load in the CF bioreactor compared to 0.03gN(2)O-N/gTN-load in an activated sludge reactor (AS reactor). N2O and CH4 emissions from the CF reactor were 42g-CO2 eq/m(3)/day, while those from the AS reactor were 725g-CO2 eq/m(3)/day. The dissolved inorganic nitrogen (DIN) in the CF reactor removed an average of 156mg/L of the NH4-N, and accumulated an average of 14mg/L of the NO3-N. In contrast, the DIN in the AS reactor removed an average 144mg/L of the NH4-N and accumulated an average 183mg/L of the NO3-N. NO2-N was almost undetectable in both reactors.	[Yamashita, Takahiro; Yokoyama, Hiroshi; Ogino, Akifumi; Osada, Takashi] Natl Agr & Food Res Org NARO, NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Yamamoto-Ikemoto, Ryoko] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa, Japan; [Kawahara, Hirofumi] Saga Prefectural Livestock Expt Stn, Takeo, Japan	Yamashita, T (reprint author), Natl Agr & Food Res Org NARO, NARO Inst Livestock & Grassland Sci, 2 Ikenodai, Tsukuba, Ibaraki 3050901, Japan.	yamatktk@affrc.go.jp			research project 'Development of mitigation technologies to climate change in the agriculture sector' - Ministry of Agriculture, Forestry, and Fisheries of Japan	We would like to thank Mses. Keiko Sumiya, Keiko Otokoyama and Keiko Yoshimura for their skillful technical assistance. This study was supported by the research project 'Development of mitigation technologies to climate change in the agriculture sector,' funded by the Ministry of Agriculture, Forestry, and Fisheries of Japan.	ZHENG H, 1994, WATER SCI TECHNOL, V30, P133; Wunderlin P, 2012, WATER RES, V46, P1027, DOI 10.1016/j.watres.2011.11.080; Thorn M, 1996, WATER RES, V30, P1543, DOI 10.1016/0043-1354(95)00327-4; Yokoyama H, 2007, APPL MICROBIOL BIOT, V77, P213, DOI 10.1007/s00253-007-1144-0; OSADA T, 1995, WATER RES, V29, P1607, DOI 10.1016/0043-1354(94)00246-4; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; MOYER CL, 1994, APPL ENVIRON MICROB, V60, P871; HANAKI K, 1992, WATER SCI TECHNOL, V26, P1027; Tallec G, 2006, WATER RES, V40, P2972, DOI 10.1016/j.watres.2006.05.037; Tallec G, 2008, BIORESOURCE TECHNOL, V99, P2200, DOI 10.1016/j.biortech.2007.05.025; Satoh H, 2006, BIOTECHNOL BIOENG, V94, P762, DOI 10.1002/bit.20894; Itokawa H, 2001, WATER RES, V35, P657, DOI 10.1016/S0043-1354(00)00309-2; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526; HYNES RK, 1984, CAN J MICROBIOL, V30, P1397; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Clescerl L. S., 1998, STANDARD METHODS EXA; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Intergovernmental Panel on Climate Change, 2007, PHYS SCI BAS; Intergovernmental Panel on Climate Change, 2006, IPCC GUIDELINES NATL; Intergovernmental Panel on Climate Change, 2013, PHYS SCI BAS; Lane D., 1991, 16S 23S RRNA SEQUENC; Matsumoto S, 2012, ENVIRON SCI TECHNOL, V46, P10175, DOI 10.1021/es3020502; National Institute for Environmental Studies, 2013, NAT GREENH GAS INV R; Osada T, 2001, WATER SCI TECHNOL, V44, P79; Osada T., 2003, NITROUS OXIDE EMISSI, P1299; Yamashita T, 2006, WATER SCI TECHNOL, V53, P151, DOI 10.2166/wst.2006.348	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	MAR	2015	86	3					358	368		10.1111/asj.12302		11	Agriculture, Dairy & Animal Science	Agriculture	CD8UE	WOS:000351371000016		
J	Matsuoka, T; Takasaki, A; Mishima, T; Kawashima, T; Kanamaru, Y; Nakamura, T; Yabe, T				Matsuoka, Takuma; Takasaki, Akihiko; Mishima, Tomoyuki; Kawashima, Takuji; Kanamaru, Yoshihiro; Nakamura, Tadasi; Yabe, Tomio			Expression and characterization of honeybee, Apis mellifera, larva chymotrypsin-like protease	APIDOLOGIE			English	Article						Apis mellifera; queen larva; chymotrypsin-like protease	ROYAL JELLY PREVENTS; PROTEOLYTIC-ENZYMES; DIGESTIVE ENZYMES; IN-VITRO; BEE; MIDGUT; PEPTIDES; ENDOPEPTIDASES; RATS; PROTEINASE	Previously, we found three enzyme fractions containing activities for the hydrolysis of royal jelly proteins from honeybee queen larvae. In this study, we identified a honeybee chymotrypsin-like protease (HCLPase) by LC-MS/MS and expressed it as a recombinant protein in Escherichia coli. The protease had an estimated molecular weight of around 26 kDa and showed high specificity for succinyl-Ala-Ala-Pro-Phe p-nitroanilide as a proteolytic substrate. Furthermore, the protease had an optimal pH of 9, and the activity was markedly inhibited by phenylmethylsulfonyl fluoride but not tosyl phenylalanyl chloromethyl ketone, both of which are irreversible inhibitors of chymotrypsin-like serine proteases. These results suggested that this recombinant protease, HCLPase, was a chymotrypsin-like serine protease with different characteristics from mammalian chymotrypsin.	[Matsuoka, Takuma; Kawashima, Takuji; Nakamura, Tadasi] Akitayahonten Co Ltd, Gifu, Gifu 5008471, Japan; [Takasaki, Akihiko; Mishima, Tomoyuki] Gifu Univ Med Sci, Dept Med Technol, Gifu 5013892, Japan; [Kanamaru, Yoshihiro; Yabe, Tomio] Gifu Univ, Dept Appl Life Sci, Gifu, Gifu 5011193, Japan	Yabe, T (reprint author), Gifu Univ, Dept Appl Life Sci, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.	yabet@gifu-u.ac.jp					Nagai T, 2006, J MED FOOD, V9, P363, DOI 10.1089/jmf.2006.9.363; Herrero S, 2005, INSECT BIOCHEM MOLEC, V35, P1073, DOI 10.1016/j.ibmb.2005.05.006; Guo H, 2008, J NUTR SCI VITAMINOL, V54, P191, DOI 10.3177/jnsv.54.191; Matsui T, 2002, J NUTR BIOCHEM, V13, P80, DOI 10.1016/S0955-2863(01)00198-X; Tokunaga KH, 2004, BIOL PHARM BULL, V27, P189, DOI 10.1248/bpb.27.189; Guo H, 2009, FOOD CHEM, V113, P238, DOI 10.1016/j.foodchem.2008.06.081; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Vinokurov KS, 2006, COMP BIOCHEM PHYS B, V145, P126, DOI 10.1016/j.cbpb.2006.05.005; Whitworth ST, 1998, J BIOL CHEM, V273, P14430, DOI 10.1074/jbc.273.23.14430; Elpidina EN, 2005, BIOCHIMIE, V87, P771, DOI 10.1016/j.biochi.2005.02.013; Wagner W, 2002, INSECT BIOCHEM MOLEC, V32, P803, DOI 10.1016/S0965-1748(01)00167-9; Louati H, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-121; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x; MOORE S, 1968, J BIOL CHEM, V243, P6281; Hidaka S, 2006, EVID-BASED COMPL ALT, V3, P339, DOI 10.1093/ecam/nel019; GIEBEL W, 1971, COMP BIOCHEM PHYSIOL, V38, P197, DOI 10.1016/0305-0491(71)90297-5; Botos I, 2000, J MOL BIOL, V298, P895, DOI 10.1006/jmbi.2000.3699; Brodsgaard HF, 2003, APIDOLOGIE, V34, P139, DOI 10.1051/apido:2003003; Burgess EPJ, 1996, J INSECT PHYSIOL, V42, P823, DOI 10.1016/0022-1910(96)00045-5; DAHLMANN B, 1978, INSECT BIOCHEM, V8, P203, DOI 10.1016/0020-1790(78)90075-6; HERBERT EW, 1983, APIDOLOGIE, V14, P191, DOI 10.1051/apido:19830304; JIMENEZ DR, 1989, APIDOLOGIE, V20, P287, DOI 10.1051/apido:19890402; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Matsuoka T, 2012, APIDOLOGIE, V43, P685, DOI 10.1007/s13592-012-0143-z; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; Nakasa T, 2003, J JPN SOC FOOD SCI, V50, P463; Niu KJ, 2013, J GERONTOL A-BIOL, V68, P1482, DOI 10.1093/gerona/glt041; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; [Цыбина Т.А. Tsybina T.A.], 2005, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V70, P370	31	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0044-8435	1297-9678		APIDOLOGIE	Apidologie	MAR	2015	46	2					167	176		10.1007/s13592-014-0313-2		10	Entomology	Entomology	CD6TY	WOS:000351223600005		
J	Fujii, T; Inoue, H; Ishikawa, K				Fujii, Tatsuya; Inoue, Hiroyuki; Ishikawa, Kazuhiko			Decreased Cellulase and Xylanase Production in the Fungus Talaromyces cellulolyticus by Disruption of tacA and tctA Genes, Encoding Putative Zinc Finger Transcriptional Factors	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Article						Biomass; Cellulase; Xylanase; ace1; ctf1; Talaromyces cellulolyticus; Acremonium cellulolyticus	TRICHODERMA-REESEI; ACREMONIUM-CELLULOLYTICUS; ASPERGILLUS-NIDULANS; EXPRESSION; SYSTEM; GLUCOSIDASE; ENZYMES; PROTEIN; XLNR	Talaromyces cellulolyticus (formerly Acremonium cellulolyticus) is one of the important strains for industrial cellulase production. An understanding of the control of cellulase gene expression in T. cellulolyticus is insufficient because only a few transcriptional factors related to cellulase gene expression have been identified. In the present study, we disrupted seven putative transcription regulator genes that showed similarity with cellulase or hemicellulase regulator genes in other filamentous fungi and investigated whether these genes are related to cellulase and xylanase production. Among the seven genes, five (tclA, tbgA, tlaA, tmcA, tclB2) had a smaller effect on cellulase and xylanase activities when culturing with cellulose. On the other hand, disruption of tacA and tctA, which are respectively homologues of ace1 (repressor of cellulase) and ctf1 (inducer of cutinase), led to a decrease in cellulase and hemicellulase production due to effects at both the enzymatic and transcriptional levels, indicating that tacA and tctA have positive roles in cellulase and xylanase production in T. cellulolyticus. These results suggest that cellulase and xylanase gene regulation in T. cellulolyticus differs from that in other filamentous fungi and imply that unknown transcriptional mechanisms function in T. cellulolyticus.	[Fujii, Tatsuya; Inoue, Hiroyuki; Ishikawa, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Hiroshima 7390046, Japan	Fujii, T (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Hiroshima 7390046, Japan.	tatsuya.fujii@aist.go.jp			MEXT/JSPS KAKENHI, Japan [26850058]	We thank Dr. Tamotsu Hoshino, Dr. Ken-ichi Nakayama, and Dr. Masahiro Watanabe of AIST for helpful discussions. This study was supported by MEXT/JSPS KAKENHI Grant Number 26850058, Japan.	Li DX, 2002, J BIOL CHEM, V277, P7905, DOI 10.1074/jbc.M108799200; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Gusakov AV, 2011, TRENDS BIOTECHNOL, V29, P419, DOI 10.1016/j.tibtech.2011.04.004; Fujii T, 2012, BIOSCI BIOTECH BIOCH, V76, P245, DOI 10.1271/bbb.110498; van Peij NNME, 1998, APPL ENVIRON MICROB, V64, P3615; Aro N, 2001, J BIOL CHEM, V276, P24309, DOI 10.1074/jbc.M003624200; Nitta M, 2012, FUNGAL GENET BIOL, V49, P388, DOI 10.1016/j.fgb.2012.02.009; Stricker AR, 2006, EUKARYOT CELL, V5, P2128, DOI 10.1128/EC.00211-06; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; COCHET N, 1984, BIOTECHNOL LETT, V6, P155, DOI 10.1007/BF00127031; DOWZER CEA, 1989, CURR GENET, V15, P457, DOI 10.1007/BF00376804; Fang X., 2009, J BIOSCI BIOENG, V106, P115; Fujii T, 2014, BIOSCI BIOTECH BIOCH, V78, P1564, DOI 10.1080/09168451.2014.923298; Fujii T, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-24; Fujii T, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-73; Fujii T, 2010, BIOSCI BIOTECH BIOCH, V74, P419, DOI 10.1271/bbb.90655; Fujii T, 2014, FEMS MICROBIOL LETT, V351, P32, DOI 10.1111/1574-6968.12352; Ilmen M, 1996, MOL GEN GENET, V253, P303, DOI 10.1007/s004380050326; Inoue H, 2013, J IND MICROBIOL BIOT, V40, P823, DOI 10.1007/s10295-013-1286-2; Kanna M, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-15; Kunitake E., 2012, APPL MICROBIOL BIOT, V97, P2017; Wen ZY, 2005, PROCESS BIOCHEM, V40, P3087, DOI 10.1016/j.procbio.2005.03.044; Yamakawa Y, 2013, BIOCHEM BIOPH RES CO, V431, P777, DOI 10.1016/j.bbrc.2013.01.031; YAMANOBE T, 1987, AGR BIOL CHEM TOKYO, V51, P65	26	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0273-2289	1559-0291		APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	MAR	2015	175	6					3218	3229		10.1007/s12010-015-1497-2		12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CD2CJ	WOS:000350881100035		
J	Stone, CB; Luminet, O; Takahashi, M				Stone, Charles B.; Luminet, Olivier; Takahashi, Masanobu			Remembering Public, Political Events: A Cross-Cultural and - Sectional Examination of Australian and Japanese Public Memories	APPLIED COGNITIVE PSYCHOLOGY			English	Article							LONG-TERM-MEMORY; FLASHBULB MEMORIES; FACIAL EXPRESSIONS; SEPTEMBER 11TH; SELF; EMOTION; AMERICAN; ATTACKS; RETENTION; BEHAVIOR	We examined and compared the initiating conditions of flashbulb memory (FBM) confidence and event memory accuracy across two different, yet similar public, political events occurring in two different countries: Australia and Japan. To do so, we seized upon the occurrence of two politically important events: the resignation of the Japanese and Australian Prime Ministers in June 2010. In a series of mean and correlation analyses, we concluded that different factors may determine event memory accuracy and FBM confidence across cultures. In particular, the way different cultures emotionally appraise and rehearse the event, their attitude toward the political parties/their political involvement and self-construal may have important implications for how individuals accurately remember the event and the confidence they hold for their memories of the context when learning of the event. We discuss avenues of future research to better understand the extent to which cultural differences drove these results. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Stone, Charles B.] CUNY John Jay Coll Criminal Justice, Dept Psychol, New York, NY 10019 USA; [Stone, Charles B.; Luminet, Olivier] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Luminet, Olivier] Fonds Rech Sci FRS FNRS, Brussels, Belgium; [Takahashi, Masanobu] Univ Cattolica Sacro Cuore, Dept Psychol, Tokyo, Japan	Stone, CB (reprint author), CUNY John Jay Coll Criminal Justice, Dept Psychol, 524 West 59th St, New York, NY 10019 USA.	chstone@jjay.cuny.edu			Louvain University Academia (AUL)/the Marie Curie Actions of the European Union (Louvain-la-Neuve, Belgium); Macquarie University Research Excellence Scholarship (Sydney, Australia)	This research was supported by the Louvain University Academia (AUL)/the Marie Curie Actions of the European Union (Louvain-la-Neuve, Belgium) and by a Macquarie University Research Excellence Scholarship (Sydney, Australia) to Charles B. Stone.	LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3; Finkenauer C, 1998, MEM COGNITION, V26, P516, DOI 10.3758/BF03201160; SINGELIS TM, 1995, HUM COMMUN RES, V21, P354, DOI 10.1111/j.1468-2958.1995.tb00351.x; Harber KD, 2005, J LANG SOC PSYCHOL, V24, P382, DOI 10.1177/0261927X05281426; Bresnahan MJ, 2005, HUM COMMUN RES, V31, P33, DOI 10.1093/hcr/31.1.33; Talarico JM, 2003, PSYCHOL SCI, V14, P455, DOI 10.1111/1467-9280.02453; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037//0033-295X.88.1.67; Sato T, 1999, J SOC PSYCHOL, V139, P426; Schuman H, 2000, AM J SOCIOL, V105, P913, DOI 10.1086/210396; Kensinger EA, 2006, PSYCHON B REV, V13, P757, DOI 10.3758/BF03193993; Hirst W, 2008, MEMORY, V16, P183, DOI 10.1080/09658210701811912; RUBIN DC, 1984, COGNITION, V16, P81, DOI 10.1016/0010-0277(84)90037-4; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Rime B, 2009, EMOT REV, V1, P60, DOI 10.1177/1754073908097189; CONWAY MA, 1994, MEM COGNITION, V22, P326, DOI 10.3758/BF03200860; Green JD, 2005, EUR J SOC PSYCHOL, V35, P225, DOI 10.1002/ejsp.242; MOLOTCH H, 1974, AM SOCIOL REV, V39, P101, DOI 10.2307/2094279; BOHANNON JN, 1988, COGNITION, V29, P179, DOI 10.1016/0010-0277(88)90036-4; Sahdra B, 2007, PERS SOC PSYCHOL B, V33, P384, DOI 10.1177/0146167206296103; Wang Q, 2001, COGNITIVE DEV, V16, P693, DOI 10.1016/S0885-2014(01)00055-7; BELL BE, 1989, J PERS SOC PSYCHOL, V56, P669, DOI 10.1037//0022-3514.56.5.669; Berntsen D, 2009, FLASHBULB MEMORIES: NEW ISSUES AND NEW PERSPECTIVES, P187; Berntsen D, 2005, J EXP PSYCHOL GEN, V134, P242, DOI 10.1037/0096-3445.134.2.242; Breslin CW, 2011, PSYCHOL SCI, V22, P1408, DOI 10.1177/0956797611419171; CHRISTIANSON SA, 1989, MEM COGNITION, V17, P435, DOI 10.3758/BF03202615; Coluccia E, 2010, APPL COGNITIVE PSYCH, V24, P177, DOI 10.1002/acp.1549; Curci A, 2006, MEMORY, V14, P329, DOI 10.1080/09658210500340816; Curci A, 2001, MEMORY, V9, P81; Dumas R., 2015, CONTEXTUALIZING HUMA, pXX; Echterhoff G, 2006, MEM COGNITION, V34, P763, DOI 10.3758/BF03193424; Green J. D., 2004, SELF IDENTITY, V3, P69, DOI DOI 10.1080/13576500342000059; HASTORF AH, 1954, J ABNORM SOC PSYCH, V49, P129, DOI 10.1037/h0057880; Hirst W., 2001, J EXPT PSYCHOL GEN; Hirst W, 2009, J EXP PSYCHOL GEN, V138, P161, DOI 10.1037/a0015527; Konrath S., 2014, EXPT EVIDENCE UNPUB; Koppel J, 2013, MEMORY, V21, P798, DOI 10.1080/09658211.2012.756040; Kulkofsky S, 2011, MEMORY, V19, P233, DOI 10.1080/09658211.2010.551132; Luminet O, 2009, MEMORY, V17, P742, DOI 10.1080/09658210903081827; Luminet O, 2004, J GEN PSYCHOL, V131, P197, DOI 10.3200/GENP.131.3.197-224; MATSUMOTO D, 1989, MOTIV EMOTION, V13, P143, DOI 10.1007/BF00992959; NEISSER U, 1992, EMORY S COG, V4, P9, DOI 10.1017/CBO9780511664069.003; Oishi S, 2002, PERS SOC PSYCHOL B, V28, P1398, DOI 10.1177/01461702236871; Rime B., 1998, EUROPEAN REV SOCIAL, V9, P145, DOI DOI 10.1080/14792779843000072; Shapiro LR, 2006, MEMORY, V14, P129, DOI 10.1080/09658210544000006; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; SINGELIS TM, 1995, J CROSS CULT PSYCHOL, V26, P622, DOI 10.1177/002202219502600607; Smith MC, 2003, APPL COGNITIVE PSYCH, V17, P1047, DOI 10.1002/acp.981; Stone CB, 2013, J APPL RES MEM COGN, V2, P166, DOI 10.1016/j.jarmac.2013.07.003; Talarico JM, 2012, APPL COGNITIVE PSYCH, V26, P746, DOI 10.1002/acp.2855; Tekcan AI, 2003, APPL COGNITIVE PSYCH, V17, P1057, DOI 10.1002/acp.985; Tinti C, 2009, APPL COGNITIVE PSYCH, V23, P236, DOI 10.1002/acp.1452; Wang Q, 2004, DEV PSYCHOL, V40, P3, DOI 10.1037/0012-1649.40.1.3; Wang Q, 2009, FLASHBULB MEMORIES: NEW ISSUES AND NEW PERSPECTIVES, P247	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0888-4080	1099-0720		APPL COGNITIVE PSYCH	Appl. Cogn. Psychol.	MAR-APR	2015	29	2					280	290		10.1002/acp.3106		11	Psychology, Experimental	Psychology	CD6BL	WOS:000351173400014		
J	Sarjoughian, F; Kananian, A; Ahmadian, J; Murata, M				Sarjoughian, Fatemeh; Kananian, Ali; Ahmadian, Jamshid; Murata, Mamoru			Chemical composition of biotite from the Kuh-e Dom pluton, Central Iran: implication for granitoid magmatism and related Cu-Au mineralization	ARABIAN JOURNAL OF GEOSCIENCES			English	Article						Biotite; Subduction; I-type; Fugacity; Halogene; High-Cl magma	ROCK-FORMING MINERALS; COMPUTER-PROGRAM MICA(+); SANANDAJ-SIRJAN ZONE; FOLD-THRUST BELT; CRYSTALLIZATION CONDITIONS; CONTINENTAL COLLISION; TRIOCTAHEDRAL MICAS; PERALUMINOUS MAGMAS; METALLOGENIC ASPECT; EVALUATING MICAS	The composition of the Kuh-e Dom intrusion (NE Ardestan, Iran), in the Urumieh-Dokhtar magmatic belt, ranges from gabbro to granite. Several diabase dikes and numerous enclaves are common in the studied rocks. The intrusive rocks contain biotite as major or minor minerals (1-19 %). The biotites are Mg-rich typical for I-type calc-alkaline rocks related to subduction setting. The biotite chemistry in the acidic rocks suggests crystallization temperatures in the range of 720-750 degrees C. Oxygen fugacity of biotite has been buffered by the Ni-NiO buffer and the intrusion crystallized under high oxygen fugacity of -15.16 bars in the acidic rocks and -13.6 bars in the intermediate-basic rocks. The average calculated H2O fugacity of these rocks is about 3 bars. The average values of the calculated log (fH(2)O/fHF) of fluid in equilibrium with the chemical composition of biotite are 4.65 for the acidic and 4.2 for the intermediate-basic rocks. The average values of the calculated log (fH(2)O/fHCl) of fluids in equilibrium with the chemical composition of biotite are 3.81 in the acidic and 3.36 in the intermediate-basic rocks. These F and Cl values for biotites in the Kuh-e Dom intrusion are similar to those of high-Cl igneous rocks and porphyry Cu ore deposits. As the Kuh-e Dom biotites are primary, their crystallization from Cl-high magma is suggested. It seems that in the subduction zone, the release of Cl-bearing fluid from a subducted slab into the mantle, causing mantle metasomatism, plays an important role in the mineralization of the Kuh-e Dom.	[Sarjoughian, Fatemeh; Kananian, Ali] Univ Tehran, Sch Geol, Coll Sci, Tehran, Iran; [Sarjoughian, Fatemeh] Univ Kurdistan, Dept Earth Sci, Fac Sci, Sanandaj, Iran; [Ahmadian, Jamshid] Payame Noor Univ, Dept Geol, Tehran, Iran; [Murata, Mamoru] Naruto Univ Educ, Dept Geosci, Takashima 7728502, Japan	Sarjoughian, F (reprint author), Univ Kurdistan, Dept Earth Sci, Fac Sci, Sanandaj, Iran.	fsarjoughian2@gmail.com			University of Tehran under research council; Research Office at the University of Payame Noor	This study is part of the Ph.D. thesis by F. Sarjoughian. Thanks go to the University of Tehran for supporting this project under grants provided by the research council. Partial funding for this project was provided by the Research Office at the University of Payame Noor and we wish to acknowledge the generous support from all staff of that office. We are grateful to Prof. G. Morgan at University of Oklahoma, USA who prepared the microprobe analyses. Dr. A.A. Shabani from Geological Survey of Iran is also thanked for wet chemistry.	Aghanabati A, 1998, MAJOR SEDIMENTARY ST; AGUE JJ, 1988, GEOL SOC AM BULL, V100, P912, DOI 10.1130/0016-7606(1988)100<0912:MAAADO>2.3.CO;2; Ahmadian J., 2008, GEOL SOC AM BULL, V121, P857; DODGE FCW, 1969, J PETROL, V10, P250; KRETZ R, 1983, AM MINERAL, V68, P277; Henry DJ, 2005, AM MINERAL, V90, P316, DOI 10.2138/am.2005.1498; Shabani AAT, 2003, CAN MINERAL, V41, P1381, DOI 10.2113/gscanmin.41.6.1381; McQuarrie N, 2004, J STRUCT GEOL, V26, P519, DOI 10.1016/j.jsg.2003.08.009; ZHU C, 1992, GEOCHIM COSMOCHIM AC, V56, P3435, DOI 10.1016/0016-7037(92)90390-5; CERNY P, 1984, REV MINERAL, V13, P257; Shafiei B, 2009, MINER DEPOSITA, V44, P265, DOI 10.1007/s00126-008-0216-0; ROBERT JL, 1976, CHEM GEOL, V17, P213, DOI 10.1016/0009-2541(76)90036-X; Tischendorf G, 1999, MINERAL MAG, V63, P57; CRERAR DA, 1976, ECON GEOL, V71, P772; Bonova K, 2010, GEOL CARPATH, V61, P3, DOI 10.2478/v10096-009-0040-1; Nachit H, 2005, CR GEOSCI, V337, P1415, DOI 10.1016/j.crte.2005.09.002; Agard P, 2011, GEOL MAG, V148, P692, DOI 10.1017/S001675681100046X; Agard P, 2005, INT J EARTH SCI, V94, P401, DOI 10.1007/s00531-005-0481-4; HAYASHI K, 1991, GEOCHIM COSMOCHIM AC, V55, P2111, DOI 10.1016/0016-7037(91)90091-I; HEWITT DA, 1984, REV MINERAL, V13, P201; Jiang YH, 2002, LITHOS, V63, P165, DOI 10.1016/S0024-4937(02)00140-8; Alavi M, 2004, AM J SCI, V304, P1, DOI 10.2475/ajs.304.1.1; Elliott BA, 2001, MINER PETROL, V72, P305, DOI 10.1007/s007100170021; Gammons CH, 1997, ECON GEOL BULL SOC, V92, P45; MUTSCHLER FE, 1981, ECON GEOL, V76, P874; Dahlquist JA, 2010, LITHOS, V115, P65, DOI 10.1016/j.lithos.2009.11.006; Shahabpour J, 2007, J ASIAN EARTH SCI, V30, P652, DOI 10.1016/j.jseaes.2007.02.004; ABDELRAHMAN AFM, 1994, J PETROL, V35, P525; ALAVI M, 1994, TECTONOPHYSICS, V229, P211, DOI 10.1016/0040-1951(94)90030-2; Sarjoughian F, 2012, J ASIAN EARTH SCI, V54-55, P49, DOI 10.1016/j.jseaes.2012.03.013; Mohajjel M, 2003, J ASIAN EARTH SCI, V21, P397, DOI 10.1016/S1367-9120(02)00035-4; Yavuz F, 2003, COMPUT GEOSCI-UK, V29, P1203, DOI 10.1016/S0098-3004(03)00142-0; Tischendorf G, 1997, MINERAL MAG, V61, P809, DOI 10.1180/minmag.1997.061.409.05; TINDLE AG, 1990, EUR J MINERAL, V2, P595; LALONDE AE, 1993, CAN MINERAL, V31, P203; BARRIERE M, 1979, CONTRIB MINERAL PETR, V70, P183, DOI 10.1007/BF00374447; Berberian F, 1981, AM GEOPHYS UNION GEO, V3, P111; BERBERIAN M, 1981, CAN J EARTH SCI, V18, P210, DOI 10.1139/e81-019; Boudreau AE, 1997, GEOLOGY, V25, P791, DOI 10.1130/0091-7613(1997)025<0791:SCIAOO>2.3.CO;2; Brookins D. G., 1989, GEOCHEMISTRY MINERAL, V8, P201; Burkhard DJM, 1993, GEOL MIJNBOUW, V71, P337; BURKHARD DJM, 1991, EARTH PLANET SC LETT, V104, P89, DOI 10.1016/0012-821X(91)90240-I; Chappell B.W., 1974, PAC GEOL, V8, P173; Coulson IM, 2001, MINER DEPOSITA, V36, P594, DOI 10.1007/s001260100191; De Albuquerque CAR, 1973, GEOCHIM COSMOCHIM AC, V37, P1779, DOI 10.1016/0016-7037(73)90163-4; ELSHESHTAWI YA, 1993, J AFR EARTH SCI, V16, P489, DOI 10.1016/0899-5362(93)90106-Z; Falcon N.L, 1974, SPEC PUBL GEOL SOC L, V4, P199, DOI [DOI 10.1144/GSL.SP.2005.004.01.11, 10.1144/GSL.SP.2005.004.01.11]; Forster MD, 1960, US GEOLOGICAL SURV B, V354, P1; Frank MR, 2002, GEOCHIM COSMOCHIM AC, V66, P3719, DOI 10.1016/S0016-7037(01)00900-0; Groves DI, 2003, ECON GEOL BULL SOC, V98, P1, DOI 10.2113/98.1.1; Hassanzadeh J., 1993, THESIS U CALIF, P204; Hecht L, 1994, METALLOGENY COLLISIO, P295; Honarmand M, 2012, NEUES JB MINER ABH, V189, P138; Idrus A, 2007, RESOUR GEOL, V57, P102, DOI 10.1111/j.1751-3928.2007.00010.x; Ishihara S, 1977, MINING GEOL TOKYO, V27, P293; Kirkham RV, 2000, GEOL SURV CAN OPEN F, V3792, P26; LOFERSKI PJ, 1995, CHEM GEOL, V123, P89, DOI 10.1016/0009-2541(95)00040-S; McCoy D, 1997, EC GEOL MONOGR, V9, P191; Mohajjel M, 2000, J STRUCT GEOL, V22, P1125, DOI 10.1016/S0191-8141(00)00023-7; MONIER G, 1986, MINERAL MAG, V50, P257, DOI 10.1180/minmag.1986.050.356.08; Muller D, 2000, POTASSIC IGNEOUS ROC, P252; Munoz JL, 1984, MICAS REV MINERALOGY, V13, P469; Munoz J.L., 1992, GEOL SOC AM ABSTR, V24, pA221; Nachit H, 1986, THESIS U BRETAGNE OC, P181; NEIVA AMR, 1981, LITHOS, V14, P149, DOI 10.1016/0024-4937(81)90051-7; Patino Douce AE, 1993, CHEM GEOL, V108, P133; Pouchou J.L., 1985, MICROBEAM ANAL, V1985, P104; Rabiee A, 2007, THESIS TARBIAT MOALE, P172; Richards JP, 1995, SHORT COURSE SER MIN, V23, P367; RUTHERFO.MJ, 1973, J PETROL, V14, P159; Sarjoughian F, 2012, J GEOSCI-CZECH, V57, P241, DOI 10.3190/jgeosci.126; Schroder JW, 1944, ECLOGAE GEOL HELV, V37, P37; Shabani AA, 2006, 26 S GEOSC GEOL SURV; SHAHABPOUR J, 1987, MINER DEPOSITA, V22, P278; Speer J.A., 1984, MIN SOC AM, V13, P299; Stocklin J., 1968, Bulletin of the American Association of Petroleum Geologists, V52, P1229; Stussi JM, 1996, J PETROL, V37, P1025, DOI 10.1093/petrology/37.5.1025; Technoexport, 1981, 9 TECHN GEOL SURV IR, P154; Wones D. R., 1981, MINING GEOLOGY, V31, P191; Wones DR, 1965, AM MINERAL, V50, P1228; Yang XM, 2005, CONTRIB MINERAL PETR, V150, P287, DOI 10.1007/s00410-005-0018-7; Yavuz F, 2003, COMPUT GEOSCI-UK, V29, P1215, DOI 10.1016/S0098-3004(03)00143-2	82	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1866-7511	1866-7538		ARAB J GEOSCI	Arab. J. Geosci.	MAR	2015	8	3					1521	1533		10.1007/s12517-013-1242-5		13	Geosciences, Multidisciplinary	Geology	CD4VQ	WOS:000351083700024		
J	Alcedo, MJ; Ito, K; Maeda, K				Alcedo, M. J.; Ito, K.; Maeda, K.			Stockmanship Competence and Its Relation to Productivity and Economic Profitability: The Context of Backyard Goat Production in the Philippines	ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES			English	Article						Stocicmanship Competence; Backyard Goat Production; Animal Welfare; Goat; Philippines	QUALITY; LAMBS; MILK	A stockperson has a significant influence on the productivity and welfare of his animals depending on his stockmanship competence. In this study, stockmanship competence (SC) is defined as the capacity of the stockperson to ensure the welfare of his animals by providing his animals' needs. The study was conducted to evaluate the SC of backyard goat raisers and examine its relationship to goat productivity and economic profitability. There were 101 respondents for this study who have all undertaken farmer livestock school on integrated goat management (FLS-IGM). Interview was conducted in Region I, Philippines on September.3 to 30, 2012 and March 4 to 17, 2013. Data on SC, goat productivity and farmer's income were gathered. Questions regarding SC were formulated based on the Philippine Recommendations for Goat Production and from other scientific literature. Housing, feeding, breeding and health and husbandry management were the indicators used in computing stockmanship competence index score (SC IS). Pearson correlation using Statistical Package for Social Science (SPSS) was carried out to analyse the relationship between SCIS, productivity and income. Based from the results of the study, a majority of the respondents raised native and upgraded goats. The computed mean SCIS before and after undergoing FLS-IGM were 38.52% and 75.81% respectively, a percentage difference of 65.23%. Both index scores resulted in significant differences in productivity and income. The median mature weight and mortality rate of goats before FLS-IGM was 14 kg and 30% respectively. After FLS-IGM, median mature weight was 19 kg and mortality rate decreased from 30% to 11.11%. Likewise, fewer goat diseases were observed by farmers who were able to undergo FLS-IGM. With regard to income, there was a 127.34% difference on the median net income derived by farmers. Result implies that improved SC could lead not only to increased productivity and income of backyard goat raisers but also to better animal welfare.	[Alcedo, M. J.] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ito, K.] Nagoya Univ, Int Cooperat Ctr Agr Educ, Nagoya, Aichi 4648601, Japan; [Maeda, K.] Univ Tokyo, Dept Vet Med Sci, Tokyo 1138654, Japan	Alcedo, MJ (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	lungayban2008@yahoo.com					Alo A., 2006, INDONESIA PHILIPPINE; Andrea U., 1982, HOHENHEIMER ARBEITEN, V121, P51; Loretz C, 2004, APPL ANIM BEHAV SCI, V87, P275, DOI 10.1016/j.applanim.2004.01.005; Napolitano F, 2006, MEAT SCI, V72, P635, DOI 10.1016/j.meatsci.2005.09.013; Sevi A, 1999, J DAIRY RES, V66, P489, DOI 10.1017/S0022029999003726; Boivin X., 1998, P EU WORKSH IMPL EXT, P43; Bondoc OL, 2005, PHILIPP AGRIC SCI, V88, P179; Burns M., 1970, COMMONWEALTH BUREAU; Collar C., 2000, ANIMAL CARE SERIES G; Davendra C, 1999, OUTLOOK AGR, V28, P215; De Jonge F. H., 2000, 4 NAHWOA WORKSH 2000, P38; EFSA, 2012, ANIMAL WELFARE; FAWC (Farm Animal Welfare Council), 2007, REP STOCKM FARM AN W; Fears R., 2014, PROGRESSIVE CATTLEMA; Hemsworth P. H., 2008, STOCKMANSHIP MAKES D; Hemsworth PH, 1998, HUMAN LIVESTOCK INTE; Leaver J., 1999, THE UFAW HDB, P17; Lensink B. J., 2001, ANIM SCI IN PRESS; Livestock Development Council (LDC), 2012, TIPS ON GOAT RAIS; Network for Animal Health and Welfare in Organic Agriculture (NAHWOA), 2000, P 3 NAHWOA WORKSH 21; Oludimu O., 1990, MANAGEMENT W AFRICAN; PCCARD (Philippine Council for Agriculture Aquatic and Natural Resources Research and Development), 2005, PHIL REC GOAT PROD; Sebei PJ, 2004, J S AFR VET ASSOC, V75, P19; Sevi A, 1998, ITAL J FOOD SCI, V10, P229; Sevi A., 2005, INFLUENCE SUNLIGHT T, P305; Sevi A, 2009, ITAL J ANIM SCI, V8, P81; Smart M., 2010, GOAT PRODUCTION MANU; Tan J., 2000, AGRIBUSINESS MAGAZIN; Walkden-Brown S. W., 1985, P SERIES, V7, P42; Weirenga H., 1987, P EU SEM SEP 16 17 1	30	0	0	ASIAN-AUSTRALASIAN ASSOC ANIMAL PRODUCTION SOC	SEOUL	ROOM 708 SAMMO SPOREX, 1638-32, SEOWON-DONG, GWANAK-GU, SEOUL 151-730, SOUTH KOREA	1011-2367	1976-5517		ASIAN AUSTRAL J ANIM	Asian Australas. J. Anim. Sci.	MAR	2015	28	3					428	434		10.5713/ajas.14.0693		7	Agriculture, Dairy & Animal Science	Agriculture	CD4DC	WOS:000351031800018		
J	Feng, ZY; Xu, L; She, JH; Guo, XX				Feng, Zhi-Yong; Xu, Li; She, Jinhua; Guo, Xue-Xun			OPTIMIZATION OF COORDINATE TRANSFORMATION MATRIX FOR H-infinity STATIC-OUTPUT-FEEDBACK CONTROL OF LINEAR DISCRETE-TIME SYSTEMS	ASIAN JOURNAL OF CONTROL			English	Article						H-infinity control; static output feedback; linear matrix inequality (LMI)	FREE VARIABLES; LMI CONDITIONS; STABILIZATION; PERFORMANCE; DESIGN	This paper presents a new iterative algorithm as an upgrade to sufficient LMI conditions for the H static-output-feedback (SOF) control of discrete-time systems. Based on an analysis of the structures of the coordinate transformation matrix and the Lyapunov matrix, the open question of how to fix the Lyapunov matrix structure raised by G. I. Bara and M. Boutayeb is replaced with the question of how to choose the coordinate transformation matrix. Then, an iterative algorithm for selecting the optimum coordinate transformation matrix that produces a locally optimal solution is presented. Finally, numerical examples demonstrate the effectiveness and advantages of this method.	[Feng, Zhi-Yong; Guo, Xue-Xun] Wuhan Univ Technol, Hubei Key Lab Adv Technol Automot Parts, Wuhan 430070, Peoples R China; [Xu, Li] Akita Prefectural Univ, Dept Elect & Informat Syst, Akita 0150055, Japan; [She, Jinhua] Tokyo Univ Technol, Sch Comp Sci, Hachioji, Tokyo 1920982, Japan	Feng, ZY (reprint author), Wuhan Univ Technol, Hubei Key Lab Adv Technol Automot Parts, Wuhan 430070, Peoples R China.	fengge81@gmail.com			Fundamental Research Funds for the Central Universities [WUT: 2014-IV-038]; National Natural Science Foundation (NNSF) of China [61174079]	This work is supported by "the Fundamental Research Funds for the Central Universities (WUT: 2014-IV-038) and partially supported by National Natural Science Foundation (NNSF) of China under Grant 61174079.	Syrmos VL, 1997, AUTOMATICA, V33, P125, DOI 10.1016/S0005-1098(96)00141-0; Correa R, 2004, SIAM J OPTIMIZ, V15, P303, DOI 10.1137/S1052623402417298; Gadewadikar J, 2007, AUTOMATICA, V43, P1597, DOI 10.1016/j.automatica.2007.02.005; Prempain E, 2001, SYST CONTROL LETT, V43, P159, DOI 10.1016/S0167-6911(01)00087-1; Cao YY, 1998, AUTOMATICA, V34, P1641, DOI 10.1016/S0005-1098(98)80021-6; Bara GL, 2005, IEEE T AUTOMAT CONTR, V50, P250, DOI 10.1109/TAC.2004.841922; Apkarian P, 2006, IEEE T AUTOMAT CONTR, V51, P71, DOI 10.1109/TAC.2005.860290; Arzelier D, 2010, P AMER CONTR CONF, P4683; Blondel V, 1997, SIAM J CONTROL OPTIM, V35, P2118, DOI 10.1137/S0363012994272630; Du X, 2010, INT J CONTROL AUTOM, V8, P163, DOI 10.1007/s12555-010-0121-z; Feng Z. -Y., 2012, ASIAN J CONTROL, V6, P1505; Feng Z. -Y., 2012, SICE J CONTROL MEAS, V5, P147; GAHINET P, 1994, INT J ROBUST NONLIN, V4, P421, DOI 10.1002/rnc.4590040403; Geromel J. C., 1995, P IEEE C DEC CONTR D, P40; Ghaout EI. L., 1997, IEEE T AUTOMAT CONTR, V42, P1171; HENRION D, 2005, P JOINT IEEE C DEC C, P7581, DOI 10.1109/CDC.2005.1583385; Lee KH, 2006, IEEE T AUTOMAT CONTR, V51, P675, DOI 10.1109/TAC.2006.872766; Leibfritz F, 2002, SIAM J OPTIMIZ, V12, P1048, DOI 10.1137/S1052623400375865; Mattei M, 2000, INT J ROBUST NONLIN, V10, P1237, DOI 10.1002/1099-1239(20001230)10:15<1237::AID-RNC512>3.0.CO;2-K; Popov A. P., 2010, P 49 IEEE C DEC CONT; Quoc T. D., 2012, IEEE T AUTOMAT CONTR, V57, P1377; Shi HB, 2009, IET CONTROL THEORY A, V3, P1051, DOI 10.1049/iet-cta.2008.0185; Shi HB, 2010, INT J SYST SCI, V41, P1067, DOI 10.1080/00207720903216582; Stingl M., 2006, THESIS	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1561-8625	1934-6093		ASIAN J CONTROL	Asian J. Control	MAR	2015	17	2					604	614		10.1002/asjc.897		11	Automation & Control Systems	Automation & Control Systems	CD5ZJ	WOS:000351167300022		
J	Miyamoto, R; Nozawa, T; Kimura, M; Shiozuka, K; Tabata, K				Miyamoto, Rei; Nozawa, Takashi; Kimura, Mayuko; Shiozuka, Koichi; Tabata, Kenji			Development and Validation of Semiautomated 96-Well Transport Assay Using LLC-PK1 Cells Transfected with Human P-Glycoprotein for High-Throughput Screening	ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES			English	Article							DRUG-DRUG INTERACTION; EFFLUX; DISCOVERY; CACO-2; EXPRESSION; DIGOXIN; LINE; GP; ESTABLISHMENT; ABSORPTION	Transport assays using P-gp-expressing cell lines are commonly used to identify P-gp substrates and inhibitors in drug discovery. The P-gp cell-based assay is performed manually in 12- or 24-well plates and requires improvement for high-throughput screening. In this study, we established an efficient semiautomated 96-well transport assay using LLC-PK1 cells transfected with human P-gp. The protocol was optimized with a microplate washer for exchanging media and buffer to enhance throughput. P-gp substrates and inhibitors, and the paracellular marker Dextran Texas Red((R)) were used to validate the 96-well transport assay. Cell monolayer integrity after washing by a microplate washer was confirmed by measuring paracellular permeability of Dextran Texas Red. Permeability and net flux ratio of the P-gp substrates and the inhibitory potency of the P-gp inhibitors were comparable in 24- and 96-well plates. The regression value of net flux ratio of P-gp substrates was high between the two formats (r(2)=0.99). The optimized 96-well transport assay using the microplate washer was found to be an efficient high-throughput screening tool that provided the same quality data as the 24-well plate for the identification of P-gp substrates and inhibitors in drug discovery.	[Miyamoto, Rei; Kimura, Mayuko; Shiozuka, Koichi] Astellas Res Technol Co Ltd, Drug Metab & Pharmacokinet Res Div, Tsukuba, Ibaraki 3058585, Japan; [Nozawa, Takashi; Tabata, Kenji] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Ibaraki, Japan	Miyamoto, R (reprint author), Astellas Res Technol Co Ltd, Drug Metab & Pharmacokinet Res Div, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	rei.miyamoto@astellas.com					Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007; Ellens H, 2013, DRUG METAB DISPOS, V41, P1367, DOI 10.1124/dmd.112.050542; TANIGAWARA Y, 1992, J PHARMACOL EXP THER, V263, P840; Balimane PV, 2004, EUR J PHARM BIOPHARM, V58, P99, DOI 10.1016/j.ejpb.2004.02.014; Bentz J, 2013, DRUG METAB DISPOS, V41, P1347, DOI 10.1124/dmd.112.050500; Yamazaki M, 2001, J PHARMACOL EXP THER, V296, P723; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; Wang ZY, 2013, INT J PHARMACEUT, V441, P40, DOI 10.1016/j.ijpharm.2012.12.011; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Ohashi R, 2006, DRUG METAB DISPOS, V34, P793, DOI 10.1124/dmd.105.007559; Takeuchi T, 2006, PHARM RES, V23, P1460, DOI 10.1007/s11095-006-0285-7; Mease K, 2012, J PHARM SCI-US, V101, P1888, DOI 10.1002/jps.23069; UEDA K, 1992, J BIOL CHEM, V267, P24248; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Inoue T, 2012, PROG NEURO-PSYCHOPH, V39, P156, DOI 10.1016/j.pnpbp.2012.06.005; Keogh JP, 2006, EUR J PHARM SCI, V27, P543, DOI 10.1016/j.ejps.2005.11.011; Kuteykin-Teplyakov K, 2010, BRIT J PHARMACOL, V160, P1453, DOI 10.1111/j.1476-5381.2010.00801.x; Larson B, 2012, JALA-J LAB AUTOM, V17, P222, DOI 10.1177/2211068211428190; Marino AM, 2005, INT J PHARM, V297, P235, DOI 10.1016/j.ijpharm.2005.03.008; Maubon N, 2007, FUND CLIN PHARMACOL, V21, P659, DOI 10.1111/j.1472-8206.2007.00550.x; Ohe T, 2003, DRUG METAB DISPOS, V31, P1251, DOI 10.1124/dmd.31.10.1251; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Sugimoto H, 2011, J PHARM SCI-US, V100, P4013, DOI 10.1002/jps.22652; Taub ME, 2005, DRUG METAB DISPOS, V33, P1679, DOI 10.1124/dmd.105.005421; Uchida Masashi, 2009, Journal of Pharmacological and Toxicological Methods, V59, P39, DOI 10.1016/j.vascn.2008.10.006; Wandel C, 2002, ANESTHESIOLOGY, V96, P913, DOI 10.1097/00000542-200204000-00019	26	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-658X	1557-8127		ASSAY DRUG DEV TECHN	ASSAY DRUG DEV. TECHNOL.	MAR 1	2015	13	2					79	87		10.1089/adt.2014.621		9	Biochemical Research Methods; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CD5UK	WOS:000351153400004		
J	Kim, K; Takatera, M; Zhu, CH; Otani, T				Kim, KyoungOk; Takatera, Masayuki; Zhu, Chunhong; Otani, Tsuyoshi			COMPARISON OF JAPANESE AND CHINESE CLOTHING EVALUATIONS BY EXPERTS TAKING INTO ACCOUNT MARKETABILIT	AUTEX RESEARCH JOURNAL			English	Article						Chinese Apparel; Japanese Apparel; Clothing Evaluation; Apparel Expert		To better understand the reasons for the marketability of clothing now designed and sold in China and Japan, we asked Japanese and Chinese experts to evaluate Chinese and Japanese brands of clothing currently for sale in the Japanese market. The marketability of the Chinese apparel items in the Japanese market was evaluated by the Japanese experts. Five Japanese jackets were purchased from a department store in Tokyo, and ten items of Chinese clothing were purchased from a department store in Beijing. Five of the Chinese clothing samples were judged as impossible to sell in Japanese department stores primarily because the sewing quality was incompatible with Japanese requirements, the designs were outdated, and the materials were of low quality. However, the other five Chinese clothing samples received high evaluations of marketability in Japan. We found that Japanese experts focused on general design and sewing finish, while Chinese experts considered more general design points. Thus, our results indicate that clothing is evaluated differently in Japan and China. We conclude that it is necessary to consider the respective evaluation points used in each country as we pursue globalisation.	[Kim, KyoungOk; Takatera, Masayuki] Shinshu Univ, Div Kansei & Fash Engn, Inst Fiber Engn IFES, Interdisciplinary Cluster Cutting Edge Res, Ueda, Nagano, Japan; [Zhu, Chunhong] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Matsumoto, Nagano, Japan; [Otani, Tsuyoshi] Shinshu Univ, Fac Text Sci & Technol, Matsumoto, Nagano, Japan	Takatera, M (reprint author), Shinshu Univ, Div Kansei & Fash Engn, Inst Fiber Engn IFES, Interdisciplinary Cluster Cutting Edge Res, Ueda, Nagano, Japan.	takatera@shinshu-u.ac.jp			JSPS KAKENHI [24220012, 23240100]	This work was supported by JSPS KAKENHI Grant number 24220012 and 23240100.	Laforet S, 2012, J WORLD BUS, V47, P54, DOI 10.1016/j.jwb.2010.10.020; Kim J. H., 2013, J RETAILING CONSUMER, V20, P68; Luo Ye, 2005, Body Image, V2, P333, DOI 10.1016/j.bodyim.2005.09.003; Masuda T., 2010, OVER QUALITY PROBLEM; Mellor D, 2013, BODY IMAGE, V10, P54, DOI 10.1016/j.bodyim.2012.10.002; Ministry of Economy Trade and Industry of Japan, 2013, REC TRENDS TEXT FASH; O'Cass A., 2013, J RETAILING CONSUMER, V20, P505; Sakaguchi M., 2006, 2 PERIOD AGENDA ENTE, P30; Tai S. H., 2005, J RETAILING CONSUMER, V12, P191, DOI 10.1016/j.jretconser.2004.06.003; Yano research institute Ltd, 2012, AN STRAT MAJ CO ACT	10	0	0	AUTEX	LODZ	TECHNICAL UNIV LODZ, FAC MATERIALS TECHNOLOGY & TEXTILE, UL ZEROMSKIEGO 116, LODZ, 90-924, POLAND	1470-9589	2300-0929		AUTEX RES J	Autex Res. J.	MAR	2015	15	1					67	76		10.2478/aut-2014-0047		10	Materials Science, Textiles	Materials Science	CD9MW	WOS:000351423400010		
J	Sato, S; Umeda, Y; Fujii, S; Takenaka, S				Sato, Shinobu; Umeda, Yuta; Fujii, Satoshi; Takenaka, Shigeori			Cooperative Binding of Ferrocenylnaphthalene Diimide Carrying beta-Cyclodextrin Converts Double-Stranded DNA to a Rod-Like Structure	BIOCONJUGATE CHEMISTRY			English	Article							SUPRAMOLECULAR COMPLEX-FORMATION; ELECTROCHEMICAL GENE DETECTION; FORCE MICROSCOPY; FERROCENE; CONDENSATION; LIGANDS	Ferrocenylnaphthalene diimide carrying beta-cyclodextrin (beta-CD), 1, intercalated into double-stranded DNA with a binding affinity of K = (6.6 +/- 0.8) x 10(4) M-1 and a binding site size of n = 4, with a high positive cooperative parameter of omega = 14. beta-CD and ferrocene moieties of the compound contributed to the formation of the intermolecular inclusion complex on DNA. Binding of 1 resulted in conversion of the DNA duplex to a rod-like form, which was cleaved upon adamantylamine addition.	[Sato, Shinobu; Umeda, Yuta; Takenaka, Shigeori] Kyushu Inst Technol, Dept Appl Chem, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan; [Sato, Shinobu; Takenaka, Shigeori] Kyushu Inst Technol, Res Ctr Biomicrosensing Technol, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan; [Fujii, Satoshi] Kyushu Inst Technol, Dept Biosci & Bioinformat, Tobata Ku, Kitakyushu, Fukuoka 8048550, Japan	Takenaka, S (reprint author), Kyushu Inst Technol, Dept Appl Chem, Tobata Ku, 1-1 Sensui Cho, Kitakyushu, Fukuoka 8048550, Japan.	shige@che.kyutech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [24750071]	This work was supported in part by Grants-in-Aid for Young Scientific Research (B) to S. S. (No. 24750071) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Watanabe S, 2011, ANAL CHEM, V83, P7290, DOI 10.1021/ac200989c; Liu Y, 2008, J AM CHEM SOC, V130, P10431, DOI 10.1021/ja802465g; Coury JE, 1996, P NATL ACAD SCI USA, V93, P12283, DOI 10.1073/pnas.93.22.12283; Liu Y, 2007, J AM CHEM SOC, V129, P10656, DOI 10.1021/ja073882b; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Choi SJ, 2002, ANAL CHEM, V74, P1998, DOI 10.1021/ac0107913; Bhosale SV, 2008, CHEM SOC REV, V37, P331, DOI 10.1039/b615857a; Chen M, 2009, TALANTA, V80, P815, DOI 10.1016/j.talanta.2009.07.068; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; YEN SF, 1982, BIOCHEMISTRY-US, V21, P2070, DOI 10.1021/bi00538a014; Casas-Solvas JM, 2009, CHEM-EUR J, V15, P8146, DOI 10.1002/chem.200900593; Aoki H, 2010, SUPRAMOL CHEM, V22, P455, DOI 10.1080/10610278.2010.486034; Cheng HB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04210; EFTINK MR, 1989, J AM CHEM SOC, V111, P6765, DOI 10.1021/ja00199a041; Ihara T, 2011, CHEM COMMUN, V47, P12388, DOI 10.1039/c1cc15365j; Kaji N, 2001, ELECTROPHORESIS, V22, P3357, DOI 10.1002/1522-2683(200109)22:16<3357::AID-ELPS3357>3.3.CO;2-3; Lu D., 2002, J INCL PHENOM MACRO, V43, P19; Sato S, 2008, J ORGANOMET CHEM, V693, P1177, DOI 10.1016/j.jorganchem.2008.01.011; Sato S, 2004, J ORGANOMET CHEM, V689, P4722, DOI 10.1016/j.jorganchem.2004.08.039; Sato S, 2005, MOLECULES, V10, P693, DOI 10.3390/10060693; Suraru S.-L., 2014, ANGEW CHEM INT EDIT, V14, P7428; Takenaka H, 2013, ELECTROANAL, V25, P1827, DOI 10.1002/elan.201300211	22	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	MAR	2015	26	3					379	382		10.1021/bc500535n		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CD9LY	WOS:000351421000002		
J	Suzuki, T; Okamura, T; Tomohiro, T; Iwabuchi, Y; Kanoh, N				Suzuki, Takahiro; Okamura, Toshitaka; Tomohiro, Takenori; Iwabuchi, Yoshiharu; Kanoh, Naoki			Third Generation Photo-Cross-Linked Small-Molecule Affinity Matrix: A Photoactivatable and Photocleavable System Enabling Quantitative Analysis of the Photo-Cross-Linked Small Molecules and Their Target Purification	BIOCONJUGATE CHEMISTRY			English	Article							NATURAL-PRODUCTS; OSTEOCLASTOGENESIS INHIBITOR; CHEMICAL GENETICS; IDENTIFICATION; PROTEIN; COMPOUND; CELLS; BINDS	The third generation of photoactivatable beads designed to capture bioactive small molecules in a chemo- and site-nonselective manner upon irradiation at 365 run of UV light and release them as coumarin conjugate 8 after exposure to UV light of 302 nm is described. These photoactivatable and photocleavable beads enable quantification of the amount and distribution of immobilized small molecules prior to the pull-down experiments to identify target protein(s) for the immobilized small molecules. The newly developed system was then used to analyze the functional group compatibility of the photo-cross-linking technology as well as the preferable nature of small molecules to be immobilized. AS a result, compounds having a hydroxyl group, carboxylic acid, or aromatic ring were shown to give multiple conjugates, indicating that these compounds are well compatible with the photoactivatable beads system.	[Suzuki, Takahiro; Okamura, Toshitaka; Iwabuchi, Yoshiharu; Kanoh, Naoki] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Tomohiro, Takenori] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan	Kanoh, N (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aza Aoba, Sendai, Miyagi 9808578, Japan.	nkanoh@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23102013]	This work was partially supported by a Grant-in-Aid for Scientific Research on the Innovative Area "Chemical Biology of Natural Products" from The Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 23102013 to N.K).	Hirohama M, 2013, ACS CHEM BIOL, V8, P2635, DOI 10.1021/cb400630z; Robles O, 2014, NAT PROD REP, V31, P318, DOI 10.1039/c3np70087a; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Kim E, 2003, J BIOCHEM MOL BIOL, V36, P299; Ong EBB, 2011, J BIOL CHEM, V286, P14049, DOI 10.1074/jbc.M110.185397; Kanoh N, 2008, TETRAHEDRON, V64, P5692, DOI 10.1016/j.tet.2008.04.031; Leslie BJ, 2008, CHEM SOC REV, V37, P1347, DOI 10.1039/b702942j; Kawamura T, 2014, BIOCHEM J, V463, P53, DOI 10.1042/BJ20140669; Peddibhotla S, 2007, J AM CHEM SOC, V129, P12222, DOI 10.1021/ja0733686; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Henkel T, 1999, ANGEW CHEM INT EDIT, V38, P643, DOI 10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G; Ueda M, 2012, CHEM LETT, V41, P658, DOI 10.1246/cl.2012.658; Sasazawa Y, 2012, ACS CHEM BIOL, V7, P892, DOI 10.1021/cb200492h; Miyazaki I, 2010, NAT CHEM BIOL, V6, P667, DOI [10.1038/nchembio.423, 10.1038/NCHEMBIO.423]; Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164; Ziegler S, 2013, ANGEW CHEM INT EDIT, V52, P2744, DOI 10.1002/anie.201208749; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Sakamoto S, 2012, BIOORGAN MED CHEM, V20, P1990, DOI 10.1016/j.bmc.2011.12.022; CIGANEK E, 1971, J AM CHEM SOC, V93, P2207, DOI 10.1021/ja00738a020; Beer PD, 2000, J CHEM SOC DALTON, P1805, DOI 10.1039/b000079p; GAUR RK, 1989, ANAL BIOCHEM, V180, P253, DOI 10.1016/0003-2697(89)90426-0; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Kanoh N, 2013, BIOCONJUGATE CHEM, V24, P44, DOI 10.1021/bc3003666; Kanoh N, 2010, BIOCONJUGATE CHEM, V21, P182, DOI 10.1021/bc900316q; Ki SW, 2000, J BIOL CHEM, V275, P39231, DOI 10.1074/jbc.M006192200; Raimer B, 2013, CHEM-EUR J, V19, P6551, DOI 10.1002/chem.201203479; Tomohiro T, 2011, BIOCONJUGATE CHEM, V22, P315, DOI 10.1021/bc100598r; Yao R, 2014, ONCOGENE, V33, P4242, DOI 10.1038/onc.2013.382	29	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	MAR	2015	26	3					389	395		10.1021/bc500559e		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CD9LY	WOS:000351421000004		
J	Hayashi, G; Yanase, M; Takeda, K; Sakakibara, D; Sakamoto, R; Wang, DO; Okamoto, A				Hayashi, Gosuke; Yanase, Masafumi; Takeda, Katsuya; Sakakibara, Daisuke; Sakamoto, Ryosuke; Wang, Dan Ohtan; Okamoto, Akimitsu			Hybridization-Sensitive Fluorescent Oligonucleotide Probe Conjugated with a Bulky Module for Compartment-Specific mRNA Monitoring in a Living Cell	BIOCONJUGATE CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; INTRACELLULAR RNA; MOLECULAR BEACONS; ARCHITECTURE	Live-cell RNA imaging at specific intracellular locations is technically limited because of the diffusive nature of small oligonudeotide probes. The bulky fluorescent light-up probes that possess streptavidin or gold nanoparticles at the end of oligonucleotides were designed and synthesized. The bulky probes allowed nucleus- and cytoplasm-selective monitoring of endogenous mRNAs through nuclear and cytoplasmic microinjection, respectively. Simultaneous use of bulky and unbulky probes conjugated with different fluorescent dyes enabled dual color imaging of mRNAs present in nucleus and cytoplasm. Furthermore, we observed that the fluorescence near the cell edge in a living HeLa cell traveled over time in coordination with the dynamic formation and deformation of the pseudopodial protrusions after lipofection of the bulky probes.	[Hayashi, Gosuke; Yanase, Masafumi; Takeda, Katsuya; Sakakibara, Daisuke; Sakamoto, Ryosuke; Okamoto, Akimitsu] Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Wang, Dan Ohtan] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Okamoto, Akimitsu] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Okamoto, A (reprint author), Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	okamoto@chembio.t.u-tokyo.ac.jp			Funding Program for Next Generation World-Leading Researchers, Japan [LR036]	This research was supported by the Funding Program for Next Generation World-Leading Researchers, Japan (LR036).	Kummer S, 2011, ANGEW CHEM INT EDIT, V50, P1931, DOI 10.1002/anie.201005902; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Tyagi S, 2004, BIOPHYS J, V87, P4153, DOI 10.1529/biophysj.104.045153; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Qiu LP, 2013, J AM CHEM SOC, V135, P12952, DOI 10.1021/ja406252w; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/nmeth.1321, 10.1038/NMETH.1321]; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Lorenz P, 2000, NUCLEIC ACIDS RES, V28, P582, DOI 10.1093/nar/28.2.582; Hayashi G, 2013, CHEM REC, V13, P209, DOI 10.1002/tcr.201200026; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Armitage BA, 2011, CURR OPIN CHEM BIOL, V15, P806, DOI 10.1016/j.cbpa.2011.10.006; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; Mhlanga MM, 2005, NUCLEIC ACIDS RES, V33, P1902, DOI 10.1093/nar/gki302; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Okamoto A, 2011, CHEM SOC REV, V40, P5815, DOI 10.1039/c1cs15025a; Wang DO, 2012, J PHOTOCH PHOTOBIO C, V13, P112, DOI 10.1016/j.jphotochemrev.2012.03.001; Kashida H, 2012, BIOORGAN MED CHEM, V20, P4310, DOI 10.1016/j.bmc.2012.05.052; Kubota T, 2009, B CHEM SOC JPN, V82, P110, DOI 10.1246/bcsj.82.110; Kubota T, 2009, BIOCONJUGATE CHEM, V20, P1256, DOI 10.1021/bc900120a; LEONETTI JP, 1991, P NATL ACAD SCI USA, V88, P2702, DOI 10.1073/pnas.88.7.2702; Tsuji A, 2000, BIOPHYS J, V78, P3260; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303	22	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	MAR	2015	26	3					412	417		10.1021/acs.bioconjchem.5b00090		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CD9LY	WOS:000351421000007		
J	Fujii, A; Sekiguchi, Y; Matsumura, H; Inoue, T; Chung, WS; Hirota, S; Matsuo, T				Fujii, Akira; Sekiguchi, Yutaka; Matsumura, Hiroyoshi; Inoue, Tsuyoshi; Chung, Wen-Sheng; Hirota, Shun; Matsuo, Takashi			Excimer Emission Properties on Pyrene-Labeled Protein Surface: Correlation between Emission Spectra, Ring Stacking Modes, and Flexibilities of Pyrene Probes	BIOCONJUGATE CHEMISTRY			English	Article							INDUCED CIRCULAR-DICHROISM; ADENYLATE KINASE; FLUORESCENCE BEHAVIOR; ESCHERICHIA-COLI; STATIC EXCIMER; DOMAIN CLOSURE; WATER; TRANSITION; MECHANISM; SOLVENTS	The excimer emission of pyrene is popularly employed for investigating the association between pyrene-labeled biomolecules or between pyrene-labeled places in a biomolecule. The property of pyrene excimer emission is affected by the fluctuation in ring stacking modes, which originates from the structural flexibilities of pyrene probes and/or of labeled places. Investigations of the excimer emission in terms of dynamics of pyrene stacking modes provide the detailed spatial information between pyrene-labeled places. In order to evaluate the effects of probe structures and fluctuation in pyrene pyrene association modes on their emission properties on protein surface, three types of pyrene probe with different linker lengths were synthesized and conjugated to two cysteine residues in the A.55C/C77S/V169C mutant of adenylate kinase (Adk), an enzyme that shows a structural transition between OPEN and CLOSED forms. In the CLOSED form of Adk labeled by a pyrene probe with a short linker, excimer emission was found to be predominated by the ground-state association of pyrenes. The pyrene stacking structure on the protein surface was successfully determined by an X-ray crystallographic analysis. However, the emission decay in the protein suggested the existence of several stacking orientations in solution. With the increase in the linker length, the effect of fluctuation in pyrene association modes on the spectral properties distinctly emerged at both ground and excited states. The combination of steady-state and time-resolved spectroscopic analyses is useful for differentiation in the origin of the excimer emission, which is essential for precisely understanding the interaction fashions between pyrene-labeled biomolecules.	[Fujii, Akira; Sekiguchi, Yutaka; Hirota, Shun; Matsuo, Takashi] Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, Nara 6300192, Japan; [Matsumura, Hiroyoshi; Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Chung, Wen-Sheng] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 30050, Taiwan	Matsumura, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	matsumura@chem.eng.osaka-u.ac.jp; wschung@nctu.edu.tw; tmatsuo@ms.naist.jp			MEXT, Japan; Sekisui Integrated Research, Inc.; NAIST, Japan	The authors thank financial support from a Grant-in-Aid for Science Research on Innovative Areas ("Stimuli-responsive Chemical Species for the Creation of Functional Molecules", MEXT, Japan), Innovations Inspired by Nature Research Program by Sekisui Integrated Research, Inc., and "The Green Photonics Project" (NAIST, Japan). This work was supported by the Platform for drug discovery, informatics, and structural life science (MEXT, Japan). The authors acknowledge Prof. Eric Wei-Guang Diau, Dr. Hung-Yu Hsu, and Ms. Yu-Pei Huang (National Chiao Tung University, Taiwan) for helping us with the TCSPC measurements.	Bains GK, 2012, BIOCHEMISTRY-US, V51, P6207, DOI 10.1021/bi3005285; MORRIS JV, 1976, J PHYS CHEM-US, V80, P969, DOI 10.1021/j100550a010; UENO A, 1989, J AM CHEM SOC, V111, P6391, DOI 10.1021/ja00198a061; You L, 2008, CHEM-EUR J, V14, P5861, DOI 10.1002/chem.200800147; Conlon P, 2008, J AM CHEM SOC, V130, P336, DOI 10.1021/ja076411y; KANO K, 1985, J AM CHEM SOC, V107, P6117, DOI 10.1021/ja00307a055; Senthilvelan A, 2009, CHEM-EUR J, V15, P6152, DOI 10.1002/chem.200802654; Nakamura M, 2012, ORG BIOMOL CHEM, V10, P9620, DOI 10.1039/c2ob26773j; BIRKS JB, 1963, PROC R SOC LON SER-A, V275, P575, DOI 10.1098/rspa.1963.0187; Maeda H, 2006, CHEM-EUR J, V12, P824, DOI 10.1002/chem.200500638; FORSTER T, 1969, ANGEW CHEM INT EDIT, V8, P333, DOI 10.1002/anie.196903331; Qing ZH, 2014, ANAL CHEM, V86, P4934, DOI 10.1021/ac500834g; Sinev MA, 1996, BIOCHEMISTRY-US, V35, P6425, DOI 10.1021/bi952687j; Karlsen KK, 2013, BIOORGAN MED CHEM, V21, P6186, DOI 10.1016/j.bmc.2013.04.062; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; BLANCHETTE MA, 1984, TETRAHEDRON LETT, V25, P2183, DOI 10.1016/S0040-4039(01)80205-7; GERSTEIN M, 1993, J MOL BIOL, V229, P494, DOI 10.1006/jmbi.1993.1048; WINNIK FM, 1993, CHEM REV, V93, P587, DOI 10.1021/cr00018a001; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; Bains G, 2011, MOLECULES, V16, P7909, DOI 10.3390/molecules16097909; Zsila F, 2003, FEBS LETT, V539, P85, DOI 10.1016/S0014-5793(03)00203-5; WELTMAN JK, 1973, J BIOL CHEM, V248, P3173; BIRKS JB, 1975, REP PROG PHYS, V38, P903, DOI 10.1088/0034-4885/38/8/001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen SX, 2012, J AM CHEM SOC, V134, P18883, DOI 10.1021/ja307179q; Costa T, 2009, J PHYS CHEM B, V113, P618, DOI 10.1021/jp806555x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, P375; de Melo JS, 2003, J PHYS CHEM B, V107, P12605, DOI 10.1021/jp0346054; Franova MD, 2014, BBA-BIOMEMBRANES, V1838, P1406, DOI 10.1016/j.bbamem.2014.01.030; Fujii A, 2013, BIOCONJUGATE CHEM, V24, P1218, DOI 10.1021/bc400160m; Fujimoto K, 2009, CHEM COMMUN, P7164, DOI 10.1039/b916543f; Hung HC, 2014, PHOTOCH PHOTOBIO SCI, V13, P370, DOI 10.1039/c3pp50175b; Krishnamurthy H, 2005, PROTEINS, V58, P88, DOI 10.1002/prot.20301; Kunst A, 1984, METHOD ENZYMAT AN, VV, P163; Lekha PK, 2011, CHEM-EUR J, V17, P8609, DOI 10.1002/chem.201100116; Matsui J, 2002, COLLOID SURFACE A, V198, P703, DOI 10.1016/S0927-7757(01)00990-6; Matsui J, 2002, J PHYS CHEM B, V106, P2468, DOI 10.1021/jp012381o; MIZUTANI T, 1994, INORG CHEM, V33, P3558, DOI 10.1021/ic00094a020; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Preuss R, 1997, J MOL BIOL, V273, P600, DOI 10.1006/jmbi.1997.1343; Tan YW, 2009, J BIOL CHEM, V284, P3306, DOI 10.1074/jbc.M803658200; WIELAND B, 1984, EUR J BIOCHEM, V143, P331, DOI 10.1111/j.1432-1033.1984.tb08376.x; YAMAZAKI I, 1987, J PHYS CHEM-US, V91, P4213, DOI 10.1021/j100300a001	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	MAR	2015	26	3					537	548		10.1021/acs.bioconjchem.5b00026		12	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CD9LY	WOS:000351421000021		
J	Takechi-Haraya, Y; Tanaka, K; Tsuji, K; Asami, Y; Izawa, H; Shigenaga, A; Otaka, A; Saito, H; Kawakami, K				Takechi-Haraya, Yuki; Tanaka, Kento; Tsuji, Kohei; Asami, Yasuo; Izawa, Hironori; Shigenaga, Akira; Otaka, Akira; Saito, Hiroyuki; Kawakami, Kohsaku			Molecular Complex Composed of beta-Cyclodextrin-Grafted Chitosan and pH-Sensitive Amphipathic Peptide for Enhancing Cellular Cholesterol Efflux under Acidic pH	BIOCONJUGATE CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MACROPHAGE FOAM CELLS; PANCREATIC TRYPSIN-INHIBITOR; APOLIPOPROTEIN-A-I; CIRCULAR-DICHROISM; PENETRATING PEPTIDE; GAMMA-CYCLODEXTRINS; SERUM ALBUMINS; GENE DELIVERY; MECHANISM	Excess of cholesterol in peripheral cells is known to lead to atherosclerosis. In this study, a molecular complex composed of beta-cyclodextrin-grafted chitosan (BCC) and cellular cholesterol efflux enhancing peptide (CEEP), synthesized by modifying pH sensitive amphipathic GALA peptide, is introduced with the eventual aim of treating atherosclerosis. BCC has a markedly enhanced ability to induce cholesterol efflux from cell membranes compared to beta-cyclodextrin, and the BCC-CEEP complex exhibited a 2-fold increase in cellular cholesterol efflux compared to BCC alone under weakly acidic conditions. Isothermal titration calorimetry and fluorescence spectroscopy measurements demonstrated that the random coil structure of CEEP at neutral pH converted to the a-helical structure at acidic pH, resulting in a three-order larger binding constant to BCC (K = 3.7 X 10(7) at pH 5.5) compared to that at pH 7.4 (K = 7.9X 10(4)). Such high-affinity binding of CEEP to BCC at acidic pH leads to the formation of 100-nm-sized aggregate with positive surface charge, which would efficiently interact with cell membranes and induce cholesterol efflux. Since the cholesterol efflux ability of HDL is thought to be impaired under acidic environments in advanced atherosclerotic lesions, the BCC-CEEP complex might serve as a novel nanomaterial for treating atherosclerosis.	[Takechi-Haraya, Yuki; Tanaka, Kento; Tsuji, Kohei; Shigenaga, Akira; Otaka, Akira; Saito, Hiroyuki] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan; [Takechi-Haraya, Yuki; Izawa, Hironori; Kawakami, Kohsaku] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Asami, Yasuo] TA Instruments Japan Inc, Shinagawa Ku, Tokyo 1410031, Japan; [Izawa, Hironori] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808552, Japan	Kawakami, K (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	kawakami.kohsaku@nims.go.jp	Izawa, Hironori/M-7037-2014	Izawa, Hironori/0000-0002-8715-8462	research program for development of intelligent Tokushima artificial exosome (iTEX) from The University of Tokushima; World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan	This work was partly supported by the research program for development of intelligent Tokushima artificial exosome (iTEX) from The University of Tokushima, and World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan.	Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; LAMB DJ, 1994, FEBS LETT, V352, P15, DOI 10.1016/0014-5793(94)00903-1; Pavinatto FJ, 2007, LANGMUIR, V23, P7666, DOI 10.1021/la700856a; Mansouri S, 2006, BIOMATERIALS, V27, P2060, DOI 10.1016/j.biomaterials.2005.09.020; Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h; Phillips MC, 2014, J BIOL CHEM, V289, P24020, DOI 10.1074/jbc.R114.583658; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; KUNTZ ID, 1968, J AM CHEM SOC, V90, P4778, DOI 10.1021/ja01020a004; KEIZER J, 1983, J AM CHEM SOC, V105, P1494, DOI 10.1021/ja00344a013; Henriksen I, 1997, INT J PHARM, V146, P193, DOI 10.1016/S0378-5173(96)04801-6; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; Wang YQ, 2007, J LUMIN, V126, P211, DOI 10.1016/j.jlumin.2006.06.013; Leman LJ, 2014, J MED CHEM, V57, P2169, DOI 10.1021/jm4005847; Nguyen SD, 2012, J LIPID RES, V53, P2115, DOI 10.1194/jlr.M028118; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Bi SY, 2005, SPECTROCHIM ACTA A, V61, P629, DOI 10.1016/j.saa.2004.05.028; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Ding F, 2009, EUR J MED CHEM, V44, P4083, DOI 10.1016/j.ejmech.2009.04.047; Breslow R, 1996, J AM CHEM SOC, V118, P8495, DOI 10.1021/ja961567b; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; Wydro P, 2007, BIOMACROMOLECULES, V8, P2611, DOI 10.1021/bm700453x; Plank C, 1998, ADV DRUG DELIVER REV, V34, P21, DOI 10.1016/S0169-409X(98)00005-2; Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; PARENTE RA, 1988, J BIOL CHEM, V263, P4724; Irie T, 1999, ADV DRUG DELIVER REV, V36, P101, DOI 10.1016/S0169-409X(98)00057-X; Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; Sreerama N, 1999, BIOCHEMISTRY-US, V38, P10814, DOI 10.1021/bi990516z; Yancey PG, 1996, J BIOL CHEM, V271, P16026; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8720, DOI 10.1021/bi00489a031; Ziegler A, 2008, BIOPHYS J, V94, P2142, DOI 10.1529/biophysj.107.113472; Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250; Gao DJ, 2005, SPECTROCHIM ACTA A, V62, P1203, DOI 10.1016/j.saa.2005.04.026; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; Schneider HJ, 1998, CHEM REV, V98, P1755, DOI 10.1021/cr970019t; Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s; Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; Major AS, 2001, ARTERIOSCL THROM VAS, V21, P1790, DOI 10.1161/hq1101.097798; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Xu GF, 2007, ASIA PAC J CLIN NUTR, V16, P313; Birner-Gruenberger R, 2014, PROG LIPID RES, V56, P36, DOI 10.1016/j.plipres.2014.07.003; Choi YH, 2001, J INCL PHENOM MACRO, V39, P71, DOI 10.1023/A:1008196029391; Daimon Y, 2014, J MATER CHEM B, V2, P1802, DOI 10.1039/c3tb21528h; Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i; JONES MK, 1992, J LIPID RES, V33, P287; Kawakami K, 1999, ANAL BIOCHEM, V269, P139, DOI 10.1006/abio.1999.4035; LAMB DJ, 1994, FEBS LETT, V338, P122, DOI 10.1016/0014-5793(94)80348-X; Lee-Rueckert M, 2010, ARTERIOSCL THROM VAS, V30, P1766, DOI 10.1161/ATVBAHA.110.211276; Lopez CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002020; MANNING MC, 1989, BIOCHEMISTRY-US, V28, P8609, DOI 10.1021/bi00447a051; MORGAN J, 1993, FEBS LETT, V333, P275, DOI 10.1016/0014-5793(93)80669-L; Nagao K, 2014, BBA-MOL CELL BIOL L, V1841, P80, DOI 10.1016/j.bbalip.2013.10.005; Nicol F, 1996, BIOPHYS J, V71, P3288; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8713, DOI 10.1021/bi00489a030; Patterson RA, 1998, FEBS LETT, V434, P317, DOI 10.1016/S0014-5793(98)01002-3; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; Sneck M, 2012, J LIPID RES, V53, P1832, DOI 10.1194/jlr.M023218; Takechi Y, 2011, LANGMUIR, V27, P7099, DOI 10.1021/la200917y; Tang WH, 2007, TETRAHEDRON-ASYMMETR, V18, P1548, DOI 10.1016/j.tetasy.2007.06.017; Tatko CD, 2002, J AM CHEM SOC, V124, P9372, DOI 10.1021/ja0262481; Yang F, 2002, BIOPHYS CHEM, V99, P99, DOI 10.1016/S0301-4622(02)00134-5	68	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	MAR	2015	26	3					572	581		10.1021/acs.bioconjchem.5b00037		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CD9LY	WOS:000351421000024		
J	Kihira, T; Sakurai, I; Yoshida, S; Wakayama, I; Takamiya, K; Okumura, R; Iinuma, Y; Iwai, K; Kajimoto, Y; Hiwatani, Y; Kohmoto, J; Okamoto, K; Kokubo, Y; Kuzuhara, S				Kihira, Tameko; Sakurai, Iori; Yoshida, Sohei; Wakayama, Ikuro; Takamiya, Koichi; Okumura, Ryo; Iinuma, Yuhto; Iwai, Keiko; Kajimoto, Yoshinori; Hiwatani, Yasuhiro; Kohmoto, Junko; Okamoto, Kazushi; Kokubo, Yasumasa; Kuzuhara, Shigeki			Neutron Activation Analysis of Scalp Hair from ALS Patients and Residents in the Kii Peninsula, Japan	BIOLOGICAL TRACE ELEMENT RESEARCH			English	Article						Kii-ALS; Metal content; Neutron activation analysis; Scalp hair; Mn	AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; DRINKING-WATER; MANGANESE; DIETARY; NEUROTOXICITY; PATHOGENESIS; METABOLISM	The aim of this study was to evaluate the accumulation of transition metals in the scalp hair of amyotrophic lateral sclerosis (ALS) patients in the Koza/Kozagawa/Kushimoto (K) area (K-ALS) in the Kii Peninsula, Japan. Metal contents were measured in the unpermed, undyed hair samples of 88 K-residents, 20 controls, 7 K-ALS patients, and 10 sporadic ALS patients using neutron activation analysis at the Research Reactor Institute, Kyoto University. A human hair standard and elemental standards were used as comparative standards. The contents of Zn, Mn, and V were higher, while that of S was lower in K-ALS patients than in the controls. The content of Mn in K-ALS patients negatively correlated with clinical durations. The content of Al was significantly higher in K-residents than in the controls, with 15.9 % of K-residents having high Mn contents over the 75th percentile of the controls. The contents of Zn, Mn, and V were high in the scalp hair of K-ALS patients and correlated with the content of Al. The accumulation of these transition metals may chronically increase metal-induced oxidative stress, which may, in turn, trigger the neuronal degeneration associated with K-ALS.	[Kihira, Tameko; Sakurai, Iori; Yoshida, Sohei; Wakayama, Ikuro] Kansai Univ Hlth Sci, Dept Hlth Sci, Osaka 5900482, Japan; [Takamiya, Koichi; Okumura, Ryo; Iinuma, Yuhto] Kyoto Univ, Inst Res Reactor, Kyoto, Japan; [Iwai, Keiko] Kansai Univ Hlth Sci, Fac Nursing, Osaka 5900482, Japan; [Kajimoto, Yoshinori; Hiwatani, Yasuhiro] Wakayama Med Univ, Dept Neurol, Wakayama, Japan; [Kohmoto, Junko] Wakayama Natl Hosp, Dept Neurol, Wakayama, Japan; [Okamoto, Kazushi] Aichi Prefectural Univ, Dept Publ Hlth, Nagakute, Aichi, Japan; [Kokubo, Yasumasa] Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie 514, Japan; [Kuzuhara, Shigeki] Suzuka Univ Med Sci, Dept Med Welf, Matsusaka, Japan	Kihira, T (reprint author), Kansai Univ Hlth Sci, Dept Hlth Sci, 2-11-1 Wakaba, Osaka 5900482, Japan.	tkihira815@kansai.ac.jp			Research Committee of Muro Disease; Ministry of Health, Labour and Welfare of Japan;  [22590967];  [16590511]	This work was supported by Grants-in-Aid from the Research Committee of Muro Disease (Chairman: Dr. Yasumasa Kokubo), the Ministry of Health, Labour and Welfare of Japan, and a Grant-in-Aid for Scientific Research of Japan (No. 22590967 and No. 16590511). A part of this research was reported at the 23th and 24th International Symposia on ALS/MND.	Ngwa HA, 2009, TOXICOL APPL PHARM, V240, P273, DOI 10.1016/j.taap.2009.07.025; Mizuno D, 2013, INT J MOL SCI, V14, P22067, DOI 10.3390/ijms141122067; Chojnacka K, 2010, ENVIRON TOXICOL PHAR, V30, P188, DOI 10.1016/j.etap.2010.06.002; WASHKO PW, 1977, J NUTR, V107, P920; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Kihira T, 2013, INTERNAL MED, V52, P1479, DOI 10.2169/internalmedicine.52.9521; YASE Y, 1972, LANCET, V2, P292; Brzoska MM, 2007, TOXICOLOGY, V237, P89, DOI 10.1016/j.tox.2007.05.001; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Brosnan JT, 2006, J NUTR, V136, p1636S; COVELL DF, 1959, ANAL CHEM, V31, P1785, DOI 10.1021/ac60155a027; Garruto RM, 1984, AMYOTROPHIC LATERAL, P265; Hansen SL, 2009, J NUTR, V139, P1474, DOI 10.3945/jn.109.105866; Huang CS, 2000, J BIOL CHEM, V275, P32516, DOI 10.1074/jbc.M005366200; IWAMI O, 1994, SCI TOTAL ENVIRON, V149, P121, DOI 10.1016/0048-9697(94)90010-8; Kapaki E, 1997, J NEUROL SCI, V147, P171, DOI 10.1016/S0022-510X(96)05334-8; Karki Pratap, 2013, Ann Occup Environ Med, V25, P4, DOI 10.1186/2052-4374-25-4; Kihira T, 2012, AMYOTROPH LATERAL SC, V13, P347, DOI 10.3109/17482968.2012.674140; KIHIRA T, 1990, J NEUROL SCI, V98, P251, DOI 10.1016/0022-510X(90)90266-P; Kim NB, 1985, TRACE ELEMENT ANAL H, P169; Man CK, 1996, SCI TOTAL ENVIRON, V191, P291, DOI 10.1016/S0048-9697(96)05268-0; MEYEROVITCH J, 1991, J CLIN INVEST, V87, P1286, DOI 10.1172/JCI115131; MITCHELL JD, 1991, EUR NEUROL, V31, P7, DOI 10.1159/000116626; Niese S, 1985, IAEATECDOC330, P95; PEAN AR, 1995, J NEUROL SCI, V129, P107, DOI 10.1016/0022-510X(95)00078-G; Ramakrishna VVS, 1996, SCI TOTAL ENVIRON, V192, P259, DOI 10.1016/S0048-9697(96)05316-8; Ripps H, 2014, MOL VIS, V20, P1067; Rodenas S, 2011, NUTR HOSP, V26, P874, DOI [10.1590/S0212-16112011000400030, 10.3305/nh.2011.26.4.5197]; Roos PM, 2013, BIOL TRACE ELEM RES, V151, P159, DOI 10.1007/s12011-012-9547-x; Shaw CA, 2008, NEUROMOL MED, V10, P1, DOI 10.1007/s12017-007-8016-8; Suliburska J, 2011, BIOL TRACE ELEM RES, V144, P77, DOI 10.1007/s12011-011-9034-9; TAKEUCHI T, 1982, J RADIOANAL CHEM, V70, P29; Yoshida M, 2007, TRACE NUTR RES, V24, P65; Zaichick S, 2010, BIOL TRACE ELEM RES, V134, P41, DOI 10.1007/s12011-009-8456-0	35	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0163-4984	1559-0720		BIOL TRACE ELEM RES	Biol. Trace Elem. Res.	MAR	2015	164	1					36	42		10.1007/s12011-014-0202-6		7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CD9SO	WOS:000351438800007		
J	Kono, K; Takada, N; Yasuda, S; Sawada, R; Niimi, S; Matsuyama, A; Sato, Y				Kono, Ken; Takada, Nozomi; Yasuda, Satoshi; Sawada, Rumi; Niimi, Shingo; Matsuyama, Akifumi; Sato, Yoji			Characterization of the cell growth analysis for detection of immortal cellular impurities in human mesenchymal stem cells	BIOLOGICALS			English	Article						Regenerative medicine; Cellular therapy; Tumorigenicity; Mesenchymal stem cell; Quality; Safety	SPONTANEOUS MALIGNANT-TRANSFORMATION; CROSS-CONTAMINATION; LINES; THERAPY; STRAINS	The analysis of in vitro cell senescence/growth after serial passaging can be one of ways to show the absence of immortalized cells, which are frequently tumorigenic, in human cell-processed therapeutic products (hCTPs). However, the performance of the cell growth analysis for detection of the immortalized cellular impurities has never been evaluated. In the present study, we examined the growth rates of human mesenchymal stem cells (hMSCs, passage 5 (P = 5)) contaminated with various doses of HeLa cells, and compared with that of hMSCs alone. The growth rates of the contaminated hMSCs were comparable to that of hMSCs alone at P = 5, but significantly increased at P = 6 (0.1% and 0.01% HeLa) or P = 7 (0.001% HeLa) within 30 days. These findings suggest that the cell growth analysis is a simple and sensitive method to detect immortalized cellular impurities in hCTPs derived from human somatic cells. (C) 2014 The Authors. Published by Elsevier Ltd on behalf of The International Alliance for Biological Standardization.	[Kono, Ken; Sawada, Rumi; Niimi, Shingo] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan; [Takada, Nozomi; Yasuda, Satoshi; Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Takada, Nozomi; Matsuyama, Akifumi] Kobe Int Business Ctr, Natl Inst Biomed Innovat, Res Dis Bioresources, Platform Therapeut Rare Dis & Hlth Policy,Chuo Ku, Kobe, Hyogo 6500047, Japan; [Yasuda, Satoshi; Sato, Yoji] Fdn Biomed Res & Innovat, Kobe, Hyogo, Japan; [Sato, Yoji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Qual Assurance Sci Pharmaceut, Nagoya, Aichi, Japan; [Sato, Yoji] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Cellular & Gene Therapy Prod, Osaka, Japan; [Sato, Yoji] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Fukuoka 812, Japan	Sato, Y (reprint author), Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Setagaya Ku, 1-18-1 Kami Yoga, Tokyo 1588501, Japan.	kenkono@nihs.go.jp; takada.n@nihs.go.jp; yasuda@nihs.go.jp; rsawada@nihs.go.jp; niimi@nihs.go.jp; akifumi-matsuyama@umin.ac.jp; yoji@nihs.go.jp			Japanese Ministry of Health, Labour and Welfare [H23-SAISEI-IPPAN-005, H24-IYAKU-SHITEI-027, H25-JITSUYOKA(SAISEI)-IPPAN-008]; Marketing Authorization Facilitation Program for Innovative Therapeutic Products	This work was supported by Research Grants from the Japanese Ministry of Health, Labour and Welfare (H23-SAISEI-IPPAN-005, H24-IYAKU-SHITEI-027, H25-JITSUYOKA(SAISEI)-IPPAN-008, and Marketing Authorization Facilitation Program for Innovative Therapeutic Products).	Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; [Anonymous], 2009, EMEA7244282009; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; de la Fuente R, 2010, CANCER RES, V70, P6682, DOI 10.1158/0008-5472.CAN-10-2451; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Blagosklonny MV, 2006, LEUKEMIA, V20, P385, DOI 10.1038/sj.leu.2404075; Dirks WG, 2010, INT J CANCER, V126, P303, DOI 10.1002/ijc.24999; Hayflick L, 1985, Clin Geriatr Med, V1, P15; Kuroda T, 2013, BIOL PHARM BULL, V36, P189; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; Prockop DJ, 2010, MOL THER, V18, P1249, DOI 10.1038/mt.2010.99; Rubio D, 2005, CANCER RES, V65, P3035; Tang DQ, 2012, AM J STEM CELLS, V1, P114	20	3	3	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1045-1056	1095-8320		BIOLOGICALS	Biologicals	MAR	2015	43	2					146	149		10.1016/j.biologicals.2014.11.007		4	Biochemical Research Methods; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	CE2OM	WOS:000351654900010		
J	Gamoh, K; Nakamura, S				Gamoh, Koichiro; Nakamura, Shigeyuki			Introduction of an update system for vaccine strains of veterinary influenza vaccines in Japan	BIOLOGICALS			English	Article						Avian influenza; Equine influenza; Veterinary vaccine	NONPATHOGENIC H5N1 VIRUS; EQUINE INFLUENZA; CHALLENGE; CHICKENS; IMMUNITY; POTENCY	The basic countermeasures used to control highly pathogenic avian influenza (HPAI) are early detection procedures and the culling of affected chickens. However, if successive HPAI outbreaks occur, the vaccination may be an option for controlling HPAI. Therefore, avian influenza (AI) vaccines are stocked by the Japanese government. By contrast, equine influenza (EI) vaccine is an effective tool for preventing or controlling EI. Because antigenic drifts affect the efficacy of AI and EI vaccines, the vaccine strains should be updated rapidly. However, the development and registration of veterinary vaccines usually takes several years. In response to this issue, the Ministry of Agriculture, Forestry, and Fisheries (MAFF) established a system that allows AI and EI vaccine strains to be updated rapidly. National Veterinary Assay Laboratory, MAFF, established a vaccine strains selection committee for veterinary influenza vaccine. The main agendas involve determining whether the current vaccine strains need to be updated and selecting the most appropriate vaccine strains. The committee concluded that A/duck/Hokkaido/Vac-3/2007(H5N1) was added to the strains of stockpiled AI vaccines and that the EI vaccine strains did not need to be changed, but that the clade 2 viruses of the Florida sub-lineage strain, A/equine/Yokohama/aq13/2010(H3N8) was added to the EI vaccine strain.	[Gamoh, Koichiro; Nakamura, Shigeyuki] Minist Agr Forestry & Fisheries, Natl Vet Assay Lab, Kokubunji, Tokyo 1858511, Japan	Gamoh, K (reprint author), Minist Agr Forestry & Fisheries, Natl Vet Assay Lab, 1-15-1 Tokura, Kokubunji, Tokyo 1858511, Japan.	kgamoh@nval.maff.go.jp					Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Shichinohe S, 2013, VET MICROBIOL, V164, P39, DOI 10.1016/j.vetmic.2013.01.041; Yamanaka T, 2008, J VET MED SCI, V70, P623, DOI 10.1292/jvms.70.623; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Ito M, 2008, J VET MED SCI, V70, P899, DOI 10.1292/jvms.70.899; Isoda N, 2008, ARCH VIROL, V153, P1685, DOI 10.1007/s00705-008-0171-1; Samad RAA, 2011, JPN J VET RES, V59, P23; Sasaki S, 2009, JPN J VET RES, V56, P189; Sasaki T, 2009, VACCINE, V27, P5174, DOI 10.1016/j.vaccine.2009.06.070; Soda K, 2008, JPN J VET RES, V55, P93; Yamanaka T, 2011, J VET MED SCI, V73, P483, DOI 10.1292/jvms.10-0408; Yamanaka T, 2014, EQUINE VET J	12	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1045-1056	1095-8320		BIOLOGICALS	Biologicals	MAR	2015	43	2					150	152		10.1016/j.biologicals.2014.12.003		3	Biochemical Research Methods; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy	CE2OM	WOS:000351654900011		
J	Nagahama, K; Kawano, D; Oyama, N; Takemoto, A; Kumano, T; Kawakami, J				Nagahama, Koji; Kawano, Daichi; Oyama, Naho; Takemoto, Ayaka; Kumano, Takayuki; Kawakami, Junji			Self-Assembling Polymer Micelle/Clay Nanodisk/Doxorubicin Hybrid Injectable Gels for Safe and Efficient Focal Treatment of Cancer	BIOMACROMOLECULES			English	Article							ANTICANCER DRUG-DELIVERY; BREAST-CANCER; LAPONITE NANODISKS; CONTROLLED-RELEASE; INSULIN DELIVERY; DOXORUBICIN; HYDROGELS; NANOPARTICLES; THERAPY; CELLS	The purpose of this study was to fabricate a safe and effective doxorubicin (DOX)-delivery system for focal cancer chemotherapy. A novel biodegradable injectable gel was developed through self-assembly of poly(D,L-lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(D,L-lactide-co-glycolide) (PLGA-PEG-PLGA) copolymer micelles, clay nanodisks (CNDs), and DOX. We discovered that DOX loaded in the hybrid gels acts as an anticancer drug and as a building block to organize new gel networks. Accordingly, long-term sustained release of DOX from hybrid injectable gels without initial burst release was achieved. Moreover, it was revealed that the DOX incorporated into gel networks controls its own release profile. This hybrid injectable gel is a self-controlled drug release system, which is a novel concept in controlled drug release. Importantly, a single injection of PLGA-PEG-PLGA/CND/DOX hybrid gel provides long-term sustained antitumor activity in vivo against human xenograft tumors in mice, suggesting the potential of hybrid gels as a valuable local DOX-delivery platform for cancer focal therapy.	[Nagahama, Koji; Kawano, Daichi; Oyama, Naho; Takemoto, Ayaka; Kumano, Takayuki; Kawakami, Junji] Konan Univ, Dept Nanobiochem, Frontiers Innovat Res Sci & Technol, Kobe, Hyogo 6500047, Japan	Nagahama, K (reprint author), Konan Univ, Dept Nanobiochem, Frontiers Innovat Res Sci & Technol, 7-1-20 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	nagahama@center.konan-u.ac.jp			JSPS KAKENHI [24700487]	Laponite was kindly supplied by Wilbur-Ellis Co. This work was partly supported by JSPS KAKENHI Grant Number 24700487.	Zhang X, 2013, ADV FUNCT MATER, V23, P4067, DOI 10.1002/adfm.201300136; Lammers T, 2009, BIOMATERIALS, V30, P3466, DOI 10.1016/j.biomaterials.2009.02.040; Carvalho C, 2009, CURR MED CHEM, V16, P3267; Wang SG, 2013, LANGMUIR, V29, P5030, DOI 10.1021/la4001363; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Swain SM, 1997, J CLIN ONCOL, V15, P1333; Loh XJ, 2012, J MATER CHEM, V22, P21249, DOI 10.1039/c2jm33777k; Tong R, 2009, J AM CHEM SOC, V131, P4744, DOI 10.1021/ja8084675; Wu CJ, 2013, MACROMOL BIOSCI, V13, P59, DOI 10.1002/mabi.201200362; Oyama N, 2014, BIOMATER SCI-UK, V2, P1057, DOI 10.1039/c4bm00074a; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Zhou L, 2011, BIOMACROMOLECULES, V12, P1460, DOI 10.1021/bm101340u; Gu Z, 2013, ACS NANO, V7, P4194, DOI 10.1021/nn400630x; Seib FP, 2013, ADV FUNCT MATER, V23, P58, DOI 10.1002/adfm.201201238; Zhao YN, 2009, J AM CHEM SOC, V131, P8398, DOI 10.1021/ja901831u; Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]; Wu WT, 2013, MACROMOL BIOSCI, V13, P1464, DOI 10.1002/mabi.201300120; Yin Q, 2013, ADV DRUG DELIVER REV, V65, P1699, DOI 10.1016/j.addr.2013.04.011; Huynh CT, 2011, SOFT MATTER, V7, P4974, DOI 10.1039/c1sm05080j; Gou PF, 2013, J MATER CHEM B, V1, P284, DOI 10.1039/c2tb00004k; Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007; Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3; Xie JB, 2013, BIOMATER SCI-UK, V1, P1216, DOI 10.1039/c3bm60174a; Prabaharan M, 2009, BIOMATERIALS, V30, P5757, DOI 10.1016/j.biomaterials.2009.07.020; Chen YY, 2013, LANGMUIR, V29, P3721, DOI 10.1021/la400268p; Lee JH, 2012, BIOMACROMOLECULES, V13, P3388, DOI 10.1021/bm301143d; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Liu ZJ, 2014, POLYM CHEM-UK, V5, P1072, DOI 10.1039/c3py01083j; Tai WY, 2014, BIOMACROMOLECULES, V15, P3495, DOI 10.1021/bm500364a; Wu YL, 2014, J MATER CHEM B, V2, P7410, DOI 10.1039/c4tb01162g; Yu L, 2013, BIOMATER SCI-UK, V1, P411, DOI 10.1039/c2bm00159d; Zeng XH, 2014, BIOMATERIALS, V35, P1227, DOI 10.1016/j.biomaterials.2013.10.042	32	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	MAR	2015	16	3					880	889		10.1021/bm5017805		10	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CD1NH	WOS:000350841100022		
J	Nabekura, T; Hiroi, T; Kawasaki, T; Uwai, Y				Nabekura, Tomohiro; Hiroi, Takashi; Kawasaki, Tatsuya; Uwai, Yuichi			Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein	BIOMEDICINE & PHARMACOTHERAPY			English	Article						P-glycoprotein; Drug transporter; Anticancer drug; NF-kappa B; Phytochemical	MULTIDRUG-RESISTANCE PROTEIN-1; REGULATED GENE-PRODUCTS; ALPHA KINASE; DIETARY PHYTOCHEMICALS; ACTIVATION PATHWAY; DOWN-REGULATION; KB-C2 CELLS; EXPRESSION; CANCER; APOPTOSIS	Drug efflux transporter P-glycoprotein plays an important role in cancer chemotherapy. The nuclear factor-kappa B (NF-kappa B) transcription factors play critical roles in development and progression of cancer. In this study, the effects of natural compounds that can inhibit NF-kappa B activation on the function of P-glycoprotein were investigated using human MDR1 gene-transfected KB/MDR1 cells. The accumulation of daunorubicin or rhodamine 123, fluorescent substrates of P-glycoprotein, in KB/MDR1 cells increased in the presence of caffeic acid phenetyl ester (CAPE), licochalcone A, anacardic acid, celastrol, xanthohumol, magnolol, and honokiol in a concentration-dependent manner. In contrast, lupeol, zerumbone, thymoquinone, emodin, and anethol had no effects. The ATPase activities of P-glycoprotein were stimulated by CAPE, licochalcone A, anacardic acid, celastrol, xanthohumol, magnolol, and honokiol. Tumor necrosis factor (TNF)-alpha stimulated NF-kappa B activation was inhibited by CAPE, licochalcone A, anacardic acid, and xanthohumol. KB/MDR1 cells were sensitized to vinblastine cytotoxicity by CAPE, licochalcone A, anacardic acid, xanthohumol, magnolol, and honokiol, showing that these natural NF-kappa B inhibitors reverse multidrug resistance. These results suggest that natural compounds, such as CAPE, licochalcone A, and anacardic acid, have dual inhibitory effects on the anticancer drug efflux transporter P-glycoprotein and NF-kappa B activation, and may become useful to enhance the efficacy of cancer chemotherapy. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Nabekura, Tomohiro; Kawasaki, Tatsuya; Uwai, Yuichi] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Nabekura, Tomohiro; Hiroi, Takashi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Niigata, Japan	Nabekura, T (reprint author), Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan.	nabekura@dpc.agu.ac.jp			Japan Society for the Promotion of Science [22590151]	We thank Prof. Kazumitsu Ueda of Kyoto University for providing KB/MDR1 cells. This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant Number 22590151) (T.N.).	Aggarwal BB, 2008, PLANTA MED, V74, P1560, DOI 10.1055/s-2008-1074578; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Jiang JH, 2008, INT J MOL MED, V21, P577; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Um JH, 2001, ONCOGENE, V20, P6048, DOI 10.1038/sj.onc.1204732; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Ahn KS, 2006, MOL CANCER RES, V4, P621, DOI 10.1158/1541-7786.MCR-06-0076; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Harikumar KB, 2009, BLOOD, V113, P2003, DOI 10.1182/blood-2008-04-151944; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Medeiros R, 2007, EUR J PHARMACOL, V559, P227, DOI 10.1016/j.ejphar.2006.12.005; Takada Y, 2005, ONCOGENE, V24, P6957, DOI 10.1038/sj.onc.1208845; Kumar A, 1998, ONCOGENE, V17, P913, DOI 10.1038/sj.onc.1201998; Lin ML, 2010, MOL CARCINOGEN, V49, P783, DOI 10.1002/mc.20652; Funakoshi-Tago M, 2009, MOL PHARMACOL, V76, P745, DOI 10.1124/mol.109.057448; Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.C700890200; Nabekura T, 2008, EUR J PHARMACOL, V600, P45, DOI 10.1016/j.ejphar.2008.10.025; Nabekura T, 2005, BIOCHEM BIOPH RES CO, V327, P866, DOI 10.1016/j.bbrc.2004.12.081; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Chainy GBN, 2000, ONCOGENE, V19, P2943, DOI 10.1038/sj.onc.1203614; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Kitagawa S, 2005, BIOL PHARM BULL, V28, P2274, DOI 10.1248/bpb.28.2274; Kitagawa S, 2004, J PHARM PHARMACOL, V56, P1001, DOI 10.1211/0022357044003; Nabekura T, 2008, CANCER CHEMOTH PHARM, V62, P867, DOI 10.1007/s00280-007-0676-4; Lee G, 2003, J PHARM SCI-US, V92, P2152, DOI 10.1002/jps.10493; Saleem M, 2004, ONCOGENE, V23, P5203, DOI 10.1038/sj.onc.1207641; Nabekura T, 2008, BIOCHEM BIOPH RES CO, V369, P363, DOI 10.1016/j.bbrc.2008.02.026; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj/onc/1205117; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Huang LF, 2011, EUR J PHARMACOL, V672, P169, DOI 10.1016/j.ejphar.2011.09.175; Belliard AM, 2004, J PHARM SCI, V93, P1523; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Ueda K, 2011, BIOSCI BIOTECH BIOCH, V75, P401, DOI 10.1271/bbb.100816; UEDA K, 1993, FEBS LETT, V330, P279, DOI 10.1016/0014-5793(93)80888-2	41	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	MAR	2015	70						140	145		10.1016/j.biopha.2015.01.007		6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CD3YI	WOS:000351019300023		
J	Kamata, M; Hosono, K; Fujita, T; Kamata, K; Majima, M				Kamata, Mariko; Hosono, Kanako; Fujita, Tomoe; Kamata, Kouju; Majima, Masataka			Role of cyclooxygenase-2 in the development of interstitial fibrosis in kidneys following unilateral ureteral obstruction in mice	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Kidney; Fibrosis; COX-2; Unilateral ureteral obstruction; TGF; FGF	TUBULOINTERSTITIAL FIBROSIS; INFLAMMATORY RESPONSE; RENAL FIBROSIS; GROWTH-FACTOR; NEPHROPATHY; FIBROBLASTS; PROSTAGLANDIN; MECHANISMS; INHIBITORS; DISEASE	Unilateral ureteral obstruction (UUO) induced tubulointerstitial fibrosis in kidneys mimics the pathogenesis of chronic kidney diseases and is considered a suitable model for studying the mechanisms leading to fibrosis. To study the role of cyclooxygenase-2 (COX-2) in kidney fibrosis, we investigated whether a selective COX-2 inhibitor, celecoxib, affected renal interstitial fibrosis during UUO in mice. To induce UUO, the left proximal ureter was ligated in male C57BL/6 mice. The mice were fed a diet with or without celecoxib from the day of UUO induction. Following UUO, the renal pelvis was observed to be dilated and the kidney cortex was significantly thinner than that of sham-operated mice. Immunofluorescent staining of type I, III, and IV collagen in UUO kidneys revealed that interstitial collagen deposition was significantly increased in the celecoxib-treated group. Expression of type I, III, and IV collagen in UUO kidneys was also significantly higher in the celecoxib-treated group than in the vehicle-treated group. In the celecoxib-treated group, mRNA levels of TGF-beta/FGF-2 were also significantly higher than those in the vehicle-treated group. The present study demonstrates that COX-2 plays a protective role against fibrosis in UUO kidneys and suggests that supplementation of COX-2 products, such as PG analogues, will be a good option for preventing interstitial fibrosis. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Kamata, Mariko; Hosono, Kanako; Fujita, Tomoe; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa 2520374, Japan; [Kamata, Mariko; Kamata, Kouju] Kitasato Univ, Sch Med, Nephrol, Sagamihara, Kanagawa 2520374, Japan; [Kamata, Mariko; Fujita, Tomoe; Majima, Masataka] Kitasato Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Sagamihara, Kanagawa 2520374, Japan	Majima, M (reprint author), Kitasato Univ, Grad Sch Med Sci, Dept Mol Pharmacol, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23116102, 24659119, 26462132, 26293055]; Kitasato University; Takeda Science Foundation; Kitasato University Graduate School of Medical Sciences; Parent's Association Grant of Kitasato University, School of Medicine	We thank Michiko Ogino, Kyoko Yoshikawa, and Mieko Hamano for their technical assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, 23116102, 24659119, 26462132, and 26293055; Kitasato University Research Grant for Young Researchers; a grant from the Takeda Science Foundation; and a grant from Kitasato University Graduate School of Medical Sciences (Integrative Research Program 2013-2014). This study was also supported by from the Parent's Association Grant of Kitasato University, School of Medicine.	Nakagawa N, 2012, KIDNEY INT, V82, P158, DOI 10.1038/ki.2012.115; Eddy AA, 2012, PEDIATR NEPHROL, V27, P1233, DOI 10.1007/s00467-011-1938-2; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Katori M, 2000, INFLAMM RES, V49, P367, DOI 10.1007/s000110050605; Majima M, 2000, BRIT J PHARMACOL, V130, P641, DOI 10.1038/sj.bjp.0703327; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/01.mnh.0000126791.93346.4a; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290; Nasu T, 2012, AM J PHYSIOL-RENAL, V302, pF1616, DOI 10.1152/ajprenal.00538.2011; El Chaar M, 2005, NEPHRON EXP NEPHROL, V100, pE150, DOI 10.1159/000085293; Foley RN, 1998, AM J KIDNEY DIS S, V32, pS112; Honma S, 2014, EUR J PHARMACOL, V740, P578, DOI 10.1016/j.ejphar.2014.06.027; Ito H, 2012, J AM SOC NEPHROL, V23, P1797, DOI 10.1681/ASN.2012020126; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Ogawa F, 2014, J CLIN INVEST; Ogino M, 1996, INFLAMM RES, V45, P335, DOI 10.1007/BF02252946; OKEGAWA T, 1983, J CLIN INVEST, V71, P81, DOI 10.1172/JCI110754; Okumura T, 2002, HYPERTENS RES, V25, P927; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; WHINNERY MA, 1982, AM J PHYSIOL, V242, pF220	26	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	MAR	2015	70						174	180		10.1016/j.biopha.2015.01.010		7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CD3YI	WOS:000351019300029		
J	Harada, S; Ehara, S; Ishii, K; Sato, T; Koka, M; Kamiya, T; Sera, K; Goto, S				Harada, Satoshi; Ehara, Shigeru; Ishii, Keizo; Sato, Takahiro; Koka, Masashi; Kamiya, Tomihiro; Sera, Koichiro; Goto, Shyoko			Targeted concurrent chemoradiotherapy, by using improved microcapsules that release carboplatin in response to radiation, improves detectability by computed tomography as well as antitumor activity while reducing adverse effect in vivo	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Drug delivery system; Microcapsule; Radiation; Cancer therapy	HYALURONIC-ACID; CANCER; DRUGS; CHEMOTHERAPY; DELIVERY; THERAPY; GROWTH; AGENTS	Purpose: The effect of alginate-hyaluronate microcapsules that release carboplatin in response to radiation was improved by adding ascorbic acid (AA). Materials and Methods: Four measures of the effectiveness of the microcapsules were evaluated: 1) release of carboplatin in response to radiation in vitro and in vivo; 2) detectability of their accumulation by computed tomography (CT) in vivo; 3) enhancement of antitumor effects in vivo; and 4) reduction of adverse effects in vivo. Results: There were significant increases in the rupture of microcapsules by adding AA in vitro. Subcutaneously injected microcapsules around the tumor could be detected by using CT and the alteration of CT-values correlated with the accumulation of the microcapsules. Those microcapsules released carboplatin and resulted in synergistic antitumor effect with concomitant radiation. With the encapsulation of carboplatin, chemotherapeutic effects were still observed two weeks after treatment. However, addition of AA did not result in increased antitumor effect in vivo. A reduction in adverse effects was observed with the encapsulation of carboplatin, through localization of carboplatin around the tumor. Conclusion: Addition of AA to the materials of microcapsules did not result in increasing antitumor effect. However encapsulation of carboplatin will be useful as a clinical cancer-therapy option. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Harada, Satoshi; Ehara, Shigeru] Iwate Med Univ, Dept Radiol, Sch Med, Morioka, Iwate 0208505, Japan; [Ishii, Keizo] Tohoku Univ, Dept Quantum Sci & Energy Engn, Sendai, Miyagi 9808579, Japan; [Sato, Takahiro; Koka, Masashi; Kamiya, Tomihiro] Japan Atom Energy Agcy, Takasaki Adv Radiat Res Inst, Takasaki, Gunma 3701292, Japan; [Sera, Koichiro] Iwate Med Univ, Cyclotron Ctr, Takizawa, Iwate 0200173, Japan; [Goto, Shyoko] Japan Radioisotope Assoc, NMCC, Takizawa, Iwate 0200173, Japan	Harada, S (reprint author), Iwate Med Univ, Dept Radiol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	sharada@iwate-med.ac.jp; eharas@iwate-med.ac.jp; keizo.ishii@qse.tohoku.ac.jp; satoh.takahiro37@jaea.go.jp; koka.masashi@jaea.go.jp; kamiya.tomihiro@jaea.go.jp; ksera@iwate-med.ac.jp; goto@jrias.or.jp			Japan society for the promotion of research [254614290]; Japan atomic energy agency [112030]	This work was supported, in part, by a grant-in-aid for scientific research from the Japan society for the promotion of research (No. 254614290). This work was also supported by a grant emphasizing corporative research from the Japan atomic energy agency (No. 112030).	Alektiar KM, 2009, GYNECOL ONCOL, V112, P142, DOI 10.1016/j.ygyno.2008.10.006; Finotelli PV, 2004, MAT SCI ENG C-BIO S, V24, P625, DOI 10.1016/j.msec.2004.08.005; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; de Souza CM, 2014, BIOMED PHARMACOTHER, V68, P51, DOI 10.1016/j.biopha.2013.08.004; Wilson GD, 2006, SEMIN RADIAT ONCOL, V16, P2, DOI 10.1016/j.semradonce.2005.08.001; Milas L, 2000, CLIN CANCER RES, V6, P701; Rezaee M, 2013, INT J RADIAT ONCOL, V87, P847, DOI 10.1016/j.ijrobp.2013.06.2037; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; MOULDER JE, 1984, INT J RADIAT ONCOL, V10, P695; Barbusinski K., 2009, CHEM DYDAKT EKOL MET, V14, P101; Belani CP, 1998, CHEST S, V113, P53; Bradley DW, 1973, CLIN CHIM ACTA, V144, P47; Brockstein B, 2004, SEMIN ONCOL, V31, P786, DOI 10.1053/j.seminoncol.2004.09.006; Chen YY, 2004, HEMATOL ONCOL CLIN N, V18, P55, DOI 10.1016/S0889-8588(03)00145-X; Cord MC, 1974, SCIENCE, V185, P529; Donnelly ET, 2004, CANCER CHEMOTH PHARM, V53, P43, DOI 10.1007/s00280-003-0715-8; Harada S, 2009, INT J RADIAT ONCOL, V75, P455, DOI 10.1016/j.ijrobp.2009.02.082; Harada S, 2012, INT J PIXE, V22, P29; Harada S, 2010, INT J PIXE, V20, P29; Hong J, 2013, PLOS ONE, V8, P1; Lin Q, 2013, J RADIAT RES, V54, P126, DOI 10.1093/jrr/rrs081; MATSUMUR.G, 1966, RADIAT RES, V28, P735, DOI 10.2307/3572179; Mirloss GC, 1997, EUR J CANCER, V33, P1299; Sera KS, 2000, INT J PIXE, V10, P101, DOI 10.1142/S0129083500000158; University of Canterbury, 2014, DET IR THIOC COL 201; WONG SF, 1981, J INORG BIOCHEM, V14, P127, DOI 10.1016/S0162-0134(00)80033-1	27	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	MAR	2015	70						196	205		10.1016/j.biopha.2015.01.006		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CD3YI	WOS:000351019300032		
J	Yamauchi, K; Mitsunaga, T; Inagaki, M; Suzuki, T				Yamauchi, Kosei; Mitsunaga, Tohru; Inagaki, Mizuho; Suzuki, Tohru			Quercetin derivatives regulate melanosome transportation via EPI64 inhibition and elongate the cell shape of B16 melanoma cells	BIOMEDICINE & PHARMACOTHERAPY			English	Article						B16 melanoma cells; EPI64; Melanosome transportation; Quercetin; Cell elongation	MYOSIN-VA; MELANOGENESIS; MELANOCYTES; TYROSINASE; PROTEIN; RAB27; SLAC2-A/MELANOPHILIN; IDENTIFICATION; BIOSYNTHESIS; TRAFFICKING	4'-O-beta-D-glucopyranosyl-quercetin-3-O-beta-D-glucopyranosyl-(1 -> 4)-beta-D-glucopyranoside (3C4'GQ), first isolated from Helminthostachys zeylanica root extract, was synthesized as a compound that stimulates intracellular melanogenesis. 3-O-methylquercetin (3MQ) and 3,4',7-O-trimethylquercetin (34'7TMQ) were synthesized as compounds that enhance extracellular melanin formation. The formation of dendrites and the expression of EBP5'-PDZ interactor of 64 kDa (EPI64) relating to melanin transportation were investigated using B16 melanoma cells treated with 3C4'GQ, 3MQ, or 34'7TMQ in order to understand the mechanism underlying the observed activities. The influence of 3C4'GQ on the increase of intracellular melanin contents enhanced the expression of EPI64, exhibited no dendrite elongation activity, and inhibited melanin transportation. On the other hand, the increase of extracellular melanin content by 3MQ and 34'7TMQ inhibited the expression of EPI64 and formed elongated cells to stimulate melanin transportation. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Yamauchi, Kosei; Mitsunaga, Tohru; Inagaki, Mizuho; Suzuki, Tohru] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan	Mitsunaga, T (reprint author), Gifu Univ, United Grad Sch Agr Sci, 1-1 Yanagido, Gifu 5011193, Japan.	mitunaga@gifu-u.ac.jp					Alvaro FS, 1995, BIOCHIM BIOPHYS ACTA, V1247, P1; Kim Sang Suk, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P617, DOI 10.1016/S2221-1691(13)60125-2; Chen QX, 2002, J AGR FOOD CHEM, V50, P4108, DOI 10.1021/jf011378z; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb670; Yang YM, 2011, PHYTOTHER RES, V25, P1166, DOI 10.1002/ptr.3417; Arung ET, 2011, FITOTERAPIA, V82, P198, DOI 10.1016/j.fitote.2010.09.008; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Lan WC, 2013, PHYTOCHEMISTRY, V89, P78, DOI 10.1016/j.phytochem.2013.01.011; Manach C, 2004, AM J CLIN NUTR, V79, P727; Chiang HM, 2014, FOOD CHEM TOXICOL, V65, P129, DOI 10.1016/j.fct.2013.12.032; Tsuji-Naito K, 2007, BIOORGAN MED CHEM, V15, P1967, DOI 10.1016/j.bmc.2006.12.042; Guo HY, 2012, BIOCHEM BIOPH RES CO, V420, P799, DOI 10.1016/j.bbrc.2012.03.077; Wang HS, 2006, LWT-FOOD SCI TECHNOL, V39, P496, DOI 10.1016/j.lwt.2005.04.001; Batubara I., 2010, Journal of Biological Sciences, V10, P138; Chan YY, 2011, J ETHNOPHARMACOL, V137, P1183, DOI 10.1016/j.jep.2011.07.050; Cooksey JC, 1998, BIOCHEM J, V333, P685; Diwakar G, 2012, FITOTERAPIA, V83, P989, DOI 10.1016/j.fitote.2012.06.004; Fuji T, 2009, BIOSCI BIOTECH BIOCH, V9, P1989; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2006, BIOCHEM SOC T, V34, P691; Gibellini L, 2009, CANCERS, V2, P1288; Hertog GLM, 1992, J AGR FOOD CHEM, V40, P2379; Hollman C. H., 1999, FOOD CHEM TOXICOL, V37, P937; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Jang YJ, 2011, J ETHNOPHARMACOL, V137, P1207; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; LUKIEWICZ S, 1972, Folia Histochemica et Cytochemica, V10, P93; Nagata H, 2004, PIGM CELL RES, V17, P66, DOI 10.1046/j.1600-0749.2003.00113.x; Oh EY, 2010, J ETHNOPHARMACOL, V132, P219, DOI 10.1016/j.jep.2010.08.010; Ohbayashi N, 2012, MOL BIOL CELL, V23, P669, DOI 10.1091/mbc.E11-04-0324; Yamauchi K, 2013, J NAT MED-TOKYO, V67, P369, DOI 10.1007/s11418-012-0672-9; Yamauchi K, 2014, BIOORGAN MED CHEM, V22, P937, DOI 10.1016/j.bmc.2013.12.062; Yamauchi K, 2014, BIOORGAN MED CHEM, V22, P3331, DOI 10.1016/j.bmc.2014.04.053; Yamauchi K, 2011, NAT RESOUR, V2, P167; Ye Y, 2010, PHYTOMEDICINE, V18, P32, DOI 10.1016/j.phymed.2010.06.004	38	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	MAR	2015	70						206	212		10.1016/j.biopha.2015.01.031		7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CD3YI	WOS:000351019300033		
J	Okizaki, S; Ito, Y; Hosono, K; Oba, K; Ohkubo, H; Amano, H; Shichiri, M; Majima, M				Okizaki, Shin-ichiro; Ito, Yoshiya; Hosono, Kanako; Oba, Kazuhito; Ohkubo, Hirotoki; Amano, Hideki; Shichiri, Masayoshi; Majima, Masataka			Suppressed recruitment of alternatively activated macrophages reduces TGF-beta 1 and impairs wound healing in streptozotocin-induced diabetic mice	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Wound healing; Diabetes; Macrophages; Phenotype	GROWTH-FACTORS; TISSUE-REPAIR; ANGIOGENESIS; PHENOTYPE; EXPRESSION; CYTOKINES; DISEASE; ROLES; MOUSE; CELLS	Background: Diabetes mellitus inhibits wound-induced angiogenesis, impairing the wound healing process and leading to the development of chronic wounds. Impaired healing of diabetic wounds is caused by persistent pro-inflammatory macrophages recruited to the granulation tissue; however, little is known about the phenotype of the macrophages involved in diabetic wound healing. The present study was conducted to examine the involvement of macrophages in impaired wound healing using streptozotocin (STZ)-induced diabetic mice. Methods: Full-thickness skin wounds were created on the backs of mice treated with STZ or vehicle. Results: Compared with controls, wound healing and angiogenesis were suppressed in STZ-treated mice, with attenuated expression of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF)-2 in wound granulation tissue. STZ-treated mice exhibited enhanced recruitment of classically activated macrophages (M1) expressing inducible nitric oxide synthase (iNOS) and suppressed recruitment of alternatively activated macrophages (M2) expressing transforming growth factor-beta-1 (TGF-beta 1). Treatment of diabetic mice with TGF-beta 1 restored wound healing and angiogenesis and normalized M1/M2 macrophage polarization in the granulation tissue. Conclusions: These results suggest that an imbalance of macrophage phenotypes contributes to impaired wound healing in STZ-induced diabetic mice, and treatment with cytokines derived from M2 macrophages may be an effective therapeutic strategy to increase angiogenesis and promote healing of diabetic wounds. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Okizaki, Shin-ichiro; Hosono, Kanako; Oba, Kazuhito; Amano, Hideki; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa 2520374, Japan; [Okizaki, Shin-ichiro; Oba, Kazuhito; Shichiri, Masayoshi] Kitasato Univ, Sch Med, Dept Endocrinol, Sagamihara, Kanagawa 2520374, Japan; [Ito, Yoshiya; Ohkubo, Hirotoki] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 2520374, Japan	Majima, M (reprint author), Kitasato Univ, Sch Med, Dept Pharmacol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp			Parent's Association of Kitasato University School of Medicine	We thank Michiko Ogino, Kyoko Yoshikawa, and Mieko Hanamo for their technical assistance. This work was supported by a grant from the Parent's Association of Kitasato University School of Medicine.	Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Kurashige C, 2014, FASEB J, V28, P1237, DOI 10.1096/fj.13-238998; Hayashi K, 2006, BIOL PHARM BULL, V29, P1110, DOI 10.1248/bpb.29.1110; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; LYNCH SE, 1989, J CLIN INVEST, V84, P640, DOI 10.1172/JCI114210; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Toda M, 2008, BIOMED PHARMACOTHER, V62, P352, DOI 10.1016/j.biopha.2008.02.003; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Fang Robert C, 2008, Biologics, V2, P1; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Miao MY, 2012, WOUND REPAIR REGEN, V20, P203, DOI 10.1111/j.1524-475X.2012.00772.x; Ochoa O, 2007, VASCULAR, V15, P350, DOI 10.2310/6670.2007.00056; Ohkubo H, 2013, FASEB J, V27, P3132, DOI 10.1096/fj.13-227421; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI DOI 10.1089/W0UND.2012.0406; Wicks K, 2014, SEMIN IMMUNOL, V26, P341, DOI 10.1016/j.smim.2014.04.006; Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574	32	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	MAR	2015	70						317	325		10.1016/j.biopha.2014.10.020		9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CD3YI	WOS:000351019300048		
